#MIM_Number	Location	Phenotype	Phenotype_MIM_number	Inheritance	Phenotype_mapping_key
#MIM_Number	Location	Phenotype	Phenotype_MIM_number	Inheritance	Phenotype_mapping_key
100650	12q24.12	Alcohol sensitivity, acute	610251	AD	3
100650	12q24.12	{Esophageal cancer, alcohol-related, susceptibility to}	_	_	3
100650	12q24.12	{Hangover, susceptibility to}	610251	AD	3
100650	12q24.12	{Sublingual nitroglycerin, susceptibility to poor response to}	_	_	3
100070	19q13	Aortic aneurysm, familial abdominal 1	100070	AD	2
100100	1q43	?Prune belly syndrome	100100	AR	3
100300	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
100678	6q25.3	?ACAT2 deficiency	614055	IC	1
100690	2q31.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100690	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
100690	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AD,AR	3
100710	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
100710	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
100720	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100720	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AD,AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
100730	2q37.1	Escobar syndrome	265000	AR	3
100730	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100740	7q22.1	[Blood group, Yt system]	112100	_	3
100790	12q23.2	Central hypoventilation syndrome, congenital	209880	AD	3
100790	12q23.2	Haddad syndrome	209880	AD	3
100800	4p16.3	Achondroplasia	100800	AD	3
100850	22q13.2	?Optic atrophy 9	616289	AR	3
100850	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
101000	22q12.2	Neurofibromatosis, type 2	101000	AD	3
101200	10q26.13	Apert syndrome	101200	AD	3
101800	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
101850	2p25-p12	?Keratoderma, palmoplantar, punctate type 3	101850	AD	2
101900	12q24.11	Acrokeratosis verruciformis	101900	AD	3
102300	12q12-q21	{Restless legs syndrome 1}	102300	AD	2
102370	15q21.1	Acromicric dysplasia	102370	AD	3
102480	22q13.33	?Male infertility due to acrosin deficiency	102480	_	2
102500	1p12	Hajdu-Cheney syndrome	102500	AD	3
102510	2q36	Acropectorovertebral dysplasia	102510	AD	2
102530	3q26.31	?Spermatogenic failure 6	102530	AR	3
102540	15q14	Atrial septal defect 5	612794	AD	3
102540	15q14	Cardiomyopathy, dilated, 1R	613424	AD	3
102540	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
102540	15q14	Left ventricular noncompaction 4	613424	AD	3
102545	2p13.1	Visceral myopathy	155310	AD	3
102560	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
102560	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
102565	7q32.1	Cardiomyopathy, familial hypertrophic, 26	_	_	3
102565	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
102565	7q32.1	Myopathy, distal, 4	614065	AD	3
102565	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
102573	1q43	Cardiomyopathy, dilated, 1AA, with or without LVNC	612158	AD	3
102573	1q43	Cardiomyopathy, hypertrophic, 23, with or without LVNC	612158	AD	3
102574	11q13.2	[Alpha-actinin-3 deficiency]	617749	_	3
102574	11q13.2	[Sprinting performance]	617749	_	3
102575	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
102576	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
102578	15q24.1	Leukemia, acute promyelocytic, PML/RARA type	_	_	3
102579	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
102582	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
102582	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
102600	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
102610	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
102610	1q42.13	Myopathy, actin, congenital, with cores	161800	AD,AR	3
102610	1q42.13	Myopathy, actin, congenital, with excess of thin myofilaments	161800	AD,AR	3
102610	1q42.13	Myopathy, congenital, with fiber-type disproportion 1	255310	AD,AR	3
102610	1q42.13	Nemaline myopathy 3, autosomal dominant or recessive	161800	AD,AR	3
102620	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
102620	10q23.31	Moyamoya disease 5	614042	_	3
102620	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
102630	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
102630	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
102680	4p16.3	{Hypertension, essential, salt-sensitive}	145500	Mu	3
102750	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
102770	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
102771	1p13.3	?Spastic paraplegia 63	615686	AR	3
102771	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
102772	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
102900	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
103000	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
103020	1p35.1	Reticular dysgenesis	267500	AR	3
103050	22q13.1	Adenylosuccinase deficiency	103050	AR	3
103072	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
103180	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
103220	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
103270	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
103280	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
103280	11p15.5	Silver-Russell syndrome	180860	AD	3
103280	11p15.5	Wilms tumor 2	194071	AD,SMu	3
103285	3q28	ADULT syndrome	103285	AD	3
103320	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
103500	3p13	Tietz albinism-deafness syndrome	103500	AD	3
103580	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
103600	4q13.3	Analbuminemia	616000	_	3
103600	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
103720	4q23	{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}	103780	Mu	3
103720	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
103850	16p11.2	Glycogen storage disease XII	611881	AR	3
103900	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
103950	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
103950	12p13.31	{Alzheimer disease, susceptibility to}	104300	AD	3
104000	18p11.3-p11.2	Alopecia areata 1	104000	Mu	2
104100	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
104150	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
104150	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
104155	16q22.2-q22.3	Prostate cancer, somatic	176807	_	3
104160	11q12.3	Polycystic kidney disease 3	600666	AD	3
104170	22q13.2	Kanzaki disease	609242	AR	3
104170	22q13.2	Schindler disease, type I	609241	AR	3
104170	22q13.2	Schindler disease, type III	609241	AR	3
104200	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
104225	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
104250	4p16.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
104260	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
104290	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
104310	19q13.32	Alzheimer disease-2	104310	AD	3
104311	14q24.2	?Acne inversa, familial, 3	613737	AD	3
104311	14q24.2	Alzheimer disease, type 3	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	AD	3
104311	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
104311	14q24.2	Dementia, frontotemporal	600274	AD	3
104311	14q24.2	Pick disease	172700	AD	3
104500	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
104510	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
104530	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
104614	2p21	Cystinuria	220100	AD,AR	3
104620	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
104760	21q21.3	Alzheimer disease 1, familial	104300	AD	3
104760	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
104770	1q23.2	{?Amyloidosis, secondary, susceptibility to}	_	_	1
105120	9q33.2	Amyloidosis, Finnish type	105120	AD	3
105150	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
105210	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
105250	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
105500	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
105550	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
105580	11q22-qter	?Anal canal carcinoma	105580	AD	2
105590	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
105600	15q21	Dyserythropoietic anemia, congenital, type III	105600	AD	2
105650	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
105800	7q11.2	Aneurysm, intracranial berry, 1	105800	AD	2
105830	15q11.2	Angelman syndrome	105830	AD	3
105850	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
106100	11q12.1	Angioedema, hereditary, types I and II	106100	AD,AR	3
106150	1q42.2	Renal tubular dysgenesis	267430	AR	3
106150	1q42.2	{Hypertension, essential, susceptibility to}	145500	Mu	3
106150	1q42.2	{Preeclampsia, susceptibility to}	_	_	3
106165	3q24	Renal tubular dysgenesis	267430	AR	3
106165	3q24	{Hypertension, essential}	145500	Mu	3
106180	17q23.3	Renal tubular dysgenesis	267430	AR	3
106180	17q23.3	[Angiotensin I-converting enzyme, benign serum increase]	_	_	3
106180	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
106180	17q23.3	{Myocardial infarction, susceptibility to}	_	_	3
106180	17q23.3	{SARS, progression of}	_	_	3
106180	17q23.3	{Stroke, hemorrhagic}	614519	_	3
106190	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
106260	3q28	Hay-Wells syndrome	106260	AD	3
106300	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
106410	4q25-q26	Cardiac arrhythmia, ankyrin-B-related	600919	AD	3
106410	4q25-q26	Long QT syndrome 4	600919	AD	3
106600	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
106700	4q12	Total anomalous pulmonary venous return	106700	AD	2
107200	18p11.23-q12.2	Anosmia, isolated congenital	107200	AD	2
107250	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
107265	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
107269	11p13	[Blood group, Indian system]	609027	_	3
107271	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
107280	14q32.13	Alpha-1-antichymotrypsin deficiency	_	_	3
107280	14q32.13	Cerebrovascular disease, occlusive	_	_	3
107300	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AD,AR	3
107310	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
107320	6p21.3	?Antiphospholipid syndrome, familial	107320	AD	2
107323	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
107400	14q32.13	Emphysema due to AAT deficiency	613490	AR	3
107400	14q32.13	Emphysema-cirrhosis, due to AAT deficiency	613490	AR	3
107400	14q32.13	Hemorrhagic diathesis due to antithrombin Pittsburgh	613490	AR	3
107400	14q32.13	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	1
107470	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
107470	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
107470	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
107470	6q23.3	{Hepatitis B virus infection, susceptibility to}	610424	_	3
107470	6q23.3	{Tuberculosis infection, protection against}	607948	_	3
107470	6q23.3	{Tuberculosis, susceptibility to}	607948	_	3
107580	6p24.3	Branchiooculofacial syndrome	113620	AD	3
107600	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
107670	1q23.3	Apolipoprotein A-II deficiency	_	_	3
107670	1q23.3	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
107680	11q23.3	Amyloidosis, 3 or more types	105200	AD	3
107680	11q23.3	ApoA-I and apoC-III deficiency, combined	_	_	3
107680	11q23.3	Corneal clouding, autosomal recessive	_	_	3
107680	11q23.3	Hypoalphalipoproteinemia	604091	_	3
107720	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
107730	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
107730	2p24.1	Hypobetalipoproteinemia	615558	AR	3
107741	19q13.32	Alzheimer disease-2	104310	AD	3
107741	19q13.32	Hyperlipoproteinemia, type III	617347	_	3
107741	19q13.32	Lipoprotein glomerulopathy	611771	_	3
107741	19q13.32	Sea-blue histiocyte disease	269600	AR	3
107741	19q13.32	{?Macular degeneration, age-related}	603075	AD	3
107741	19q13.32	{Coronary artery disease, severe, susceptibility to}	617347	_	3
107770	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
107773	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
107776	7p14.3	[Aquaporin-1 deficiency]	110450	_	3
107776	7p14.3	[Blood group, Colton]	110450	_	3
107777	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
107820	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
107910	15q21.2	Aromatase deficiency	613546	_	3
107910	15q21.2	Aromatase excess syndrome	139300	AD	3
107930	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
107970	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
108145	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
108300	12q13.11	Stickler syndrome, type I	108300	AD	3
108370	7q21.3	Asparagine synthetase deficiency	615574	AR	3
108420	Chr.1	Spermatogenic failure 2	108420	AD	2
108500	19p13.13	Episodic ataxia, type 2	108500	AD	3
108600	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
108720	3p14.3	Atelosteogenesis, type I	108720	AD	3
108721	3p14.3	Atelosteogenesis, type III	108721	AD	3
108725	19p13.3-p13.2	{Atherosclerosis, susceptibility to}	108725	AD	2
108730	16p11.2	Brody myopathy	601003	AR	3
108733	3p25.3	{Deafness, autosomal recessive 12, modifier of}	601386	AR	3
108740	12q24.11	Acrokeratosis verruciformis	101900	AD	3
108740	12q24.11	Darier disease	124200	AD	3
108746	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
108770	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
108780	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
108780	1p36.22	Atrial standstill 2	615745	AR	3
108800	5p	Atrial septal defect 1	108800	AD	2
108900	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
108961	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
108961	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
108961	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
108962	5p13.3	?Hypertension, salt-resistant	_	_	1
108985	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
109091	19p13.13	Myelofibrosis, somatic	254450	_	3
109091	19p13.13	Thrombocythemia, somatic	187950	_	3
109150	14q32.12	Machado-Joseph disease	109150	AD	3
109200	3q26	Alopecia, androgenetic, 1	109200	AD	2
109270	17q21.31	Cryohydrocytosis	185020	AD	3
109270	17q21.31	Ovalocytosis, SA type	166900	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
109270	17q21.31	Spherocytosis, type 4	612653	AD	3
109270	17q21.31	[Blood group, Diego]	110500	_	3
109270	17q21.31	[Blood group, Froese]	601551	_	3
109270	17q21.31	[Blood group, Swann]	601550	_	3
109270	17q21.31	[Blood group, Waldner]	112010	_	3
109270	17q21.31	[Blood group, Wright]	112050	_	3
109270	17q21.31	[Malaria, resistance to]	611162	_	3
109350	13q14	Gastroesophageal reflux	109350	AD	2
109480	19p13.3	[Blood group, OK]	111380	_	3
109535	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
109543	13q14	{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	AD	2
109560	19q13.32	Leukemia/lymphoma, B-cell, 3	109560	_	2
109565	3q27.3	Lymphoma, B-cell	109565	_	2
109630	10q25.3	[Resting heart rate]	607276	_	3
109630	10q25.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
109690	5q32	Beta-2-adrenoreceptor agonist, reduced response to	_	_	3
109690	5q32	{Asthma, nocturnal, susceptibility to}	600807	AD	3
109690	5q32	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109691	8p11.23	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109700	15q21.1	?Amyloidosis, familial visceral	105200	AD	3
109700	15q21.1	Immunodeficiency 43	241600	AR	3
109720	3p12-q13.2	Biliary cirrhosis, primary, 1	109720	AD	2
109730	9q34.3	Aortic valve disease 1	109730	AD	3
109750	7p13	Hyperbiliverdinemia	614156	AD,AR	3
109760	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
110300	9q34.2	[Blood group, ABO system]	616093	_	3
110500	17q21.31	[Blood group, Diego]	110500	_	3
110600	12p12.3	[Blood group, Dombrock]	616060	_	3
110700	1q23.2	[Blood group, Duffy system]	110700	AD,AR	3
110750	2q14.3	[Blood group, Gerbich]	616089	_	3
110750	2q14.3	{Malaria, resistance to}	611162	_	3
110900	7q34	[Blood group, Kell]	110900	_	3
111000	18q12.3	[Blood group, Kidd]	111000	_	3
111100	19p13.3	[Blood group, Lewis]	_	_	3
111150	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
111250	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
111300	4q31.21	[Blood group, MNSs system]	111300	_	3
111380	19p13.3	[Blood group, OK]	111380	_	3
111600	2q35	[Blood group, Langereis system]	111600	_	3
111620	1p34.2	[Blood group, Radin]	111620	_	3
111680	1p36.11	[Rh-negative blood type]	_	_	3
111700	1p36.11	Rh-null disease, amorph type	617970	_	3
111700	1p36.11	[Blood group, Rhesus]	_	_	3
111740	4q31.21	[Blood group, Ss]	111740	_	3
111750	1p34.2	[Blood group, Scianna system]	111750	_	3
111800	4q28-q31	[Blood group, Stoltzfus system]	111800	_	2
112010	17q21.31	[Blood group, Waldner]	112010	_	3
112050	17q21.31	[Blood group, Wright]	112050	_	3
112100	7q22.1	[Blood group, Yt system]	112100	_	3
112205	19q13.2	Agammaglobulinemia 3	613501	AR	3
112210	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
112240	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
112250	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
112261	20p12.3	Brachydactyly, type A2	112600	AD	3
112261	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
112261	20p12.3	{HFE hemochromatosis, modifier of}	235200	AR	3
112262	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
112262	14q22.2	Orofacial cleft 11	600625	_	3
112264	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
112310	3p14.3	Boomerang dysplasia	112310	AD	3
112410	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
112500	2q35	Brachydactyly, type A1	112500	AD	3
113000	9q22.31	Brachydactyly, type B1	113000	AD	3
113100	20q11.22	Brachydactyly, type C	113100	AD	3
113200	2q31.1	Brachydactyly, type D	113200	AD	3
113300	2q31.1	Brachydactyly, type E	113300	AD	3
113500	12q24.11	Brachyolmia type 3	113500	AD	3
113520	12p12.1	?Hyperleucinemia-isoleucinemia or hypervalinemia	_	_	1
113530	19q13.33	?Hypervalinemia or hyperleucine-isoleucinemia	_	_	1
113620	6p24.3	Branchiooculofacial syndrome	113620	AD	3
113650	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
113705	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
113705	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	AD,Mu	3
113705	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
113721	17p13.3	Breast cancer	_	_	1
113810	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
113810	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, localisata variant	226650	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
113811	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
113970	8q24.21	Burkitt lymphoma, somatic	113970	_	3
114000	17q21.33	Caffey disease	114000	AD	3
114010	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
114019	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
114021	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
114021	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
114025	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
114078	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
114078	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
114090	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
114105	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
114105	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
114131	7q21.3	{Osteoporosis, postmenopausal, susceptibility}	166710	AD	3
114180	14q32.11	Long QT syndrome 14	616247	AD	3
114180	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
114182	2p21	Long QT syndrome 15	616249	AD	3
114200	3q11.2-q13.12	Camptodactyly 1	114200	AD	2
114205	12p13.33	Brugada syndrome 3	611875	_	3
114205	12p13.33	Long QT syndrome 8	618447	_	3
114205	12p13.33	Timothy syndrome	601005	AD	3
114206	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
114206	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
114208	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
114208	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
114208	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
114220	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
114250	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
114251	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
114300	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
114350	9q34.13	Leukemia, acute myeloid, somatic	601626	_	3
114350	9q34.13	Leukemia, T-cell acute lymphoblastic, somatic	613065	_	3
114350	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
114580	2p22.3-p21	Candidiasis, familial, 1, autosomal dominant	114580	AD	2
114760	17q23.1	Retinitis pigmentosa 17	600852	AD	3
114761	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
114815	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
114835	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
114840	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
115080	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
115150	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
115195	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
115196	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
115197	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
115200	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
115210	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
115300	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
115310	1p36.13	Paragangliomas 4	115310	AD	3
115430	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
115440	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
115470	22q11	Cat eye syndrome	115470	AD	4
115500	11p13	Acatalasemia	614097	_	3
115501	9p23	Albinism, oculocutaneous, type III	203290	AR	3
115501	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
115650	14q22-q23	Cataract 32, multiple types	115650	AD	2
115660	17q24	Cataract 7	115660	AD	2
115665	1pter-p36.13	Cataract 8, multiple types	115665	AD	2
115700	2q33.3	Cataract 4, multiple types	115700	AD	3
115800	2pter-p24	Cataract 29, coralliform	115800	AD	2
115900	2q35	?Cataract 42	115900	AD	3
116100	3q27.3	Cataract 20, multiple types	116100	AD	3
116200	1q21.2	Cataract 1, multiple types	116200	AD	3
116300	10p13	Cataract 30, pulverulent	116300	AD	3
116400	4p16.1	?Cataract 41	116400	AD	3
116600	1p36.13	Cataract 6, multiple types	116600	AD	3
116700	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
116790	22q11.21	{Panic disorder, susceptibility to}	167870	?AD	3
116790	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
116800	16q22.1	Cataract 5, multiple types	116800	AD	3
116805	5q31.2	Macular dystrophy, patterned, 2	608970	AD	3
116806	3p22.1	Colorectal cancer, somatic	114500	_	3
116806	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
116806	3p22.1	Hepatocellular carcinoma, somatic	114550	_	3
116806	3p22.1	Medulloblastoma, somatic	155255	_	3
116806	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
116806	3p22.1	Ovarian cancer, somatic	167000	_	3
116806	3p22.1	Pilomatricoma, somatic	132600	_	3
116810	8p23.1	Keratolytic winter erythema	148370	AD	4
116840	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
116896	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
116897	19q13.11	?Leukemia, acute myeloid	601626	AD,SMu	3
116897	19q13.11	Leukemia, acute myeloid, somatic	601626	_	3
116920	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
116945	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
116952	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
116955	3q21.3	Myotonic dystrophy 2	602668	AD	3
117100	11p13	Centrotemporal epilepsy	117100	IC	2
117143	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
117210	16q21	Spinocerebellar ataxia 31	117210	AD	3
117300	13q14.2	Dementia, familial Danish	117300	AD	3
117360	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
117550	5q35.3	Sotos syndrome 1	117550	AD	3
117650	20p13	Cerebrocostomandibular syndrome	117650	AD	3
117700	3q24-q25	Cerebellar ataxia	604290	AR	3
117700	3q24-q25	Hemosiderosis, systemic, due to aceruloplasminemia	604290	AR	3
117700	3q24-q25	[Hypoceruloplasminemia, hereditary]	604290	AR	3
118100	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
118190	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
118190	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
118200	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
118210	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
118220	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
118300	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
118400	4p16.3	Cherubism	118400	AD	3
118423	2q31.1	Duane retraction syndrome 2	604356	_	3
118425	7q34	Myotonia congenita, dominant	160800	AD	3
118425	7q34	Myotonia congenita, recessive	255700	AR	3
118425	7q34	Myotonia levior, recessive	_	_	3
118450	20p12.2	Alagille syndrome 1	118450	AD	3
118470	16q13	Hyperalphalipoproteinemia	143470	AD	3
118470	16q13	[High density lipoprotein cholesterol level QTL 10]	143470	AD	3
118485	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
118490	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
118494	1q43	?Prune belly syndrome	100100	AR	3
118502	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
118503	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118504	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
118504	20q13.33	{Nicotine addiction, susceptibility to}	188890	_	3
118505	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118505	15q25.1	{Nicotine dependence, susceptibility to}	612052	_	3
118507	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
118600	5p15.2	Chondrocalcinosis 2	118600	AD	3
118661	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
118700	14q13.3	Chorea, hereditary benign	118700	AD	3
118800	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
118955	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
119100	1q42.2-q43	Split-hand/foot malformation with long bone deficiency 1	119100	AD	2
119300	1q32.2	van der Woude syndrome	119300	AD	3
119500	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
119530	6p24.3	Orofacial cleft-1	119530	AD	2
119580	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
119800	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
119900	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
120070	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120070	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
120070	2q36.3	Hematuria, benign familial	141200	AD	3
120080	7q21.12	{Colchicine resistance}	120080	_	3
120090	13q34	Brain small vessel disease 2	614483	AD	3
120090	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120100	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
120110	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
120120	3p21.31	EBD inversa	226600	AR	3
120120	3p21.31	EBD, Bart type	132000	AD	3
120120	3p21.31	EBD, localisata variant	_	_	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AR	226600	AR	3
120120	3p21.31	Epidermolysis bullosa pruriginosa	604129	AD,AR	3
120120	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
120120	3p21.31	Toenail dystrophy, isolated	607523	AD	3
120120	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
120130	13q34	?Retinal arteries, tortuosity of	180000	AD	3
120130	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
120130	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
120130	13q34	Schizencephaly	269160	_	3
120130	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120131	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120131	2q36.3	Hematuria, familial benign	141200	AD	3
120140	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
120140	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
120140	12q13.11	Czech dysplasia	609162	AD	3
120140	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
120140	12q13.11	Kniest dysplasia	156550	AD	3
120140	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
120140	12q13.11	Osteoarthritis with mild chondrodysplasia	604864	AD	3
120140	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
120140	12q13.11	SED congenita	183900	AD	3
120140	12q13.11	SMED Strudwick type	184250	AD	3
120140	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
120140	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
120140	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
120140	12q13.11	Stickler syndrome, type I	108300	AD	3
120140	12q13.11	Vitreoretinopathy with phalangeal epiphyseal dysplasia	_	_	3
120150	17q21.33	Caffey disease	114000	AD	3
120150	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
120150	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
120150	17q21.33	Osteogenesis imperfecta, type II	166210	AD	3
120150	17q21.33	Osteogenesis imperfecta, type III	259420	AD	3
120150	17q21.33	Osteogenesis imperfecta, type IV	166220	AD	3
120150	17q21.33	{Bone mineral density variation QTL, osteoporosis}	166710	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
120160	7q21.3	Osteogenesis imperfecta, type II	166210	AD	3
120160	7q21.3	Osteogenesis imperfecta, type III	259420	AD	3
120160	7q21.3	Osteogenesis imperfecta, type IV	166220	AD	3
120160	7q21.3	{Osteoporosis, postmenopausal}	166710	AD	3
120180	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
120180	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
120190	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
120200	11p13	?Coloboma, ocular	120200	AD	3
120210	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
120210	6q13	Stickler syndrome, type IV	614134	_	3
120215	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
120220	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120220	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120240	21q22.3	?Myosclerosis, congenital	255600	AR	3
120240	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120240	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120250	2q37.3	Bethlem myopathy 1	158810	AD,AR	3
120250	2q37.3	Dystonia 27	616411	AR	3
120250	2q37.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120252	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
120252	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
120260	1p34.2	?Stickler syndrome, type V	614284	AR	3
120260	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
120270	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
120270	20q13.33	{Intervertebral disc disease, susceptibility to}	603932	_	3
120280	1p21.1	Fibrochondrogenesis 1	228520	AR	3
120280	1p21.1	Marshall syndrome	154780	AD	3
120280	1p21.1	Stickler syndrome, type II	604841	AD	3
120280	1p21.1	{Lumbar disc herniation, susceptibility to}	603932	_	3
120290	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
120290	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
120290	6p21.32	Fibrochondrogenesis 2	614524	AD,AR	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
120320	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
120320	6q13-q14	Bethlem myopathy 2	616471	AD	3
120328	21q22.3	Knobloch syndrome, type 1	267750	AR	3
120330	10q24.31	Papillorenal syndrome	120330	AD	3
120350	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
120353	11q22.2	COPD, rate of decline of lung function in	606963	_	3
120353	11q22.2	{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}	226600	AR	3
120360	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
120361	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
120433	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
120435	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
120436	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
120436	3p22.2	Mismatch repair cancer syndrome	276300	AR	3
120436	3p22.2	Muir-Torre syndrome	158320	AD	3
120470	18q21.2	Colorectal cancer, somatic	114500	_	3
120470	18q21.2	Esophageal carcinoma, somatic	133239	_	3
120470	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
120470	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
120502	1q31	Branchiootic syndrome 2	120502	AD	2
120520	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
120520	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AD,AR	3
120550	1p36.12	C1q deficiency	613652	AR	3
120570	1p36.12	C1q deficiency	613652	AR	3
120575	1p36.12	C1q deficiency	613652	AR	3
120580	12p13.31	C1s deficiency	613783	_	3
120580	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
120620	1q32.2	CR1 deficiency	_	_	1
120620	1q32.2	[Blood group, Knops system]	607486	_	3
120620	1q32.2	{?SLE susceptibility}	_	_	1
120620	1q32.2	{Malaria, severe, resistance to}	611162	_	3
120650	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
120650	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
120700	19p13.3	C3 deficiency	613779	AR	3
120700	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
120700	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
120790	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
120810	6p21.33	C4a deficiency	614380	AR	3
120810	6p21.33	[Blood group, Rodgers]	614374	_	3
120820	6p21.33	C4B deficiency	614379	_	3
120900	9q33.2	C5 deficiency	609536	_	3
120900	9q33.2	[Eculizumab, poor response to]	615749	AD	3
120920	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AD,AR	3
120940	5p13.1	C9 deficiency	613825	_	3
120940	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
120950	1p32.2	C8 deficiency, type I	613790	AR	3
120960	1p32.2	C8 deficiency, type II	613789	AR	3
120970	19q13.33	Cone-rod retinal dystrophy-2	120970	AD	3
121011	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
121011	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
121011	13q12.11	Deafness, autosomal recessive 1A	220290	AR	3
121011	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
121011	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
121011	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
121011	13q12.11	Vohwinkel syndrome	124500	AD	3
121013	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
121013	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
121014	6q22.31	Atrioventricular septal defect 3	600309	AD	3
121014	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
121014	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
121014	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
121014	6q22.31	Oculodentodigital dysplasia	164200	AD	3
121014	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
121014	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
121014	6q22.31	Syndactyly, type III	186100	AD	3
121015	13q12.11	Cataract 14, multiple types	601885	AD	3
121050	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
121201	8q24.22	Seizures, benign neonatal, 2	121201	AD	3
121210	8q13-q21	Febrile seizures, familial, 1	121210	AD	2
121360	16q22.1	Myeloid leukemia, acute, M4/M4Eo subtype, somatic	601626	_	1
121400	12q21.33	Cornea plana 1, autosomal dominant	121400	AD	2
121800	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
121820	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
121850	2q34	Corneal fleck dystrophy	121850	AD	3
121900	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
122000	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
122200	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
122400	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
122470	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
122500	14q32.13	Corticosteroid-binding globulin deficiency	611489	AD,AR	3
122600	16p11.2	Spondylocostal dysostosis 5	122600	AD,AR	3
122720	19q13.2	Coumarin resistance	122700	AD	3
122720	19q13.2	{Lung cancer, resistance to}	211980	AD,SMu	3
122720	19q13.2	{Nicotine addiction, protection from}	188890	_	3
122860	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
122880	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
123000	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
123100	7p21.1	Craniosynostosis 1	123100	AD	3
123101	5q35.2	Craniosynostosis 2	604757	AD	3
123101	5q35.2	Parietal foramina 1	168500	AD	3
123101	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
123155	8q12.2-q21.2	?Hydrocephalus, autosomal dominant	123155	AD	2
123270	14q32	[Creatine kinase, brain type, ectopic expression of]	123270	_	2
123320	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
123500	10q26.13	Crouzon syndrome	123500	AD	3
123570	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
123580	21q22.3	Cataract 9, multiple types	604219	AD,AR	3
123590	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
123590	11q23.1	Cataract 16, multiple types	613763	AD,AR	3
123590	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
123590	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
123610	17q11.2	Cataract 10, multiple types	600881	AD	3
123620	22q11.23	Cataract 3, multiple types	601547	AD	3
123630	22q11.23	Cataract 22	609741	AD,AR	3
123631	22q12.1	Cataract 23	610425	_	3
123670	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
123680	2q33.3	Cataract 2, multiple types	604307	AD	3
123690	2q33.3	Cataract 4, multiple types	115700	AD	3
123695	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
123700	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
123730	3q27.3	Cataract 20, multiple types	116100	AD	3
123740	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
123790	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
123805	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
123810	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
123825	4p12	Retinitis pigmentosa 49	613756	_	3
123829	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
123831	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
123833	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
123841	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
123860	1p34.2	Immunodeficiency 24	615897	AR	3
123870	11q13.1	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
123889	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
123889	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
123890	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
123890	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
123890	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
123890	2q33.2	{Hashimoto thyroiditis}	140300	AD	3
123890	2q33.2	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
123930	19q13.2	Efavirenz, poor metabolism of	614546	_	3
123930	19q13.2	{Efavirenz central nervous system toxicity, susceptibility to}	614546	_	3
123940	12q13.13	White sponge nevus 1	193900	AD	3
123970	7p15.3	Thrombocytopenia 4	612004	AD	3
123980	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
124000	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
124015	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
124015	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
124020	10q23.33	Clopidogrel, impaired responsiveness to	609535	AR	3
124020	10q23.33	Mephenytoin poor metabolizer	609535	AR	3
124020	10q23.33	Omeprazole poor metabolizer	609535	AR	3
124020	10q23.33	Proguanil poor metabolizer	609535	AR	3
124030	22q13.2	{Codeine sensitivity}	608902	AR	3
124030	22q13.2	{Debrisoquine sensitivity}	608902	AR	3
124080	8q24.3	Aldosterone to renin ratio raised	_	_	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
124080	8q24.3	{Low renin hypertension, susceptibility to}	_	_	3
124089	19q13.12	Mitochondrial complex IV deficiency	220110	Mi,AR	3
124092	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
124092	1q32.1	{HIV-1, susceptibility to}	609423	_	3
124092	1q32.1	{Rheumatoid arthritis, progression of}	180300	_	3
124200	12q24.11	Darier disease	124200	AD	3
124480	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
124500	13q12.11	Vohwinkel syndrome	124500	AD	3
124900	5q31.3	Deafness, autosomal dominant 1	124900	AD	3
125240	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
125240	1q32.2	[Blood group Cromer]	613793	AR	3
125250	3q29	Optic atrophy plus syndrome	125250	AD	3
125255	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
125264	6p22.3	Leukemia, acute nonlymphocytic	125264	_	2
125270	9q32	Porphyria, acute hepatic	612740	AR	3
125270	9q32	{Lead poisoning, susceptibility to}	612740	AR	3
125310	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
125350	3p21.31	Failure of tooth eruption, primary	125350	AD	3
125370	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
125400	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
125420	4q22.1	Dentin dysplasia, type II	125420	AD	3
125480	18p	{Major affective disorder 1}	125480	AD	2
125485	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
125485	4q22.1	Dentin dysplasia, type II	125420	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125490	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125500	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125505	16p13.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
125520	22q11	Cayler cardiofacial syndrome	125520	AD	2
125595	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
125630	19p13.12	Vibratory urticaria	125630	AD	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11	610476	AD,AR	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	AD,AR	3
125647	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
125647	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
125647	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
125647	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
125647	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
125647	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
125660	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
125660	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
125660	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
125670	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
125670	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
125671	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
125671	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
125700	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
125800	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
125850	20q13.12	MODY, type I	125850	AD	3
125851	7p13	MODY, type II	125851	AD	3
125852	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
125860	16q22.1	{Benzene toxicity, susceptibility to}	_	_	3
125860	16q22.1	{Breast cancer, poor survival after chemotherapy for}	_	_	3
125860	16q22.1	{Leukemia, post-chemotherapy, susceptibility to}	_	_	3
126060	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
126063	14q24.3	Paragangliomas 7	618475	AD	3
126064	16q22.2	Miller syndrome	263750	AR	3
126065	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
126090	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
126141	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
126141	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
126150	5q31.3	{Diphtheria, susceptibility to}	_	_	1
126340	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
126340	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
126340	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
126375	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
126375	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
126380	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
126420	20q12	DNA topoisomerase I, camptothecin-resistant	_	_	3
126430	17q21.2	DNA topoisomerase II, resistance to inhibition of, by amsacrine	_	_	3
126451	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
126451	3q13.31	{Schizophrenia, susceptibility to}	181500	AD	3
126452	11p15.5	Autonomic nervous system dysfunction	_	_	3
126452	11p15.5	[Novelty seeking personality]	601696	?AD	1
126452	11p15.5	{Attention deficit-hyperactivity disorder}	143465	AD	3
126453	4p16.1	{Attention deficit-hyperactivity disorder, susceptibility to}	143465	AD	3
126453	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
126455	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
126455	5p15.33	{Nicotine dependence, protection against}	188890	_	3
126600	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
126650	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
126700	1q31.3	Basal laminar drusen	126700	AD	3
126800	8q13	Duane retraction syndrome 1	126800	AD	2
126900	16q11.1-q22	Dupuytren contracture 1	126900	AD	2
127000	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
127400	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
127500	6q24.2-q25.2	Dyschromatosis universalis hereditaria 1	127500	AD	2
127550	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
127600	4q35	Dyskeratosis, hereditary benign intraepithelial	127600	AD	2
127700	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
128100	9q34.11	Dystonia-1, torsion	128100	AD	3
128101	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
128200	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
128230	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
128235	19q13.2	Dystonia-12	128235	AD	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
128260	1q32.1	Hypotrichosis 11	615059	AD	3
128700	8q11.1-q13.3	?Preauricular fistulae, congenital	128700	AD	2
129010	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
129010	10q21.3	Dejerine-Sottas disease	145900	AD,AR	3
129010	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AD,AR	3
129190	6q14.3	Calcification of joints and arteries	211800	AR	3
129200	4q22.3	Basan syndrome	129200	AD	3
129400	3q28	Rapp-Hodgkin syndrome	129400	AD	3
129490	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
129500	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
129600	15q21.1	Ectopia lentis, familial	129600	AD	3
129900	7q11.2-q21.3	?EEC syndrome-1	129900	AD	2
130000	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
130010	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
130050	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
130060	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
130070	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
130080	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
130130	19p13.3	Neutropenia, cyclic	162800	AD	3
130130	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
130160	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
130160	7q11.23	Supravalvar aortic stenosis	185500	AD	3
130410	19q13.41	Glutaric acidemia IIB	231680	AR	3
130500	1p35.3	Elliptocytosis-1	611804	AD,AR	3
130600	1q23.1	Elliptocytosis-2	130600	AD	3
130610	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
130620	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
130720	19p13.12	Lateral meningocele syndrome	130720	AD	3
130900	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
131100	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
131195	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
131200	10q26	{Endometriosis, susceptibility to, 1}	131200	AR,Mu	2
131222	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
131230	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
131240	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
131240	6p24.1	Question mark ears, isolated	612798	AD	3
131240	6p24.1	{High density lipoprotein cholesterol level QTL 7}	_	_	3
131242	20q13.32	Central hypoventilation syndrome, congenital	209880	AD	3
131242	20q13.32	Waardenburg syndrome, type 4B	613265	AD,AR	3
131242	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
131243	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
131243	4q31.22-q31.23	{Migraine, resistance to}	157300	AD	3
131244	13q22.3	ABCD syndrome	600501	AR	3
131244	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
131244	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
131300	19q13.2	Camurati-Engelmann disease	131300	AD	3
131320	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
131340	20p13	Spinocerebellar ataxia 23	610245	AD	3
131370	17p13.2	?Glycogen storage disease XIII	612932	AR	3
131399	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
131400	5q31-q33	Eosinophilia, familial	131400	AD	2
131440	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
131530	4q25	Hypomagnesemia 4, renal	611718	_	3
131550	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
131550	7p11.2	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	{Nonsmall cell lung cancer, susceptibility to}	211980	AD,SMu	3
131705	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
131750	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
131850	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
131950	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
131960	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
132000	3p21.31	EBD, Bart type	132000	AD	3
132100	6p21.1	Photoparoxysmal response 1	132100	AD	2
132400	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
132450	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
132700	16q12.1	Cylindromatosis, familial	132700	AD	3
132800	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
132810	1q42.12	?Hypercholanemia, familial	607748	AR	3
132811	8p21.2-p21.1	{Hypercholesterolemia, familial, due to LDLR defect, modifier of}	143890	AD	3
132890	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
132900	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
133170	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
133170	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
133170	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
133171	19p13.2	[Erythrocytosis, familial, 1]	133100	AD	3
133180	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
133190	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
133200	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AD,AR	3
133430	6q25.1-q25.2	Breast cancer, somatic	114480	_	3
133430	6q25.1-q25.2	Estrogen resistance	615363	AR	3
133430	6q25.1-q25.2	{Atherosclerosis, susceptibility to}	_	_	3
133430	6q25.1-q25.2	{HDL response to hormone replacement, augmented}	_	_	3
133430	6q25.1-q25.2	{Migraine, susceptibility to}	157300	AD	3
133430	6q25.1-q25.2	{Myocardial infarction, susceptibility to}	608446	_	3
133440	4q23	{Autism, susceptibility to, 19}	615091	_	3
133450	22q12.2	Ewing sarcoma	612219	_	3
133450	22q12.2	Neuroepithelioma	612219	_	3
133510	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
133510	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
133520	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
133520	16p13.12	Xeroderma pigmentosum, group F	278760	AR	3
133520	16p13.12	Xeroderma pigmentosum, type F/Cockayne syndrome	278760	AR	3
133520	16p13.12	XFE progeroid syndrome	610965	AR	3
133530	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G	278780	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G/Cockayne syndrome	278780	AR	3
133540	10q11.23	Cockayne syndrome, type B	133540	AR	3
133550	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
133550	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
133700	8q24.11	Exostoses, multiple, type 1	133700	AD	3
133701	11p11.2	Exostoses, multiple, type 2	133701	AD	3
134350	19p13.3	Complement factor D deficiency	613912	AR	3
134370	1q31.3	Basal laminar drusen	126700	AD	3
134370	1q31.3	Complement factor H deficiency	609814	AD,AR	3
134370	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	AD,AR	3
134370	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
134371	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AD,AR	3
134371	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
134570	6p25.1	Factor XIIIA deficiency	613225	AR	3
134570	6p25.1	{Myocardial infarction, protection against}	608446	_	3
134570	6p25.1	{Venous thrombosis, protection against}	188050	AD	3
134580	1q31.3	Factor XIIIB deficiency	613235	AR	3
134600	15q15.3	Fanconi renotubular syndrome 1	134600	AD	2
134610	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
134629	1q22	Porokeratosis 9, multiple types	616631	AD	3
134637	10q23.31	Autoimmune lymphoproliferative syndrome, type IA	601859	AD	3
134637	10q23.31	Squamous cell carcinoma, burn scar-related, somatic	_	_	3
134637	10q23.31	{Autoimmune lymphoproliferative syndrome}	601859	AD	3
134638	1q24.3	Autoimmune lymphoproliferative syndrome, type IB	601859	AD	3
134638	1q24.3	{Lung cancer, susceptibility to}	211980	AD,SMu	3
134770	11q12.3	?Hemochromatosis, type 5	615517	AD	3
134790	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
134790	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AD,AR	3
134790	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
134797	15q21.1	Acromicric dysplasia	102370	AD	3
134797	15q21.1	Ectopia lentis, familial	129600	AD	3
134797	15q21.1	Geleophysic dysplasia 2	614185	AD	3
134797	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
134797	15q21.1	Marfan syndrome	154700	AD	3
134797	15q21.1	MASS syndrome	604308	_	3
134797	15q21.1	Stiff skin syndrome	184900	AD	3
134797	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
134820	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134820	4q31.3	Amyloidosis, familial visceral	105200	AD	3
134820	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134820	4q31.3	Hypodysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134830	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Hypofibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Afibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Dysfibrinogenemia, congenital	616004	_	3
134850	4q32.1	Hypodysfibrinogenemia	616004	_	3
134850	4q32.1	Hypofibrinogenemia, congenital	202400	AR	3
134934	4p16.3	Achondroplasia	100800	AD	3
134934	4p16.3	Bladder cancer, somatic	109800	_	3
134934	4p16.3	CATSHL syndrome	610474	AD,AR	3
134934	4p16.3	Cervical cancer, somatic	603956	_	3
134934	4p16.3	Colorectal cancer, somatic	114500	_	3
134934	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
134934	4p16.3	Hypochondroplasia	146000	AD	3
134934	4p16.3	LADD syndrome	149730	AD	3
134934	4p16.3	Muenke syndrome	602849	AD	3
134934	4p16.3	Nevus, epidermal, somatic	162900	_	3
134934	4p16.3	SADDAN	616482	AD	3
134934	4p16.3	Spermatocytic seminoma, somatic	273300	_	3
134934	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
134934	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
134935	5q35.2	{Cancer progression/metastasis}	_	_	3
135100	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
135150	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
135290	5q22.2	Desmoid disease, hereditary	135290	AD	3
135300	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
135400	17q24.2-q24.3	Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400	AR	4
135500	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
135600	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
135600	2q35	Plasma fibronectin deficiency	614101	AD	1
135600	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
135750	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
135820	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
135900	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
135940	1q21.3	Ichthyosis vulgaris	146700	AD	3
135940	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
136000	4q22.3	Adermatoglyphia	136000	AD	3
136120	16q22.1	Fish-eye disease	136120	AR	3
136132	1q24.3	Trimethylaminuria	602079	AR	3
136140	16p11.2	Floating-Harbor syndrome	136140	AD	3
136350	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
136350	8p11.23	Hartsfield syndrome	615465	AD	3
136350	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
136350	8p11.23	Jackson-Weiss syndrome	123150	AD	3
136350	8p11.23	Osteoglophonic dysplasia	166250	AD	3
136350	8p11.23	Pfeiffer syndrome	101600	AD	3
136350	8p11.23	Trigonocephaly 1	190440	AD	3
136351	13q12.2	Leukemia, acute lymphoblastic, somatic	613065	_	3
136351	13q12.2	Leukemia, acute myeloid, reduced survival in, somatic	601626	_	3
136351	13q12.2	Leukemia, acute myeloid, somatic	601626	_	3
136352	5q35.3	Hemangioma, capillary infantile, somatic	602089	_	3
136352	5q35.3	Lymphatic malformation 1	153100	AD	3
136430	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
136435	2p16.3	Ovarian dysgenesis 1	233300	AR	3
136435	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
136435	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
136440	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
136520	11p13	Foveal hypoplasia 1	136520	AD	3
136530	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
136533	13q14.11	Rhabdomyosarcoma, alveolar	268220	SMu	3
136550	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
136570	16p12	Chromosome 16p12.1 deletion syndrome, 520kb	136570	_	4
136630	12q13.12	Mental retardation, FRA12A type	136630	AD	3
136680	11p13	Frasier syndrome	136680	AD,SMu	3
136760	1p13.3	Frontonasal dysplasia 1	136760	AR	3
136800	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
136836	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
136850	1q43	Fumarase deficiency	606812	AR	3
136850	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
136900	22q12.3	Sorsby fundus dystrophy	136900	AD	3
137035	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
137060	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
137070	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
137070	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
137100	6p21.3	Immunoglobulin A deficiency	137100	AD,AR,IC	2
137140	4p12	{Alcohol dependence, susceptibility to}	103780	Mu	3
137150	16p13.2	GABA-transaminase deficiency	613163	AR	3
137160	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
137160	5q34	{Epilepsy, childhood absence, susceptibility to, 4}	611136	_	3
137160	5q34	{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136	_	3
137163	1p36.33	{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	AD	3
137163	1p36.33	{Epilepsy, idiopathic generalized, 10}	613060	AD	3
137163	1p36.33	{Epilepsy, juvenile myoclonic, susceptibility to}	613060	AD	3
137164	5q34	Epilepsy, generalized, with febrile seizures plus, type 3	607681	AD	3
137164	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
137164	5q34	Febrile seizures, familial, 8	607681	AD	3
137165	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
137167	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
137167	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
137181	22q11.21	[Gamma-glutamyltransferase, familial high serum]	137181	_	2
137190	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
137192	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
137192	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
137200	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
137241	19q13.32	[Plasma glucose, 2-hour, QTL 2]	137241	_	2
137245	1p22.3	Lymphoma, MALT, somatic	137245	_	3
137290	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
137295	3q21.3	Emberger syndrome	614038	AD	3
137295	3q21.3	Immunodeficiency 21	614172	AD	3
137295	3q21.3	{Leukemia, acute myeloid, susceptibility to}	601626	AD,SMu	3
137295	3q21.3	{Myelodysplastic syndrome, susceptibility to}	614286	_	3
137350	9q33.2	Amyloidosis, Finnish type	105120	AD	3
137580	11q23	Tourette syndrome	137580	AD	2
137600	4q25	Anterior segment dysgenesis 4	137600	AD	3
137750	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
137760	10p13	Glaucoma 1, open angle, E	137760	AD	3
137780	17q21.31	Alexander disease	203450	AD	3
137920	17q12	Renal cysts and diabetes syndrome	137920	AD	3
137940	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
137950	1q32	Glomerulopathy with fibronectin deposits 1	137950	AD	2
137960	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
137960	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
138000	1p22.1	Glomuvenous malformations	138000	AD	3
138030	2q24.2	[?Hyperproglucagonemia]	_	_	1
138033	17q25.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138040	5q31.3	Glucocorticoid resistance	615962	AD	3
138079	7p13	Diabetes mellitus, noninsulin-dependent, late onset	125853	AD	3
138079	7p13	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
138079	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
138079	7p13	MODY, type II	125851	AD	3
138090	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
138130	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
138140	1p34.2	Dystonia 9	601042	AD	3
138140	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AD,AR	3
138140	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
138140	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
138140	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
138160	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
138160	3q26.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138180	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
138210	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
138244	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
138246	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
138250	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
138250	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
138250	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
138250	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
138252	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
138252	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
138253	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
138280	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
138280	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
138280	2q32.2	Global developmental delay, progressive ataxia, and elevated glutamine	618312	_	3
138290	1q25.3	Glutamine deficiency, congenital	610015	AR	3
138292	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
138295	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
138300	8p12	Hemolytic anemia due to glutathione reductase deficiency	_	_	1
138320	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
138322	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
138420	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
138430	2q24.1	{Diabetes, type 2, susceptibility to}	125853	AD	3
138470	6p21.33	?Complement factor B deficiency	615561	_	3
138470	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
138470	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
138491	5q33.1	Hyperekplexia 1	149400	AD,AR	3
138492	4q32.1	Hyperekplexia 2	614619	AR	3
138570	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
138571	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
138680	3q27.3	?Alopecia-mental retardation syndrome 1	203650	AR	3
138720	22q11.21	Bernard-Soulier syndrome, type B	231200	AR	3
138720	22q11.21	Giant platelet disorder, isolated	231200	AR	3
138760	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
138800	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
138850	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
138890	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
138900	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
138945	17q21.31	Aphasia, primary progressive	607485	AD	3
138945	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
138945	17q21.31	Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485	AD	3
138971	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
138981	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
139090	3p21.31	Gray platelet syndrome	139090	AR	3
139130	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
139130	12p13.31	{Hypertension, essential, susceptibility to}	145500	Mu	3
139150	5q14.3	Basal cell carcinoma, somatic	605462	_	3
139150	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
139190	20q11.23	?Isolated growth hormone deficiency due to defect in GHRF	_	_	1
139190	20q11.23	Gigantism due to GHRF hypersecretion	_	_	1
139191	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
139210	18q21.2	Myhre syndrome	139210	AD	3
139250	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
139250	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
139250	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
139250	17q23.3	Kowarski syndrome	262650	AR	3
139300	15q21.2	Aromatase excess syndrome	139300	AD	3
139311	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
139311	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
139312	18p11.21	Dystonia 25	615073	AD	3
139313	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
139313	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
139320	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
139320	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
139320	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
139320	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
139320	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ib	603233	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
139320	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
139330	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
139330	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
139340	1p13.3	Achromatopsia 4	613856	_	3
139350	12q13.13	Epidermolytic hyperkeratosis	113800	AD,AR	3
139350	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
139350	12q13.13	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
139350	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
139350	12q13.13	Palmoplantar keratoderma, epidermolytic	144200	AD	3
139350	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
139360	3p21.31	Pituitary ACTH-secreting adenoma	_	_	3
139360	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
139370	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
139380	1p36.33	Leukemia, acute lymphoblastic, somatic	613065	_	3
139380	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
139393	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
139396	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
139450	1q21.3	Hair, curly	139450	AD	2
139900	2p12-q22	[Handedness]	139900	AD	2
140000	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
140100	16q22.2	[Anhaptoglobinemia]	614081	_	3
140100	16q22.2	[Hypohaptoglobinemia]	614081	_	3
140300	8q23-q24	Hashimoto thyroiditis	140300	AD	2
140350	12q24.31	Hawkinsinuria	140350	AD	3
140400	1q32	Progressive familial heart block, type II	140400	AD	2
140600	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
141250	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
141250	22q12.3	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	3
141750	16pter-p13.3	Alpha-thalassemia/mental retardation syndrome, type 1	141750	AD	4
141800	16p13.3	Erythrocytosis, 7	617981	_	3
141800	16p13.3	Heinz body anemias, alpha-	140700	AD	3
141800	16p13.3	Hemoglobin H disease, nondeletional	613978	_	3
141800	16p13.3	Methemoglobinemia, alpha type	617973	_	3
141800	16p13.3	Thalassemias, alpha-	604131	_	3
141850	16p13.3	Erythrocytosis 7	617981	_	3
141850	16p13.3	Heinz body anemia	140700	AD	3
141850	16p13.3	Hemoglobin H disease, deletional and nondeletional	613978	_	3
141850	16p13.3	Thalassemia, alpha-	604131	_	3
141900	11p15.4	Delta-beta thalassemia	141749	AD	3
141900	11p15.4	Erythrocytosis 6	617980	_	3
141900	11p15.4	Heinz body anemia	140700	AD	3
141900	11p15.4	Hereditary persistence of fetal hemoglobin	141749	AD	3
141900	11p15.4	Methmoglobinemia, beta type	617971	_	3
141900	11p15.4	Sickle cell anemia	603903	AR	3
141900	11p15.4	Thalassemia, beta	613985	_	3
141900	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
141900	11p15.4	{Malaria, resistance to}	611162	_	3
142000	11p15.4	Thalassemia due to Hb Lepore	_	_	3
142000	11p15.4	Thalassemia, delta-	_	_	3
142200	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142220	6p22.2	Rahman syndrome	617537	AD	3
142250	11p15.4	Cyanosis, transient neonatal	613977	AD	3
142250	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142330	12q24.31	Hepatic adenoma, somatic	142330	_	3
142335	2p16.1	[Fetal hemoglobin QTL5]	142335	AD	2
142340	15q26.1	Hernia, congenital diaphragmatic 1	142340	Mu	2
142360	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
142409	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
142410	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
142410	12q24.31	Hepatic adenoma, somatic	142330	_	3
142410	12q24.31	MODY, type III	600496	AD	3
142410	12q24.31	Renal cell carcinoma	144700	_	3
142410	12q24.31	{Diabetes mellitus, insulin-dependent}	222100	AR	3
142410	12q24.31	{Diabetes mellitus, noninsulin-dependent, 2}	125853	AD	3
142445	8p12	{?Schizophrenia, susceptibility to}	603013	_	1
142461	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
142461	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
142470	6q22.3-q23.1	Fetal hemoglobin quantitative trait locus 2	142470	AD	2
142600	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
142600	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
142600	10q22.1	Retinitis pigmentosa 79	617460	AD	3
142622	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
142640	3q27.3	Thrombophilia due to elevated HRG	613116	AD	1
142640	3q27.3	Thrombophilia due to HRG deficiency	613116	AD	3
142669	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
142680	12p13.31	Periodic fever, familial	142680	AD	3
142690	1q23.2	Acne inversa, familial, 1	142690	AD	3
142700	13q22	Developmental dysplasia of the hip 1	142700	Mu	2
142704	15q21.2	{Gilles de la Tourette syndrome, susceptibility to}	137580	AD	3
142800	6p22.1	{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}	608579	_	3
142810	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
142810	5q31.3	Usher syndrome type 3B	614504	AR	3
142830	6p21.33	{Abacavir hypersensitivity, susceptibility to}	_	_	3
142830	6p21.33	{Drug-induced liver injury due to flucloxacillin}	_	_	3
142830	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
142830	6p21.33	{Stevens-Johnson syndrome, susceptibility to}	608579	_	3
142830	6p21.33	{Synovitis, chronic, susceptibility to}	_	_	3
142830	6p21.33	{Toxic epidermal necrolysis, susceptibility to}	608579	_	3
142840	6p21.33	{HIV-1 viremia, susceptibility to}	609423	_	3
142840	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
142857	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
142857	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
142858	6p21.32	{Beryllium disease, chronic, susceptibility to}	_	_	3
142871	6p22.1	{Asthma, susceptibility to}	600807	AD	2
142900	12q24.21	Holt-Oram syndrome	142900	AD	3
142910	5q13.3	[Low density lipoprotein cholesterol level QTL 3]	_	_	3
142910	5q13.3	[Statins, attenuated cholesterol lowering by]	_	_	3
142945	7q36.3	Holoprosencephaly 3	142945	AD	3
142946	18p11.31	Holoprosencephaly 4	142946	AD	3
142955	7p15.2	Athabaskan brainstem dysgenesis syndrome	601536	_	3
142955	7p15.2	Bosley-Salih-Alorainy syndrome	601536	_	3
142958	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
142959	7p15.2	?Guttmacher syndrome	176305	AD	3
142959	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
142968	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
142976	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
142983	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
142983	4p16.2	Orofacial cleft 5	608874	_	3
142983	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
142984	2q31.1	Charcot-Marie-Tooth disease, foot deformity of	192950	AD	3
142984	2q31.1	Vertical talus, congenital	192950	AD	3
142989	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
142989	2q31.1	Brachydactyly, type D	113200	AD	3
142989	2q31.1	Brachydactyly, type E	113300	AD	3
142989	2q31.1	Syndactyly, type V	186300	AD	3
142989	2q31.1	Synpolydactyly 1	186000	AD	3
142992	4p16.1	Oculoauricular syndrome	612109	AR	3
142993	14q24.3	Microphthalmia with coloboma 3	610092	_	3
142993	14q24.3	Microphthalmia, isolated 2	610093	_	3
142994	7q36.3	Currarino syndrome	176450	AD	3
143054	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
143095	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
143100	4p16.3	Huntington disease	143100	AD	3
143200	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
143400	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
143450	2p23.3	Trifunctional protein deficiency	609015	AR	3
143500	2q37.1	[Gilbert syndrome]	143500	AR	3
143850	18q	Orthostatic hypotensive disorder of Streeten	143850	AD	2
143860	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
143870	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
143880	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
144010	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
144110	14q11.2-q13	Hyperhidrosis palmaris et plantaris	144110	AD	2
144120	14q32.33	?Hyperimmunoglobulin G1 syndrome	144120	AD	2
144250	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
144650	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
144755	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
145000	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
145250	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
145260	1q31-q42	Pseudohypoaldosteronism, type IIA	145260	AD	2
145410	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
145420	22q11.23	Hypertelorism, Teebi type	145420	AD	3
145505	16p12.3	{?Hypertension, essential}	_	_	1
145650	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
145680	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
145701	8q22	?Hypertrichosis universalis congenita, Ambras type	145701	AD	2
145750	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
145980	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
145981	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
146000	4p16.3	Hypochondroplasia	146000	AD	3
146110	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
146255	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
146390	18p	Chromosome 18p deletion syndrome	146390	AD	4
146450	7q32.2-q36.1	Hypospadias 3, autosomal	146450	AD,Mu	2
146500	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AD,AR	3
146510	7p14.1	Pallister-Hall syndrome	146510	AD	3
146520	6p21.33	Hypotrichosis 2	146520	AD	3
146550	8p21.3	Hypotrichosis 4	146550	AD	3
146590	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
146660	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
146661	5p13.2	Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type	608971	AR	3
146690	7q32.1	Leber congenital amaurosis 11	613837	AD	3
146690	7q32.1	Retinitis pigmentosa 10	180105	AD	3
146691	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
146700	1q21.3	Ichthyosis vulgaris	146700	AD	3
146738	19p13.11	Cryptorchidism	219050	AD	3
146740	1q23.3	Immunodeficiency 20	615707	AR	3
146760	1q21.2	[IgG receptor I, phagocytic, familial deficiency of]	_	_	3
146770	22q11.23	Agammaglobulinemia 2	613500	AR	3
146790	1q23.3	{Lupus nephritis, susceptibility to}	152700	AD	3
146790	1q23.3	{Malaria, severe, susceptibility to}	611162	_	3
146790	1q23.3	{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	AR	3
146800	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
146880	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
146920	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
146920	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
146929	2q35	{AIDS, slow progression to}	609423	_	3
146933	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
147020	14q32.33	Agammaglobulinemia 1	601495	AR	3
147060	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
147061	5q31.1	{?Allergy and asthma susceptibility}	147061	_	2
147110	14q32.33	IgG2 deficiency, selective	_	_	3
147138	11q12.1	{Atopy, susceptibility to}	147050	AD	3
147141	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
147183	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
147200	2p11.2	Kappa light chain deficiency	614102	AR	3
147245	17q23.3	Agammaglobulinemia 6	612692	AR	3
147250	7q36.3	Single median maxillary central incisor	147250	AD	3
147265	3p26.1	Gillespie syndrome	206700	AD,AR	3
147265	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
147265	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
147267	6p21.31	{Diabetes, type 1, susceptibility to}	222100	AR	2
147280	6q25.3	Hepatocellular carcinoma, somatic	114550	_	3
147370	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
147430	14q11.2	?Marsili syndrome	147430	AD	3
147440	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
147450	21q22.11	Amyotrophic lateral sclerosis 1	105400	AD,AR	3
147460	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
147470	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
147480	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
147520	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
147520	20p13	[Inosine triphosphatase deficiency]	613850	_	3
147545	2q36.3	{Coronary artery disease, susceptibility to}	_	_	3
147545	2q36.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
147556	2q31.1	Epidermolysis bullosa, junctional, with pyloric stenosis	226730	AR	3
147557	17q25.1	Epidermolysis bullosa of hands and feet	131800	AD	3
147557	17q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
147557	17q25.1	Epidermolysis bullosa, junctional, with pyloric atresia	226730	AR	3
147558	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
147569	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
147570	12q15	{AIDS, rapid progression to}	609423	_	3
147570	12q15	{Aplastic anemia}	609135	_	3
147570	12q15	{Hepatitis C virus, response to therapy of}	609532	_	3
147570	12q15	{TSC2 angiomyolipomas, renal, modifier of}	613254	AD	3
147570	12q15	{Tuberculosis, protection against}	607948	_	3
147571	1p36.33	Immunodeficiency 38	616126	AR	3
147575	5q31.1	Gastric cancer, somatic	613659	_	3
147575	5q31.1	Myelodysplastic syndrome, preleukemic	_	_	3
147575	5q31.1	Myelogenous leukemia, acute	_	_	3
147575	5q31.1	Nonsmall cell lung cancer, somatic	211980	_	3
147582	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
147620	7p15.3	{Crohn disease-associated growth failure}	266600	Mu	3
147620	7p15.3	{Diabetes, susceptibility to},	222100	AR	3
147620	7p15.3	{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	AD	3
147620	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
147620	7p15.3	{Rheumatoid arthritis, systemic juvenile}	604302	_	3
147630	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
147650	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
147660	9p21.3	Interferon, alpha, deficiency	_	_	1
147670	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
147670	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
147670	19p13.2	Leprechaunism	246200	AR	3
147670	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
147679	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
147679	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147679	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
147683	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
147683	5q31.1	{Asthma, susceptibility to}	600807	AD	3
147700	2q34	{Glioma, susceptibility to, somatic}	137800	_	3
147720	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147730	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
147730	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
147750	20q13.2	IVIC syndrome	147750	AD	3
147781	16p12.1	{AIDS, slow progression to}	609423	_	3
147781	16p12.1	{Atopy, susceptibility to}	147050	AD	3
147791	11q23	Jacobsen syndrome	147791	IC	4
147796	9p24.1	Erythrocytosis, somatic	133100	_	3
147796	9p24.1	Leukemia, acute myeloid, somatic	601626	_	3
147796	9p24.1	Myelofibrosis, somatic	254450	_	3
147796	9p24.1	Polycythemia vera, somatic	263300	_	3
147796	9p24.1	Thrombocythemia 3	614521	AD,SMu	3
147796	9p24.1	{Budd-Chiari syndrome, somatic}	600880	_	3
147840	19p13.2	{Malaria, cerebral, susceptibility to}	611162	_	3
147880	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
147880	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
147891	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
147910	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
147920	12q13.12	Kabuki syndrome 1	147920	AD	3
147950	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
148000	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
148040	12q13.13	Dowling-Degos disease 1	179850	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148040	12q13.13	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148040	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
148040	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
148041	12q13.13	Pachyonychia congenita 3	615726	_	3
148042	12q13.13	Pachyonychia congenita 4	615728	_	3
148043	12q13.13	Meesmann corneal dystrophy	122100	AD	3
148050	16q24.3	KBG syndrome	148050	AD	3
148060	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148060	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148065	17q21.2	White sponge nevus 2	615785	AD	3
148066	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148066	17q21.2	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148066	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
148067	17q21.2	Pachyonychia congenita 1	167200	AD	3
148067	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
148069	17q21.2	Pachyonychia congenita 2	167210	AD	3
148069	17q21.2	Steatocystoma multiplex	184500	AD	3
148070	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148070	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148080	17q21.2	Epidermolytic hyperkeratosis	113800	AD,AR	3
148080	17q21.2	Ichthyosis with confetti	609165	AD	3
148080	17q21.2	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
148190	11p13	Keratitis	148190	AD	3
148200	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
148210	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
148300	20p11.21	Keratoconus 1	148300	AD	3
148350	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
148370	8p23-p22	Keratolytic winter erythema	148370	AD	2
148500	17q25.1	Tylosis with esophageal cancer	148500	AD	3
148600	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
148700	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
148760	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
148820	2q36.1	Waardenburg syndrome, type 3	148820	AD,AR	3
149000	8q22.3	Klippel-Trenaunay-Weber syndrome	149000	IC	2
149200	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
149400	5q33.1	Hyperekplexia 1	149400	AD,AR	3
149700	1p13.1	?Lacrimal duct defect	149700	AR	3
150000	11p15.1	Glycogen storage disease XI	612933	AR	3
150100	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
150200	17q23.3	[Placental lactogen deficiency]	_	_	1
150230	8q24.11-q24.13	Trichorhinophalangeal syndrome, type II	150230	AD	4
150240	7q31.1	Lissencephaly 5	615191	AR	3
150250	3p14.3	Larsen syndrome	150250	AD	3
150270	6p21.3-p21.2	?Laryngeal adductor paralysis	150270	AD	2
150292	1q25.3	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150292	1q25.3	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150310	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
150310	1q32.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150310	1q32.2	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150320	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
150325	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
150325	3p21.31	Pierson syndrome	609049	AR	3
150330	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
150330	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
150330	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
150330	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
150330	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
150330	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
150330	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
150330	1q22	Malouf syndrome	212112	AD	3
150330	1q22	Mandibuloacral dysplasia	248370	AR	3
150330	1q22	Muscular dystrophy, congenital	613205	AD	3
150330	1q22	Restrictive dermopathy, lethal	275210	AR	3
150340	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
150341	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
150341	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
150370	3p22.1	Asplenia, isolated congenital	271400	AD	3
150400	2q35	Tooth agenesis, selective, 4	150400	AD,AR	3
150571	22q13.1	{Myocardial infarction, susceptibility to}	608446	_	3
150600	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
150699	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
150800	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
151050	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
151100	12q24.13	LEOPARD syndrome 1	151100	AD	3
151200	8q22.1	Leri pleonosteosis chromosome duplication syndrome	151200	AD	4
151210	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
151350	5q32	?Infantile liver failure syndrome 1	615438	AR	3
151385	21q22.12	Leukemia, acute myeloid	601626	AD,SMu	3
151385	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
151410	22q11.23	Leukemia, acute lymphocytic, somatic	613065	_	3
151410	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
151430	18q21.33	Leukemia/lymphoma, B-cell, 2	_	_	3
151440	19p13.13	Leukemia, T-cell acute lymphoblastoid	151440	_	2
151443	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
151460	1q31.3-q32.1	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	AR	3
151460	1q31.3-q32.1	{Hepatitis C virus, susceptibility to}	609532	_	3
151600	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AD,AR	3
151623	17p13.1	Li-Fraumeni syndrome	151623	AD	3
151660	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
151670	15q21.3	Hepatic lipase deficiency	614025	AR	3
151670	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
151670	15q21.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
151750	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
152200	6q25-q26	[LPA deficiency, congenital]	_	_	3
152200	6q25-q26	{Coronary artery disease, susceptibility to}	_	_	1
152390	10q11.21	{Asthma, diminished response to antileukotriene treatment in}	600807	AD	3
152390	10q11.21	{Atherosclerosis, susceptibility to}	_	_	3
152424	11p15.4	Thalassemia, Hispanic gamma-delta-beta	613985	_	3
152427	7q36.1	Long QT syndrome 2	613688	AD	3
152427	7q36.1	Short QT syndrome 1	609620	_	3
152427	7q36.1	{Long QT syndrome 2, acquired, susceptibility to}	613688	AD	3
152430	4q25	[Longevity 1]	152430	_	2
152445	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
152760	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
152780	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
152790	2p16.3	Leydig cell adenoma, somatic, with precocious puberty	176410	_	3
152790	2p16.3	Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	AR	3
152790	2p16.3	Leydig cell hypoplasia with pseudohermaphroditism	238320	AR	3
152790	2p16.3	Luteinizing hormone resistance, female	238320	AR	3
152790	2p16.3	Precocious puberty, male	176410	AD	3
152950	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
153100	5q35.3	Lymphatic malformation 1	153100	AD	3
153245	4q25	Sebaceous tumors, somatic	_	_	3
153390	1p35.2	?Immunodeficiency 22	615758	AR	3
153440	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
153440	6p21.33	{Myocardial infarction, susceptibility to}	608446	_	3
153440	6p21.33	{Psoriatic arthritis, susceptibility to}	607507	_	3
153450	12q15	Amyloidosis, renal	105200	AD	3
153454	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
153455	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
153456	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
153550	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
153600	6p21.3	{Macroglobulinemia, Waldenstrom, susceptibility to, 1}	153600	AD	2
153620	22q11.23	{Rheumatoid arthritis, systemic juvenile, susceptibility to}	604302	_	3
153622	8p22	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
153670	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
153700	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
153800	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
153880	7p21-p15	Macular dystrophy, dominant cystoid	153880	AD	2
154020	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
154045	19q13.41	Cataract 19, multiple types	615277	AR	3
154050	12q13.3	Cataract 15, multiple types	615274	AD	3
154100	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
154230	9p24.3	46XY sex reversal 4	154230	_	4
154235	6p24.2	Retinitis pigmentosa 62	614181	AR	3
154275	17q11.2-q24	{Malignant hyperthermia susceptibility 2}	154275	AD	2
154276	7q21-q22	{Malignant hyperthermia susceptibility 3}	154276	AD	2
154400	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
154500	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
154545	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
154550	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
154700	15q21.1	Marfan syndrome	154700	AD	3
154780	1p21.1	Marshall syndrome	154780	AD	3
154870	12p12.3	Keutel syndrome	245150	AR	3
154950	14q23.3	{Pheochromocytoma, susceptibility to}	171300	AD	3
155100	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
155310	2p13.1	Visceral myopathy	155310	AD	3
155500	3q26.32	Macrodactyly, somatic	155500	_	3
155540	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
155541	18q21.32	Obesity (BMIQ20)	618406	_	3
155541	18q21.32	{Obesity, resistence to (BMIQ20)}	618306	_	3
155555	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	AR	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	AR	3
155555	16q24.3	{Albinism, oculocutaneous, type II, modifier of}	203200	AR	3
155555	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
155555	16q24.3	{UV-induced skin damage}	266300	AR	3
155600	1p36	{Melanoma, cutaneous malignant, 1}	155600	AD	2
155601	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
155755	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
155760	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
155760	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
155760	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
155900	9p11	?Melkersson-Rosenthal syndrome	155900	AD	2
156100	22q12.1	Meningioma	607174	AD	3
156200	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
156225	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
156225	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
156232	2q24-q32	Mesomelic dysplasia, Kantaputra type	156232	AD	2
156250	12q24.13	Metachondromatosis	156250	AD	3
156400	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
156490	17q21.33	Neuroblastoma	256700	AD,SMu	3
156500	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
156510	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
156530	12q24.11	Metatropic dysplasia	156530	AD	3
156540	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
156550	12q13.11	Kniest dysplasia	156550	AD	3
156560	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
156560	12q13.3	Interstitial lung and liver disease	615486	AR	3
156570	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
156570	1q43	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
156600	13q32	Microcoria, congenital	156600	AD	4
156610	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
156845	3p13	COMMAD syndrome	617306	AR	3
156845	3p13	Tietz albinism-deafness syndrome	103500	AD	3
156845	3p13	Waardenburg syndrome, type 2A	193510	AD	3
156845	3p13	Waardenburg syndrome/ocular albinism, digenic	103470	AD	3
156845	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
156850	16p13.3	Microphthalmia with cataract 1	156850	AD	2
157140	17q21.31	Dementia, frontotemporal, with or without parkinsonism	600274	AD	3
157140	17q21.31	Pick disease	172700	AD	3
157140	17q21.31	Supranuclear palsy, progressive	601104	AD	3
157140	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
157140	17q21.31	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
157145	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
157147	4q23	Abetalipoproteinemia	200100	AR	3
157147	4q23	{Metabolic syndrome, protection against}	605552	AD	3
157170	2p21	Holoprosencephaly 2	157170	AD	3
157300	4q24	{Migraine with or without aura, susceptibility to, 1}	157300	AD	2
157600	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
157640	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
157655	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
157660	9p13.3	Anauxetic dysplasia 1	607095	AR	3
157660	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
157660	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
157700	16p12.1-p11.2	Mitral valve prolapse, myxomatous 1	157700	AD	2
157800	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
157900	13q12.2-q13	?Moebius syndrome	157900	AD,IC	2
158105	17q12	{Coronary artery disease, modifier of}	_	_	3
158105	17q12	{HIV-1, resistance to}	609423	_	3
158105	17q12	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
158105	17q12	{Spina bifida, susceptibility to}	182940	AD	3
158170	9p	Chromosome 9p deletion syndrome	158170	AD	4
158300	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
158330	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
158340	1q22	Medullary cystic kidney disease 1	174000	AD	3
158375	4q13.3	{Asthma, protection against}	600807	AD	3
158378	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
158580	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
158590	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
158600	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
158900	4q35	Facioscapulohumeral muscular dystrophy 1	158900	AD	4
158901	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
159350	5q22.2	Colorectal cancer, somatic	114500	_	3
159440	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
159440	1q23.3	Dejerine-Sottas disease	145900	AD,AR	3
159440	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
159440	1q23.3	Roussy-Levy syndrome	180800	AD	3
159460	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
159465	6p22.1	?Narcolepsy 7	614250	AD	3
159530	1p34.2	Myelofibrosis with myeloid metaplasia, somatic	254450	_	3
159530	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
159530	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
159550	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
159555	11q23.3	Leukemia, myeloid/lymphoid or mixed-lineage	159555	AD	2
159555	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
159595	21q11.2	Leukemia, transient, of Down syndrome	159595	_	2
159900	7q21.3	Dystonia-11, myoclonic	159900	AD	3
159950	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
159990	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
160120	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
160500	14q11.2	Laing distal myopathy	160500	AD	3
160565	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
160700	18p11.31	Myopia-2	160700	AD	2
160710	14q11.2	Atrial septal defect 3	614089	_	3
160710	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
160710	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
160710	14q11.2	{Sick sinus syndrome 3}	614090	_	3
160720	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
160720	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
160740	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AD,AR	3
160741	17p13.1	Carney complex variant	608837	_	3
160741	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
160745	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
160760	14q11.2	Cardiomyopathy, dilated, 1S	613426	AD	3
160760	14q11.2	Cardiomyopathy, hypertrophic, 1	192600	AD	3
160760	14q11.2	Laing distal myopathy	160500	AD	3
160760	14q11.2	Left ventricular noncompaction 5	613426	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
160760	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
160770	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
160775	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
160775	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
160777	15q21.2	Griscelli syndrome, type 1	214450	AR	3
160780	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
160781	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
160790	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AD,AR	3
160794	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
160794	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
160800	7q34	Myotonia congenita, dominant	160800	AD	3
160900	19q13.32	Myotonic dystrophy 1	160900	AD	3
160980	17q24.2	Carney complex, type 1	160980	AD	3
160998	6p25.2	{?Breast cancer susceptibility}	114480	AD,SMu	1
161000	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
161015	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
161200	9q33.3	Nail-patella syndrome	161200	AD	3
161400	17q21.2	?Narcolepsy 1	161400	AD	3
161550	6p21.3	{Nasopharyngeal carcinoma, susceptibility to, 2}	161550	_	2
161561	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
161650	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
161900	1q21	Nephropathy-hypertension	161900	AD	2
161950	6q22-q23	{IgA nephropathy, susceptibility to, 1}	161950	?AD	2
162000	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
162030	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
162080	14q11-q12	Retinal degeneration, autosomal recessive, clumped pigment type	_	_	3
162080	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
162100	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
162150	5q15	Obesity with impaired prohormone processing	600955	AR	3
162150	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
162200	17q11.2	Neurofibromatosis, type 1	162200	AD	3
162210	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
162230	22q12.2	?{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
162230	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AD,AR	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
162300	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
162330	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
162332	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
162350	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
162400	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
162500	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
162643	2q22.1	Myelokathexis, isolated	_	_	3
162643	2q22.1	WHIM syndrome	193670	AD	3
162662	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
162800	19p13.3	Neutropenia, cyclic	162800	AD	3
162820	7q22-qter	?Neutrophil chemotactic response, abnormal	162820	AD	2
163000	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
163500	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
163729	7q36.1	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
163729	7q36.1	{Coronary artery spasm 1, susceptibility to}	_	_	3
163729	7q36.1	{Hypertension, pregnancy-induced}	189800	AD	3
163729	7q36.1	{Hypertension, susceptibility to}	145500	Mu	3
163729	7q36.1	{Ischemic stroke, susceptibility to}	601367	Mu	3
163729	7q36.1	{Placental abruption}	_	_	3
163730	17q11.2	{Hypertension, susceptibility to}	145500	Mu	2
163730	17q11.2	{Malaria, resistance to}	611162	_	3
163800	15q24.1	Sick sinus syndrome 2	163800	AD	3
163890	4q22.1	Dementia, Lewy body	127750	AD	3
163890	4q22.1	Parkinson disease 1	168601	AD	3
163890	4q22.1	Parkinson disease 4	605543	AD	3
163950	12q24.13	Noonan syndrome 1	163950	AD	3
163970	16q12.2	?Orthostatic intolerance	604715	_	3
164005	19p13.13	Marshall-Smith syndrome	602535	AD	3
164005	19p13.13	Sotos syndrome 2	614753	AD	3
164008	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
164009	11q13.4	Leukemia, acute promyelocytic, somatic	612376	_	3
164010	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
164011	4q24	Immunodeficiency, common variable, 12	616576	AD	3
164012	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
164014	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
164015	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
164017	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
164017	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
164040	5q35.1	Leukemia, acute myeloid, somatic	601626	_	3
164050	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
164100	6p12	Nystagmus 2, congenital, autosomal dominant	164100	AD	2
164160	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
164200	6q22.31	Oculodentodigital dysplasia	164200	AD	3
164210	14q32	Hemifacial microsomia	164210	AD	2
164280	2p24.3	Feingold syndrome 1	164280	AD	3
164300	14q11.2	Oculopharyngeal muscular dystrophy	164300	AD	3
164360	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
164360	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
164400	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
164500	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
164690	1q25.2	Leukemia, acute myeloid, with eosinophilia	_	_	1
164730	14q32.33	Breast cancer, somatic	114480	_	3
164730	14q32.33	Colorectal cancer, somatic	114500	_	3
164730	14q32.33	Cowden syndrome 6	615109	_	3
164730	14q32.33	Ovarian cancer, somatic	167000	_	3
164730	14q32.33	Proteus syndrome, somatic	176920	_	3
164730	14q32.33	{Schizophrenia, susceptibility to}	181500	AD	2
164731	19q13.2	Diabetes mellitus, type II	125853	AD	3
164731	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
164745	17q21.31	Omodysplasia 2	164745	AD	3
164750	1p31.3	Omphalocele due to duplication of 1p31.3	164750	IC	4
164757	7q34	Adenocarcinoma of lung, somatic	211980	_	3
164757	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
164757	7q34	Colorectal cancer, somatic	_	_	3
164757	7q34	LEOPARD syndrome 3	613707	AD	3
164757	7q34	Melanoma, malignant, somatic	_	_	3
164757	7q34	Nonsmall cell lung cancer, somatic	_	_	3
164757	7q34	Noonan syndrome 7	613706	AD	3
164760	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
164760	3p25.2	LEOPARD syndrome 2	611554	_	3
164760	3p25.2	Noonan syndrome 5	611553	AD	3
164761	10q11.21	Central hypoventilation syndrome, congenital	209880	AD	3
164761	10q11.21	Medullary thyroid carcinoma	155240	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
164761	10q11.21	Pheochromocytoma	171300	AD	3
164761	10q11.21	{Hirschsprung disease, protection against}	142623	AD	3
164761	10q11.21	{Hirschsprung disease, susceptibility to, 1}	142623	AD	3
164770	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
164770	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
164780	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
164785	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
164790	1p13.2	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	614470	_	3
164790	1p13.2	Colorectal cancer, somatic	114500	_	3
164790	1p13.2	Epidermal nevus, somatic	162900	_	3
164790	1p13.2	Melanocytic nevus syndrome, congenital, somatic	137550	_	3
164790	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
164790	1p13.2	Noonan syndrome 6	613224	AD	3
164790	1p13.2	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
164790	1p13.2	Thyroid carcinoma, follicular, somatic	188470	_	3
164820	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
164820	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
164840	2p24.3	Feingold syndrome 1	164280	AD	3
164860	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
164860	7q31.2	Hepatocellular carcinoma, childhood type, somatic	114550	_	3
164860	7q31.2	Renal cell carcinoma, papillary, 1, familial and somatic	605074	_	3
164860	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
164870	17q12	Adenocarcinoma of lung, somatic	211980	_	3
164870	17q12	Gastric cancer, somatic	613659	_	3
164870	17q12	Glioblastoma, somatic	137800	_	3
164870	17q12	Ovarian cancer, somatic	_	_	3
164874	14q12	Rett syndrome, congenital variant	613454	AD	3
164920	4q12	Gastrointestinal stromal tumor, familial	606764	AD,IC	3
164920	4q12	Germ cell tumors, somatic	273300	_	3
164920	4q12	Leukemia, acute myeloid	601626	AD,SMu	3
164920	4q12	Mastocytosis, cutaneous	154800	AD	3
164920	4q12	Mastocytosis, systemic, somatic	154800	_	3
164920	4q12	Piebaldism	172800	AD	3
164950	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
164953	19p13.2-q13.3	Liposarcoma	_	_	1
165190	4q21.21	Trichomegaly	190330	AR	3
165215	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
165220	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
165220	12q13.3	Polydactyly, preaxial I	174400	AR	3
165230	2q14.2	Culler-Jones syndrome	615849	AD	3
165230	2q14.2	Holoprosencephaly 9	610829	AD	3
165240	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
165240	7p14.1	Pallister-Hall syndrome	146510	AD	3
165240	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
165240	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
165240	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
165300	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
165320	2q14-q21	?Hepatocellular carcinoma	_	_	1
165330	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
165360	11q23.3	?Juvenile myelomonocytic leukemia	607785	AD,SMu	3
165360	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
165500	3q29	Optic atrophy 1	165500	AD	3
165550	11p13	Optic nerve hypoplasia	165550	AD	3
165640	2p25.1	{Colonic adenoma recurrence, reduced risk of}	114500	AD,SMu	3
165720	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
165800	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
166200	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
166250	8p11.23	Osteoglophonic dysplasia	166250	AD	3
166260	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
166300	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
166350	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
166600	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
166750	11q13	Otodental dysplasia chromosome deletion syndrome	166750	AD	4
166760	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
166780	8q13.3	?Otofaciocervical syndrome	166780	AD	3
166800	15q26.1-qter	Otosclerosis 1	166800	AD	2
166900	17q21.31	Ovalocytosis, SA type	166900	AD	3
167030	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
167200	17q21.2	Pachyonychia congenita 1	167200	AD	3
167210	17q21.2	Pachyonychia congenita 2	167210	AD	3
167250	5q35.3	Paget disease of bone 3	167250	AD	3
167320	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
167400	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
167409	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
167409	10q24.31	Papillorenal syndrome	120330	AD	3
167410	1p36.13	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
167411	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
167413	7q32.1	Diabetes mellitus, type 2	125853	AD	3
167413	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
167413	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AD,AR	3
167414	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
167415	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
167416	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
167420	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
167790	5q32	Pancreatitis, hereditary	167800	AD	3
167790	5q32	Tropical calcific pancreatitis	608189	AD,AR	3
167790	5q32	{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	AD,AR	3
167870	13q22-q32	Panic disorder syndrome 1	167870	?AD	2
168000	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
168300	17q23.3	Paramyotonia congenita	168300	AD	3
168400	12q24.11	Parastremmatic dwarfism	168400	AD	3
168450	11p15.3	Hypoparathyroidism, autosomal dominant	146200	AD,AR	3
168450	11p15.3	Hypoparathyroidism, autosomal recessive	146200	AD,AR	3
168461	11q13.3	{Colorectal cancer, susceptibility to}	114500	AD,SMu	3
168461	11q13.3	{Multiple myeloma, susceptibility to}	254500	SMu	3
168461	11q13.3	{von Hippel-Lindau syndrome, modifier of}	193300	AD	3
168468	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
168468	3p21.31	Eiken syndrome	600002	AR	3
168468	3p21.31	Failure of tooth eruption, primary	125350	AD	3
168468	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
168470	12p11.22	Brachydactyly, type E2	613382	AD	3
168500	5q35.2	Parietal foramina 1	168500	AD	3
168550	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
168601	4q22.1	Parkinson disease 1	168601	AD	3
168605	2p13.1	Perry syndrome	168605	AD	3
168820	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
168820	7q21.3	{Coronary artery spasm 2, susceptibility to	_	_	3
168820	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
168820	7q21.3	{Organophosphate poisoning, sensitivity to}	_	_	3
168860	17q21-q22	Patella aplasia or hypoplasia	168860	AD	2
169100	6p12.3	Char syndrome	169100	AD	3
169150	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
169400	1q42.12	Pelger-Huet anomaly	169400	AD	3
169500	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
169600	3q22.1	Hailey-Hailey disease	169600	AD	3
170100	19q13.11	Prolidase deficiency	170100	AR	3
170260	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
170261	6p21.32	Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	AR	3
170280	10q22.1	Aplastic anemia	609135	_	3
170280	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
170280	10q22.1	Lymphoma, non-Hodgkin	605027	_	3
170285	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
170290	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
170390	17q24.3	Andersen syndrome	170390	AD	3
170400	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
170500	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
170650	11q14.2	Periodontitis 1, juvenile	170650	AR	3
170710	12q13.12	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
170715	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
170993	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
170993	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
170995	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
170998	22q13.31	{Hyperapobetalipoproteinemia, susceptibility to}	_	_	3
171050	7q21.12	{Colchicine resistance}	120080	_	3
171050	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
171060	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AD,AR	3
171060	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
171060	7q21.12	Gallbladder disease 1	600803	AD,AR	3
171200	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
171400	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
171640	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
171650	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
171720	9q34.13	{Alkaline phosphatase, plasma level of, QTL1}	171720	?AD	2
171760	1p36.12	Hypophosphatasia, adult	146300	AD,AR	3
171760	1p36.12	Hypophosphatasia, childhood	241510	AR	3
171760	1p36.12	Hypophosphatasia, infantile	241500	AR	3
171760	1p36.12	Odontohypophosphatasia	146300	AD,AR	3
171833	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
171833	5q13.1	Immunodeficiency 36	616005	AD	3
171833	5q13.1	SHORT syndrome	269880	AD	3
171834	3q26.32	Breast cancer, somatic	114480	_	3
171834	3q26.32	CLAPO syndrome, somatic	613089	_	3
171834	3q26.32	CLOVE syndrome, somatic	612918	_	3
171834	3q26.32	Colorectal cancer, somatic	114500	_	3
171834	3q26.32	Cowden syndrome 5	615108	_	3
171834	3q26.32	Gastric cancer, somatic	613659	_	3
171834	3q26.32	Hepatocellular carcinoma, somatic	114550	_	3
171834	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
171834	3q26.32	Macrodactyly, somatic	155500	_	3
171834	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
171834	3q26.32	Nevus, epidermal, somatic	162900	_	3
171834	3q26.32	Nonsmall cell lung cancer, somatic	211980	_	3
171834	3q26.32	Ovarian cancer, somatic	167000	_	3
171860	21q22.3	Hemolytic anemia due to phosphofructokinase deficiency	_	_	1
171900	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
172100	6q14.1	Immunodeficiency 23	615816	AR	3
172400	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
172405	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
172405	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
172411	1p36.13	{?Colorectal cancer, susceptibility to}	114500	AD,SMu	3
172425	20q13.12	[High density lipoprotein cholesterol level QTL 9]	_	_	3
172430	1p36.23	Enolase deficiency	_	_	1
172460	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
172460	14q23.3	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
172471	16p11.2	Cirrhosis due to liver phosphorylase kinase deficiency	_	_	3
172471	16p11.2	Glycogen storage disease IXc	613027	AR	3
172480	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
172490	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
172860	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
172870	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
173100	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
173110	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AD,AR	3
173200	17q25.3	Pityriasis rubra pilaris	173200	AD	3
173321	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
173325	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
173325	17q21.2	Naxos disease	601214	AR	3
173335	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
173335	6q23.2	Cole disease	615522	AD	3
173335	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
173335	6q23.2	{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	AD	3
173335	6q23.2	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
173350	6q26	Dysplasminogenemia	217090	AR	3
173350	6q26	Plasminogen deficiency, type I	217090	AR	3
173360	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AD,AR	3
173360	7q22.1	{Transcription of plasminogen activator inhibitor, modulator of}	_	_	3
173370	8p11.21	Hyperfibrinolysis, familial, due to increased release of PLAT	612348	_	1
173370	8p11.21	Thrombophilia, familial, due to decreased release of PLAT	612348	_	1
173410	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
173410	5q32	Kosaki overgrowth syndrome	616592	AD	3
173410	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
173410	5q32	Myofibromatosis, infantile, 1	228550	AD	3
173410	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
173470	17q21.32	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
173470	17q21.32	Glanzmann thrombasthenia	273800	AR	3
173470	17q21.32	Purpura, posttransfusion	_	_	3
173470	17q21.32	Thrombocytopenia, neonatal alloimmune	_	_	3
173470	17q21.32	{Myocardial infarction, susceptibility to}	608446	_	3
173490	4q12	Gastrointestinal stromal tumor, somatic or familial	606764	_	3
173490	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
173510	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
173510	7q21.11	[Macrothrombocytopenia]	_	_	1
173510	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
173510	7q21.11	{Malaria, cerebral, reduced risk of}	611162	_	3
173510	7q21.11	{Malaria, cerebral, susceptibility to}	611162	_	3
173515	3q21.3	Bernard-Soulier syndrome, type C	231200	AR	3
173600	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
173650	20p12.3	Kindler syndrome	173650	AR	3
173900	16p13.3	Polycystic kidney disease 1	173900	AD	3
173910	4q22.1	Polycystic kidney disease 2	613095	AD	3
174000	1q22	Medullary cystic kidney disease 1	174000	AD	3
174050	19p13.2	Polycystic liver disease 1	174050	AD	3
174200	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
174300	1q32.1	Orofaciodigital syndrome V	174300	AR	3
174400	12q13.3	Polydactyly, preaxial I	174400	AR	3
174700	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
174761	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
174761	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
174762	12q24.33	FILS syndrome	615139	AR	3
174762	12q24.33	IMAGE-I syndrome	618336	AR	3
174762	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
174763	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
174800	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
174810	18q21.33	Osteolysis, familial expansile	174810	AD	3
175050	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
175200	19p13.3	Peutz-Jeghers syndrome	175200	AD	3
175700	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
175780	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
175800	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
175850	12q24.1-q24.2	Porokeratosis 2, palmar, plantar, and disseminated	175850	AD	2
175900	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
176258	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
176260	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
176261	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
176261	21q22.12	Long QT syndrome 5	613695	AD	3
176262	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
176264	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
176266	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
176267	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
176300	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
176300	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
176300	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
176305	7p15.2	?Guttmacher syndrome	176305	AD	3
176310	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
176400	19p13.3	?Precocious puberty, central, 1	176400	AD	3
176430	15q15.1	[Premature chromatid separation trait]	176430	AD	3
176450	7q36.3	Currarino syndrome	176450	AD	3
176500	13q14.2	Dementia, familial British	176500	AD	3
176610	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
176640	20p13	Cerebral amyloid angiopathy, PRNP-related	137440	AD	3
176640	20p13	Creutzfeldt-Jakob disease	123400	AD	3
176640	20p13	Gerstmann-Straussler disease	137440	AD	3
176640	20p13	Huntington disease-like 1	603218	AD	3
176640	20p13	Insomnia, fatal familial	600072	AD	3
176640	20p13	Prion disease with protracted course	606688	AD	3
176640	20p13	{Kuru, susceptibility to}	245300	_	3
176670	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
176705	17q21.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
176730	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
176730	11p15.5	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
176730	11p15.5	Hyperproinsulinemia	616214	AD	3
176730	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
176740	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
176761	5p13.2	Hyperprolactinemia	615555	AD,AR	3
176761	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
176763	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type, digenic	277400	AR	3
176780	1q31	{Pelvic organ prolapse, susceptibility to, 1}	176780	AD	2
176790	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
176797	11q23.2	Leukemia, acute promyelocytic, PL2F/RARA type	_	_	3
176797	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
176801	10q22.1	Combined SAP deficiency	611721	AR	3
176801	10q22.1	Gaucher disease, atypical	610539	_	3
176801	10q22.1	Krabbe disease, atypical	611722	AR	3
176801	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
176804	14q22.1	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
176830	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
176830	2p23.3	{Obesity, early-onset, susceptibility to}	601665	AD,AR,Mu	3
176860	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
176872	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
176876	12q24.13	LEOPARD syndrome 1	151100	AD	3
176876	12q24.13	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
176876	12q24.13	Metachondromatosis	156250	AD	3
176876	12q24.13	Noonan syndrome 1	163950	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
176885	20q13.13	{Insulin resistance, susceptibility to}	125853	AD	3
176893	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
176894	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
176895	13q34	[Protein Z deficiency]	614024	_	3
176915	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
176920	14q32.33	Proteus syndrome, somatic	176920	_	3
176930	11p11.2	Dysprothrombinemia	613679	AR	3
176930	11p11.2	Hypoprothrombinemia	613679	AR	3
176930	11p11.2	Thrombophilia due to thrombin defect	188050	AD	3
176930	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
176930	11p11.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
176941	19p13.2	Immunodeficiency 35	611521	AR	3
176943	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
176943	10q26.13	Apert syndrome	101200	AD	3
176943	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
176943	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
176943	10q26.13	Craniofacial-skeletal-dermatologic dysplasia	101600	AD	3
176943	10q26.13	Craniosynostosis, nonspecific	_	_	3
176943	10q26.13	Crouzon syndrome	123500	AD	3
176943	10q26.13	Gastric cancer, somatic	613659	_	3
176943	10q26.13	Jackson-Weiss syndrome	123150	AD	3
176943	10q26.13	LADD syndrome	149730	AD	3
176943	10q26.13	Pfeiffer syndrome	101600	AD	3
176943	10q26.13	Saethre-Chotzen syndrome	101400	AD	3
176943	10q26.13	Scaphocephaly and Axenfeld-Rieger anomaly	_	_	3
176943	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
176946	1p36.13	Cataract 6, multiple types	116600	AD	3
176947	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
176947	2q11.2	Immunodeficiency 48	269840	AR	3
176960	17q24.2	Pituitary tumor, invasive	_	_	3
176977	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
176980	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
177000	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
177045	6p21.32	?Proteasome-associated autoinflammatory syndrome 3, digenic	617591	AR	3
177046	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
177060	19p13.2	Polycystic liver disease 1	174050	AD	3
177070	15q15.2	Spherocytosis, type 5	612690	_	3
177075	16q23.2	Ayme-Gripp syndrome	601088	AD	3
177075	16q23.2	Cataract 21, multiple types	610202	AD	3
177170	19p13.11	Pseudoachondroplasia	177170	AD	3
177200	16p12.2	Liddle syndrome 1	177200	AD	3
177400	3q26.1	Butyrylcholinesterase deficiency	617936	_	3
177400	3q26.1	{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}	617936	_	3
177650	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
177700	12q14	Glaucoma 1, open angle, P	177700	AD	4
177735	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
177820	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
177850	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
177900	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
178110	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
178300	1p34.1-p32	Ptosis, hereditary congenital, 1	178300	AD	2
178620	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
178640	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
178642	10q22.3	Pulmonary fibrosis, idiopathic	178500	AD	3
179010	12q	Pyloric stenosis, infantile hypertrophic 1	179010	AD,Mu	2
179035	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
179035	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
179060	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
179095	5q31.1	?Male infertility	_	_	1
179410	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
179450	6p21.3	?Ragweed sensitivity	179450	AD	2
179502	4q23	Lymphocytic leukemia, acute T-cell	_	_	3
179590	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
179605	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
179605	6p21.1	Leber congenital amaurosis 18	608133	AD,AR	3
179605	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
179605	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
179605	6p21.1	Retinitis pigmentosa 7 and digenic form	608133	AD,AR	3
179605	6p21.1	Retinitis punctata albescens	136880	AD,AR	3
179615	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
179615	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179615	11p12	Omenn syndrome	603554	AR	3
179615	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179616	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179616	11p12	Omenn syndrome	603554	AR	3
179616	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179617	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
179617	15q15.1	Mirror movements 2	614508	AD	3
179617	15q15.1	{Breast cancer, susceptibility to}	114480	AD,SMu	3
179620	11p15.5	[Blood group, Raph]	179620	_	3
179755	1q23.1	Renal cell carcinoma, papillary	605074	_	3
179800	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
179820	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
179820	1q32.1	Renal tubular dysgenesis	267430	AR	3
179820	1q32.1	[Hyperproreninemia]	_	_	3
179850	12q13.13	Dowling-Degos disease 1	179850	AD	3
180000	13q34	?Retinal arteries, tortuosity of	180000	AD	3
180020	6q25-q26	?Retinal cone dystrophy-1	180020	AD	2
180040	1q32.3	Leber congenital amaurosis 12	610612	AR	3
180069	1p31.3	Leber congenital amaurosis 2	204100	AR	3
180069	1p31.3	Retinitis pigmentosa 20	613794	AR	3
180071	5q32	Retinitis pigmentosa 43	613810	_	3
180072	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
180072	4p16.3	Retinitis pigmentosa-40	613801	AR	3
180073	17q25.3	Retinitis pigmentosa 57	613582	AR	3
180090	15q26.1	Bothnia retinal dystrophy	607475	AR	3
180090	15q26.1	Fundus albipunctatus	136880	AD,AR	3
180090	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
180090	15q26.1	Retinitis punctata albescens	136880	AD,AR	3
180100	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AD,AR	3
180104	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
180105	7q32.1	Retinitis pigmentosa 10	180105	AD	3
180220	3p24.2	Microphthalmia, syndromic 12	615524	AD,AR	3
180240	17q21.2	Leukemia, acute promyelocytic	612376	_	1
180250	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
180250	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
180290	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
180295	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
180297	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
180297	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
180300	6q23	{Rheumatoid arthritis, susceptibility to}	180300	_	2
180380	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
180380	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AD,AR	3
180380	3q22.1	Retinitis punctata albescens	136880	AD,AR	3
180381	13q34	Oguchi disease-2	613411	_	3
180385	11p13	Leukemia, acute T-cell	180385	_	2
180430	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
180435	1q25.3	Prostate cancer 1	601518	AD	3
180468	3q29	Diamond-Blackfan anemia 5	612528	AD	3
180472	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
180500	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
180550	4q25	Ring dermoid of cornea	180550	AD	3
180700	3p14.3	Robinow syndrome, autosomal dominant 1	180700	AD	3
180721	11q12.3	Retinitis pigmentosa 7, digenic form	608133	AD,AR	3
180750	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
180849	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
180860	7p11.2	Silver-Russell syndrome	180860	AD	4
180901	19q13.2	Central core disease	117000	AD,AR	3
180901	19q13.2	King-Denborough syndrome	145600	AD	3
180901	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
180901	19q13.2	Neuromuscular disease, congenital, with uniform type 1 fiber	117000	AD,AR	3
180901	19q13.2	{Malignant hyperthermia susceptibility 1}	145600	AD	3
180902	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
180902	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
180920	5p12	Aplasia of lacrimal and salivary glands	180920	AD	3
180960	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
181000	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
181030	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
181031	2q37.1	Oguchi disease-1	258100	AR	3
181031	2q37.1	Retinitis pigmentosa 47	613758	_	3
181270	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
181350	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
181400	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
181405	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
181430	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
181450	12q24.21	Ulnar-mammary syndrome	181450	AD	3
181460	5q31-q33	{Schistosoma mansoni infection, susceptibility/resistance to}	181460	AD	2
181510	5q23-q35	{Schizophrenia}	181500	AD	2
181590	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
181600	4q22.3	Huriez syndrome	181600	AD	3
181800	19p13.3	Scoliosis, idiopathic 1	181800	AD	2
182000	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
182100	19q13.33	[Bombay phenotype, digenic]	616754	AR	3
182100	19q13.33	{Norwalk virus infection, resistance to}	_	_	3
182100	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
182120	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
182125	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
182135	13q14.2	{Alcohol dependence, susceptibility to}	103780	Mu	3
182135	13q14.2	{Anorexia nervosa, susceptibility to}	606788	_	3
182135	13q14.2	{Major depressive disorder, response to citalopram therapy in}	608516	_	3
182135	13q14.2	{Obsessive-compulsive disorder, susceptibility to}	164230	AD	3
182135	13q14.2	{Schizophrenia, susceptibility to}	181500	AD	3
182135	13q14.2	{Seasonal affective disorder, susceptibility to}	608516	_	3
182138	17q11.2	{Anxiety-related personality traits}	607834	_	3
182138	17q11.2	{Obsessive-compulsive disorder}	164230	AD	3
182170	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
182212	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
182250	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
182279	15q11.2	Prader-Willi syndrome	176270	AD	3
182280	3p23-p21	Small-cell cancer of lung	182280	AD	2
182282	20p13	Cerebrocostomandibular syndrome	117650	AD	3
182283	17q12	{HIV infection, resistance to}	609423	_	2
182290	17p11.2	Smith-Magenis syndrome	182290	AD,IC	3
182307	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
182309	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
182309	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
182309	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
182310	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
182310	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
182330	1q24.2	[Blood pressure regulation QTL]	145500	Mu	2
182340	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
182340	1q23.2	Migraine, familial basilar	602481	AD	3
182340	1q23.2	Migraine, familial hemiplegic, 2	602481	AD	3
182350	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
182350	19q13.2	CAPOS syndrome	601338	AD	3
182350	19q13.2	Dystonia-12	128235	AD	3
182380	22q12.3	Glucose/galactose malabsorption	606824	AR	3
182381	16p11.2	Renal glucosuria	233100	AD,AR	3
182389	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 2	604403	AD	3
182389	2q24.3	Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)	607208	AD	3
182389	2q24.3	Febrile seizures, familial, 3A	604403	AD	3
182389	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
182390	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
182390	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
182391	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
182391	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
182410	22q11.1	?Sneddon syndrome	182410	AR	3
182455	16p13.3	Somatostatin analog, resistance to	_	_	3
182465	21q22.11	ZTTK syndrome	617140	AD	3
182500	15q21.1	?Cataract, congenital	182500	_	2
182530	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
182530	2p22.1	Noonan syndrome 4	610733	AD	3
182600	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
182601	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
182810	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
182860	1q23.1	Elliptocytosis-2	130600	AD	3
182860	1q23.1	Pyropoikilocytosis	266140	AR	3
182860	1q23.1	Spherocytosis, type 3	270970	AR	3
182870	14q23.3	Anemia, neonatal hemolytic, fatal or near-fatal	617948	_	3
182870	14q23.3	Elliptocytosis-3	617948	_	3
182870	14q23.3	Spherocytosis, type 2	616649	AD	3
182888	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
182889	7q11.23	Oocyte maturation defect 3	617712	AD	3
182900	8p11.21	Spherocytosis, type 1	182900	AD,AR	3
182920	5q31.2	Myopathy, spheroid body	182920	AD	3
182960	7q34-q36	Neuronopathy, distal hereditary motor, type I	182960	AD	2
182980	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
183086	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
183600	7q21.2-q21.3	Split hand/foot malformation 1	183600	AD	4
183840	9q31-q34	{Spondyloarthropathy, susceptibility to, 2}	183840	AD	2
183900	12q13.11	SED congenita	183900	AD	3
184095	12q24.11	SED, Maroteaux type	184095	AD	3
184100	12q13	Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100	AD	2
184250	12q13.11	SMED Strudwick type	184250	AD	3
184252	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
184255	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
184260	14q32.12	Osteochondrodysplasia	184260	AR	3
184420	8p23.1	Squalene synthase deficiency	618156	_	3
184429	3q26.33	Microphthalmia, syndromic 3	206900	AD	3
184429	3q26.33	Optic nerve hypoplasia and abnormalities of the central nervous system	206900	AD	3
184450	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
184460	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
184500	17q21.2	Steatocystoma multiplex	184500	AD	3
184600	3q21.1	Peeling skin syndrome 4	607936	AR	3
184700	19p13.2	Polycystic ovary syndrome 1	184700	AD	2
184745	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
184745	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
184745	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
184755	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
184757	9q33.3	46, XX sex reversal 4	617480	AD	3
184757	9q33.3	46XY sex reversal 3	612965	AD	3
184757	9q33.3	Adrenocortical insufficiency	612964	AD	3
184757	9q33.3	Premature ovarian failure 7	612964	AD	3
184757	9q33.3	Spermatogenic failure 8	613957	AD	3
184840	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
184900	15q21.1	Stiff skin syndrome	184900	AD	3
185000	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
185020	17q21.31	Cryohydrocytosis	185020	AD	3
185070	11p15.4	Stormorken syndrome	185070	AD	3
185100	7p22.1	{Strabismus, susceptibility to, 1}	185100	_	2
185250	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
185300	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
185470	1p36.13	Gastrointestinal stromal tumor	606764	AD,IC	3
185470	1p36.13	Paraganglioma and gastric stromal sarcoma	606864	_	3
185470	1p36.13	Paragangliomas 4	115310	AD	3
185470	1p36.13	Pheochromocytoma	171300	AD	3
185490	4p15.2	[Superoxide dismutase, elevated extracellular]	_	_	3
185500	7q11.23	Supravalvar aortic stenosis	185500	AD	3
185535	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
185535	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
185605	12q21.2	Baker-Gordon syndrome	618218	AD	3
185620	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
185620	9q34.2	Leigh syndrome, due to COX IV deficiency	256000	Mi,AR	3
185800	17q22	Symphalangism, proximal, 1A	185800	AD	3
185880	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
185880	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
185900	2q34-q36	Syndactyly, type 1, with or without craniosynostosis	185900	AD	4
186000	2q31.1	Synpolydactyly 1	186000	AD	3
186100	6q22.31	Syndactyly, type III	186100	AD	3
186200	7q36.3	Syndactyly, type IV	186200	AD	3
186300	2q31.1	Syndactyly, type V	186300	AD	3
186357	1p35.2	{Obesity, association with}	601665	AD,AR,Mu	3
186500	17q22	Multiple synostoses syndrome 1	186500	AD	3
186550	5q31.1	Liebenberg syndrome	186550	AD	4
186570	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
186580	16q12.1	Blau syndrome	186580	AD	3
186711	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
186740	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
186780	1q24.2	?Immunodeficiency 25	610163	AR	3
186790	11q23.3	Immunodeficiency 19	615617	AR	3
186830	11q23.3	Immunodeficiency 18	615615	AR	3
186830	11q23.3	Immunodeficiency 18, SCID variant	615615	AR	3
186845	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
186855	9q31.2	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
186860	2q34	Leukemia/lymphoma, T-cell	186860	_	2
186880	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
186910	2p11.2	CD8 deficiency, familial	608957	AR	3
186921	11p15.4	Leukemia, T-cell acute lymphoblastic	186921	_	2
186940	12p13.31	OKT4 epitope deficiency	613949	_	3
186960	14q32.13	Leukemia/lymphoma, T-cell	186960	_	2
186973	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
187011	17q12	{HIV-1 disease, delayed progression of}	_	_	3
187011	17q12	{HIV-1 disease, rapid progression of}	_	_	3
187040	1p33	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
187260	5q14	Telangiectasia, hereditary benign	187260	AD	2
187270	5p15.33	{Dyskeratosis congenita, autosomal dominant 2}	613989	AD,AR	3
187270	5p15.33	{Dyskeratosis congenita, autosomal recessive 4}	613989	AD,AR	3
187270	5p15.33	{Leukemia, acute myeloid}	601626	AD,SMu	3
187270	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
187270	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
187300	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
187370	2q31.3-q32.1	Arthrogryposis, distal, type 10	187370	AD	2
187380	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
187395	3p21.31	Forebrain defects	_	_	3
187600	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
187601	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
187680	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
187900	9q34.13	Bleeding disorder, platelet-type, 17	187900	AD,AR	3
188000	10p12.1	Thrombocytopenia 2	188000	AD	3
188025	11q23	?Thrombocytopenia, Paris-Trousseau type	188025	IC	4
188030	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
188040	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
188040	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
188061	6q27	{Lumbar disc herniation, susceptibility to}	603932	_	3
188070	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
188250	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
188250	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
188400	22q11.21	DiGeorge syndrome	188400	AD	3
188450	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
188450	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
188540	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
188545	8q23.1	Thyrotropin-releasing hormone resistance, generalized	_	_	3
188550	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
188570	3p24.2	Thyroid hormone resistance	188570	AD	3
188580	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
188740	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
188826	22q12.3	Sorsby fundus dystrophy	136900	AD	3
188830	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
188830	17q24.2	Adrenocortical tumor, somatic	_	_	3
188830	17q24.2	Carney complex, type 1	160980	AD	3
188830	17q24.2	Myxoma, intracardiac	255960	AD	3
188830	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
188840	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
188840	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
188840	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
188840	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
188840	2q31.2	Salih myopathy	611705	AR	3
188840	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
189500	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
189800	2p13	Preeclampsia/eclampsia 1	189800	AD	2
189907	17q12	Diabetes mellitus, noninsulin-dependent	125853	AD	3
189907	17q12	Renal cysts and diabetes syndrome	137920	AD	3
189907	17q12	{Renal cell carcinoma}	144700	_	3
189909	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
189909	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
189964	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
189967	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
189980	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
189980	9q34.12	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	_	_	3
189990	6q23.3	{T-cell acute lymphoblastic leukemia}	_	_	3
190000	3q22.1	Atransferrinemia	209300	AR	3
190010	3q29	Immunodeficiency 46	616740	AR	3
190020	11p15.5	Bladder cancer, somatic	109800	_	3
190020	11p15.5	Congenital myopathy with excess of muscle spindles	218040	AD	3
190020	11p15.5	Costello syndrome	218040	AD	3
190020	11p15.5	Nevus sebaceous or woolly hair nevus, somatic	162900	_	3
190020	11p15.5	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190020	11p15.5	Spitz nevus or nevus spilus, somatic	137550	_	3
190020	11p15.5	Thyroid carcinoma, follicular, somatic	188470	_	3
190040	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
190040	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
190040	22q13.1	Meningioma, SIS-related	607174	AD	3
190070	12p12.1	Arteriovenous malformation of the brain, somatic	108010	_	3
190070	12p12.1	Bladder cancer, somatic	109800	_	3
190070	12p12.1	Breast cancer, somatic	114480	_	3
190070	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
190070	12p12.1	Gastric cancer, somatic	137215	_	3
190070	12p12.1	Leukemia, acute myeloid	601626	AD,SMu	3
190070	12p12.1	Lung cancer, somatic	211980	_	3
190070	12p12.1	Noonan syndrome 3	609942	AD	3
190070	12p12.1	Pancreatic carcinoma, somatic	260350	_	3
190070	12p12.1	RAS-associated autoimmune leukoproliferative disorder	614470	AD	3
190070	12p12.1	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190080	8q24.21	Burkitt lymphoma, somatic	113970	_	3
190090	20q11.23	?Thrombocytopenia 6	616937	AD	3
190090	20q11.23	Colon cancer, advanced, somatic	114500	_	3
190100	9q13-q21	Geniospasm	190100	AD	2
190120	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
190151	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
190151	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
190160	3p24.2	Thyroid hormone resistance	188570	AD	3
190160	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
190160	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
190180	19q13.2	Camurati-Engelmann disease	131300	AD	3
190180	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
190180	19q13.2	{Cystic fibrosis lung disease, modifier of}	219700	AR	3
190181	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
190181	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
190182	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
190182	3p24.1	Esophageal cancer, somatic	133239	_	3
190182	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
190195	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
190197	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
190198	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
190198	9q34.3	Aortic valve disease 1	109730	AD	3
190220	1q41	Loeys-Dietz syndrome 4	614816	AD	3
190230	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
190230	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
190300	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
190315	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
190315	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
190320	17q21.33	Trichodontoosseous syndrome	190320	AD	3
190330	4q21.21	Trichomegaly	190330	AR	3
190350	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
190351	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
190370	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
190440	8p11.23	Trigonocephaly 1	190440	AD	3
190450	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
190685	21q22.3	Down syndrome	190685	IC	4
190900	7q32.1	Colorblindness, tritan	190900	AD	3
190990	9p13.3	Arthrogryposis, distal, type 1A	108120	AD	3
190990	9p13.3	Arthrogryposis, distal, type 2B4	108120	AD	3
190990	9p13.3	CAP myopathy 2	609285	AD	3
190990	9p13.3	Nemaline myopathy 4, autosomal dominant	609285	AD	3
191010	15q22.2	Cardiomyopathy, dilated, 1Y	611878	AD	3
191010	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
191010	15q22.2	Left ventricular noncompaction 9	611878	AD	3
191030	1q21.3	CAP myopathy 1	609284	AD,AR	3
191030	1q21.3	Myopathy, congenital, with fiber-type disproportion	255310	AD,AR	3
191030	1q21.3	Nemaline myopathy 1, autosomal dominant or recessive	609284	AD,AR	3
191040	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
191040	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
191041	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
191043	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
191044	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
191044	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
191044	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
191044	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
191045	1q32.1	Cardiomyopathy, dilated, 1D	601494	AD	3
191045	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
191045	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
191045	1q32.1	Left ventricular noncompaction 6	601494	AD	3
191050	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
191070	4q32.1	[?Hypertryptophanemia]	600627	AR	3
191092	16p13.3	?Focal cortical dysplasia, type II, somatic	607341	_	3
191092	16p13.3	Lymphangioleiomyomatosis, somatic	606690	_	3
191092	16p13.3	Tuberous sclerosis-2	613254	AD	3
191100	9q34.13	Tuberous sclerosis-1	191100	AD	3
191110	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
191130	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
191130	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
191135	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
191160	6p21.33	{Asthma, susceptibility to}	600807	AD	3
191160	6p21.33	{Dementia, vascular, susceptibility to}	_	_	3
191160	6p21.33	{Malaria, cerebral, susceptibility to}	611162	_	3
191160	6p21.33	{Migraine without aura, susceptibility to}	157300	AD	3
191160	6p21.33	{Septic shock, susceptibility to}	_	_	3
191163	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
191170	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
191170	17p13.1	Breast cancer, somatic	114480	_	3
191170	17p13.1	Hepatocellular carcinoma, somatic	114550	_	3
191170	17p13.1	Li-Fraumeni syndrome	151623	AD	3
191170	17p13.1	Nasopharyngeal carcinoma, somatic	607107	_	3
191170	17p13.1	Pancreatic cancer, somatic	260350	_	3
191170	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
191170	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
191170	17p13.1	{Choroid plexus papilloma}	260500	AD	3
191170	17p13.1	{Colorectal cancer}	114500	AD,SMu	3
191170	17p13.1	{Glioma susceptibility 1}	137800	AD,SMu	3
191170	17p13.1	{Osteosarcoma}	259500	SMu	3
191181	11q13	Cervical carcinoma	191181	_	2
191190	12p13.31	Periodic fever, familial	142680	AD	3
191190	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
191195	10p11.23	Lung cancer, somatic	211980	_	3
191290	11p15.5	Segawa syndrome, recessive	605407	AR	3
191305	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
191306	4q12	Hemangioma, capillary infantile, somatic	602089	_	3
191306	4q12	{Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
191311	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
191311	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
191315	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
191315	1q23.1	Medullary thyroid carcinoma, familial	155240	AD	3
191329	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
191330	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
191342	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
191342	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
191350	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
191350	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
191390	7q22	{Inflammatory bowel disease 11}	191390	Mu	2
191480	1p36.13	Uncombable hair syndrome	191480	AR	3
191523	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
191525	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
191540	1p22	[Urate oxidase deficiency]	_	_	1
191740	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
191740	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
191740	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
191740	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
191740	2q37.1	[Gilbert syndrome]	143500	AR	3
191830	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
191840	10q22.2	Quebec platelet disorder	601709	AD	3
191840	10q22.2	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
191845	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
191845	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
191845	16p12.3	Medullary cystic kidney disease 2	603860	_	3
191900	1q44	Muckle-Wells syndrome	191900	AD	3
192090	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
192090	16q22.1	Endometrial carcinoma, somatic	608089	_	3
192090	16q22.1	Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate	137215	AD	3
192090	16q22.1	Ovarian cancer, somatic	167000	_	3
192090	16q22.1	{Breast cancer, lobular}	114480	AD,SMu	3
192090	16q22.1	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
192132	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
192150	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
192240	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
192315	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
192340	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
192430	22q11.21	Velocardiofacial syndrome	192430	AD	3
192605	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
192974	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
192977	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
193000	1p13	Vesicoureteral reflux	193000	AD	2
193001	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
193003	13q31-q33	Nystagmus 4, congenital, autosomal dominant	193003	AD	2
193007	6q	Vestibulopathy, familial	193007	AD	2
193060	10p13	Cataract 30, pulverulent	116300	AD	3
193065	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
193065	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
193067	11q24.3	Bleeding disorder, platelet-type, 21	617443	AD,AR	3
193100	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
193200	6p21.3	{Vitiligo-associated multiple autoimmune disease susceptibility 6}	193200	AR	2
193230	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
193235	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
193400	12p13.31	von Willebrand disease, type 1	193400	AD	3
193500	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
193510	3p13	Waardenburg syndrome, type 2A	193510	AD	3
193520	17q11.2	Watson syndrome	193520	AD	3
193670	2q22.1	WHIM syndrome	193670	AD	3
193700	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
193900	12q13.13	White sponge nevus 1	193900	AD	3
194050	7q11.23	Williams-Beuren syndrome	194050	AD	4
194071	11p15.5	Wilms tumor 2	194071	AD,SMu	3
194072	11p13	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	AD,SMu	4
194080	11p13	Denys-Drash syndrome	194080	AD,SMu	3
194090	16q	Wilms tumor, type 3	194090	AD	2
194190	4p16.3	Wolf-Hirschhorn syndrome	194190	IC	4
194200	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
194300	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
194355	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
194360	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
194363	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
194380	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
194648	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
195000	11q12.2	Oocyte maturation defect 1	615774	AR	3
200100	4q23	Abetalipoproteinemia	200100	AR	3
200110	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
200150	9q21.2	Choreoacanthocytosis	200150	AR	3
200350	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
200500	7q36.3	Acheiropody	200500	AR	3
200600	14q32.12	Achondrogenesis, type IA	200600	AR	3
200610	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
200700	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
200950	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
201000	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
201100	8q24.3	Acrodermatitis enteropathica	201100	AR	3
201250	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
201300	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
201400	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
201450	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
201470	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
201475	17p13.1	VLCAD deficiency	201475	AR	3
201710	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
201750	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
201810	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
202010	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
202200	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
202300	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
202370	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
202650	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
202700	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
203100	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
203290	9p23	Albinism, oculocutaneous, type III	203290	AR	3
203300	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
203400	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
203450	17q21.31	Alexander disease	203450	AD	3
203500	3q13.33	Alkaptonuria	203500	AR	3
203650	3q26.3-q27.3	Alopecia-mental retardation syndrome 1	203650	AR	2
203655	8p21.3	Alopecia universalis	203655	AR	3
203700	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
203740	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
203750	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
203800	2p13.1	Alstrom syndrome	203800	AR	3
204000	17p13.1	Leber congenital amaurosis 1	204000	AR	3
204100	1p31.3	Leber congenital amaurosis 2	204100	AR	3
204200	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
204300	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
204500	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
204650	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
204690	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
204700	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
204750	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
204870	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
205100	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
205400	9q31.1	Tangier disease	205400	AR	3
205950	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
206100	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
206200	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
206500	5q22.3	?Anencephaly	206500	AR	3
206700	3p26.1	Gillespie syndrome	206700	AD,AR	3
206800	20p13	Anonychia congenita	206800	AR	3
206920	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
207410	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
207750	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
207800	6q23.2	Argininemia	207800	AR	3
207900	7q11.21	Argininosuccinic aciduria	207900	AR	3
208000	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
208050	20q13.12	Arterial tortuosity syndrome	208050	AR	3
208085	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
208100	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
208150	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
208250	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
208400	4q34.3	Aspartylglucosaminuria	208400	AR	3
208500	15q13	Short-rib thoracic dysplasia 1 with or without polydactyly	208500	AR	2
208530	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
208540	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
208900	11q22.3	Ataxia-telangiectasia	208900	AR	3
208920	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
209300	3q22.1	Atransferrinemia	209300	AR	3
209500	8p21.3	Atrichia with papular lesions	209500	AR	3
209850	7q22	{Autism susceptibility 1}	209850	IC,Mu	2
209885	2q37.3	Barber-Say syndrome	209885	AD	3
209901	11q13.2	Bardet-Biedl syndrome 1	209900	DR,AR	3
209950	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
210000	3q29	Behr syndrome	210000	AR	3
210100	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
210200	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
210210	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
210370	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
210600	3q23	Seckel syndrome 1	210600	AR	3
210710	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
210720	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
210900	15q26.1	Bloom syndrome	210900	AR	3
211100	19q13.33	[Bombay phenotype]	616754	AR	3
211180	12p13.31	Bowen-Conradi syndrome	211180	AR	3
211380	16q21	Elsahy-Waters syndrome	211380	AR	3
211500	20p13	?Fazio-Londe disease	211500	AR	3
211530	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
211600	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
211750	3q13.1-q13.2	C syndrome	211750	AD	3
211800	6q14.3	Calcification of joints and arteries	211800	AR	3
211900	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
212050	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
212065	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
212066	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
212070	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
212093	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
212112	1q22	Malouf syndrome	212112	AD	3
212138	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
212140	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
212200	18q21.3	Carnosinemia	212200	AR	2
212350	7q34	Sengers syndrome	212350	AR	3
212500	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
212550	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
212720	1q41	Martsolf syndrome	212720	AR	3
212780	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
212840	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
213200	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
213300	9q34.3	Joubert syndrome 1	213300	AR	3
213600	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
213700	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
213980	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
214100	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
214110	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
214150	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
214300	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
214350	21q22.3	CHAND syndrome	214350	AR	3
214400	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
214450	15q21.2	Griscelli syndrome, type 1	214450	AR	3
214500	1q42.3	Chediak-Higashi syndrome	214500	AR	3
214700	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
214900	15q	Cholestasis-lymphedema syndrome	214900	AR	2
214950	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
215045	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
215100	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
215140	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
215150	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
215300	8q24.11	Chondrosarcoma	215300	AR	3
215400	6q27	{Chordoma, susceptibility to}	215400	AD	4
215470	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
215500	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
215700	9q34.11	Citrullinemia	215700	AR	3
216340	6q21	Yunis-Varon syndrome	216340	AR	3
216400	5q12.1	Cockayne syndrome, type A	216400	AR	3
216550	8q22.2	Cohen syndrome	216550	AR	3
216820	14q11.2	?Coloboma, ocular, autosomal recessive	216820	AR	3
216900	2q11.2	Achromatopsia 2	216900	AR	3
217000	6p21.33	C2 deficiency	217000	AR	3
217030	4q25	Complement factor I deficiency	610984	AR	3
217030	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
217030	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
217050	5p13.1	C6 deficiency	612446	_	3
217050	5p13.1	Combined C6/C7 deficiency	_	_	3
217070	5p13.1	C7 deficiency	610102	_	3
217080	2q11.2	Jalili syndrome	217080	AR	3
217085	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
217300	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
217400	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
217700	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
217800	16q23.1	Macular corneal dystrophy	217800	AR	3
218000	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
218030	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
218330	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
218340	12p13.31	Temtamy syndrome	218340	AR	3
218400	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
218600	8q24.3	Baller-Gerold syndrome	218600	AR	3
218700	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
218800	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
219000	4q21.21	Fraser syndrome 1	219000	AR	3
219050	19p13.11	Cryptorchidism	219050	AD	3
219080	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
219090	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
219100	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
219150	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
219200	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
219500	1p31.1	Cystathioninuria	219500	AR	3
219730	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
219750	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
219900	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
220111	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
220120	3p21.2	D-glyceric aciduria	220120	AR	3
220150	11q13.1	Hypouricemia, renal	220150	AR	3
220200	3q22-q24	Dandy-Walker syndrome	220200	IC	4
220210	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
220400	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
220500	16p13.3	DOORS syndrome	220500	AR	3
220600	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
221200	13q31.1	Deafness and myopia	221200	AR	3
221750	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
221770	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
221820	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
221900	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
222100	6p21.3	{Diabetes mellitus, insulin-dependent-1}	222100	AR	2
222300	4p16.1	Wolfram syndrome 1	222300	AR	3
222400	8p23.1	Hernia, congenital diaphragmatic 2	222400	AR	2
222448	2q31.1	Donnai-Barrow syndrome	222448	AR	3
222470	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
222700	14q11.2	Lysinuric protein intolerance	222700	AR	3
222730	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
222748	8q22.3	Dihydropyrimidinuria	222748	AR	3
222765	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
222800	7q33	Erythrocytosis, familial, 8	222800	AR	3
222900	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
223000	2q21.3	Lactase deficiency, congenital	223000	AR	3
223100	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
223360	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
223800	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
223900	9q31.3	Dysautonomia, familial	223900	AR	3
224050	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
224100	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
224120	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
224230	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
224410	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
224500	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
224690	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
224750	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
224900	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
225100	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
225200	1q21.2	Ectopia lentis et pupillae	225200	AR	3
225250	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
225280	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
225300	12q13.12	Split-hand/foot malformation 6	225300	AR	3
225320	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
225400	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
225410	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
225750	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AD,AR	3
225753	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
225790	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
226200	21q21.1	Enterokinase deficiency	226200	AR	3
226300	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
226400	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
226670	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
226750	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
226900	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
226980	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
226990	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
227050	19q13.2	Transient erythroblastopenia of childhood	227050	AR	2
227260	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
227300	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
227400	1q24.2	Factor V deficiency	227400	AR	3
227500	13q34	Factor VII deficiency	227500	AR	3
227600	13q34	Factor X deficiency	227600	AR	3
227645	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
227646	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
227650	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
227810	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
228000	8p22	Farber lipogranulomatosis	228000	AR	3
228300	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
228520	1p21.1	Fibrochondrogenesis 1	228520	AR	3
228550	5q32	Myofibromatosis, infantile, 1	228550	AD	3
228600	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
228900	20q11.22	Du Pan syndrome	228900	AR	3
228930	3p25.1	Fuhrmann syndrome	228930	AR	3
228980	1p36.13	[Fleck retina, familial benign]	228980	AR	3
229000	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
229050	17q11.2	Folate malabsorption, hereditary	229050	AR	3
229070	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
229100	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
229200	16q24.2	Brittle cornea syndrome 1	229200	AR	3
229600	9q31.1	Fructose intolerance, hereditary	229600	AR	3
229700	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
229800	2p23.3	[Fructosuria]	229800	AR	3
230000	1p36.11	Fucosidosis	230000	AR	3
230200	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
230350	1p36.11	Galactose epimerase deficiency	230350	AR	3
230400	9p13.3	Galactosemia	230400	AR	3
230450	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
230500	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
230600	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
230650	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
230740	2p13.3	GAPO syndrome	230740	AR	3
230800	1q22	Gaucher disease, type I	230800	AR	3
230900	1q22	Gaucher disease, type II	230900	AR	3
231000	1q22	Gaucher disease, type III	231000	AR	3
231005	1q22	Gaucher disease, type IIIC	231005	AR	3
231050	9q34.2	Geleophysic dysplasia 1	231050	AR	3
231070	1q24.2	Geroderma osteodysplasticum	231070	AR	3
231090	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
231095	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
231300	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
231530	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
231550	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
231670	19p13.13	Glutaricaciduria, type I	231670	AR	3
231675	4q32.1	Glutaric acidemia IIC	231680	AR	3
231690	7p14.1	Glutaric aciduria III	231690	AR	3
231900	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
231950	22q11.23	?Glutathioninuria	231950	AR	3
232000	13q32.3	Propionicacidemia	606054	AR	3
232050	3q22.3	Propionicacidemia	606054	AR	3
232200	17q21.31	Glycogen storage disease Ia	232200	AR	3
232220	11q23.3	Glycogen storage disease Ib	232220	AR	3
232240	11q23.3	Glycogen storage disease Ic	232240	AR	3
232300	17q25.3	Glycogen storage disease II	232300	AR	3
232500	3p12.2	Glycogen storage disease IV	232500	AR	3
232600	11q13.1	McArdle disease	232600	AR	3
232700	14q22.1	Glycogen storage disease VI	232700	AR	3
232800	12q13.11	Glycogen storage disease VII	232800	AR	3
233100	16p11.2	Renal glucosuria	233100	AD,AR	3
233300	2p16.3	Ovarian dysgenesis 1	233300	AR	3
233400	5q23.1	Perrault syndrome 1	233400	AR	3
233420	12q13.12	46XY sex reversal 7	233420	AR	3
233600	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
233690	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
233700	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
233710	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
233910	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
234000	5q35.3	Factor XII deficiency	234000	AR	3
234050	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
234200	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
234500	5p15.33	Hartnup disorder	234500	AR	3
234580	7q21.2	Heimler syndrome 1	234580	AR	3
234810	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
235000	11p15	Hemihypertrophy	235000	AD	2
235510	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
235550	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
235555	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
235700	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
235730	2q22.3	Mowat-Wilson syndrome	235730	AD	3
235800	12q23.1	[Histidinemia]	235800	AD,AR	3
236000	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
236100	21q22.3	Holoprosencephaly 1	236100	AD,IC	2
236250	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
236270	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
236500	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
236600	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
236670	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
236680	11q24.2	Hydrolethalus syndrome	236680	AR	3
236700	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
236730	10q24.2	Urofacial syndrome 1	236730	AR	3
236792	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
236800	2q22.2	?Hydroxykynureninuria	236800	AR	3
237300	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
237310	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
237500	10q24.2	Dubin-Johnson syndrome	237500	AR	3
237900	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
238300	9p24.1	Glycine encephalopathy	605899	AR	3
238310	3p21.31	Glycine encephalopathy	605899	AR	3
238330	16q23.2	?Glycine encephalopathy	605899	AR	3
238331	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
238700	7q31.32	Hyperlysinemia	238700	AR	3
238970	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
239000	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
239100	17q21.31	Van Buchem disease	239100	AR	3
239200	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
239300	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
239500	22q11.21	Hyperprolinemia, type I	239500	AR	3
239510	1p36.13	Hyperprolinemia, type II	239510	AR	3
239850	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
240300	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AD,AR	3
240400	8p21.1	Scurvy	_	_	3
240500	17p11.2	Immunodeficiency, common variable, 2	240500	AD,AR	3
240600	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
240800	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
240900	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
241080	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
241200	11q24.3	Bartter syndrome, type 2	241200	AR	3
241410	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
241500	1p36.12	Hypophosphatasia, infantile	241500	AR	3
241510	1p36.12	Hypophosphatasia, childhood	241510	AR	3
241520	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
241530	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
241550	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
241600	15q21.1	Immunodeficiency 43	241600	AR	3
241800	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
241850	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
242100	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
242300	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
242500	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
242840	18q12.3-q21.1	Vici syndrome	242840	AR	3
242860	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
242900	2q35	Schimke immunoosseous dysplasia	242900	AR	3
243060	19q13.43	Spermatogenic failure 5	243060	AR	3
243150	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
243300	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
243305	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
243310	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
243400	8p22	[Acetylation, slow]	243400	AR	3
243500	15q15.1	Isovaleric acidemia	243500	AR	3
243605	1q41	Stromme syndrome	243605	AR	3
243700	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
243800	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
244200	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
244400	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
244450	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
244460	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
245000	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
245010	11q14.2	Haim-Munk syndrome	245010	AR	3
245050	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
245150	12p12.3	Keutel syndrome	245150	AR	3
245200	14q31.3	Krabbe disease	245200	AR	3
245300	20p13	{Kuru, susceptibility to}	245300	_	3
245340	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
245348	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
245349	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
245400	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
245450	16q23.1	D-lactic aciduria	245450	AR	3
245480	14q11.2	Specific granule deficiency	245480	AR	3
245570	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
245590	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
245600	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
245660	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
245800	19p13.2	?Laurence-Moon syndrome	245800	AR	3
245900	16q22.1	Norum disease	245900	AR	3
246200	19p13.2	Leprechaunism	246200	AR	3
246300	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
246450	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
246530	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
246560	10q24	Split-hand/foot malformation 3, gene duplication syndrome	246560	AD	4
246600	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
246650	16p13.3	Lipase deficiency, combined	246650	AR	3
246700	5q31.1	Chylomicron retention disease	246700	AR	3
246900	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
247100	1q21.2	Urbach-Wiethe disease	247100	AR	3
247200	17p13.3	Miller-Dieker lissencephaly syndrome	247200	AD	4
247420	19q13.32	[Blood group, Lutheran null]	247420	AR	3
247640	9p22-p21	Leukemia, acute lymphoblastic	247640	AR	2
248000	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
248190	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
248250	3q28	Hypomagnesemia 3, renal	248250	AR	3
248300	8q24.3	Meleda disease	248300	AR	3
248310	5q31-q33	{Malaria, intensity of infection}	248310	AR	2
248340	8q24.12	3MC syndrome 3	248340	AR	3
248360	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
248370	1q22	Mandibuloacral dysplasia	248370	AR	3
248390	6p21.1	Treacher Collins syndrome 3	248390	AR	3
248450	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
248500	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
248510	4q24	Mannosidosis, beta	248510	AR	3
248610	1p21.2	Maple syrup urine disease, type II	248600	AR	3
248611	6q14.1	Maple syrup urine disease, type Ib	248600	AR	3
248700	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
248800	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
248900	15q22.31	Mast syndrome	248900	AR	3
249000	17q22	Meckel syndrome 1	249000	AR	3
249100	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
249270	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
249400	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
249420	5q35.1	Frank-ter Haar syndrome	249420	AR	3
249500	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
249900	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
250100	22q13.33	Metachromatic leukodystrophy	250100	AR	3
250220	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
250250	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
250400	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
250410	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
250460	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
250620	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
250790	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
250940	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
250950	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
251000	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
251100	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
251110	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
251120	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
251170	12q24.11	Hyper-IgD syndrome	260920	AR	3
251170	12q24.11	Mevalonic aciduria	610377	AR	3
251170	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
251200	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
251230	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
251255	18q11.2	Jawad syndrome	251255	AR	3
251260	8q21.3	Nijmegen breakage syndrome	251260	AR	3
251270	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
251280	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
251290	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
251300	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
251450	17q25.3	Desbuquois dysplasia 1	251450	AR	3
251600	14q32	Microphthalmia, isolated 1	251600	AR	2
251750	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
251850	18q21.1	Microvillus inclusion disease	251850	AR	3
251880	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
251900	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
251950	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
252010	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
252150	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
252160	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
252270	7q	Myelodysplasia and leukemia syndrome with monosomy 7	252270	AR	4
252350	3p26-p24.2	Moyamoya disease	252350	AR	2
252500	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
252600	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
252605	16p13.3	Mucolipidosis III gamma	252605	AR	3
252650	19p13.2	Mucolipidosis IV	252650	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
252800	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
252900	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
252920	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
252930	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
252940	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
253000	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
253010	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
253200	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
253220	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
253250	17q22	Mulibrey nanism	253250	AR	3
253260	3p25.1	Biotinidase deficiency	253260	AR	3
253270	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
253280	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
253300	5q13.2	Spinal muscular atrophy-1	253300	AR	3
253310	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
253550	5q13.2	Spinal muscular atrophy-2	253550	AR	3
253600	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
253601	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
253700	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
253800	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
254110	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
254130	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
254210	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
254300	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
254600	17q22	Myeloperoxidase deficiency	254600	AR	3
254770	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
254800	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
254900	4q21.1	Epilepsy, progressive myoclonic 4, with or without renal failure	254900	AR	3
254940	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
255100	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
255110	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
255120	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
255125	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
255160	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
255200	2q14.3	Centronuclear myopathy 2	255200	AR	3
255320	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
255500	14q22.1-q24.2	Myopia 18	255500	AR	2
255600	21q22.3	?Myosclerosis, congenital	255600	AR	3
255700	7q34	Myotonia congenita, recessive	255700	AR	3
255800	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
255960	17q24.2	Myxoma, intracardiac	255960	AD	3
255995	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
256030	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
256040	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
256100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
256300	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
256370	11p13	Nephrotic syndrome, type 4	256370	AD	3
256450	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
256500	5q32	Netherton syndrome	256500	AR	3
256520	1p12	Neu-Laxova syndrome 1	256520	AR	3
256540	20q13.12	Galactosialidosis	256540	AR	3
256600	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
256730	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
256731	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
256800	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
256810	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
256840	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
256850	16q23.2	Giant axonal neuropathy-1	256850	AR	3
257200	11p15.4	Niemann-Pick disease, type A	257200	AR	3
257270	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
257300	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
257320	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
257550	2q13	Oculomotor apraxia, congenital, Cogan-type	257550	AR	2
257850	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
257920	3q27.3	3MC syndrome 1	257920	AR	3
257980	2q35	Odontoonychodermal dysplasia	257980	AR	3
258100	2q37.1	Oguchi disease-1	258100	AR	3
258315	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
258450	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
258480	11q13.4	Opsismodysplasia	258480	AR	3
258500	8q21-q22	Optic atrophy 6	258500	AR	2
258501	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
258660	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
258860	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
258870	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
258900	3q21.2	Orotic aciduria	258900	AR	3
259050	3q13.31	Primrose syndrome	259050	AD	3
259440	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
259450	17q21.2	Bruck syndrome 1	259450	AR	3
259600	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
259700	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
259710	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
259720	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
259730	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
259770	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
259775	7p22.3	Raine syndrome	259775	AR	3
259900	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
260000	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
260005	8q24.3	5-oxoprolinase deficiency	260005	AD,AR	3
260300	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
260370	13q12.2	Pancreatic agenesis 1	260370	AR	3
260400	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
260500	17p13.1	{Choroid plexus papilloma}	260500	AD	3
260540	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
260565	17q12	PEHO syndrome	260565	AR	3
260600	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
260660	1p12	Cousin syndrome	260660	AR	3
260800	17q25.3	[Pentosuria]	260800	AR	3
260920	12q24.11	Hyper-IgD syndrome	260920	AR	3
261000	11q12.1	Intrinsic factor deficiency	261000	AR	3
261500	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
261515	5q23.1	D-bifunctional protein deficiency	261515	AR	3
261540	13q12.3	Peters-plus syndrome	261540	AR	3
261630	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
261640	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
261650	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
261670	7p13	Glycogen storage disease X	261670	AR	3
261680	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
261740	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
261750	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
261800	17q24.3-q25.1	Pierre Robin syndrome	261800	AR	2
261990	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
262000	2q35	Bjornstad syndrome	262000	AR	3
262190	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
262300	8q21.3	Achromatopsia 3	262300	AR	3
262400	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
262500	5p13-p12	Laron dwarfism	262500	AR	3
262600	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
262650	17q23.3	Kowarski syndrome	262650	AR	3
262700	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
262850	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
262890	12q12	Scott syndrome	262890	AR	3
263200	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
263210	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
263300	9p24.1	Polycythemia vera, somatic	263300	_	3
263400	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
263450	13q13.3-q21	Polydactyly, postaxial, type A5	263450	AR	2
263520	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	DR,AR	3
263570	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
263650	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
263700	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
263750	16q22.2	Miller syndrome	263750	AR	3
263800	16q13	Gitelman syndrome	263800	AR	3
264070	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
264080	11q22.1	?Progesterone resistance	264080	AR	2
264090	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
264300	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
264470	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
264600	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
264700	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
264900	4q35.2	Factor XI deficiency, autosomal dominant	612416	_	3
264900	4q35.2	Factor XI deficiency, autosomal recessive	612416	_	3
265000	2q37.1	Escobar syndrome	265000	AR	3
265050	2p25.3	3MC syndrome 2	265050	AR	3
265100	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
265120	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
265380	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
265450	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
265800	1q21.3	Pycnodysostosis	265800	AR	3
265900	7p14.1	Pyle disease	265900	AR	3
266100	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
266120	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
266130	20q11.22	Glutathione synthetase deficiency	266130	AR	3
266140	1q23.1	Pyropoikilocytosis	266140	AR	3
266150	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
266200	1q22	Pyruvate kinase deficiency	266200	AR	3
266265	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
266280	8q24.3	RAPADILINO syndrome	266280	AR	3
266500	10p13	Refsum disease	266500	AR	3
266510	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
266900	2q13	Senior-Loken syndrome-1	266900	AR	3
266920	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
267000	2q37.1	Perlman syndrome	267000	AR	3
267010	3q22.1	Meckel syndrome 7	267010	AR	3
267300	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
267500	1p35.1	Reticular dysgenesis	267500	AR	3
267700	9q21.3-q22	Hemophagocytic lymphohistiocytosis, familial, 1	267700	AR	2
267750	21q22.3	Knobloch syndrome, type 1	267750	AR	3
268100	15q23	Enhanced S-cone syndrome	268100	AR	3
268130	14q12	Revesz syndrome	268130	AD	3
268150	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
268200	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
268210	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
268300	8p21.1	Roberts syndrome	268300	AR	3
268305	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
268310	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
268400	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
268700	7q31.32	Saccharopinuria	268700	AR	1
268800	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
268900	9q34.2	[Sarcosinemia]	268900	AR	3
269000	8p21.1	SC phocomelia syndrome	269000	AR	3
269150	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
269250	1p31.3	Schneckenbecken dysplasia	269250	AR	3
269400	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
269500	17q21.31	Sclerosteosis 1	269500	AR	3
269600	19q13.32	Sea-blue histiocyte disease	269600	AR	3
269700	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
269840	2q11.2	Immunodeficiency 48	269840	AR	3
269880	5q13.1	SHORT syndrome	269880	AD	3
269920	6q13	Sialic acid storage disorder, infantile	269920	AR	3
269921	9p13.3	Sialuria	269921	AD	3
270100	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
270200	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
270300	6p21.33	Peeling skin syndrome 1	270300	AR	3
270400	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
270420	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
270450	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
270550	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
270685	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
270700	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
270750	1q32.1	Spastic paraplegia 23	270750	AR	3
270800	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
270970	1q23.1	Spherocytosis, type 3	270970	AR	3
271150	5q13.2	Spinal muscular atrophy-4	271150	AR	3
271245	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
271250	6p23-p21	Spinocerebellar ataxia, autosomal recessive 3	271250	AR	2
271400	3p22.1	Asplenia, isolated congenital	271400	AD	3
271640	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
271665	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
271700	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
271900	17p13.2	Canavan disease	271900	AR	3
271930	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
271980	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
272120	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
272200	3p26.1	Multiple sulfatase deficiency	272200	AR	3
272300	12q13.2	Sulfite oxidase deficiency	272300	AR	3
272430	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
272440	2q14.1	Filippi syndrome	272440	AR	3
272460	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
272750	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
273395	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
273750	6p21.1	3-M syndrome 1	273750	AR	3
273900	5p13.1	Thrombocytopenia 3	273900	AR	3
274000	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
274150	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
274180	7q34	?Thromboxane synthase deficiency	614158	AD	1
274180	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
274300	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
274400	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
274500	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
274600	7q22.3	Pendred syndrome	274600	AR	3
274700	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
274800	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
274900	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
275000	14q31	{Graves disease, susceptibility to, 1}	275000	AR	2
275100	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
275120	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
275200	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
275220	8q24.1	?Tibial hemimelia	275220	AR	2
275350	22q12.2	Transcobalamin II deficiency	275350	AR	3
275360	11q23.3	Trehalase deficiency	612119	AR	3
275400	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
275630	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
275900	13q13.3	Troyer syndrome	275900	AR	3
276000	7q34	Pancreatitis, hereditary	167800	AD	3
276000	7q34	Trypsinogen deficiency	614044	AR	1
276400	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
276600	16q22.2	Tyrosinemia, type II	276600	AR	3
276700	15q25.1	Tyrosinemia, type I	276700	AR	3
276710	12q24.31	Tyrosinemia, type III	276710	AR	3
276820	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
276880	3q21.3	?Urocanase deficiency	276880	AR	3
276900	11q13.5	Usher syndrome, type 1B	276900	AR	3
276902	3q25.1	Usher syndrome, type 3A	276902	AR	3
276903	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
276903	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
276903	11q13.5	Usher syndrome, type 1B	276900	AR	3
276904	11p15.1	Usher syndrome, type 1C	276904	AR	3
277170	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
277180	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
277300	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
277380	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
277440	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
277450	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
277460	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
277470	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
277480	12p13.31	von Willibrand disease, type 3	277480	AR	3
277580	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
277590	7q36.1	Weaver syndrome	277590	AD	3
277600	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
277700	8p12	Werner syndrome	277700	AR	3
277900	13q14.3	Wilson disease	277900	AR	3
277950	14q11.2	?Winchester syndrome	277950	_	3
278250	12q24.31	Wrinkly skin syndrome	278250	AR	3
278300	2p23.1	Xanthinuria, type I	278300	AR	3
278700	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
278720	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
278730	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
278740	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
278750	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
278800	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
278850	17q24.3-q25.1	46XX sex reversal 2	278850	AD	4
280000	17p11.2	CHIME syndrome	280000	AR	3
300000	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300004	Xp21.3	Proud syndrome	300004	XL	3
300005	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300005	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300005	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300005	Xq28	Rett syndrome	312750	XLD	3
300005	Xq28	Rett syndrome, atypical	312750	XLD	3
300005	Xq28	Rett syndrome, preserved speech variant	312750	XLD	3
300005	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300008	Xp11.23	Dent disease	300009	XLR	3
300008	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300008	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
300008	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
300009	Xp11.23	Dent disease	300009	XLR	3
300011	Xq21.1	Menkes disease	309400	XLR	3
300011	Xq21.1	Occipital horn syndrome	304150	XLR	3
300011	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300013	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
300013	Xq28	Ogden syndrome	300855	XLR,XLD	3
300014	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
300017	Xq28	?FG syndrome 2	300321	XL	3
300017	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
300017	Xq28	Congenital short bowel syndrome	300048	XLR	3
300017	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
300017	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300017	Xq28	Intestinal pseudoobstruction, neuronal	300048	XLR	3
300017	Xq28	Melnick-Needles syndrome	309350	XLD	3
300017	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
300017	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
300017	Xq28	Terminal osseous dysplasia	300244	XLD	3
300018	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300019	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
300029	Xp11.4	Retinitis pigmentosa 3	300029	_	3
300030	Xp21.2	Deafness, X-linked 3	300030	XL	2
300032	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300032	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
300032	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
300035	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
300036	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300037	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
300037	Xq26.2	Wilms tumor, somatic	194070	_	3
300039	Xq21.1	Deafness, X-linked 2	304400	XLR	3
300040	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300046	Xq23-q24	Mental retardation, X-linked 23	300046	XL	2
300047	Xp11-q21	Mental retardation, X-linked 20	300047	XL	2
300049	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300055	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300056	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
300060	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
300062	Xp11.3-q13.3	Mental retardation, X-linked 14	300062	XL	2
300066	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300068	Xq12	Androgen insensitivity	300068	XLR	3
300071	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300072	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300072	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300075	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
300075	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300076	Xq26-qter	Woods-Black-Norbury syndrome	300076	XLD	2
300078	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
300079	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300080	Xp11.3	TARP syndrome	311900	XLR	3
300082	Xq	[Social cognition]	300082	XL	2
300084	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300085	Xq27	Cone dystrophy, progressive X-linked, 2	300085	XL	2
300087	Xq13.2	X-inactivation, familial skewed	300087	_	3
300088	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300090	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300095	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300096	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300104	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300105	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
300106	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
300108	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300110	Xp11.23	Aland Island eye disease	300600	XL	3
300110	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300110	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300114	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
300115	Xp11.3-p11.21	Mental retardation, X-linked 50	300115	XL	2
300120	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300121	Xq23	Lissencephaly, X-linked	300067	XL	3
300121	Xq23	Subcortical laminal heterotopia, X-linked	300067	XL	3
300123	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
300125	Xq	{Migraine, familial typical, susceptibility to, 2}	300125	XL	2
300126	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
300127	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300128	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300131	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300135	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
300136	Xp11	{Diabetes mellitus, insulin-dependent, X-linked}	300136	_	2
300137	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300138	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300139	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300142	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300143	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300144	Xq24	{Parkinson disease, age of onset, modifier}	168600	AD,Mu	3
300145	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300147	Xq27-q28	{Prostate cancer, hereditary, X-linked 1}	300147	_	2
300148	Xp22.11	MEHMO syndrome	300148	XLR	3
300155	Xq26-q27	Retinitis pigmentosa 24	300155	_	2
300157	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300160	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300161	Xp22.11	MEHMO syndrome	300148	XLR	3
300163	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300163	Xq26.3	Emery-Dreifuss muscular dystrophy 6, X-linked	300696	XLR	3
300163	Xq26.3	Myopathy, X-linked, with postural muscle atrophy	300696	XLR	3
300163	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300163	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300163	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300166	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300168	Xq26.2	Keipert syndrome	301026	XLR	3
300169	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300169	Xq26.1	Cowchock syndrome	310490	XLR	3
300169	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300170	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300170	Xp22.2	Joubert syndrome 10	300804	XLR	3
300170	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
300170	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300172	Xp11.4	FG syndrome 4	300422	_	3
300172	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300172	Xp11.4	Mental retardation, with or without nystagmus	300422	_	3
300179	Xq25-q26	X inactivation, familial skewed, 2	300179	_	2
300180	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
300188	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
300188	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300188	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
300189	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300192	Xp11.22	?Sarcoma, synovial	300813	_	3
300193	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300194	Xq22.3	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis	300194	_	4
300195	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300197	Xq28	Immunodeficiency 47	300972	XLR	3
300199	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300200	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300202	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
300203	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300204	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300205	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
300205	Xp11.23	MEND syndrome	300960	XLR	3
300206	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300209	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300210	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300211	Xp22.3	Episodic muscle weakness, X-linked	300211	_	2
300218	Xp11.3-q22	Mental retardation, X-linked syndromic 7	300218	_	2
300221	Xpter-p22.32	{Hodgkin disease susceptibility, pseudoautosomal}	300221	_	2
300226	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300228	Xq27	Testicular germ cell tumor	300228	_	2
300231	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300238	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300243	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300244	Xq28	Terminal osseous dysplasia	300244	XLD	3
300245	Xq24-q27.1	Ptosis, hereditary congenital 2	300245	XLD	2
300247	Xp11.22	Ovarian dysgenesis 2	300510	XL	3
300247	Xp11.22	Premature ovarian failure 4	300510	XL	3
300248	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300248	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300248	Xq28	Immunodeficiency 33	300636	XLR	3
300248	Xq28	Immunodeficiency, isolated	300584	_	3
300248	Xq28	Incontinentia pigmenti	308300	XLD	3
300248	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300255	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300256	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300257	Xq24	Danon disease	300257	XLD	3
300259	Xq	{Mycobacterium tuberculosis, susceptibility, X-linked}	300259	_	2
300260	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300261	Xq28	Mental retardation syndrome, X-linked, Armfield type	300261	XLR	2
300262	Xq13.2	Mental retardation, X-linked syndromic, Abidi type	300262	_	2
300263	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300264	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300265	Xq26.3	Congenital heart defects, nonsyndromic, 1, X-linked	306955	XLR	3
300265	Xq26.3	Heterotaxy, visceral, 1, X-linked	306955	XLR	3
300265	Xq26.3	VACTERL association, X-linked	314390	XLR	3
300266	Xq11.2	Spastic paraplegia 16, X-linked, complicated	300266	XLR	2
300269	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300271	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300272	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300273	Xp22	Goiter, multinodular, 2	300273	XLD	2
300275	Xq28	CHILD syndrome	308050	XLD	3
300275	Xq28	CK syndrome	300831	XLR	3
300278	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
300280	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300291	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300292	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
300294	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300294	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
300294	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
300294	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
300298	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300299	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300300	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300300	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
300301	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300304	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300306	Xq24	{Obesity, susceptibility to, BMIQ11}	300306	_	2
300307	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
300307	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
300310	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300311	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
300321	Xq28	?FG syndrome 2	300321	XL	3
300322	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
300323	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
300324	Xq22.2-q26	Mental retardation, X-linked 53	300324	XLR	2
300331	Chr.X	Thrombocythemia, X-linked	300331	XLR	2
300336	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300336	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300345	Chr.X	Microphthalmia with coloboma 1	300345	_	2
300350	Xq23	Megalocornea 1, X-linked	309300	XLR	3
300351	Xp11	{Graves disease, susceptibility to, X-linked}	300351	_	2
300352	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300354	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300355	Xp22.2	Mental retardation, X-linked 73	300355	XLR	2
300356	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
300367	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
300368	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
300371	Xq28	Adrenoleukodystrophy	300100	XLR	3
300371	Xq28	Adrenomyeloneuropathy, adult	300100	XLR	3
300372	Xq26	Mental retardation, X-linked 42	300372	_	2
300373	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300374	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300376	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
300377	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
300378	Xq24-q25	Radial ray deficiency	300378	_	2
300379	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300382	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
300382	Xp21.3	Hydranencephaly with abnormal genitalia	300215	XL	3
300382	Xp21.3	Lissencephaly, X-linked 2	300215	XL	3
300382	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300382	Xp21.3	Partington syndrome	309510	XLR	3
300382	Xp21.3	Proud syndrome	300004	XL	3
300383	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
300384	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
300386	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
300387	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300388	Xq27.2-q28	Polymicrogyria, bilateral perisylvian	300388	XLD	2
300390	Xq21.2	Choroideremia	303100	XLD	3
300391	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
300392	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked	313900	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked, intermittent	313900	XLR	3
300392	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
300393	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300394	Xq28	Barth syndrome	302060	XLR	3
300395	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300398	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300400	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
300401	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
300401	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
300403	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
300403	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300406	Xp22.3	FG syndrome 3	300406	_	2
300414	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
300415	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
300419	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300423	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300424	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300425	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300427	Xp22.32-p22.31	Mental retardation, X-linked	300495	IC,Mu,XL	3
300427	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300427	Xp22.32-p22.31	{Autism susceptibility, X-linked 2}	300495	IC,Mu,XL	3
300428	Xp22.3	Mental retardation, X-linked 2	300428	XL	2
300429	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300433	Xp11.2-q12	Mental retardation, X-linked 81	300433	XLR	2
300434	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300436	Xq25-q26	Mental retardation, X-linked 46	300436	XLR	2
300438	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300448	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300451	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
300451	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
300454	Xq12-q21.3	Mental retardation, X-linked 77	300454	XLR	2
300455	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
300457	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
300457	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
300460	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300461	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
300463	Xp11.23	Renpenning syndrome	309500	XLR	3
300464	Xq23-q26	{Coronary heart disease, susceptibility to, 3}	300464	_	2
300470	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300471	Chr.X	Cubitus valgus with mental retardation and unusual facies	300471	XLR	2
300472	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300473	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300473	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300474	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
300475	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300476	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300481	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
300481	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300484	Chr.X	Orofaciodigital syndrome VIII	300484	XLR	2
300485	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300486	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300488	Xp21.3	{Menopause, natural, age at, QTL1}	300488	XLD	2
300489	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300490	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
300491	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
300494	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300496	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300497	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300498	Xp11.3-p11.21	Mental retardation,X-linked 45	300498	XL	2
300499	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
300500	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300502	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
300505	Xp11.3-q22.3	Mental retardation, X-linked 84	300505	XLR	2
300509	Xq27.3	{Dyslexia, susceptibility to, 9}	300509	_	2
300511	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300514	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300515	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300516	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
300518	Xq24-q25	Mental retardation, X-linked 82	300518	XLR	2
300519	Chr.X	Mental retardation, X-linked, syndromic, Martin-Probst type	300519	XLR	2
300521	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300522	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
300523	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300524	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300526	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300534	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
300535	Xq26.1	Dent disease 2	300555	XLR	3
300535	Xq26.1	Lowe syndrome	309000	XLR	3
300536	Xq27	[Bone mineral density QTL 4]	300536	_	2
300538	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
300538	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300539	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300545	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
300546	Xp11.22	Aarskog-Scott syndrome	305400	XLR	3
300546	Xp11.22	Mental retardation, X-linked syndromic 16	305400	XLR	3
300550	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
300552	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300553	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300554	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300555	Xq26.1	Dent disease 2	300555	XLR	3
300556	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300556	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300557	Xq21-q25	{Parkinson disease 12}	300557	_	2
300558	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300559	Xq13.1	Muscle glycogenosis	300559	XLR	3
300560	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300572	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300576	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300577	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300578	Xp11.3	Chromosome Xp11.3 deletion syndrome	300578	XLR	4
300579	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300580	Xq13.1-q22.1	Myopathy, congenital, with fiber-type disproportion, X-linked	300580	XLD	2
300581	Xq22.3	FG syndrome 5	300581	_	2
300584	Xq28	Immunodeficiency, isolated	300584	_	3
300589	Xp11.4	Nystagmus 5, congenital, X-linked	300589	XLD	2
300590	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300591	Xq24-q25	{Stature QTL 6}	300591	_	2
300600	Xp11.23	Aland Island eye disease	300600	XL	3
300603	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300604	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300605	Xq28	Retinitis pigmentosa 34	300605	_	2
300607	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300610	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300611	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300613	Xq23-q27.2	Myopia 13	300613	_	2
300614	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300622	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300623	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
300624	Xq27.3	Fragile X syndrome	300624	XLD	3
300628	Xq26.2	Nystagmus 1, congenital, X-linked	310700	XL	3
300628	Xq26.2	Nystagmus, infantile periodic alternating, X-linked	310700	XL	3
300629	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
300633	Xq12	Hypospadias 1, X-linked	300633	XLR	3
300635	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300636	Xq28	Immunodeficiency 33	300636	XLR	3
300640	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300642	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300643	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300644	Xq22.1	Fabry disease	301500	XL	3
300644	Xq22.1	Fabry disease, cardiac variant	301500	XL	3
300645	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300646	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300647	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300650	Xp22.3	Ocular albinism with sensorineural deafness	300650	XL	2
300651	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
300652	Xp11.3-q12	Angio serpiginosum	300652	XLD	2
300653	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
300658	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
300658	Xp11.3	Norrie disease	310600	XLR	3
300659	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300660	Xq25-q27	Leukoencephalopathy with metaphyseal chondrodysplasia	300660	XLR	2
300672	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300673	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300676	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300679	Xp21	Chromosome Xp21 deletion syndrome	300679	_	4
300695	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300697	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
300699	Xq25	Mental retardation, X-linked 94	300699	XLR	3
300700	Xq24-q26	Albinism-deafness syndrome	300700	XL	2
300703	Xq25-q27.1	Spinocerebellar ataxia, X-linked 5	300703	XLR	2
300704	Xp11.22	{Prostate cancer, hereditary, X-linked 2}	300704	_	2
300705	Xp11.22	Xp11.22 microduplication syndrome	300705	_	4
300707	Xq28	STAR syndrome	300707	XLD	3
300708	Xq28	STAR syndrome	300707	XLD	3
300709	Xq12-q21.31	Mental retardation, X-linked, syndromic 9	300709	_	2
300710	Xq11-q12	Alopecia, androgenetic, 2	300710	_	2
300711	Xq23	Pyloric stenosis, infantile hypertrophic, 4	300711	_	2
300712	Xq26-q27	?Craniofacioskeletal syndrome	300712	XLR,XLD	2
300715	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300716	Chr.X	Mental retardation, X-linked 95	300716	XLD	2
300717	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300718	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300719	Chr.X	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	XLR	2
300724	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
300746	Xq27.1	Hemophilia B	306900	XLR	3
300746	Xq27.1	Thrombophilia, X-linked, due to factor IX defect	300807	_	3
300746	Xq27.1	{Deep venous thrombosis, protection against}	300807	_	3
300746	Xq27.1	{Warfarin sensitivity}	122700	AD	3
300747	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
300749	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300750	Xq24-q25	Spastic paraplegia 34, X-linked	300750	XLR	2
300751	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
300752	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
300755	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300756	Xq21.3	{Alzheimer disease 16}	300756	_	2
300757	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
300758	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300770	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
300774	Xq28	?Waisman syndrome	311510	XLR	3
300774	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300776	Xq23	?Congenital disorder of glycosylation, type Is	300884	XLD	3
300776	Xq23	Epileptic encephalopathy, early infantile, 36	300884	XLD	3
300777	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300778	Xp22.3	Corneal dystrophy, Lisch epithelial	300778	XLD	2
300779	Xq25	Corneal dystrophy, endothelial, X-linked	300779	XLD	2
300798	Xp22.13	Glycogen storage disease, type IXa1	306000	XLR	3
300798	Xp22.13	Glycogen storage disease, type IXa2	306000	XLR	3
300799	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300801	Xp11.23-p11.22	Chromosome Xp11.23-p11.22 duplication syndrome	300801	XLD	4
300802	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
300803	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
300804	Xp22.2	Joubert syndrome 10	300804	XLR	3
300806	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
300808	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300808	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300809	Xq28	{Systemic lupus erythematosus, susceptibility to, 15}	300809	_	2
300814	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300815	Xq28	Chromosome Xq28 duplication syndrome	300815	_	4
300816	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300818	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
300821	Xq28	Blue cone monochromacy	303700	XLR	3
300821	Xq28	Colorblindness, deutan	303800	XL	3
300822	Xq28	Blue cone monochromacy	303700	XLR	3
300822	Xq28	Colorblindness, protan	303900	XL	3
300823	Xq28	Mucopolysaccharidosis II	309900	XLR	3
300826	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
300827	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
300828	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300830	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300831	Xq28	CK syndrome	300831	XLR	3
300833	Xq26.3	46XX sex reversal 3	300833	XLD	4
300834	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
300835	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
300836	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
300838	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300839	Xp22.13	Retinoschisis	312700	XLR	3
300841	Xq28	Hemophilia A	306700	XLR	3
300842	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
300843	Xq28	Bornholm eye disease	300843	XLR	2
300844	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300845	Xq28	Moyamoya disease 4	300845	XLR	4
300847	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
300848	Xp11.3	Mental retardation, X-linked 89	300848	XLD	2
300849	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300850	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300851	Xp11.3	Mental retardation, X-linked 92	300851	XLR	2
300852	Xq24	Mental retardation, X-linked 88	300852	XL	2
300853	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300854	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
300855	Xq28	Ogden syndrome	300855	XLR,XLD	3
300856	Xp11.22	{Hypospadias 4, X-linked, susceptibility to}	300856	_	2
300857	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300858	Xp21.1-p11.23	Mental retardation, X-linked, syndromic 17	300858	XLR	2
300859	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300860	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
300861	Xq21.33-q23	Mental retardation, X-linked, syndromic, Chudley-Schwartz type	300861	XLR	2
300863	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300864	Chr.X	Cerebral-cerebellar-coloboma syndrome, X-linked	300864	XLR	2
300867	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300868	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
300869	Xq27.3-q28	Chromosome Xq27.3-q28 duplication syndrome	300869	XLR	4
300870	Xp22	Aneurysm, intracranial berry, 5	300870	_	2
300872	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300882	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300885	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300886	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300887	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300888	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300894	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300895	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300896	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
300897	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
300905	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300906	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300908	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
300909	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300910	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300911	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300912	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300913	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
300914	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
300915	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300918	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300919	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300923	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300928	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300932	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
300933	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300934	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300942	Xq26.3	Chromosome Xq26.3 duplication syndrome	300942	XLD	4
300943	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300945	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300946	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300951	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300952	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300953	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300957	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300958	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300960	Xp11.23	MEND syndrome	300960	XLR	3
300963	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300964	Xq12	Wilson-Turner syndrome	309585	XLR	3
300966	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
300967	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300968	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300969	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
300971	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300972	Xq28	Immunodeficiency 47	300972	XLR	3
300975	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300978	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300979	Xq25	Xq25 duplication syndrome	300979	XL	4
300980	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300982	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300983	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300984	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300985	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300986	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300988	Xq12	Immunodeficiency 50	300988	XLR	3
300989	Xq28	Meester-Loeys syndrome	300989	XL	3
300990	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300991	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300997	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300998	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
301000	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
301006	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
301008	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
301010	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301012	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301013	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301014	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
301015	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
301018	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
301020	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
301021	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
301022	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
301024	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
301025	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
301026	Xq26.2	Keipert syndrome	301026	XLR	3
301040	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
301050	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
301200	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
301201	Xq22-q28	?Amelogenesis imperfecta, type IE, X-linked 2	301201	XL	2
301220	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
301300	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
301300	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
301310	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
301590	Xq27-q28	?Microphthalmia, syndromic 4	301590	XLR	2
301770	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301830	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
301835	Xq22.3	Arts syndrome	301835	XLR	3
301845	Xq24-q27	Bazex syndrome	301845	XLD	2
301870	Xq28	Meester-Loeys syndrome	300989	XL	3
301870	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
301900	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
302045	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
302060	Xq28	Barth syndrome	302060	XLR	3
302200	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
302350	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
302500	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
302800	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
302801	Xp22.2	Charcot-Marie-Tooth neuropathy, X-linked recessive, 2	302801	XLR	2
302802	Xq26	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	XLR	4
302905	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
302910	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
302950	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
302960	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
303100	Xq21.2	Choroideremia	303100	XLD	3
303110	Xq21	Choroideremia, deafness, and mental retardation	303110	XLR	4
303400	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
303600	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
303630	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
303631	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
303800	Xq28	Colorblindness, deutan	303800	XL	3
303900	Xq28	Colorblindness, protan	303900	XL	3
304020	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
304040	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
304050	Xp22	Aicardi syndrome	304050	XLD	2
304100	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
304110	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
304120	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
304150	Xq21.1	Occipital horn syndrome	304150	XLR	3
304340	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
304400	Xq21.1	Deafness, X-linked 2	304400	XLR	3
304500	Xq22.3	Deafness, X-linked 1	304500	XL	3
304700	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
304730	Xq24-qter	Dermoids of cornea	304730	XL	2
304790	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
304800	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
305000	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
305100	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
305371	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
305371	Xp11.23	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	_	3
305371	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
305371	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
305390	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
305435	Xp22.2	Fetal hemoglobin quantitative trait locus 3	305435	XL	2
305450	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
305600	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
305620	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
305900	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
305900	Xq28	{Resistance to malaria due to G6PD deficiency}	611162	_	3
305915	Xq25	Mental retardation, X-linked 94	300699	XLR	3
306250	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
306400	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
306700	Xq28	Hemophilia A	306700	XLR	3
306900	Xq27.1	Hemophilia B	306900	XLR	3
306995	Xq28	[?Homosexuality, male]	306995	XL	2
307030	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
307150	Xq27.1	Hypertrichosis, congenital generalized	307150	XLD	4
307200	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
307700	Xq27.1	Hypoparathyroidism, X-linked	307700	XL	4
307800	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
308000	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
308000	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
308050	Xq28	CHILD syndrome	308050	XLD	3
308100	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
308205	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
308230	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
308240	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
308300	Xq28	Incontinentia pigmenti	308300	XLD	3
308350	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
308380	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
308380	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
308700	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
308800	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
308840	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
308840	Xq28	CRASH syndrome	303350	XLR	3
308840	Xq28	Hydrocephalus due to aqueductal stenosis	307000	XLR	3
308840	Xq28	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	XLR	3
308840	Xq28	Hydrocephalus with Hirschsprung disease	307000	XLR	3
308840	Xq28	MASA syndrome	303350	XLR	3
308905	Xp11	{Leber optic atrophy, susceptibility to}	308905	XL	2
308990	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
309000	Xq26.1	Lowe syndrome	309000	XLR	3
309060	Xq24	Danon disease	300257	XLD	3
309120	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
309200	Xq28	{?Major affective disorder 2}	309200	XLD	2
309300	Xq23	Megalocornea 1, X-linked	309300	XLR	3
309350	Xq28	Melnick-Needles syndrome	309350	XLD	3
309400	Xq21.1	Menkes disease	309400	XLR	3
309500	Xp11.23	Renpenning syndrome	309500	XLR	3
309510	Xp21.3	Partington syndrome	309510	XLR	3
309520	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
309530	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
309541	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
309545	Xp11	?Mental retardation, X-linked, syndromic 12	309545	XL	2
309548	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
309549	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
309550	Xq27.3	Fragile X syndrome	300624	XLD	3
309550	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
309550	Xq27.3	Premature ovarian failure 1	311360	XL	3
309555	Xq26	Gustavson syndrome	309555	XL	2
309580	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
309583	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
309585	Xq12	Wilson-Turner syndrome	309585	XLR	3
309590	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
309610	Xp11-q21	Prieto syndrome	309610	XLR	2
309620	Xq28	Mental retardation-skeletal dysplasia	309620	XL	2
309630	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
309800	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
309801	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
309845	Xq12	Immunodeficiency 50	300988	XLR	3
309850	Xp11.3	Brunner syndrome	300615	XLR	3
309850	Xp11.3	{Antisocial behavior}	300615	XLR	3
309900	Xq28	Mucopolysaccharidosis II	309900	XLR	3
310200	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
310300	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
310400	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
310440	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
310460	Xq28	Myopia-1	310460	XLR	2
310468	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
310490	Xq26.1	Cowchock syndrome	310490	XLR	3
310500	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
310600	Xp11.3	Norrie disease	310600	XLR	3
311050	Xp11.4-p11.21	Optic atrophy 2, X-linked	311050	XL	2
311070	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311200	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
311250	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
311300	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
311360	Xq27.3	Premature ovarian failure 1	311360	XL	3
311510	Xq28	?Waisman syndrome	311510	XLR	3
311770	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
311770	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
311800	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
311850	Xq22.3	Arts syndrome	301835	XLR	3
311850	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311850	Xq22.3	Deafness, X-linked 1	304500	XL	3
311850	Xq22.3	Gout, PRPS-related	300661	XLR	3
311850	Xq22.3	Phosphoribosylpyrophosphate synthetase superactivity	300661	XLR	3
311870	Xq13.1	Muscle glycogenosis	300559	XLR	3
311900	Xp11.3	TARP syndrome	311900	XLR	3
312000	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
312040	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
312060	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
312080	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
312170	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
312173	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
312173	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
312180	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
312300	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
312600	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
312610	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
312610	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
312610	Xp11.4	Retinitis pigmentosa 3	300029	_	3
312610	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
312612	Xp21.3-p21.2	?Retinitis pigmentosa, X-linked recessive, 6	312612	XL	2
312700	Xp22.13	Retinoschisis	312700	XLR	3
312820	Xp11.23	?Sarcoma, synovial	300813	_	3
312863	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
312865	Xp22.33	Langer mesomelic dysplasia	249700	_	3
312865	Xp22.33	Leri-Weill dyschondrosteosis	127300	_	3
312865	Xp22.33	Short stature, idiopathic familial	300582	_	3
312870	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
312920	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
313000	Xp22.33	Turner syndrome-associated neurocognitive phenotype	313000	?XLR	2
313000	Xp22.33	[Visuospatial/perceptual abilities]	313000	?XLR	2
313200	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313350	Xq26	Split hand/foot malformation 2	313350	XL	2
313400	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
313430	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
313430	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
313440	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
313475	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
313500	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
313650	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
313650	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
313700	Xq12	Androgen insensitivity	300068	XLR	3
313700	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
313700	Xq12	Hypospadias 1, X-linked	300633	XLR	3
313700	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313700	Xq12	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
313850	Xq25-q26.1	Thoracoabdominal syndrome	313850	XL	2
314050	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
314200	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
314250	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
314300	Xq28	Goeminne TKCR syndrome	314300	XL	2
314310	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
314370	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
314375	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
314390	Xq26.3	VACTERL association, X-linked	314390	XLR	3
314400	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
314580	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
314670	Xq13.2	X-inactivation, familial skewed	300087	_	3
314690	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
314700	Xpter-p22.32	[Blood group, XG system]	_	_	3
314850	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
314990	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
400003	Yq11.223	?Sertoli-cell-only syndrome	_	_	1
400004	Chr.Y	Retinitis pigmentosa, Y-linked	400004	YL	2
400005	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
400020	Yp11.2	Langer mesomelic dysplasia	249700	_	3
400020	Yp11.2	Leri-Weill dyschondrosteosis	127300	_	3
400020	Yp11.2	Short stature, idiopathic familial	300582	_	3
400033	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
400042	Yq11	Spermatogenic failure, Y-linked, 1	400042	_	4
400043	Chr.Y	Deafness, Y-linked 1	400043	YL	2
400044	Yp11.2	46XY sex reversal 1	400044	YL	3
400045	Yp11.2	46XX sex reversal 1	400045	XLD	4
400047	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
415000	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
425500	Yq	?Hairy ears, Y-linked	425500	YL	2
480000	Yp11.2	46XX sex reversal 1	400045	XLD	4
480000	Yp11.2	46XY sex reversal 1	400044	YL	3
580000	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
600001	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
600002	3p21.31	Eiken syndrome	600002	AR	3
600003	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
600005	16p13.13	Bare lymphocyte syndrome, type II, complementation group A	209920	AR	3
600005	16p13.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600008	11q23.2	Homocysteine plasma level	600008	_	2
600011	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
600011	7q22.1	Lymphatic malformation 7	617300	AD	3
600013	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
600014	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
600016	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
600019	17q23.3	Orthostatic hypotension 2	618182	AR	3
600020	10q25.2	Neurofibrosarcoma, somatic	_	_	3
600020	10q25.2	Prostate cancer, somatic	176807	_	3
600023	16q21	Elsahy-Waters syndrome	211380	AR	3
600024	1q42.12	?Reynolds syndrome	613471	AD	3
600024	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
600024	1q42.12	Pelger-Huet anomaly	169400	AD	3
600024	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
600028	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
600031	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
600035	10q26.11	Schizencephaly	269160	_	3
600037	14q22.3	Microphthalmia, syndromic 5	610125	AD	3
600037	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
600037	14q22.3	Retinal dystrophy, early-onset, with or without pituitary dysfunction	610125	AD	3
600040	19q13.33	Colorectal cancer, somatic	114500	_	3
600040	19q13.33	T-cell acute lymphoblastic leukemia, somatic	613065	_	3
600044	3q27.1	Thrombocythemia 1	187950	AD	3
600046	9q31.1	HDL deficiency, type 2	604091	_	3
600046	9q31.1	Tangier disease	205400	AR	3
600049	3q26	Myelodysplasia syndrome-1	_	_	3
600053	2q11.2	Achromatopsia 2	216900	AR	3
600059	17p13.3	Retinitis pigmentosa 13	600059	AD	3
600060	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
600065	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
600072	20p13	Insomnia, fatal familial	600072	AD	3
600073	2q31.1	Donnai-Barrow syndrome	222448	AR	3
600075	6q27	Spinocerebellar ataxia 17	607136	AD	3
600075	6q27	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
600079	7q11.23	Colon cancer, somatic	114500	_	3
600081	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
600089	6p21.3	?Diabetes mellitus, insulin-dependent, neonatal	600089	AR	2
600098	11p15.2	Ovarian carcinoma	_	_	3
600101	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
600104	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
600105	1q31.3	Retinitis pigmentosa-12	600105	AR	3
600108	11q22.2	Metaphyseal anadysplasia 1	602111	AD	3
600108	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
600108	11q22.2	Spondyloepimetaphyseal dysplasia, Missouri type	602111	AD	3
600110	6q14.1	Stargardt disease 3	600110	AD	3
600111	5p13.2	Episodic ataxia, type 6	612656	AD	3
600112	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
600112	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
600112	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
600116	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
600118	2q21.3	Warburg micro syndrome 1	600118	AR	3
600119	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
600121	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
600124	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
600129	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
600131	8q24	Epilepsy, childhood absence, 1	600131	AD	2
600132	6p21.31	Retinitis pigmentosa 14	600132	AR	3
600133	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
600138	19q13.42	Retinitis pigmentosa 11	600138	AD	3
600140	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
600140	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
600142	10q26.13	CARASIL syndrome	600142	AR	3
600143	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
600144	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
600145	1p13.1	Caudal regression syndrome	600145	AD	3
600147	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
600150	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
600150	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
600151	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
600154	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
600155	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
600156	9q31	{Hirschsprung disease, susceptibility to, 5}	600156	AD	2
600160	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
600160	9p21.3	Orolaryngeal cancer, multiple	_	_	3
600160	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
600160	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
600163	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
600163	3p22.2	Brugada syndrome 1	601144	AD	3
600163	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
600163	3p22.2	Heart block, nonprogressive	113900	AD	3
600163	3p22.2	Heart block, progressive, type IA	113900	AD	3
600163	3p22.2	Long QT syndrome-3	603830	AD	3
600163	3p22.2	Sick sinus syndrome 1	608567	AR	3
600163	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
600163	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
600165	11p	Nanophthalmos-1	600165	AD	2
600168	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
600170	9p13.3	[Blood group GIL]	607457	_	3
600173	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600175	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
600179	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
600179	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
600179	17p13.1	Leber congenital amaurosis 1	204000	AR	3
600184	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
600185	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
600185	13q13.1	Wilms tumor	194070	AD,SMu	3
600185	13q13.1	{Breast cancer, male, susceptibility to}	114480	AD,SMu	3
600185	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
600185	13q13.1	{Glioblastoma 3}	613029	AR	3
600185	13q13.1	{Medulloblastoma}	155255	AD,AR	3
600185	13q13.1	{Pancreatic cancer 2}	613347	_	3
600185	13q13.1	{Prostate cancer}	176807	AD,SMu	3
600192	18q11.2	Sarcoma, synovial	_	_	1
600193	1p21-p13.3	Waardenburg syndrome, type 2B	600193	AD	2
600194	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
600195	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	_	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, dark/light hair]	611742	_	3
600202	6p22-p21	{Dyslexia, susceptibility to, 2}	600202	AD	2
600204	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
600206	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
600209	19p	Exostoses, multiple, type 3	600209	AD	2
600211	6p21.1	Cleidocranial dysplasia	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	AD	3
600211	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
600220	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
600220	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
600221	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
600221	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600223	16q22.1	Spinocerebellar ataxia 4	600223	AD	2
600224	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
600225	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
600225	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
600228	12p13.31	?Liddle syndrome 3	618126	AD	3
600228	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
600228	12p13.31	Pseudohypoaldosteronism, type I	264350	AR	3
600229	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
600231	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600232	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
600234	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
600235	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
600235	19q13.11	Brugada syndrome 5	612838	_	3
600235	19q13.11	Cardiac conduction defect, nonspecific	612838	_	3
600235	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
600235	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
600236	1q41	Stromme syndrome	243605	AR	3
600238	20p13	?Uncombable hair syndrome 2	617251	AR	3
600244	2q37.3	{Multiple sclerosis, disease progression, modifier of}	126200	Mu	3
600244	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
600251	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
600253	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
600257	8q12.2-q21.2	Bor-Duane hydrocephalus contiguous gene syndrome	600257	AD	4
600259	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
600259	7p22.1	Mismatch repair cancer syndrome	276300	AR	3
600263	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
600266	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
600266	2q35	{Mycobacterium tuberculosis, susceptibility to infection by}	607948	_	3
600271	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
600273	16p13.3	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	AD	4
600275	1p12	Alagille syndrome 2	610205	AD	3
600275	1p12	Hajdu-Cheney syndrome	102500	AD	3
600276	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
600276	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
600276	19p13.12	Lateral meningocele syndrome	130720	AD	3
600279	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
600281	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
600281	20q13.12	MODY, type I	125850	AD	3
600281	20q13.12	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600286	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
600287	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
600287	7p14.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
600291	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
600293	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
600294	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
600300	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
600301	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
600309	6q22.31	Atrioventricular septal defect 3	600309	AD	3
600310	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
600310	19p13.11	Pseudoachondroplasia	177170	AD	3
600315	1p36.33	?Immunodeficiency 16	615593	AR	3
600316	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
600318	15q26	{Diabetes mellitus, insulin-dependent, 3}	600318	_	2
600319	11q13	{Diabetes mellitus, insulin-dependent, 4}	600319	_	2
600320	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
600321	2q31	{Diabetes mellitus, insulin-dependent, 7}	600321	_	2
600322	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
600332	1q41	Rippling muscle disease-1	600332	AD	2
600334	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
600336	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
600342	10q23.1	Retinitis pigmentosa 44	613769	_	3
600346	17q12	Turnpenny-Fry syndrome	618371	AD	3
600348	14q32.2	Band heterotopia	600348	AR	3
600354	5q13.2	Spinal muscular atrophy-1	253300	AR	3
600354	5q13.2	Spinal muscular atrophy-2	253550	AR	3
600354	5q13.2	Spinal muscular atrophy-3	253400	AR	3
600354	5q13.2	Spinal muscular atrophy-4	271150	AR	3
600359	11q24.3	Bartter syndrome, type 2	241200	AR	3
600361	4q34.3-q35.2	Hereditary motor and sensory neuropathy V	600361	AD	2
600363	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
600364	6p21.1	Cone dystrophy-3	602093	AD	3
600364	6p21.1	Cone-rod dystrophy 14	602093	AD	3
600370	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
600373	19p13.3	CODAS syndrome	600373	AR	3
600374	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
600375	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
600376	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
600383	8q13	Mesomelia-synostoses syndrome	600383	AD	4
600397	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
600414	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
600414	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
600414	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
600415	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
600417	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
600423	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
600423	1p36.12	{Hypertension, essential, susceptibility to}	145500	Mu	3
600429	6p24.3-p24.2	Adult i phenotype without cataract	110800	AD	3
600429	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
600429	6p24.3-p24.2	[Blood group, Ii]	110800	AD	3
600430	2q37	Chromosome 2q37 deletion syndrome	600430	AD	4
600438	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
600442	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600450	10p15.1	46XY sex reversal 8	614279	AR	3
600451	10p15.1	{46XY sex reversal 8, modifier of}	614279	AR	3
600456	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
600456	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
600462	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
600463	15q26.3	Microphthalmia, isolated 8	615113	AR	3
600465	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
600467	3q13.1	{Malignant hyperthermia susceptibility 4}	600467	AD	2
600470	3q24	Craniosynostosis 6	616602	AD	3
600473	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
600478	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
600480	15q21.3	Craniosynostosis 3	615314	AD	3
600483	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
600492	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
600495	3q27.1	{Parkinson disease 18}	614251	AD	3
600496	12q24.31	MODY, type III	600496	AD	3
600501	13q22.3	ABCD syndrome	600501	AR	3
600502	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
600502	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
600509	11p15.1	Diabetes mellitus, noninsulin-dependent	125853	AD	3
600509	11p15.1	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
600509	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
600509	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
600509	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
600510	7q35-q36	Pigment dispersion syndrome	600510	AD	2
600511	6p23	{Schizophrenia}	181500	AD	2
600512	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
600513	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
600514	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
600514	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
600515	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
600521	3q27.3	3MC syndrome 1	257920	AR	3
600522	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
600523	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
600525	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
600525	17q21.33	Trichodontoosseous syndrome	190320	AD	3
600528	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
600529	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
600532	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
600533	1q23.2	Neural tube defects	182940	AD	3
600536	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
600542	9q31.1	Chondrosarcoma, extraskeletal myxoid	612237	_	3
600543	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
600548	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
600548	5q31.2	Even-plus syndrome	616854	AR	3
600555	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
600555	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
600555	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
600556	12q13.3	Immunodeficiency 44	616636	AR	3
600558	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
600565	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
600565	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
600570	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
600570	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
600570	3q27.1	{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile absence, susceptibility to, 2}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	AD	3
600571	4q12	Fibromatosis, gingival, 5	617626	AD	3
600571	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
600574	22q11.21	Noonan syndrome 10	616564	AD	3
600574	22q11.21	Noonan syndrome 2	605275	AR	3
600574	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
600576	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
600576	8p23.1	Atrial septal defect 2	607941	AD	3
600576	8p23.1	Atrioventricular septal defect 4	614430	AD	3
600576	8p23.1	Tetralogy of Fallot	187500	AD	3
600576	8p23.1	Ventricular septal defect 1	614429	AD	3
600577	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
600579	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
600582	8q12.3	Traboulsi syndrome	601552	AR	3
600584	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
600584	5q35.1	Conotruncal heart malformations, variable	217095	_	3
600584	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
600584	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
600584	5q35.1	Tetralogy of Fallot	187500	AD	3
600584	5q35.1	Ventricular septal defect 3	614432	AD	3
600590	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
600593	4p16	Craniosynostosis, Adelaide type	600593	?AD	2
600599	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
600599	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
600599	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
600608	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
600617	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
600618	12p13.2	Leukemia, acute myeloid, somatic	601626	_	3
600618	12p13.2	Thrombocytopenia 5	616216	AD	3
600624	18q21.1-q21.3	Cone-rod retinal dystrophy-1	600624	AD	2
600625	14q22.2	Orofacial cleft 11	600625	_	3
600627	4q32.1	[?Hypertryptophanemia]	600627	AR	3
600630	10q11.23	UV-sensitive syndrome 1	600630	AR	3
600631	13q13-q14.3	Enuresis, nocturnal, 1	600631	AD	2
600632	11q25	Ovarian cancer, somatic	167000	_	3
600635	14q13.3	Chorea, hereditary benign	118700	AD	3
600635	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
600635	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
600638	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
600644	11q23.3	Cleft lip/palate-ectodermal dysplasia syndrome	225060	AR	3
600644	11q23.3	Orofacial cleft 7	225060	AR	3
600649	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
600650	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
600650	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AD,AR	3
600652	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
600660	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
600662	5q14.3	Chromosome 5q14.3 deletion syndrome	613443	AD	4
600662	5q14.3	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	613443	AD	3
600664	10q24.31	Cocoon syndrome	613630	_	3
600666	11q12.3	Polycystic kidney disease 3	600666	AD	3
600667	17q21.31	Omodysplasia 2	164745	AD	3
600668	8q	Chondrocalcinosis with early-onset osteoarthritis	600668	AD	2
600669	8q24	{Epilepsy, idiopathic generalized, susceptibility to, 1}	600669	AD	2
600673	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
600675	14q32.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600675	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
600678	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
600678	2p16.3	Mismatch repair cancer syndrome	276300	AR	3
600678	2p16.3	{Endometrial cancer, familial}	608089	_	3
600681	17q24.3	Andersen syndrome	170390	AD	3
600681	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
600681	17q24.3	Short QT syndrome 3	609622	_	3
600682	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
600682	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
600682	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AD,AR	3
600692	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
600698	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
600700	3q27-q28	Leukemia, acute myeloid	601626	AD,SMu	3
600700	3q27-q28	Lipoma	_	_	3
600701	6p21.31	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
600702	12q13.13	?Myoclonus, familial, 2	618364	AD	3
600702	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
600702	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
600702	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
600709	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
600712	9q21.32	Au-Kline syndrome	616580	AD	3
600713	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
600716	1p13.2	{Diabetes, type 1, susceptibility to}	222100	AR	3
600716	1p13.2	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600716	1p13.2	{Systemic lupus erythematosus susceptibility to}	152700	AD	3
600721	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
600722	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
600724	16q21	Retinitis pigmentosa 45	613767	AR	3
600725	7q36.3	Holoprosencephaly 3	142945	AD	3
600725	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
600725	7q36.3	Schizencephaly	269160	_	3
600725	7q36.3	Single median maxillary central incisor	147250	AD	3
600726	2q35	Acrocapitofemoral dysplasia	607778	AR	3
600726	2q35	Brachydactyly, type A1	112500	AD	3
600727	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
600728	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
600733	13q12.2	MODY, type IV	606392	_	3
600733	13q12.2	Pancreatic agenesis 1	260370	AR	3
600733	13q12.2	{Diabetes mellitus, type II, susceptibility to}	125853	AD	3
600734	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
600734	11q24.3	Long QT syndrome 13	613485	AD	3
600740	19q13.32	Hypocalciuric hypercalcemia, type III	600740	AD	3
600747	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
600749	14q11.2	Specific granule deficiency	245480	AR	3
600754	14q11.2	?Winchester syndrome	277950	_	3
600755	3p25.2	{Schizophrenia, susceptibility to}	181500	AD	3
600757	19q13	Orofacial cleft 3	600757	?AD	2
600759	1q42.13	Alzheimer disease-4	606889	AD	3
600759	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
600760	16p12.2	Bronchiectasis with or without elevated sweat chloride 1	211400	AD	3
600760	16p12.2	Liddle syndrome 1	177200	AD	3
600760	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600761	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
600761	16p12.2	Liddle syndrome 2	618114	AD	3
600761	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600770	11p15.5	{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	AD	3
600774	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
600775	19q13.2	Craniosynostosis 4	600775	AD	3
600778	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
600783	5q31.3	?Perrault syndrome 2	614926	AR	3
600790	6q14-q16.2	Chorioretinal atrophy, progressive bifocal	600790	AD	2
600792	14q12	Deafness, autosomal recessive 5	600792	AR	2
600795	3p11.2	Dementia, familial, nonspecific	600795	AD	3
600797	13q34	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, familial primary, 1, with or without HHT	178600	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	AD	3
600799	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
600802	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600803	7q21.12	Gallbladder disease 1	600803	AD,AR	3
600804	11q14.3	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600805	18q11.2	Epidermolysis bullosa, generalized atrophic benign	226650	AR	3
600805	18q11.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
600805	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
600808	12q13-q21	Enuresis, nocturnal, 2	600808	AD	2
600810	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AD,AR	3
600811	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
600814	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
600820	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
600824	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
600824	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
600825	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
600827	10q23.33	Cone dystrophy 4	613093	AR	3
600829	11q13.4	Opsismodysplasia	258480	AR	3
600835	10q11.21	{AIDS, resistance to}	609423	_	3
600836	2q35	?Cataract 42	115900	AD	3
600837	5p13.2	Central hypoventilation syndrome	209880	AD	3
600837	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
600837	5p13.2	{Pheochromocytoma, modifier of}	171300	AD	3
600838	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
600839	15q21.1	Bartter syndrome, type 1	601678	AR	3
600842	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
600844	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
600850	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
600852	17q23.1	Retinitis pigmentosa 17	600852	AD	3
600853	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
600855	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
600856	11p15.4	Beckwith-Wiedemann syndrome	130650	AD	3
600856	11p15.4	IMAGE syndrome	614732	AD	3
600857	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
600857	5p15.33	Leigh syndrome	256000	Mi,AR	3
600857	5p15.33	Mitochondrial respiratory chain complex II deficiency	252011	AR	3
600857	5p15.33	Paragangliomas 5	614165	AD	3
600858	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
600859	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
600864	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
600871	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
600871	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
600877	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
600881	17q11.2	Cataract 10, multiple types	600881	AD	3
600882	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
600883	6q25-q27	{Diabetes mellitus, insulin-dependent, 8}	600883	_	2
600884	9q13	Cardiomyopathy, dilated 1B	600884	AD	2
600886	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
600887	5q14.1	Endometrial carcinoma, somatic	608089	_	3
600887	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
600890	2p23.3	Fatty liver, acute, of pregnancy	609016	AR	3
600890	2p23.3	HELLP syndrome, maternal, of pregnancy	609016	AR	3
600890	2p23.3	LCHAD deficiency	609016	AR	3
600890	2p23.3	Trifunctional protein deficiency	609015	AR	3
600897	1q21.2	Cataract 1, multiple types	116200	AD	3
600898	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
600899	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
600900	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
600901	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
600909	21q22.3	Cataract 44	616509	AR	3
600909	21q22.3	Hypotrichosis 14	618275	AR	3
600917	7q31.1	Insulin resistance, severe, digenic	125853	AD	3
600920	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
600921	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
600922	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
600923	1q23.3	Porphyria variegata	176200	AD	3
600924	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
600925	11p11.2	Colon cancer, somatic	114500	_	3
600928	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
600929	22q12.1	Cataract 17, multiple types	611544	AD,AR	3
600936	5q34	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600937	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
600937	11p15.1	Diabetes, permanent neonatal, with or without neurologic features	606176	AD,AR	3
600937	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
600937	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
600937	11p15.1	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600939	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
600943	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
600943	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
600944	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
600946	5p13-p12	Growth hormone insensitivity, partial	604271	AD	3
600946	5p13-p12	Increased responsiveness to growth hormone	604271	AD	3
600946	5p13-p12	Laron dwarfism	262500	AR	3
600946	5p13-p12	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
600955	5q15	Obesity with impaired prohormone processing	600955	AR	3
600956	12q13.13	Persistent Mullerian duct syndrome, type II	261550	AR	3
600957	19p13.3	Persistent Mullerian duct syndrome, type I	261550	AR	3
600958	11p11.2	Cardiomyopathy, dilated, 1MM	615396	AD	3
600958	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
600958	11p11.2	Left ventricular noncompaction 10	615396	AD	3
600960	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
600962	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
600963	19q13.32	Branchiootorenal syndrome 2	610896	_	3
600965	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
600968	16q13	Gitelman syndrome	263800	AR	3
600969	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
600970	6q14.1	Deafness, autosomal dominant 22	606346	AD	3
600970	6q14.1	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	AD	3
600970	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
600971	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
600972	5q32	Achondrogenesis Ib	600972	AR	3
600974	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
600975	1p36.2-p36.1	Glaucoma 3, primary infantile, B	600975	AR	2
600977	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
600980	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
600982	5q11.2	46XY sex reversal 6	613762	AD	3
600983	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
600983	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
600985	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
600985	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
600987	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
600993	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
600993	18q21.2	Myhre syndrome	139210	AD	3
600993	18q21.2	Pancreatic cancer, somatic	260350	_	3
600993	18q21.2	Polyposis, juvenile intestinal	174900	AD	3
600994	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
600995	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
600996	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
600997	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
600997	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
600998	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
600998	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
601002	20q11.22	Glutathione synthetase deficiency	266130	AR	3
601002	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
601003	16p11.2	Brody myopathy	601003	AR	3
601005	12p13.33	Timothy syndrome	601005	AD	3
601007	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
601011	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
601011	19p13.13	Episodic ataxia, type 2	108500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1	141500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	AD	3
601011	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
601013	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
601015	14q24.3	Niemann-pick disease, type C2	607625	AR	3
601017	20q11.21	Long QT syndrome 12	612955	AD	3
601019	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
601022	6p21.33	{Rheumatoid arthritis, susceptibility to}	180300	_	3
601023	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
601023	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
601023	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
601040	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
601042	1p34.2	Dystonia 9	601042	AD	3
601045	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
601047	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
601047	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
601047	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
601065	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
601065	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
601068	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
601072	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
601088	16q23.2	Ayme-Gripp syndrome	601088	AD	3
601089	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
601090	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601090	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
601093	5q35.1	Enlarged vestibular aqueduct	600791	AR	3
601094	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
601094	1p33	Cataract 34, multiple types	612968	_	3
601094	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
601097	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
601097	17p12	Dejerine-Sottas disease	145900	AD,AR	3
601097	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
601097	17p12	Roussy-Levy syndrome	180800	AD	3
601098	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
601101	5q31.3-q32	Telangiectasia, hereditary hemorrhagic, type 3	601101	_	2
601103	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
601104	17q21.31	Supranuclear palsy, progressive	601104	AD	3
601105	1q21.3	Pycnodysostosis	265800	AR	3
601107	10q24.2	Dubin-Johnson syndrome	237500	AR	3
601110	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
601119	19p13.3	Perrault syndrome 3	614129	AR	3
601129	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
601130	10q23.33	Tolbutamide poor metabolizer	_	_	3
601130	10q23.33	Warfarin sensitivity	122700	AD	3
601134	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
601143	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
601143	2p13.1	Perry syndrome	168605	AD	3
601143	2p13.1	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
601144	3p22.2	Brugada syndrome 1	601144	AD	3
601145	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
601146	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
601146	20q11.22	Brachydactyly, type A1, C	615072	AD,AR	3
601146	20q11.22	Brachydactyly, type A2	112600	AD	3
601146	20q11.22	Brachydactyly, type C	113100	AD	3
601146	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
601146	20q11.22	Du Pan syndrome	228900	AR	3
601146	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
601146	20q11.22	Symphalangism, proximal, 1B	615298	_	3
601146	20q11.22	{Osteoarthritis-5}	612400	_	3
601147	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
601147	8q22.1	Leber congenital amaurosis 17	615360	AR	3
601147	8q22.1	Microphthalmia with coloboma 6, digenic	613703	AD	3
601147	8q22.1	Microphthalmia, isolated 4	613094	_	3
601147	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
601150	12p11.21	Warsaw breakage syndrome	613398	AR	3
601152	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
601154	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
601156	17q12	{Asthma, susceptibility to}	600807	AD	3
601156	17q12	{HIV1, resistance to}	609423	_	3
601162	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
601176	1p22.1	{Myocardial infarction, susceptibility to}	608446	_	3
601181	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
601184	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
601188	10pter-q11	Prostate adenocarcinoma	601188	_	2
601190	12p12.3	Achromatopsia 6	610024	AD,AR	3
601190	12p12.3	Retinal cone dystrophy 3	610024	AD,AR	3
601192	1p36.13	[Fleck retina, familial benign]	228980	AR	3
601194	4p14	{Leprosy, protection against}	613223	_	3
601194	4p14	{Leprosy, susceptibility to, 5}	613223	_	3
601197	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
601199	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant	601198	AD	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	AD	3
601199	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
601199	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
601200	14q32.13	Pleuropulmonary blastoma	601200	AD	3
601202	17p13	Cataract 24, anterior polar	601202	AD	2
601205	14q23.1	Branchiootic syndrome 3	608389	AD	3
601205	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
601208	14q24.3-q31	{Diabetes mellitus, insulin-dependent, 11}	601208	_	2
601214	17q21.2	Naxos disease	601214	AR	3
601215	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
601215	3q23	Seckel syndrome 1	210600	AR	3
601216	11q13.1	Dental anomalies and short stature	601216	AR	3
601224	11p11.2	Potocki-Shaffer syndrome	601224	_	4
601228	15q15.3-q22.1	Polyposis syndrome, mixed hereditary 1	601228	AD	4
601228	15q15.3-q22.1	{Colorectal cancer, susceptibility to, 4}	601228	AD	4
601231	1p36.22	Focal cortical dysplasia, type II, somatic	607341	_	3
601231	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
601238	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
601239	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
601240	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
601243	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
601243	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
601247	14q21.3	Noonan syndrome 9	616559	AD	3
601248	2q14.3	Centronuclear myopathy 2	255200	AR	3
601253	3p25.3	Cardiomyopathy, familial hypertrophic	192600	AD	3
601253	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
601253	3p25.3	Long QT syndrome 9	611818	AD	3
601253	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
601253	3p25.3	Rippling muscle disease 2	606072	AD	3
601255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
601255	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
601255	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
601259	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
601263	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
601265	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
601267	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601269	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
601277	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
601280	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
601282	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
601282	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
601282	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
601283	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
601284	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
601287	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601288	8q22.3	Popov-Chang syndrome	618428	AD	3
601295	13q33.1	Bile acid malabsorption, primary	613291	AR	3
601296	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
601296	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
601299	10q23.2	Juvenile polyposis syndrome, infantile form	174900	AD	3
601299	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
601299	10q23.2	Polyposis, juvenile intestinal	174900	AD	3
601300	12q13.13	Pancreatic cancer, somatic	_	_	3
601309	9q22.32	Basal cell carcinoma, somatic	605462	_	3
601309	9q22.32	Basal cell nevus syndrome	109400	AD	3
601309	9q22.32	Holoprosencephaly 7	610828	AD	3
601313	16p13.3	Polycystic kidney disease 1	173900	AD	3
601314	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
601316	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
601317	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
601318	2q34	{Diabetes mellitus, insulin-dependent, 13}	601318	_	2
601321	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
601327	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
601330	12p12.3	Diarrhea 6	614616	AD	3
601330	12p12.3	Meconium ileus	614665	AR	3
601331	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
601336	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
601338	19q13.2	CAPOS syndrome	601338	AD	3
601349	6q21	Microphthalmia, syndromic 8	601349	?AD	2
601358	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
601362	10p14-p13	DiGeorge syndrome/velocardiofacial syndrome complex-2	601362	_	2
601363	17q12-q21	Wilms tumor, type 4	601363	AD	2
601365	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
601368	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
601369	14q12	Deafness, autosomal dominant 9	601369	AD	3
601373	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
601373	3p21.31	{Hepatitis C virus, resistance to}	609532	_	3
601373	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601373	3p21.31	{West nile virus, susceptibility to}	610379	_	3
601382	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
601385	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
601388	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
601390	11p15.4	Van Maldergem syndrome 1	601390	AR	3
601395	17q11.2	{HIV/AIDS, susceptibility to}	609423	_	3
601397	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
601397	6q27	{Neural tube defects, susceptibility to}	182940	AD	3
601399	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
601402	3q25.32	Leukemia, acute myeloid	601626	AD,SMu	1
601404	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
601405	1p36.21	{Pancreatitis, chronic, susceptibility to}	167800	AD	3
601406	12q24.31	B-cell non-Hodgkin lymphoma, high-grade	_	_	3
601407	12q24.2	Diabetes mellitus, noninsulin-dependent, 2	601407	_	2
601408	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
601410	6q24	{Diabetes mellitus, transient neonatal, 1}	601410	AD	4
601411	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
601411	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601412	1q21-q23	Deafness, autosomal dominant 7	601412	AD	2
601414	1q21.2	Retinitis pigmentosa 18	601414	AD	3
601419	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
601421	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
601421	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
601424	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
601428	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
601428	2q14.2	Roifman syndrome	616651	AR	3
601439	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
601439	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
601439	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
601440	17q22	Nephrotic syndrome, type 7	615008	AR	3
601440	17q22	{Hemolytic uremic syndrome, atypical, susceptibility to, 7}	615008	AR	3
601443	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
601445	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
601454	4q	{Psoriasis susceptibility 3}	601454	_	2
601455	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
601458	12p13.2-q24.1	{Inflammatory bowel disease 2}	601458	_	2
601460	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
601462	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
601465	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
601465	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
601465	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
601470	3p22.2	{Coronary artery disease, resistance to}	607339	_	3
601470	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
601470	3p22.2	{Rapid progression to AIDS from HIV1 infection}	609423	_	3
601471	3q21-q22	Facial paresis, hereditary congenital, 1	601471	AD	2
601472	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
601479	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
601485	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
601486	3p24.3	{Spermatogenic failure, susceptibility to}	_	_	3
601487	3p25.2	Carotid intimal medial thickness 1	609338	_	3
601487	3p25.2	Insulin resistance, severe, digenic	604367	AD	3
601487	3p25.2	Lipodystrophy, familial partial, type 3	604367	AD	3
601487	3p25.2	Obesity, severe	601665	AD,AR,Mu	3
601487	3p25.2	[Obesity, resistance to]	_	_	3
601487	3p25.2	{Diabetes, type 2}	125853	AD	3
601488	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
601489	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
601492	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
601495	14q32.33	Agammaglobulinemia 1	601495	AR	3
601498	6p21.1	Heimler syndrome 2	616617	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4B	614863	AD,AR	3
601499	13q14	Rieger syndrome, type 2	601499	AD	2
601500	7q32.1	Basal cell carcinoma, somatic	605462	_	3
601500	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601501	16q11.2	{Parkinson disease 17}	614203	AD	3
601513	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
601515	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
601517	12q24.12	Spinocerebellar ataxia 2	183090	AD	3
601517	12q24.12	{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	AD	3
601517	12q24.12	{Parkinson disease, late-onset, susceptibility to}	168600	AD,Mu	3
601518	1q25.3	Prostate cancer 1	601518	AD	3
601525	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
601525	1q32.1	{Schizophrenia, susceptibility to}	181500	AD	3
601527	12q21.31	?Frontonasal dysplasia 3	613456	_	3
601528	4q34.3	Lymphatic malformation 4	615907	AD	3
601530	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
601530	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
601530	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
601530	5q35.3	Paget disease of bone 3	167250	AD	3
601538	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
601539	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
601542	4q25	Anterior segment dysgenesis 4	137600	AD	3
601542	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
601542	4q25	Ring dermoid of cornea	180550	AD	3
601543	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
601544	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
601545	17p13.3	Lissencephaly 1	607432	AD	3
601545	17p13.3	Subcortical laminar heterotopia	607432	AD	3
601547	22q11.23	Cataract 3, multiple types	601547	AD	3
601548	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
601550	17q21.31	[Blood group, Swann]	601550	_	3
601551	17q21.31	[Blood group, Froese]	601551	_	3
601552	8q12.3	Traboulsi syndrome	601552	AR	3
601553	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
601556	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
601559	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
601564	7q34	{Pancreatitis, chronic, protection against}	167800	AD	3
601565	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
601565	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
601566	13q34	Squamous cell carcinoma, head and neck, somatic	275355	_	3
601567	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
601568	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
601570	3p25.1	Fuhrmann syndrome	228930	AR	3
601570	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
601573	7q36.1	Weaver syndrome	277590	AD	3
601574	17q12	Chondrosarcoma, extraskeletal myxoid	612237	_	1
601583	7p14.1	{Wilms tumor susceptibility-5}	601583	AD,SMu	3
601592	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
601592	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
601593	2q35	{Breast cancer, susceptibility to}	114480	AD,SMu	3
601596	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
601601	6p12.3	Char syndrome	169100	AD	3
601601	6p12.3	Patent ductus arteriosus 2	617035	AD	3
601604	19p13.11	Immunodeficiency 30	614891	AR	3
601606	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
601607	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
601607	22q11.23	Rhabdoid tumors, somatic	609322	_	3
601607	22q11.23	{Rhabdoid tumor predisposition syndrome 1}	609322	AD	3
601607	22q11.23	{Schwannomatosis-1, susceptibility to}	162091	AD	3
601609	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
601609	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
601614	17p13.1	Mirror movements 4	618264	AD	3
601615	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
601617	12q13.2	Fundus albipunctatus	136880	AD,AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
601620	12q24.21	Holt-Oram syndrome	142900	AD	3
601621	12q24.21	Ulnar-mammary syndrome	181450	AD	3
601622	7p21.1	Craniosynostosis 1	123100	AD	3
601622	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
601622	7p21.1	Saethre-Chotzen syndrome with or without eyelid anomalies	101400	AD	3
601622	7p21.1	Sweeney-Cox syndrome	617746	AD	3
601623	15q11.2	Angelman syndrome	105830	AD	3
601627	5q13.2	{Spinal muscular atrophy, type III, modifier of}	253400	AR	3
601631	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601639	19p13.12	Cushing syndrome, ACTH-independent adrenal, somatic	615830	_	3
601641	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
601646	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
601650	11q12.2	Paragangliomas 2	601650	AD	3
601652	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
601653	8q13.3	?Otofaciocervical syndrome	166780	AD	3
601653	8q13.3	Anterior segment anomalies with or without cataract	602588	AD	3
601653	8q13.3	Branchiootic syndrome 1	602588	AD	3
601653	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
601656	18q11.2	Atrial septal defect 9	614475	AD	3
601656	18q11.2	Atrioventricular septal defect 5	614474	AD	3
601656	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
601656	18q11.2	Persistent truncus arteriosus	217095	_	3
601656	18q11.2	Tetralogy of Fallot	187500	AD	3
601663	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
601664	2q11.2	Retinitis pigmentosa 33	610359	AD	3
601666	6q21	{Diabetes mellitus, insulin-dependent, 15}	601666	_	2
601671	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
601675	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
601676	1p31	Acute insulin response	601676	_	2
601678	15q21.1	Bartter syndrome, type 1	601678	AR	3
601680	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
601682	3q21-q24	Glaucoma 1C, primary open angle	601682	AD	2
601683	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
601687	17q21.2	Meesmann corneal dystrophy	122100	AD	3
601688	4q34.1	Cranioosteoarthropathy	259100	AR	3
601688	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
601688	4q34.1	Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	AR	3
601689	18q11.2	?Spermatogenic failure 13	615841	AR	3
601690	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
601690	6p12.3	{Asthma, susceptibility to}	600807	AD	3
601690	6p12.3	{Atopy, susceptibility to}	147050	AD	3
601691	1p22.1	Cone-rod dystrophy 3	604116	_	3
601691	1p22.1	Fundus flavimaculatus	248200	AR	3
601691	1p22.1	Retinal dystrophy, early-onset severe	248200	AR	3
601691	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601691	1p22.1	Stargardt disease 1	248200	AR	3
601691	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
601692	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
601692	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
601692	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
601692	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
601692	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
601692	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
601692	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
601693	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
601694	2p21	[Leptin serum levels QTL1]	601694	_	2
601696	11p15.5	[Novelty seeking personality]	601696	?AD	1
601697	18q22.1	Peeling skin syndrome 5	617115	AR	3
601699	20q13.13	Hypertension, essential	145500	Mu	3
601705	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
601707	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601709	10q22.2	Quebec platelet disorder	601709	AD	3
601717	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
601718	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601719	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
601724	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
601724	2q31.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
601725	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
601728	10q23.31	Cowden syndrome 1	158350	AD	3
601728	10q23.31	Lhermitte-Duclos syndrome	158350	AD	3
601728	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
601728	10q23.31	Prostate cancer, somatic	176807	_	3
601728	10q23.31	{Glioma susceptibility 2}	613028	_	3
601728	10q23.31	{Meningioma}	607174	AD	3
601730	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
601731	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
601734	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
601736	17q23.3	Specific granule deficiency 2	617475	AR	3
601740	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
601743	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
601746	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
601749	1p22.1	Glomuvenous malformations	138000	AD	3
601752	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
601756	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
601757	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
601757	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
601758	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
601758	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
601762	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
601762	2q33.1	Gastric cancer, somatic	613659	_	3
601762	2q33.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
601763	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
601763	2q33.1	Hepatocellular carcinoma, somatic	114550	_	3
601763	2q33.1	{Breast cancer, protection against}	114480	AD,SMu	3
601763	2q33.1	{Lung cancer, protection against}	211980	AD,SMu	3
601764	19q	Seizures, benign familial infantile, 1	601764	AD	2
601768	19p13.3	Leukemia, acute myeloid	601626	AD,SMu	1
601769	12q13.11	?Osteoporosis, involutional	166710	AD	1
601769	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
601771	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
601771	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
601776	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
601777	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
601780	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
601785	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
601788	2q32.2	Muscle hypertrophy	614160	_	3
601789	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
601789	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
601791	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
601802	3p14.3	Growth hormone deficiency with pituitary anomalies	182230	AD,AR	3
601802	3p14.3	Pituitary hormone deficiency, combined, 5	182230	AD,AR	3
601802	3p14.3	Septooptic dysplasia	182230	AD,AR	3
601803	12p	Pallister-Killian syndrome	601803	SMo	4
601806	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
601807	12q13.2	Cavitary optic disc anomalies	611543	AD	3
601808	18q	Chromosome 18q deletion syndrome	601808	AD	4
601810	10q21.3	?Seckel syndrome 8	615807	AR	3
601810	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
601812	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
601813	11q13.2	Exudative vitreoretinopathy 4	601813	AD,AR	3
601814	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
601815	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
601816	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
601819	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
601820	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
601825	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
601837	13q33.3	LIG4 syndrome	606593	AR	3
601837	13q33.3	{Multiple myeloma, resistance to}	254500	SMu	3
601843	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
601844	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
601846	19p13.3	Muscular dystrophy with rimmed vacuoles	601846	AD	2
601847	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
601855	19q13.2	?Immunodeficiency 62	618459	AR	3
601860	5q23.1	D-bifunctional protein deficiency	261515	AR	3
601860	5q23.1	Perrault syndrome 1	233400	AR	3
601861	13q13.3	Bare lymphocyte syndrome, type II, complementation group D	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group C	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group E	209920	AR	3
601865	3q24	Bruck syndrome 2	609220	AR	3
601868	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
601869	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
601873	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
601881	18q21.32	Microphthalmia, isolated 3	611038	AR	3
601884	11q13.2	[Bone mineral density variability 1]	601884	AD	3
601885	13q12.11	Cataract 14, multiple types	601885	AD	3
601887	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
601888	5p	{Malignant hyperthermia susceptibility 6}	601888	_	2
601893	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
601894	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
601896	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
601897	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
601898	3q26.31	Growth hormone deficiency, isolated partial	615925	AD,AR	3
601900	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
601902	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
601903	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
601906	12q13.12	Split-hand/foot malformation 6	225300	AR	3
601906	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
601911	17q21.33	?Orofacial cleft 15	616788	AD	3
601912	2q33.1	?Orofacial cleft 10	613705	IC	3
601918	5q31.1	?Premature ovarian failure 14	618014	AR	3
601920	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
601920	20p12.2	Alagille syndrome 1	118450	AD	3
601920	20p12.2	Tetralogy of Fallot	187500	AD	3
601924	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
601925	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
601928	12q13.13	Monilethrix	158000	AD	3
601933	12q23.3	{Delayed sleep phase disorder, susceptibility to}	614163	AD	3
601941	18q21	{Diabetes mellitus, insulin-dependent, 6}	601941	_	2
601942	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
601949	2q23.3	Episodic ataxia, type 5	613855	AD	3
601949	2q23.3	{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	AD	3
601949	2q23.3	{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	AD	3
601952	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
601954	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
601962	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
601968	1p13.2	Diarrhea 9	618168	AR	3
601972	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
601975	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
601977	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
601978	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
601978	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
601982	3p25.3	Renal cell carcinoma, clear cell, somatic	144700	_	3
601992	9p23-p11	Friedreich ataxia 2	601992	AR	2
602011	3p25	?Pancreatic endocrine tumors	_	_	1
602014	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
602023	1p36.13	Bartter syndrome, type 3	607364	AR	3
602023	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602024	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602025	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
602026	10p13	Refsum disease	266500	AR	3
602032	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602033	14q32.2	Band heterotopia	600348	AR	3
602037	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
602044	11q13.4	{Obesity, severe, and type II diabetes}	601665	AD,AR,Mu	3
602048	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
602049	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
602053	10p15.2	Gastric cancer, somatic	613659	_	3
602053	10p15.2	Prostate cancer, somatic	176807	_	3
602054	22q11.21	Conotruncal anomaly face syndrome	217095	_	3
602054	22q11.21	DiGeorge syndrome	188400	AD	3
602054	22q11.21	Tetralogy of Fallot	187500	AD	3
602054	22q11.21	Velocardiofacial syndrome	192430	AD	3
602063	11p15.5	Transaldolase deficiency	606003	AR	3
602064	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
602066	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
602072	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
602078	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602079	1q24.3	Trimethylaminuria	602079	AR	3
602080	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
602081	7q31.1	Speech-language disorder-1	602081	AD	3
602082	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
602083	10q21.1	Usher syndrome, type 1F	602083	AR	3
602085	13q21-q32	Postaxial polydactyly, type A2	602085	AD	2
602086	14q12-q22	Arrhythmogenic right ventricular dysplasia 3	602086	AD	2
602087	2q32.1-q32.3	Arrhythmogenic right ventricular dysplasia 4	602087	AD	2
602088	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
602090	11q13.1	Dental anomalies and short stature	601216	AR	3
602090	11q13.1	Geleophysic dysplasia 3	617809	AD	3
602091	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
602091	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
602091	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
602092	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
602096	12p11.23-q13.12	Alzheimer disease-5	602096	AD	2
602097	21q21	Usher syndrome, type 1E	602097	AR	2
602099	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
602104	4p16.3	Cherubism	118400	AD	3
602109	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
602109	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
602109	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
602134	2p25-p22	Essential tremor, hereditary, 2	602134	AD	2
602136	7q21.2	Heimler syndrome 1	234580	AR	3
602136	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
602136	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
602137	5q31.3	?Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3
602138	22q13.2	Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3
602140	10q24.31	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3
602141	11q13.2	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3
602142	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AR,AD	3
602144	1p22.1	?Spermatogenic failure 21	617644	AR	3
602146	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
602149	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
602149	5q31.1	Liebenberg syndrome	186550	AD	4
602150	8q11.21	Piebaldism	172800	AD	3
602150	8q11.21	Waardenburg syndrome, type 2D	608890	AR	3
602152	8q22.1	?RHYNS syndrome	602152	AR	3
602153	12q13.13	Monilethrix	158000	AD	3
602166	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
602167	14q24.3	Deafness, autosomal recessive 35	608565	AR	3
602168	14q32.2	Pontocerebellar hypoplasia type 1A	607596	AR	3
602170	3p22.2	Macroglobulinemia, Waldenstrom, somatic	153600	_	3
602170	3p22.2	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	_	3
602177	1q21.3	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms	617591	AR	3
602183	4p15.33	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3
602286	11q23.3-q24.1	Lathosterolosis	607330	AR	3
602290	9q33.1	?Bardet-Biedl syndrome 11	615988	AR	3
602290	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
602292	10q26.3	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3
602293	15q26.1	Epidermodysplasia verruciformis 3	618267	AR	3
602296	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
602298	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
602302	8p21.3	Alopecia universalis	203655	AR	3
602302	8p21.3	Atrichia with papular lesions	209500	AR	3
602302	8p21.3	Hypotrichosis 4	146550	AD	3
602311	16q22.1	{Leanness, inherited}	_	_	3
602311	16q22.1	{Obesity, late-onset}	601665	AR,Mu,AD	3
602322	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
602322	3q26.2	{Aplastic anemia}	614743	AD	3
602322	3q26.2	{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	AD	3
602332	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
602334	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
602336	1p31.3	?Deafness, autosomal recessive 108	617654	AR	3
602337	9q22.31	Brachydactyly, type B1	113000	AD	3
602337	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
602342	3q26.32	Pierpont syndrome	602342	AD	3
602345	4q27	?Spinocerebellar ataxia 41	616410	AD	3
602346	17q21.2	Hypomyelinating neuropathy, congenital, 3	618186	AR	3
602346	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
602347	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
602354	16p11.2	Immunodeficiency 52	617514	AR	3
602357	2q31.1	?Wiskott-Aldrich syndrome 2	614493	_	3
602358	17q21.2	?Narcolepsy 1	161400	AD	3
602360	15q21.1	Cerebral creatine deficiency syndrome 3	612718	AR	3
602361	11q12.1	Gracile bone dysplasia	602361	AD	3
602365	11q14.2	Haim-Munk syndrome	245010	AR	3
602365	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
602365	11q14.2	Periodontitis 1, juvenile	170650	AR	3
602368	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
602376	21q22.11	?Immunodeficiency 45	616669	AR	3
602376	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
602377	9q34.11	Epileptic encephalopathy, early infantile, 31	616346	AD	3
602378	19p13.2	Centronuclear myopathy 1	160150	AD	3
602378	19p13.2	Charcot-Marie-Tooth disease, axonal type 2M	606482	AD	3
602378	19p13.2	Charcot-Marie-Tooth disease, dominant intermediate B	606482	AD	3
602378	19p13.2	Lethal congenital contracture syndrome 5	615368	AR	3
602382	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
602389	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
602390	1q21.1	Hemochromatosis, type 2A	602390	AR	3
602397	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
602397	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
602397	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
602398	1p32.3	Desmosterolosis	602398	AR	3
602400	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
602401	18q22.1-q22.3	Ectodermal dysplasia 8, hair/tooth/nail type	602401	AR	2
602402	16q24.1	Lymphedema-distichiasis syndrome	153400	AD	3
602402	16q24.1	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400	AD	3
602404	2p13	{Parkinson disease 3}	602404	_	2
602409	10p12.31	Leukemia, acute myeloid	601626	SMu,AD	3
602410	3p25.3	Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3
602412	10q22.3	Diamond-blackfan anemia 3	610629	AD	3
602413	1q23.3	Gastrointestinal stromal tumor	606764	IC,AD	3
602413	1q23.3	Paraganglioma and gastric stromal sarcoma	606864	_	3
602413	1q23.3	Paragangliomas 3	605373	AD	3
602421	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
602421	7q31.2	Cystic fibrosis	219700	AR	3
602421	7q31.2	Sweat chloride elevation without CF	_	_	3
602421	7q31.2	{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	AD	3
602421	7q31.2	{Hypertrypsinemia, neonatal}	_	_	3
602421	7q31.2	{Pancreatitis, hereditary}	167800	AD	3
602427	16p11.2	Spondylocostal dysostosis 5	122600	AR,AD	3
602429	8q23	Glaucoma 1D, primary open angle	602429	_	2
602431	3p12.3	Vesicoureteral reflux 2	610878	_	3
602432	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
602432	10p13	Glaucoma 1, open angle, E	137760	AD	3
602432	10p13	{Glaucoma, normal tension, susceptibility to}	606657	_	3
602433	9q34.13	Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3
602438	16q22.1	Cataract 5, multiple types	116800	AD	3
602441	3p21.2	{Bacteremia, susceptibility to}	614383	_	3
602441	3p21.2	{Malaria, susceptibility to}	611162	_	3
602441	3p21.2	{Tuberculosis, susceptibility to}	607948	_	3
602445	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
602447	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
602450	10p13	Severe combined immunodeficiency, Athabascan type	602450	AR	3
602452	2q13	Colorectal cancer with chromosomal instability, somatic	_	_	3
602457	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
602458	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
602459	5q32	Deafness, autosomal dominant 15	602459	AD	3
602460	5q32	Deafness, autosomal dominant 15	602459	AD	3
602466	13q31.1	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3
602471	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
602473	19q13.31	Ethylmalonic encephalopathy	602473	AR	3
602477	19p13.3	Febrile seizures, familial, 2	602477	AD	2
602482	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
602483	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
602485	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
602486	8q22.2	Anauxetic dysplasia 2	617396	AR	3
602490	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
602491	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
602498	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
602498	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
602499	2p22.2	Macrophthalmia, colobomatous, with microcornea	602499	AD	4
602501	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
602529	12q13.12	Lissencephaly 3	611603	AD	3
602531	1q22	Grange syndrome	602531	AR	3
602533	1p36.23	Parkinson disease 7, autosomal recessive early-onset	606324	AR	3
602535	19p13.13	Marshall-Smith syndrome	602535	AD	3
602536	2q21.3	Warburg micro syndrome 1	600118	AR	3
602537	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
602540	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
602541	22q13.33	Muscular dystrophy, congenital, megaconial type	602541	AR	3
602544	6q26	Adenocarcinoma of lung, somatic	211980	_	3
602544	6q26	Ovarian cancer, somatic	167000	_	3
602544	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
602552	17p13.2	Fetal akinesia deformation sequence 4	618393	AR	3
602557	20p13	Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3
602568	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
602568	5p15.31	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
602569	5q35.2	Dementia, Lewy body	127750	AD	3
602572	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
602574	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
602574	11q23.3	Deafness, autosomal recessive 21	603629	AR	3
602575	9q33.3	Nail-patella syndrome	161200	AD	3
602576	7p22.3	Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3
602579	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
602589	14q23.3	Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3
602590	11q13.5-q14.1	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3
602591	5q12.1	Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3
602593	6p21.33	Hypotrichosis 2	146520	AD	3
602593	6p21.33	Peeling skin syndrome 1	270300	AR	3
602594	16p12.3-p12.1	Retinitis pigmentosa 22	602594	_	2
602600	1p32.3	{Myocardial infarction, susceptibility to}	608446	_	3
602601	12p13.2	{Myocardial infarction, susceptibility to}	608446	_	3
602606	5q13.2	{?Obesity, susceptibility to}	601665	AR,Mu,AD	3
602614	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
602614	6q15	Frontometaphyseal dysplasia 2	617137	AD	3
602616	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
602617	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
602617	9q22.33	{Thyroid cancer, nonmedullary, 4}	616534	AD	3
602618	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
602623	6p21.31	{Major depressive disorder and accelerated response to antidepressant drug treatment}	608516	_	3
602627	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
602629	8p11.21	Dystonia 6, torsion	602629	AD	3
602630	18p11.31	Holoprosencephaly 4	142946	AD	3
602631	11p15.4	Breast cancer, somatic	114480	_	3
602631	11p15.4	Lung cancer, somatic	211980	_	3
602631	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
602635	11p15.5	?Dyskinesia, seizures, and intellectual developmental disorder	617171	AR	3
602635	11p15.5	Mental retardation, autosomal dominant 24	615828	AD	3
602638	8q11.21	Immunodeficiency 54	609981	AR	3
602639	16q12.1	Tooth agenesis, selective, 2	602639	_	2
602642	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
602643	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
602656	16p13.3	Familial adenomatous polyposis 3	616415	AR	3
602660	9q34.3	Leber congenital amaurosis with early-onset deafness	617879	AD	3
602661	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
602661	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
602662	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
602662	19p13.3	Leukodystrophy, hypomyelinating, 6	612438	AD	3
602666	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
602667	8q21.3	Aplastic anemia	609135	_	3
602667	8q21.3	Leukemia, acute lymphoblastic	613065	_	3
602667	8q21.3	Nijmegen breakage syndrome	251260	AR	3
602668	3q21.3	Myotonic dystrophy 2	602668	AD	3
602669	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
602669	10q24.32	Cataract 11, multiple types	610623	AR,AD	3
602669	10q24.32	Cataract 11, syndromic, autosomal recessive	610623	AR,AD	3
602671	11q23.3	Glycogen storage disease Ib	232220	AR	3
602671	11q23.3	Glycogen storage disease Ic	232240	AR	3
602676	2q37.1	?Joubert syndrome 22	615665	AR	3
602678	14q32.32-q32.33	?Visual impairment and progressive phthisis bulbi	618283	AR	3
602685	15q24	Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685	_	2
602686	7p22.3	Lymphoma, somatic	_	_	3
602686	7p22.3	Prostate cancer, somatic	176807	_	3
602690	11q23.1	Mitochondrial complex II deficiency	252011	AR	3
602690	11q23.1	Paraganglioma and gastric stromal sarcoma	606864	_	3
602690	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
602690	11q23.1	Pheochromocytoma	171300	AD	3
602694	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
602696	22q12.3	?Meier-Gorlin syndrome 8	617564	AR	3
602700	22q13.2	Colorectal cancer, somatic	114500	_	3
602700	22q13.2	Menke-Hennekam syndrome 2	618333	_	3
602700	22q13.2	Rubinstein-Taybi syndrome 2	613684	AD	3
602703	16q21	Lissencephaly 6, with microcephaly	616212	AR	3
602713	8p11.22	Cone-rod dystrophy 9	612775	_	3
602716	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
602717	19q13.33	Epileptic encephalopathy, early infantile, 46	617162	AD	3
602722	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
602723	17q25.3	Psoriasis 2	602723	AD	3
602727	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
602727	16p13.3	Osteopetrosis, autosomal recessive 4	611490	AR	3
602730	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
602731	5p13.1	Thrombocytopenia 3	273900	AR	3
602743	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
602743	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
602743	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
602744	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
602748	12q21.33	Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3
602753	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602754	19q13.31	Dehydrated hereditary stomatocytosis 2	616689	AD	3
602759	1q42.2-q43	{Prostate cancer, susceptibility to}	602759	_	2
602765	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
602765	12q13.13	Monilethrix	158000	AD	3
602767	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602768	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
602769	2p23.3	Acute myeloid leukemia, somatic	601626	_	3
602769	2p23.3	Tatton-Brown-Rahman syndrome	615879	AD	3
602770	17q25.3	?46XY sex reversal 5	613080	AR	3
602771	1p36.11	Muscular dystrophy, rigid spine, 1	602771	AR	3
602772	6q12	Retinitis pigmentosa 25	602772	AR	3
602773	3q21.1	Renal cell carcinoma	144700	_	1
602774	17q22	Fanconi anemia, complementation group O	613390	AR	3
602774	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
602775	10q25.2	Noonan-like syndrome with loose anagen hair	607721	AD	3
602780	5p12	Epileptic encephalopathy, early infantile, 24	615871	AD	3
602780	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
602782	10q22.1	Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3
602783	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
602821	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
602821	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
602821	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
602839	1p36.22	Immunodeficiency 14	615513	AD	3
602840	19p13.3	Lymphoproliferative syndrome 3	618261	AR	3
602842	6p22.3	Meier-Gorlin syndrome 6	616835	AD	3
602849	4p16.3	Muenke syndrome	602849	AD	3
602851	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
602851	5q14.3	Usher syndrome, type 2C	605472	AR	3
602851	5q14.3	Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	AR	3
602855	14q13.2	{Myocardial infarction, susceptibility to}	608446	_	3
602858	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
602859	1p36.32	Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3
602859	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
602860	15q15.1	Colorectal cancer, somatic	114500	_	3
602860	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
602860	15q15.1	[Premature chromatid separation trait]	176430	AD	3
602861	12p11.21	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3
602867	4q12	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3
602869	1q44	Epileptic encephalopathy, early infantile, 54	617391	AD	3
602870	6q14.1	Macular dystrophy, vitelliform, 4	616151	AD	3
602875	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
602876	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
602879	20q11.23	?Mental retardation, autosomal dominant 11	614257	AD	3
602880	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
602880	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
602900	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
606025	3q13.31	Primrose syndrome	259050	AD	3
606220	13q22.3	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3
604270	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
604270	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
604270	11p11.2	Sclerosteosis 2	614305	AR,AD	3
603295	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
605635	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
606612	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	AR	3
603685	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
606613	9p	[High density lipoprotein cholesterol level QTL 1]	606613	_	2
606806	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
607001	9q34.3	Kleefstra syndrome 1	610253	AD	3
606807	3p14.3	Hypogonadotropic hypogonadism 18 with or without anosmia	615267	AR,AD	3
603297	11q22.3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR,DR	3
605637	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AR,AD	3
606808	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607002	3p13	Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3
604272	22q13.33	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	AR	3
604272	22q13.33	Myopia 6	608908	AD	3
605833	1q21-q23	[Bone mineral density QTL 2]	605833	_	2
607196	17q25.1	Microcephaly, Amish type	607196	AR	3
603490	1p36.12	?SERKAL syndrome	611812	AR	3
603490	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
606224	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
604273	17p11.2	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3
603491	1p13.1	?Lacrimal duct defect	149700	AR	3
603688	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
607198	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
607004	5p13.3-p13.2	Brachydactyly, type A1, B	607004	AD	2
603301	2p25.1	Maturity-onset diabetes of the young, type VII	610508	_	3
607199	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
607199	1q32.2	van der Woude syndrome	119300	AD	3
607199	1q32.2	{Orofacial cleft 6}	608864	AD	3
607976	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
608170	5q35.3	{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3
606810	22q11.21	Hyperprolinemia, type I	239500	AR	3
606810	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
603689	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
603690	3q25.31	Congenital cataracts, hearing loss, and neurodegeneration	614482	AR	3
603690	3q25.31	Spastic paraplegia 42, autosomal dominant	612539	AD	3
608171	12p13.33	Retinal cone dystrophy 4	610478	AR	3
608172	1p36.11	?Congenital disorder of glycosylation, type 1bb	613861	AR	3
608172	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
608172	1p36.11	Retinitis pigmentosa 59	613861	AR	3
607393	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
607393	1q31.2	Hyperparathyroidism-jaw tumor syndrome	145001	AD	3
607393	1q31.2	Parathyroid adenoma with cystic changes	145001	AD	3
607393	1q31.2	Parathyroid carcinoma	608266	_	3
603511	7q36.3	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3
602911	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
603467	11p14.3	Fanconi anemia, complementation group F	603467	_	3
604261	6q21	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3
605102	1p36.22	MASP2 deficiency	613791	AR	3
605376	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
606771	14p11.2-q13	{Adiponectin, serum level of, QTL3}	606771	_	2
604710	19q13.2	Cutis laxa, autosomal recessive, type IC	613177	AR	3
605572	17p12	Abdominal obesity-metabolic syndrome	605572	AD	2
604144	19q13.11	Cystinuria	220100	AR,AD	3
604507	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
606494	1p34.1	?Epileptic encephalopathy, early infantile, 15	615006	AR	3
606494	1p34.1	Mental retardation, autosomal recessive 12	611090	AR	3
606454	14q24.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606454	14q24.3	Ovarioleukodystrophy	603896	AR	3
603390	5q13.3	Pigmented nodular adrenocortical disease, primary, 3	614190	_	3
603390	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
603550	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
603550	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
604223	7q22.1	Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease	617718	AR	3
607017	6p24.1-p22.3	Deafness, autosomal dominant 21	607017	AD	2
606258	13q32-q33	{Stature QTL 4}	606258	_	2
607095	9p13.3	Anauxetic dysplasia 1	607095	AR	3
605377	19q13.32	Myotonic dystrophy 1	160900	AD	3
604145	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
606972	14q23	{Epilepsy, idiopathic generalized, susceptibility to, 2}	606972	_	2
603513	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
606933	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
606933	11q14.3	Albinism, oculocutaneous, type IB	606952	_	3
606933	11q14.3	Waardenburg syndrome/albinism, digenic	103470	AD	3
606933	11q14.3	[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	AD	3
606933	11q14.3	[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	AD	3
606933	11q14.3	{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	AD	3
605573	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
607096	11q13.1	Hypouricemia, renal	220150	AR	3
607134	13q21	Specific language impairment QTL, 3	607134	_	2
603028	4q31.3	{Colorectal cancer, susceptibility to}	114500	SMu,AD	3
603028	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
603028	4q31.3	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
604827	15q14	Epilepsy, juvenile myoclonic	604827	AR	2
604827	15q14	{Epilepsy, idiopathic generalized, susceptibility to, 7}	604827	AR	2
604624	5q11.2	?Neuronopathy, distal hereditary motor, type IIC	613376	AD	3
604712	8q22.3	Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	AR	3
604712	8q22.3	Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	AR	3
604712	8q22.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3
603830	3p22.2	Long QT syndrome-3	603830	AD	3
603147	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
607373	3q25-q27	{Autism susceptibility 8}	607373	IC,Mu	2
603714	2p21	Holoprosencephaly 2	157170	AD	3
603714	2p21	Schizencephaly	269160	_	3
606934	15q15.1	Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3
604985	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
604985	11q13.2	Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3
603552	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
605610	19q13.33	Ataxia-oculomotor apraxia 4	616267	AR	3
605610	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
605378	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
607295	22q12.1	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3
603629	11q23.3	Deafness, autosomal recessive 21	603629	AR	3
606973	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
607056	3q12.3	Macular dystrophy, vitelliform, 5	616152	AD	3
607056	3q12.3	Retinitis pigmentosa 56	613581	AR	3
606896	3p12-q13	{Dyslexia, susceptibility to, 5}	606896	_	2
605379	16q23.2	Giant axonal neuropathy-1	256850	AR	3
604625	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
605814	7q21.3	Citrullinemia, type II, neonatal-onset	605814	AR	3
606214	19q13.2	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3
604025	17q24.1	Colorectal cancer, somatic	114500	_	3
604025	17q24.1	Oligodontia-colorectal cancer syndrome	608615	AD	3
606496	6p12.2	?Candidiasis, familial, 6, autosomal dominant	613956	_	3
606856	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
607572	6q25	{Leprosy, susceptibility to, 2}	607572	_	2
606936	19q13.33	Progressive familial heart block, type IB	604559	AD	3
604346	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
607100	2q13	Joubert syndrome 4	609583	AR	3
607100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
607100	2q13	Senior-Loken syndrome-1	266900	AR	3
605815	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
604305	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
604305	6p21.32	{Creutzfeldt-Jakob disease, variant, resistance to}	123400	AD	3
604305	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
607728	15q25.1-q26.1	Porokeratosis 4, disseminated superficial actinic	607728	_	2
606215	1p31-p21	{Atrioventricular septal defect, susceptibility to, 1}	606215	_	2
603553	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
603667	2q31.1	Epileptic encephalopathy, early infantile, 39	612949	AR	3
604946	19q13.42	{AIDS, delayed/rapid progression to}	609423	_	3
603395	8q22.2	Ciliary dyskinesia, primary, 28	615505	AR	3
606574	5p13.2	Albinism, oculocutaneous, type IV	606574	_	3
603716	6p24.2	Hyperparathyroidism 4	617343	AD	3
603716	6p24.2	Hypoparathyroidism, familial isolated	146200	AR,AD	3
606857	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
606857	6p12.1	{Myocardial infarction, susceptibility to}	608446	_	3
605577	11q13.1	?Bleeding disorder, platelet-type, 18	615888	AR	3
607057	22q11.21	Pseudo-TORCH syndrome 2	617397	AR	3
606938	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
605537	1q23.3	Achromatopsia 7	616517	AR	3
604027	17q21.32	Epilepsy, progressive myoclonic 6	614018	AR	3
605495	12p12.2	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3
604065	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
604065	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
603263	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
603150	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
607457	9p13.3	[Blood group GIL]	607457	_	3
607731	8q13-q23	Charcot-Marie-Tooth disease, axonal, type 2H	607731	AR	2
606897	1q42.3	Chediak-Higashi syndrome	214500	AR	3
607536	19p13.11	Mucoepidermoid salivary gland carcinoma	_	_	3
605579	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
608160	17q24.3	Acampomelic campomelic dysplasia	114290	AD	3
608160	17q24.3	Campomelic dysplasia	114290	AD	3
608160	17q24.3	Campomelic dysplasia with autosomal sex reversal	114290	AD	3
606060	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
603188	10p	{Obesity, susceptibility to, BMIQ8}	603188	_	2
607613	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
607613	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
607458	7q22-q32	Spinocerebellar ataxia 18	607458	AD	2
603313	12q12	{Long QT syndrome, acquired, reduced susceptibility to}	613688	AD	3
606382	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
606012	3q22	Deafness, autosomal dominant 18	606012	AD	2
604185	10q21.3-q22.1	Facial paresis, hereditary congenital, 2	604185	AD	2
606939	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
606939	8p21.3	Zimmermann-Laband syndrome 2	616455	AD	3
607574	22q13.33	Metachromatic leukodystrophy	250100	AR	3
607614	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
604867	7q31.32	[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}	617956	_	3
608161	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
607459	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
604348	2q37.3	Advanced sleep phase syndrome, familial, 1	604348	AD	3
606821	7q22.3	Congenital disorder of glycosylation, type IIi	613612	_	3
604110	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
604110	16q21	Polymicrogyria, bilateral perisylvian	615752	_	3
604831	4p16.2	?Weyers acrofacial dysostosis	193530	AD	3
604831	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607965	10q22.3	{Systemic lupus erythematosus with nephritis, susceptibility to, 1}	607965	_	2
603632	6p21.31	Diamond-Blackfan anemia 9	613308	AD	3
608320	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
603590	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3
603590	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	AR	3
607537	11q21	Mucoepidermoid salivary gland carcinoma	_	_	3
607339	16pter-p13	{Coronary heart disease, susceptibility to}	607339	_	2
608904	17p11	{Attention deficit-hyperactivity disorder}	143465	AD	2
608787	3q22-q24	Otosclerosis 5	608787	_	2
603671	5q12.1	Acromelic frontonasal dysostosis	603671	AD	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3
606822	1p34.1	Retinitis pigmentosa 76	617123	AR	3
605582	6q12-q16	Cardiomyopathy, dilated, 1K	605582	_	2
605497	3p22.3	Osteogenesis imperfecta, type VII	610682	AR	3
603718	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
608905	6q12	{Attention deficit-hyperactivity disorder}	143465	AD	2
606061	7p14.2	Atrial septal defect 4	611363	_	3
604629	11q22.2	Amelogenesis imperfecta, type IIA2	612529	AR	3
604149	7q21.3	Dystonia-11, myoclonic	159900	AD	3
608358	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
605025	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
608124	16p12.3	Desbuquois dysplasia 2	615777	AR	3
608124	16p12.3	{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3
606179	16q22	Aneurysmal bone cysts	606179	_	2
608593	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
603673	1p34.1	Basal cell carcinoma, somatic	605462	_	3
603673	1p34.1	Basal cell nevus syndrome	109400	AD	3
603673	1p34.1	Medulloblastoma, somatic	155255	_	3
607461	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
607461	18q21.1	Smith-McCort dysplasia	607326	AR	3
606180	4q27	Pontocerebellar hypoplasia, type 1D	618065	AR	3
606384	18q21.31	Periventricular nodular heterotopia 7	617201	AD	3
604630	1p36.11	Obesity, mild, early-onset	601665	AR,Mu,AD	3
603557	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
608982	3p26	{Stature QTL 5}	608982	_	2
606824	22q12.3	Glucose/galactose malabsorption	606824	AR	3
608125	17q21.33	Spondyloocular syndrome	605822	AR	3
608125	17q21.33	{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3
603756	4q22.1	[Junior blood group system]	614490	_	3
603756	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
607462	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
608906	5p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
604067	17q24.1	Bradyopsia	608415	_	3
605818	2q23-q31	Deafness, autosomal recessive 27	605818	AR	2
608047	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
608515	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
606860	11q12.1	Angioedema, hereditary, types I and II	106100	AR,AD	3
606860	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
608709	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
605380	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
605380	12p13.32	Osteomalacia, tumor-induced	_	_	1
605380	12p13.32	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	_	3
603795	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
607258	4q33-qter	Hypercalciuria, absorptive	607258	_	2
608907	19p13.3	{Alzheimer disease 9, susceptibility to}	608907	AD	3
607966	2q34-q35	{Systemic lupus erythematosus with nephritis, susceptibility to, 2}	607966	_	2
608594	9q34.3	Lipodystrophy, congenital generalized, type 1	608594	AR	3
603796	21q22.11	Atrial fibrillation, familial, 4	611493	_	3
603796	21q22.11	Long QT syndrome 6	613693	AD	3
608710	6p21.3	Granulomatosis with polyangiitis	608710	_	2
604834	12q14.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3
604834	12q14.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3
607967	11p15.5	{Systemic lupus erythematosus with nephritis, susceptibility to, 3}	607967	_	2
603758	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
607059	8q24.3	Acrodermatitis enteropathica	201100	AR	3
603560	22q13.33	Charcot-Marie-Tooth disease, type 4B3	615284	AR	3
607027	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
607027	3q13.31	Epileptic encephalopathy, infantile or early childhood, 3	618012	AD	3
609060	3q25.32	Combined oxidative phosphorylation deficiency 1	609060	AR	3
608908	22q13.33	Myopia 6	608908	AD	3
607259	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
607417	3p26.2	Mental retardation, autosomal recessive 2	607417	AR	3
608323	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
607060	12q12	{Parkinson disease 8}	607060	AD	3
607968	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
607464	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
607616	11p15.4	Niemann-Pick disease, type B	607616	AR	3
609334	18q22	Chromosome 18 pericentric inversion	609334	_	4
604349	9q34.12	Cortical malformations, occipital	614115	AR	3
608049	13q14.2-q14.1	{Autism susceptibility 3}	608049	IC,Mu	2
608984	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
607465	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
607847	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
604114	15q15.1	Platelet PLC beta-2 deficiency	_	_	1
606693	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
608051	4p15.32	Macular dystrophy, retinal, 2	608051	AD	3
609023	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
609179	15q11.2-q12	{Migraine with aura, susceptibility to, 7}	609179	_	2
609607	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
607849	14q24.1	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3
609180	17p13.1	Congenital disorder of glycosylation, type If	609180	AR	3
604115	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
608713	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
606742	4q32.3	Atrial septal defect 6	613087	AD	3
609412	5q12.1	Cockayne syndrome, type A	216400	AR	3
609412	5q12.1	UV-sensitive syndrome 2	614621	AR	3
604427	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
607468	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
608869	1p13.2	Urofacial syndrome 2	615112	AR	3
609840	14q32.12	Amelogenesis imperfecta, type IIA5	615887	AR	3
609840	14q32.12	[Skin/hair/eye pigmentation 6, blond/brown hair]	210750	AR	3
609840	14q32.12	[Skin/hair/eye pigmentation 6, blue/green eyes]	210750	AR	3
609025	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
604116	1p22.1	Cone-rod dystrophy 3	604116	_	3
603799	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
609918	1p36.21	Gallbladder disease 2	609918	_	2
609452	10q23.2	Myopathy, myofibrillar, 4	609452	AD	3
607850	9q22.31	{Osteoarthritis susceptibility 3}	607850	AD	3
604473	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
604473	6q24.3	Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3
610113	1q21.2	Ectopia lentis et pupillae	225200	AR	3
610113	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
610192	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
607498	6p21.1-p12.2	{Migraine with or without aura, susceptibility to, 3}	607498	AD	2
604117	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
610193	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
606744	18q11.2	Seckel syndrome 2	606744	AR	3
609062	7p14.1	{Wilms tumor susceptibility-5}	601583	SMu,AD	3
610230	22q13.31	Liver failure, transient infantile	613070	AR	3
610230	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
607499	10p	{Bulimia nervosa, susceptibility to}	607499	Mu	2
603563	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
603355	16q23.3-q24.1	?Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3
610308	13q12.3	Peters-plus syndrome	261540	AR	3
610542	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
603356	6q21	?Deafness, autosomal dominant 66	616969	AD	3
609919	1p34.3	Gallbladder disease 3	609919	_	2
609026	6p12-q12	{Cataract 28, age-related cortical, susceptibility to}	609026	_	2
610114	9q22	{Stature QTL 8}	610114	_	2
610425	22q12.1	Cataract 23	610425	_	3
610543	16p13.3	Chromosome 16p13.3 deletion syndrome	610543	_	4
608053	15q24.2-q24.3	Glutaric acidemia IIA	231680	AR	3
608360	9q34.11	?Agammaglobulinemia 5	613506	AD	3
610504	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
610698	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
606694	5p13.2	?Atrial fibrillation 15	615770	AR	3
607853	9q31	Panic disorder 2	607853	_	2
603592	18q12.2	Xanthinuria, type II	603592	AR	3
604556	19q13.2	Abdominal obesity-metabolic syndrome 3	615812	AD	3
610194	1q42.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	AR	3
610738	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
609255	6q22-q24	Febrile seizures, familial, 5	609255	AD	2
610815	8q22.3	?Exercise intolerance, riboflavin-responsive	616839	AR	3
603593	14q11.2	Lysinuric protein intolerance	222700	AR	3
604557	16q12.1	Joubert syndrome 19	614844	AR,AD	3
604557	16q12.1	Nephronophthisis 14	614844	AR,AD	3
610505	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
609027	11p13	[Blood group, Indian system]	609027	_	3
610621	4q28.1	?Orofaciodigital syndrome XVII	617926	AR	3
610621	4q28.1	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3
608553	1p36.22	Leber congenital amaurosis 9	608553	AR	3
608361	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
610582	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
610933	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
609610	15q15.3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3
611088	12q13.12	Ciliary dyskinesia, primary, 27	615504	AR	3
610350	15q26.3	Mental retardation, autosomal recessive 27	614340	AR	3
609256	11p13	Myopia 7	609256	Mu	2
603594	1q25.1	{Myocardial infarction, susceptibility to}	608446	_	3
609958	2p16	{Asthma-related traits, susceptibility to, 3}	609958	_	2
610934	7q35	Premature ovarian failure 5	611548	AD	3
609257	3q26	Myopia 8	609257	Mu	2
610427	11q13.2	Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3
603357	18q21.33	Palmoplantar keratoderma, Nagashima type	615598	AR	3
610389	1q22	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3
608874	4p16.2	Orofacial cleft 5	608874	_	3
609922	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
610855	10p12.1	Thrombocytopenia 2	188000	AD	3
608875	14q32	{Gene expression, variation in, QTL}	608875	_	2
610353	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
610622	19q13.33	{Neural tube defects, susceptibility to}	182940	AD	3
611051	3q28	?Deafness, autosomal dominant 44	607453	AD	3
604558	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
610197	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
610197	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
608716	1q31.3	Microcephaly 5, primary, autosomal recessive	608716	AR	3
610234	14q11.2-q12	Synpolydactyly 3	610234	_	2
609883	17q22	Bardet-Biedl syndrome 13	615990	AR	3
609883	17q22	Joubert syndrome 28	617121	AR	3
609883	17q22	Meckel syndrome 1	249000	AR	3
603564	9q34.11	Congenital disorder of glycosylation, type Iu	615042	AR	3
608363	22q11.2	Chromosome 22q11.2 microduplication syndrome	608363	IC,AD	4
610198	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
603358	2q35	GRACILE syndrome	603358	_	3
608364	12q13.12	[Low density lipoprotein cholesterol level QTL 8]	618079	_	3
611209	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
607575	22q11.1	?Sneddon syndrome	182410	AR	3
607575	22q11.1	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3
610236	2q31.1	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3
609727	1p31.1-p21.1	Spastic paraplegia 29, autosomal dominant	609727	AD	2
609762	19q13.32	Hermansky-Pudlak syndrome 8	614077	AR	3
607892	18q12.1	Hypotrichosis 6	607903	AR	3
611363	7p14.2	Atrial septal defect 4	611363	_	3
611283	11q25	Isobutyryl-CoA dehydrogenase deficiency	611283	_	3
603805	15q15.2	Peeling skin syndrome 2	609796	AR	3
609923	9p21.1	Retinitis pigmentosa 31	609923	_	3
604559	19q13.33	Progressive familial heart block, type IB	604559	AD	3
609728	2q33.1	?Combined oxidative phosphorylation deficiency 25	616430	AR	3
609728	2q33.1	Spastic ataxia 3, autosomal recessive	611390	AR	3
607893	3p25-p22	{Ovarian cancer, susceptibility to}	607893	_	2
611211	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
611556	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
608367	7p15	Myopia 17	608367	AD	2
607854	11q12.3	Bestrophinopathy, autosomal recessive	611809	_	3
607854	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
607854	11q12.3	Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	193220	AD	3
607854	11q12.3	Retinitis pigmentosa, concentric	613194	_	3
607854	11q12.3	Retinitis pigmentosa-50	613194	_	3
607854	11q12.3	Vitreoretinochoroidopathy	193220	AD	3
611053	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
611364	5q12-q14	Myoclonic epilepsy, juvenile, 4	611364	AD	2
611595	18q23	Burn-McKeown syndrome	608572	AR	3
607855	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
609063	22q12.3	?Combined oxidative phosphorylation deficiency 29	616811	AR	3
611868	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
611634	3p24.2-p23	Febrile seizures, familial, 9	611634	AD	2
609258	4q12	Myopia 9	609258	Mu	2
610819	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
609924	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
611907	19q13	Episodic ataxia, type 7	611907	AD	2
603570	6q23.2	[High density lipoprotein cholesterol level QTL 8]	_	_	3
607776	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
610624	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
611715	4q12	Congenital disorder of glycosylation, type Iq	612379	AR	3
611715	4q12	Kahrizi syndrome	612713	AR	3
607501	14q21.2-q22.3	{Migraine without aura, susceptibility to, 4}	607501	AD	2
610430	4q	{Macroglobulinemia, Waldenstrom, susceptibility to, 2}	610430	_	2
608877	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
608878	20q13	{Gene expression, variation in, QTL}	608878	_	2
607778	2q35	Acrocapitofemoral dysplasia	607778	AR	3
607857	4q31-q34	{Psoriasis susceptibility 9}	607857	_	2
612298	11p13	?Aniridia 3	617142	AD	3
611716	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
611716	12q24.31	Wrinkly skin syndrome	278250	AR	3
603810	11q21	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3
611637	4p16	Primary lateral sclerosis, adult, 1	611637	AD	2
611247	16p12	Major affective disorder 4	611247	_	2
609646	3q13.33	Deafness, autosomal recessive 42	609646	AR	3
609647	18p11.32-p11.31	Deafness, autosomal recessive 46	609647	AR	2
603601	11p15.1	Oculoskeletodental syndrome	618440	AR	3
611638	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
612025	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
609965	14q11.2-q12	Deafness, autosomal dominant 53	609965	AD	2
608879	15q22.2	Parkinson disease 23, autosomal recessive, early onset	616840	AR	3
612453	5q23.2	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	614399	AR	3
612453	5q23.2	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	614399	AR	3
611597	3q22.1	Cataract 12, multiple types	611597	AD	3
603811	11q13.1	Nestor-Guillermo progeria syndrome	614008	AR	3
609648	19q13.42	Familial cold autoinflammatory syndrome 2	611762	AD	3
612570	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
612570	5q23.3	Macular degeneration, early-onset	616118	AD	3
608556	1q41	{Legionnaire disease, susceptibility to}	608556	_	3
609259	8p23	Myopia 10	609259	Mu	2
611718	4q25	Hypomagnesemia 4, renal	611718	_	3
611951	19q13.2	?Meckel syndrome 10	614175	AR	3
611951	19q13.2	Joubert syndrome 34	614175	AR	3
612648	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
611598	4q27	{Autoimmune disease, susceptibility to, 5}	611598	_	2
611598	4q27	{Celiac disease, susceptibility to, 6}	611598	_	2
613077	8q22.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3
612804	19q13.2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3
612300	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
612026	4q25	Alazami syndrome	615071	AR	3
613155	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	AR	3
612882	6q21	{Menarche, age at, QTL2}	612882	_	2
613078	5q31.1	Nijmegen breakage syndrome-like disorder	613078	_	3
612649	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
612301	18q21.33	Osteopetrosis, autosomal recessive 7	612301	AR	3
612961	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
609260	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
603813	1p36.11	Hypercholesterolemia, familial, 4	603813	AR	3
612378	6q23	{Systemic lupus erythematosus, susceptibility to, 13}	612378	_	2
612999	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
604961	2q31.2	Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3
613038	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AR,AD	3
612805	1q21.2	?Combined oxidative phosphorylation deficiency 21	615918	AR	3
607472	10p12.1	?Optic atrophy 11	617302	AR	3
609261	12q24.1	Stuttering, familial persistent, 2	609261	_	2
610355	16p12.2	Fanconi anemia, complementation group N	610832	_	3
610355	16p12.2	{Breast cancer, susceptibility to}	114480	SMu,AD	3
610355	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
610823	19p13.11	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3
613195	15q26.3	Weill-Marchesani 4 syndrome, recessive	613195	AR	3
613000	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
611010	11p15	Fibromatosis, gingival, 4	611010	_	2
612336	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
609262	3p26.2	Mental retardation, autosomal recessive 2	607417	AR	3
612105	10q23.31	Cowden syndrome 4	615107	_	3
607473	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
612337	1q44	Mental retardation, autosomal dominant 22	612337	AD	3
610826	5q22.1	Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3
612379	4q12	Congenital disorder of glycosylation, type Iq	612379	AR	3
613274	18q12.2	Xanthinuria, type II	603592	AR	3
610827	20q13.12	Microcephaly 10, primary, autosomal recessive	615095	AR	3
612650	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
608750	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
608557	13q12	{Myocardial infarction, susceptibility to, 2}	608557	_	2
612651	6p12.1	Endocrine-cerebroosteodysplasia	612651	AR	3
611875	12p13.33	Brugada syndrome 3	611875	_	3
613468	8p22	Farber lipogranulomatosis	228000	AR	3
613468	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
612571	5p15.33	{Lung cancer susceptibility 3}	612571	_	2
609769	12q13.3	Ichthyosis, congenital, autosomal recessive 13	617574	AR	3
613818	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
613896	7q33	Erythrocytosis, familial, 8	222800	AR	3
613545	1p34-p32	Macrostomia	613545	_	2
612380	17q21.2	{Inflammatory bowel disease 22}	612380	_	2
612381	1q32.1	{Inflammatory bowel disease 23}	612381	_	2
613001	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
609968	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
613819	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
614091	2p24.1	Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3
612572	20p13	Retinitis pigmentosa 46	612572	_	3
614052	8q21.11	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3
614208	9p23-p13.3	Mental retardation, autosomal recessive 16	614208	AR	2
613662	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
612107	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
610397	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
613350	20p13	?Fazio-Londe disease	211500	AR	3
613350	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
613002	4q35.1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}	613002	AR,AD	3
612653	17q21.31	Spherocytosis, type 4	612653	AD	3
613897	11p14.3	Fanconi anemia, complementation group F	603467	_	3
612108	2q24-q32	[Fasting plasma glucose level QTL 1]	612108	_	2
614169	3p21.31	Gray platelet syndrome	139090	AR	3
612573	12q24.31	[Mean platelet volume QTL1]	612573	_	2
613118	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AR,AD	3
607982	11q13.1	Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3
612067	2q31.2	Dystonia 16	612067	AR	3
607983	1q24.2	Geroderma osteodysplasticum	231070	AR	3
612574	3p21-p13	[Mean platelet volume QTL2]	612574	_	2
613702	12p13.31	Klippel-Feil syndrome 3, autosomal dominant	613702	_	3
613119	11q13.4	?Brugada syndrome 6	613119	_	3
614170	4q27	Brittle cornea syndrome 2	614170	AR	3
613779	19p13.3	C3 deficiency	613779	AR	3
614559	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
612921	2q35	3-M syndrome 2	612921	AR	3
613780	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
614482	3q25.31	Congenital cataracts, hearing loss, and neurodegeneration	614482	AR	3
608988	6q14-q16	Atrial fibrillation, familial, 2	608988	_	2
613352	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
613820	2q24.3	Nephronophthisis 12	613820	AR,AD	3
613665	1q23.2	[Blood group, Duffy system]	110700	AR,AD	3
613665	1q23.2	[White blood cell count QTL]	611862	AR	3
613665	1q23.2	{Malaria, vivax, protection against}	611162	_	3
612847	10q23.2-q23.3	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3
614209	17p11.2	?Meckel syndrome 9	614209	AR	3
612575	17q11.2	[Mean platelet volume QTL3]	612575	_	2
614053	20q13.32	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	_	3
614676	7p12.1-q21	Cardiomyopathy, hypertrophic, 21	614676	AD	2
614210	3q28	{Lung cancer susceptibility 5}	614210	_	2
613079	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
604965	20q13.12	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	_	3
612848	19q13.12	Mitochondrial complex II deficiency	252011	AR	3
603816	16p13.3	?Caudal duplication anomaly	607864	_	3
603816	16p13.3	Hepatocellular carcinoma, somatic	114550	_	3
614249	6q23.2	Mental retardation, autosomal recessive 18	614249	AR	3
612109	4p16.1	Oculoauricular syndrome	612109	AR	3
614949	16q23.1	Joubert syndrome 20	614970	AR	3
614949	16q23.1	Meckel syndrome 11	615397	AR	3
603604	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
603604	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
603604	22q13.1	Parkinson disease 14, autosomal recessive	612953	AR	3
613080	17q25.3	?46XY sex reversal 5	613080	AR	3
614250	6p22.1	?Narcolepsy 7	614250	AD	3
614055	6q25.3	?ACAT2 deficiency	614055	IC	1
604267	19q13.2	Carpenter syndrome 2	614976	AR	3
614756	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
614325	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
612110	13q14	[Bone mineral density QTL 9]	612110	_	2
603720	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
615145	4q34.3-q35.1	Microphthalmia, isolated, with coloboma 9	615145	AR	3
603576	15q13.3	Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	_	3
614757	11p15.5	Osteogenesis imperfecta, type V	610967	AD	3
614871	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
614677	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
603605	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
607508	19p13	{Migraine with or without aura, susceptibility to, 5}	607508	AD	2
613587	8p23.1	Occult macular dystrophy	613587	AD	3
613506	9q34.11	?Agammaglobulinemia 5	613506	AD	3
614251	3q27.1	{Parkinson disease 18}	614251	AD	3
613823	15q21.1	Seckel syndrome 5	613823	AR	3
615028	11q22.3	Epidermolysis bullosa, nonspecific, autosomal recessive	615028	AR	3
615262	17q25.1	Mental retardation, autosomal recessive 44	615942	AR	3
614252	8p22	Aneurysm, intracranial berry, 11	614252	_	2
613507	3q24	?Glycogen storage disease XV	613507	AR	3
613003	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
613390	17q22	Fanconi anemia, complementation group O	613390	AR	3
614872	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
610828	9q22.32	Holoprosencephaly 7	610828	AD	3
615457	6q14.2	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3
614211	13q34	Deafness, autosomal dominant 33	614211	AD	2
615224	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
615302	19p13.3	Mental retardation, autosomal recessive 36	615286	AR	3
615264	1p36.32	[Blood group, Vel system]	615264	AR	3
613589	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
613824	17q11.2	?Nephronophthisis 9	613824	_	3
613004	4p16.3	Huntington disease	143100	AD	3
613004	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
614095	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
615418	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
615184	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
610829	2q14.2	Holoprosencephaly 9	610829	AD	3
613666	13q14.3	Congenital disorder of glycosylation, type Ip	613661	AR	3
613121	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
613121	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
612727	16q23	[Bone mineral density QTL 13]	612727	_	2
614873	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
615225	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
614561	17p13.1	Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3
607511	15q26.3	Weill-Marchesani 4 syndrome, recessive	613195	AR	3
615574	7q21.3	Asparagine synthetase deficiency	615574	AR	3
615067	19q13.33	Ciliary dyskinesia, primary, 20	615067	AR	3
613898	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
614131	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
613825	5p13.1	C9 deficiency	613825	_	3
615185	3q26.33	Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3
614988	11p15.5	Deafness autosomal recessive 106	617637	AR	3
610356	9p24.2	Retinal cone dystrophy 3B	610356	AR	3
615226	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
615575	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
613391	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
606702	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
612850	6p25.2	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3
613899	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
614096	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
614874	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
615068	18q12.3-q21.1	Vici syndrome	242840	AR	3
615030	4q25	Spastic paraplegia 56, autosomal recessive	615030	AR	3
607512	16q23.1	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3
613122	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
612851	14q11.2	{Narcolepsy 5}	612851	_	2
604269	5q33.1	Spinocerebellar ataxia 45	617769	AD	3
603722	9q31.3	Dysautonomia, familial	223900	AR	3
615340	3p22.1	Nemaline myopathy 8, autosomal recessive	615348	_	3
613704	12p13.31	Microphthalmia, isolated 7	613704	AD	3
615381	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
613667	6q21	Mental retardation, anterior maxillary protrusion, and strabismus	613671	AR	3
614563	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
613625	2p21	Factor V and factor VIII, combined deficiency of	613625	_	3
613783	12p13.31	C1s deficiency	613783	_	3
615031	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
614212	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AR,AD	3
614097	11p13	Acatalasemia	614097	_	3
615770	5p13.2	?Atrial fibrillation 15	615770	AR	3
615458	16q23.1	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3
614832	4q21.1	Amelogenesis imperfecta, type IIA4	614832	AR	3
613392	17p12-q11.2	Deafness, autosomal recessive 85	613392	AR	2
613668	11q21	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3
614564	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
613784	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
615032	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
615731	2q31.1	Nemaline myopathy 9	615731	AR	3
615187	11p15.4	Hyperphosphatasia with mental retardation syndrome 3	614207	AR	3
615228	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
613900	20p13	Spinocerebellar ataxia 35	613908	AD	3
613393	2p13.3	[?Birbeck granule deficiency]	613393	_	3
614640	4p16.3	UV-sensitive syndrome 3	614640	AR	3
610595	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
615382	9q22.33	Nephronophthisis 16	615382	AR	3
615809	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
615887	14q32.12	Amelogenesis imperfecta, type IIA5	615887	AR	3
614833	18q22.2	Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3
615342	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
614602	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
615033	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
613123	15q24.1	Brugada syndrome 8	613123	_	3
616082	12p13.32	Mental retardation, autosomal recessive 66	618221	AR	3
614834	17q24.3	{Thyrotoxic periodic paralysis, susceptibility to, 3}	614834	_	2
613508	12q24.11	[Sodium serum level QTL 1]	613508	_	3
612539	3q25.31	Spastic paraplegia 42, autosomal dominant	612539	AD	3
613785	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
615188	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
615888	11q13.1	?Bleeding disorder, platelet-type, 18	615888	AR	3
615034	11p14.3-p14.2	Dystonia 24	615034	AD	3
616083	10p15.3	Mental retardation, autosomal dominant 30	616083	AD	3
613509	4q21	Chromosome 4q21 deletion syndrome	613509	IC	4
614565	17q12	Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3
615147	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
614876	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
613629	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
615419	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
616005	5q13.1	Immunodeficiency 36	616005	AD	3
615654	2p21-p12	Deafness, autosomal dominant 58	615654	AD	2
614643	7p21.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3
616044	16p13.3	Deafness, autosomal dominant 65	616044	AD	3
613596	2p15	Retinitis pigmentosa 28	606068	_	3
615343	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
616199	3q24	Polyglucosan body myopathy 2	616199	AR	3
612540	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
613741	14q22.1	Glycogen storage disease VI	232700	AR	3
603725	8p21.3	Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3
615496	15q25.3	Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3
607514	10q23.33	{Obesity, susceptibility to}	607514	_	3
615420	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
614759	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
613630	10q24.31	Cocoon syndrome	613630	_	3
616045	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
613597	10q24.2	Hyperoxaluria, primary, type III	613616	_	3
615656	15q11.2	Chromosome 15q11.2 deletion syndrome	615656	AD	4
615735	12q13.13	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3
615812	19q13.2	Abdominal obesity-metabolic syndrome 3	615812	AD	3
614877	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
616200	1q42.2	Ruijs-Aalfs syndrome	616200	AR	3
615926	15q25.1	?Webb-Dattani syndrome	615926	AR	3
603824	9p13.3	Nonaka myopathy	605820	AR	3
603824	9p13.3	Sialuria	269921	AD	3
612113	8q24	[Bone mineral density QTL 10]	612113	_	2
614836	3p22	{Human herpesvirus 8, susceptibility to}	614836	_	2
616394	2p23.3	Retinitis pigmentosa 71	616394	AR	3
616277	10q26.3	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3
615071	4q25	Alazami syndrome	615071	AR	3
613705	2q33.1	?Orofacial cleft 10	613705	IC	3
613598	2p23.3	?Retinitis pigmentosa 58	613617	AR	3
616201	3p24.3	Chronic atrial and intestinal dysrhythmia	616201	AR	3
612114	6q25	[Bone mineral density QTL 11]	612114	_	2
614837	19p13.3	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3
613599	20p11.21	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3
616355	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
614213	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
616395	6q25.3	Trichothiodystrophy 3, photosensitive	616395	_	3
613742	17q21.31	Glycogen storage disease Ia	232200	AR	3
615344	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
616278	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
616589	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
614838	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
616084	3p26.2	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3
614878	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
614839	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
607516	1q31	{Migraine with or without aura, susceptibility to, 6}	607516	AD	2
607516	1q31	{Migraine, familial hemiplegic, 4}	607516	AD	2
612542	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
616433	5q35.1	Immunodeficiency 40	616433	AR	3
615345	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
614603	14q22.1	Spastic paraplegia 28, autosomal recessive	609340	AR	3
614879	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
603826	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
616279	17q12	?Cataract 43	616279	AD	3
614840	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
613128	10q24.33	Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3
616629	2q37.3	Senior-Loken syndrome 9	616629	AR	3
614215	10q22.1	?Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3
614215	10q22.1	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
613669	10p11.23	?Spastic ataxia 4, autosomal recessive	613672	AR	3
613789	1p32.2	C8 deficiency, type II	613789	AR	3
614841	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
615696	3q13.33	Dowling-Degos disease 4	615696	AD	3
616668	15q21.1	Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3
616592	5q32	Kosaki overgrowth syndrome	616592	AD	3
616006	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
613790	1p32.2	C8 deficiency, type I	613790	AR	3
613602	2p24.1	Cranioectodermal dysplasia 2	613610	AR	3
613602	2p24.1	Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3
604277	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
616398	22q12.3	Dystonia 26, myoclonic	616398	AD	3
616007	1q41	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3
616901	17p13.3	Developmental delay with short stature, dysmorphic features, and sparse hair	616901	AR	3
615191	7q31.1	Lissencephaly 5	615191	AR	3
614842	1q32.1	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3
616126	1p36.33	Immunodeficiency 38	616126	AR	3
613706	7q34	Noonan syndrome 7	613706	AD	3
616239	11q14.1	Combined oxidative phosphorylation deficiency 24	616239	AR	3
615889	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
615421	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
616086	1q42.2	Ruijs-Aalfs syndrome	616200	AR	3
616127	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
615658	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
613670	3p13	Mental retardation with language impairment and with or without autistic features	613670	AD	3
614880	2q14.3	{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3
613129	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
606703	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
613671	6q21	Mental retardation, anterior maxillary protrusion, and strabismus	613671	AR	3
616669	21q22.11	?Immunodeficiency 45	616669	AR	3
616399	1p13.2	Brugada syndrome 9	616399	AD	3
616784	16p12.1	Joubert syndrome 26	616784	AR	3
612498	14q32.33	Myopathy, distal, 5	617030	AR	3
613672	10p11.23	?Spastic ataxia 4, autosomal recessive	613672	AR	3
614881	2q35	Spinal muscular atrophy, distal, autosomal recessive, 5	614881	AR	3
617020	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
615422	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
617021	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
614845	11q23.3	Nephronophthisis 15	614845	AR	3
614882	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
616280	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
616087	13q22.2	{Diabetes mellitus, noninsulin-dependent, 5}	616087	_	3
617214	12p12.3	?Spermatogenic failure 17	617214	AR	3
615966	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
617022	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
614883	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
606705	9q21.13	Deafness, autosomal dominant 36	606705	AD	3
616672	13q34	Combined oxidative phosphorylation deficiency 27	616672	AR	3
614846	15q26-qter	Levy-Shanske syndrome	614846	_	4
614678	9p13.2	Pontocerebellar hypoplasia, type 1B	614678	AR	3
615192	6p22.3	[Birth weight QTL4]	615192	_	2
613908	20p13	Spinocerebellar ataxia 35	613908	AD	3
614847	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
614679	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
614884	2q11.2	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3
606706	9q21.13	Deafness, autosomal dominant 36	606705	AD	3
606706	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
603727	3p21.31	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3
617370	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
616089	2q14.3	[Blood group, Gerbich]	616089	_	3
617409	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
616357	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
617061	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
616281	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
613909	7q32-q33	Spinocerebellar ataxia 32	613909	AD	2
617565	17q11.2	Perrault syndrome 6	617565	AR	3
615193	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
615771	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
617682	5q15-q21	Pilarowski-Bjornsson syndrome	617682	AD	3
617175	13q14.2	Retinal dystrophy with or without extraocular anomalies	617175	AR	3
612965	9q33.3	46XY sex reversal 3	612965	AD	3
617023	2p23.3	Retinitis pigmentosa 75	617023	AR	3
617799	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
614680	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
617643	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
617526	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
617099	5p15.2	Autoinflammation, panniculitis, and dermatosis syndrome	617099	AR	3
617024	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
616282	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
616981	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
617062	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
617100	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
616982	5q23.2	Patent ductus arteriosus 3	617039	AD	3
617063	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
617527	9p21.2	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3
617137	6q15	Frontometaphyseal dysplasia 2	617137	AD	3
617644	1p22.1	?Spermatogenic failure 21	617644	AR	3
617760	2q31.1	Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3
615892	1p31	Orofacial cleft 14	615892	AR	2
612576	17p13.3-p13.1	Split-hand/foot malformation with long bone deficiency 3	612576	AD	4
612577	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
616093	9q34.2	[Blood group, ABO system]	616093	_	3
612967	17q23.2-q25.1	[Body mass index QTL 15]	612967	_	2
617449	14q22.3	Structural heart defects and renal anomalies syndrome	617478	AR	3
618074	16p12.1	?Epilepsy, familial adult myoclonic, 6	618074	_	3
617064	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
618152	12q24.31	Spermatogenic failure 33	618152	AR	3
618113	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
617917	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
612578	8q21.13	{Stature QTL 15}	612578	_	2
612968	1p33	Cataract 34, multiple types	612968	_	3
617995	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
617956	7q31.32	[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}	617956	_	3
618114	16p12.2	Liddle syndrome 2	618114	AD	3
617450	17q23.2	Jansen de Vries syndrome	617450	AD	3
613707	7q34	LEOPARD syndrome 3	613707	AD	3
618230	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
616094	8p11.21	?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12	616094	AR	3
612579	15q22.32	{Stature QTL 16}	612579	_	2
613708	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
612502	2p25.3	3MC syndrome 2	265050	AR	3
618347	21q22.3	Galloway-Mowat syndrome 6	618347	AR	3
618115	9q34.3	Spermatogenic failure 32	618115	AD	3
618386	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
618153	2q32.1	Spermatogenic failure 34	618153	AR	3
614017	14q24.3	Ciliary dyskinesia, primary, 16	614017	AR	3
618075	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
618269	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
612503	17q24.3	?Hypertrichosis, congenital generalized, with gingival hyperplasia	135400	AR	3
616095	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AR,AD	3
618154	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
618309	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
616361	3q22	Parkinson disease 21	616361	AD	2
618425	2q35	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3
615197	5q31	{Restless legs syndrome 8}	615197	_	2
618348	12q15	Galloway-Mowat syndrome 7	618348	AR	3
618076	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
618310	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
614018	17q21.32	Epilepsy, progressive myoclonic 6	614018	AR	3
618116	1p32.1	Bone marrow failure syndrome 4	618116	AR	3
617959	7q21.13	Spermatogenic failure 24	617959	AR	3
612580	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
614019	16p13.11	Lissencephaly 4 (with microcephaly)	614019	AR	3
616097	11q12.3	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3
618270	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
612581	11q24.2	Mental retardation, autosomal dominant 4	612581	AD	2
618117	3q23	Ovarian dysgenesis 7	618117	AR	3
618426	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
616098	1p22.3	?Immunodeficiency 37	616098	AR	3
612582	6pter-p24	Chromosome 6pter-p24 deletion syndrome	612582	IC	4
618387	1p32.3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3
618155	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
614020	19p13.12	Mental retardation, autosomal recessive 14	614020	AR	3
617960	8p12	Spermatogenic failure 25	617960	AR	3
618313	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
618388	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
617961	2q11.2	?Spermatogenic failure 26	617961	AR	3
618156	8p23.1	Squalene synthase deficiency	618156	_	3
618389	4p16.3	?Fetal akinesia deformation sequence 3	618389	_	3
618314	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
618272	14q32.13	GLOW syndrome, somatic mosaic	618272	_	3
618428	8q22.3	Popov-Chang syndrome	618428	AD	3
603409	8q22.3	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	AR	3
603066	7q22.1	Lysyl hydroxylase 3 deficiency	612394	AR	3
604210	1q31.3	Leber congenital amaurosis 8	613835	_	3
604210	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
604210	1q31.3	Retinitis pigmentosa-12	600105	AR	3
603324	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
603324	1p34.3	Deafness, autosomal dominant, with peripheral neuropathy	_	_	3
603324	1p34.3	Deafness, autosomal recessive	_	_	3
603324	1p34.3	Deafness, digenic, GJB2/GJB3	220290	AR	3
603324	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AR,AD	3
602997	10p13	Megaloblastic anemia-1, Finnish type	261100	AR	3
603448	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
606843	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
606557	2p16.1	Dias-Logan syndrome	617101	AD	3
603829	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
605239	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
606464	19q13.12	Hemochromatosis, type 2B	613313	AR	3
606082	3q26.1-q26.3	Goiter, multinodular, 3	606082	_	2
607014	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
603933	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
606240	2q21	{Thyroid carcinoma, nonmedullary, 3}	606240	AD	2
604595	13q	[Cholesterol level QTL 1]	604595	_	2
603544	14q32.2	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3
604365	4p15.32	Cone-rod dystrophy 12	612657	_	3
604365	4p15.32	Macular dystrophy, retinal, 2	608051	AD	3
604365	4p15.32	Retinitis pigmentosa 41	612095	AR	3
604365	4p15.32	Stargardt disease 4	603786	_	3
603951	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
605789	18q12.1-q12.2	Symmetric circumferential skin creases, congenital, 2	616734	AD	3
603368	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
605205	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
606755	1p36.13	Uncombable hair syndrome	191480	AR	3
605909	1p36.12	Parkinson disease 6, early onset	605909	AR	3
606721	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
604906	1q42.2	{Schizophrenia 9, susceptibility to}	604906	_	3
603426	2q37.3	Advanced sleep phase syndrome, familial, 1	604348	AD	3
606257	12p11.2-q14	{Stature QTL 3}	606257	_	2
604400	3p25.1	Arrhythmogenic right ventricular dysplasia 5	604400	AD	3
603465	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
603527	17p13.3	Developmental delay with short stature, dysmorphic features, and sparse hair	616901	AR	3
603122	5q35.1	Immunodeficiency 40	616433	AR	3
607086	11q23.3-q24	Aortic aneurysm, familial thoracic 1	607086	_	2
605546	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
606540	18q21.1	Microvillus inclusion disease	251850	AR	3
605389	18p11.22	Hypotrichosis 1	605389	AD	3
605981	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
606521	17q25.1	Microcephaly, Amish type	607196	AR	3
606521	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
607144	22q13.33	Congenital disorder of glycosylation, type Ig	607143	AR	3
604774	1p31.3	Hypobetalipoproteinemia, familial, 2	605019	AR	3
605257	12p13.31	Immunodeficiency with hyper-IgM, type 2	605258	AR	3
606100	19p13.12	Vibratory urticaria	125630	AD	3
604417	5q31.1	CHOPS syndrome	616368	AD	3
603649	6q13	Cone-rod dystrophy 7	603649	_	3
606394	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
605206	15q24.1	Brugada syndrome 8	613123	_	3
605206	15q24.1	Sick sinus syndrome 2	163800	AD	3
603342	11q14-q21	{?Schizophrenia}	181500	AD	2
605427	12q24.11	?Avascular necrosis of femoral head, primary, 2	617383	AD	3
605427	12q24.11	Brachyolmia type 3	113500	AD	3
605427	12q24.11	Digital arthropathy-brachydactyly, familial	606835	AD	3
605427	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
605427	12q24.11	Metatropic dysplasia	156530	AD	3
605427	12q24.11	Parastremmatic dwarfism	168400	AD	3
605427	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
605427	12q24.11	SED, Maroteaux type	184095	AD	3
605427	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
605427	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
605427	12q24.11	[Sodium serum level QTL 1]	613508	_	3
604125	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
604459	12q14.3	{Asthma susceptibility 5}	611064	_	3
605367	17p12	Combined oxidative phosphorylation deficiency 17	615440	AR	3
605367	17p12	{Prostate cancer, hereditary, 2, susceptibility to}	614731	_	3
605998	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
605080	8q21.3	Achromatopsia 3	262300	AR	3
605080	8q21.3	Macular degeneration, juvenile	248200	AR	3
607202	15q11-q13	{Celiac disease, susceptibility to, 5}	607202	_	2
606558	14q32.2	Immunodeficiency 49	617237	AD	3
606558	14q32.2	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3
604383	9q34.13	Bleeding disorder, platelet-type, 17	187900	AR,AD	3
604093	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
606777	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AR,AD	3
607087	5q13-q14	Aortic aneurysm, familial thoracic 2	607087	_	2
604322	6q13	Salla disease	604369	AR	3
604322	6q13	Sialic acid storage disorder, infantile	269920	AR	3
604194	9q34.11	Ichthyosis prematurity syndrome	608649	_	3
603427	1p36.23	?Advanced sleep phase syndrome, familial, 3	616882	AD	3
606151	16q13	Bardet-Biedl syndrome 2	615981	AR	3
606151	16q13	Retinitis pigmentosa 74	616562	AR	3
606019	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
602981	7p13	Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3
606195	16q12.2	Hamamy syndrome	611174	AR	3
606885	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
603123	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
606869	15q23	GM2-gangliosidosis, several forms	272800	AR	3
606869	15q23	Tay-Sachs disease	272800	AR	3
606869	15q23	[Hex A pseudodeficiency]	272800	AR	3
604401	10p14-p12	Arrhythmogenic right ventricular dysplasia 6	604401	_	2
603164	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
603164	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
605483	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
605207	2p13.2	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	_	3
607237	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
604613	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
604873	11q23.3	Deafness, autosomal recessive 111	618145	AR	3
606522	12p13.31	Klippel-Feil syndrome 3, autosomal dominant	613702	_	3
606522	12p13.31	Microphthalmia with coloboma 6	613703	AD	3
606522	12p13.31	Microphthalmia, isolated 7	613704	AD	3
604638	19q13.2	Glomerulosclerosis, focal segmental, 1	603278	AD	3
607330	11q23.3-q24.1	Lathosterolosis	607330	AR	3
603220	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
603650	2q31.1	Bardet-Biedl syndrome 5	615983	AR	3
603072	20q13.2	{Colon cancer, susceptibility to}	114500	SMu,AD	3
607015	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
603294	21q22.3	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3
606350	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
606263	5q31	Paget disease of bone 4	606263	AD	2
607313	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
607254	22q12.3	{Schizophrenia}	181500	AD	1
604775	8q21.11	?Episodic pain syndrome, familial, 1	615040	AD	3
607293	6p21.1	?Deafness, autosomal recessive 103	616042	AR	3
607145	6p22.3	Hermansky-Pudlak syndrome 7	614076	AR	3
605258	12p13.31	Immunodeficiency with hyper-IgM, type 2	605258	AR	3
604307	2q33.3	Cataract 2, multiple types	604307	AD	3
607111	13q13.3	Troyer syndrome	275900	AR	3
604384	3q22.1	Hailey-Hailey disease	169600	AD	3
603033	3p25.1	Myasthenic syndrome, congenital, 5	603034	AR	3
603202	2q21.3	Lactase deficiency, congenital	223000	AR	3
606940	8q21.13	?Ptosis, congenital	178300	AD	2
605910	19p13.2	Plasma triglyceride level QTL, low	615881	AD	3
606523	12q14.2	{Thyroid cancer, nonmedullary, 2}	188470	SMu,AD	3
603546	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
603165	3q21	{Dermatitis, atopic, susceptibility to, 1}	603165	AD	2
606580	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
606580	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
605874	8q24.3	Birk-Barel mental retardation dysmorphism syndrome	612292	_	3
607088	11q13	Spinal muscular atrophy, chronic distal, autosomal recessive	607088	AR	2
605407	11p15.5	Segawa syndrome, recessive	605407	AR	3
606152	2q36.3	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	AR	3
607016	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
603107	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
603305	1q32.2	Temple-Baraitser syndrome	611816	AD	3
603305	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
604802	4p15.3	Huntington disease-like 3	604802	AR	2
603221	12q21-q23	Myopia-3	603221	AD	2
604212	16p13.12	Dyskeratosis congenita, autosomal recessive 6	616353	AR	3
604212	16p13.12	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371	AD	3
603345	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
604173	16q21	Poikiloderma with neutropenia	604173	AR	3
602931	15q22.31	Aortic valve disease 2	614823	AD	3
602931	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
605911	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
603073	13q32.3	Holoprosencephaly 5	609637	AD	3
605309	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
604614	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
605947	17p11.2	CHIME syndrome	280000	AR	3
603729	10q22.1	Nephrotic syndrome, type 14	617575	AR	3
606887	12q13.2	Sulfite oxidase deficiency	272300	AR	3
606264	12p13.2	Candidiasis, familial, 4, autosomal recessive	613108	AR	3
606264	12p13.2	{Aspergillosis, susceptibility to}	614079	_	3
605507	2q14.1	Psoriasis 14, pustular	614204	AR	3
607070	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
604418	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
604418	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
604418	13q12.11	Deafness, digenic GJB2/GJB6	220290	AR	3
604418	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
606871	11q25	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3
605983	19q13.41	Mental retardation, autosomal dominant 36	616362	AD	3
607314	11q13.2	Deafness, autosomal recessive 93	614899	AR	3
603034	3p25.1	Myasthenic syndrome, congenital, 5	603034	AR	3
604094	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
607397	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
605549	1q12-q24	Cone-rod dystrophy 8	605549	AR	2
604308	15q21.1	MASS syndrome	604308	_	3
607647	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
603633	14q21.3	Diamond-Blackfan anemia 13	615909	AD	3
604213	1p13.3	Chudley-McCullough syndrome	604213	AR	3
605792	17q22	?Spermatogenic failure 23	617707	AR	3
605653	13q22.3	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3
607486	1q32.2	[Blood group, Knops system]	607486	_	3
603902	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
604366	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
604402	2p11.2	Salt and pepper developmental regression syndrome	609056	AR	3
605428	4q31.21	?Deafness, autosomal recessive 26	605428	AR	3
607071	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
604804	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
604385	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
604385	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
606448	22q11.21	?Glucocorticoid deficiency 5	617825	AR	3
606102	19p13.3	Lethal congenital contractural syndrome 3	611369	AR	3
604174	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
607031	4p14	Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3
605984	11q14.2	Cohen-Gibson syndrome	617561	AD	3
604875	15q23	Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3
603204	15q24	Epilepsy, nocturnal frontal lobe, type 2	603204	AD	2
607667	10q21.3	Arrhythmogenic right ventricular dysplasia, familial, 13	615616	AD	3
607526	17q21.31	?Diamond-Blackfan anemia 16	617408	AD	3
604653	2q32.2	Hemochromatosis, type 4	606069	AD	3
604325	5q32	Spinocerebellar ataxia 12	604326	AD	3
604214	7q21.2	Cavernous malformations of CNS and retina	116860	AD	3
604214	7q21.2	Cerebral cavernous malformations-1	116860	AD	3
604214	7q21.2	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860	AD	3
605654	6q16.1-q16.2	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3
605192	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
606210	1p36.11	Muscular dystrophy, rigid spine, 1	602771	AR	3
606210	1p36.11	Myopathy, congenital, with fiber-type disproportion	255310	AR,AD	3
603612	8p21.3	Squamous cell carcinoma, head and neck	275355	AR	3
606351	1p36.31	Deafness, autosomal recessive 36	609006	AR	3
606351	1p36.31	Deafness, neurosensory, without vestibular involvement, autosomal dominant	_	_	3
607398	21q22.11	Glucocorticoid deficiency 2	607398	AR	3
603834	12p13.32	Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3
605429	1q24	{Deafness, nonsyndromic, modifier 1}	605429	AD	2
602932	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
606241	14q32.13	GLOW syndrome, somatic mosaic	618272	_	3
606241	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
606241	14q32.13	Pleuropulmonary blastoma	601200	AD	3
606241	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
604095	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
604095	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
604095	2q13	[Hair morphology 1, hair thickness]	612630	_	3
607829	11p15.4	Mitral valve prolapse 2	607829	AD	3
606844	2p13.1	Alstrom syndrome	203800	AR	3
607701	2q31.1	Nemaline myopathy 9	615731	AR	3
607684	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
605010	5q32	Netherton syndrome	256500	AR	3
604515	10q24.1	?Agammaglobulinemia 4	613502	AR	3
603835	2q37.3	Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3
607261	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607261	4p16.2	Weyers acrofacial dysostosis	193530	AD	3
604127	1p12	Cousin syndrome	260660	AR	3
607875	17p13.3	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3
607354	17p11.2	Scoliosis, idiopathic 2	607354	_	2
607907	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
604326	5q32	Spinocerebellar ataxia 12	604326	AD	3
603307	20p12.1	Cataract 33, multiple types	611391	AR,AD	3
603183	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
607239	10p11.23-q21.1	Deafness, autosomal recessive 33	607239	AR	2
604805	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
604368	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
603206	18p	{Schizophrenia}	181500	AD	2
604386	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
604386	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
605031	4q28.1	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3
606242	1p36.32-p35.3	Kondoh syndrome	606242	AR	2
606544	5q13.3	Combined oxidative phosphorylation deficiency 39	618397	AR	3
603634	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
607685	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
607908	2q14.3	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3
604237	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
604197	15q25.1	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3
607876	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
606581	1p33	{Drug addiction, susceptibility to}	606581	_	3
607998	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
607998	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
607830	4q21.21	Fraser syndrome 1	219000	AR	3
605552	3q27	Abdominal obesity-metabolic syndrome 1	605552	AD	2
605446	14q11.2	Cone-rod dystrophy 13	608194	_	3
605446	14q11.2	Leber congenital amaurosis 6	613826	_	3
607649	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
606597	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
606597	2q36.1	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
606597	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
606597	2q36.1	Waardenburg syndrome, type 3	148820	AR,AD	3
604369	6q13	Salla disease	604369	AR	3
603330	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
605313	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
604175	1p36.11	Diamond-Blackfan anemia 7	612562	AD	3
607487	17q12	Cardiomyopathy, hypertrophic, 25	607487	AD	3
605011	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
603371	9q34.11	Congenital arthrogryposis with anterior horn cell disease	611890	AR	3
603371	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
604129	3p21.31	Epidermolysis bullosa pruriginosa	604129	AR,AD	3
604577	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
604198	19p13.2	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3
607999	1q22	Mental retardation, autosomal dominant 52	617796	AD	3
605896	2q37.1	Arthrogryposis, distal, type 5D	615065	AR	3
604404	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
607812	14q21.1	Craniolenticulosutural dysplasia	607812	AR	3
605352	8p23.1	Malignant fibrous histiocytoma	605352	_	2
606545	17p13.1	Ichthyosis, congenital, autosomal recessive 3	606545	AR	3
604096	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
604808	20p12.1	Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3
603489	15q22.31	{Lumbar disc disease, susceptibility to}	603932	_	3
605370	5q31.3	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
607687	16q24.1	{High density lipoprotein cholesterol, low serum, 3}	607687	_	2
603372	14q31.1	Hyperthyroidism, familial gestational	603373	_	3
603372	14q31.1	Hyperthyroidism, nonautoimmune	609152	AD	3
603372	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
603372	14q31.1	Thyroid adenoma, hyperfunctioning, somatic	_	_	3
603372	14q31.1	Thyroid carcinoma with thyrotoxicosis	_	_	3
606598	8q21.11	Charcot-Marie-Tooth disease, axonal, type 2K	607831	AR,AD	3
606598	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
606598	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
606598	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
606470	5q35.3	Dyskeratosis congenita, autosomal recessive 2	613987	AR	3
607488	18p11	Dystonia-15, myoclonic	607488	AD	2
607221	4p15	Epilepsy, partial, with pericentral spikes	607221	_	2
607566	6q24.3	Epilepsy, progressive myoclonic 2A (Lafora)	254780	AR	3
608181	15q22.31	Mast syndrome	248900	AR	3
605013	16p13.11	?Microhydranencephaly	605013	AR	3
603903	11p15.4	Sickle cell anemia	603903	AR	3
605293	18q12.2-q12.3	Optic atrophy 4	605293	_	2
605353	3p25.3	{Obesity, susceptibility to}	601665	AR,Mu,AD	3
608097	20q13.13	Periventricular heterotopia with microcephaly	608097	AR	3
606889	1q42.13	Alzheimer disease-4	606889	AD	3
603386	19p13.2	Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386	_	2
605511	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
604387	3q22.1	Nephronophthisis 3	604387	AR	3
605259	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
605194	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
606045	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
606243	17q25.3	Alveolar soft-part sarcoma	606243	_	3
603867	1q21.1	?Peroxisome biogenesis disorder 14B	614920	AR	3
603968	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
608115	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
604943	7q22.1	?Deafness, autosomal recessive 61	613865	AR	3
603918	17q	{Hypertension, essential, susceptibility to, 1}	145500	Mu	2
607434	6p21.1	Jaberi-Elahi syndrome	617988	AR	3
608000	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
605913	1q23	Bleeding disorder, east Texas type	605913	_	2
603652	11q22.1	Glomerulosclerosis, focal segmental, 2	603965	AD	3
608232	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
607832	6p12.3	Glomerulosclerosis, focal segmental, 3	607832	_	3
606410	2p13.3	GAPO syndrome	230740	AR	3
606410	2p13.3	{?Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
608266	1q31.2	Parathyroid carcinoma	608266	_	3
605809	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AR,AD	3
604641	11p11.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
603373	14q31.1	Hyperthyroidism, familial gestational	603373	_	3
606636	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
606636	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
606636	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
603208	2q37.1	Leber congenital amaurosis 16	614186	AR	3
603208	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
604254	2p16-p15	{Dyslexia, susceptibility to, 3}	604254	_	2
605014	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
606847	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
607091	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
608033	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
607331	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
605210	1q42.2	{Schizophrenia 9, susceptibility to}	604906	_	3
607688	2q37.1	{Parkinson disease 11}	607688	_	3
603332	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
603332	3p21.1	Spermatogenic failure 18	617576	AR	3
606352	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
606352	2q33.1	Primary lateral sclerosis, juvenile	606353	AR	3
606352	2q33.1	Spastic paralysis, infantile onset ascending	607225	AR	3
607928	9q32	Deafness, autosomal recessive 31	607084	AR	3
607928	9q32	Usher syndrome, type 2D	611383	AR	3
606153	20q13.32	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	_	3
605554	1q23.3	{Rheumatoid arthritis, susceptibility to}	180300	_	3
607317	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
605294	16q23.1	Macular corneal dystrophy	217800	AR	3
604310	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
607047	14q32.12	Machado-Joseph disease	109150	AD	3
608328	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
607669	16p12.3	?Spastic paraplegia 61, autosomal recessive	615685	AR	3
607371	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
604777	19p13.12	Ichthyosis, congenital, autosomal recessive 5	604777	AR	3
603904	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
603904	13q14.2	Dementia, familial British	176500	AD	3
603904	13q14.2	Dementia, familial Danish	117300	AD	3
608345	7p11.2	Nystagmus 3, congenital, autosomal dominant	608345	AD	2
605242	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
605242	11p15.1	Usher syndrome, type 1C	276904	AR	3
607035	10q24.32	Basal cell nevus syndrome	109400	AD	3
607035	10q24.32	Joubert syndrome 32	617757	AR	3
607035	10q24.32	Medulloblastoma, desmoplastic	155255	AR,AD	3
607035	10q24.32	{Meningioma, familial, susceptibility to}	607174	AD	3
607814	19q13.11	Bradyopsia	608415	_	3
604327	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
603387	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
607450	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
603868	15q21.3	Griscelli syndrome, type 2	607624	AR	3
605512	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
605512	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
605512	6q14.1	Stargardt disease 3	600110	AD	3
604819	8q24.3	Verheij syndrome	615583	AD	3
606526	2q37.3	Griscelli syndrome, type 3	609227	AR	3
607490	16q23.1	D-lactic aciduria	245450	AR	3
603506	11q13.2	Exudative vitreoretinopathy 4	601813	AR,AD	3
603506	11q13.2	Hyperostosis, endosteal	144750	AD	3
603506	11q13.2	Osteopetrosis, autosomal dominant 1	607634	AD	3
603506	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
603506	11q13.2	Osteosclerosis	144750	AD	3
603506	11q13.2	Polycystic liver disease 4 with or without kidney cysts	617875	AD	3
603506	11q13.2	van Buchem disease, type 2	607636	AD	3
603506	11q13.2	[Bone mineral density variability 1]	601884	AD	3
603506	11q13.2	{Osteoporosis}	166710	AD	3
605629	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
603051	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
603349	2p21	Erythrocytosis, familial, 4	611783	_	3
605880	10q22.2	Genitopatellar syndrome	606170	AD	3
605880	10q22.2	SBBYSS syndrome	603736	AD	3
604370	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	Mu,AD	3
608233	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
607654	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
603005	10q23.2-q23.3	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3
607529	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
605810	3q23	Combined oxidative phosphorylation deficiency 5	611719	AR	3
605810	3q23	Ovarian dysgenesis 7	618117	AR	3
607590	4q27	Bardet-Biedl syndrome 7	615984	AR	3
607759	17q21.31	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
607759	17q21.31	Glanzmann thrombasthenia	273800	AR	3
607759	17q21.31	Thrombocytopenia, neonatal alloimmune, BAK antigen related	_	_	3
603309	7p14.1	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3
608303	19q13.12	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	617468	AR	3
605371	20q13.13	Periventricular heterotopia with microcephaly	608097	AR	3
606353	2q33.1	Primary lateral sclerosis, juvenile	606353	AR	3
603636	13q12.2	Hypotrichosis 12	615885	AD	3
607568	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
606656	2q37	Basal ganglia calcification, idiopathic, 2	606656	_	2
605795	8p12	Spermatogenic failure 25	617960	AR	3
608389	14q23.1	Branchiootic syndrome 3	608389	AD	3
605195	15q26.1	Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3
603191	21q22.3	Retinal dystrophy with macular staphyloma	617547	AR	3
603191	21q22.3	Spondylometaphyseal dysplasia, axial	602271	AR	3
608372	1q21-q23	Deafness, autosomal dominant 49	608372	AD	2
607435	17q11.2	Perrault syndrome 6	617565	AR	3
603935	1q21	{Psoriasis susceptibility 4}	603935	_	2
605047	11p15.5	?Immunodeficiency 39	616345	AR	3
607721	10q25.2	Noonan-like syndrome with loose anagen hair	607721	AD	3
607929	7p13	Cerebral cavernous malformations-2	603284	AD	3
604579	11q14.2	Exudative vitreoretinopathy 1	133780	AD	3
604579	11q14.2	Retinopathy of prematurity	133780	AD	3
608183	15q26.3	Temtamy preaxial brachydactyly syndrome	605282	AR	3
606411	20q13.12	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3
605593	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
607860	1q22	Grange syndrome	602531	AR	3
606919	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
608441	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
608441	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
605881	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
608567	3p22.2	Sick sinus syndrome 1	608567	AR	3
607944	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
606282	4q35-qter	Deafness, autosomal dominant 24	606282	AD	2
607491	20q11.21	Dowling-Degos disease 2	615327	AD	3
608002	3q22.1	Meckel syndrome 7	267010	AR	3
608002	3q22.1	Nephronophthisis 3	604387	AR	3
608002	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
603507	12p13.2	Tooth agenesis, selective, 7	616724	AD	3
603507	12p13.2	{Coronary artery disease, autosomal dominant, 2}	610947	AD	3
605431	16p13.3	Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3
608034	17p13.2	Canavan disease	271900	AR	3
602966	2p13	Orofacial cleft 2	602966	_	2
608545	6p25	Larsen-like syndrome	608545	IC	2
606483	10q24.1-q25.1	Charcot-Marie-Tooth disease, dominant intermediate A	606483	AD	2
603388	20q13.11	{Graves disease, susceptibility to, 2}	603388	_	2
605967	7q36	Acropectoral syndrome	605967	AD	2
607690	5q31.1	Chylomicron retention disease	246700	AR	3
607861	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
604580	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
604580	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
604580	14q32.12	Macular degeneration, age-related, 3	608895	AD	3
604580	14q32.12	Neuropathy, hereditary, with or without age-related macular degeneration	608895	AD	3
606397	3q25.1	Retinitis pigmentosa 61	614180	_	3
606397	3q25.1	Usher syndrome, type 3A	276902	AR	3
603531	7q22.1	MEDNIK syndrome	609313	AR	3
604616	2q24.2	Intellectual developmental disorder with autism and speech delay	606053	AD	3
608442	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
604519	6p21.3	{Inflammatory bowel disease 3}	604519	AD	2
608568	19q13.33	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3
608568	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
608638	3q25-q27	{Asperger syndrome susceptibility 1}	608638	IC,Mu	2
607704	9p24.3	Cerebral palsy, spastic quadriplegic, 2	612900	_	3
605262	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
608201	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
605317	7q31.1	Speech-language disorder-1	602081	AD	3
606048	19q13.42	Mental retardation, autosomal recessive 57	617188	AR	3
603335	5p15.2	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	_	3
604060	11q25-qter	Deafness, autosomal recessive 20	604060	AR	2
608755	17q25.1	?Pontocerebellar hypoplasia type 5	610204	AR	3
608755	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
608755	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
605244	2p16	Carney complex, type II	605244	_	2
604536	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
605197	2q22.2	?Hydroxykynureninuria	236800	AR	3
605197	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
607671	1p36.32-p36.13	Dystonia 13, torsion	607671	AD	2
608305	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
606471	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
608145	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
608546	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
608735	11p11.2	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3
607655	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
608845	3q11.2	?Retinitis pigmentosa 55	613575	_	3
608845	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
608845	3q11.2	{Bardet-Biedl syndrome 1, modifier of}	209900	AR,DR	3
608166	7q21.11	?CHARGE syndrome	214800	AD	3
607592	19q	{Prostate cancer aggressiveness QTL}	607592	_	2
606528	11p15-p14	Chromosome 11p15-p14 deletion syndrome	606528	AR	4
604927	18q23	Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3
606585	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
606585	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
606689	2cen-q13	Glaucoma 1B, primary open angle, adult onset	606689	_	2
604241	6p12.3	Glomerulosclerosis, focal segmental, 3	607832	_	3
604061	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
604061	17q25.3	Leukemia, acute myeloid, therapy-related	_	_	1
604061	17q25.3	Ovarian carcinoma	_	_	1
605373	1q23.3	Paragangliomas 3	605373	AD	3
606658	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
606068	2p15	Retinitis pigmentosa 28	606068	_	3
608846	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
605632	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
605837	15q13.1	Mental retardation, autosomal recessive 38	615516	AR	3
605837	15q13.1	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3
605837	15q13.1	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3
603360	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
603360	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
607182	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
607672	11q13.2	Cold-induced sweating syndrome 2	610313	AR	3
603839	2q33.1	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3
604537	6q14.1	Leber congenital amaurosis 5	604537	_	3
605120	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
608605	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
608347	17q25.3	[Pentosuria]	260800	AR	3
608656	20q13	{Prostate cancer, susceptibility to, 3}	608656	_	2
608118	1p36.11	Zinc deficiency, transient neonatal	608118	AD	3
604312	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
604312	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
605820	9p13.3	Nonaka myopathy	605820	AR	3
608756	1q25.3	Pontocerebellar hypoplasia, type 2F	617026	AR	3
608921	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
608083	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
604581	18p11.21	Spastic ataxia 5, autosomal recessive	614487	AR	3
604581	18p11.21	Spinocerebellar ataxia 28	610246	AD	3
606049	Chr.11	Acromegaloid features, overgrowth, cleft palate, and hernia	606049	_	2
604134	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
607223	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
607878	5p12	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3
604878	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
604928	4q24	Wolfram syndrome 2	604928	AR	3
608829	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
606412	1p32.3	Bartter syndrome, type 4a	602522	AR	3
606412	1p32.3	Sensorineural deafness with mild renal dysfunction	602522	AR	3
604619	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
604521	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
607532	13q21.3-q22.1	Joubert syndrome 33	617767	AR	3
608996	3q22.3	Premature ovarian failure 3	608996	AD	3
603377	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
606247	2p13.1	Microcephaly-capillary malformation syndrome	614261	AR	3
609054	17q23.2	Fanconi anemia, complementation group J	609054	_	3
606069	2q32.2	Hemochromatosis, type 4	606069	AD	3
608547	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
608547	16p11.2	Warfarin resistance	122700	AD	3
608236	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
603956	4p16.3	Cervical cancer, somatic	603956	_	3
608898	17q25.1	Hemophagocytic lymphohistiocytosis, familial, 3	608898	_	3
604313	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
603937	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AR,AD	3
605616	3p21.31	Hyperglycinuria	138500	AD	3
605616	3p21.31	Iminoglycinuria, digenic	242600	AR,DR	3
607864	16p13.3	?Caudal duplication anomaly	607864	_	3
603921	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
607817	8q22.2	Cohen syndrome	216550	AR	3
608757	11q12.1	Pontocerebellar hypoplasia, type 10	615803	AR	3
604217	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
608348	19q13.2	Maple syrup urine disease, type Ia	248600	AR	3
605432	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
607706	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
608374	1q21.1	Hemochromatosis, type 2A	602390	AR	3
608706	15q21.3	Ciliary dyskinesia, primary, 25	615482	AR	3
608706	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
604539	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
608167	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
608167	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
607745	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
608461	9q32	Steel syndrome	615155	AR	3
606797	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
606070	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
606530	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
607818	10q21.2	{Nephrolithiasis, uric acid, susceptibility to}	605990	_	3
608940	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
608512	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
609162	12q13.11	Czech dysplasia	609162	AD	3
607093	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
607093	1p36.22	{Neural tube defects, susceptibility to}	601634	AR	3
607093	1p36.22	{Schizophrenia, susceptibility to}	181500	AD	3
607093	1p36.22	{Thromboembolism, susceptibility to}	188050	AD	3
607093	1p36.22	{Vascular disease, susceptibility to}	_	_	3
607707	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
607693	9q22.2	Thyroid hormone metabolism, abnormal	609698	_	3
609320	9q	[Hematocrit/hemoglobin quantitative trait locus 2]	609320	_	2
605018	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
605018	16q12.1	Cylindromatosis, familial	132700	AD	3
605018	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
608758	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
604391	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
603212	3q22.1	Cataract 12, multiple types	611597	AD	3
604218	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
604242	13q12.13	Esophageal carcinoma, somatic	133239	_	3
608736	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
608736	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
603175	6q13-q26	{Schizophrenia}	181500	AD	2
606692	16p13.3	Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3
607834	17q11.2	{Anxiety-related personality traits}	607834	_	3
609408	14q13	Holoprosencephaly 8	609408	_	2
608830	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
608462	16q23	{Hirschsprung disease, susceptibility to, 8}	608462	_	2
606227	11q23.3	Microphthalmia, isolated 5	611040	AR	3
606227	11q23.3	Nanophthalmos 2	609549	_	3
608375	1p31.3	Parkinson disease 19a, juvenile-onset	615528	AR	3
608375	1p31.3	Parkinson disease 19b, early-onset	615528	AR	3
606798	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
609056	2p11.2	Salt and pepper developmental regression syndrome	609056	AR	3
609533	10q21.1	Deafness, autosomal recessive 23	609533	AR	3
608707	11q24.2	Holoprosencephaly 11	614226	AD	3
607300	17p13.3	Retinitis pigmentosa 13	600059	AD	3
609186	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
603213	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
608658	7p11-q21	{Prostate cancer, susceptibility to, 4}	608658	_	2
607225	2q33.1	Spastic paralysis, infantile onset ascending	607225	AR	3
609304	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
609204	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
605704	20q13.32	Amyotrophic lateral sclerosis 8	608627	AD	3
605704	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
608289	3q27.2	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
609321	1p21.2	?Microcephaly 14, primary, autosomal recessive	616402	AR	3
603639	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
609057	11p15.5	Nephropathy with pretibial epidermolysis bullosa and deafness	609057	_	3
608569	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
603176	13q32	{Schizophrenia}	181500	AD	2
606708	2q31	Split-hand/foot malformation 5	606708	_	2
605634	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
604931	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
609187	7p14.1	Glutaric aciduria III	231690	AR	3
604329	15q	{Hypertension, essential, susceptibility to, 2}	145500	Mu	2
608132	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
608132	14q31.3	Bardet-Biedl syndrome 8	615985	AR	3
605266	8q21.11	?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K	607831	AR,AD	3
607301	1q21.2	Retinitis pigmentosa 18	601414	AD	3
608776	11q23.1	Congenital disorder of glycosylation, type Il	608776	AR	3
609698	9q22.2	Thyroid hormone metabolism, abnormal	609698	_	3
608957	2p11.2	CD8 deficiency, familial	608957	AR	3
606268	2q35	Odontoonychodermal dysplasia	257980	AR	3
606268	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
606268	2q35	Tooth agenesis, selective, 4	150400	AR,AD	3
606873	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
605822	17q21.33	Spondyloocular syndrome	605822	AR	3
609145	1q32.1	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3
608219	6q26-q27	Deafness, autosomal recessive 38	608219	AR	2
606170	10q22.2	Genitopatellar syndrome	606170	AD	3
608850	5p15.33-p13.1	Macular dystrophy, retinal, 3	608850	AD	2
606071	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
608831	14q13-q21	{Restless legs syndrome 2}	608831	_	2
609058	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
604373	22q12.1	Li-Fraumeni syndrome	609265	_	3
604373	22q12.1	Osteosarcoma, somatic	259500	_	3
604373	22q12.1	{Breast and colorectal cancer, susceptibility to}	_	_	3
604373	22q12.1	{Breast cancer, susceptibility to}	114480	SMu,AD	3
604373	22q12.1	{Prostate cancer, familial, susceptibility to}	176807	SMu,AD	3
609427	6p21.31	Deafness, autosomal recessive 67	610265	AR	3
606416	1q44	CINCA syndrome	607115	AD	3
606416	1q44	Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3
606416	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
606416	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
606416	1q44	Muckle-Wells syndrome	191900	AD	3
607694	10q22.3	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3
604219	21q22.3	Cataract 9, multiple types	604219	AR,AD	3
607151	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
609014	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
608148	2q33.1	Glass syndrome	612313	AD	3
606709	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
603924	10q25.3	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3
603924	10q25.3	{Venous thromboembolism, susceptibility to}	188050	AD	3
605019	1p31.3	Hypobetalipoproteinemia, familial, 2	605019	AR	3
609739	3q13.33	Deafness, autosomal recessive 42	609646	AR	3
609283	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
606874	3p21	{Hirschsprung disease, susceptibility to, 6}	606874	_	2
607594	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
606531	5q32	{Asthma, susceptibility to}	600807	AD	3
609428	21q22	Tukel syndrome	609428	AR	2
609915	7q22.3-q31.1	Cardiomyopathy, dilated, 1Q	609915	_	2
609188	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
605705	21q22.3	Epileptic encephalopathy, early infantile, 30	616341	AD	3
607101	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607657	1p31.1	Cystathioninuria	219500	AR	3
607657	1p31.1	Homocysteine, total plasma, elevated	_	_	3
608548	1q25.3-q31.1	{Macular degeneration, age-related, 1}	603075	AD	3
606603	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
606603	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
609536	9q33.2	C5 deficiency	609536	_	3
608517	10q21.3	Cardiomyopathy, dilated, 1KK	615248	AD	3
608517	10q21.3	Cardiomyopathy, familial restrictive, 4	615248	AD	3
608517	10q21.3	Cardiomyopathy, hypertrophic, 22	615248	AD	3
608517	10q21.3	Nemaline myopathy 11, autosomal recessive	617336	AR	3
608149	14q32	Kagami-Ogata syndrome	608149	AD	4
604063	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
607152	9q	Spastic paraplegia 19, autosomal dominant	607152	AD	2
608220	6q23-q24.1	Spastic paraplegia 25, autosomal recessive	608220	AR	2
605514	10q21.1	Deafness, autosomal recessive 23	609533	AR	3
605514	10q21.1	Usher syndrome, type 1D/F digenic	601067	AR,DR	3
605514	10q21.1	Usher syndrome, type 1F	602083	AR	3
609876	21q22.13-qter	[Bone mineral density QTL 6]	609876	_	2
603178	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
608761	2q12.3	Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3
608761	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
607379	22q12.2	Meningioma, NF2-related, somatic	607174	_	3
607379	22q12.2	Neurofibromatosis, type 2	101000	AD	3
607379	22q12.2	Schwannomatosis, somatic	162091	_	3
608173	6p11	{Autoimmune thyroid disease, susceptibility to, 1}	608173	_	2
609757	7q11.23	Chromosome 7q11.23 duplication syndrome	609757	AD	4
609113	14q23.2	[Telomere length, mean leukocyte]	609113	_	2
609588	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
609588	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
605642	1q21	Thyroid carcinoma, papillary, with papillary renal neoplasia	605642	_	2
609446	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
606451	15q25-q26	Deafness, autosomal dominant 30	606451	AD	2
606417	10q26.12	Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3
608549	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
606711	16q	Specific language impairment QTL, 1	606711	Mu	2
608762	9q32-q33	{Epilepsy, idiopathic generalized, susceptibility to, 3}	608762	AR	2
604316	3q21	{Psoriasis susceptibility 5}	604316	_	2
608832	1q43	Tooth agenesis, selective, 9	617275	AD	3
604392	17p13.2	Cone-rod dystrophy	604393	AR	3
604392	17p13.2	Leber congenital amaurosis 4	604393	AR	3
604392	17p13.2	Retinitis pigmentosa, juvenile	604393	AR	3
607102	11p13	Denys-Drash syndrome	194080	SMu,AD	3
607102	11p13	Frasier syndrome	136680	SMu,AD	3
607102	11p13	Meacham syndrome	608978	_	3
607102	11p13	Mesothelioma, somatic	156240	_	3
607102	11p13	Nephrotic syndrome, type 4	256370	AD	3
607102	11p13	Wilms tumor, type 1	194070	SMu,AD	3
604330	17p11.2	Deafness, autosomal recessive 114	618456	AR	3
610004	4q25	Fibrosis of extraocular muscles, congenital, 5	616219	AR	3
610055	19p13.12	Mental retardation, autosomal recessive 3	608443	AR	3
606072	3p25.3	Rippling muscle disease 2	606072	AD	3
603381	3p14.3	Atelosteogenesis, type I	108720	AD	3
603381	3p14.3	Atelosteogenesis, type III	108721	AD	3
603381	3p14.3	Boomerang dysplasia	112310	AD	3
603381	3p14.3	Larsen syndrome	150250	AD	3
603381	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
610021	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
609681	13q31.1	Deafness and myopia	221200	AR	3
609825	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
609825	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AR,AD	3
605706	21q22.3	CHAND syndrome	214350	AR	3
605706	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
602985	1q23.3	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3
606362	19q13.33	Amelogenesis imperfecta, type IJ	617297	AR	3
603382	6p21.33	?Premature ovarian failure 13	617442	AR	3
607380	2q37.3	Senior-Loken syndrome 9	616629	AR	3
607440	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
606875	19q12	{Hirschsprung disease, susceptibility to, 7}	606875	_	2
609826	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
607709	9q21.11	Cholestasis, progressive familial intrahepatic 4	615878	AR	3
607709	9q21.11	Hypercholanemia, familial	607748	AR	3
610181	13q14.3	Aicardi-Goutieres syndrome 2	610181	AR	3
608833	20q13.33	Dyskeratosis congenita, autosomal dominant 4	615190	AR,AD	3
608833	20q13.33	Dyskeratosis congenita, autosomal recessive 5	615190	AR,AD	3
608833	20q13.33	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373	AD	3
609842	15q24.1	?Mental retardation, autosomal recessive 50	616460	AR	3
608135	9q22.31	{Lumbar disc degeneration}	603932	_	3
608135	9q22.31	{Osteoarthritis susceptibility 3}	607850	AD	3
610248	20q13.2-q13.3	Deafness, autosomal recessive 65	610248	AR	2
606799	5q12	{Stroke, susceptibility to, 1}	606799	_	2
605841	4p13-q21	Narcolepsy 2	605841	_	2
609306	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
606230	22q13.33	Phelan-McDermid syndrome	606232	AD	3
606230	22q13.33	{Schizophrenia 15}	613950	AD	3
608174	5q31-q33	{Autoimmune thyroid disease, susceptibility to, 2}	608174	_	2
605799	14q32.32	Megaloblastic anemia-1, Norwegian type	261100	AR	3
608088	3p24-p22	Neuropathy, hereditary sensory, type IB	608088	AD	2
607949	2q35	{Tuberculosis, susceptibility to}	607949	_	2
604229	11p13	Anterior segment dysgenesis 5, multiple subtypes	604229	_	3
609225	7p22.1	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3
607696	17q25.1	Usher syndrome, type 1G	606943	AR	3
608552	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
604317	19q13.12	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3
603383	7q36.1	Glaucoma 1, open angle, F	603383	_	3
609741	22q11.23	Cataract 22	609741	AR,AD	3
610005	3q26.2-q26.3	Mental retardation, autosomal recessive 54	617028	AR	3
606712	19q	Specific language impairment QTL, 2	606712	Mu	2
606453	4q31.3	Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3
605515	3p13	Mental retardation with language impairment and with or without autistic features	613670	AD	3
608136	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
607270	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
609059	11p15.5	Neutral lipid storage disease with myopathy	610717	AR	3
610438	9p24-p22	{Restless legs syndrome 3}	610438	_	2
610299	1p13.3	Mental retardation, autosomal recessive 48	616269	AR	3
609226	17q25.3	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3
610282	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
610090	17q21.32	Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3
609307	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
609570	5q21	{Migraine, susceptibility to, 8}	609570	_	2
610057	19p13.12	Mental retardation, autosomal recessive 14	614020	AR	3
604201	6q22-q23	{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}	604201	_	2
604377	22q13.33	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	AR	3
605218	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
610439	2q33	{Restless legs syndrome 4}	610439	_	2
606713	1p36.11	Van der Woude syndrome 2	606713	AD	3
609397	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
604319	14q12	Dyskeratosis congenita, autosomal dominant 3	613990	AD	3
604319	14q12	Revesz syndrome	268130	AD	3
609227	2q37.3	Griscelli syndrome, type 3	609227	AR	3
607154	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
609017	1p34.2	[Blood group, Radin]	111620	_	3
609017	1p34.2	[Blood group, Scianna system]	111750	_	3
607596	14q32.2	Pontocerebellar hypoplasia type 1A	607596	AR	3
608222	22q13.1	Adenylosuccinase deficiency	103050	AR	3
607697	11p15.4	Charcot-Marie-Tooth disease, type 4B2	604563	AR	3
603941	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
608558	16p13	[Body mass index QTL5]	608558	_	2
610381	19p13.3	Cone-rod dystrophy 11	610381	AD	3
610320	1p36	Myopia 14	610320	_	2
606418	1p32.3	Desmosterolosis	602398	AR	3
609644	14q21.2	?Premature ovarian failure 15	618096	AR	3
609644	14q21.2	Spermatogenic failure 28	618086	AR	3
610250	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
610206	20p13	Corneal dystrophy, Fuchs endothelial, 4	613268	_	3
610206	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
610206	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
605882	17q23.2	Fanconi anemia, complementation group J	609054	_	3
605882	17q23.2	{Breast cancer, early-onset, susceptibility to}	114480	SMu,AD	3
610283	1q22	Cone-rod dystrophy 10	610283	AR	3
605828	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
603317	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
603317	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
608765	8q12	{Scoliosis, isolated, susceptibility to, 3}	608765	_	2
607304	2p12	Cataract 27, nuclear progressive	607304	_	2
602987	7p14.3	?Deafness, autosomal dominant 74	618140	AD	3
607764	16p11.2	Bile acid synthesis defect, congenital, 1	607765	AR	3
603942	3q24	?Glycogen storage disease XV	613507	AR	3
603942	3q24	Polyglucosan body myopathy 2	616199	AR	3
609308	9q34.13	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3
610092	14q24.3	Microphthalmia with coloboma 3	610092	_	3
609649	3p24-p21.2	Trichilemmal cyst 1	609649	AD	2
606419	19q13.42	Retinitis pigmentosa 11	600138	AD	3
605516	10q22.1	Deafness, autosomal recessive 12	601386	AR	3
605516	10q22.1	Usher syndrome, type 1D	601067	AR,DR	3
605516	10q22.1	Usher syndrome, type 1D/F digenic	601067	AR,DR	3
605516	10q22.1	{Pituitary adenoma 5, multiple types}	617540	AD	3
609115	4q21.22	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3
609520	8p11.21	Dystonia 6, torsion	602629	AD	3
610284	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
607271	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
606232	22q13.33	Phelan-McDermid syndrome	606232	AD	3
609898	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
608852	6q21-q22	{Pulmonary function}	608852	_	2
608778	17q21.2	Spermatogenic failure 11	615081	AD	3
608137	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
605219	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
609018	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
606800	17q25.3	Glycogen storage disease II	232300	AR	3
607765	16p11.2	Bile acid synthesis defect, congenital, 1	607765	AR	3
610651	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
608559	20pter-p11.2	[Body mass index QTL6]	608559	_	2
607155	19q13.32	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3
609591	1q22	Noonan syndrome 8	615355	AD	3
605020	20p11.21	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	_	3
605020	20p11.21	Keratoconus 1	148300	AD	3
604202	22q11.21	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3
607951	11q21	Mosaic variegated aneuploidy syndrome 2	614114	AR	3
604320	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
610339	1p34.2	Osteogenesis imperfecta, type VIII	610915	AR	3
602974	9p13.3	[Glycerol quantitative trait locus]	614411	AR	3
608465	9q34.13	Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3
608465	9q34.13	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3
607381	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
609884	8q22.1	?RHYNS syndrome	602152	AR	3
609884	8q22.1	COACH syndrome	216360	AR	3
609884	8q22.1	Joubert syndrome 6	610688	AR	3
609884	8q22.1	Meckel syndrome 3	607361	AR	3
609884	8q22.1	Nephronophthisis 11	613550	AR	3
609884	8q22.1	{Bardet-Biedl syndrome 14, modifier of}	615991	AR	3
604649	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
610774	6p21.1	Epileptic encephalopathy, early infantile, 60	617929	AR	3
610265	6p21.31	Deafness, autosomal recessive 67	610265	AR	3
610130	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
609286	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
610938	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
610285	4p16.3	?Fetal akinesia deformation sequence 3	618389	_	3
610285	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
610652	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
610652	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
604544	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
604544	3p21.31	Perrault syndrome 4	615300	AR	3
609927	8p22	Spastic paraplegia 53, autosomal recessive	614898	AR	3
605844	13q12-q14	{Dermatitis, atopic, susceptibility to, 5}	605844	_	2
609701	17q21.2	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3
609701	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
610455	7q21.2	Tumoral calcinosis, familial, normophosphatemic	610455	AR	3
610612	1q32.3	Leber congenital amaurosis 12	610612	AR	3
604139	2q35	Spinal muscular atrophy, distal, autosomal recessive, 5	614881	AR	3
609469	11q24	Nephropathy, progressive, with deafness	609469	_	2
610321	15q12	{Prostate cancer, hereditary, 7}	610321	_	2
609572	13q31.3	Photoparoxysmal response 2	609572	_	2
610253	9q34.3	Kleefstra syndrome 1	610253	AD	3
609845	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
608176	10q	{Autoimmune thyroid disease, susceptibility to, 4}	608176	_	2
609309	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
609309	2p21-p16	Mismatch repair cancer syndrome	276300	AR	3
609309	2p21-p16	Muir-Torre syndrome	158320	AD	3
609573	7q32	Photoparoxysmal response 3	609573	_	2
610538	1q32.1	Fanconi anemia, complementation group T	616435	AR	3
606252	11q24.2	{Bacteremia, protection against}	614382	_	3
606252	11q24.2	{Malaria, protection against}	611162	_	3
606252	11q24.2	{Pneumococcal disease, invasive, protection against}	610799	_	3
606252	11q24.2	{Tuberculosis, protection against}	607948	_	3
607554	11p15.5-p15.4	Atrial fibrillation, familial, 3	607554	AD	3
610613	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
610613	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
609192	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
608958	20q13.12	Adenosine deaminase deficiency, partial	102700	AR,SMo	3
608958	20q13.12	Severe combined immunodeficiency due to ADA deficiency	102700	AR,SMo	3
608836	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
609310	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
610185	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
610006	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
609539	12q12	Coffin-Siris syndrome 6	617808	AD	3
605622	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
610303	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
610107	14q11.2	Galloway-Mowat syndrome 3	617729	AR	3
610687	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
607598	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
604321	15q15.1	Microcephaly 4, primary, autosomal recessive	604321	AR	3
608779	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
609400	4q13-q21	{Autoimmune disease, susceptibility to, 4}	609400	_	2
610991	2q35	3-M syndrome 2	612921	AR	3
608837	17p13.1	Carney complex variant	608837	_	3
611154	1q25	{Alzheimer disease-14}	611154	_	2
610883	17p11.2	Potocki-Lupski syndrome	610883	IC	4
610598	17q25.1	Retinitis pigmentosa 36	610599	_	3
610758	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
609116	10q26	[Respiratory rhythmicity in sleep]	609116	_	2
605802	2q22.3	Mowat-Wilson syndrome	235730	AD	3
604933	1p34.1	Adenomas, multiple colorectal	608456	AR	3
604933	1p34.1	Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas	132600	SMu	3
604933	1p34.1	Gastric cancer, somatic	613659	_	3
610956	1q25.1	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3
609311	12p11.21	Charcot-Marie-Tooth disease, type 4H	609311	AR	3
610688	8q22.1	Joubert syndrome 6	610688	AR	3
605021	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
605803	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
610759	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
609541	11q13.2	Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3
611155	3q22-q24	{Alzheimer disease-15}	611155	_	2
610957	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
604233	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
608224	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
607273	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
607273	17p11.2	Colorectal cancer, somatic	114500	_	3
607273	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
607273	17p11.2	Renal carcinoma, chromophobe, somatic	144700	_	3
610635	8q22.3	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
610760	2p24-p22	[Cholesterol level QTL 2]	610760	_	2
609720	9q33.3	Focal segmental glomerulosclerosis 9	616220	AR	3
609720	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
609761	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
604882	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
610599	17q25.1	Retinitis pigmentosa 36	610599	_	3
611274	15q22-q24	Glaucoma 1, open angle, N	611274	_	2
603384	6p21.32	Mental retardation, autosomal dominant 5	612621	AD	3
604416	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
603930	14q23.3-q24.1	Molybdenum cofactor deficiency C	615501	AR	3
607306	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
610131	17q23.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3
606718	5q32	Achondrogenesis Ib	600972	AR	3
606718	5q32	Atelosteogenesis, type II	256050	AR	3
606718	5q32	De la Chapelle dysplasia	256050	AR	3
606718	5q32	Diastrophic dysplasia	222600	AR	3
606718	5q32	Diastrophic dysplasia, broad bone-platyspondylic variant	222600	AR	3
606718	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
608780	6q25.3	Trichothiodystrophy 3, photosensitive	616395	_	3
608977	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
611543	12q13.2	Cavitary optic disc anomalies	611543	AD	3
604395	14q24.3	Colorectal cancer, hereditary nonpolyposis, type 7	614385	_	3
604395	14q24.3	Colorectal cancer, somatic	114500	_	3
604395	14q24.3	{Endometrial cancer, susceptibility to}	608089	_	3
606438	16q24.2	Huntington disease-like 2	606438	AD	3
610942	9q21.12	?Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3
610906	1p31	{Asthma-related traits, susceptibility to, 4}	610906	_	2
606719	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
602978	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
610456	7q21.2	MIRAGE syndrome	617053	AD	3
610456	7q21.2	Tumoral calcinosis, familial, normophosphatemic	610455	AR	3
611276	2p16-p15	Glaucoma 1, open angle, H	611276	_	2
609118	3q26.1	Cerebral cavernous malformations 3	603285	_	3
611644	4q31.3-q32.3	{Hirschsprung disease, susceptibility to, 9}	611644	_	2
610110	11p14.3-p14.2	Dystonia 24	615034	AD	3
611458	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
611458	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
611458	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
611458	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
610852	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
611087	17q23.3	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3
610761	3q24-q26	[High density lipoprotein cholesterol level QTL 5]	610761	_	2
610187	8q23.1	Diaphragmatic hernia 3	610187	_	3
610313	11q13.2	Cold-induced sweating syndrome 2	610313	AR	3
608978	11p13	Meacham syndrome	608978	_	3
611258	9q22.33	Cataract 36	613887	AR	3
610044	1q31.3	?Epileptic encephalopathy, early infantile, 57	617771	AD	3
609019	3p25.1	Biotinidase deficiency	253260	AR	3
611604	10q24.31	Spastic paraplegia 62	615681	AR	3
608781	1q21-q22	{Asperger syndrome susceptibility 3}	608781	_	2
611390	2q33.1	Spastic ataxia 3, autosomal recessive	611390	AR	3
611562	16p13.3	Spermatogenic failure 10	614822	AD	3
610978	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
610188	12q21.32	Joubert syndrome 5	610188	AR	3
606157	20p13	HARP syndrome	607236	AR	3
606157	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
611773	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
611605	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
611492	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
610045	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
608562	7q22	Polydactyly, postaxial, type A4	608562	_	2
611407	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
610992	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
608226	10q26.11	Spermatogenic failure 12	615413	AD	3
610908	12q14.2	{Autism susceptibility 13}	610908	_	2
609903	13q32	{Systemic lupus erythematosus, susceptibility to, 5}	609903	_	2
611960	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
611493	21q22.11	Atrial fibrillation, familial, 4	611493	_	3
611408	6q14.1	Leber congenital amaurosis 5	604537	_	3
606255	6q24-q25	{Stature QTL 1}	606255	_	2
611936	3q29	Chromosome 3q29 microduplication syndrome	611936	AD	4
611528	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
607601	19p13.3	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AR,AD	3
611494	4q25	{Atrial fibrillation, familial, 5}	611494	_	2
610189	12q21.32	Senior-Loken syndrome 6	610189	AR	3
611738	20p12.3	{Osteoporosis}	166710	AD	2
611409	15q12-q13	Albinism, brown oculocutaneous	203200	AR	3
611409	15q12-q13	Albinism, oculocutaneous, type II	203200	AR	3
611409	15q12-q13	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3
611409	15q12-q13	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3
611812	1p36.12	?SERKAL syndrome	611812	AR	3
611495	19p13.12	Ichthyosis, congenital, autosomal recessive 5	604777	AR	3
609706	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
611410	6p22.3	?Deafness, autosomal recessive 104	616515	AR	3
612228	20q11.22	{Stature QTL 14}	612228	_	2
608782	8q22.1	Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3
610539	10q22.1	Gaucher disease, atypical	610539	_	3
611496	20q13.33	Congenital heart defects, multiple types, 5	617912	AR,AD	3
611775	19q13.2	{Kawasaki disease, susceptibility to}	611775	_	3
611884	7p15.3	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3
612245	7q32.1	{Inflammatory bowel disease 14}	612245	_	3
612012	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
606439	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
606439	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
610048	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
612280	1p36.11	Fucosidosis	230000	AR	3
611497	17q21.31	?Osteopetrosis, autosomal recessive 6	611497	AR	3
611938	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
602991	17q22	Brachydactyly, type B2	611377	AD	3
602991	17q22	Multiple synostoses syndrome 1	186500	AD	3
602991	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
602991	17q22	Symphalangism, proximal, 1A	185800	AD	3
602991	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
611332	7q36.3	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3
606158	11q12.3	Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3
606158	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
606158	11q12.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
606158	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
611606	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
610540	20q13.32	Pseudohypoparathyroidism, type IB	603233	AD	3
609029	22q11.2	Emanuel syndrome	609029	ICB	4
612013	4p15.32	COACH syndrome	216360	AR	3
612013	4p15.32	Joubert syndrome 9	612285	AR	3
612013	4p15.32	Meckel syndrome 6	612284	AR	3
612319	16q23.1	Spastic paraplegia 35, autosomal recessive	612319	AR	3
611391	20p12.1	Cataract 33, multiple types	611391	AR,AD	3
609617	1p36.11	Zinc deficiency, transient neonatal	608118	AD	3
611045	17q21.31	Dursun syndrome	612541	AR	3
611045	17q21.31	Neutropenia, severe congenital 4, autosomal recessive	612541	AR	3
611776	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
606440	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
611279	1q32.1	?Meckel syndrome 12	616258	AR	3
611279	1q32.1	Microcephaly 20, primary, autosomal recessive	617914	AR	3
612399	19p13.3	Preimplantation embryonic lethality	616814	AR	3
611565	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
612074	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
606256	7q31.3	{Stature QTL 2}	606256	_	2
612229	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
612123	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
612433	1q43-q44	Deafness, autosomal recessive 45	612433	AR	2
611046	8q12-q13	{Mycobacterium tuberculosis, susceptibility to, 2}	611046	_	2
610190	19q13.11	?Peeling skin syndrome 3	616265	AR	3
612014	2q24.3	Nephronophthisis 12	613820	AR,AD	3
612014	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
612263	20q11.2	{Melanoma, cutaneous malignant, 7}	612263	_	2
612230	10p14	{Colorectal cancer, susceptibility to, 5}	612230	_	2
612400	20q11.22	{Osteoarthritis-5}	612400	_	3
611777	3p22.3	Brugada syndrome 2	611777	_	3
612599	5q31.1-q33.1	{Psoriasis susceptibility 11}	612599	_	2
612124	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
610982	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
610982	14q32.33	Glomerulosclerosis, focal segmental, 5	613237	_	3
612015	3p21.1	Congenital disorder of glycosylation, type In	612015	AR	3
609148	6p21.33	{Malaria, mild, susceptibility to}	609148	_	3
612656	5p13.2	Episodic ataxia, type 6	612656	AD	3
609853	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
612691	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
607664	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
609708	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
609708	8p21.3	Lipoprotein lipase deficiency	238600	AR	3
609708	8p21.3	[High density lipoprotein cholesterol level QTL 11]	238600	AR	3
612517	14q21.3	Ciliary dyskinesia, primary, 10	612518	_	3
606441	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
606441	2p13.1	{Parkinson disease 13}	610297	_	3
612372	12p13.3	{Major affective disorder-9, susceptibility to}	612372	_	2
612761	4q22.3	Adermatoglyphia	136000	AD	3
612761	4q22.3	Basan syndrome	129200	AD	3
612761	4q22.3	Huriez syndrome	181600	AD	3
612469	11p13-p12	WAGRO syndrome	612469	_	4
612728	1p33-p32	[Bone mineral density QTL 14]	612728	_	2
610316	2p16.1	Combined oxidative phosphorylation deficiency 13	614932	AR	3
610316	2p16.1	Deafness, autosomal recessive 70	614934	AR	3
610984	4q25	Complement factor I deficiency	610984	AR	3
612692	17q23.3	Agammaglobulinemia 6	612692	AR	3
612657	4p15.32	Cone-rod dystrophy 12	612657	_	3
612674	20p11.21	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3
612401	3p24.3	{Osteoarthritis susceptibility 6}	612401	_	2
612373	10q22.1	Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3
612632	15q22-q23	Usher syndrome, type 1H	612632	_	2
612781	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
612798	6p24.1	Question mark ears, isolated	612798	AD	3
611282	10q24.2	Cataract 48	618415	AR	3
607556	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
607556	2q37.3	Barber-Say syndrome	209885	AD	3
607556	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
612931	7p13	Glycogen storage disease X	261670	AR	3
610419	19p13.2	Deafness, autosomal recessive 68	610419	AR	3
612878	11q22.3	Epidermolysis bullosa, nonspecific, autosomal recessive	615028	AR	3
611263	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
612247	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
612862	6p21.3	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}	612862	_	2
612231	8q23	{Colorectal cancer, susceptibility to, 6}	612231	_	2
611778	3p22.3	Brugada syndrome 2	611777	_	3
609402	2p25	Preeclampsia/eclampsia 2	609402	_	2
607557	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
612932	17p13.2	?Glycogen storage disease XIII	612932	AR	3
612729	8q23	[Lean body mass QTL 1]	612729	_	2
612633	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
612016	1q42.13	Coenzyme Q10 deficiency, primary, 4	612016	AR	3
613031	20q13.33	{Glioma susceptibility 6}	613031	_	2
607786	1p32.3	Hypercholesterolemia, familial, 3	603776	AD	3
607786	1p32.3	{Low density lipoprotein cholesterol level QTL 1}	603776	AD	3
612374	5q31.2	STING-associated vasculopathy, infantile-onset	615934	AD	3
611816	1q32.2	Temple-Baraitser syndrome	611816	AD	3
612991	2p23.3	Shashi-Pena syndrome	617190	AD	3
605479	2q31.1	Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3
612975	12p12.1	[Short sleeper]	612975	AD	3
612863	6q24-q25	Chromosome 6q25-q25 deletion syndrome	612863	_	4
613014	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
612017	11q14-q22	Pyloric stenosis, infantile hypertrophic, 3	612017	_	2
612095	4p15.32	Retinitis pigmentosa 41	612095	AR	3
612799	16p12.2	Combined oxidative phosphorylation deficiency 12	614924	AR	3
613093	10q23.33	Cone dystrophy 4	613093	AR	3
613071	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
612837	16q21	Coenzyme Q10 deficiency, primary, 5	614654	AR	3
612232	11q23	{Colorectal cancer, susceptibility to, 7}	612232	_	2
612634	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
612126	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
610420	14q11.2-q12	Preauricular tag, isolated, autosomal dominant, 1	610420	AD	2
609403	9p13	Preeclampsia/eclampsia 3	609403	_	2
607604	9p24.2	Retinal cone dystrophy 3B	610356	AR	3
605480	4p16-p15.2	{Systemic lupus erythematosus, susceptibility to, 3}	605480	_	2
613032	8q24.21	{Glioma susceptibility 7}	613032	_	2
613015	6p22	{Neuroblastoma, susceptibility to, 4}	613015	_	2
613055	16q22	Atrial fibrillation, familial, 8	613055	_	2
612018	10q23.31	Cataract 47, juvenile, with microcornea	612018	AD	3
609033	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
612635	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
613094	8q22.1	Microphthalmia, isolated 4	613094	_	3
612881	5q14.3-q15	Periventricular nodular heterotopia 5	612881	_	4
605804	20p	{Dermatitis, atopic, susceptibility to, 3}	605804	_	2
610947	12p13.2	{Coronary artery disease, autosomal dominant, 2}	610947	AD	3
612233	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
612034	19p13.3	?Sotos syndrome 3	617169	AR	3
608786	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
612782	12q24.31	Immunodeficiency 9	612782	AR	3
610199	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
613111	20q13.12	Galactosialidosis	256540	AR	3
612712	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
609712	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
609712	1q22	Pyruvate kinase deficiency	266200	AR	3
612471	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
610093	14q24.3	Microphthalmia, isolated 2	610093	_	3
612096	9p13.1-q21.11	Otosclerosis 8	612096	AD	2
610053	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
611611	15q24.3	Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3
613180	22q11.21	Cortical dysplasia, complex, with other brain malformations 8	613180	AR	3
610948	3p14.1-q12.3	{Hypertension, essential, susceptibility to, 7}	610948	_	2
613145	1q21-q23	{Systemic lupus erythematosus, susceptibility to, 14}	613145	_	2
605481	1q31.3	Microcephaly 5, primary, autosomal recessive	608716	AR	3
613270	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
612783	11p15.4	Immunodeficiency 10	612783	AR	3
605805	17q25.3	{Dermatitis, atopic, susceptibility to, 4}	605805	_	2
613112	20q13.32	Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	AD	3
613219	7p15-p13	[Birth weight QTL 1]	613219	_	2
613219	7p15-p13	[Fasting plasma glucose level QTL 2]	613219	_	2
613236	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
612452	17q21.31	Koolen-De Vries syndrome	610443	AD	3
607788	2p21	Factor V and factor VIII, combined deficiency of	613625	_	3
611888	19q13.2	Chitayat syndrome	617180	AD	3
611888	19q13.2	Craniosynostosis 4	600775	AD	3
612800	13q34	Combined oxidative phosphorylation deficiency 27	616672	AR	3
607955	6q24.3-q25.1	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3
607955	6q24.3-q25.1	Dyschromatosis universalis hereditaria 1	127500	AD	3
613095	4q22.1	Polycystic kidney disease 2	613095	AD	3
611705	2q31.2	Salih myopathy	611705	AR	3
611908	3p21.1	Congenital disorder of glycosylation, type In	612015	AR	3
610422	3q26.2-q26.31	Alopecia-mental retardation syndrome 2	610422	AR	2
609312	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
612035	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
612035	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
613016	2q35	{Neuroblastoma, susceptibility to, 5}	613016	_	2
612713	4q12	Kahrizi syndrome	612713	AR	3
613290	6p22.3	{?Hearing loss, cisplatin-induced, susceptibility to}	613290	_	2
609855	17q21.2	Neurodegeneration with brain iron accumulation 6	615643	AR	3
609855	17q21.2	Pontocerebellar hypoplasia, type 12	618266	AR	3
613163	16p13.2	GABA-transaminase deficiency	613163	AR	3
610949	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
612020	19p13.2	Spastic paraplegia 39, autosomal recessive	612020	AR	3
611966	8q24.3	Mental retardation, autosomal recessive 13	613192	AR	3
613271	9p24.1-p22.1	Corneal dystrophy, Fuchs endothelial, 7	613271	_	2
607606	17q21.2	Palmoplantar keratoderma, epidermolytic	144200	AD	3
611706	10q22-q23	{Migraine, with or without aura, susceptibility to, 12}	611706	AD	2
613096	12q23-q24	Spastic paraplegia 36, autosomal dominant	613096	AD	2
613146	15q25.1	EDICT syndrome	614303	AD	3
609313	7q22.1	MEDNIK syndrome	609313	AR	3
613435	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
612994	4p15.33	Cone-rod dystrophy 18	615374	AR	3
610423	14q32.33	Epileptic encephalopathy, early infantile, 66	618067	AD	3
609620	7q36.1	Short QT syndrome 1	609620	_	3
613033	5p15.33	{Glioma susceptibility 8}	613033	_	2
613401	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
612714	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
613072	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
613291	13q33.1	Bile acid malabsorption, primary	613291	AR	3
613418	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
613237	14q32.33	Glomerulosclerosis, focal segmental, 5	613237	_	3
613058	1q42	{Basal cell carcinoma, susceptibility to, 2}	613058	_	2
611124	4q28.2	Ceroid lipofuscinosis, neuronal, 7	610951	AR	3
611124	4q28.2	Macular dystrophy with central cone involvement	616170	AR	3
613471	1q42.12	?Reynolds syndrome	613471	AD	3
613529	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613529	15q21.1	Seckel syndrome 5	613823	AR	3
610132	1p13.1	Caudal regression syndrome	600145	AD	3
610132	1p13.1	{Neural tube defects, susceptibility to}	182940	AD	3
612036	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
613581	3q12.3	Retinitis pigmentosa 56	613581	AR	3
606187	10p13	Alzheimer disease-7	606187	_	2
613547	16q24	{Stature QTL 22}	613547	_	2
612021	8q21.3	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3
613017	1q21.1	{Neuroblastoma, susceptibility to, 6}	613017	_	2
612251	7q32.1	{Systemic lupus erythematosus, susceptibility to, 10}	612251	_	3
613436	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
612866	1p21.3	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3
611531	12p13.31	Bowen-Conradi syndrome	211180	AR	3
612386	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
613690	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
613402	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
610951	4q28.2	Ceroid lipofuscinosis, neuronal, 7	610951	AR	3
613238	2q36.1-q36.3	{Spondyloarthropathy, susceptibility to, 3}	613238	_	2
609621	11p15.5-p15.4	Short QT syndrome 2	609621	AD	3
607560	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
606460	6q21	[Longevity 2]	606460	_	2
613113	17q11.2	Leukemia, juvenile myelomonocytic	607785	SMu,AD	3
613113	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
613113	17q11.2	Neurofibromatosis, type 1	162200	AD	3
613113	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
613113	17q11.2	Watson syndrome	193520	AD	3
613752	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
608742	12p12.2-p12.1	{Hypertension, essential, susceptibility to, 4}	145500	Mu	2
613453	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
613564	2p12-p11.2	Chromosome 2p12-p11.2 deletion syndrome	613564	_	4
613255	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
613582	17q25.3	Retinitis pigmentosa 57	613582	AR	3
610489	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
611818	3p25.3	Long QT syndrome 9	611818	AD	3
611398	17q12	?Ciliary dyskinesia, primary, 41	618449	AR	3
611192	16q24.3	KBG syndrome	148050	AD	3
611060	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
611060	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
613059	5p15.33	{Basal cell carcinoma, susceptibility to, 3}	613059	_	2
613715	13q12.2	Treacher Collins syndrome 2	613717	AR,AD	3
613857	1p33	Orofacial cleft 13	613857	AD	2
612356	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
613548	1p32	{Stature QTL 23}	613548	_	2
613325	19p13.2	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3
611910	10q23.31	Cataract 47, juvenile, with microcornea	612018	AD	3
613798	3q26.33	Ciliary dyskinesia, primary, 14	613807	_	3
613815	6p21.33	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	AR	3
613815	6p21.33	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	AR	3
612387	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
613239	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
609622	17q24.3	Short QT syndrome 3	609622	_	3
613420	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
613769	10q23.1	Retinitis pigmentosa 44	613769	_	3
610997	17q21-q22	{Prostate cancer, hereditary, 9}	610997	_	2
613673	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
613293	5q35.1	Frank-ter Haar syndrome	249420	AR	3
613148	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
611290	2q35	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	_	3
613891	3q21.2	Orotic aciduria	258900	AR	3
613381	21q22.3	Homocystinuria, B6-responsive and nonresponsive types	236200	AR	3
613381	21q22.3	Thrombosis, hyperhomocysteinemic	236200	AR	3
611890	9q34.11	Congenital arthrogryposis with anterior horn cell disease	611890	AR	3
612098	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
613858	2q37.1	Microphthalmia, isolated 6	613517	AR	3
612357	10q21	{Major affective disorder-8, susceptibility to}	612357	_	2
613454	14q12	Rett syndrome, congenital variant	613454	AD	3
612474	1q21.1	Chromosome 1q21.1 deletion syndrome	612474	IC,AD	4
612933	11p15.1	Glycogen storage disease XI	612933	AR	3
613276	16q21	Poikiloderma with neutropenia	604173	AR	3
607791	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
612238	9q31.2-q34.2	{Scoliosis, idiopathic, susceptibility to, 4}	612238	_	2
613874	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
613530	3p25.1-p23	Muscular dystrophy, limb-girdle, type 1H	613530	AD	2
611073	8p12-q22	{Alzheimer disease 12}	611073	_	2
613403	2q11.2	{Pheochromocytoma, susceptibility to}	171300	AD	3
613549	2p16	{Stature QTL 24}	613549	_	2
614009	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
611978	1q25.1	?Combined oxidative phosphorylation deficiency 38	618378	AR	3
614034	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
613674	8q11.23	Vesicoureteral reflux 3	613674	AD	3
611911	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
613183	2p13.1	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3
613382	12p11.22	Brachydactyly, type E2	613382	AD	3
610502	6q21	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	616732	AR	3
612099	9p21	Trichoepithelioma, multiple familial, 2	612099	_	2
614098	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
613404	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
611126	3q21.3	Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3
612636	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
611820	7q21.2	?Long QT syndrome-11	611820	AD	3
612388	10q22.3	{Sarcoidosis, susceptibility to, 3}	612388	_	2
612475	1q21.1	Chromosome 1q21.1 duplication syndrome	612475	IC,AD	4
614074	11p15.1	Hermansky-Pudlak syndrome 5	614074	AR	3
613036	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
614231	18q21.1	Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3
613061	12q13	{Basal cell carcinoma, susceptibility to, 4}	613061	_	2
614187	14q31	Hypertelorism, preauricular sinus, punctal pits, and deafness	614187	AD	2
612239	17q25.3	{Scoliosis, idiopathic, susceptibility to, 5}	612239	_	2
612997	11q13.1	Spermatogenic failure 7	612997	AR	3
612253	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
613326	8q22.3	Dihydropyrimidinuria	222748	AR	3
610954	18q21.2	Pitt-Hopkins syndrome	610954	AD	3
614254	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
611801	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
613204	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
609122	1p36.13-p34.3	Aneurysm, intracranial berry, 3	609122	AD	2
614035	21q22.13	Deafness, autosomal recessive 29	614035	AR	3
613860	1p36.11	Immunodeficiency due to ficolin 3 deficiency	613860	AR	3
612801	1q41	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3
610762	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
614151	16q23.1	?Fanconi anemia, complementation group W	617784	AR	3
610432	18q12.1	Tenorio syndrome	616260	AD	3
611783	2p21	Erythrocytosis, familial, 4	611783	_	3
612417	22q13	{Narcolepsy 4}	612417	_	2
612732	3q11.2	Coproporphyria	121300	AD	3
612732	3q11.2	Harderoporphyria	121300	AD	3
613257	1q32.1	Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3
612389	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
606190	1p11	Meningioma, radiation-induced	606190	_	2
611376	8q23-q24	Mungan syndrome	611376	AR	2
612358	3q27.3	[High molecular weight kininogen deficiency]	228960	AR	3
612358	3q27.3	[Kininogen deficiency]	228960	AR	3
610988	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
613717	13q12.2	Treacher Collins syndrome 2	613717	AR,AD	3
614168	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
612254	8p23.1	{Systemic lupus erythematosus, susceptibility to, 12}	612254	_	2
613327	17q21.2	Lipodystrophy, congenital generalized, type 4	613327	AR	3
612868	12q21.33	Corneal dystrophy, posterior amorphous	612868	AD	4
614134	6q13	Stickler syndrome, type IV	614134	_	3
614058	2p23.3	[Fructosuria]	229800	AR	3
613976	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
613940	4q28.1	Epilepsy, hearing loss, and mental retardation syndrome	616577	AR	3
613583	19q13.12	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3
612637	3q26.2-q26.33	Febrile seizures, familial, 10	612637	_	2
613826	14q11.2	Leber congenital amaurosis 6	613826	_	3
614171	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
610098	6q22.31	Ovarian dysgenesis 4	616185	AR	3
614326	13q31.3	Feingold syndrome 2	614326	AD	3
612390	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
612998	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
613277	11q12.2	Joubert syndrome 2	608091	AR	3
613277	11q12.2	Meckel syndrome 2	603194	AR	3
614152	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
611089	3p25.3	{Centronuclear myopathy, autosomal, modifier of}	160150	AD	3
612584	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
614075	10q24.32	Hermansky-Pudlak syndrome 6	614075	AR	3
613862	2q13	Retinitis pigmentosa 38	613862	AR	3
614232	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
613756	4p12	Retinitis pigmentosa 49	613756	_	3
614327	3p21.1	Tumor predisposition syndrome	614327	AD	3
612554	5p15.33-p15.2	Myopia 16	612554	_	2
614188	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
613603	4q32.1-q32.2	Chromosome 4q32.1-q32.2 triplication syndrome	613603	AD	4
612100	7q35-q36	{Autism susceptibility 15}	612100	_	3
613278	16p13.3	Fanconi anemia, complementation group P	613951	AR	3
613328	15q11-q21.1	?Roifman-Chitayat syndrome	613328	AR	2
613977	11p15.4	Cyanosis, transient neonatal	613977	AD	3
613037	9q34.3	Joubert syndrome 1	213300	AR	3
613037	9q34.3	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	AR	3
612360	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
612418	8q21.11	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3
611804	1p35.3	Elliptocytosis-1	611804	AR,AD	3
614343	18p11.3	Mental retardation, autosomal recessive 19	614343	AR	2
613827	6p21.1	Retinitis pigmentosa 48	613827	_	3
614172	3q21.3	Immunodeficiency 21	614172	AD	3
612638	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
613757	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
613924	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
614255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
614328	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
613842	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
610099	8p22-q11	Myopathy, distal 3	610099	AD	2
611403	17q21	{Asthma-related traits, susceptibility to, 6}	611403	_	2
614291	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
612639	12q15	{Inflammatory bowel disease 26}	612639	_	2
612586	2q33.1	{Aneurysm, intracranial berry, 9}	612586	_	2
612392	8q22.1	Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3
612361	2q32.1	{Schizophrenia, susceptibility to, 14}	612361	_	2
614395	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
613279	14q31.3	Mental retardation, autosomal recessive 56	617125	AR	3
611805	6p12.1	Spinocerebellar ataxia 38	615957	AD	3
610100	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
614452	10q23.31	Hyperekplexia 4	618011	AR	3
612555	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
611535	2q22-q24	{Major affective disorder 5}	611535	_	2
614329	4q12-q13.1	Mental retardation, autosomal recessive 31	614329	AR	2
613006	10q23.31	{Diabetes mellitus, insulin-dependent, 24}	613006	_	2
611341	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
613675	17q11.2	Chromosome 17q11.2 deletion syndrome, 1.4Mb	613675	AD	4
612362	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
612458	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
611719	3q23	Combined oxidative phosphorylation deficiency 5	611719	AR	3
613405	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
612621	6p21.32	Mental retardation, autosomal dominant 5	612621	AD	3
613843	6p21.31	Leber congenital amaurosis 15	613843	AR	3
613205	1q22	Muscular dystrophy, congenital	613205	AD	3
611090	1p34.1	Mental retardation, autosomal recessive 12	611090	AR	3
614429	8p23.1	Ventricular septal defect 1	614429	AD	3
613329	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AR,AD	3
613150	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
612622	4q27	{Diabetes mellitus, insulin-dependent, 23}	612622	_	2
613758	2q37.1	Retinitis pigmentosa 47	613758	_	3
614292	3q28	Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3
614233	19pter-p13.1	Hyperpigmentation, familial progressive, 1	614233	_	2
613406	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
612641	8p11.21	Spherocytosis, type 1	182900	AR,AD	3
612001	15q13.3	Chromosome 15q13.3 microdeletion syndrome	612001	_	4
611788	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
611170	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
614521	9p24.1	Thrombocythemia 3	614521	SMu,AD	3
612459	2q14.1	[Body mass index QTL13]	612459	_	2
613942	20q11.21	Spermatogenic failure 16	617187	AR	3
614411	9p13.3	[Glycerol quantitative trait locus]	614411	AR	3
613385	20q11.22	Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3
613828	6q16.3-q22.31	Epilepsy, generalized, with febrile seizures plus, type 8	613828	_	2
612587	8q12.1	{Aneurysm, intracranial berry, 10}	612587	_	2
613477	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
614344	11p13-q14.1	Mental retardation, autosomal recessive 23	614344	AR	2
613676	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
613114	5p15.1	Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3
612623	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
613007	6p21.3	{Biliary cirrhosis, primary, 2}	613007	_	2
613533	17q21.31	Chromosome 17q21.31 duplication syndrome	613533	_	4
612556	3q27.3	Adiponectin deficiency	612556	_	3
613151	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
612240	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
614504	5q31.3	Usher syndrome type 3B	614504	AR	3
608792	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
614293	6q13	Hydatidiform mole, recurrent, 2	614293	AR	3
613845	19q13.2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3
612642	11p14.2-q12.3	Deafness, autosomal dominant 59	612642	AD	2
613008	1p31.2	{Biliary cirrhosis, primary, 3}	613008	_	2
611536	6q23-q24	{Major affective disorder 6}	611536	_	2
613759	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
614487	18p11.21	Spastic ataxia 5, autosomal recessive	614487	AR	3
613604	16p12.2-p11.2	Chromosome 16p12.2-p11.2 deletion syndrome	613604	IC	4
612255	10q21	{Inflammatory bowel disease 15}	612255	_	2
614468	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
614345	6p12.2-q12	Mental retardation, autosomal recessive 24	614345	AR	2
613280	1q41	Hypermanganesemia with dystonia 1	613280	AR	3
614831	6q24.3	Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3
612241	3p21.3	{Inflammatory bowel disease 12}	612241	_	2
614505	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
614700	4q31.3	Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3
614331	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
612557	9q34.1	{Leukemia, chronic lymphocytic, susceptibility to, 3}	612557	_	2
612643	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
613943	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
613407	13q14.11	{Leprosy, susceptibility to, 6}	613407	_	2
611913	16p11.2	Chromosome 16p11.2 deletion syndrome, 593kb	611913	_	4
611913	16p11.2	{Autism susceptibility 14A}	611913	_	2
614864	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
611482	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
611482	4q35.1	?Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3
612119	11q23.3	Trehalase deficiency	612119	AR	3
613605	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
613206	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
614848	11q23.3	Nephronophthisis 15	614845	AR	3
614190	5q13.3	Pigmented nodular adrenocortical disease, primary, 3	614190	_	3
614619	4q32.1	Hyperekplexia 2	614619	AR	3
612802	6p21.33	Combined oxidative phosphorylation deficiency 20	615917	AR	3
611003	10q22	{Smoking as a quantitative trait locus 1}	611003	_	2
614010	8q12.1	Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3
612589	14q22.2	{Colorectal cancer, susceptibility to, 8}	612589	_	2
612676	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
613115	5p15.1	Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3
609625	10q26	Chromosome 10q26 deletion syndrome	609625	AD	4
614946	6p25.1	Combined oxidative phosphorylation deficiency 14	614946	AR	3
612624	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
612256	19p13.13	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3
614173	12q24.11	Joubert syndrome 13	614173	AR	3
612120	3p25.3	?Lipodystrophy, familial partial, type 5	615238	AR	3
612242	10q23	Chromosome 10q22.3-q23.2 deletion syndrome	612242	_	4
612644	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
614455	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
613761	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
613207	9q33	{Asthma-related traits, susceptibility to, 8}	613207	_	2
613944	2q36	{IgA nephropathy, susceptibility to, 2}	613944	?AD	2
614947	15q22.31	Combined oxidative phosphorylation deficiency 15	614947	AR	3
613606	1p33-p31.1	Forsythe-Wakeling syndrome	613606	AR	2
611570	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
614541	16q22	Chromosome 16q22 deletion syndrome	614541	IC	4
614849	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
614456	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
614814	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
613534	15q13.3	Interstitial nephritis, karyomegalic	614817	AR	3
615135	4q22.1	?Maple syrup urine disease, mild variant	615135	_	3
614414	1p36.31-p36.13	Deafness, autosomal recessive 96	614414	AR	2
611004	22q12	{Smoking as a quantitative trait locus 2}	611004	_	2
613550	8q22.1	Nephronophthisis 11	613550	AR	3
613386	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
613386	13q12.3	Proteasome-associated autoinflammatory syndrome 2	618048	AD	3
615003	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
613190	16q24.1	Ciliary dyskinesia, primary, 13	613193	AR	3
613208	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
613566	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
612243	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
614929	12q13.13	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3
615119	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
614736	5p12	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3
615083	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
615271	20p12.1	Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3
613387	11q23	{Fatty liver disease, nonalcoholic, susceptibility to, 2}	613387	Mu	2
613282	22q13	{Fatty liver disease, nonalcoholic, susceptibility to, 1}	613282	Mu	2
613846	12q24.31	?Meckel syndrome 8	613885	AR	3
613846	12q24.31	Joubert syndrome 24	616654	AR	3
613009	4p15.2	Pontocerebellar hypoplasia type 2D	613811	AR	3
612625	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
614278	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
612160	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
614620	16p13.3	Retinitis pigmentosa 80	617781	AR	3
614620	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
614815	10q24.1	Joubert syndrome 18	614815	AR	3
615084	20p11.23	Mitochondrial DNA depletion syndrome 11	615084	AR	3
614644	6p21.3-p21.2	Mean platelet volume QTL4	614644	_	2
614582	3q22.1	Combined oxidative phosphorylation deficiency 9	614582	AR	3
614490	4q22.1	[Junior blood group system]	614490	_	3
611091	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
613283	4p13	Deafness, autosomal recessive 25	613285	AR	3
612161	11q24-q25	Aneurysm, intracranial berry, 7	612161	_	2
614621	5q12.1	UV-sensitive syndrome 2	614621	AR	3
611571	16q22.1-q23.1	{Otosclerosis 4}	611571	AD	2
611092	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
615085	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
615515	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
613847	10q24.1	Joubert syndrome 18	614815	AR	3
613847	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
613608	5p15.31-p15.1	Epilepsy, myoclonic, familial adult, 3	613608	AD	2
614063	4p16.3	?N-acetylaspartate deficiency	614063	AR	3
615463	1p34.2	Epileptic encephalopathy, early infantile, 18	615476	AR	3
615427	2p11.2	?Deafness, autosomal recessive 88	615429	AR	3
614622	5q14.1-q21.3	Keratoconus 5	614622	AD	2
613284	22q12-q13	[Hematocrit/hemoglobin quantitative trait locus 3]	613284	_	2
615481	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
615272	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
615311	11p14.1	{Bone mineral density, low, susceptibility to}	615311	_	3
615549	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
611572	6q13-q16.1	Otosclerosis 7	611572	AD	2
614583	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
615273	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
615787	5p13.2	?2,4-dienoyl-CoA reductase deficiency	616034	AR	3
615567	19q13.2	Nephrotic syndrome, type 9	615573	AR	3
615288	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614645	6q23.3	Mean platelet volume QTL5	614645	_	2
615767	4q27	?Immunodeficiency, common variable, 11	615767	AR	3
614021	7p22-p14	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	2
612244	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
615120	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
615500	21q22.11	Ciliary dyskinesia, primary, 26	615500	AR	3
612558	6p25	{Leukemia, chronic lymphocytic susceptibility to, 4}	612558	_	2
615464	1q32.1	Orofaciodigital syndrome V	174300	AR	3
611539	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
614915	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
614738	6q27	Mitochondrial pyruvate carrier deficiency	614741	AR	3
614491	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
612590	16q22.1	{Colorectal cancer, susceptibility to, 9}	612590	_	2
615586	3q29	Morbid obesity and spermatogenic failure	615703	AR	3
615274	12q13.3	Cataract 15, multiple types	615274	AD	3
615159	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
614022	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
615721	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
615550	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
611093	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
613848	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
615004	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
615429	2p11.2	?Deafness, autosomal recessive 88	615429	AR	3
615843	1q42.11	Leukodystrophy, hypomyelinating, 18	618404	AR	3
614492	12p13.33	Pseudohypoaldosteronism, type IIC	614492	AD	3
613285	4p13	Deafness, autosomal recessive 25	613285	AR	3
615902	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
615902	14q13.2	Spermatogenic failure 36	618420	AD	3
615501	14q23.3-q24.1	Molybdenum cofactor deficiency C	615501	AR	3
615482	15q21.3	Ciliary dyskinesia, primary, 25	615482	AR	3
613876	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
615368	19p13.2	Lethal congenital contracture syndrome 5	615368	AR	3
613345	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
615312	4q24	Albinism, oculocutaneous, type V	615312	AR	2
615551	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
614623	9q34	Keratoconus 6	614623	AD	2
614506	7p22.3	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3
614506	7p22.3	Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3
615390	12p11-q13	Vesicoureteral reflux 7	615390	_	2
613849	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
612559	11q24.1	{Leukemia, chronic lymphocytic susceptibility to, 5}	612559	_	2
612259	9q32	{Inflammatory bowel disease 16}	612259	_	2
615683	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
615465	8p11.23	Hartsfield syndrome	615465	AD	3
615327	20q11.21	Dowling-Degos disease 2	615327	AD	3
615179	10q22.2-q22.3	Albinism, oculocutaneous, type VII	615179	AR	3
613609	6p22.2	Hemochromatosis	235200	AR	3
613609	6p22.2	[Transferrin serum level QTL2]	614193	_	3
613609	6p22.2	{Alzheimer disease, susceptibility to}	104300	AD	3
613609	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
613609	6p22.2	{Porphyria cutanea tarda, susceptibility to}	176100	AR,AD	3
613609	6p22.2	{Porphyria variegata, susceptibility to}	176200	AD	3
611663	20p13	Warburg micro syndrome 4	615663	AR	3
611377	17q22	Brachydactyly, type B2	611377	AD	3
615160	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
612803	11q14.1	?Deafness, autosomal recessive 94	618434	AR	3
612803	11q14.1	Combined oxidative phosphorylation deficiency 24	616239	AR	3
616033	4q23	Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3
616053	14q32.11-q32.12	?Spinocerebellar ataxia 40	616053	AD	3
613850	20p13	[Inosine triphosphatase deficiency]	613850	_	3
616182	12q13	{Chronic mountain sickness, susceptibility to}	616182	_	2
614916	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
616202	14q32.33	Cerebellofaciodental syndrome	616202	AR	3
615502	16q22.1	Mental retardation, autosomal dominant 21	615502	AD	3
614739	6q25.3	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3
614507	1p36.12	?Congenital disorder of glycosylation, type Ir	614507	AR	3
615684	1p22.2	Premature ovarian failure 9	615724	AR	3
613551	11q24.2	{Autoimmune disease, susceptibility to, 6}	613551	_	3
613286	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
611664	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
615903	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
615903	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
615903	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
612260	3p22.2	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	_	3
611971	9q34.3	Combined oxidative phosphorylation deficiency 36	617950	AR	3
615992	2p15	?Bardet-Biedl syndrome 15	615992	AR	3
616219	4q25	Fibrosis of extraocular muscles, congenital, 5	616219	AR	3
616295	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
614895	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
613877	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
616034	5p13.2	?2,4-dienoyl-CoA reductase deficiency	616034	AR	3
611006	9q21.33	Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3
614917	6q25.1	Combined oxidative phosphorylation deficiency 11	614922	AR	3
616255	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
614076	6p22.3	Hermansky-Pudlak syndrome 7	614076	AR	3
613610	2p24.1	Cranioectodermal dysplasia 2	613610	AR	3
615503	7q36.3	Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3
616329	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
613011	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
616054	18q12.2	Mental retardation, autosomal recessive 58	617270	AR	3
615993	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
612261	1p31.3	{Inflammatory bowel disease 17, protection against}	612261	_	3
615162	17q21.31-q22	Mental retardation, autosomal recessive 35	615162	AR	2
613211	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
615956	19p13.2	Ciliary dyskinesia, primary, 30	616037	AR	3
614524	6p21.32	Fibrochondrogenesis 2	614524	AR,AD	3
615181	1q42.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	AR	3
613611	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
615860	14q24.3	Cone-rod dystrophy 19	615860	AR	3
614740	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
616462	2p11.2	Acrofacial dysostosis, Cincinnati type	616462	AD	3
615504	12q13.12	Ciliary dyskinesia, primary, 27	615504	AR	3
615846	2q24.2	Aicardi-Goutieres syndrome 7	615846	AD	3
614023	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
614896	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
615314	15q21.3	Craniosynostosis 3	615314	AD	3
615122	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
616346	9q34.11	Epileptic encephalopathy, early infantile, 31	616346	AD	3
614800	2p24.3	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3
616531	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
615005	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
613852	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
616330	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
612262	5p13.1	{Inflammatory bowel disease 18}	612262	_	2
616410	4q27	?Spinocerebellar ataxia 41	616410	AD	3
613612	7q22.3	Congenital disorder of glycosylation, type IIi	613612	_	3
615861	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
615483	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
616481	6q25.3	Ciliary dyskinesia, primary, 32	616481	AR	3
614508	15q15.1	Mirror movements 2	614508	AD	3
616055	1p36.13-p34.3	Episodic ataxia, type 8	616055	AD	2
614493	2q31.1	?Wiskott-Aldrich syndrome 2	614493	_	3
614897	7q21.11	{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3
615431	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
613878	13q34	Factor VII deficiency	227500	AR	3
613878	13q34	{Myocardial infarction, decreased susceptibility to}	608446	_	3
616719	11q13.1	Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3
612482	17q22	Sessile serrated polyposis cancer syndrome	617108	AD	3
612421	20p11.22	Alopecia, androgenetic, 3	612421	_	2
613347	13q13.1	{Pancreatic cancer 2}	613347	_	3
616411	2q37.3	Dystonia 27	616411	AR	3
613865	7q22.1	?Deafness, autosomal recessive 61	613865	AR	3
615862	12q22	Nephronophthisis 18	615862	AR	3
615505	8q22.2	Ciliary dyskinesia, primary, 28	615505	AR	3
616532	19q13.33	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3
616428	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
615065	2q37.1	Arthrogryposis, distal, type 5D	615065	AR	3
613301	7q31.32	Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3
616736	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
615847	12q22	Nephronophthisis 18	615862	AR	3
616720	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
616204	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
615942	17q25.1	Mental retardation, autosomal recessive 44	615942	AR	3
615276	15q26.3	Ichthyosis, congenital, autosomal recessive 9	615023	AR	3
614024	13q34	[Protein Z deficiency]	614024	_	3
616685	20q13.12	{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3
615905	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
615532	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
616331	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
612591	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
616645	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
614646	7q22.3	Mean platelet volume QTL6	614646	_	2
614920	1q21.1	?Peroxisome biogenesis disorder 14B	614920	AR	3
614741	6q27	Mitochondrial pyruvate carrier deficiency	614741	AR	3
616165	3p14.1	Nemaline myopathy 10	616165	AR	3
615066	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
615432	2q36.3	{Specific language impairment 5}	615432	AD	3
616625	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
616549	22q12.1	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3
612592	20p12.3	{Colorectal cancer, susceptibility to, 11}	612592	_	2
614332	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
615506	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
616445	3p25.3	Candidiasis, familial, 9	616445	AR	3
615957	6p12.1	Spinocerebellar ataxia 38	615957	AD	3
616646	17q21.2	Woolly hair, autosomal recessive 3	616760	AR	3
614898	8p22	Spastic paraplegia 53, autosomal recessive	614898	AR	3
616166	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
614526	17q12	Chromosome 17q12 duplication syndrome	614526	AD	4
614921	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
611666	9p24.1	Phospholipid phosphatase 6	611666	_	3
616183	17p13.1	?Joubert syndrome 29	617562	AR	3
616183	17p13.1	Meckel syndrome 13	617562	AR	3
616183	17p13.1	Orofaciodigital syndrome XVI	617563	AR	3
616312	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
616430	2q33.1	?Combined oxidative phosphorylation deficiency 25	616430	AR	3
616840	15q22.2	Parkinson disease 23, autosomal recessive, early onset	616840	AR	3
612422	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
614025	15q21.3	Hepatic lipase deficiency	614025	AR	3
616647	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
612736	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
616515	6p22.3	?Deafness, autosomal recessive 104	616515	AR	3
615768	16p13.3	Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3
613012	3q21.3	?Urocanase deficiency	276880	AR	3
614922	6q25.1	Combined oxidative phosphorylation deficiency 11	614922	AR	3
615072	20q11.22	Brachydactyly, type A1, C	615072	AR,AD	3
615907	4q34.3	Lymphatic malformation 4	615907	AD	3
615978	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
612423	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
616056	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
616313	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
614333	4q27-q28.2	Mental retardation, autosomal recessive 29	614333	AR	2
614415	20q11.23	?Chilblain lupus 2	614415	AD	3
613213	22q13.2	Methemoglobinemia, type I	250800	AR	3
613213	22q13.2	Methemoglobinemia, type II	250800	AR	3
612737	7p15	{Stature QTL 17}	612737	_	2
617083	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
616516	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
616534	9q22.33	{Thyroid cancer, nonmedullary, 4}	616534	AD	3
616648	16q21-q22	Optic atrophy 8	616648	AD	2
616737	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
613348	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
617066	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
617025	14q24.3	Nevus comedonicus, somatic	617025	_	3
615828	11p15.5	Mental retardation, autosomal dominant 24	615828	AD	3
614742	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
615552	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
616413	1q25.3	Basal ganglia calcification, idiopathic, 6	616413	AD	3
614457	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
616276	9q34.11	Coenzyme Q10 deficiency, primary, 7	616276	AR	3
615444	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
611974	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
614527	17q12	Chromosome 17q12 deletion syndrome	614527	AD	4
612424	6q12	Retinitis pigmentosa 25	602772	AR	3
615468	18q21.32	Immunodeficiency 12	615468	AR	3
616314	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
613214	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
611542	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
615073	18p11.21	Dystonia 25	615073	AD	3
617174	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
616535	10q25.3	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3
614494	6q23	Retinitis pigmentosa 63	614494	AD	2
614923	16p11.2	Branched-chain ketoacid dehydrogenase kinase deficiency	614923	_	3
616788	17q21.33	?Orofacial cleft 15	616788	AD	3
615277	19q13.41	Cataract 19, multiple types	615277	AR	3
616649	14q23.3	Spherocytosis, type 2	616649	AD	3
615789	2p21	Short stature with microcephaly and distinctive facies	615789	AR	3
615829	1p36.1-p35.3	Xia-Gibbs syndrome	615829	AD	3
615091	4q23	{Autism, susceptibility to, 19}	615091	_	3
616258	1q32.1	?Meckel syndrome 12	616258	AR	3
616517	1q23.3	Achromatopsia 7	616517	AR	3
617140	21q22.11	ZTTK syndrome	617140	AD	3
617044	3p21.1	Short stature, developmental delay, and congenital heart defects	617044	AR	3
615163	10q26	Cone-rod dystrophy 17	615163	AD	2
613215	17p13.3	Chromosome 17p13.3 duplication syndrome	613215	_	4
615994	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
616892	16q13	Nephrotic syndrome, type 12	616892	AR	3
616414	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
615533	11q14.1	Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3
615485	18q12.1	Bainbridge-Ropers syndrome	615485	AD	3
617157	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
616738	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
616185	6q22.31	Ovarian dysgenesis 4	616185	AR	3
616283	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
614899	11q13.2	Deafness, autosomal recessive 93	614899	AR	3
614416	2p13.2	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	_	3
616756	6q16.3	Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3
615909	14q21.3	Diamond-Blackfan anemia 13	615909	AD	3
616650	16p12.1	Joubert syndrome 26	616784	AR	3
614458	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
612162	14q23	Aneurysm, intracranial berry, 8	612162	_	2
613349	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
617180	19q13.2	Chitayat syndrome	617180	AD	3
617121	17q22	Joubert syndrome 28	617121	AR	3
614924	16p12.2	Combined oxidative phosphorylation deficiency 12	614924	AR	3
617068	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
615092	18q11.2	Left ventricular noncompaction 7	615092	AD	3
614335	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
613135	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
615959	2q35	Centronuclear myopathy 5	615959	AR	3
615790	1p36.1-p35.3	Xia-Gibbs syndrome	615829	AD	3
615127	3q26.32-q28	Epilepsy, myoclonic, familial adult, 4	615127	AD	2
616208	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
613776	17p13.1	Chromosome 17p13.1 deletion syndrome	613776	AD	4
617248	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
617158	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
616415	16p13.3	Familial adenomatous polyposis 3	616415	AR	3
616893	7q33	?Nephrotic syndrome, type 13	616893	_	3
617004	6q21	Polycystic liver disease 2	617004	AD	3
615573	19q13.2	Nephrotic syndrome, type 9	615573	AR	3
617282	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
615589	1q41-q44	Otosclerosis 10	615589	AD	2
616559	14q21.3	Noonan syndrome 9	616559	AD	3
615534	3q13.33	Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3
615830	19p13	Pigmented nodular adrenocortical disease, primary, 4	615830	AD	4
612163	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
616186	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
616284	1q21.3	Peeling skin syndrome 6	618084	AR	3
613216	15q13.3	Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	_	3
614744	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
617069	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
614925	12q21.31	Deafness, autosomal recessive 84B	614944	AR	3
616661	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3
615486	12q13.3	Interstitial lung and liver disease	615486	AR	3
616037	19p13.2	Ciliary dyskinesia, primary, 30	616037	AR	3
615944	11q13.4	Orofaciodigital syndrome XIV	615948	AR	3
616209	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
613330	4p15.33	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3
614459	11q12.2	Joubert syndrome 16	614465	AR	3
613388	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
617213	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
615960	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
617141	11p13	?Aniridia 2	617141	AD	3
616789	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
616260	18q12.1	Tenorio syndrome	616260	AD	3
615577	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
615553	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
616432	19p13.2	Retinitis pigmentosa 78	617433	AR	3
616187	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
615278	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
615979	16q24.2	?Mental retardation, autosomal recessive 45	615979	AR	3
617046	6p25.1	Spastic paraplegia 77, autosomal recessive	617046	AR	3
611669	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
615910	13q34	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3
614417	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
617070	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
614530	12q22	?Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3
616758	1p36.11	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3
613353	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
614336	16p13.3	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3
616910	2q31.1	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3
616858	20p11.23	?Cowden syndrome 7	616858	AD	3
615590	15q21.3	{Alzheimer disease 18, susceptibility to}	615590	_	3
617352	20q11-q13	Mulchandani-Bhoj-Conlin syndrome	617352	_	3
616261	7q22.3	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3
616651	2q14.2	Roifman syndrome	616651	AR	3
612164	9q34.11	Epileptic encephalopathy, early infantile, 4	612164	AD	3
612593	6p21.33	{Lung cancer susceptibility 4}	612593	_	2
617300	7q22.1	Lymphatic malformation 7	617300	AD	3
616739	2q22.1	Mental retardation, autosomal recessive 51	616739	AR	3
615919	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
615554	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
615792	13q14.2	{Thiopurines, poor metabolism of, 2}	616903	AD	3
616631	1q22	Porokeratosis 9, multiple types	616631	AD	3
615980	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
615279	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
616482	4p16.3	SADDAN	616482	AD	3
615911	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
616705	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
614512	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
613073	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
614077	19q13.32	Hermansky-Pudlak syndrome 8	614077	AR	3
614745	15q24.1	[Blood group, John-Milton-Hagen system]	614745	_	3
613217	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
615945	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
614900	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
615961	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
616687	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
616286	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
616188	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
616038	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
616963	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
617142	11p13	?Aniridia 3	617142	AD	3
615591	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
613440	2q37.1	{Stature QTL 21}	613440	_	2
616663	17p13.1	Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3
617123	1p34.1	Retinitis pigmentosa 76	617123	AR	3
616652	17p12-p11.2	Yuan-Harel-Lupski syndrome	616652	AD	4
615863	8q24.3	?Diarrhea 7, protein-losing enteropathy type	615863	AR	3
617353	3q29	Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3
616894	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
610436	18q22.2	Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3
616859	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
617159	12p13.31	Sifrim-Hitz-Weiss syndrome	617159	AD	3
614337	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
617387	3p21.31	Ververi-Brady syndrome	617982	AD	3
617404	17p13.3	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3
617284	19q13.12	Dystonia 28, childhood-onset	617284	AD	3
616632	5q31.3	Seizures, cortical blindness, microcephaly syndrome	616632	AR	3
615981	16q13	Bardet-Biedl syndrome 2	615981	AR	3
615280	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
616483	2p24.3	Infantile liver failure syndrome 2	616483	AR	3
617047	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
612165	4q32-q34	Retinitis pigmentosa 29	612165	AR	2
617478	14q22.3	Structural heart defects and renal anomalies syndrome	617478	AR	3
616777	3p21.31	Seckel syndrome 9	616777	AR	3
615095	20q13.12	Microcephaly 10, primary, autosomal recessive	615095	AR	3
617301	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
616875	1p36.13	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3
615831	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
614752	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
614078	8q12.1	Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3
616335	15q15.3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3
614647	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
614028	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
613778	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
614926	5q31.3	?Perrault syndrome 2	614926	AR	3
615555	5p13.2	Hyperprolactinemia	615555	AR,AD	3
615774	11q12.2	Oocyte maturation defect 1	615774	AR	3
614901	16p11.2	Branched-chain ketoacid dehydrogenase kinase deficiency	614923	_	3
617424	1q42.11-q42.12	Skraban-Deardorff syndrome	617616	AD	3
616287	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
617086	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
614746	19q13	[Uric acid concentration, serum, QTL5]	614746	_	2
613074	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
615592	8p11.21	Immunodeficiency 15B	615592	AR	3
615946	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
617143	2q12.3	Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3
614418	8q13.2	Febrile seizures, familial, 11	614418	AR	3
616521	2p25.3	Mental retardation, autosomal dominant 39	616521	AD	3
613441	22q12.2	Transcobalamin II deficiency	275350	AR	3
617441	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
612594	10p15.1	{Multiple sclerosis, susceptibility to, 2}	612594	_	2
614461	6p21.31	Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3
613138	7q31.31	Exudative vitreoretinopathy 5	613310	AD	3
616860	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
617336	10q21.3	Nemaline myopathy 11, autosomal recessive	617336	AR	3
616740	3q29	Immunodeficiency 46	616740	AR	3
615281	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
613218	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
617531	19p13.11	Brain small vessel disease 3	618360	AR	3
617072	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
616562	16q13	Retinitis pigmentosa 74	616562	AR	3
616538	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
616211	16q23.1-q23.2	Epileptic encephalopathy, early infantile, 28	616211	AR	3
614338	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
617217	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
615074	1q21.3	Mental retardation, autosomal dominant 18	615074	AD	3
617388	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
616500	2q11.2	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3	616500	AR	3
614927	10q24.32-q25.1	Ectodermal dysplasia 5, hair/nail type	614927	AR	2
617405	3q29	Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3
616688	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3
616827	2q14.3	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3
614747	1q21.1	[Uric acid concentration, serum, QTL6]	614747	_	2
613791	1p36.22	MASP2 deficiency	613791	AR	3
617302	10p12.1	?Optic atrophy 11	617302	AR	3
612595	5p13.2	{Multiple sclerosis, susceptibility to, 3}	612595	_	2
614419	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
617425	8p21.1	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3
611672	17q11.2	Folate malabsorption, hereditary	229050	AR	3
617087	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
615182	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
616418	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
617125	14q31.3	Mental retardation, autosomal recessive 56	617125	AR	3
617442	6p21.33	?Premature ovarian failure 13	617442	AR	3
617532	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
617619	1q22	Myopathy, mitochondrial, and ataxia	617675	AR,AD	3
615593	1p36.33	?Immunodeficiency 16	615593	AR	3
616435	1q32.1	Fanconi anemia, complementation group T	616435	AR	3
614462	4p14	Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3
615282	2q23.1-q23.2	Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3
616170	4q28.2	Macular dystrophy with central cone involvement	616170	AR	3
617480	9q33.3	46, XX sex reversal 4	617480	AD	3
617389	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
614080	18q21.33	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3
616501	1q42.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	616501	AR	3
614928	17p12-q21.2	Ectodermal dysplasia 6, hair/nail type	614928	AR	2
617218	12q21.32	Lissencephaly 8	617255	AR	3
615490	4q31.3	Charcot-Marie-Tooth disease, type 2R	615490	AR	3
617406	8q22.1	Bardet-Biedl syndrome 21	617406	AR	3
615075	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
616896	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
616212	16q21	Lissencephaly 6, with microcephaly	616212	AR	3
615833	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
614748	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
617232	3q13.33	?Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3
614514	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
613354	9q34.3	Deafness, autosomal recessive 79	613307	AR	3
614420	3p14.3	Systemic lupus erythematosus 16	614420	AR	3
613615	1q43-q44	Senior-Loken syndrome 7	613615	_	3
615471	6q16.1-q16.2	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3
612596	1p36	{Multiple sclerosis, susceptibility to, 4}	612596	_	2
613792	3pter-p25	3p- syndrome	613792	AD	4
617319	19p13.11	Anterior segment dysgenesis 8	617319	AR	3
617088	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
616539	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
617514	16p11.2	Immunodeficiency 52	617514	AR	3
613075	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
617637	11p15.5	Deafness autosomal recessive 106	617637	AR	3
616436	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
617443	11q24.3	Bleeding disorder, platelet-type, 21	617443	AR,AD	3
617145	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
615328	13q14.11	Shaheen syndrome	615328	AR	3
615962	5q31.3	Glucocorticoid resistance	615962	AD	3
617219	19q13.11	Chromosome 19q13.11 deletion syndrome, proximal	617219	AD	4
617585	19q13.32	?Immunodeficiency 53	617585	AR	3
617765	1q42.3	?Immunodeficiency, common variable, 14	617765	AD	3
615491	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
617730	20q13.12	Galloway-Mowat syndrome 4	617730	AR	3
613616	10q24.2	Hyperoxaluria, primary, type III	613616	_	3
613355	17q23.1-q23.2	Chromosome 17q23.1-q23.2 deletion syndrome	613355	IC	4
615777	16p12.3	Desbuquois dysplasia 2	615777	AR	3
614340	15q26.3	Mental retardation, autosomal recessive 27	614340	AR	3
615947	8q24.3	Hyperlipoproteinemia, type 1D	615947	AR	3
615866	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
615834	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
617800	3q23	?Microcephaly 19, primary, autosomal recessive	617800	AR	3
617481	1q21.3	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3
617713	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
616502	1p13.3	Cone-rod dystrophy 21	616502	AR	3
615535	19q13.12	Deafness, autosomal recessive 76	615540	AR	3
613444	16p11.2	Chromosome 16p11.2 deletion syndrome, 220kb	613444	_	4
613444	16p11.2	[Body mass index QTL16]	613444	_	4
616863	16p13.2	Chromosome 16p13.2 deletion syndrome	616863	AD	4
616878	22q11.21	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3
617659	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
616244	7p11.2	Parkinson disease 22, autosomal dominant	616710	AD	3
616828	2q21.1	Congenital disorder of glycosylation, type IIo	616828	AR	3
617320	19p13.12	Ichthyosis, congenital, autosomal recessive 12	617320	AR	3
615963	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
616689	19q13.31	Dehydrated hereditary stomatocytosis 2	616689	AD	3
616437	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
616486	1p34.2	Microcephaly 15, primary, autosomal recessive	616486	AR	3
617220	12p12.1	Myopathy, myofibrillar, 8	617258	AR	3
617675	1q22	Myopathy, mitochondrial, and ataxia	617675	AR,AD	3
614515	17q12	Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3
617731	2p13.1	Galloway-Mowat syndrome 5	617731	AR	3
615595	6p25.1	?Combined oxidative phosphorylation deficiency 19	615595	AR	3
617146	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
613076	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
614422	12q24.2-q24.3	Cataract 37, autosomal dominant	614422	AD	2
617182	15q21.2	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182	AR	3
617782	18q11.1-q11.2	Renal hypodysplasia/aplasia 3	617805	AD	3
617922	4q31.21	[Blood group, MNSs system]	111300	_	3
617922	4q31.21	{Malaria, resistance to}	611162	_	3
616214	11p15.5	Hyperproinsulinemia	616214	AD	3
614341	17p13.2-p13.1	Mental retardation, autosomal recessive 33	614341	AR	2
613793	1q32.2	[Blood group Cromer]	613793	AR	3
617408	17q21.31	?Diamond-Blackfan anemia 16	617408	AD	3
617698	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
615473	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
615948	11q13.4	Orofaciodigital syndrome XIV	615948	AR	3
617006	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
617321	16q12.1	{Yao syndrome}	617321	Mu	3
614649	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
616829	17q11.2	Congenital disorder of glycosylation, type IIp	616829	AR	3
617090	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
616690	1p36.32	Joubert syndrome 25	616781	AR	3
617660	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
616487	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
616503	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
615330	1q42.13	Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3
616540	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
617783	19p13.2	Nephrotic syndrome, type 16	617783	AR	3
616636	12q13.3	Immunodeficiency 44	616636	AR	3
617767	13q21.3-q22.1	Joubert syndrome 33	617767	AR	3
617183	1p36.33	Harel-Yoon syndrome	617183	AR,AD	3
615557	1q41	{Melioidosis, susceptibility to}	615557	_	3
614342	6q12-q15	Mental retardation, autosomal recessive 30	614342	AR	2
617871	14q24.3	?Retinitis pigmentosa 81	617871	AR	3
615493	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
617980	11p15.4	Erythrocytosis 6	617980	_	3
617466	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
618049	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
617412	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
616215	11p11.2	Osteogenesis imperfecta, type XVI	616229	AR	3
615407	16q13	Retinitis pigmentosa with or without situs inversus	615434	AR	3
616289	22q13.2	?Optic atrophy 9	616289	AR	3
616830	22q11.21	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3
615949	17q11.2	Nanophthalmos 4	615972	AD	3
617768	7q36.1	Kleefstra syndrome 2	617768	AD	3
616488	9q34.12	Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3
618126	12p13.31	?Liddle syndrome 3	618126	AD	3
618143	17q11.2	Glycosylphosphatidylinositol biosynthesis defect 18	618143	AR	3
615537	15q21.3	Reticulate acropigmentation of Kitamura	615537	AD	3
617638	7p22.2	Immunodeficiency 11B with atopic dermatitis	617638	AD	3
614423	2q33.1	Joubert syndrome 14	614424	AR	3
617802	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
617904	9q22.33	Epileptic encephalopathy, early infantile, 59	617904	AD	3
616339	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
617836	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
617872	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
617570	3q22.3	Polycystic kidney disease 5	617610	AR	3
616911	10q23.33	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3
616439	12q14.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3
618067	14q32.33	Epileptic encephalopathy, early infantile, 66	618067	AD	3
615950	2q35	Centronuclear myopathy 5	615959	AR	3
618050	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
616638	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
617516	17q24.2	Stankiewicz-Isidor syndrome	617516	AD	3
617602	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
614749	9p13.3	Hyperphosphatasia with mental retardation syndrome 2	614749	AR	3
615494	21q22.11	Ciliary dyskinesia, primary, 26	615500	AR	3
617941	15q25.2	Shwachman-Diamond syndrome 2	617941	AR	3
615332	1q42.3	?Immunodeficiency, common variable, 14	617765	AD	3
618015	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
616059	22q13.1	?Mirror movements 3	616059	AR	3
613446	5q23.2	Joubert syndrome 31	617761	AR	3
613446	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
616247	14q32.11	Long QT syndrome 14	616247	AD	3
618182	17q23.3	Orthostatic hypotension 2	618182	AR	3
617784	16q23.1	?Fanconi anemia, complementation group W	617784	AR	3
617639	17q25.1	Deafness, autosomal recessive 107	617639	AR	3
616489	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
618051	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
616389	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
618307	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
616639	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
617184	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
615796	2q32.1	Spermatogenic failure 34	618153	AR	3
618273	19p13.13	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3
616897	4p15.32	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3
614033	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
616216	12p13.2	Thrombocytopenia 5	616216	AD	3
618165	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
618331	16q24.3	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3
615408	10p12.1	Ciliary dyskinesia, primary, 23	615451	AR	3
617008	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
616881	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
616541	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
618016	1p21.1	?Growth hormone deficiency, isolated, type V	618160	AR	3
615969	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
617303	12q24.31	Mucopolysaccharidosis-plus syndrome	617303	AR	3
618183	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
616490	14q23.1	Joubert syndrome 23	616490	AR	3
616340	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
617468	19q13.12	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	617468	AR	3
616248	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
616640	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
617873	1p34.2	Combined oxidative phosphorylation deficiency 35	617873	AR	3
618367	15q25.1	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3
618384	20q13.12	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3
616806	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
615495	2q35	Alacrima, achalasia, and mental retardation syndrome	615510	AR	3
618128	1p12	Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3
618332	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
618481	17q12	?Deafness, autosomal recessive 99	618481	_	3
616217	6p22.3	Nephronophthisis 19	616217	AR	3
617661	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
615970	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
618406	18q21.32	Obesity (BMIQ20)	618406	_	3
616291	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
617874	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
614750	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
615951	5q12.1	Acromelic frontonasal dysostosis	603671	AD	3
615951	5q12.1	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3
618275	21q22.3	Hypotrichosis 14	618275	AR	3
617304	19p13.3	Retinitis pigmentosa 77	617304	AR	3
616913	17q12	Bleeding disorder, platelet-type, 20	616913	AD	3
617537	6p22.2	Rahman syndrome	617537	AD	3
616491	17q21.2	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3
618422	5q21.1	Deafness, autosomal recessive 100	618422	AR	3
616341	21q22.3	Epileptic encephalopathy, early infantile, 30	616341	AD	3
617323	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
616866	15q22.31	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3
618333	22q13.2	Menke-Hennekam syndrome 2	618333	_	3
617186	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
617641	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
616564	22q11.21	Noonan syndrome 10	616564	AD	3
616390	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
617538	15q25.2	Shwachman-Diamond syndrome 2	617941	AR	3
616249	2p21	Long QT syndrome 15	616249	AD	3
617839	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
616060	12p12.3	[Blood group, Dombrock]	616060	_	3
616914	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
618129	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
617662	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
617982	3p21.31	Ververi-Brady syndrome	617982	AD	3
616441	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
617604	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
617519	19q13.2	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3
614518	7q21.2	?Cardiomyopathy, dilated, 2B	614672	AR	3
618252	10q24.31	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3
616882	1p36.23	?Advanced sleep phase syndrome, familial, 3	616882	AD	3
618103	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
618350	7q22.1	?Microcephaly 25, primary, autosomal recessive	618351	AR	3
617642	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
617875	11q13.2	Polycystic liver disease 4 with or without kidney cysts	617875	AD	3
617222	4q24	Sudden cardiac failure, infantile	617222	AR	3
615952	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
616842	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
617907	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
617605	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
616898	15q14	Chromosome 15q14 deletion syndrome	616898	AD	4
617663	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
617520	4q21.23	?Microcephaly 18, primary, autosomal dominant	617520	AD	3
617983	12p13.31	?Microcephaly 21, primary, autosomal recessive	617983	AR	3
618351	7q22.1	?Microcephaly 25, primary, autosomal recessive	618351	AR	3
616342	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
618276	9q21.33	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3
616566	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
618424	6q21	Spermatogenic failure 38	618433	AR	3
616809	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
616843	16q24.3	Lymphatic malformation 6	616843	AR	3
615076	20p11.23	Mitochondrial DNA depletion syndrome 11	615084	AR	3
617984	11q25	Microcephaly 22, primary, autosomal recessive	617984	AR	3
618291	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3
617223	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
618429	3p22.2	Spermatogenic failure 37	618429	AR	3
615410	6q14.2	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3
618369	1p12	Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3
618201	3p22.1	Epileptic encephalopathy, early infantile, 68	618201	AR	3
618036	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
617985	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
617820	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
615596	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
617162	19q13.33	Epileptic encephalopathy, early infantile, 46	617162	AD	3
617452	8q21.3	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3
617571	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
616899	4q24	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3
615953	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
618462	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
618353	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
618430	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
618410	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
617787	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
617963	14q32.33	?Spermatogenic failure 30	618110	AR	3
617717	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
616568	7q31.33	{Glioma susceptibility 9}	616568	AD	3
617606	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
618253	22q13.2	Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3
617360	7p14.1	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3
615954	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
618292	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
618018	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
616867	10q22.1	?Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3
618431	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
617821	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
616062	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
618354	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
616900	4q24	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3
618464	17p13.2	Paragangliomas 6	618464	AD	3
615972	17q11.2	Nanophthalmos 4	615972	AD	3
618106	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
617718	7q22.1	Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease	617718	AR	3
616321	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
617964	7p21.3	Leukodystrophy, hypomyelinating, 16	617964	AD	3
618019	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
617607	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
617804	3p21.31	Neurodevelopmental disorder with severe motor impairment and absent language	617804	AD	3
616887	2q11.2	?Mental retardation, autosomal recessive, 52	616887	AR	3
617788	11q13.2	Mental retardation, autosomal dominant 51	617788	AD	3
615597	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
616868	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
617840	1p34.2	Combined oxidative phosphorylation deficiency 35	617873	AR	3
616322	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
618107	17q21.31	Osteopetrosis, autosomal dominant 3	618107	AD	3
618086	14q21.2	Spermatogenic failure 28	618086	AR	3
616063	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
618204	8p11.21	Immunodeficiency 15A	618204	AD	3
618482	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
616811	22q12.3	?Combined oxidative phosphorylation deficiency 29	616811	AR	3
617923	4q31.21	[Blood group, Ss]	111740	_	3
617923	4q31.21	{Malaria, resistance to}	611162	_	3
616345	11p15.5	?Immunodeficiency 39	616345	AR	3
613360	1p13.3	Cone-rod dystrophy 21	616502	AR	3
617719	17q25.3	Epiphyseal dysplasia, multiple, 7	617719	AR	3
618218	12q21.2	Baker-Gordon syndrome	618218	AD	3
618184	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
618087	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
615598	18q21.33	Palmoplantar keratoderma, Nagashima type	615598	AR	3
616812	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
617924	6p12.1	{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3
615870	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
618108	6p25.2	Immunodeficiency 57	618108	AR	3
617681	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
617225	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
618088	14q24.3	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3
618185	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
618219	8q22.1	?Polydactyly, postaxial, type A9	618219	AR	3
616294	4q26	Cole-Carpenter syndrome 2	616294	AR	3
616393	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
618205	17p13.1	Snijders Blok-Campeau syndrome	618205	AD	3
614204	2q14.1	Psoriasis 14, pustular	614204	AR	3
617706	16p13.3	?Spermatogenic failure 22	617706	AR	3
616890	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
618315	9q33.3	?Diamond-Blackfan anemia 19	618312	_	3
618073	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
617608	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
615080	6p21.2	Alzheimer disease 17	615080	_	2
618432	11q13.2	Hydatidiform mole, recurrent, 4	618432	_	3
618220	16q22.2	Retinitis pigmentosa 84	618220	AR	3
617911	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
618186	17q21.2	Hypomyelinating neuropathy, congenital, 3	618186	AR	3
618109	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
617721	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
616400	17p13.2	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3
618021	8q23.1	Tetraamelia syndrome 2	618021	AR	3
617925	4q28.1	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3
614205	19q13.32	3-M syndrome 3	614205	AR	3
618433	6q21	Spermatogenic failure 38	618433	AR	3
617592	10q25.1	Spermatogenic failure 19	617592	AR	3
615081	17q21.2	Spermatogenic failure 11	615081	AD	3
617912	20q13.33	Congenital heart defects, multiple types, 5	617912	AR,AD	3
617364	14q12	Congenital heart defects and ectodermal dysplasia	617364	AD	3
618077	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
617822	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
616871	5q35.3	{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3
616323	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
618434	11q14.1	?Deafness, autosomal recessive 94	618434	AR	3
618316	17q25.1	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3
617707	17q22	?Spermatogenic failure 23	617707	AR	3
615082	6p22.1	[C3HEX, ability to smell]	615082	AD	3
617609	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
617686	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
616697	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
618110	14q32.33	?Spermatogenic failure 30	618110	AR	3
618221	12p13.32	Mental retardation, autosomal recessive 66	618221	AR	3
617926	4q28.1	?Orofaciodigital syndrome XVII	617926	AR	3
616402	1p21.2	?Microcephaly 14, primary, autosomal recessive	616402	AR	3
618187	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
617610	3q22.3	Polycystic kidney disease 5	617610	AR	3
618089	2p16.3	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3
616814	19p13.3	Preimplantation embryonic lethality	616814	AR	3
618435	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
618443	16p13.3	Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3
617687	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
618022	8q23.1	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3
617593	3q13.2	?Spermatogenic failure 20	617593	AR	3
617927	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
615922	9q32	Retinitis pigmentosa 70	615922	AD	3
618317	9p13.3	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3
618436	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
618090	2q31.1	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3
616815	17q11.2	Congenital disorder of glycosylation, type IIp	616829	AR	3
618188	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
618222	11q13.2	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3
617709	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
618091	4q12	?Spermatogenic failure 29	618091	AR	3
617825	22q11.21	?Glucocorticoid deficiency 5	617825	AR	3
617710	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
616846	1p36.13	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3
618223	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
614424	2q33.1	Joubert syndrome 14	614424	AR	3
617164	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
617928	2q21.1	Keratoconus 9	617928	AD	3
615923	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
618189	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
617690	9q34.3	Ovarian dysgenesis 5	617690	AR	3
617929	6p21.1	Epileptic encephalopathy, early infantile, 60	617929	AR	3
617965	14q32.2	?Spermatogenic failure 27	617965	AR	3
618092	14q32.2	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3
617691	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
617711	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
615924	11q12.3	Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3
618447	12p13.33	Long QT syndrome 8	618447	_	3
618437	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
617930	1p35	Chromosome 1p35 deletion syndrome	617930	AD	4
618093	16p13.3	?Spinocerebellar ataxia 48	618093	AD	3
617460	10q22.1	Retinitis pigmentosa 79	617460	AD	3
614207	11p15.4	Hyperphosphatasia with mental retardation syndrome 3	614207	AR	3
617712	7q11.23	Oocyte maturation defect 3	617712	AD	3
618438	15q15.1	?Spastic ataxia 9, autosomal recessive	618438	AR	3
617931	1p35.2	Spinocerebellar ataxia 47	617931	AD	3
618094	14q12	?Deafness, autosomal recessive 110	618094	AR	3
614426	8p12	Mental retardation, autosomal recessive 39	615541	AR	3
618112	16q22.2	Spermatogenic failure 31	618112	AR	3
617166	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
618321	13q34	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3
614464	7q32.2	Joubert syndrome 15	614464	AR	3
614427	18q22.3	Aural atresia, congenital	607842	AD	3
618193	6p21.1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	_	3
616654	12q24.31	Joubert syndrome 24	616654	AR	3
618027	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
616254	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
618440	11p15.1	Oculoskeletodental syndrome	618440	AR	3
614218	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
614218	17p13.3	Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3
618323	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
618095	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
617694	16q24.3	Al Kaissi syndrome	617694	AR	3
617933	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
618120	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
617695	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
617306	3p13	COMMAD syndrome	617306	AR	3
618469	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
617913	17p13.3	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3
614219	19p13.2	Adams-Oliver syndrome 2	614219	AR	3
618096	14q21.2	?Premature ovarian failure 15	618096	AR	3
614465	11q12.2	Joubert syndrome 16	614465	AR	3
618470	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
617308	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
614220	7q32	Biliary cirrhosis, primary, 4	614220	_	2
614466	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
614221	17q12	Biliary cirrhosis, primary, 5	614221	_	2
617330	10q26.3	Hypotonia, ataxia, and delayed development syndrome	617330	AD	3
618123	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
618224	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
616039	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
614222	10p12.1	Warburg micro syndrome 3	614222	AR	3
618124	21q22.3	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3
613339	10q21.3-q22.3	Epilepsy, hot water, 1	613339	AD	2
614223	19p13.2	Narcolepsy 6	614223	_	2
618225	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
618195	15q24.3	Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3
616324	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
616067	8q23.1	46XY sex reversal 9	616067	AD	3
614224	4q12	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3
616325	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
618196	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
617967	17p13.3	Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3
616040	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
618449	17q12	?Ciliary dyskinesia, primary, 41	618449	AR	3
617011	15q22.31	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3
618197	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
616326	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
614225	1q41	Warburg micro syndrome 2	614225	AR	3
617333	3p25.3	Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3
616917	4p16.3	Mental retardation, autosomal recessive 53	616917	AR	3
614226	11q24.2	Holoprosencephaly 11	614226	AD	3
616327	13q34	Mental retardation, autosomal dominant 40	616579	AD	3
618198	15q23	Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3
616918	4p16.3	Mental retardation, autosomal recessive 53	616917	AR	3
617970	1p36.11	Rh-null disease, amorph type	617970	_	3
614227	2p22.1-p21	Hyperuricemic nephropathy, familial juvenile, 3	614227	AD	2
617013	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
616042	6p21.1	?Deafness, autosomal recessive 103	616042	AR	3
618226	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
616069	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
618031	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
614228	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
618227	11p15.5	Ciliary dyskinesia, primary, 39	618254	AR	3
614229	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
614230	8q21.11	Chromosome 8q21.11 deletion syndrome	614230	IC,AD	4
618451	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
618228	1q23.3	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3
618229	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
618231	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
618453	7p22.1	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3
618454	7q22.1	Developmental delay with or without dysmorphic facies and autism	618454	AD	3
618455	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
617612	2q37.1	Joubert syndrome 30	617622	AR	3
618232	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
617613	9q21.33	Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3
614082	9p13.3	Fanconi anemia, complementation group G	614082	_	3
618233	5q12.1	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3
614083	2p16.1	Fanconi anemia, complementation group L	614083	AR	3
618234	15q15.1	Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3
617475	17q23.3	Specific granule deficiency 2	617475	AR	3
616404	2p11.2	Acrofacial dysostosis, Cincinnati type	616462	AD	3
616050	2p22.3	Autoinflammation with infantile enterocolitis	616050	AD	3
616051	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
616052	7p21.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3
614084	7q34	Oocyte maturation defect 5	617996	AR	3
618475	14q24.3	Paragangliomas 7	618475	AD	3
618476	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
618477	15q25.3	[Uridine-cytidineuria]	618477	AR	3
618479	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
618480	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
603859	7q21.3	Citrullinemia, adult-onset type II	603471	AR	3
603859	7q21.3	Citrullinemia, type II, neonatal-onset	605814	AR	3
606202	5p13.2	Albinism, oculocutaneous, type IV	606574	_	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	AR	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	AR	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	AR	3
605225	1p36	{Inflammatory bowel disease 7}	605225	_	2
604584	8p22	Colorectal cancer, somatic	114500	_	3
604584	8p22	Hepatocellular cancer, somatic	114550	_	3
607036	15q15.1	Isovaleric acidemia	243500	AR	3
604004	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603848	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
604983	17q23.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3
607072	3p21.31	Epilepsy, familial focal, with variable foci 2	617116	AD	3
603694	20q12-q13.1	{Diabetes mellitus, noninsulin-dependent}	125853	AD	2
604499	11p	Hyperlipidemia, combined, 2	604499	_	2
607250	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
604566	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
605236	4p12	Preeclampsia/eclampsia 5	614595	_	3
606236	17q25.3	Alveolar soft-part sarcoma	606243	_	3
603113	11q23.1	Lung cancer, somatic	211980	_	3
606608	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
607292	1q22	Cone-rod dystrophy 10	610283	AR	3
607292	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
606960	22q12.1-q12.2	Insulinoma	_	_	1
603707	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
607131	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
603495	19q13.43	Spermatogenic failure 5	243060	AR	3
605725	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
605725	19q13.2	Dejerine-Sottas disease	145900	AR,AD	3
605425	1p34.3	Erythrokeratodermia variabilis et progressiva 2	617524	AD	3
606053	2q24.2	Intellectual developmental disorder with autism and speech delay	606053	AD	3
604286	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
604484	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
605383	16p12.1	Immunodeficiency 56	615207	AR	3
605383	16p12.1	[IgE, elevated level of]	147050	AD	3
606635	21q21.1	Enterokinase deficiency	226200	AR	3
607479	18p11.22	Hypotrichosis 1	605389	AD	3
604433	11q13.4	?Brugada syndrome 6	613119	_	3
606763	19q13.42	Ciliary dyskinesia, primary, 2	606763	AR	3
605275	22q11.21	Noonan syndrome 2	605275	AR	3
606686	12q24.31	Leukoencephalopathy with vanishing white matter	603896	AR	3
606425	1q42.2	Erythrocytosis, familial, 3	609820	AD	3
606425	1q42.2	[Hemoglobin, high altitude adaptation]	609070	AD	3
602926	9q34.11	Epileptic encephalopathy, early infantile, 4	612164	AD	3
605073	17q22	Mulibrey nanism	253250	AR	3
604973	1p36.11	Immunodeficiency due to ficolin 3 deficiency	613860	AR	3
607408	13q33.2	{Schizophrenia}	181500	AD	2
606985	11p13	?Aniridia 2	617141	AD	3
607037	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
606566	20q11.21	Cardiomyopathy, hypertrophic, 1, digenic	192600	AD	3
605286	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
605872	19p13.2	SARS infection, protection against	605872	_	2
604258	8p22	Colorectal cancer, somatic	114500	_	3
605226	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
605115	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
606077	1p13.3	Megakaryoblastic leukemia, acute	606077	_	2
607447	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
607623	18q11.2	Niemann-Pick disease, type C1	257220	AR	3
607623	18q11.2	Niemann-Pick disease, type D	257220	AR	3
607170	3p25.3	Atrioventricular septal defect, partial, with heterotaxy syndrome	606217	AD	3
607170	3p25.3	{Atrioventricular septal defect, susceptibility to, 2}	606217	AD	3
605543	4q22.1	Parkinson disease 4	605543	AD	3
604455	9q34.2	[Sarcosinemia]	268900	AR	3
607361	8q22.1	Meckel syndrome 3	607361	AR	3
605336	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AR,AD	3
605336	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
606609	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AR,AD	3
606609	3p21.31	Chilblain lupus	610448	AD	3
606609	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
606609	3p21.31	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
605755	6p22.3	?Deafness, autosomal recessive 66	610212	AR	3
605755	6p22.3	Nephronophthisis 19	616217	AR	3
605755	6p22.3	Sclerosing cholangitis, neonatal	617394	AR	3
605692	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
607143	22q13.33	Congenital disorder of glycosylation, type Ig	607143	AR	3
604485	15q23	Enhanced S-cone syndrome	268100	AR	3
604485	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
606974	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
605978	9q21.2	Choreoacanthocytosis	200150	AR	3
606367	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
607839	3p12.2	Glycogen storage disease IV	232500	AR	3
607839	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
604190	5q31.1	{Rheumatoid arthritis, susceptibility to}	180300	_	3
607084	9q32	Deafness, autosomal recessive 31	607084	AR	3
607236	20p13	HARP syndrome	607236	AR	3
603860	16p12.3	Medullary cystic kidney disease 2	603860	_	3
605564	15q25.1	Deafness, autosomal recessive 48	609439	AR	3
605564	15q25.1	Usher syndrome, type IJ	614869	AR	3
608031	20p13	Amyotrophic lateral sclerosis 7	608031	_	2
605254	1q23.2	Acne inversa, familial, 1	142690	AD	3
605726	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
606323	5q33.3	Epileptic encephalopathy, early infantile, 65	618008	AD	3
605158	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
604720	7q22.1	Hemochromatosis, type 3	604250	AR	3
607329	2p25-p24	{Hypertension, essential, susceptibility to, 3}	145500	Mu	2
607186	4q26	Cole-Carpenter syndrome 2	616294	AR	3
605526	10q24	Alzheimer disease 6	605526	_	2
604610	15q26.1	Bloom syndrome	210900	AR	3
603422	5q31.1	{Osteoporosis, susceptibility to}	166710	AD	3
603023	7p12.2	Immunodeficiency, common variable, 13	616873	AD	3
605325	7q22.1	{Hypertension, salt-sensitive essential, susceptibility to}	145500	Mu	3
606078	22q13.1-q13.2	Megakaryoblastic leukemia, acute	_	_	3
604500	17q12	PEHO syndrome	260565	AR	3
607252	22q12.3	{Schizophrenia}	181500	AD	1
603048	8q24.3	Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3
604032	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
608111	2p16.1	Fanconi anemia, complementation group L	614083	AR	3
607204	1p35.2	Spinocerebellar ataxia 47	617931	AD	3
606962	17q25.1	Deafness, autosomal recessive 107	617639	AR	3
605517	11q13.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3
605452	2q35	Dyschromatosis universalis hereditaria 3	615402	AD	3
605452	2q35	Microphthalmia, isolated, with coloboma 7	614497	AD	3
605452	2q35	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	3
605452	2q35	[Blood group, Langereis system]	111600	_	3
604360	15q21.1	Spastic paraplegia 11, autosomal recessive	604360	AR	3
608264	22q11.21-q12.1	Deafness, autosomal recessive 40	608264	AR	2
607215	1p36.31	Nephronophthisis 4	606966	AR	3
607215	1p36.31	Senior-Loken syndrome 4	606996	AR	3
608309	1p36.12	Parkinson disease 6, early onset	605909	AR	3
603131	7q22.1	Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3
607038	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
604288	2q14-q22	Cardiomyopathy, dilated, 1H	604288	_	2
606368	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
606368	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
608035	1p22	{Melanoma, cutaneous malignant, 4}	608035	_	2
605185	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
607900	20p12.3	Kindler syndrome	173650	AR	3
605411	1p13.2	Brugada syndrome 9	616399	AD	3
605411	1p13.2	Spinocerebellar ataxia 19	607346	AD	3
604975	12p12.1	Lamb-Shaffer syndrome	616803	AD	3
608156	8q22.1	Nablus mask-like facial syndrome	608156	AD	4
603967	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
603967	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
603967	17q23.3	Myasthenic syndrome, congenital, 16	614198	AR	3
603967	17q23.3	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3
603967	17q23.3	Paramyotonia congenita	168300	AD	3
607521	11p15.1	Hermansky-Pudlak syndrome 5	614074	AR	3
608205	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
607624	15q21.3	Griscelli syndrome, type 2	607624	AR	3
605100	17q23.2	Breast cancer, somatic	114480	_	3
605100	17q23.2	Jansen de Vries syndrome	617450	AD	3
607135	3p	Creatinine clearance QTL	607135	_	2
606324	1p36.23	Parkinson disease 7, autosomal recessive early-onset	606324	AR	3
604772	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
603861	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
604103	5q31.2	Myopathy, myofibrillar, 3	609200	AD	3
604103	5q31.2	Myopathy, spheroid body	182920	AD	3
605848	19p13.12	Ichthyosis, congenital, autosomal recessive 12	617320	AR	3
605124	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
603457	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
603474	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
605039	20q11.21	Bohring-Opitz syndrome	605039	AD	3
604900	8q24.3	?Diarrhea 7, protein-losing enteropathy type	615863	AR	3
606142	4p16.1	Hypouricemia, renal, 2	612076	AR,AD	3
606142	4p16.1	{Uric acid concentration, serum, QTL 2}	612076	AR,AD	3
607481	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
606882	13q14.3	Wilson disease	277900	AR	3
603767	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
604501	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
604501	15q22.31	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3
608078	10q22.3	{Schizophrenia}	181500	AD	2
605938	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
603615	1p34.1	Adenocarcinoma, colonic, somatic	_	_	3
603615	1p34.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
603615	1p34.1	{Breast cancer, invasive ductal}	114480	SMu,AD	3
603516	22q13.31	Spinocerebellar ataxia 10	603516	AD	3
605000	16p11.2	Immunodeficiency 8	615401	AR	3
608429	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
604705	2q13	Retinitis pigmentosa 38	613862	AR	3
606056	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
606963	2q	Pulmonary disease, chronic obstructive, severe early-onset	606963	_	2
606829	9q21.11	Friedreich ataxia	229300	AR	3
606829	9q21.11	Friedreich ataxia with retained reflexes	229300	AR	3
604990	17q25.1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3
603010	7q31	Deafness, autosomal recessive 17	603010	AR	2
606407	2p21	Hypotonia-cystinuria syndrome	606407	AR	4
604297	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
604297	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
608414	10q23.33	Nephrotic syndrome, type 3	610725	AR	3
605727	7q34-q36	Otosclerosis 2	605727	_	2
606568	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
608310	7q11.21	Argininosuccinic aciduria	207900	AR	3
603290	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
604457	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
604457	2q37.1	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
607901	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
606034	19p13.13	Aicardi-Goutieres syndrome 4	610333	AR	3
605544	5q13-q22	Fibromatosis, gingival, 2	605544	_	2
604841	1p21.1	Stickler syndrome, type II	604841	AD	3
606687	2p23.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606687	2p23.3	Ovarioleukodystrophy	603896	AR	3
606854	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
606639	3q25.32	Combined oxidative phosphorylation deficiency 1	609060	AR	3
608265	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
607039	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
608036	5q34-q35.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	2
604588	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	AR,DR	3
604588	4q33	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3
607625	14q24.3	Niemann-pick disease, type C2	607625	AR	3
604611	8p12	Werner syndrome	277700	AR	3
608371	4q21-q31	Orofacial cleft 4	608371	_	2
608533	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
605289	3q28	Split-hand/foot malformation 4	605289	AD	3
608112	3p22.1	Epileptic encephalopathy, early infantile, 68	618201	AR	3
604773	11q25	Isobutyryl-CoA dehydrogenase deficiency	611283	_	3
608241	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
606999	9p13.3	Galactosemia	230400	AR	3
608331	5q33.1	Hyperglycinuria	138500	AD	3
608331	5q33.1	Iminoglycinuria, digenic	242600	AR,DR	3
608283	12q12	Fibrosis of extraocular muscles, congenital, 1	135700	AD	3
608283	12q12	Fibrosis of extraocular muscles, congenital, 3B	135700	AD	3
605101	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
606988	15q15.1	?Spastic ataxia 9, autosomal recessive	618438	AR	3
608100	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
604901	16q22	North American Indian childhood cirrhosis	604901	_	2
606475	19p13.2	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	_	3
604289	8q22.1	Colon cancer, somatic	114500	_	3
604289	8q22.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
603056	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
608443	19p13.12	Mental retardation, autosomal recessive 3	608443	AR	3
607053	8q23	[High density lipoprotein cholesterol level QTL 2]	607053	_	2
604526	20p13	Retinitis pigmentosa 46	612572	_	3
605714	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
603517	1p22.3	?Immunodeficiency 37	616098	AR	3
603517	1p22.3	Lymphoma, MALT, somatic	137245	_	3
603517	1p22.3	{Lymphoma, follicular, somatic}	605027	_	3
603517	1p22.3	{Male germ cell tumor, somatic}	273300	_	3
603517	1p22.3	{Mesothelioma, somatic}	156240	_	3
603517	1p22.3	{Sezary syndrome, somatic}	_	_	3
606370	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
607482	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
607411	12q24	{Patent ductus arteriosus, susceptibility to}	607411	AR	2
606062	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
606640	18q21	Amyotrophic lateral sclerosis 3	606640	AD	2
606830	9q21.33	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3
606035	6q22-q24	[Fasting insulin level quantitative trait locus 1]	606035	_	2
605728	15q21-q22	Cataract 25	605728	_	2
603024	1p36.11	Coffin-Siris syndrome 2	614607	AD	3
608645	6p21.3	Deafness, autosomal dominant 31	608645	AD	2
607364	1p36.13	Bartter syndrome, type 3	607364	AR	3
607961	15q24.1	[Blood group, John-Milton-Hagen system]	614745	_	3
602959	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
602959	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
606144	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
608695	9q22	Glaucoma, primary open angle, juvenile-onset, 2	608695	_	2
606408	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
607040	16q12.1	[Axillary odor, variation in]	117800	AD	3
607040	16q12.1	[Colostrum secretion, variation in]	117800	AD	3
607040	16q12.1	[Earwax, wet/dry]	117800	AD	3
604159	11p15.1	Hyperekplexia 3	614618	AR,AD	3
606129	8p23.3-p22	Diamond-Blackfan anemia 2	606129	_	2
603850	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
603850	12p11.21	Optic atrophy 5	610708	AD	3
602935	1p33	{Drug addiction, susceptibility to}	606581	_	3
605849	5q14.1	Dimethylglycine dehydrogenase deficiency	605850	AR	3
606325	6q21	?Heterotaxy, visceral, 3, autosomal	606325	_	2
605290	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
605290	3q29	Behr syndrome	210000	AR	3
605290	3q29	Optic atrophy 1	165500	AD	3
605290	3q29	Optic atrophy plus syndrome	125250	AD	3
605290	3q29	{Glaucoma, normal tension, susceptibility to}	606657	_	3
608480	6p21.31	Spermatogenic failure 3	606766	AD	3
608271	1p34.3	Lissencephaly 9 with complex brainstem malformation	618325	AD	3
606883	12q12	Invasive pneumococcal disease, recurrent isolated, 1	610799	_	3
606883	12q12	IRAK4 deficiency	607676	_	3
604723	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
606476	19q13.2	{Kawasaki disease, susceptibility to}	611775	_	3
608010	7p13	[Ezetimibe, nonresponse to]	617966	_	3
608010	7p13	[Low density lipoprotein cholesterol level QTL 7]	617966	_	3
606551	8p21.3	Esophageal squamous cell carcinoma, somatic	133239	_	3
608633	11q22.3	{Sepsis, susceptibility to}	_	_	3
604902	14q32.33	Cerebellofaciodental syndrome	616202	AR	3
605267	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
607823	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
605361	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
608603	15q21.2	Lethal congenital contracture syndrome 11	617194	AR	3
603883	10q26.11	Cardiomyopathy, dilated, 1HH	613881	AD	3
603883	10q26.11	Myopathy, myofibrillar, 6	612954	AD	3
608723	6p24.1	Epileptic encephalopathy, early infantile, 70	618298	AD	3
607903	18q12.1	Hypotrichosis 6	607903	AR	3
606036	15q25.1	?Webb-Dattani syndrome	615926	AR	3
608390	17q23.3	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3
607136	6q27	Spinocerebellar ataxia 17	607136	AD	3
603057	11p15.4	Mitral valve prolapse 2	607829	AD	3
603057	11p15.4	Van Maldergem syndrome 1	601390	AR	3
603025	11q14.2	Leukemia, acute myeloid, somatic	601626	_	3
606831	2p22.3	?Familial cold autoinflammatory syndrome 4	616115	AD	3
606831	2p22.3	Autoinflammation with infantile enterocolitis	616050	AD	3
606641	7q32.3	[Body mass index QTL1]	606641	_	2
608177	8q24.11	Chondrosarcoma	215300	AR	3
608177	8q24.11	Exostoses, multiple, type 1	133700	AD	3
608646	15q13.1-q15.1	Ciliary dyskinesia, primary, 4	608646	_	2
607311	11q22.1	?Progesterone resistance	264080	AR	2
603254	19p13.2	Coffin-Siris syndrome 4	614609	AD	3
603254	19p13.2	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3
605850	5q14.1	Dimethylglycine dehydrogenase deficiency	605850	AR	3
607453	3q28	?Deafness, autosomal dominant 44	607453	AD	3
606269	22q13.2	Immunodeficiency, common variable, 4	613494	AR	3
606409	20q11.22	Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3
603769	14q32.13	Leukemia/lymphoma, T-cell	603769	_	2
607365	3q27.2	Hypotrichosis 7	604379	AR	3
607365	3q27.2	Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379	AR	3
603851	4p13	Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	AD	3
603851	4p13	Neuroblastoma with Hirschsprung disease	613013	_	3
603851	4p13	{Neuroblastoma, susceptibility to, 2}	613013	_	3
607626	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
608634	7q11.23	Neuropathy, distal hereditary motor, type IIB	608634	AD	3
603678	7q31	Deafness, autosomal recessive 14	603678	AR	2
608416	10q26.2	Heterotaxy, visceral, 7, autosomal	616749	AR	3
605670	11q23.3	Retinal degeneration, late-onset, autosomal dominant	605670	AD	3
605744	8p21.1	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3
605268	16q24.2	Huntington disease-like 2	606438	AD	3
606966	1p36.31	Nephronophthisis 4	606966	AR	3
606989	17q22	Myeloperoxidase deficiency	254600	AR	3
606989	17q22	{Alzheimer disease, susceptibility to}	104300	AD	3
606989	17q22	{Lung cancer, protection against, in smokers}	_	_	3
608256	11q23.3	Atrial fibrillation, familial, 17	611819	AD	3
608256	11q23.3	Long QT syndrome-10	611819	AD	3
607276	10q25.3	[Resting heart rate]	607276	_	3
606145	20q13.12	Arterial tortuosity syndrome	208050	AR	3
605362	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
607243	14q12	Spastic paraplegia 52, autosomal recessive	614067	AR	3
608243	15q13.1	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3
608391	Chr.7	{Autoimmune disease, susceptibility to, 2}	608391	_	2
607137	4q21.22	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3
603026	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
606326	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
606037	3q13.1-q13.2	C syndrome	211750	AD	3
606754	20q11.23	?Chilblain lupus 2	614415	AD	3
606754	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
608313	6q23.2	Argininemia	207800	AR	3
608696	20p12	Glaucoma 1K, primary open angle, juvenile-onset	608696	_	2
605555	11q13.2	Pituitary adenoma 1, multiple types	102200	SMu,AD	3
605555	11q13.2	Pituitary adenoma predisposition	102200	SMu,AD	3
607454	1p36.33	Spinocerebellar ataxia 21	607454	AD	3
604088	7p14.3	{Hypercholesterolemia, susceptibility to}	143890	AD	3
607042	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
608272	6p21.33	Sialidosis, type I	256550	AR	3
608272	6p21.33	Sialidosis, type II	256550	AR	3
608647	16q22.2	Ciliary dyskinesia, primary, 5	608647	AR	3
603258	8p11.21	Immunodeficiency 15A	618204	AD	3
603258	8p11.21	Immunodeficiency 15B	615592	AR	3
606570	7p14.1	Pyle disease	265900	AR	3
606781	3p21.1	Short stature, developmental delay, and congenital heart defects	617044	AR	3
607984	5q31.3	Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3
608565	14q24.3	Deafness, autosomal recessive 35	608565	AR	3
608980	9p22.3	Bifid nose with or without anorectal and renal anomalies	608980	_	3
608662	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
608662	11p14.3	Miyoshi muscular dystrophy 3	613319	AR	3
608662	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
606478	7q31.33	{Glioma susceptibility 9}	616568	AD	3
606478	7q31.33	{Melanoma, cutaneous malignant, susceptibility to, 10}	615848	AD	3
608380	2q31.3	Retinitis pigmentosa 26	608380	_	3
607008	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
603518	2p13.3	Welander distal myopathy	604454	AR,AD	3
609040	12p11.21	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3
604714	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
608536	19p13.11	Combined oxidative phosphorylation deficiency 23	616198	AR	3
608803	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608803	1q42.13	Lymphatic malformation 3	613480	AD	3
608803	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
606990	3q23	?Microcephaly 19, primary, autosomal recessive	617800	AR	3
605363	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
608392	Chr.8	{Autoimmune disease, susceptibility to, 3}	608392	_	2
606967	16q22.1	Fish-eye disease	136120	AR	3
606967	16q22.1	Norum disease	245900	AR	3
607244	15q21.2	Spastic paraplegia 51, autosomal recessive	613744	AR	3
607244	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
608744	1p13.3	Fontaine progeroid syndrome	612289	AD	3
606833	7q36.1	Kleefstra syndrome 2	617768	AD	3
608697	2p13.3	Premature ovarian failure 6	612310	AD	3
608611	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
605229	3q27-q28	Spastic paraplegia 14, autosomal recessive	605229	AR	2
603136	2q36.2	Pseudohypoaldosteronism, type IIE	614496	AD	3
608684	14q22.1	?Seckel syndrome 7	614851	AR	3
605988	10p13	Omenn syndrome	603554	AR	3
605988	10p13	Severe combined immunodeficiency, Athabascan type	602450	AR	3
603644	17p13.1	Mitochondrial complex IV deficiency	220110	Mi,AR	3
608918	17p11.2	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3
607277	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
607043	6q21	?Candidiasis, familial, 8	615527	AR	3
607043	6q21	{Psoriasis susceptibility 13}	614070	_	3
606373	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
606421	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
606271	1q42.2	Schizophrenia	181500	AD	2
607474	3q13.33	Alkaptonuria	203500	AR	3
606520	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
609247	3q25.1	Epileptic encephalopathy, early infantile, 73	618379	AD	3
606837	8q11.23	Breast cancer, somatic	114480	_	3
607009	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
604824	13q13.1	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	_	3
608663	12q12	Scott syndrome	262890	AR	3
603339	7p15.3	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3
606643	13q14	[Body mass index QTL2]	606643	_	2
608648	6q21	Polycystic liver disease 2	617004	AD	3
609141	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
606890	14q31.3	Krabbe disease	245200	AR	3
604715	16q12.2	?Orthostatic intolerance	604715	_	3
606834	19q13.12	Dystonia 28, childhood-onset	617284	AD	3
608445	3p12-q13	{Speech-sound disorder}	608445	_	2
607245	1p13.2	Spastic paraplegia 47, autosomal recessive	614066	AR	3
605588	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
605041	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
607840	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
607840	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
604757	5q35.2	Craniosynostosis 2	604757	AD	3
605032	4p16.3	Epileptic encephalopathy, early infantile, 63	617976	AR	3
609382	18q21.1	Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3
608526	1q25	Periodontitis, aggressive, 2	608526	_	2
608393	13q12.12-q12.13	Microcephaly 6, primary, autosomal recessive	608393	AR	3
607278	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
609302	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
609195	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
604487	11p15.1	Deafness, autosomal recessive 18B	614945	AR	3
608013	1q22	Gaucher disease, perinatal lethal	608013	AR	3
607475	15q26.1	Bothnia retinal dystrophy	607475	AR	3
608636	15q11	{Autism susceptibility 4}	608636	AD	2
608354	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
607323	20q13.2	Duane-radial ray syndrome	607323	AD	3
608194	14q11.2	Cone-rod dystrophy 13	608194	_	3
606628	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
609053	15q26.1	Fanconi anemia, complementation group I	609053	AR	3
605270	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
609628	18p11.31	Majeed syndrome	609628	_	3
608419	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
606480	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
606480	1p34.2	Restrictive dermopathy, lethal	275210	AR	3
604161	19p13.3	?Precocious puberty, central, 1	176400	AD	3
604161	19p13.3	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3
604758	19q13.32	?Immunodeficiency 53	617585	AR	3
608699	7p14.3	Diaphanospondylodysostosis	608022	AR	3
607279	11q14	{Systemic lupus erythematosus with hemolytic anemia}	607279	_	2
605589	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
603646	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
603646	10q24.2	Leigh syndrome due to cytochrome c oxidase deficiency	256000	Mi,AR	3
603424	2q31.2	Dystonia 16	612067	AR	3
607246	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
608897	17q25.1	Hemophagocytic lymphohistiocytosis, familial, 3	608898	_	3
605042	6q23.2	Mental retardation, autosomal recessive 18	614249	AR	3
609196	21q22.11	Glucocorticoid deficiency 2	607398	AR	3
609657	5q	{Bone size QTL}	609657	_	2
604488	17q12	Cardiomyopathy, hypertrophic, 25	607487	AD	3
604488	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
603060	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
609510	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
607476	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
609314	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
609449	16p13.11	?Microhydranencephaly	605013	AR	3
609449	16p13.11	Lissencephaly 4 (with microcephaly)	614019	AR	3
608572	18q23	Burn-McKeown syndrome	608572	AR	3
609750	10q25-q26	{Epilepsy, idiopathic generalized, susceptibility to 4}	609750	_	2
608804	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608990	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
608890	8q11.21	Waardenburg syndrome, type 2D	608890	AR	3
609332	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
608433	1q44	Mental retardation, autosomal dominant 22	612337	AD	3
605364	19p13	{Psoriasis susceptibility 6}	605364	_	2
609279	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
609279	13q12.12-q12.13	Microcephaly 6, primary, autosomal recessive	608393	AR	3
608151	4p14	?Cranioectodermal dysplasia 4	614378	AR	3
608151	4p14	?Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3
608151	4p14	Nephronophthisis 13	614377	AR	3
608151	4p14	Senior-Loken syndrome 8	616307	AR	3
606374	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
607324	19p13.2-p13.1	Polydactyly, postaxial, type A3	607324	_	2
609575	17p13.1	VLCAD deficiency	201475	AR	3
608665	17q21.2	Ovarian dysgenesis 3	614324	AR	3
609383	5q33.3	Ichthyosis, congenital, autosomal recessive 6	612281	AR	3
604759	12q23.2	Pregnancy loss, recurrent, 4	270960	AD	3
604759	12q23.2	Spermatogenic failure 4	270960	AD	3
609669	5q22.1	Glaucoma 1, open angle, G	609887	_	3
609237	3q13.33	Senior-Loken syndrome 5	609254	AR	3
608394	2p12	Deafness, autosomal dominant 43	608394	AD	2
607631	6p12.2	{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3
608649	9q34.11	Ichthyosis prematurity syndrome	608649	_	3
609435	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
609435	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
604717	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
606765	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
605602	4q26	Cardiomyopathy, hypertrophic, 16	613838	AD	3
603708	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
609528	22q11.21	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3
608022	7p14.3	Diaphanospondylodysostosis	608022	AR	3
608179	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
609695	12q24.31	Hawkinsinuria	140350	AD	3
609695	12q24.31	Tyrosinemia, type III	276710	AR	3
603647	2q35	Bjornstad syndrome	262000	AR	3
603647	2q35	GRACILE syndrome	603358	_	3
603647	2q35	Leigh syndrome	256000	Mi,AR	3
603647	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
609454	1q31.1	Supranuclear palsy, progressive, 2	609454	AD	2
609736	2p16.1	?PEHO syndrome-like	617507	AR	3
608700	1p36.22	Leber congenital amaurosis 9	608553	AR	3
605231	20p12.2	Bardet-Biedl syndrome 6	605231	AR	3
608014	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
608014	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
609197	8q11.2-q13.2	Glucocorticoid deficiency 3	609197	AR	2
606893	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
608805	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
609640	14q22.1-q22.3	Frias syndrome	609640	AD	4
608901	3q21.1-q21.2	{Coronary heart disease, susceptibility to, 5}	608901	_	3
608747	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
609670	11q24	{Migraine with aura, susceptibility to, 9}	609670	_	2
609280	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
608666	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
608666	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
604083	2q35	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3
603709	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
609988	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
609988	4q24	Sudden cardiac failure, infantile	617222	AR	3
608728	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
609529	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
608612	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
609751	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
610066	20q13	{Systemic lupus erythematosus, susceptibility to, 8}	610066	_	2
603266	10q25	{Diabetes mellitus, insulin-dependent, 17}	603266	_	2
606766	6p21.31	Spermatogenic failure 3	606766	AD	3
607248	15q23-q26.3	{Glioma susceptibility 4}	607248	_	2
607179	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
605232	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
605232	12p13.33	Pseudohypoaldosteronism, type IIC	614492	AD	3
608404	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
609346	19p13.3	Retinitis pigmentosa 77	617304	AR	3
608687	11q12	Spinocerebellar ataxia 20	608687	AD	4
604733	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
609512	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
609512	3p11.2	Dementia, familial, nonspecific	600795	AD	3
609289	15q26	Syncope, familial vasovagal	609289	AD	2
609630	11p11	{Leukemia, chronic lymphocytic, susceptibility to, 1}	609630	_	2
607326	18q21.1	Smith-McCort dysplasia	607326	AR	3
609502	10q23.1	Cone-rod dystrophy 15	613660	AR	3
609502	10q23.1	Retinitis pigmentosa 65	613660	AR	3
609671	2q14.2	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3
608667	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
608751	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AR,AD	3
609875	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
608922	3q11.1-q11.2	Joubert syndrome 8	612291	AR	3
610202	16q23.2	Cataract 21, multiple types	610202	AD	3
608892	8q12.2	CHARGE syndrome	214800	AD	3
608892	8q12.2	Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3
610034	12q24.31	Mucopolysaccharidosis-plus syndrome	617303	AR	3
610219	2q31.2	Deafness, autosomal recessive 59	610220	AR	3
609530	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
608447	12q24	Carotid intimal medial thickness	608447	_	2
609822	1p21	{Stature QTL 7}	609822	_	2
608180	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
610015	1q25.3	Glutamine deficiency, congenital	610015	AR	3
604364	22q12.2-q12.3	Epilepsy, familial focal, with variable foci 1	604364	AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal dominant	615625	AR,AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal recessive	615625	AR,AD	3
610239	4q32.3	[High density lipoprotein cholesterol level QTL 4]	610239	_	2
609317	5q22.3	?Anencephaly	206500	AR	3
610513	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
610513	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
610256	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
609787	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
603400	6q21	Arthropathy, progressive pseudorheumatoid, of childhood	208230	AR	3
603400	6q21	Spondyloepiphyseal dysplasia tarda with progressive arthropathy	208230	AR	3
610535	5q22.1-q32	Glaucoma 1, open angle, M	610535	AD	2
608668	10p15.3	Mental retardation, autosomal dominant 30	616083	AD	3
610475	2q31.2	Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3
608893	5p15.33	Hartnup disorder	234500	AR	3
608893	5p15.33	Hyperglycinuria	138500	AD	3
608893	5p15.33	Iminoglycinuria, digenic	242600	AR,DR	3
604982	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
608752	11q23.3	Retinal degeneration, late-onset, autosomal dominant	605670	AD	3
609886	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
610162	1p35.2	{Bardet-Biedl syndrome 1, modifier of}	209900	AR,DR	3
608614	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
610035	1q21.2	Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3
610220	2q31.2	Deafness, autosomal recessive 59	610220	AR	3
608688	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
604677	5q13.3	Mental retardation, autosomal dominant 34	616351	AD	3
610647	4p16.3	?N-acetylaspartate deficiency	614063	AR	3
609631	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
607632	19q13.12	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3
610271	17q11.2	Glycosylphosphatidylinositol biosynthesis defect 18	618143	AR	3
609823	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
610140	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
609470	11p15	Left ventricular noncompaction 2	609470	_	2
603401	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
603711	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
603711	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
608396	3q24	{?Autism susceptibility 16}	613410	_	3
605746	16q13-q21	Anisomastia	605746	_	2
610069	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
605235	16q22.1	?Myoclonus, familial, 1	614937	AD	3
610685	6q14.1	Split-hand/foot malformation with long bone deficiency 2	610685	_	2
610840	13q31.3-q32.1	Mitral valve prolapse, myxomatous 3	610840	AD	2
609006	1p36.31	Deafness, autosomal recessive 36	609006	AR	3
608730	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
610859	16q22.1	Immunodeficiency 58	618131	AR	3
610536	17q21.31	Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3
607841	12q13-q14	Deafness, autosomal dominant 48	607841	AD	2
610648	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
610662	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
610359	2q11.2	Retinitis pigmentosa 33	610359	AD	3
609439	15q25.1	Deafness, autosomal recessive 48	609439	AR	3
609577	6p21.1	3-M syndrome 1	273750	AR	3
608187	20p12.3	?Premature ovarian failure 10	612885	AR	3
610804	1p31.3	Schneckenbecken dysplasia	269250	AR	3
610017	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
610222	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
608652	9p22-p21	Deafness, autosomal dominant 47	608652	AD	2
610141	1q23.3	[QT interval, variation in]	610141	_	2
610272	20q13.12	?Paroxysmal nocturnal hemoglobinuria 2	615399	SMu,AD	3
610272	20q13.12	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3
609887	5q22.1	Glaucoma 1, open angle, G	609887	_	3
608691	15q25.3-q26.2	Major depressive disorder 2	608516	_	2
609952	4q12-q13.2	Deafness, autosomal recessive 55	609952	AR	2
608840	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	AR	3
609753	19p13.11	{Celiac disease, susceptibility to, 4}	609753	_	3
611023	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
607633	2p23.1	Xanthinuria, type I	278300	AR	3
609745	15q11-q13	Glaucoma 1, open angle, I	609745	_	2
609007	12q12	{Parkinson disease 8}	607060	AD	3
610649	8q24	[Bone size quantitative trait locus 3]	610649	_	2
609578	10q23.3	Cardiomyopathy, familial restrictive, 2	609578	_	2
611064	12q14.3	{Asthma susceptibility 5}	611064	_	3
611034	6p22.2	[Uric acid concentration, serum, QTL4]	612671	AD	3
611034	6p22.2	{Gout susceptibility 4}	612671	AD	3
603846	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
609888	10p13	{Leprosy, paucibacillary type, susceptibility to}	609888	_	2
608615	17q24.1	Oligodontia-colorectal cancer syndrome	608615	AD	3
610549	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
606075	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
606075	10q24.31	Perrault syndrome 5	616138	AR	3
606075	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
609471	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
610676	17q21	{Autism susceptibility 7}	610676	_	2
609754	5q31-q33	{Celiac disease, susceptibility to, 2}	609754	_	2
607634	11q13.2	Osteopetrosis, autosomal dominant 1	607634	AD	3
610290	9q22.33	{Colorectal cancer, susceptibility to, 1}	608812	_	3
610326	13q14.3	Aicardi-Goutieres syndrome 2	610181	AR	3
608841	19p13.11	Anterior segment dysgenesis 8	617319	AR	3
610071	2p14-p13.3	Hyperparathyroidism 3	610071	_	2
611065	4q22.1	?Maple syrup urine disease, mild variant	615135	_	3
609856	3q26.31	?Spermatogenic failure 6	102530	AR	3
608732	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
606164	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
611177	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
609981	8q11.21	Immunodeficiency 54	609981	AR	3
609755	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
611107	1p21.1-p13.3	Mental retardation, autosomal recessive, 4	611107	AR	2
610478	12p13.33	Retinal cone dystrophy 4	610478	AR	3
610550	10q22.3	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850	AR,AD	3
610550	10q22.3	Methionine adenosyltransferase deficiency, autosomal recessive	250850	AR,AD	3
608653	1p21.2	Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3
607012	5q13.2	?Deafness, autosomal recessive 112	618257	AR	3
610260	16p13-p12	Pyloric stenosis, infantile hypertrophic, 2	610260	_	2
610453	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
610453	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
609653	5q12.1	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3
609797	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
609797	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3
611225	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
610965	16p13.12	XFE progeroid syndrome	610965	AR	3
611302	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
609954	3p24-p21	{Asperger syndrome susceptibility 4}	609954	_	2
610860	1p21.2	Glycogen storage disease IIIa	232400	AR	3
610860	1p21.2	Glycogen storage disease IIIb	232400	AR	3
610931	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
608400	1q41	Retinitis pigmentosa 39	613809	_	3
608400	1q41	Usher syndrome, type 2A	276901	AR	3
610516	3p21.2	D-glyceric aciduria	220120	AR	3
609579	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
610551	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
609955	2p23.3-p22.3	Fibromatosis, gingival, 3	609955	_	2
611378	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
611423	4q12	Microcephaly 8, primary, autosomal recessive	614673	AR	3
610655	7p14	Telangiectasia, hereditary hemorrhagic, type 4	610655	AD	2
605763	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
610753	16q11-q22	Alopecia areata 2	610753	AR,AD	2
611109	4q32.3	[Cinnamon odor, pleasantness of]	611109	_	2
604741	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
611037	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
604165	17p13.2	Paragangliomas 6	618464	AD	3
610966	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
610966	16q12.2	{Obesity, susceptibility to, BMIQ14}	612460	AR	3
605130	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
610706	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
610665	1q23.3	Neutropenia, alloimmune neonatal	_	_	3
609790	9p22.1	Alzheimer disease-11	609790	_	2
610019	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
611642	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3
611642	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	AD	3
611291	2q35	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	_	3
611654	8q13.1-q13.2	Joubert syndrome 21	615636	AR	3
611724	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
610967	11p15.5	Osteogenesis imperfecta, type V	610967	AD	3
609798	14q24.3	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3
609798	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
609798	14q24.3	Nevus comedonicus, somatic	617025	_	3
603009	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
603009	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
603009	2p13.2	Myopathy, distal, with anterior tibial onset	606768	AR	3
610460	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
611038	18q21.32	Microphthalmia, isolated 3	611038	AR	3
603734	19q13.33	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3
606652	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
606768	2p13.2	Myopathy, distal, with anterior tibial onset	606768	AR	3
610036	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
609782	4q31	Aortic aneurysm, familial abdominal 2	609782	_	2
605131	16q23.1-q23.2	Epileptic encephalopathy, early infantile, 28	616211	AR	3
605131	16q23.1-q23.2	Esophageal squamous cell carcinoma, somatic	133239	_	3
605131	16q23.1-q23.2	Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3
609791	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
609352	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
610968	17q21.2	Osteogenesis imperfecta, type XI	610968	AR	3
611725	7q11.21	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3
610863	3q26.33	Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3
604432	15q15.2	Spinocerebellar ataxia 11	604432	AD	3
609868	14q31.3	Leber congenital amaurosis 3	604232	_	3
609868	14q31.3	Retinitis pigmentosa, juvenile, autosomal recessive	604232	_	3
611953	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
609656	17q23	{Bone size QTL}	609656	_	2
610657	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
610657	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
611892	9p21	{Aneurysm, intracranial berry, 6}	611892	_	2
611655	2q33.1	Mental retardation, autosomal recessive 42	615802	AR	3
610755	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
609985	4q31-q34	Panic disorder 3	609985	_	2
612083	14q24.3	Muscle strength quantitative trait locus 1	612083	_	2
604685	7p15.2	?Microtia, hearing impairment, and cleft palate (AR)	612290	AR,AD	3
604685	7p15.2	Microtia with or without hearing impairment (AD)	612290	AR,AD	3
611867	22q11.2	Chromosome 22q11.2 deletion syndrome, distal	611867	_	4
611379	12q13.12	Mental retardation, FRA12A type	136630	AD	3
611242	20p13	{Restless legs syndrome 5}	611242	_	2
609353	8p21.1	Roberts syndrome	268300	AR	3
609353	8p21.1	SC phocomelia syndrome	269000	AR	3
609799	17q11.2	?Nephronophthisis 9	613824	_	3
609799	17q11.2	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3
609253	18p11.2	Febrile seizures, familial, 6	609253	AD	2
604167	16q22.1	Mental retardation, autosomal dominant 21	615502	AD	3
609721	7p12.3	Heterotaxy, visceral, 8, autosomal	617205	AR	3
607522	10q24.32	Hermansky-Pudlak syndrome 6	614075	AR	3
611893	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
611040	11q23.3	Microphthalmia, isolated 5	611040	AR	3
611295	3q27.1	Epidermolysis bullosa simplex, generalized, with scarring and hair loss	617294	AD	3
611026	16q23.1	Spastic paraplegia 35, autosomal recessive	612319	AR	3
611549	13q32.3-q33.1	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3
611549	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
610552	3q22.1	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3
610552	3q22.1	Epileptic encephalopathy, early infantile, 44	617132	AR	3
610842	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
609010	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
612223	7q21	{Stature QTL 11}	612223	_	2
612048	3p25.1	Arrhythmogenic right ventricular dysplasia 5	604400	AD	3
612048	3p25.1	Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3
611726	7q11.21	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3
606770	5p15.2-p14	{Adiponectin, serum level of, QTL2}	606770	_	2
610341	3q28	Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3
611876	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
609254	3q13.33	Senior-Loken syndrome 5	609254	AR	3
609354	11q23	[Bone mineral density QTL 5]	609354	_	2
611934	10p11.22	{Epilepsy, idiopathic generalized, susceptibility to, 5}	611934	_	2
607523	3p21.31	Toenail dystrophy, isolated	607523	AD	3
609800	2p24	Epilepsy, generalized, with febrile seizures plus, type 4	609800	AD	2
611955	17q12	{Prostate cancer, hereditary, 11}	611955	_	2
611550	6p21.33	{Malaria, mild, susceptibility to}	609148	_	3
609239	13q14.2	Hypotrichosis 8	278150	AR	3
609239	13q14.2	Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	AR	3
605764	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
609069	10p12.2	Pancreatic and cerebellar agenesis	609069	AR	3
610553	13q13.3	Leukodystrophy, hypomyelinating, 14	617899	AR	3
610773	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
612310	2p13.3	Premature ovarian failure 6	612310	AD	3
611381	1p22	{Kala-azar, susceptibility to, 2}	611381	_	2
612283	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
612283	2q14.3	Thrombophilia due to protein C deficiency, autosomal recessive	612304	AR	3
612460	16q12.2	{Obesity, susceptibility to, BMIQ14}	612460	AR	3
612349	12q23.2	Phenylketonuria	261600	AR	3
612349	12q23.2	[Hyperphenylalaninemia, non-PKU mild]	261600	AR	3
611895	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
609070	1q42.2	[Hemoglobin, high altitude adaptation]	609070	AD	3
609802	15q21.1	Albinism, oculocutaneous, type VI	113750	AR	3
609802	15q21.1	[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	AR	3
610329	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
611014	18q21.2	{Hypertension, essential, susceptibility to, 8}	611014	_	2
612369	10q21	{Alkaline phosphatase, plasma level of, QTL4}	612369	_	2
610661	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
610898	11p12-p11	Supranuclear palsy, progressive, 3	610898	_	2
610844	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
610844	15q21.1	Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3
610844	15q21.1	Spastic paraplegia 11, autosomal recessive	604360	AR	3
611382	6q27	{Kala-azar, susceptibility to, 3}	611382	_	2
609264	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
611428	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
611428	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
612311	2q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 5}	612311	_	2
612659	6q22.1	Mitchell-Riley syndrome	615710	AR	3
612753	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
612271	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
610670	4q25	Spastic paraplegia 56, autosomal recessive	615030	AR	3
608532	7q36.3	Kahn-Kahn-Katsanis syndrome	618460	AR	3
612718	15q21.1	Cerebral creatine deficiency syndrome 3	612718	AR	3
611015	7q31	{Autism, susceptibility to, 9}	611015	_	2
603084	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
612626	15q26-qter	Chromosome 15q26-qter deletion syndrome	612626	IC	4
609102	16q24.2	?Mental retardation, autosomal recessive 45	615979	AR	3
611067	1p36.31	Spinal muscular atrophy, distal, autosomal recessive, 4	611067	AR	3
610330	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
610554	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
612796	13q13.3	{Inflammatory bowel disease 27}	612796	_	2
609039	21q11.2	Narcolepsy 3	609039	AD	2
612853	2p14-p13	{Restless legs syndrome 7}	612853	_	2
612370	8q12.2	Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3
608654	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
612335	4p16-p15	Spastic paraplegia 38, autosomal dominant	612335	AD	2
610798	1q22	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3
612520	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
612312	13q12.11	{Attention deficit-hyperactivity disorder, susceptibility to, 6}	612312	_	2
611521	19p13.2	Immunodeficiency 35	611521	AR	3
609265	22q12.1	Li-Fraumeni syndrome	609265	_	3
612567	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
611897	2q11-q14	Nanophthalmos 3	611897	_	2
610936	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
610936	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
612911	3p21.31	Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3
612900	9p24.3	Cerebral palsy, spastic quadriplegic, 2	612900	_	3
611879	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
612719	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
605060	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
612003	2q37.1	{Parkinson disease 11}	607688	_	3
609413	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
609413	10q11.23	Cockayne syndrome, type B	133540	AR	3
609413	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
609413	10q11.23	Premature ovarian failure 11	616946	AD	3
609413	10q11.23	UV-sensitive syndrome 1	600630	AR	3
609413	10q11.23	{Lung cancer, susceptibility to}	211980	SMu,AD	3
609413	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
609975	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
612371	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
609831	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type	277400	AR	3
612702	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
611016	7q36	{Autism, susceptibility to, 10}	611016	_	2
612521	6q25	{Diabetes mellitus, insulin-dependent, 21}	612521	_	2
606759	15q21.1	Thyroid dyshormonogenesis 6	607200	AR	3
613088	9q21	{Pelvic organ prolapse, susceptibility to, 2}	613088	_	2
611430	3p22.2	Spermatogenic failure 37	618429	AR	3
613065	10q21	{Leukemia, acute lymphocytic, susceptibility to, 1}	613065	_	2
610370	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
612797	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
612313	2q33.1	Glass syndrome	612313	AD	3
611630	4q13.2-q21.3	Epilepsy, familial temporal lobe, 3	611630	AD	2
604687	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
612004	7p15.3	Thrombocytopenia 4	612004	AD	3
612661	17p13.1	Dyskeratosis congenita, autosomal recessive 3	613988	AR	3
612952	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
610672	19p13.13	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3
609414	2q34	Corneal fleck dystrophy	121850	AD	3
611095	14q11.2-q12	Mental retardation, autosomal recessive, 9/26	611095	AR	2
609796	15q15.2	Peeling skin syndrome 2	609796	AR	3
611729	11q13.2	Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3
610060	6p21.1	Leukodystrophy, hypomyelinating, 11	616494	AR	3
610060	6p21.1	Treacher Collins syndrome 3	248390	AR	3
613229	13q31.1	?Trichotillomania	613229	Mu,AD	3
613309	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
611880	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
612522	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
611584	22q13.1	Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	AD	3
608410	4p15-p14	{Obesity, susceptibility to, BMIQ7}	608410	_	2
612394	7q22.1	Lysyl hydroxylase 3 deficiency	612394	AR	3
613464	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
612005	1q31	{Celiac disease, susceptibility to, 7}	612005	_	2
612901	20q13.32	Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	AD	3
613320	16p13.3	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3
612627	1p36.12-p35.1	Seizures, benign familial infantile, 4	612627	_	2
611631	9q21-q22	Epilepsy, familial temporal lobe, 4	611631	AD	2
613171	10q25.2	Cardiomyopathy, dilated, 1DD	613172	AD	3
611523	6q15	Pontocerebellar hypoplasia, type 6	611523	AR	3
613495	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
612874	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
612703	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
609734	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
613105	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
613024	6p21.33	{Follicular lymphoma, susceptibility to, 1}	613024	_	2
611881	16p11.2	Glycogen storage disease XII	611881	AR	3
613571	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
613370	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
613618	17q23.1-q23.2	Chromosome 17q23.1-q23.2 duplication syndrome	613618	AD	4
609415	13q31.3	Feingold syndrome 2	614326	AD	3
612431	4q12-q13.1	Deafness, autosomal dominant 27	612431	AD	2
612976	3p26.1-p25.1	{Age-related hearing impairment 2}	612976	_	2
611139	9p21	{Coronary heart disease, susceptibility to, 8}	611139	_	2
609523	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
613640	14q24.3	Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3
612089	13q13.1	Hypophosphatemic rickets and hyperparathyroidism	612089	AD	2
613677	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
612943	7p15.3	Retinitis pigmentosa 42	612943	AD	3
612274	15q24-q25	Ciliary dyskinesia, primary, 8	612274	_	2
612343	4q22	[Musical aptitude QTL 1]	612343	_	2
612929	20q13.31-q13.33	{Mycobacterium tuberculosis, susceptibility to, 3}	612929	_	2
613310	7q31.31	Exudative vitreoretinopathy 5	613310	AD	3
611632	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
612395	22q13.33	Muscular dystrophy, congenital, megaconial type	602541	AR	3
612006	2q11-q12	{Celiac disease, susceptibility to, 8}	612006	_	2
613172	10q25.2	Cardiomyopathy, dilated, 1DD	613172	AD	3
610463	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
610463	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
613722	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
613106	22q12	Vertigo, benign recurrent, 2	613106	_	2
613371	4q34.3-q35.1	?Spinocerebellar ataxia 30	613371	AD	2
612315	12q13.13	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3
612628	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
613496	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
613158	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
613641	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
610756	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
611140	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
612789	8p22-p21.3	Deafness, autosomal recessive 71	612789	AR	2
609524	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
613410	3q24	{?Autism susceptibility 16}	613410	_	3
613619	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
612944	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
613830	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
612007	3p21	{Celiac disease, susceptibility to, 9}	612007	_	2
610474	4p16.3	CATSHL syndrome	610474	AR,AD	3
612629	11q23-q24	{Adiponectin, serum level of, QTL4}	612629	_	2
610333	19p13.13	Aicardi-Goutieres syndrome 4	610333	AR	3
612525	16q24.3	Pyloric stenosis, infantile hypertrophic, 5	612525	_	2
611524	6q15	Pontocerebellar hypoplasia, type 6	611523	AR	3
610970	16q24.3	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3
613890	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
613689	22q12.3-q13.1	Mammary-digital-nail syndrome	613689	AD	2
613723	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
613879	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
613497	10q23.31	Cholesteryl ester storage disease	278000	AR	3
613497	10q23.31	Wolman disease	278000	AR	3
613642	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
612121	6p21.31	Ichthyosis, congenital, autosomal recessive 10	615024	AR	3
612858	8q24.3	Orofacial cleft 12	612858	_	2
613107	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
612316	1p36.33	Harel-Yoon syndrome	617183	AR,AD	3
611031	16q13-q22.1	Episodic kinesigenic dyskinesia 2	611031	AD	2
612008	3q25-q26	{Celiac disease, susceptibility to, 10}	612008	_	2
613485	11q24.3	Long QT syndrome 13	613485	AD	3
613558	9q21.11	Deafness, autosomal dominant 51	613558	AD	4
613174	5p13	Chromosome 5p13 duplication syndrome	613174	IC	4
612892	6p22.1	{Stature QTL 18}	612892	_	2
613972	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
612304	2q14.3	Thrombophilia due to protein C deficiency, autosomal recessive	612304	AR	3
613805	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
613680	16p13.3	Beaulieu-Boycott-Innes syndrome	613680	AR	3
613724	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
614073	22q12.1	Hermansky-Pudlak syndrome 4	614073	AR	3
612877	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
612345	2q31.2	Chromosome 2q31.2 deletion syndrome	612345	_	4
606761	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
610608	20p11.21	Immunodeficiency 55	617827	AR	3
614114	11q21	Mosaic variegated aneuploidy syndrome 2	614114	AR	3
613621	14q12	Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3
612630	2q13	[Hair morphology 1, hair thickness]	612630	_	3
612893	6p21.31	{Stature QTL 19}	612893	_	2
611544	22q12.1	Cataract 17, multiple types	611544	AR,AD	3
613990	14q12	Dyskeratosis congenita, autosomal dominant 3	613990	AD	3
612953	22q13.1	Parkinson disease 14, autosomal recessive	612953	AR	3
614049	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
614139	2p25.3	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3
613559	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
613108	12p13.2	Candidiasis, familial, 4, autosomal recessive	613108	AR	3
613881	10q26.11	Cardiomyopathy, dilated, 1HH	613881	AD	3
614038	3q21.3	Emberger syndrome	614038	AD	3
611081	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
612318	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
606762	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
613681	2q31.1	Chromosome 2q31.1 duplication syndrome	613681	AD	4
614200	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
613643	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
612631	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
612954	10q26.11	Myopathy, myofibrillar, 6	612954	AD	3
614185	15q21.1	Geleophysic dysplasia 2	614185	AD	3
614050	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
614261	2p13.1	Microcephaly-capillary malformation syndrome	614261	AR	3
612792	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
612306	5q13	[Thyroid-stimulating hormone level QTL 1]	612306	_	2
614297	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614297	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
613950	22q13.33	{Schizophrenia 15}	613950	AD	3
612666	1q32.1	Congenital anomalies of kidney and urinary tract 1	610805	AD	3
612666	1q32.1	Spastic paraplegia 23	270750	AR	3
612894	13q14.3	{Stature QTL 20}	612894	_	2
613067	7p12.2	{Leukemia, acute lymphoblastic, susceptibility to, 2}	613067	_	2
614140	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
614140	22q11.23	Hypertelorism, Teebi type	145420	AD	3
614140	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
614115	9q34.12	Cortical malformations, occipital	614115	AR	3
613159	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613109	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
614322	16q23.1-q23.2	Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3
614243	8q24.3	5-oxoprolinase deficiency	260005	AR,AD	3
611022	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
614262	14q24.3	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3
614377	4p14	Nephronophthisis 13	614377	AR	3
612955	20q11.21	Long QT syndrome 12	612955	AD	3
614298	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
614388	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
611920	10q23-q24	[C-reactive protein QTL]	611920	_	2
612645	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
614366	12q23.3	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3
613311	6p25.1	?Combined oxidative phosphorylation deficiency 19	615595	AR	3
613428	2p23.2	Retinitis pigmentosa 54	613428	_	3
614609	19p13.2	Coffin-Siris syndrome 4	614609	AD	3
613622	11q24.2	Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3
614312	17p13.2	?Spermatogenic failure 14	615842	AR	3
613152	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
613951	16p13.3	Fanconi anemia, complementation group P	613951	AR	3
614141	4q31.3	Charcot-Marie-Tooth disease, type 2R	615490	AR	3
614153	20p13	Spinocerebellar ataxia 36	614153	AD	3
614116	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
614064	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
612956	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
611547	12q14.3	{Stature QTL 9}	611547	_	2
614651	10p12.1	Coenzyme Q10 deficiency, primary, 2	614651	AR	3
614702	6q13	Combined oxidative phosphorylation deficiency 10	614702	AR	3
612794	15q14	Atrial septal defect 5	612794	AD	3
613930	18q11.2-q12.2	Alopecia-mental retardation syndrome 3	613930	AR	2
614450	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
612957	1p36.12	{Vitamin B6 plasma level QTL 1}	612957	_	2
612030	8p22	{Coronary heart disease, susceptibility to, 9}	612030	_	2
611515	21q22	Febrile seizures, familial, 7	611515	_	2
614610	19p13.2	Nephrotic syndrome, type 16	617783	AR	3
614610	19p13.2	Palmoplantar keratoderma and woolly hair	616099	AR	3
611548	7q35	Premature ovarian failure 5	611548	AD	3
609595	1p34.3	Palmoplantar hyperkeratosis and true hermaphroditism	610644	AR	3
609595	1p34.3	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644	AR	3
614154	20p13	Spinocerebellar ataxia 36	614153	AD	3
614574	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
613953	22q11.1	Immunodeficiency 51	613953	AR	3
612870	6q14.1	Developmental delay, intellectual disability, obesity, and dysmorphic features	617991	AD	3
614556	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
611731	5q22.2	Adenoma, periampullary, somatic	_	_	3
611731	5q22.2	Adenomatous polyposis coli	175100	AD	3
611731	5q22.2	Brain tumor-polyposis syndrome 2	175100	AD	3
611731	5q22.2	Colorectal cancer, somatic	114500	_	3
611731	5q22.2	Desmoid disease, hereditary	135290	AD	3
611731	5q22.2	Gardner syndrome	175100	AD	3
611731	5q22.2	Gastric cancer, somatic	613659	_	3
611731	5q22.2	Hepatoblastoma, somatic	114550	_	3
614324	17q21.2	Ovarian dysgenesis 3	614324	AR	3
614662	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
613931	1p34.1	Pontocerebellar hypoplasia, type 7	614969	AR	3
614065	7q32.1	Myopathy, distal, 4	614065	AD	3
613451	11p11.2	Frontonasal dysplasia 2	613451	AR	3
614156	7p13	Hyperbiliverdinemia	614156	AR,AD	3
612169	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
614817	15q13.3	Interstitial nephritis, karyomegalic	614817	AR	3
615011	5q35.3	[?Phosphohydroxylysinuria]	615011	_	3
613456	12q21.31	?Frontonasal dysplasia 3	613456	_	3
612277	9q34.2	Geleophysic dysplasia 1	231050	AR	3
614779	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
614972	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AR,AD	3
614870	1p36.32	Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3
614590	6p21.3	{Podoconiosis, susceptibility to}	614590	_	2
614789	3p14.1	Adams-Oliver syndrome 4	615297	AR	3
614858	10q26.12	Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3
614299	2p13.1	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3
614575	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
612278	5q33.1	{Inflammatory bowel disease (Crohn disease) 19}	612278	_	3
614780	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
611383	9q32	Usher syndrome, type 2D	611383	AR	3
614144	17p11.2	?Meckel syndrome 9	614209	AR	3
614144	17p11.2	Joubert syndrome 27	617120	AR	3
614859	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
614885	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
614931	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
614591	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
614591	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
611935	2q23.2	Homocystinuria, cblD type, variant 1	277410	AR	3
611935	2q23.2	Methylmalonic aciduria and homocystinuria, cblD type	277410	AR	3
611935	2q23.2	Methylmalonic aciduria, cblD type, variant 2	277410	AR	3
611384	10p15	{Plasmodium falciparum fever episodes QTL1}	611384	_	2
614819	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
614557	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
615023	15q26.3	Ichthyosis, congenital, autosomal recessive 9	615023	AR	3
612309	1q24.2	Factor V deficiency	227400	AR	3
612309	1q24.2	Thrombophilia due to activated protein C resistance	188055	AD	3
612309	1q24.2	{Budd-Chiari syndrome}	600880	AR	3
612309	1q24.2	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3
612309	1q24.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
612309	1q24.2	{Thrombophilia, susceptibility to, due to factor V Leiden}	188055	AD	3
614628	14q24.3	Keratoconus 8	614628	AD	2
611061	7p22.3	Raine syndrome	259775	AR	3
614984	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
614984	10p14	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3
615219	9p23	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3
614886	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
615249	8p11.21	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	615249	AR	3
614629	13q32	Keratoconus 7	614629	AD	2
615294	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614145	19q13.32	3-M syndrome 3	614205	AR	3
615024	6p21.31	Ichthyosis, congenital, autosomal recessive 10	615024	AR	3
615220	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
614592	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
611062	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
615238	3p25.3	?Lipodystrophy, familial partial, type 5	615238	AR	3
614714	16q24.2	Porokeratosis 7, multiple types	614714	AD	3
615041	12q14.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3
612279	8p23-p21	Epilepsy, generalized, with febrile seizures plus, type 6	612279	_	2
614558	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
614820	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
613954	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
614706	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
615270	8p21.3	Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3
615221	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
615363	6q25.1-q25.2	Estrogen resistance	615363	AR	3
612281	5q33.3	Ichthyosis, congenital, autosomal recessive 6	612281	AR	3
614860	9q34	Dystonia 23	614860	AD	2
614974	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
615042	9q34.11	Congenital disorder of glycosylation, type Iu	615042	AR	3
615352	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
615025	10p14	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3
614566	19q13.42	Ciliary dyskinesia, primary, 2	606763	AR	3
615364	14q32.2	?Spermatogenic failure 27	617965	AR	3
612041	4p16.3	Recombination rate QTL 1	612042	_	3
615376	1p36.31	Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3
614300	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
615434	16q13	Retinitis pigmentosa with or without situs inversus	615434	AR	3
615222	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
614861	21q22.3	?Deafness, autosomal recessive 98	614861	AR	3
612042	4p16.3	Recombination rate QTL 1	612042	_	3
615316	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
615316	1q42.13	Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3
615026	17p13.2	Riboflavin deficiency	615026	AD	3
615043	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614245	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
615134	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
615474	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
612530	1q41-q42	Chromosome 1q41-q42 deletion syndrome	612530	IC	4
615541	8p12	Mental retardation, autosomal recessive 39	615541	AR	3
614998	1q21.3	Mental retardation, autosomal dominant 18	615074	AD	3
614477	8q22.1	Bardet-Biedl syndrome 21	617406	AR	3
614477	8q22.1	Cone-rod dystrophy 16	614500	AR	3
614477	8q22.1	Retinitis pigmentosa 64	614500	AR	3
615048	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
615561	6p21.33	?Complement factor B deficiency	615561	_	3
614567	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
615623	1p32.3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3
614862	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
615512	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
613955	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
615395	2q36.1	?Combined oxidative phosphorylation deficiency 16	615395	AR	3
614594	17p13.2	Olmsted syndrome	614594	AD	3
615451	10p12.1	Ciliary dyskinesia, primary, 23	615451	AR	3
615317	14q24.3	Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3
611943	3q29	RIDDLE syndrome	611943	AR	3
612883	9q31.2	{Menarche, age at, QTL3}	612883	_	2
614822	16p13.3	Spermatogenic failure 10	614822	AD	3
615542	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
615049	10p12.1	Desanto-Shinawi syndrome	616708	AD	3
612526	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
613646	19p13.2	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	_	3
615436	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
615584	11q12.1	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	615704	AD	3
612884	19q13.4	{Menopause, natural, age at, QTL2}	612884	_	2
614595	4p12	Preeclampsia/eclampsia 5	614595	_	3
614665	12p12.3	Meconium ileus	614665	AR	3
613956	6p12.2	?Candidiasis, familial, 6, autosomal dominant	613956	_	3
613893	12q14.2	Spermatogenic failure 9	613958	AR	3
614823	15q22.31	Aortic valve disease 2	614823	AD	3
613733	11q13.1	Adrenal adenoma, somatic	_	_	3
613733	11q13.1	Angiofibroma, somatic	_	_	3
613733	11q13.1	Carcinoid tumor of lung	_	_	3
613733	11q13.1	Lipoma, somatic	_	_	3
613733	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
613733	11q13.1	Parathyroid adenoma, somatic	_	_	3
614707	8q24.3	Brown-Vialetto-Van Laere syndrome 2	614707	AR	3
615706	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
614576	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
615016	6p22.1	[C3HEX, ability to smell]	615082	AD	3
611944	6q16.2-q22.1	Lymphatic malformation 2	611944	AD	2
614256	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
615544	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
615665	2q37.1	?Joubert syndrome 22	615665	AR	3
613957	9q33.3	Spermatogenic failure 8	613957	AD	3
615585	16q23.3	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3
615707	1q23.3	Immunodeficiency 20	615707	AR	3
613734	2q21.1	Congenital disorder of glycosylation, type IIo	616828	AR	3
615476	1p34.2	Epileptic encephalopathy, early infantile, 18	615476	AR	3
615453	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
615355	1q22	Noonan syndrome 8	615355	AD	3
615636	8q13.1-q13.2	Joubert syndrome 21	615636	AR	3
615564	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
613735	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
612527	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
615438	5q32	?Infantile liver failure syndrome 1	615438	AR	3
615730	1p31.3	Epileptic encephalopathy, early infantile, 23	615859	AR	3
615000	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
615752	16q21	Polymicrogyria, bilateral perisylvian	615752	_	3
613700	22q11.2	Supernumerary der(22)t(8-22) syndrome	613700	_	4
614157	8q22.3	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	AR	3
615397	16q23.1	Meckel syndrome 11	615397	AR	3
614825	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
615709	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
615743	3p25.3	Mental retardation, autosomal dominant 23	615761	AD	3
615565	1q32.3	?Retinitis pigmentosa 67	615565	AR	3
612528	3q29	Diamond-Blackfan anemia 5	612528	AD	3
615356	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
615637	19q13.32	Mental retardation, autosomal recessive 41	615637	AR	3
615377	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
612936	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
615817	12q23.3	?Mental retardation, autosomal recessive 43	615817	AR	3
615876	6q25.3	Ciliary dyskinesia, primary, 32	616481	AR	3
615720	3q26.2	Retinitis pigmentosa 68	615725	AR	3
614158	7q34	?Thromboxane synthase deficiency	614158	AD	1
615744	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
613736	19q13.12	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3
615763	6p25.2	Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3
615035	12q24.31	Spastic paraplegia 55, autosomal recessive	615035	AR	3
615710	6q22.1	Mitchell-Riley syndrome	615710	AR	3
615398	20q13.12	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3
614666	16p13.3	?Centronuclear myopathy 4	614807	AD	3
615006	1p34.1	?Epileptic encephalopathy, early infantile, 15	615006	AR	3
613737	14q24.2	?Acne inversa, familial, 3	613737	AD	3
612813	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
615638	12p13.31	?Microcephaly 21, primary, autosomal recessive	617983	AR	3
615895	20p13	Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3
614571	5p13.2	Joubert syndrome 17	614615	AR	3
614571	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
613710	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
614159	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
615599	8q24.12	Mental retardation, autosomal recessive 40	615599	AR	3
615232	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
615974	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
615838	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
615995	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
614932	2p16.1	Combined oxidative phosphorylation deficiency 13	614932	AR	3
615399	20q13.12	?Paroxysmal nocturnal hemoglobinuria 2	615399	SMu,AD	3
615745	1p36.22	Atrial standstill 2	615745	AR	3
614473	16p13.11	Arterial calcification, generalized, of infancy, 2	614473	AR	3
615722	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
615877	4q31.3	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AR,AD	3
614667	6q13	Combined oxidative phosphorylation deficiency 10	614702	AR	3
615982	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
615896	12q13.13	?Hypotrichosis 13	615896	AD	3
615233	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
613711	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
615007	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
616026	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
614160	2q32.2	Muscle hypertrophy	614160	_	3
615723	7q22.1	Premature ovarian failure 8	615723	AR	3
615996	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
615897	1p34.2	Immunodeficiency 24	615897	AR	3
613712	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
615983	2q31.1	Bardet-Biedl syndrome 5	615983	AR	3
616116	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
615400	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
616105	6q14.3	Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3
615724	1p22.2	Premature ovarian failure 9	615724	AR	3
614161	4q27	Brittle cornea syndrome 2	614170	AR	3
615878	9q21.11	Cholestasis, progressive familial intrahepatic 4	615878	AR	3
614607	1p36.11	Coffin-Siris syndrome 2	614607	AD	3
615649	5q31	Deafness, autosomal dominant 54	615649	AD	2
615038	19q13.33	Ciliary dyskinesia, primary, 20	615067	AR	3
614782	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
615234	2q14.2	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3
615667	9q22.32	Bone marrow failure syndrome 2	615715	AR	3
614608	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
612795	11q12-q13.1	[Polyunsaturated fatty acids plasma level QTL1]	612795	_	2
615879	2p23.3	Tatton-Brown-Rahman syndrome	615879	AD	3
616117	1p31.1	Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3
614934	2p16.1	Deafness, autosomal recessive 70	614934	AR	3
614783	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
615984	4q27	Bardet-Biedl syndrome 7	615984	AR	3
615401	16p11.2	Immunodeficiency 8	615401	AR	3
615235	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
616230	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
615378	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
616267	19q13.33	Ataxia-oculomotor apraxia 4	616267	AR	3
615668	5q12	Chromosome 5q12 deletion syndrome	615668	AD	4
615139	12q24.33	FILS syndrome	615139	AR	3
615651	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
615681	10q24.31	Spastic paraplegia 62	615681	AR	3
616118	5q23.3	Macular degeneration, early-onset	616118	AD	3
614935	8q24.22	Ciliary dyskinesia, primary, 19	614935	AR	3
615985	14q31.3	Bardet-Biedl syndrome 8	615985	AR	3
616151	6q14.1	Macular dystrophy, vitelliform, 4	616151	AD	3
616198	19p13.11	Combined oxidative phosphorylation deficiency 23	616198	AR	3
613375	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
616268	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
615986	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
616231	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
613376	5q11.2	?Neuronopathy, distal hereditary motor, type IIC	613376	AD	3
616269	1p13.3	Mental retardation, autosomal recessive 48	616269	AR	3
615140	12p13.31	Temtamy syndrome	218340	AR	3
616304	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
615237	11q24.1	Congenital short bowel syndrome	615237	AR	3
615360	8q22.1	Leber congenital amaurosis 17	615360	AR	3
614990	10p11.21-q21.1	Usher syndrome, type IK	614990	AR	2
616409	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
616220	9q33.3	Focal segmental glomerulosclerosis 9	616220	AR	3
615841	18q11.2	?Spermatogenic failure 13	615841	AR	3
616152	3q12.3	Macular dystrophy, vitelliform, 5	616152	AD	3
616305	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
616370	14q24.3	Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3
614723	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
615725	3q26.2	Retinitis pigmentosa 68	615725	AR	3
616451	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
615361	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
615685	16p12.3	?Spastic paraplegia 61, autosomal recessive	615685	AR	3
615881	19p13.2	Plasma triglyceride level QTL, low	615881	AD	3
616371	16p13.12	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371	AD	3
615508	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
616479	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
616511	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
616171	4q28.1	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3
613398	12p11.21	Warsaw breakage syndrome	613398	AR	3
615686	1p13.3	?Spastic paraplegia 63	615686	AR	3
615362	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
616583	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
616682	11p11.2	?Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3
615338	16p13.3	Epileptic encephalopathy, early infantile, 16	615338	AR	3
616902	11p13	Chromosome 11p13 deletion syndrome, distal	616902	AD	4
616351	5q13.3	Mental retardation, autosomal dominant 34	616351	AD	3
616728	1p36.12	Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3
615697	3q25-q26	Epilepsy, familial temporal lobe, 6	615697	AD	2
616683	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
616716	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
612937	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
616468	11p11.2	?Exudative vitreoretinopathy 6	616468	AD	3
615900	2p23.3	Retinitis pigmentosa 75	617023	AR	3
616831	3p21.31	Luscan-Lumish syndrome	616831	AD	3
614585	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
616307	4p14	Senior-Loken syndrome 8	616307	AR	3
615698	19q13.2	?Spinocerebellar ataxia 46	617770	AD	3
616154	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
615510	2q35	Alacrima, achalasia, and mental retardation syndrome	615510	AR	3
612560	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
616903	13q14.2	{Thiopurines, poor metabolism of, 2}	616903	AD	3
617018	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
617053	7q21.2	MIRAGE syndrome	617053	AD	3
616373	20q13.33	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373	AD	3
612938	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
616585	16q13	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3
615688	22q11.1	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3
616469	11p11.2	Retinitis pigmentosa 72	616469	AR	3
616849	4q22.3	Brachydactyly, type A1, D	616849	AD	3
614936	8q24.13-q24.21	Keratoderma, palmoplantar, punctate type IB	614936	AD	2
616586	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
617026	1q25.3	Pontocerebellar hypoplasia, type 2F	617026	AR	3
617101	2p16.1	Dias-Logan syndrome	617101	AD	3
616602	3q24	Craniosynostosis 6	616602	AD	3
613399	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
616544	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
612009	3q28	{Celiac disease, susceptibility to, 11}	612009	_	2
617054	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
617027	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
616851	19q13.1-q13.2	?Cataract 45	616851	AR	3
617272	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
616924	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
612561	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
617247	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
617273	8q22.1	?Polydactyly, postaxial, type A9	618219	AR	3
617028	3q26.2-q26.3	Mental retardation, autosomal recessive 54	617028	AR	3
615987	12q21.2	Bardet-Biedl syndrome 10	615987	AR	3
616959	3p26.2	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3
617102	20q13.12	Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3
614937	16q22.1	?Myoclonus, familial, 1	614937	AD	3
617236	9q21.2	Cone-rod dystrophy and hearing loss	617236	AR	3
617403	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
617251	20p13	?Uncombable hair syndrome 2	617251	AR	3
617055	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
615988	9q33.1	?Bardet-Biedl syndrome 11	615988	AR	3
616833	1q21.3	Paget disease of bone 6	616833	AD	3
612010	6q25.3	{Celiac disease, susceptibility to, 12}	612010	_	2
614104	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
617525	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
617080	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
615989	4q27	Bardet-Biedl syndrome 12	615989	AR	3
616622	1q21.3	Immunodeficiency 42	616622	AR	3
617341	10q24.33	Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3
617413	1q21.3	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3
616730	12q15	Nephrotic syndrome, type 11	616730	AR	3
615916	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
616311	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
617056	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
612562	1p36.11	Diamond-Blackfan anemia 7	612562	AD	3
615990	17q22	Bardet-Biedl syndrome 13	615990	AR	3
612011	12q24	{Celiac disease, susceptibility to, 13}	612011	_	2
617616	1q42.11-q42.12	Skraban-Deardorff syndrome	617616	AD	3
617629	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
617237	14q32.2	Immunodeficiency 49	617237	AD	3
614105	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
617547	21q22.3	Retinal dystrophy with macular staphyloma	617547	AR	3
616732	6q21	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	616732	AR	3
613653	7p22.1	Spastic paraplegia 48, autosomal recessive	613647	AR	3
617252	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
617105	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
617392	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
613457	14q11-q22	Chromosome 14q11-q22 deletion syndrome	613457	IC	4
614784	12q21.33	Cone-rod dystrophy 20	615973	AR	3
614317	5q14.2	Vesicoureteral reflux 4	614317	_	2
616733	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
617393	19p13.13	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3
617809	11q13.1	Geleophysic dysplasia 3	617809	AD	3
617830	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
616155	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
616734	18q12.1-q12.2	Symmetric circumferential skin creases, congenital, 2	616734	AD	3
617506	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
611145	8q24.11	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
617810	8q24.3	Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3
617877	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
617082	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
617631	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
617253	8q24.13	Seckel syndrome 10	617253	AR	3
613458	16p13.3	Chromosome 16p13.3 duplication syndrome	613458	IC,AD	4
613655	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
612563	2p25.3	Diamond-Blackfan anemia 8	612563	AD	3
614785	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
616735	3p25.1	Hypotonia, infantile, with psychomotor retardation	616816	AR	3
617878	2q21.1	Keratoconus 9	617928	AD	3
615917	6p21.33	Combined oxidative phosphorylation deficiency 20	615917	AR	3
617091	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
613656	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
617622	2q37.1	Joubert syndrome 30	617622	AR	3
613459	3q25.3	[Birth weight QTL 2]	613459	_	2
611146	1q41	Hypermanganesemia with dystonia 1	613280	AR	3
617493	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
617394	6p22.3	Sclerosing cholangitis, neonatal	617394	AR	3
617633	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
615386	11q13.2	Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3
617507	2p16.1	?PEHO syndrome-like	617507	AR	3
611147	2q31	Paroxysmal nonkinesigenic dyskinesia 2	611147	AD	2
617751	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
617664	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
617395	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
618131	16q22.1	Immunodeficiency 58	618131	AR	3
617255	12q21.32	Lissencephaly 8	617255	AR	3
615918	1q21.2	?Combined oxidative phosphorylation deficiency 21	615918	AR	3
617954	7q22.1	Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3
617752	2q36.3	Mental retardation, autosomal dominant 49	617752	AD	3
617092	17q21.2	Ciliary dyskinesia, primary, 35	617092	AR	3
615387	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
616744	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
617987	1q24.3	?{Deafness, autosomal recessive 26, modifier of}	605429	AD	3
613657	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
617557	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
615925	3q26.31	Growth hormone deficiency, isolated partial	615925	AR,AD	3
615058	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
618279	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
617988	6p21.1	Jaberi-Elahi syndrome	617988	AR	3
618336	12q24.33	IMAGE-I syndrome	618336	AR	3
617432	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
618260	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
613460	3q21	[Birth weight QTL 3]	613460	_	2
613460	3q21	[Fasting plasma glucose level QTL 6]	613460	_	2
613460	3q21	[Plasma glucose, 2-hour, QTL 1]	613460	_	2
617057	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
618379	3q25.1	Epileptic encephalopathy, early infantile, 73	618379	AD	3
617780	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
617093	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
617014	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
613658	2q36.2	Rajab syndrome	613658	AR	2
617903	9q22.33	Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3
617433	19p13.2	Retinitis pigmentosa 78	617433	AR	3
615059	1q32.1	Hypotrichosis 11	615059	AD	3
618416	19p13.11	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3
617396	8q22.2	Anauxetic dysplasia 2	617396	AR	3
615155	9q32	Steel syndrome	615155	AR	3
616420	1q42.12	Leukodystrophy, hypomyelinating, 10	616420	AR	3
612566	20q13	{Inflammatory bowel disease 24}	612566	_	2
617755	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
613932	1p31.1	Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3
617781	16p13.3	Retinitis pigmentosa 80	617781	AR	3
617584	6q21	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3
617558	10q25.1	Spermatogenic failure 19	617592	AR	3
615156	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
617065	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
617914	1q32.1	Microcephaly 20, primary, autosomal recessive	617914	AR	3
617756	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
613933	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
618261	19p13.3	Lymphoproliferative syndrome 3	618261	AR	3
618324	16q22.1	Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3
618398	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
615157	17p12	Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3
617559	3q13.2	?Spermatogenic failure 20	617593	AR	3
618280	11q12.2	Cardiac-urogenital syndrome	618280	AD	3
617796	1q22	Mental retardation, autosomal dominant 52	617796	AD	3
617094	20q13.12	Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3
616421	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
617595	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
617816	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
617397	22q11.21	Pseudo-TORCH syndrome 2	617397	AR	3
613462	7p21.2	[Fasting plasma glucose level QTL 4]	613462	_	2
617560	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
617095	17q21.2	Ciliary dyskinesia, primary, 35	617092	AR	3
617827	20p11.21	Immunodeficiency 55	617827	AR	3
616158	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
617915	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
615748	12q23.3	?Mental retardation, autosomal recessive 43	615817	AR	3
613463	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
617757	10q24.32	Joubert syndrome 32	617757	AR	3
617862	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
617073	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
618325	1p34.3	Lissencephaly 9 with complex brainstem malformation	618325	AD	3
617561	11q14.2	Cohen-Gibson syndrome	617561	AD	3
618011	10q23.31	Hyperekplexia 4	618011	AR	3
618339	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
615749	9q33.2	[Eculizumab, poor response to]	615749	AD	3
617106	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
617879	9q34.3	Leber congenital amaurosis with early-onset deafness	617879	AD	3
617828	14q11.2	?Marsili syndrome	147430	AD	3
617864	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
617540	10q22.1	{Pituitary adenoma 5, multiple types}	617540	AD	3
614111	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
617865	5q12.1	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3
618295	11p15.4	Mental retardation, autosomal recessive 67	618295	AR	3
617829	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
617761	5q23.2	Joubert syndrome 31	617761	AR	3
617866	14q24.3	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3
617107	11q13.1	Thauvin-Robinet-Faivre syndrome	617107	AR	3
617665	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
618060	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
618048	13q12.3	Proteasome-associated autoinflammatory syndrome 2	618048	AD	3
617075	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
617108	17q22	Sessile serrated polyposis cancer syndrome	617108	AD	3
617762	11q13.5	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3
618052	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
613938	20q12-q13.12	Parasomnia, sleepwalking type	613938	Mu,AD	2
614113	9p24	Mental retardation, autosomal dominant 2	614113	AD	4
617402	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
618061	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
614588	2q14.3-q21.3	Dystonia 21	614588	AD	2
617831	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
617916	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
615820	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
618400	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
614589	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
617110	9q21.2	Cone-rod dystrophy and hearing loss	617236	AR	3
618173	10q24.32	Retinitis pigmentosa 83	618173	AD	3
615821	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
618160	1p21.1	?Growth hormone deficiency, isolated, type V	618160	AR	3
613949	12p13.31	OKT4 epitope deficiency	613949	_	3
617882	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
617111	3p21.2	?Macular dystrophy, patterned, 3	617111	AD	3
613661	13q14.3	Congenital disorder of glycosylation, type Ip	613661	AR	3
617883	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
618298	6p24.1	Epileptic encephalopathy, early infantile, 70	618298	AD	3
618402	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
617112	17p13.1	?Orofaciodigital syndrome XV	617127	AR	3
618056	7p22.3	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3
618328	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
618057	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
618058	11q22.1	Ciliary dyskinesia, primary, 38	618063	AR	3
618329	19p13.3	Combined oxidative phosphorylation deficiency 37	618329	AR	3
618404	1q42.11	Leukodystrophy, hypomyelinating, 18	618404	AR	3
615824	6p21.31	Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3
618161	10q24.32	Joubert syndrome 35	618161	AR	3
618162	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
618330	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
618163	17q25.1	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3
617666	13q13.3	Fraser syndrome 2	617666	AR	3
618164	16p13.3	Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3
618414	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
615837	5q32	?Deafness, autosomal recessive 101	615837	AR	3
618415	10q24.2	Cataract 48	618415	AR	3
617854	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
616423	3p21.31	Neurodevelopmental disorder with severe motor impairment and absent language	617804	AD	3
617017	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AR,AD	3
615511	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
617542	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
616425	17q24	46XY sex reversal 10	616425	AD	4
617030	14q32.33	Myopathy, distal, 5	617030	AR	3
617258	12p12.1	Myopathy, myofibrillar, 8	617258	AR	3
617729	14q11.2	Galloway-Mowat syndrome 3	617729	AR	3
617383	12q24.11	?Avascular necrosis of femoral head, primary, 2	617383	AD	3
616449	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
617563	17p13.1	Orofaciodigital syndrome XVI	617563	AR	3
618174	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
616470	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
618175	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
617384	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
618282	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
618176	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
616471	6q13-q14	Bethlem myopathy 2	616471	AD	3
618177	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
618178	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
604633	11q13.1	Cutis laxa, autosomal recessive, type IB	614437	AR	3
604296	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
606953	1p36.11	Galactose epimerase deficiency	230350	AR	3
606666	11p14.1	{Bone mineral density, low, susceptibility to}	615311	_	3
605742	22q11.21	Cortical dysplasia, complex, with other brain malformations 8	613180	AR	3
603786	4p15.32	Stargardt disease 4	603786	_	3
604592	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
605779	17p13	Nail disorder, nonsyndromic congenital, 7	605779	AD	2
606789	8q	Fetal hemoglobin quantitative trait locus 4	606789	_	2
606969	17p13.3	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3
606660	3q24-q26	{Melanoma, uveal, susceptibility to, 1}	606660	_	2
603700	13q12.3	{Stroke, susceptibility to}	601367	Mu	3
603873	9p21.2	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3
605111	19p13.2	Deafness, autosomal recessive 68	610419	AR	3
603666	20q13.32	Pseudohypoparathyroidism, type IB	603233	AD	3
605956	16q12.1	Blau syndrome	186580	AD	3
605956	16q12.1	{Inflammatory bowel disease 1, Crohn disease}	266600	Mu	3
605956	16q12.1	{Psoriatic arthritis, susceptibility to}	607507	_	2
605956	16q12.1	{Yao syndrome}	617321	Mu	3
605950	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
605676	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
604672	19p13.2	{Dengue fever, protection against}	614371	_	3
604672	19p13.2	{HIV type 1, susceptibility to}	609423	_	3
604672	19p13.2	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
606672	17p13.2	Bernard-Soulier syndrome, type A1 (recessive)	231200	AR	3
606672	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
606672	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
606672	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
606207	15q25.3	[Uridine-cytidineuria]	618477	AR	3
605347	1p36.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
604436	8p11.23	Epilepsy, early-onset, vitamin B6-dependent	617290	AR	3
605093	12q24.12	Erythrocytosis, somatic	133100	_	3
605093	12q24.12	Myelofibrosis, somatic	254450	_	3
605093	12q24.12	Thrombocythemia, somatic	187950	_	3
606979	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
607357	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
604124	18q11.2	Jawad syndrome	251255	AR	3
604124	18q11.2	Pancreatic carcinoma, somatic	_	_	3
604124	18q11.2	Seckel syndrome 2	606744	AR	3
607584	13q14	Spastic paraplegia 24, autosomal recessive	607584	AR	2
607115	1q44	CINCA syndrome	607115	AD	3
605394	6q15	Immunodeficiency 60	618394	AD	3
605724	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
606000	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
603741	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
603103	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
603157	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
605387	20q11.22	Cataract 31, multiple types	605387	AD	3
605280	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
603013	8p21	{Schizophrenia}	181500	AD	2
605204	9q34.11	Dystonia-1, torsion	128100	AD	3
605204	9q34.11	{Dystonia-1, modifier of}	_	_	3
606579	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
603198	17q21.2	Lipodystrophy, congenital generalized, type 4	613327	AR	3
607212	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
606673	22q11.23	Beta-ureidopropionase deficiency	613161	AR	3
607206	17p13.1	Ichthyosis, congenital, autosomal recessive 3	606545	AR	3
604574	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
603116	22q12-q13	CDAGS syndrome	603116	AR	2
604011	17q11.2	?Cone-rod dystrophy	_	_	3
604011	17q11.2	?Immunodeficiency 13	615518	AD	3
607078	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
603701	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
605388	9p12-q12	Cerebral palsy, ataxic, autosomal recessive	605388	AR	2
606995	3q22	Senior-Loken syndrome 3	606995	AR	2
605711	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
607116	20p	Alzheimer disease 8	607116	_	2
605753	4q12	?Spermatogenic failure 29	618091	AR	3
603499	18q21.33	Osteolysis, familial expansile	174810	AD	3
603499	18q21.33	Osteopetrosis, autosomal recessive 7	612301	AR	3
603499	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
605375	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
606980	1q42.13	Coenzyme Q10 deficiency, primary, 4	612016	AR	3
605747	1p36.11	Hypercholesterolemia, familial, 4	603813	AR	3
603158	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
606685	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
606996	1p36.31	Senior-Loken syndrome 4	606996	AR	3
607207	16p13.3	?Spinocerebellar ataxia 48	618093	AD	3
607207	16p13.3	Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3
606389	11q13.1	Spermatogenic failure 7	612997	AR	3
606668	16p	{Inflammatory bowel disease 8}	606668	_	2
605083	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
603674	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
607836	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
606785	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
605748	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
606347	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
607880	2p13.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3
605906	10q23.2	Cardiomyopathy, dilated, 1C, with or without LVNC	601493	AD	3
605906	10q23.2	Cardiomyopathy, hypertrophic, 24	601493	AD	3
605906	10q23.2	Left ventricular noncompaction 3	601493	AD	3
605906	10q23.2	Myopathy, myofibrillar, 4	609452	AD	3
603914	11p15.4	Mental retardation, autosomal recessive 67	618295	AR	3
603283	6q22.31	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	AR	3
607805	2q11.2	Jalili syndrome	217080	AR	3
607683	5q31.1-q32	Deafness, autosomal dominant 52	607683	AD	2
605712	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
607117	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
603218	20p13	Huntington disease-like 1	603218	AD	3
605414	19p13.3	{Alzheimer disease 9, susceptibility to}	608907	AD	3
607541	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
603702	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
606688	20p13	Prion disease with protracted course	606688	AD	3
604846	2q14.3	{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3
605749	9q13-q22	Cataract 26, multiple types	605749	_	2
604352	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
606348	5q31	{Inflammatory bowel disease 5}	606348	_	2
605907	16p13.3	Congenital disorder of glycosylation, type Ik	608540	AR	3
604299	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
605084	10q22.1	Myopathy with extrapyramidal signs	615673	AR	3
607066	17p13.2	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3
607066	17p13.2	Olmsted syndrome	614594	AD	3
605178	16q24.3	Ciliary dyskinesia, primary, 33	616726	AR	3
606272	17p13.2	Cystinosis, atypical nephropathic	219800	AR	3
606272	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
606272	17p13.2	Cystinosis, nephropathic	219800	AR	3
606272	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
603284	7p13	Cerebral cavernous malformations-2	603284	AD	3
604450	17q24.2	Stankiewicz-Isidor syndrome	617516	AD	3
604505	14q32.12	Achondrogenesis, type IA	200600	AR	3
604505	14q32.12	Osteochondrodysplasia	184260	AR	3
603622	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
607932	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
603015	7q22.1	Developmental delay with or without dysmorphic facies and autism	618454	AD	3
608040	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
604912	8q24.12	Mental retardation, autosomal recessive 40	615599	AR	3
605518	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
603543	3q28	Limb-mammary syndrome	603543	AD	3
605775	5q31.2	Pseudohypoaldosteronism, type IID	614495	AR,AD	3
607446	6q23-q25	[Body mass index QTL3]	607446	_	2
607795	9q32	Retinitis pigmentosa 70	615922	AD	3
605237	1q25.3	Basal ganglia calcification, idiopathic, 6	616413	AD	3
605355	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
605738	15q12-q15	Microphthalmia with coloboma 2	605738	_	2
606014	1p13.3	Frontonasal dysplasia 1	136760	AR	3
607194	10p12.2	Pancreatic agenesis 2	615935	AR	3
607194	10p12.2	Pancreatic and cerebellar agenesis	609069	AR	3
603200	19p13.11	MHC class II deficiency, complementation group B	209920	AR	3
605419	15q15	{Schizophrenia 10}	605419	AD	2
603285	3q26.1	Cerebral cavernous malformations 3	603285	_	3
604142	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
605423	12q13.12	46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	_	3
605423	12q13.12	46XY sex reversal 7	233420	AR	3
607939	3p26.1	Multiple sulfatase deficiency	272200	AR	3
604918	7q21.11	?Pontocerebellar hypoplasia, type 3	608027	AR	3
603623	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
605750	11p13-p12	Exudative vitreoretinopathy 3	605750	AD	2
605384	4q27	?Immunodeficiency, common variable, 11	615767	AR	3
608029	20q11-q13	Spinocerebellar ataxia, autosomal recessive 6	608029	AR	2
608212	5q33.1	{Inflammatory bowel disease (Crohn disease) 19}	612278	_	3
608212	5q33.1	{Mycobacterium tuberculosis, protection against}	607948	_	3
607118	3q22.1	Combined oxidative phosphorylation deficiency 9	614582	AR	3
604934	1q42.3	Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3
604934	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
604934	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
607800	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
607800	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
605720	11q13.1	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3
606852	1p32	{Parkinson disease 10}	606852	_	2
606928	1p36	[Bone mineral density QTL 3]	606928	_	2
607585	11q22.3	Ataxia-telangiectasia	208900	AR	3
607585	11q22.3	Lymphoma, B-cell non-Hodgkin, somatic	_	_	3
607585	11q22.3	Lymphoma, mantle cell, somatic	_	_	3
607585	11q22.3	T-cell prolymphocytic leukemia, somatic	_	_	3
607585	11q22.3	{Breast cancer, susceptibility to}	114480	SMu,AD	3
607542	11p15.5-p15.4	Atrial fibrillation, familial, 3	607554	AD	3
607542	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
607542	11p15.5-p15.4	Long QT syndrome 1	192500	AD	3
607542	11p15.5-p15.4	Short QT syndrome 2	609621	AD	3
607542	11p15.5-p15.4	{Long QT syndrome 1, acquired, susceptibility to}	192500	AD	3
606725	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
606725	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
605565	19p13.2	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
605565	19p13.2	{Hypertension, insulin resistance-related, susceptibility to}	125853	AD	3
608300	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
602937	6q24.1	Atrial septal defect 8	614433	AD	3
602937	6q24.1	Ventricular septal defect 2	614431	AD	3
605113	7q31.32	Hyperlysinemia	238700	AR	3
605113	7q31.32	Saccharopinuria	268700	AR	1
603046	8q24.13	Renal cell carcinoma	144700	_	3
608206	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
608206	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
608318	14q32	{Coronary heart disease, susceptibility to, 4}	608318	_	2
605739	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
605908	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603658	2p25.3	Diamond-Blackfan anemia 8	612563	AD	3
603273	3q28	ADULT syndrome	103285	AD	3
603273	3q28	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3
603273	3q28	Hay-Wells syndrome	106260	AD	3
603273	3q28	Limb-mammary syndrome	603543	AD	3
603273	3q28	Orofacial cleft 8	618149	_	3
603273	3q28	Rapp-Hodgkin syndrome	129400	AD	3
603273	3q28	Split-hand/foot malformation 4	605289	AD	3
606159	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
605519	18p11.31	Majeed syndrome	609628	_	3
603945	3q27.1	Leukoencephalopathy with vanishing white matter	603896	AR	3
603945	3q27.1	Ovarioleukodystrophy	603896	AR	3
605238	2q22.1	Mental retardation, autosomal recessive 51	616739	AR	3
605238	2q22.1	{Asthma, susceptibility to}	600807	AD	3
607906	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
604590	1q23.3	{Malaria, resistance to}	611162	_	3
604590	1q23.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
605356	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
603537	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
607562	1p31.3	{Inflammatory bowel disease 17, protection against}	612261	_	3
607562	1p31.3	{Psoriasis, protection against}	605606	_	3
606726	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
606726	20q13.12	{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3
607200	15q21.1	Thyroid dyshormonogenesis 6	607200	AR	3
608520	12q22-q23.2	Major depressive disorder 1	608516	_	2
605751	16p11.2	Seizures, benign familial infantile, 2	605751	AD	3
602938	9q31.1	Hypercholanemia, familial	607748	AR	3
607080	12q13.12	46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	_	3
608455	11q13.1	McArdle disease	232600	AR	3
604439	4q31.21	?Deafness, autosomal recessive 26	605428	AR	3
603236	16q24.2	Porokeratosis 7, multiple types	614714	AD	3
604607	17q21.32	{Prostate cancer, hereditary, 9}	610997	_	3
604799	15q25.2	?Deafness, autosomal dominant 68	616707	AD	3
605109	15q22.31	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3
608207	22q12	{Kala-azar, susceptibility to, 1}	608207	_	2
608630	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
606879	1p12	Neu-Laxova syndrome 1	256520	AR	3
606879	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
608329	11q12.2	Cardiac-urogenital syndrome	618280	AD	3
608329	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
608030	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
603946	10q23.33	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3
608109	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
607941	8p23.1	Atrial septal defect 2	607941	AD	3
608703	2p21-p13	Spinocerebellar ataxia 25	608703	AD	2
608500	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
608631	17p13	{Asperger syndrome susceptibility 2}	608631	IC,Mu	2
605201	11q23.3	High density lipoprotein cholesterol level QTL14	605201	_	2
605566	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
603415	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 7	613863	AD	3
603415	2q24.3	Erythermalgia, primary	133020	AD	3
603415	2q24.3	Febrile seizures, familial, 3B	613863	AD	3
603415	2q24.3	HSAN2D, autosomal recessive	243000	AR	3
603415	2q24.3	Insensitivity to pain, congenital	243000	AR	3
603415	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
603415	2q24.3	Small fiber neuropathy	133020	AD	3
603415	2q24.3	{Dravet syndrome, modifier of}	607208	AD	3
607210	7p22.2	B-cell expansion with NFKB and T-cell anergy	616452	AD	3
607210	7p22.2	Immunodeficiency 11A	615206	AR	3
607210	7p22.2	Immunodeficiency 11B with atopic dermatitis	617638	AD	3
608456	1p34.1	Adenomas, multiple colorectal	608456	AR	3
605713	14q24.3	Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3
608815	6p12.2	{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3
608815	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
606674	19p13	{Inflammatory bowel disease 6}	606674	_	2
606593	13q33.3	LIG4 syndrome	606593	AR	3
608677	18q11.2	Left ventricular noncompaction 7	615092	AD	3
608798	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
603089	3p21.1	Tumor predisposition syndrome	614327	AD	3
608340	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
608885	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
608474	17q21-q22	Myopia 5	608474	AD	2
607478	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
607478	12q21.1	{Unipolar depression, susceptibility to}	608516	_	3
603286	1q32.1	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3
608810	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
605870	13q12.13	?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	AR	3
608248	12q13.13	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3
608248	12q13.13	?Hypotrichosis 3	613981	AD	3
608248	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
605420	11p11.2	Frontonasal dysplasia 2	613451	AR	3
605420	11p11.2	Parietal foramina 2	609597	AD	3
605420	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
608307	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
608307	2q34	{Pulmonary hypertension, neonatal, susceptibility to}	615371	_	3
604332	4q12	{Leukemia, acute myeloid}	601626	SMu,AD	3
607211	17q25.3	Pityriasis rubra pilaris	173200	AD	3
607211	17q25.3	Psoriasis 2	602723	AD	3
608995	1p36-p34	{Dyslexia, susceptibility to, 8}	608995	Mu,AD	2
603276	1q23.3	[Blood pressure regulation QTL]	145500	Mu	2
608251	Chr.14	Phobia, specific	608251	_	2
608799	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
608641	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608930	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AR,AD	3
608542	19q13	Aneurysm, intracranial berry, 2	608542	_	2
608894	6q23.3	Joubert syndrome 3	608629	AR	3
608470	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
607640	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
608673	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
606595	7q11.23	Charcot-Marie-Tooth disease, axonal, type 2F	606595	AD	3
603287	17q21.32	Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3
608214	11q24.1	Atrial fibrillation, familial, 16	613120	AD	3
608214	11q24.1	Brugada syndrome 7	613120	AD	3
608625	17q23.1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3
606621	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
605202	9q22.33	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442	AR	3
609200	5q31.2	Myopathy, myofibrillar, 3	609200	AD	3
608471	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
603234	16p13.11	Arterial calcification, generalized, of infancy, 2	614473	AR	3
603234	16p13.11	Pseudoxanthoma elasticum	264800	AR	3
603234	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
607544	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
605435	14q12	Congenital heart defects and ectodermal dysplasia	617364	AD	3
608543	1p36.2	{Schizophrenia 12}	181500	AD	2
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
608507	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
604593	2q23.1-q23.2	Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3
607734	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AR,AD	3
603277	12p13.31	Sifrim-Hitz-Weiss syndrome	617159	AD	3
609220	3q24	Bruck syndrome 2	609220	AR	3
609369	11q13.1	Neuropathy, hereditary sensory, type IF	615632	AD	3
608626	17q23.3	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3
609044	10q23.33	{Obesity, susceptibility to}	607514	_	3
604860	18q21.32	Immunodeficiency 12	615468	AR	3
607641	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
609338	3p25.2	Carotid intimal medial thickness 1	609338	_	3
609242	22q13.2	Kanzaki disease	609242	AR	3
608862	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
607617	12q15	?Ovarian dysgenesis 6	618078	AR	3
607617	12q15	Galloway-Mowat syndrome 7	618348	AR	3
607617	12q15	Nephrotic syndrome, type 11	616730	AR	3
608627	20q13.32	Amyotrophic lateral sclerosis 8	608627	AD	3
608896	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
608210	11p11.2	?Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3
608210	11p11.2	Exostoses, multiple, type 2	133701	AD	3
608812	9q22.33	{Colorectal cancer, susceptibility to, 1}	608812	_	3
608643	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
609136	22q13.1	PCWH syndrome	609136	AD	3
608381	2q31.3	Retinitis pigmentosa 26	608380	_	3
608965	11q13.2	Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3
606976	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
606976	16q22.1	Saul-Wilson syndrome	618150	AD	3
607608	11p15.4	Niemann-Pick disease, type A	257200	AR	3
607608	11p15.4	Niemann-Pick disease, type B	607616	AR	3
606002	9q34.13	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3
609506	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
609291	15q14	Legius syndrome	611431	AD	3
606622	2q35	Schimke immunoosseous dysplasia	242900	AR	3
608644	5p15.2	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	_	3
609458	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
608903	16p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
610032	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
610261	20q11-q13	{Hypertension, essential, susceptibility to, 5}	145500	Mu	2
610213	5p15.2-p14.3	Aneurysm, intracranial berry, 4	610213	_	2
609132	1p36.12	Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3
610224	9q34.3	Ovarian dysgenesis 5	617690	AR	3
610224	9q34.3	Spermatogenic failure 32	618115	AD	3
609213	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
609139	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
609139	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
610362	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
610362	19p13.3	Cone-rod dystrophy 11	610381	AD	3
607642	17p11.2	Smith-Magenis syndrome	182290	IC,AD	3
610377	12q24.11	Mevalonic aciduria	610377	AR	3
609821	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
606977	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
606977	13q14.11	Shaheen syndrome	615328	AR	3
610168	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
610498	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
609342	11q12.1	Intrinsic factor deficiency	261000	AR	3
609041	10q22.1-q24.1	Spastic paraplegia 27, autosomal recessive	609041	AR	2
608864	1q32.2	{Orofacial cleft 6}	608864	AD	3
608675	16q22.1	Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3
610512	20p11.23	?Cowden syndrome 7	616858	AD	3
610512	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
603743	22q12.3	{End-stage renal disease, nondiabetic, susceptibility to}	612551	_	3
603743	22q12.3	{Glomerulosclerosis, focal segmental, 4, susceptibility to}	612551	_	3
609815	3p21.31	Zygodactyly 1	609815	_	2
610274	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
609549	11q23.3	Nanophthalmos 2	609549	_	3
610243	10q24.2	Spastic paraplegia 33, autosomal dominant	610244	AD	3
610767	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
607643	17q25.3	Retinitis pigmentosa 30	607921	_	3
603278	19q13.2	Glomerulosclerosis, focal segmental, 1	603278	AD	3
610838	21p13-q11	{Autism susceptibility 12}	610838	_	2
610832	16p12.2	Fanconi anemia, complementation group N	610832	_	3
610127	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
608800	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
611182	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
609891	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
609140	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
610163	1q24.2	?Immunodeficiency 25	610163	AR	3
610079	11q24.2	{Autoimmune disease, susceptibility to, 6}	613551	_	3
610262	5p13-q12	{Hypertension, essential, susceptibility to, 6}	145500	Mu	2
610915	1p34.2	Osteogenesis imperfecta, type VIII	610915	AR	3
606273	1p34.1	Leukoencephalopathy with vanishing white matter	603896	AR	3
611150	22q13.31	Spinocerebellar ataxia 10	603516	AD	3
609319	6q23	[Hematocrit/hemoglobin quantitative trait locus 1]	609319	_	2
610363	1p36.13	Preimplantation embryonic lethality 2	617234	AR	3
610244	10q24.2	Spastic paraplegia 33, autosomal dominant	610244	AD	3
610523	7q32.2	Joubert syndrome 15	614464	AR	3
604801	1q42	Muscular dystrophy, congenital, 1B	604801	AR	2
611220	17q12	?Cataract 43	616279	AD	3
610928	8q11.23	Vesicoureteral reflux 3	613674	AD	3
610713	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
605557	1p36.32	Cardiomyopathy, dilated, 1LL	615373	AD	3
605557	1p36.32	Left ventricular noncompaction 8	615373	AD	3
610768	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
611102	15q15.3	Deafness and male infertility	611102	AR	4
609507	9p21.1	Retinitis pigmentosa 31	609923	_	3
610565	22q13.1	?Mirror movements 3	616059	AR	3
607545	4q32.3	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3
609340	14q22.1	Spastic paraplegia 28, autosomal recessive	609340	AR	3
609129	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
606489	9p13.2	Pontocerebellar hypoplasia, type 1B	614678	AR	3
603680	13q21.33	Spinocerebellar ataxia 8	608768	AD	3
603680	13q21.33	{Parkinson disease, susceptibility to}	168600	Mu,AD	3
610733	2p22.1	Noonan syndrome 4	610733	AD	3
610128	12q23.3	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3
610839	2q33.3	{Osteoarthritis susceptibility 4}	610839	_	2
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	AD	3
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	AD	3
605597	3q22.3	Premature ovarian failure 3	608996	AD	3
610873	22q13	{Menarche, age at, QTL}	610873	_	2
610263	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
608801	19p13.13	Glutaricaciduria, type I	231670	AR	3
610707	16q	{Psoriasis susceptibility 8}	610707	_	2
610745	15q24.1	Microphthalmia, isolated, with coloboma 8	601186	AR	3
610745	15q24.1	Microphthalmia, syndromic 9	601186	AR	3
610444	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
610245	20p13	Spinocerebellar ataxia 23	610245	AD	3
611174	16q12.2	Hamamy syndrome	611174	AR	3
610916	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
611228	6q21	Charcot-Marie-Tooth disease, type 4J	611228	AR	3
609913	1p21.3-p13.3	Retinitis pigmentosa 32	609913	_	2
610805	1q32.1	Congenital anomalies of kidney and urinary tract 1	610805	AD	3
609552	2q11.2	?Mental retardation, autosomal recessive, 52	616887	AR	3
608423	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
609508	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
611448	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
610531	7p15.3	Leukodystrophy, hypomyelinating, 5	610532	AR	3
610876	6q16.3	Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3
605598	5q31.1-q33.1	{Diabetes mellitus, insulin-dependent, 18}	605598	_	2
609893	15q25.3-q26.1	Hypothyroidism, congenital, nongoitrous, 3	609893	_	2
611588	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
610865	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
610142	12q21.32	?Bardet-Biedl syndrome 14	615991	AR	3
610142	12q21.32	Joubert syndrome 5	610188	AR	3
610142	12q21.32	Leber congenital amaurosis 10	611755	_	3
610142	12q21.32	Meckel syndrome 4	611134	AR	3
610142	12q21.32	Senior-Loken syndrome 6	610189	AR	3
610708	12p11.21	Optic atrophy 5	610708	AD	3
610226	17q25.3	Seborrhea-like dermatitis with psoriasiform elements	610227	_	3
610600	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
607882	8q24.3	Brown-Vialetto-Van Laere syndrome 2	614707	AR	3
608428	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
610246	18p11.21	Spinocerebellar ataxia 28	610246	AD	3
611082	22q12.1	{Myocardial infarction, susceptibility to}	608446	_	3
609633	21q22.13	{Major affective disorder 3, early onset}	609633	_	2
610911	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
610739	16p12.1	?Epilepsy, familial adult myoclonic, 6	618074	_	3
609144	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
609376	19q13	Cataract 35, congenital nuclear	609376	AR	2
610746	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
611103	3q21.3	Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3
611152	1q21	{Alzheimer disease-13}	611152	_	2
608807	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
610293	1q23.2	Glycosylphosphatidylinositol deficiency	610293	AR	3
611369	19p13.3	Lethal congenital contractural syndrome 3	611369	AR	3
610528	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
609299	3p26	{Prostate cancer, hereditary, 5}	609299	_	2
608437	12q24	{Systemic lupus erythematosus, susceptibility to, 4}	608437	_	2
611131	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
610297	2p13.1	{Parkinson disease 13}	610297	_	3
609218	16q23.3	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3
609048	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
609245	1p13.3	Chudley-McCullough syndrome	604213	AR	3
611762	19q13.42	Familial cold autoinflammatory syndrome 2	611762	AD	3
609862	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
609300	10q24.32	17,20-lyase deficiency, isolated	202110	AR	3
609300	10q24.32	17-alpha-hydroxylase/17,20-lyase deficiency	202110	AR	3
610345	7q34	Cataract 38, autosomal recessive	614691	AR	3
610345	7q34	Sengers syndrome	212350	AR	3
610912	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
605740	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
605740	17q21.31	Sclerosteosis 1	269500	AR	3
605740	17q21.31	Van Buchem disease	239100	AR	3
611104	12p11.21	Charcot-Marie-Tooth disease, type 4H	609311	AR	3
609489	4q24	Mannosidosis, beta	248510	AR	3
609161	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
609460	10q22.1	Goldberg-Shprintzen megacolon syndrome	609460	AR	3
610532	7p15.3	Leukodystrophy, hypomyelinating, 5	610532	AR	3
605845	5q31-q33	{Dermatitis, atopic, susceptibility to, 6}	605845	_	2
608576	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
608576	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608576	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
607483	2q36.3	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	AR	3
608488	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
610445	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
606003	11p15.5	Transaldolase deficiency	606003	AR	3
609049	3p21.31	Pierson syndrome	609049	AR	3
611204	14q32.11-q32.12	?Spinocerebellar ataxia 40	616053	AD	3
611204	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
611456	6p23	Essential tremor, hereditary, 3	611456	_	2
609863	12q24.11	Joubert syndrome 13	614173	AR	3
611184	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
611184	16q24.3	Lymphatic malformation 6	616843	AR	3
611647	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
611153	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
610743	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
608586	3p14-q13	Keratoconus 3	608586	_	2
612078	16q24.2	Brittle cornea syndrome 1	229200	AR	3
605437	14q23.1	{Cerebral infarction, susceptibility to}	601367	Mu	3
610812	16q22.2	Ciliary dyskinesia, primary, 5	608647	AR	3
610913	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
611739	11p12	{Osteoporosis}	166710	AD	2
607622	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
604862	2p13.3	[?Birbeck granule deficiency]	613393	_	3
608489	7q22.1	Premature ovarian failure 8	615723	AR	3
609689	20q11.22	Cone-rod dystrophy and hearing loss 2	618358	AR	3
608808	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
606978	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
612291	3q11.1-q11.2	Joubert syndrome 8	612291	AR	3
609889	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
611770	8p21.2	Conotruncal heart malformations	217095	_	3
611770	8p21.2	Persistent truncus arteriosus	217095	_	3
612285	4p15.32	Joubert syndrome 9	612285	AR	3
610083	4q34.3-q35.1	Microphthalmia, isolated, with coloboma 9	615145	AR	3
604809	6p21.3	Panbronchiolitis, diffuse	604809	Mu	2
609273	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
612222	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
611185	6p21	{Restless legs syndrome 6}	611185	_	2
610725	10q23.33	Nephrotic syndrome, type 3	610725	AR	3
612411	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
612411	4q28.1	Van Maldergem syndrome 2	615546	AR	3
610568	1q21.3	Paget disease of bone 6	616833	AD	3
611722	10q22.1	Krabbe disease, atypical	611722	AR	3
611105	1q25.1	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3
612138	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
612465	13q22.2	{Diabetes mellitus, noninsulin-dependent, 5}	616087	_	3
610170	5p13	Kyphoscoliosis 1	610170	_	2
610446	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
608968	20q12	Duane retraction syndrome 3	617041	AD	3
608968	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
612448	8q24.13-q24.22	{Age-related hearing impairment 1}	612448	_	2
609173	15q15.1	Microcephaly 4, primary, autosomal recessive	604321	AR	3
611590	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
603539	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
612079	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
612348	8p12	?Thrombophilia due to decreased release of tissue plasminogen	_	_	1
608075	12p12.3	?Spermatogenic failure 17	617214	AR	3
611648	5q21.1	Deafness, autosomal recessive 100	618422	AR	3
611687	6q13	Hydatidiform mole, recurrent, 2	614293	AR	3
610217	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
610294	6p25.3-p22.3	{Intelligence QTL3}	610294	_	2
612267	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
609690	2q36.1	Rajab interstitial lung disease with brain calcifications	613658	AR	3
604594	2p21	Short stature with microcephaly and distinctive facies	615789	AR	3
611766	15q22.31	Combined oxidative phosphorylation deficiency 15	614947	AR	3
611766	15q22.31	Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3
612923	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
607736	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
608025	2p24.3	Infantile liver failure syndrome 2	616483	AR	3
608025	2p24.3	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3
612775	8p11.22	Cone-rod dystrophy 9	612775	_	3
611223	1q43-q44	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3
607492	11q13.1-q13.2	Schuurs-Hoeijmakers syndrome	615009	AD	3
610618	5q35.3	Angioedema, hereditary, type III	610618	AD	3
613085	14q24.3	Glaucoma 3, primary congenital, C	613085	_	2
610143	12p13.2-p11.23	Deafness, autosomal recessive 62	610143	AR	2
612958	17q23.3	Mitochondrial complex IV deficiency	220110	Mi,AR	3
612716	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
612176	1p32.1	Bone marrow failure syndrome 4	618116	AR	3
613092	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
608448	3p26	{Inflammatory bowel disease 9}	608448	_	2
611994	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
611771	19q13.32	Lipoprotein glomerulopathy	611771	_	3
611603	12q13.12	Lissencephaly 3	611603	AD	3
604863	4q32.1	Leber congenital amaurosis 14	613341	AR	3
604863	4q32.1	Retinal dystrophy, early-onset severe	613341	AR	3
604863	4q32.1	Retinitis pigmentosa, juvenile	613341	AR	3
613168	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
612286	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
613161	22q11.23	Beta-ureidopropionase deficiency	613161	AR	3
611459	4q31.22	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3
612192	6p22.1	Diabetes mellitus, transient neonatal, 1	601410	AD	3
612224	4q31	{Stature QTL 12}	612224	_	2
609165	17q21.2	Ichthyosis with confetti	609165	AD	3
613251	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
611945	8p21.1-q13.3	Spastic paraplegia 37, autosomal dominant	611945	AD	2
612132	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
613027	16p11.2	Glycogen storage disease IXc	613027	AR	3
610295	2q24.1-q31.1	{Intelligence QTL3}	610295	_	2
613265	20q13.32	Waardenburg syndrome, type 4B	613265	AR,AD	3
613235	1q31.3	Factor XIIIB deficiency	613235	AR	3
612518	14q21.3	Ciliary dyskinesia, primary, 10	612518	_	3
613228	4q34.3	Aspartylglucosaminuria	208400	AR	3
611307	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
612690	15q15.2	Spherocytosis, type 5	612690	_	3
610508	2p25.1	Maturity-onset diabetes of the young, type VII	610508	_	3
609820	1q42.2	Erythrocytosis, familial, 3	609820	AD	3
610836	1q41-q42	{Autism susceptibility 11}	610836	_	2
612350	11p11.2	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3
608026	9q31-q32	Hypertensive nephropathy	608026	_	2
612924	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
612268	14q24.3	Cone-rod dystrophy 19	615860	AR	3
613179	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
613413	7p21.3	Leukodystrophy, hypomyelinating, 16	617964	AD	3
608316	2q21.1-q22	{Coronary heart disease, susceptibility to, 2}	608316	_	2
612080	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
611203	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
609946	2p25.1-p24.3	Deafness, neurosensory, autosomal recessive 47	609946	AR	2
610921	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
611224	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
609562	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
609562	8q13.2	Febrile seizures, familial, 11	614418	AR	3
613086	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
613019	11q12.2	Paragangliomas 2	601650	AD	3
604597	12q14.3	Fraser syndrome 3	617667	AR	3
612647	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
612406	20p11.2-q13.12	Dystonia-17, primary torsion	612406	AR	2
608931	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
609456	4p16.3	Muscular dystrophy, congenital, merosin-positive	609456	AR	2
608537	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
608537	3p25.3	Hemangioblastoma, cerebellar, somatic	_	_	3
608537	3p25.3	Pheochromocytoma	171300	AD	3
608537	3p25.3	Renal cell carcinoma, somatic	144700	_	3
608537	3p25.3	von Hippel-Lindau syndrome	193300	AD	3
611469	8q24	{Colorectal cancer, susceptibility to, 2}	611469	_	2
612292	8q24.3	Birk-Barel mental retardation dysmorphism syndrome	612292	_	3
613480	1q42.13	Lymphatic malformation 3	613480	AD	3
608622	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
613169	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
609275	1q41	Martsolf syndrome	212720	AR	3
609275	1q41	Warburg micro syndrome 2	614225	AR	3
613098	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
610619	5q35.3	Angioedema, hereditary, type III	610618	AD	3
610619	5q35.3	Factor XII deficiency	234000	AR	3
612959	8q22.1	?Deafness, autosomal recessive 109	618013	AR	3
610178	14q23.1	Joubert syndrome 23	616490	AR	3
610178	14q23.1	Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3
610357	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
613541	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
613541	12q24.31	Spastic paraplegia 55, autosomal recessive	615035	AR	3
611357	6q14.1	Osteogenesis imperfecta, type XVIII	617952	AR	3
613695	21q22.12	Long QT syndrome 5	613695	AD	3
611252	14q12-q21	Spastic paraplegia 32, autosomal recessive	611252	AR	2
612287	17q25.1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3
609270	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
613719	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
613028	10q23.31	{Glioma susceptibility 2}	613028	_	3
613728	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
612437	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
612925	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
613768	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
611421	16p11.2	Floating-Harbor syndrome	136140	AD	3
612444	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
612529	11q22.2	Amelogenesis imperfecta, type IIA2	612529	AR	3
613744	15q21.2	Spastic paraplegia 51, autosomal recessive	613744	AR	3
606675	14q11-q12	{Inflammatory bowel disease 4}	606675	_	2
608595	7p14.3	{Asthma, susceptibility to, 2}	608584	_	3
612186	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
612186	15q21.2	?Polyendocrine-polyneuropathy syndrome	616113	AR	3
610448	3p21.31	Chilblain lupus	610448	AD	3
613153	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3
613762	5q11.2	46XY sex reversal 6	613762	AD	3
613835	1q31.3	Leber congenital amaurosis 8	613835	_	3
612225	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
608027	7q21.11	?Pontocerebellar hypoplasia, type 3	608027	AR	3
613162	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
613869	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
612757	8q24.3	Hyperlipoproteinemia, type 1D	615947	AR	3
613883	7q34	[Blood group, Kell]	110900	_	3
608932	16q22.3-q23.1	Keratoconus 2	608932	_	2
614037	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
613087	4q32.3	Atrial septal defect 6	613087	AD	3
612988	11q14.1	Optic atrophy 7	612989	AR	3
613521	1p34.1	Porphyria cutanea tarda	176100	AR,AD	3
613521	1p34.1	Porphyria, hepatoerythropoietic	176100	AR,AD	3
609367	10q22.1	Goldberg-Shprintzen megacolon syndrome	609460	AR	3
614044	7q34	Trypsinogen deficiency	614044	AR	1
613500	22q11.23	Agammaglobulinemia 2	613500	AR	3
613099	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
612293	1p31.3-p31.1	Porokeratosis 5, disseminated superficial actinic	612293	_	2
611849	2q36.1	?Combined oxidative phosphorylation deficiency 16	615395	AR	3
610361	13q33.1-q34	Orofacial cleft 9	610361	_	2
612199	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
611958	11q13	{Prostate cancer, hereditary, 14}	611958	_	2
611891	9p21	{Aneurysm, familial abdominal 3}	611891	_	2
613553	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613230	19q13.11	Prolidase deficiency	170100	AR	3
612288	10q23-q24	{Inflammatory bowel disease 20}	612288	_	2
613920	2q11.2	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3	616500	AR	3
612051	16q21	Spinocerebellar ataxia 31	117210	AD	3
611553	3p25.2	Noonan syndrome 5	611553	AD	3
609271	2p24	Keratoconus 4	609271	_	2
604632	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
613252	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
613636	11p14	[Tuberculin skin test reactivity, absence of]	613636	_	2
608769	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
607883	17p13.2	Riboflavin deficiency	615026	AD	3
609276	11q25	Microcephaly 22, primary, autosomal recessive	617984	AR	3
613720	20q13.33	Epileptic encephalopathy, early infantile, 7	613720	AD	3
614237	10q11.23-q22.3	Hypotrichosis 9	614237	AR	2
611134	12q21.32	Meckel syndrome 4	611134	AR	3
614303	15q25.1	EDICT syndrome	614303	AD	3
614067	14q12	Spastic paraplegia 52, autosomal recessive	614067	AR	3
611623	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
614258	10q22.3	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3
614258	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
608439	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
614402	10q25.3	?Microphthalmia, syndromic 11	614402	AR	3
614374	6p21.33	[Blood group, Rodgers]	614374	_	3
609479	2q31.1	Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3
609479	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
613763	11q23.1	Cataract 16, multiple types	613763	AR,AD	3
614280	2q33-q36	{Epilepsy, juvenile myoclonic, susceptibility to, 9}	614280	AD	2
613884	13q14	Chromosome 13q14 deletion syndrome	613884	IC,AD	4
614478	12q13.12	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
613224	1p13.2	Noonan syndrome 6	613224	AD	3
614319	18q12.3	Vesicoureteral reflux 6	614319	_	2
614039	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
612462	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
612926	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
614381	12q23.3	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3
613021	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
613164	1q32	{Parkinson disease 16}	613164	_	2
613029	13q13.1	{Glioblastoma 3}	613029	AR	3
613969	5p15.1-p13.3	Myopia 19	613969	AD	2
612226	4p15.3	{Stature QTL 13}	612226	_	2
614433	6q24.1	Atrial septal defect 8	614433	AD	3
613289	13q21	Spinocerebellar ataxia 8	608768	AD	3
614135	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
609948	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
613836	16q23.3	{Adiponectin, serum level of, QTL5]	613836	_	2
611862	1q23.2	[White blood cell count QTL]	611862	AR	3
613814	17p12	Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3
614120	15q26.1	?Hydrolethalus syndrome 2	614120	AR	3
612082	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
614165	5p15.33	Paragangliomas 5	614165	AD	3
614199	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
613154	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3
613192	8q24.3	Mental retardation, autosomal recessive 13	613192	AR	3
613176	19q13.31	Heart and brain malformation syndrome	616920	AR	3
612989	11q14.1	Optic atrophy 7	612989	AR	3
613870	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
614616	12p12.3	Diarrhea 6	614616	AD	3
613958	12q14.2	Spermatogenic failure 9	613958	AR	3
610374	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
613915	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
611096	16p12.2-q12.1	Mental retardation, autosomal recessive 10/20	611096	AR	2
613064	11q13.5	{Dermatitis, atopic, susceptibility to, 7}	613064	_	2
611554	3p25.2	LEOPARD syndrome 2	611554	_	3
612758	4p15.32	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3
611236	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
614672	7q21.2	?Cardiomyopathy, dilated, 2B	614672	AR	3
613721	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
613794	1p31.3	Retinitis pigmentosa 20	613794	AR	3
614238	7p22.3-p21.3	Hypotrichosis 10	614238	AR	2
614382	11q24.2	{Bacteremia, protection against}	614382	_	3
614727	4q12	Congenital disorder of glycosylation, type IIk	614727	AR	3
609806	11q23.3	Porphyria, acute intermittent	176000	AD	3
609806	11q23.3	Porphyria, acute intermittent, nonerythroid variant	176000	AD	3
614691	7q34	Cataract 38, autosomal recessive	614691	AR	3
614290	18p	Tetrasomy 18p	614290	_	4
613340	4q24-q28	Epilepsy, hot water, 2	613340	_	2
608770	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
607904	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
607904	16p13.3	{Epilepsy, childhood absence, susceptibility to, 6}	611942	_	3
607904	16p13.3	{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942	_	3
613854	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
613970	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
612463	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
613165	17q25.3	Desbuquois dysplasia 1	251450	AR	3
613165	17q25.3	Epiphyseal dysplasia, multiple, 7	617719	AR	3
613522	7q32.1	Colorblindness, tritan	190900	AD	3
614375	12q13.3	Aortic aneurysm, familial abdominal, 4	614375	_	2
612227	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AR,AD	3
603909	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
609168	3p24.3	Chronic atrial and intestinal dysrhythmia	616201	AR	3
609678	13q31.1	?Trichotillomania	613229	Mu,AD	3
609678	13q31.1	Tourette syndrome	137580	AD	3
614852	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613573	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
614166	13q12.12	Myopia 20, autosomal dominant	614166	_	2
613885	12q24.31	?Meckel syndrome 8	613885	AR	3
614193	6p22.2	[Transferrin serum level QTL2]	614193	_	3
613837	7q32.1	Leber congenital amaurosis 11	613837	AD	3
614501	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
614976	19q13.2	Carpenter syndrome 2	614976	AR	3
614397	1p34.2	Microcephaly 15, primary, autosomal recessive	616486	AR	3
612289	1p13.3	Fontaine progeroid syndrome	612289	AD	3
614893	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
612759	2q24.1	Synesthesia	612759	_	2
613916	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
614389	1q24.2	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3
611863	4p16-p15	Microtia with nasolacrimal duct imperforation and eye coloboma	611863	_	4
613022	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
614863	6p21.1	Peroxisome biogenesis disorder 4B	614863	AR,AD	3
614383	3p21.2	{Bacteremia, susceptibility to}	614383	_	3
613156	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
613959	7q36.3	Schizophrenia 16	613959	_	4
613089	3q26.32	CLAPO syndrome, somatic	613089	_	3
615103	18p11.21	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction	617732	AD	3
613765	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
612990	20q11.21	Bohring-Opitz syndrome	605039	AD	3
612990	20q11.21	Myelodysplastic syndrome, somatic	614286	_	3
614434	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
613307	9q34.3	Deafness, autosomal recessive 79	613307	AR	3
613829	19q13.33	Leber congenital amaurosis 7	613829	_	3
613068	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
613177	19q13.2	Cutis laxa, autosomal recessive, type IC	613177	AR	3
615214	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
613030	9p21.3	{Glioma susceptibility 5}	613030	_	2
612221	3q23	{Stature QTL 10}	612221	_	2
610204	17q25.1	?Pontocerebellar hypoplasia type 5	610204	AR	3
614654	16q21	Coenzyme Q10 deficiency, primary, 5	614654	AR	3
614728	3q22.2	?Seckel syndrome 6	614728	AR	3
608771	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
608771	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
614068	14q24.3	?Cranioectodermal dysplasia 3	614099	AR	3
614068	14q24.3	?Retinitis pigmentosa 81	617871	AR	3
614068	14q24.3	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3
614661	15q21.1	Oocyte maturation defect 4	617743	AR	3
614194	19p13.2	Adams-Oliver syndrome 2	614219	AR	3
612182	8p22	[Acetylation, slow]	243400	AR	3
614698	1q44	Mitochondrial complex IV deficiency	220110	Mi,AR	3
614480	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
613855	2q23.3	Episodic ataxia, type 5	613855	AD	3
612410	18p11.23	{Psoriasis susceptibility 10}	612410	_	2
614369	19q13.33	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3
613501	19q13.2	Agammaglobulinemia 3	613501	AR	3
614305	11p11.2	Sclerosteosis 2	614305	AR,AD	3
614320	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
613523	8p11	Chromosome 8p11 myeloproliferative syndrome	613523	_	4
613308	6p21.31	Diamond-Blackfan anemia 9	613308	AD	3
613157	1p34.1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3
614294	15q25	Chromosome 15q25 deletion syndrome	614294	AD	4
613726	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
614692	6p21.3	{?Membranous nephropathy, susceptibility to}	614692	_	2
614376	4p14	?Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3
614404	17q25.1	Tylosis with esophageal cancer	148500	AD	3
611360	15q26.1	Fanconi anemia, complementation group I	609053	AR	3
610205	1p12	Alagille syndrome 2	610205	AD	3
614201	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
612438	19p13.3	Leukodystrophy, hypomyelinating, 6	612438	AD	3
615284	22q13.33	Charcot-Marie-Tooth disease, type 4B3	615284	AR	3
611254	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
611254	15q26.1	?Hydrolethalus syndrome 2	614120	AR	3
611254	15q26.1	Acrocallosal syndrome	200990	AR	3
611254	15q26.1	Joubert syndrome 12	200990	AR	3
613025	15q13	{Schizophrenia, susceptibility to, 13}	613025	_	2
613062	9p21	{Basal cell carcinoma, susceptibility to, 5}	613062	_	2
611097	19q13.2-q13.3	Mental retardation, autosomal recessive, 11	611097	AR	2
613979	20q13.33	Retinitis pigmentosa 60	613983	AD	3
615300	3p21.31	Perrault syndrome 4	615300	AR	3
613838	4q26	Cardiomyopathy, hypertrophic, 16	613838	AD	3
615440	17p12	Combined oxidative phosphorylation deficiency 17	615440	AR	3
614982	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
614982	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
615548	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
614283	7p21.3	{Glucocorticoid therapy, response to}	614400	_	3
613488	12q13.1	Myxoid liposarcoma	613488	_	4
607905	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
607905	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
614195	20p11.21	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	_	3
613871	15q25.1	Tyrosinemia, type I	276700	AR	3
614306	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
614668	16q12.1-q23.1	Stuttering, familial persistent, 4	614668	_	2
613750	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
614321	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
615374	4p15.33	Cone-rod dystrophy 18	615374	AR	3
614295	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
613070	22q13.31	Liver failure, transient infantile	613070	AR	3
614699	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
614655	3q13.2-q13.33	Stuttering, familial persistent, 3	614655	_	2
614866	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
615611	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
614390	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
615538	22q13	Chromosome 22q13 duplication syndrome	615538	IC	4
614378	4p14	?Cranioectodermal dysplasia 4	614378	AR	3
615670	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
613489	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
614483	13q34	Brain small vessel disease 2	614483	AD	3
615521	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
613502	10q24.1	?Agammaglobulinemia 4	613502	AR	3
614908	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
614122	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
613233	11q21-q22	[Fasting plasma glucose level QTL 3]	613233	_	2
613018	16q22.2	Tyrosinemia, type II	276600	AR	3
614202	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
615726	12q13.13	Pachyonychia congenita 3	615726	_	3
614370	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
615158	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
615242	1p36.32	[Blood group, Vel system]	615264	AR	3
613839	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
613960	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
615285	1q21.2	Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3
615441	6q22.31	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	AR	3
615612	3p22.2	Developmental dysplasia of the hip 2	615612	AD	2
616120	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
616079	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
614669	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AR,AD	3
616032	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
613026	19q13.11	Chromosome 19q13.11 deletion syndrome, distal	613026	AD	4
614284	1p34.2	?Stickler syndrome, type V	614284	AR	3
615629	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
614307	5p13.2	Alpha-methylacyl-CoA racemase deficiency	614307	AR	3
613872	13q34	Factor X deficiency	227600	AR	3
613411	13q34	Oguchi disease-2	613411	_	3
615872	5q11.2	Ciliary dyskinesia, primary, 29	615872	AR	3
610212	6p22.3	?Deafness, autosomal recessive 66	610212	AR	3
615369	15q26.1	Epileptic encephalopathy, childhood-onset	615369	AD	3
615558	2p24.1	Hypobetalipoproteinemia	615558	AR	3
614346	12q13.11-q15	Mental retardation, autosomal recessive 25	614346	AR	2
614196	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
615423	3q12.3	Combined oxidative phosphorylation deficiency 30	616974	AR	3
615760	3p21.31	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3
615412	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
615849	2q14.2	Culler-Jones syndrome	615849	AD	3
616178	17q12	?Deafness, autosomal recessive 99	618481	_	3
609457	12q23.1	[Histidinemia]	235800	AR,AD	3
615522	6q23.2	Cole disease	615522	AD	3
614123	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
613516	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
614810	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
613637	5p15	[Tuberculin skin test reactivity QTL]	613637	_	2
615348	3p22.1	Nemaline myopathy 8, autosomal recessive	615348	_	3
614435	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
612322	2q33.3	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
615785	17q21.2	White sponge nevus 2	615785	AD	3
613727	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
613524	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
613524	1q43-q44	Senior-Loken syndrome 7	613615	_	3
616080	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
616025	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
615413	10q26.11	Spermatogenic failure 12	615413	AD	3
613751	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
615850	17p13.3	Pontocerebellar hypoplasia, type 2E	615851	AR	3
615630	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
616362	19q13.41	Mental retardation, autosomal dominant 36	616362	AD	3
615618	3q13.33	?Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3
615618	3q13.33	Dowling-Degos disease 4	615696	AD	3
615370	9q22.33	Nephronophthisis 16	615382	AR	3
614203	16q11.2	{Parkinson disease 17}	614203	AD	3
616265	19q13.11	?Peeling skin syndrome 3	616265	AR	3
615021	3q26.1	[Blood group, globoside system]	615021	_	3
615559	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
612414	11q13.4	Deafness, autosomal recessive 63	611451	AR	3
615112	1p13.2	Urofacial syndrome 2	615112	AR	3
615424	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
613517	2q37.1	Microphthalmia, isolated 6	613517	AR	3
615873	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
614318	13q33.2	Vesicoureteral reflux 5	614318	_	2
615885	13q12.2	Hypotrichosis 12	615885	AD	3
615643	17q21.2	Neurodegeneration with brain iron accumulation 6	615643	AR	3
615761	3p25.3	Mental retardation, autosomal dominant 23	615761	AD	3
615107	10q23.31	Cowden syndrome 4	615107	_	3
613312	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
615349	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
616222	14q32	Temple syndrome	616222	AD	4
612346	22q11.23	?Glutathioninuria	231950	AR	3
613767	16q21	Retinitis pigmentosa 45	613767	AR	3
615539	6q22.1	Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3
616012	3p25.3	Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3
616172	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
615523	15q25.3	Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3
614347	6q26-q27	Mental retardation, autosomal recessive 28	614347	AR	2
615113	15q26.3	Microphthalmia, isolated 8	615113	AR	3
614954	9q31.1	Congenital heart defects, multiple types, 3	614954	AD	2
615802	2q33.1	Mental retardation, autosomal recessive 42	615802	AR	3
613980	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
616406	1q42.12	Leukodystrophy, hypomyelinating, 10	616420	AR	3
616580	9q21.32	Au-Kline syndrome	616580	AD	3
615631	15q14	Dyserythropoietic anemia, congenital, type Ib	615631	AR	3
616111	11q12.3	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3
612778	3p21.31	Luscan-Lumish syndrome	616831	AD	3
614856	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
616455	8p21.3	Zimmermann-Laband syndrome 2	616455	AD	3
616494	6p21.1	Leukodystrophy, hypomyelinating, 11	616494	AR	3
611100	8q24	{Prostate cancer, hereditary, 10}	611100	_	2
614041	13q14.2	Bladder cancer, somatic	109800	_	3
614041	13q14.2	Osteosarcoma, somatic	259500	_	3
614041	13q14.2	Retinoblastoma	180200	SMu,AD	3
614041	13q14.2	Retinoblastoma, trilateral	180200	SMu,AD	3
614041	13q14.2	Small cell cancer of the lung, somatic	182280	_	3
614696	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
613412	5q22	{Esophagitis, eosinophilic, 2}	613412	Mu	2
614770	19p13.2	Mitochondrial complex IV deficiency	220110	Mi,AR	3
613873	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
616368	5q31.1	CHOPS syndrome	616368	AD	3
615350	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
613313	19q13.12	Hemochromatosis, type 2B	613313	AR	3
615582	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
616144	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
615244	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
615425	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
611317	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
616726	16q24.3	Ciliary dyskinesia, primary, 33	616726	AR	3
614671	16p11.2	Chromosome 16p11.2 duplication syndrome	614671	_	4
614671	16p11.2	{Autism, susceptibility to, 14B}	614671	_	2
608796	8q23	Moyamoya disease 3	608796	_	2
615779	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
614730	9p13.3	Hyperphosphatasia with mental retardation syndrome 2	614749	AR	3
614828	3p22.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AR	3
614828	3p22.1	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3
616461	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
615022	12p11.2-q13.1	Ichthyosis, congenital, autosomal recessive 7	615022	AR	2
613684	22q13.2	Rubinstein-Taybi syndrome 2	613684	AD	3
604569	7q35-q36	Cortical dysplasia-focal epilepsy syndrome	610042	AR	3
604569	7q35-q36	Pitt-Hopkins like syndrome 1	610042	AR	3
604569	7q35-q36	{Autism susceptibility 15}	612100	_	3
615101	6p25.2	Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3
614486	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
616228	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
612347	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
613193	16q24.1	Ciliary dyskinesia, primary, 13	613193	AR	3
613554	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
612898	9q34.11	Coenzyme Q10 deficiency, primary, 7	616276	AR	3
613886	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
613795	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
615560	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
613575	3q11.2	?Retinitis pigmentosa 55	613575	_	3
616835	6p22.3	Meier-Gorlin syndrome 6	616835	AD	3
614673	4q12	Microcephaly 8, primary, autosomal recessive	614673	AR	3
613518	4q22.1	{Dermatitis, atopic, susceptibility to, 8}	613518	_	2
613882	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
614701	8q24.11	Cornelia de Lange syndrome 4	614701	AD	3
615414	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
615712	5p15.2	Autoinflammation, panniculitis, and dermatosis syndrome	617099	AR	3
615266	5q31.3	Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3
615632	11q13.1	Neuropathy, hereditary sensory, type IF	615632	AD	3
614198	17q23.3	Myasthenic syndrome, congenital, 16	614198	AR	3
615402	2q35	Dyschromatosis universalis hereditaria 3	615402	AD	3
616763	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
616721	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
616975	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
615426	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
616969	6q21	?Deafness, autosomal dominant 66	616969	AD	3
614857	14q24.3	Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3
614008	11q13.1	Nestor-Guillermo progeria syndrome	614008	AR	3
616266	13q32.3-q33.1	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3
614296	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
610564	6q21	Coenzyme Q10 deficiency, primary, 3	614652	AR	3
616364	1q21.3	White-Sutton syndrome	616364	AD	3
616947	10q26.3	?Premature ovarian failure 12	616947	AR	3
616145	13q32.1	Catel-Manzke syndrome	616145	AR	3
614042	10q23.31	Moyamoya disease 5	614042	_	3
616027	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
615540	19q13.12	Deafness, autosomal recessive 76	615540	AR	3
616786	15q15.1	Nephronophthisis 20	617271	AR	3
615583	8q24.3	Verheij syndrome	615583	AD	3
614184	2q37.1	Perlman syndrome	267000	AR	3
617156	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
616922	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
615351	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
614485	9p22.3	Trigonocephaly 2	614485	AD	3
616224	2p21	Myasthenic syndrome, congenital, 22	616224	AR	3
617132	3q22.1	Epileptic encephalopathy, early infantile, 44	617132	AR	3
617052	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
611451	11q13.4	Deafness, autosomal recessive 63	611451	AR	3
614731	17p12	{Prostate cancer, hereditary, 2, susceptibility to}	614731	_	3
616941	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
614930	8q24.22	Ciliary dyskinesia, primary, 19	614935	AR	3
613084	2p25.3	Mental retardation, autosomal dominant 39	616521	AD	3
614385	14q24.3	Colorectal cancer, hereditary nonpolyposis, type 7	614385	_	3
613887	9q22.33	Cataract 36	613887	AR	3
615108	3q26.32	Cowden syndrome 5	615108	_	3
616013	4q23	Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3
615673	10q22.1	Myopathy with extrapyramidal signs	615673	AR	3
614149	17q25.1-q25.3	Nail disorder, nonsyndromic congenital, 9	614149	AR	2
611431	15q14	Legius syndrome	611431	AD	3
614036	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
616779	10q26.13	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	616779	AD	3
617173	15q21.2	Intellectual developmental disorder with cardiac arrhythmia	617173	AR	3
614302	3p25.1	Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3
616138	10q24.31	Perrault syndrome 5	616138	AR	3
613796	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
616270	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
616299	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
613856	1p13.3	Achromatopsia 4	613856	_	3
614409	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
614495	5q31.2	Pseudohypoaldosteronism, type IID	614495	AR,AD	3
616509	21q22.3	Cataract 44	616509	AR	3
616457	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
617234	1p36.13	Preimplantation embryonic lethality 2	617234	AR	3
616028	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
616948	2q11.2	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3
617168	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
616229	11p11.2	Osteogenesis imperfecta, type XVI	616229	AR	3
614813	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
617260	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
615803	11q12.1	Pontocerebellar hypoplasia, type 10	615803	AR	3
615620	19q13.32	Mental retardation, autosomal recessive 41	615637	AR	3
614732	11p15.4	IMAGE syndrome	614732	AD	3
615633	9q34.11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3
614772	1q42.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	616501	AR	3
611101	1p36.31	Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3
611101	1p36.31	Spinal muscular atrophy, distal, autosomal recessive, 4	611067	AR	3
615545	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
617574	12q13.3	Ichthyosis, congenital, autosomal recessive 13	617574	AR	3
617041	20q12	Duane retraction syndrome 3	617041	AD	3
615973	12q21.33	Cone-rod dystrophy 20	615973	AR	3
615415	17q11.2	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3
614162	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
617187	20q11.21	Spermatogenic failure 16	617187	AR	3
617391	1q44	Epileptic encephalopathy, early infantile, 54	617391	AD	3
615040	8q21.11	?Episodic pain syndrome, familial, 1	615040	AD	3
614386	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
614386	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
614386	16p11.2	Seizures, benign familial infantile, 2	605751	AD	3
616271	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
616780	10p15.3	Oocyte maturation defect 2	616780	AR,AD	3
617113	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
617600	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
615433	3q13.31	Chromosome 3q13.31 deletion syndrome	615433	AD	4
617744	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
616146	13q32.1	Catel-Manzke syndrome	616145	AR	3
614496	2q36.2	Pseudohypoaldosteronism, type IIE	614496	AD	3
612899	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
616029	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
616680	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
617898	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
616655	19q13.1-q13.2	?Cataract 45	616851	AR	3
616139	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
614436	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
617575	10q22.1	Nephrotic syndrome, type 14	617575	AR	3
612940	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
613576	7p21.2-p14.3	Ectodermal dysplasia-syndactyly syndrome 2	613576	AR	2
616977	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
617242	4q13.1	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	3
613799	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
617169	19p13.3	?Sotos syndrome 3	617169	AR	3
617807	19p13.2	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3
617133	3q22.1	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3
614980	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
617188	19q13.42	Mental retardation, autosomal recessive 57	617188	AR	3
614867	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
617952	6q14.1	Osteogenesis imperfecta, type XVIII	617952	AR	3
617235	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
617294	3q27.1	Epidermolysis bullosa simplex, generalized, with scarring and hair loss	617294	AD	3
614940	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
616681	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
617337	1p36.11	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3
608072	6p22.3	Epilepsy, progressive myoclonic 2B (Lafora)	254780	AR	3
615206	7p22.2	Immunodeficiency 11A	615206	AR	3
614807	16p13.3	?Centronuclear myopathy 4	614807	AD	3
617048	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
616458	9q34.12	Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3
615762	5q32	?Deafness, autosomal recessive 101	615837	AR	3
617991	6q14.1	Developmental delay, intellectual disability, obesity, and dysmorphic features	617991	AD	3
617114	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
614497	2q35	Microphthalmia, isolated, with coloboma 7	614497	AD	3
615416	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
615416	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
615439	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
616781	1p36.32	Joubert syndrome 25	616781	AR	3
613519	3p24	{Dermatitis, atopic, susceptibility to, 9}	613519	_	2
617770	19q13.2	?Spinocerebellar ataxia 46	617770	AD	3
615115	18q12.1	Bainbridge-Ropers syndrome	615485	AD	3
618005	14q23.3	Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3
617576	3p21.1	Spermatogenic failure 18	617576	AR	3
612779	1p21.3	5-fluorouracil toxicity	274270	AR	3
612779	1p21.3	Dihydropyrimidine dehydrogenase deficiency	274270	AR	3
615462	7q36.3	Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3
615816	6q14.1	Immunodeficiency 23	615816	AR	3
617808	12q12	Coffin-Siris syndrome 6	617808	AD	3
617935	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
616452	7p22.2	B-cell expansion with NFKB and T-cell anergy	616452	AD	3
617946	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
617035	6p12.3	Patent ductus arteriosus 2	617035	AD	3
618013	8q22.1	?Deafness, autosomal recessive 109	618013	AR	3
615578	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
616140	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
614808	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
615602	5q34	[Memory, enhanced, QTL]	615602	_	3
615999	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
614868	20q13.12	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	_	3
617435	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
614829	4q21.1	Amelogenesis imperfecta, type IIA4	614832	AR	3
614498	7p22.3	Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3
615109	14q32.33	Cowden syndrome 6	615109	_	3
615605	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
617243	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
617992	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
615616	10q21.3	Arrhythmogenic right ventricular dysplasia, familial, 13	615616	AD	3
618236	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
616722	9q21.12	?Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3
618084	1q21.3	Peeling skin syndrome 6	618084	AR	3
615757	20p11.23	Retinitis pigmentosa 69	615780	AR	3
615807	10q21.3	?Seckel syndrome 8	615807	AR	3
618014	5q31.1	?Premature ovarian failure 14	618014	AR	3
614809	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
617205	7p12.3	Heterotaxy, visceral, 8, autosomal	617205	AR	3
614441	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
618284	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
617190	2p23.3	Shashi-Pena syndrome	617190	AD	3
616749	10q26.2	Heterotaxy, visceral, 7, autosomal	616749	AR	3
614430	8p23.1	Atrioventricular septal defect 4	614430	AD	3
618138	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
615291	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
615291	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
616227	1p21.3	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3
617892	4q33	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3
617049	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
616973	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
617238	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
616943	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
615617	11q23.3	Immunodeficiency 19	615617	AR	3
616386	22q12.3	Dystonia 26, myoclonic	616398	AD	3
615758	1p35.2	?Immunodeficiency 22	615758	AR	3
618085	16q22.2	Spermatogenic failure 31	618112	AR	3
618257	5q13.2	?Deafness, autosomal recessive 112	618257	AR	3
616459	11q24.2	Al-Raqad syndrome	616459	AR	3
618266	17q21.2	Pontocerebellar hypoplasia, type 12	618266	AR	3
616000	4q13.3	Analbuminemia	616000	_	3
614830	3p22.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AR	3
618006	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
614163	17q25	{Delayed sleep phase syndrome, susceptibility to}	614163	AD	2
617153	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
615207	16p12.1	Immunodeficiency 56	615207	AR	3
615054	7q36.1	Glaucoma 1, open angle, F	603383	_	3
618341	17q25.1	Spermatogenic failure 35	618341	AR	3
617239	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
616657	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
616723	16q13	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3
618346	21q22.3	Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3
613868	18q12.3	[Blood group, Kidd]	111000	_	3
614499	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
616949	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
618213	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
617993	12p13.32	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	_	3
617577	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
617746	7p21.1	Sweeney-Cox syndrome	617746	AD	3
615859	1p31.3	Epileptic encephalopathy, early infantile, 23	615859	AR	3
617244	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
618097	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
617971	11p15.4	Methmoglobinemia, beta type	617971	_	3
615883	12q24.31	Myopathy, tubular aggregate, 2	615883	AD	3
616001	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
615604	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AR,AD	3
614260	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
615292	11q12.1	Gracile bone dysplasia	602361	AD	3
615292	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
613493	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
614869	15q25.1	Usher syndrome, type IJ	614869	AR	3
615842	17p13.2	?Spermatogenic failure 14	615842	AR	3
618242	14q12	Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3
618145	11q23.3	Deafness, autosomal recessive 111	618145	AR	3
618267	15q26.1	Epidermodysplasia verruciformis 3	618267	AR	3
616078	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
618300	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
618360	19p13.11	Brain small vessel disease 3	618360	AR	3
616724	12p13.2	Tooth agenesis, selective, 7	616724	AD	3
612780	1q23.2	SESAME syndrome	612780	AR	3
616546	14q23.1	Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3
617564	22q12.3	?Meier-Gorlin syndrome 8	617564	AR	3
618078	12q15	?Ovarian dysgenesis 6	618078	AR	3
617885	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
618248	15q22.31	Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3
618396	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
614850	19p13.3	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AR,AD	3
608797	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
616603	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
617667	12q14.3	Fraser syndrome 3	617667	AR	3
615546	4q28.1	Van Maldergem syndrome 2	615546	AR	3
614431	6q24.1	Ventricular septal defect 2	614431	AD	3
615371	2q34	{Pulmonary hypertension, neonatal, susceptibility to}	615371	_	3
614164	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
615759	2p25.1	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3
616658	19p13.3	Combined oxidative phosphorylation deficiency 37	618329	AR	3
618285	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
618140	7p14.3	?Deafness, autosomal dominant 74	618140	AD	3
617596	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
617268	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
614941	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
618146	12q24.31	Spermatogenic failure 33	618152	AR	3
617339	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
616366	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
617115	18q22.1	Peeling skin syndrome 5	617115	AR	3
618063	11q22.1	Ciliary dyskinesia, primary, 38	618063	AR	3
616974	3q12.3	Combined oxidative phosphorylation deficiency 30	616974	AR	3
616263	17q23.1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3
617672	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
615524	3p24.2	Microphthalmia, syndromic 12	615524	AR,AD	3
616298	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
615009	11q13.1-q13.2	Schuurs-Hoeijmakers syndrome	615009	AD	3
616950	10q26.3	?Spermatogenic failure 15	616950	AR	3
617994	13q13.1	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	_	3
618268	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
616954	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
618098	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
618397	5q13.3	Combined oxidative phosphorylation deficiency 39	618397	AR	3
618349	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
617241	15q13.1	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3
618286	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
617798	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
618147	14q32.2	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3
618000	7p13	Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3
615626	15q14	Dyserythropoietic anemia, congenital, type Ib	615631	AR	3
618141	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
617207	1q42.3	Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3
616367	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
617523	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
615547	15q11.2	Schaaf-Yang syndrome	615547	AD	3
616570	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
618243	2q37.3	Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3
618237	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
614088	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
618342	7q22.3	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3
617973	16p13.3	Methemoglobinemia, alpha type	617973	_	3
617343	6p24.2	Hyperparathyroidism 4	617343	AD	3
614851	14q22.1	?Seckel syndrome 7	614851	AR	3
615848	7q31.33	{Melanoma, cutaneous malignant, susceptibility to, 10}	615848	AD	3
610924	20p13	Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3
616944	3q26.32	Mental retardation, autosomal dominant 41	616944	AD	3
617116	3p21.31	Epilepsy, familial focal, with variable foci 2	617116	AD	3
617290	8p11.23	Epilepsy, early-onset, vitamin B6-dependent	617290	AR	3
615674	17p13.3	Dowling-Degos disease 3	615674	AD	2
616839	8q22.3	?Exercise intolerance, riboflavin-responsive	616839	AR	3
614474	18q11.2	Atrioventricular septal defect 5	614474	AD	3
618079	12q13.12	[Low density lipoprotein cholesterol level QTL 8]	618079	_	3
618287	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
616460	15q24.1	?Mental retardation, autosomal recessive 50	616460	AR	3
614089	14q11.2	Atrial septal defect 3	614089	_	3
614432	5q35.1	Ventricular septal defect 3	614432	AD	3
617732	18p11.21	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction	617732	AD	3
617974	4q35.1	?Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3
618148	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
617805	18q11.1-q11.2	Renal hypodysplasia/aplasia 3	617805	AD	3
616852	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
616617	6p21.1	Heimler syndrome 2	616617	AR	3
618371	17q12	Turnpenny-Fry syndrome	618371	AD	3
617895	12q24.11	Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3
617439	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
618356	1q32.1	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3
614475	18q11.2	Atrial septal defect 9	614475	AD	3
616300	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
618343	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
618456	17p11.2	Deafness, autosomal recessive 114	618456	AR	3
616792	11p15	{Neuroblastoma, susceptibility to, 7}	616792	_	2
617245	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
610925	3p25.3	Candidiasis, familial, 9	616445	AR	3
617771	1q31.3	?Epileptic encephalopathy, early infantile, 57	617771	AD	3
614944	12q21.31	Deafness, autosomal recessive 84B	614944	AR	3
618302	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
618235	5q31.3	?Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3
614437	11q13.1	Cutis laxa, autosomal recessive, type IB	614437	AR	3
618418	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
616112	3p14.1	Nemaline myopathy 10	616165	AR	3
613494	22q13.2	Immunodeficiency, common variable, 4	613494	AR	3
616604	14q32	{Myeloproliferative neoplasms, familial, susceptibility to}	616604	AD	4
617524	1p34.3	Erythrokeratodermia variabilis et progressiva 2	617524	AD	3
618264	17p13.1	Mirror movements 4	618264	AD	3
614090	14q11.2	{Sick sinus syndrome 3}	614090	_	3
618142	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
617572	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
617270	18q12.2	Mental retardation, autosomal recessive 58	617270	AR	3
618244	12q22	?Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3
616907	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
614257	20q11.23	?Mental retardation, autosomal dominant 11	614257	AD	3
617772	1q44	Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3
615010	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
618249	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
618149	3q28	Orofacial cleft 8	618149	_	3
618277	10q25.3	FINCA syndrome	618278	AR	3
618135	3p22.1	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3
618357	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
617228	13q12.12	Combined oxidative phosphorylation deficiency 31	617228	AR	3
617278	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
617036	11q13.5	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3
618419	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
617349	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
610926	10q11.2-q21	Tooth agenesis, selective, 5	610926	_	2
614265	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
613498	17p13	[Sex hormone-binding globulin circulating level QTL 1]	613498	_	2
617668	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
616113	15q21.2	?Polyendocrine-polyneuropathy syndrome	616113	AR	3
617598	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
618250	11q14.1	Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3
618150	16q22.1	Saul-Wilson syndrome	618150	AD	3
614751	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
610927	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
615607	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
614689	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
618372	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
617773	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
617599	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
614438	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
618278	10q25.3	FINCA syndrome	618278	AR	3
618457	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
618420	14q13.2	Spermatogenic failure 36	618420	AD	3
617669	2p25.3	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3
617579	13q32.1	HELIX syndrome	617671	AR	3
616946	10q11.23	Premature ovarian failure 11	616946	AD	3
614753	19p13.13	Sotos syndrome 2	614753	AD	3
617246	8q24.13	Seckel syndrome 10	617253	AR	3
618251	3q13.33	Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3
617350	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
617170	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
614816	1q41	Loeys-Dietz syndrome 4	614816	AD	3
616353	16p13.12	Dyskeratosis congenita, autosomal recessive 6	616353	AR	3
618304	17q25.1	Spermatogenic failure 35	618341	AR	3
616920	19q13.31	Heart and brain malformation syndrome	616920	AR	3
617670	16p13.3	?Spermatogenic failure 22	617706	AR	3
616030	7q31.32	Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3
618373	6q24.3-q25.1	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3
615780	20p11.23	Retinitis pigmentosa 69	615780	AR	3
618459	19q13.2	?Immunodeficiency 62	618459	AR	3
618345	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
616794	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
618245	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
616968	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
616354	6q14.3	Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3
618283	14q32.32-q32.33	?Visual impairment and progressive phthisis bulbi	618283	AR	3
617171	11p15.5	?Dyskinesia, seizures, and intellectual developmental disorder	617171	AR	3
617280	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
618254	11p15.5	Ciliary dyskinesia, primary, 39	618254	AR	3
617271	15q15.1	Nephronophthisis 20	617271	AR	3
616115	2p22.3	?Familial cold autoinflammatory syndrome 4	616115	AD	3
618460	7q36.3	Kahn-Kahn-Katsanis syndrome	618460	AR	3
618374	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
618144	17q24.2	Usher syndrome, type IV	618144	AR	3
618255	9p13.3	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3
617281	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
615781	2q36.1	{Psoriasis 15, pustular, susceptibility to}	616106	AD	3
618246	2q33.1	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3
617671	13q32.1	HELIX syndrome	617671	AR	3
616854	5q31.2	Even-plus syndrome	616854	AR	3
615715	9q22.32	Bone marrow failure syndrome 2	615715	AR	3
617743	15q21.1	Oocyte maturation defect 4	617743	AR	3
618377	1p33	?Pain sensitivity QTL1	618377	AD	4
617039	5q23.2	Patent ductus arteriosus 3	617039	AD	3
618383	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
618247	12p13.32	Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3
617275	1q43	Tooth agenesis, selective, 9	617275	AD	3
618378	1q25.1	?Combined oxidative phosphorylation deficiency 38	618378	AR	3
616795	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
616505	5q22.1	Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3
618362	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
616606	Chr.14	Ring chromosome 14 syndrome	616606	IC	4
618392	16q23.3-q24.1	?Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3
614826	1q31.3-q32.1	Nystagmus 7, congenital, autosomal dominant	614826	AD	2
618363	4q31.22	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3
616873	7p12.2	Immunodeficiency, common variable, 13	616873	AD	3
618381	11q13.1	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3
618364	12q13.13	?Myoclonus, familial, 2	618364	AD	3
618393	17p13.2	Fetal akinesia deformation sequence 4	618393	AR	3
617601	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
618394	6q15	Immunodeficiency 60	618394	AD	3
617276	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
618395	2p13.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3
616507	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
616937	20q11.23	?Thrombocytopenia 6	616937	AD	3
616938	17q21.2	Coffin-Siris syndrome 5	616938	AD	3
616939	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
604604	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
603736	10q22.2	SBBYSS syndrome	603736	AD	3
603201	2q31.1	Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3
603201	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
604169	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
604490	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
605606	1p	{Psoriasis susceptibility 7}	605606	_	2
606392	13q12.2	MODY, type IV	606392	_	3
603453	6p25.2	Immunodeficiency 57	618108	AR	3
605285	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
605461	22q11.1	Immunodeficiency 51	613953	AR	3
603961	7q21.11	{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3
605583	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
605648	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
603464	16q24.3	Al Kaissi syndrome	617694	AR	3
605829	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
604292	3q28	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3
605951	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
606812	1q43	Fumarase deficiency	606812	AR	3
606661	3p25.2-p25.1	{Melanoma, uveal, susceptibility to, 2}	606661	_	2
605525	16q24.3	Meier-Gorlin syndrome 4	613804	AR	3
603785	9p23	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3
603964	2q23-q24.3	Deafness, autosomal dominant 16	603964	AD	2
606941	11q23.1	Congenital disorder of glycosylation, type Il	608776	AR	3
606941	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
605282	15q26.3	Temtamy preaxial brachydactyly syndrome	605282	AR	3
606629	6q13	Cone-rod dystrophy 7	603649	_	3
605393	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
603094	3q26.1	[Blood group, globoside system]	615021	_	3
603094	3q26.1	[Blood group, P1PK system, P(k) phenotype]	111400	_	3
604356	2q31.1	Duane retraction syndrome 2	604356	_	3
603214	14q24.3	Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3
604278	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
607120	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
603693	8q23.1	46XY sex reversal 9	616067	AD	3
603693	8q23.1	Diaphragmatic hernia 3	610187	_	3
603693	8q23.1	Tetralogy of Fallot	187500	AD	3
606119	8q24.3	Meleda disease	248300	AR	3
607123	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
603683	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
605584	16q22.2	Retinitis pigmentosa 84	618220	AR	3
603783	4p16-q34	{Intelligence QTL1}	603783	_	2
606662	8p23	Waardenburg syndrome, type 2C	606662	_	2
606782	12p13.2	{Aspergillosis, susceptibility to}	614079	_	3
603617	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
603663	4p	{Mental health wellness-1}	603663	_	2
606664	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
605924	21q22.3	Galloway-Mowat syndrome 6	618347	AR	3
605924	21q22.3	Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3
604605	3q21.1-q21.2	{Coronary heart disease, susceptibility to, 5}	608901	_	3
603040	11q23	{Nonsmall cell lung cancer}	603040	_	2
605934	2q37.1-q37.3	Holoprosencephaly 6	605934	_	2
603029	4q35.1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}	613002	AR,AD	3
603029	4q35.1	{HIV1 infection, resistance to}	609423	_	3
603965	11q22.1	Glomerulosclerosis, focal segmental, 2	603965	AD	3
603892	17q21.31	Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3
606787	1p31	Peripheral arterial occlusive disease 1	606787	_	2
606107	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
605489	12q24.11	Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3
606682	22q12.1	Hermansky-Pudlak syndrome 4	614073	AR	3
604843	12p12.1	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3
606616	18p11.2	{Dyslexia, susceptibility to, 6}	606616	_	2
603454	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
604040	5q31.1	Nijmegen breakage syndrome-like disorder	613078	_	3
603780	8q24.3	Baller-Gerold syndrome	218600	AR	3
603780	8q24.3	RAPADILINO syndrome	266280	AR	3
603780	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
604250	7q22.1	Hemochromatosis, type 3	604250	AR	3
604121	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
607444	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
607444	7q11.21	{Aplastic anemia, susceptibility to}	609135	_	3
605391	10q23.2	{Thyroid carcinoma, follicular}	188470	SMu,AD	3
605958	3p21.31	Seckel syndrome 9	616777	AR	3
603959	3q28	Hypomagnesemia 3, renal	248250	AR	3
604765	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
605441	3q27.3	Adiponectin deficiency	612556	_	3
607429	10p12.1	Coenzyme Q10 deficiency, primary, 2	614651	AR	3
605608	21q22.13	Deafness, autosomal recessive 29	614035	AR	3
607107	4p15.1-q12	{Nasopharyngeal carcinoma 1}	607107	_	2
606680	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
605590	2q33.1	Myelodysplastic syndrome, somatic	614286	_	3
603098	7q34-q36	Deafness, autosomal recessive 13	603098	AR	2
606811	1p36.13	Hyperprolinemia, type II	239510	AR	3
606462	8q24.11	?Mungan syndrome	611376	AR	3
606462	8q24.11	Cornelia de Lange syndrome 4	614701	AD	3
603248	4q22.3	Acromesomelic dysplasia, Demirhan type	609441	AR	3
603248	4q22.3	Brachydactyly, type A1, D	616849	AD	3
603248	4q22.3	Brachydactyly, type A2	112600	AD	3
607752	5q11.2	Ciliary dyskinesia, primary, 29	615872	AR	3
605993	8q22.1	Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3
607636	11q13.2	van Buchem disease, type 2	607636	AD	3
603664	4q	{Mental health wellness-2}	603664	_	2
604498	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
603155	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
604357	4q31.3	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AR,AD	3
604489	5p13.2	Alpha-methylacyl-CoA racemase deficiency	614307	AR	3
604489	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
606200	12p12.1	[Short sleeper]	612975	AD	3
604001	7q21.2	?Long QT syndrome-11	611820	AD	3
606943	17q25.1	Usher syndrome, type 1G	606943	AR	3
606951	2q24.2	Aicardi-Goutieres syndrome 7	615846	AD	3
606951	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
605522	7q36.3	Acheiropody	200500	AR	3
605522	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
605522	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
605522	7q36.3	Polydactyly, preaxial type II	174500	AD	3
605522	7q36.3	Syndactyly, type IV	186200	AD	3
605522	7q36.3	Triphalangeal thumb, type I	174500	AD	3
605522	7q36.3	Triphalangeal thumb-polysyndactyly syndrome	174500	AD	3
605862	12q14.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3
607421	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
603194	11q12.2	Meckel syndrome 2	603194	AR	3
604260	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
604260	17q21.2	Leukemia, acute promyelocytic, somatic	102578	_	3
606835	12q24.11	Digital arthropathy-brachydactyly, familial	606835	AD	3
604187	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
603196	14q12	?Deafness, autosomal recessive 110	618094	AR	3
603196	14q12	Deafness, autosomal dominant 9	601369	AD	3
604294	10q25.3	?Microphthalmia, syndromic 11	614402	AR	3
607677	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
607218	7q32.1	{Inflammatory bowel disease 14}	612245	_	3
607218	7q32.1	{Systemic lupus erythematosus, susceptibility to, 10}	612251	_	3
607402	19q13.2	{Hepatitis C virus infection, response to therapy of}	609532	_	3
604895	17q21.32	Asthma and nasal polyps	208550	AR	3
604895	17q21.32	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
605921	11p15.4	Immunodeficiency 10	612783	AR	3
605921	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
605921	11p15.4	Stormorken syndrome	185070	AD	3
604443	5q31.1	Myelodysplastic syndrome	_	_	3
604443	5q31.1	Myelogenous leukemia, acute	_	_	3
605490	19p13.3	CODAS syndrome	600373	AR	3
603288	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
606681	5q35.3	Leukemia, acute myeloid	601626	SMu,AD	1
606681	5q35.3	Sotos syndrome 1	117550	AD	3
603855	19q13.2-q13.4	{Meconium ileus in cystic fibrosis, susceptibility to}	603855	_	2
607844	12q14.3	Buschke-Ollendorff syndrome	166700	AD	3
607844	12q14.3	Osteopoikilosis with or without melorheostosis	166700	AD	3
607407	10q26.3	Hypotonia, ataxia, and delayed development syndrome	617330	AD	3
604506	2q36.3	Mental retardation, autosomal dominant 49	617752	AD	3
607108	11p13	?Coloboma of optic nerve	120430	AD	3
607108	11p13	?Coloboma, ocular	120200	AD	3
607108	11p13	?Morning glory disc anomaly	120430	AD	3
607108	11p13	Aniridia	106210	AD	3
607108	11p13	Anterior segment dysgenesis 5, multiple subtypes	604229	_	3
607108	11p13	Cataract with late-onset corneal dystrophy	106210	AD	3
607108	11p13	Foveal hypoplasia 1	136520	AD	3
607108	11p13	Keratitis	148190	AD	3
607108	11p13	Optic nerve hypoplasia	165550	AD	3
606952	11q14.3	Albinism, oculocutaneous, type IB	606952	_	3
607871	2p16.3	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3
604766	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
604694	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
607340	9q22.33	Epileptic encephalopathy, early infantile, 59	617904	AD	3
607340	9q22.33	Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3
607340	9q22.33	{Nicotine dependence, protection against}	188890	_	3
607340	9q22.33	{Nicotine dependence, susceptibility to}	188890	_	3
608104	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608296	11q13.1	Thauvin-Robinet-Faivre syndrome	617107	AR	3
607678	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
608092	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	AR	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3
608041	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
608107	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
608107	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
608945	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
608945	13q13.3	Fraser syndrome 2	617666	AR	3
607213	16q11.2	Meier-Gorlin syndrome 3	613803	AR	3
604188	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
606945	19p13.2	Hypercholesterolemia, familial, 1	143890	AD	3
606945	19p13.2	LDL cholesterol level QTL2	143890	AD	3
608508	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
604041	17p13.1	Congenital disorder of glycosylation, type If	609180	AR	3
605558	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
608244	6p22.3-p21.3	Otosclerosis 3	608244	AD	2
607838	16p13.3	Mucolipidosis III gamma	252605	AR	3
604896	20p12.2	Bardet-Biedl syndrome 6	605231	AR	3
604896	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
603041	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
607751	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
604780	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
607352	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
605594	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
607539	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
607166	2q11.2	?Spermatogenic failure 26	617961	AR	3
603856	15q11.2	Precocious puberty, central, 2	615346	AD	3
608317	1p36.11	Van der Woude syndrome 2	606713	AD	3
609153	2q35-q36	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	2
605248	19p13.2	Mucolipidosis IV	252650	AR	3
608451	19q13.31	Ethylmalonic encephalopathy	602473	AR	3
608203	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
603197	19p13.2	?Laurence-Moon syndrome	245800	AR	3
603197	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
603197	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
603197	19p13.2	Spastic paraplegia 39, autosomal recessive	612020	AR	3
606554	1q42	Episodic ataxia, type 3	606554	AD	2
608105	16p12-p11.2	Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp	608105	AR	2
609814	1q31.3	Complement factor H deficiency	609814	AR,AD	3
610148	12q21.2	Bardet-Biedl syndrome 10	615987	AR	3
609634	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
603704	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
604283	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
607343	20q13.2	Duane-radial ray syndrome	607323	AD	3
607343	20q13.2	IVIC syndrome	147750	AD	3
610629	10q22.3	Diamond-blackfan anemia 3	610629	AD	3
610277	12q24.31	Immunodeficiency 9	612782	AR	3
610277	12q24.31	Myopathy, tubular aggregate, 2	615883	AD	3
607386	2p23.3	Retinitis pigmentosa 71	616394	AR	3
607386	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
605145	5p15.2	Chondrocalcinosis 2	118600	AD	3
605145	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
610572	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
609390	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
609390	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
609390	6q21	Charcot-Marie-Tooth disease, type 4J	611228	AR	3
609390	6q21	Yunis-Varon syndrome	216340	AR	3
610062	14q24.3	Ciliary dyskinesia, primary, 16	614017	AR	3
608059	17p13.1	Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3
610273	1q23.2	Glycosylphosphatidylinositol deficiency	610293	AR	3
605995	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
605995	1p36.22	Pheochromocytoma	171300	AD	3
605995	1p36.22	{Neuroblastoma, susceptibility to, 1}	256700	SMu,AD	3
607676	12q12	IRAK4 deficiency	607676	_	3
607921	17q25.3	Retinitis pigmentosa 30	607921	_	3
609583	2q13	Joubert syndrome 4	609583	AR	3
610156	9q34.3	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	AR	3
609378	17q11	{Autism susceptibility 6}	609378	_	2
609384	13q12.11	Fibrosis of extraocular muscles, congenital, 3C	609384	AD	2
610000	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
607842	18q22.3	Aural atresia, congenital	607842	AD	3
603100	9q34.3	Lipodystrophy, congenital generalized, type 1	608594	AR	3
603681	2p23.3	Auditory neuropathy, autosomal recessive, 1	601071	AR	3
603681	2p23.3	Deafness, autosomal recessive 9	601071	AR	3
610150	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
608204	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
609432	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
610683	4q27	Bardet-Biedl syndrome 12	615989	AR	3
607803	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
607803	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
610575	8q23.1	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3
610575	8q23.1	Tetraamelia syndrome 2	618021	AR	3
609584	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
607872	1p36	Chromosome 1p36 deletion syndrome	607872	IC	4
610153	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
609425	3q29	Chromosome 3q29 microdeletion syndrome	609425	IC	4
607936	3q21.1	Peeling skin syndrome 4	607936	AR	3
607922	22q13.2	NOR polyagglutination syndrome	111400	_	3
607922	22q13.2	[Blood group, P1Pk system, p phenotype]	111400	_	3
607922	22q13.2	[Blood group, P1Pk system, P(2) phenotype]	111400	_	3
607063	17q21.2	Bruck syndrome 1	259450	AR	3
607063	17q21.2	Osteogenesis imperfecta, type XI	610968	AR	3
608093	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
611507	4q24	Wolfram syndrome 2	604928	AR	3
610717	11p15.5	Neutral lipid storage disease with myopathy	610717	AR	3
603031	1q41	{Legionnaire disease, susceptibility to}	608556	_	3
603031	1q41	{Melioidosis, susceptibility to}	615557	_	3
603031	1q41	{Systemic lupus erythematosus, resistance to}	601744	_	3
603031	1q41	{Systemic lupus erythematosus, susceptibility to, 1}	601744	_	3
609566	4q21-q23	Parietal foramina 3	609566	AD	2
606201	4p16.1	?Cataract 41	116400	AD	3
606201	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
606201	4p16.1	Wolfram syndrome 1	222300	AR	3
606201	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
606201	4p16.1	{Diabetes mellitus, noninsulin-dependent, association with}	125853	AD	3
610678	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
609404	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
611501	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
609994	4q22-q27	Myopia 11	609994	_	2
608106	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
610275	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
611486	10q26.3	?Premature ovarian failure 12	616947	AR	3
611486	10q26.3	?Spermatogenic failure 15	616950	AR	3
611755	12q21.32	Leber congenital amaurosis 10	611755	_	3
605990	10q21.2	{Nephrolithiasis, uric acid, susceptibility to}	605990	_	3
610627	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
610690	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
610064	Chr.17	{Opioid dependence, susceptibility to, 1}	610064	_	2
610573	20p13	Anonychia congenita	206800	AR	3
610158	13pter-q12.13	Corneal dystrophy, Fuchs endothelial, 2	610158	AD	2
610227	17q25.3	Seborrhea-like dermatitis with psoriasiform elements	610227	_	3
608091	11q12.2	Joubert syndrome 2	608091	AR	3
609909	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
612717	10q21.1	Myopia 15	612717	AD	2
611119	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
611119	7p15.3	Retinitis pigmentosa 42	612943	AD	3
607809	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
611489	14q32.13	Corticosteroid-binding globulin deficiency	611489	AR,AD	3
612447	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
612367	1p36	{Alkaline phosphatase, plasma level of, QTL 2}	612367	_	2
611466	17q21.31	?Osteopetrosis, autosomal recessive 6	611497	AR	3
611466	17q21.31	Osteopetrosis, autosomal dominant 3	618107	AD	3
611761	16p13.3	Lipase deficiency, combined	246650	AR	3
610442	9q22.33	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442	AR	3
612772	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
605086	6p21.1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	_	3
611615	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
604285	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
602943	1q21.3	Immunodeficiency 42	616622	AR	3
610003	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
609812	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
611313	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
610896	19q13.32	Branchiootorenal syndrome 2	610896	_	3
608245	12q13.13	?Hypotrichosis 13	615896	AD	3
610065	20p12	{Systemic lupus erythematosus, susceptibility to, 7}	610065	_	2
612950	20q13	{Psoriasis susceptibility 12}	612950	_	2
613268	20p13	Corneal dystrophy, Fuchs endothelial, 4	613268	_	3
604695	10q24.32	Joubert syndrome 35	618161	AR	3
604695	10q24.32	Retinitis pigmentosa 83	618173	AD	3
609637	13q32.3	Holoprosencephaly 5	609637	AD	3
602954	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
611498	16p13.3	Nephronophthisis 7	611498	_	3
612368	6p22	{Alkaline phosphatase, plasma level of, QTL3}	612368	_	2
613063	7q32	{Basal cell carcinoma, susceptibility to, 6}	613063	_	2
611432	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
612907	3p26.2	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3
612907	3p26.2	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3
612773	19q13.32	[Blood group, Auberger system]	111200	_	3
612773	19q13.32	[Blood group, Lutheran null]	247420	AR	3
612773	19q13.32	[Blood group, Lutheran system]	111200	_	3
609558	22q12.3	{Prostate cancer, susceptibility to}	609558	_	2
609813	7p22.3	Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3
613100	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
608944	9p22.3	Bifid nose with or without anorectal and renal anomalies	608980	_	3
608944	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
608944	9p22.3	Trigonocephaly 2	614485	AD	3
612920	21q22.3	?Deafness, autosomal recessive 98	614861	AR	3
612920	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
613425	2p23.2	Retinitis pigmentosa 54	613428	_	3
612841	1p21.1-q21.3	Hypotrichosis 5	612841	AD	2
613617	2p23.3	?Retinitis pigmentosa 58	613617	AR	3
613697	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
610693	11q24.2	Hydrolethalus syndrome	236680	AR	3
608753	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
610628	3p13	Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3
613269	5q33.1-q35.2	Corneal dystrophy, Fuchs endothelial, 5	613269	_	2
613988	17p13.1	Dyskeratosis congenita, autosomal recessive 3	613988	AR	3
611386	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
611959	19q13.4	{Prostate cancer, hereditary, 15}	611959	_	2
613693	21q22.11	Long QT syndrome 6	613693	AD	3
610878	3p12.3	Vesicoureteral reflux 2	610878	_	3
612353	18p11.3	Porokeratosis 6, multiple types	612353	AD	2
612951	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
613927	6p21.33	C2 deficiency	217000	AR	3
613927	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
610897	20q11.22	Cataract 31, multiple types	605387	AD	3
608935	6q23-q25	{Lung cancer susceptibility}	608935	_	2
610084	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
604358	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
613698	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
613266	22q13.1	Waardenburg syndrome, type 4C	613266	AD	3
613544	6q11-q14	Chromosome 6q11-q14 deletion syndrome	613544	IC	4
613800	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
613982	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
614372	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
613363	9q34.11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3
613803	16q11.2	Meier-Gorlin syndrome 3	613803	AR	3
614380	6p21.33	C4a deficiency	614380	AR	3
613810	5q32	Retinitis pigmentosa 43	613810	_	3
602955	7q22.1	Alazami-Yuan syndrome	617126	AR	3
606463	1q22	Gaucher disease, perinatal lethal	608013	AR	3
606463	1q22	Gaucher disease, type I	230800	AR	3
606463	1q22	Gaucher disease, type II	230900	AR	3
606463	1q22	Gaucher disease, type III	231000	AR	3
606463	1q22	Gaucher disease, type IIIC	231005	AR	3
606463	1q22	{Lewy body dementia, susceptibility to}	127750	AD	3
606463	1q22	{Parkinson disease, late-onset, susceptibility to}	168600	Mu,AD	3
611472	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
613834	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
611927	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
614072	3q24	Hermansky-Pudlak syndrome 3	614072	AR	3
613686	17p13.1	Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3
614373	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
612284	4p15.32	Meckel syndrome 6	612284	AR	3
613563	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
612885	20p12.3	?Premature ovarian failure 10	612885	AR	3
612918	3q26.32	CLOVE syndrome, somatic	612918	_	3
614724	3q22.2	?Seckel syndrome 6	614728	AR	3
611488	9q32-q33	Macular degeneration, age-related, 10	611488	_	2
614615	5p13.2	Joubert syndrome 17	614615	AR	3
609636	7q36	Alzheimer disease-10	609636	AD	2
614631	7p21.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3
614631	7p21.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3
612688	3q29	RIDDLE syndrome	611943	AR	3
614167	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
614391	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
611499	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
614776	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
614138	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
613925	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3
614963	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
613694	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
611720	14q24.3	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3
613801	4p16.3	Retinitis pigmentosa-40	613801	AR	3
614101	2q35	Plasma fibronectin deficiency	614101	AD	1
614891	19p13.11	Immunodeficiency 30	614891	AR	3
612839	4q24	Myelodysplastic syndrome, somatic	614286	_	3
614888	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
613287	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
611928	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
614069	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
608754	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
615403	16p13.3	Beaulieu-Boycott-Innes syndrome	613680	AR	3
614379	6p21.33	C4B deficiency	614379	_	3
613364	11p14.1-p11.2	?Spastic paraplegia 41, autosomal dominant	613364	AD	2
614652	6q21	Coenzyme Q10 deficiency, primary, 3	614652	AR	3
613267	18q21.2	Corneal dystrophy, Fuchs endothelial, 3	613267	AD	3
613807	3q26.33	Ciliary dyskinesia, primary, 14	613807	_	3
614632	4p16.3	UV-sensitive syndrome 3	614640	AR	3
614617	16p13.3	Deafness , autosomal recessive 86	614617	AR	3
615286	19p13.3	Mental retardation, autosomal recessive 36	615286	AR	3
612886	5q35.2	{Menopause, natural, age at, QTL4}	612886	_	2
613160	12p13.31	von Willebrand disease, type 1	193400	AD	3
613160	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
613160	12p13.31	von Willibrand disease, type 3	277480	AR	3
615217	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
612073	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
615268	13q12.13	?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	AR	3
613546	15q21.2	Aromatase deficiency	613546	_	3
615513	1p36.22	Immunodeficiency 14	615513	AD	3
613926	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	AD	3
615663	20p13	Warburg micro syndrome 4	615663	AR	3
611721	10q22.1	Combined SAP deficiency	611721	AR	3
612354	18p11	{Inflammatory bowel disease 21}	612354	AD	2
616108	14q24.1	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3
613091	11q22.3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR,DR	3
612908	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
616022	3p25.3	Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3
602956	9p13.3	Fanconi anemia, complementation group G	614082	_	3
615290	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
612852	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
614128	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
616101	1p36.33	Spinocerebellar ataxia 21	607454	AD	3
613647	7p22.1	Spastic paraplegia 48, autosomal recessive	613647	AR	3
615298	20q11.22	Symphalangism, proximal, 1B	615298	_	3
614889	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
614066	1p13.2	Spastic paraplegia 47, autosomal recessive	614066	AR	3
613912	19p13.3	Complement factor D deficiency	613912	AR	3
614725	6q25.3	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3
616109	11q13.2	Hydatidiform mole, recurrent, 4	618432	_	3
608005	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
613577	16p13.3	Deafness , autosomal recessive 86	614617	AR	3
613577	16p13.3	Deafness, autosomal dominant 65	616044	AD	3
613577	16p13.3	DOORS syndrome	220500	AR	3
613577	16p13.3	Epileptic encephalopathy, early infantile, 16	615338	AR	3
613577	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
615287	11q13.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3
603109	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
609560	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
614618	11p15.1	Hyperekplexia 3	614618	AR,AD	3
604447	15q21.2	Intellectual developmental disorder with cardiac arrhythmia	617173	AR	3
604447	15q21.2	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182	AR	3
616817	1q32.1	Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3
616579	13q34	Mental retardation, autosomal dominant 40	616579	AD	3
615851	17p13.3	Pontocerebellar hypoplasia, type 2E	615851	AR	3
616221	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
614892	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
614099	14q24.3	?Cranioectodermal dysplasia 3	614099	AR	3
614129	19p13.3	Perrault syndrome 3	614129	AR	3
610247	7q11.2	{Esophagitis, eosinophilic, 1}	610247	Mu	2
615934	5q31.2	STING-associated vasculopathy, infantile-onset	615934	AD	3
615293	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
615404	2q36.3	{Specific language impairment 5}	615432	AD	3
614887	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
613318	8q22.3	Miyoshi muscular dystrophy 2	613318	_	2
604454	2p13.3	Welander distal myopathy	604454	AR,AD	3
604123	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
617769	5q33.1	Spinocerebellar ataxia 45	617769	AD	3
616192	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
613981	12q13.13	?Hypotrichosis 3	613981	AD	3
614890	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
618179	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
614726	4q12	Congenital disorder of glycosylation, type IIk	614727	AR	3
617654	1p31.3	?Deafness, autosomal recessive 108	617654	AR	3
614102	2p11.2	Kappa light chain deficiency	614102	AR	3
617051	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
607426	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
618012	3q13.31	Epileptic encephalopathy, infantile or early childhood, 3	618012	AD	3
616710	7p11.2	Parkinson disease 22, autosomal dominant	616710	AD	3
616834	4q32.3	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3
616684	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
610511	14q21.1	Craniolenticulosutural dysplasia	607812	AR	3
607821	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
615297	3p14.1	Adams-Oliver syndrome 4	615297	AR	3
618004	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
615269	12q21.33	Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3
618180	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
614371	19p13.2	{Dengue fever, protection against}	614371	_	3
613101	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
615703	3q29	Morbid obesity and spermatogenic failure	615703	AR	3
614787	1q21.3	White-Sutton syndrome	616364	AD	3
616768	10p15.3	Oocyte maturation defect 2	616780	AR,AD	3
612446	5p13.1	C6 deficiency	612446	_	3
618239	8q22.1	Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3
618157	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
617193	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
617976	4p16.3	Epileptic encephalopathy, early infantile, 63	617976	AR	3
616081	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
617118	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
617950	9q34.3	Combined oxidative phosphorylation deficiency 36	617950	AR	3
616576	4q24	Immunodeficiency, common variable, 12	616576	AD	3
618168	1p13.2	Diarrhea 9	618168	AR	3
616193	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
613319	11p14.3	Miyoshi muscular dystrophy 3	613319	AR	3
617120	17p11.2	Joubert syndrome 27	617120	AR	3
615517	11q12.3	?Hemochromatosis, type 5	615517	AD	3
617297	19q13.33	Amelogenesis imperfecta, type IJ	617297	AR	3
616174	2q14.1	Filippi syndrome	272440	AR	3
613986	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
616803	12p12.1	Lamb-Shaffer syndrome	616803	AD	3
615871	5p12	Epileptic encephalopathy, early infantile, 24	615871	AD	3
617626	4q12	Fibromatosis, gingival, 5	617626	AD	3
614400	7p21.3	{Glucocorticoid therapy, response to}	614400	_	3
616577	4q28.1	Epilepsy, hearing loss, and mental retardation syndrome	616577	AR	3
617119	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
618008	5q33.3	Epileptic encephalopathy, early infantile, 65	618008	AD	3
617201	18q21.31	Periventricular nodular heterotopia 7	617201	AD	3
616099	19p13.2	Palmoplantar keratoderma and woolly hair	616099	AR	3
615346	15q11.2	Precocious puberty, central, 2	615346	AD	3
616760	17q21.2	Woolly hair, autosomal recessive 3	616760	AR	3
613102	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
618158	11q13.5-q14.1	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3
616707	15q25.2	?Deafness, autosomal dominant 68	616707	AD	3
616818	13q31.1	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3
617763	9q34.12	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	617763	AR	3
606097	18q21.33	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3
616816	3p25.1	Hypotonia, infantile, with psychomotor retardation	616816	AR	3
616801	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
618167	12q23.3	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3
611490	16p13.3	Osteopetrosis, autosomal recessive 4	611490	AR	3
617296	2p25.1	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3
616819	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
603111	17q21.2	Coffin-Siris syndrome 5	616938	AD	3
603111	17q21.2	{Meningioma, familial, susceptibility to}	607174	AD	3
617996	7q34	Oocyte maturation defect 5	617996	AR	3
604168	18q23	Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3
616100	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
618003	10q24.31	Deafness, autosomal recessive 57	618003	AR	3
610443	17q21.31	Koolen-De Vries syndrome	610443	AD	3
616921	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
614958	17q12	Bleeding disorder, platelet-type, 20	616913	AD	3
614070	6q21	{Psoriasis susceptibility 13}	614070	_	3
616708	10p12.1	Desanto-Shinawi syndrome	616708	AD	3
617315	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
616106	2q36.1	{Psoriasis 15, pustular, susceptibility to}	616106	AD	3
613804	16q24.3	Meier-Gorlin syndrome 4	613804	AR	3
614959	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
617899	13q13.3	Leukodystrophy, hypomyelinating, 14	617899	AR	3
614945	11p15.1	Deafness, autosomal recessive 18B	614945	AR	3
617949	7q21.13	Spermatogenic failure 24	617959	AR	3
614674	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
615935	10p12.2	Pancreatic agenesis 2	615935	AR	3
618010	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
608584	7p14.3	{Asthma, susceptibility to, 2}	608584	_	3
618065	4q27	Pontocerebellar hypoplasia, type 1D	618065	AR	3
608099	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
608581	8p23.1	Occult macular dystrophy	613587	AD	3
613718	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
613806	3p21	Cholangitis, primary sclerosing	613806	_	2
615527	6q21	?Candidiasis, familial, 8	615527	AR	3
616107	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
617938	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
613561	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
609441	4q22.3	Acromesomelic dysplasia, Demirhan type	609441	AR	3
615728	12q13.13	Pachyonychia congenita 4	615728	_	3
617900	12q14.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3
613729	7q11.23	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	_	4
614653	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
618181	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
608102	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
617951	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
608970	5q21.3-q33.2	Macular dystrophy, butterfly-shaped pigmentary, 2	608970	AD	2
609937	2q31.1	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3
613730	11q25	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3
610533	5q34	[Memory, enhanced, QTL]	615602	_	3
608103	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608103	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
608628	3q26.32	Mental retardation, autosomal dominant 41	616944	AD	3
608628	3q26.32	Pierpont syndrome	602342	AD	3
610534	11q24.2	Al-Raqad syndrome	616459	AR	3
614961	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
617485	4q21.23	?Microcephaly 18, primary, autosomal dominant	617520	AD	3
615750	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
616176	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
608629	6q23.3	Joubert syndrome 3	608629	AR	3
609941	11p13-p12	Deafness, autosomal recessive 51	609941	AR	2
618240	3p21.31	Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3
616454	11p11.2	?Exudative vitreoretinopathy 6	616468	AD	3
616454	11p11.2	Retinitis pigmentosa 72	616469	AR	3
615937	1q43-q44	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3
605925	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
610681	12q13.11	Glycogen storage disease VII	232800	AR	3
616177	20p13	Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3
611693	11q24.1	Congenital short bowel syndrome	615237	AR	3
610682	3p22.3	Osteogenesis imperfecta, type VII	610682	AR	3
608583	10q22-q24	Atrial fibrillation, familial, 1	608583	AD	2
618241	11q24.2	Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3
609995	2q37.1	Myopia 12	609995	_	2
611695	15q15.2	Spinocerebellar ataxia 11	604432	AD	3
615938	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
609939	16p12.3-q12.2	{Systemic lupus erythematosus, susceptibility to, 6}	609939	_	2
608679	20q13.12	Galloway-Mowat syndrome 4	617730	AR	3
614962	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
617050	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
613731	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AR,AD	3
614650	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
613469	10q24.2	Urofacial syndrome 1	236730	AR	3
612715	12q21-q23	Dyschromatosis universalis hereditaria 2	612715	_	2
613983	20q13.33	Retinitis pigmentosa 60	613983	AD	3
608680	2p13.1	Galloway-Mowat syndrome 5	617731	AR	3
613743	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
615751	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
613984	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
613808	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
613809	1q41	Retinitis pigmentosa 39	613809	_	3
613638	19p13.13	Chromosome 19p13.13 deletion syndrome	613638	_	4
613638	19p13.13	Chromosome 19p13.13 duplication syndrome	613638	_	4
615411	5q12.1	Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3
610008	17q24.2	Usher syndrome, type IV	618144	AR	3
610154	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
605463	14q11.2	Radiation sensitivity/chromosome instability syndrome, autosomal dominant	_	_	1
610937	16q12.2	COACH syndrome	216360	AR	3
610937	16q12.2	Joubert syndrome 7	611560	AR	3
610937	16q12.2	Meckel syndrome 5	611561	AR	3
604043	1q32.3	?Retinitis pigmentosa 67	615565	AR	3
609942	12p12.1	Noonan syndrome 3	609942	AD	3
603504	1p21.2	Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3
606118	3q24	Hermansky-Pudlak syndrome 3	614072	AR	3
610379	3p21.31	{West nile virus, susceptibility to}	610379	_	3
607085	6p21.3	Myasthenia gravis with thymus hyperplasia	607085	_	2
612325	6p12.1	Endocrine-cerebroosteodysplasia	612651	AR	3
612325	6p12.1	{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3
607346	1p13.2	Spinocerebellar ataxia 19	607346	AD	3
605460	2p21	Sitosterolemia	210250	AR	3
605460	2p21	{Gallbladder disease 4}	611465	_	3
603585	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
605392	6q27	Myeloproliferative disorder	605392	_	2
607358	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AR,AD	3
605459	2p21	Sitosterolemia	210250	AR	3
607867	13q14.2	Retinal dystrophy with or without extraocular anomalies	617175	AR	3
608539	16p13.3	Nephronophthisis 7	611498	_	3
605283	15q11.2	Schaaf-Yang syndrome	615547	AD	3
609557	2p21	Myasthenic syndrome, congenital, 22	616224	AR	3
612201	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
610102	5p13.1	C7 deficiency	610102	_	3
610087	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
605955	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
612922	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AR,AD	3
606633	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
607644	11p13-q12	Candidiasis, familial, 3	607644	AD	2
611465	2p21	{Gallbladder disease 4}	611465	_	3
611561	16q12.2	Meckel syndrome 5	611561	AR	3
612269	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
607139	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
604563	11p15.4	Charcot-Marie-Tooth disease, type 4B2	604563	AR	3
614186	2q37.1	Leber congenital amaurosis 16	614186	AR	3
614352	7q33	?Nephrotic syndrome, type 13	616893	_	3
609638	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
614180	3q25.1	Retinitis pigmentosa 61	614180	_	3
604179	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
610881	11q13.2	Mental retardation, autosomal dominant 51	617788	AD	3
603503	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
609152	14q31.1	Hyperthyroidism, nonautoimmune	609152	AD	3
614401	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
613580	2p15	?Bardet-Biedl syndrome 15	615992	AR	3
613580	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
613470	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
612515	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
609377	16q22.1	?Dyskeratosis congenita, autosomal dominant 6	616553	AR,AD	3
609377	16q22.1	?Dyskeratosis congenita, autosomal recessive 7	616553	AR,AD	3
613812	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
605078	1p36.22	Amyotrophic lateral sclerosis 10, with or without FTD	612069	AD	3
605078	1p36.22	Frontotemporal lobar degeneration, TARDBP-related	612069	AD	3
615716	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
607620	8q24.12	3MC syndrome 3	248340	AR	3
605462	1p36	{Basal cell carcinoma, susceptibility to, 1}	605462	_	2
618170	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
613225	6p25.1	Factor XIIIA deficiency	613225	AR	3
617921	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
614351	16q13	Nephrotic syndrome, type 12	616892	AR	3
613227	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
617127	17p13.1	?Orofaciodigital syndrome XV	617127	AR	3
614191	22q12.2-q12.3	Epilepsy, familial focal, with variable foci 1	604364	AD	3
612840	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
608096	12q22-q23.3	Epilepsy, familial temporal lobe, 2	608096	AD	2
605284	9q34.13	Focal cortical dysplasia, type II, somatic	607341	_	3
605284	9q34.13	Lymphangioleiomyomatosis	606690	_	3
605284	9q34.13	Tuberous sclerosis-1	191100	AD	3
614614	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
611592	6p25.1	Combined oxidative phosphorylation deficiency 14	614946	AR	3
611592	6p25.1	Spastic paraplegia 77, autosomal recessive	617046	AR	3
617126	7q22.1	Alazami-Yuan syndrome	617126	AR	3
608098	5p15.1	Periventricular nodular heterotopia 3	608098	_	2
613244	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
605942	6q22.1	Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3
617635	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
613811	4p15.2	Pontocerebellar hypoplasia type 2D	613811	AR	3
605253	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AR,AD	3
614970	16q23.1	Joubert syndrome 20	614970	AR	3
615518	17q11.2	?Immunodeficiency 13	615518	AD	3
618358	20q11.22	Cone-rod dystrophy and hearing loss 2	618358	AR	3
617920	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
609597	11p11.2	Parietal foramina 2	609597	AD	3
608681	15q26.1	Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3
613685	9p23-p21.2	Deafness, autosomal recessive 83	613685	AR	2
610155	2q24.3	{Diabetes mellitus, insulin-dependent, 19}	610155	_	2
614675	4q12	Bone marrow failure syndrome 1	614675	AD	3
615530	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
614350	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
614181	6p24.2	Retinitis pigmentosa 62	614181	AR	3
615705	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
613243	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
612655	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
604907	17p11.2	Immunodeficiency, common variable, 2	240500	AR,AD	3
604907	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
618238	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
610031	6p25.2	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3
617194	15q21.2	Lethal congenital contracture syndrome 11	617194	AR	3
616002	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
617977	17q25.3	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3
614537	10q22.2-q22.3	Albinism, oculocutaneous, type VII	615179	AR	3
603470	9q34.11	Citrullinemia	215700	AR	3
614613	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
612513	2p16.1-p15	Chromosome 2p16.1-p15 deletion syndrome	612513	IC	4
608816	6p21	Epilepsy, juvenile myoclonic 3	608816	_	2
614683	5q35.3	[?Phosphohydroxylysinuria]	615011	_	3
614969	1p34.1	Pontocerebellar hypoplasia, type 7	614969	AR	3
612724	9q31.1	Fructose intolerance, hereditary	229600	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
606731	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
612971	10q24.31	Deafness, autosomal recessive 57	618003	AR	3
612971	10q24.31	Usher syndrome, type IIC, GPR98/PDZD7 digenic	605472	AR	3
612971	10q24.31	{Retinal disease in Usher syndrome type IIA, modifier of}	276901	AR	3
615529	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
603471	7q21.3	Citrullinemia, adult-onset type II	603471	AR	3
608540	16p13.3	Congenital disorder of glycosylation, type Ik	608540	AR	3
618265	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
609661	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
#MIM_Number	Location	Phenotype	Phenotype_MIM_number	Inheritance	Phenotype_mapping_key
100650	12q24.12	Alcohol sensitivity, acute	610251	AD	3
100650	12q24.12	{Esophageal cancer, alcohol-related, susceptibility to}	_	_	3
100650	12q24.12	{Hangover, susceptibility to}	610251	AD	3
100650	12q24.12	{Sublingual nitroglycerin, susceptibility to poor response to}	_	_	3
100070	19q13	Aortic aneurysm, familial abdominal 1	100070	AD	2
100100	1q43	?Prune belly syndrome	100100	AR	3
100300	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
100678	6q25.3	?ACAT2 deficiency	614055	IC	1
100690	2q31.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100690	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
100690	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AD,AR	3
100710	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
100710	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
100720	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100720	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AD,AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
100730	2q37.1	Escobar syndrome	265000	AR	3
100730	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100740	7q22.1	[Blood group, Yt system]	112100	_	3
100790	12q23.2	Central hypoventilation syndrome, congenital	209880	AD	3
100790	12q23.2	Haddad syndrome	209880	AD	3
100800	4p16.3	Achondroplasia	100800	AD	3
100850	22q13.2	?Optic atrophy 9	616289	AR	3
100850	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
101000	22q12.2	Neurofibromatosis, type 2	101000	AD	3
101200	10q26.13	Apert syndrome	101200	AD	3
101800	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
101850	2p25-p12	?Keratoderma, palmoplantar, punctate type 3	101850	AD	2
101900	12q24.11	Acrokeratosis verruciformis	101900	AD	3
102300	12q12-q21	{Restless legs syndrome 1}	102300	AD	2
102370	15q21.1	Acromicric dysplasia	102370	AD	3
102480	22q13.33	?Male infertility due to acrosin deficiency	102480	_	2
102500	1p12	Hajdu-Cheney syndrome	102500	AD	3
102510	2q36	Acropectorovertebral dysplasia	102510	AD	2
102530	3q26.31	?Spermatogenic failure 6	102530	AR	3
102540	15q14	Atrial septal defect 5	612794	AD	3
102540	15q14	Cardiomyopathy, dilated, 1R	613424	AD	3
102540	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
102540	15q14	Left ventricular noncompaction 4	613424	AD	3
102545	2p13.1	Visceral myopathy	155310	AD	3
102560	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
102560	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
102565	7q32.1	Cardiomyopathy, familial hypertrophic, 26	_	_	3
102565	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
102565	7q32.1	Myopathy, distal, 4	614065	AD	3
102565	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
102573	1q43	Cardiomyopathy, dilated, 1AA, with or without LVNC	612158	AD	3
102573	1q43	Cardiomyopathy, hypertrophic, 23, with or without LVNC	612158	AD	3
102574	11q13.2	[Alpha-actinin-3 deficiency]	617749	_	3
102574	11q13.2	[Sprinting performance]	617749	_	3
102575	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
102576	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
102578	15q24.1	Leukemia, acute promyelocytic, PML/RARA type	_	_	3
102579	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
102582	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
102582	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
102600	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
102610	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
102610	1q42.13	Myopathy, actin, congenital, with cores	161800	AD,AR	3
102610	1q42.13	Myopathy, actin, congenital, with excess of thin myofilaments	161800	AD,AR	3
102610	1q42.13	Myopathy, congenital, with fiber-type disproportion 1	255310	AD,AR	3
102610	1q42.13	Nemaline myopathy 3, autosomal dominant or recessive	161800	AD,AR	3
102620	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
102620	10q23.31	Moyamoya disease 5	614042	_	3
102620	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
102630	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
102630	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
102680	4p16.3	{Hypertension, essential, salt-sensitive}	145500	Mu	3
102750	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
102770	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
102771	1p13.3	?Spastic paraplegia 63	615686	AR	3
102771	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
102772	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
102900	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
103000	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
103020	1p35.1	Reticular dysgenesis	267500	AR	3
103050	22q13.1	Adenylosuccinase deficiency	103050	AR	3
103072	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
103180	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
103220	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
103270	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
103280	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
103280	11p15.5	Silver-Russell syndrome	180860	AD	3
103280	11p15.5	Wilms tumor 2	194071	AD,SMu	3
103285	3q28	ADULT syndrome	103285	AD	3
103320	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
103500	3p13	Tietz albinism-deafness syndrome	103500	AD	3
103580	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
103600	4q13.3	Analbuminemia	616000	_	3
103600	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
103720	4q23	{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}	103780	Mu	3
103720	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
103850	16p11.2	Glycogen storage disease XII	611881	AR	3
103900	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
103950	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
103950	12p13.31	{Alzheimer disease, susceptibility to}	104300	AD	3
104000	18p11.3-p11.2	Alopecia areata 1	104000	Mu	2
104100	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
104150	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
104150	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
104155	16q22.2-q22.3	Prostate cancer, somatic	176807	_	3
104160	11q12.3	Polycystic kidney disease 3	600666	AD	3
104170	22q13.2	Kanzaki disease	609242	AR	3
104170	22q13.2	Schindler disease, type I	609241	AR	3
104170	22q13.2	Schindler disease, type III	609241	AR	3
104200	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
104225	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
104250	4p16.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
104260	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
104290	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
104310	19q13.32	Alzheimer disease-2	104310	AD	3
104311	14q24.2	?Acne inversa, familial, 3	613737	AD	3
104311	14q24.2	Alzheimer disease, type 3	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	AD	3
104311	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
104311	14q24.2	Dementia, frontotemporal	600274	AD	3
104311	14q24.2	Pick disease	172700	AD	3
104500	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
104510	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
104530	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
104614	2p21	Cystinuria	220100	AD,AR	3
104620	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
104760	21q21.3	Alzheimer disease 1, familial	104300	AD	3
104760	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
104770	1q23.2	{?Amyloidosis, secondary, susceptibility to}	_	_	1
105120	9q33.2	Amyloidosis, Finnish type	105120	AD	3
105150	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
105210	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
105250	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
105500	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
105550	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
105580	11q22-qter	?Anal canal carcinoma	105580	AD	2
105590	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
105600	15q21	Dyserythropoietic anemia, congenital, type III	105600	AD	2
105650	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
105800	7q11.2	Aneurysm, intracranial berry, 1	105800	AD	2
105830	15q11.2	Angelman syndrome	105830	AD	3
105850	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
106100	11q12.1	Angioedema, hereditary, types I and II	106100	AD,AR	3
106150	1q42.2	Renal tubular dysgenesis	267430	AR	3
106150	1q42.2	{Hypertension, essential, susceptibility to}	145500	Mu	3
106150	1q42.2	{Preeclampsia, susceptibility to}	_	_	3
106165	3q24	Renal tubular dysgenesis	267430	AR	3
106165	3q24	{Hypertension, essential}	145500	Mu	3
106180	17q23.3	Renal tubular dysgenesis	267430	AR	3
106180	17q23.3	[Angiotensin I-converting enzyme, benign serum increase]	_	_	3
106180	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
106180	17q23.3	{Myocardial infarction, susceptibility to}	_	_	3
106180	17q23.3	{SARS, progression of}	_	_	3
106180	17q23.3	{Stroke, hemorrhagic}	614519	_	3
106190	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
106260	3q28	Hay-Wells syndrome	106260	AD	3
106300	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
106410	4q25-q26	Cardiac arrhythmia, ankyrin-B-related	600919	AD	3
106410	4q25-q26	Long QT syndrome 4	600919	AD	3
106600	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
106700	4q12	Total anomalous pulmonary venous return	106700	AD	2
107200	18p11.23-q12.2	Anosmia, isolated congenital	107200	AD	2
107250	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
107265	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
107269	11p13	[Blood group, Indian system]	609027	_	3
107271	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
107280	14q32.13	Alpha-1-antichymotrypsin deficiency	_	_	3
107280	14q32.13	Cerebrovascular disease, occlusive	_	_	3
107300	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AD,AR	3
107310	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
107320	6p21.3	?Antiphospholipid syndrome, familial	107320	AD	2
107323	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
107400	14q32.13	Emphysema due to AAT deficiency	613490	AR	3
107400	14q32.13	Emphysema-cirrhosis, due to AAT deficiency	613490	AR	3
107400	14q32.13	Hemorrhagic diathesis due to antithrombin Pittsburgh	613490	AR	3
107400	14q32.13	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	1
107470	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
107470	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
107470	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
107470	6q23.3	{Hepatitis B virus infection, susceptibility to}	610424	_	3
107470	6q23.3	{Tuberculosis infection, protection against}	607948	_	3
107470	6q23.3	{Tuberculosis, susceptibility to}	607948	_	3
107580	6p24.3	Branchiooculofacial syndrome	113620	AD	3
107600	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
107670	1q23.3	Apolipoprotein A-II deficiency	_	_	3
107670	1q23.3	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
107680	11q23.3	Amyloidosis, 3 or more types	105200	AD	3
107680	11q23.3	ApoA-I and apoC-III deficiency, combined	_	_	3
107680	11q23.3	Corneal clouding, autosomal recessive	_	_	3
107680	11q23.3	Hypoalphalipoproteinemia	604091	_	3
107720	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
107730	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
107730	2p24.1	Hypobetalipoproteinemia	615558	AR	3
107741	19q13.32	Alzheimer disease-2	104310	AD	3
107741	19q13.32	Hyperlipoproteinemia, type III	617347	_	3
107741	19q13.32	Lipoprotein glomerulopathy	611771	_	3
107741	19q13.32	Sea-blue histiocyte disease	269600	AR	3
107741	19q13.32	{?Macular degeneration, age-related}	603075	AD	3
107741	19q13.32	{Coronary artery disease, severe, susceptibility to}	617347	_	3
107770	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
107773	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
107776	7p14.3	[Aquaporin-1 deficiency]	110450	_	3
107776	7p14.3	[Blood group, Colton]	110450	_	3
107777	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
107820	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
107910	15q21.2	Aromatase deficiency	613546	_	3
107910	15q21.2	Aromatase excess syndrome	139300	AD	3
107930	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
107970	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
108145	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
108300	12q13.11	Stickler syndrome, type I	108300	AD	3
108370	7q21.3	Asparagine synthetase deficiency	615574	AR	3
108420	Chr.1	Spermatogenic failure 2	108420	AD	2
108500	19p13.13	Episodic ataxia, type 2	108500	AD	3
108600	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
108720	3p14.3	Atelosteogenesis, type I	108720	AD	3
108721	3p14.3	Atelosteogenesis, type III	108721	AD	3
108725	19p13.3-p13.2	{Atherosclerosis, susceptibility to}	108725	AD	2
108730	16p11.2	Brody myopathy	601003	AR	3
108733	3p25.3	{Deafness, autosomal recessive 12, modifier of}	601386	AR	3
108740	12q24.11	Acrokeratosis verruciformis	101900	AD	3
108740	12q24.11	Darier disease	124200	AD	3
108746	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
108770	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
108780	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
108780	1p36.22	Atrial standstill 2	615745	AR	3
108800	5p	Atrial septal defect 1	108800	AD	2
108900	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
108961	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
108961	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
108961	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
108962	5p13.3	?Hypertension, salt-resistant	_	_	1
108985	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
109091	19p13.13	Myelofibrosis, somatic	254450	_	3
109091	19p13.13	Thrombocythemia, somatic	187950	_	3
109150	14q32.12	Machado-Joseph disease	109150	AD	3
109200	3q26	Alopecia, androgenetic, 1	109200	AD	2
109270	17q21.31	Cryohydrocytosis	185020	AD	3
109270	17q21.31	Ovalocytosis, SA type	166900	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
109270	17q21.31	Spherocytosis, type 4	612653	AD	3
109270	17q21.31	[Blood group, Diego]	110500	_	3
109270	17q21.31	[Blood group, Froese]	601551	_	3
109270	17q21.31	[Blood group, Swann]	601550	_	3
109270	17q21.31	[Blood group, Waldner]	112010	_	3
109270	17q21.31	[Blood group, Wright]	112050	_	3
109270	17q21.31	[Malaria, resistance to]	611162	_	3
109350	13q14	Gastroesophageal reflux	109350	AD	2
109480	19p13.3	[Blood group, OK]	111380	_	3
109535	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
109543	13q14	{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	AD	2
109560	19q13.32	Leukemia/lymphoma, B-cell, 3	109560	_	2
109565	3q27.3	Lymphoma, B-cell	109565	_	2
109630	10q25.3	[Resting heart rate]	607276	_	3
109630	10q25.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
109690	5q32	Beta-2-adrenoreceptor agonist, reduced response to	_	_	3
109690	5q32	{Asthma, nocturnal, susceptibility to}	600807	AD	3
109690	5q32	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109691	8p11.23	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109700	15q21.1	?Amyloidosis, familial visceral	105200	AD	3
109700	15q21.1	Immunodeficiency 43	241600	AR	3
109720	3p12-q13.2	Biliary cirrhosis, primary, 1	109720	AD	2
109730	9q34.3	Aortic valve disease 1	109730	AD	3
109750	7p13	Hyperbiliverdinemia	614156	AD,AR	3
109760	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
110300	9q34.2	[Blood group, ABO system]	616093	_	3
110500	17q21.31	[Blood group, Diego]	110500	_	3
110600	12p12.3	[Blood group, Dombrock]	616060	_	3
110700	1q23.2	[Blood group, Duffy system]	110700	AD,AR	3
110750	2q14.3	[Blood group, Gerbich]	616089	_	3
110750	2q14.3	{Malaria, resistance to}	611162	_	3
110900	7q34	[Blood group, Kell]	110900	_	3
111000	18q12.3	[Blood group, Kidd]	111000	_	3
111100	19p13.3	[Blood group, Lewis]	_	_	3
111150	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
111250	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
111300	4q31.21	[Blood group, MNSs system]	111300	_	3
111380	19p13.3	[Blood group, OK]	111380	_	3
111600	2q35	[Blood group, Langereis system]	111600	_	3
111620	1p34.2	[Blood group, Radin]	111620	_	3
111680	1p36.11	[Rh-negative blood type]	_	_	3
111700	1p36.11	Rh-null disease, amorph type	617970	_	3
111700	1p36.11	[Blood group, Rhesus]	_	_	3
111740	4q31.21	[Blood group, Ss]	111740	_	3
111750	1p34.2	[Blood group, Scianna system]	111750	_	3
111800	4q28-q31	[Blood group, Stoltzfus system]	111800	_	2
112010	17q21.31	[Blood group, Waldner]	112010	_	3
112050	17q21.31	[Blood group, Wright]	112050	_	3
112100	7q22.1	[Blood group, Yt system]	112100	_	3
112205	19q13.2	Agammaglobulinemia 3	613501	AR	3
112210	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
112240	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
112250	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
112261	20p12.3	Brachydactyly, type A2	112600	AD	3
112261	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
112261	20p12.3	{HFE hemochromatosis, modifier of}	235200	AR	3
112262	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
112262	14q22.2	Orofacial cleft 11	600625	_	3
112264	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
112310	3p14.3	Boomerang dysplasia	112310	AD	3
112410	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
112500	2q35	Brachydactyly, type A1	112500	AD	3
113000	9q22.31	Brachydactyly, type B1	113000	AD	3
113100	20q11.22	Brachydactyly, type C	113100	AD	3
113200	2q31.1	Brachydactyly, type D	113200	AD	3
113300	2q31.1	Brachydactyly, type E	113300	AD	3
113500	12q24.11	Brachyolmia type 3	113500	AD	3
113520	12p12.1	?Hyperleucinemia-isoleucinemia or hypervalinemia	_	_	1
113530	19q13.33	?Hypervalinemia or hyperleucine-isoleucinemia	_	_	1
113620	6p24.3	Branchiooculofacial syndrome	113620	AD	3
113650	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
113705	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
113705	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	AD,Mu	3
113705	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
113721	17p13.3	Breast cancer	_	_	1
113810	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
113810	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, localisata variant	226650	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
113811	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
113970	8q24.21	Burkitt lymphoma, somatic	113970	_	3
114000	17q21.33	Caffey disease	114000	AD	3
114010	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
114019	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
114021	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
114021	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
114025	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
114078	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
114078	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
114090	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
114105	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
114105	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
114131	7q21.3	{Osteoporosis, postmenopausal, susceptibility}	166710	AD	3
114180	14q32.11	Long QT syndrome 14	616247	AD	3
114180	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
114182	2p21	Long QT syndrome 15	616249	AD	3
114200	3q11.2-q13.12	Camptodactyly 1	114200	AD	2
114205	12p13.33	Brugada syndrome 3	611875	_	3
114205	12p13.33	Long QT syndrome 8	618447	_	3
114205	12p13.33	Timothy syndrome	601005	AD	3
114206	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
114206	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
114208	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
114208	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
114208	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
114220	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
114250	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
114251	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
114300	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
114350	9q34.13	Leukemia, acute myeloid, somatic	601626	_	3
114350	9q34.13	Leukemia, T-cell acute lymphoblastic, somatic	613065	_	3
114350	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
114580	2p22.3-p21	Candidiasis, familial, 1, autosomal dominant	114580	AD	2
114760	17q23.1	Retinitis pigmentosa 17	600852	AD	3
114761	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
114815	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
114835	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
114840	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
115080	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
115150	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
115195	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
115196	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
115197	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
115200	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
115210	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
115300	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
115310	1p36.13	Paragangliomas 4	115310	AD	3
115430	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
115440	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
115470	22q11	Cat eye syndrome	115470	AD	4
115500	11p13	Acatalasemia	614097	_	3
115501	9p23	Albinism, oculocutaneous, type III	203290	AR	3
115501	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
115650	14q22-q23	Cataract 32, multiple types	115650	AD	2
115660	17q24	Cataract 7	115660	AD	2
115665	1pter-p36.13	Cataract 8, multiple types	115665	AD	2
115700	2q33.3	Cataract 4, multiple types	115700	AD	3
115800	2pter-p24	Cataract 29, coralliform	115800	AD	2
115900	2q35	?Cataract 42	115900	AD	3
116100	3q27.3	Cataract 20, multiple types	116100	AD	3
116200	1q21.2	Cataract 1, multiple types	116200	AD	3
116300	10p13	Cataract 30, pulverulent	116300	AD	3
116400	4p16.1	?Cataract 41	116400	AD	3
116600	1p36.13	Cataract 6, multiple types	116600	AD	3
116700	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
116790	22q11.21	{Panic disorder, susceptibility to}	167870	?AD	3
116790	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
116800	16q22.1	Cataract 5, multiple types	116800	AD	3
116805	5q31.2	Macular dystrophy, patterned, 2	608970	AD	3
116806	3p22.1	Colorectal cancer, somatic	114500	_	3
116806	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
116806	3p22.1	Hepatocellular carcinoma, somatic	114550	_	3
116806	3p22.1	Medulloblastoma, somatic	155255	_	3
116806	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
116806	3p22.1	Ovarian cancer, somatic	167000	_	3
116806	3p22.1	Pilomatricoma, somatic	132600	_	3
116810	8p23.1	Keratolytic winter erythema	148370	AD	4
116840	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
116896	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
116897	19q13.11	?Leukemia, acute myeloid	601626	AD,SMu	3
116897	19q13.11	Leukemia, acute myeloid, somatic	601626	_	3
116920	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
116945	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
116952	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
116955	3q21.3	Myotonic dystrophy 2	602668	AD	3
117100	11p13	Centrotemporal epilepsy	117100	IC	2
117143	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
117210	16q21	Spinocerebellar ataxia 31	117210	AD	3
117300	13q14.2	Dementia, familial Danish	117300	AD	3
117360	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
117550	5q35.3	Sotos syndrome 1	117550	AD	3
117650	20p13	Cerebrocostomandibular syndrome	117650	AD	3
117700	3q24-q25	Cerebellar ataxia	604290	AR	3
117700	3q24-q25	Hemosiderosis, systemic, due to aceruloplasminemia	604290	AR	3
117700	3q24-q25	[Hypoceruloplasminemia, hereditary]	604290	AR	3
118100	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
118190	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
118190	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
118200	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
118210	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
118220	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
118300	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
118400	4p16.3	Cherubism	118400	AD	3
118423	2q31.1	Duane retraction syndrome 2	604356	_	3
118425	7q34	Myotonia congenita, dominant	160800	AD	3
118425	7q34	Myotonia congenita, recessive	255700	AR	3
118425	7q34	Myotonia levior, recessive	_	_	3
118450	20p12.2	Alagille syndrome 1	118450	AD	3
118470	16q13	Hyperalphalipoproteinemia	143470	AD	3
118470	16q13	[High density lipoprotein cholesterol level QTL 10]	143470	AD	3
118485	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
118490	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
118494	1q43	?Prune belly syndrome	100100	AR	3
118502	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
118503	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118504	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
118504	20q13.33	{Nicotine addiction, susceptibility to}	188890	_	3
118505	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118505	15q25.1	{Nicotine dependence, susceptibility to}	612052	_	3
118507	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
118600	5p15.2	Chondrocalcinosis 2	118600	AD	3
118661	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
118700	14q13.3	Chorea, hereditary benign	118700	AD	3
118800	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
118955	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
119100	1q42.2-q43	Split-hand/foot malformation with long bone deficiency 1	119100	AD	2
119300	1q32.2	van der Woude syndrome	119300	AD	3
119500	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
119530	6p24.3	Orofacial cleft-1	119530	AD	2
119580	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
119800	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
119900	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
120070	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120070	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
120070	2q36.3	Hematuria, benign familial	141200	AD	3
120080	7q21.12	{Colchicine resistance}	120080	_	3
120090	13q34	Brain small vessel disease 2	614483	AD	3
120090	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120100	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
120110	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
120120	3p21.31	EBD inversa	226600	AR	3
120120	3p21.31	EBD, Bart type	132000	AD	3
120120	3p21.31	EBD, localisata variant	_	_	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AR	226600	AR	3
120120	3p21.31	Epidermolysis bullosa pruriginosa	604129	AD,AR	3
120120	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
120120	3p21.31	Toenail dystrophy, isolated	607523	AD	3
120120	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
120130	13q34	?Retinal arteries, tortuosity of	180000	AD	3
120130	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
120130	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
120130	13q34	Schizencephaly	269160	_	3
120130	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120131	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120131	2q36.3	Hematuria, familial benign	141200	AD	3
120140	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
120140	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
120140	12q13.11	Czech dysplasia	609162	AD	3
120140	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
120140	12q13.11	Kniest dysplasia	156550	AD	3
120140	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
120140	12q13.11	Osteoarthritis with mild chondrodysplasia	604864	AD	3
120140	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
120140	12q13.11	SED congenita	183900	AD	3
120140	12q13.11	SMED Strudwick type	184250	AD	3
120140	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
120140	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
120140	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
120140	12q13.11	Stickler syndrome, type I	108300	AD	3
120140	12q13.11	Vitreoretinopathy with phalangeal epiphyseal dysplasia	_	_	3
120150	17q21.33	Caffey disease	114000	AD	3
120150	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
120150	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
120150	17q21.33	Osteogenesis imperfecta, type II	166210	AD	3
120150	17q21.33	Osteogenesis imperfecta, type III	259420	AD	3
120150	17q21.33	Osteogenesis imperfecta, type IV	166220	AD	3
120150	17q21.33	{Bone mineral density variation QTL, osteoporosis}	166710	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
120160	7q21.3	Osteogenesis imperfecta, type II	166210	AD	3
120160	7q21.3	Osteogenesis imperfecta, type III	259420	AD	3
120160	7q21.3	Osteogenesis imperfecta, type IV	166220	AD	3
120160	7q21.3	{Osteoporosis, postmenopausal}	166710	AD	3
120180	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
120180	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
120190	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
120200	11p13	?Coloboma, ocular	120200	AD	3
120210	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
120210	6q13	Stickler syndrome, type IV	614134	_	3
120215	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
120220	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120220	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120240	21q22.3	?Myosclerosis, congenital	255600	AR	3
120240	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120240	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120250	2q37.3	Bethlem myopathy 1	158810	AD,AR	3
120250	2q37.3	Dystonia 27	616411	AR	3
120250	2q37.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120252	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
120252	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
120260	1p34.2	?Stickler syndrome, type V	614284	AR	3
120260	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
120270	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
120270	20q13.33	{Intervertebral disc disease, susceptibility to}	603932	_	3
120280	1p21.1	Fibrochondrogenesis 1	228520	AR	3
120280	1p21.1	Marshall syndrome	154780	AD	3
120280	1p21.1	Stickler syndrome, type II	604841	AD	3
120280	1p21.1	{Lumbar disc herniation, susceptibility to}	603932	_	3
120290	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
120290	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
120290	6p21.32	Fibrochondrogenesis 2	614524	AD,AR	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
120320	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
120320	6q13-q14	Bethlem myopathy 2	616471	AD	3
120328	21q22.3	Knobloch syndrome, type 1	267750	AR	3
120330	10q24.31	Papillorenal syndrome	120330	AD	3
120350	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
120353	11q22.2	COPD, rate of decline of lung function in	606963	_	3
120353	11q22.2	{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}	226600	AR	3
120360	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
120361	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
120433	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
120435	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
120436	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
120436	3p22.2	Mismatch repair cancer syndrome	276300	AR	3
120436	3p22.2	Muir-Torre syndrome	158320	AD	3
120470	18q21.2	Colorectal cancer, somatic	114500	_	3
120470	18q21.2	Esophageal carcinoma, somatic	133239	_	3
120470	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
120470	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
120502	1q31	Branchiootic syndrome 2	120502	AD	2
120520	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
120520	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AD,AR	3
120550	1p36.12	C1q deficiency	613652	AR	3
120570	1p36.12	C1q deficiency	613652	AR	3
120575	1p36.12	C1q deficiency	613652	AR	3
120580	12p13.31	C1s deficiency	613783	_	3
120580	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
120620	1q32.2	CR1 deficiency	_	_	1
120620	1q32.2	[Blood group, Knops system]	607486	_	3
120620	1q32.2	{?SLE susceptibility}	_	_	1
120620	1q32.2	{Malaria, severe, resistance to}	611162	_	3
120650	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
120650	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
120700	19p13.3	C3 deficiency	613779	AR	3
120700	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
120700	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
120790	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
120810	6p21.33	C4a deficiency	614380	AR	3
120810	6p21.33	[Blood group, Rodgers]	614374	_	3
120820	6p21.33	C4B deficiency	614379	_	3
120900	9q33.2	C5 deficiency	609536	_	3
120900	9q33.2	[Eculizumab, poor response to]	615749	AD	3
120920	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AD,AR	3
120940	5p13.1	C9 deficiency	613825	_	3
120940	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
120950	1p32.2	C8 deficiency, type I	613790	AR	3
120960	1p32.2	C8 deficiency, type II	613789	AR	3
120970	19q13.33	Cone-rod retinal dystrophy-2	120970	AD	3
121011	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
121011	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
121011	13q12.11	Deafness, autosomal recessive 1A	220290	AR	3
121011	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
121011	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
121011	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
121011	13q12.11	Vohwinkel syndrome	124500	AD	3
121013	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
121013	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
121014	6q22.31	Atrioventricular septal defect 3	600309	AD	3
121014	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
121014	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
121014	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
121014	6q22.31	Oculodentodigital dysplasia	164200	AD	3
121014	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
121014	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
121014	6q22.31	Syndactyly, type III	186100	AD	3
121015	13q12.11	Cataract 14, multiple types	601885	AD	3
121050	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
121201	8q24.22	Seizures, benign neonatal, 2	121201	AD	3
121210	8q13-q21	Febrile seizures, familial, 1	121210	AD	2
121360	16q22.1	Myeloid leukemia, acute, M4/M4Eo subtype, somatic	601626	_	1
121400	12q21.33	Cornea plana 1, autosomal dominant	121400	AD	2
121800	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
121820	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
121850	2q34	Corneal fleck dystrophy	121850	AD	3
121900	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
122000	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
122200	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
122400	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
122470	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
122500	14q32.13	Corticosteroid-binding globulin deficiency	611489	AD,AR	3
122600	16p11.2	Spondylocostal dysostosis 5	122600	AD,AR	3
122720	19q13.2	Coumarin resistance	122700	AD	3
122720	19q13.2	{Lung cancer, resistance to}	211980	AD,SMu	3
122720	19q13.2	{Nicotine addiction, protection from}	188890	_	3
122860	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
122880	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
123000	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
123100	7p21.1	Craniosynostosis 1	123100	AD	3
123101	5q35.2	Craniosynostosis 2	604757	AD	3
123101	5q35.2	Parietal foramina 1	168500	AD	3
123101	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
123155	8q12.2-q21.2	?Hydrocephalus, autosomal dominant	123155	AD	2
123270	14q32	[Creatine kinase, brain type, ectopic expression of]	123270	_	2
123320	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
123500	10q26.13	Crouzon syndrome	123500	AD	3
123570	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
123580	21q22.3	Cataract 9, multiple types	604219	AD,AR	3
123590	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
123590	11q23.1	Cataract 16, multiple types	613763	AD,AR	3
123590	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
123590	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
123610	17q11.2	Cataract 10, multiple types	600881	AD	3
123620	22q11.23	Cataract 3, multiple types	601547	AD	3
123630	22q11.23	Cataract 22	609741	AD,AR	3
123631	22q12.1	Cataract 23	610425	_	3
123670	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
123680	2q33.3	Cataract 2, multiple types	604307	AD	3
123690	2q33.3	Cataract 4, multiple types	115700	AD	3
123695	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
123700	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
123730	3q27.3	Cataract 20, multiple types	116100	AD	3
123740	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
123790	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
123805	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
123810	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
123825	4p12	Retinitis pigmentosa 49	613756	_	3
123829	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
123831	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
123833	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
123841	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
123860	1p34.2	Immunodeficiency 24	615897	AR	3
123870	11q13.1	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
123889	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
123889	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
123890	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
123890	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
123890	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
123890	2q33.2	{Hashimoto thyroiditis}	140300	AD	3
123890	2q33.2	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
123930	19q13.2	Efavirenz, poor metabolism of	614546	_	3
123930	19q13.2	{Efavirenz central nervous system toxicity, susceptibility to}	614546	_	3
123940	12q13.13	White sponge nevus 1	193900	AD	3
123970	7p15.3	Thrombocytopenia 4	612004	AD	3
123980	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
124000	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
124015	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
124015	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
124020	10q23.33	Clopidogrel, impaired responsiveness to	609535	AR	3
124020	10q23.33	Mephenytoin poor metabolizer	609535	AR	3
124020	10q23.33	Omeprazole poor metabolizer	609535	AR	3
124020	10q23.33	Proguanil poor metabolizer	609535	AR	3
124030	22q13.2	{Codeine sensitivity}	608902	AR	3
124030	22q13.2	{Debrisoquine sensitivity}	608902	AR	3
124080	8q24.3	Aldosterone to renin ratio raised	_	_	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
124080	8q24.3	{Low renin hypertension, susceptibility to}	_	_	3
124089	19q13.12	Mitochondrial complex IV deficiency	220110	Mi,AR	3
124092	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
124092	1q32.1	{HIV-1, susceptibility to}	609423	_	3
124092	1q32.1	{Rheumatoid arthritis, progression of}	180300	_	3
124200	12q24.11	Darier disease	124200	AD	3
124480	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
124500	13q12.11	Vohwinkel syndrome	124500	AD	3
124900	5q31.3	Deafness, autosomal dominant 1	124900	AD	3
125240	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
125240	1q32.2	[Blood group Cromer]	613793	AR	3
125250	3q29	Optic atrophy plus syndrome	125250	AD	3
125255	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
125264	6p22.3	Leukemia, acute nonlymphocytic	125264	_	2
125270	9q32	Porphyria, acute hepatic	612740	AR	3
125270	9q32	{Lead poisoning, susceptibility to}	612740	AR	3
125310	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
125350	3p21.31	Failure of tooth eruption, primary	125350	AD	3
125370	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
125400	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
125420	4q22.1	Dentin dysplasia, type II	125420	AD	3
125480	18p	{Major affective disorder 1}	125480	AD	2
125485	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
125485	4q22.1	Dentin dysplasia, type II	125420	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125490	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125500	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125505	16p13.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
125520	22q11	Cayler cardiofacial syndrome	125520	AD	2
125595	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
125630	19p13.12	Vibratory urticaria	125630	AD	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11	610476	AD,AR	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	AD,AR	3
125647	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
125647	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
125647	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
125647	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
125647	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
125647	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
125660	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
125660	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
125660	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
125670	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
125670	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
125671	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
125671	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
125700	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
125800	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
125850	20q13.12	MODY, type I	125850	AD	3
125851	7p13	MODY, type II	125851	AD	3
125852	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
125860	16q22.1	{Benzene toxicity, susceptibility to}	_	_	3
125860	16q22.1	{Breast cancer, poor survival after chemotherapy for}	_	_	3
125860	16q22.1	{Leukemia, post-chemotherapy, susceptibility to}	_	_	3
126060	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
126063	14q24.3	Paragangliomas 7	618475	AD	3
126064	16q22.2	Miller syndrome	263750	AR	3
126065	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
126090	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
126141	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
126141	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
126150	5q31.3	{Diphtheria, susceptibility to}	_	_	1
126340	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
126340	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
126340	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
126375	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
126375	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
126380	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
126420	20q12	DNA topoisomerase I, camptothecin-resistant	_	_	3
126430	17q21.2	DNA topoisomerase II, resistance to inhibition of, by amsacrine	_	_	3
126451	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
126451	3q13.31	{Schizophrenia, susceptibility to}	181500	AD	3
126452	11p15.5	Autonomic nervous system dysfunction	_	_	3
126452	11p15.5	[Novelty seeking personality]	601696	?AD	1
126452	11p15.5	{Attention deficit-hyperactivity disorder}	143465	AD	3
126453	4p16.1	{Attention deficit-hyperactivity disorder, susceptibility to}	143465	AD	3
126453	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
126455	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
126455	5p15.33	{Nicotine dependence, protection against}	188890	_	3
126600	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
126650	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
126700	1q31.3	Basal laminar drusen	126700	AD	3
126800	8q13	Duane retraction syndrome 1	126800	AD	2
126900	16q11.1-q22	Dupuytren contracture 1	126900	AD	2
127000	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
127400	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
127500	6q24.2-q25.2	Dyschromatosis universalis hereditaria 1	127500	AD	2
127550	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
127600	4q35	Dyskeratosis, hereditary benign intraepithelial	127600	AD	2
127700	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
128100	9q34.11	Dystonia-1, torsion	128100	AD	3
128101	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
128200	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
128230	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
128235	19q13.2	Dystonia-12	128235	AD	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
128260	1q32.1	Hypotrichosis 11	615059	AD	3
128700	8q11.1-q13.3	?Preauricular fistulae, congenital	128700	AD	2
129010	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
129010	10q21.3	Dejerine-Sottas disease	145900	AD,AR	3
129010	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AD,AR	3
129190	6q14.3	Calcification of joints and arteries	211800	AR	3
129200	4q22.3	Basan syndrome	129200	AD	3
129400	3q28	Rapp-Hodgkin syndrome	129400	AD	3
129490	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
129500	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
129600	15q21.1	Ectopia lentis, familial	129600	AD	3
129900	7q11.2-q21.3	?EEC syndrome-1	129900	AD	2
130000	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
130010	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
130050	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
130060	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
130070	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
130080	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
130130	19p13.3	Neutropenia, cyclic	162800	AD	3
130130	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
130160	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
130160	7q11.23	Supravalvar aortic stenosis	185500	AD	3
130410	19q13.41	Glutaric acidemia IIB	231680	AR	3
130500	1p35.3	Elliptocytosis-1	611804	AD,AR	3
130600	1q23.1	Elliptocytosis-2	130600	AD	3
130610	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
130620	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
130720	19p13.12	Lateral meningocele syndrome	130720	AD	3
130900	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
131100	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
131195	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
131200	10q26	{Endometriosis, susceptibility to, 1}	131200	AR,Mu	2
131222	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
131230	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
131240	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
131240	6p24.1	Question mark ears, isolated	612798	AD	3
131240	6p24.1	{High density lipoprotein cholesterol level QTL 7}	_	_	3
131242	20q13.32	Central hypoventilation syndrome, congenital	209880	AD	3
131242	20q13.32	Waardenburg syndrome, type 4B	613265	AD,AR	3
131242	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
131243	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
131243	4q31.22-q31.23	{Migraine, resistance to}	157300	AD	3
131244	13q22.3	ABCD syndrome	600501	AR	3
131244	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
131244	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
131300	19q13.2	Camurati-Engelmann disease	131300	AD	3
131320	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
131340	20p13	Spinocerebellar ataxia 23	610245	AD	3
131370	17p13.2	?Glycogen storage disease XIII	612932	AR	3
131399	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
131400	5q31-q33	Eosinophilia, familial	131400	AD	2
131440	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
131530	4q25	Hypomagnesemia 4, renal	611718	_	3
131550	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
131550	7p11.2	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	{Nonsmall cell lung cancer, susceptibility to}	211980	AD,SMu	3
131705	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
131750	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
131850	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
131950	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
131960	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
132000	3p21.31	EBD, Bart type	132000	AD	3
132100	6p21.1	Photoparoxysmal response 1	132100	AD	2
132400	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
132450	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
132700	16q12.1	Cylindromatosis, familial	132700	AD	3
132800	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
132810	1q42.12	?Hypercholanemia, familial	607748	AR	3
132811	8p21.2-p21.1	{Hypercholesterolemia, familial, due to LDLR defect, modifier of}	143890	AD	3
132890	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
132900	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
133170	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
133170	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
133170	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
133171	19p13.2	[Erythrocytosis, familial, 1]	133100	AD	3
133180	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
133190	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
133200	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AD,AR	3
133430	6q25.1-q25.2	Breast cancer, somatic	114480	_	3
133430	6q25.1-q25.2	Estrogen resistance	615363	AR	3
133430	6q25.1-q25.2	{Atherosclerosis, susceptibility to}	_	_	3
133430	6q25.1-q25.2	{HDL response to hormone replacement, augmented}	_	_	3
133430	6q25.1-q25.2	{Migraine, susceptibility to}	157300	AD	3
133430	6q25.1-q25.2	{Myocardial infarction, susceptibility to}	608446	_	3
133440	4q23	{Autism, susceptibility to, 19}	615091	_	3
133450	22q12.2	Ewing sarcoma	612219	_	3
133450	22q12.2	Neuroepithelioma	612219	_	3
133510	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
133510	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
133520	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
133520	16p13.12	Xeroderma pigmentosum, group F	278760	AR	3
133520	16p13.12	Xeroderma pigmentosum, type F/Cockayne syndrome	278760	AR	3
133520	16p13.12	XFE progeroid syndrome	610965	AR	3
133530	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G	278780	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G/Cockayne syndrome	278780	AR	3
133540	10q11.23	Cockayne syndrome, type B	133540	AR	3
133550	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
133550	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
133700	8q24.11	Exostoses, multiple, type 1	133700	AD	3
133701	11p11.2	Exostoses, multiple, type 2	133701	AD	3
134350	19p13.3	Complement factor D deficiency	613912	AR	3
134370	1q31.3	Basal laminar drusen	126700	AD	3
134370	1q31.3	Complement factor H deficiency	609814	AD,AR	3
134370	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	AD,AR	3
134370	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
134371	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AD,AR	3
134371	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
134570	6p25.1	Factor XIIIA deficiency	613225	AR	3
134570	6p25.1	{Myocardial infarction, protection against}	608446	_	3
134570	6p25.1	{Venous thrombosis, protection against}	188050	AD	3
134580	1q31.3	Factor XIIIB deficiency	613235	AR	3
134600	15q15.3	Fanconi renotubular syndrome 1	134600	AD	2
134610	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
134629	1q22	Porokeratosis 9, multiple types	616631	AD	3
134637	10q23.31	Autoimmune lymphoproliferative syndrome, type IA	601859	AD	3
134637	10q23.31	Squamous cell carcinoma, burn scar-related, somatic	_	_	3
134637	10q23.31	{Autoimmune lymphoproliferative syndrome}	601859	AD	3
134638	1q24.3	Autoimmune lymphoproliferative syndrome, type IB	601859	AD	3
134638	1q24.3	{Lung cancer, susceptibility to}	211980	AD,SMu	3
134770	11q12.3	?Hemochromatosis, type 5	615517	AD	3
134790	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
134790	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AD,AR	3
134790	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
134797	15q21.1	Acromicric dysplasia	102370	AD	3
134797	15q21.1	Ectopia lentis, familial	129600	AD	3
134797	15q21.1	Geleophysic dysplasia 2	614185	AD	3
134797	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
134797	15q21.1	Marfan syndrome	154700	AD	3
134797	15q21.1	MASS syndrome	604308	_	3
134797	15q21.1	Stiff skin syndrome	184900	AD	3
134797	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
134820	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134820	4q31.3	Amyloidosis, familial visceral	105200	AD	3
134820	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134820	4q31.3	Hypodysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134830	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Hypofibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Afibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Dysfibrinogenemia, congenital	616004	_	3
134850	4q32.1	Hypodysfibrinogenemia	616004	_	3
134850	4q32.1	Hypofibrinogenemia, congenital	202400	AR	3
134934	4p16.3	Achondroplasia	100800	AD	3
134934	4p16.3	Bladder cancer, somatic	109800	_	3
134934	4p16.3	CATSHL syndrome	610474	AD,AR	3
134934	4p16.3	Cervical cancer, somatic	603956	_	3
134934	4p16.3	Colorectal cancer, somatic	114500	_	3
134934	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
134934	4p16.3	Hypochondroplasia	146000	AD	3
134934	4p16.3	LADD syndrome	149730	AD	3
134934	4p16.3	Muenke syndrome	602849	AD	3
134934	4p16.3	Nevus, epidermal, somatic	162900	_	3
134934	4p16.3	SADDAN	616482	AD	3
134934	4p16.3	Spermatocytic seminoma, somatic	273300	_	3
134934	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
134934	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
134935	5q35.2	{Cancer progression/metastasis}	_	_	3
135100	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
135150	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
135290	5q22.2	Desmoid disease, hereditary	135290	AD	3
135300	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
135400	17q24.2-q24.3	Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400	AR	4
135500	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
135600	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
135600	2q35	Plasma fibronectin deficiency	614101	AD	1
135600	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
135750	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
135820	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
135900	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
135940	1q21.3	Ichthyosis vulgaris	146700	AD	3
135940	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
136000	4q22.3	Adermatoglyphia	136000	AD	3
136120	16q22.1	Fish-eye disease	136120	AR	3
136132	1q24.3	Trimethylaminuria	602079	AR	3
136140	16p11.2	Floating-Harbor syndrome	136140	AD	3
136350	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
136350	8p11.23	Hartsfield syndrome	615465	AD	3
136350	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
136350	8p11.23	Jackson-Weiss syndrome	123150	AD	3
136350	8p11.23	Osteoglophonic dysplasia	166250	AD	3
136350	8p11.23	Pfeiffer syndrome	101600	AD	3
136350	8p11.23	Trigonocephaly 1	190440	AD	3
136351	13q12.2	Leukemia, acute lymphoblastic, somatic	613065	_	3
136351	13q12.2	Leukemia, acute myeloid, reduced survival in, somatic	601626	_	3
136351	13q12.2	Leukemia, acute myeloid, somatic	601626	_	3
136352	5q35.3	Hemangioma, capillary infantile, somatic	602089	_	3
136352	5q35.3	Lymphatic malformation 1	153100	AD	3
136430	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
136435	2p16.3	Ovarian dysgenesis 1	233300	AR	3
136435	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
136435	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
136440	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
136520	11p13	Foveal hypoplasia 1	136520	AD	3
136530	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
136533	13q14.11	Rhabdomyosarcoma, alveolar	268220	SMu	3
136550	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
136570	16p12	Chromosome 16p12.1 deletion syndrome, 520kb	136570	_	4
136630	12q13.12	Mental retardation, FRA12A type	136630	AD	3
136680	11p13	Frasier syndrome	136680	AD,SMu	3
136760	1p13.3	Frontonasal dysplasia 1	136760	AR	3
136800	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
136836	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
136850	1q43	Fumarase deficiency	606812	AR	3
136850	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
136900	22q12.3	Sorsby fundus dystrophy	136900	AD	3
137035	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
137060	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
137070	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
137070	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
137100	6p21.3	Immunoglobulin A deficiency	137100	AD,AR,IC	2
137140	4p12	{Alcohol dependence, susceptibility to}	103780	Mu	3
137150	16p13.2	GABA-transaminase deficiency	613163	AR	3
137160	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
137160	5q34	{Epilepsy, childhood absence, susceptibility to, 4}	611136	_	3
137160	5q34	{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136	_	3
137163	1p36.33	{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	AD	3
137163	1p36.33	{Epilepsy, idiopathic generalized, 10}	613060	AD	3
137163	1p36.33	{Epilepsy, juvenile myoclonic, susceptibility to}	613060	AD	3
137164	5q34	Epilepsy, generalized, with febrile seizures plus, type 3	607681	AD	3
137164	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
137164	5q34	Febrile seizures, familial, 8	607681	AD	3
137165	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
137167	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
137167	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
137181	22q11.21	[Gamma-glutamyltransferase, familial high serum]	137181	_	2
137190	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
137192	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
137192	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
137200	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
137241	19q13.32	[Plasma glucose, 2-hour, QTL 2]	137241	_	2
137245	1p22.3	Lymphoma, MALT, somatic	137245	_	3
137290	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
137295	3q21.3	Emberger syndrome	614038	AD	3
137295	3q21.3	Immunodeficiency 21	614172	AD	3
137295	3q21.3	{Leukemia, acute myeloid, susceptibility to}	601626	AD,SMu	3
137295	3q21.3	{Myelodysplastic syndrome, susceptibility to}	614286	_	3
137350	9q33.2	Amyloidosis, Finnish type	105120	AD	3
137580	11q23	Tourette syndrome	137580	AD	2
137600	4q25	Anterior segment dysgenesis 4	137600	AD	3
137750	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
137760	10p13	Glaucoma 1, open angle, E	137760	AD	3
137780	17q21.31	Alexander disease	203450	AD	3
137920	17q12	Renal cysts and diabetes syndrome	137920	AD	3
137940	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
137950	1q32	Glomerulopathy with fibronectin deposits 1	137950	AD	2
137960	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
137960	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
138000	1p22.1	Glomuvenous malformations	138000	AD	3
138030	2q24.2	[?Hyperproglucagonemia]	_	_	1
138033	17q25.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138040	5q31.3	Glucocorticoid resistance	615962	AD	3
138079	7p13	Diabetes mellitus, noninsulin-dependent, late onset	125853	AD	3
138079	7p13	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
138079	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
138079	7p13	MODY, type II	125851	AD	3
138090	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
138130	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
138140	1p34.2	Dystonia 9	601042	AD	3
138140	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AD,AR	3
138140	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
138140	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
138140	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
138160	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
138160	3q26.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138180	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
138210	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
138244	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
138246	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
138250	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
138250	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
138250	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
138250	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
138252	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
138252	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
138253	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
138280	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
138280	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
138280	2q32.2	Global developmental delay, progressive ataxia, and elevated glutamine	618312	_	3
138290	1q25.3	Glutamine deficiency, congenital	610015	AR	3
138292	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
138295	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
138300	8p12	Hemolytic anemia due to glutathione reductase deficiency	_	_	1
138320	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
138322	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
138420	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
138430	2q24.1	{Diabetes, type 2, susceptibility to}	125853	AD	3
138470	6p21.33	?Complement factor B deficiency	615561	_	3
138470	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
138470	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
138491	5q33.1	Hyperekplexia 1	149400	AD,AR	3
138492	4q32.1	Hyperekplexia 2	614619	AR	3
138570	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
138571	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
138680	3q27.3	?Alopecia-mental retardation syndrome 1	203650	AR	3
138720	22q11.21	Bernard-Soulier syndrome, type B	231200	AR	3
138720	22q11.21	Giant platelet disorder, isolated	231200	AR	3
138760	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
138800	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
138850	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
138890	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
138900	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
138945	17q21.31	Aphasia, primary progressive	607485	AD	3
138945	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
138945	17q21.31	Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485	AD	3
138971	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
138981	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
139090	3p21.31	Gray platelet syndrome	139090	AR	3
139130	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
139130	12p13.31	{Hypertension, essential, susceptibility to}	145500	Mu	3
139150	5q14.3	Basal cell carcinoma, somatic	605462	_	3
139150	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
139190	20q11.23	?Isolated growth hormone deficiency due to defect in GHRF	_	_	1
139190	20q11.23	Gigantism due to GHRF hypersecretion	_	_	1
139191	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
139210	18q21.2	Myhre syndrome	139210	AD	3
139250	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
139250	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
139250	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
139250	17q23.3	Kowarski syndrome	262650	AR	3
139300	15q21.2	Aromatase excess syndrome	139300	AD	3
139311	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
139311	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
139312	18p11.21	Dystonia 25	615073	AD	3
139313	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
139313	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
139320	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
139320	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
139320	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
139320	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
139320	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ib	603233	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
139320	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
139330	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
139330	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
139340	1p13.3	Achromatopsia 4	613856	_	3
139350	12q13.13	Epidermolytic hyperkeratosis	113800	AD,AR	3
139350	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
139350	12q13.13	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
139350	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
139350	12q13.13	Palmoplantar keratoderma, epidermolytic	144200	AD	3
139350	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
139360	3p21.31	Pituitary ACTH-secreting adenoma	_	_	3
139360	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
139370	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
139380	1p36.33	Leukemia, acute lymphoblastic, somatic	613065	_	3
139380	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
139393	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
139396	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
139450	1q21.3	Hair, curly	139450	AD	2
139900	2p12-q22	[Handedness]	139900	AD	2
140000	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
140100	16q22.2	[Anhaptoglobinemia]	614081	_	3
140100	16q22.2	[Hypohaptoglobinemia]	614081	_	3
140300	8q23-q24	Hashimoto thyroiditis	140300	AD	2
140350	12q24.31	Hawkinsinuria	140350	AD	3
140400	1q32	Progressive familial heart block, type II	140400	AD	2
140600	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
141250	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
141250	22q12.3	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	3
141750	16pter-p13.3	Alpha-thalassemia/mental retardation syndrome, type 1	141750	AD	4
141800	16p13.3	Erythrocytosis, 7	617981	_	3
141800	16p13.3	Heinz body anemias, alpha-	140700	AD	3
141800	16p13.3	Hemoglobin H disease, nondeletional	613978	_	3
141800	16p13.3	Methemoglobinemia, alpha type	617973	_	3
141800	16p13.3	Thalassemias, alpha-	604131	_	3
141850	16p13.3	Erythrocytosis 7	617981	_	3
141850	16p13.3	Heinz body anemia	140700	AD	3
141850	16p13.3	Hemoglobin H disease, deletional and nondeletional	613978	_	3
141850	16p13.3	Thalassemia, alpha-	604131	_	3
141900	11p15.4	Delta-beta thalassemia	141749	AD	3
141900	11p15.4	Erythrocytosis 6	617980	_	3
141900	11p15.4	Heinz body anemia	140700	AD	3
141900	11p15.4	Hereditary persistence of fetal hemoglobin	141749	AD	3
141900	11p15.4	Methmoglobinemia, beta type	617971	_	3
141900	11p15.4	Sickle cell anemia	603903	AR	3
141900	11p15.4	Thalassemia, beta	613985	_	3
141900	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
141900	11p15.4	{Malaria, resistance to}	611162	_	3
142000	11p15.4	Thalassemia due to Hb Lepore	_	_	3
142000	11p15.4	Thalassemia, delta-	_	_	3
142200	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142220	6p22.2	Rahman syndrome	617537	AD	3
142250	11p15.4	Cyanosis, transient neonatal	613977	AD	3
142250	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142330	12q24.31	Hepatic adenoma, somatic	142330	_	3
142335	2p16.1	[Fetal hemoglobin QTL5]	142335	AD	2
142340	15q26.1	Hernia, congenital diaphragmatic 1	142340	Mu	2
142360	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
142409	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
142410	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
142410	12q24.31	Hepatic adenoma, somatic	142330	_	3
142410	12q24.31	MODY, type III	600496	AD	3
142410	12q24.31	Renal cell carcinoma	144700	_	3
142410	12q24.31	{Diabetes mellitus, insulin-dependent}	222100	AR	3
142410	12q24.31	{Diabetes mellitus, noninsulin-dependent, 2}	125853	AD	3
142445	8p12	{?Schizophrenia, susceptibility to}	603013	_	1
142461	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
142461	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
142470	6q22.3-q23.1	Fetal hemoglobin quantitative trait locus 2	142470	AD	2
142600	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
142600	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
142600	10q22.1	Retinitis pigmentosa 79	617460	AD	3
142622	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
142640	3q27.3	Thrombophilia due to elevated HRG	613116	AD	1
142640	3q27.3	Thrombophilia due to HRG deficiency	613116	AD	3
142669	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
142680	12p13.31	Periodic fever, familial	142680	AD	3
142690	1q23.2	Acne inversa, familial, 1	142690	AD	3
142700	13q22	Developmental dysplasia of the hip 1	142700	Mu	2
142704	15q21.2	{Gilles de la Tourette syndrome, susceptibility to}	137580	AD	3
142800	6p22.1	{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}	608579	_	3
142810	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
142810	5q31.3	Usher syndrome type 3B	614504	AR	3
142830	6p21.33	{Abacavir hypersensitivity, susceptibility to}	_	_	3
142830	6p21.33	{Drug-induced liver injury due to flucloxacillin}	_	_	3
142830	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
142830	6p21.33	{Stevens-Johnson syndrome, susceptibility to}	608579	_	3
142830	6p21.33	{Synovitis, chronic, susceptibility to}	_	_	3
142830	6p21.33	{Toxic epidermal necrolysis, susceptibility to}	608579	_	3
142840	6p21.33	{HIV-1 viremia, susceptibility to}	609423	_	3
142840	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
142857	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
142857	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
142858	6p21.32	{Beryllium disease, chronic, susceptibility to}	_	_	3
142871	6p22.1	{Asthma, susceptibility to}	600807	AD	2
142900	12q24.21	Holt-Oram syndrome	142900	AD	3
142910	5q13.3	[Low density lipoprotein cholesterol level QTL 3]	_	_	3
142910	5q13.3	[Statins, attenuated cholesterol lowering by]	_	_	3
142945	7q36.3	Holoprosencephaly 3	142945	AD	3
142946	18p11.31	Holoprosencephaly 4	142946	AD	3
142955	7p15.2	Athabaskan brainstem dysgenesis syndrome	601536	_	3
142955	7p15.2	Bosley-Salih-Alorainy syndrome	601536	_	3
142958	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
142959	7p15.2	?Guttmacher syndrome	176305	AD	3
142959	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
142968	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
142976	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
142983	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
142983	4p16.2	Orofacial cleft 5	608874	_	3
142983	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
142984	2q31.1	Charcot-Marie-Tooth disease, foot deformity of	192950	AD	3
142984	2q31.1	Vertical talus, congenital	192950	AD	3
142989	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
142989	2q31.1	Brachydactyly, type D	113200	AD	3
142989	2q31.1	Brachydactyly, type E	113300	AD	3
142989	2q31.1	Syndactyly, type V	186300	AD	3
142989	2q31.1	Synpolydactyly 1	186000	AD	3
142992	4p16.1	Oculoauricular syndrome	612109	AR	3
142993	14q24.3	Microphthalmia with coloboma 3	610092	_	3
142993	14q24.3	Microphthalmia, isolated 2	610093	_	3
142994	7q36.3	Currarino syndrome	176450	AD	3
143054	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
143095	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
143100	4p16.3	Huntington disease	143100	AD	3
143200	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
143400	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
143450	2p23.3	Trifunctional protein deficiency	609015	AR	3
143500	2q37.1	[Gilbert syndrome]	143500	AR	3
143850	18q	Orthostatic hypotensive disorder of Streeten	143850	AD	2
143860	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
143870	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
143880	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
144010	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
144110	14q11.2-q13	Hyperhidrosis palmaris et plantaris	144110	AD	2
144120	14q32.33	?Hyperimmunoglobulin G1 syndrome	144120	AD	2
144250	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
144650	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
144755	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
145000	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
145250	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
145260	1q31-q42	Pseudohypoaldosteronism, type IIA	145260	AD	2
145410	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
145420	22q11.23	Hypertelorism, Teebi type	145420	AD	3
145505	16p12.3	{?Hypertension, essential}	_	_	1
145650	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
145680	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
145701	8q22	?Hypertrichosis universalis congenita, Ambras type	145701	AD	2
145750	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
145980	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
145981	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
146000	4p16.3	Hypochondroplasia	146000	AD	3
146110	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
146255	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
146390	18p	Chromosome 18p deletion syndrome	146390	AD	4
146450	7q32.2-q36.1	Hypospadias 3, autosomal	146450	AD,Mu	2
146500	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AD,AR	3
146510	7p14.1	Pallister-Hall syndrome	146510	AD	3
146520	6p21.33	Hypotrichosis 2	146520	AD	3
146550	8p21.3	Hypotrichosis 4	146550	AD	3
146590	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
146660	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
146661	5p13.2	Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type	608971	AR	3
146690	7q32.1	Leber congenital amaurosis 11	613837	AD	3
146690	7q32.1	Retinitis pigmentosa 10	180105	AD	3
146691	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
146700	1q21.3	Ichthyosis vulgaris	146700	AD	3
146738	19p13.11	Cryptorchidism	219050	AD	3
146740	1q23.3	Immunodeficiency 20	615707	AR	3
146760	1q21.2	[IgG receptor I, phagocytic, familial deficiency of]	_	_	3
146770	22q11.23	Agammaglobulinemia 2	613500	AR	3
146790	1q23.3	{Lupus nephritis, susceptibility to}	152700	AD	3
146790	1q23.3	{Malaria, severe, susceptibility to}	611162	_	3
146790	1q23.3	{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	AR	3
146800	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
146880	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
146920	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
146920	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
146929	2q35	{AIDS, slow progression to}	609423	_	3
146933	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
147020	14q32.33	Agammaglobulinemia 1	601495	AR	3
147060	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
147061	5q31.1	{?Allergy and asthma susceptibility}	147061	_	2
147110	14q32.33	IgG2 deficiency, selective	_	_	3
147138	11q12.1	{Atopy, susceptibility to}	147050	AD	3
147141	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
147183	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
147200	2p11.2	Kappa light chain deficiency	614102	AR	3
147245	17q23.3	Agammaglobulinemia 6	612692	AR	3
147250	7q36.3	Single median maxillary central incisor	147250	AD	3
147265	3p26.1	Gillespie syndrome	206700	AD,AR	3
147265	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
147265	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
147267	6p21.31	{Diabetes, type 1, susceptibility to}	222100	AR	2
147280	6q25.3	Hepatocellular carcinoma, somatic	114550	_	3
147370	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
147430	14q11.2	?Marsili syndrome	147430	AD	3
147440	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
147450	21q22.11	Amyotrophic lateral sclerosis 1	105400	AD,AR	3
147460	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
147470	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
147480	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
147520	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
147520	20p13	[Inosine triphosphatase deficiency]	613850	_	3
147545	2q36.3	{Coronary artery disease, susceptibility to}	_	_	3
147545	2q36.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
147556	2q31.1	Epidermolysis bullosa, junctional, with pyloric stenosis	226730	AR	3
147557	17q25.1	Epidermolysis bullosa of hands and feet	131800	AD	3
147557	17q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
147557	17q25.1	Epidermolysis bullosa, junctional, with pyloric atresia	226730	AR	3
147558	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
147569	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
147570	12q15	{AIDS, rapid progression to}	609423	_	3
147570	12q15	{Aplastic anemia}	609135	_	3
147570	12q15	{Hepatitis C virus, response to therapy of}	609532	_	3
147570	12q15	{TSC2 angiomyolipomas, renal, modifier of}	613254	AD	3
147570	12q15	{Tuberculosis, protection against}	607948	_	3
147571	1p36.33	Immunodeficiency 38	616126	AR	3
147575	5q31.1	Gastric cancer, somatic	613659	_	3
147575	5q31.1	Myelodysplastic syndrome, preleukemic	_	_	3
147575	5q31.1	Myelogenous leukemia, acute	_	_	3
147575	5q31.1	Nonsmall cell lung cancer, somatic	211980	_	3
147582	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
147620	7p15.3	{Crohn disease-associated growth failure}	266600	Mu	3
147620	7p15.3	{Diabetes, susceptibility to},	222100	AR	3
147620	7p15.3	{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	AD	3
147620	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
147620	7p15.3	{Rheumatoid arthritis, systemic juvenile}	604302	_	3
147630	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
147650	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
147660	9p21.3	Interferon, alpha, deficiency	_	_	1
147670	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
147670	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
147670	19p13.2	Leprechaunism	246200	AR	3
147670	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
147679	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
147679	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147679	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
147683	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
147683	5q31.1	{Asthma, susceptibility to}	600807	AD	3
147700	2q34	{Glioma, susceptibility to, somatic}	137800	_	3
147720	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147730	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
147730	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
147750	20q13.2	IVIC syndrome	147750	AD	3
147781	16p12.1	{AIDS, slow progression to}	609423	_	3
147781	16p12.1	{Atopy, susceptibility to}	147050	AD	3
147791	11q23	Jacobsen syndrome	147791	IC	4
147796	9p24.1	Erythrocytosis, somatic	133100	_	3
147796	9p24.1	Leukemia, acute myeloid, somatic	601626	_	3
147796	9p24.1	Myelofibrosis, somatic	254450	_	3
147796	9p24.1	Polycythemia vera, somatic	263300	_	3
147796	9p24.1	Thrombocythemia 3	614521	AD,SMu	3
147796	9p24.1	{Budd-Chiari syndrome, somatic}	600880	_	3
147840	19p13.2	{Malaria, cerebral, susceptibility to}	611162	_	3
147880	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
147880	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
147891	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
147910	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
147920	12q13.12	Kabuki syndrome 1	147920	AD	3
147950	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
148000	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
148040	12q13.13	Dowling-Degos disease 1	179850	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148040	12q13.13	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148040	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
148040	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
148041	12q13.13	Pachyonychia congenita 3	615726	_	3
148042	12q13.13	Pachyonychia congenita 4	615728	_	3
148043	12q13.13	Meesmann corneal dystrophy	122100	AD	3
148050	16q24.3	KBG syndrome	148050	AD	3
148060	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148060	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148065	17q21.2	White sponge nevus 2	615785	AD	3
148066	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148066	17q21.2	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148066	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
148067	17q21.2	Pachyonychia congenita 1	167200	AD	3
148067	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
148069	17q21.2	Pachyonychia congenita 2	167210	AD	3
148069	17q21.2	Steatocystoma multiplex	184500	AD	3
148070	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148070	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148080	17q21.2	Epidermolytic hyperkeratosis	113800	AD,AR	3
148080	17q21.2	Ichthyosis with confetti	609165	AD	3
148080	17q21.2	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
148190	11p13	Keratitis	148190	AD	3
148200	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
148210	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
148300	20p11.21	Keratoconus 1	148300	AD	3
148350	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
148370	8p23-p22	Keratolytic winter erythema	148370	AD	2
148500	17q25.1	Tylosis with esophageal cancer	148500	AD	3
148600	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
148700	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
148760	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
148820	2q36.1	Waardenburg syndrome, type 3	148820	AD,AR	3
149000	8q22.3	Klippel-Trenaunay-Weber syndrome	149000	IC	2
149200	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
149400	5q33.1	Hyperekplexia 1	149400	AD,AR	3
149700	1p13.1	?Lacrimal duct defect	149700	AR	3
150000	11p15.1	Glycogen storage disease XI	612933	AR	3
150100	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
150200	17q23.3	[Placental lactogen deficiency]	_	_	1
150230	8q24.11-q24.13	Trichorhinophalangeal syndrome, type II	150230	AD	4
150240	7q31.1	Lissencephaly 5	615191	AR	3
150250	3p14.3	Larsen syndrome	150250	AD	3
150270	6p21.3-p21.2	?Laryngeal adductor paralysis	150270	AD	2
150292	1q25.3	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150292	1q25.3	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150310	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
150310	1q32.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150310	1q32.2	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150320	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
150325	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
150325	3p21.31	Pierson syndrome	609049	AR	3
150330	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
150330	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
150330	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
150330	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
150330	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
150330	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
150330	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
150330	1q22	Malouf syndrome	212112	AD	3
150330	1q22	Mandibuloacral dysplasia	248370	AR	3
150330	1q22	Muscular dystrophy, congenital	613205	AD	3
150330	1q22	Restrictive dermopathy, lethal	275210	AR	3
150340	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
150341	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
150341	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
150370	3p22.1	Asplenia, isolated congenital	271400	AD	3
150400	2q35	Tooth agenesis, selective, 4	150400	AD,AR	3
150571	22q13.1	{Myocardial infarction, susceptibility to}	608446	_	3
150600	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
150699	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
150800	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
151050	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
151100	12q24.13	LEOPARD syndrome 1	151100	AD	3
151200	8q22.1	Leri pleonosteosis chromosome duplication syndrome	151200	AD	4
151210	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
151350	5q32	?Infantile liver failure syndrome 1	615438	AR	3
151385	21q22.12	Leukemia, acute myeloid	601626	AD,SMu	3
151385	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
151410	22q11.23	Leukemia, acute lymphocytic, somatic	613065	_	3
151410	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
151430	18q21.33	Leukemia/lymphoma, B-cell, 2	_	_	3
151440	19p13.13	Leukemia, T-cell acute lymphoblastoid	151440	_	2
151443	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
151460	1q31.3-q32.1	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	AR	3
151460	1q31.3-q32.1	{Hepatitis C virus, susceptibility to}	609532	_	3
151600	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AD,AR	3
151623	17p13.1	Li-Fraumeni syndrome	151623	AD	3
151660	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
151670	15q21.3	Hepatic lipase deficiency	614025	AR	3
151670	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
151670	15q21.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
151750	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
152200	6q25-q26	[LPA deficiency, congenital]	_	_	3
152200	6q25-q26	{Coronary artery disease, susceptibility to}	_	_	1
152390	10q11.21	{Asthma, diminished response to antileukotriene treatment in}	600807	AD	3
152390	10q11.21	{Atherosclerosis, susceptibility to}	_	_	3
152424	11p15.4	Thalassemia, Hispanic gamma-delta-beta	613985	_	3
152427	7q36.1	Long QT syndrome 2	613688	AD	3
152427	7q36.1	Short QT syndrome 1	609620	_	3
152427	7q36.1	{Long QT syndrome 2, acquired, susceptibility to}	613688	AD	3
152430	4q25	[Longevity 1]	152430	_	2
152445	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
152760	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
152780	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
152790	2p16.3	Leydig cell adenoma, somatic, with precocious puberty	176410	_	3
152790	2p16.3	Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	AR	3
152790	2p16.3	Leydig cell hypoplasia with pseudohermaphroditism	238320	AR	3
152790	2p16.3	Luteinizing hormone resistance, female	238320	AR	3
152790	2p16.3	Precocious puberty, male	176410	AD	3
152950	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
153100	5q35.3	Lymphatic malformation 1	153100	AD	3
153245	4q25	Sebaceous tumors, somatic	_	_	3
153390	1p35.2	?Immunodeficiency 22	615758	AR	3
153440	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
153440	6p21.33	{Myocardial infarction, susceptibility to}	608446	_	3
153440	6p21.33	{Psoriatic arthritis, susceptibility to}	607507	_	3
153450	12q15	Amyloidosis, renal	105200	AD	3
153454	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
153455	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
153456	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
153550	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
153600	6p21.3	{Macroglobulinemia, Waldenstrom, susceptibility to, 1}	153600	AD	2
153620	22q11.23	{Rheumatoid arthritis, systemic juvenile, susceptibility to}	604302	_	3
153622	8p22	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
153670	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
153700	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
153800	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
153880	7p21-p15	Macular dystrophy, dominant cystoid	153880	AD	2
154020	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
154045	19q13.41	Cataract 19, multiple types	615277	AR	3
154050	12q13.3	Cataract 15, multiple types	615274	AD	3
154100	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
154230	9p24.3	46XY sex reversal 4	154230	_	4
154235	6p24.2	Retinitis pigmentosa 62	614181	AR	3
154275	17q11.2-q24	{Malignant hyperthermia susceptibility 2}	154275	AD	2
154276	7q21-q22	{Malignant hyperthermia susceptibility 3}	154276	AD	2
154400	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
154500	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
154545	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
154550	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
154700	15q21.1	Marfan syndrome	154700	AD	3
154780	1p21.1	Marshall syndrome	154780	AD	3
154870	12p12.3	Keutel syndrome	245150	AR	3
154950	14q23.3	{Pheochromocytoma, susceptibility to}	171300	AD	3
155100	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
155310	2p13.1	Visceral myopathy	155310	AD	3
155500	3q26.32	Macrodactyly, somatic	155500	_	3
155540	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
155541	18q21.32	Obesity (BMIQ20)	618406	_	3
155541	18q21.32	{Obesity, resistence to (BMIQ20)}	618306	_	3
155555	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	AR	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	AR	3
155555	16q24.3	{Albinism, oculocutaneous, type II, modifier of}	203200	AR	3
155555	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
155555	16q24.3	{UV-induced skin damage}	266300	AR	3
155600	1p36	{Melanoma, cutaneous malignant, 1}	155600	AD	2
155601	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
155755	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
155760	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
155760	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
155760	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
155900	9p11	?Melkersson-Rosenthal syndrome	155900	AD	2
156100	22q12.1	Meningioma	607174	AD	3
156200	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
156225	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
156225	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
156232	2q24-q32	Mesomelic dysplasia, Kantaputra type	156232	AD	2
156250	12q24.13	Metachondromatosis	156250	AD	3
156400	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
156490	17q21.33	Neuroblastoma	256700	AD,SMu	3
156500	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
156510	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
156530	12q24.11	Metatropic dysplasia	156530	AD	3
156540	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
156550	12q13.11	Kniest dysplasia	156550	AD	3
156560	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
156560	12q13.3	Interstitial lung and liver disease	615486	AR	3
156570	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
156570	1q43	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
156600	13q32	Microcoria, congenital	156600	AD	4
156610	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
156845	3p13	COMMAD syndrome	617306	AR	3
156845	3p13	Tietz albinism-deafness syndrome	103500	AD	3
156845	3p13	Waardenburg syndrome, type 2A	193510	AD	3
156845	3p13	Waardenburg syndrome/ocular albinism, digenic	103470	AD	3
156845	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
156850	16p13.3	Microphthalmia with cataract 1	156850	AD	2
157140	17q21.31	Dementia, frontotemporal, with or without parkinsonism	600274	AD	3
157140	17q21.31	Pick disease	172700	AD	3
157140	17q21.31	Supranuclear palsy, progressive	601104	AD	3
157140	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
157140	17q21.31	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
157145	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
157147	4q23	Abetalipoproteinemia	200100	AR	3
157147	4q23	{Metabolic syndrome, protection against}	605552	AD	3
157170	2p21	Holoprosencephaly 2	157170	AD	3
157300	4q24	{Migraine with or without aura, susceptibility to, 1}	157300	AD	2
157600	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
157640	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
157655	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
157660	9p13.3	Anauxetic dysplasia 1	607095	AR	3
157660	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
157660	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
157700	16p12.1-p11.2	Mitral valve prolapse, myxomatous 1	157700	AD	2
157800	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
157900	13q12.2-q13	?Moebius syndrome	157900	AD,IC	2
158105	17q12	{Coronary artery disease, modifier of}	_	_	3
158105	17q12	{HIV-1, resistance to}	609423	_	3
158105	17q12	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
158105	17q12	{Spina bifida, susceptibility to}	182940	AD	3
158170	9p	Chromosome 9p deletion syndrome	158170	AD	4
158300	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
158330	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
158340	1q22	Medullary cystic kidney disease 1	174000	AD	3
158375	4q13.3	{Asthma, protection against}	600807	AD	3
158378	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
158580	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
158590	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
158600	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
158900	4q35	Facioscapulohumeral muscular dystrophy 1	158900	AD	4
158901	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
159350	5q22.2	Colorectal cancer, somatic	114500	_	3
159440	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
159440	1q23.3	Dejerine-Sottas disease	145900	AD,AR	3
159440	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
159440	1q23.3	Roussy-Levy syndrome	180800	AD	3
159460	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
159465	6p22.1	?Narcolepsy 7	614250	AD	3
159530	1p34.2	Myelofibrosis with myeloid metaplasia, somatic	254450	_	3
159530	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
159530	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
159550	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
159555	11q23.3	Leukemia, myeloid/lymphoid or mixed-lineage	159555	AD	2
159555	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
159595	21q11.2	Leukemia, transient, of Down syndrome	159595	_	2
159900	7q21.3	Dystonia-11, myoclonic	159900	AD	3
159950	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
159990	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
160120	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
160500	14q11.2	Laing distal myopathy	160500	AD	3
160565	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
160700	18p11.31	Myopia-2	160700	AD	2
160710	14q11.2	Atrial septal defect 3	614089	_	3
160710	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
160710	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
160710	14q11.2	{Sick sinus syndrome 3}	614090	_	3
160720	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
160720	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
160740	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AD,AR	3
160741	17p13.1	Carney complex variant	608837	_	3
160741	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
160745	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
160760	14q11.2	Cardiomyopathy, dilated, 1S	613426	AD	3
160760	14q11.2	Cardiomyopathy, hypertrophic, 1	192600	AD	3
160760	14q11.2	Laing distal myopathy	160500	AD	3
160760	14q11.2	Left ventricular noncompaction 5	613426	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
160760	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
160770	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
160775	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
160775	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
160777	15q21.2	Griscelli syndrome, type 1	214450	AR	3
160780	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
160781	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
160790	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AD,AR	3
160794	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
160794	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
160800	7q34	Myotonia congenita, dominant	160800	AD	3
160900	19q13.32	Myotonic dystrophy 1	160900	AD	3
160980	17q24.2	Carney complex, type 1	160980	AD	3
160998	6p25.2	{?Breast cancer susceptibility}	114480	AD,SMu	1
161000	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
161015	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
161200	9q33.3	Nail-patella syndrome	161200	AD	3
161400	17q21.2	?Narcolepsy 1	161400	AD	3
161550	6p21.3	{Nasopharyngeal carcinoma, susceptibility to, 2}	161550	_	2
161561	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
161650	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
161900	1q21	Nephropathy-hypertension	161900	AD	2
161950	6q22-q23	{IgA nephropathy, susceptibility to, 1}	161950	?AD	2
162000	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
162030	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
162080	14q11-q12	Retinal degeneration, autosomal recessive, clumped pigment type	_	_	3
162080	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
162100	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
162150	5q15	Obesity with impaired prohormone processing	600955	AR	3
162150	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
162200	17q11.2	Neurofibromatosis, type 1	162200	AD	3
162210	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
162230	22q12.2	?{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
162230	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AD,AR	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
162300	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
162330	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
162332	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
162350	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
162400	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
162500	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
162643	2q22.1	Myelokathexis, isolated	_	_	3
162643	2q22.1	WHIM syndrome	193670	AD	3
162662	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
162800	19p13.3	Neutropenia, cyclic	162800	AD	3
162820	7q22-qter	?Neutrophil chemotactic response, abnormal	162820	AD	2
163000	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
163500	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
163729	7q36.1	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
163729	7q36.1	{Coronary artery spasm 1, susceptibility to}	_	_	3
163729	7q36.1	{Hypertension, pregnancy-induced}	189800	AD	3
163729	7q36.1	{Hypertension, susceptibility to}	145500	Mu	3
163729	7q36.1	{Ischemic stroke, susceptibility to}	601367	Mu	3
163729	7q36.1	{Placental abruption}	_	_	3
163730	17q11.2	{Hypertension, susceptibility to}	145500	Mu	2
163730	17q11.2	{Malaria, resistance to}	611162	_	3
163800	15q24.1	Sick sinus syndrome 2	163800	AD	3
163890	4q22.1	Dementia, Lewy body	127750	AD	3
163890	4q22.1	Parkinson disease 1	168601	AD	3
163890	4q22.1	Parkinson disease 4	605543	AD	3
163950	12q24.13	Noonan syndrome 1	163950	AD	3
163970	16q12.2	?Orthostatic intolerance	604715	_	3
164005	19p13.13	Marshall-Smith syndrome	602535	AD	3
164005	19p13.13	Sotos syndrome 2	614753	AD	3
164008	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
164009	11q13.4	Leukemia, acute promyelocytic, somatic	612376	_	3
164010	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
164011	4q24	Immunodeficiency, common variable, 12	616576	AD	3
164012	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
164014	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
164015	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
164017	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
164017	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
164040	5q35.1	Leukemia, acute myeloid, somatic	601626	_	3
164050	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
164100	6p12	Nystagmus 2, congenital, autosomal dominant	164100	AD	2
164160	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
164200	6q22.31	Oculodentodigital dysplasia	164200	AD	3
164210	14q32	Hemifacial microsomia	164210	AD	2
164280	2p24.3	Feingold syndrome 1	164280	AD	3
164300	14q11.2	Oculopharyngeal muscular dystrophy	164300	AD	3
164360	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
164360	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
164400	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
164500	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
164690	1q25.2	Leukemia, acute myeloid, with eosinophilia	_	_	1
164730	14q32.33	Breast cancer, somatic	114480	_	3
164730	14q32.33	Colorectal cancer, somatic	114500	_	3
164730	14q32.33	Cowden syndrome 6	615109	_	3
164730	14q32.33	Ovarian cancer, somatic	167000	_	3
164730	14q32.33	Proteus syndrome, somatic	176920	_	3
164730	14q32.33	{Schizophrenia, susceptibility to}	181500	AD	2
164731	19q13.2	Diabetes mellitus, type II	125853	AD	3
164731	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
164745	17q21.31	Omodysplasia 2	164745	AD	3
164750	1p31.3	Omphalocele due to duplication of 1p31.3	164750	IC	4
164757	7q34	Adenocarcinoma of lung, somatic	211980	_	3
164757	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
164757	7q34	Colorectal cancer, somatic	_	_	3
164757	7q34	LEOPARD syndrome 3	613707	AD	3
164757	7q34	Melanoma, malignant, somatic	_	_	3
164757	7q34	Nonsmall cell lung cancer, somatic	_	_	3
164757	7q34	Noonan syndrome 7	613706	AD	3
164760	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
164760	3p25.2	LEOPARD syndrome 2	611554	_	3
164760	3p25.2	Noonan syndrome 5	611553	AD	3
164761	10q11.21	Central hypoventilation syndrome, congenital	209880	AD	3
164761	10q11.21	Medullary thyroid carcinoma	155240	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
164761	10q11.21	Pheochromocytoma	171300	AD	3
164761	10q11.21	{Hirschsprung disease, protection against}	142623	AD	3
164761	10q11.21	{Hirschsprung disease, susceptibility to, 1}	142623	AD	3
164770	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
164770	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
164780	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
164785	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
164790	1p13.2	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	614470	_	3
164790	1p13.2	Colorectal cancer, somatic	114500	_	3
164790	1p13.2	Epidermal nevus, somatic	162900	_	3
164790	1p13.2	Melanocytic nevus syndrome, congenital, somatic	137550	_	3
164790	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
164790	1p13.2	Noonan syndrome 6	613224	AD	3
164790	1p13.2	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
164790	1p13.2	Thyroid carcinoma, follicular, somatic	188470	_	3
164820	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
164820	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
164840	2p24.3	Feingold syndrome 1	164280	AD	3
164860	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
164860	7q31.2	Hepatocellular carcinoma, childhood type, somatic	114550	_	3
164860	7q31.2	Renal cell carcinoma, papillary, 1, familial and somatic	605074	_	3
164860	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
164870	17q12	Adenocarcinoma of lung, somatic	211980	_	3
164870	17q12	Gastric cancer, somatic	613659	_	3
164870	17q12	Glioblastoma, somatic	137800	_	3
164870	17q12	Ovarian cancer, somatic	_	_	3
164874	14q12	Rett syndrome, congenital variant	613454	AD	3
164920	4q12	Gastrointestinal stromal tumor, familial	606764	AD,IC	3
164920	4q12	Germ cell tumors, somatic	273300	_	3
164920	4q12	Leukemia, acute myeloid	601626	AD,SMu	3
164920	4q12	Mastocytosis, cutaneous	154800	AD	3
164920	4q12	Mastocytosis, systemic, somatic	154800	_	3
164920	4q12	Piebaldism	172800	AD	3
164950	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
164953	19p13.2-q13.3	Liposarcoma	_	_	1
165190	4q21.21	Trichomegaly	190330	AR	3
165215	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
165220	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
165220	12q13.3	Polydactyly, preaxial I	174400	AR	3
165230	2q14.2	Culler-Jones syndrome	615849	AD	3
165230	2q14.2	Holoprosencephaly 9	610829	AD	3
165240	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
165240	7p14.1	Pallister-Hall syndrome	146510	AD	3
165240	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
165240	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
165240	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
165300	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
165320	2q14-q21	?Hepatocellular carcinoma	_	_	1
165330	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
165360	11q23.3	?Juvenile myelomonocytic leukemia	607785	AD,SMu	3
165360	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
165500	3q29	Optic atrophy 1	165500	AD	3
165550	11p13	Optic nerve hypoplasia	165550	AD	3
165640	2p25.1	{Colonic adenoma recurrence, reduced risk of}	114500	AD,SMu	3
165720	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
165800	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
166200	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
166250	8p11.23	Osteoglophonic dysplasia	166250	AD	3
166260	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
166300	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
166350	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
166600	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
166750	11q13	Otodental dysplasia chromosome deletion syndrome	166750	AD	4
166760	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
166780	8q13.3	?Otofaciocervical syndrome	166780	AD	3
166800	15q26.1-qter	Otosclerosis 1	166800	AD	2
166900	17q21.31	Ovalocytosis, SA type	166900	AD	3
167030	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
167200	17q21.2	Pachyonychia congenita 1	167200	AD	3
167210	17q21.2	Pachyonychia congenita 2	167210	AD	3
167250	5q35.3	Paget disease of bone 3	167250	AD	3
167320	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
167400	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
167409	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
167409	10q24.31	Papillorenal syndrome	120330	AD	3
167410	1p36.13	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
167411	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
167413	7q32.1	Diabetes mellitus, type 2	125853	AD	3
167413	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
167413	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AD,AR	3
167414	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
167415	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
167416	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
167420	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
167790	5q32	Pancreatitis, hereditary	167800	AD	3
167790	5q32	Tropical calcific pancreatitis	608189	AD,AR	3
167790	5q32	{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	AD,AR	3
167870	13q22-q32	Panic disorder syndrome 1	167870	?AD	2
168000	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
168300	17q23.3	Paramyotonia congenita	168300	AD	3
168400	12q24.11	Parastremmatic dwarfism	168400	AD	3
168450	11p15.3	Hypoparathyroidism, autosomal dominant	146200	AD,AR	3
168450	11p15.3	Hypoparathyroidism, autosomal recessive	146200	AD,AR	3
168461	11q13.3	{Colorectal cancer, susceptibility to}	114500	AD,SMu	3
168461	11q13.3	{Multiple myeloma, susceptibility to}	254500	SMu	3
168461	11q13.3	{von Hippel-Lindau syndrome, modifier of}	193300	AD	3
168468	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
168468	3p21.31	Eiken syndrome	600002	AR	3
168468	3p21.31	Failure of tooth eruption, primary	125350	AD	3
168468	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
168470	12p11.22	Brachydactyly, type E2	613382	AD	3
168500	5q35.2	Parietal foramina 1	168500	AD	3
168550	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
168601	4q22.1	Parkinson disease 1	168601	AD	3
168605	2p13.1	Perry syndrome	168605	AD	3
168820	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
168820	7q21.3	{Coronary artery spasm 2, susceptibility to	_	_	3
168820	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
168820	7q21.3	{Organophosphate poisoning, sensitivity to}	_	_	3
168860	17q21-q22	Patella aplasia or hypoplasia	168860	AD	2
169100	6p12.3	Char syndrome	169100	AD	3
169150	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
169400	1q42.12	Pelger-Huet anomaly	169400	AD	3
169500	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
169600	3q22.1	Hailey-Hailey disease	169600	AD	3
170100	19q13.11	Prolidase deficiency	170100	AR	3
170260	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
170261	6p21.32	Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	AR	3
170280	10q22.1	Aplastic anemia	609135	_	3
170280	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
170280	10q22.1	Lymphoma, non-Hodgkin	605027	_	3
170285	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
170290	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
170390	17q24.3	Andersen syndrome	170390	AD	3
170400	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
170500	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
170650	11q14.2	Periodontitis 1, juvenile	170650	AR	3
170710	12q13.12	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
170715	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
170993	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
170993	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
170995	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
170998	22q13.31	{Hyperapobetalipoproteinemia, susceptibility to}	_	_	3
171050	7q21.12	{Colchicine resistance}	120080	_	3
171050	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
171060	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AD,AR	3
171060	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
171060	7q21.12	Gallbladder disease 1	600803	AD,AR	3
171200	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
171400	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
171640	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
171650	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
171720	9q34.13	{Alkaline phosphatase, plasma level of, QTL1}	171720	?AD	2
171760	1p36.12	Hypophosphatasia, adult	146300	AD,AR	3
171760	1p36.12	Hypophosphatasia, childhood	241510	AR	3
171760	1p36.12	Hypophosphatasia, infantile	241500	AR	3
171760	1p36.12	Odontohypophosphatasia	146300	AD,AR	3
171833	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
171833	5q13.1	Immunodeficiency 36	616005	AD	3
171833	5q13.1	SHORT syndrome	269880	AD	3
171834	3q26.32	Breast cancer, somatic	114480	_	3
171834	3q26.32	CLAPO syndrome, somatic	613089	_	3
171834	3q26.32	CLOVE syndrome, somatic	612918	_	3
171834	3q26.32	Colorectal cancer, somatic	114500	_	3
171834	3q26.32	Cowden syndrome 5	615108	_	3
171834	3q26.32	Gastric cancer, somatic	613659	_	3
171834	3q26.32	Hepatocellular carcinoma, somatic	114550	_	3
171834	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
171834	3q26.32	Macrodactyly, somatic	155500	_	3
171834	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
171834	3q26.32	Nevus, epidermal, somatic	162900	_	3
171834	3q26.32	Nonsmall cell lung cancer, somatic	211980	_	3
171834	3q26.32	Ovarian cancer, somatic	167000	_	3
171860	21q22.3	Hemolytic anemia due to phosphofructokinase deficiency	_	_	1
171900	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
172100	6q14.1	Immunodeficiency 23	615816	AR	3
172400	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
172405	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
172405	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
172411	1p36.13	{?Colorectal cancer, susceptibility to}	114500	AD,SMu	3
172425	20q13.12	[High density lipoprotein cholesterol level QTL 9]	_	_	3
172430	1p36.23	Enolase deficiency	_	_	1
172460	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
172460	14q23.3	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
172471	16p11.2	Cirrhosis due to liver phosphorylase kinase deficiency	_	_	3
172471	16p11.2	Glycogen storage disease IXc	613027	AR	3
172480	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
172490	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
172860	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
172870	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
173100	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
173110	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AD,AR	3
173200	17q25.3	Pityriasis rubra pilaris	173200	AD	3
173321	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
173325	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
173325	17q21.2	Naxos disease	601214	AR	3
173335	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
173335	6q23.2	Cole disease	615522	AD	3
173335	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
173335	6q23.2	{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	AD	3
173335	6q23.2	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
173350	6q26	Dysplasminogenemia	217090	AR	3
173350	6q26	Plasminogen deficiency, type I	217090	AR	3
173360	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AD,AR	3
173360	7q22.1	{Transcription of plasminogen activator inhibitor, modulator of}	_	_	3
173370	8p11.21	Hyperfibrinolysis, familial, due to increased release of PLAT	612348	_	1
173370	8p11.21	Thrombophilia, familial, due to decreased release of PLAT	612348	_	1
173410	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
173410	5q32	Kosaki overgrowth syndrome	616592	AD	3
173410	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
173410	5q32	Myofibromatosis, infantile, 1	228550	AD	3
173410	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
173470	17q21.32	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
173470	17q21.32	Glanzmann thrombasthenia	273800	AR	3
173470	17q21.32	Purpura, posttransfusion	_	_	3
173470	17q21.32	Thrombocytopenia, neonatal alloimmune	_	_	3
173470	17q21.32	{Myocardial infarction, susceptibility to}	608446	_	3
173490	4q12	Gastrointestinal stromal tumor, somatic or familial	606764	_	3
173490	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
173510	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
173510	7q21.11	[Macrothrombocytopenia]	_	_	1
173510	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
173510	7q21.11	{Malaria, cerebral, reduced risk of}	611162	_	3
173510	7q21.11	{Malaria, cerebral, susceptibility to}	611162	_	3
173515	3q21.3	Bernard-Soulier syndrome, type C	231200	AR	3
173600	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
173650	20p12.3	Kindler syndrome	173650	AR	3
173900	16p13.3	Polycystic kidney disease 1	173900	AD	3
173910	4q22.1	Polycystic kidney disease 2	613095	AD	3
174000	1q22	Medullary cystic kidney disease 1	174000	AD	3
174050	19p13.2	Polycystic liver disease 1	174050	AD	3
174200	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
174300	1q32.1	Orofaciodigital syndrome V	174300	AR	3
174400	12q13.3	Polydactyly, preaxial I	174400	AR	3
174700	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
174761	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
174761	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
174762	12q24.33	FILS syndrome	615139	AR	3
174762	12q24.33	IMAGE-I syndrome	618336	AR	3
174762	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
174763	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
174800	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
174810	18q21.33	Osteolysis, familial expansile	174810	AD	3
175050	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
175200	19p13.3	Peutz-Jeghers syndrome	175200	AD	3
175700	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
175780	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
175800	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
175850	12q24.1-q24.2	Porokeratosis 2, palmar, plantar, and disseminated	175850	AD	2
175900	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
176258	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
176260	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
176261	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
176261	21q22.12	Long QT syndrome 5	613695	AD	3
176262	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
176264	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
176266	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
176267	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
176300	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
176300	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
176300	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
176305	7p15.2	?Guttmacher syndrome	176305	AD	3
176310	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
176400	19p13.3	?Precocious puberty, central, 1	176400	AD	3
176430	15q15.1	[Premature chromatid separation trait]	176430	AD	3
176450	7q36.3	Currarino syndrome	176450	AD	3
176500	13q14.2	Dementia, familial British	176500	AD	3
176610	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
176640	20p13	Cerebral amyloid angiopathy, PRNP-related	137440	AD	3
176640	20p13	Creutzfeldt-Jakob disease	123400	AD	3
176640	20p13	Gerstmann-Straussler disease	137440	AD	3
176640	20p13	Huntington disease-like 1	603218	AD	3
176640	20p13	Insomnia, fatal familial	600072	AD	3
176640	20p13	Prion disease with protracted course	606688	AD	3
176640	20p13	{Kuru, susceptibility to}	245300	_	3
176670	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
176705	17q21.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
176730	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
176730	11p15.5	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
176730	11p15.5	Hyperproinsulinemia	616214	AD	3
176730	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
176740	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
176761	5p13.2	Hyperprolactinemia	615555	AD,AR	3
176761	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
176763	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type, digenic	277400	AR	3
176780	1q31	{Pelvic organ prolapse, susceptibility to, 1}	176780	AD	2
176790	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
176797	11q23.2	Leukemia, acute promyelocytic, PL2F/RARA type	_	_	3
176797	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
176801	10q22.1	Combined SAP deficiency	611721	AR	3
176801	10q22.1	Gaucher disease, atypical	610539	_	3
176801	10q22.1	Krabbe disease, atypical	611722	AR	3
176801	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
176804	14q22.1	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
176830	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
176830	2p23.3	{Obesity, early-onset, susceptibility to}	601665	AD,AR,Mu	3
176860	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
176872	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
176876	12q24.13	LEOPARD syndrome 1	151100	AD	3
176876	12q24.13	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
176876	12q24.13	Metachondromatosis	156250	AD	3
176876	12q24.13	Noonan syndrome 1	163950	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
176885	20q13.13	{Insulin resistance, susceptibility to}	125853	AD	3
176893	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
176894	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
176895	13q34	[Protein Z deficiency]	614024	_	3
176915	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
176920	14q32.33	Proteus syndrome, somatic	176920	_	3
176930	11p11.2	Dysprothrombinemia	613679	AR	3
176930	11p11.2	Hypoprothrombinemia	613679	AR	3
176930	11p11.2	Thrombophilia due to thrombin defect	188050	AD	3
176930	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
176930	11p11.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
176941	19p13.2	Immunodeficiency 35	611521	AR	3
176943	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
176943	10q26.13	Apert syndrome	101200	AD	3
176943	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
176943	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
176943	10q26.13	Craniofacial-skeletal-dermatologic dysplasia	101600	AD	3
176943	10q26.13	Craniosynostosis, nonspecific	_	_	3
176943	10q26.13	Crouzon syndrome	123500	AD	3
176943	10q26.13	Gastric cancer, somatic	613659	_	3
176943	10q26.13	Jackson-Weiss syndrome	123150	AD	3
176943	10q26.13	LADD syndrome	149730	AD	3
176943	10q26.13	Pfeiffer syndrome	101600	AD	3
176943	10q26.13	Saethre-Chotzen syndrome	101400	AD	3
176943	10q26.13	Scaphocephaly and Axenfeld-Rieger anomaly	_	_	3
176943	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
176946	1p36.13	Cataract 6, multiple types	116600	AD	3
176947	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
176947	2q11.2	Immunodeficiency 48	269840	AR	3
176960	17q24.2	Pituitary tumor, invasive	_	_	3
176977	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
176980	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
177000	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
177045	6p21.32	?Proteasome-associated autoinflammatory syndrome 3, digenic	617591	AR	3
177046	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
177060	19p13.2	Polycystic liver disease 1	174050	AD	3
177070	15q15.2	Spherocytosis, type 5	612690	_	3
177075	16q23.2	Ayme-Gripp syndrome	601088	AD	3
177075	16q23.2	Cataract 21, multiple types	610202	AD	3
177170	19p13.11	Pseudoachondroplasia	177170	AD	3
177200	16p12.2	Liddle syndrome 1	177200	AD	3
177400	3q26.1	Butyrylcholinesterase deficiency	617936	_	3
177400	3q26.1	{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}	617936	_	3
177650	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
177700	12q14	Glaucoma 1, open angle, P	177700	AD	4
177735	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
177820	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
177850	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
177900	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
178110	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
178300	1p34.1-p32	Ptosis, hereditary congenital, 1	178300	AD	2
178620	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
178640	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
178642	10q22.3	Pulmonary fibrosis, idiopathic	178500	AD	3
179010	12q	Pyloric stenosis, infantile hypertrophic 1	179010	AD,Mu	2
179035	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
179035	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
179060	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
179095	5q31.1	?Male infertility	_	_	1
179410	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
179450	6p21.3	?Ragweed sensitivity	179450	AD	2
179502	4q23	Lymphocytic leukemia, acute T-cell	_	_	3
179590	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
179605	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
179605	6p21.1	Leber congenital amaurosis 18	608133	AD,AR	3
179605	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
179605	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
179605	6p21.1	Retinitis pigmentosa 7 and digenic form	608133	AD,AR	3
179605	6p21.1	Retinitis punctata albescens	136880	AD,AR	3
179615	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
179615	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179615	11p12	Omenn syndrome	603554	AR	3
179615	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179616	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179616	11p12	Omenn syndrome	603554	AR	3
179616	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179617	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
179617	15q15.1	Mirror movements 2	614508	AD	3
179617	15q15.1	{Breast cancer, susceptibility to}	114480	AD,SMu	3
179620	11p15.5	[Blood group, Raph]	179620	_	3
179755	1q23.1	Renal cell carcinoma, papillary	605074	_	3
179800	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
179820	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
179820	1q32.1	Renal tubular dysgenesis	267430	AR	3
179820	1q32.1	[Hyperproreninemia]	_	_	3
179850	12q13.13	Dowling-Degos disease 1	179850	AD	3
180000	13q34	?Retinal arteries, tortuosity of	180000	AD	3
180020	6q25-q26	?Retinal cone dystrophy-1	180020	AD	2
180040	1q32.3	Leber congenital amaurosis 12	610612	AR	3
180069	1p31.3	Leber congenital amaurosis 2	204100	AR	3
180069	1p31.3	Retinitis pigmentosa 20	613794	AR	3
180071	5q32	Retinitis pigmentosa 43	613810	_	3
180072	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
180072	4p16.3	Retinitis pigmentosa-40	613801	AR	3
180073	17q25.3	Retinitis pigmentosa 57	613582	AR	3
180090	15q26.1	Bothnia retinal dystrophy	607475	AR	3
180090	15q26.1	Fundus albipunctatus	136880	AD,AR	3
180090	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
180090	15q26.1	Retinitis punctata albescens	136880	AD,AR	3
180100	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AD,AR	3
180104	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
180105	7q32.1	Retinitis pigmentosa 10	180105	AD	3
180220	3p24.2	Microphthalmia, syndromic 12	615524	AD,AR	3
180240	17q21.2	Leukemia, acute promyelocytic	612376	_	1
180250	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
180250	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
180290	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
180295	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
180297	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
180297	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
180300	6q23	{Rheumatoid arthritis, susceptibility to}	180300	_	2
180380	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
180380	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AD,AR	3
180380	3q22.1	Retinitis punctata albescens	136880	AD,AR	3
180381	13q34	Oguchi disease-2	613411	_	3
180385	11p13	Leukemia, acute T-cell	180385	_	2
180430	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
180435	1q25.3	Prostate cancer 1	601518	AD	3
180468	3q29	Diamond-Blackfan anemia 5	612528	AD	3
180472	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
180500	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
180550	4q25	Ring dermoid of cornea	180550	AD	3
180700	3p14.3	Robinow syndrome, autosomal dominant 1	180700	AD	3
180721	11q12.3	Retinitis pigmentosa 7, digenic form	608133	AD,AR	3
180750	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
180849	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
180860	7p11.2	Silver-Russell syndrome	180860	AD	4
180901	19q13.2	Central core disease	117000	AD,AR	3
180901	19q13.2	King-Denborough syndrome	145600	AD	3
180901	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
180901	19q13.2	Neuromuscular disease, congenital, with uniform type 1 fiber	117000	AD,AR	3
180901	19q13.2	{Malignant hyperthermia susceptibility 1}	145600	AD	3
180902	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
180902	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
180920	5p12	Aplasia of lacrimal and salivary glands	180920	AD	3
180960	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
181000	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
181030	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
181031	2q37.1	Oguchi disease-1	258100	AR	3
181031	2q37.1	Retinitis pigmentosa 47	613758	_	3
181270	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
181350	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
181400	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
181405	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
181430	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
181450	12q24.21	Ulnar-mammary syndrome	181450	AD	3
181460	5q31-q33	{Schistosoma mansoni infection, susceptibility/resistance to}	181460	AD	2
181510	5q23-q35	{Schizophrenia}	181500	AD	2
181590	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
181600	4q22.3	Huriez syndrome	181600	AD	3
181800	19p13.3	Scoliosis, idiopathic 1	181800	AD	2
182000	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
182100	19q13.33	[Bombay phenotype, digenic]	616754	AR	3
182100	19q13.33	{Norwalk virus infection, resistance to}	_	_	3
182100	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
182120	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
182125	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
182135	13q14.2	{Alcohol dependence, susceptibility to}	103780	Mu	3
182135	13q14.2	{Anorexia nervosa, susceptibility to}	606788	_	3
182135	13q14.2	{Major depressive disorder, response to citalopram therapy in}	608516	_	3
182135	13q14.2	{Obsessive-compulsive disorder, susceptibility to}	164230	AD	3
182135	13q14.2	{Schizophrenia, susceptibility to}	181500	AD	3
182135	13q14.2	{Seasonal affective disorder, susceptibility to}	608516	_	3
182138	17q11.2	{Anxiety-related personality traits}	607834	_	3
182138	17q11.2	{Obsessive-compulsive disorder}	164230	AD	3
182170	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
182212	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
182250	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
182279	15q11.2	Prader-Willi syndrome	176270	AD	3
182280	3p23-p21	Small-cell cancer of lung	182280	AD	2
182282	20p13	Cerebrocostomandibular syndrome	117650	AD	3
182283	17q12	{HIV infection, resistance to}	609423	_	2
182290	17p11.2	Smith-Magenis syndrome	182290	AD,IC	3
182307	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
182309	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
182309	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
182309	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
182310	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
182310	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
182330	1q24.2	[Blood pressure regulation QTL]	145500	Mu	2
182340	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
182340	1q23.2	Migraine, familial basilar	602481	AD	3
182340	1q23.2	Migraine, familial hemiplegic, 2	602481	AD	3
182350	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
182350	19q13.2	CAPOS syndrome	601338	AD	3
182350	19q13.2	Dystonia-12	128235	AD	3
182380	22q12.3	Glucose/galactose malabsorption	606824	AR	3
182381	16p11.2	Renal glucosuria	233100	AD,AR	3
182389	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 2	604403	AD	3
182389	2q24.3	Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)	607208	AD	3
182389	2q24.3	Febrile seizures, familial, 3A	604403	AD	3
182389	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
182390	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
182390	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
182391	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
182391	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
182410	22q11.1	?Sneddon syndrome	182410	AR	3
182455	16p13.3	Somatostatin analog, resistance to	_	_	3
182465	21q22.11	ZTTK syndrome	617140	AD	3
182500	15q21.1	?Cataract, congenital	182500	_	2
182530	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
182530	2p22.1	Noonan syndrome 4	610733	AD	3
182600	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
182601	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
182810	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
182860	1q23.1	Elliptocytosis-2	130600	AD	3
182860	1q23.1	Pyropoikilocytosis	266140	AR	3
182860	1q23.1	Spherocytosis, type 3	270970	AR	3
182870	14q23.3	Anemia, neonatal hemolytic, fatal or near-fatal	617948	_	3
182870	14q23.3	Elliptocytosis-3	617948	_	3
182870	14q23.3	Spherocytosis, type 2	616649	AD	3
182888	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
182889	7q11.23	Oocyte maturation defect 3	617712	AD	3
182900	8p11.21	Spherocytosis, type 1	182900	AD,AR	3
182920	5q31.2	Myopathy, spheroid body	182920	AD	3
182960	7q34-q36	Neuronopathy, distal hereditary motor, type I	182960	AD	2
182980	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
183086	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
183600	7q21.2-q21.3	Split hand/foot malformation 1	183600	AD	4
183840	9q31-q34	{Spondyloarthropathy, susceptibility to, 2}	183840	AD	2
183900	12q13.11	SED congenita	183900	AD	3
184095	12q24.11	SED, Maroteaux type	184095	AD	3
184100	12q13	Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100	AD	2
184250	12q13.11	SMED Strudwick type	184250	AD	3
184252	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
184255	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
184260	14q32.12	Osteochondrodysplasia	184260	AR	3
184420	8p23.1	Squalene synthase deficiency	618156	_	3
184429	3q26.33	Microphthalmia, syndromic 3	206900	AD	3
184429	3q26.33	Optic nerve hypoplasia and abnormalities of the central nervous system	206900	AD	3
184450	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
184460	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
184500	17q21.2	Steatocystoma multiplex	184500	AD	3
184600	3q21.1	Peeling skin syndrome 4	607936	AR	3
184700	19p13.2	Polycystic ovary syndrome 1	184700	AD	2
184745	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
184745	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
184745	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
184755	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
184757	9q33.3	46, XX sex reversal 4	617480	AD	3
184757	9q33.3	46XY sex reversal 3	612965	AD	3
184757	9q33.3	Adrenocortical insufficiency	612964	AD	3
184757	9q33.3	Premature ovarian failure 7	612964	AD	3
184757	9q33.3	Spermatogenic failure 8	613957	AD	3
184840	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
184900	15q21.1	Stiff skin syndrome	184900	AD	3
185000	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
185020	17q21.31	Cryohydrocytosis	185020	AD	3
185070	11p15.4	Stormorken syndrome	185070	AD	3
185100	7p22.1	{Strabismus, susceptibility to, 1}	185100	_	2
185250	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
185300	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
185470	1p36.13	Gastrointestinal stromal tumor	606764	AD,IC	3
185470	1p36.13	Paraganglioma and gastric stromal sarcoma	606864	_	3
185470	1p36.13	Paragangliomas 4	115310	AD	3
185470	1p36.13	Pheochromocytoma	171300	AD	3
185490	4p15.2	[Superoxide dismutase, elevated extracellular]	_	_	3
185500	7q11.23	Supravalvar aortic stenosis	185500	AD	3
185535	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
185535	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
185605	12q21.2	Baker-Gordon syndrome	618218	AD	3
185620	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
185620	9q34.2	Leigh syndrome, due to COX IV deficiency	256000	Mi,AR	3
185800	17q22	Symphalangism, proximal, 1A	185800	AD	3
185880	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
185880	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
185900	2q34-q36	Syndactyly, type 1, with or without craniosynostosis	185900	AD	4
186000	2q31.1	Synpolydactyly 1	186000	AD	3
186100	6q22.31	Syndactyly, type III	186100	AD	3
186200	7q36.3	Syndactyly, type IV	186200	AD	3
186300	2q31.1	Syndactyly, type V	186300	AD	3
186357	1p35.2	{Obesity, association with}	601665	AD,AR,Mu	3
186500	17q22	Multiple synostoses syndrome 1	186500	AD	3
186550	5q31.1	Liebenberg syndrome	186550	AD	4
186570	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
186580	16q12.1	Blau syndrome	186580	AD	3
186711	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
186740	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
186780	1q24.2	?Immunodeficiency 25	610163	AR	3
186790	11q23.3	Immunodeficiency 19	615617	AR	3
186830	11q23.3	Immunodeficiency 18	615615	AR	3
186830	11q23.3	Immunodeficiency 18, SCID variant	615615	AR	3
186845	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
186855	9q31.2	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
186860	2q34	Leukemia/lymphoma, T-cell	186860	_	2
186880	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
186910	2p11.2	CD8 deficiency, familial	608957	AR	3
186921	11p15.4	Leukemia, T-cell acute lymphoblastic	186921	_	2
186940	12p13.31	OKT4 epitope deficiency	613949	_	3
186960	14q32.13	Leukemia/lymphoma, T-cell	186960	_	2
186973	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
187011	17q12	{HIV-1 disease, delayed progression of}	_	_	3
187011	17q12	{HIV-1 disease, rapid progression of}	_	_	3
187040	1p33	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
187260	5q14	Telangiectasia, hereditary benign	187260	AD	2
187270	5p15.33	{Dyskeratosis congenita, autosomal dominant 2}	613989	AD,AR	3
187270	5p15.33	{Dyskeratosis congenita, autosomal recessive 4}	613989	AD,AR	3
187270	5p15.33	{Leukemia, acute myeloid}	601626	AD,SMu	3
187270	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
187270	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
187300	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
187370	2q31.3-q32.1	Arthrogryposis, distal, type 10	187370	AD	2
187380	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
187395	3p21.31	Forebrain defects	_	_	3
187600	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
187601	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
187680	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
187900	9q34.13	Bleeding disorder, platelet-type, 17	187900	AD,AR	3
188000	10p12.1	Thrombocytopenia 2	188000	AD	3
188025	11q23	?Thrombocytopenia, Paris-Trousseau type	188025	IC	4
188030	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
188040	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
188040	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
188061	6q27	{Lumbar disc herniation, susceptibility to}	603932	_	3
188070	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
188250	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
188250	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
188400	22q11.21	DiGeorge syndrome	188400	AD	3
188450	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
188450	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
188540	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
188545	8q23.1	Thyrotropin-releasing hormone resistance, generalized	_	_	3
188550	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
188570	3p24.2	Thyroid hormone resistance	188570	AD	3
188580	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
188740	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
188826	22q12.3	Sorsby fundus dystrophy	136900	AD	3
188830	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
188830	17q24.2	Adrenocortical tumor, somatic	_	_	3
188830	17q24.2	Carney complex, type 1	160980	AD	3
188830	17q24.2	Myxoma, intracardiac	255960	AD	3
188830	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
188840	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
188840	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
188840	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
188840	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
188840	2q31.2	Salih myopathy	611705	AR	3
188840	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
189500	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
189800	2p13	Preeclampsia/eclampsia 1	189800	AD	2
189907	17q12	Diabetes mellitus, noninsulin-dependent	125853	AD	3
189907	17q12	Renal cysts and diabetes syndrome	137920	AD	3
189907	17q12	{Renal cell carcinoma}	144700	_	3
189909	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
189909	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
189964	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
189967	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
189980	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
189980	9q34.12	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	_	_	3
189990	6q23.3	{T-cell acute lymphoblastic leukemia}	_	_	3
190000	3q22.1	Atransferrinemia	209300	AR	3
190010	3q29	Immunodeficiency 46	616740	AR	3
190020	11p15.5	Bladder cancer, somatic	109800	_	3
190020	11p15.5	Congenital myopathy with excess of muscle spindles	218040	AD	3
190020	11p15.5	Costello syndrome	218040	AD	3
190020	11p15.5	Nevus sebaceous or woolly hair nevus, somatic	162900	_	3
190020	11p15.5	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190020	11p15.5	Spitz nevus or nevus spilus, somatic	137550	_	3
190020	11p15.5	Thyroid carcinoma, follicular, somatic	188470	_	3
190040	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
190040	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
190040	22q13.1	Meningioma, SIS-related	607174	AD	3
190070	12p12.1	Arteriovenous malformation of the brain, somatic	108010	_	3
190070	12p12.1	Bladder cancer, somatic	109800	_	3
190070	12p12.1	Breast cancer, somatic	114480	_	3
190070	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
190070	12p12.1	Gastric cancer, somatic	137215	_	3
190070	12p12.1	Leukemia, acute myeloid	601626	AD,SMu	3
190070	12p12.1	Lung cancer, somatic	211980	_	3
190070	12p12.1	Noonan syndrome 3	609942	AD	3
190070	12p12.1	Pancreatic carcinoma, somatic	260350	_	3
190070	12p12.1	RAS-associated autoimmune leukoproliferative disorder	614470	AD	3
190070	12p12.1	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190080	8q24.21	Burkitt lymphoma, somatic	113970	_	3
190090	20q11.23	?Thrombocytopenia 6	616937	AD	3
190090	20q11.23	Colon cancer, advanced, somatic	114500	_	3
190100	9q13-q21	Geniospasm	190100	AD	2
190120	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
190151	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
190151	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
190160	3p24.2	Thyroid hormone resistance	188570	AD	3
190160	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
190160	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
190180	19q13.2	Camurati-Engelmann disease	131300	AD	3
190180	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
190180	19q13.2	{Cystic fibrosis lung disease, modifier of}	219700	AR	3
190181	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
190181	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
190182	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
190182	3p24.1	Esophageal cancer, somatic	133239	_	3
190182	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
190195	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
190197	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
190198	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
190198	9q34.3	Aortic valve disease 1	109730	AD	3
190220	1q41	Loeys-Dietz syndrome 4	614816	AD	3
190230	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
190230	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
190300	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
190315	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
190315	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
190320	17q21.33	Trichodontoosseous syndrome	190320	AD	3
190330	4q21.21	Trichomegaly	190330	AR	3
190350	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
190351	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
190370	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
190440	8p11.23	Trigonocephaly 1	190440	AD	3
190450	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
190685	21q22.3	Down syndrome	190685	IC	4
190900	7q32.1	Colorblindness, tritan	190900	AD	3
190990	9p13.3	Arthrogryposis, distal, type 1A	108120	AD	3
190990	9p13.3	Arthrogryposis, distal, type 2B4	108120	AD	3
190990	9p13.3	CAP myopathy 2	609285	AD	3
190990	9p13.3	Nemaline myopathy 4, autosomal dominant	609285	AD	3
191010	15q22.2	Cardiomyopathy, dilated, 1Y	611878	AD	3
191010	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
191010	15q22.2	Left ventricular noncompaction 9	611878	AD	3
191030	1q21.3	CAP myopathy 1	609284	AD,AR	3
191030	1q21.3	Myopathy, congenital, with fiber-type disproportion	255310	AD,AR	3
191030	1q21.3	Nemaline myopathy 1, autosomal dominant or recessive	609284	AD,AR	3
191040	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
191040	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
191041	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
191043	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
191044	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
191044	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
191044	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
191044	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
191045	1q32.1	Cardiomyopathy, dilated, 1D	601494	AD	3
191045	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
191045	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
191045	1q32.1	Left ventricular noncompaction 6	601494	AD	3
191050	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
191070	4q32.1	[?Hypertryptophanemia]	600627	AR	3
191092	16p13.3	?Focal cortical dysplasia, type II, somatic	607341	_	3
191092	16p13.3	Lymphangioleiomyomatosis, somatic	606690	_	3
191092	16p13.3	Tuberous sclerosis-2	613254	AD	3
191100	9q34.13	Tuberous sclerosis-1	191100	AD	3
191110	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
191130	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
191130	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
191135	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
191160	6p21.33	{Asthma, susceptibility to}	600807	AD	3
191160	6p21.33	{Dementia, vascular, susceptibility to}	_	_	3
191160	6p21.33	{Malaria, cerebral, susceptibility to}	611162	_	3
191160	6p21.33	{Migraine without aura, susceptibility to}	157300	AD	3
191160	6p21.33	{Septic shock, susceptibility to}	_	_	3
191163	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
191170	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
191170	17p13.1	Breast cancer, somatic	114480	_	3
191170	17p13.1	Hepatocellular carcinoma, somatic	114550	_	3
191170	17p13.1	Li-Fraumeni syndrome	151623	AD	3
191170	17p13.1	Nasopharyngeal carcinoma, somatic	607107	_	3
191170	17p13.1	Pancreatic cancer, somatic	260350	_	3
191170	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
191170	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
191170	17p13.1	{Choroid plexus papilloma}	260500	AD	3
191170	17p13.1	{Colorectal cancer}	114500	AD,SMu	3
191170	17p13.1	{Glioma susceptibility 1}	137800	AD,SMu	3
191170	17p13.1	{Osteosarcoma}	259500	SMu	3
191181	11q13	Cervical carcinoma	191181	_	2
191190	12p13.31	Periodic fever, familial	142680	AD	3
191190	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
191195	10p11.23	Lung cancer, somatic	211980	_	3
191290	11p15.5	Segawa syndrome, recessive	605407	AR	3
191305	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
191306	4q12	Hemangioma, capillary infantile, somatic	602089	_	3
191306	4q12	{Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
191311	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
191311	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
191315	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
191315	1q23.1	Medullary thyroid carcinoma, familial	155240	AD	3
191329	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
191330	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
191342	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
191342	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
191350	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
191350	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
191390	7q22	{Inflammatory bowel disease 11}	191390	Mu	2
191480	1p36.13	Uncombable hair syndrome	191480	AR	3
191523	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
191525	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
191540	1p22	[Urate oxidase deficiency]	_	_	1
191740	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
191740	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
191740	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
191740	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
191740	2q37.1	[Gilbert syndrome]	143500	AR	3
191830	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
191840	10q22.2	Quebec platelet disorder	601709	AD	3
191840	10q22.2	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
191845	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
191845	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
191845	16p12.3	Medullary cystic kidney disease 2	603860	_	3
191900	1q44	Muckle-Wells syndrome	191900	AD	3
192090	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
192090	16q22.1	Endometrial carcinoma, somatic	608089	_	3
192090	16q22.1	Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate	137215	AD	3
192090	16q22.1	Ovarian cancer, somatic	167000	_	3
192090	16q22.1	{Breast cancer, lobular}	114480	AD,SMu	3
192090	16q22.1	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
192132	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
192150	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
192240	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
192315	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
192340	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
192430	22q11.21	Velocardiofacial syndrome	192430	AD	3
192605	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
192974	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
192977	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
193000	1p13	Vesicoureteral reflux	193000	AD	2
193001	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
193003	13q31-q33	Nystagmus 4, congenital, autosomal dominant	193003	AD	2
193007	6q	Vestibulopathy, familial	193007	AD	2
193060	10p13	Cataract 30, pulverulent	116300	AD	3
193065	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
193065	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
193067	11q24.3	Bleeding disorder, platelet-type, 21	617443	AD,AR	3
193100	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
193200	6p21.3	{Vitiligo-associated multiple autoimmune disease susceptibility 6}	193200	AR	2
193230	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
193235	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
193400	12p13.31	von Willebrand disease, type 1	193400	AD	3
193500	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
193510	3p13	Waardenburg syndrome, type 2A	193510	AD	3
193520	17q11.2	Watson syndrome	193520	AD	3
193670	2q22.1	WHIM syndrome	193670	AD	3
193700	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
193900	12q13.13	White sponge nevus 1	193900	AD	3
194050	7q11.23	Williams-Beuren syndrome	194050	AD	4
194071	11p15.5	Wilms tumor 2	194071	AD,SMu	3
194072	11p13	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	AD,SMu	4
194080	11p13	Denys-Drash syndrome	194080	AD,SMu	3
194090	16q	Wilms tumor, type 3	194090	AD	2
194190	4p16.3	Wolf-Hirschhorn syndrome	194190	IC	4
194200	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
194300	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
194355	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
194360	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
194363	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
194380	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
194648	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
195000	11q12.2	Oocyte maturation defect 1	615774	AR	3
200100	4q23	Abetalipoproteinemia	200100	AR	3
200110	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
200150	9q21.2	Choreoacanthocytosis	200150	AR	3
200350	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
200500	7q36.3	Acheiropody	200500	AR	3
200600	14q32.12	Achondrogenesis, type IA	200600	AR	3
200610	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
200700	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
200950	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
201000	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
201100	8q24.3	Acrodermatitis enteropathica	201100	AR	3
201250	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
201300	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
201400	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
201450	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
201470	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
201475	17p13.1	VLCAD deficiency	201475	AR	3
201710	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
201750	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
201810	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
202010	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
202200	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
202300	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
202370	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
202650	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
202700	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
203100	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
203290	9p23	Albinism, oculocutaneous, type III	203290	AR	3
203300	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
203400	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
203450	17q21.31	Alexander disease	203450	AD	3
203500	3q13.33	Alkaptonuria	203500	AR	3
203650	3q26.3-q27.3	Alopecia-mental retardation syndrome 1	203650	AR	2
203655	8p21.3	Alopecia universalis	203655	AR	3
203700	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
203740	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
203750	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
203800	2p13.1	Alstrom syndrome	203800	AR	3
204000	17p13.1	Leber congenital amaurosis 1	204000	AR	3
204100	1p31.3	Leber congenital amaurosis 2	204100	AR	3
204200	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
204300	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
204500	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
204650	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
204690	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
204700	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
204750	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
204870	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
205100	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
205400	9q31.1	Tangier disease	205400	AR	3
205950	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
206100	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
206200	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
206500	5q22.3	?Anencephaly	206500	AR	3
206700	3p26.1	Gillespie syndrome	206700	AD,AR	3
206800	20p13	Anonychia congenita	206800	AR	3
206920	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
207410	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
207750	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
207800	6q23.2	Argininemia	207800	AR	3
207900	7q11.21	Argininosuccinic aciduria	207900	AR	3
208000	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
208050	20q13.12	Arterial tortuosity syndrome	208050	AR	3
208085	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
208100	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
208150	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
208250	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
208400	4q34.3	Aspartylglucosaminuria	208400	AR	3
208500	15q13	Short-rib thoracic dysplasia 1 with or without polydactyly	208500	AR	2
208530	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
208540	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
208900	11q22.3	Ataxia-telangiectasia	208900	AR	3
208920	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
209300	3q22.1	Atransferrinemia	209300	AR	3
209500	8p21.3	Atrichia with papular lesions	209500	AR	3
209850	7q22	{Autism susceptibility 1}	209850	IC,Mu	2
209885	2q37.3	Barber-Say syndrome	209885	AD	3
209901	11q13.2	Bardet-Biedl syndrome 1	209900	DR,AR	3
209950	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
210000	3q29	Behr syndrome	210000	AR	3
210100	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
210200	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
210210	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
210370	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
210600	3q23	Seckel syndrome 1	210600	AR	3
210710	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
210720	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
210900	15q26.1	Bloom syndrome	210900	AR	3
211100	19q13.33	[Bombay phenotype]	616754	AR	3
211180	12p13.31	Bowen-Conradi syndrome	211180	AR	3
211380	16q21	Elsahy-Waters syndrome	211380	AR	3
211500	20p13	?Fazio-Londe disease	211500	AR	3
211530	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
211600	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
211750	3q13.1-q13.2	C syndrome	211750	AD	3
211800	6q14.3	Calcification of joints and arteries	211800	AR	3
211900	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
212050	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
212065	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
212066	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
212070	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
212093	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
212112	1q22	Malouf syndrome	212112	AD	3
212138	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
212140	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
212200	18q21.3	Carnosinemia	212200	AR	2
212350	7q34	Sengers syndrome	212350	AR	3
212500	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
212550	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
212720	1q41	Martsolf syndrome	212720	AR	3
212780	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
212840	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
213200	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
213300	9q34.3	Joubert syndrome 1	213300	AR	3
213600	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
213700	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
213980	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
214100	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
214110	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
214150	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
214300	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
214350	21q22.3	CHAND syndrome	214350	AR	3
214400	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
214450	15q21.2	Griscelli syndrome, type 1	214450	AR	3
214500	1q42.3	Chediak-Higashi syndrome	214500	AR	3
214700	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
214900	15q	Cholestasis-lymphedema syndrome	214900	AR	2
214950	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
215045	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
215100	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
215140	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
215150	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
215300	8q24.11	Chondrosarcoma	215300	AR	3
215400	6q27	{Chordoma, susceptibility to}	215400	AD	4
215470	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
215500	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
215700	9q34.11	Citrullinemia	215700	AR	3
216340	6q21	Yunis-Varon syndrome	216340	AR	3
216400	5q12.1	Cockayne syndrome, type A	216400	AR	3
216550	8q22.2	Cohen syndrome	216550	AR	3
216820	14q11.2	?Coloboma, ocular, autosomal recessive	216820	AR	3
216900	2q11.2	Achromatopsia 2	216900	AR	3
217000	6p21.33	C2 deficiency	217000	AR	3
217030	4q25	Complement factor I deficiency	610984	AR	3
217030	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
217030	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
217050	5p13.1	C6 deficiency	612446	_	3
217050	5p13.1	Combined C6/C7 deficiency	_	_	3
217070	5p13.1	C7 deficiency	610102	_	3
217080	2q11.2	Jalili syndrome	217080	AR	3
217085	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
217300	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
217400	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
217700	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
217800	16q23.1	Macular corneal dystrophy	217800	AR	3
218000	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
218030	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
218330	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
218340	12p13.31	Temtamy syndrome	218340	AR	3
218400	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
218600	8q24.3	Baller-Gerold syndrome	218600	AR	3
218700	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
218800	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
219000	4q21.21	Fraser syndrome 1	219000	AR	3
219050	19p13.11	Cryptorchidism	219050	AD	3
219080	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
219090	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
219100	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
219150	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
219200	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
219500	1p31.1	Cystathioninuria	219500	AR	3
219730	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
219750	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
219900	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
220111	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
220120	3p21.2	D-glyceric aciduria	220120	AR	3
220150	11q13.1	Hypouricemia, renal	220150	AR	3
220200	3q22-q24	Dandy-Walker syndrome	220200	IC	4
220210	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
220400	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
220500	16p13.3	DOORS syndrome	220500	AR	3
220600	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
221200	13q31.1	Deafness and myopia	221200	AR	3
221750	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
221770	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
221820	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
221900	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
222100	6p21.3	{Diabetes mellitus, insulin-dependent-1}	222100	AR	2
222300	4p16.1	Wolfram syndrome 1	222300	AR	3
222400	8p23.1	Hernia, congenital diaphragmatic 2	222400	AR	2
222448	2q31.1	Donnai-Barrow syndrome	222448	AR	3
222470	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
222700	14q11.2	Lysinuric protein intolerance	222700	AR	3
222730	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
222748	8q22.3	Dihydropyrimidinuria	222748	AR	3
222765	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
222800	7q33	Erythrocytosis, familial, 8	222800	AR	3
222900	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
223000	2q21.3	Lactase deficiency, congenital	223000	AR	3
223100	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
223360	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
223800	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
223900	9q31.3	Dysautonomia, familial	223900	AR	3
224050	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
224100	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
224120	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
224230	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
224410	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
224500	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
224690	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
224750	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
224900	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
225100	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
225200	1q21.2	Ectopia lentis et pupillae	225200	AR	3
225250	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
225280	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
225300	12q13.12	Split-hand/foot malformation 6	225300	AR	3
225320	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
225400	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
225410	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
225750	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AD,AR	3
225753	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
225790	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
226200	21q21.1	Enterokinase deficiency	226200	AR	3
226300	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
226400	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
226670	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
226750	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
226900	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
226980	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
226990	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
227050	19q13.2	Transient erythroblastopenia of childhood	227050	AR	2
227260	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
227300	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
227400	1q24.2	Factor V deficiency	227400	AR	3
227500	13q34	Factor VII deficiency	227500	AR	3
227600	13q34	Factor X deficiency	227600	AR	3
227645	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
227646	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
227650	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
227810	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
228000	8p22	Farber lipogranulomatosis	228000	AR	3
228300	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
228520	1p21.1	Fibrochondrogenesis 1	228520	AR	3
228550	5q32	Myofibromatosis, infantile, 1	228550	AD	3
228600	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
228900	20q11.22	Du Pan syndrome	228900	AR	3
228930	3p25.1	Fuhrmann syndrome	228930	AR	3
228980	1p36.13	[Fleck retina, familial benign]	228980	AR	3
229000	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
229050	17q11.2	Folate malabsorption, hereditary	229050	AR	3
229070	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
229100	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
229200	16q24.2	Brittle cornea syndrome 1	229200	AR	3
229600	9q31.1	Fructose intolerance, hereditary	229600	AR	3
229700	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
229800	2p23.3	[Fructosuria]	229800	AR	3
230000	1p36.11	Fucosidosis	230000	AR	3
230200	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
230350	1p36.11	Galactose epimerase deficiency	230350	AR	3
230400	9p13.3	Galactosemia	230400	AR	3
230450	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
230500	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
230600	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
230650	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
230740	2p13.3	GAPO syndrome	230740	AR	3
230800	1q22	Gaucher disease, type I	230800	AR	3
230900	1q22	Gaucher disease, type II	230900	AR	3
231000	1q22	Gaucher disease, type III	231000	AR	3
231005	1q22	Gaucher disease, type IIIC	231005	AR	3
231050	9q34.2	Geleophysic dysplasia 1	231050	AR	3
231070	1q24.2	Geroderma osteodysplasticum	231070	AR	3
231090	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
231095	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
231300	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
231530	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
231550	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
231670	19p13.13	Glutaricaciduria, type I	231670	AR	3
231675	4q32.1	Glutaric acidemia IIC	231680	AR	3
231690	7p14.1	Glutaric aciduria III	231690	AR	3
231900	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
231950	22q11.23	?Glutathioninuria	231950	AR	3
232000	13q32.3	Propionicacidemia	606054	AR	3
232050	3q22.3	Propionicacidemia	606054	AR	3
232200	17q21.31	Glycogen storage disease Ia	232200	AR	3
232220	11q23.3	Glycogen storage disease Ib	232220	AR	3
232240	11q23.3	Glycogen storage disease Ic	232240	AR	3
232300	17q25.3	Glycogen storage disease II	232300	AR	3
232500	3p12.2	Glycogen storage disease IV	232500	AR	3
232600	11q13.1	McArdle disease	232600	AR	3
232700	14q22.1	Glycogen storage disease VI	232700	AR	3
232800	12q13.11	Glycogen storage disease VII	232800	AR	3
233100	16p11.2	Renal glucosuria	233100	AD,AR	3
233300	2p16.3	Ovarian dysgenesis 1	233300	AR	3
233400	5q23.1	Perrault syndrome 1	233400	AR	3
233420	12q13.12	46XY sex reversal 7	233420	AR	3
233600	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
233690	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
233700	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
233710	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
233910	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
234000	5q35.3	Factor XII deficiency	234000	AR	3
234050	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
234200	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
234500	5p15.33	Hartnup disorder	234500	AR	3
234580	7q21.2	Heimler syndrome 1	234580	AR	3
234810	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
235000	11p15	Hemihypertrophy	235000	AD	2
235510	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
235550	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
235555	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
235700	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
235730	2q22.3	Mowat-Wilson syndrome	235730	AD	3
235800	12q23.1	[Histidinemia]	235800	AD,AR	3
236000	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
236100	21q22.3	Holoprosencephaly 1	236100	AD,IC	2
236250	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
236270	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
236500	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
236600	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
236670	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
236680	11q24.2	Hydrolethalus syndrome	236680	AR	3
236700	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
236730	10q24.2	Urofacial syndrome 1	236730	AR	3
236792	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
236800	2q22.2	?Hydroxykynureninuria	236800	AR	3
237300	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
237310	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
237500	10q24.2	Dubin-Johnson syndrome	237500	AR	3
237900	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
238300	9p24.1	Glycine encephalopathy	605899	AR	3
238310	3p21.31	Glycine encephalopathy	605899	AR	3
238330	16q23.2	?Glycine encephalopathy	605899	AR	3
238331	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
238700	7q31.32	Hyperlysinemia	238700	AR	3
238970	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
239000	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
239100	17q21.31	Van Buchem disease	239100	AR	3
239200	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
239300	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
239500	22q11.21	Hyperprolinemia, type I	239500	AR	3
239510	1p36.13	Hyperprolinemia, type II	239510	AR	3
239850	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
240300	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AD,AR	3
240400	8p21.1	Scurvy	_	_	3
240500	17p11.2	Immunodeficiency, common variable, 2	240500	AD,AR	3
240600	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
240800	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
240900	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
241080	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
241200	11q24.3	Bartter syndrome, type 2	241200	AR	3
241410	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
241500	1p36.12	Hypophosphatasia, infantile	241500	AR	3
241510	1p36.12	Hypophosphatasia, childhood	241510	AR	3
241520	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
241530	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
241550	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
241600	15q21.1	Immunodeficiency 43	241600	AR	3
241800	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
241850	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
242100	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
242300	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
242500	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
242840	18q12.3-q21.1	Vici syndrome	242840	AR	3
242860	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
242900	2q35	Schimke immunoosseous dysplasia	242900	AR	3
243060	19q13.43	Spermatogenic failure 5	243060	AR	3
243150	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
243300	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
243305	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
243310	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
243400	8p22	[Acetylation, slow]	243400	AR	3
243500	15q15.1	Isovaleric acidemia	243500	AR	3
243605	1q41	Stromme syndrome	243605	AR	3
243700	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
243800	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
244200	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
244400	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
244450	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
244460	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
245000	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
245010	11q14.2	Haim-Munk syndrome	245010	AR	3
245050	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
245150	12p12.3	Keutel syndrome	245150	AR	3
245200	14q31.3	Krabbe disease	245200	AR	3
245300	20p13	{Kuru, susceptibility to}	245300	_	3
245340	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
245348	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
245349	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
245400	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
245450	16q23.1	D-lactic aciduria	245450	AR	3
245480	14q11.2	Specific granule deficiency	245480	AR	3
245570	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
245590	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
245600	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
245660	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
245800	19p13.2	?Laurence-Moon syndrome	245800	AR	3
245900	16q22.1	Norum disease	245900	AR	3
246200	19p13.2	Leprechaunism	246200	AR	3
246300	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
246450	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
246530	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
246560	10q24	Split-hand/foot malformation 3, gene duplication syndrome	246560	AD	4
246600	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
246650	16p13.3	Lipase deficiency, combined	246650	AR	3
246700	5q31.1	Chylomicron retention disease	246700	AR	3
246900	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
247100	1q21.2	Urbach-Wiethe disease	247100	AR	3
247200	17p13.3	Miller-Dieker lissencephaly syndrome	247200	AD	4
247420	19q13.32	[Blood group, Lutheran null]	247420	AR	3
247640	9p22-p21	Leukemia, acute lymphoblastic	247640	AR	2
248000	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
248190	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
248250	3q28	Hypomagnesemia 3, renal	248250	AR	3
248300	8q24.3	Meleda disease	248300	AR	3
248310	5q31-q33	{Malaria, intensity of infection}	248310	AR	2
248340	8q24.12	3MC syndrome 3	248340	AR	3
248360	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
248370	1q22	Mandibuloacral dysplasia	248370	AR	3
248390	6p21.1	Treacher Collins syndrome 3	248390	AR	3
248450	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
248500	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
248510	4q24	Mannosidosis, beta	248510	AR	3
248610	1p21.2	Maple syrup urine disease, type II	248600	AR	3
248611	6q14.1	Maple syrup urine disease, type Ib	248600	AR	3
248700	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
248800	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
248900	15q22.31	Mast syndrome	248900	AR	3
249000	17q22	Meckel syndrome 1	249000	AR	3
249100	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
249270	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
249400	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
249420	5q35.1	Frank-ter Haar syndrome	249420	AR	3
249500	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
249900	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
250100	22q13.33	Metachromatic leukodystrophy	250100	AR	3
250220	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
250250	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
250400	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
250410	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
250460	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
250620	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
250790	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
250940	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
250950	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
251000	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
251100	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
251110	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
251120	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
251170	12q24.11	Hyper-IgD syndrome	260920	AR	3
251170	12q24.11	Mevalonic aciduria	610377	AR	3
251170	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
251200	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
251230	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
251255	18q11.2	Jawad syndrome	251255	AR	3
251260	8q21.3	Nijmegen breakage syndrome	251260	AR	3
251270	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
251280	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
251290	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
251300	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
251450	17q25.3	Desbuquois dysplasia 1	251450	AR	3
251600	14q32	Microphthalmia, isolated 1	251600	AR	2
251750	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
251850	18q21.1	Microvillus inclusion disease	251850	AR	3
251880	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
251900	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
251950	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
252010	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
252150	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
252160	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
252270	7q	Myelodysplasia and leukemia syndrome with monosomy 7	252270	AR	4
252350	3p26-p24.2	Moyamoya disease	252350	AR	2
252500	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
252600	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
252605	16p13.3	Mucolipidosis III gamma	252605	AR	3
252650	19p13.2	Mucolipidosis IV	252650	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
252800	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
252900	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
252920	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
252930	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
252940	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
253000	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
253010	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
253200	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
253220	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
253250	17q22	Mulibrey nanism	253250	AR	3
253260	3p25.1	Biotinidase deficiency	253260	AR	3
253270	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
253280	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
253300	5q13.2	Spinal muscular atrophy-1	253300	AR	3
253310	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
253550	5q13.2	Spinal muscular atrophy-2	253550	AR	3
253600	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
253601	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
253700	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
253800	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
254110	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
254130	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
254210	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
254300	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
254600	17q22	Myeloperoxidase deficiency	254600	AR	3
254770	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
254800	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
254900	4q21.1	Epilepsy, progressive myoclonic 4, with or without renal failure	254900	AR	3
254940	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
255100	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
255110	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
255120	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
255125	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
255160	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
255200	2q14.3	Centronuclear myopathy 2	255200	AR	3
255320	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
255500	14q22.1-q24.2	Myopia 18	255500	AR	2
255600	21q22.3	?Myosclerosis, congenital	255600	AR	3
255700	7q34	Myotonia congenita, recessive	255700	AR	3
255800	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
255960	17q24.2	Myxoma, intracardiac	255960	AD	3
255995	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
256030	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
256040	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
256100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
256300	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
256370	11p13	Nephrotic syndrome, type 4	256370	AD	3
256450	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
256500	5q32	Netherton syndrome	256500	AR	3
256520	1p12	Neu-Laxova syndrome 1	256520	AR	3
256540	20q13.12	Galactosialidosis	256540	AR	3
256600	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
256730	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
256731	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
256800	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
256810	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
256840	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
256850	16q23.2	Giant axonal neuropathy-1	256850	AR	3
257200	11p15.4	Niemann-Pick disease, type A	257200	AR	3
257270	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
257300	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
257320	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
257550	2q13	Oculomotor apraxia, congenital, Cogan-type	257550	AR	2
257850	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
257920	3q27.3	3MC syndrome 1	257920	AR	3
257980	2q35	Odontoonychodermal dysplasia	257980	AR	3
258100	2q37.1	Oguchi disease-1	258100	AR	3
258315	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
258450	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
258480	11q13.4	Opsismodysplasia	258480	AR	3
258500	8q21-q22	Optic atrophy 6	258500	AR	2
258501	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
258660	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
258860	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
258870	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
258900	3q21.2	Orotic aciduria	258900	AR	3
259050	3q13.31	Primrose syndrome	259050	AD	3
259440	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
259450	17q21.2	Bruck syndrome 1	259450	AR	3
259600	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
259700	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
259710	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
259720	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
259730	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
259770	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
259775	7p22.3	Raine syndrome	259775	AR	3
259900	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
260000	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
260005	8q24.3	5-oxoprolinase deficiency	260005	AD,AR	3
260300	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
260370	13q12.2	Pancreatic agenesis 1	260370	AR	3
260400	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
260500	17p13.1	{Choroid plexus papilloma}	260500	AD	3
260540	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
260565	17q12	PEHO syndrome	260565	AR	3
260600	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
260660	1p12	Cousin syndrome	260660	AR	3
260800	17q25.3	[Pentosuria]	260800	AR	3
260920	12q24.11	Hyper-IgD syndrome	260920	AR	3
261000	11q12.1	Intrinsic factor deficiency	261000	AR	3
261500	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
261515	5q23.1	D-bifunctional protein deficiency	261515	AR	3
261540	13q12.3	Peters-plus syndrome	261540	AR	3
261630	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
261640	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
261650	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
261670	7p13	Glycogen storage disease X	261670	AR	3
261680	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
261740	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
261750	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
261800	17q24.3-q25.1	Pierre Robin syndrome	261800	AR	2
261990	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
262000	2q35	Bjornstad syndrome	262000	AR	3
262190	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
262300	8q21.3	Achromatopsia 3	262300	AR	3
262400	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
262500	5p13-p12	Laron dwarfism	262500	AR	3
262600	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
262650	17q23.3	Kowarski syndrome	262650	AR	3
262700	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
262850	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
262890	12q12	Scott syndrome	262890	AR	3
263200	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
263210	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
263300	9p24.1	Polycythemia vera, somatic	263300	_	3
263400	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
263450	13q13.3-q21	Polydactyly, postaxial, type A5	263450	AR	2
263520	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	DR,AR	3
263570	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
263650	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
263700	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
263750	16q22.2	Miller syndrome	263750	AR	3
263800	16q13	Gitelman syndrome	263800	AR	3
264070	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
264080	11q22.1	?Progesterone resistance	264080	AR	2
264090	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
264300	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
264470	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
264600	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
264700	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
264900	4q35.2	Factor XI deficiency, autosomal dominant	612416	_	3
264900	4q35.2	Factor XI deficiency, autosomal recessive	612416	_	3
265000	2q37.1	Escobar syndrome	265000	AR	3
265050	2p25.3	3MC syndrome 2	265050	AR	3
265100	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
265120	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
265380	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
265450	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
265800	1q21.3	Pycnodysostosis	265800	AR	3
265900	7p14.1	Pyle disease	265900	AR	3
266100	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
266120	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
266130	20q11.22	Glutathione synthetase deficiency	266130	AR	3
266140	1q23.1	Pyropoikilocytosis	266140	AR	3
266150	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
266200	1q22	Pyruvate kinase deficiency	266200	AR	3
266265	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
266280	8q24.3	RAPADILINO syndrome	266280	AR	3
266500	10p13	Refsum disease	266500	AR	3
266510	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
266900	2q13	Senior-Loken syndrome-1	266900	AR	3
266920	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
267000	2q37.1	Perlman syndrome	267000	AR	3
267010	3q22.1	Meckel syndrome 7	267010	AR	3
267300	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
267500	1p35.1	Reticular dysgenesis	267500	AR	3
267700	9q21.3-q22	Hemophagocytic lymphohistiocytosis, familial, 1	267700	AR	2
267750	21q22.3	Knobloch syndrome, type 1	267750	AR	3
268100	15q23	Enhanced S-cone syndrome	268100	AR	3
268130	14q12	Revesz syndrome	268130	AD	3
268150	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
268200	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
268210	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
268300	8p21.1	Roberts syndrome	268300	AR	3
268305	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
268310	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
268400	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
268700	7q31.32	Saccharopinuria	268700	AR	1
268800	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
268900	9q34.2	[Sarcosinemia]	268900	AR	3
269000	8p21.1	SC phocomelia syndrome	269000	AR	3
269150	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
269250	1p31.3	Schneckenbecken dysplasia	269250	AR	3
269400	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
269500	17q21.31	Sclerosteosis 1	269500	AR	3
269600	19q13.32	Sea-blue histiocyte disease	269600	AR	3
269700	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
269840	2q11.2	Immunodeficiency 48	269840	AR	3
269880	5q13.1	SHORT syndrome	269880	AD	3
269920	6q13	Sialic acid storage disorder, infantile	269920	AR	3
269921	9p13.3	Sialuria	269921	AD	3
270100	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
270200	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
270300	6p21.33	Peeling skin syndrome 1	270300	AR	3
270400	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
270420	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
270450	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
270550	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
270685	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
270700	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
270750	1q32.1	Spastic paraplegia 23	270750	AR	3
270800	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
270970	1q23.1	Spherocytosis, type 3	270970	AR	3
271150	5q13.2	Spinal muscular atrophy-4	271150	AR	3
271245	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
271250	6p23-p21	Spinocerebellar ataxia, autosomal recessive 3	271250	AR	2
271400	3p22.1	Asplenia, isolated congenital	271400	AD	3
271640	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
271665	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
271700	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
271900	17p13.2	Canavan disease	271900	AR	3
271930	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
271980	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
272120	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
272200	3p26.1	Multiple sulfatase deficiency	272200	AR	3
272300	12q13.2	Sulfite oxidase deficiency	272300	AR	3
272430	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
272440	2q14.1	Filippi syndrome	272440	AR	3
272460	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
272750	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
273395	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
273750	6p21.1	3-M syndrome 1	273750	AR	3
273900	5p13.1	Thrombocytopenia 3	273900	AR	3
274000	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
274150	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
274180	7q34	?Thromboxane synthase deficiency	614158	AD	1
274180	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
274300	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
274400	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
274500	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
274600	7q22.3	Pendred syndrome	274600	AR	3
274700	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
274800	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
274900	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
275000	14q31	{Graves disease, susceptibility to, 1}	275000	AR	2
275100	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
275120	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
275200	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
275220	8q24.1	?Tibial hemimelia	275220	AR	2
275350	22q12.2	Transcobalamin II deficiency	275350	AR	3
275360	11q23.3	Trehalase deficiency	612119	AR	3
275400	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
275630	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
275900	13q13.3	Troyer syndrome	275900	AR	3
276000	7q34	Pancreatitis, hereditary	167800	AD	3
276000	7q34	Trypsinogen deficiency	614044	AR	1
276400	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
276600	16q22.2	Tyrosinemia, type II	276600	AR	3
276700	15q25.1	Tyrosinemia, type I	276700	AR	3
276710	12q24.31	Tyrosinemia, type III	276710	AR	3
276820	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
276880	3q21.3	?Urocanase deficiency	276880	AR	3
276900	11q13.5	Usher syndrome, type 1B	276900	AR	3
276902	3q25.1	Usher syndrome, type 3A	276902	AR	3
276903	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
276903	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
276903	11q13.5	Usher syndrome, type 1B	276900	AR	3
276904	11p15.1	Usher syndrome, type 1C	276904	AR	3
277170	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
277180	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
277300	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
277380	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
277440	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
277450	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
277460	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
277470	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
277480	12p13.31	von Willibrand disease, type 3	277480	AR	3
277580	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
277590	7q36.1	Weaver syndrome	277590	AD	3
277600	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
277700	8p12	Werner syndrome	277700	AR	3
277900	13q14.3	Wilson disease	277900	AR	3
277950	14q11.2	?Winchester syndrome	277950	_	3
278250	12q24.31	Wrinkly skin syndrome	278250	AR	3
278300	2p23.1	Xanthinuria, type I	278300	AR	3
278700	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
278720	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
278730	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
278740	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
278750	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
278800	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
278850	17q24.3-q25.1	46XX sex reversal 2	278850	AD	4
280000	17p11.2	CHIME syndrome	280000	AR	3
300000	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300004	Xp21.3	Proud syndrome	300004	XL	3
300005	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300005	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300005	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300005	Xq28	Rett syndrome	312750	XLD	3
300005	Xq28	Rett syndrome, atypical	312750	XLD	3
300005	Xq28	Rett syndrome, preserved speech variant	312750	XLD	3
300005	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300008	Xp11.23	Dent disease	300009	XLR	3
300008	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300008	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
300008	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
300009	Xp11.23	Dent disease	300009	XLR	3
300011	Xq21.1	Menkes disease	309400	XLR	3
300011	Xq21.1	Occipital horn syndrome	304150	XLR	3
300011	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300013	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
300013	Xq28	Ogden syndrome	300855	XLR,XLD	3
300014	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
300017	Xq28	?FG syndrome 2	300321	XL	3
300017	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
300017	Xq28	Congenital short bowel syndrome	300048	XLR	3
300017	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
300017	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300017	Xq28	Intestinal pseudoobstruction, neuronal	300048	XLR	3
300017	Xq28	Melnick-Needles syndrome	309350	XLD	3
300017	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
300017	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
300017	Xq28	Terminal osseous dysplasia	300244	XLD	3
300018	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300019	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
300029	Xp11.4	Retinitis pigmentosa 3	300029	_	3
300030	Xp21.2	Deafness, X-linked 3	300030	XL	2
300032	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300032	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
300032	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
300035	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
300036	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300037	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
300037	Xq26.2	Wilms tumor, somatic	194070	_	3
300039	Xq21.1	Deafness, X-linked 2	304400	XLR	3
300040	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300046	Xq23-q24	Mental retardation, X-linked 23	300046	XL	2
300047	Xp11-q21	Mental retardation, X-linked 20	300047	XL	2
300049	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300055	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300056	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
300060	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
300062	Xp11.3-q13.3	Mental retardation, X-linked 14	300062	XL	2
300066	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300068	Xq12	Androgen insensitivity	300068	XLR	3
300071	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300072	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300072	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300075	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
300075	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300076	Xq26-qter	Woods-Black-Norbury syndrome	300076	XLD	2
300078	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
300079	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300080	Xp11.3	TARP syndrome	311900	XLR	3
300082	Xq	[Social cognition]	300082	XL	2
300084	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300085	Xq27	Cone dystrophy, progressive X-linked, 2	300085	XL	2
300087	Xq13.2	X-inactivation, familial skewed	300087	_	3
300088	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300090	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300095	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300096	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300104	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300105	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
300106	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
300108	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300110	Xp11.23	Aland Island eye disease	300600	XL	3
300110	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300110	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300114	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
300115	Xp11.3-p11.21	Mental retardation, X-linked 50	300115	XL	2
300120	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300121	Xq23	Lissencephaly, X-linked	300067	XL	3
300121	Xq23	Subcortical laminal heterotopia, X-linked	300067	XL	3
300123	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
300125	Xq	{Migraine, familial typical, susceptibility to, 2}	300125	XL	2
300126	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
300127	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300128	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300131	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300135	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
300136	Xp11	{Diabetes mellitus, insulin-dependent, X-linked}	300136	_	2
300137	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300138	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300139	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300142	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300143	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300144	Xq24	{Parkinson disease, age of onset, modifier}	168600	AD,Mu	3
300145	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300147	Xq27-q28	{Prostate cancer, hereditary, X-linked 1}	300147	_	2
300148	Xp22.11	MEHMO syndrome	300148	XLR	3
300155	Xq26-q27	Retinitis pigmentosa 24	300155	_	2
300157	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300160	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300161	Xp22.11	MEHMO syndrome	300148	XLR	3
300163	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300163	Xq26.3	Emery-Dreifuss muscular dystrophy 6, X-linked	300696	XLR	3
300163	Xq26.3	Myopathy, X-linked, with postural muscle atrophy	300696	XLR	3
300163	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300163	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300163	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300166	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300168	Xq26.2	Keipert syndrome	301026	XLR	3
300169	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300169	Xq26.1	Cowchock syndrome	310490	XLR	3
300169	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300170	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300170	Xp22.2	Joubert syndrome 10	300804	XLR	3
300170	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
300170	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300172	Xp11.4	FG syndrome 4	300422	_	3
300172	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300172	Xp11.4	Mental retardation, with or without nystagmus	300422	_	3
300179	Xq25-q26	X inactivation, familial skewed, 2	300179	_	2
300180	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
300188	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
300188	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300188	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
300189	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300192	Xp11.22	?Sarcoma, synovial	300813	_	3
300193	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300194	Xq22.3	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis	300194	_	4
300195	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300197	Xq28	Immunodeficiency 47	300972	XLR	3
300199	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300200	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300202	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
300203	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300204	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300205	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
300205	Xp11.23	MEND syndrome	300960	XLR	3
300206	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300209	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300210	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300211	Xp22.3	Episodic muscle weakness, X-linked	300211	_	2
300218	Xp11.3-q22	Mental retardation, X-linked syndromic 7	300218	_	2
300221	Xpter-p22.32	{Hodgkin disease susceptibility, pseudoautosomal}	300221	_	2
300226	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300228	Xq27	Testicular germ cell tumor	300228	_	2
300231	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300238	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300243	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300244	Xq28	Terminal osseous dysplasia	300244	XLD	3
300245	Xq24-q27.1	Ptosis, hereditary congenital 2	300245	XLD	2
300247	Xp11.22	Ovarian dysgenesis 2	300510	XL	3
300247	Xp11.22	Premature ovarian failure 4	300510	XL	3
300248	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300248	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300248	Xq28	Immunodeficiency 33	300636	XLR	3
300248	Xq28	Immunodeficiency, isolated	300584	_	3
300248	Xq28	Incontinentia pigmenti	308300	XLD	3
300248	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300255	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300256	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300257	Xq24	Danon disease	300257	XLD	3
300259	Xq	{Mycobacterium tuberculosis, susceptibility, X-linked}	300259	_	2
300260	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300261	Xq28	Mental retardation syndrome, X-linked, Armfield type	300261	XLR	2
300262	Xq13.2	Mental retardation, X-linked syndromic, Abidi type	300262	_	2
300263	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300264	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300265	Xq26.3	Congenital heart defects, nonsyndromic, 1, X-linked	306955	XLR	3
300265	Xq26.3	Heterotaxy, visceral, 1, X-linked	306955	XLR	3
300265	Xq26.3	VACTERL association, X-linked	314390	XLR	3
300266	Xq11.2	Spastic paraplegia 16, X-linked, complicated	300266	XLR	2
300269	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300271	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300272	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300273	Xp22	Goiter, multinodular, 2	300273	XLD	2
300275	Xq28	CHILD syndrome	308050	XLD	3
300275	Xq28	CK syndrome	300831	XLR	3
300278	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
300280	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300291	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300292	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
300294	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300294	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
300294	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
300294	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
300298	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300299	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300300	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300300	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
300301	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300304	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300306	Xq24	{Obesity, susceptibility to, BMIQ11}	300306	_	2
300307	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
300307	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
300310	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300311	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
300321	Xq28	?FG syndrome 2	300321	XL	3
300322	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
300323	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
300324	Xq22.2-q26	Mental retardation, X-linked 53	300324	XLR	2
300331	Chr.X	Thrombocythemia, X-linked	300331	XLR	2
300336	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300336	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300345	Chr.X	Microphthalmia with coloboma 1	300345	_	2
300350	Xq23	Megalocornea 1, X-linked	309300	XLR	3
300351	Xp11	{Graves disease, susceptibility to, X-linked}	300351	_	2
300352	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300354	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300355	Xp22.2	Mental retardation, X-linked 73	300355	XLR	2
300356	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
300367	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
300368	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
300371	Xq28	Adrenoleukodystrophy	300100	XLR	3
300371	Xq28	Adrenomyeloneuropathy, adult	300100	XLR	3
300372	Xq26	Mental retardation, X-linked 42	300372	_	2
300373	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300374	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300376	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
300377	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
300378	Xq24-q25	Radial ray deficiency	300378	_	2
300379	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300382	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
300382	Xp21.3	Hydranencephaly with abnormal genitalia	300215	XL	3
300382	Xp21.3	Lissencephaly, X-linked 2	300215	XL	3
300382	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300382	Xp21.3	Partington syndrome	309510	XLR	3
300382	Xp21.3	Proud syndrome	300004	XL	3
300383	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
300384	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
300386	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
300387	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300388	Xq27.2-q28	Polymicrogyria, bilateral perisylvian	300388	XLD	2
300390	Xq21.2	Choroideremia	303100	XLD	3
300391	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
300392	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked	313900	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked, intermittent	313900	XLR	3
300392	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
300393	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300394	Xq28	Barth syndrome	302060	XLR	3
300395	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300398	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300400	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
300401	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
300401	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
300403	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
300403	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300406	Xp22.3	FG syndrome 3	300406	_	2
300414	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
300415	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
300419	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300423	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300424	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300425	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300427	Xp22.32-p22.31	Mental retardation, X-linked	300495	IC,Mu,XL	3
300427	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300427	Xp22.32-p22.31	{Autism susceptibility, X-linked 2}	300495	IC,Mu,XL	3
300428	Xp22.3	Mental retardation, X-linked 2	300428	XL	2
300429	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300433	Xp11.2-q12	Mental retardation, X-linked 81	300433	XLR	2
300434	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300436	Xq25-q26	Mental retardation, X-linked 46	300436	XLR	2
300438	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300448	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300451	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
300451	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
300454	Xq12-q21.3	Mental retardation, X-linked 77	300454	XLR	2
300455	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
300457	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
300457	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
300460	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300461	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
300463	Xp11.23	Renpenning syndrome	309500	XLR	3
300464	Xq23-q26	{Coronary heart disease, susceptibility to, 3}	300464	_	2
300470	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300471	Chr.X	Cubitus valgus with mental retardation and unusual facies	300471	XLR	2
300472	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300473	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300473	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300474	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
300475	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300476	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300481	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
300481	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300484	Chr.X	Orofaciodigital syndrome VIII	300484	XLR	2
300485	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300486	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300488	Xp21.3	{Menopause, natural, age at, QTL1}	300488	XLD	2
300489	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300490	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
300491	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
300494	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300496	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300497	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300498	Xp11.3-p11.21	Mental retardation,X-linked 45	300498	XL	2
300499	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
300500	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300502	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
300505	Xp11.3-q22.3	Mental retardation, X-linked 84	300505	XLR	2
300509	Xq27.3	{Dyslexia, susceptibility to, 9}	300509	_	2
300511	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300514	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300515	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300516	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
300518	Xq24-q25	Mental retardation, X-linked 82	300518	XLR	2
300519	Chr.X	Mental retardation, X-linked, syndromic, Martin-Probst type	300519	XLR	2
300521	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300522	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
300523	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300524	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300526	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300534	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
300535	Xq26.1	Dent disease 2	300555	XLR	3
300535	Xq26.1	Lowe syndrome	309000	XLR	3
300536	Xq27	[Bone mineral density QTL 4]	300536	_	2
300538	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
300538	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300539	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300545	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
300546	Xp11.22	Aarskog-Scott syndrome	305400	XLR	3
300546	Xp11.22	Mental retardation, X-linked syndromic 16	305400	XLR	3
300550	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
300552	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300553	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300554	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300555	Xq26.1	Dent disease 2	300555	XLR	3
300556	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300556	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300557	Xq21-q25	{Parkinson disease 12}	300557	_	2
300558	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300559	Xq13.1	Muscle glycogenosis	300559	XLR	3
300560	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300572	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300576	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300577	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300578	Xp11.3	Chromosome Xp11.3 deletion syndrome	300578	XLR	4
300579	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300580	Xq13.1-q22.1	Myopathy, congenital, with fiber-type disproportion, X-linked	300580	XLD	2
300581	Xq22.3	FG syndrome 5	300581	_	2
300584	Xq28	Immunodeficiency, isolated	300584	_	3
300589	Xp11.4	Nystagmus 5, congenital, X-linked	300589	XLD	2
300590	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300591	Xq24-q25	{Stature QTL 6}	300591	_	2
300600	Xp11.23	Aland Island eye disease	300600	XL	3
300603	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300604	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300605	Xq28	Retinitis pigmentosa 34	300605	_	2
300607	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300610	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300611	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300613	Xq23-q27.2	Myopia 13	300613	_	2
300614	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300622	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300623	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
300624	Xq27.3	Fragile X syndrome	300624	XLD	3
300628	Xq26.2	Nystagmus 1, congenital, X-linked	310700	XL	3
300628	Xq26.2	Nystagmus, infantile periodic alternating, X-linked	310700	XL	3
300629	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
300633	Xq12	Hypospadias 1, X-linked	300633	XLR	3
300635	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300636	Xq28	Immunodeficiency 33	300636	XLR	3
300640	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300642	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300643	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300644	Xq22.1	Fabry disease	301500	XL	3
300644	Xq22.1	Fabry disease, cardiac variant	301500	XL	3
300645	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300646	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300647	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300650	Xp22.3	Ocular albinism with sensorineural deafness	300650	XL	2
300651	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
300652	Xp11.3-q12	Angio serpiginosum	300652	XLD	2
300653	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
300658	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
300658	Xp11.3	Norrie disease	310600	XLR	3
300659	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300660	Xq25-q27	Leukoencephalopathy with metaphyseal chondrodysplasia	300660	XLR	2
300672	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300673	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300676	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300679	Xp21	Chromosome Xp21 deletion syndrome	300679	_	4
300695	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300697	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
300699	Xq25	Mental retardation, X-linked 94	300699	XLR	3
300700	Xq24-q26	Albinism-deafness syndrome	300700	XL	2
300703	Xq25-q27.1	Spinocerebellar ataxia, X-linked 5	300703	XLR	2
300704	Xp11.22	{Prostate cancer, hereditary, X-linked 2}	300704	_	2
300705	Xp11.22	Xp11.22 microduplication syndrome	300705	_	4
300707	Xq28	STAR syndrome	300707	XLD	3
300708	Xq28	STAR syndrome	300707	XLD	3
300709	Xq12-q21.31	Mental retardation, X-linked, syndromic 9	300709	_	2
300710	Xq11-q12	Alopecia, androgenetic, 2	300710	_	2
300711	Xq23	Pyloric stenosis, infantile hypertrophic, 4	300711	_	2
300712	Xq26-q27	?Craniofacioskeletal syndrome	300712	XLR,XLD	2
300715	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300716	Chr.X	Mental retardation, X-linked 95	300716	XLD	2
300717	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300718	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300719	Chr.X	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	XLR	2
300724	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
300746	Xq27.1	Hemophilia B	306900	XLR	3
300746	Xq27.1	Thrombophilia, X-linked, due to factor IX defect	300807	_	3
300746	Xq27.1	{Deep venous thrombosis, protection against}	300807	_	3
300746	Xq27.1	{Warfarin sensitivity}	122700	AD	3
300747	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
300749	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300750	Xq24-q25	Spastic paraplegia 34, X-linked	300750	XLR	2
300751	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
300752	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
300755	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300756	Xq21.3	{Alzheimer disease 16}	300756	_	2
300757	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
300758	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300770	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
300774	Xq28	?Waisman syndrome	311510	XLR	3
300774	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300776	Xq23	?Congenital disorder of glycosylation, type Is	300884	XLD	3
300776	Xq23	Epileptic encephalopathy, early infantile, 36	300884	XLD	3
300777	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300778	Xp22.3	Corneal dystrophy, Lisch epithelial	300778	XLD	2
300779	Xq25	Corneal dystrophy, endothelial, X-linked	300779	XLD	2
300798	Xp22.13	Glycogen storage disease, type IXa1	306000	XLR	3
300798	Xp22.13	Glycogen storage disease, type IXa2	306000	XLR	3
300799	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300801	Xp11.23-p11.22	Chromosome Xp11.23-p11.22 duplication syndrome	300801	XLD	4
300802	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
300803	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
300804	Xp22.2	Joubert syndrome 10	300804	XLR	3
300806	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
300808	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300808	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300809	Xq28	{Systemic lupus erythematosus, susceptibility to, 15}	300809	_	2
300814	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300815	Xq28	Chromosome Xq28 duplication syndrome	300815	_	4
300816	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300818	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
300821	Xq28	Blue cone monochromacy	303700	XLR	3
300821	Xq28	Colorblindness, deutan	303800	XL	3
300822	Xq28	Blue cone monochromacy	303700	XLR	3
300822	Xq28	Colorblindness, protan	303900	XL	3
300823	Xq28	Mucopolysaccharidosis II	309900	XLR	3
300826	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
300827	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
300828	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300830	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300831	Xq28	CK syndrome	300831	XLR	3
300833	Xq26.3	46XX sex reversal 3	300833	XLD	4
300834	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
300835	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
300836	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
300838	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300839	Xp22.13	Retinoschisis	312700	XLR	3
300841	Xq28	Hemophilia A	306700	XLR	3
300842	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
300843	Xq28	Bornholm eye disease	300843	XLR	2
300844	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300845	Xq28	Moyamoya disease 4	300845	XLR	4
300847	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
300848	Xp11.3	Mental retardation, X-linked 89	300848	XLD	2
300849	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300850	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300851	Xp11.3	Mental retardation, X-linked 92	300851	XLR	2
300852	Xq24	Mental retardation, X-linked 88	300852	XL	2
300853	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300854	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
300855	Xq28	Ogden syndrome	300855	XLR,XLD	3
300856	Xp11.22	{Hypospadias 4, X-linked, susceptibility to}	300856	_	2
300857	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300858	Xp21.1-p11.23	Mental retardation, X-linked, syndromic 17	300858	XLR	2
300859	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300860	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
300861	Xq21.33-q23	Mental retardation, X-linked, syndromic, Chudley-Schwartz type	300861	XLR	2
300863	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300864	Chr.X	Cerebral-cerebellar-coloboma syndrome, X-linked	300864	XLR	2
300867	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300868	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
300869	Xq27.3-q28	Chromosome Xq27.3-q28 duplication syndrome	300869	XLR	4
300870	Xp22	Aneurysm, intracranial berry, 5	300870	_	2
300872	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300882	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300885	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300886	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300887	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300888	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300894	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300895	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300896	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
300897	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
300905	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300906	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300908	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
300909	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300910	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300911	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300912	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300913	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
300914	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
300915	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300918	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300919	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300923	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300928	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300932	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
300933	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300934	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300942	Xq26.3	Chromosome Xq26.3 duplication syndrome	300942	XLD	4
300943	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300945	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300946	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300951	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300952	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300953	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300957	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300958	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300960	Xp11.23	MEND syndrome	300960	XLR	3
300963	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300964	Xq12	Wilson-Turner syndrome	309585	XLR	3
300966	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
300967	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300968	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300969	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
300971	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300972	Xq28	Immunodeficiency 47	300972	XLR	3
300975	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300978	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300979	Xq25	Xq25 duplication syndrome	300979	XL	4
300980	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300982	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300983	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300984	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300985	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300986	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300988	Xq12	Immunodeficiency 50	300988	XLR	3
300989	Xq28	Meester-Loeys syndrome	300989	XL	3
300990	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300991	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300997	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300998	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
301000	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
301006	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
301008	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
301010	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301012	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301013	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301014	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
301015	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
301018	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
301020	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
301021	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
301022	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
301024	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
301025	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
301026	Xq26.2	Keipert syndrome	301026	XLR	3
301040	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
301050	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
301200	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
301201	Xq22-q28	?Amelogenesis imperfecta, type IE, X-linked 2	301201	XL	2
301220	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
301300	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
301300	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
301310	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
301590	Xq27-q28	?Microphthalmia, syndromic 4	301590	XLR	2
301770	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301830	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
301835	Xq22.3	Arts syndrome	301835	XLR	3
301845	Xq24-q27	Bazex syndrome	301845	XLD	2
301870	Xq28	Meester-Loeys syndrome	300989	XL	3
301870	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
301900	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
302045	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
302060	Xq28	Barth syndrome	302060	XLR	3
302200	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
302350	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
302500	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
302800	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
302801	Xp22.2	Charcot-Marie-Tooth neuropathy, X-linked recessive, 2	302801	XLR	2
302802	Xq26	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	XLR	4
302905	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
302910	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
302950	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
302960	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
303100	Xq21.2	Choroideremia	303100	XLD	3
303110	Xq21	Choroideremia, deafness, and mental retardation	303110	XLR	4
303400	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
303600	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
303630	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
303631	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
303800	Xq28	Colorblindness, deutan	303800	XL	3
303900	Xq28	Colorblindness, protan	303900	XL	3
304020	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
304040	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
304050	Xp22	Aicardi syndrome	304050	XLD	2
304100	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
304110	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
304120	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
304150	Xq21.1	Occipital horn syndrome	304150	XLR	3
304340	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
304400	Xq21.1	Deafness, X-linked 2	304400	XLR	3
304500	Xq22.3	Deafness, X-linked 1	304500	XL	3
304700	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
304730	Xq24-qter	Dermoids of cornea	304730	XL	2
304790	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
304800	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
305000	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
305100	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
305371	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
305371	Xp11.23	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	_	3
305371	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
305371	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
305390	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
305435	Xp22.2	Fetal hemoglobin quantitative trait locus 3	305435	XL	2
305450	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
305600	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
305620	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
305900	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
305900	Xq28	{Resistance to malaria due to G6PD deficiency}	611162	_	3
305915	Xq25	Mental retardation, X-linked 94	300699	XLR	3
306250	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
306400	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
306700	Xq28	Hemophilia A	306700	XLR	3
306900	Xq27.1	Hemophilia B	306900	XLR	3
306995	Xq28	[?Homosexuality, male]	306995	XL	2
307030	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
307150	Xq27.1	Hypertrichosis, congenital generalized	307150	XLD	4
307200	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
307700	Xq27.1	Hypoparathyroidism, X-linked	307700	XL	4
307800	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
308000	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
308000	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
308050	Xq28	CHILD syndrome	308050	XLD	3
308100	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
308205	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
308230	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
308240	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
308300	Xq28	Incontinentia pigmenti	308300	XLD	3
308350	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
308380	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
308380	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
308700	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
308800	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
308840	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
308840	Xq28	CRASH syndrome	303350	XLR	3
308840	Xq28	Hydrocephalus due to aqueductal stenosis	307000	XLR	3
308840	Xq28	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	XLR	3
308840	Xq28	Hydrocephalus with Hirschsprung disease	307000	XLR	3
308840	Xq28	MASA syndrome	303350	XLR	3
308905	Xp11	{Leber optic atrophy, susceptibility to}	308905	XL	2
308990	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
309000	Xq26.1	Lowe syndrome	309000	XLR	3
309060	Xq24	Danon disease	300257	XLD	3
309120	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
309200	Xq28	{?Major affective disorder 2}	309200	XLD	2
309300	Xq23	Megalocornea 1, X-linked	309300	XLR	3
309350	Xq28	Melnick-Needles syndrome	309350	XLD	3
309400	Xq21.1	Menkes disease	309400	XLR	3
309500	Xp11.23	Renpenning syndrome	309500	XLR	3
309510	Xp21.3	Partington syndrome	309510	XLR	3
309520	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
309530	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
309541	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
309545	Xp11	?Mental retardation, X-linked, syndromic 12	309545	XL	2
309548	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
309549	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
309550	Xq27.3	Fragile X syndrome	300624	XLD	3
309550	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
309550	Xq27.3	Premature ovarian failure 1	311360	XL	3
309555	Xq26	Gustavson syndrome	309555	XL	2
309580	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
309583	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
309585	Xq12	Wilson-Turner syndrome	309585	XLR	3
309590	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
309610	Xp11-q21	Prieto syndrome	309610	XLR	2
309620	Xq28	Mental retardation-skeletal dysplasia	309620	XL	2
309630	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
309800	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
309801	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
309845	Xq12	Immunodeficiency 50	300988	XLR	3
309850	Xp11.3	Brunner syndrome	300615	XLR	3
309850	Xp11.3	{Antisocial behavior}	300615	XLR	3
309900	Xq28	Mucopolysaccharidosis II	309900	XLR	3
310200	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
310300	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
310400	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
310440	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
310460	Xq28	Myopia-1	310460	XLR	2
310468	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
310490	Xq26.1	Cowchock syndrome	310490	XLR	3
310500	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
310600	Xp11.3	Norrie disease	310600	XLR	3
311050	Xp11.4-p11.21	Optic atrophy 2, X-linked	311050	XL	2
311070	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311200	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
311250	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
311300	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
311360	Xq27.3	Premature ovarian failure 1	311360	XL	3
311510	Xq28	?Waisman syndrome	311510	XLR	3
311770	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
311770	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
311800	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
311850	Xq22.3	Arts syndrome	301835	XLR	3
311850	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311850	Xq22.3	Deafness, X-linked 1	304500	XL	3
311850	Xq22.3	Gout, PRPS-related	300661	XLR	3
311850	Xq22.3	Phosphoribosylpyrophosphate synthetase superactivity	300661	XLR	3
311870	Xq13.1	Muscle glycogenosis	300559	XLR	3
311900	Xp11.3	TARP syndrome	311900	XLR	3
312000	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
312040	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
312060	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
312080	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
312170	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
312173	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
312173	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
312180	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
312300	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
312600	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
312610	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
312610	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
312610	Xp11.4	Retinitis pigmentosa 3	300029	_	3
312610	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
312612	Xp21.3-p21.2	?Retinitis pigmentosa, X-linked recessive, 6	312612	XL	2
312700	Xp22.13	Retinoschisis	312700	XLR	3
312820	Xp11.23	?Sarcoma, synovial	300813	_	3
312863	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
312865	Xp22.33	Langer mesomelic dysplasia	249700	_	3
312865	Xp22.33	Leri-Weill dyschondrosteosis	127300	_	3
312865	Xp22.33	Short stature, idiopathic familial	300582	_	3
312870	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
312920	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
313000	Xp22.33	Turner syndrome-associated neurocognitive phenotype	313000	?XLR	2
313000	Xp22.33	[Visuospatial/perceptual abilities]	313000	?XLR	2
313200	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313350	Xq26	Split hand/foot malformation 2	313350	XL	2
313400	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
313430	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
313430	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
313440	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
313475	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
313500	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
313650	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
313650	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
313700	Xq12	Androgen insensitivity	300068	XLR	3
313700	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
313700	Xq12	Hypospadias 1, X-linked	300633	XLR	3
313700	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313700	Xq12	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
313850	Xq25-q26.1	Thoracoabdominal syndrome	313850	XL	2
314050	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
314200	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
314250	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
314300	Xq28	Goeminne TKCR syndrome	314300	XL	2
314310	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
314370	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
314375	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
314390	Xq26.3	VACTERL association, X-linked	314390	XLR	3
314400	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
314580	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
314670	Xq13.2	X-inactivation, familial skewed	300087	_	3
314690	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
314700	Xpter-p22.32	[Blood group, XG system]	_	_	3
314850	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
314990	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
400003	Yq11.223	?Sertoli-cell-only syndrome	_	_	1
400004	Chr.Y	Retinitis pigmentosa, Y-linked	400004	YL	2
400005	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
400020	Yp11.2	Langer mesomelic dysplasia	249700	_	3
400020	Yp11.2	Leri-Weill dyschondrosteosis	127300	_	3
400020	Yp11.2	Short stature, idiopathic familial	300582	_	3
400033	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
400042	Yq11	Spermatogenic failure, Y-linked, 1	400042	_	4
400043	Chr.Y	Deafness, Y-linked 1	400043	YL	2
400044	Yp11.2	46XY sex reversal 1	400044	YL	3
400045	Yp11.2	46XX sex reversal 1	400045	XLD	4
400047	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
415000	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
425500	Yq	?Hairy ears, Y-linked	425500	YL	2
480000	Yp11.2	46XX sex reversal 1	400045	XLD	4
480000	Yp11.2	46XY sex reversal 1	400044	YL	3
580000	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
600001	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
600002	3p21.31	Eiken syndrome	600002	AR	3
600003	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
600005	16p13.13	Bare lymphocyte syndrome, type II, complementation group A	209920	AR	3
600005	16p13.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600008	11q23.2	Homocysteine plasma level	600008	_	2
600011	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
600011	7q22.1	Lymphatic malformation 7	617300	AD	3
600013	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
600014	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
600016	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
600019	17q23.3	Orthostatic hypotension 2	618182	AR	3
600020	10q25.2	Neurofibrosarcoma, somatic	_	_	3
600020	10q25.2	Prostate cancer, somatic	176807	_	3
600023	16q21	Elsahy-Waters syndrome	211380	AR	3
600024	1q42.12	?Reynolds syndrome	613471	AD	3
600024	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
600024	1q42.12	Pelger-Huet anomaly	169400	AD	3
600024	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
600028	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
600031	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
600035	10q26.11	Schizencephaly	269160	_	3
600037	14q22.3	Microphthalmia, syndromic 5	610125	AD	3
600037	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
600037	14q22.3	Retinal dystrophy, early-onset, with or without pituitary dysfunction	610125	AD	3
600040	19q13.33	Colorectal cancer, somatic	114500	_	3
600040	19q13.33	T-cell acute lymphoblastic leukemia, somatic	613065	_	3
600044	3q27.1	Thrombocythemia 1	187950	AD	3
600046	9q31.1	HDL deficiency, type 2	604091	_	3
600046	9q31.1	Tangier disease	205400	AR	3
600049	3q26	Myelodysplasia syndrome-1	_	_	3
600053	2q11.2	Achromatopsia 2	216900	AR	3
600059	17p13.3	Retinitis pigmentosa 13	600059	AD	3
600060	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
600065	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
600072	20p13	Insomnia, fatal familial	600072	AD	3
600073	2q31.1	Donnai-Barrow syndrome	222448	AR	3
600075	6q27	Spinocerebellar ataxia 17	607136	AD	3
600075	6q27	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
600079	7q11.23	Colon cancer, somatic	114500	_	3
600081	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
600089	6p21.3	?Diabetes mellitus, insulin-dependent, neonatal	600089	AR	2
600098	11p15.2	Ovarian carcinoma	_	_	3
600101	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
600104	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
600105	1q31.3	Retinitis pigmentosa-12	600105	AR	3
600108	11q22.2	Metaphyseal anadysplasia 1	602111	AD	3
600108	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
600108	11q22.2	Spondyloepimetaphyseal dysplasia, Missouri type	602111	AD	3
600110	6q14.1	Stargardt disease 3	600110	AD	3
600111	5p13.2	Episodic ataxia, type 6	612656	AD	3
600112	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
600112	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
600112	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
600116	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
600118	2q21.3	Warburg micro syndrome 1	600118	AR	3
600119	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
600121	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
600124	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
600129	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
600131	8q24	Epilepsy, childhood absence, 1	600131	AD	2
600132	6p21.31	Retinitis pigmentosa 14	600132	AR	3
600133	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
600138	19q13.42	Retinitis pigmentosa 11	600138	AD	3
600140	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
600140	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
600142	10q26.13	CARASIL syndrome	600142	AR	3
600143	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
600144	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
600145	1p13.1	Caudal regression syndrome	600145	AD	3
600147	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
600150	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
600150	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
600151	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
600154	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
600155	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
600156	9q31	{Hirschsprung disease, susceptibility to, 5}	600156	AD	2
600160	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
600160	9p21.3	Orolaryngeal cancer, multiple	_	_	3
600160	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
600160	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
600163	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
600163	3p22.2	Brugada syndrome 1	601144	AD	3
600163	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
600163	3p22.2	Heart block, nonprogressive	113900	AD	3
600163	3p22.2	Heart block, progressive, type IA	113900	AD	3
600163	3p22.2	Long QT syndrome-3	603830	AD	3
600163	3p22.2	Sick sinus syndrome 1	608567	AR	3
600163	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
600163	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
600165	11p	Nanophthalmos-1	600165	AD	2
600168	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
600170	9p13.3	[Blood group GIL]	607457	_	3
600173	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600175	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
600179	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
600179	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
600179	17p13.1	Leber congenital amaurosis 1	204000	AR	3
600184	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
600185	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
600185	13q13.1	Wilms tumor	194070	AD,SMu	3
600185	13q13.1	{Breast cancer, male, susceptibility to}	114480	AD,SMu	3
600185	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
600185	13q13.1	{Glioblastoma 3}	613029	AR	3
600185	13q13.1	{Medulloblastoma}	155255	AD,AR	3
600185	13q13.1	{Pancreatic cancer 2}	613347	_	3
600185	13q13.1	{Prostate cancer}	176807	AD,SMu	3
600192	18q11.2	Sarcoma, synovial	_	_	1
600193	1p21-p13.3	Waardenburg syndrome, type 2B	600193	AD	2
600194	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
600195	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	_	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, dark/light hair]	611742	_	3
600202	6p22-p21	{Dyslexia, susceptibility to, 2}	600202	AD	2
600204	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
600206	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
600209	19p	Exostoses, multiple, type 3	600209	AD	2
600211	6p21.1	Cleidocranial dysplasia	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	AD	3
600211	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
600220	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
600220	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
600221	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
600221	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600223	16q22.1	Spinocerebellar ataxia 4	600223	AD	2
600224	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
600225	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
600225	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
600228	12p13.31	?Liddle syndrome 3	618126	AD	3
600228	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
600228	12p13.31	Pseudohypoaldosteronism, type I	264350	AR	3
600229	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
600231	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600232	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
600234	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
600235	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
600235	19q13.11	Brugada syndrome 5	612838	_	3
600235	19q13.11	Cardiac conduction defect, nonspecific	612838	_	3
600235	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
600235	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
600236	1q41	Stromme syndrome	243605	AR	3
600238	20p13	?Uncombable hair syndrome 2	617251	AR	3
600244	2q37.3	{Multiple sclerosis, disease progression, modifier of}	126200	Mu	3
600244	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
600251	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
600253	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
600257	8q12.2-q21.2	Bor-Duane hydrocephalus contiguous gene syndrome	600257	AD	4
600259	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
600259	7p22.1	Mismatch repair cancer syndrome	276300	AR	3
600263	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
600266	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
600266	2q35	{Mycobacterium tuberculosis, susceptibility to infection by}	607948	_	3
600271	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
600273	16p13.3	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	AD	4
600275	1p12	Alagille syndrome 2	610205	AD	3
600275	1p12	Hajdu-Cheney syndrome	102500	AD	3
600276	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
600276	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
600276	19p13.12	Lateral meningocele syndrome	130720	AD	3
600279	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
600281	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
600281	20q13.12	MODY, type I	125850	AD	3
600281	20q13.12	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600286	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
600287	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
600287	7p14.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
600291	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
600293	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
600294	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
600300	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
600301	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
600309	6q22.31	Atrioventricular septal defect 3	600309	AD	3
600310	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
600310	19p13.11	Pseudoachondroplasia	177170	AD	3
600315	1p36.33	?Immunodeficiency 16	615593	AR	3
600316	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
600318	15q26	{Diabetes mellitus, insulin-dependent, 3}	600318	_	2
600319	11q13	{Diabetes mellitus, insulin-dependent, 4}	600319	_	2
600320	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
600321	2q31	{Diabetes mellitus, insulin-dependent, 7}	600321	_	2
600322	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
600332	1q41	Rippling muscle disease-1	600332	AD	2
600334	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
600336	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
600342	10q23.1	Retinitis pigmentosa 44	613769	_	3
600346	17q12	Turnpenny-Fry syndrome	618371	AD	3
600348	14q32.2	Band heterotopia	600348	AR	3
600354	5q13.2	Spinal muscular atrophy-1	253300	AR	3
600354	5q13.2	Spinal muscular atrophy-2	253550	AR	3
600354	5q13.2	Spinal muscular atrophy-3	253400	AR	3
600354	5q13.2	Spinal muscular atrophy-4	271150	AR	3
600359	11q24.3	Bartter syndrome, type 2	241200	AR	3
600361	4q34.3-q35.2	Hereditary motor and sensory neuropathy V	600361	AD	2
600363	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
600364	6p21.1	Cone dystrophy-3	602093	AD	3
600364	6p21.1	Cone-rod dystrophy 14	602093	AD	3
600370	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
600373	19p13.3	CODAS syndrome	600373	AR	3
600374	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
600375	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
600376	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
600383	8q13	Mesomelia-synostoses syndrome	600383	AD	4
600397	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
600414	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
600414	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
600414	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
600415	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
600417	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
600423	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
600423	1p36.12	{Hypertension, essential, susceptibility to}	145500	Mu	3
600429	6p24.3-p24.2	Adult i phenotype without cataract	110800	AD	3
600429	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
600429	6p24.3-p24.2	[Blood group, Ii]	110800	AD	3
600430	2q37	Chromosome 2q37 deletion syndrome	600430	AD	4
600438	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
600442	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600450	10p15.1	46XY sex reversal 8	614279	AR	3
600451	10p15.1	{46XY sex reversal 8, modifier of}	614279	AR	3
600456	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
600456	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
600462	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
600463	15q26.3	Microphthalmia, isolated 8	615113	AR	3
600465	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
600467	3q13.1	{Malignant hyperthermia susceptibility 4}	600467	AD	2
600470	3q24	Craniosynostosis 6	616602	AD	3
600473	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
600478	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
600480	15q21.3	Craniosynostosis 3	615314	AD	3
600483	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
600492	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
600495	3q27.1	{Parkinson disease 18}	614251	AD	3
600496	12q24.31	MODY, type III	600496	AD	3
600501	13q22.3	ABCD syndrome	600501	AR	3
600502	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
600502	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
600509	11p15.1	Diabetes mellitus, noninsulin-dependent	125853	AD	3
600509	11p15.1	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
600509	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
600509	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
600509	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
600510	7q35-q36	Pigment dispersion syndrome	600510	AD	2
600511	6p23	{Schizophrenia}	181500	AD	2
600512	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
600513	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
600514	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
600514	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
600515	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
600521	3q27.3	3MC syndrome 1	257920	AR	3
600522	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
600523	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
600525	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
600525	17q21.33	Trichodontoosseous syndrome	190320	AD	3
600528	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
600529	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
600532	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
600533	1q23.2	Neural tube defects	182940	AD	3
600536	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
600542	9q31.1	Chondrosarcoma, extraskeletal myxoid	612237	_	3
600543	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
600548	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
600548	5q31.2	Even-plus syndrome	616854	AR	3
600555	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
600555	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
600555	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
600556	12q13.3	Immunodeficiency 44	616636	AR	3
600558	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
600565	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
600565	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
600570	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
600570	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
600570	3q27.1	{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile absence, susceptibility to, 2}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	AD	3
600571	4q12	Fibromatosis, gingival, 5	617626	AD	3
600571	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
600574	22q11.21	Noonan syndrome 10	616564	AD	3
600574	22q11.21	Noonan syndrome 2	605275	AR	3
600574	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
600576	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
600576	8p23.1	Atrial septal defect 2	607941	AD	3
600576	8p23.1	Atrioventricular septal defect 4	614430	AD	3
600576	8p23.1	Tetralogy of Fallot	187500	AD	3
600576	8p23.1	Ventricular septal defect 1	614429	AD	3
600577	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
600579	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
600582	8q12.3	Traboulsi syndrome	601552	AR	3
600584	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
600584	5q35.1	Conotruncal heart malformations, variable	217095	_	3
600584	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
600584	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
600584	5q35.1	Tetralogy of Fallot	187500	AD	3
600584	5q35.1	Ventricular septal defect 3	614432	AD	3
600590	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
600593	4p16	Craniosynostosis, Adelaide type	600593	?AD	2
600599	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
600599	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
600599	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
600608	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
600617	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
600618	12p13.2	Leukemia, acute myeloid, somatic	601626	_	3
600618	12p13.2	Thrombocytopenia 5	616216	AD	3
600624	18q21.1-q21.3	Cone-rod retinal dystrophy-1	600624	AD	2
600625	14q22.2	Orofacial cleft 11	600625	_	3
600627	4q32.1	[?Hypertryptophanemia]	600627	AR	3
600630	10q11.23	UV-sensitive syndrome 1	600630	AR	3
600631	13q13-q14.3	Enuresis, nocturnal, 1	600631	AD	2
600632	11q25	Ovarian cancer, somatic	167000	_	3
600635	14q13.3	Chorea, hereditary benign	118700	AD	3
600635	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
600635	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
600638	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
600644	11q23.3	Cleft lip/palate-ectodermal dysplasia syndrome	225060	AR	3
600644	11q23.3	Orofacial cleft 7	225060	AR	3
600649	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
600650	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
600650	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AD,AR	3
600652	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
600660	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
600662	5q14.3	Chromosome 5q14.3 deletion syndrome	613443	AD	4
600662	5q14.3	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	613443	AD	3
600664	10q24.31	Cocoon syndrome	613630	_	3
600666	11q12.3	Polycystic kidney disease 3	600666	AD	3
600667	17q21.31	Omodysplasia 2	164745	AD	3
600668	8q	Chondrocalcinosis with early-onset osteoarthritis	600668	AD	2
600669	8q24	{Epilepsy, idiopathic generalized, susceptibility to, 1}	600669	AD	2
600673	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
600675	14q32.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600675	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
600678	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
600678	2p16.3	Mismatch repair cancer syndrome	276300	AR	3
600678	2p16.3	{Endometrial cancer, familial}	608089	_	3
600681	17q24.3	Andersen syndrome	170390	AD	3
600681	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
600681	17q24.3	Short QT syndrome 3	609622	_	3
600682	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
600682	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
600682	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AD,AR	3
600692	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
600698	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
600700	3q27-q28	Leukemia, acute myeloid	601626	AD,SMu	3
600700	3q27-q28	Lipoma	_	_	3
600701	6p21.31	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
600702	12q13.13	?Myoclonus, familial, 2	618364	AD	3
600702	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
600702	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
600702	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
600709	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
600712	9q21.32	Au-Kline syndrome	616580	AD	3
600713	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
600716	1p13.2	{Diabetes, type 1, susceptibility to}	222100	AR	3
600716	1p13.2	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600716	1p13.2	{Systemic lupus erythematosus susceptibility to}	152700	AD	3
600721	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
600722	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
600724	16q21	Retinitis pigmentosa 45	613767	AR	3
600725	7q36.3	Holoprosencephaly 3	142945	AD	3
600725	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
600725	7q36.3	Schizencephaly	269160	_	3
600725	7q36.3	Single median maxillary central incisor	147250	AD	3
600726	2q35	Acrocapitofemoral dysplasia	607778	AR	3
600726	2q35	Brachydactyly, type A1	112500	AD	3
600727	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
600728	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
600733	13q12.2	MODY, type IV	606392	_	3
600733	13q12.2	Pancreatic agenesis 1	260370	AR	3
600733	13q12.2	{Diabetes mellitus, type II, susceptibility to}	125853	AD	3
600734	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
600734	11q24.3	Long QT syndrome 13	613485	AD	3
600740	19q13.32	Hypocalciuric hypercalcemia, type III	600740	AD	3
600747	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
600749	14q11.2	Specific granule deficiency	245480	AR	3
600754	14q11.2	?Winchester syndrome	277950	_	3
600755	3p25.2	{Schizophrenia, susceptibility to}	181500	AD	3
600757	19q13	Orofacial cleft 3	600757	?AD	2
600759	1q42.13	Alzheimer disease-4	606889	AD	3
600759	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
600760	16p12.2	Bronchiectasis with or without elevated sweat chloride 1	211400	AD	3
600760	16p12.2	Liddle syndrome 1	177200	AD	3
600760	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600761	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
600761	16p12.2	Liddle syndrome 2	618114	AD	3
600761	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600770	11p15.5	{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	AD	3
600774	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
600775	19q13.2	Craniosynostosis 4	600775	AD	3
600778	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
600783	5q31.3	?Perrault syndrome 2	614926	AR	3
600790	6q14-q16.2	Chorioretinal atrophy, progressive bifocal	600790	AD	2
600792	14q12	Deafness, autosomal recessive 5	600792	AR	2
600795	3p11.2	Dementia, familial, nonspecific	600795	AD	3
600797	13q34	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, familial primary, 1, with or without HHT	178600	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	AD	3
600799	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
600802	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600803	7q21.12	Gallbladder disease 1	600803	AD,AR	3
600804	11q14.3	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600805	18q11.2	Epidermolysis bullosa, generalized atrophic benign	226650	AR	3
600805	18q11.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
600805	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
600808	12q13-q21	Enuresis, nocturnal, 2	600808	AD	2
600810	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AD,AR	3
600811	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
600814	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
600820	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
600824	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
600824	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
600825	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
600827	10q23.33	Cone dystrophy 4	613093	AR	3
600829	11q13.4	Opsismodysplasia	258480	AR	3
600835	10q11.21	{AIDS, resistance to}	609423	_	3
600836	2q35	?Cataract 42	115900	AD	3
600837	5p13.2	Central hypoventilation syndrome	209880	AD	3
600837	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
600837	5p13.2	{Pheochromocytoma, modifier of}	171300	AD	3
600838	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
600839	15q21.1	Bartter syndrome, type 1	601678	AR	3
600842	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
600844	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
600850	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
600852	17q23.1	Retinitis pigmentosa 17	600852	AD	3
600853	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
600855	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
600856	11p15.4	Beckwith-Wiedemann syndrome	130650	AD	3
600856	11p15.4	IMAGE syndrome	614732	AD	3
600857	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
600857	5p15.33	Leigh syndrome	256000	Mi,AR	3
600857	5p15.33	Mitochondrial respiratory chain complex II deficiency	252011	AR	3
600857	5p15.33	Paragangliomas 5	614165	AD	3
600858	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
600859	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
600864	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
600871	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
600871	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
600877	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
600881	17q11.2	Cataract 10, multiple types	600881	AD	3
600882	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
600883	6q25-q27	{Diabetes mellitus, insulin-dependent, 8}	600883	_	2
600884	9q13	Cardiomyopathy, dilated 1B	600884	AD	2
600886	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
600887	5q14.1	Endometrial carcinoma, somatic	608089	_	3
600887	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
600890	2p23.3	Fatty liver, acute, of pregnancy	609016	AR	3
600890	2p23.3	HELLP syndrome, maternal, of pregnancy	609016	AR	3
600890	2p23.3	LCHAD deficiency	609016	AR	3
600890	2p23.3	Trifunctional protein deficiency	609015	AR	3
600897	1q21.2	Cataract 1, multiple types	116200	AD	3
600898	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
600899	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
600900	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
600901	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
600909	21q22.3	Cataract 44	616509	AR	3
600909	21q22.3	Hypotrichosis 14	618275	AR	3
600917	7q31.1	Insulin resistance, severe, digenic	125853	AD	3
600920	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
600921	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
600922	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
600923	1q23.3	Porphyria variegata	176200	AD	3
600924	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
600925	11p11.2	Colon cancer, somatic	114500	_	3
600928	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
600929	22q12.1	Cataract 17, multiple types	611544	AD,AR	3
600936	5q34	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600937	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
600937	11p15.1	Diabetes, permanent neonatal, with or without neurologic features	606176	AD,AR	3
600937	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
600937	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
600937	11p15.1	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600939	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
600943	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
600943	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
600944	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
600946	5p13-p12	Growth hormone insensitivity, partial	604271	AD	3
600946	5p13-p12	Increased responsiveness to growth hormone	604271	AD	3
600946	5p13-p12	Laron dwarfism	262500	AR	3
600946	5p13-p12	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
600955	5q15	Obesity with impaired prohormone processing	600955	AR	3
600956	12q13.13	Persistent Mullerian duct syndrome, type II	261550	AR	3
600957	19p13.3	Persistent Mullerian duct syndrome, type I	261550	AR	3
600958	11p11.2	Cardiomyopathy, dilated, 1MM	615396	AD	3
600958	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
600958	11p11.2	Left ventricular noncompaction 10	615396	AD	3
600960	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
600962	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
600963	19q13.32	Branchiootorenal syndrome 2	610896	_	3
600965	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
600968	16q13	Gitelman syndrome	263800	AR	3
600969	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
600970	6q14.1	Deafness, autosomal dominant 22	606346	AD	3
600970	6q14.1	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	AD	3
600970	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
600971	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
600972	5q32	Achondrogenesis Ib	600972	AR	3
600974	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
600975	1p36.2-p36.1	Glaucoma 3, primary infantile, B	600975	AR	2
600977	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
600980	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
600982	5q11.2	46XY sex reversal 6	613762	AD	3
600983	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
600983	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
600985	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
600985	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
600987	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
600993	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
600993	18q21.2	Myhre syndrome	139210	AD	3
600993	18q21.2	Pancreatic cancer, somatic	260350	_	3
600993	18q21.2	Polyposis, juvenile intestinal	174900	AD	3
600994	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
600995	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
600996	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
600997	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
600997	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
600998	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
600998	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
601002	20q11.22	Glutathione synthetase deficiency	266130	AR	3
601002	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
601003	16p11.2	Brody myopathy	601003	AR	3
601005	12p13.33	Timothy syndrome	601005	AD	3
601007	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
601011	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
601011	19p13.13	Episodic ataxia, type 2	108500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1	141500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	AD	3
601011	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
601013	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
601015	14q24.3	Niemann-pick disease, type C2	607625	AR	3
601017	20q11.21	Long QT syndrome 12	612955	AD	3
601019	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
601022	6p21.33	{Rheumatoid arthritis, susceptibility to}	180300	_	3
601023	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
601023	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
601023	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
601040	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
601042	1p34.2	Dystonia 9	601042	AD	3
601045	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
601047	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
601047	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
601047	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
601065	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
601065	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
601068	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
601072	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
601088	16q23.2	Ayme-Gripp syndrome	601088	AD	3
601089	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
601090	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601090	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
601093	5q35.1	Enlarged vestibular aqueduct	600791	AR	3
601094	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
601094	1p33	Cataract 34, multiple types	612968	_	3
601094	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
601097	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
601097	17p12	Dejerine-Sottas disease	145900	AD,AR	3
601097	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
601097	17p12	Roussy-Levy syndrome	180800	AD	3
601098	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
601101	5q31.3-q32	Telangiectasia, hereditary hemorrhagic, type 3	601101	_	2
601103	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
601104	17q21.31	Supranuclear palsy, progressive	601104	AD	3
601105	1q21.3	Pycnodysostosis	265800	AR	3
601107	10q24.2	Dubin-Johnson syndrome	237500	AR	3
601110	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
601119	19p13.3	Perrault syndrome 3	614129	AR	3
601129	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
601130	10q23.33	Tolbutamide poor metabolizer	_	_	3
601130	10q23.33	Warfarin sensitivity	122700	AD	3
601134	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
601143	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
601143	2p13.1	Perry syndrome	168605	AD	3
601143	2p13.1	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
601144	3p22.2	Brugada syndrome 1	601144	AD	3
601145	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
601146	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
601146	20q11.22	Brachydactyly, type A1, C	615072	AD,AR	3
601146	20q11.22	Brachydactyly, type A2	112600	AD	3
601146	20q11.22	Brachydactyly, type C	113100	AD	3
601146	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
601146	20q11.22	Du Pan syndrome	228900	AR	3
601146	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
601146	20q11.22	Symphalangism, proximal, 1B	615298	_	3
601146	20q11.22	{Osteoarthritis-5}	612400	_	3
601147	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
601147	8q22.1	Leber congenital amaurosis 17	615360	AR	3
601147	8q22.1	Microphthalmia with coloboma 6, digenic	613703	AD	3
601147	8q22.1	Microphthalmia, isolated 4	613094	_	3
601147	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
601150	12p11.21	Warsaw breakage syndrome	613398	AR	3
601152	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
601154	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
601156	17q12	{Asthma, susceptibility to}	600807	AD	3
601156	17q12	{HIV1, resistance to}	609423	_	3
601162	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
601176	1p22.1	{Myocardial infarction, susceptibility to}	608446	_	3
601181	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
601184	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
601188	10pter-q11	Prostate adenocarcinoma	601188	_	2
601190	12p12.3	Achromatopsia 6	610024	AD,AR	3
601190	12p12.3	Retinal cone dystrophy 3	610024	AD,AR	3
601192	1p36.13	[Fleck retina, familial benign]	228980	AR	3
601194	4p14	{Leprosy, protection against}	613223	_	3
601194	4p14	{Leprosy, susceptibility to, 5}	613223	_	3
601197	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
601199	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant	601198	AD	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	AD	3
601199	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
601199	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
601200	14q32.13	Pleuropulmonary blastoma	601200	AD	3
601202	17p13	Cataract 24, anterior polar	601202	AD	2
601205	14q23.1	Branchiootic syndrome 3	608389	AD	3
601205	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
601208	14q24.3-q31	{Diabetes mellitus, insulin-dependent, 11}	601208	_	2
601214	17q21.2	Naxos disease	601214	AR	3
601215	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
601215	3q23	Seckel syndrome 1	210600	AR	3
601216	11q13.1	Dental anomalies and short stature	601216	AR	3
601224	11p11.2	Potocki-Shaffer syndrome	601224	_	4
601228	15q15.3-q22.1	Polyposis syndrome, mixed hereditary 1	601228	AD	4
601228	15q15.3-q22.1	{Colorectal cancer, susceptibility to, 4}	601228	AD	4
601231	1p36.22	Focal cortical dysplasia, type II, somatic	607341	_	3
601231	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
601238	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
601239	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
601240	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
601243	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
601243	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
601247	14q21.3	Noonan syndrome 9	616559	AD	3
601248	2q14.3	Centronuclear myopathy 2	255200	AR	3
601253	3p25.3	Cardiomyopathy, familial hypertrophic	192600	AD	3
601253	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
601253	3p25.3	Long QT syndrome 9	611818	AD	3
601253	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
601253	3p25.3	Rippling muscle disease 2	606072	AD	3
601255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
601255	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
601255	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
601259	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
601263	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
601265	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
601267	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601269	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
601277	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
601280	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
601282	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
601282	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
601282	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
601283	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
601284	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
601287	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601288	8q22.3	Popov-Chang syndrome	618428	AD	3
601295	13q33.1	Bile acid malabsorption, primary	613291	AR	3
601296	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
601296	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
601299	10q23.2	Juvenile polyposis syndrome, infantile form	174900	AD	3
601299	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
601299	10q23.2	Polyposis, juvenile intestinal	174900	AD	3
601300	12q13.13	Pancreatic cancer, somatic	_	_	3
601309	9q22.32	Basal cell carcinoma, somatic	605462	_	3
601309	9q22.32	Basal cell nevus syndrome	109400	AD	3
601309	9q22.32	Holoprosencephaly 7	610828	AD	3
601313	16p13.3	Polycystic kidney disease 1	173900	AD	3
601314	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
601316	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
601317	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
601318	2q34	{Diabetes mellitus, insulin-dependent, 13}	601318	_	2
601321	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
601327	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
601330	12p12.3	Diarrhea 6	614616	AD	3
601330	12p12.3	Meconium ileus	614665	AR	3
601331	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
601336	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
601338	19q13.2	CAPOS syndrome	601338	AD	3
601349	6q21	Microphthalmia, syndromic 8	601349	?AD	2
601358	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
601362	10p14-p13	DiGeorge syndrome/velocardiofacial syndrome complex-2	601362	_	2
601363	17q12-q21	Wilms tumor, type 4	601363	AD	2
601365	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
601368	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
601369	14q12	Deafness, autosomal dominant 9	601369	AD	3
601373	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
601373	3p21.31	{Hepatitis C virus, resistance to}	609532	_	3
601373	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601373	3p21.31	{West nile virus, susceptibility to}	610379	_	3
601382	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
601385	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
601388	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
601390	11p15.4	Van Maldergem syndrome 1	601390	AR	3
601395	17q11.2	{HIV/AIDS, susceptibility to}	609423	_	3
601397	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
601397	6q27	{Neural tube defects, susceptibility to}	182940	AD	3
601399	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
601402	3q25.32	Leukemia, acute myeloid	601626	AD,SMu	1
601404	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
601405	1p36.21	{Pancreatitis, chronic, susceptibility to}	167800	AD	3
601406	12q24.31	B-cell non-Hodgkin lymphoma, high-grade	_	_	3
601407	12q24.2	Diabetes mellitus, noninsulin-dependent, 2	601407	_	2
601408	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
601410	6q24	{Diabetes mellitus, transient neonatal, 1}	601410	AD	4
601411	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
601411	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601412	1q21-q23	Deafness, autosomal dominant 7	601412	AD	2
601414	1q21.2	Retinitis pigmentosa 18	601414	AD	3
601419	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
601421	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
601421	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
601424	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
601428	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
601428	2q14.2	Roifman syndrome	616651	AR	3
601439	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
601439	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
601439	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
601440	17q22	Nephrotic syndrome, type 7	615008	AR	3
601440	17q22	{Hemolytic uremic syndrome, atypical, susceptibility to, 7}	615008	AR	3
601443	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
601445	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
601454	4q	{Psoriasis susceptibility 3}	601454	_	2
601455	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
601458	12p13.2-q24.1	{Inflammatory bowel disease 2}	601458	_	2
601460	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
601462	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
601465	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
601465	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
601465	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
601470	3p22.2	{Coronary artery disease, resistance to}	607339	_	3
601470	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
601470	3p22.2	{Rapid progression to AIDS from HIV1 infection}	609423	_	3
601471	3q21-q22	Facial paresis, hereditary congenital, 1	601471	AD	2
601472	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
601479	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
601485	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
601486	3p24.3	{Spermatogenic failure, susceptibility to}	_	_	3
601487	3p25.2	Carotid intimal medial thickness 1	609338	_	3
601487	3p25.2	Insulin resistance, severe, digenic	604367	AD	3
601487	3p25.2	Lipodystrophy, familial partial, type 3	604367	AD	3
601487	3p25.2	Obesity, severe	601665	AD,AR,Mu	3
601487	3p25.2	[Obesity, resistance to]	_	_	3
601487	3p25.2	{Diabetes, type 2}	125853	AD	3
601488	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
601489	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
601492	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
601495	14q32.33	Agammaglobulinemia 1	601495	AR	3
601498	6p21.1	Heimler syndrome 2	616617	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4B	614863	AD,AR	3
601499	13q14	Rieger syndrome, type 2	601499	AD	2
601500	7q32.1	Basal cell carcinoma, somatic	605462	_	3
601500	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601501	16q11.2	{Parkinson disease 17}	614203	AD	3
601513	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
601515	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
601517	12q24.12	Spinocerebellar ataxia 2	183090	AD	3
601517	12q24.12	{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	AD	3
601517	12q24.12	{Parkinson disease, late-onset, susceptibility to}	168600	AD,Mu	3
601518	1q25.3	Prostate cancer 1	601518	AD	3
601525	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
601525	1q32.1	{Schizophrenia, susceptibility to}	181500	AD	3
601527	12q21.31	?Frontonasal dysplasia 3	613456	_	3
601528	4q34.3	Lymphatic malformation 4	615907	AD	3
601530	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
601530	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
601530	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
601530	5q35.3	Paget disease of bone 3	167250	AD	3
601538	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
601539	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
601542	4q25	Anterior segment dysgenesis 4	137600	AD	3
601542	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
601542	4q25	Ring dermoid of cornea	180550	AD	3
601543	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
601544	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
601545	17p13.3	Lissencephaly 1	607432	AD	3
601545	17p13.3	Subcortical laminar heterotopia	607432	AD	3
601547	22q11.23	Cataract 3, multiple types	601547	AD	3
601548	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
601550	17q21.31	[Blood group, Swann]	601550	_	3
601551	17q21.31	[Blood group, Froese]	601551	_	3
601552	8q12.3	Traboulsi syndrome	601552	AR	3
601553	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
601556	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
601559	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
601564	7q34	{Pancreatitis, chronic, protection against}	167800	AD	3
601565	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
601565	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
601566	13q34	Squamous cell carcinoma, head and neck, somatic	275355	_	3
601567	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
601568	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
601570	3p25.1	Fuhrmann syndrome	228930	AR	3
601570	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
601573	7q36.1	Weaver syndrome	277590	AD	3
601574	17q12	Chondrosarcoma, extraskeletal myxoid	612237	_	1
601583	7p14.1	{Wilms tumor susceptibility-5}	601583	AD,SMu	3
601592	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
601592	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
601593	2q35	{Breast cancer, susceptibility to}	114480	AD,SMu	3
601596	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
601601	6p12.3	Char syndrome	169100	AD	3
601601	6p12.3	Patent ductus arteriosus 2	617035	AD	3
601604	19p13.11	Immunodeficiency 30	614891	AR	3
601606	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
601607	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
601607	22q11.23	Rhabdoid tumors, somatic	609322	_	3
601607	22q11.23	{Rhabdoid tumor predisposition syndrome 1}	609322	AD	3
601607	22q11.23	{Schwannomatosis-1, susceptibility to}	162091	AD	3
601609	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
601609	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
601614	17p13.1	Mirror movements 4	618264	AD	3
601615	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
601617	12q13.2	Fundus albipunctatus	136880	AD,AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
601620	12q24.21	Holt-Oram syndrome	142900	AD	3
601621	12q24.21	Ulnar-mammary syndrome	181450	AD	3
601622	7p21.1	Craniosynostosis 1	123100	AD	3
601622	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
601622	7p21.1	Saethre-Chotzen syndrome with or without eyelid anomalies	101400	AD	3
601622	7p21.1	Sweeney-Cox syndrome	617746	AD	3
601623	15q11.2	Angelman syndrome	105830	AD	3
601627	5q13.2	{Spinal muscular atrophy, type III, modifier of}	253400	AR	3
601631	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601639	19p13.12	Cushing syndrome, ACTH-independent adrenal, somatic	615830	_	3
601641	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
601646	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
601650	11q12.2	Paragangliomas 2	601650	AD	3
601652	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
601653	8q13.3	?Otofaciocervical syndrome	166780	AD	3
601653	8q13.3	Anterior segment anomalies with or without cataract	602588	AD	3
601653	8q13.3	Branchiootic syndrome 1	602588	AD	3
601653	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
601656	18q11.2	Atrial septal defect 9	614475	AD	3
601656	18q11.2	Atrioventricular septal defect 5	614474	AD	3
601656	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
601656	18q11.2	Persistent truncus arteriosus	217095	_	3
601656	18q11.2	Tetralogy of Fallot	187500	AD	3
601663	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
601664	2q11.2	Retinitis pigmentosa 33	610359	AD	3
601666	6q21	{Diabetes mellitus, insulin-dependent, 15}	601666	_	2
601671	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
601675	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
601676	1p31	Acute insulin response	601676	_	2
601678	15q21.1	Bartter syndrome, type 1	601678	AR	3
601680	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
601682	3q21-q24	Glaucoma 1C, primary open angle	601682	AD	2
601683	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
601687	17q21.2	Meesmann corneal dystrophy	122100	AD	3
601688	4q34.1	Cranioosteoarthropathy	259100	AR	3
601688	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
601688	4q34.1	Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	AR	3
601689	18q11.2	?Spermatogenic failure 13	615841	AR	3
601690	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
601690	6p12.3	{Asthma, susceptibility to}	600807	AD	3
601690	6p12.3	{Atopy, susceptibility to}	147050	AD	3
601691	1p22.1	Cone-rod dystrophy 3	604116	_	3
601691	1p22.1	Fundus flavimaculatus	248200	AR	3
601691	1p22.1	Retinal dystrophy, early-onset severe	248200	AR	3
601691	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601691	1p22.1	Stargardt disease 1	248200	AR	3
601691	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
601692	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
601692	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
601692	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
601692	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
601692	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
601692	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
601692	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
601693	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
601694	2p21	[Leptin serum levels QTL1]	601694	_	2
601696	11p15.5	[Novelty seeking personality]	601696	?AD	1
601697	18q22.1	Peeling skin syndrome 5	617115	AR	3
601699	20q13.13	Hypertension, essential	145500	Mu	3
601705	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
601707	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601709	10q22.2	Quebec platelet disorder	601709	AD	3
601717	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
601718	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601719	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
601724	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
601724	2q31.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
601725	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
601728	10q23.31	Cowden syndrome 1	158350	AD	3
601728	10q23.31	Lhermitte-Duclos syndrome	158350	AD	3
601728	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
601728	10q23.31	Prostate cancer, somatic	176807	_	3
601728	10q23.31	{Glioma susceptibility 2}	613028	_	3
601728	10q23.31	{Meningioma}	607174	AD	3
601730	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
601731	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
601734	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
601736	17q23.3	Specific granule deficiency 2	617475	AR	3
601740	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
601743	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
601746	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
601749	1p22.1	Glomuvenous malformations	138000	AD	3
601752	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
601756	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
601757	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
601757	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
601758	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
601758	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
601762	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
601762	2q33.1	Gastric cancer, somatic	613659	_	3
601762	2q33.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
601763	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
601763	2q33.1	Hepatocellular carcinoma, somatic	114550	_	3
601763	2q33.1	{Breast cancer, protection against}	114480	AD,SMu	3
601763	2q33.1	{Lung cancer, protection against}	211980	AD,SMu	3
601764	19q	Seizures, benign familial infantile, 1	601764	AD	2
601768	19p13.3	Leukemia, acute myeloid	601626	AD,SMu	1
601769	12q13.11	?Osteoporosis, involutional	166710	AD	1
601769	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
601771	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
601771	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
601776	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
601777	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
601780	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
601785	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
601788	2q32.2	Muscle hypertrophy	614160	_	3
601789	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
601789	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
601791	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
601802	3p14.3	Growth hormone deficiency with pituitary anomalies	182230	AD,AR	3
601802	3p14.3	Pituitary hormone deficiency, combined, 5	182230	AD,AR	3
601802	3p14.3	Septooptic dysplasia	182230	AD,AR	3
601803	12p	Pallister-Killian syndrome	601803	SMo	4
601806	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
601807	12q13.2	Cavitary optic disc anomalies	611543	AD	3
601808	18q	Chromosome 18q deletion syndrome	601808	AD	4
601810	10q21.3	?Seckel syndrome 8	615807	AR	3
601810	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
601812	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
601813	11q13.2	Exudative vitreoretinopathy 4	601813	AD,AR	3
601814	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
601815	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
601816	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
601819	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
601820	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
601825	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
601837	13q33.3	LIG4 syndrome	606593	AR	3
601837	13q33.3	{Multiple myeloma, resistance to}	254500	SMu	3
601843	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
601844	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
601846	19p13.3	Muscular dystrophy with rimmed vacuoles	601846	AD	2
601847	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
601855	19q13.2	?Immunodeficiency 62	618459	AR	3
601860	5q23.1	D-bifunctional protein deficiency	261515	AR	3
601860	5q23.1	Perrault syndrome 1	233400	AR	3
601861	13q13.3	Bare lymphocyte syndrome, type II, complementation group D	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group C	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group E	209920	AR	3
601865	3q24	Bruck syndrome 2	609220	AR	3
601868	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
601869	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
601873	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
601881	18q21.32	Microphthalmia, isolated 3	611038	AR	3
601884	11q13.2	[Bone mineral density variability 1]	601884	AD	3
601885	13q12.11	Cataract 14, multiple types	601885	AD	3
601887	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
601888	5p	{Malignant hyperthermia susceptibility 6}	601888	_	2
601893	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
601894	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
601896	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
601897	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
601898	3q26.31	Growth hormone deficiency, isolated partial	615925	AD,AR	3
601900	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
601902	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
601903	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
601906	12q13.12	Split-hand/foot malformation 6	225300	AR	3
601906	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
601911	17q21.33	?Orofacial cleft 15	616788	AD	3
601912	2q33.1	?Orofacial cleft 10	613705	IC	3
601918	5q31.1	?Premature ovarian failure 14	618014	AR	3
601920	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
601920	20p12.2	Alagille syndrome 1	118450	AD	3
601920	20p12.2	Tetralogy of Fallot	187500	AD	3
601924	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
601925	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
601928	12q13.13	Monilethrix	158000	AD	3
601933	12q23.3	{Delayed sleep phase disorder, susceptibility to}	614163	AD	3
601941	18q21	{Diabetes mellitus, insulin-dependent, 6}	601941	_	2
601942	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
601949	2q23.3	Episodic ataxia, type 5	613855	AD	3
601949	2q23.3	{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	AD	3
601949	2q23.3	{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	AD	3
601952	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
601954	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
601962	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
601968	1p13.2	Diarrhea 9	618168	AR	3
601972	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
601975	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
601977	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
601978	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
601978	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
601982	3p25.3	Renal cell carcinoma, clear cell, somatic	144700	_	3
601992	9p23-p11	Friedreich ataxia 2	601992	AR	2
602011	3p25	?Pancreatic endocrine tumors	_	_	1
602014	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
602023	1p36.13	Bartter syndrome, type 3	607364	AR	3
602023	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602024	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602025	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
602026	10p13	Refsum disease	266500	AR	3
602032	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602033	14q32.2	Band heterotopia	600348	AR	3
602037	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
602044	11q13.4	{Obesity, severe, and type II diabetes}	601665	AD,AR,Mu	3
602048	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
602049	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
602053	10p15.2	Gastric cancer, somatic	613659	_	3
602053	10p15.2	Prostate cancer, somatic	176807	_	3
602054	22q11.21	Conotruncal anomaly face syndrome	217095	_	3
602054	22q11.21	DiGeorge syndrome	188400	AD	3
602054	22q11.21	Tetralogy of Fallot	187500	AD	3
602054	22q11.21	Velocardiofacial syndrome	192430	AD	3
602063	11p15.5	Transaldolase deficiency	606003	AR	3
602064	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
602066	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
602072	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
602078	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602079	1q24.3	Trimethylaminuria	602079	AR	3
602080	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
602081	7q31.1	Speech-language disorder-1	602081	AD	3
602082	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
602083	10q21.1	Usher syndrome, type 1F	602083	AR	3
602085	13q21-q32	Postaxial polydactyly, type A2	602085	AD	2
602086	14q12-q22	Arrhythmogenic right ventricular dysplasia 3	602086	AD	2
602087	2q32.1-q32.3	Arrhythmogenic right ventricular dysplasia 4	602087	AD	2
602088	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
602090	11q13.1	Dental anomalies and short stature	601216	AR	3
602090	11q13.1	Geleophysic dysplasia 3	617809	AD	3
602091	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
602091	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
602091	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
602092	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
602096	12p11.23-q13.12	Alzheimer disease-5	602096	AD	2
602097	21q21	Usher syndrome, type 1E	602097	AR	2
602099	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
602104	4p16.3	Cherubism	118400	AD	3
602109	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
602109	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
602109	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
602134	2p25-p22	Essential tremor, hereditary, 2	602134	AD	2
602136	7q21.2	Heimler syndrome 1	234580	AR	3
602136	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
602136	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
602137	5q31.3	?Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3
602138	22q13.2	Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3
602140	10q24.31	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3
602141	11q13.2	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3
602142	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AR,AD	3
602144	1p22.1	?Spermatogenic failure 21	617644	AR	3
602146	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
602149	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
602149	5q31.1	Liebenberg syndrome	186550	AD	4
602150	8q11.21	Piebaldism	172800	AD	3
602150	8q11.21	Waardenburg syndrome, type 2D	608890	AR	3
602152	8q22.1	?RHYNS syndrome	602152	AR	3
602153	12q13.13	Monilethrix	158000	AD	3
602166	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
602167	14q24.3	Deafness, autosomal recessive 35	608565	AR	3
602168	14q32.2	Pontocerebellar hypoplasia type 1A	607596	AR	3
602170	3p22.2	Macroglobulinemia, Waldenstrom, somatic	153600	_	3
602170	3p22.2	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	_	3
602177	1q21.3	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms	617591	AR	3
602183	4p15.33	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3
602286	11q23.3-q24.1	Lathosterolosis	607330	AR	3
602290	9q33.1	?Bardet-Biedl syndrome 11	615988	AR	3
602290	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
602292	10q26.3	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3
602293	15q26.1	Epidermodysplasia verruciformis 3	618267	AR	3
602296	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
602298	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
602302	8p21.3	Alopecia universalis	203655	AR	3
602302	8p21.3	Atrichia with papular lesions	209500	AR	3
602302	8p21.3	Hypotrichosis 4	146550	AD	3
602311	16q22.1	{Leanness, inherited}	_	_	3
602311	16q22.1	{Obesity, late-onset}	601665	AR,Mu,AD	3
602322	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
602322	3q26.2	{Aplastic anemia}	614743	AD	3
602322	3q26.2	{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	AD	3
602332	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
602334	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
602336	1p31.3	?Deafness, autosomal recessive 108	617654	AR	3
602337	9q22.31	Brachydactyly, type B1	113000	AD	3
602337	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
602342	3q26.32	Pierpont syndrome	602342	AD	3
602345	4q27	?Spinocerebellar ataxia 41	616410	AD	3
602346	17q21.2	Hypomyelinating neuropathy, congenital, 3	618186	AR	3
602346	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
602347	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
602354	16p11.2	Immunodeficiency 52	617514	AR	3
602357	2q31.1	?Wiskott-Aldrich syndrome 2	614493	_	3
602358	17q21.2	?Narcolepsy 1	161400	AD	3
602360	15q21.1	Cerebral creatine deficiency syndrome 3	612718	AR	3
602361	11q12.1	Gracile bone dysplasia	602361	AD	3
602365	11q14.2	Haim-Munk syndrome	245010	AR	3
602365	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
602365	11q14.2	Periodontitis 1, juvenile	170650	AR	3
602368	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
602376	21q22.11	?Immunodeficiency 45	616669	AR	3
602376	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
602377	9q34.11	Epileptic encephalopathy, early infantile, 31	616346	AD	3
602378	19p13.2	Centronuclear myopathy 1	160150	AD	3
602378	19p13.2	Charcot-Marie-Tooth disease, axonal type 2M	606482	AD	3
602378	19p13.2	Charcot-Marie-Tooth disease, dominant intermediate B	606482	AD	3
602378	19p13.2	Lethal congenital contracture syndrome 5	615368	AR	3
602382	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
602389	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
602390	1q21.1	Hemochromatosis, type 2A	602390	AR	3
602397	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
602397	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
602397	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
602398	1p32.3	Desmosterolosis	602398	AR	3
602400	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
602401	18q22.1-q22.3	Ectodermal dysplasia 8, hair/tooth/nail type	602401	AR	2
602402	16q24.1	Lymphedema-distichiasis syndrome	153400	AD	3
602402	16q24.1	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400	AD	3
602404	2p13	{Parkinson disease 3}	602404	_	2
602409	10p12.31	Leukemia, acute myeloid	601626	SMu,AD	3
602410	3p25.3	Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3
602412	10q22.3	Diamond-blackfan anemia 3	610629	AD	3
602413	1q23.3	Gastrointestinal stromal tumor	606764	IC,AD	3
602413	1q23.3	Paraganglioma and gastric stromal sarcoma	606864	_	3
602413	1q23.3	Paragangliomas 3	605373	AD	3
602421	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
602421	7q31.2	Cystic fibrosis	219700	AR	3
602421	7q31.2	Sweat chloride elevation without CF	_	_	3
602421	7q31.2	{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	AD	3
602421	7q31.2	{Hypertrypsinemia, neonatal}	_	_	3
602421	7q31.2	{Pancreatitis, hereditary}	167800	AD	3
602427	16p11.2	Spondylocostal dysostosis 5	122600	AR,AD	3
602429	8q23	Glaucoma 1D, primary open angle	602429	_	2
602431	3p12.3	Vesicoureteral reflux 2	610878	_	3
602432	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
602432	10p13	Glaucoma 1, open angle, E	137760	AD	3
602432	10p13	{Glaucoma, normal tension, susceptibility to}	606657	_	3
602433	9q34.13	Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3
602438	16q22.1	Cataract 5, multiple types	116800	AD	3
602441	3p21.2	{Bacteremia, susceptibility to}	614383	_	3
602441	3p21.2	{Malaria, susceptibility to}	611162	_	3
602441	3p21.2	{Tuberculosis, susceptibility to}	607948	_	3
602445	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
602447	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
602450	10p13	Severe combined immunodeficiency, Athabascan type	602450	AR	3
602452	2q13	Colorectal cancer with chromosomal instability, somatic	_	_	3
602457	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
602458	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
602459	5q32	Deafness, autosomal dominant 15	602459	AD	3
602460	5q32	Deafness, autosomal dominant 15	602459	AD	3
602466	13q31.1	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3
602471	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
602473	19q13.31	Ethylmalonic encephalopathy	602473	AR	3
602477	19p13.3	Febrile seizures, familial, 2	602477	AD	2
602482	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
602483	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
602485	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
602486	8q22.2	Anauxetic dysplasia 2	617396	AR	3
602490	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
602491	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
602498	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
602498	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
602499	2p22.2	Macrophthalmia, colobomatous, with microcornea	602499	AD	4
602501	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
602529	12q13.12	Lissencephaly 3	611603	AD	3
602531	1q22	Grange syndrome	602531	AR	3
602533	1p36.23	Parkinson disease 7, autosomal recessive early-onset	606324	AR	3
602535	19p13.13	Marshall-Smith syndrome	602535	AD	3
602536	2q21.3	Warburg micro syndrome 1	600118	AR	3
602537	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
602540	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
602541	22q13.33	Muscular dystrophy, congenital, megaconial type	602541	AR	3
602544	6q26	Adenocarcinoma of lung, somatic	211980	_	3
602544	6q26	Ovarian cancer, somatic	167000	_	3
602544	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
602552	17p13.2	Fetal akinesia deformation sequence 4	618393	AR	3
602557	20p13	Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3
602568	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
602568	5p15.31	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
602569	5q35.2	Dementia, Lewy body	127750	AD	3
602572	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
602574	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
602574	11q23.3	Deafness, autosomal recessive 21	603629	AR	3
602575	9q33.3	Nail-patella syndrome	161200	AD	3
602576	7p22.3	Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3
602579	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
602589	14q23.3	Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3
602590	11q13.5-q14.1	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3
602591	5q12.1	Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3
602593	6p21.33	Hypotrichosis 2	146520	AD	3
602593	6p21.33	Peeling skin syndrome 1	270300	AR	3
602594	16p12.3-p12.1	Retinitis pigmentosa 22	602594	_	2
602600	1p32.3	{Myocardial infarction, susceptibility to}	608446	_	3
602601	12p13.2	{Myocardial infarction, susceptibility to}	608446	_	3
602606	5q13.2	{?Obesity, susceptibility to}	601665	AR,Mu,AD	3
602614	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
602614	6q15	Frontometaphyseal dysplasia 2	617137	AD	3
602616	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
602617	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
602617	9q22.33	{Thyroid cancer, nonmedullary, 4}	616534	AD	3
602618	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
602623	6p21.31	{Major depressive disorder and accelerated response to antidepressant drug treatment}	608516	_	3
602627	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
602629	8p11.21	Dystonia 6, torsion	602629	AD	3
602630	18p11.31	Holoprosencephaly 4	142946	AD	3
602631	11p15.4	Breast cancer, somatic	114480	_	3
602631	11p15.4	Lung cancer, somatic	211980	_	3
602631	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
602635	11p15.5	?Dyskinesia, seizures, and intellectual developmental disorder	617171	AR	3
602635	11p15.5	Mental retardation, autosomal dominant 24	615828	AD	3
602638	8q11.21	Immunodeficiency 54	609981	AR	3
602639	16q12.1	Tooth agenesis, selective, 2	602639	_	2
602642	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
602643	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
602656	16p13.3	Familial adenomatous polyposis 3	616415	AR	3
602660	9q34.3	Leber congenital amaurosis with early-onset deafness	617879	AD	3
602661	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
602661	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
602662	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
602662	19p13.3	Leukodystrophy, hypomyelinating, 6	612438	AD	3
602666	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
602667	8q21.3	Aplastic anemia	609135	_	3
602667	8q21.3	Leukemia, acute lymphoblastic	613065	_	3
602667	8q21.3	Nijmegen breakage syndrome	251260	AR	3
602668	3q21.3	Myotonic dystrophy 2	602668	AD	3
602669	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
602669	10q24.32	Cataract 11, multiple types	610623	AR,AD	3
602669	10q24.32	Cataract 11, syndromic, autosomal recessive	610623	AR,AD	3
602671	11q23.3	Glycogen storage disease Ib	232220	AR	3
602671	11q23.3	Glycogen storage disease Ic	232240	AR	3
602676	2q37.1	?Joubert syndrome 22	615665	AR	3
602678	14q32.32-q32.33	?Visual impairment and progressive phthisis bulbi	618283	AR	3
602685	15q24	Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685	_	2
602686	7p22.3	Lymphoma, somatic	_	_	3
602686	7p22.3	Prostate cancer, somatic	176807	_	3
602690	11q23.1	Mitochondrial complex II deficiency	252011	AR	3
602690	11q23.1	Paraganglioma and gastric stromal sarcoma	606864	_	3
602690	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
602690	11q23.1	Pheochromocytoma	171300	AD	3
602694	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
602696	22q12.3	?Meier-Gorlin syndrome 8	617564	AR	3
602700	22q13.2	Colorectal cancer, somatic	114500	_	3
602700	22q13.2	Menke-Hennekam syndrome 2	618333	_	3
602700	22q13.2	Rubinstein-Taybi syndrome 2	613684	AD	3
602703	16q21	Lissencephaly 6, with microcephaly	616212	AR	3
602713	8p11.22	Cone-rod dystrophy 9	612775	_	3
602716	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
602717	19q13.33	Epileptic encephalopathy, early infantile, 46	617162	AD	3
602722	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
602723	17q25.3	Psoriasis 2	602723	AD	3
602727	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
602727	16p13.3	Osteopetrosis, autosomal recessive 4	611490	AR	3
602730	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
602731	5p13.1	Thrombocytopenia 3	273900	AR	3
602743	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
602743	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
602743	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
602744	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
602748	12q21.33	Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3
602753	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602754	19q13.31	Dehydrated hereditary stomatocytosis 2	616689	AD	3
602759	1q42.2-q43	{Prostate cancer, susceptibility to}	602759	_	2
602765	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
602765	12q13.13	Monilethrix	158000	AD	3
602767	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602768	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
602769	2p23.3	Acute myeloid leukemia, somatic	601626	_	3
602769	2p23.3	Tatton-Brown-Rahman syndrome	615879	AD	3
602770	17q25.3	?46XY sex reversal 5	613080	AR	3
602771	1p36.11	Muscular dystrophy, rigid spine, 1	602771	AR	3
602772	6q12	Retinitis pigmentosa 25	602772	AR	3
602773	3q21.1	Renal cell carcinoma	144700	_	1
602774	17q22	Fanconi anemia, complementation group O	613390	AR	3
602774	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
602775	10q25.2	Noonan-like syndrome with loose anagen hair	607721	AD	3
602780	5p12	Epileptic encephalopathy, early infantile, 24	615871	AD	3
602780	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
602782	10q22.1	Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3
602783	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
602821	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
602821	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
602821	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
602839	1p36.22	Immunodeficiency 14	615513	AD	3
602840	19p13.3	Lymphoproliferative syndrome 3	618261	AR	3
602842	6p22.3	Meier-Gorlin syndrome 6	616835	AD	3
602849	4p16.3	Muenke syndrome	602849	AD	3
602851	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
602851	5q14.3	Usher syndrome, type 2C	605472	AR	3
602851	5q14.3	Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	AR	3
602855	14q13.2	{Myocardial infarction, susceptibility to}	608446	_	3
602858	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
602859	1p36.32	Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3
602859	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
602860	15q15.1	Colorectal cancer, somatic	114500	_	3
602860	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
602860	15q15.1	[Premature chromatid separation trait]	176430	AD	3
602861	12p11.21	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3
602867	4q12	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3
602869	1q44	Epileptic encephalopathy, early infantile, 54	617391	AD	3
602870	6q14.1	Macular dystrophy, vitelliform, 4	616151	AD	3
602875	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
602876	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
602879	20q11.23	?Mental retardation, autosomal dominant 11	614257	AD	3
602880	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
602880	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
602900	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
606025	3q13.31	Primrose syndrome	259050	AD	3
606220	13q22.3	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3
604270	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
604270	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
604270	11p11.2	Sclerosteosis 2	614305	AR,AD	3
603295	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
605635	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
606612	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	AR	3
603685	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
606613	9p	[High density lipoprotein cholesterol level QTL 1]	606613	_	2
606806	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
607001	9q34.3	Kleefstra syndrome 1	610253	AD	3
606807	3p14.3	Hypogonadotropic hypogonadism 18 with or without anosmia	615267	AR,AD	3
603297	11q22.3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR,DR	3
605637	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AR,AD	3
606808	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607002	3p13	Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3
604272	22q13.33	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	AR	3
604272	22q13.33	Myopia 6	608908	AD	3
605833	1q21-q23	[Bone mineral density QTL 2]	605833	_	2
607196	17q25.1	Microcephaly, Amish type	607196	AR	3
603490	1p36.12	?SERKAL syndrome	611812	AR	3
603490	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
606224	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
604273	17p11.2	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3
603491	1p13.1	?Lacrimal duct defect	149700	AR	3
603688	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
607198	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
607004	5p13.3-p13.2	Brachydactyly, type A1, B	607004	AD	2
603301	2p25.1	Maturity-onset diabetes of the young, type VII	610508	_	3
607199	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
607199	1q32.2	van der Woude syndrome	119300	AD	3
607199	1q32.2	{Orofacial cleft 6}	608864	AD	3
607976	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
608170	5q35.3	{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3
606810	22q11.21	Hyperprolinemia, type I	239500	AR	3
606810	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
603689	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
603690	3q25.31	Congenital cataracts, hearing loss, and neurodegeneration	614482	AR	3
603690	3q25.31	Spastic paraplegia 42, autosomal dominant	612539	AD	3
608171	12p13.33	Retinal cone dystrophy 4	610478	AR	3
608172	1p36.11	?Congenital disorder of glycosylation, type 1bb	613861	AR	3
608172	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
608172	1p36.11	Retinitis pigmentosa 59	613861	AR	3
607393	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
607393	1q31.2	Hyperparathyroidism-jaw tumor syndrome	145001	AD	3
607393	1q31.2	Parathyroid adenoma with cystic changes	145001	AD	3
607393	1q31.2	Parathyroid carcinoma	608266	_	3
603511	7q36.3	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3
602911	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
603467	11p14.3	Fanconi anemia, complementation group F	603467	_	3
604261	6q21	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3
605102	1p36.22	MASP2 deficiency	613791	AR	3
605376	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
606771	14p11.2-q13	{Adiponectin, serum level of, QTL3}	606771	_	2
604710	19q13.2	Cutis laxa, autosomal recessive, type IC	613177	AR	3
605572	17p12	Abdominal obesity-metabolic syndrome	605572	AD	2
604144	19q13.11	Cystinuria	220100	AR,AD	3
604507	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
606494	1p34.1	?Epileptic encephalopathy, early infantile, 15	615006	AR	3
606494	1p34.1	Mental retardation, autosomal recessive 12	611090	AR	3
606454	14q24.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606454	14q24.3	Ovarioleukodystrophy	603896	AR	3
603390	5q13.3	Pigmented nodular adrenocortical disease, primary, 3	614190	_	3
603390	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
603550	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
603550	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
604223	7q22.1	Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease	617718	AR	3
607017	6p24.1-p22.3	Deafness, autosomal dominant 21	607017	AD	2
606258	13q32-q33	{Stature QTL 4}	606258	_	2
607095	9p13.3	Anauxetic dysplasia 1	607095	AR	3
605377	19q13.32	Myotonic dystrophy 1	160900	AD	3
604145	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
606972	14q23	{Epilepsy, idiopathic generalized, susceptibility to, 2}	606972	_	2
603513	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
606933	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
606933	11q14.3	Albinism, oculocutaneous, type IB	606952	_	3
606933	11q14.3	Waardenburg syndrome/albinism, digenic	103470	AD	3
606933	11q14.3	[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	AD	3
606933	11q14.3	[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	AD	3
606933	11q14.3	{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	AD	3
605573	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
607096	11q13.1	Hypouricemia, renal	220150	AR	3
607134	13q21	Specific language impairment QTL, 3	607134	_	2
603028	4q31.3	{Colorectal cancer, susceptibility to}	114500	SMu,AD	3
603028	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
603028	4q31.3	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
604827	15q14	Epilepsy, juvenile myoclonic	604827	AR	2
604827	15q14	{Epilepsy, idiopathic generalized, susceptibility to, 7}	604827	AR	2
604624	5q11.2	?Neuronopathy, distal hereditary motor, type IIC	613376	AD	3
604712	8q22.3	Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	AR	3
604712	8q22.3	Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	AR	3
604712	8q22.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3
603830	3p22.2	Long QT syndrome-3	603830	AD	3
603147	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
607373	3q25-q27	{Autism susceptibility 8}	607373	IC,Mu	2
603714	2p21	Holoprosencephaly 2	157170	AD	3
603714	2p21	Schizencephaly	269160	_	3
606934	15q15.1	Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3
604985	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
604985	11q13.2	Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3
603552	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
605610	19q13.33	Ataxia-oculomotor apraxia 4	616267	AR	3
605610	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
605378	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
607295	22q12.1	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3
603629	11q23.3	Deafness, autosomal recessive 21	603629	AR	3
606973	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
607056	3q12.3	Macular dystrophy, vitelliform, 5	616152	AD	3
607056	3q12.3	Retinitis pigmentosa 56	613581	AR	3
606896	3p12-q13	{Dyslexia, susceptibility to, 5}	606896	_	2
605379	16q23.2	Giant axonal neuropathy-1	256850	AR	3
604625	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
605814	7q21.3	Citrullinemia, type II, neonatal-onset	605814	AR	3
606214	19q13.2	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3
604025	17q24.1	Colorectal cancer, somatic	114500	_	3
604025	17q24.1	Oligodontia-colorectal cancer syndrome	608615	AD	3
606496	6p12.2	?Candidiasis, familial, 6, autosomal dominant	613956	_	3
606856	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
607572	6q25	{Leprosy, susceptibility to, 2}	607572	_	2
606936	19q13.33	Progressive familial heart block, type IB	604559	AD	3
604346	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
607100	2q13	Joubert syndrome 4	609583	AR	3
607100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
607100	2q13	Senior-Loken syndrome-1	266900	AR	3
605815	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
604305	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
604305	6p21.32	{Creutzfeldt-Jakob disease, variant, resistance to}	123400	AD	3
604305	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
607728	15q25.1-q26.1	Porokeratosis 4, disseminated superficial actinic	607728	_	2
606215	1p31-p21	{Atrioventricular septal defect, susceptibility to, 1}	606215	_	2
603553	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
603667	2q31.1	Epileptic encephalopathy, early infantile, 39	612949	AR	3
604946	19q13.42	{AIDS, delayed/rapid progression to}	609423	_	3
603395	8q22.2	Ciliary dyskinesia, primary, 28	615505	AR	3
606574	5p13.2	Albinism, oculocutaneous, type IV	606574	_	3
603716	6p24.2	Hyperparathyroidism 4	617343	AD	3
603716	6p24.2	Hypoparathyroidism, familial isolated	146200	AR,AD	3
606857	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
606857	6p12.1	{Myocardial infarction, susceptibility to}	608446	_	3
605577	11q13.1	?Bleeding disorder, platelet-type, 18	615888	AR	3
607057	22q11.21	Pseudo-TORCH syndrome 2	617397	AR	3
606938	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
605537	1q23.3	Achromatopsia 7	616517	AR	3
604027	17q21.32	Epilepsy, progressive myoclonic 6	614018	AR	3
605495	12p12.2	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3
604065	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
604065	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
603263	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
603150	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
607457	9p13.3	[Blood group GIL]	607457	_	3
607731	8q13-q23	Charcot-Marie-Tooth disease, axonal, type 2H	607731	AR	2
606897	1q42.3	Chediak-Higashi syndrome	214500	AR	3
607536	19p13.11	Mucoepidermoid salivary gland carcinoma	_	_	3
605579	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
608160	17q24.3	Acampomelic campomelic dysplasia	114290	AD	3
608160	17q24.3	Campomelic dysplasia	114290	AD	3
608160	17q24.3	Campomelic dysplasia with autosomal sex reversal	114290	AD	3
606060	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
603188	10p	{Obesity, susceptibility to, BMIQ8}	603188	_	2
607613	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
607613	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
607458	7q22-q32	Spinocerebellar ataxia 18	607458	AD	2
603313	12q12	{Long QT syndrome, acquired, reduced susceptibility to}	613688	AD	3
606382	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
606012	3q22	Deafness, autosomal dominant 18	606012	AD	2
604185	10q21.3-q22.1	Facial paresis, hereditary congenital, 2	604185	AD	2
606939	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
606939	8p21.3	Zimmermann-Laband syndrome 2	616455	AD	3
607574	22q13.33	Metachromatic leukodystrophy	250100	AR	3
607614	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
604867	7q31.32	[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}	617956	_	3
608161	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
607459	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
604348	2q37.3	Advanced sleep phase syndrome, familial, 1	604348	AD	3
606821	7q22.3	Congenital disorder of glycosylation, type IIi	613612	_	3
604110	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
604110	16q21	Polymicrogyria, bilateral perisylvian	615752	_	3
604831	4p16.2	?Weyers acrofacial dysostosis	193530	AD	3
604831	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607965	10q22.3	{Systemic lupus erythematosus with nephritis, susceptibility to, 1}	607965	_	2
603632	6p21.31	Diamond-Blackfan anemia 9	613308	AD	3
608320	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
603590	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3
603590	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	AR	3
607537	11q21	Mucoepidermoid salivary gland carcinoma	_	_	3
607339	16pter-p13	{Coronary heart disease, susceptibility to}	607339	_	2
608904	17p11	{Attention deficit-hyperactivity disorder}	143465	AD	2
608787	3q22-q24	Otosclerosis 5	608787	_	2
603671	5q12.1	Acromelic frontonasal dysostosis	603671	AD	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3
606822	1p34.1	Retinitis pigmentosa 76	617123	AR	3
605582	6q12-q16	Cardiomyopathy, dilated, 1K	605582	_	2
605497	3p22.3	Osteogenesis imperfecta, type VII	610682	AR	3
603718	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
608905	6q12	{Attention deficit-hyperactivity disorder}	143465	AD	2
606061	7p14.2	Atrial septal defect 4	611363	_	3
604629	11q22.2	Amelogenesis imperfecta, type IIA2	612529	AR	3
604149	7q21.3	Dystonia-11, myoclonic	159900	AD	3
608358	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
605025	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
608124	16p12.3	Desbuquois dysplasia 2	615777	AR	3
608124	16p12.3	{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3
606179	16q22	Aneurysmal bone cysts	606179	_	2
608593	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
603673	1p34.1	Basal cell carcinoma, somatic	605462	_	3
603673	1p34.1	Basal cell nevus syndrome	109400	AD	3
603673	1p34.1	Medulloblastoma, somatic	155255	_	3
607461	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
607461	18q21.1	Smith-McCort dysplasia	607326	AR	3
606180	4q27	Pontocerebellar hypoplasia, type 1D	618065	AR	3
606384	18q21.31	Periventricular nodular heterotopia 7	617201	AD	3
604630	1p36.11	Obesity, mild, early-onset	601665	AR,Mu,AD	3
603557	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
608982	3p26	{Stature QTL 5}	608982	_	2
606824	22q12.3	Glucose/galactose malabsorption	606824	AR	3
608125	17q21.33	Spondyloocular syndrome	605822	AR	3
608125	17q21.33	{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3
603756	4q22.1	[Junior blood group system]	614490	_	3
603756	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
607462	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
608906	5p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
604067	17q24.1	Bradyopsia	608415	_	3
605818	2q23-q31	Deafness, autosomal recessive 27	605818	AR	2
608047	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
608515	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
606860	11q12.1	Angioedema, hereditary, types I and II	106100	AR,AD	3
606860	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
608709	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
605380	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
605380	12p13.32	Osteomalacia, tumor-induced	_	_	1
605380	12p13.32	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	_	3
603795	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
607258	4q33-qter	Hypercalciuria, absorptive	607258	_	2
608907	19p13.3	{Alzheimer disease 9, susceptibility to}	608907	AD	3
607966	2q34-q35	{Systemic lupus erythematosus with nephritis, susceptibility to, 2}	607966	_	2
608594	9q34.3	Lipodystrophy, congenital generalized, type 1	608594	AR	3
603796	21q22.11	Atrial fibrillation, familial, 4	611493	_	3
603796	21q22.11	Long QT syndrome 6	613693	AD	3
608710	6p21.3	Granulomatosis with polyangiitis	608710	_	2
604834	12q14.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3
604834	12q14.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3
607967	11p15.5	{Systemic lupus erythematosus with nephritis, susceptibility to, 3}	607967	_	2
603758	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
607059	8q24.3	Acrodermatitis enteropathica	201100	AR	3
603560	22q13.33	Charcot-Marie-Tooth disease, type 4B3	615284	AR	3
607027	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
607027	3q13.31	Epileptic encephalopathy, infantile or early childhood, 3	618012	AD	3
609060	3q25.32	Combined oxidative phosphorylation deficiency 1	609060	AR	3
608908	22q13.33	Myopia 6	608908	AD	3
607259	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
607417	3p26.2	Mental retardation, autosomal recessive 2	607417	AR	3
608323	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
607060	12q12	{Parkinson disease 8}	607060	AD	3
607968	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
607464	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
607616	11p15.4	Niemann-Pick disease, type B	607616	AR	3
609334	18q22	Chromosome 18 pericentric inversion	609334	_	4
604349	9q34.12	Cortical malformations, occipital	614115	AR	3
608049	13q14.2-q14.1	{Autism susceptibility 3}	608049	IC,Mu	2
608984	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
607465	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
607847	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
604114	15q15.1	Platelet PLC beta-2 deficiency	_	_	1
606693	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
608051	4p15.32	Macular dystrophy, retinal, 2	608051	AD	3
609023	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
609179	15q11.2-q12	{Migraine with aura, susceptibility to, 7}	609179	_	2
609607	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
607849	14q24.1	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3
609180	17p13.1	Congenital disorder of glycosylation, type If	609180	AR	3
604115	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
608713	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
606742	4q32.3	Atrial septal defect 6	613087	AD	3
609412	5q12.1	Cockayne syndrome, type A	216400	AR	3
609412	5q12.1	UV-sensitive syndrome 2	614621	AR	3
604427	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
607468	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
608869	1p13.2	Urofacial syndrome 2	615112	AR	3
609840	14q32.12	Amelogenesis imperfecta, type IIA5	615887	AR	3
609840	14q32.12	[Skin/hair/eye pigmentation 6, blond/brown hair]	210750	AR	3
609840	14q32.12	[Skin/hair/eye pigmentation 6, blue/green eyes]	210750	AR	3
609025	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
604116	1p22.1	Cone-rod dystrophy 3	604116	_	3
603799	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
609918	1p36.21	Gallbladder disease 2	609918	_	2
609452	10q23.2	Myopathy, myofibrillar, 4	609452	AD	3
607850	9q22.31	{Osteoarthritis susceptibility 3}	607850	AD	3
604473	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
604473	6q24.3	Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3
610113	1q21.2	Ectopia lentis et pupillae	225200	AR	3
610113	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
610192	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
607498	6p21.1-p12.2	{Migraine with or without aura, susceptibility to, 3}	607498	AD	2
604117	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
610193	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
606744	18q11.2	Seckel syndrome 2	606744	AR	3
609062	7p14.1	{Wilms tumor susceptibility-5}	601583	SMu,AD	3
610230	22q13.31	Liver failure, transient infantile	613070	AR	3
610230	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
607499	10p	{Bulimia nervosa, susceptibility to}	607499	Mu	2
603563	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
603355	16q23.3-q24.1	?Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3
610308	13q12.3	Peters-plus syndrome	261540	AR	3
610542	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
603356	6q21	?Deafness, autosomal dominant 66	616969	AD	3
609919	1p34.3	Gallbladder disease 3	609919	_	2
609026	6p12-q12	{Cataract 28, age-related cortical, susceptibility to}	609026	_	2
610114	9q22	{Stature QTL 8}	610114	_	2
610425	22q12.1	Cataract 23	610425	_	3
610543	16p13.3	Chromosome 16p13.3 deletion syndrome	610543	_	4
608053	15q24.2-q24.3	Glutaric acidemia IIA	231680	AR	3
608360	9q34.11	?Agammaglobulinemia 5	613506	AD	3
610504	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
610698	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
606694	5p13.2	?Atrial fibrillation 15	615770	AR	3
607853	9q31	Panic disorder 2	607853	_	2
603592	18q12.2	Xanthinuria, type II	603592	AR	3
604556	19q13.2	Abdominal obesity-metabolic syndrome 3	615812	AD	3
610194	1q42.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	AR	3
610738	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
609255	6q22-q24	Febrile seizures, familial, 5	609255	AD	2
610815	8q22.3	?Exercise intolerance, riboflavin-responsive	616839	AR	3
603593	14q11.2	Lysinuric protein intolerance	222700	AR	3
604557	16q12.1	Joubert syndrome 19	614844	AR,AD	3
604557	16q12.1	Nephronophthisis 14	614844	AR,AD	3
610505	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
609027	11p13	[Blood group, Indian system]	609027	_	3
610621	4q28.1	?Orofaciodigital syndrome XVII	617926	AR	3
610621	4q28.1	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3
608553	1p36.22	Leber congenital amaurosis 9	608553	AR	3
608361	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
610582	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
610933	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
609610	15q15.3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3
611088	12q13.12	Ciliary dyskinesia, primary, 27	615504	AR	3
610350	15q26.3	Mental retardation, autosomal recessive 27	614340	AR	3
609256	11p13	Myopia 7	609256	Mu	2
603594	1q25.1	{Myocardial infarction, susceptibility to}	608446	_	3
609958	2p16	{Asthma-related traits, susceptibility to, 3}	609958	_	2
610934	7q35	Premature ovarian failure 5	611548	AD	3
609257	3q26	Myopia 8	609257	Mu	2
610427	11q13.2	Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3
603357	18q21.33	Palmoplantar keratoderma, Nagashima type	615598	AR	3
610389	1q22	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3
608874	4p16.2	Orofacial cleft 5	608874	_	3
609922	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
610855	10p12.1	Thrombocytopenia 2	188000	AD	3
608875	14q32	{Gene expression, variation in, QTL}	608875	_	2
610353	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
610622	19q13.33	{Neural tube defects, susceptibility to}	182940	AD	3
611051	3q28	?Deafness, autosomal dominant 44	607453	AD	3
604558	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
610197	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
610197	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
608716	1q31.3	Microcephaly 5, primary, autosomal recessive	608716	AR	3
610234	14q11.2-q12	Synpolydactyly 3	610234	_	2
609883	17q22	Bardet-Biedl syndrome 13	615990	AR	3
609883	17q22	Joubert syndrome 28	617121	AR	3
609883	17q22	Meckel syndrome 1	249000	AR	3
603564	9q34.11	Congenital disorder of glycosylation, type Iu	615042	AR	3
608363	22q11.2	Chromosome 22q11.2 microduplication syndrome	608363	IC,AD	4
610198	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
603358	2q35	GRACILE syndrome	603358	_	3
608364	12q13.12	[Low density lipoprotein cholesterol level QTL 8]	618079	_	3
611209	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
607575	22q11.1	?Sneddon syndrome	182410	AR	3
607575	22q11.1	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3
610236	2q31.1	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3
609727	1p31.1-p21.1	Spastic paraplegia 29, autosomal dominant	609727	AD	2
609762	19q13.32	Hermansky-Pudlak syndrome 8	614077	AR	3
607892	18q12.1	Hypotrichosis 6	607903	AR	3
611363	7p14.2	Atrial septal defect 4	611363	_	3
611283	11q25	Isobutyryl-CoA dehydrogenase deficiency	611283	_	3
603805	15q15.2	Peeling skin syndrome 2	609796	AR	3
609923	9p21.1	Retinitis pigmentosa 31	609923	_	3
604559	19q13.33	Progressive familial heart block, type IB	604559	AD	3
609728	2q33.1	?Combined oxidative phosphorylation deficiency 25	616430	AR	3
609728	2q33.1	Spastic ataxia 3, autosomal recessive	611390	AR	3
607893	3p25-p22	{Ovarian cancer, susceptibility to}	607893	_	2
611211	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
611556	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
608367	7p15	Myopia 17	608367	AD	2
607854	11q12.3	Bestrophinopathy, autosomal recessive	611809	_	3
607854	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
607854	11q12.3	Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	193220	AD	3
607854	11q12.3	Retinitis pigmentosa, concentric	613194	_	3
607854	11q12.3	Retinitis pigmentosa-50	613194	_	3
607854	11q12.3	Vitreoretinochoroidopathy	193220	AD	3
611053	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
611364	5q12-q14	Myoclonic epilepsy, juvenile, 4	611364	AD	2
611595	18q23	Burn-McKeown syndrome	608572	AR	3
607855	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
609063	22q12.3	?Combined oxidative phosphorylation deficiency 29	616811	AR	3
611868	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
611634	3p24.2-p23	Febrile seizures, familial, 9	611634	AD	2
609258	4q12	Myopia 9	609258	Mu	2
610819	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
609924	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
611907	19q13	Episodic ataxia, type 7	611907	AD	2
603570	6q23.2	[High density lipoprotein cholesterol level QTL 8]	_	_	3
607776	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
610624	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
611715	4q12	Congenital disorder of glycosylation, type Iq	612379	AR	3
611715	4q12	Kahrizi syndrome	612713	AR	3
607501	14q21.2-q22.3	{Migraine without aura, susceptibility to, 4}	607501	AD	2
610430	4q	{Macroglobulinemia, Waldenstrom, susceptibility to, 2}	610430	_	2
608877	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
608878	20q13	{Gene expression, variation in, QTL}	608878	_	2
607778	2q35	Acrocapitofemoral dysplasia	607778	AR	3
607857	4q31-q34	{Psoriasis susceptibility 9}	607857	_	2
612298	11p13	?Aniridia 3	617142	AD	3
611716	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
611716	12q24.31	Wrinkly skin syndrome	278250	AR	3
603810	11q21	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3
611637	4p16	Primary lateral sclerosis, adult, 1	611637	AD	2
611247	16p12	Major affective disorder 4	611247	_	2
609646	3q13.33	Deafness, autosomal recessive 42	609646	AR	3
609647	18p11.32-p11.31	Deafness, autosomal recessive 46	609647	AR	2
603601	11p15.1	Oculoskeletodental syndrome	618440	AR	3
611638	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
612025	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
609965	14q11.2-q12	Deafness, autosomal dominant 53	609965	AD	2
608879	15q22.2	Parkinson disease 23, autosomal recessive, early onset	616840	AR	3
612453	5q23.2	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	614399	AR	3
612453	5q23.2	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	614399	AR	3
611597	3q22.1	Cataract 12, multiple types	611597	AD	3
603811	11q13.1	Nestor-Guillermo progeria syndrome	614008	AR	3
609648	19q13.42	Familial cold autoinflammatory syndrome 2	611762	AD	3
612570	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
612570	5q23.3	Macular degeneration, early-onset	616118	AD	3
608556	1q41	{Legionnaire disease, susceptibility to}	608556	_	3
609259	8p23	Myopia 10	609259	Mu	2
611718	4q25	Hypomagnesemia 4, renal	611718	_	3
611951	19q13.2	?Meckel syndrome 10	614175	AR	3
611951	19q13.2	Joubert syndrome 34	614175	AR	3
612648	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
611598	4q27	{Autoimmune disease, susceptibility to, 5}	611598	_	2
611598	4q27	{Celiac disease, susceptibility to, 6}	611598	_	2
613077	8q22.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3
612804	19q13.2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3
612300	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
612026	4q25	Alazami syndrome	615071	AR	3
613155	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	AR	3
612882	6q21	{Menarche, age at, QTL2}	612882	_	2
613078	5q31.1	Nijmegen breakage syndrome-like disorder	613078	_	3
612649	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
612301	18q21.33	Osteopetrosis, autosomal recessive 7	612301	AR	3
612961	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
609260	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
603813	1p36.11	Hypercholesterolemia, familial, 4	603813	AR	3
612378	6q23	{Systemic lupus erythematosus, susceptibility to, 13}	612378	_	2
612999	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
604961	2q31.2	Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3
613038	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AR,AD	3
612805	1q21.2	?Combined oxidative phosphorylation deficiency 21	615918	AR	3
607472	10p12.1	?Optic atrophy 11	617302	AR	3
609261	12q24.1	Stuttering, familial persistent, 2	609261	_	2
610355	16p12.2	Fanconi anemia, complementation group N	610832	_	3
610355	16p12.2	{Breast cancer, susceptibility to}	114480	SMu,AD	3
610355	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
610823	19p13.11	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3
613195	15q26.3	Weill-Marchesani 4 syndrome, recessive	613195	AR	3
613000	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
611010	11p15	Fibromatosis, gingival, 4	611010	_	2
612336	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
609262	3p26.2	Mental retardation, autosomal recessive 2	607417	AR	3
612105	10q23.31	Cowden syndrome 4	615107	_	3
607473	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
612337	1q44	Mental retardation, autosomal dominant 22	612337	AD	3
610826	5q22.1	Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3
612379	4q12	Congenital disorder of glycosylation, type Iq	612379	AR	3
613274	18q12.2	Xanthinuria, type II	603592	AR	3
610827	20q13.12	Microcephaly 10, primary, autosomal recessive	615095	AR	3
612650	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
608750	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
608557	13q12	{Myocardial infarction, susceptibility to, 2}	608557	_	2
612651	6p12.1	Endocrine-cerebroosteodysplasia	612651	AR	3
611875	12p13.33	Brugada syndrome 3	611875	_	3
613468	8p22	Farber lipogranulomatosis	228000	AR	3
613468	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
612571	5p15.33	{Lung cancer susceptibility 3}	612571	_	2
609769	12q13.3	Ichthyosis, congenital, autosomal recessive 13	617574	AR	3
613818	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
613896	7q33	Erythrocytosis, familial, 8	222800	AR	3
613545	1p34-p32	Macrostomia	613545	_	2
612380	17q21.2	{Inflammatory bowel disease 22}	612380	_	2
612381	1q32.1	{Inflammatory bowel disease 23}	612381	_	2
613001	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
609968	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
613819	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
614091	2p24.1	Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3
612572	20p13	Retinitis pigmentosa 46	612572	_	3
614052	8q21.11	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3
614208	9p23-p13.3	Mental retardation, autosomal recessive 16	614208	AR	2
613662	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
612107	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
610397	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
613350	20p13	?Fazio-Londe disease	211500	AR	3
613350	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
613002	4q35.1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}	613002	AR,AD	3
612653	17q21.31	Spherocytosis, type 4	612653	AD	3
613897	11p14.3	Fanconi anemia, complementation group F	603467	_	3
612108	2q24-q32	[Fasting plasma glucose level QTL 1]	612108	_	2
614169	3p21.31	Gray platelet syndrome	139090	AR	3
612573	12q24.31	[Mean platelet volume QTL1]	612573	_	2
613118	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AR,AD	3
607982	11q13.1	Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3
612067	2q31.2	Dystonia 16	612067	AR	3
607983	1q24.2	Geroderma osteodysplasticum	231070	AR	3
612574	3p21-p13	[Mean platelet volume QTL2]	612574	_	2
613702	12p13.31	Klippel-Feil syndrome 3, autosomal dominant	613702	_	3
613119	11q13.4	?Brugada syndrome 6	613119	_	3
614170	4q27	Brittle cornea syndrome 2	614170	AR	3
613779	19p13.3	C3 deficiency	613779	AR	3
614559	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
612921	2q35	3-M syndrome 2	612921	AR	3
613780	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
614482	3q25.31	Congenital cataracts, hearing loss, and neurodegeneration	614482	AR	3
608988	6q14-q16	Atrial fibrillation, familial, 2	608988	_	2
613352	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
613820	2q24.3	Nephronophthisis 12	613820	AR,AD	3
613665	1q23.2	[Blood group, Duffy system]	110700	AR,AD	3
613665	1q23.2	[White blood cell count QTL]	611862	AR	3
613665	1q23.2	{Malaria, vivax, protection against}	611162	_	3
612847	10q23.2-q23.3	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3
614209	17p11.2	?Meckel syndrome 9	614209	AR	3
612575	17q11.2	[Mean platelet volume QTL3]	612575	_	2
614053	20q13.32	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	_	3
614676	7p12.1-q21	Cardiomyopathy, hypertrophic, 21	614676	AD	2
614210	3q28	{Lung cancer susceptibility 5}	614210	_	2
613079	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
604965	20q13.12	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	_	3
612848	19q13.12	Mitochondrial complex II deficiency	252011	AR	3
603816	16p13.3	?Caudal duplication anomaly	607864	_	3
603816	16p13.3	Hepatocellular carcinoma, somatic	114550	_	3
614249	6q23.2	Mental retardation, autosomal recessive 18	614249	AR	3
612109	4p16.1	Oculoauricular syndrome	612109	AR	3
614949	16q23.1	Joubert syndrome 20	614970	AR	3
614949	16q23.1	Meckel syndrome 11	615397	AR	3
603604	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
603604	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
603604	22q13.1	Parkinson disease 14, autosomal recessive	612953	AR	3
613080	17q25.3	?46XY sex reversal 5	613080	AR	3
614250	6p22.1	?Narcolepsy 7	614250	AD	3
614055	6q25.3	?ACAT2 deficiency	614055	IC	1
604267	19q13.2	Carpenter syndrome 2	614976	AR	3
614756	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
614325	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
612110	13q14	[Bone mineral density QTL 9]	612110	_	2
603720	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
615145	4q34.3-q35.1	Microphthalmia, isolated, with coloboma 9	615145	AR	3
603576	15q13.3	Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	_	3
614757	11p15.5	Osteogenesis imperfecta, type V	610967	AD	3
614871	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
614677	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
603605	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
607508	19p13	{Migraine with or without aura, susceptibility to, 5}	607508	AD	2
613587	8p23.1	Occult macular dystrophy	613587	AD	3
613506	9q34.11	?Agammaglobulinemia 5	613506	AD	3
614251	3q27.1	{Parkinson disease 18}	614251	AD	3
613823	15q21.1	Seckel syndrome 5	613823	AR	3
615028	11q22.3	Epidermolysis bullosa, nonspecific, autosomal recessive	615028	AR	3
615262	17q25.1	Mental retardation, autosomal recessive 44	615942	AR	3
614252	8p22	Aneurysm, intracranial berry, 11	614252	_	2
613507	3q24	?Glycogen storage disease XV	613507	AR	3
613003	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
613390	17q22	Fanconi anemia, complementation group O	613390	AR	3
614872	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
610828	9q22.32	Holoprosencephaly 7	610828	AD	3
615457	6q14.2	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3
614211	13q34	Deafness, autosomal dominant 33	614211	AD	2
615224	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
615302	19p13.3	Mental retardation, autosomal recessive 36	615286	AR	3
615264	1p36.32	[Blood group, Vel system]	615264	AR	3
613589	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
613824	17q11.2	?Nephronophthisis 9	613824	_	3
613004	4p16.3	Huntington disease	143100	AD	3
613004	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
614095	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
615418	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
615184	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
610829	2q14.2	Holoprosencephaly 9	610829	AD	3
613666	13q14.3	Congenital disorder of glycosylation, type Ip	613661	AR	3
613121	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
613121	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
612727	16q23	[Bone mineral density QTL 13]	612727	_	2
614873	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
615225	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
614561	17p13.1	Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3
607511	15q26.3	Weill-Marchesani 4 syndrome, recessive	613195	AR	3
615574	7q21.3	Asparagine synthetase deficiency	615574	AR	3
615067	19q13.33	Ciliary dyskinesia, primary, 20	615067	AR	3
613898	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
614131	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
613825	5p13.1	C9 deficiency	613825	_	3
615185	3q26.33	Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3
614988	11p15.5	Deafness autosomal recessive 106	617637	AR	3
610356	9p24.2	Retinal cone dystrophy 3B	610356	AR	3
615226	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
615575	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
613391	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
606702	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
612850	6p25.2	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3
613899	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
614096	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
614874	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
615068	18q12.3-q21.1	Vici syndrome	242840	AR	3
615030	4q25	Spastic paraplegia 56, autosomal recessive	615030	AR	3
607512	16q23.1	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3
613122	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
612851	14q11.2	{Narcolepsy 5}	612851	_	2
604269	5q33.1	Spinocerebellar ataxia 45	617769	AD	3
603722	9q31.3	Dysautonomia, familial	223900	AR	3
615340	3p22.1	Nemaline myopathy 8, autosomal recessive	615348	_	3
613704	12p13.31	Microphthalmia, isolated 7	613704	AD	3
615381	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
613667	6q21	Mental retardation, anterior maxillary protrusion, and strabismus	613671	AR	3
614563	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
613625	2p21	Factor V and factor VIII, combined deficiency of	613625	_	3
613783	12p13.31	C1s deficiency	613783	_	3
615031	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
614212	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AR,AD	3
614097	11p13	Acatalasemia	614097	_	3
615770	5p13.2	?Atrial fibrillation 15	615770	AR	3
615458	16q23.1	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3
614832	4q21.1	Amelogenesis imperfecta, type IIA4	614832	AR	3
613392	17p12-q11.2	Deafness, autosomal recessive 85	613392	AR	2
613668	11q21	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3
614564	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
613784	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
615032	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
615731	2q31.1	Nemaline myopathy 9	615731	AR	3
615187	11p15.4	Hyperphosphatasia with mental retardation syndrome 3	614207	AR	3
615228	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
613900	20p13	Spinocerebellar ataxia 35	613908	AD	3
613393	2p13.3	[?Birbeck granule deficiency]	613393	_	3
614640	4p16.3	UV-sensitive syndrome 3	614640	AR	3
610595	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
615382	9q22.33	Nephronophthisis 16	615382	AR	3
615809	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
615887	14q32.12	Amelogenesis imperfecta, type IIA5	615887	AR	3
614833	18q22.2	Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3
615342	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
614602	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
615033	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
613123	15q24.1	Brugada syndrome 8	613123	_	3
616082	12p13.32	Mental retardation, autosomal recessive 66	618221	AR	3
614834	17q24.3	{Thyrotoxic periodic paralysis, susceptibility to, 3}	614834	_	2
613508	12q24.11	[Sodium serum level QTL 1]	613508	_	3
612539	3q25.31	Spastic paraplegia 42, autosomal dominant	612539	AD	3
613785	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
615188	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
615888	11q13.1	?Bleeding disorder, platelet-type, 18	615888	AR	3
615034	11p14.3-p14.2	Dystonia 24	615034	AD	3
616083	10p15.3	Mental retardation, autosomal dominant 30	616083	AD	3
613509	4q21	Chromosome 4q21 deletion syndrome	613509	IC	4
614565	17q12	Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3
615147	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
614876	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
613629	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
615419	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
616005	5q13.1	Immunodeficiency 36	616005	AD	3
615654	2p21-p12	Deafness, autosomal dominant 58	615654	AD	2
614643	7p21.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3
616044	16p13.3	Deafness, autosomal dominant 65	616044	AD	3
613596	2p15	Retinitis pigmentosa 28	606068	_	3
615343	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
616199	3q24	Polyglucosan body myopathy 2	616199	AR	3
612540	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
613741	14q22.1	Glycogen storage disease VI	232700	AR	3
603725	8p21.3	Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3
615496	15q25.3	Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3
607514	10q23.33	{Obesity, susceptibility to}	607514	_	3
615420	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
614759	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
613630	10q24.31	Cocoon syndrome	613630	_	3
616045	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
613597	10q24.2	Hyperoxaluria, primary, type III	613616	_	3
615656	15q11.2	Chromosome 15q11.2 deletion syndrome	615656	AD	4
615735	12q13.13	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3
615812	19q13.2	Abdominal obesity-metabolic syndrome 3	615812	AD	3
614877	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
616200	1q42.2	Ruijs-Aalfs syndrome	616200	AR	3
615926	15q25.1	?Webb-Dattani syndrome	615926	AR	3
603824	9p13.3	Nonaka myopathy	605820	AR	3
603824	9p13.3	Sialuria	269921	AD	3
612113	8q24	[Bone mineral density QTL 10]	612113	_	2
614836	3p22	{Human herpesvirus 8, susceptibility to}	614836	_	2
616394	2p23.3	Retinitis pigmentosa 71	616394	AR	3
616277	10q26.3	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3
615071	4q25	Alazami syndrome	615071	AR	3
613705	2q33.1	?Orofacial cleft 10	613705	IC	3
613598	2p23.3	?Retinitis pigmentosa 58	613617	AR	3
616201	3p24.3	Chronic atrial and intestinal dysrhythmia	616201	AR	3
612114	6q25	[Bone mineral density QTL 11]	612114	_	2
614837	19p13.3	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3
613599	20p11.21	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3
616355	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
614213	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
616395	6q25.3	Trichothiodystrophy 3, photosensitive	616395	_	3
613742	17q21.31	Glycogen storage disease Ia	232200	AR	3
615344	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
616278	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
616589	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
614838	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
616084	3p26.2	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3
614878	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
614839	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
607516	1q31	{Migraine with or without aura, susceptibility to, 6}	607516	AD	2
607516	1q31	{Migraine, familial hemiplegic, 4}	607516	AD	2
612542	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
616433	5q35.1	Immunodeficiency 40	616433	AR	3
615345	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
614603	14q22.1	Spastic paraplegia 28, autosomal recessive	609340	AR	3
614879	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
603826	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
616279	17q12	?Cataract 43	616279	AD	3
614840	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
613128	10q24.33	Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3
616629	2q37.3	Senior-Loken syndrome 9	616629	AR	3
614215	10q22.1	?Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3
614215	10q22.1	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
613669	10p11.23	?Spastic ataxia 4, autosomal recessive	613672	AR	3
613789	1p32.2	C8 deficiency, type II	613789	AR	3
614841	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
615696	3q13.33	Dowling-Degos disease 4	615696	AD	3
616668	15q21.1	Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3
616592	5q32	Kosaki overgrowth syndrome	616592	AD	3
616006	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
613790	1p32.2	C8 deficiency, type I	613790	AR	3
613602	2p24.1	Cranioectodermal dysplasia 2	613610	AR	3
613602	2p24.1	Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3
604277	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
616398	22q12.3	Dystonia 26, myoclonic	616398	AD	3
616007	1q41	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3
616901	17p13.3	Developmental delay with short stature, dysmorphic features, and sparse hair	616901	AR	3
615191	7q31.1	Lissencephaly 5	615191	AR	3
614842	1q32.1	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3
616126	1p36.33	Immunodeficiency 38	616126	AR	3
613706	7q34	Noonan syndrome 7	613706	AD	3
616239	11q14.1	Combined oxidative phosphorylation deficiency 24	616239	AR	3
615889	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
615421	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
616086	1q42.2	Ruijs-Aalfs syndrome	616200	AR	3
616127	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
615658	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
613670	3p13	Mental retardation with language impairment and with or without autistic features	613670	AD	3
614880	2q14.3	{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3
613129	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
606703	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
613671	6q21	Mental retardation, anterior maxillary protrusion, and strabismus	613671	AR	3
616669	21q22.11	?Immunodeficiency 45	616669	AR	3
616399	1p13.2	Brugada syndrome 9	616399	AD	3
616784	16p12.1	Joubert syndrome 26	616784	AR	3
612498	14q32.33	Myopathy, distal, 5	617030	AR	3
613672	10p11.23	?Spastic ataxia 4, autosomal recessive	613672	AR	3
614881	2q35	Spinal muscular atrophy, distal, autosomal recessive, 5	614881	AR	3
617020	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
615422	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
617021	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
614845	11q23.3	Nephronophthisis 15	614845	AR	3
614882	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
616280	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
616087	13q22.2	{Diabetes mellitus, noninsulin-dependent, 5}	616087	_	3
617214	12p12.3	?Spermatogenic failure 17	617214	AR	3
615966	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
617022	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
614883	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
606705	9q21.13	Deafness, autosomal dominant 36	606705	AD	3
616672	13q34	Combined oxidative phosphorylation deficiency 27	616672	AR	3
614846	15q26-qter	Levy-Shanske syndrome	614846	_	4
614678	9p13.2	Pontocerebellar hypoplasia, type 1B	614678	AR	3
615192	6p22.3	[Birth weight QTL4]	615192	_	2
613908	20p13	Spinocerebellar ataxia 35	613908	AD	3
614847	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
614679	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
614884	2q11.2	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3
606706	9q21.13	Deafness, autosomal dominant 36	606705	AD	3
606706	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
603727	3p21.31	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3
617370	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
616089	2q14.3	[Blood group, Gerbich]	616089	_	3
617409	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
616357	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
617061	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
616281	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
613909	7q32-q33	Spinocerebellar ataxia 32	613909	AD	2
617565	17q11.2	Perrault syndrome 6	617565	AR	3
615193	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
615771	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
617682	5q15-q21	Pilarowski-Bjornsson syndrome	617682	AD	3
617175	13q14.2	Retinal dystrophy with or without extraocular anomalies	617175	AR	3
612965	9q33.3	46XY sex reversal 3	612965	AD	3
617023	2p23.3	Retinitis pigmentosa 75	617023	AR	3
617799	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
614680	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
617643	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
617526	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
617099	5p15.2	Autoinflammation, panniculitis, and dermatosis syndrome	617099	AR	3
617024	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
616282	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
616981	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
617062	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
617100	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
616982	5q23.2	Patent ductus arteriosus 3	617039	AD	3
617063	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
617527	9p21.2	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3
617137	6q15	Frontometaphyseal dysplasia 2	617137	AD	3
617644	1p22.1	?Spermatogenic failure 21	617644	AR	3
617760	2q31.1	Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3
615892	1p31	Orofacial cleft 14	615892	AR	2
612576	17p13.3-p13.1	Split-hand/foot malformation with long bone deficiency 3	612576	AD	4
612577	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
616093	9q34.2	[Blood group, ABO system]	616093	_	3
612967	17q23.2-q25.1	[Body mass index QTL 15]	612967	_	2
617449	14q22.3	Structural heart defects and renal anomalies syndrome	617478	AR	3
618074	16p12.1	?Epilepsy, familial adult myoclonic, 6	618074	_	3
617064	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
618152	12q24.31	Spermatogenic failure 33	618152	AR	3
618113	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
617917	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
612578	8q21.13	{Stature QTL 15}	612578	_	2
612968	1p33	Cataract 34, multiple types	612968	_	3
617995	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
617956	7q31.32	[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}	617956	_	3
618114	16p12.2	Liddle syndrome 2	618114	AD	3
617450	17q23.2	Jansen de Vries syndrome	617450	AD	3
613707	7q34	LEOPARD syndrome 3	613707	AD	3
618230	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
616094	8p11.21	?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12	616094	AR	3
612579	15q22.32	{Stature QTL 16}	612579	_	2
613708	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
612502	2p25.3	3MC syndrome 2	265050	AR	3
618347	21q22.3	Galloway-Mowat syndrome 6	618347	AR	3
618115	9q34.3	Spermatogenic failure 32	618115	AD	3
618386	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
618153	2q32.1	Spermatogenic failure 34	618153	AR	3
614017	14q24.3	Ciliary dyskinesia, primary, 16	614017	AR	3
618075	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
618269	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
612503	17q24.3	?Hypertrichosis, congenital generalized, with gingival hyperplasia	135400	AR	3
616095	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AR,AD	3
618154	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
618309	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
616361	3q22	Parkinson disease 21	616361	AD	2
618425	2q35	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3
615197	5q31	{Restless legs syndrome 8}	615197	_	2
618348	12q15	Galloway-Mowat syndrome 7	618348	AR	3
618076	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
618310	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
614018	17q21.32	Epilepsy, progressive myoclonic 6	614018	AR	3
618116	1p32.1	Bone marrow failure syndrome 4	618116	AR	3
617959	7q21.13	Spermatogenic failure 24	617959	AR	3
612580	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
614019	16p13.11	Lissencephaly 4 (with microcephaly)	614019	AR	3
616097	11q12.3	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3
618270	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
612581	11q24.2	Mental retardation, autosomal dominant 4	612581	AD	2
618117	3q23	Ovarian dysgenesis 7	618117	AR	3
618426	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
616098	1p22.3	?Immunodeficiency 37	616098	AR	3
612582	6pter-p24	Chromosome 6pter-p24 deletion syndrome	612582	IC	4
618387	1p32.3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3
618155	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
614020	19p13.12	Mental retardation, autosomal recessive 14	614020	AR	3
617960	8p12	Spermatogenic failure 25	617960	AR	3
618313	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
618388	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
617961	2q11.2	?Spermatogenic failure 26	617961	AR	3
618156	8p23.1	Squalene synthase deficiency	618156	_	3
618389	4p16.3	?Fetal akinesia deformation sequence 3	618389	_	3
618314	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
618272	14q32.13	GLOW syndrome, somatic mosaic	618272	_	3
618428	8q22.3	Popov-Chang syndrome	618428	AD	3
603409	8q22.3	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	AR	3
603066	7q22.1	Lysyl hydroxylase 3 deficiency	612394	AR	3
604210	1q31.3	Leber congenital amaurosis 8	613835	_	3
604210	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
604210	1q31.3	Retinitis pigmentosa-12	600105	AR	3
603324	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
603324	1p34.3	Deafness, autosomal dominant, with peripheral neuropathy	_	_	3
603324	1p34.3	Deafness, autosomal recessive	_	_	3
603324	1p34.3	Deafness, digenic, GJB2/GJB3	220290	AR	3
603324	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AR,AD	3
602997	10p13	Megaloblastic anemia-1, Finnish type	261100	AR	3
603448	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
606843	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
606557	2p16.1	Dias-Logan syndrome	617101	AD	3
603829	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
605239	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
606464	19q13.12	Hemochromatosis, type 2B	613313	AR	3
606082	3q26.1-q26.3	Goiter, multinodular, 3	606082	_	2
607014	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
603933	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
606240	2q21	{Thyroid carcinoma, nonmedullary, 3}	606240	AD	2
604595	13q	[Cholesterol level QTL 1]	604595	_	2
603544	14q32.2	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3
604365	4p15.32	Cone-rod dystrophy 12	612657	_	3
604365	4p15.32	Macular dystrophy, retinal, 2	608051	AD	3
604365	4p15.32	Retinitis pigmentosa 41	612095	AR	3
604365	4p15.32	Stargardt disease 4	603786	_	3
603951	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
605789	18q12.1-q12.2	Symmetric circumferential skin creases, congenital, 2	616734	AD	3
603368	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
605205	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
606755	1p36.13	Uncombable hair syndrome	191480	AR	3
605909	1p36.12	Parkinson disease 6, early onset	605909	AR	3
606721	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
604906	1q42.2	{Schizophrenia 9, susceptibility to}	604906	_	3
603426	2q37.3	Advanced sleep phase syndrome, familial, 1	604348	AD	3
606257	12p11.2-q14	{Stature QTL 3}	606257	_	2
604400	3p25.1	Arrhythmogenic right ventricular dysplasia 5	604400	AD	3
603465	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
603527	17p13.3	Developmental delay with short stature, dysmorphic features, and sparse hair	616901	AR	3
603122	5q35.1	Immunodeficiency 40	616433	AR	3
607086	11q23.3-q24	Aortic aneurysm, familial thoracic 1	607086	_	2
605546	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
606540	18q21.1	Microvillus inclusion disease	251850	AR	3
605389	18p11.22	Hypotrichosis 1	605389	AD	3
605981	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
606521	17q25.1	Microcephaly, Amish type	607196	AR	3
606521	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
607144	22q13.33	Congenital disorder of glycosylation, type Ig	607143	AR	3
604774	1p31.3	Hypobetalipoproteinemia, familial, 2	605019	AR	3
605257	12p13.31	Immunodeficiency with hyper-IgM, type 2	605258	AR	3
606100	19p13.12	Vibratory urticaria	125630	AD	3
604417	5q31.1	CHOPS syndrome	616368	AD	3
603649	6q13	Cone-rod dystrophy 7	603649	_	3
606394	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
605206	15q24.1	Brugada syndrome 8	613123	_	3
605206	15q24.1	Sick sinus syndrome 2	163800	AD	3
603342	11q14-q21	{?Schizophrenia}	181500	AD	2
605427	12q24.11	?Avascular necrosis of femoral head, primary, 2	617383	AD	3
605427	12q24.11	Brachyolmia type 3	113500	AD	3
605427	12q24.11	Digital arthropathy-brachydactyly, familial	606835	AD	3
605427	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
605427	12q24.11	Metatropic dysplasia	156530	AD	3
605427	12q24.11	Parastremmatic dwarfism	168400	AD	3
605427	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
605427	12q24.11	SED, Maroteaux type	184095	AD	3
605427	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
605427	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
605427	12q24.11	[Sodium serum level QTL 1]	613508	_	3
604125	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
604459	12q14.3	{Asthma susceptibility 5}	611064	_	3
605367	17p12	Combined oxidative phosphorylation deficiency 17	615440	AR	3
605367	17p12	{Prostate cancer, hereditary, 2, susceptibility to}	614731	_	3
605998	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
605080	8q21.3	Achromatopsia 3	262300	AR	3
605080	8q21.3	Macular degeneration, juvenile	248200	AR	3
607202	15q11-q13	{Celiac disease, susceptibility to, 5}	607202	_	2
606558	14q32.2	Immunodeficiency 49	617237	AD	3
606558	14q32.2	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3
604383	9q34.13	Bleeding disorder, platelet-type, 17	187900	AR,AD	3
604093	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
606777	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AR,AD	3
607087	5q13-q14	Aortic aneurysm, familial thoracic 2	607087	_	2
604322	6q13	Salla disease	604369	AR	3
604322	6q13	Sialic acid storage disorder, infantile	269920	AR	3
604194	9q34.11	Ichthyosis prematurity syndrome	608649	_	3
603427	1p36.23	?Advanced sleep phase syndrome, familial, 3	616882	AD	3
606151	16q13	Bardet-Biedl syndrome 2	615981	AR	3
606151	16q13	Retinitis pigmentosa 74	616562	AR	3
606019	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
602981	7p13	Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3
606195	16q12.2	Hamamy syndrome	611174	AR	3
606885	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
603123	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
606869	15q23	GM2-gangliosidosis, several forms	272800	AR	3
606869	15q23	Tay-Sachs disease	272800	AR	3
606869	15q23	[Hex A pseudodeficiency]	272800	AR	3
604401	10p14-p12	Arrhythmogenic right ventricular dysplasia 6	604401	_	2
603164	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
603164	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
605483	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
605207	2p13.2	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	_	3
607237	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
604613	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
604873	11q23.3	Deafness, autosomal recessive 111	618145	AR	3
606522	12p13.31	Klippel-Feil syndrome 3, autosomal dominant	613702	_	3
606522	12p13.31	Microphthalmia with coloboma 6	613703	AD	3
606522	12p13.31	Microphthalmia, isolated 7	613704	AD	3
604638	19q13.2	Glomerulosclerosis, focal segmental, 1	603278	AD	3
607330	11q23.3-q24.1	Lathosterolosis	607330	AR	3
603220	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
603650	2q31.1	Bardet-Biedl syndrome 5	615983	AR	3
603072	20q13.2	{Colon cancer, susceptibility to}	114500	SMu,AD	3
607015	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
603294	21q22.3	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3
606350	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
606263	5q31	Paget disease of bone 4	606263	AD	2
607313	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
607254	22q12.3	{Schizophrenia}	181500	AD	1
604775	8q21.11	?Episodic pain syndrome, familial, 1	615040	AD	3
607293	6p21.1	?Deafness, autosomal recessive 103	616042	AR	3
607145	6p22.3	Hermansky-Pudlak syndrome 7	614076	AR	3
605258	12p13.31	Immunodeficiency with hyper-IgM, type 2	605258	AR	3
604307	2q33.3	Cataract 2, multiple types	604307	AD	3
607111	13q13.3	Troyer syndrome	275900	AR	3
604384	3q22.1	Hailey-Hailey disease	169600	AD	3
603033	3p25.1	Myasthenic syndrome, congenital, 5	603034	AR	3
603202	2q21.3	Lactase deficiency, congenital	223000	AR	3
606940	8q21.13	?Ptosis, congenital	178300	AD	2
605910	19p13.2	Plasma triglyceride level QTL, low	615881	AD	3
606523	12q14.2	{Thyroid cancer, nonmedullary, 2}	188470	SMu,AD	3
603546	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
603165	3q21	{Dermatitis, atopic, susceptibility to, 1}	603165	AD	2
606580	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
606580	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
605874	8q24.3	Birk-Barel mental retardation dysmorphism syndrome	612292	_	3
607088	11q13	Spinal muscular atrophy, chronic distal, autosomal recessive	607088	AR	2
605407	11p15.5	Segawa syndrome, recessive	605407	AR	3
606152	2q36.3	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	AR	3
607016	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
603107	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
603305	1q32.2	Temple-Baraitser syndrome	611816	AD	3
603305	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
604802	4p15.3	Huntington disease-like 3	604802	AR	2
603221	12q21-q23	Myopia-3	603221	AD	2
604212	16p13.12	Dyskeratosis congenita, autosomal recessive 6	616353	AR	3
604212	16p13.12	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371	AD	3
603345	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
604173	16q21	Poikiloderma with neutropenia	604173	AR	3
602931	15q22.31	Aortic valve disease 2	614823	AD	3
602931	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
605911	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
603073	13q32.3	Holoprosencephaly 5	609637	AD	3
605309	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
604614	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
605947	17p11.2	CHIME syndrome	280000	AR	3
603729	10q22.1	Nephrotic syndrome, type 14	617575	AR	3
606887	12q13.2	Sulfite oxidase deficiency	272300	AR	3
606264	12p13.2	Candidiasis, familial, 4, autosomal recessive	613108	AR	3
606264	12p13.2	{Aspergillosis, susceptibility to}	614079	_	3
605507	2q14.1	Psoriasis 14, pustular	614204	AR	3
607070	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
604418	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
604418	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
604418	13q12.11	Deafness, digenic GJB2/GJB6	220290	AR	3
604418	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
606871	11q25	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3
605983	19q13.41	Mental retardation, autosomal dominant 36	616362	AD	3
607314	11q13.2	Deafness, autosomal recessive 93	614899	AR	3
603034	3p25.1	Myasthenic syndrome, congenital, 5	603034	AR	3
604094	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
607397	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
605549	1q12-q24	Cone-rod dystrophy 8	605549	AR	2
604308	15q21.1	MASS syndrome	604308	_	3
607647	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
603633	14q21.3	Diamond-Blackfan anemia 13	615909	AD	3
604213	1p13.3	Chudley-McCullough syndrome	604213	AR	3
605792	17q22	?Spermatogenic failure 23	617707	AR	3
605653	13q22.3	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3
607486	1q32.2	[Blood group, Knops system]	607486	_	3
603902	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
604366	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
604402	2p11.2	Salt and pepper developmental regression syndrome	609056	AR	3
605428	4q31.21	?Deafness, autosomal recessive 26	605428	AR	3
607071	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
604804	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
604385	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
604385	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
606448	22q11.21	?Glucocorticoid deficiency 5	617825	AR	3
606102	19p13.3	Lethal congenital contractural syndrome 3	611369	AR	3
604174	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
607031	4p14	Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3
605984	11q14.2	Cohen-Gibson syndrome	617561	AD	3
604875	15q23	Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3
603204	15q24	Epilepsy, nocturnal frontal lobe, type 2	603204	AD	2
607667	10q21.3	Arrhythmogenic right ventricular dysplasia, familial, 13	615616	AD	3
607526	17q21.31	?Diamond-Blackfan anemia 16	617408	AD	3
604653	2q32.2	Hemochromatosis, type 4	606069	AD	3
604325	5q32	Spinocerebellar ataxia 12	604326	AD	3
604214	7q21.2	Cavernous malformations of CNS and retina	116860	AD	3
604214	7q21.2	Cerebral cavernous malformations-1	116860	AD	3
604214	7q21.2	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860	AD	3
605654	6q16.1-q16.2	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3
605192	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
606210	1p36.11	Muscular dystrophy, rigid spine, 1	602771	AR	3
606210	1p36.11	Myopathy, congenital, with fiber-type disproportion	255310	AR,AD	3
603612	8p21.3	Squamous cell carcinoma, head and neck	275355	AR	3
606351	1p36.31	Deafness, autosomal recessive 36	609006	AR	3
606351	1p36.31	Deafness, neurosensory, without vestibular involvement, autosomal dominant	_	_	3
607398	21q22.11	Glucocorticoid deficiency 2	607398	AR	3
603834	12p13.32	Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3
605429	1q24	{Deafness, nonsyndromic, modifier 1}	605429	AD	2
602932	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
606241	14q32.13	GLOW syndrome, somatic mosaic	618272	_	3
606241	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
606241	14q32.13	Pleuropulmonary blastoma	601200	AD	3
606241	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
604095	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
604095	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
604095	2q13	[Hair morphology 1, hair thickness]	612630	_	3
607829	11p15.4	Mitral valve prolapse 2	607829	AD	3
606844	2p13.1	Alstrom syndrome	203800	AR	3
607701	2q31.1	Nemaline myopathy 9	615731	AR	3
607684	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
605010	5q32	Netherton syndrome	256500	AR	3
604515	10q24.1	?Agammaglobulinemia 4	613502	AR	3
603835	2q37.3	Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3
607261	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607261	4p16.2	Weyers acrofacial dysostosis	193530	AD	3
604127	1p12	Cousin syndrome	260660	AR	3
607875	17p13.3	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3
607354	17p11.2	Scoliosis, idiopathic 2	607354	_	2
607907	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
604326	5q32	Spinocerebellar ataxia 12	604326	AD	3
603307	20p12.1	Cataract 33, multiple types	611391	AR,AD	3
603183	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
607239	10p11.23-q21.1	Deafness, autosomal recessive 33	607239	AR	2
604805	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
604368	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
603206	18p	{Schizophrenia}	181500	AD	2
604386	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
604386	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
605031	4q28.1	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3
606242	1p36.32-p35.3	Kondoh syndrome	606242	AR	2
606544	5q13.3	Combined oxidative phosphorylation deficiency 39	618397	AR	3
603634	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
607685	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
607908	2q14.3	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3
604237	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
604197	15q25.1	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3
607876	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
606581	1p33	{Drug addiction, susceptibility to}	606581	_	3
607998	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
607998	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
607830	4q21.21	Fraser syndrome 1	219000	AR	3
605552	3q27	Abdominal obesity-metabolic syndrome 1	605552	AD	2
605446	14q11.2	Cone-rod dystrophy 13	608194	_	3
605446	14q11.2	Leber congenital amaurosis 6	613826	_	3
607649	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
606597	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
606597	2q36.1	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
606597	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
606597	2q36.1	Waardenburg syndrome, type 3	148820	AR,AD	3
604369	6q13	Salla disease	604369	AR	3
603330	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
605313	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
604175	1p36.11	Diamond-Blackfan anemia 7	612562	AD	3
607487	17q12	Cardiomyopathy, hypertrophic, 25	607487	AD	3
605011	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
603371	9q34.11	Congenital arthrogryposis with anterior horn cell disease	611890	AR	3
603371	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
604129	3p21.31	Epidermolysis bullosa pruriginosa	604129	AR,AD	3
604577	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
604198	19p13.2	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3
607999	1q22	Mental retardation, autosomal dominant 52	617796	AD	3
605896	2q37.1	Arthrogryposis, distal, type 5D	615065	AR	3
604404	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
607812	14q21.1	Craniolenticulosutural dysplasia	607812	AR	3
605352	8p23.1	Malignant fibrous histiocytoma	605352	_	2
606545	17p13.1	Ichthyosis, congenital, autosomal recessive 3	606545	AR	3
604096	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
604808	20p12.1	Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3
603489	15q22.31	{Lumbar disc disease, susceptibility to}	603932	_	3
605370	5q31.3	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
607687	16q24.1	{High density lipoprotein cholesterol, low serum, 3}	607687	_	2
603372	14q31.1	Hyperthyroidism, familial gestational	603373	_	3
603372	14q31.1	Hyperthyroidism, nonautoimmune	609152	AD	3
603372	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
603372	14q31.1	Thyroid adenoma, hyperfunctioning, somatic	_	_	3
603372	14q31.1	Thyroid carcinoma with thyrotoxicosis	_	_	3
606598	8q21.11	Charcot-Marie-Tooth disease, axonal, type 2K	607831	AR,AD	3
606598	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
606598	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
606598	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
606470	5q35.3	Dyskeratosis congenita, autosomal recessive 2	613987	AR	3
607488	18p11	Dystonia-15, myoclonic	607488	AD	2
607221	4p15	Epilepsy, partial, with pericentral spikes	607221	_	2
607566	6q24.3	Epilepsy, progressive myoclonic 2A (Lafora)	254780	AR	3
608181	15q22.31	Mast syndrome	248900	AR	3
605013	16p13.11	?Microhydranencephaly	605013	AR	3
603903	11p15.4	Sickle cell anemia	603903	AR	3
605293	18q12.2-q12.3	Optic atrophy 4	605293	_	2
605353	3p25.3	{Obesity, susceptibility to}	601665	AR,Mu,AD	3
608097	20q13.13	Periventricular heterotopia with microcephaly	608097	AR	3
606889	1q42.13	Alzheimer disease-4	606889	AD	3
603386	19p13.2	Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386	_	2
605511	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
604387	3q22.1	Nephronophthisis 3	604387	AR	3
605259	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
605194	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
606045	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
606243	17q25.3	Alveolar soft-part sarcoma	606243	_	3
603867	1q21.1	?Peroxisome biogenesis disorder 14B	614920	AR	3
603968	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
608115	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
604943	7q22.1	?Deafness, autosomal recessive 61	613865	AR	3
603918	17q	{Hypertension, essential, susceptibility to, 1}	145500	Mu	2
607434	6p21.1	Jaberi-Elahi syndrome	617988	AR	3
608000	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
605913	1q23	Bleeding disorder, east Texas type	605913	_	2
603652	11q22.1	Glomerulosclerosis, focal segmental, 2	603965	AD	3
608232	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
607832	6p12.3	Glomerulosclerosis, focal segmental, 3	607832	_	3
606410	2p13.3	GAPO syndrome	230740	AR	3
606410	2p13.3	{?Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
608266	1q31.2	Parathyroid carcinoma	608266	_	3
605809	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AR,AD	3
604641	11p11.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
603373	14q31.1	Hyperthyroidism, familial gestational	603373	_	3
606636	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
606636	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
606636	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
603208	2q37.1	Leber congenital amaurosis 16	614186	AR	3
603208	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
604254	2p16-p15	{Dyslexia, susceptibility to, 3}	604254	_	2
605014	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
606847	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
607091	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
608033	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
607331	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
605210	1q42.2	{Schizophrenia 9, susceptibility to}	604906	_	3
607688	2q37.1	{Parkinson disease 11}	607688	_	3
603332	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
603332	3p21.1	Spermatogenic failure 18	617576	AR	3
606352	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
606352	2q33.1	Primary lateral sclerosis, juvenile	606353	AR	3
606352	2q33.1	Spastic paralysis, infantile onset ascending	607225	AR	3
607928	9q32	Deafness, autosomal recessive 31	607084	AR	3
607928	9q32	Usher syndrome, type 2D	611383	AR	3
606153	20q13.32	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	_	3
605554	1q23.3	{Rheumatoid arthritis, susceptibility to}	180300	_	3
607317	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
605294	16q23.1	Macular corneal dystrophy	217800	AR	3
604310	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
607047	14q32.12	Machado-Joseph disease	109150	AD	3
608328	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
607669	16p12.3	?Spastic paraplegia 61, autosomal recessive	615685	AR	3
607371	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
604777	19p13.12	Ichthyosis, congenital, autosomal recessive 5	604777	AR	3
603904	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
603904	13q14.2	Dementia, familial British	176500	AD	3
603904	13q14.2	Dementia, familial Danish	117300	AD	3
608345	7p11.2	Nystagmus 3, congenital, autosomal dominant	608345	AD	2
605242	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
605242	11p15.1	Usher syndrome, type 1C	276904	AR	3
607035	10q24.32	Basal cell nevus syndrome	109400	AD	3
607035	10q24.32	Joubert syndrome 32	617757	AR	3
607035	10q24.32	Medulloblastoma, desmoplastic	155255	AR,AD	3
607035	10q24.32	{Meningioma, familial, susceptibility to}	607174	AD	3
607814	19q13.11	Bradyopsia	608415	_	3
604327	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
603387	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
607450	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
603868	15q21.3	Griscelli syndrome, type 2	607624	AR	3
605512	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
605512	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
605512	6q14.1	Stargardt disease 3	600110	AD	3
604819	8q24.3	Verheij syndrome	615583	AD	3
606526	2q37.3	Griscelli syndrome, type 3	609227	AR	3
607490	16q23.1	D-lactic aciduria	245450	AR	3
603506	11q13.2	Exudative vitreoretinopathy 4	601813	AR,AD	3
603506	11q13.2	Hyperostosis, endosteal	144750	AD	3
603506	11q13.2	Osteopetrosis, autosomal dominant 1	607634	AD	3
603506	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
603506	11q13.2	Osteosclerosis	144750	AD	3
603506	11q13.2	Polycystic liver disease 4 with or without kidney cysts	617875	AD	3
603506	11q13.2	van Buchem disease, type 2	607636	AD	3
603506	11q13.2	[Bone mineral density variability 1]	601884	AD	3
603506	11q13.2	{Osteoporosis}	166710	AD	3
605629	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
603051	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
603349	2p21	Erythrocytosis, familial, 4	611783	_	3
605880	10q22.2	Genitopatellar syndrome	606170	AD	3
605880	10q22.2	SBBYSS syndrome	603736	AD	3
604370	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	Mu,AD	3
608233	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
607654	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
603005	10q23.2-q23.3	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3
607529	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
605810	3q23	Combined oxidative phosphorylation deficiency 5	611719	AR	3
605810	3q23	Ovarian dysgenesis 7	618117	AR	3
607590	4q27	Bardet-Biedl syndrome 7	615984	AR	3
607759	17q21.31	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
607759	17q21.31	Glanzmann thrombasthenia	273800	AR	3
607759	17q21.31	Thrombocytopenia, neonatal alloimmune, BAK antigen related	_	_	3
603309	7p14.1	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3
608303	19q13.12	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	617468	AR	3
605371	20q13.13	Periventricular heterotopia with microcephaly	608097	AR	3
606353	2q33.1	Primary lateral sclerosis, juvenile	606353	AR	3
603636	13q12.2	Hypotrichosis 12	615885	AD	3
607568	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
606656	2q37	Basal ganglia calcification, idiopathic, 2	606656	_	2
605795	8p12	Spermatogenic failure 25	617960	AR	3
608389	14q23.1	Branchiootic syndrome 3	608389	AD	3
605195	15q26.1	Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3
603191	21q22.3	Retinal dystrophy with macular staphyloma	617547	AR	3
603191	21q22.3	Spondylometaphyseal dysplasia, axial	602271	AR	3
608372	1q21-q23	Deafness, autosomal dominant 49	608372	AD	2
607435	17q11.2	Perrault syndrome 6	617565	AR	3
603935	1q21	{Psoriasis susceptibility 4}	603935	_	2
605047	11p15.5	?Immunodeficiency 39	616345	AR	3
607721	10q25.2	Noonan-like syndrome with loose anagen hair	607721	AD	3
607929	7p13	Cerebral cavernous malformations-2	603284	AD	3
604579	11q14.2	Exudative vitreoretinopathy 1	133780	AD	3
604579	11q14.2	Retinopathy of prematurity	133780	AD	3
608183	15q26.3	Temtamy preaxial brachydactyly syndrome	605282	AR	3
606411	20q13.12	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3
605593	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
607860	1q22	Grange syndrome	602531	AR	3
606919	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
608441	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
608441	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
605881	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
608567	3p22.2	Sick sinus syndrome 1	608567	AR	3
607944	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
606282	4q35-qter	Deafness, autosomal dominant 24	606282	AD	2
607491	20q11.21	Dowling-Degos disease 2	615327	AD	3
608002	3q22.1	Meckel syndrome 7	267010	AR	3
608002	3q22.1	Nephronophthisis 3	604387	AR	3
608002	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
603507	12p13.2	Tooth agenesis, selective, 7	616724	AD	3
603507	12p13.2	{Coronary artery disease, autosomal dominant, 2}	610947	AD	3
605431	16p13.3	Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3
608034	17p13.2	Canavan disease	271900	AR	3
602966	2p13	Orofacial cleft 2	602966	_	2
608545	6p25	Larsen-like syndrome	608545	IC	2
606483	10q24.1-q25.1	Charcot-Marie-Tooth disease, dominant intermediate A	606483	AD	2
603388	20q13.11	{Graves disease, susceptibility to, 2}	603388	_	2
605967	7q36	Acropectoral syndrome	605967	AD	2
607690	5q31.1	Chylomicron retention disease	246700	AR	3
607861	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
604580	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
604580	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
604580	14q32.12	Macular degeneration, age-related, 3	608895	AD	3
604580	14q32.12	Neuropathy, hereditary, with or without age-related macular degeneration	608895	AD	3
606397	3q25.1	Retinitis pigmentosa 61	614180	_	3
606397	3q25.1	Usher syndrome, type 3A	276902	AR	3
603531	7q22.1	MEDNIK syndrome	609313	AR	3
604616	2q24.2	Intellectual developmental disorder with autism and speech delay	606053	AD	3
608442	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
604519	6p21.3	{Inflammatory bowel disease 3}	604519	AD	2
608568	19q13.33	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3
608568	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
608638	3q25-q27	{Asperger syndrome susceptibility 1}	608638	IC,Mu	2
607704	9p24.3	Cerebral palsy, spastic quadriplegic, 2	612900	_	3
605262	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
608201	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
605317	7q31.1	Speech-language disorder-1	602081	AD	3
606048	19q13.42	Mental retardation, autosomal recessive 57	617188	AR	3
603335	5p15.2	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	_	3
604060	11q25-qter	Deafness, autosomal recessive 20	604060	AR	2
608755	17q25.1	?Pontocerebellar hypoplasia type 5	610204	AR	3
608755	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
608755	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
605244	2p16	Carney complex, type II	605244	_	2
604536	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
605197	2q22.2	?Hydroxykynureninuria	236800	AR	3
605197	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
607671	1p36.32-p36.13	Dystonia 13, torsion	607671	AD	2
608305	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
606471	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
608145	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
608546	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
608735	11p11.2	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3
607655	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
608845	3q11.2	?Retinitis pigmentosa 55	613575	_	3
608845	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
608845	3q11.2	{Bardet-Biedl syndrome 1, modifier of}	209900	AR,DR	3
608166	7q21.11	?CHARGE syndrome	214800	AD	3
607592	19q	{Prostate cancer aggressiveness QTL}	607592	_	2
606528	11p15-p14	Chromosome 11p15-p14 deletion syndrome	606528	AR	4
604927	18q23	Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3
606585	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
606585	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
606689	2cen-q13	Glaucoma 1B, primary open angle, adult onset	606689	_	2
604241	6p12.3	Glomerulosclerosis, focal segmental, 3	607832	_	3
604061	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
604061	17q25.3	Leukemia, acute myeloid, therapy-related	_	_	1
604061	17q25.3	Ovarian carcinoma	_	_	1
605373	1q23.3	Paragangliomas 3	605373	AD	3
606658	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
606068	2p15	Retinitis pigmentosa 28	606068	_	3
608846	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
605632	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
605837	15q13.1	Mental retardation, autosomal recessive 38	615516	AR	3
605837	15q13.1	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3
605837	15q13.1	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3
603360	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
603360	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
607182	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
607672	11q13.2	Cold-induced sweating syndrome 2	610313	AR	3
603839	2q33.1	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3
604537	6q14.1	Leber congenital amaurosis 5	604537	_	3
605120	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
608605	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
608347	17q25.3	[Pentosuria]	260800	AR	3
608656	20q13	{Prostate cancer, susceptibility to, 3}	608656	_	2
608118	1p36.11	Zinc deficiency, transient neonatal	608118	AD	3
604312	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
604312	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
605820	9p13.3	Nonaka myopathy	605820	AR	3
608756	1q25.3	Pontocerebellar hypoplasia, type 2F	617026	AR	3
608921	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
608083	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
604581	18p11.21	Spastic ataxia 5, autosomal recessive	614487	AR	3
604581	18p11.21	Spinocerebellar ataxia 28	610246	AD	3
606049	Chr.11	Acromegaloid features, overgrowth, cleft palate, and hernia	606049	_	2
604134	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
607223	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
607878	5p12	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3
604878	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
604928	4q24	Wolfram syndrome 2	604928	AR	3
608829	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
606412	1p32.3	Bartter syndrome, type 4a	602522	AR	3
606412	1p32.3	Sensorineural deafness with mild renal dysfunction	602522	AR	3
604619	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
604521	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
607532	13q21.3-q22.1	Joubert syndrome 33	617767	AR	3
608996	3q22.3	Premature ovarian failure 3	608996	AD	3
603377	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
606247	2p13.1	Microcephaly-capillary malformation syndrome	614261	AR	3
609054	17q23.2	Fanconi anemia, complementation group J	609054	_	3
606069	2q32.2	Hemochromatosis, type 4	606069	AD	3
608547	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
608547	16p11.2	Warfarin resistance	122700	AD	3
608236	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
603956	4p16.3	Cervical cancer, somatic	603956	_	3
608898	17q25.1	Hemophagocytic lymphohistiocytosis, familial, 3	608898	_	3
604313	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
603937	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AR,AD	3
605616	3p21.31	Hyperglycinuria	138500	AD	3
605616	3p21.31	Iminoglycinuria, digenic	242600	AR,DR	3
607864	16p13.3	?Caudal duplication anomaly	607864	_	3
603921	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
607817	8q22.2	Cohen syndrome	216550	AR	3
608757	11q12.1	Pontocerebellar hypoplasia, type 10	615803	AR	3
604217	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
608348	19q13.2	Maple syrup urine disease, type Ia	248600	AR	3
605432	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
607706	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
608374	1q21.1	Hemochromatosis, type 2A	602390	AR	3
608706	15q21.3	Ciliary dyskinesia, primary, 25	615482	AR	3
608706	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
604539	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
608167	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
608167	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
607745	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
608461	9q32	Steel syndrome	615155	AR	3
606797	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
606070	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
606530	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
607818	10q21.2	{Nephrolithiasis, uric acid, susceptibility to}	605990	_	3
608940	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
608512	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
609162	12q13.11	Czech dysplasia	609162	AD	3
607093	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
607093	1p36.22	{Neural tube defects, susceptibility to}	601634	AR	3
607093	1p36.22	{Schizophrenia, susceptibility to}	181500	AD	3
607093	1p36.22	{Thromboembolism, susceptibility to}	188050	AD	3
607093	1p36.22	{Vascular disease, susceptibility to}	_	_	3
607707	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
607693	9q22.2	Thyroid hormone metabolism, abnormal	609698	_	3
609320	9q	[Hematocrit/hemoglobin quantitative trait locus 2]	609320	_	2
605018	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
605018	16q12.1	Cylindromatosis, familial	132700	AD	3
605018	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
608758	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
604391	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
603212	3q22.1	Cataract 12, multiple types	611597	AD	3
604218	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
604242	13q12.13	Esophageal carcinoma, somatic	133239	_	3
608736	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
608736	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
603175	6q13-q26	{Schizophrenia}	181500	AD	2
606692	16p13.3	Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3
607834	17q11.2	{Anxiety-related personality traits}	607834	_	3
609408	14q13	Holoprosencephaly 8	609408	_	2
608830	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
608462	16q23	{Hirschsprung disease, susceptibility to, 8}	608462	_	2
606227	11q23.3	Microphthalmia, isolated 5	611040	AR	3
606227	11q23.3	Nanophthalmos 2	609549	_	3
608375	1p31.3	Parkinson disease 19a, juvenile-onset	615528	AR	3
608375	1p31.3	Parkinson disease 19b, early-onset	615528	AR	3
606798	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
609056	2p11.2	Salt and pepper developmental regression syndrome	609056	AR	3
609533	10q21.1	Deafness, autosomal recessive 23	609533	AR	3
608707	11q24.2	Holoprosencephaly 11	614226	AD	3
607300	17p13.3	Retinitis pigmentosa 13	600059	AD	3
609186	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
603213	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
608658	7p11-q21	{Prostate cancer, susceptibility to, 4}	608658	_	2
607225	2q33.1	Spastic paralysis, infantile onset ascending	607225	AR	3
609304	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
609204	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
605704	20q13.32	Amyotrophic lateral sclerosis 8	608627	AD	3
605704	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
608289	3q27.2	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
609321	1p21.2	?Microcephaly 14, primary, autosomal recessive	616402	AR	3
603639	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
609057	11p15.5	Nephropathy with pretibial epidermolysis bullosa and deafness	609057	_	3
608569	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
603176	13q32	{Schizophrenia}	181500	AD	2
606708	2q31	Split-hand/foot malformation 5	606708	_	2
605634	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
604931	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
609187	7p14.1	Glutaric aciduria III	231690	AR	3
604329	15q	{Hypertension, essential, susceptibility to, 2}	145500	Mu	2
608132	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
608132	14q31.3	Bardet-Biedl syndrome 8	615985	AR	3
605266	8q21.11	?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K	607831	AR,AD	3
607301	1q21.2	Retinitis pigmentosa 18	601414	AD	3
608776	11q23.1	Congenital disorder of glycosylation, type Il	608776	AR	3
609698	9q22.2	Thyroid hormone metabolism, abnormal	609698	_	3
608957	2p11.2	CD8 deficiency, familial	608957	AR	3
606268	2q35	Odontoonychodermal dysplasia	257980	AR	3
606268	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
606268	2q35	Tooth agenesis, selective, 4	150400	AR,AD	3
606873	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
605822	17q21.33	Spondyloocular syndrome	605822	AR	3
609145	1q32.1	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3
608219	6q26-q27	Deafness, autosomal recessive 38	608219	AR	2
606170	10q22.2	Genitopatellar syndrome	606170	AD	3
608850	5p15.33-p13.1	Macular dystrophy, retinal, 3	608850	AD	2
606071	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
608831	14q13-q21	{Restless legs syndrome 2}	608831	_	2
609058	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
604373	22q12.1	Li-Fraumeni syndrome	609265	_	3
604373	22q12.1	Osteosarcoma, somatic	259500	_	3
604373	22q12.1	{Breast and colorectal cancer, susceptibility to}	_	_	3
604373	22q12.1	{Breast cancer, susceptibility to}	114480	SMu,AD	3
604373	22q12.1	{Prostate cancer, familial, susceptibility to}	176807	SMu,AD	3
609427	6p21.31	Deafness, autosomal recessive 67	610265	AR	3
606416	1q44	CINCA syndrome	607115	AD	3
606416	1q44	Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3
606416	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
606416	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
606416	1q44	Muckle-Wells syndrome	191900	AD	3
607694	10q22.3	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3
604219	21q22.3	Cataract 9, multiple types	604219	AR,AD	3
607151	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
609014	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
608148	2q33.1	Glass syndrome	612313	AD	3
606709	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
603924	10q25.3	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3
603924	10q25.3	{Venous thromboembolism, susceptibility to}	188050	AD	3
605019	1p31.3	Hypobetalipoproteinemia, familial, 2	605019	AR	3
609739	3q13.33	Deafness, autosomal recessive 42	609646	AR	3
609283	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
606874	3p21	{Hirschsprung disease, susceptibility to, 6}	606874	_	2
607594	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
606531	5q32	{Asthma, susceptibility to}	600807	AD	3
609428	21q22	Tukel syndrome	609428	AR	2
609915	7q22.3-q31.1	Cardiomyopathy, dilated, 1Q	609915	_	2
609188	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
605705	21q22.3	Epileptic encephalopathy, early infantile, 30	616341	AD	3
607101	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607657	1p31.1	Cystathioninuria	219500	AR	3
607657	1p31.1	Homocysteine, total plasma, elevated	_	_	3
608548	1q25.3-q31.1	{Macular degeneration, age-related, 1}	603075	AD	3
606603	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
606603	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
609536	9q33.2	C5 deficiency	609536	_	3
608517	10q21.3	Cardiomyopathy, dilated, 1KK	615248	AD	3
608517	10q21.3	Cardiomyopathy, familial restrictive, 4	615248	AD	3
608517	10q21.3	Cardiomyopathy, hypertrophic, 22	615248	AD	3
608517	10q21.3	Nemaline myopathy 11, autosomal recessive	617336	AR	3
608149	14q32	Kagami-Ogata syndrome	608149	AD	4
604063	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
607152	9q	Spastic paraplegia 19, autosomal dominant	607152	AD	2
608220	6q23-q24.1	Spastic paraplegia 25, autosomal recessive	608220	AR	2
605514	10q21.1	Deafness, autosomal recessive 23	609533	AR	3
605514	10q21.1	Usher syndrome, type 1D/F digenic	601067	AR,DR	3
605514	10q21.1	Usher syndrome, type 1F	602083	AR	3
609876	21q22.13-qter	[Bone mineral density QTL 6]	609876	_	2
603178	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
608761	2q12.3	Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3
608761	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
607379	22q12.2	Meningioma, NF2-related, somatic	607174	_	3
607379	22q12.2	Neurofibromatosis, type 2	101000	AD	3
607379	22q12.2	Schwannomatosis, somatic	162091	_	3
608173	6p11	{Autoimmune thyroid disease, susceptibility to, 1}	608173	_	2
609757	7q11.23	Chromosome 7q11.23 duplication syndrome	609757	AD	4
609113	14q23.2	[Telomere length, mean leukocyte]	609113	_	2
609588	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
609588	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
605642	1q21	Thyroid carcinoma, papillary, with papillary renal neoplasia	605642	_	2
609446	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
606451	15q25-q26	Deafness, autosomal dominant 30	606451	AD	2
606417	10q26.12	Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3
608549	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
606711	16q	Specific language impairment QTL, 1	606711	Mu	2
608762	9q32-q33	{Epilepsy, idiopathic generalized, susceptibility to, 3}	608762	AR	2
604316	3q21	{Psoriasis susceptibility 5}	604316	_	2
608832	1q43	Tooth agenesis, selective, 9	617275	AD	3
604392	17p13.2	Cone-rod dystrophy	604393	AR	3
604392	17p13.2	Leber congenital amaurosis 4	604393	AR	3
604392	17p13.2	Retinitis pigmentosa, juvenile	604393	AR	3
607102	11p13	Denys-Drash syndrome	194080	SMu,AD	3
607102	11p13	Frasier syndrome	136680	SMu,AD	3
607102	11p13	Meacham syndrome	608978	_	3
607102	11p13	Mesothelioma, somatic	156240	_	3
607102	11p13	Nephrotic syndrome, type 4	256370	AD	3
607102	11p13	Wilms tumor, type 1	194070	SMu,AD	3
604330	17p11.2	Deafness, autosomal recessive 114	618456	AR	3
610004	4q25	Fibrosis of extraocular muscles, congenital, 5	616219	AR	3
610055	19p13.12	Mental retardation, autosomal recessive 3	608443	AR	3
606072	3p25.3	Rippling muscle disease 2	606072	AD	3
603381	3p14.3	Atelosteogenesis, type I	108720	AD	3
603381	3p14.3	Atelosteogenesis, type III	108721	AD	3
603381	3p14.3	Boomerang dysplasia	112310	AD	3
603381	3p14.3	Larsen syndrome	150250	AD	3
603381	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
610021	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
609681	13q31.1	Deafness and myopia	221200	AR	3
609825	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
609825	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AR,AD	3
605706	21q22.3	CHAND syndrome	214350	AR	3
605706	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
602985	1q23.3	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3
606362	19q13.33	Amelogenesis imperfecta, type IJ	617297	AR	3
603382	6p21.33	?Premature ovarian failure 13	617442	AR	3
607380	2q37.3	Senior-Loken syndrome 9	616629	AR	3
607440	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
606875	19q12	{Hirschsprung disease, susceptibility to, 7}	606875	_	2
609826	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
607709	9q21.11	Cholestasis, progressive familial intrahepatic 4	615878	AR	3
607709	9q21.11	Hypercholanemia, familial	607748	AR	3
610181	13q14.3	Aicardi-Goutieres syndrome 2	610181	AR	3
608833	20q13.33	Dyskeratosis congenita, autosomal dominant 4	615190	AR,AD	3
608833	20q13.33	Dyskeratosis congenita, autosomal recessive 5	615190	AR,AD	3
608833	20q13.33	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373	AD	3
609842	15q24.1	?Mental retardation, autosomal recessive 50	616460	AR	3
608135	9q22.31	{Lumbar disc degeneration}	603932	_	3
608135	9q22.31	{Osteoarthritis susceptibility 3}	607850	AD	3
610248	20q13.2-q13.3	Deafness, autosomal recessive 65	610248	AR	2
606799	5q12	{Stroke, susceptibility to, 1}	606799	_	2
605841	4p13-q21	Narcolepsy 2	605841	_	2
609306	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
606230	22q13.33	Phelan-McDermid syndrome	606232	AD	3
606230	22q13.33	{Schizophrenia 15}	613950	AD	3
608174	5q31-q33	{Autoimmune thyroid disease, susceptibility to, 2}	608174	_	2
605799	14q32.32	Megaloblastic anemia-1, Norwegian type	261100	AR	3
608088	3p24-p22	Neuropathy, hereditary sensory, type IB	608088	AD	2
607949	2q35	{Tuberculosis, susceptibility to}	607949	_	2
604229	11p13	Anterior segment dysgenesis 5, multiple subtypes	604229	_	3
609225	7p22.1	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3
607696	17q25.1	Usher syndrome, type 1G	606943	AR	3
608552	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
604317	19q13.12	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3
603383	7q36.1	Glaucoma 1, open angle, F	603383	_	3
609741	22q11.23	Cataract 22	609741	AR,AD	3
610005	3q26.2-q26.3	Mental retardation, autosomal recessive 54	617028	AR	3
606712	19q	Specific language impairment QTL, 2	606712	Mu	2
606453	4q31.3	Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3
605515	3p13	Mental retardation with language impairment and with or without autistic features	613670	AD	3
608136	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
607270	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
609059	11p15.5	Neutral lipid storage disease with myopathy	610717	AR	3
610438	9p24-p22	{Restless legs syndrome 3}	610438	_	2
610299	1p13.3	Mental retardation, autosomal recessive 48	616269	AR	3
609226	17q25.3	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3
610282	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
610090	17q21.32	Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3
609307	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
609570	5q21	{Migraine, susceptibility to, 8}	609570	_	2
610057	19p13.12	Mental retardation, autosomal recessive 14	614020	AR	3
604201	6q22-q23	{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}	604201	_	2
604377	22q13.33	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	AR	3
605218	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
610439	2q33	{Restless legs syndrome 4}	610439	_	2
606713	1p36.11	Van der Woude syndrome 2	606713	AD	3
609397	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
604319	14q12	Dyskeratosis congenita, autosomal dominant 3	613990	AD	3
604319	14q12	Revesz syndrome	268130	AD	3
609227	2q37.3	Griscelli syndrome, type 3	609227	AR	3
607154	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
609017	1p34.2	[Blood group, Radin]	111620	_	3
609017	1p34.2	[Blood group, Scianna system]	111750	_	3
607596	14q32.2	Pontocerebellar hypoplasia type 1A	607596	AR	3
608222	22q13.1	Adenylosuccinase deficiency	103050	AR	3
607697	11p15.4	Charcot-Marie-Tooth disease, type 4B2	604563	AR	3
603941	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
608558	16p13	[Body mass index QTL5]	608558	_	2
610381	19p13.3	Cone-rod dystrophy 11	610381	AD	3
610320	1p36	Myopia 14	610320	_	2
606418	1p32.3	Desmosterolosis	602398	AR	3
609644	14q21.2	?Premature ovarian failure 15	618096	AR	3
609644	14q21.2	Spermatogenic failure 28	618086	AR	3
610250	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
610206	20p13	Corneal dystrophy, Fuchs endothelial, 4	613268	_	3
610206	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
610206	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
605882	17q23.2	Fanconi anemia, complementation group J	609054	_	3
605882	17q23.2	{Breast cancer, early-onset, susceptibility to}	114480	SMu,AD	3
610283	1q22	Cone-rod dystrophy 10	610283	AR	3
605828	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
603317	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
603317	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
608765	8q12	{Scoliosis, isolated, susceptibility to, 3}	608765	_	2
607304	2p12	Cataract 27, nuclear progressive	607304	_	2
602987	7p14.3	?Deafness, autosomal dominant 74	618140	AD	3
607764	16p11.2	Bile acid synthesis defect, congenital, 1	607765	AR	3
603942	3q24	?Glycogen storage disease XV	613507	AR	3
603942	3q24	Polyglucosan body myopathy 2	616199	AR	3
609308	9q34.13	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3
610092	14q24.3	Microphthalmia with coloboma 3	610092	_	3
609649	3p24-p21.2	Trichilemmal cyst 1	609649	AD	2
606419	19q13.42	Retinitis pigmentosa 11	600138	AD	3
605516	10q22.1	Deafness, autosomal recessive 12	601386	AR	3
605516	10q22.1	Usher syndrome, type 1D	601067	AR,DR	3
605516	10q22.1	Usher syndrome, type 1D/F digenic	601067	AR,DR	3
605516	10q22.1	{Pituitary adenoma 5, multiple types}	617540	AD	3
609115	4q21.22	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3
609520	8p11.21	Dystonia 6, torsion	602629	AD	3
610284	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
607271	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
606232	22q13.33	Phelan-McDermid syndrome	606232	AD	3
609898	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
608852	6q21-q22	{Pulmonary function}	608852	_	2
608778	17q21.2	Spermatogenic failure 11	615081	AD	3
608137	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
605219	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
609018	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
606800	17q25.3	Glycogen storage disease II	232300	AR	3
607765	16p11.2	Bile acid synthesis defect, congenital, 1	607765	AR	3
610651	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
608559	20pter-p11.2	[Body mass index QTL6]	608559	_	2
607155	19q13.32	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3
609591	1q22	Noonan syndrome 8	615355	AD	3
605020	20p11.21	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	_	3
605020	20p11.21	Keratoconus 1	148300	AD	3
604202	22q11.21	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3
607951	11q21	Mosaic variegated aneuploidy syndrome 2	614114	AR	3
604320	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
610339	1p34.2	Osteogenesis imperfecta, type VIII	610915	AR	3
602974	9p13.3	[Glycerol quantitative trait locus]	614411	AR	3
608465	9q34.13	Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3
608465	9q34.13	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3
607381	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
609884	8q22.1	?RHYNS syndrome	602152	AR	3
609884	8q22.1	COACH syndrome	216360	AR	3
609884	8q22.1	Joubert syndrome 6	610688	AR	3
609884	8q22.1	Meckel syndrome 3	607361	AR	3
609884	8q22.1	Nephronophthisis 11	613550	AR	3
609884	8q22.1	{Bardet-Biedl syndrome 14, modifier of}	615991	AR	3
604649	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
610774	6p21.1	Epileptic encephalopathy, early infantile, 60	617929	AR	3
610265	6p21.31	Deafness, autosomal recessive 67	610265	AR	3
610130	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
609286	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
610938	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
610285	4p16.3	?Fetal akinesia deformation sequence 3	618389	_	3
610285	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
610652	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
610652	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
604544	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
604544	3p21.31	Perrault syndrome 4	615300	AR	3
609927	8p22	Spastic paraplegia 53, autosomal recessive	614898	AR	3
605844	13q12-q14	{Dermatitis, atopic, susceptibility to, 5}	605844	_	2
609701	17q21.2	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3
609701	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
610455	7q21.2	Tumoral calcinosis, familial, normophosphatemic	610455	AR	3
610612	1q32.3	Leber congenital amaurosis 12	610612	AR	3
604139	2q35	Spinal muscular atrophy, distal, autosomal recessive, 5	614881	AR	3
609469	11q24	Nephropathy, progressive, with deafness	609469	_	2
610321	15q12	{Prostate cancer, hereditary, 7}	610321	_	2
609572	13q31.3	Photoparoxysmal response 2	609572	_	2
610253	9q34.3	Kleefstra syndrome 1	610253	AD	3
609845	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
608176	10q	{Autoimmune thyroid disease, susceptibility to, 4}	608176	_	2
609309	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
609309	2p21-p16	Mismatch repair cancer syndrome	276300	AR	3
609309	2p21-p16	Muir-Torre syndrome	158320	AD	3
609573	7q32	Photoparoxysmal response 3	609573	_	2
610538	1q32.1	Fanconi anemia, complementation group T	616435	AR	3
606252	11q24.2	{Bacteremia, protection against}	614382	_	3
606252	11q24.2	{Malaria, protection against}	611162	_	3
606252	11q24.2	{Pneumococcal disease, invasive, protection against}	610799	_	3
606252	11q24.2	{Tuberculosis, protection against}	607948	_	3
607554	11p15.5-p15.4	Atrial fibrillation, familial, 3	607554	AD	3
610613	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
610613	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
609192	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
608958	20q13.12	Adenosine deaminase deficiency, partial	102700	AR,SMo	3
608958	20q13.12	Severe combined immunodeficiency due to ADA deficiency	102700	AR,SMo	3
608836	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
609310	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
610185	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
610006	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
609539	12q12	Coffin-Siris syndrome 6	617808	AD	3
605622	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
610303	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
610107	14q11.2	Galloway-Mowat syndrome 3	617729	AR	3
610687	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
607598	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
604321	15q15.1	Microcephaly 4, primary, autosomal recessive	604321	AR	3
608779	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
609400	4q13-q21	{Autoimmune disease, susceptibility to, 4}	609400	_	2
610991	2q35	3-M syndrome 2	612921	AR	3
608837	17p13.1	Carney complex variant	608837	_	3
611154	1q25	{Alzheimer disease-14}	611154	_	2
610883	17p11.2	Potocki-Lupski syndrome	610883	IC	4
610598	17q25.1	Retinitis pigmentosa 36	610599	_	3
610758	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
609116	10q26	[Respiratory rhythmicity in sleep]	609116	_	2
605802	2q22.3	Mowat-Wilson syndrome	235730	AD	3
604933	1p34.1	Adenomas, multiple colorectal	608456	AR	3
604933	1p34.1	Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas	132600	SMu	3
604933	1p34.1	Gastric cancer, somatic	613659	_	3
610956	1q25.1	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3
609311	12p11.21	Charcot-Marie-Tooth disease, type 4H	609311	AR	3
610688	8q22.1	Joubert syndrome 6	610688	AR	3
605021	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
605803	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
610759	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
609541	11q13.2	Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3
611155	3q22-q24	{Alzheimer disease-15}	611155	_	2
610957	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
604233	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
608224	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
607273	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
607273	17p11.2	Colorectal cancer, somatic	114500	_	3
607273	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
607273	17p11.2	Renal carcinoma, chromophobe, somatic	144700	_	3
610635	8q22.3	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
610760	2p24-p22	[Cholesterol level QTL 2]	610760	_	2
609720	9q33.3	Focal segmental glomerulosclerosis 9	616220	AR	3
609720	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
609761	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
604882	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
610599	17q25.1	Retinitis pigmentosa 36	610599	_	3
611274	15q22-q24	Glaucoma 1, open angle, N	611274	_	2
603384	6p21.32	Mental retardation, autosomal dominant 5	612621	AD	3
604416	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
603930	14q23.3-q24.1	Molybdenum cofactor deficiency C	615501	AR	3
607306	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
610131	17q23.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3
606718	5q32	Achondrogenesis Ib	600972	AR	3
606718	5q32	Atelosteogenesis, type II	256050	AR	3
606718	5q32	De la Chapelle dysplasia	256050	AR	3
606718	5q32	Diastrophic dysplasia	222600	AR	3
606718	5q32	Diastrophic dysplasia, broad bone-platyspondylic variant	222600	AR	3
606718	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
608780	6q25.3	Trichothiodystrophy 3, photosensitive	616395	_	3
608977	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
611543	12q13.2	Cavitary optic disc anomalies	611543	AD	3
604395	14q24.3	Colorectal cancer, hereditary nonpolyposis, type 7	614385	_	3
604395	14q24.3	Colorectal cancer, somatic	114500	_	3
604395	14q24.3	{Endometrial cancer, susceptibility to}	608089	_	3
606438	16q24.2	Huntington disease-like 2	606438	AD	3
610942	9q21.12	?Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3
610906	1p31	{Asthma-related traits, susceptibility to, 4}	610906	_	2
606719	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
602978	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
610456	7q21.2	MIRAGE syndrome	617053	AD	3
610456	7q21.2	Tumoral calcinosis, familial, normophosphatemic	610455	AR	3
611276	2p16-p15	Glaucoma 1, open angle, H	611276	_	2
609118	3q26.1	Cerebral cavernous malformations 3	603285	_	3
611644	4q31.3-q32.3	{Hirschsprung disease, susceptibility to, 9}	611644	_	2
610110	11p14.3-p14.2	Dystonia 24	615034	AD	3
611458	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
611458	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
611458	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
611458	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
610852	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
611087	17q23.3	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3
610761	3q24-q26	[High density lipoprotein cholesterol level QTL 5]	610761	_	2
610187	8q23.1	Diaphragmatic hernia 3	610187	_	3
610313	11q13.2	Cold-induced sweating syndrome 2	610313	AR	3
608978	11p13	Meacham syndrome	608978	_	3
611258	9q22.33	Cataract 36	613887	AR	3
610044	1q31.3	?Epileptic encephalopathy, early infantile, 57	617771	AD	3
609019	3p25.1	Biotinidase deficiency	253260	AR	3
611604	10q24.31	Spastic paraplegia 62	615681	AR	3
608781	1q21-q22	{Asperger syndrome susceptibility 3}	608781	_	2
611390	2q33.1	Spastic ataxia 3, autosomal recessive	611390	AR	3
611562	16p13.3	Spermatogenic failure 10	614822	AD	3
610978	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
610188	12q21.32	Joubert syndrome 5	610188	AR	3
606157	20p13	HARP syndrome	607236	AR	3
606157	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
611773	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
611605	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
611492	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
610045	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
608562	7q22	Polydactyly, postaxial, type A4	608562	_	2
611407	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
610992	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
608226	10q26.11	Spermatogenic failure 12	615413	AD	3
610908	12q14.2	{Autism susceptibility 13}	610908	_	2
609903	13q32	{Systemic lupus erythematosus, susceptibility to, 5}	609903	_	2
611960	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
611493	21q22.11	Atrial fibrillation, familial, 4	611493	_	3
611408	6q14.1	Leber congenital amaurosis 5	604537	_	3
606255	6q24-q25	{Stature QTL 1}	606255	_	2
611936	3q29	Chromosome 3q29 microduplication syndrome	611936	AD	4
611528	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
607601	19p13.3	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AR,AD	3
611494	4q25	{Atrial fibrillation, familial, 5}	611494	_	2
610189	12q21.32	Senior-Loken syndrome 6	610189	AR	3
611738	20p12.3	{Osteoporosis}	166710	AD	2
611409	15q12-q13	Albinism, brown oculocutaneous	203200	AR	3
611409	15q12-q13	Albinism, oculocutaneous, type II	203200	AR	3
611409	15q12-q13	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3
611409	15q12-q13	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3
611812	1p36.12	?SERKAL syndrome	611812	AR	3
611495	19p13.12	Ichthyosis, congenital, autosomal recessive 5	604777	AR	3
609706	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
611410	6p22.3	?Deafness, autosomal recessive 104	616515	AR	3
612228	20q11.22	{Stature QTL 14}	612228	_	2
608782	8q22.1	Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3
610539	10q22.1	Gaucher disease, atypical	610539	_	3
611496	20q13.33	Congenital heart defects, multiple types, 5	617912	AR,AD	3
611775	19q13.2	{Kawasaki disease, susceptibility to}	611775	_	3
611884	7p15.3	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3
612245	7q32.1	{Inflammatory bowel disease 14}	612245	_	3
612012	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
606439	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
606439	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
610048	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
612280	1p36.11	Fucosidosis	230000	AR	3
611497	17q21.31	?Osteopetrosis, autosomal recessive 6	611497	AR	3
611938	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
602991	17q22	Brachydactyly, type B2	611377	AD	3
602991	17q22	Multiple synostoses syndrome 1	186500	AD	3
602991	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
602991	17q22	Symphalangism, proximal, 1A	185800	AD	3
602991	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
611332	7q36.3	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3
606158	11q12.3	Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3
606158	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
606158	11q12.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
606158	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
611606	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
610540	20q13.32	Pseudohypoparathyroidism, type IB	603233	AD	3
609029	22q11.2	Emanuel syndrome	609029	ICB	4
612013	4p15.32	COACH syndrome	216360	AR	3
612013	4p15.32	Joubert syndrome 9	612285	AR	3
612013	4p15.32	Meckel syndrome 6	612284	AR	3
612319	16q23.1	Spastic paraplegia 35, autosomal recessive	612319	AR	3
611391	20p12.1	Cataract 33, multiple types	611391	AR,AD	3
609617	1p36.11	Zinc deficiency, transient neonatal	608118	AD	3
611045	17q21.31	Dursun syndrome	612541	AR	3
611045	17q21.31	Neutropenia, severe congenital 4, autosomal recessive	612541	AR	3
611776	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
606440	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
611279	1q32.1	?Meckel syndrome 12	616258	AR	3
611279	1q32.1	Microcephaly 20, primary, autosomal recessive	617914	AR	3
612399	19p13.3	Preimplantation embryonic lethality	616814	AR	3
611565	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
612074	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
606256	7q31.3	{Stature QTL 2}	606256	_	2
612229	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
612123	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
612433	1q43-q44	Deafness, autosomal recessive 45	612433	AR	2
611046	8q12-q13	{Mycobacterium tuberculosis, susceptibility to, 2}	611046	_	2
610190	19q13.11	?Peeling skin syndrome 3	616265	AR	3
612014	2q24.3	Nephronophthisis 12	613820	AR,AD	3
612014	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
612263	20q11.2	{Melanoma, cutaneous malignant, 7}	612263	_	2
612230	10p14	{Colorectal cancer, susceptibility to, 5}	612230	_	2
612400	20q11.22	{Osteoarthritis-5}	612400	_	3
611777	3p22.3	Brugada syndrome 2	611777	_	3
612599	5q31.1-q33.1	{Psoriasis susceptibility 11}	612599	_	2
612124	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
610982	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
610982	14q32.33	Glomerulosclerosis, focal segmental, 5	613237	_	3
612015	3p21.1	Congenital disorder of glycosylation, type In	612015	AR	3
609148	6p21.33	{Malaria, mild, susceptibility to}	609148	_	3
612656	5p13.2	Episodic ataxia, type 6	612656	AD	3
609853	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
612691	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
607664	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
609708	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
609708	8p21.3	Lipoprotein lipase deficiency	238600	AR	3
609708	8p21.3	[High density lipoprotein cholesterol level QTL 11]	238600	AR	3
612517	14q21.3	Ciliary dyskinesia, primary, 10	612518	_	3
606441	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
606441	2p13.1	{Parkinson disease 13}	610297	_	3
612372	12p13.3	{Major affective disorder-9, susceptibility to}	612372	_	2
612761	4q22.3	Adermatoglyphia	136000	AD	3
612761	4q22.3	Basan syndrome	129200	AD	3
612761	4q22.3	Huriez syndrome	181600	AD	3
612469	11p13-p12	WAGRO syndrome	612469	_	4
612728	1p33-p32	[Bone mineral density QTL 14]	612728	_	2
610316	2p16.1	Combined oxidative phosphorylation deficiency 13	614932	AR	3
610316	2p16.1	Deafness, autosomal recessive 70	614934	AR	3
610984	4q25	Complement factor I deficiency	610984	AR	3
612692	17q23.3	Agammaglobulinemia 6	612692	AR	3
612657	4p15.32	Cone-rod dystrophy 12	612657	_	3
612674	20p11.21	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3
612401	3p24.3	{Osteoarthritis susceptibility 6}	612401	_	2
612373	10q22.1	Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3
612632	15q22-q23	Usher syndrome, type 1H	612632	_	2
612781	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
612798	6p24.1	Question mark ears, isolated	612798	AD	3
611282	10q24.2	Cataract 48	618415	AR	3
607556	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
607556	2q37.3	Barber-Say syndrome	209885	AD	3
607556	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
612931	7p13	Glycogen storage disease X	261670	AR	3
610419	19p13.2	Deafness, autosomal recessive 68	610419	AR	3
612878	11q22.3	Epidermolysis bullosa, nonspecific, autosomal recessive	615028	AR	3
611263	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
612247	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
612862	6p21.3	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}	612862	_	2
612231	8q23	{Colorectal cancer, susceptibility to, 6}	612231	_	2
611778	3p22.3	Brugada syndrome 2	611777	_	3
609402	2p25	Preeclampsia/eclampsia 2	609402	_	2
607557	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
612932	17p13.2	?Glycogen storage disease XIII	612932	AR	3
612729	8q23	[Lean body mass QTL 1]	612729	_	2
612633	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
612016	1q42.13	Coenzyme Q10 deficiency, primary, 4	612016	AR	3
613031	20q13.33	{Glioma susceptibility 6}	613031	_	2
607786	1p32.3	Hypercholesterolemia, familial, 3	603776	AD	3
607786	1p32.3	{Low density lipoprotein cholesterol level QTL 1}	603776	AD	3
612374	5q31.2	STING-associated vasculopathy, infantile-onset	615934	AD	3
611816	1q32.2	Temple-Baraitser syndrome	611816	AD	3
612991	2p23.3	Shashi-Pena syndrome	617190	AD	3
605479	2q31.1	Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3
612975	12p12.1	[Short sleeper]	612975	AD	3
612863	6q24-q25	Chromosome 6q25-q25 deletion syndrome	612863	_	4
613014	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
612017	11q14-q22	Pyloric stenosis, infantile hypertrophic, 3	612017	_	2
612095	4p15.32	Retinitis pigmentosa 41	612095	AR	3
612799	16p12.2	Combined oxidative phosphorylation deficiency 12	614924	AR	3
613093	10q23.33	Cone dystrophy 4	613093	AR	3
613071	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
612837	16q21	Coenzyme Q10 deficiency, primary, 5	614654	AR	3
612232	11q23	{Colorectal cancer, susceptibility to, 7}	612232	_	2
612634	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
612126	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
610420	14q11.2-q12	Preauricular tag, isolated, autosomal dominant, 1	610420	AD	2
609403	9p13	Preeclampsia/eclampsia 3	609403	_	2
607604	9p24.2	Retinal cone dystrophy 3B	610356	AR	3
605480	4p16-p15.2	{Systemic lupus erythematosus, susceptibility to, 3}	605480	_	2
613032	8q24.21	{Glioma susceptibility 7}	613032	_	2
613015	6p22	{Neuroblastoma, susceptibility to, 4}	613015	_	2
613055	16q22	Atrial fibrillation, familial, 8	613055	_	2
612018	10q23.31	Cataract 47, juvenile, with microcornea	612018	AD	3
609033	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
612635	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
613094	8q22.1	Microphthalmia, isolated 4	613094	_	3
612881	5q14.3-q15	Periventricular nodular heterotopia 5	612881	_	4
605804	20p	{Dermatitis, atopic, susceptibility to, 3}	605804	_	2
610947	12p13.2	{Coronary artery disease, autosomal dominant, 2}	610947	AD	3
612233	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
612034	19p13.3	?Sotos syndrome 3	617169	AR	3
608786	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
612782	12q24.31	Immunodeficiency 9	612782	AR	3
610199	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
613111	20q13.12	Galactosialidosis	256540	AR	3
612712	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
609712	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
609712	1q22	Pyruvate kinase deficiency	266200	AR	3
612471	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
610093	14q24.3	Microphthalmia, isolated 2	610093	_	3
612096	9p13.1-q21.11	Otosclerosis 8	612096	AD	2
610053	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
611611	15q24.3	Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3
613180	22q11.21	Cortical dysplasia, complex, with other brain malformations 8	613180	AR	3
610948	3p14.1-q12.3	{Hypertension, essential, susceptibility to, 7}	610948	_	2
613145	1q21-q23	{Systemic lupus erythematosus, susceptibility to, 14}	613145	_	2
605481	1q31.3	Microcephaly 5, primary, autosomal recessive	608716	AR	3
613270	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
612783	11p15.4	Immunodeficiency 10	612783	AR	3
605805	17q25.3	{Dermatitis, atopic, susceptibility to, 4}	605805	_	2
613112	20q13.32	Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	AD	3
613219	7p15-p13	[Birth weight QTL 1]	613219	_	2
613219	7p15-p13	[Fasting plasma glucose level QTL 2]	613219	_	2
613236	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
612452	17q21.31	Koolen-De Vries syndrome	610443	AD	3
607788	2p21	Factor V and factor VIII, combined deficiency of	613625	_	3
611888	19q13.2	Chitayat syndrome	617180	AD	3
611888	19q13.2	Craniosynostosis 4	600775	AD	3
612800	13q34	Combined oxidative phosphorylation deficiency 27	616672	AR	3
607955	6q24.3-q25.1	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3
607955	6q24.3-q25.1	Dyschromatosis universalis hereditaria 1	127500	AD	3
613095	4q22.1	Polycystic kidney disease 2	613095	AD	3
611705	2q31.2	Salih myopathy	611705	AR	3
611908	3p21.1	Congenital disorder of glycosylation, type In	612015	AR	3
610422	3q26.2-q26.31	Alopecia-mental retardation syndrome 2	610422	AR	2
609312	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
612035	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
612035	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
613016	2q35	{Neuroblastoma, susceptibility to, 5}	613016	_	2
612713	4q12	Kahrizi syndrome	612713	AR	3
613290	6p22.3	{?Hearing loss, cisplatin-induced, susceptibility to}	613290	_	2
609855	17q21.2	Neurodegeneration with brain iron accumulation 6	615643	AR	3
609855	17q21.2	Pontocerebellar hypoplasia, type 12	618266	AR	3
613163	16p13.2	GABA-transaminase deficiency	613163	AR	3
610949	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
612020	19p13.2	Spastic paraplegia 39, autosomal recessive	612020	AR	3
611966	8q24.3	Mental retardation, autosomal recessive 13	613192	AR	3
613271	9p24.1-p22.1	Corneal dystrophy, Fuchs endothelial, 7	613271	_	2
607606	17q21.2	Palmoplantar keratoderma, epidermolytic	144200	AD	3
611706	10q22-q23	{Migraine, with or without aura, susceptibility to, 12}	611706	AD	2
613096	12q23-q24	Spastic paraplegia 36, autosomal dominant	613096	AD	2
613146	15q25.1	EDICT syndrome	614303	AD	3
609313	7q22.1	MEDNIK syndrome	609313	AR	3
613435	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
612994	4p15.33	Cone-rod dystrophy 18	615374	AR	3
610423	14q32.33	Epileptic encephalopathy, early infantile, 66	618067	AD	3
609620	7q36.1	Short QT syndrome 1	609620	_	3
613033	5p15.33	{Glioma susceptibility 8}	613033	_	2
613401	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
612714	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
613072	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
613291	13q33.1	Bile acid malabsorption, primary	613291	AR	3
613418	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
613237	14q32.33	Glomerulosclerosis, focal segmental, 5	613237	_	3
613058	1q42	{Basal cell carcinoma, susceptibility to, 2}	613058	_	2
611124	4q28.2	Ceroid lipofuscinosis, neuronal, 7	610951	AR	3
611124	4q28.2	Macular dystrophy with central cone involvement	616170	AR	3
613471	1q42.12	?Reynolds syndrome	613471	AD	3
613529	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613529	15q21.1	Seckel syndrome 5	613823	AR	3
610132	1p13.1	Caudal regression syndrome	600145	AD	3
610132	1p13.1	{Neural tube defects, susceptibility to}	182940	AD	3
612036	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
613581	3q12.3	Retinitis pigmentosa 56	613581	AR	3
606187	10p13	Alzheimer disease-7	606187	_	2
613547	16q24	{Stature QTL 22}	613547	_	2
612021	8q21.3	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3
613017	1q21.1	{Neuroblastoma, susceptibility to, 6}	613017	_	2
612251	7q32.1	{Systemic lupus erythematosus, susceptibility to, 10}	612251	_	3
613436	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
612866	1p21.3	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3
611531	12p13.31	Bowen-Conradi syndrome	211180	AR	3
612386	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
613690	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
613402	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
610951	4q28.2	Ceroid lipofuscinosis, neuronal, 7	610951	AR	3
613238	2q36.1-q36.3	{Spondyloarthropathy, susceptibility to, 3}	613238	_	2
609621	11p15.5-p15.4	Short QT syndrome 2	609621	AD	3
607560	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
606460	6q21	[Longevity 2]	606460	_	2
613113	17q11.2	Leukemia, juvenile myelomonocytic	607785	SMu,AD	3
613113	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
613113	17q11.2	Neurofibromatosis, type 1	162200	AD	3
613113	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
613113	17q11.2	Watson syndrome	193520	AD	3
613752	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
608742	12p12.2-p12.1	{Hypertension, essential, susceptibility to, 4}	145500	Mu	2
613453	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
613564	2p12-p11.2	Chromosome 2p12-p11.2 deletion syndrome	613564	_	4
613255	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
613582	17q25.3	Retinitis pigmentosa 57	613582	AR	3
610489	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
611818	3p25.3	Long QT syndrome 9	611818	AD	3
611398	17q12	?Ciliary dyskinesia, primary, 41	618449	AR	3
611192	16q24.3	KBG syndrome	148050	AD	3
611060	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
611060	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
613059	5p15.33	{Basal cell carcinoma, susceptibility to, 3}	613059	_	2
613715	13q12.2	Treacher Collins syndrome 2	613717	AR,AD	3
613857	1p33	Orofacial cleft 13	613857	AD	2
612356	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
613548	1p32	{Stature QTL 23}	613548	_	2
613325	19p13.2	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3
611910	10q23.31	Cataract 47, juvenile, with microcornea	612018	AD	3
613798	3q26.33	Ciliary dyskinesia, primary, 14	613807	_	3
613815	6p21.33	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	AR	3
613815	6p21.33	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	AR	3
612387	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
613239	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
609622	17q24.3	Short QT syndrome 3	609622	_	3
613420	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
613769	10q23.1	Retinitis pigmentosa 44	613769	_	3
610997	17q21-q22	{Prostate cancer, hereditary, 9}	610997	_	2
613673	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
613293	5q35.1	Frank-ter Haar syndrome	249420	AR	3
613148	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
611290	2q35	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	_	3
613891	3q21.2	Orotic aciduria	258900	AR	3
613381	21q22.3	Homocystinuria, B6-responsive and nonresponsive types	236200	AR	3
613381	21q22.3	Thrombosis, hyperhomocysteinemic	236200	AR	3
611890	9q34.11	Congenital arthrogryposis with anterior horn cell disease	611890	AR	3
612098	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
613858	2q37.1	Microphthalmia, isolated 6	613517	AR	3
612357	10q21	{Major affective disorder-8, susceptibility to}	612357	_	2
613454	14q12	Rett syndrome, congenital variant	613454	AD	3
612474	1q21.1	Chromosome 1q21.1 deletion syndrome	612474	IC,AD	4
612933	11p15.1	Glycogen storage disease XI	612933	AR	3
613276	16q21	Poikiloderma with neutropenia	604173	AR	3
607791	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
612238	9q31.2-q34.2	{Scoliosis, idiopathic, susceptibility to, 4}	612238	_	2
613874	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
613530	3p25.1-p23	Muscular dystrophy, limb-girdle, type 1H	613530	AD	2
611073	8p12-q22	{Alzheimer disease 12}	611073	_	2
613403	2q11.2	{Pheochromocytoma, susceptibility to}	171300	AD	3
613549	2p16	{Stature QTL 24}	613549	_	2
614009	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
611978	1q25.1	?Combined oxidative phosphorylation deficiency 38	618378	AR	3
614034	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
613674	8q11.23	Vesicoureteral reflux 3	613674	AD	3
611911	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
613183	2p13.1	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3
613382	12p11.22	Brachydactyly, type E2	613382	AD	3
610502	6q21	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	616732	AR	3
612099	9p21	Trichoepithelioma, multiple familial, 2	612099	_	2
614098	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
613404	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
611126	3q21.3	Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3
612636	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
611820	7q21.2	?Long QT syndrome-11	611820	AD	3
612388	10q22.3	{Sarcoidosis, susceptibility to, 3}	612388	_	2
612475	1q21.1	Chromosome 1q21.1 duplication syndrome	612475	IC,AD	4
614074	11p15.1	Hermansky-Pudlak syndrome 5	614074	AR	3
613036	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
614231	18q21.1	Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3
613061	12q13	{Basal cell carcinoma, susceptibility to, 4}	613061	_	2
614187	14q31	Hypertelorism, preauricular sinus, punctal pits, and deafness	614187	AD	2
612239	17q25.3	{Scoliosis, idiopathic, susceptibility to, 5}	612239	_	2
612997	11q13.1	Spermatogenic failure 7	612997	AR	3
612253	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
613326	8q22.3	Dihydropyrimidinuria	222748	AR	3
610954	18q21.2	Pitt-Hopkins syndrome	610954	AD	3
614254	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
611801	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
613204	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
609122	1p36.13-p34.3	Aneurysm, intracranial berry, 3	609122	AD	2
614035	21q22.13	Deafness, autosomal recessive 29	614035	AR	3
613860	1p36.11	Immunodeficiency due to ficolin 3 deficiency	613860	AR	3
612801	1q41	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3
610762	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
614151	16q23.1	?Fanconi anemia, complementation group W	617784	AR	3
610432	18q12.1	Tenorio syndrome	616260	AD	3
611783	2p21	Erythrocytosis, familial, 4	611783	_	3
612417	22q13	{Narcolepsy 4}	612417	_	2
612732	3q11.2	Coproporphyria	121300	AD	3
612732	3q11.2	Harderoporphyria	121300	AD	3
613257	1q32.1	Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3
612389	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
606190	1p11	Meningioma, radiation-induced	606190	_	2
611376	8q23-q24	Mungan syndrome	611376	AR	2
612358	3q27.3	[High molecular weight kininogen deficiency]	228960	AR	3
612358	3q27.3	[Kininogen deficiency]	228960	AR	3
610988	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
613717	13q12.2	Treacher Collins syndrome 2	613717	AR,AD	3
614168	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
612254	8p23.1	{Systemic lupus erythematosus, susceptibility to, 12}	612254	_	2
613327	17q21.2	Lipodystrophy, congenital generalized, type 4	613327	AR	3
612868	12q21.33	Corneal dystrophy, posterior amorphous	612868	AD	4
614134	6q13	Stickler syndrome, type IV	614134	_	3
614058	2p23.3	[Fructosuria]	229800	AR	3
613976	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
613940	4q28.1	Epilepsy, hearing loss, and mental retardation syndrome	616577	AR	3
613583	19q13.12	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3
612637	3q26.2-q26.33	Febrile seizures, familial, 10	612637	_	2
613826	14q11.2	Leber congenital amaurosis 6	613826	_	3
614171	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
610098	6q22.31	Ovarian dysgenesis 4	616185	AR	3
614326	13q31.3	Feingold syndrome 2	614326	AD	3
612390	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
612998	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
613277	11q12.2	Joubert syndrome 2	608091	AR	3
613277	11q12.2	Meckel syndrome 2	603194	AR	3
614152	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
611089	3p25.3	{Centronuclear myopathy, autosomal, modifier of}	160150	AD	3
612584	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
614075	10q24.32	Hermansky-Pudlak syndrome 6	614075	AR	3
613862	2q13	Retinitis pigmentosa 38	613862	AR	3
614232	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
613756	4p12	Retinitis pigmentosa 49	613756	_	3
614327	3p21.1	Tumor predisposition syndrome	614327	AD	3
612554	5p15.33-p15.2	Myopia 16	612554	_	2
614188	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
613603	4q32.1-q32.2	Chromosome 4q32.1-q32.2 triplication syndrome	613603	AD	4
612100	7q35-q36	{Autism susceptibility 15}	612100	_	3
613278	16p13.3	Fanconi anemia, complementation group P	613951	AR	3
613328	15q11-q21.1	?Roifman-Chitayat syndrome	613328	AR	2
613977	11p15.4	Cyanosis, transient neonatal	613977	AD	3
613037	9q34.3	Joubert syndrome 1	213300	AR	3
613037	9q34.3	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	AR	3
612360	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
612418	8q21.11	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3
611804	1p35.3	Elliptocytosis-1	611804	AR,AD	3
614343	18p11.3	Mental retardation, autosomal recessive 19	614343	AR	2
613827	6p21.1	Retinitis pigmentosa 48	613827	_	3
614172	3q21.3	Immunodeficiency 21	614172	AD	3
612638	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
613757	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
613924	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
614255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
614328	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
613842	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
610099	8p22-q11	Myopathy, distal 3	610099	AD	2
611403	17q21	{Asthma-related traits, susceptibility to, 6}	611403	_	2
614291	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
612639	12q15	{Inflammatory bowel disease 26}	612639	_	2
612586	2q33.1	{Aneurysm, intracranial berry, 9}	612586	_	2
612392	8q22.1	Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3
612361	2q32.1	{Schizophrenia, susceptibility to, 14}	612361	_	2
614395	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
613279	14q31.3	Mental retardation, autosomal recessive 56	617125	AR	3
611805	6p12.1	Spinocerebellar ataxia 38	615957	AD	3
610100	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
614452	10q23.31	Hyperekplexia 4	618011	AR	3
612555	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
611535	2q22-q24	{Major affective disorder 5}	611535	_	2
614329	4q12-q13.1	Mental retardation, autosomal recessive 31	614329	AR	2
613006	10q23.31	{Diabetes mellitus, insulin-dependent, 24}	613006	_	2
611341	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
613675	17q11.2	Chromosome 17q11.2 deletion syndrome, 1.4Mb	613675	AD	4
612362	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
612458	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
611719	3q23	Combined oxidative phosphorylation deficiency 5	611719	AR	3
613405	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
612621	6p21.32	Mental retardation, autosomal dominant 5	612621	AD	3
613843	6p21.31	Leber congenital amaurosis 15	613843	AR	3
613205	1q22	Muscular dystrophy, congenital	613205	AD	3
611090	1p34.1	Mental retardation, autosomal recessive 12	611090	AR	3
614429	8p23.1	Ventricular septal defect 1	614429	AD	3
613329	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AR,AD	3
613150	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
612622	4q27	{Diabetes mellitus, insulin-dependent, 23}	612622	_	2
613758	2q37.1	Retinitis pigmentosa 47	613758	_	3
614292	3q28	Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3
614233	19pter-p13.1	Hyperpigmentation, familial progressive, 1	614233	_	2
613406	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
612641	8p11.21	Spherocytosis, type 1	182900	AR,AD	3
612001	15q13.3	Chromosome 15q13.3 microdeletion syndrome	612001	_	4
611788	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
611170	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
614521	9p24.1	Thrombocythemia 3	614521	SMu,AD	3
612459	2q14.1	[Body mass index QTL13]	612459	_	2
613942	20q11.21	Spermatogenic failure 16	617187	AR	3
614411	9p13.3	[Glycerol quantitative trait locus]	614411	AR	3
613385	20q11.22	Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3
613828	6q16.3-q22.31	Epilepsy, generalized, with febrile seizures plus, type 8	613828	_	2
612587	8q12.1	{Aneurysm, intracranial berry, 10}	612587	_	2
613477	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
614344	11p13-q14.1	Mental retardation, autosomal recessive 23	614344	AR	2
613676	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
613114	5p15.1	Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3
612623	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
613007	6p21.3	{Biliary cirrhosis, primary, 2}	613007	_	2
613533	17q21.31	Chromosome 17q21.31 duplication syndrome	613533	_	4
612556	3q27.3	Adiponectin deficiency	612556	_	3
613151	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
612240	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
614504	5q31.3	Usher syndrome type 3B	614504	AR	3
608792	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
614293	6q13	Hydatidiform mole, recurrent, 2	614293	AR	3
613845	19q13.2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3
612642	11p14.2-q12.3	Deafness, autosomal dominant 59	612642	AD	2
613008	1p31.2	{Biliary cirrhosis, primary, 3}	613008	_	2
611536	6q23-q24	{Major affective disorder 6}	611536	_	2
613759	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
614487	18p11.21	Spastic ataxia 5, autosomal recessive	614487	AR	3
613604	16p12.2-p11.2	Chromosome 16p12.2-p11.2 deletion syndrome	613604	IC	4
612255	10q21	{Inflammatory bowel disease 15}	612255	_	2
614468	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
614345	6p12.2-q12	Mental retardation, autosomal recessive 24	614345	AR	2
613280	1q41	Hypermanganesemia with dystonia 1	613280	AR	3
614831	6q24.3	Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3
612241	3p21.3	{Inflammatory bowel disease 12}	612241	_	2
614505	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
614700	4q31.3	Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3
614331	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
612557	9q34.1	{Leukemia, chronic lymphocytic, susceptibility to, 3}	612557	_	2
612643	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
613943	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
613407	13q14.11	{Leprosy, susceptibility to, 6}	613407	_	2
611913	16p11.2	Chromosome 16p11.2 deletion syndrome, 593kb	611913	_	4
611913	16p11.2	{Autism susceptibility 14A}	611913	_	2
614864	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
611482	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
611482	4q35.1	?Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3
612119	11q23.3	Trehalase deficiency	612119	AR	3
613605	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
613206	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
614848	11q23.3	Nephronophthisis 15	614845	AR	3
614190	5q13.3	Pigmented nodular adrenocortical disease, primary, 3	614190	_	3
614619	4q32.1	Hyperekplexia 2	614619	AR	3
612802	6p21.33	Combined oxidative phosphorylation deficiency 20	615917	AR	3
611003	10q22	{Smoking as a quantitative trait locus 1}	611003	_	2
614010	8q12.1	Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3
612589	14q22.2	{Colorectal cancer, susceptibility to, 8}	612589	_	2
612676	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
613115	5p15.1	Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3
609625	10q26	Chromosome 10q26 deletion syndrome	609625	AD	4
614946	6p25.1	Combined oxidative phosphorylation deficiency 14	614946	AR	3
612624	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
612256	19p13.13	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3
614173	12q24.11	Joubert syndrome 13	614173	AR	3
612120	3p25.3	?Lipodystrophy, familial partial, type 5	615238	AR	3
612242	10q23	Chromosome 10q22.3-q23.2 deletion syndrome	612242	_	4
612644	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
614455	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
613761	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
613207	9q33	{Asthma-related traits, susceptibility to, 8}	613207	_	2
613944	2q36	{IgA nephropathy, susceptibility to, 2}	613944	?AD	2
614947	15q22.31	Combined oxidative phosphorylation deficiency 15	614947	AR	3
613606	1p33-p31.1	Forsythe-Wakeling syndrome	613606	AR	2
611570	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
614541	16q22	Chromosome 16q22 deletion syndrome	614541	IC	4
614849	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
614456	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
614814	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
613534	15q13.3	Interstitial nephritis, karyomegalic	614817	AR	3
615135	4q22.1	?Maple syrup urine disease, mild variant	615135	_	3
614414	1p36.31-p36.13	Deafness, autosomal recessive 96	614414	AR	2
611004	22q12	{Smoking as a quantitative trait locus 2}	611004	_	2
613550	8q22.1	Nephronophthisis 11	613550	AR	3
613386	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
613386	13q12.3	Proteasome-associated autoinflammatory syndrome 2	618048	AD	3
615003	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
613190	16q24.1	Ciliary dyskinesia, primary, 13	613193	AR	3
613208	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
613566	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
612243	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
614929	12q13.13	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3
615119	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
614736	5p12	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3
615083	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
615271	20p12.1	Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3
613387	11q23	{Fatty liver disease, nonalcoholic, susceptibility to, 2}	613387	Mu	2
613282	22q13	{Fatty liver disease, nonalcoholic, susceptibility to, 1}	613282	Mu	2
613846	12q24.31	?Meckel syndrome 8	613885	AR	3
613846	12q24.31	Joubert syndrome 24	616654	AR	3
613009	4p15.2	Pontocerebellar hypoplasia type 2D	613811	AR	3
612625	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
614278	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
612160	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
614620	16p13.3	Retinitis pigmentosa 80	617781	AR	3
614620	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
614815	10q24.1	Joubert syndrome 18	614815	AR	3
615084	20p11.23	Mitochondrial DNA depletion syndrome 11	615084	AR	3
614644	6p21.3-p21.2	Mean platelet volume QTL4	614644	_	2
614582	3q22.1	Combined oxidative phosphorylation deficiency 9	614582	AR	3
614490	4q22.1	[Junior blood group system]	614490	_	3
611091	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
613283	4p13	Deafness, autosomal recessive 25	613285	AR	3
612161	11q24-q25	Aneurysm, intracranial berry, 7	612161	_	2
614621	5q12.1	UV-sensitive syndrome 2	614621	AR	3
611571	16q22.1-q23.1	{Otosclerosis 4}	611571	AD	2
611092	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
615085	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
615515	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
613847	10q24.1	Joubert syndrome 18	614815	AR	3
613847	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
613608	5p15.31-p15.1	Epilepsy, myoclonic, familial adult, 3	613608	AD	2
614063	4p16.3	?N-acetylaspartate deficiency	614063	AR	3
615463	1p34.2	Epileptic encephalopathy, early infantile, 18	615476	AR	3
615427	2p11.2	?Deafness, autosomal recessive 88	615429	AR	3
614622	5q14.1-q21.3	Keratoconus 5	614622	AD	2
613284	22q12-q13	[Hematocrit/hemoglobin quantitative trait locus 3]	613284	_	2
615481	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
615272	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
615311	11p14.1	{Bone mineral density, low, susceptibility to}	615311	_	3
615549	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
611572	6q13-q16.1	Otosclerosis 7	611572	AD	2
614583	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
615273	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
615787	5p13.2	?2,4-dienoyl-CoA reductase deficiency	616034	AR	3
615567	19q13.2	Nephrotic syndrome, type 9	615573	AR	3
615288	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614645	6q23.3	Mean platelet volume QTL5	614645	_	2
615767	4q27	?Immunodeficiency, common variable, 11	615767	AR	3
614021	7p22-p14	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	2
612244	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
615120	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
615500	21q22.11	Ciliary dyskinesia, primary, 26	615500	AR	3
612558	6p25	{Leukemia, chronic lymphocytic susceptibility to, 4}	612558	_	2
615464	1q32.1	Orofaciodigital syndrome V	174300	AR	3
611539	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
614915	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
614738	6q27	Mitochondrial pyruvate carrier deficiency	614741	AR	3
614491	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
612590	16q22.1	{Colorectal cancer, susceptibility to, 9}	612590	_	2
615586	3q29	Morbid obesity and spermatogenic failure	615703	AR	3
615274	12q13.3	Cataract 15, multiple types	615274	AD	3
615159	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
614022	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
615721	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
615550	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
611093	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
613848	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
615004	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
615429	2p11.2	?Deafness, autosomal recessive 88	615429	AR	3
615843	1q42.11	Leukodystrophy, hypomyelinating, 18	618404	AR	3
614492	12p13.33	Pseudohypoaldosteronism, type IIC	614492	AD	3
613285	4p13	Deafness, autosomal recessive 25	613285	AR	3
615902	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
615902	14q13.2	Spermatogenic failure 36	618420	AD	3
615501	14q23.3-q24.1	Molybdenum cofactor deficiency C	615501	AR	3
615482	15q21.3	Ciliary dyskinesia, primary, 25	615482	AR	3
613876	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
615368	19p13.2	Lethal congenital contracture syndrome 5	615368	AR	3
613345	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
615312	4q24	Albinism, oculocutaneous, type V	615312	AR	2
615551	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
614623	9q34	Keratoconus 6	614623	AD	2
614506	7p22.3	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3
614506	7p22.3	Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3
615390	12p11-q13	Vesicoureteral reflux 7	615390	_	2
613849	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
612559	11q24.1	{Leukemia, chronic lymphocytic susceptibility to, 5}	612559	_	2
612259	9q32	{Inflammatory bowel disease 16}	612259	_	2
615683	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
615465	8p11.23	Hartsfield syndrome	615465	AD	3
615327	20q11.21	Dowling-Degos disease 2	615327	AD	3
615179	10q22.2-q22.3	Albinism, oculocutaneous, type VII	615179	AR	3
613609	6p22.2	Hemochromatosis	235200	AR	3
613609	6p22.2	[Transferrin serum level QTL2]	614193	_	3
613609	6p22.2	{Alzheimer disease, susceptibility to}	104300	AD	3
613609	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
613609	6p22.2	{Porphyria cutanea tarda, susceptibility to}	176100	AR,AD	3
613609	6p22.2	{Porphyria variegata, susceptibility to}	176200	AD	3
611663	20p13	Warburg micro syndrome 4	615663	AR	3
611377	17q22	Brachydactyly, type B2	611377	AD	3
615160	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
612803	11q14.1	?Deafness, autosomal recessive 94	618434	AR	3
612803	11q14.1	Combined oxidative phosphorylation deficiency 24	616239	AR	3
616033	4q23	Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3
616053	14q32.11-q32.12	?Spinocerebellar ataxia 40	616053	AD	3
613850	20p13	[Inosine triphosphatase deficiency]	613850	_	3
616182	12q13	{Chronic mountain sickness, susceptibility to}	616182	_	2
614916	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
616202	14q32.33	Cerebellofaciodental syndrome	616202	AR	3
615502	16q22.1	Mental retardation, autosomal dominant 21	615502	AD	3
614739	6q25.3	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3
614507	1p36.12	?Congenital disorder of glycosylation, type Ir	614507	AR	3
615684	1p22.2	Premature ovarian failure 9	615724	AR	3
613551	11q24.2	{Autoimmune disease, susceptibility to, 6}	613551	_	3
613286	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
611664	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
615903	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
615903	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
615903	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
612260	3p22.2	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	_	3
611971	9q34.3	Combined oxidative phosphorylation deficiency 36	617950	AR	3
615992	2p15	?Bardet-Biedl syndrome 15	615992	AR	3
616219	4q25	Fibrosis of extraocular muscles, congenital, 5	616219	AR	3
616295	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
614895	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
613877	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
616034	5p13.2	?2,4-dienoyl-CoA reductase deficiency	616034	AR	3
611006	9q21.33	Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3
614917	6q25.1	Combined oxidative phosphorylation deficiency 11	614922	AR	3
616255	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
614076	6p22.3	Hermansky-Pudlak syndrome 7	614076	AR	3
613610	2p24.1	Cranioectodermal dysplasia 2	613610	AR	3
615503	7q36.3	Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3
616329	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
613011	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
616054	18q12.2	Mental retardation, autosomal recessive 58	617270	AR	3
615993	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
612261	1p31.3	{Inflammatory bowel disease 17, protection against}	612261	_	3
615162	17q21.31-q22	Mental retardation, autosomal recessive 35	615162	AR	2
613211	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
615956	19p13.2	Ciliary dyskinesia, primary, 30	616037	AR	3
614524	6p21.32	Fibrochondrogenesis 2	614524	AR,AD	3
615181	1q42.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	AR	3
613611	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
615860	14q24.3	Cone-rod dystrophy 19	615860	AR	3
614740	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
616462	2p11.2	Acrofacial dysostosis, Cincinnati type	616462	AD	3
615504	12q13.12	Ciliary dyskinesia, primary, 27	615504	AR	3
615846	2q24.2	Aicardi-Goutieres syndrome 7	615846	AD	3
614023	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
614896	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
615314	15q21.3	Craniosynostosis 3	615314	AD	3
615122	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
616346	9q34.11	Epileptic encephalopathy, early infantile, 31	616346	AD	3
614800	2p24.3	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3
616531	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
615005	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
613852	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
616330	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
612262	5p13.1	{Inflammatory bowel disease 18}	612262	_	2
616410	4q27	?Spinocerebellar ataxia 41	616410	AD	3
613612	7q22.3	Congenital disorder of glycosylation, type IIi	613612	_	3
615861	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
615483	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
616481	6q25.3	Ciliary dyskinesia, primary, 32	616481	AR	3
614508	15q15.1	Mirror movements 2	614508	AD	3
616055	1p36.13-p34.3	Episodic ataxia, type 8	616055	AD	2
614493	2q31.1	?Wiskott-Aldrich syndrome 2	614493	_	3
614897	7q21.11	{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3
615431	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
613878	13q34	Factor VII deficiency	227500	AR	3
613878	13q34	{Myocardial infarction, decreased susceptibility to}	608446	_	3
616719	11q13.1	Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3
612482	17q22	Sessile serrated polyposis cancer syndrome	617108	AD	3
612421	20p11.22	Alopecia, androgenetic, 3	612421	_	2
613347	13q13.1	{Pancreatic cancer 2}	613347	_	3
616411	2q37.3	Dystonia 27	616411	AR	3
613865	7q22.1	?Deafness, autosomal recessive 61	613865	AR	3
615862	12q22	Nephronophthisis 18	615862	AR	3
615505	8q22.2	Ciliary dyskinesia, primary, 28	615505	AR	3
616532	19q13.33	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3
616428	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
615065	2q37.1	Arthrogryposis, distal, type 5D	615065	AR	3
613301	7q31.32	Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3
616736	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
615847	12q22	Nephronophthisis 18	615862	AR	3
616720	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
616204	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
615942	17q25.1	Mental retardation, autosomal recessive 44	615942	AR	3
615276	15q26.3	Ichthyosis, congenital, autosomal recessive 9	615023	AR	3
614024	13q34	[Protein Z deficiency]	614024	_	3
616685	20q13.12	{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3
615905	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
615532	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
616331	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
612591	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
616645	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
614646	7q22.3	Mean platelet volume QTL6	614646	_	2
614920	1q21.1	?Peroxisome biogenesis disorder 14B	614920	AR	3
614741	6q27	Mitochondrial pyruvate carrier deficiency	614741	AR	3
616165	3p14.1	Nemaline myopathy 10	616165	AR	3
615066	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
615432	2q36.3	{Specific language impairment 5}	615432	AD	3
616625	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
616549	22q12.1	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3
612592	20p12.3	{Colorectal cancer, susceptibility to, 11}	612592	_	2
614332	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
615506	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
616445	3p25.3	Candidiasis, familial, 9	616445	AR	3
615957	6p12.1	Spinocerebellar ataxia 38	615957	AD	3
616646	17q21.2	Woolly hair, autosomal recessive 3	616760	AR	3
614898	8p22	Spastic paraplegia 53, autosomal recessive	614898	AR	3
616166	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
614526	17q12	Chromosome 17q12 duplication syndrome	614526	AD	4
614921	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
611666	9p24.1	Phospholipid phosphatase 6	611666	_	3
616183	17p13.1	?Joubert syndrome 29	617562	AR	3
616183	17p13.1	Meckel syndrome 13	617562	AR	3
616183	17p13.1	Orofaciodigital syndrome XVI	617563	AR	3
616312	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
616430	2q33.1	?Combined oxidative phosphorylation deficiency 25	616430	AR	3
616840	15q22.2	Parkinson disease 23, autosomal recessive, early onset	616840	AR	3
612422	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
614025	15q21.3	Hepatic lipase deficiency	614025	AR	3
616647	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
612736	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
616515	6p22.3	?Deafness, autosomal recessive 104	616515	AR	3
615768	16p13.3	Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3
613012	3q21.3	?Urocanase deficiency	276880	AR	3
614922	6q25.1	Combined oxidative phosphorylation deficiency 11	614922	AR	3
615072	20q11.22	Brachydactyly, type A1, C	615072	AR,AD	3
615907	4q34.3	Lymphatic malformation 4	615907	AD	3
615978	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
612423	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
616056	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
616313	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
614333	4q27-q28.2	Mental retardation, autosomal recessive 29	614333	AR	2
614415	20q11.23	?Chilblain lupus 2	614415	AD	3
613213	22q13.2	Methemoglobinemia, type I	250800	AR	3
613213	22q13.2	Methemoglobinemia, type II	250800	AR	3
612737	7p15	{Stature QTL 17}	612737	_	2
617083	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
616516	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
616534	9q22.33	{Thyroid cancer, nonmedullary, 4}	616534	AD	3
616648	16q21-q22	Optic atrophy 8	616648	AD	2
616737	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
613348	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
617066	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
617025	14q24.3	Nevus comedonicus, somatic	617025	_	3
615828	11p15.5	Mental retardation, autosomal dominant 24	615828	AD	3
614742	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
615552	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
616413	1q25.3	Basal ganglia calcification, idiopathic, 6	616413	AD	3
614457	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
616276	9q34.11	Coenzyme Q10 deficiency, primary, 7	616276	AR	3
615444	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
611974	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
614527	17q12	Chromosome 17q12 deletion syndrome	614527	AD	4
612424	6q12	Retinitis pigmentosa 25	602772	AR	3
615468	18q21.32	Immunodeficiency 12	615468	AR	3
616314	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
613214	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
611542	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
615073	18p11.21	Dystonia 25	615073	AD	3
617174	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
616535	10q25.3	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3
614494	6q23	Retinitis pigmentosa 63	614494	AD	2
614923	16p11.2	Branched-chain ketoacid dehydrogenase kinase deficiency	614923	_	3
616788	17q21.33	?Orofacial cleft 15	616788	AD	3
615277	19q13.41	Cataract 19, multiple types	615277	AR	3
616649	14q23.3	Spherocytosis, type 2	616649	AD	3
615789	2p21	Short stature with microcephaly and distinctive facies	615789	AR	3
615829	1p36.1-p35.3	Xia-Gibbs syndrome	615829	AD	3
615091	4q23	{Autism, susceptibility to, 19}	615091	_	3
616258	1q32.1	?Meckel syndrome 12	616258	AR	3
616517	1q23.3	Achromatopsia 7	616517	AR	3
617140	21q22.11	ZTTK syndrome	617140	AD	3
617044	3p21.1	Short stature, developmental delay, and congenital heart defects	617044	AR	3
615163	10q26	Cone-rod dystrophy 17	615163	AD	2
613215	17p13.3	Chromosome 17p13.3 duplication syndrome	613215	_	4
615994	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
616892	16q13	Nephrotic syndrome, type 12	616892	AR	3
616414	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
615533	11q14.1	Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3
615485	18q12.1	Bainbridge-Ropers syndrome	615485	AD	3
617157	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
616738	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
616185	6q22.31	Ovarian dysgenesis 4	616185	AR	3
616283	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
614899	11q13.2	Deafness, autosomal recessive 93	614899	AR	3
614416	2p13.2	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	_	3
616756	6q16.3	Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3
615909	14q21.3	Diamond-Blackfan anemia 13	615909	AD	3
616650	16p12.1	Joubert syndrome 26	616784	AR	3
614458	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
612162	14q23	Aneurysm, intracranial berry, 8	612162	_	2
613349	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
617180	19q13.2	Chitayat syndrome	617180	AD	3
617121	17q22	Joubert syndrome 28	617121	AR	3
614924	16p12.2	Combined oxidative phosphorylation deficiency 12	614924	AR	3
617068	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
615092	18q11.2	Left ventricular noncompaction 7	615092	AD	3
614335	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
613135	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
615959	2q35	Centronuclear myopathy 5	615959	AR	3
615790	1p36.1-p35.3	Xia-Gibbs syndrome	615829	AD	3
615127	3q26.32-q28	Epilepsy, myoclonic, familial adult, 4	615127	AD	2
616208	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
613776	17p13.1	Chromosome 17p13.1 deletion syndrome	613776	AD	4
617248	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
617158	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
616415	16p13.3	Familial adenomatous polyposis 3	616415	AR	3
616893	7q33	?Nephrotic syndrome, type 13	616893	_	3
617004	6q21	Polycystic liver disease 2	617004	AD	3
615573	19q13.2	Nephrotic syndrome, type 9	615573	AR	3
617282	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
615589	1q41-q44	Otosclerosis 10	615589	AD	2
616559	14q21.3	Noonan syndrome 9	616559	AD	3
615534	3q13.33	Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3
615830	19p13	Pigmented nodular adrenocortical disease, primary, 4	615830	AD	4
612163	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
616186	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
616284	1q21.3	Peeling skin syndrome 6	618084	AR	3
613216	15q13.3	Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	_	3
614744	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
617069	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
614925	12q21.31	Deafness, autosomal recessive 84B	614944	AR	3
616661	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3
615486	12q13.3	Interstitial lung and liver disease	615486	AR	3
616037	19p13.2	Ciliary dyskinesia, primary, 30	616037	AR	3
615944	11q13.4	Orofaciodigital syndrome XIV	615948	AR	3
616209	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
613330	4p15.33	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3
614459	11q12.2	Joubert syndrome 16	614465	AR	3
613388	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
617213	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
615960	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
617141	11p13	?Aniridia 2	617141	AD	3
616789	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
616260	18q12.1	Tenorio syndrome	616260	AD	3
615577	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
615553	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
616432	19p13.2	Retinitis pigmentosa 78	617433	AR	3
616187	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
615278	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
615979	16q24.2	?Mental retardation, autosomal recessive 45	615979	AR	3
617046	6p25.1	Spastic paraplegia 77, autosomal recessive	617046	AR	3
611669	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
615910	13q34	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3
614417	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
617070	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
614530	12q22	?Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3
616758	1p36.11	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3
613353	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
614336	16p13.3	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3
616910	2q31.1	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3
616858	20p11.23	?Cowden syndrome 7	616858	AD	3
615590	15q21.3	{Alzheimer disease 18, susceptibility to}	615590	_	3
617352	20q11-q13	Mulchandani-Bhoj-Conlin syndrome	617352	_	3
616261	7q22.3	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3
616651	2q14.2	Roifman syndrome	616651	AR	3
612164	9q34.11	Epileptic encephalopathy, early infantile, 4	612164	AD	3
612593	6p21.33	{Lung cancer susceptibility 4}	612593	_	2
617300	7q22.1	Lymphatic malformation 7	617300	AD	3
616739	2q22.1	Mental retardation, autosomal recessive 51	616739	AR	3
615919	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
615554	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
615792	13q14.2	{Thiopurines, poor metabolism of, 2}	616903	AD	3
616631	1q22	Porokeratosis 9, multiple types	616631	AD	3
615980	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
615279	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
616482	4p16.3	SADDAN	616482	AD	3
615911	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
616705	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
614512	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
613073	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
614077	19q13.32	Hermansky-Pudlak syndrome 8	614077	AR	3
614745	15q24.1	[Blood group, John-Milton-Hagen system]	614745	_	3
613217	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
615945	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
614900	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
615961	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
616687	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
616286	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
616188	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
616038	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
616963	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
617142	11p13	?Aniridia 3	617142	AD	3
615591	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
613440	2q37.1	{Stature QTL 21}	613440	_	2
616663	17p13.1	Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3
617123	1p34.1	Retinitis pigmentosa 76	617123	AR	3
616652	17p12-p11.2	Yuan-Harel-Lupski syndrome	616652	AD	4
615863	8q24.3	?Diarrhea 7, protein-losing enteropathy type	615863	AR	3
617353	3q29	Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3
616894	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
610436	18q22.2	Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3
616859	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
617159	12p13.31	Sifrim-Hitz-Weiss syndrome	617159	AD	3
614337	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
617387	3p21.31	Ververi-Brady syndrome	617982	AD	3
617404	17p13.3	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3
617284	19q13.12	Dystonia 28, childhood-onset	617284	AD	3
616632	5q31.3	Seizures, cortical blindness, microcephaly syndrome	616632	AR	3
615981	16q13	Bardet-Biedl syndrome 2	615981	AR	3
615280	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
616483	2p24.3	Infantile liver failure syndrome 2	616483	AR	3
617047	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
612165	4q32-q34	Retinitis pigmentosa 29	612165	AR	2
617478	14q22.3	Structural heart defects and renal anomalies syndrome	617478	AR	3
616777	3p21.31	Seckel syndrome 9	616777	AR	3
615095	20q13.12	Microcephaly 10, primary, autosomal recessive	615095	AR	3
617301	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
616875	1p36.13	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3
615831	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
614752	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
614078	8q12.1	Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3
616335	15q15.3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3
614647	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
614028	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
613778	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
614926	5q31.3	?Perrault syndrome 2	614926	AR	3
615555	5p13.2	Hyperprolactinemia	615555	AR,AD	3
615774	11q12.2	Oocyte maturation defect 1	615774	AR	3
614901	16p11.2	Branched-chain ketoacid dehydrogenase kinase deficiency	614923	_	3
617424	1q42.11-q42.12	Skraban-Deardorff syndrome	617616	AD	3
616287	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
617086	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
614746	19q13	[Uric acid concentration, serum, QTL5]	614746	_	2
613074	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
615592	8p11.21	Immunodeficiency 15B	615592	AR	3
615946	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
617143	2q12.3	Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3
614418	8q13.2	Febrile seizures, familial, 11	614418	AR	3
616521	2p25.3	Mental retardation, autosomal dominant 39	616521	AD	3
613441	22q12.2	Transcobalamin II deficiency	275350	AR	3
617441	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
612594	10p15.1	{Multiple sclerosis, susceptibility to, 2}	612594	_	2
614461	6p21.31	Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3
613138	7q31.31	Exudative vitreoretinopathy 5	613310	AD	3
616860	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
617336	10q21.3	Nemaline myopathy 11, autosomal recessive	617336	AR	3
616740	3q29	Immunodeficiency 46	616740	AR	3
615281	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
613218	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
617531	19p13.11	Brain small vessel disease 3	618360	AR	3
617072	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
616562	16q13	Retinitis pigmentosa 74	616562	AR	3
616538	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
616211	16q23.1-q23.2	Epileptic encephalopathy, early infantile, 28	616211	AR	3
614338	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
617217	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
615074	1q21.3	Mental retardation, autosomal dominant 18	615074	AD	3
617388	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
616500	2q11.2	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3	616500	AR	3
614927	10q24.32-q25.1	Ectodermal dysplasia 5, hair/nail type	614927	AR	2
617405	3q29	Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3
616688	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3
616827	2q14.3	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3
614747	1q21.1	[Uric acid concentration, serum, QTL6]	614747	_	2
613791	1p36.22	MASP2 deficiency	613791	AR	3
617302	10p12.1	?Optic atrophy 11	617302	AR	3
612595	5p13.2	{Multiple sclerosis, susceptibility to, 3}	612595	_	2
614419	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
617425	8p21.1	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3
611672	17q11.2	Folate malabsorption, hereditary	229050	AR	3
617087	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
615182	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
616418	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
617125	14q31.3	Mental retardation, autosomal recessive 56	617125	AR	3
617442	6p21.33	?Premature ovarian failure 13	617442	AR	3
617532	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
617619	1q22	Myopathy, mitochondrial, and ataxia	617675	AR,AD	3
615593	1p36.33	?Immunodeficiency 16	615593	AR	3
616435	1q32.1	Fanconi anemia, complementation group T	616435	AR	3
614462	4p14	Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3
615282	2q23.1-q23.2	Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3
616170	4q28.2	Macular dystrophy with central cone involvement	616170	AR	3
617480	9q33.3	46, XX sex reversal 4	617480	AD	3
617389	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
614080	18q21.33	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3
616501	1q42.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	616501	AR	3
614928	17p12-q21.2	Ectodermal dysplasia 6, hair/nail type	614928	AR	2
617218	12q21.32	Lissencephaly 8	617255	AR	3
615490	4q31.3	Charcot-Marie-Tooth disease, type 2R	615490	AR	3
617406	8q22.1	Bardet-Biedl syndrome 21	617406	AR	3
615075	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
616896	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
616212	16q21	Lissencephaly 6, with microcephaly	616212	AR	3
615833	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
614748	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
617232	3q13.33	?Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3
614514	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
613354	9q34.3	Deafness, autosomal recessive 79	613307	AR	3
614420	3p14.3	Systemic lupus erythematosus 16	614420	AR	3
613615	1q43-q44	Senior-Loken syndrome 7	613615	_	3
615471	6q16.1-q16.2	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3
612596	1p36	{Multiple sclerosis, susceptibility to, 4}	612596	_	2
613792	3pter-p25	3p- syndrome	613792	AD	4
617319	19p13.11	Anterior segment dysgenesis 8	617319	AR	3
617088	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
616539	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
617514	16p11.2	Immunodeficiency 52	617514	AR	3
613075	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
617637	11p15.5	Deafness autosomal recessive 106	617637	AR	3
616436	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
617443	11q24.3	Bleeding disorder, platelet-type, 21	617443	AR,AD	3
617145	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
615328	13q14.11	Shaheen syndrome	615328	AR	3
615962	5q31.3	Glucocorticoid resistance	615962	AD	3
617219	19q13.11	Chromosome 19q13.11 deletion syndrome, proximal	617219	AD	4
617585	19q13.32	?Immunodeficiency 53	617585	AR	3
617765	1q42.3	?Immunodeficiency, common variable, 14	617765	AD	3
615491	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
617730	20q13.12	Galloway-Mowat syndrome 4	617730	AR	3
613616	10q24.2	Hyperoxaluria, primary, type III	613616	_	3
613355	17q23.1-q23.2	Chromosome 17q23.1-q23.2 deletion syndrome	613355	IC	4
615777	16p12.3	Desbuquois dysplasia 2	615777	AR	3
614340	15q26.3	Mental retardation, autosomal recessive 27	614340	AR	3
615947	8q24.3	Hyperlipoproteinemia, type 1D	615947	AR	3
615866	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
615834	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
617800	3q23	?Microcephaly 19, primary, autosomal recessive	617800	AR	3
617481	1q21.3	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3
617713	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
616502	1p13.3	Cone-rod dystrophy 21	616502	AR	3
615535	19q13.12	Deafness, autosomal recessive 76	615540	AR	3
613444	16p11.2	Chromosome 16p11.2 deletion syndrome, 220kb	613444	_	4
613444	16p11.2	[Body mass index QTL16]	613444	_	4
616863	16p13.2	Chromosome 16p13.2 deletion syndrome	616863	AD	4
616878	22q11.21	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3
617659	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
616244	7p11.2	Parkinson disease 22, autosomal dominant	616710	AD	3
616828	2q21.1	Congenital disorder of glycosylation, type IIo	616828	AR	3
617320	19p13.12	Ichthyosis, congenital, autosomal recessive 12	617320	AR	3
615963	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
616689	19q13.31	Dehydrated hereditary stomatocytosis 2	616689	AD	3
616437	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
616486	1p34.2	Microcephaly 15, primary, autosomal recessive	616486	AR	3
617220	12p12.1	Myopathy, myofibrillar, 8	617258	AR	3
617675	1q22	Myopathy, mitochondrial, and ataxia	617675	AR,AD	3
614515	17q12	Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3
617731	2p13.1	Galloway-Mowat syndrome 5	617731	AR	3
615595	6p25.1	?Combined oxidative phosphorylation deficiency 19	615595	AR	3
617146	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
613076	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
614422	12q24.2-q24.3	Cataract 37, autosomal dominant	614422	AD	2
617182	15q21.2	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182	AR	3
617782	18q11.1-q11.2	Renal hypodysplasia/aplasia 3	617805	AD	3
617922	4q31.21	[Blood group, MNSs system]	111300	_	3
617922	4q31.21	{Malaria, resistance to}	611162	_	3
616214	11p15.5	Hyperproinsulinemia	616214	AD	3
614341	17p13.2-p13.1	Mental retardation, autosomal recessive 33	614341	AR	2
613793	1q32.2	[Blood group Cromer]	613793	AR	3
617408	17q21.31	?Diamond-Blackfan anemia 16	617408	AD	3
617698	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
615473	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
615948	11q13.4	Orofaciodigital syndrome XIV	615948	AR	3
617006	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
617321	16q12.1	{Yao syndrome}	617321	Mu	3
614649	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
616829	17q11.2	Congenital disorder of glycosylation, type IIp	616829	AR	3
617090	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
616690	1p36.32	Joubert syndrome 25	616781	AR	3
617660	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
616487	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
616503	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
615330	1q42.13	Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3
616540	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
617783	19p13.2	Nephrotic syndrome, type 16	617783	AR	3
616636	12q13.3	Immunodeficiency 44	616636	AR	3
617767	13q21.3-q22.1	Joubert syndrome 33	617767	AR	3
617183	1p36.33	Harel-Yoon syndrome	617183	AR,AD	3
615557	1q41	{Melioidosis, susceptibility to}	615557	_	3
614342	6q12-q15	Mental retardation, autosomal recessive 30	614342	AR	2
617871	14q24.3	?Retinitis pigmentosa 81	617871	AR	3
615493	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
617980	11p15.4	Erythrocytosis 6	617980	_	3
617466	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
618049	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
617412	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
616215	11p11.2	Osteogenesis imperfecta, type XVI	616229	AR	3
615407	16q13	Retinitis pigmentosa with or without situs inversus	615434	AR	3
616289	22q13.2	?Optic atrophy 9	616289	AR	3
616830	22q11.21	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3
615949	17q11.2	Nanophthalmos 4	615972	AD	3
617768	7q36.1	Kleefstra syndrome 2	617768	AD	3
616488	9q34.12	Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3
618126	12p13.31	?Liddle syndrome 3	618126	AD	3
618143	17q11.2	Glycosylphosphatidylinositol biosynthesis defect 18	618143	AR	3
615537	15q21.3	Reticulate acropigmentation of Kitamura	615537	AD	3
617638	7p22.2	Immunodeficiency 11B with atopic dermatitis	617638	AD	3
614423	2q33.1	Joubert syndrome 14	614424	AR	3
617802	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
617904	9q22.33	Epileptic encephalopathy, early infantile, 59	617904	AD	3
616339	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
617836	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
617872	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
617570	3q22.3	Polycystic kidney disease 5	617610	AR	3
616911	10q23.33	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3
616439	12q14.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3
618067	14q32.33	Epileptic encephalopathy, early infantile, 66	618067	AD	3
615950	2q35	Centronuclear myopathy 5	615959	AR	3
618050	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
616638	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
617516	17q24.2	Stankiewicz-Isidor syndrome	617516	AD	3
617602	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
614749	9p13.3	Hyperphosphatasia with mental retardation syndrome 2	614749	AR	3
615494	21q22.11	Ciliary dyskinesia, primary, 26	615500	AR	3
617941	15q25.2	Shwachman-Diamond syndrome 2	617941	AR	3
615332	1q42.3	?Immunodeficiency, common variable, 14	617765	AD	3
618015	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
616059	22q13.1	?Mirror movements 3	616059	AR	3
613446	5q23.2	Joubert syndrome 31	617761	AR	3
613446	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
616247	14q32.11	Long QT syndrome 14	616247	AD	3
618182	17q23.3	Orthostatic hypotension 2	618182	AR	3
617784	16q23.1	?Fanconi anemia, complementation group W	617784	AR	3
617639	17q25.1	Deafness, autosomal recessive 107	617639	AR	3
616489	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
618051	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
616389	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
618307	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
616639	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
617184	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
615796	2q32.1	Spermatogenic failure 34	618153	AR	3
618273	19p13.13	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3
616897	4p15.32	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3
614033	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
616216	12p13.2	Thrombocytopenia 5	616216	AD	3
618165	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
618331	16q24.3	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3
615408	10p12.1	Ciliary dyskinesia, primary, 23	615451	AR	3
617008	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
616881	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
616541	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
618016	1p21.1	?Growth hormone deficiency, isolated, type V	618160	AR	3
615969	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
617303	12q24.31	Mucopolysaccharidosis-plus syndrome	617303	AR	3
618183	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
616490	14q23.1	Joubert syndrome 23	616490	AR	3
616340	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
617468	19q13.12	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	617468	AR	3
616248	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
616640	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
617873	1p34.2	Combined oxidative phosphorylation deficiency 35	617873	AR	3
618367	15q25.1	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3
618384	20q13.12	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3
616806	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
615495	2q35	Alacrima, achalasia, and mental retardation syndrome	615510	AR	3
618128	1p12	Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3
618332	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
618481	17q12	?Deafness, autosomal recessive 99	618481	_	3
616217	6p22.3	Nephronophthisis 19	616217	AR	3
617661	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
615970	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
618406	18q21.32	Obesity (BMIQ20)	618406	_	3
616291	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
617874	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
614750	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
615951	5q12.1	Acromelic frontonasal dysostosis	603671	AD	3
615951	5q12.1	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3
618275	21q22.3	Hypotrichosis 14	618275	AR	3
617304	19p13.3	Retinitis pigmentosa 77	617304	AR	3
616913	17q12	Bleeding disorder, platelet-type, 20	616913	AD	3
617537	6p22.2	Rahman syndrome	617537	AD	3
616491	17q21.2	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3
618422	5q21.1	Deafness, autosomal recessive 100	618422	AR	3
616341	21q22.3	Epileptic encephalopathy, early infantile, 30	616341	AD	3
617323	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
616866	15q22.31	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3
618333	22q13.2	Menke-Hennekam syndrome 2	618333	_	3
617186	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
617641	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
616564	22q11.21	Noonan syndrome 10	616564	AD	3
616390	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
617538	15q25.2	Shwachman-Diamond syndrome 2	617941	AR	3
616249	2p21	Long QT syndrome 15	616249	AD	3
617839	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
616060	12p12.3	[Blood group, Dombrock]	616060	_	3
616914	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
618129	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
617662	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
617982	3p21.31	Ververi-Brady syndrome	617982	AD	3
616441	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
617604	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
617519	19q13.2	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3
614518	7q21.2	?Cardiomyopathy, dilated, 2B	614672	AR	3
618252	10q24.31	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3
616882	1p36.23	?Advanced sleep phase syndrome, familial, 3	616882	AD	3
618103	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
618350	7q22.1	?Microcephaly 25, primary, autosomal recessive	618351	AR	3
617642	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
617875	11q13.2	Polycystic liver disease 4 with or without kidney cysts	617875	AD	3
617222	4q24	Sudden cardiac failure, infantile	617222	AR	3
615952	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
616842	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
617907	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
617605	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
616898	15q14	Chromosome 15q14 deletion syndrome	616898	AD	4
617663	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
617520	4q21.23	?Microcephaly 18, primary, autosomal dominant	617520	AD	3
617983	12p13.31	?Microcephaly 21, primary, autosomal recessive	617983	AR	3
618351	7q22.1	?Microcephaly 25, primary, autosomal recessive	618351	AR	3
616342	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
618276	9q21.33	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3
616566	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
618424	6q21	Spermatogenic failure 38	618433	AR	3
616809	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
616843	16q24.3	Lymphatic malformation 6	616843	AR	3
615076	20p11.23	Mitochondrial DNA depletion syndrome 11	615084	AR	3
617984	11q25	Microcephaly 22, primary, autosomal recessive	617984	AR	3
618291	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3
617223	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
618429	3p22.2	Spermatogenic failure 37	618429	AR	3
615410	6q14.2	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3
618369	1p12	Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3
618201	3p22.1	Epileptic encephalopathy, early infantile, 68	618201	AR	3
618036	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
617985	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
617820	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
615596	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
617162	19q13.33	Epileptic encephalopathy, early infantile, 46	617162	AD	3
617452	8q21.3	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3
617571	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
616899	4q24	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3
615953	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
618462	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
618353	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
618430	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
618410	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
617787	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
617963	14q32.33	?Spermatogenic failure 30	618110	AR	3
617717	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
616568	7q31.33	{Glioma susceptibility 9}	616568	AD	3
617606	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
618253	22q13.2	Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3
617360	7p14.1	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3
615954	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
618292	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
618018	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
616867	10q22.1	?Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3
618431	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
617821	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
616062	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
618354	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
616900	4q24	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3
618464	17p13.2	Paragangliomas 6	618464	AD	3
615972	17q11.2	Nanophthalmos 4	615972	AD	3
618106	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
617718	7q22.1	Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease	617718	AR	3
616321	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
617964	7p21.3	Leukodystrophy, hypomyelinating, 16	617964	AD	3
618019	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
617607	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
617804	3p21.31	Neurodevelopmental disorder with severe motor impairment and absent language	617804	AD	3
616887	2q11.2	?Mental retardation, autosomal recessive, 52	616887	AR	3
617788	11q13.2	Mental retardation, autosomal dominant 51	617788	AD	3
615597	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
616868	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
617840	1p34.2	Combined oxidative phosphorylation deficiency 35	617873	AR	3
616322	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
618107	17q21.31	Osteopetrosis, autosomal dominant 3	618107	AD	3
618086	14q21.2	Spermatogenic failure 28	618086	AR	3
616063	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
618204	8p11.21	Immunodeficiency 15A	618204	AD	3
618482	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
616811	22q12.3	?Combined oxidative phosphorylation deficiency 29	616811	AR	3
617923	4q31.21	[Blood group, Ss]	111740	_	3
617923	4q31.21	{Malaria, resistance to}	611162	_	3
616345	11p15.5	?Immunodeficiency 39	616345	AR	3
613360	1p13.3	Cone-rod dystrophy 21	616502	AR	3
617719	17q25.3	Epiphyseal dysplasia, multiple, 7	617719	AR	3
618218	12q21.2	Baker-Gordon syndrome	618218	AD	3
618184	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
618087	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
615598	18q21.33	Palmoplantar keratoderma, Nagashima type	615598	AR	3
616812	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
617924	6p12.1	{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3
615870	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
618108	6p25.2	Immunodeficiency 57	618108	AR	3
617681	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
617225	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
618088	14q24.3	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3
618185	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
618219	8q22.1	?Polydactyly, postaxial, type A9	618219	AR	3
616294	4q26	Cole-Carpenter syndrome 2	616294	AR	3
616393	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
618205	17p13.1	Snijders Blok-Campeau syndrome	618205	AD	3
614204	2q14.1	Psoriasis 14, pustular	614204	AR	3
617706	16p13.3	?Spermatogenic failure 22	617706	AR	3
616890	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
618315	9q33.3	?Diamond-Blackfan anemia 19	618312	_	3
618073	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
617608	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
615080	6p21.2	Alzheimer disease 17	615080	_	2
618432	11q13.2	Hydatidiform mole, recurrent, 4	618432	_	3
618220	16q22.2	Retinitis pigmentosa 84	618220	AR	3
617911	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
618186	17q21.2	Hypomyelinating neuropathy, congenital, 3	618186	AR	3
618109	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
617721	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
616400	17p13.2	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3
618021	8q23.1	Tetraamelia syndrome 2	618021	AR	3
617925	4q28.1	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3
614205	19q13.32	3-M syndrome 3	614205	AR	3
618433	6q21	Spermatogenic failure 38	618433	AR	3
617592	10q25.1	Spermatogenic failure 19	617592	AR	3
615081	17q21.2	Spermatogenic failure 11	615081	AD	3
617912	20q13.33	Congenital heart defects, multiple types, 5	617912	AR,AD	3
617364	14q12	Congenital heart defects and ectodermal dysplasia	617364	AD	3
618077	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
617822	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
616871	5q35.3	{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3
616323	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
618434	11q14.1	?Deafness, autosomal recessive 94	618434	AR	3
618316	17q25.1	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3
617707	17q22	?Spermatogenic failure 23	617707	AR	3
615082	6p22.1	[C3HEX, ability to smell]	615082	AD	3
617609	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
617686	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
616697	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
618110	14q32.33	?Spermatogenic failure 30	618110	AR	3
618221	12p13.32	Mental retardation, autosomal recessive 66	618221	AR	3
617926	4q28.1	?Orofaciodigital syndrome XVII	617926	AR	3
616402	1p21.2	?Microcephaly 14, primary, autosomal recessive	616402	AR	3
618187	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
617610	3q22.3	Polycystic kidney disease 5	617610	AR	3
618089	2p16.3	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3
616814	19p13.3	Preimplantation embryonic lethality	616814	AR	3
618435	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
618443	16p13.3	Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3
617687	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
618022	8q23.1	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3
617593	3q13.2	?Spermatogenic failure 20	617593	AR	3
617927	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
615922	9q32	Retinitis pigmentosa 70	615922	AD	3
618317	9p13.3	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3
618436	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
618090	2q31.1	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3
616815	17q11.2	Congenital disorder of glycosylation, type IIp	616829	AR	3
618188	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
618222	11q13.2	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3
617709	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
618091	4q12	?Spermatogenic failure 29	618091	AR	3
617825	22q11.21	?Glucocorticoid deficiency 5	617825	AR	3
617710	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
616846	1p36.13	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3
618223	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
614424	2q33.1	Joubert syndrome 14	614424	AR	3
617164	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
617928	2q21.1	Keratoconus 9	617928	AD	3
615923	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
618189	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
617690	9q34.3	Ovarian dysgenesis 5	617690	AR	3
617929	6p21.1	Epileptic encephalopathy, early infantile, 60	617929	AR	3
617965	14q32.2	?Spermatogenic failure 27	617965	AR	3
618092	14q32.2	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3
617691	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
617711	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
615924	11q12.3	Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3
618447	12p13.33	Long QT syndrome 8	618447	_	3
618437	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
617930	1p35	Chromosome 1p35 deletion syndrome	617930	AD	4
618093	16p13.3	?Spinocerebellar ataxia 48	618093	AD	3
617460	10q22.1	Retinitis pigmentosa 79	617460	AD	3
614207	11p15.4	Hyperphosphatasia with mental retardation syndrome 3	614207	AR	3
617712	7q11.23	Oocyte maturation defect 3	617712	AD	3
618438	15q15.1	?Spastic ataxia 9, autosomal recessive	618438	AR	3
617931	1p35.2	Spinocerebellar ataxia 47	617931	AD	3
618094	14q12	?Deafness, autosomal recessive 110	618094	AR	3
614426	8p12	Mental retardation, autosomal recessive 39	615541	AR	3
618112	16q22.2	Spermatogenic failure 31	618112	AR	3
617166	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
618321	13q34	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3
614464	7q32.2	Joubert syndrome 15	614464	AR	3
614427	18q22.3	Aural atresia, congenital	607842	AD	3
618193	6p21.1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	_	3
616654	12q24.31	Joubert syndrome 24	616654	AR	3
618027	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
616254	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
618440	11p15.1	Oculoskeletodental syndrome	618440	AR	3
614218	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
614218	17p13.3	Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3
618323	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
618095	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
617694	16q24.3	Al Kaissi syndrome	617694	AR	3
617933	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
618120	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
617695	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
617306	3p13	COMMAD syndrome	617306	AR	3
618469	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
617913	17p13.3	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3
614219	19p13.2	Adams-Oliver syndrome 2	614219	AR	3
618096	14q21.2	?Premature ovarian failure 15	618096	AR	3
614465	11q12.2	Joubert syndrome 16	614465	AR	3
618470	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
617308	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
614220	7q32	Biliary cirrhosis, primary, 4	614220	_	2
614466	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
614221	17q12	Biliary cirrhosis, primary, 5	614221	_	2
617330	10q26.3	Hypotonia, ataxia, and delayed development syndrome	617330	AD	3
618123	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
618224	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
616039	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
614222	10p12.1	Warburg micro syndrome 3	614222	AR	3
618124	21q22.3	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3
613339	10q21.3-q22.3	Epilepsy, hot water, 1	613339	AD	2
614223	19p13.2	Narcolepsy 6	614223	_	2
618225	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
618195	15q24.3	Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3
616324	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
616067	8q23.1	46XY sex reversal 9	616067	AD	3
614224	4q12	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3
616325	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
618196	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
617967	17p13.3	Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3
616040	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
618449	17q12	?Ciliary dyskinesia, primary, 41	618449	AR	3
617011	15q22.31	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3
618197	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
616326	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
614225	1q41	Warburg micro syndrome 2	614225	AR	3
617333	3p25.3	Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3
616917	4p16.3	Mental retardation, autosomal recessive 53	616917	AR	3
614226	11q24.2	Holoprosencephaly 11	614226	AD	3
616327	13q34	Mental retardation, autosomal dominant 40	616579	AD	3
618198	15q23	Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3
616918	4p16.3	Mental retardation, autosomal recessive 53	616917	AR	3
617970	1p36.11	Rh-null disease, amorph type	617970	_	3
614227	2p22.1-p21	Hyperuricemic nephropathy, familial juvenile, 3	614227	AD	2
617013	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
616042	6p21.1	?Deafness, autosomal recessive 103	616042	AR	3
618226	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
616069	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
618031	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
614228	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
618227	11p15.5	Ciliary dyskinesia, primary, 39	618254	AR	3
614229	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
614230	8q21.11	Chromosome 8q21.11 deletion syndrome	614230	IC,AD	4
618451	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
618228	1q23.3	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3
618229	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
618231	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
618453	7p22.1	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3
618454	7q22.1	Developmental delay with or without dysmorphic facies and autism	618454	AD	3
618455	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
617612	2q37.1	Joubert syndrome 30	617622	AR	3
618232	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
617613	9q21.33	Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3
614082	9p13.3	Fanconi anemia, complementation group G	614082	_	3
618233	5q12.1	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3
614083	2p16.1	Fanconi anemia, complementation group L	614083	AR	3
618234	15q15.1	Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3
617475	17q23.3	Specific granule deficiency 2	617475	AR	3
616404	2p11.2	Acrofacial dysostosis, Cincinnati type	616462	AD	3
616050	2p22.3	Autoinflammation with infantile enterocolitis	616050	AD	3
616051	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
616052	7p21.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3
614084	7q34	Oocyte maturation defect 5	617996	AR	3
618475	14q24.3	Paragangliomas 7	618475	AD	3
618476	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
618477	15q25.3	[Uridine-cytidineuria]	618477	AR	3
618479	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
618480	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
603859	7q21.3	Citrullinemia, adult-onset type II	603471	AR	3
603859	7q21.3	Citrullinemia, type II, neonatal-onset	605814	AR	3
606202	5p13.2	Albinism, oculocutaneous, type IV	606574	_	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	AR	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	AR	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	AR	3
605225	1p36	{Inflammatory bowel disease 7}	605225	_	2
604584	8p22	Colorectal cancer, somatic	114500	_	3
604584	8p22	Hepatocellular cancer, somatic	114550	_	3
607036	15q15.1	Isovaleric acidemia	243500	AR	3
604004	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603848	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
604983	17q23.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3
607072	3p21.31	Epilepsy, familial focal, with variable foci 2	617116	AD	3
603694	20q12-q13.1	{Diabetes mellitus, noninsulin-dependent}	125853	AD	2
604499	11p	Hyperlipidemia, combined, 2	604499	_	2
607250	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
604566	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
605236	4p12	Preeclampsia/eclampsia 5	614595	_	3
606236	17q25.3	Alveolar soft-part sarcoma	606243	_	3
603113	11q23.1	Lung cancer, somatic	211980	_	3
606608	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
607292	1q22	Cone-rod dystrophy 10	610283	AR	3
607292	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
606960	22q12.1-q12.2	Insulinoma	_	_	1
603707	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
607131	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
603495	19q13.43	Spermatogenic failure 5	243060	AR	3
605725	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
605725	19q13.2	Dejerine-Sottas disease	145900	AR,AD	3
605425	1p34.3	Erythrokeratodermia variabilis et progressiva 2	617524	AD	3
606053	2q24.2	Intellectual developmental disorder with autism and speech delay	606053	AD	3
604286	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
604484	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
605383	16p12.1	Immunodeficiency 56	615207	AR	3
605383	16p12.1	[IgE, elevated level of]	147050	AD	3
606635	21q21.1	Enterokinase deficiency	226200	AR	3
607479	18p11.22	Hypotrichosis 1	605389	AD	3
604433	11q13.4	?Brugada syndrome 6	613119	_	3
606763	19q13.42	Ciliary dyskinesia, primary, 2	606763	AR	3
605275	22q11.21	Noonan syndrome 2	605275	AR	3
606686	12q24.31	Leukoencephalopathy with vanishing white matter	603896	AR	3
606425	1q42.2	Erythrocytosis, familial, 3	609820	AD	3
606425	1q42.2	[Hemoglobin, high altitude adaptation]	609070	AD	3
602926	9q34.11	Epileptic encephalopathy, early infantile, 4	612164	AD	3
605073	17q22	Mulibrey nanism	253250	AR	3
604973	1p36.11	Immunodeficiency due to ficolin 3 deficiency	613860	AR	3
607408	13q33.2	{Schizophrenia}	181500	AD	2
606985	11p13	?Aniridia 2	617141	AD	3
607037	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
606566	20q11.21	Cardiomyopathy, hypertrophic, 1, digenic	192600	AD	3
605286	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
605872	19p13.2	SARS infection, protection against	605872	_	2
604258	8p22	Colorectal cancer, somatic	114500	_	3
605226	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
605115	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
606077	1p13.3	Megakaryoblastic leukemia, acute	606077	_	2
607447	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
607623	18q11.2	Niemann-Pick disease, type C1	257220	AR	3
607623	18q11.2	Niemann-Pick disease, type D	257220	AR	3
607170	3p25.3	Atrioventricular septal defect, partial, with heterotaxy syndrome	606217	AD	3
607170	3p25.3	{Atrioventricular septal defect, susceptibility to, 2}	606217	AD	3
605543	4q22.1	Parkinson disease 4	605543	AD	3
604455	9q34.2	[Sarcosinemia]	268900	AR	3
607361	8q22.1	Meckel syndrome 3	607361	AR	3
605336	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AR,AD	3
605336	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
606609	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AR,AD	3
606609	3p21.31	Chilblain lupus	610448	AD	3
606609	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
606609	3p21.31	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
605755	6p22.3	?Deafness, autosomal recessive 66	610212	AR	3
605755	6p22.3	Nephronophthisis 19	616217	AR	3
605755	6p22.3	Sclerosing cholangitis, neonatal	617394	AR	3
605692	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
607143	22q13.33	Congenital disorder of glycosylation, type Ig	607143	AR	3
604485	15q23	Enhanced S-cone syndrome	268100	AR	3
604485	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
606974	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
605978	9q21.2	Choreoacanthocytosis	200150	AR	3
606367	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
607839	3p12.2	Glycogen storage disease IV	232500	AR	3
607839	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
604190	5q31.1	{Rheumatoid arthritis, susceptibility to}	180300	_	3
607084	9q32	Deafness, autosomal recessive 31	607084	AR	3
607236	20p13	HARP syndrome	607236	AR	3
603860	16p12.3	Medullary cystic kidney disease 2	603860	_	3
605564	15q25.1	Deafness, autosomal recessive 48	609439	AR	3
605564	15q25.1	Usher syndrome, type IJ	614869	AR	3
608031	20p13	Amyotrophic lateral sclerosis 7	608031	_	2
605254	1q23.2	Acne inversa, familial, 1	142690	AD	3
605726	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
606323	5q33.3	Epileptic encephalopathy, early infantile, 65	618008	AD	3
605158	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
604720	7q22.1	Hemochromatosis, type 3	604250	AR	3
607329	2p25-p24	{Hypertension, essential, susceptibility to, 3}	145500	Mu	2
607186	4q26	Cole-Carpenter syndrome 2	616294	AR	3
605526	10q24	Alzheimer disease 6	605526	_	2
604610	15q26.1	Bloom syndrome	210900	AR	3
603422	5q31.1	{Osteoporosis, susceptibility to}	166710	AD	3
603023	7p12.2	Immunodeficiency, common variable, 13	616873	AD	3
605325	7q22.1	{Hypertension, salt-sensitive essential, susceptibility to}	145500	Mu	3
606078	22q13.1-q13.2	Megakaryoblastic leukemia, acute	_	_	3
604500	17q12	PEHO syndrome	260565	AR	3
607252	22q12.3	{Schizophrenia}	181500	AD	1
603048	8q24.3	Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3
604032	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
608111	2p16.1	Fanconi anemia, complementation group L	614083	AR	3
607204	1p35.2	Spinocerebellar ataxia 47	617931	AD	3
606962	17q25.1	Deafness, autosomal recessive 107	617639	AR	3
605517	11q13.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3
605452	2q35	Dyschromatosis universalis hereditaria 3	615402	AD	3
605452	2q35	Microphthalmia, isolated, with coloboma 7	614497	AD	3
605452	2q35	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	3
605452	2q35	[Blood group, Langereis system]	111600	_	3
604360	15q21.1	Spastic paraplegia 11, autosomal recessive	604360	AR	3
608264	22q11.21-q12.1	Deafness, autosomal recessive 40	608264	AR	2
607215	1p36.31	Nephronophthisis 4	606966	AR	3
607215	1p36.31	Senior-Loken syndrome 4	606996	AR	3
608309	1p36.12	Parkinson disease 6, early onset	605909	AR	3
603131	7q22.1	Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3
607038	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
604288	2q14-q22	Cardiomyopathy, dilated, 1H	604288	_	2
606368	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
606368	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
608035	1p22	{Melanoma, cutaneous malignant, 4}	608035	_	2
605185	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
607900	20p12.3	Kindler syndrome	173650	AR	3
605411	1p13.2	Brugada syndrome 9	616399	AD	3
605411	1p13.2	Spinocerebellar ataxia 19	607346	AD	3
604975	12p12.1	Lamb-Shaffer syndrome	616803	AD	3
608156	8q22.1	Nablus mask-like facial syndrome	608156	AD	4
603967	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
603967	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
603967	17q23.3	Myasthenic syndrome, congenital, 16	614198	AR	3
603967	17q23.3	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3
603967	17q23.3	Paramyotonia congenita	168300	AD	3
607521	11p15.1	Hermansky-Pudlak syndrome 5	614074	AR	3
608205	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
607624	15q21.3	Griscelli syndrome, type 2	607624	AR	3
605100	17q23.2	Breast cancer, somatic	114480	_	3
605100	17q23.2	Jansen de Vries syndrome	617450	AD	3
607135	3p	Creatinine clearance QTL	607135	_	2
606324	1p36.23	Parkinson disease 7, autosomal recessive early-onset	606324	AR	3
604772	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
603861	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
604103	5q31.2	Myopathy, myofibrillar, 3	609200	AD	3
604103	5q31.2	Myopathy, spheroid body	182920	AD	3
605848	19p13.12	Ichthyosis, congenital, autosomal recessive 12	617320	AR	3
605124	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
603457	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
603474	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
605039	20q11.21	Bohring-Opitz syndrome	605039	AD	3
604900	8q24.3	?Diarrhea 7, protein-losing enteropathy type	615863	AR	3
606142	4p16.1	Hypouricemia, renal, 2	612076	AR,AD	3
606142	4p16.1	{Uric acid concentration, serum, QTL 2}	612076	AR,AD	3
607481	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
606882	13q14.3	Wilson disease	277900	AR	3
603767	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
604501	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
604501	15q22.31	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3
608078	10q22.3	{Schizophrenia}	181500	AD	2
605938	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
603615	1p34.1	Adenocarcinoma, colonic, somatic	_	_	3
603615	1p34.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
603615	1p34.1	{Breast cancer, invasive ductal}	114480	SMu,AD	3
603516	22q13.31	Spinocerebellar ataxia 10	603516	AD	3
605000	16p11.2	Immunodeficiency 8	615401	AR	3
608429	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
604705	2q13	Retinitis pigmentosa 38	613862	AR	3
606056	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
606963	2q	Pulmonary disease, chronic obstructive, severe early-onset	606963	_	2
606829	9q21.11	Friedreich ataxia	229300	AR	3
606829	9q21.11	Friedreich ataxia with retained reflexes	229300	AR	3
604990	17q25.1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3
603010	7q31	Deafness, autosomal recessive 17	603010	AR	2
606407	2p21	Hypotonia-cystinuria syndrome	606407	AR	4
604297	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
604297	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
608414	10q23.33	Nephrotic syndrome, type 3	610725	AR	3
605727	7q34-q36	Otosclerosis 2	605727	_	2
606568	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
608310	7q11.21	Argininosuccinic aciduria	207900	AR	3
603290	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
604457	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
604457	2q37.1	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
607901	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
606034	19p13.13	Aicardi-Goutieres syndrome 4	610333	AR	3
605544	5q13-q22	Fibromatosis, gingival, 2	605544	_	2
604841	1p21.1	Stickler syndrome, type II	604841	AD	3
606687	2p23.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606687	2p23.3	Ovarioleukodystrophy	603896	AR	3
606854	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
606639	3q25.32	Combined oxidative phosphorylation deficiency 1	609060	AR	3
608265	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
607039	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
608036	5q34-q35.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	2
604588	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	AR,DR	3
604588	4q33	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3
607625	14q24.3	Niemann-pick disease, type C2	607625	AR	3
604611	8p12	Werner syndrome	277700	AR	3
608371	4q21-q31	Orofacial cleft 4	608371	_	2
608533	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
605289	3q28	Split-hand/foot malformation 4	605289	AD	3
608112	3p22.1	Epileptic encephalopathy, early infantile, 68	618201	AR	3
604773	11q25	Isobutyryl-CoA dehydrogenase deficiency	611283	_	3
608241	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
606999	9p13.3	Galactosemia	230400	AR	3
608331	5q33.1	Hyperglycinuria	138500	AD	3
608331	5q33.1	Iminoglycinuria, digenic	242600	AR,DR	3
608283	12q12	Fibrosis of extraocular muscles, congenital, 1	135700	AD	3
608283	12q12	Fibrosis of extraocular muscles, congenital, 3B	135700	AD	3
605101	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
606988	15q15.1	?Spastic ataxia 9, autosomal recessive	618438	AR	3
608100	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
604901	16q22	North American Indian childhood cirrhosis	604901	_	2
606475	19p13.2	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	_	3
604289	8q22.1	Colon cancer, somatic	114500	_	3
604289	8q22.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
603056	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
608443	19p13.12	Mental retardation, autosomal recessive 3	608443	AR	3
607053	8q23	[High density lipoprotein cholesterol level QTL 2]	607053	_	2
604526	20p13	Retinitis pigmentosa 46	612572	_	3
605714	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
603517	1p22.3	?Immunodeficiency 37	616098	AR	3
603517	1p22.3	Lymphoma, MALT, somatic	137245	_	3
603517	1p22.3	{Lymphoma, follicular, somatic}	605027	_	3
603517	1p22.3	{Male germ cell tumor, somatic}	273300	_	3
603517	1p22.3	{Mesothelioma, somatic}	156240	_	3
603517	1p22.3	{Sezary syndrome, somatic}	_	_	3
606370	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
607482	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
607411	12q24	{Patent ductus arteriosus, susceptibility to}	607411	AR	2
606062	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
606640	18q21	Amyotrophic lateral sclerosis 3	606640	AD	2
606830	9q21.33	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3
606035	6q22-q24	[Fasting insulin level quantitative trait locus 1]	606035	_	2
605728	15q21-q22	Cataract 25	605728	_	2
603024	1p36.11	Coffin-Siris syndrome 2	614607	AD	3
608645	6p21.3	Deafness, autosomal dominant 31	608645	AD	2
607364	1p36.13	Bartter syndrome, type 3	607364	AR	3
607961	15q24.1	[Blood group, John-Milton-Hagen system]	614745	_	3
602959	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
602959	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
606144	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
608695	9q22	Glaucoma, primary open angle, juvenile-onset, 2	608695	_	2
606408	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
607040	16q12.1	[Axillary odor, variation in]	117800	AD	3
607040	16q12.1	[Colostrum secretion, variation in]	117800	AD	3
607040	16q12.1	[Earwax, wet/dry]	117800	AD	3
604159	11p15.1	Hyperekplexia 3	614618	AR,AD	3
606129	8p23.3-p22	Diamond-Blackfan anemia 2	606129	_	2
603850	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
603850	12p11.21	Optic atrophy 5	610708	AD	3
602935	1p33	{Drug addiction, susceptibility to}	606581	_	3
605849	5q14.1	Dimethylglycine dehydrogenase deficiency	605850	AR	3
606325	6q21	?Heterotaxy, visceral, 3, autosomal	606325	_	2
605290	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
605290	3q29	Behr syndrome	210000	AR	3
605290	3q29	Optic atrophy 1	165500	AD	3
605290	3q29	Optic atrophy plus syndrome	125250	AD	3
605290	3q29	{Glaucoma, normal tension, susceptibility to}	606657	_	3
608480	6p21.31	Spermatogenic failure 3	606766	AD	3
608271	1p34.3	Lissencephaly 9 with complex brainstem malformation	618325	AD	3
606883	12q12	Invasive pneumococcal disease, recurrent isolated, 1	610799	_	3
606883	12q12	IRAK4 deficiency	607676	_	3
604723	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
606476	19q13.2	{Kawasaki disease, susceptibility to}	611775	_	3
608010	7p13	[Ezetimibe, nonresponse to]	617966	_	3
608010	7p13	[Low density lipoprotein cholesterol level QTL 7]	617966	_	3
606551	8p21.3	Esophageal squamous cell carcinoma, somatic	133239	_	3
608633	11q22.3	{Sepsis, susceptibility to}	_	_	3
604902	14q32.33	Cerebellofaciodental syndrome	616202	AR	3
605267	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
607823	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
605361	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
608603	15q21.2	Lethal congenital contracture syndrome 11	617194	AR	3
603883	10q26.11	Cardiomyopathy, dilated, 1HH	613881	AD	3
603883	10q26.11	Myopathy, myofibrillar, 6	612954	AD	3
608723	6p24.1	Epileptic encephalopathy, early infantile, 70	618298	AD	3
607903	18q12.1	Hypotrichosis 6	607903	AR	3
606036	15q25.1	?Webb-Dattani syndrome	615926	AR	3
608390	17q23.3	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3
607136	6q27	Spinocerebellar ataxia 17	607136	AD	3
603057	11p15.4	Mitral valve prolapse 2	607829	AD	3
603057	11p15.4	Van Maldergem syndrome 1	601390	AR	3
603025	11q14.2	Leukemia, acute myeloid, somatic	601626	_	3
606831	2p22.3	?Familial cold autoinflammatory syndrome 4	616115	AD	3
606831	2p22.3	Autoinflammation with infantile enterocolitis	616050	AD	3
606641	7q32.3	[Body mass index QTL1]	606641	_	2
608177	8q24.11	Chondrosarcoma	215300	AR	3
608177	8q24.11	Exostoses, multiple, type 1	133700	AD	3
608646	15q13.1-q15.1	Ciliary dyskinesia, primary, 4	608646	_	2
607311	11q22.1	?Progesterone resistance	264080	AR	2
603254	19p13.2	Coffin-Siris syndrome 4	614609	AD	3
603254	19p13.2	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3
605850	5q14.1	Dimethylglycine dehydrogenase deficiency	605850	AR	3
607453	3q28	?Deafness, autosomal dominant 44	607453	AD	3
606269	22q13.2	Immunodeficiency, common variable, 4	613494	AR	3
606409	20q11.22	Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3
603769	14q32.13	Leukemia/lymphoma, T-cell	603769	_	2
607365	3q27.2	Hypotrichosis 7	604379	AR	3
607365	3q27.2	Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379	AR	3
603851	4p13	Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	AD	3
603851	4p13	Neuroblastoma with Hirschsprung disease	613013	_	3
603851	4p13	{Neuroblastoma, susceptibility to, 2}	613013	_	3
607626	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
608634	7q11.23	Neuropathy, distal hereditary motor, type IIB	608634	AD	3
603678	7q31	Deafness, autosomal recessive 14	603678	AR	2
608416	10q26.2	Heterotaxy, visceral, 7, autosomal	616749	AR	3
605670	11q23.3	Retinal degeneration, late-onset, autosomal dominant	605670	AD	3
605744	8p21.1	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3
605268	16q24.2	Huntington disease-like 2	606438	AD	3
606966	1p36.31	Nephronophthisis 4	606966	AR	3
606989	17q22	Myeloperoxidase deficiency	254600	AR	3
606989	17q22	{Alzheimer disease, susceptibility to}	104300	AD	3
606989	17q22	{Lung cancer, protection against, in smokers}	_	_	3
608256	11q23.3	Atrial fibrillation, familial, 17	611819	AD	3
608256	11q23.3	Long QT syndrome-10	611819	AD	3
607276	10q25.3	[Resting heart rate]	607276	_	3
606145	20q13.12	Arterial tortuosity syndrome	208050	AR	3
605362	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
607243	14q12	Spastic paraplegia 52, autosomal recessive	614067	AR	3
608243	15q13.1	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3
608391	Chr.7	{Autoimmune disease, susceptibility to, 2}	608391	_	2
607137	4q21.22	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3
603026	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
606326	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
606037	3q13.1-q13.2	C syndrome	211750	AD	3
606754	20q11.23	?Chilblain lupus 2	614415	AD	3
606754	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
608313	6q23.2	Argininemia	207800	AR	3
608696	20p12	Glaucoma 1K, primary open angle, juvenile-onset	608696	_	2
605555	11q13.2	Pituitary adenoma 1, multiple types	102200	SMu,AD	3
605555	11q13.2	Pituitary adenoma predisposition	102200	SMu,AD	3
607454	1p36.33	Spinocerebellar ataxia 21	607454	AD	3
604088	7p14.3	{Hypercholesterolemia, susceptibility to}	143890	AD	3
607042	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
608272	6p21.33	Sialidosis, type I	256550	AR	3
608272	6p21.33	Sialidosis, type II	256550	AR	3
608647	16q22.2	Ciliary dyskinesia, primary, 5	608647	AR	3
603258	8p11.21	Immunodeficiency 15A	618204	AD	3
603258	8p11.21	Immunodeficiency 15B	615592	AR	3
606570	7p14.1	Pyle disease	265900	AR	3
606781	3p21.1	Short stature, developmental delay, and congenital heart defects	617044	AR	3
607984	5q31.3	Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3
608565	14q24.3	Deafness, autosomal recessive 35	608565	AR	3
608980	9p22.3	Bifid nose with or without anorectal and renal anomalies	608980	_	3
608662	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
608662	11p14.3	Miyoshi muscular dystrophy 3	613319	AR	3
608662	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
606478	7q31.33	{Glioma susceptibility 9}	616568	AD	3
606478	7q31.33	{Melanoma, cutaneous malignant, susceptibility to, 10}	615848	AD	3
608380	2q31.3	Retinitis pigmentosa 26	608380	_	3
607008	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
603518	2p13.3	Welander distal myopathy	604454	AR,AD	3
609040	12p11.21	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3
604714	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
608536	19p13.11	Combined oxidative phosphorylation deficiency 23	616198	AR	3
608803	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608803	1q42.13	Lymphatic malformation 3	613480	AD	3
608803	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
606990	3q23	?Microcephaly 19, primary, autosomal recessive	617800	AR	3
605363	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
608392	Chr.8	{Autoimmune disease, susceptibility to, 3}	608392	_	2
606967	16q22.1	Fish-eye disease	136120	AR	3
606967	16q22.1	Norum disease	245900	AR	3
607244	15q21.2	Spastic paraplegia 51, autosomal recessive	613744	AR	3
607244	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
608744	1p13.3	Fontaine progeroid syndrome	612289	AD	3
606833	7q36.1	Kleefstra syndrome 2	617768	AD	3
608697	2p13.3	Premature ovarian failure 6	612310	AD	3
608611	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
605229	3q27-q28	Spastic paraplegia 14, autosomal recessive	605229	AR	2
603136	2q36.2	Pseudohypoaldosteronism, type IIE	614496	AD	3
608684	14q22.1	?Seckel syndrome 7	614851	AR	3
605988	10p13	Omenn syndrome	603554	AR	3
605988	10p13	Severe combined immunodeficiency, Athabascan type	602450	AR	3
603644	17p13.1	Mitochondrial complex IV deficiency	220110	Mi,AR	3
608918	17p11.2	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3
607277	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
607043	6q21	?Candidiasis, familial, 8	615527	AR	3
607043	6q21	{Psoriasis susceptibility 13}	614070	_	3
606373	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
606421	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
606271	1q42.2	Schizophrenia	181500	AD	2
607474	3q13.33	Alkaptonuria	203500	AR	3
606520	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
609247	3q25.1	Epileptic encephalopathy, early infantile, 73	618379	AD	3
606837	8q11.23	Breast cancer, somatic	114480	_	3
607009	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
604824	13q13.1	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	_	3
608663	12q12	Scott syndrome	262890	AR	3
603339	7p15.3	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3
606643	13q14	[Body mass index QTL2]	606643	_	2
608648	6q21	Polycystic liver disease 2	617004	AD	3
609141	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
606890	14q31.3	Krabbe disease	245200	AR	3
604715	16q12.2	?Orthostatic intolerance	604715	_	3
606834	19q13.12	Dystonia 28, childhood-onset	617284	AD	3
608445	3p12-q13	{Speech-sound disorder}	608445	_	2
607245	1p13.2	Spastic paraplegia 47, autosomal recessive	614066	AR	3
605588	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
605041	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
607840	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
607840	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
604757	5q35.2	Craniosynostosis 2	604757	AD	3
605032	4p16.3	Epileptic encephalopathy, early infantile, 63	617976	AR	3
609382	18q21.1	Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3
608526	1q25	Periodontitis, aggressive, 2	608526	_	2
608393	13q12.12-q12.13	Microcephaly 6, primary, autosomal recessive	608393	AR	3
607278	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
609302	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
609195	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
604487	11p15.1	Deafness, autosomal recessive 18B	614945	AR	3
608013	1q22	Gaucher disease, perinatal lethal	608013	AR	3
607475	15q26.1	Bothnia retinal dystrophy	607475	AR	3
608636	15q11	{Autism susceptibility 4}	608636	AD	2
608354	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
607323	20q13.2	Duane-radial ray syndrome	607323	AD	3
608194	14q11.2	Cone-rod dystrophy 13	608194	_	3
606628	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
609053	15q26.1	Fanconi anemia, complementation group I	609053	AR	3
605270	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
609628	18p11.31	Majeed syndrome	609628	_	3
608419	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
606480	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
606480	1p34.2	Restrictive dermopathy, lethal	275210	AR	3
604161	19p13.3	?Precocious puberty, central, 1	176400	AD	3
604161	19p13.3	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3
604758	19q13.32	?Immunodeficiency 53	617585	AR	3
608699	7p14.3	Diaphanospondylodysostosis	608022	AR	3
607279	11q14	{Systemic lupus erythematosus with hemolytic anemia}	607279	_	2
605589	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
603646	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
603646	10q24.2	Leigh syndrome due to cytochrome c oxidase deficiency	256000	Mi,AR	3
603424	2q31.2	Dystonia 16	612067	AR	3
607246	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
608897	17q25.1	Hemophagocytic lymphohistiocytosis, familial, 3	608898	_	3
605042	6q23.2	Mental retardation, autosomal recessive 18	614249	AR	3
609196	21q22.11	Glucocorticoid deficiency 2	607398	AR	3
609657	5q	{Bone size QTL}	609657	_	2
604488	17q12	Cardiomyopathy, hypertrophic, 25	607487	AD	3
604488	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
603060	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
609510	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
607476	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
609314	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
609449	16p13.11	?Microhydranencephaly	605013	AR	3
609449	16p13.11	Lissencephaly 4 (with microcephaly)	614019	AR	3
608572	18q23	Burn-McKeown syndrome	608572	AR	3
609750	10q25-q26	{Epilepsy, idiopathic generalized, susceptibility to 4}	609750	_	2
608804	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608990	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
608890	8q11.21	Waardenburg syndrome, type 2D	608890	AR	3
609332	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
608433	1q44	Mental retardation, autosomal dominant 22	612337	AD	3
605364	19p13	{Psoriasis susceptibility 6}	605364	_	2
609279	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
609279	13q12.12-q12.13	Microcephaly 6, primary, autosomal recessive	608393	AR	3
608151	4p14	?Cranioectodermal dysplasia 4	614378	AR	3
608151	4p14	?Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3
608151	4p14	Nephronophthisis 13	614377	AR	3
608151	4p14	Senior-Loken syndrome 8	616307	AR	3
606374	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
607324	19p13.2-p13.1	Polydactyly, postaxial, type A3	607324	_	2
609575	17p13.1	VLCAD deficiency	201475	AR	3
608665	17q21.2	Ovarian dysgenesis 3	614324	AR	3
609383	5q33.3	Ichthyosis, congenital, autosomal recessive 6	612281	AR	3
604759	12q23.2	Pregnancy loss, recurrent, 4	270960	AD	3
604759	12q23.2	Spermatogenic failure 4	270960	AD	3
609669	5q22.1	Glaucoma 1, open angle, G	609887	_	3
609237	3q13.33	Senior-Loken syndrome 5	609254	AR	3
608394	2p12	Deafness, autosomal dominant 43	608394	AD	2
607631	6p12.2	{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3
608649	9q34.11	Ichthyosis prematurity syndrome	608649	_	3
609435	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
609435	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
604717	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
606765	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
605602	4q26	Cardiomyopathy, hypertrophic, 16	613838	AD	3
603708	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
609528	22q11.21	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3
608022	7p14.3	Diaphanospondylodysostosis	608022	AR	3
608179	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
609695	12q24.31	Hawkinsinuria	140350	AD	3
609695	12q24.31	Tyrosinemia, type III	276710	AR	3
603647	2q35	Bjornstad syndrome	262000	AR	3
603647	2q35	GRACILE syndrome	603358	_	3
603647	2q35	Leigh syndrome	256000	Mi,AR	3
603647	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
609454	1q31.1	Supranuclear palsy, progressive, 2	609454	AD	2
609736	2p16.1	?PEHO syndrome-like	617507	AR	3
608700	1p36.22	Leber congenital amaurosis 9	608553	AR	3
605231	20p12.2	Bardet-Biedl syndrome 6	605231	AR	3
608014	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
608014	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
609197	8q11.2-q13.2	Glucocorticoid deficiency 3	609197	AR	2
606893	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
608805	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
609640	14q22.1-q22.3	Frias syndrome	609640	AD	4
608901	3q21.1-q21.2	{Coronary heart disease, susceptibility to, 5}	608901	_	3
608747	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
609670	11q24	{Migraine with aura, susceptibility to, 9}	609670	_	2
609280	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
608666	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
608666	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
604083	2q35	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3
603709	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
609988	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
609988	4q24	Sudden cardiac failure, infantile	617222	AR	3
608728	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
609529	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
608612	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
609751	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
610066	20q13	{Systemic lupus erythematosus, susceptibility to, 8}	610066	_	2
603266	10q25	{Diabetes mellitus, insulin-dependent, 17}	603266	_	2
606766	6p21.31	Spermatogenic failure 3	606766	AD	3
607248	15q23-q26.3	{Glioma susceptibility 4}	607248	_	2
607179	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
605232	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
605232	12p13.33	Pseudohypoaldosteronism, type IIC	614492	AD	3
608404	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
609346	19p13.3	Retinitis pigmentosa 77	617304	AR	3
608687	11q12	Spinocerebellar ataxia 20	608687	AD	4
604733	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
609512	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
609512	3p11.2	Dementia, familial, nonspecific	600795	AD	3
609289	15q26	Syncope, familial vasovagal	609289	AD	2
609630	11p11	{Leukemia, chronic lymphocytic, susceptibility to, 1}	609630	_	2
607326	18q21.1	Smith-McCort dysplasia	607326	AR	3
609502	10q23.1	Cone-rod dystrophy 15	613660	AR	3
609502	10q23.1	Retinitis pigmentosa 65	613660	AR	3
609671	2q14.2	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3
608667	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
608751	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AR,AD	3
609875	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
608922	3q11.1-q11.2	Joubert syndrome 8	612291	AR	3
610202	16q23.2	Cataract 21, multiple types	610202	AD	3
608892	8q12.2	CHARGE syndrome	214800	AD	3
608892	8q12.2	Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3
610034	12q24.31	Mucopolysaccharidosis-plus syndrome	617303	AR	3
610219	2q31.2	Deafness, autosomal recessive 59	610220	AR	3
609530	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
608447	12q24	Carotid intimal medial thickness	608447	_	2
609822	1p21	{Stature QTL 7}	609822	_	2
608180	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
610015	1q25.3	Glutamine deficiency, congenital	610015	AR	3
604364	22q12.2-q12.3	Epilepsy, familial focal, with variable foci 1	604364	AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal dominant	615625	AR,AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal recessive	615625	AR,AD	3
610239	4q32.3	[High density lipoprotein cholesterol level QTL 4]	610239	_	2
609317	5q22.3	?Anencephaly	206500	AR	3
610513	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
610513	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
610256	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
609787	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
603400	6q21	Arthropathy, progressive pseudorheumatoid, of childhood	208230	AR	3
603400	6q21	Spondyloepiphyseal dysplasia tarda with progressive arthropathy	208230	AR	3
610535	5q22.1-q32	Glaucoma 1, open angle, M	610535	AD	2
608668	10p15.3	Mental retardation, autosomal dominant 30	616083	AD	3
610475	2q31.2	Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3
608893	5p15.33	Hartnup disorder	234500	AR	3
608893	5p15.33	Hyperglycinuria	138500	AD	3
608893	5p15.33	Iminoglycinuria, digenic	242600	AR,DR	3
604982	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
608752	11q23.3	Retinal degeneration, late-onset, autosomal dominant	605670	AD	3
609886	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
610162	1p35.2	{Bardet-Biedl syndrome 1, modifier of}	209900	AR,DR	3
608614	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
610035	1q21.2	Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3
610220	2q31.2	Deafness, autosomal recessive 59	610220	AR	3
608688	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
604677	5q13.3	Mental retardation, autosomal dominant 34	616351	AD	3
610647	4p16.3	?N-acetylaspartate deficiency	614063	AR	3
609631	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
607632	19q13.12	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3
610271	17q11.2	Glycosylphosphatidylinositol biosynthesis defect 18	618143	AR	3
609823	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
610140	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
609470	11p15	Left ventricular noncompaction 2	609470	_	2
603401	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
603711	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
603711	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
608396	3q24	{?Autism susceptibility 16}	613410	_	3
605746	16q13-q21	Anisomastia	605746	_	2
610069	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
605235	16q22.1	?Myoclonus, familial, 1	614937	AD	3
610685	6q14.1	Split-hand/foot malformation with long bone deficiency 2	610685	_	2
610840	13q31.3-q32.1	Mitral valve prolapse, myxomatous 3	610840	AD	2
609006	1p36.31	Deafness, autosomal recessive 36	609006	AR	3
608730	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
610859	16q22.1	Immunodeficiency 58	618131	AR	3
610536	17q21.31	Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3
607841	12q13-q14	Deafness, autosomal dominant 48	607841	AD	2
610648	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
610662	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
610359	2q11.2	Retinitis pigmentosa 33	610359	AD	3
609439	15q25.1	Deafness, autosomal recessive 48	609439	AR	3
609577	6p21.1	3-M syndrome 1	273750	AR	3
608187	20p12.3	?Premature ovarian failure 10	612885	AR	3
610804	1p31.3	Schneckenbecken dysplasia	269250	AR	3
610017	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
610222	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
608652	9p22-p21	Deafness, autosomal dominant 47	608652	AD	2
610141	1q23.3	[QT interval, variation in]	610141	_	2
610272	20q13.12	?Paroxysmal nocturnal hemoglobinuria 2	615399	SMu,AD	3
610272	20q13.12	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3
609887	5q22.1	Glaucoma 1, open angle, G	609887	_	3
608691	15q25.3-q26.2	Major depressive disorder 2	608516	_	2
609952	4q12-q13.2	Deafness, autosomal recessive 55	609952	AR	2
608840	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	AR	3
609753	19p13.11	{Celiac disease, susceptibility to, 4}	609753	_	3
611023	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
607633	2p23.1	Xanthinuria, type I	278300	AR	3
609745	15q11-q13	Glaucoma 1, open angle, I	609745	_	2
609007	12q12	{Parkinson disease 8}	607060	AD	3
610649	8q24	[Bone size quantitative trait locus 3]	610649	_	2
609578	10q23.3	Cardiomyopathy, familial restrictive, 2	609578	_	2
611064	12q14.3	{Asthma susceptibility 5}	611064	_	3
611034	6p22.2	[Uric acid concentration, serum, QTL4]	612671	AD	3
611034	6p22.2	{Gout susceptibility 4}	612671	AD	3
603846	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
609888	10p13	{Leprosy, paucibacillary type, susceptibility to}	609888	_	2
608615	17q24.1	Oligodontia-colorectal cancer syndrome	608615	AD	3
610549	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
606075	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
606075	10q24.31	Perrault syndrome 5	616138	AR	3
606075	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
609471	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
610676	17q21	{Autism susceptibility 7}	610676	_	2
609754	5q31-q33	{Celiac disease, susceptibility to, 2}	609754	_	2
607634	11q13.2	Osteopetrosis, autosomal dominant 1	607634	AD	3
610290	9q22.33	{Colorectal cancer, susceptibility to, 1}	608812	_	3
610326	13q14.3	Aicardi-Goutieres syndrome 2	610181	AR	3
608841	19p13.11	Anterior segment dysgenesis 8	617319	AR	3
610071	2p14-p13.3	Hyperparathyroidism 3	610071	_	2
611065	4q22.1	?Maple syrup urine disease, mild variant	615135	_	3
609856	3q26.31	?Spermatogenic failure 6	102530	AR	3
608732	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
606164	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
611177	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
609981	8q11.21	Immunodeficiency 54	609981	AR	3
609755	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
611107	1p21.1-p13.3	Mental retardation, autosomal recessive, 4	611107	AR	2
610478	12p13.33	Retinal cone dystrophy 4	610478	AR	3
610550	10q22.3	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850	AR,AD	3
610550	10q22.3	Methionine adenosyltransferase deficiency, autosomal recessive	250850	AR,AD	3
608653	1p21.2	Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3
607012	5q13.2	?Deafness, autosomal recessive 112	618257	AR	3
610260	16p13-p12	Pyloric stenosis, infantile hypertrophic, 2	610260	_	2
610453	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
610453	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
609653	5q12.1	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3
609797	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
609797	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3
611225	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
610965	16p13.12	XFE progeroid syndrome	610965	AR	3
611302	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
609954	3p24-p21	{Asperger syndrome susceptibility 4}	609954	_	2
610860	1p21.2	Glycogen storage disease IIIa	232400	AR	3
610860	1p21.2	Glycogen storage disease IIIb	232400	AR	3
610931	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
608400	1q41	Retinitis pigmentosa 39	613809	_	3
608400	1q41	Usher syndrome, type 2A	276901	AR	3
610516	3p21.2	D-glyceric aciduria	220120	AR	3
609579	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
610551	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
609955	2p23.3-p22.3	Fibromatosis, gingival, 3	609955	_	2
611378	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
611423	4q12	Microcephaly 8, primary, autosomal recessive	614673	AR	3
610655	7p14	Telangiectasia, hereditary hemorrhagic, type 4	610655	AD	2
605763	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
610753	16q11-q22	Alopecia areata 2	610753	AR,AD	2
611109	4q32.3	[Cinnamon odor, pleasantness of]	611109	_	2
604741	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
611037	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
604165	17p13.2	Paragangliomas 6	618464	AD	3
610966	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
610966	16q12.2	{Obesity, susceptibility to, BMIQ14}	612460	AR	3
605130	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
610706	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
610665	1q23.3	Neutropenia, alloimmune neonatal	_	_	3
609790	9p22.1	Alzheimer disease-11	609790	_	2
610019	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
611642	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3
611642	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	AD	3
611291	2q35	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	_	3
611654	8q13.1-q13.2	Joubert syndrome 21	615636	AR	3
611724	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
610967	11p15.5	Osteogenesis imperfecta, type V	610967	AD	3
609798	14q24.3	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3
609798	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
609798	14q24.3	Nevus comedonicus, somatic	617025	_	3
603009	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
603009	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
603009	2p13.2	Myopathy, distal, with anterior tibial onset	606768	AR	3
610460	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
611038	18q21.32	Microphthalmia, isolated 3	611038	AR	3
603734	19q13.33	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3
606652	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
606768	2p13.2	Myopathy, distal, with anterior tibial onset	606768	AR	3
610036	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
609782	4q31	Aortic aneurysm, familial abdominal 2	609782	_	2
605131	16q23.1-q23.2	Epileptic encephalopathy, early infantile, 28	616211	AR	3
605131	16q23.1-q23.2	Esophageal squamous cell carcinoma, somatic	133239	_	3
605131	16q23.1-q23.2	Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3
609791	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
609352	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
610968	17q21.2	Osteogenesis imperfecta, type XI	610968	AR	3
611725	7q11.21	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3
610863	3q26.33	Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3
604432	15q15.2	Spinocerebellar ataxia 11	604432	AD	3
609868	14q31.3	Leber congenital amaurosis 3	604232	_	3
609868	14q31.3	Retinitis pigmentosa, juvenile, autosomal recessive	604232	_	3
611953	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
609656	17q23	{Bone size QTL}	609656	_	2
610657	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
610657	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
611892	9p21	{Aneurysm, intracranial berry, 6}	611892	_	2
611655	2q33.1	Mental retardation, autosomal recessive 42	615802	AR	3
610755	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
609985	4q31-q34	Panic disorder 3	609985	_	2
612083	14q24.3	Muscle strength quantitative trait locus 1	612083	_	2
604685	7p15.2	?Microtia, hearing impairment, and cleft palate (AR)	612290	AR,AD	3
604685	7p15.2	Microtia with or without hearing impairment (AD)	612290	AR,AD	3
611867	22q11.2	Chromosome 22q11.2 deletion syndrome, distal	611867	_	4
611379	12q13.12	Mental retardation, FRA12A type	136630	AD	3
611242	20p13	{Restless legs syndrome 5}	611242	_	2
609353	8p21.1	Roberts syndrome	268300	AR	3
609353	8p21.1	SC phocomelia syndrome	269000	AR	3
609799	17q11.2	?Nephronophthisis 9	613824	_	3
609799	17q11.2	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3
609253	18p11.2	Febrile seizures, familial, 6	609253	AD	2
604167	16q22.1	Mental retardation, autosomal dominant 21	615502	AD	3
609721	7p12.3	Heterotaxy, visceral, 8, autosomal	617205	AR	3
607522	10q24.32	Hermansky-Pudlak syndrome 6	614075	AR	3
611893	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
611040	11q23.3	Microphthalmia, isolated 5	611040	AR	3
611295	3q27.1	Epidermolysis bullosa simplex, generalized, with scarring and hair loss	617294	AD	3
611026	16q23.1	Spastic paraplegia 35, autosomal recessive	612319	AR	3
611549	13q32.3-q33.1	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3
611549	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
610552	3q22.1	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3
610552	3q22.1	Epileptic encephalopathy, early infantile, 44	617132	AR	3
610842	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
609010	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
612223	7q21	{Stature QTL 11}	612223	_	2
612048	3p25.1	Arrhythmogenic right ventricular dysplasia 5	604400	AD	3
612048	3p25.1	Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3
611726	7q11.21	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3
606770	5p15.2-p14	{Adiponectin, serum level of, QTL2}	606770	_	2
610341	3q28	Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3
611876	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
609254	3q13.33	Senior-Loken syndrome 5	609254	AR	3
609354	11q23	[Bone mineral density QTL 5]	609354	_	2
611934	10p11.22	{Epilepsy, idiopathic generalized, susceptibility to, 5}	611934	_	2
607523	3p21.31	Toenail dystrophy, isolated	607523	AD	3
609800	2p24	Epilepsy, generalized, with febrile seizures plus, type 4	609800	AD	2
611955	17q12	{Prostate cancer, hereditary, 11}	611955	_	2
611550	6p21.33	{Malaria, mild, susceptibility to}	609148	_	3
609239	13q14.2	Hypotrichosis 8	278150	AR	3
609239	13q14.2	Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	AR	3
605764	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
609069	10p12.2	Pancreatic and cerebellar agenesis	609069	AR	3
610553	13q13.3	Leukodystrophy, hypomyelinating, 14	617899	AR	3
610773	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
612310	2p13.3	Premature ovarian failure 6	612310	AD	3
611381	1p22	{Kala-azar, susceptibility to, 2}	611381	_	2
612283	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
612283	2q14.3	Thrombophilia due to protein C deficiency, autosomal recessive	612304	AR	3
612460	16q12.2	{Obesity, susceptibility to, BMIQ14}	612460	AR	3
612349	12q23.2	Phenylketonuria	261600	AR	3
612349	12q23.2	[Hyperphenylalaninemia, non-PKU mild]	261600	AR	3
611895	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
609070	1q42.2	[Hemoglobin, high altitude adaptation]	609070	AD	3
609802	15q21.1	Albinism, oculocutaneous, type VI	113750	AR	3
609802	15q21.1	[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	AR	3
610329	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
611014	18q21.2	{Hypertension, essential, susceptibility to, 8}	611014	_	2
612369	10q21	{Alkaline phosphatase, plasma level of, QTL4}	612369	_	2
610661	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
610898	11p12-p11	Supranuclear palsy, progressive, 3	610898	_	2
610844	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
610844	15q21.1	Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3
610844	15q21.1	Spastic paraplegia 11, autosomal recessive	604360	AR	3
611382	6q27	{Kala-azar, susceptibility to, 3}	611382	_	2
609264	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
611428	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
611428	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
612311	2q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 5}	612311	_	2
612659	6q22.1	Mitchell-Riley syndrome	615710	AR	3
612753	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
612271	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
610670	4q25	Spastic paraplegia 56, autosomal recessive	615030	AR	3
608532	7q36.3	Kahn-Kahn-Katsanis syndrome	618460	AR	3
612718	15q21.1	Cerebral creatine deficiency syndrome 3	612718	AR	3
611015	7q31	{Autism, susceptibility to, 9}	611015	_	2
603084	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
612626	15q26-qter	Chromosome 15q26-qter deletion syndrome	612626	IC	4
609102	16q24.2	?Mental retardation, autosomal recessive 45	615979	AR	3
611067	1p36.31	Spinal muscular atrophy, distal, autosomal recessive, 4	611067	AR	3
610330	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
610554	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
612796	13q13.3	{Inflammatory bowel disease 27}	612796	_	2
609039	21q11.2	Narcolepsy 3	609039	AD	2
612853	2p14-p13	{Restless legs syndrome 7}	612853	_	2
612370	8q12.2	Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3
608654	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
612335	4p16-p15	Spastic paraplegia 38, autosomal dominant	612335	AD	2
610798	1q22	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3
612520	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
612312	13q12.11	{Attention deficit-hyperactivity disorder, susceptibility to, 6}	612312	_	2
611521	19p13.2	Immunodeficiency 35	611521	AR	3
609265	22q12.1	Li-Fraumeni syndrome	609265	_	3
612567	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
611897	2q11-q14	Nanophthalmos 3	611897	_	2
610936	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
610936	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
612911	3p21.31	Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3
612900	9p24.3	Cerebral palsy, spastic quadriplegic, 2	612900	_	3
611879	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
612719	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
605060	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
612003	2q37.1	{Parkinson disease 11}	607688	_	3
609413	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
609413	10q11.23	Cockayne syndrome, type B	133540	AR	3
609413	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
609413	10q11.23	Premature ovarian failure 11	616946	AD	3
609413	10q11.23	UV-sensitive syndrome 1	600630	AR	3
609413	10q11.23	{Lung cancer, susceptibility to}	211980	SMu,AD	3
609413	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
609975	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
612371	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
609831	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type	277400	AR	3
612702	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
611016	7q36	{Autism, susceptibility to, 10}	611016	_	2
612521	6q25	{Diabetes mellitus, insulin-dependent, 21}	612521	_	2
606759	15q21.1	Thyroid dyshormonogenesis 6	607200	AR	3
613088	9q21	{Pelvic organ prolapse, susceptibility to, 2}	613088	_	2
611430	3p22.2	Spermatogenic failure 37	618429	AR	3
613065	10q21	{Leukemia, acute lymphocytic, susceptibility to, 1}	613065	_	2
610370	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
612797	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
612313	2q33.1	Glass syndrome	612313	AD	3
611630	4q13.2-q21.3	Epilepsy, familial temporal lobe, 3	611630	AD	2
604687	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
612004	7p15.3	Thrombocytopenia 4	612004	AD	3
612661	17p13.1	Dyskeratosis congenita, autosomal recessive 3	613988	AR	3
612952	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
610672	19p13.13	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3
609414	2q34	Corneal fleck dystrophy	121850	AD	3
611095	14q11.2-q12	Mental retardation, autosomal recessive, 9/26	611095	AR	2
609796	15q15.2	Peeling skin syndrome 2	609796	AR	3
611729	11q13.2	Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3
610060	6p21.1	Leukodystrophy, hypomyelinating, 11	616494	AR	3
610060	6p21.1	Treacher Collins syndrome 3	248390	AR	3
613229	13q31.1	?Trichotillomania	613229	Mu,AD	3
613309	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
611880	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
612522	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
611584	22q13.1	Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	AD	3
608410	4p15-p14	{Obesity, susceptibility to, BMIQ7}	608410	_	2
612394	7q22.1	Lysyl hydroxylase 3 deficiency	612394	AR	3
613464	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
612005	1q31	{Celiac disease, susceptibility to, 7}	612005	_	2
612901	20q13.32	Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	AD	3
613320	16p13.3	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3
612627	1p36.12-p35.1	Seizures, benign familial infantile, 4	612627	_	2
611631	9q21-q22	Epilepsy, familial temporal lobe, 4	611631	AD	2
613171	10q25.2	Cardiomyopathy, dilated, 1DD	613172	AD	3
611523	6q15	Pontocerebellar hypoplasia, type 6	611523	AR	3
613495	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
612874	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
612703	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
609734	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
613105	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
613024	6p21.33	{Follicular lymphoma, susceptibility to, 1}	613024	_	2
611881	16p11.2	Glycogen storage disease XII	611881	AR	3
613571	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
613370	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
613618	17q23.1-q23.2	Chromosome 17q23.1-q23.2 duplication syndrome	613618	AD	4
609415	13q31.3	Feingold syndrome 2	614326	AD	3
612431	4q12-q13.1	Deafness, autosomal dominant 27	612431	AD	2
612976	3p26.1-p25.1	{Age-related hearing impairment 2}	612976	_	2
611139	9p21	{Coronary heart disease, susceptibility to, 8}	611139	_	2
609523	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
613640	14q24.3	Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3
612089	13q13.1	Hypophosphatemic rickets and hyperparathyroidism	612089	AD	2
613677	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
612943	7p15.3	Retinitis pigmentosa 42	612943	AD	3
612274	15q24-q25	Ciliary dyskinesia, primary, 8	612274	_	2
612343	4q22	[Musical aptitude QTL 1]	612343	_	2
612929	20q13.31-q13.33	{Mycobacterium tuberculosis, susceptibility to, 3}	612929	_	2
613310	7q31.31	Exudative vitreoretinopathy 5	613310	AD	3
611632	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
612395	22q13.33	Muscular dystrophy, congenital, megaconial type	602541	AR	3
612006	2q11-q12	{Celiac disease, susceptibility to, 8}	612006	_	2
613172	10q25.2	Cardiomyopathy, dilated, 1DD	613172	AD	3
610463	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
610463	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
613722	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
613106	22q12	Vertigo, benign recurrent, 2	613106	_	2
613371	4q34.3-q35.1	?Spinocerebellar ataxia 30	613371	AD	2
612315	12q13.13	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3
612628	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
613496	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
613158	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
613641	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
610756	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
611140	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
612789	8p22-p21.3	Deafness, autosomal recessive 71	612789	AR	2
609524	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
613410	3q24	{?Autism susceptibility 16}	613410	_	3
613619	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
612944	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
613830	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
612007	3p21	{Celiac disease, susceptibility to, 9}	612007	_	2
610474	4p16.3	CATSHL syndrome	610474	AR,AD	3
612629	11q23-q24	{Adiponectin, serum level of, QTL4}	612629	_	2
610333	19p13.13	Aicardi-Goutieres syndrome 4	610333	AR	3
612525	16q24.3	Pyloric stenosis, infantile hypertrophic, 5	612525	_	2
611524	6q15	Pontocerebellar hypoplasia, type 6	611523	AR	3
610970	16q24.3	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3
613890	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
613689	22q12.3-q13.1	Mammary-digital-nail syndrome	613689	AD	2
613723	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
613879	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
613497	10q23.31	Cholesteryl ester storage disease	278000	AR	3
613497	10q23.31	Wolman disease	278000	AR	3
613642	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
612121	6p21.31	Ichthyosis, congenital, autosomal recessive 10	615024	AR	3
612858	8q24.3	Orofacial cleft 12	612858	_	2
613107	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
612316	1p36.33	Harel-Yoon syndrome	617183	AR,AD	3
611031	16q13-q22.1	Episodic kinesigenic dyskinesia 2	611031	AD	2
612008	3q25-q26	{Celiac disease, susceptibility to, 10}	612008	_	2
613485	11q24.3	Long QT syndrome 13	613485	AD	3
613558	9q21.11	Deafness, autosomal dominant 51	613558	AD	4
613174	5p13	Chromosome 5p13 duplication syndrome	613174	IC	4
612892	6p22.1	{Stature QTL 18}	612892	_	2
613972	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
612304	2q14.3	Thrombophilia due to protein C deficiency, autosomal recessive	612304	AR	3
613805	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
613680	16p13.3	Beaulieu-Boycott-Innes syndrome	613680	AR	3
613724	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
614073	22q12.1	Hermansky-Pudlak syndrome 4	614073	AR	3
612877	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
612345	2q31.2	Chromosome 2q31.2 deletion syndrome	612345	_	4
606761	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
610608	20p11.21	Immunodeficiency 55	617827	AR	3
614114	11q21	Mosaic variegated aneuploidy syndrome 2	614114	AR	3
613621	14q12	Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3
612630	2q13	[Hair morphology 1, hair thickness]	612630	_	3
612893	6p21.31	{Stature QTL 19}	612893	_	2
611544	22q12.1	Cataract 17, multiple types	611544	AR,AD	3
613990	14q12	Dyskeratosis congenita, autosomal dominant 3	613990	AD	3
612953	22q13.1	Parkinson disease 14, autosomal recessive	612953	AR	3
614049	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
614139	2p25.3	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3
613559	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
613108	12p13.2	Candidiasis, familial, 4, autosomal recessive	613108	AR	3
613881	10q26.11	Cardiomyopathy, dilated, 1HH	613881	AD	3
614038	3q21.3	Emberger syndrome	614038	AD	3
611081	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
612318	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
606762	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
613681	2q31.1	Chromosome 2q31.1 duplication syndrome	613681	AD	4
614200	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
613643	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
612631	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
612954	10q26.11	Myopathy, myofibrillar, 6	612954	AD	3
614185	15q21.1	Geleophysic dysplasia 2	614185	AD	3
614050	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
614261	2p13.1	Microcephaly-capillary malformation syndrome	614261	AR	3
612792	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
612306	5q13	[Thyroid-stimulating hormone level QTL 1]	612306	_	2
614297	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614297	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
613950	22q13.33	{Schizophrenia 15}	613950	AD	3
612666	1q32.1	Congenital anomalies of kidney and urinary tract 1	610805	AD	3
612666	1q32.1	Spastic paraplegia 23	270750	AR	3
612894	13q14.3	{Stature QTL 20}	612894	_	2
613067	7p12.2	{Leukemia, acute lymphoblastic, susceptibility to, 2}	613067	_	2
614140	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
614140	22q11.23	Hypertelorism, Teebi type	145420	AD	3
614140	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
614115	9q34.12	Cortical malformations, occipital	614115	AR	3
613159	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613109	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
614322	16q23.1-q23.2	Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3
614243	8q24.3	5-oxoprolinase deficiency	260005	AR,AD	3
611022	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
614262	14q24.3	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3
614377	4p14	Nephronophthisis 13	614377	AR	3
612955	20q11.21	Long QT syndrome 12	612955	AD	3
614298	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
614388	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
611920	10q23-q24	[C-reactive protein QTL]	611920	_	2
612645	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
614366	12q23.3	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3
613311	6p25.1	?Combined oxidative phosphorylation deficiency 19	615595	AR	3
613428	2p23.2	Retinitis pigmentosa 54	613428	_	3
614609	19p13.2	Coffin-Siris syndrome 4	614609	AD	3
613622	11q24.2	Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3
614312	17p13.2	?Spermatogenic failure 14	615842	AR	3
613152	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
613951	16p13.3	Fanconi anemia, complementation group P	613951	AR	3
614141	4q31.3	Charcot-Marie-Tooth disease, type 2R	615490	AR	3
614153	20p13	Spinocerebellar ataxia 36	614153	AD	3
614116	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
614064	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
612956	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
611547	12q14.3	{Stature QTL 9}	611547	_	2
614651	10p12.1	Coenzyme Q10 deficiency, primary, 2	614651	AR	3
614702	6q13	Combined oxidative phosphorylation deficiency 10	614702	AR	3
612794	15q14	Atrial septal defect 5	612794	AD	3
613930	18q11.2-q12.2	Alopecia-mental retardation syndrome 3	613930	AR	2
614450	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
612957	1p36.12	{Vitamin B6 plasma level QTL 1}	612957	_	2
612030	8p22	{Coronary heart disease, susceptibility to, 9}	612030	_	2
611515	21q22	Febrile seizures, familial, 7	611515	_	2
614610	19p13.2	Nephrotic syndrome, type 16	617783	AR	3
614610	19p13.2	Palmoplantar keratoderma and woolly hair	616099	AR	3
611548	7q35	Premature ovarian failure 5	611548	AD	3
609595	1p34.3	Palmoplantar hyperkeratosis and true hermaphroditism	610644	AR	3
609595	1p34.3	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644	AR	3
614154	20p13	Spinocerebellar ataxia 36	614153	AD	3
614574	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
613953	22q11.1	Immunodeficiency 51	613953	AR	3
612870	6q14.1	Developmental delay, intellectual disability, obesity, and dysmorphic features	617991	AD	3
614556	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
611731	5q22.2	Adenoma, periampullary, somatic	_	_	3
611731	5q22.2	Adenomatous polyposis coli	175100	AD	3
611731	5q22.2	Brain tumor-polyposis syndrome 2	175100	AD	3
611731	5q22.2	Colorectal cancer, somatic	114500	_	3
611731	5q22.2	Desmoid disease, hereditary	135290	AD	3
611731	5q22.2	Gardner syndrome	175100	AD	3
611731	5q22.2	Gastric cancer, somatic	613659	_	3
611731	5q22.2	Hepatoblastoma, somatic	114550	_	3
614324	17q21.2	Ovarian dysgenesis 3	614324	AR	3
614662	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
613931	1p34.1	Pontocerebellar hypoplasia, type 7	614969	AR	3
614065	7q32.1	Myopathy, distal, 4	614065	AD	3
613451	11p11.2	Frontonasal dysplasia 2	613451	AR	3
614156	7p13	Hyperbiliverdinemia	614156	AR,AD	3
612169	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
614817	15q13.3	Interstitial nephritis, karyomegalic	614817	AR	3
615011	5q35.3	[?Phosphohydroxylysinuria]	615011	_	3
613456	12q21.31	?Frontonasal dysplasia 3	613456	_	3
612277	9q34.2	Geleophysic dysplasia 1	231050	AR	3
614779	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
614972	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AR,AD	3
614870	1p36.32	Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3
614590	6p21.3	{Podoconiosis, susceptibility to}	614590	_	2
614789	3p14.1	Adams-Oliver syndrome 4	615297	AR	3
614858	10q26.12	Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3
614299	2p13.1	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3
614575	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
612278	5q33.1	{Inflammatory bowel disease (Crohn disease) 19}	612278	_	3
614780	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
611383	9q32	Usher syndrome, type 2D	611383	AR	3
614144	17p11.2	?Meckel syndrome 9	614209	AR	3
614144	17p11.2	Joubert syndrome 27	617120	AR	3
614859	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
614885	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
614931	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
614591	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
614591	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
611935	2q23.2	Homocystinuria, cblD type, variant 1	277410	AR	3
611935	2q23.2	Methylmalonic aciduria and homocystinuria, cblD type	277410	AR	3
611935	2q23.2	Methylmalonic aciduria, cblD type, variant 2	277410	AR	3
611384	10p15	{Plasmodium falciparum fever episodes QTL1}	611384	_	2
614819	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
614557	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
615023	15q26.3	Ichthyosis, congenital, autosomal recessive 9	615023	AR	3
612309	1q24.2	Factor V deficiency	227400	AR	3
612309	1q24.2	Thrombophilia due to activated protein C resistance	188055	AD	3
612309	1q24.2	{Budd-Chiari syndrome}	600880	AR	3
612309	1q24.2	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3
612309	1q24.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
612309	1q24.2	{Thrombophilia, susceptibility to, due to factor V Leiden}	188055	AD	3
614628	14q24.3	Keratoconus 8	614628	AD	2
611061	7p22.3	Raine syndrome	259775	AR	3
614984	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
614984	10p14	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3
615219	9p23	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3
614886	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
615249	8p11.21	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	615249	AR	3
614629	13q32	Keratoconus 7	614629	AD	2
615294	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614145	19q13.32	3-M syndrome 3	614205	AR	3
615024	6p21.31	Ichthyosis, congenital, autosomal recessive 10	615024	AR	3
615220	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
614592	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
611062	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
615238	3p25.3	?Lipodystrophy, familial partial, type 5	615238	AR	3
614714	16q24.2	Porokeratosis 7, multiple types	614714	AD	3
615041	12q14.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3
612279	8p23-p21	Epilepsy, generalized, with febrile seizures plus, type 6	612279	_	2
614558	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
614820	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
613954	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
614706	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
615270	8p21.3	Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3
615221	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
615363	6q25.1-q25.2	Estrogen resistance	615363	AR	3
612281	5q33.3	Ichthyosis, congenital, autosomal recessive 6	612281	AR	3
614860	9q34	Dystonia 23	614860	AD	2
614974	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
615042	9q34.11	Congenital disorder of glycosylation, type Iu	615042	AR	3
615352	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
615025	10p14	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3
614566	19q13.42	Ciliary dyskinesia, primary, 2	606763	AR	3
615364	14q32.2	?Spermatogenic failure 27	617965	AR	3
612041	4p16.3	Recombination rate QTL 1	612042	_	3
615376	1p36.31	Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3
614300	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
615434	16q13	Retinitis pigmentosa with or without situs inversus	615434	AR	3
615222	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
614861	21q22.3	?Deafness, autosomal recessive 98	614861	AR	3
612042	4p16.3	Recombination rate QTL 1	612042	_	3
615316	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
615316	1q42.13	Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3
615026	17p13.2	Riboflavin deficiency	615026	AD	3
615043	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614245	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
615134	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
615474	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
612530	1q41-q42	Chromosome 1q41-q42 deletion syndrome	612530	IC	4
615541	8p12	Mental retardation, autosomal recessive 39	615541	AR	3
614998	1q21.3	Mental retardation, autosomal dominant 18	615074	AD	3
614477	8q22.1	Bardet-Biedl syndrome 21	617406	AR	3
614477	8q22.1	Cone-rod dystrophy 16	614500	AR	3
614477	8q22.1	Retinitis pigmentosa 64	614500	AR	3
615048	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
615561	6p21.33	?Complement factor B deficiency	615561	_	3
614567	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
615623	1p32.3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3
614862	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
615512	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
613955	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
615395	2q36.1	?Combined oxidative phosphorylation deficiency 16	615395	AR	3
614594	17p13.2	Olmsted syndrome	614594	AD	3
615451	10p12.1	Ciliary dyskinesia, primary, 23	615451	AR	3
615317	14q24.3	Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3
611943	3q29	RIDDLE syndrome	611943	AR	3
612883	9q31.2	{Menarche, age at, QTL3}	612883	_	2
614822	16p13.3	Spermatogenic failure 10	614822	AD	3
615542	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
615049	10p12.1	Desanto-Shinawi syndrome	616708	AD	3
612526	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
613646	19p13.2	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	_	3
615436	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
615584	11q12.1	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	615704	AD	3
612884	19q13.4	{Menopause, natural, age at, QTL2}	612884	_	2
614595	4p12	Preeclampsia/eclampsia 5	614595	_	3
614665	12p12.3	Meconium ileus	614665	AR	3
613956	6p12.2	?Candidiasis, familial, 6, autosomal dominant	613956	_	3
613893	12q14.2	Spermatogenic failure 9	613958	AR	3
614823	15q22.31	Aortic valve disease 2	614823	AD	3
613733	11q13.1	Adrenal adenoma, somatic	_	_	3
613733	11q13.1	Angiofibroma, somatic	_	_	3
613733	11q13.1	Carcinoid tumor of lung	_	_	3
613733	11q13.1	Lipoma, somatic	_	_	3
613733	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
613733	11q13.1	Parathyroid adenoma, somatic	_	_	3
614707	8q24.3	Brown-Vialetto-Van Laere syndrome 2	614707	AR	3
615706	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
614576	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
615016	6p22.1	[C3HEX, ability to smell]	615082	AD	3
611944	6q16.2-q22.1	Lymphatic malformation 2	611944	AD	2
614256	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
615544	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
615665	2q37.1	?Joubert syndrome 22	615665	AR	3
613957	9q33.3	Spermatogenic failure 8	613957	AD	3
615585	16q23.3	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3
615707	1q23.3	Immunodeficiency 20	615707	AR	3
613734	2q21.1	Congenital disorder of glycosylation, type IIo	616828	AR	3
615476	1p34.2	Epileptic encephalopathy, early infantile, 18	615476	AR	3
615453	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
615355	1q22	Noonan syndrome 8	615355	AD	3
615636	8q13.1-q13.2	Joubert syndrome 21	615636	AR	3
615564	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
613735	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
612527	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
615438	5q32	?Infantile liver failure syndrome 1	615438	AR	3
615730	1p31.3	Epileptic encephalopathy, early infantile, 23	615859	AR	3
615000	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
615752	16q21	Polymicrogyria, bilateral perisylvian	615752	_	3
613700	22q11.2	Supernumerary der(22)t(8-22) syndrome	613700	_	4
614157	8q22.3	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	AR	3
615397	16q23.1	Meckel syndrome 11	615397	AR	3
614825	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
615709	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
615743	3p25.3	Mental retardation, autosomal dominant 23	615761	AD	3
615565	1q32.3	?Retinitis pigmentosa 67	615565	AR	3
612528	3q29	Diamond-Blackfan anemia 5	612528	AD	3
615356	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
615637	19q13.32	Mental retardation, autosomal recessive 41	615637	AR	3
615377	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
612936	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
615817	12q23.3	?Mental retardation, autosomal recessive 43	615817	AR	3
615876	6q25.3	Ciliary dyskinesia, primary, 32	616481	AR	3
615720	3q26.2	Retinitis pigmentosa 68	615725	AR	3
614158	7q34	?Thromboxane synthase deficiency	614158	AD	1
615744	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
613736	19q13.12	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3
615763	6p25.2	Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3
615035	12q24.31	Spastic paraplegia 55, autosomal recessive	615035	AR	3
615710	6q22.1	Mitchell-Riley syndrome	615710	AR	3
615398	20q13.12	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3
614666	16p13.3	?Centronuclear myopathy 4	614807	AD	3
615006	1p34.1	?Epileptic encephalopathy, early infantile, 15	615006	AR	3
613737	14q24.2	?Acne inversa, familial, 3	613737	AD	3
612813	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
615638	12p13.31	?Microcephaly 21, primary, autosomal recessive	617983	AR	3
615895	20p13	Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3
614571	5p13.2	Joubert syndrome 17	614615	AR	3
614571	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
613710	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
614159	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
615599	8q24.12	Mental retardation, autosomal recessive 40	615599	AR	3
615232	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
615974	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
615838	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
615995	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
614932	2p16.1	Combined oxidative phosphorylation deficiency 13	614932	AR	3
615399	20q13.12	?Paroxysmal nocturnal hemoglobinuria 2	615399	SMu,AD	3
615745	1p36.22	Atrial standstill 2	615745	AR	3
614473	16p13.11	Arterial calcification, generalized, of infancy, 2	614473	AR	3
615722	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
615877	4q31.3	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AR,AD	3
614667	6q13	Combined oxidative phosphorylation deficiency 10	614702	AR	3
615982	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
615896	12q13.13	?Hypotrichosis 13	615896	AD	3
615233	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
613711	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
615007	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
616026	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
614160	2q32.2	Muscle hypertrophy	614160	_	3
615723	7q22.1	Premature ovarian failure 8	615723	AR	3
615996	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
615897	1p34.2	Immunodeficiency 24	615897	AR	3
613712	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
615983	2q31.1	Bardet-Biedl syndrome 5	615983	AR	3
616116	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
615400	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
616105	6q14.3	Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3
615724	1p22.2	Premature ovarian failure 9	615724	AR	3
614161	4q27	Brittle cornea syndrome 2	614170	AR	3
615878	9q21.11	Cholestasis, progressive familial intrahepatic 4	615878	AR	3
614607	1p36.11	Coffin-Siris syndrome 2	614607	AD	3
615649	5q31	Deafness, autosomal dominant 54	615649	AD	2
615038	19q13.33	Ciliary dyskinesia, primary, 20	615067	AR	3
614782	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
615234	2q14.2	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3
615667	9q22.32	Bone marrow failure syndrome 2	615715	AR	3
614608	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
612795	11q12-q13.1	[Polyunsaturated fatty acids plasma level QTL1]	612795	_	2
615879	2p23.3	Tatton-Brown-Rahman syndrome	615879	AD	3
616117	1p31.1	Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3
614934	2p16.1	Deafness, autosomal recessive 70	614934	AR	3
614783	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
615984	4q27	Bardet-Biedl syndrome 7	615984	AR	3
615401	16p11.2	Immunodeficiency 8	615401	AR	3
615235	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
616230	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
615378	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
616267	19q13.33	Ataxia-oculomotor apraxia 4	616267	AR	3
615668	5q12	Chromosome 5q12 deletion syndrome	615668	AD	4
615139	12q24.33	FILS syndrome	615139	AR	3
615651	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
615681	10q24.31	Spastic paraplegia 62	615681	AR	3
616118	5q23.3	Macular degeneration, early-onset	616118	AD	3
614935	8q24.22	Ciliary dyskinesia, primary, 19	614935	AR	3
615985	14q31.3	Bardet-Biedl syndrome 8	615985	AR	3
616151	6q14.1	Macular dystrophy, vitelliform, 4	616151	AD	3
616198	19p13.11	Combined oxidative phosphorylation deficiency 23	616198	AR	3
613375	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
616268	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
615986	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
616231	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
613376	5q11.2	?Neuronopathy, distal hereditary motor, type IIC	613376	AD	3
616269	1p13.3	Mental retardation, autosomal recessive 48	616269	AR	3
615140	12p13.31	Temtamy syndrome	218340	AR	3
616304	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
615237	11q24.1	Congenital short bowel syndrome	615237	AR	3
615360	8q22.1	Leber congenital amaurosis 17	615360	AR	3
614990	10p11.21-q21.1	Usher syndrome, type IK	614990	AR	2
616409	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
616220	9q33.3	Focal segmental glomerulosclerosis 9	616220	AR	3
615841	18q11.2	?Spermatogenic failure 13	615841	AR	3
616152	3q12.3	Macular dystrophy, vitelliform, 5	616152	AD	3
616305	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
616370	14q24.3	Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3
614723	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
615725	3q26.2	Retinitis pigmentosa 68	615725	AR	3
616451	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
615361	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
615685	16p12.3	?Spastic paraplegia 61, autosomal recessive	615685	AR	3
615881	19p13.2	Plasma triglyceride level QTL, low	615881	AD	3
616371	16p13.12	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371	AD	3
615508	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
616479	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
616511	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
616171	4q28.1	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3
613398	12p11.21	Warsaw breakage syndrome	613398	AR	3
615686	1p13.3	?Spastic paraplegia 63	615686	AR	3
615362	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
616583	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
616682	11p11.2	?Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3
615338	16p13.3	Epileptic encephalopathy, early infantile, 16	615338	AR	3
616902	11p13	Chromosome 11p13 deletion syndrome, distal	616902	AD	4
616351	5q13.3	Mental retardation, autosomal dominant 34	616351	AD	3
616728	1p36.12	Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3
615697	3q25-q26	Epilepsy, familial temporal lobe, 6	615697	AD	2
616683	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
616716	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
612937	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
616468	11p11.2	?Exudative vitreoretinopathy 6	616468	AD	3
615900	2p23.3	Retinitis pigmentosa 75	617023	AR	3
616831	3p21.31	Luscan-Lumish syndrome	616831	AD	3
614585	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
616307	4p14	Senior-Loken syndrome 8	616307	AR	3
615698	19q13.2	?Spinocerebellar ataxia 46	617770	AD	3
616154	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
615510	2q35	Alacrima, achalasia, and mental retardation syndrome	615510	AR	3
612560	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
616903	13q14.2	{Thiopurines, poor metabolism of, 2}	616903	AD	3
617018	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
617053	7q21.2	MIRAGE syndrome	617053	AD	3
616373	20q13.33	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373	AD	3
612938	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
616585	16q13	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3
615688	22q11.1	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3
616469	11p11.2	Retinitis pigmentosa 72	616469	AR	3
616849	4q22.3	Brachydactyly, type A1, D	616849	AD	3
614936	8q24.13-q24.21	Keratoderma, palmoplantar, punctate type IB	614936	AD	2
616586	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
617026	1q25.3	Pontocerebellar hypoplasia, type 2F	617026	AR	3
617101	2p16.1	Dias-Logan syndrome	617101	AD	3
616602	3q24	Craniosynostosis 6	616602	AD	3
613399	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
616544	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
612009	3q28	{Celiac disease, susceptibility to, 11}	612009	_	2
617054	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
617027	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
616851	19q13.1-q13.2	?Cataract 45	616851	AR	3
617272	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
616924	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
612561	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
617247	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
617273	8q22.1	?Polydactyly, postaxial, type A9	618219	AR	3
617028	3q26.2-q26.3	Mental retardation, autosomal recessive 54	617028	AR	3
615987	12q21.2	Bardet-Biedl syndrome 10	615987	AR	3
616959	3p26.2	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3
617102	20q13.12	Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3
614937	16q22.1	?Myoclonus, familial, 1	614937	AD	3
617236	9q21.2	Cone-rod dystrophy and hearing loss	617236	AR	3
617403	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
617251	20p13	?Uncombable hair syndrome 2	617251	AR	3
617055	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
615988	9q33.1	?Bardet-Biedl syndrome 11	615988	AR	3
616833	1q21.3	Paget disease of bone 6	616833	AD	3
612010	6q25.3	{Celiac disease, susceptibility to, 12}	612010	_	2
614104	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
617525	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
617080	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
615989	4q27	Bardet-Biedl syndrome 12	615989	AR	3
616622	1q21.3	Immunodeficiency 42	616622	AR	3
617341	10q24.33	Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3
617413	1q21.3	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3
616730	12q15	Nephrotic syndrome, type 11	616730	AR	3
615916	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
616311	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
617056	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
612562	1p36.11	Diamond-Blackfan anemia 7	612562	AD	3
615990	17q22	Bardet-Biedl syndrome 13	615990	AR	3
612011	12q24	{Celiac disease, susceptibility to, 13}	612011	_	2
617616	1q42.11-q42.12	Skraban-Deardorff syndrome	617616	AD	3
617629	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
617237	14q32.2	Immunodeficiency 49	617237	AD	3
614105	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
617547	21q22.3	Retinal dystrophy with macular staphyloma	617547	AR	3
616732	6q21	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	616732	AR	3
613653	7p22.1	Spastic paraplegia 48, autosomal recessive	613647	AR	3
617252	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
617105	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
617392	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
613457	14q11-q22	Chromosome 14q11-q22 deletion syndrome	613457	IC	4
614784	12q21.33	Cone-rod dystrophy 20	615973	AR	3
614317	5q14.2	Vesicoureteral reflux 4	614317	_	2
616733	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
617393	19p13.13	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3
617809	11q13.1	Geleophysic dysplasia 3	617809	AD	3
617830	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
616155	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
616734	18q12.1-q12.2	Symmetric circumferential skin creases, congenital, 2	616734	AD	3
617506	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
611145	8q24.11	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
617810	8q24.3	Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3
617877	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
617082	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
617631	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
617253	8q24.13	Seckel syndrome 10	617253	AR	3
613458	16p13.3	Chromosome 16p13.3 duplication syndrome	613458	IC,AD	4
613655	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
612563	2p25.3	Diamond-Blackfan anemia 8	612563	AD	3
614785	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
616735	3p25.1	Hypotonia, infantile, with psychomotor retardation	616816	AR	3
617878	2q21.1	Keratoconus 9	617928	AD	3
615917	6p21.33	Combined oxidative phosphorylation deficiency 20	615917	AR	3
617091	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
613656	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
617622	2q37.1	Joubert syndrome 30	617622	AR	3
613459	3q25.3	[Birth weight QTL 2]	613459	_	2
611146	1q41	Hypermanganesemia with dystonia 1	613280	AR	3
617493	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
617394	6p22.3	Sclerosing cholangitis, neonatal	617394	AR	3
617633	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
615386	11q13.2	Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3
617507	2p16.1	?PEHO syndrome-like	617507	AR	3
611147	2q31	Paroxysmal nonkinesigenic dyskinesia 2	611147	AD	2
617751	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
617664	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
617395	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
618131	16q22.1	Immunodeficiency 58	618131	AR	3
617255	12q21.32	Lissencephaly 8	617255	AR	3
615918	1q21.2	?Combined oxidative phosphorylation deficiency 21	615918	AR	3
617954	7q22.1	Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3
617752	2q36.3	Mental retardation, autosomal dominant 49	617752	AD	3
617092	17q21.2	Ciliary dyskinesia, primary, 35	617092	AR	3
615387	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
616744	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
617987	1q24.3	?{Deafness, autosomal recessive 26, modifier of}	605429	AD	3
613657	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
617557	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
615925	3q26.31	Growth hormone deficiency, isolated partial	615925	AR,AD	3
615058	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
618279	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
617988	6p21.1	Jaberi-Elahi syndrome	617988	AR	3
618336	12q24.33	IMAGE-I syndrome	618336	AR	3
617432	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
618260	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
613460	3q21	[Birth weight QTL 3]	613460	_	2
613460	3q21	[Fasting plasma glucose level QTL 6]	613460	_	2
613460	3q21	[Plasma glucose, 2-hour, QTL 1]	613460	_	2
617057	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
618379	3q25.1	Epileptic encephalopathy, early infantile, 73	618379	AD	3
617780	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
617093	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
617014	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
613658	2q36.2	Rajab syndrome	613658	AR	2
617903	9q22.33	Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3
617433	19p13.2	Retinitis pigmentosa 78	617433	AR	3
615059	1q32.1	Hypotrichosis 11	615059	AD	3
618416	19p13.11	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3
617396	8q22.2	Anauxetic dysplasia 2	617396	AR	3
615155	9q32	Steel syndrome	615155	AR	3
616420	1q42.12	Leukodystrophy, hypomyelinating, 10	616420	AR	3
612566	20q13	{Inflammatory bowel disease 24}	612566	_	2
617755	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
613932	1p31.1	Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3
617781	16p13.3	Retinitis pigmentosa 80	617781	AR	3
617584	6q21	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3
617558	10q25.1	Spermatogenic failure 19	617592	AR	3
615156	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
617065	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
617914	1q32.1	Microcephaly 20, primary, autosomal recessive	617914	AR	3
617756	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
613933	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
618261	19p13.3	Lymphoproliferative syndrome 3	618261	AR	3
618324	16q22.1	Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3
618398	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
615157	17p12	Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3
617559	3q13.2	?Spermatogenic failure 20	617593	AR	3
618280	11q12.2	Cardiac-urogenital syndrome	618280	AD	3
617796	1q22	Mental retardation, autosomal dominant 52	617796	AD	3
617094	20q13.12	Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3
616421	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
617595	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
617816	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
617397	22q11.21	Pseudo-TORCH syndrome 2	617397	AR	3
613462	7p21.2	[Fasting plasma glucose level QTL 4]	613462	_	2
617560	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
617095	17q21.2	Ciliary dyskinesia, primary, 35	617092	AR	3
617827	20p11.21	Immunodeficiency 55	617827	AR	3
616158	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
617915	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
615748	12q23.3	?Mental retardation, autosomal recessive 43	615817	AR	3
613463	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
617757	10q24.32	Joubert syndrome 32	617757	AR	3
617862	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
617073	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
618325	1p34.3	Lissencephaly 9 with complex brainstem malformation	618325	AD	3
617561	11q14.2	Cohen-Gibson syndrome	617561	AD	3
618011	10q23.31	Hyperekplexia 4	618011	AR	3
618339	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
615749	9q33.2	[Eculizumab, poor response to]	615749	AD	3
617106	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
617879	9q34.3	Leber congenital amaurosis with early-onset deafness	617879	AD	3
617828	14q11.2	?Marsili syndrome	147430	AD	3
617864	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
617540	10q22.1	{Pituitary adenoma 5, multiple types}	617540	AD	3
614111	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
617865	5q12.1	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3
618295	11p15.4	Mental retardation, autosomal recessive 67	618295	AR	3
617829	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
617761	5q23.2	Joubert syndrome 31	617761	AR	3
617866	14q24.3	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3
617107	11q13.1	Thauvin-Robinet-Faivre syndrome	617107	AR	3
617665	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
618060	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
618048	13q12.3	Proteasome-associated autoinflammatory syndrome 2	618048	AD	3
617075	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
617108	17q22	Sessile serrated polyposis cancer syndrome	617108	AD	3
617762	11q13.5	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3
618052	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
613938	20q12-q13.12	Parasomnia, sleepwalking type	613938	Mu,AD	2
614113	9p24	Mental retardation, autosomal dominant 2	614113	AD	4
617402	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
618061	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
614588	2q14.3-q21.3	Dystonia 21	614588	AD	2
617831	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
617916	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
615820	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
618400	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
614589	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
617110	9q21.2	Cone-rod dystrophy and hearing loss	617236	AR	3
618173	10q24.32	Retinitis pigmentosa 83	618173	AD	3
615821	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
618160	1p21.1	?Growth hormone deficiency, isolated, type V	618160	AR	3
613949	12p13.31	OKT4 epitope deficiency	613949	_	3
617882	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
617111	3p21.2	?Macular dystrophy, patterned, 3	617111	AD	3
613661	13q14.3	Congenital disorder of glycosylation, type Ip	613661	AR	3
617883	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
618298	6p24.1	Epileptic encephalopathy, early infantile, 70	618298	AD	3
618402	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
617112	17p13.1	?Orofaciodigital syndrome XV	617127	AR	3
618056	7p22.3	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3
618328	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
618057	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
618058	11q22.1	Ciliary dyskinesia, primary, 38	618063	AR	3
618329	19p13.3	Combined oxidative phosphorylation deficiency 37	618329	AR	3
618404	1q42.11	Leukodystrophy, hypomyelinating, 18	618404	AR	3
615824	6p21.31	Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3
618161	10q24.32	Joubert syndrome 35	618161	AR	3
618162	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
618330	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
618163	17q25.1	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3
617666	13q13.3	Fraser syndrome 2	617666	AR	3
618164	16p13.3	Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3
618414	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
615837	5q32	?Deafness, autosomal recessive 101	615837	AR	3
618415	10q24.2	Cataract 48	618415	AR	3
617854	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
616423	3p21.31	Neurodevelopmental disorder with severe motor impairment and absent language	617804	AD	3
617017	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AR,AD	3
615511	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
617542	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
616425	17q24	46XY sex reversal 10	616425	AD	4
617030	14q32.33	Myopathy, distal, 5	617030	AR	3
617258	12p12.1	Myopathy, myofibrillar, 8	617258	AR	3
617729	14q11.2	Galloway-Mowat syndrome 3	617729	AR	3
617383	12q24.11	?Avascular necrosis of femoral head, primary, 2	617383	AD	3
616449	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
617563	17p13.1	Orofaciodigital syndrome XVI	617563	AR	3
618174	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
616470	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
618175	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
617384	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
618282	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
618176	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
616471	6q13-q14	Bethlem myopathy 2	616471	AD	3
618177	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
618178	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
604633	11q13.1	Cutis laxa, autosomal recessive, type IB	614437	AR	3
604296	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
606953	1p36.11	Galactose epimerase deficiency	230350	AR	3
606666	11p14.1	{Bone mineral density, low, susceptibility to}	615311	_	3
605742	22q11.21	Cortical dysplasia, complex, with other brain malformations 8	613180	AR	3
603786	4p15.32	Stargardt disease 4	603786	_	3
604592	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
605779	17p13	Nail disorder, nonsyndromic congenital, 7	605779	AD	2
606789	8q	Fetal hemoglobin quantitative trait locus 4	606789	_	2
606969	17p13.3	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3
606660	3q24-q26	{Melanoma, uveal, susceptibility to, 1}	606660	_	2
603700	13q12.3	{Stroke, susceptibility to}	601367	Mu	3
603873	9p21.2	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3
605111	19p13.2	Deafness, autosomal recessive 68	610419	AR	3
603666	20q13.32	Pseudohypoparathyroidism, type IB	603233	AD	3
605956	16q12.1	Blau syndrome	186580	AD	3
605956	16q12.1	{Inflammatory bowel disease 1, Crohn disease}	266600	Mu	3
605956	16q12.1	{Psoriatic arthritis, susceptibility to}	607507	_	2
605956	16q12.1	{Yao syndrome}	617321	Mu	3
605950	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
605676	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
604672	19p13.2	{Dengue fever, protection against}	614371	_	3
604672	19p13.2	{HIV type 1, susceptibility to}	609423	_	3
604672	19p13.2	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
606672	17p13.2	Bernard-Soulier syndrome, type A1 (recessive)	231200	AR	3
606672	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
606672	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
606672	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
606207	15q25.3	[Uridine-cytidineuria]	618477	AR	3
605347	1p36.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
604436	8p11.23	Epilepsy, early-onset, vitamin B6-dependent	617290	AR	3
605093	12q24.12	Erythrocytosis, somatic	133100	_	3
605093	12q24.12	Myelofibrosis, somatic	254450	_	3
605093	12q24.12	Thrombocythemia, somatic	187950	_	3
606979	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
607357	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
604124	18q11.2	Jawad syndrome	251255	AR	3
604124	18q11.2	Pancreatic carcinoma, somatic	_	_	3
604124	18q11.2	Seckel syndrome 2	606744	AR	3
607584	13q14	Spastic paraplegia 24, autosomal recessive	607584	AR	2
607115	1q44	CINCA syndrome	607115	AD	3
605394	6q15	Immunodeficiency 60	618394	AD	3
605724	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
606000	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
603741	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
603103	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
603157	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
605387	20q11.22	Cataract 31, multiple types	605387	AD	3
605280	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
603013	8p21	{Schizophrenia}	181500	AD	2
605204	9q34.11	Dystonia-1, torsion	128100	AD	3
605204	9q34.11	{Dystonia-1, modifier of}	_	_	3
606579	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
603198	17q21.2	Lipodystrophy, congenital generalized, type 4	613327	AR	3
607212	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
606673	22q11.23	Beta-ureidopropionase deficiency	613161	AR	3
607206	17p13.1	Ichthyosis, congenital, autosomal recessive 3	606545	AR	3
604574	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
603116	22q12-q13	CDAGS syndrome	603116	AR	2
604011	17q11.2	?Cone-rod dystrophy	_	_	3
604011	17q11.2	?Immunodeficiency 13	615518	AD	3
607078	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
603701	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
605388	9p12-q12	Cerebral palsy, ataxic, autosomal recessive	605388	AR	2
606995	3q22	Senior-Loken syndrome 3	606995	AR	2
605711	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
607116	20p	Alzheimer disease 8	607116	_	2
605753	4q12	?Spermatogenic failure 29	618091	AR	3
603499	18q21.33	Osteolysis, familial expansile	174810	AD	3
603499	18q21.33	Osteopetrosis, autosomal recessive 7	612301	AR	3
603499	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
605375	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
606980	1q42.13	Coenzyme Q10 deficiency, primary, 4	612016	AR	3
605747	1p36.11	Hypercholesterolemia, familial, 4	603813	AR	3
603158	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
606685	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
606996	1p36.31	Senior-Loken syndrome 4	606996	AR	3
607207	16p13.3	?Spinocerebellar ataxia 48	618093	AD	3
607207	16p13.3	Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3
606389	11q13.1	Spermatogenic failure 7	612997	AR	3
606668	16p	{Inflammatory bowel disease 8}	606668	_	2
605083	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
603674	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
607836	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
606785	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
605748	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
606347	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
607880	2p13.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3
605906	10q23.2	Cardiomyopathy, dilated, 1C, with or without LVNC	601493	AD	3
605906	10q23.2	Cardiomyopathy, hypertrophic, 24	601493	AD	3
605906	10q23.2	Left ventricular noncompaction 3	601493	AD	3
605906	10q23.2	Myopathy, myofibrillar, 4	609452	AD	3
603914	11p15.4	Mental retardation, autosomal recessive 67	618295	AR	3
603283	6q22.31	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	AR	3
607805	2q11.2	Jalili syndrome	217080	AR	3
607683	5q31.1-q32	Deafness, autosomal dominant 52	607683	AD	2
605712	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
607117	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
603218	20p13	Huntington disease-like 1	603218	AD	3
605414	19p13.3	{Alzheimer disease 9, susceptibility to}	608907	AD	3
607541	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
603702	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
606688	20p13	Prion disease with protracted course	606688	AD	3
604846	2q14.3	{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3
605749	9q13-q22	Cataract 26, multiple types	605749	_	2
604352	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
606348	5q31	{Inflammatory bowel disease 5}	606348	_	2
605907	16p13.3	Congenital disorder of glycosylation, type Ik	608540	AR	3
604299	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
605084	10q22.1	Myopathy with extrapyramidal signs	615673	AR	3
607066	17p13.2	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3
607066	17p13.2	Olmsted syndrome	614594	AD	3
605178	16q24.3	Ciliary dyskinesia, primary, 33	616726	AR	3
606272	17p13.2	Cystinosis, atypical nephropathic	219800	AR	3
606272	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
606272	17p13.2	Cystinosis, nephropathic	219800	AR	3
606272	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
603284	7p13	Cerebral cavernous malformations-2	603284	AD	3
604450	17q24.2	Stankiewicz-Isidor syndrome	617516	AD	3
604505	14q32.12	Achondrogenesis, type IA	200600	AR	3
604505	14q32.12	Osteochondrodysplasia	184260	AR	3
603622	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
607932	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
603015	7q22.1	Developmental delay with or without dysmorphic facies and autism	618454	AD	3
608040	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
604912	8q24.12	Mental retardation, autosomal recessive 40	615599	AR	3
605518	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
603543	3q28	Limb-mammary syndrome	603543	AD	3
605775	5q31.2	Pseudohypoaldosteronism, type IID	614495	AR,AD	3
607446	6q23-q25	[Body mass index QTL3]	607446	_	2
607795	9q32	Retinitis pigmentosa 70	615922	AD	3
605237	1q25.3	Basal ganglia calcification, idiopathic, 6	616413	AD	3
605355	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
605738	15q12-q15	Microphthalmia with coloboma 2	605738	_	2
606014	1p13.3	Frontonasal dysplasia 1	136760	AR	3
607194	10p12.2	Pancreatic agenesis 2	615935	AR	3
607194	10p12.2	Pancreatic and cerebellar agenesis	609069	AR	3
603200	19p13.11	MHC class II deficiency, complementation group B	209920	AR	3
605419	15q15	{Schizophrenia 10}	605419	AD	2
603285	3q26.1	Cerebral cavernous malformations 3	603285	_	3
604142	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
605423	12q13.12	46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	_	3
605423	12q13.12	46XY sex reversal 7	233420	AR	3
607939	3p26.1	Multiple sulfatase deficiency	272200	AR	3
604918	7q21.11	?Pontocerebellar hypoplasia, type 3	608027	AR	3
603623	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
605750	11p13-p12	Exudative vitreoretinopathy 3	605750	AD	2
605384	4q27	?Immunodeficiency, common variable, 11	615767	AR	3
608029	20q11-q13	Spinocerebellar ataxia, autosomal recessive 6	608029	AR	2
608212	5q33.1	{Inflammatory bowel disease (Crohn disease) 19}	612278	_	3
608212	5q33.1	{Mycobacterium tuberculosis, protection against}	607948	_	3
607118	3q22.1	Combined oxidative phosphorylation deficiency 9	614582	AR	3
604934	1q42.3	Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3
604934	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
604934	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
607800	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
607800	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
605720	11q13.1	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3
606852	1p32	{Parkinson disease 10}	606852	_	2
606928	1p36	[Bone mineral density QTL 3]	606928	_	2
607585	11q22.3	Ataxia-telangiectasia	208900	AR	3
607585	11q22.3	Lymphoma, B-cell non-Hodgkin, somatic	_	_	3
607585	11q22.3	Lymphoma, mantle cell, somatic	_	_	3
607585	11q22.3	T-cell prolymphocytic leukemia, somatic	_	_	3
607585	11q22.3	{Breast cancer, susceptibility to}	114480	SMu,AD	3
607542	11p15.5-p15.4	Atrial fibrillation, familial, 3	607554	AD	3
607542	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
607542	11p15.5-p15.4	Long QT syndrome 1	192500	AD	3
607542	11p15.5-p15.4	Short QT syndrome 2	609621	AD	3
607542	11p15.5-p15.4	{Long QT syndrome 1, acquired, susceptibility to}	192500	AD	3
606725	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
606725	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
605565	19p13.2	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
605565	19p13.2	{Hypertension, insulin resistance-related, susceptibility to}	125853	AD	3
608300	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
602937	6q24.1	Atrial septal defect 8	614433	AD	3
602937	6q24.1	Ventricular septal defect 2	614431	AD	3
605113	7q31.32	Hyperlysinemia	238700	AR	3
605113	7q31.32	Saccharopinuria	268700	AR	1
603046	8q24.13	Renal cell carcinoma	144700	_	3
608206	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
608206	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
608318	14q32	{Coronary heart disease, susceptibility to, 4}	608318	_	2
605739	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
605908	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603658	2p25.3	Diamond-Blackfan anemia 8	612563	AD	3
603273	3q28	ADULT syndrome	103285	AD	3
603273	3q28	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3
603273	3q28	Hay-Wells syndrome	106260	AD	3
603273	3q28	Limb-mammary syndrome	603543	AD	3
603273	3q28	Orofacial cleft 8	618149	_	3
603273	3q28	Rapp-Hodgkin syndrome	129400	AD	3
603273	3q28	Split-hand/foot malformation 4	605289	AD	3
606159	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
605519	18p11.31	Majeed syndrome	609628	_	3
603945	3q27.1	Leukoencephalopathy with vanishing white matter	603896	AR	3
603945	3q27.1	Ovarioleukodystrophy	603896	AR	3
605238	2q22.1	Mental retardation, autosomal recessive 51	616739	AR	3
605238	2q22.1	{Asthma, susceptibility to}	600807	AD	3
607906	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
604590	1q23.3	{Malaria, resistance to}	611162	_	3
604590	1q23.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
605356	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
603537	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
607562	1p31.3	{Inflammatory bowel disease 17, protection against}	612261	_	3
607562	1p31.3	{Psoriasis, protection against}	605606	_	3
606726	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
606726	20q13.12	{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3
607200	15q21.1	Thyroid dyshormonogenesis 6	607200	AR	3
608520	12q22-q23.2	Major depressive disorder 1	608516	_	2
605751	16p11.2	Seizures, benign familial infantile, 2	605751	AD	3
602938	9q31.1	Hypercholanemia, familial	607748	AR	3
607080	12q13.12	46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	_	3
608455	11q13.1	McArdle disease	232600	AR	3
604439	4q31.21	?Deafness, autosomal recessive 26	605428	AR	3
603236	16q24.2	Porokeratosis 7, multiple types	614714	AD	3
604607	17q21.32	{Prostate cancer, hereditary, 9}	610997	_	3
604799	15q25.2	?Deafness, autosomal dominant 68	616707	AD	3
605109	15q22.31	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3
608207	22q12	{Kala-azar, susceptibility to, 1}	608207	_	2
608630	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
606879	1p12	Neu-Laxova syndrome 1	256520	AR	3
606879	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
608329	11q12.2	Cardiac-urogenital syndrome	618280	AD	3
608329	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
608030	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
603946	10q23.33	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3
608109	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
607941	8p23.1	Atrial septal defect 2	607941	AD	3
608703	2p21-p13	Spinocerebellar ataxia 25	608703	AD	2
608500	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
608631	17p13	{Asperger syndrome susceptibility 2}	608631	IC,Mu	2
605201	11q23.3	High density lipoprotein cholesterol level QTL14	605201	_	2
605566	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
603415	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 7	613863	AD	3
603415	2q24.3	Erythermalgia, primary	133020	AD	3
603415	2q24.3	Febrile seizures, familial, 3B	613863	AD	3
603415	2q24.3	HSAN2D, autosomal recessive	243000	AR	3
603415	2q24.3	Insensitivity to pain, congenital	243000	AR	3
603415	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
603415	2q24.3	Small fiber neuropathy	133020	AD	3
603415	2q24.3	{Dravet syndrome, modifier of}	607208	AD	3
607210	7p22.2	B-cell expansion with NFKB and T-cell anergy	616452	AD	3
607210	7p22.2	Immunodeficiency 11A	615206	AR	3
607210	7p22.2	Immunodeficiency 11B with atopic dermatitis	617638	AD	3
608456	1p34.1	Adenomas, multiple colorectal	608456	AR	3
605713	14q24.3	Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3
608815	6p12.2	{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3
608815	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
606674	19p13	{Inflammatory bowel disease 6}	606674	_	2
606593	13q33.3	LIG4 syndrome	606593	AR	3
608677	18q11.2	Left ventricular noncompaction 7	615092	AD	3
608798	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
603089	3p21.1	Tumor predisposition syndrome	614327	AD	3
608340	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
608885	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
608474	17q21-q22	Myopia 5	608474	AD	2
607478	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
607478	12q21.1	{Unipolar depression, susceptibility to}	608516	_	3
603286	1q32.1	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3
608810	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
605870	13q12.13	?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	AR	3
608248	12q13.13	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3
608248	12q13.13	?Hypotrichosis 3	613981	AD	3
608248	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
605420	11p11.2	Frontonasal dysplasia 2	613451	AR	3
605420	11p11.2	Parietal foramina 2	609597	AD	3
605420	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
608307	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
608307	2q34	{Pulmonary hypertension, neonatal, susceptibility to}	615371	_	3
604332	4q12	{Leukemia, acute myeloid}	601626	SMu,AD	3
607211	17q25.3	Pityriasis rubra pilaris	173200	AD	3
607211	17q25.3	Psoriasis 2	602723	AD	3
608995	1p36-p34	{Dyslexia, susceptibility to, 8}	608995	Mu,AD	2
603276	1q23.3	[Blood pressure regulation QTL]	145500	Mu	2
608251	Chr.14	Phobia, specific	608251	_	2
608799	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
608641	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608930	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AR,AD	3
608542	19q13	Aneurysm, intracranial berry, 2	608542	_	2
608894	6q23.3	Joubert syndrome 3	608629	AR	3
608470	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
607640	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
608673	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
606595	7q11.23	Charcot-Marie-Tooth disease, axonal, type 2F	606595	AD	3
603287	17q21.32	Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3
608214	11q24.1	Atrial fibrillation, familial, 16	613120	AD	3
608214	11q24.1	Brugada syndrome 7	613120	AD	3
608625	17q23.1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3
606621	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
605202	9q22.33	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442	AR	3
609200	5q31.2	Myopathy, myofibrillar, 3	609200	AD	3
608471	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
603234	16p13.11	Arterial calcification, generalized, of infancy, 2	614473	AR	3
603234	16p13.11	Pseudoxanthoma elasticum	264800	AR	3
603234	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
607544	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
605435	14q12	Congenital heart defects and ectodermal dysplasia	617364	AD	3
608543	1p36.2	{Schizophrenia 12}	181500	AD	2
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
608507	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
604593	2q23.1-q23.2	Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3
607734	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AR,AD	3
603277	12p13.31	Sifrim-Hitz-Weiss syndrome	617159	AD	3
609220	3q24	Bruck syndrome 2	609220	AR	3
609369	11q13.1	Neuropathy, hereditary sensory, type IF	615632	AD	3
608626	17q23.3	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3
609044	10q23.33	{Obesity, susceptibility to}	607514	_	3
604860	18q21.32	Immunodeficiency 12	615468	AR	3
607641	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
609338	3p25.2	Carotid intimal medial thickness 1	609338	_	3
609242	22q13.2	Kanzaki disease	609242	AR	3
608862	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
607617	12q15	?Ovarian dysgenesis 6	618078	AR	3
607617	12q15	Galloway-Mowat syndrome 7	618348	AR	3
607617	12q15	Nephrotic syndrome, type 11	616730	AR	3
608627	20q13.32	Amyotrophic lateral sclerosis 8	608627	AD	3
608896	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
608210	11p11.2	?Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3
608210	11p11.2	Exostoses, multiple, type 2	133701	AD	3
608812	9q22.33	{Colorectal cancer, susceptibility to, 1}	608812	_	3
608643	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
609136	22q13.1	PCWH syndrome	609136	AD	3
608381	2q31.3	Retinitis pigmentosa 26	608380	_	3
608965	11q13.2	Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3
606976	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
606976	16q22.1	Saul-Wilson syndrome	618150	AD	3
607608	11p15.4	Niemann-Pick disease, type A	257200	AR	3
607608	11p15.4	Niemann-Pick disease, type B	607616	AR	3
606002	9q34.13	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3
609506	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
609291	15q14	Legius syndrome	611431	AD	3
606622	2q35	Schimke immunoosseous dysplasia	242900	AR	3
608644	5p15.2	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	_	3
609458	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
608903	16p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
610032	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
610261	20q11-q13	{Hypertension, essential, susceptibility to, 5}	145500	Mu	2
610213	5p15.2-p14.3	Aneurysm, intracranial berry, 4	610213	_	2
609132	1p36.12	Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3
610224	9q34.3	Ovarian dysgenesis 5	617690	AR	3
610224	9q34.3	Spermatogenic failure 32	618115	AD	3
609213	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
609139	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
609139	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
610362	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
610362	19p13.3	Cone-rod dystrophy 11	610381	AD	3
607642	17p11.2	Smith-Magenis syndrome	182290	IC,AD	3
610377	12q24.11	Mevalonic aciduria	610377	AR	3
609821	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
606977	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
606977	13q14.11	Shaheen syndrome	615328	AR	3
610168	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
610498	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
609342	11q12.1	Intrinsic factor deficiency	261000	AR	3
609041	10q22.1-q24.1	Spastic paraplegia 27, autosomal recessive	609041	AR	2
608864	1q32.2	{Orofacial cleft 6}	608864	AD	3
608675	16q22.1	Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3
610512	20p11.23	?Cowden syndrome 7	616858	AD	3
610512	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
603743	22q12.3	{End-stage renal disease, nondiabetic, susceptibility to}	612551	_	3
603743	22q12.3	{Glomerulosclerosis, focal segmental, 4, susceptibility to}	612551	_	3
609815	3p21.31	Zygodactyly 1	609815	_	2
610274	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
609549	11q23.3	Nanophthalmos 2	609549	_	3
610243	10q24.2	Spastic paraplegia 33, autosomal dominant	610244	AD	3
610767	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
607643	17q25.3	Retinitis pigmentosa 30	607921	_	3
603278	19q13.2	Glomerulosclerosis, focal segmental, 1	603278	AD	3
610838	21p13-q11	{Autism susceptibility 12}	610838	_	2
610832	16p12.2	Fanconi anemia, complementation group N	610832	_	3
610127	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
608800	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
611182	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
609891	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
609140	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
610163	1q24.2	?Immunodeficiency 25	610163	AR	3
610079	11q24.2	{Autoimmune disease, susceptibility to, 6}	613551	_	3
610262	5p13-q12	{Hypertension, essential, susceptibility to, 6}	145500	Mu	2
610915	1p34.2	Osteogenesis imperfecta, type VIII	610915	AR	3
606273	1p34.1	Leukoencephalopathy with vanishing white matter	603896	AR	3
611150	22q13.31	Spinocerebellar ataxia 10	603516	AD	3
609319	6q23	[Hematocrit/hemoglobin quantitative trait locus 1]	609319	_	2
610363	1p36.13	Preimplantation embryonic lethality 2	617234	AR	3
610244	10q24.2	Spastic paraplegia 33, autosomal dominant	610244	AD	3
610523	7q32.2	Joubert syndrome 15	614464	AR	3
604801	1q42	Muscular dystrophy, congenital, 1B	604801	AR	2
611220	17q12	?Cataract 43	616279	AD	3
610928	8q11.23	Vesicoureteral reflux 3	613674	AD	3
610713	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
605557	1p36.32	Cardiomyopathy, dilated, 1LL	615373	AD	3
605557	1p36.32	Left ventricular noncompaction 8	615373	AD	3
610768	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
611102	15q15.3	Deafness and male infertility	611102	AR	4
609507	9p21.1	Retinitis pigmentosa 31	609923	_	3
610565	22q13.1	?Mirror movements 3	616059	AR	3
607545	4q32.3	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3
609340	14q22.1	Spastic paraplegia 28, autosomal recessive	609340	AR	3
609129	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
606489	9p13.2	Pontocerebellar hypoplasia, type 1B	614678	AR	3
603680	13q21.33	Spinocerebellar ataxia 8	608768	AD	3
603680	13q21.33	{Parkinson disease, susceptibility to}	168600	Mu,AD	3
610733	2p22.1	Noonan syndrome 4	610733	AD	3
610128	12q23.3	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3
610839	2q33.3	{Osteoarthritis susceptibility 4}	610839	_	2
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	AD	3
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	AD	3
605597	3q22.3	Premature ovarian failure 3	608996	AD	3
610873	22q13	{Menarche, age at, QTL}	610873	_	2
610263	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
608801	19p13.13	Glutaricaciduria, type I	231670	AR	3
610707	16q	{Psoriasis susceptibility 8}	610707	_	2
610745	15q24.1	Microphthalmia, isolated, with coloboma 8	601186	AR	3
610745	15q24.1	Microphthalmia, syndromic 9	601186	AR	3
610444	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
610245	20p13	Spinocerebellar ataxia 23	610245	AD	3
611174	16q12.2	Hamamy syndrome	611174	AR	3
610916	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
611228	6q21	Charcot-Marie-Tooth disease, type 4J	611228	AR	3
609913	1p21.3-p13.3	Retinitis pigmentosa 32	609913	_	2
610805	1q32.1	Congenital anomalies of kidney and urinary tract 1	610805	AD	3
609552	2q11.2	?Mental retardation, autosomal recessive, 52	616887	AR	3
608423	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
609508	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
611448	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
610531	7p15.3	Leukodystrophy, hypomyelinating, 5	610532	AR	3
610876	6q16.3	Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3
605598	5q31.1-q33.1	{Diabetes mellitus, insulin-dependent, 18}	605598	_	2
609893	15q25.3-q26.1	Hypothyroidism, congenital, nongoitrous, 3	609893	_	2
611588	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
610865	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
610142	12q21.32	?Bardet-Biedl syndrome 14	615991	AR	3
610142	12q21.32	Joubert syndrome 5	610188	AR	3
610142	12q21.32	Leber congenital amaurosis 10	611755	_	3
610142	12q21.32	Meckel syndrome 4	611134	AR	3
610142	12q21.32	Senior-Loken syndrome 6	610189	AR	3
610708	12p11.21	Optic atrophy 5	610708	AD	3
610226	17q25.3	Seborrhea-like dermatitis with psoriasiform elements	610227	_	3
610600	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
607882	8q24.3	Brown-Vialetto-Van Laere syndrome 2	614707	AR	3
608428	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
610246	18p11.21	Spinocerebellar ataxia 28	610246	AD	3
611082	22q12.1	{Myocardial infarction, susceptibility to}	608446	_	3
609633	21q22.13	{Major affective disorder 3, early onset}	609633	_	2
610911	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
610739	16p12.1	?Epilepsy, familial adult myoclonic, 6	618074	_	3
609144	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
609376	19q13	Cataract 35, congenital nuclear	609376	AR	2
610746	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
611103	3q21.3	Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3
611152	1q21	{Alzheimer disease-13}	611152	_	2
608807	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
610293	1q23.2	Glycosylphosphatidylinositol deficiency	610293	AR	3
611369	19p13.3	Lethal congenital contractural syndrome 3	611369	AR	3
610528	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
609299	3p26	{Prostate cancer, hereditary, 5}	609299	_	2
608437	12q24	{Systemic lupus erythematosus, susceptibility to, 4}	608437	_	2
611131	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
610297	2p13.1	{Parkinson disease 13}	610297	_	3
609218	16q23.3	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3
609048	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
609245	1p13.3	Chudley-McCullough syndrome	604213	AR	3
611762	19q13.42	Familial cold autoinflammatory syndrome 2	611762	AD	3
609862	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
609300	10q24.32	17,20-lyase deficiency, isolated	202110	AR	3
609300	10q24.32	17-alpha-hydroxylase/17,20-lyase deficiency	202110	AR	3
610345	7q34	Cataract 38, autosomal recessive	614691	AR	3
610345	7q34	Sengers syndrome	212350	AR	3
610912	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
605740	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
605740	17q21.31	Sclerosteosis 1	269500	AR	3
605740	17q21.31	Van Buchem disease	239100	AR	3
611104	12p11.21	Charcot-Marie-Tooth disease, type 4H	609311	AR	3
609489	4q24	Mannosidosis, beta	248510	AR	3
609161	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
609460	10q22.1	Goldberg-Shprintzen megacolon syndrome	609460	AR	3
610532	7p15.3	Leukodystrophy, hypomyelinating, 5	610532	AR	3
605845	5q31-q33	{Dermatitis, atopic, susceptibility to, 6}	605845	_	2
608576	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
608576	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608576	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
607483	2q36.3	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	AR	3
608488	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
610445	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
606003	11p15.5	Transaldolase deficiency	606003	AR	3
609049	3p21.31	Pierson syndrome	609049	AR	3
611204	14q32.11-q32.12	?Spinocerebellar ataxia 40	616053	AD	3
611204	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
611456	6p23	Essential tremor, hereditary, 3	611456	_	2
609863	12q24.11	Joubert syndrome 13	614173	AR	3
611184	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
611184	16q24.3	Lymphatic malformation 6	616843	AR	3
611647	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
611153	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
610743	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
608586	3p14-q13	Keratoconus 3	608586	_	2
612078	16q24.2	Brittle cornea syndrome 1	229200	AR	3
605437	14q23.1	{Cerebral infarction, susceptibility to}	601367	Mu	3
610812	16q22.2	Ciliary dyskinesia, primary, 5	608647	AR	3
610913	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
611739	11p12	{Osteoporosis}	166710	AD	2
607622	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
604862	2p13.3	[?Birbeck granule deficiency]	613393	_	3
608489	7q22.1	Premature ovarian failure 8	615723	AR	3
609689	20q11.22	Cone-rod dystrophy and hearing loss 2	618358	AR	3
608808	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
606978	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
612291	3q11.1-q11.2	Joubert syndrome 8	612291	AR	3
609889	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
611770	8p21.2	Conotruncal heart malformations	217095	_	3
611770	8p21.2	Persistent truncus arteriosus	217095	_	3
612285	4p15.32	Joubert syndrome 9	612285	AR	3
610083	4q34.3-q35.1	Microphthalmia, isolated, with coloboma 9	615145	AR	3
604809	6p21.3	Panbronchiolitis, diffuse	604809	Mu	2
609273	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
612222	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
611185	6p21	{Restless legs syndrome 6}	611185	_	2
610725	10q23.33	Nephrotic syndrome, type 3	610725	AR	3
612411	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
612411	4q28.1	Van Maldergem syndrome 2	615546	AR	3
610568	1q21.3	Paget disease of bone 6	616833	AD	3
611722	10q22.1	Krabbe disease, atypical	611722	AR	3
611105	1q25.1	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3
612138	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
612465	13q22.2	{Diabetes mellitus, noninsulin-dependent, 5}	616087	_	3
610170	5p13	Kyphoscoliosis 1	610170	_	2
610446	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
608968	20q12	Duane retraction syndrome 3	617041	AD	3
608968	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
612448	8q24.13-q24.22	{Age-related hearing impairment 1}	612448	_	2
609173	15q15.1	Microcephaly 4, primary, autosomal recessive	604321	AR	3
611590	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
603539	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
612079	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
612348	8p12	?Thrombophilia due to decreased release of tissue plasminogen	_	_	1
608075	12p12.3	?Spermatogenic failure 17	617214	AR	3
611648	5q21.1	Deafness, autosomal recessive 100	618422	AR	3
611687	6q13	Hydatidiform mole, recurrent, 2	614293	AR	3
610217	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
610294	6p25.3-p22.3	{Intelligence QTL3}	610294	_	2
612267	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
609690	2q36.1	Rajab interstitial lung disease with brain calcifications	613658	AR	3
604594	2p21	Short stature with microcephaly and distinctive facies	615789	AR	3
611766	15q22.31	Combined oxidative phosphorylation deficiency 15	614947	AR	3
611766	15q22.31	Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3
612923	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
607736	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
608025	2p24.3	Infantile liver failure syndrome 2	616483	AR	3
608025	2p24.3	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3
612775	8p11.22	Cone-rod dystrophy 9	612775	_	3
611223	1q43-q44	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3
607492	11q13.1-q13.2	Schuurs-Hoeijmakers syndrome	615009	AD	3
610618	5q35.3	Angioedema, hereditary, type III	610618	AD	3
613085	14q24.3	Glaucoma 3, primary congenital, C	613085	_	2
610143	12p13.2-p11.23	Deafness, autosomal recessive 62	610143	AR	2
612958	17q23.3	Mitochondrial complex IV deficiency	220110	Mi,AR	3
612716	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
612176	1p32.1	Bone marrow failure syndrome 4	618116	AR	3
613092	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
608448	3p26	{Inflammatory bowel disease 9}	608448	_	2
611994	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
611771	19q13.32	Lipoprotein glomerulopathy	611771	_	3
611603	12q13.12	Lissencephaly 3	611603	AD	3
604863	4q32.1	Leber congenital amaurosis 14	613341	AR	3
604863	4q32.1	Retinal dystrophy, early-onset severe	613341	AR	3
604863	4q32.1	Retinitis pigmentosa, juvenile	613341	AR	3
613168	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
612286	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
613161	22q11.23	Beta-ureidopropionase deficiency	613161	AR	3
611459	4q31.22	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3
612192	6p22.1	Diabetes mellitus, transient neonatal, 1	601410	AD	3
612224	4q31	{Stature QTL 12}	612224	_	2
609165	17q21.2	Ichthyosis with confetti	609165	AD	3
613251	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
611945	8p21.1-q13.3	Spastic paraplegia 37, autosomal dominant	611945	AD	2
612132	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
613027	16p11.2	Glycogen storage disease IXc	613027	AR	3
610295	2q24.1-q31.1	{Intelligence QTL3}	610295	_	2
613265	20q13.32	Waardenburg syndrome, type 4B	613265	AR,AD	3
613235	1q31.3	Factor XIIIB deficiency	613235	AR	3
612518	14q21.3	Ciliary dyskinesia, primary, 10	612518	_	3
613228	4q34.3	Aspartylglucosaminuria	208400	AR	3
611307	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
612690	15q15.2	Spherocytosis, type 5	612690	_	3
610508	2p25.1	Maturity-onset diabetes of the young, type VII	610508	_	3
609820	1q42.2	Erythrocytosis, familial, 3	609820	AD	3
610836	1q41-q42	{Autism susceptibility 11}	610836	_	2
612350	11p11.2	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3
608026	9q31-q32	Hypertensive nephropathy	608026	_	2
612924	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
612268	14q24.3	Cone-rod dystrophy 19	615860	AR	3
613179	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
613413	7p21.3	Leukodystrophy, hypomyelinating, 16	617964	AD	3
608316	2q21.1-q22	{Coronary heart disease, susceptibility to, 2}	608316	_	2
612080	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
611203	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
609946	2p25.1-p24.3	Deafness, neurosensory, autosomal recessive 47	609946	AR	2
610921	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
611224	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
609562	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
609562	8q13.2	Febrile seizures, familial, 11	614418	AR	3
613086	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
613019	11q12.2	Paragangliomas 2	601650	AD	3
604597	12q14.3	Fraser syndrome 3	617667	AR	3
612647	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
612406	20p11.2-q13.12	Dystonia-17, primary torsion	612406	AR	2
608931	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
609456	4p16.3	Muscular dystrophy, congenital, merosin-positive	609456	AR	2
608537	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
608537	3p25.3	Hemangioblastoma, cerebellar, somatic	_	_	3
608537	3p25.3	Pheochromocytoma	171300	AD	3
608537	3p25.3	Renal cell carcinoma, somatic	144700	_	3
608537	3p25.3	von Hippel-Lindau syndrome	193300	AD	3
611469	8q24	{Colorectal cancer, susceptibility to, 2}	611469	_	2
612292	8q24.3	Birk-Barel mental retardation dysmorphism syndrome	612292	_	3
613480	1q42.13	Lymphatic malformation 3	613480	AD	3
608622	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
613169	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
609275	1q41	Martsolf syndrome	212720	AR	3
609275	1q41	Warburg micro syndrome 2	614225	AR	3
613098	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
610619	5q35.3	Angioedema, hereditary, type III	610618	AD	3
610619	5q35.3	Factor XII deficiency	234000	AR	3
612959	8q22.1	?Deafness, autosomal recessive 109	618013	AR	3
610178	14q23.1	Joubert syndrome 23	616490	AR	3
610178	14q23.1	Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3
610357	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
613541	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
613541	12q24.31	Spastic paraplegia 55, autosomal recessive	615035	AR	3
611357	6q14.1	Osteogenesis imperfecta, type XVIII	617952	AR	3
613695	21q22.12	Long QT syndrome 5	613695	AD	3
611252	14q12-q21	Spastic paraplegia 32, autosomal recessive	611252	AR	2
612287	17q25.1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3
609270	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
613719	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
613028	10q23.31	{Glioma susceptibility 2}	613028	_	3
613728	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
612437	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
612925	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
613768	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
611421	16p11.2	Floating-Harbor syndrome	136140	AD	3
612444	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
612529	11q22.2	Amelogenesis imperfecta, type IIA2	612529	AR	3
613744	15q21.2	Spastic paraplegia 51, autosomal recessive	613744	AR	3
606675	14q11-q12	{Inflammatory bowel disease 4}	606675	_	2
608595	7p14.3	{Asthma, susceptibility to, 2}	608584	_	3
612186	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
612186	15q21.2	?Polyendocrine-polyneuropathy syndrome	616113	AR	3
610448	3p21.31	Chilblain lupus	610448	AD	3
613153	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3
613762	5q11.2	46XY sex reversal 6	613762	AD	3
613835	1q31.3	Leber congenital amaurosis 8	613835	_	3
612225	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
608027	7q21.11	?Pontocerebellar hypoplasia, type 3	608027	AR	3
613162	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
613869	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
612757	8q24.3	Hyperlipoproteinemia, type 1D	615947	AR	3
613883	7q34	[Blood group, Kell]	110900	_	3
608932	16q22.3-q23.1	Keratoconus 2	608932	_	2
614037	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
613087	4q32.3	Atrial septal defect 6	613087	AD	3
612988	11q14.1	Optic atrophy 7	612989	AR	3
613521	1p34.1	Porphyria cutanea tarda	176100	AR,AD	3
613521	1p34.1	Porphyria, hepatoerythropoietic	176100	AR,AD	3
609367	10q22.1	Goldberg-Shprintzen megacolon syndrome	609460	AR	3
614044	7q34	Trypsinogen deficiency	614044	AR	1
613500	22q11.23	Agammaglobulinemia 2	613500	AR	3
613099	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
612293	1p31.3-p31.1	Porokeratosis 5, disseminated superficial actinic	612293	_	2
611849	2q36.1	?Combined oxidative phosphorylation deficiency 16	615395	AR	3
610361	13q33.1-q34	Orofacial cleft 9	610361	_	2
612199	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
611958	11q13	{Prostate cancer, hereditary, 14}	611958	_	2
611891	9p21	{Aneurysm, familial abdominal 3}	611891	_	2
613553	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613230	19q13.11	Prolidase deficiency	170100	AR	3
612288	10q23-q24	{Inflammatory bowel disease 20}	612288	_	2
613920	2q11.2	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3	616500	AR	3
612051	16q21	Spinocerebellar ataxia 31	117210	AD	3
611553	3p25.2	Noonan syndrome 5	611553	AD	3
609271	2p24	Keratoconus 4	609271	_	2
604632	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
613252	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
613636	11p14	[Tuberculin skin test reactivity, absence of]	613636	_	2
608769	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
607883	17p13.2	Riboflavin deficiency	615026	AD	3
609276	11q25	Microcephaly 22, primary, autosomal recessive	617984	AR	3
613720	20q13.33	Epileptic encephalopathy, early infantile, 7	613720	AD	3
614237	10q11.23-q22.3	Hypotrichosis 9	614237	AR	2
611134	12q21.32	Meckel syndrome 4	611134	AR	3
614303	15q25.1	EDICT syndrome	614303	AD	3
614067	14q12	Spastic paraplegia 52, autosomal recessive	614067	AR	3
611623	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
614258	10q22.3	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3
614258	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
608439	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
614402	10q25.3	?Microphthalmia, syndromic 11	614402	AR	3
614374	6p21.33	[Blood group, Rodgers]	614374	_	3
609479	2q31.1	Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3
609479	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
613763	11q23.1	Cataract 16, multiple types	613763	AR,AD	3
614280	2q33-q36	{Epilepsy, juvenile myoclonic, susceptibility to, 9}	614280	AD	2
613884	13q14	Chromosome 13q14 deletion syndrome	613884	IC,AD	4
614478	12q13.12	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
613224	1p13.2	Noonan syndrome 6	613224	AD	3
614319	18q12.3	Vesicoureteral reflux 6	614319	_	2
614039	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
612462	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
612926	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
614381	12q23.3	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3
613021	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
613164	1q32	{Parkinson disease 16}	613164	_	2
613029	13q13.1	{Glioblastoma 3}	613029	AR	3
613969	5p15.1-p13.3	Myopia 19	613969	AD	2
612226	4p15.3	{Stature QTL 13}	612226	_	2
614433	6q24.1	Atrial septal defect 8	614433	AD	3
613289	13q21	Spinocerebellar ataxia 8	608768	AD	3
614135	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
609948	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
613836	16q23.3	{Adiponectin, serum level of, QTL5]	613836	_	2
611862	1q23.2	[White blood cell count QTL]	611862	AR	3
613814	17p12	Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3
614120	15q26.1	?Hydrolethalus syndrome 2	614120	AR	3
612082	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
614165	5p15.33	Paragangliomas 5	614165	AD	3
614199	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
613154	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3
613192	8q24.3	Mental retardation, autosomal recessive 13	613192	AR	3
613176	19q13.31	Heart and brain malformation syndrome	616920	AR	3
612989	11q14.1	Optic atrophy 7	612989	AR	3
613870	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
614616	12p12.3	Diarrhea 6	614616	AD	3
613958	12q14.2	Spermatogenic failure 9	613958	AR	3
610374	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
613915	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
611096	16p12.2-q12.1	Mental retardation, autosomal recessive 10/20	611096	AR	2
613064	11q13.5	{Dermatitis, atopic, susceptibility to, 7}	613064	_	2
611554	3p25.2	LEOPARD syndrome 2	611554	_	3
612758	4p15.32	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3
611236	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
614672	7q21.2	?Cardiomyopathy, dilated, 2B	614672	AR	3
613721	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
613794	1p31.3	Retinitis pigmentosa 20	613794	AR	3
614238	7p22.3-p21.3	Hypotrichosis 10	614238	AR	2
614382	11q24.2	{Bacteremia, protection against}	614382	_	3
614727	4q12	Congenital disorder of glycosylation, type IIk	614727	AR	3
609806	11q23.3	Porphyria, acute intermittent	176000	AD	3
609806	11q23.3	Porphyria, acute intermittent, nonerythroid variant	176000	AD	3
614691	7q34	Cataract 38, autosomal recessive	614691	AR	3
614290	18p	Tetrasomy 18p	614290	_	4
613340	4q24-q28	Epilepsy, hot water, 2	613340	_	2
608770	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
607904	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
607904	16p13.3	{Epilepsy, childhood absence, susceptibility to, 6}	611942	_	3
607904	16p13.3	{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942	_	3
613854	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
613970	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
612463	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
613165	17q25.3	Desbuquois dysplasia 1	251450	AR	3
613165	17q25.3	Epiphyseal dysplasia, multiple, 7	617719	AR	3
613522	7q32.1	Colorblindness, tritan	190900	AD	3
614375	12q13.3	Aortic aneurysm, familial abdominal, 4	614375	_	2
612227	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AR,AD	3
603909	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
609168	3p24.3	Chronic atrial and intestinal dysrhythmia	616201	AR	3
609678	13q31.1	?Trichotillomania	613229	Mu,AD	3
609678	13q31.1	Tourette syndrome	137580	AD	3
614852	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613573	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
614166	13q12.12	Myopia 20, autosomal dominant	614166	_	2
613885	12q24.31	?Meckel syndrome 8	613885	AR	3
614193	6p22.2	[Transferrin serum level QTL2]	614193	_	3
613837	7q32.1	Leber congenital amaurosis 11	613837	AD	3
614501	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
614976	19q13.2	Carpenter syndrome 2	614976	AR	3
614397	1p34.2	Microcephaly 15, primary, autosomal recessive	616486	AR	3
612289	1p13.3	Fontaine progeroid syndrome	612289	AD	3
614893	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
612759	2q24.1	Synesthesia	612759	_	2
613916	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
614389	1q24.2	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3
611863	4p16-p15	Microtia with nasolacrimal duct imperforation and eye coloboma	611863	_	4
613022	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
614863	6p21.1	Peroxisome biogenesis disorder 4B	614863	AR,AD	3
614383	3p21.2	{Bacteremia, susceptibility to}	614383	_	3
613156	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
613959	7q36.3	Schizophrenia 16	613959	_	4
613089	3q26.32	CLAPO syndrome, somatic	613089	_	3
615103	18p11.21	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction	617732	AD	3
613765	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
612990	20q11.21	Bohring-Opitz syndrome	605039	AD	3
612990	20q11.21	Myelodysplastic syndrome, somatic	614286	_	3
614434	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
613307	9q34.3	Deafness, autosomal recessive 79	613307	AR	3
613829	19q13.33	Leber congenital amaurosis 7	613829	_	3
613068	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
613177	19q13.2	Cutis laxa, autosomal recessive, type IC	613177	AR	3
615214	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
613030	9p21.3	{Glioma susceptibility 5}	613030	_	2
612221	3q23	{Stature QTL 10}	612221	_	2
610204	17q25.1	?Pontocerebellar hypoplasia type 5	610204	AR	3
614654	16q21	Coenzyme Q10 deficiency, primary, 5	614654	AR	3
614728	3q22.2	?Seckel syndrome 6	614728	AR	3
608771	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
608771	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
614068	14q24.3	?Cranioectodermal dysplasia 3	614099	AR	3
614068	14q24.3	?Retinitis pigmentosa 81	617871	AR	3
614068	14q24.3	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3
614661	15q21.1	Oocyte maturation defect 4	617743	AR	3
614194	19p13.2	Adams-Oliver syndrome 2	614219	AR	3
612182	8p22	[Acetylation, slow]	243400	AR	3
614698	1q44	Mitochondrial complex IV deficiency	220110	Mi,AR	3
614480	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
613855	2q23.3	Episodic ataxia, type 5	613855	AD	3
612410	18p11.23	{Psoriasis susceptibility 10}	612410	_	2
614369	19q13.33	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3
613501	19q13.2	Agammaglobulinemia 3	613501	AR	3
614305	11p11.2	Sclerosteosis 2	614305	AR,AD	3
614320	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
613523	8p11	Chromosome 8p11 myeloproliferative syndrome	613523	_	4
613308	6p21.31	Diamond-Blackfan anemia 9	613308	AD	3
613157	1p34.1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3
614294	15q25	Chromosome 15q25 deletion syndrome	614294	AD	4
613726	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
614692	6p21.3	{?Membranous nephropathy, susceptibility to}	614692	_	2
614376	4p14	?Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3
614404	17q25.1	Tylosis with esophageal cancer	148500	AD	3
611360	15q26.1	Fanconi anemia, complementation group I	609053	AR	3
610205	1p12	Alagille syndrome 2	610205	AD	3
614201	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
612438	19p13.3	Leukodystrophy, hypomyelinating, 6	612438	AD	3
615284	22q13.33	Charcot-Marie-Tooth disease, type 4B3	615284	AR	3
611254	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
611254	15q26.1	?Hydrolethalus syndrome 2	614120	AR	3
611254	15q26.1	Acrocallosal syndrome	200990	AR	3
611254	15q26.1	Joubert syndrome 12	200990	AR	3
613025	15q13	{Schizophrenia, susceptibility to, 13}	613025	_	2
613062	9p21	{Basal cell carcinoma, susceptibility to, 5}	613062	_	2
611097	19q13.2-q13.3	Mental retardation, autosomal recessive, 11	611097	AR	2
613979	20q13.33	Retinitis pigmentosa 60	613983	AD	3
615300	3p21.31	Perrault syndrome 4	615300	AR	3
613838	4q26	Cardiomyopathy, hypertrophic, 16	613838	AD	3
615440	17p12	Combined oxidative phosphorylation deficiency 17	615440	AR	3
614982	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
614982	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
615548	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
614283	7p21.3	{Glucocorticoid therapy, response to}	614400	_	3
613488	12q13.1	Myxoid liposarcoma	613488	_	4
607905	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
607905	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
614195	20p11.21	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	_	3
613871	15q25.1	Tyrosinemia, type I	276700	AR	3
614306	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
614668	16q12.1-q23.1	Stuttering, familial persistent, 4	614668	_	2
613750	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
614321	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
615374	4p15.33	Cone-rod dystrophy 18	615374	AR	3
614295	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
613070	22q13.31	Liver failure, transient infantile	613070	AR	3
614699	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
614655	3q13.2-q13.33	Stuttering, familial persistent, 3	614655	_	2
614866	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
615611	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
614390	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
615538	22q13	Chromosome 22q13 duplication syndrome	615538	IC	4
614378	4p14	?Cranioectodermal dysplasia 4	614378	AR	3
615670	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
613489	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
614483	13q34	Brain small vessel disease 2	614483	AD	3
615521	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
613502	10q24.1	?Agammaglobulinemia 4	613502	AR	3
614908	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
614122	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
613233	11q21-q22	[Fasting plasma glucose level QTL 3]	613233	_	2
613018	16q22.2	Tyrosinemia, type II	276600	AR	3
614202	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
615726	12q13.13	Pachyonychia congenita 3	615726	_	3
614370	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
615158	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
615242	1p36.32	[Blood group, Vel system]	615264	AR	3
613839	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
613960	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
615285	1q21.2	Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3
615441	6q22.31	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	AR	3
615612	3p22.2	Developmental dysplasia of the hip 2	615612	AD	2
616120	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
616079	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
614669	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AR,AD	3
616032	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
613026	19q13.11	Chromosome 19q13.11 deletion syndrome, distal	613026	AD	4
614284	1p34.2	?Stickler syndrome, type V	614284	AR	3
615629	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
614307	5p13.2	Alpha-methylacyl-CoA racemase deficiency	614307	AR	3
613872	13q34	Factor X deficiency	227600	AR	3
613411	13q34	Oguchi disease-2	613411	_	3
615872	5q11.2	Ciliary dyskinesia, primary, 29	615872	AR	3
610212	6p22.3	?Deafness, autosomal recessive 66	610212	AR	3
615369	15q26.1	Epileptic encephalopathy, childhood-onset	615369	AD	3
615558	2p24.1	Hypobetalipoproteinemia	615558	AR	3
614346	12q13.11-q15	Mental retardation, autosomal recessive 25	614346	AR	2
614196	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
615423	3q12.3	Combined oxidative phosphorylation deficiency 30	616974	AR	3
615760	3p21.31	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3
615412	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
615849	2q14.2	Culler-Jones syndrome	615849	AD	3
616178	17q12	?Deafness, autosomal recessive 99	618481	_	3
609457	12q23.1	[Histidinemia]	235800	AR,AD	3
615522	6q23.2	Cole disease	615522	AD	3
614123	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
613516	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
614810	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
613637	5p15	[Tuberculin skin test reactivity QTL]	613637	_	2
615348	3p22.1	Nemaline myopathy 8, autosomal recessive	615348	_	3
614435	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
612322	2q33.3	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
615785	17q21.2	White sponge nevus 2	615785	AD	3
613727	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
613524	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
613524	1q43-q44	Senior-Loken syndrome 7	613615	_	3
616080	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
616025	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
615413	10q26.11	Spermatogenic failure 12	615413	AD	3
613751	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
615850	17p13.3	Pontocerebellar hypoplasia, type 2E	615851	AR	3
615630	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
616362	19q13.41	Mental retardation, autosomal dominant 36	616362	AD	3
615618	3q13.33	?Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3
615618	3q13.33	Dowling-Degos disease 4	615696	AD	3
615370	9q22.33	Nephronophthisis 16	615382	AR	3
614203	16q11.2	{Parkinson disease 17}	614203	AD	3
616265	19q13.11	?Peeling skin syndrome 3	616265	AR	3
615021	3q26.1	[Blood group, globoside system]	615021	_	3
615559	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
612414	11q13.4	Deafness, autosomal recessive 63	611451	AR	3
615112	1p13.2	Urofacial syndrome 2	615112	AR	3
615424	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
613517	2q37.1	Microphthalmia, isolated 6	613517	AR	3
615873	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
614318	13q33.2	Vesicoureteral reflux 5	614318	_	2
615885	13q12.2	Hypotrichosis 12	615885	AD	3
615643	17q21.2	Neurodegeneration with brain iron accumulation 6	615643	AR	3
615761	3p25.3	Mental retardation, autosomal dominant 23	615761	AD	3
615107	10q23.31	Cowden syndrome 4	615107	_	3
613312	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
615349	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
616222	14q32	Temple syndrome	616222	AD	4
612346	22q11.23	?Glutathioninuria	231950	AR	3
613767	16q21	Retinitis pigmentosa 45	613767	AR	3
615539	6q22.1	Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3
616012	3p25.3	Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3
616172	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
615523	15q25.3	Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3
614347	6q26-q27	Mental retardation, autosomal recessive 28	614347	AR	2
615113	15q26.3	Microphthalmia, isolated 8	615113	AR	3
614954	9q31.1	Congenital heart defects, multiple types, 3	614954	AD	2
615802	2q33.1	Mental retardation, autosomal recessive 42	615802	AR	3
613980	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
616406	1q42.12	Leukodystrophy, hypomyelinating, 10	616420	AR	3
616580	9q21.32	Au-Kline syndrome	616580	AD	3
615631	15q14	Dyserythropoietic anemia, congenital, type Ib	615631	AR	3
616111	11q12.3	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3
612778	3p21.31	Luscan-Lumish syndrome	616831	AD	3
614856	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
616455	8p21.3	Zimmermann-Laband syndrome 2	616455	AD	3
616494	6p21.1	Leukodystrophy, hypomyelinating, 11	616494	AR	3
611100	8q24	{Prostate cancer, hereditary, 10}	611100	_	2
614041	13q14.2	Bladder cancer, somatic	109800	_	3
614041	13q14.2	Osteosarcoma, somatic	259500	_	3
614041	13q14.2	Retinoblastoma	180200	SMu,AD	3
614041	13q14.2	Retinoblastoma, trilateral	180200	SMu,AD	3
614041	13q14.2	Small cell cancer of the lung, somatic	182280	_	3
614696	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
613412	5q22	{Esophagitis, eosinophilic, 2}	613412	Mu	2
614770	19p13.2	Mitochondrial complex IV deficiency	220110	Mi,AR	3
613873	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
616368	5q31.1	CHOPS syndrome	616368	AD	3
615350	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
613313	19q13.12	Hemochromatosis, type 2B	613313	AR	3
615582	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
616144	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
615244	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
615425	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
611317	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
616726	16q24.3	Ciliary dyskinesia, primary, 33	616726	AR	3
614671	16p11.2	Chromosome 16p11.2 duplication syndrome	614671	_	4
614671	16p11.2	{Autism, susceptibility to, 14B}	614671	_	2
608796	8q23	Moyamoya disease 3	608796	_	2
615779	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
614730	9p13.3	Hyperphosphatasia with mental retardation syndrome 2	614749	AR	3
614828	3p22.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AR	3
614828	3p22.1	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3
616461	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
615022	12p11.2-q13.1	Ichthyosis, congenital, autosomal recessive 7	615022	AR	2
613684	22q13.2	Rubinstein-Taybi syndrome 2	613684	AD	3
604569	7q35-q36	Cortical dysplasia-focal epilepsy syndrome	610042	AR	3
604569	7q35-q36	Pitt-Hopkins like syndrome 1	610042	AR	3
604569	7q35-q36	{Autism susceptibility 15}	612100	_	3
615101	6p25.2	Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3
614486	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
616228	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
612347	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
613193	16q24.1	Ciliary dyskinesia, primary, 13	613193	AR	3
613554	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
612898	9q34.11	Coenzyme Q10 deficiency, primary, 7	616276	AR	3
613886	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
613795	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
615560	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
613575	3q11.2	?Retinitis pigmentosa 55	613575	_	3
616835	6p22.3	Meier-Gorlin syndrome 6	616835	AD	3
614673	4q12	Microcephaly 8, primary, autosomal recessive	614673	AR	3
613518	4q22.1	{Dermatitis, atopic, susceptibility to, 8}	613518	_	2
613882	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
614701	8q24.11	Cornelia de Lange syndrome 4	614701	AD	3
615414	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
615712	5p15.2	Autoinflammation, panniculitis, and dermatosis syndrome	617099	AR	3
615266	5q31.3	Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3
615632	11q13.1	Neuropathy, hereditary sensory, type IF	615632	AD	3
614198	17q23.3	Myasthenic syndrome, congenital, 16	614198	AR	3
615402	2q35	Dyschromatosis universalis hereditaria 3	615402	AD	3
616763	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
616721	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
616975	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
615426	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
616969	6q21	?Deafness, autosomal dominant 66	616969	AD	3
614857	14q24.3	Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3
614008	11q13.1	Nestor-Guillermo progeria syndrome	614008	AR	3
616266	13q32.3-q33.1	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3
614296	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
610564	6q21	Coenzyme Q10 deficiency, primary, 3	614652	AR	3
616364	1q21.3	White-Sutton syndrome	616364	AD	3
616947	10q26.3	?Premature ovarian failure 12	616947	AR	3
616145	13q32.1	Catel-Manzke syndrome	616145	AR	3
614042	10q23.31	Moyamoya disease 5	614042	_	3
616027	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
615540	19q13.12	Deafness, autosomal recessive 76	615540	AR	3
616786	15q15.1	Nephronophthisis 20	617271	AR	3
615583	8q24.3	Verheij syndrome	615583	AD	3
614184	2q37.1	Perlman syndrome	267000	AR	3
617156	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
616922	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
615351	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
614485	9p22.3	Trigonocephaly 2	614485	AD	3
616224	2p21	Myasthenic syndrome, congenital, 22	616224	AR	3
617132	3q22.1	Epileptic encephalopathy, early infantile, 44	617132	AR	3
617052	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
611451	11q13.4	Deafness, autosomal recessive 63	611451	AR	3
614731	17p12	{Prostate cancer, hereditary, 2, susceptibility to}	614731	_	3
616941	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
614930	8q24.22	Ciliary dyskinesia, primary, 19	614935	AR	3
613084	2p25.3	Mental retardation, autosomal dominant 39	616521	AD	3
614385	14q24.3	Colorectal cancer, hereditary nonpolyposis, type 7	614385	_	3
613887	9q22.33	Cataract 36	613887	AR	3
615108	3q26.32	Cowden syndrome 5	615108	_	3
616013	4q23	Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3
615673	10q22.1	Myopathy with extrapyramidal signs	615673	AR	3
614149	17q25.1-q25.3	Nail disorder, nonsyndromic congenital, 9	614149	AR	2
611431	15q14	Legius syndrome	611431	AD	3
614036	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
616779	10q26.13	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	616779	AD	3
617173	15q21.2	Intellectual developmental disorder with cardiac arrhythmia	617173	AR	3
614302	3p25.1	Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3
616138	10q24.31	Perrault syndrome 5	616138	AR	3
613796	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
616270	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
616299	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
613856	1p13.3	Achromatopsia 4	613856	_	3
614409	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
614495	5q31.2	Pseudohypoaldosteronism, type IID	614495	AR,AD	3
616509	21q22.3	Cataract 44	616509	AR	3
616457	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
617234	1p36.13	Preimplantation embryonic lethality 2	617234	AR	3
616028	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
616948	2q11.2	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3
617168	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
616229	11p11.2	Osteogenesis imperfecta, type XVI	616229	AR	3
614813	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
617260	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
615803	11q12.1	Pontocerebellar hypoplasia, type 10	615803	AR	3
615620	19q13.32	Mental retardation, autosomal recessive 41	615637	AR	3
614732	11p15.4	IMAGE syndrome	614732	AD	3
615633	9q34.11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3
614772	1q42.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	616501	AR	3
611101	1p36.31	Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3
611101	1p36.31	Spinal muscular atrophy, distal, autosomal recessive, 4	611067	AR	3
615545	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
617574	12q13.3	Ichthyosis, congenital, autosomal recessive 13	617574	AR	3
617041	20q12	Duane retraction syndrome 3	617041	AD	3
615973	12q21.33	Cone-rod dystrophy 20	615973	AR	3
615415	17q11.2	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3
614162	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
617187	20q11.21	Spermatogenic failure 16	617187	AR	3
617391	1q44	Epileptic encephalopathy, early infantile, 54	617391	AD	3
615040	8q21.11	?Episodic pain syndrome, familial, 1	615040	AD	3
614386	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
614386	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
614386	16p11.2	Seizures, benign familial infantile, 2	605751	AD	3
616271	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
616780	10p15.3	Oocyte maturation defect 2	616780	AR,AD	3
617113	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
617600	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
615433	3q13.31	Chromosome 3q13.31 deletion syndrome	615433	AD	4
617744	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
616146	13q32.1	Catel-Manzke syndrome	616145	AR	3
614496	2q36.2	Pseudohypoaldosteronism, type IIE	614496	AD	3
612899	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
616029	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
616680	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
617898	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
616655	19q13.1-q13.2	?Cataract 45	616851	AR	3
616139	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
614436	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
617575	10q22.1	Nephrotic syndrome, type 14	617575	AR	3
612940	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
613576	7p21.2-p14.3	Ectodermal dysplasia-syndactyly syndrome 2	613576	AR	2
616977	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
617242	4q13.1	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	3
613799	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
617169	19p13.3	?Sotos syndrome 3	617169	AR	3
617807	19p13.2	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3
617133	3q22.1	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3
614980	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
617188	19q13.42	Mental retardation, autosomal recessive 57	617188	AR	3
614867	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
617952	6q14.1	Osteogenesis imperfecta, type XVIII	617952	AR	3
617235	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
617294	3q27.1	Epidermolysis bullosa simplex, generalized, with scarring and hair loss	617294	AD	3
614940	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
616681	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
617337	1p36.11	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3
608072	6p22.3	Epilepsy, progressive myoclonic 2B (Lafora)	254780	AR	3
615206	7p22.2	Immunodeficiency 11A	615206	AR	3
614807	16p13.3	?Centronuclear myopathy 4	614807	AD	3
617048	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
616458	9q34.12	Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3
615762	5q32	?Deafness, autosomal recessive 101	615837	AR	3
617991	6q14.1	Developmental delay, intellectual disability, obesity, and dysmorphic features	617991	AD	3
617114	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
614497	2q35	Microphthalmia, isolated, with coloboma 7	614497	AD	3
615416	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
615416	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
615439	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
616781	1p36.32	Joubert syndrome 25	616781	AR	3
613519	3p24	{Dermatitis, atopic, susceptibility to, 9}	613519	_	2
617770	19q13.2	?Spinocerebellar ataxia 46	617770	AD	3
615115	18q12.1	Bainbridge-Ropers syndrome	615485	AD	3
618005	14q23.3	Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3
617576	3p21.1	Spermatogenic failure 18	617576	AR	3
612779	1p21.3	5-fluorouracil toxicity	274270	AR	3
612779	1p21.3	Dihydropyrimidine dehydrogenase deficiency	274270	AR	3
615462	7q36.3	Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3
615816	6q14.1	Immunodeficiency 23	615816	AR	3
617808	12q12	Coffin-Siris syndrome 6	617808	AD	3
617935	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
616452	7p22.2	B-cell expansion with NFKB and T-cell anergy	616452	AD	3
617946	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
617035	6p12.3	Patent ductus arteriosus 2	617035	AD	3
618013	8q22.1	?Deafness, autosomal recessive 109	618013	AR	3
615578	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
616140	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
614808	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
615602	5q34	[Memory, enhanced, QTL]	615602	_	3
615999	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
614868	20q13.12	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	_	3
617435	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
614829	4q21.1	Amelogenesis imperfecta, type IIA4	614832	AR	3
614498	7p22.3	Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3
615109	14q32.33	Cowden syndrome 6	615109	_	3
615605	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
617243	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
617992	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
615616	10q21.3	Arrhythmogenic right ventricular dysplasia, familial, 13	615616	AD	3
618236	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
616722	9q21.12	?Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3
618084	1q21.3	Peeling skin syndrome 6	618084	AR	3
615757	20p11.23	Retinitis pigmentosa 69	615780	AR	3
615807	10q21.3	?Seckel syndrome 8	615807	AR	3
618014	5q31.1	?Premature ovarian failure 14	618014	AR	3
614809	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
617205	7p12.3	Heterotaxy, visceral, 8, autosomal	617205	AR	3
614441	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
618284	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
617190	2p23.3	Shashi-Pena syndrome	617190	AD	3
616749	10q26.2	Heterotaxy, visceral, 7, autosomal	616749	AR	3
614430	8p23.1	Atrioventricular septal defect 4	614430	AD	3
618138	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
615291	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
615291	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
616227	1p21.3	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3
617892	4q33	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3
617049	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
616973	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
617238	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
616943	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
615617	11q23.3	Immunodeficiency 19	615617	AR	3
616386	22q12.3	Dystonia 26, myoclonic	616398	AD	3
615758	1p35.2	?Immunodeficiency 22	615758	AR	3
618085	16q22.2	Spermatogenic failure 31	618112	AR	3
618257	5q13.2	?Deafness, autosomal recessive 112	618257	AR	3
616459	11q24.2	Al-Raqad syndrome	616459	AR	3
618266	17q21.2	Pontocerebellar hypoplasia, type 12	618266	AR	3
616000	4q13.3	Analbuminemia	616000	_	3
614830	3p22.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AR	3
618006	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
614163	17q25	{Delayed sleep phase syndrome, susceptibility to}	614163	AD	2
617153	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
615207	16p12.1	Immunodeficiency 56	615207	AR	3
615054	7q36.1	Glaucoma 1, open angle, F	603383	_	3
618341	17q25.1	Spermatogenic failure 35	618341	AR	3
617239	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
616657	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
616723	16q13	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3
618346	21q22.3	Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3
613868	18q12.3	[Blood group, Kidd]	111000	_	3
614499	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
616949	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
618213	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
617993	12p13.32	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	_	3
617577	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
617746	7p21.1	Sweeney-Cox syndrome	617746	AD	3
615859	1p31.3	Epileptic encephalopathy, early infantile, 23	615859	AR	3
617244	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
618097	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
617971	11p15.4	Methmoglobinemia, beta type	617971	_	3
615883	12q24.31	Myopathy, tubular aggregate, 2	615883	AD	3
616001	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
615604	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AR,AD	3
614260	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
615292	11q12.1	Gracile bone dysplasia	602361	AD	3
615292	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
613493	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
614869	15q25.1	Usher syndrome, type IJ	614869	AR	3
615842	17p13.2	?Spermatogenic failure 14	615842	AR	3
618242	14q12	Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3
618145	11q23.3	Deafness, autosomal recessive 111	618145	AR	3
618267	15q26.1	Epidermodysplasia verruciformis 3	618267	AR	3
616078	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
618300	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
618360	19p13.11	Brain small vessel disease 3	618360	AR	3
616724	12p13.2	Tooth agenesis, selective, 7	616724	AD	3
612780	1q23.2	SESAME syndrome	612780	AR	3
616546	14q23.1	Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3
617564	22q12.3	?Meier-Gorlin syndrome 8	617564	AR	3
618078	12q15	?Ovarian dysgenesis 6	618078	AR	3
617885	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
618248	15q22.31	Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3
618396	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
614850	19p13.3	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AR,AD	3
608797	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
616603	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
617667	12q14.3	Fraser syndrome 3	617667	AR	3
615546	4q28.1	Van Maldergem syndrome 2	615546	AR	3
614431	6q24.1	Ventricular septal defect 2	614431	AD	3
615371	2q34	{Pulmonary hypertension, neonatal, susceptibility to}	615371	_	3
614164	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
615759	2p25.1	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3
616658	19p13.3	Combined oxidative phosphorylation deficiency 37	618329	AR	3
618285	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
618140	7p14.3	?Deafness, autosomal dominant 74	618140	AD	3
617596	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
617268	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
614941	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
618146	12q24.31	Spermatogenic failure 33	618152	AR	3
617339	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
616366	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
617115	18q22.1	Peeling skin syndrome 5	617115	AR	3
618063	11q22.1	Ciliary dyskinesia, primary, 38	618063	AR	3
616974	3q12.3	Combined oxidative phosphorylation deficiency 30	616974	AR	3
616263	17q23.1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3
617672	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
615524	3p24.2	Microphthalmia, syndromic 12	615524	AR,AD	3
616298	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
615009	11q13.1-q13.2	Schuurs-Hoeijmakers syndrome	615009	AD	3
616950	10q26.3	?Spermatogenic failure 15	616950	AR	3
617994	13q13.1	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	_	3
618268	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
616954	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
618098	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
618397	5q13.3	Combined oxidative phosphorylation deficiency 39	618397	AR	3
618349	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
617241	15q13.1	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3
618286	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
617798	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
618147	14q32.2	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3
618000	7p13	Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3
615626	15q14	Dyserythropoietic anemia, congenital, type Ib	615631	AR	3
618141	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
617207	1q42.3	Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3
616367	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
617523	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
615547	15q11.2	Schaaf-Yang syndrome	615547	AD	3
616570	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
618243	2q37.3	Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3
618237	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
614088	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
618342	7q22.3	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3
617973	16p13.3	Methemoglobinemia, alpha type	617973	_	3
617343	6p24.2	Hyperparathyroidism 4	617343	AD	3
614851	14q22.1	?Seckel syndrome 7	614851	AR	3
615848	7q31.33	{Melanoma, cutaneous malignant, susceptibility to, 10}	615848	AD	3
610924	20p13	Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3
616944	3q26.32	Mental retardation, autosomal dominant 41	616944	AD	3
617116	3p21.31	Epilepsy, familial focal, with variable foci 2	617116	AD	3
617290	8p11.23	Epilepsy, early-onset, vitamin B6-dependent	617290	AR	3
615674	17p13.3	Dowling-Degos disease 3	615674	AD	2
616839	8q22.3	?Exercise intolerance, riboflavin-responsive	616839	AR	3
614474	18q11.2	Atrioventricular septal defect 5	614474	AD	3
618079	12q13.12	[Low density lipoprotein cholesterol level QTL 8]	618079	_	3
618287	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
616460	15q24.1	?Mental retardation, autosomal recessive 50	616460	AR	3
614089	14q11.2	Atrial septal defect 3	614089	_	3
614432	5q35.1	Ventricular septal defect 3	614432	AD	3
617732	18p11.21	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction	617732	AD	3
617974	4q35.1	?Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3
618148	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
617805	18q11.1-q11.2	Renal hypodysplasia/aplasia 3	617805	AD	3
616852	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
616617	6p21.1	Heimler syndrome 2	616617	AR	3
618371	17q12	Turnpenny-Fry syndrome	618371	AD	3
617895	12q24.11	Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3
617439	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
618356	1q32.1	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3
614475	18q11.2	Atrial septal defect 9	614475	AD	3
616300	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
618343	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
618456	17p11.2	Deafness, autosomal recessive 114	618456	AR	3
616792	11p15	{Neuroblastoma, susceptibility to, 7}	616792	_	2
617245	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
610925	3p25.3	Candidiasis, familial, 9	616445	AR	3
617771	1q31.3	?Epileptic encephalopathy, early infantile, 57	617771	AD	3
614944	12q21.31	Deafness, autosomal recessive 84B	614944	AR	3
618302	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
618235	5q31.3	?Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3
614437	11q13.1	Cutis laxa, autosomal recessive, type IB	614437	AR	3
618418	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
616112	3p14.1	Nemaline myopathy 10	616165	AR	3
613494	22q13.2	Immunodeficiency, common variable, 4	613494	AR	3
616604	14q32	{Myeloproliferative neoplasms, familial, susceptibility to}	616604	AD	4
617524	1p34.3	Erythrokeratodermia variabilis et progressiva 2	617524	AD	3
618264	17p13.1	Mirror movements 4	618264	AD	3
614090	14q11.2	{Sick sinus syndrome 3}	614090	_	3
618142	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
617572	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
617270	18q12.2	Mental retardation, autosomal recessive 58	617270	AR	3
618244	12q22	?Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3
616907	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
614257	20q11.23	?Mental retardation, autosomal dominant 11	614257	AD	3
617772	1q44	Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3
615010	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
618249	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
618149	3q28	Orofacial cleft 8	618149	_	3
618277	10q25.3	FINCA syndrome	618278	AR	3
618135	3p22.1	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3
618357	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
617228	13q12.12	Combined oxidative phosphorylation deficiency 31	617228	AR	3
617278	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
617036	11q13.5	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3
618419	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
617349	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
610926	10q11.2-q21	Tooth agenesis, selective, 5	610926	_	2
614265	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
613498	17p13	[Sex hormone-binding globulin circulating level QTL 1]	613498	_	2
617668	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
616113	15q21.2	?Polyendocrine-polyneuropathy syndrome	616113	AR	3
617598	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
618250	11q14.1	Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3
618150	16q22.1	Saul-Wilson syndrome	618150	AD	3
614751	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
610927	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
615607	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
614689	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
618372	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
617773	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
617599	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
614438	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
618278	10q25.3	FINCA syndrome	618278	AR	3
618457	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
618420	14q13.2	Spermatogenic failure 36	618420	AD	3
617669	2p25.3	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3
617579	13q32.1	HELIX syndrome	617671	AR	3
616946	10q11.23	Premature ovarian failure 11	616946	AD	3
614753	19p13.13	Sotos syndrome 2	614753	AD	3
617246	8q24.13	Seckel syndrome 10	617253	AR	3
618251	3q13.33	Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3
617350	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
617170	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
614816	1q41	Loeys-Dietz syndrome 4	614816	AD	3
616353	16p13.12	Dyskeratosis congenita, autosomal recessive 6	616353	AR	3
618304	17q25.1	Spermatogenic failure 35	618341	AR	3
616920	19q13.31	Heart and brain malformation syndrome	616920	AR	3
617670	16p13.3	?Spermatogenic failure 22	617706	AR	3
616030	7q31.32	Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3
618373	6q24.3-q25.1	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3
615780	20p11.23	Retinitis pigmentosa 69	615780	AR	3
618459	19q13.2	?Immunodeficiency 62	618459	AR	3
618345	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
616794	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
618245	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
616968	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
616354	6q14.3	Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3
618283	14q32.32-q32.33	?Visual impairment and progressive phthisis bulbi	618283	AR	3
617171	11p15.5	?Dyskinesia, seizures, and intellectual developmental disorder	617171	AR	3
617280	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
618254	11p15.5	Ciliary dyskinesia, primary, 39	618254	AR	3
617271	15q15.1	Nephronophthisis 20	617271	AR	3
616115	2p22.3	?Familial cold autoinflammatory syndrome 4	616115	AD	3
618460	7q36.3	Kahn-Kahn-Katsanis syndrome	618460	AR	3
618374	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
618144	17q24.2	Usher syndrome, type IV	618144	AR	3
618255	9p13.3	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3
617281	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
615781	2q36.1	{Psoriasis 15, pustular, susceptibility to}	616106	AD	3
618246	2q33.1	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3
617671	13q32.1	HELIX syndrome	617671	AR	3
616854	5q31.2	Even-plus syndrome	616854	AR	3
615715	9q22.32	Bone marrow failure syndrome 2	615715	AR	3
617743	15q21.1	Oocyte maturation defect 4	617743	AR	3
618377	1p33	?Pain sensitivity QTL1	618377	AD	4
617039	5q23.2	Patent ductus arteriosus 3	617039	AD	3
618383	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
618247	12p13.32	Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3
617275	1q43	Tooth agenesis, selective, 9	617275	AD	3
618378	1q25.1	?Combined oxidative phosphorylation deficiency 38	618378	AR	3
616795	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
616505	5q22.1	Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3
618362	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
616606	Chr.14	Ring chromosome 14 syndrome	616606	IC	4
618392	16q23.3-q24.1	?Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3
614826	1q31.3-q32.1	Nystagmus 7, congenital, autosomal dominant	614826	AD	2
618363	4q31.22	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3
616873	7p12.2	Immunodeficiency, common variable, 13	616873	AD	3
618381	11q13.1	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3
618364	12q13.13	?Myoclonus, familial, 2	618364	AD	3
618393	17p13.2	Fetal akinesia deformation sequence 4	618393	AR	3
617601	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
618394	6q15	Immunodeficiency 60	618394	AD	3
617276	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
618395	2p13.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3
616507	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
616937	20q11.23	?Thrombocytopenia 6	616937	AD	3
616938	17q21.2	Coffin-Siris syndrome 5	616938	AD	3
616939	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
604604	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
603736	10q22.2	SBBYSS syndrome	603736	AD	3
603201	2q31.1	Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3
603201	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
604169	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
604490	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
605606	1p	{Psoriasis susceptibility 7}	605606	_	2
606392	13q12.2	MODY, type IV	606392	_	3
603453	6p25.2	Immunodeficiency 57	618108	AR	3
605285	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
605461	22q11.1	Immunodeficiency 51	613953	AR	3
603961	7q21.11	{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3
605583	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
605648	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
603464	16q24.3	Al Kaissi syndrome	617694	AR	3
605829	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
604292	3q28	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3
605951	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
606812	1q43	Fumarase deficiency	606812	AR	3
606661	3p25.2-p25.1	{Melanoma, uveal, susceptibility to, 2}	606661	_	2
605525	16q24.3	Meier-Gorlin syndrome 4	613804	AR	3
603785	9p23	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3
603964	2q23-q24.3	Deafness, autosomal dominant 16	603964	AD	2
606941	11q23.1	Congenital disorder of glycosylation, type Il	608776	AR	3
606941	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
605282	15q26.3	Temtamy preaxial brachydactyly syndrome	605282	AR	3
606629	6q13	Cone-rod dystrophy 7	603649	_	3
605393	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
603094	3q26.1	[Blood group, globoside system]	615021	_	3
603094	3q26.1	[Blood group, P1PK system, P(k) phenotype]	111400	_	3
604356	2q31.1	Duane retraction syndrome 2	604356	_	3
603214	14q24.3	Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3
604278	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
607120	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
603693	8q23.1	46XY sex reversal 9	616067	AD	3
603693	8q23.1	Diaphragmatic hernia 3	610187	_	3
603693	8q23.1	Tetralogy of Fallot	187500	AD	3
606119	8q24.3	Meleda disease	248300	AR	3
607123	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
603683	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
605584	16q22.2	Retinitis pigmentosa 84	618220	AR	3
603783	4p16-q34	{Intelligence QTL1}	603783	_	2
606662	8p23	Waardenburg syndrome, type 2C	606662	_	2
606782	12p13.2	{Aspergillosis, susceptibility to}	614079	_	3
603617	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
603663	4p	{Mental health wellness-1}	603663	_	2
606664	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
605924	21q22.3	Galloway-Mowat syndrome 6	618347	AR	3
605924	21q22.3	Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3
604605	3q21.1-q21.2	{Coronary heart disease, susceptibility to, 5}	608901	_	3
603040	11q23	{Nonsmall cell lung cancer}	603040	_	2
605934	2q37.1-q37.3	Holoprosencephaly 6	605934	_	2
603029	4q35.1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}	613002	AR,AD	3
603029	4q35.1	{HIV1 infection, resistance to}	609423	_	3
603965	11q22.1	Glomerulosclerosis, focal segmental, 2	603965	AD	3
603892	17q21.31	Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3
606787	1p31	Peripheral arterial occlusive disease 1	606787	_	2
606107	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
605489	12q24.11	Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3
606682	22q12.1	Hermansky-Pudlak syndrome 4	614073	AR	3
604843	12p12.1	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3
606616	18p11.2	{Dyslexia, susceptibility to, 6}	606616	_	2
603454	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
604040	5q31.1	Nijmegen breakage syndrome-like disorder	613078	_	3
603780	8q24.3	Baller-Gerold syndrome	218600	AR	3
603780	8q24.3	RAPADILINO syndrome	266280	AR	3
603780	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
604250	7q22.1	Hemochromatosis, type 3	604250	AR	3
604121	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
607444	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
607444	7q11.21	{Aplastic anemia, susceptibility to}	609135	_	3
605391	10q23.2	{Thyroid carcinoma, follicular}	188470	SMu,AD	3
605958	3p21.31	Seckel syndrome 9	616777	AR	3
603959	3q28	Hypomagnesemia 3, renal	248250	AR	3
604765	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
605441	3q27.3	Adiponectin deficiency	612556	_	3
607429	10p12.1	Coenzyme Q10 deficiency, primary, 2	614651	AR	3
605608	21q22.13	Deafness, autosomal recessive 29	614035	AR	3
607107	4p15.1-q12	{Nasopharyngeal carcinoma 1}	607107	_	2
606680	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
605590	2q33.1	Myelodysplastic syndrome, somatic	614286	_	3
603098	7q34-q36	Deafness, autosomal recessive 13	603098	AR	2
606811	1p36.13	Hyperprolinemia, type II	239510	AR	3
606462	8q24.11	?Mungan syndrome	611376	AR	3
606462	8q24.11	Cornelia de Lange syndrome 4	614701	AD	3
603248	4q22.3	Acromesomelic dysplasia, Demirhan type	609441	AR	3
603248	4q22.3	Brachydactyly, type A1, D	616849	AD	3
603248	4q22.3	Brachydactyly, type A2	112600	AD	3
607752	5q11.2	Ciliary dyskinesia, primary, 29	615872	AR	3
605993	8q22.1	Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3
607636	11q13.2	van Buchem disease, type 2	607636	AD	3
603664	4q	{Mental health wellness-2}	603664	_	2
604498	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
603155	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
604357	4q31.3	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AR,AD	3
604489	5p13.2	Alpha-methylacyl-CoA racemase deficiency	614307	AR	3
604489	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
606200	12p12.1	[Short sleeper]	612975	AD	3
604001	7q21.2	?Long QT syndrome-11	611820	AD	3
606943	17q25.1	Usher syndrome, type 1G	606943	AR	3
606951	2q24.2	Aicardi-Goutieres syndrome 7	615846	AD	3
606951	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
605522	7q36.3	Acheiropody	200500	AR	3
605522	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
605522	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
605522	7q36.3	Polydactyly, preaxial type II	174500	AD	3
605522	7q36.3	Syndactyly, type IV	186200	AD	3
605522	7q36.3	Triphalangeal thumb, type I	174500	AD	3
605522	7q36.3	Triphalangeal thumb-polysyndactyly syndrome	174500	AD	3
605862	12q14.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3
607421	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
603194	11q12.2	Meckel syndrome 2	603194	AR	3
604260	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
604260	17q21.2	Leukemia, acute promyelocytic, somatic	102578	_	3
606835	12q24.11	Digital arthropathy-brachydactyly, familial	606835	AD	3
604187	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
603196	14q12	?Deafness, autosomal recessive 110	618094	AR	3
603196	14q12	Deafness, autosomal dominant 9	601369	AD	3
604294	10q25.3	?Microphthalmia, syndromic 11	614402	AR	3
607677	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
607218	7q32.1	{Inflammatory bowel disease 14}	612245	_	3
607218	7q32.1	{Systemic lupus erythematosus, susceptibility to, 10}	612251	_	3
607402	19q13.2	{Hepatitis C virus infection, response to therapy of}	609532	_	3
604895	17q21.32	Asthma and nasal polyps	208550	AR	3
604895	17q21.32	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
605921	11p15.4	Immunodeficiency 10	612783	AR	3
605921	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
605921	11p15.4	Stormorken syndrome	185070	AD	3
604443	5q31.1	Myelodysplastic syndrome	_	_	3
604443	5q31.1	Myelogenous leukemia, acute	_	_	3
605490	19p13.3	CODAS syndrome	600373	AR	3
603288	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
606681	5q35.3	Leukemia, acute myeloid	601626	SMu,AD	1
606681	5q35.3	Sotos syndrome 1	117550	AD	3
603855	19q13.2-q13.4	{Meconium ileus in cystic fibrosis, susceptibility to}	603855	_	2
607844	12q14.3	Buschke-Ollendorff syndrome	166700	AD	3
607844	12q14.3	Osteopoikilosis with or without melorheostosis	166700	AD	3
607407	10q26.3	Hypotonia, ataxia, and delayed development syndrome	617330	AD	3
604506	2q36.3	Mental retardation, autosomal dominant 49	617752	AD	3
607108	11p13	?Coloboma of optic nerve	120430	AD	3
607108	11p13	?Coloboma, ocular	120200	AD	3
607108	11p13	?Morning glory disc anomaly	120430	AD	3
607108	11p13	Aniridia	106210	AD	3
607108	11p13	Anterior segment dysgenesis 5, multiple subtypes	604229	_	3
607108	11p13	Cataract with late-onset corneal dystrophy	106210	AD	3
607108	11p13	Foveal hypoplasia 1	136520	AD	3
607108	11p13	Keratitis	148190	AD	3
607108	11p13	Optic nerve hypoplasia	165550	AD	3
606952	11q14.3	Albinism, oculocutaneous, type IB	606952	_	3
607871	2p16.3	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3
604766	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
604694	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
607340	9q22.33	Epileptic encephalopathy, early infantile, 59	617904	AD	3
607340	9q22.33	Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3
607340	9q22.33	{Nicotine dependence, protection against}	188890	_	3
607340	9q22.33	{Nicotine dependence, susceptibility to}	188890	_	3
608104	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608296	11q13.1	Thauvin-Robinet-Faivre syndrome	617107	AR	3
607678	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
608092	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	AR	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3
608041	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
608107	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
608107	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
608945	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
608945	13q13.3	Fraser syndrome 2	617666	AR	3
607213	16q11.2	Meier-Gorlin syndrome 3	613803	AR	3
604188	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
606945	19p13.2	Hypercholesterolemia, familial, 1	143890	AD	3
606945	19p13.2	LDL cholesterol level QTL2	143890	AD	3
608508	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
604041	17p13.1	Congenital disorder of glycosylation, type If	609180	AR	3
605558	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
608244	6p22.3-p21.3	Otosclerosis 3	608244	AD	2
607838	16p13.3	Mucolipidosis III gamma	252605	AR	3
604896	20p12.2	Bardet-Biedl syndrome 6	605231	AR	3
604896	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
603041	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
607751	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
604780	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
607352	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
605594	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
607539	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
607166	2q11.2	?Spermatogenic failure 26	617961	AR	3
603856	15q11.2	Precocious puberty, central, 2	615346	AD	3
608317	1p36.11	Van der Woude syndrome 2	606713	AD	3
609153	2q35-q36	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	2
605248	19p13.2	Mucolipidosis IV	252650	AR	3
608451	19q13.31	Ethylmalonic encephalopathy	602473	AR	3
608203	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
603197	19p13.2	?Laurence-Moon syndrome	245800	AR	3
603197	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
603197	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
603197	19p13.2	Spastic paraplegia 39, autosomal recessive	612020	AR	3
606554	1q42	Episodic ataxia, type 3	606554	AD	2
608105	16p12-p11.2	Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp	608105	AR	2
609814	1q31.3	Complement factor H deficiency	609814	AR,AD	3
610148	12q21.2	Bardet-Biedl syndrome 10	615987	AR	3
609634	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
603704	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
604283	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
607343	20q13.2	Duane-radial ray syndrome	607323	AD	3
607343	20q13.2	IVIC syndrome	147750	AD	3
610629	10q22.3	Diamond-blackfan anemia 3	610629	AD	3
610277	12q24.31	Immunodeficiency 9	612782	AR	3
610277	12q24.31	Myopathy, tubular aggregate, 2	615883	AD	3
607386	2p23.3	Retinitis pigmentosa 71	616394	AR	3
607386	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
605145	5p15.2	Chondrocalcinosis 2	118600	AD	3
605145	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
610572	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
609390	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
609390	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
609390	6q21	Charcot-Marie-Tooth disease, type 4J	611228	AR	3
609390	6q21	Yunis-Varon syndrome	216340	AR	3
610062	14q24.3	Ciliary dyskinesia, primary, 16	614017	AR	3
608059	17p13.1	Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3
610273	1q23.2	Glycosylphosphatidylinositol deficiency	610293	AR	3
605995	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
605995	1p36.22	Pheochromocytoma	171300	AD	3
605995	1p36.22	{Neuroblastoma, susceptibility to, 1}	256700	SMu,AD	3
607676	12q12	IRAK4 deficiency	607676	_	3
607921	17q25.3	Retinitis pigmentosa 30	607921	_	3
609583	2q13	Joubert syndrome 4	609583	AR	3
610156	9q34.3	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	AR	3
609378	17q11	{Autism susceptibility 6}	609378	_	2
609384	13q12.11	Fibrosis of extraocular muscles, congenital, 3C	609384	AD	2
610000	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
607842	18q22.3	Aural atresia, congenital	607842	AD	3
603100	9q34.3	Lipodystrophy, congenital generalized, type 1	608594	AR	3
603681	2p23.3	Auditory neuropathy, autosomal recessive, 1	601071	AR	3
603681	2p23.3	Deafness, autosomal recessive 9	601071	AR	3
610150	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
608204	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
609432	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
610683	4q27	Bardet-Biedl syndrome 12	615989	AR	3
607803	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
607803	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
610575	8q23.1	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3
610575	8q23.1	Tetraamelia syndrome 2	618021	AR	3
609584	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
607872	1p36	Chromosome 1p36 deletion syndrome	607872	IC	4
610153	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
609425	3q29	Chromosome 3q29 microdeletion syndrome	609425	IC	4
607936	3q21.1	Peeling skin syndrome 4	607936	AR	3
607922	22q13.2	NOR polyagglutination syndrome	111400	_	3
607922	22q13.2	[Blood group, P1Pk system, p phenotype]	111400	_	3
607922	22q13.2	[Blood group, P1Pk system, P(2) phenotype]	111400	_	3
607063	17q21.2	Bruck syndrome 1	259450	AR	3
607063	17q21.2	Osteogenesis imperfecta, type XI	610968	AR	3
608093	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
611507	4q24	Wolfram syndrome 2	604928	AR	3
610717	11p15.5	Neutral lipid storage disease with myopathy	610717	AR	3
603031	1q41	{Legionnaire disease, susceptibility to}	608556	_	3
603031	1q41	{Melioidosis, susceptibility to}	615557	_	3
603031	1q41	{Systemic lupus erythematosus, resistance to}	601744	_	3
603031	1q41	{Systemic lupus erythematosus, susceptibility to, 1}	601744	_	3
609566	4q21-q23	Parietal foramina 3	609566	AD	2
606201	4p16.1	?Cataract 41	116400	AD	3
606201	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
606201	4p16.1	Wolfram syndrome 1	222300	AR	3
606201	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
606201	4p16.1	{Diabetes mellitus, noninsulin-dependent, association with}	125853	AD	3
610678	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
609404	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
611501	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
609994	4q22-q27	Myopia 11	609994	_	2
608106	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
610275	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
611486	10q26.3	?Premature ovarian failure 12	616947	AR	3
611486	10q26.3	?Spermatogenic failure 15	616950	AR	3
611755	12q21.32	Leber congenital amaurosis 10	611755	_	3
605990	10q21.2	{Nephrolithiasis, uric acid, susceptibility to}	605990	_	3
610627	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
610690	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
610064	Chr.17	{Opioid dependence, susceptibility to, 1}	610064	_	2
610573	20p13	Anonychia congenita	206800	AR	3
610158	13pter-q12.13	Corneal dystrophy, Fuchs endothelial, 2	610158	AD	2
610227	17q25.3	Seborrhea-like dermatitis with psoriasiform elements	610227	_	3
608091	11q12.2	Joubert syndrome 2	608091	AR	3
609909	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
612717	10q21.1	Myopia 15	612717	AD	2
611119	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
611119	7p15.3	Retinitis pigmentosa 42	612943	AD	3
607809	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
611489	14q32.13	Corticosteroid-binding globulin deficiency	611489	AR,AD	3
612447	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
612367	1p36	{Alkaline phosphatase, plasma level of, QTL 2}	612367	_	2
611466	17q21.31	?Osteopetrosis, autosomal recessive 6	611497	AR	3
611466	17q21.31	Osteopetrosis, autosomal dominant 3	618107	AD	3
611761	16p13.3	Lipase deficiency, combined	246650	AR	3
610442	9q22.33	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442	AR	3
612772	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
605086	6p21.1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	_	3
611615	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
604285	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
602943	1q21.3	Immunodeficiency 42	616622	AR	3
610003	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
609812	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
611313	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
610896	19q13.32	Branchiootorenal syndrome 2	610896	_	3
608245	12q13.13	?Hypotrichosis 13	615896	AD	3
610065	20p12	{Systemic lupus erythematosus, susceptibility to, 7}	610065	_	2
612950	20q13	{Psoriasis susceptibility 12}	612950	_	2
613268	20p13	Corneal dystrophy, Fuchs endothelial, 4	613268	_	3
604695	10q24.32	Joubert syndrome 35	618161	AR	3
604695	10q24.32	Retinitis pigmentosa 83	618173	AD	3
609637	13q32.3	Holoprosencephaly 5	609637	AD	3
602954	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
611498	16p13.3	Nephronophthisis 7	611498	_	3
612368	6p22	{Alkaline phosphatase, plasma level of, QTL3}	612368	_	2
613063	7q32	{Basal cell carcinoma, susceptibility to, 6}	613063	_	2
611432	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
612907	3p26.2	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3
612907	3p26.2	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3
612773	19q13.32	[Blood group, Auberger system]	111200	_	3
612773	19q13.32	[Blood group, Lutheran null]	247420	AR	3
612773	19q13.32	[Blood group, Lutheran system]	111200	_	3
609558	22q12.3	{Prostate cancer, susceptibility to}	609558	_	2
609813	7p22.3	Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3
613100	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
608944	9p22.3	Bifid nose with or without anorectal and renal anomalies	608980	_	3
608944	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
608944	9p22.3	Trigonocephaly 2	614485	AD	3
612920	21q22.3	?Deafness, autosomal recessive 98	614861	AR	3
612920	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
613425	2p23.2	Retinitis pigmentosa 54	613428	_	3
612841	1p21.1-q21.3	Hypotrichosis 5	612841	AD	2
613617	2p23.3	?Retinitis pigmentosa 58	613617	AR	3
613697	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
610693	11q24.2	Hydrolethalus syndrome	236680	AR	3
608753	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
610628	3p13	Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3
613269	5q33.1-q35.2	Corneal dystrophy, Fuchs endothelial, 5	613269	_	2
613988	17p13.1	Dyskeratosis congenita, autosomal recessive 3	613988	AR	3
611386	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
611959	19q13.4	{Prostate cancer, hereditary, 15}	611959	_	2
613693	21q22.11	Long QT syndrome 6	613693	AD	3
610878	3p12.3	Vesicoureteral reflux 2	610878	_	3
612353	18p11.3	Porokeratosis 6, multiple types	612353	AD	2
612951	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
613927	6p21.33	C2 deficiency	217000	AR	3
613927	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
610897	20q11.22	Cataract 31, multiple types	605387	AD	3
608935	6q23-q25	{Lung cancer susceptibility}	608935	_	2
610084	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
604358	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
613698	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
613266	22q13.1	Waardenburg syndrome, type 4C	613266	AD	3
613544	6q11-q14	Chromosome 6q11-q14 deletion syndrome	613544	IC	4
613800	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
613982	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
614372	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
613363	9q34.11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3
613803	16q11.2	Meier-Gorlin syndrome 3	613803	AR	3
614380	6p21.33	C4a deficiency	614380	AR	3
613810	5q32	Retinitis pigmentosa 43	613810	_	3
602955	7q22.1	Alazami-Yuan syndrome	617126	AR	3
606463	1q22	Gaucher disease, perinatal lethal	608013	AR	3
606463	1q22	Gaucher disease, type I	230800	AR	3
606463	1q22	Gaucher disease, type II	230900	AR	3
606463	1q22	Gaucher disease, type III	231000	AR	3
606463	1q22	Gaucher disease, type IIIC	231005	AR	3
606463	1q22	{Lewy body dementia, susceptibility to}	127750	AD	3
606463	1q22	{Parkinson disease, late-onset, susceptibility to}	168600	Mu,AD	3
611472	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
613834	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
611927	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
614072	3q24	Hermansky-Pudlak syndrome 3	614072	AR	3
613686	17p13.1	Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3
614373	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
612284	4p15.32	Meckel syndrome 6	612284	AR	3
613563	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
612885	20p12.3	?Premature ovarian failure 10	612885	AR	3
612918	3q26.32	CLOVE syndrome, somatic	612918	_	3
614724	3q22.2	?Seckel syndrome 6	614728	AR	3
611488	9q32-q33	Macular degeneration, age-related, 10	611488	_	2
614615	5p13.2	Joubert syndrome 17	614615	AR	3
609636	7q36	Alzheimer disease-10	609636	AD	2
614631	7p21.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3
614631	7p21.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3
612688	3q29	RIDDLE syndrome	611943	AR	3
614167	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
614391	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
611499	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
614776	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
614138	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
613925	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3
614963	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
613694	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
611720	14q24.3	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3
613801	4p16.3	Retinitis pigmentosa-40	613801	AR	3
614101	2q35	Plasma fibronectin deficiency	614101	AD	1
614891	19p13.11	Immunodeficiency 30	614891	AR	3
612839	4q24	Myelodysplastic syndrome, somatic	614286	_	3
614888	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
613287	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
611928	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
614069	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
608754	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
615403	16p13.3	Beaulieu-Boycott-Innes syndrome	613680	AR	3
614379	6p21.33	C4B deficiency	614379	_	3
613364	11p14.1-p11.2	?Spastic paraplegia 41, autosomal dominant	613364	AD	2
614652	6q21	Coenzyme Q10 deficiency, primary, 3	614652	AR	3
613267	18q21.2	Corneal dystrophy, Fuchs endothelial, 3	613267	AD	3
613807	3q26.33	Ciliary dyskinesia, primary, 14	613807	_	3
614632	4p16.3	UV-sensitive syndrome 3	614640	AR	3
614617	16p13.3	Deafness , autosomal recessive 86	614617	AR	3
615286	19p13.3	Mental retardation, autosomal recessive 36	615286	AR	3
612886	5q35.2	{Menopause, natural, age at, QTL4}	612886	_	2
613160	12p13.31	von Willebrand disease, type 1	193400	AD	3
613160	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
613160	12p13.31	von Willibrand disease, type 3	277480	AR	3
615217	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
612073	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
615268	13q12.13	?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	AR	3
613546	15q21.2	Aromatase deficiency	613546	_	3
615513	1p36.22	Immunodeficiency 14	615513	AD	3
613926	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	AD	3
615663	20p13	Warburg micro syndrome 4	615663	AR	3
611721	10q22.1	Combined SAP deficiency	611721	AR	3
612354	18p11	{Inflammatory bowel disease 21}	612354	AD	2
616108	14q24.1	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3
613091	11q22.3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR,DR	3
612908	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
616022	3p25.3	Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3
602956	9p13.3	Fanconi anemia, complementation group G	614082	_	3
615290	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
612852	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
614128	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
616101	1p36.33	Spinocerebellar ataxia 21	607454	AD	3
613647	7p22.1	Spastic paraplegia 48, autosomal recessive	613647	AR	3
615298	20q11.22	Symphalangism, proximal, 1B	615298	_	3
614889	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
614066	1p13.2	Spastic paraplegia 47, autosomal recessive	614066	AR	3
613912	19p13.3	Complement factor D deficiency	613912	AR	3
614725	6q25.3	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3
616109	11q13.2	Hydatidiform mole, recurrent, 4	618432	_	3
608005	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
613577	16p13.3	Deafness , autosomal recessive 86	614617	AR	3
613577	16p13.3	Deafness, autosomal dominant 65	616044	AD	3
613577	16p13.3	DOORS syndrome	220500	AR	3
613577	16p13.3	Epileptic encephalopathy, early infantile, 16	615338	AR	3
613577	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
615287	11q13.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3
603109	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
609560	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
614618	11p15.1	Hyperekplexia 3	614618	AR,AD	3
604447	15q21.2	Intellectual developmental disorder with cardiac arrhythmia	617173	AR	3
604447	15q21.2	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182	AR	3
616817	1q32.1	Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3
616579	13q34	Mental retardation, autosomal dominant 40	616579	AD	3
615851	17p13.3	Pontocerebellar hypoplasia, type 2E	615851	AR	3
616221	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
614892	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
614099	14q24.3	?Cranioectodermal dysplasia 3	614099	AR	3
614129	19p13.3	Perrault syndrome 3	614129	AR	3
610247	7q11.2	{Esophagitis, eosinophilic, 1}	610247	Mu	2
615934	5q31.2	STING-associated vasculopathy, infantile-onset	615934	AD	3
615293	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
615404	2q36.3	{Specific language impairment 5}	615432	AD	3
614887	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
613318	8q22.3	Miyoshi muscular dystrophy 2	613318	_	2
604454	2p13.3	Welander distal myopathy	604454	AR,AD	3
604123	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
617769	5q33.1	Spinocerebellar ataxia 45	617769	AD	3
616192	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
613981	12q13.13	?Hypotrichosis 3	613981	AD	3
614890	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
618179	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
614726	4q12	Congenital disorder of glycosylation, type IIk	614727	AR	3
617654	1p31.3	?Deafness, autosomal recessive 108	617654	AR	3
614102	2p11.2	Kappa light chain deficiency	614102	AR	3
617051	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
607426	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
618012	3q13.31	Epileptic encephalopathy, infantile or early childhood, 3	618012	AD	3
616710	7p11.2	Parkinson disease 22, autosomal dominant	616710	AD	3
616834	4q32.3	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3
616684	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
610511	14q21.1	Craniolenticulosutural dysplasia	607812	AR	3
607821	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
615297	3p14.1	Adams-Oliver syndrome 4	615297	AR	3
618004	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
615269	12q21.33	Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3
618180	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
614371	19p13.2	{Dengue fever, protection against}	614371	_	3
613101	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
615703	3q29	Morbid obesity and spermatogenic failure	615703	AR	3
614787	1q21.3	White-Sutton syndrome	616364	AD	3
616768	10p15.3	Oocyte maturation defect 2	616780	AR,AD	3
612446	5p13.1	C6 deficiency	612446	_	3
618239	8q22.1	Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3
618157	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
617193	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
617976	4p16.3	Epileptic encephalopathy, early infantile, 63	617976	AR	3
616081	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
617118	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
617950	9q34.3	Combined oxidative phosphorylation deficiency 36	617950	AR	3
616576	4q24	Immunodeficiency, common variable, 12	616576	AD	3
618168	1p13.2	Diarrhea 9	618168	AR	3
616193	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
613319	11p14.3	Miyoshi muscular dystrophy 3	613319	AR	3
617120	17p11.2	Joubert syndrome 27	617120	AR	3
615517	11q12.3	?Hemochromatosis, type 5	615517	AD	3
617297	19q13.33	Amelogenesis imperfecta, type IJ	617297	AR	3
616174	2q14.1	Filippi syndrome	272440	AR	3
613986	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
616803	12p12.1	Lamb-Shaffer syndrome	616803	AD	3
615871	5p12	Epileptic encephalopathy, early infantile, 24	615871	AD	3
617626	4q12	Fibromatosis, gingival, 5	617626	AD	3
614400	7p21.3	{Glucocorticoid therapy, response to}	614400	_	3
616577	4q28.1	Epilepsy, hearing loss, and mental retardation syndrome	616577	AR	3
617119	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
618008	5q33.3	Epileptic encephalopathy, early infantile, 65	618008	AD	3
617201	18q21.31	Periventricular nodular heterotopia 7	617201	AD	3
616099	19p13.2	Palmoplantar keratoderma and woolly hair	616099	AR	3
615346	15q11.2	Precocious puberty, central, 2	615346	AD	3
616760	17q21.2	Woolly hair, autosomal recessive 3	616760	AR	3
613102	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
618158	11q13.5-q14.1	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3
616707	15q25.2	?Deafness, autosomal dominant 68	616707	AD	3
616818	13q31.1	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3
617763	9q34.12	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	617763	AR	3
606097	18q21.33	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3
616816	3p25.1	Hypotonia, infantile, with psychomotor retardation	616816	AR	3
616801	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
618167	12q23.3	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3
611490	16p13.3	Osteopetrosis, autosomal recessive 4	611490	AR	3
617296	2p25.1	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3
616819	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
603111	17q21.2	Coffin-Siris syndrome 5	616938	AD	3
603111	17q21.2	{Meningioma, familial, susceptibility to}	607174	AD	3
617996	7q34	Oocyte maturation defect 5	617996	AR	3
604168	18q23	Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3
616100	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
618003	10q24.31	Deafness, autosomal recessive 57	618003	AR	3
610443	17q21.31	Koolen-De Vries syndrome	610443	AD	3
616921	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
614958	17q12	Bleeding disorder, platelet-type, 20	616913	AD	3
614070	6q21	{Psoriasis susceptibility 13}	614070	_	3
616708	10p12.1	Desanto-Shinawi syndrome	616708	AD	3
617315	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
616106	2q36.1	{Psoriasis 15, pustular, susceptibility to}	616106	AD	3
613804	16q24.3	Meier-Gorlin syndrome 4	613804	AR	3
614959	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
617899	13q13.3	Leukodystrophy, hypomyelinating, 14	617899	AR	3
614945	11p15.1	Deafness, autosomal recessive 18B	614945	AR	3
617949	7q21.13	Spermatogenic failure 24	617959	AR	3
614674	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
615935	10p12.2	Pancreatic agenesis 2	615935	AR	3
618010	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
608584	7p14.3	{Asthma, susceptibility to, 2}	608584	_	3
618065	4q27	Pontocerebellar hypoplasia, type 1D	618065	AR	3
608099	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
608581	8p23.1	Occult macular dystrophy	613587	AD	3
613718	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
613806	3p21	Cholangitis, primary sclerosing	613806	_	2
615527	6q21	?Candidiasis, familial, 8	615527	AR	3
616107	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
617938	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
613561	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
609441	4q22.3	Acromesomelic dysplasia, Demirhan type	609441	AR	3
615728	12q13.13	Pachyonychia congenita 4	615728	_	3
617900	12q14.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3
613729	7q11.23	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	_	4
614653	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
618181	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
608102	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
617951	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
608970	5q21.3-q33.2	Macular dystrophy, butterfly-shaped pigmentary, 2	608970	AD	2
609937	2q31.1	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3
613730	11q25	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3
610533	5q34	[Memory, enhanced, QTL]	615602	_	3
608103	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608103	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
608628	3q26.32	Mental retardation, autosomal dominant 41	616944	AD	3
608628	3q26.32	Pierpont syndrome	602342	AD	3
610534	11q24.2	Al-Raqad syndrome	616459	AR	3
614961	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
617485	4q21.23	?Microcephaly 18, primary, autosomal dominant	617520	AD	3
615750	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
616176	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
608629	6q23.3	Joubert syndrome 3	608629	AR	3
609941	11p13-p12	Deafness, autosomal recessive 51	609941	AR	2
618240	3p21.31	Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3
616454	11p11.2	?Exudative vitreoretinopathy 6	616468	AD	3
616454	11p11.2	Retinitis pigmentosa 72	616469	AR	3
615937	1q43-q44	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3
605925	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
610681	12q13.11	Glycogen storage disease VII	232800	AR	3
616177	20p13	Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3
611693	11q24.1	Congenital short bowel syndrome	615237	AR	3
610682	3p22.3	Osteogenesis imperfecta, type VII	610682	AR	3
608583	10q22-q24	Atrial fibrillation, familial, 1	608583	AD	2
618241	11q24.2	Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3
609995	2q37.1	Myopia 12	609995	_	2
611695	15q15.2	Spinocerebellar ataxia 11	604432	AD	3
615938	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
609939	16p12.3-q12.2	{Systemic lupus erythematosus, susceptibility to, 6}	609939	_	2
608679	20q13.12	Galloway-Mowat syndrome 4	617730	AR	3
614962	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
617050	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
613731	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AR,AD	3
614650	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
613469	10q24.2	Urofacial syndrome 1	236730	AR	3
612715	12q21-q23	Dyschromatosis universalis hereditaria 2	612715	_	2
613983	20q13.33	Retinitis pigmentosa 60	613983	AD	3
608680	2p13.1	Galloway-Mowat syndrome 5	617731	AR	3
613743	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
615751	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
613984	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
613808	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
613809	1q41	Retinitis pigmentosa 39	613809	_	3
613638	19p13.13	Chromosome 19p13.13 deletion syndrome	613638	_	4
613638	19p13.13	Chromosome 19p13.13 duplication syndrome	613638	_	4
615411	5q12.1	Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3
610008	17q24.2	Usher syndrome, type IV	618144	AR	3
610154	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
605463	14q11.2	Radiation sensitivity/chromosome instability syndrome, autosomal dominant	_	_	1
610937	16q12.2	COACH syndrome	216360	AR	3
610937	16q12.2	Joubert syndrome 7	611560	AR	3
610937	16q12.2	Meckel syndrome 5	611561	AR	3
604043	1q32.3	?Retinitis pigmentosa 67	615565	AR	3
609942	12p12.1	Noonan syndrome 3	609942	AD	3
603504	1p21.2	Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3
606118	3q24	Hermansky-Pudlak syndrome 3	614072	AR	3
610379	3p21.31	{West nile virus, susceptibility to}	610379	_	3
607085	6p21.3	Myasthenia gravis with thymus hyperplasia	607085	_	2
612325	6p12.1	Endocrine-cerebroosteodysplasia	612651	AR	3
612325	6p12.1	{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3
607346	1p13.2	Spinocerebellar ataxia 19	607346	AD	3
605460	2p21	Sitosterolemia	210250	AR	3
605460	2p21	{Gallbladder disease 4}	611465	_	3
603585	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
605392	6q27	Myeloproliferative disorder	605392	_	2
607358	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AR,AD	3
605459	2p21	Sitosterolemia	210250	AR	3
607867	13q14.2	Retinal dystrophy with or without extraocular anomalies	617175	AR	3
608539	16p13.3	Nephronophthisis 7	611498	_	3
605283	15q11.2	Schaaf-Yang syndrome	615547	AD	3
609557	2p21	Myasthenic syndrome, congenital, 22	616224	AR	3
612201	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
610102	5p13.1	C7 deficiency	610102	_	3
610087	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
605955	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
612922	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AR,AD	3
606633	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
607644	11p13-q12	Candidiasis, familial, 3	607644	AD	2
611465	2p21	{Gallbladder disease 4}	611465	_	3
611561	16q12.2	Meckel syndrome 5	611561	AR	3
612269	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
607139	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
604563	11p15.4	Charcot-Marie-Tooth disease, type 4B2	604563	AR	3
614186	2q37.1	Leber congenital amaurosis 16	614186	AR	3
614352	7q33	?Nephrotic syndrome, type 13	616893	_	3
609638	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
614180	3q25.1	Retinitis pigmentosa 61	614180	_	3
604179	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
610881	11q13.2	Mental retardation, autosomal dominant 51	617788	AD	3
603503	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
609152	14q31.1	Hyperthyroidism, nonautoimmune	609152	AD	3
614401	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
613580	2p15	?Bardet-Biedl syndrome 15	615992	AR	3
613580	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
613470	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
612515	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
609377	16q22.1	?Dyskeratosis congenita, autosomal dominant 6	616553	AR,AD	3
609377	16q22.1	?Dyskeratosis congenita, autosomal recessive 7	616553	AR,AD	3
613812	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
605078	1p36.22	Amyotrophic lateral sclerosis 10, with or without FTD	612069	AD	3
605078	1p36.22	Frontotemporal lobar degeneration, TARDBP-related	612069	AD	3
615716	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
607620	8q24.12	3MC syndrome 3	248340	AR	3
605462	1p36	{Basal cell carcinoma, susceptibility to, 1}	605462	_	2
618170	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
613225	6p25.1	Factor XIIIA deficiency	613225	AR	3
617921	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
614351	16q13	Nephrotic syndrome, type 12	616892	AR	3
613227	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
617127	17p13.1	?Orofaciodigital syndrome XV	617127	AR	3
614191	22q12.2-q12.3	Epilepsy, familial focal, with variable foci 1	604364	AD	3
612840	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
608096	12q22-q23.3	Epilepsy, familial temporal lobe, 2	608096	AD	2
605284	9q34.13	Focal cortical dysplasia, type II, somatic	607341	_	3
605284	9q34.13	Lymphangioleiomyomatosis	606690	_	3
605284	9q34.13	Tuberous sclerosis-1	191100	AD	3
614614	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
611592	6p25.1	Combined oxidative phosphorylation deficiency 14	614946	AR	3
611592	6p25.1	Spastic paraplegia 77, autosomal recessive	617046	AR	3
617126	7q22.1	Alazami-Yuan syndrome	617126	AR	3
608098	5p15.1	Periventricular nodular heterotopia 3	608098	_	2
613244	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
605942	6q22.1	Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3
617635	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
613811	4p15.2	Pontocerebellar hypoplasia type 2D	613811	AR	3
605253	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AR,AD	3
614970	16q23.1	Joubert syndrome 20	614970	AR	3
615518	17q11.2	?Immunodeficiency 13	615518	AD	3
618358	20q11.22	Cone-rod dystrophy and hearing loss 2	618358	AR	3
617920	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
609597	11p11.2	Parietal foramina 2	609597	AD	3
608681	15q26.1	Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3
613685	9p23-p21.2	Deafness, autosomal recessive 83	613685	AR	2
610155	2q24.3	{Diabetes mellitus, insulin-dependent, 19}	610155	_	2
614675	4q12	Bone marrow failure syndrome 1	614675	AD	3
615530	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
614350	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
614181	6p24.2	Retinitis pigmentosa 62	614181	AR	3
615705	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
613243	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
612655	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
604907	17p11.2	Immunodeficiency, common variable, 2	240500	AR,AD	3
604907	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
618238	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
610031	6p25.2	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3
617194	15q21.2	Lethal congenital contracture syndrome 11	617194	AR	3
616002	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
617977	17q25.3	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3
614537	10q22.2-q22.3	Albinism, oculocutaneous, type VII	615179	AR	3
603470	9q34.11	Citrullinemia	215700	AR	3
614613	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
612513	2p16.1-p15	Chromosome 2p16.1-p15 deletion syndrome	612513	IC	4
608816	6p21	Epilepsy, juvenile myoclonic 3	608816	_	2
614683	5q35.3	[?Phosphohydroxylysinuria]	615011	_	3
614969	1p34.1	Pontocerebellar hypoplasia, type 7	614969	AR	3
612724	9q31.1	Fructose intolerance, hereditary	229600	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
606731	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
612971	10q24.31	Deafness, autosomal recessive 57	618003	AR	3
612971	10q24.31	Usher syndrome, type IIC, GPR98/PDZD7 digenic	605472	AR	3
612971	10q24.31	{Retinal disease in Usher syndrome type IIA, modifier of}	276901	AR	3
615529	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
603471	7q21.3	Citrullinemia, adult-onset type II	603471	AR	3
608540	16p13.3	Congenital disorder of glycosylation, type Ik	608540	AR	3
618265	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
609661	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
158150	_	_	_	_	_
179030	_	_	_	_	_
142930	_	_	_	_	_
245190	_	_	_	_	_
142510	_	_	_	_	_
300077	_	_	_	_	_
251945	_	_	_	_	_
151442	_	_	_	_	_
126449	_	_	_	_	_
123550	_	_	_	_	_
260980	_	_	_	_	_
152422	_	_	_	_	_
139255	_	_	_	_	_
189150	_	_	_	_	_
159580	_	_	_	_	_
173870	_	_	_	_	_
165070	_	_	_	_	_
182132	_	_	_	_	_
118980	_	_	_	_	_
182400	_	_	_	_	_
300302	_	_	_	_	_
208550	_	_	_	_	_
300156	_	_	_	_	_
164343	_	_	_	_	_
186950	_	_	_	_	_
156590	_	_	_	_	_
147410	_	_	_	_	_
143040	_	_	_	_	_
264420	_	_	_	_	_
234030	_	_	_	_	_
131560	_	_	_	_	_
194533	_	_	_	_	_
242170	_	_	_	_	_
140581	_	_	_	_	_
180452	_	_	_	_	_
100050	_	_	_	_	_
300361	_	_	_	_	_
116898	_	_	_	_	_
226735	_	_	_	_	_
113950	_	_	_	_	_
114550	_	_	_	_	_
167960	_	_	_	_	_
185600	_	_	_	_	_
212850	_	_	_	_	_
135700	_	_	_	_	_
188020	_	_	_	_	_
193090	_	_	_	_	_
162010	_	_	_	_	_
142550	_	_	_	_	_
300007	_	_	_	_	_
223500	_	_	_	_	_
220219	_	_	_	_	_
147678	_	_	_	_	_
216920	_	_	_	_	_
300229	_	_	_	_	_
163200	_	_	_	_	_
139259	_	_	_	_	_
155720	_	_	_	_	_
153640	_	_	_	_	_
189200	_	_	_	_	_
276500	_	_	_	_	_
109635	_	_	_	_	_
300081	_	_	_	_	_
191730	_	_	_	_	_
123555	_	_	_	_	_
204800	_	_	_	_	_
300158	_	_	_	_	_
156620	_	_	_	_	_
211350	_	_	_	_	_
159590	_	_	_	_	_
126450	_	_	_	_	_
252011	_	_	_	_	_
183800	_	_	_	_	_
189973	_	_	_	_	_
182133	_	_	_	_	_
118445	_	_	_	_	_
208600	_	_	_	_	_
123995	_	_	_	_	_
168100	_	_	_	_	_
142940	_	_	_	_	_
242400	_	_	_	_	_
200900	_	_	_	_	_
114600	_	_	_	_	_
173871	_	_	_	_	_
166210	_	_	_	_	_
137570	_	_	_	_	_
248910	_	_	_	_	_
300442	_	_	_	_	_
162020	_	_	_	_	_
146960	_	_	_	_	_
147420	_	_	_	_	_
164345	_	_	_	_	_
300732	_	_	_	_	_
158250	_	_	_	_	_
180453	_	_	_	_	_
142560	_	_	_	_	_
261100	_	_	_	_	_
121009	_	_	_	_	_
153650	_	_	_	_	_
229120	_	_	_	_	_
216950	_	_	_	_	_
176390	_	_	_	_	_
118990	_	_	_	_	_
116899	_	_	_	_	_
300596	_	_	_	_	_
223540	_	_	_	_	_
300083	_	_	_	_	_
189974	_	_	_	_	_
234100	_	_	_	_	_
193190	_	_	_	_	_
208700	_	_	_	_	_
270960	_	_	_	_	_
131600	_	_	_	_	_
126500	_	_	_	_	_
276800	_	_	_	_	_
258470	_	_	_	_	_
135800	_	_	_	_	_
100200	_	_	_	_	_
300010	_	_	_	_	_
133800	_	_	_	_	_
182134	_	_	_	_	_
123557	_	_	_	_	_
226800	_	_	_	_	_
229150	_	_	_	_	_
123996	_	_	_	_	_
204850	_	_	_	_	_
237450	_	_	_	_	_
191741	_	_	_	_	_
300527	_	_	_	_	_
125550	_	_	_	_	_
185610	_	_	_	_	_
137575	_	_	_	_	_
261400	_	_	_	_	_
242510	_	_	_	_	_
186970	_	_	_	_	_
103780	_	_	_	_	_
212890	_	_	_	_	_
217090	_	_	_	_	_
300086	_	_	_	_	_
146970	_	_	_	_	_
276821	_	_	_	_	_
112266	_	_	_	_	_
100500	_	_	_	_	_
190030	_	_	_	_	_
208750	_	_	_	_	_
182450	_	_	_	_	_
116900	_	_	_	_	_
180454	_	_	_	_	_
300668	_	_	_	_	_
114610	_	_	_	_	_
168200	_	_	_	_	_
211355	_	_	_	_	_
119000	_	_	_	_	_
142570	_	_	_	_	_
300789	_	_	_	_	_
142950	_	_	_	_	_
300159	_	_	_	_	_
140700	_	_	_	_	_
220220	_	_	_	_	_
182137	_	_	_	_	_
159600	_	_	_	_	_
191742	_	_	_	_	_
133900	_	_	_	_	_
123997	_	_	_	_	_
137700	_	_	_	_	_
131760	_	_	_	_	_
135821	_	_	_	_	_
226810	_	_	_	_	_
261510	_	_	_	_	_
300961	_	_	_	_	_
186975	_	_	_	_	_
300012	_	_	_	_	_
193210	_	_	_	_	_
248950	_	_	_	_	_
242520	_	_	_	_	_
204900	_	_	_	_	_
180460	_	_	_	_	_
183802	_	_	_	_	_
136890	_	_	_	_	_
123560	_	_	_	_	_
156700	_	_	_	_	_
300443	_	_	_	_	_
166220	_	_	_	_	_
114620	_	_	_	_	_
176391	_	_	_	_	_
237550	_	_	_	_	_
300528	_	_	_	_	_
189230	_	_	_	_	_
182451	_	_	_	_	_
191743	_	_	_	_	_
173880	_	_	_	_	_
223550	_	_	_	_	_
208800	_	_	_	_	_
212895	_	_	_	_	_
300669	_	_	_	_	_
300790	_	_	_	_	_
305425	_	_	_	_	_
168350	_	_	_	_	_
151445	_	_	_	_	_
234250	_	_	_	_	_
145800	_	_	_	_	_
258650	_	_	_	_	_
134000	_	_	_	_	_
142580	_	_	_	_	_
264450	_	_	_	_	_
135950	_	_	_	_	_
146980	_	_	_	_	_
300597	_	_	_	_	_
300162	_	_	_	_	_
153840	_	_	_	_	_
220290	_	_	_	_	_
159700	_	_	_	_	_
136950	_	_	_	_	_
179760	_	_	_	_	_
191750	_	_	_	_	_
114650	_	_	_	_	_
119540	_	_	_	_	_
100600	_	_	_	_	_
156790	_	_	_	_	_
147680	_	_	_	_	_
212900	_	_	_	_	_
129905	_	_	_	_	_
276822	_	_	_	_	_
229230	_	_	_	_	_
308310	_	_	_	_	_
186977	_	_	_	_	_
182139	_	_	_	_	_
152423	_	_	_	_	_
245210	_	_	_	_	_
226850	_	_	_	_	_
220300	_	_	_	_	_
134100	_	_	_	_	_
193220	_	_	_	_	_
153860	_	_	_	_	_
208850	_	_	_	_	_
205000	_	_	_	_	_
147421	_	_	_	_	_
176844	_	_	_	_	_
168360	_	_	_	_	_
151450	_	_	_	_	_
112267	_	_	_	_	_
163260	_	_	_	_	_
300164	_	_	_	_	_
400038	_	_	_	_	_
137000	_	_	_	_	_
113955	_	_	_	_	_
268030	_	_	_	_	_
242530	_	_	_	_	_
300670	_	_	_	_	_
182140	_	_	_	_	_
130020	_	_	_	_	_
136100	_	_	_	_	_
155730	_	_	_	_	_
176392	_	_	_	_	_
271100	_	_	_	_	_
258700	_	_	_	_	_
220700	_	_	_	_	_
193240	_	_	_	_	_
142951	_	_	_	_	_
152425	_	_	_	_	_
245500	_	_	_	_	_
153870	_	_	_	_	_
264475	_	_	_	_	_
223600	_	_	_	_	_
145900	_	_	_	_	_
179770	_	_	_	_	_
600048	_	_	_	_	_
226950	_	_	_	_	_
242550	_	_	_	_	_
168440	_	_	_	_	_
114700	_	_	_	_	_
212905	_	_	_	_	_
102681	_	_	_	_	_
300598	_	_	_	_	_
400039	_	_	_	_	_
116901	_	_	_	_	_
300733	_	_	_	_	_
182141	_	_	_	_	_
268040	_	_	_	_	_
130090	_	_	_	_	_
140750	_	_	_	_	_
191760	_	_	_	_	_
176393	_	_	_	_	_
234280	_	_	_	_	_
600245	_	_	_	_	_
226960	_	_	_	_	_
300791	_	_	_	_	_
146990	_	_	_	_	_
159800	_	_	_	_	_
312530	_	_	_	_	_
300230	_	_	_	_	_
300671	_	_	_	_	_
182143	_	_	_	_	_
220800	_	_	_	_	_
188035	_	_	_	_	_
155735	_	_	_	_	_
261550	_	_	_	_	_
114750	_	_	_	_	_
152426	_	_	_	_	_
109636	_	_	_	_	_
137763	_	_	_	_	_
213000	_	_	_	_	_
300889	_	_	_	_	_
156810	_	_	_	_	_
300529	_	_	_	_	_
308370	_	_	_	_	_
223610	_	_	_	_	_
130100	_	_	_	_	_
146150	_	_	_	_	_
112270	_	_	_	_	_
600246	_	_	_	_	_
142952	_	_	_	_	_
147000	_	_	_	_	_
229250	_	_	_	_	_
191800	_	_	_	_	_
276850	_	_	_	_	_
153890	_	_	_	_	_
226985	_	_	_	_	_
208870	_	_	_	_	_
119550	_	_	_	_	_
234300	_	_	_	_	_
600305	_	_	_	_	_
300674	_	_	_	_	_
168460	_	_	_	_	_
264480	_	_	_	_	_
152450	_	_	_	_	_
155740	_	_	_	_	_
156830	_	_	_	_	_
112300	_	_	_	_	_
176845	_	_	_	_	_
213002	_	_	_	_	_
174100	_	_	_	_	_
137010	_	_	_	_	_
300530	_	_	_	_	_
100640	_	_	_	_	_
301850	_	_	_	_	_
268050	_	_	_	_	_
516001	_	_	_	_	_
190060	_	_	_	_	_
300165	_	_	_	_	_
179780	_	_	_	_	_
242600	_	_	_	_	_
159970	_	_	_	_	_
151465	_	_	_	_	_
170600	_	_	_	_	_
600471	_	_	_	_	_
114770	_	_	_	_	_
153900	_	_	_	_	_
300792	_	_	_	_	_
300232	_	_	_	_	_
600416	_	_	_	_	_
143050	_	_	_	_	_
234350	_	_	_	_	_
155741	_	_	_	_	_
109640	_	_	_	_	_
126550	_	_	_	_	_
300089	_	_	_	_	_
268060	_	_	_	_	_
151500	_	_	_	_	_
600537	_	_	_	_	_
156900	_	_	_	_	_
312550	_	_	_	_	_
300167	_	_	_	_	_
600247	_	_	_	_	_
154000	_	_	_	_	_
308385	_	_	_	_	_
224000	_	_	_	_	_
119570	_	_	_	_	_
273120	_	_	_	_	_
264500	_	_	_	_	_
163400	_	_	_	_	_
137765	_	_	_	_	_
276901	_	_	_	_	_
176846	_	_	_	_	_
245550	_	_	_	_	_
600651	_	_	_	_	_
300793	_	_	_	_	_
516002	_	_	_	_	_
151510	_	_	_	_	_
134200	_	_	_	_	_
600177	_	_	_	_	_
168600	_	_	_	_	_
159980	_	_	_	_	_
300091	_	_	_	_	_
600472	_	_	_	_	_
142953	_	_	_	_	_
234700	_	_	_	_	_
308400	_	_	_	_	_
273150	_	_	_	_	_
590050	_	_	_	_	_
600711	_	_	_	_	_
140850	_	_	_	_	_
130120	_	_	_	_	_
189300	_	_	_	_	_
205200	_	_	_	_	_
600178	_	_	_	_	_
600653	_	_	_	_	_
155750	_	_	_	_	_
147010	_	_	_	_	_
159991	_	_	_	_	_
126660	_	_	_	_	_
600776	_	_	_	_	_
170700	_	_	_	_	_
224200	_	_	_	_	_
114780	_	_	_	_	_
600180	_	_	_	_	_
516003	_	_	_	_	_
137020	_	_	_	_	_
134300	_	_	_	_	_
109650	_	_	_	_	_
205250	_	_	_	_	_
142954	_	_	_	_	_
183849	_	_	_	_	_
245552	_	_	_	_	_
301880	_	_	_	_	_
261560	_	_	_	_	_
157100	_	_	_	_	_
234750	_	_	_	_	_
163600	_	_	_	_	_
600474	_	_	_	_	_
126830	_	_	_	_	_
220900	_	_	_	_	_
155770	_	_	_	_	_
109660	_	_	_	_	_
147040	_	_	_	_	_
600714	_	_	_	_	_
308500	_	_	_	_	_
600777	_	_	_	_	_
143055	_	_	_	_	_
217095	_	_	_	_	_
116930	_	_	_	_	_
276905	_	_	_	_	_
114800	_	_	_	_	_
163700	_	_	_	_	_
140900	_	_	_	_	_
189490	_	_	_	_	_
168610	_	_	_	_	_
300171	_	_	_	_	_
245650	_	_	_	_	_
600843	_	_	_	_	_
179830	_	_	_	_	_
300890	_	_	_	_	_
157129	_	_	_	_	_
109670	_	_	_	_	_
273250	_	_	_	_	_
600050	_	_	_	_	_
276950	_	_	_	_	_
221000	_	_	_	_	_
142956	_	_	_	_	_
600181	_	_	_	_	_
113960	_	_	_	_	_
141000	_	_	_	_	_
168710	_	_	_	_	_
300734	_	_	_	_	_
180461	_	_	_	_	_
155800	_	_	_	_	_
600418	_	_	_	_	_
600475	_	_	_	_	_
400040	_	_	_	_	_
102699	_	_	_	_	_
600715	_	_	_	_	_
224250	_	_	_	_	_
160000	_	_	_	_	_
208905	_	_	_	_	_
143060	_	_	_	_	_
134390	_	_	_	_	_
300794	_	_	_	_	_
116935	_	_	_	_	_
600051	_	_	_	_	_
147045	_	_	_	_	_
118455	_	_	_	_	_
179835	_	_	_	_	_
261575	_	_	_	_	_
590055	_	_	_	_	_
600779	_	_	_	_	_
300891	_	_	_	_	_
600419	_	_	_	_	_
217100	_	_	_	_	_
188050	_	_	_	_	_
300092	_	_	_	_	_
191081	_	_	_	_	_
208910	_	_	_	_	_
277000	_	_	_	_	_
168730	_	_	_	_	_
600248	_	_	_	_	_
141180	_	_	_	_	_
600654	_	_	_	_	_
224300	_	_	_	_	_
109675	_	_	_	_	_
600538	_	_	_	_	_
165080	_	_	_	_	_
600366	_	_	_	_	_
600780	_	_	_	_	_
300795	_	_	_	_	_
600182	_	_	_	_	_
189600	_	_	_	_	_
300735	_	_	_	_	_
301940	_	_	_	_	_
400041	_	_	_	_	_
300892	_	_	_	_	_
157130	_	_	_	_	_
600420	_	_	_	_	_
134400	_	_	_	_	_
590060	_	_	_	_	_
300173	_	_	_	_	_
300675	_	_	_	_	_
191090	_	_	_	_	_
151520	_	_	_	_	_
179836	_	_	_	_	_
600249	_	_	_	_	_
142957	_	_	_	_	_
600539	_	_	_	_	_
268080	_	_	_	_	_
277100	_	_	_	_	_
224400	_	_	_	_	_
165090	_	_	_	_	_
141200	_	_	_	_	_
217150	_	_	_	_	_
168790	_	_	_	_	_
300736	_	_	_	_	_
134430	_	_	_	_	_
157132	_	_	_	_	_
100660	_	_	_	_	_
600845	_	_	_	_	_
114830	_	_	_	_	_
176847	_	_	_	_	_
189700	_	_	_	_	_
600183	_	_	_	_	_
183850	_	_	_	_	_
300093	_	_	_	_	_
151523	_	_	_	_	_
103800	_	_	_	_	_
160010	_	_	_	_	_
590065	_	_	_	_	_
249210	_	_	_	_	_
168800	_	_	_	_	_
300233	_	_	_	_	_
155950	_	_	_	_	_
179837	_	_	_	_	_
601159	_	_	_	_	_
246000	_	_	_	_	_
600250	_	_	_	_	_
600476	_	_	_	_	_
142960	_	_	_	_	_
134450	_	_	_	_	_
113995	_	_	_	_	_
600781	_	_	_	_	_
308600	_	_	_	_	_
217200	_	_	_	_	_
180462	_	_	_	_	_
151525	_	_	_	_	_
137800	_	_	_	_	_
516004	_	_	_	_	_
154030	_	_	_	_	_
160100	_	_	_	_	_
143065	_	_	_	_	_
300893	_	_	_	_	_
268220	_	_	_	_	_
100670	_	_	_	_	_
102700	_	_	_	_	_
600540	_	_	_	_	_
114836	_	_	_	_	_
600717	_	_	_	_	_
155960	_	_	_	_	_
590070	_	_	_	_	_
165095	_	_	_	_	_
300094	_	_	_	_	_
600477	_	_	_	_	_
134500	_	_	_	_	_
114020	_	_	_	_	_
217500	_	_	_	_	_
137900	_	_	_	_	_
180463	_	_	_	_	_
142961	_	_	_	_	_
301950	_	_	_	_	_
601337	_	_	_	_	_
600186	_	_	_	_	_
600479	_	_	_	_	_
100675	_	_	_	_	_
268240	_	_	_	_	_
400046	_	_	_	_	_
151530	_	_	_	_	_
601099	_	_	_	_	_
114841	_	_	_	_	_
600367	_	_	_	_	_
590075	_	_	_	_	_
154040	_	_	_	_	_
601339	_	_	_	_	_
119600	_	_	_	_	_
600782	_	_	_	_	_
114030	_	_	_	_	_
600541	_	_	_	_	_
155970	_	_	_	_	_
180464	_	_	_	_	_
138032	_	_	_	_	_
224550	_	_	_	_	_
302000	_	_	_	_	_
103830	_	_	_	_	_
308750	_	_	_	_	_
217520	_	_	_	_	_
209000	_	_	_	_	_
300097	_	_	_	_	_
268250	_	_	_	_	_
516005	_	_	_	_	_
205600	_	_	_	_	_
402500	_	_	_	_	_
277150	_	_	_	_	_
246400	_	_	_	_	_
100680	_	_	_	_	_
601217	_	_	_	_	_
600544	_	_	_	_	_
114050	_	_	_	_	_
176851	_	_	_	_	_
155975	_	_	_	_	_
601453	_	_	_	_	_
180465	_	_	_	_	_
157150	_	_	_	_	_
109684	_	_	_	_	_
224570	_	_	_	_	_
302020	_	_	_	_	_
138035	_	_	_	_	_
601340	_	_	_	_	_
242650	_	_	_	_	_
277175	_	_	_	_	_
142962	_	_	_	_	_
103870	_	_	_	_	_
165098	_	_	_	_	_
600984	_	_	_	_	_
205700	_	_	_	_	_
600545	_	_	_	_	_
160150	_	_	_	_	_
601519	_	_	_	_	_
114051	_	_	_	_	_
601456	_	_	_	_	_
601587	_	_	_	_	_
403000	_	_	_	_	_
138060	_	_	_	_	_
224600	_	_	_	_	_
600481	_	_	_	_	_
209010	_	_	_	_	_
300098	_	_	_	_	_
277200	_	_	_	_	_
601588	_	_	_	_	_
264800	_	_	_	_	_
217600	_	_	_	_	_
116940	_	_	_	_	_
151540	_	_	_	_	_
205900	_	_	_	_	_
142963	_	_	_	_	_
601787	_	_	_	_	_
224700	_	_	_	_	_
180466	_	_	_	_	_
601520	_	_	_	_	_
176870	_	_	_	_	_
147050	_	_	_	_	_
601915	_	_	_	_	_
189880	_	_	_	_	_
600846	_	_	_	_	_
209050	_	_	_	_	_
138070	_	_	_	_	_
107450	_	_	_	_	_
217980	_	_	_	_	_
602018	_	_	_	_	_
206000	_	_	_	_	_
516006	_	_	_	_	_
601969	_	_	_	_	_
277320	_	_	_	_	_
601790	_	_	_	_	_
600655	_	_	_	_	_
209100	_	_	_	_	_
600252	_	_	_	_	_
147070	_	_	_	_	_
165110	_	_	_	_	_
224800	_	_	_	_	_
600482	_	_	_	_	_
180467	_	_	_	_	_
601341	_	_	_	_	_
601160	_	_	_	_	_
142964	_	_	_	_	_
217990	_	_	_	_	_
138100	_	_	_	_	_
206300	_	_	_	_	_
200930	_	_	_	_	_
601916	_	_	_	_	_
601048	_	_	_	_	_
151550	_	_	_	_	_
190110	_	_	_	_	_
147080	_	_	_	_	_
601274	_	_	_	_	_
601391	_	_	_	_	_
126840	_	_	_	_	_
157151	_	_	_	_	_
268315	_	_	_	_	_
105400	_	_	_	_	_
601521	_	_	_	_	_
158270	_	_	_	_	_
107460	_	_	_	_	_
601161	_	_	_	_	_
600254	_	_	_	_	_
163728	_	_	_	_	_
180469	_	_	_	_	_
601457	_	_	_	_	_
206400	_	_	_	_	_
209400	_	_	_	_	_
200970	_	_	_	_	_
601792	_	_	_	_	_
147090	_	_	_	_	_
102710	_	_	_	_	_
249230	_	_	_	_	_
601917	_	_	_	_	_
602276	_	_	_	_	_
602194	10q26.13	CARASIL syndrome	600142	AR	3
602194	10q26.13	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	616779	AD	3
602194	10q26.13	{Macular degeneration, age-related, 7}	610149	_	3
602194	10q26.13	{Macular degeneration, age-related, neovascular type}	610149	_	3
601342	_	_	_	_	_
151570	_	_	_	_	_
600656	_	_	_	_	_
601392	_	_	_	_	_
157160	_	_	_	_	_
600718	_	_	_	_	_
165120	_	_	_	_	_
225000	_	_	_	_	_
218010	_	_	_	_	_
601275	_	_	_	_	_
600484	_	_	_	_	_
126850	_	_	_	_	_
601163	_	_	_	_	_
600052	_	_	_	_	_
163731	_	_	_	_	_
602135	_	_	_	_	_
600908	_	_	_	_	_
601049	_	_	_	_	_
209600	_	_	_	_	_
105563	_	_	_	_	_
118457	_	_	_	_	_
200980	_	_	_	_	_
134510	_	_	_	_	_
601164	_	_	_	_	_
601970	_	_	_	_	_
601522	_	_	_	_	_
107480	_	_	_	_	_
264810	_	_	_	_	_
277350	_	_	_	_	_
151580	_	_	_	_	_
601919	_	_	_	_	_
601393	_	_	_	_	_
213010	_	_	_	_	_
602509	_	_	_	_	_
102720	_	_	_	_	_
116946	_	_	_	_	_
600719	_	_	_	_	_
242670	_	_	_	_	_
602561	_	_	_	_	_
601276	_	_	_	_	_
118480	_	_	_	_	_
180470	_	_	_	_	_
174310	_	_	_	_	_
218040	_	_	_	_	_
600485	_	_	_	_	_
602449	_	_	_	_	_
601343	_	_	_	_	_
600986	_	_	_	_	_
601921	_	_	_	_	_
206550	_	_	_	_	_
601165	_	_	_	_	_
147100	_	_	_	_	_
601394	_	_	_	_	_
602195	7q11.23	Charcot-Marie-Tooth disease, axonal, type 2F	606595	AD	3
602195	7q11.23	Neuropathy, distal hereditary motor, type IIB	608634	AD	3
602235	20q13.33	Epileptic encephalopathy, early infantile, 7	613720	AD	3
602235	20q13.33	Myokymia	121200	AD	3
602235	20q13.33	Seizures, benign neonatal, 1	121200	AD	3
602139	_	_	_	_	_
600657	_	_	_	_	_
116947	_	_	_	_	_
602019	_	_	_	_	_
107500	_	_	_	_	_
600720	_	_	_	_	_
102730	_	_	_	_	_
229300	_	_	_	_	_
601050	_	_	_	_	_
602451	_	_	_	_	_
277400	_	_	_	_	_
206570	_	_	_	_	_
602844	_	_	_	_	_
242680	_	_	_	_	_
600486	_	_	_	_	_
601278	_	_	_	_	_
600988	_	_	_	_	_
180471	_	_	_	_	_
218050	_	_	_	_	_
126950	_	_	_	_	_
602236	_	_	_	_	_
602799	_	_	_	_	_
147120	_	_	_	_	_
601971	_	_	_	_	_
600723	_	_	_	_	_
601166	_	_	_	_	_
151590	_	_	_	_	_
174500	_	_	_	_	_
601344	_	_	_	_	_
242700	_	_	_	_	_
225040	_	_	_	_	_
600054	_	_	_	_	_
602237	_	_	_	_	_
277410	_	_	_	_	_
218090	_	_	_	_	_
147130	_	_	_	_	_
600487	_	_	_	_	_
602453	_	_	_	_	_
601396	_	_	_	_	_
127100	_	_	_	_	_
601051	_	_	_	_	_
410000	_	_	_	_	_
242800	_	_	_	_	_
603002	_	_	_	_	_
601345	_	_	_	_	_
229310	_	_	_	_	_
601167	_	_	_	_	_
601279	_	_	_	_	_
600729	_	_	_	_	_
602899	_	_	_	_	_
218100	_	_	_	_	_
151610	_	_	_	_	_
602739	_	_	_	_	_
158280	_	_	_	_	_
602020	_	_	_	_	_
300234	_	_	_	_	_
601168	_	_	_	_	_
127200	_	_	_	_	_
225050	_	_	_	_	_
600658	_	_	_	_	_
603003	_	_	_	_	_
242850	_	_	_	_	_
112350	_	_	_	_	_
249240	_	_	_	_	_
601281	_	_	_	_	_
265140	_	_	_	_	_
602901	_	_	_	_	_
424000	_	_	_	_	_
603416	_	_	_	_	_
157200	_	_	_	_	_
601052	_	_	_	_	_
601346	_	_	_	_	_
225060	_	_	_	_	_
242870	_	_	_	_	_
600488	_	_	_	_	_
602196	_	_	_	_	_
601169	_	_	_	_	_
602845	_	_	_	_	_
300235	_	_	_	_	_
112370	_	_	_	_	_
127300	_	_	_	_	_
600730	_	_	_	_	_
603065	_	_	_	_	_
603172	_	_	_	_	_
602386	_	_	_	_	_
603583	_	_	_	_	_
603237	_	_	_	_	_
602021	_	_	_	_	_
603417	_	_	_	_	_
601053	_	_	_	_	_
602846	_	_	_	_	_
601285	_	_	_	_	_
242880	_	_	_	_	_
602902	_	_	_	_	_
600731	_	_	_	_	_
147435	_	_	_	_	_
600595	_	_	_	_	_
163850	_	_	_	_	_
225290	_	_	_	_	_
603887	_	_	_	_	_
601054	_	_	_	_	_
265150	_	_	_	_	_
602022	_	_	_	_	_
603943	_	_	_	_	_
600659	_	_	_	_	_
603173	_	_	_	_	_
603719	_	_	_	_	_
603828	_	_	_	_	_
604044	_	_	_	_	_
190170	_	_	_	_	_
600732	_	_	_	_	_
114065	_	_	_	_	_
603120	_	_	_	_	_
603888	_	_	_	_	_
602740	_	_	_	_	_
602903	_	_	_	_	_
516020	_	_	_	_	_
603418	_	_	_	_	_
603584	_	_	_	_	_
604092	_	_	_	_	_
604155	_	_	_	_	_
603994	_	_	_	_	_
424500	_	_	_	_	_
163900	_	_	_	_	_
601055	_	_	_	_	_
604222	_	_	_	_	_
225310	_	_	_	_	_
265200	_	_	_	_	_
603067	_	_	_	_	_
151620	_	_	_	_	_
603944	_	_	_	_	_
600735	_	_	_	_	_
190190	_	_	_	_	_
603468	_	_	_	_	_
602847	_	_	_	_	_
225350	_	_	_	_	_
603526	_	_	_	_	_
603174	_	_	_	_	_
604045	_	_	_	_	_
600736	_	_	_	_	_
604224	_	_	_	_	_
114070	_	_	_	_	_
602904	_	_	_	_	_
136130	_	_	_	_	_
147139	_	_	_	_	_
603947	_	_	_	_	_
151625	_	_	_	_	_
229400	_	_	_	_	_
602387	_	_	_	_	_
602454	_	_	_	_	_
602238	9q34.12	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	617763	AR	3
603586	_	_	_	_	_
602741	_	_	_	_	_
190196	_	_	_	_	_
603469	_	_	_	_	_
604156	_	_	_	_	_
604097	_	_	_	_	_
147485	_	_	_	_	_
163905	_	_	_	_	_
601056	_	_	_	_	_
136131	_	_	_	_	_
603068	_	_	_	_	_
602905	_	_	_	_	_
602455	_	_	_	_	_
604046	_	_	_	_	_
516030	_	_	_	_	_
604354	_	_	_	_	_
602143	_	_	_	_	_
225360	_	_	_	_	_
603528	_	_	_	_	_
602848	_	_	_	_	_
602388	_	_	_	_	_
603472	_	_	_	_	_
600546	_	_	_	_	_
147490	_	_	_	_	_
602456	_	_	_	_	_
602239	_	_	_	_	_
100700	_	_	_	_	_
603419	_	_	_	_	_
155980	_	_	_	_	_
602906	_	_	_	_	_
603121	_	_	_	_	_
601057	_	_	_	_	_
600737	_	_	_	_	_
151626	_	_	_	_	_
603238	_	_	_	_	_
136150	_	_	_	_	_
425000	_	_	_	_	_
601649	_	_	_	_	_
229500	_	_	_	_	_
602145	_	_	_	_	_
604422	_	_	_	_	_
603889	_	_	_	_	_
127350	_	_	_	_	_
602075	_	_	_	_	_
112430	_	_	_	_	_
604355	_	_	_	_	_
602800	_	_	_	_	_
600596	_	_	_	_	_
604476	_	_	_	_	_
268320	_	_	_	_	_
107550	_	_	_	_	_
602742	_	_	_	_	_
206600	_	_	_	_	_
265300	_	_	_	_	_
604599	_	_	_	_	_
602027	_	_	_	_	_
604281	_	_	_	_	_
100735	_	_	_	_	_
242890	_	_	_	_	_
137025	_	_	_	_	_
218200	_	_	_	_	_
114080	_	_	_	_	_
603473	_	_	_	_	_
603529	_	_	_	_	_
603420	_	_	_	_	_
147510	_	_	_	_	_
602461	_	_	_	_	_
112440	_	_	_	_	_
602850	_	_	_	_	_
225450	_	_	_	_	_
268500	_	_	_	_	_
602801	_	_	_	_	_
604423	_	_	_	_	_
206750	_	_	_	_	_
604707	_	_	_	_	_
116948	_	_	_	_	_
604534	_	_	_	_	_
213100	_	_	_	_	_
604600	_	_	_	_	_
603890	_	_	_	_	_
603069	_	_	_	_	_
601347	_	_	_	_	_
604157	_	_	_	_	_
601922	_	_	_	_	_
516040	_	_	_	_	_
604098	_	_	_	_	_
179838	_	_	_	_	_
602326	_	_	_	_	_
603421	_	_	_	_	_
164350	_	_	_	_	_
602076	_	_	_	_	_
604477	_	_	_	_	_
100820	_	_	_	_	_
601651	_	_	_	_	_
112450	_	_	_	_	_
603070	_	_	_	_	_
137026	_	_	_	_	_
600547	_	_	_	_	_
604359	_	_	_	_	_
426000	_	_	_	_	_
602852	_	_	_	_	_
603891	_	_	_	_	_
600661	_	_	_	_	_
107601	_	_	_	_	_
602240	_	_	_	_	_
601398	_	_	_	_	_
603296	_	_	_	_	_
602745	_	_	_	_	_
600597	_	_	_	_	_
603530	_	_	_	_	_
179840	_	_	_	_	_
604361	_	_	_	_	_
164600	_	_	_	_	_
602147	_	_	_	_	_
116949	_	_	_	_	_
601348	_	_	_	_	_
602907	_	_	_	_	_
156000	_	_	_	_	_
602949	_	_	_	_	_
603071	_	_	_	_	_
603423	_	_	_	_	_
604099	_	_	_	_	_
137028	_	_	_	_	_
268650	_	_	_	_	_
600598	_	_	_	_	_
100880	_	_	_	_	_
225500	_	_	_	_	_
603298	_	_	_	_	_
163906	_	_	_	_	_
604478	_	_	_	_	_
604535	_	_	_	_	_
602746	_	_	_	_	_
602148	_	_	_	_	_
600549	_	_	_	_	_
602950	_	_	_	_	_
179900	_	_	_	_	_
603532	_	_	_	_	_
603893	_	_	_	_	_
127750	_	_	_	_	_
603074	_	_	_	_	_
602908	_	_	_	_	_
604158	_	_	_	_	_
604538	_	_	_	_	_
600663	_	_	_	_	_
601400	_	_	_	_	_
602747	_	_	_	_	_
206780	_	_	_	_	_
180050	_	_	_	_	_
600600	_	_	_	_	_
265400	_	_	_	_	_
603425	_	_	_	_	_
604282	_	_	_	_	_
190200	_	_	_	_	_
602241	13q12.12	Combined oxidative phosphorylation deficiency 31	617228	AR	3
603299	_	_	_	_	_
604100	_	_	_	_	_
174600	_	_	_	_	_
116950	_	_	_	_	_
602951	_	_	_	_	_
300174	_	_	_	_	_
600665	_	_	_	_	_
602909	_	_	_	_	_
602462	_	_	_	_	_
127800	_	_	_	_	_
602151	_	_	_	_	_
603300	_	_	_	_	_
602028	_	_	_	_	_
174750	_	_	_	_	_
603428	_	_	_	_	_
604160	_	_	_	_	_
136200	_	_	_	_	_
156190	_	_	_	_	_
265430	_	_	_	_	_
604924	_	_	_	_	_
116951	_	_	_	_	_
206900	_	_	_	_	_
600670	_	_	_	_	_
604540	_	_	_	_	_
605033	_	_	_	_	_
602463	_	_	_	_	_
190231	_	_	_	_	_
603302	_	_	_	_	_
602154	_	_	_	_	_
136300	_	_	_	_	_
107640	_	_	_	_	_
137030	_	_	_	_	_
174760	_	_	_	_	_
156220	_	_	_	_	_
265500	_	_	_	_	_
600671	_	_	_	_	_
516050	_	_	_	_	_
604225	_	_	_	_	_
605138	_	_	_	_	_
603429	_	_	_	_	_
602749	_	_	_	_	_
605251	_	_	_	_	_
602029	_	_	_	_	_
605034	_	_	_	_	_
603587	_	_	_	_	_
603948	_	_	_	_	_
602155	_	_	_	_	_
600601	_	_	_	_	_
156230	_	_	_	_	_
190232	_	_	_	_	_
600672	_	_	_	_	_
602464	_	_	_	_	_
136400	_	_	_	_	_
604816	_	_	_	_	_
600550	_	_	_	_	_
127820	_	_	_	_	_
605315	_	_	_	_	_
604284	_	_	_	_	_
605252	_	_	_	_	_
604162	_	_	_	_	_
603124	_	_	_	_	_
604101	_	_	_	_	_
602030	_	_	_	_	_
603588	_	_	_	_	_
603430	_	_	_	_	_
600738	_	_	_	_	_
265600	_	_	_	_	_
603894	_	_	_	_	_
605035	_	_	_	_	_
602853	_	_	_	_	_
604362	_	_	_	_	_
603303	_	_	_	_	_
604817	_	_	_	_	_
156240	_	_	_	_	_
600602	_	_	_	_	_
603431	_	_	_	_	_
605255	_	_	_	_	_
602802	_	_	_	_	_
116953	_	_	_	_	_
602750	_	_	_	_	_
603125	_	_	_	_	_
602242	19q13.32	Hypocalciuric hypercalcemia, type III	600740	AD	3
265850	_	_	_	_	_
604601	_	_	_	_	_
229650	_	_	_	_	_
605036	_	_	_	_	_
605499	_	_	_	_	_
605443	_	_	_	_	_
603895	_	_	_	_	_
114085	_	_	_	_	_
604163	_	_	_	_	_
190310	_	_	_	_	_
128000	_	_	_	_	_
300175	_	_	_	_	_
137033	_	_	_	_	_
164680	_	_	_	_	_
603432	_	_	_	_	_
156300	_	_	_	_	_
605562	_	_	_	_	_
604363	_	_	_	_	_
600551	_	_	_	_	_
605369	_	_	_	_	_
604818	_	_	_	_	_
602243	11p15.5	Nephropathy with pretibial epidermolysis bullosa and deafness	609057	_	3
602243	11p15.5	[Blood group, Raph]	179620	_	3
603126	_	_	_	_	_
112600	_	_	_	_	_
602031	_	_	_	_	_
116954	_	_	_	_	_
605256	_	_	_	_	_
213400	_	_	_	_	_
604102	_	_	_	_	_
190340	_	_	_	_	_
601523	_	_	_	_	_
114100	_	_	_	_	_
605444	_	_	_	_	_
603304	_	_	_	_	_
604164	_	_	_	_	_
605037	_	_	_	_	_
603433	_	_	_	_	_
163910	_	_	_	_	_
600674	_	_	_	_	_
602854	_	_	_	_	_
300176	_	_	_	_	_
600739	_	_	_	_	_
602751	_	_	_	_	_
600603	_	_	_	_	_
605626	_	_	_	_	_
605679	_	_	_	_	_
602034	_	_	_	_	_
601524	_	_	_	_	_
603949	_	_	_	_	_
600552	_	_	_	_	_
604602	_	_	_	_	_
602952	_	_	_	_	_
112700	_	_	_	_	_
604976	_	_	_	_	_
603896	_	_	_	_	_
268670	_	_	_	_	_
603306	_	_	_	_	_
604424	_	_	_	_	_
114106	_	_	_	_	_
601526	_	_	_	_	_
136425	_	_	_	_	_
213500	_	_	_	_	_
602244	3p14.3	Systemic lupus erythematosus 16	614420	AR	3
601058	_	_	_	_	_
602803	_	_	_	_	_
163920	_	_	_	_	_
602953	_	_	_	_	_
137040	_	_	_	_	_
603533	_	_	_	_	_
605372	_	_	_	_	_
604603	_	_	_	_	_
136470	_	_	_	_	_
604760	_	_	_	_	_
114107	_	_	_	_	_
604820	_	_	_	_	_
603308	_	_	_	_	_
604425	_	_	_	_	_
605680	_	_	_	_	_
602035	_	_	_	_	_
163955	_	_	_	_	_
300177	_	_	_	_	_
605445	_	_	_	_	_
605627	_	_	_	_	_
605038	_	_	_	_	_
601059	_	_	_	_	_
604761	_	_	_	_	_
602856	_	_	_	_	_
602752	_	_	_	_	_
136480	_	_	_	_	_
600553	_	_	_	_	_
112800	_	_	_	_	_
602036	_	_	_	_	_
603434	_	_	_	_	_
268850	_	_	_	_	_
603950	_	_	_	_	_
602804	_	_	_	_	_
600741	_	_	_	_	_
207000	_	_	_	_	_
600604	_	_	_	_	_
114110	_	_	_	_	_
601060	_	_	_	_	_
605563	_	_	_	_	_
116957	_	_	_	_	_
605374	_	_	_	_	_
605858	_	_	_	_	_
605260	_	_	_	_	_
604047	_	_	_	_	_
163980	_	_	_	_	_
602805	_	_	_	_	_
602755	_	_	_	_	_
603952	_	_	_	_	_
600554	_	_	_	_	_
605914	_	_	_	_	_
300178	_	_	_	_	_
190345	_	_	_	_	_
605040	_	_	_	_	_
603435	_	_	_	_	_
600605	_	_	_	_	_
107650	_	_	_	_	_
605681	_	_	_	_	_
116960	_	_	_	_	_
603310	_	_	_	_	_
605567	_	_	_	_	_
605915	_	_	_	_	_
605734	_	_	_	_	_
605794	_	_	_	_	_
604048	_	_	_	_	_
601061	_	_	_	_	_
600557	_	_	_	_	_
602156	_	_	_	_	_
156310	_	_	_	_	_
603953	_	_	_	_	_
604479	_	_	_	_	_
107690	_	_	_	_	_
602465	_	_	_	_	_
603436	_	_	_	_	_
602756	_	_	_	_	_
606135	_	_	_	_	_
605381	_	_	_	_	_
605682	_	_	_	_	_
603239	_	_	_	_	_
604762	_	_	_	_	_
117000	_	_	_	_	_
605796	_	_	_	_	_
606191	_	_	_	_	_
605447	_	_	_	_	_
605683	_	_	_	_	_
606305	_	_	_	_	_
603897	_	_	_	_	_
605082	_	_	_	_	_
604480	_	_	_	_	_
601529	_	_	_	_	_
207300	_	_	_	_	_
604763	_	_	_	_	_
602757	_	_	_	_	_
606415	_	_	_	_	_
605182	_	_	_	_	_
600742	_	_	_	_	_
606087	_	_	_	_	_
605916	_	_	_	_	_
603240	_	_	_	_	_
603075	_	_	_	_	_
156340	_	_	_	_	_
603475	_	_	_	_	_
213820	_	_	_	_	_
605684	_	_	_	_	_
605735	_	_	_	_	_
603954	_	_	_	_	_
605085	_	_	_	_	_
117139	_	_	_	_	_
600743	_	_	_	_	_
604104	_	_	_	_	_
107700	_	_	_	_	_
604821	_	_	_	_	_
112900	_	_	_	_	_
605628	_	_	_	_	_
602758	_	_	_	_	_
605261	_	_	_	_	_
268950	_	_	_	_	_
601531	_	_	_	_	_
604977	_	_	_	_	_
603241	_	_	_	_	_
604049	_	_	_	_	_
606136	_	_	_	_	_
128240	_	_	_	_	_
606251	_	_	_	_	_
606088	_	_	_	_	_
605685	_	_	_	_	_
606356	_	_	_	_	_
602857	_	_	_	_	_
147521	_	_	_	_	_
602467	_	_	_	_	_
606192	_	_	_	_	_
605087	_	_	_	_	_
603898	_	_	_	_	_
600744	_	_	_	_	_
603311	_	_	_	_	_
605139	_	_	_	_	_
605568	_	_	_	_	_
117140	_	_	_	_	_
606420	_	_	_	_	_
605859	_	_	_	_	_
604822	_	_	_	_	_
606253	_	_	_	_	_
107710	_	_	_	_	_
605382	_	_	_	_	_
605797	_	_	_	_	_
605183	_	_	_	_	_
603242	_	_	_	_	_
604978	_	_	_	_	_
604764	_	_	_	_	_
128290	_	_	_	_	_
606479	_	_	_	_	_
602468	_	_	_	_	_
601532	_	_	_	_	_
605736	_	_	_	_	_
605569	_	_	_	_	_
601923	_	_	_	_	_
600745	_	_	_	_	_
602862	_	_	_	_	_
164000	_	_	_	_	_
112910	_	_	_	_	_
605448	_	_	_	_	_
269160	_	_	_	_	_
603476	_	_	_	_	_
604767	_	_	_	_	_
602038	_	_	_	_	_
604481	_	_	_	_	_
606533	_	_	_	_	_
605184	_	_	_	_	_
156349	_	_	_	_	_
114120	_	_	_	_	_
601533	_	_	_	_	_
604050	_	_	_	_	_
600676	_	_	_	_	_
605385	_	_	_	_	_
603312	_	_	_	_	_
604823	_	_	_	_	_
606589	_	_	_	_	_
605449	_	_	_	_	_
164013	_	_	_	_	_
128300	_	_	_	_	_
602863	_	_	_	_	_
603899	_	_	_	_	_
107740	_	_	_	_	_
600746	_	_	_	_	_
117141	_	_	_	_	_
605263	_	_	_	_	_
604979	_	_	_	_	_
605798	_	_	_	_	_
604768	_	_	_	_	_
606193	_	_	_	_	_
164016	_	_	_	_	_
604051	_	_	_	_	_
601534	_	_	_	_	_
207500	_	_	_	_	_
107748	_	_	_	_	_
128400	_	_	_	_	_
600748	_	_	_	_	_
605450	_	_	_	_	_
603314	_	_	_	_	_
147522	_	_	_	_	_
604980	_	_	_	_	_
604105	_	_	_	_	_
604482	_	_	_	_	_
602864	_	_	_	_	_
117142	_	_	_	_	_
606653	_	_	_	_	_
603243	_	_	_	_	_
606089	_	_	_	_	_
207600	_	_	_	_	_
604825	_	_	_	_	_
164018	_	_	_	_	_
606357	_	_	_	_	_
600750	_	_	_	_	_
604106	_	_	_	_	_
600677	_	_	_	_	_
605451	_	_	_	_	_
604483	_	_	_	_	_
605737	_	_	_	_	_
603534	_	_	_	_	_
606654	_	_	_	_	_
602865	_	_	_	_	_
601535	_	_	_	_	_
601654	_	_	_	_	_
605264	_	_	_	_	_
606306	_	_	_	_	_
604107	_	_	_	_	_
603244	_	_	_	_	_
605186	_	_	_	_	_
606358	_	_	_	_	_
113301	_	_	_	_	_
605570	_	_	_	_	_
164019	_	_	_	_	_
604981	_	_	_	_	_
606534	_	_	_	_	_
603900	_	_	_	_	_
600679	_	_	_	_	_
107750	_	_	_	_	_
606090	_	_	_	_	_
603245	_	_	_	_	_
605453	_	_	_	_	_
605265	_	_	_	_	_
603315	_	_	_	_	_
602760	_	_	_	_	_
207620	_	_	_	_	_
606194	_	_	_	_	_
604108	_	_	_	_	_
604826	_	_	_	_	_
603535	_	_	_	_	_
603901	_	_	_	_	_
606590	_	_	_	_	_
605386	_	_	_	_	_
603246	_	_	_	_	_
606091	_	_	_	_	_
601655	_	_	_	_	_
602866	_	_	_	_	_
604984	_	_	_	_	_
113310	_	_	_	_	_
606655	_	_	_	_	_
606359	_	_	_	_	_
605043	_	_	_	_	_
107760	_	_	_	_	_
605454	_	_	_	_	_
606793	_	_	_	_	_
606092	_	_	_	_	_
207700	_	_	_	_	_
604109	_	_	_	_	_
604052	_	_	_	_	_
603536	_	_	_	_	_
606196	_	_	_	_	_
605390	_	_	_	_	_
600680	_	_	_	_	_
604986	_	_	_	_	_
606732	_	_	_	_	_
605917	_	_	_	_	_
605800	_	_	_	_	_
603905	_	_	_	_	_
602157	_	_	_	_	_
602469	_	_	_	_	_
606657	_	_	_	_	_
606307	_	_	_	_	_
606794	_	_	_	_	_
605044	_	_	_	_	_
605918	_	_	_	_	_
207720	_	_	_	_	_
602761	_	_	_	_	_
602039	_	_	_	_	_
605500	_	_	_	_	_
174770	_	_	_	_	_
604111	_	_	_	_	_
602868	_	_	_	_	_
606591	_	_	_	_	_
606733	_	_	_	_	_
605395	_	_	_	_	_
604828	_	_	_	_	_
602158	_	_	_	_	_
605455	_	_	_	_	_
164020	_	_	_	_	_
604486	_	_	_	_	_
600683	_	_	_	_	_
603906	_	_	_	_	_
605801	_	_	_	_	_
606795	_	_	_	_	_
602470	_	_	_	_	_
601536	_	_	_	_	_
606197	_	_	_	_	_
601657	_	_	_	_	_
603076	_	_	_	_	_
606360	_	_	_	_	_
605686	_	_	_	_	_
603127	_	_	_	_	_
117200	_	_	_	_	_
164021	_	_	_	_	_
604659	_	_	_	_	_
602871	_	_	_	_	_
605140	_	_	_	_	_
604769	_	_	_	_	_
602159	_	_	_	_	_
605396	_	_	_	_	_
606796	_	_	_	_	_
606920	_	_	_	_	_
606659	_	_	_	_	_
605501	_	_	_	_	_
605919	_	_	_	_	_
601658	_	_	_	_	_
604112	_	_	_	_	_
603077	_	_	_	_	_
606993	_	_	_	_	_
603128	_	_	_	_	_
601926	_	_	_	_	_
605687	_	_	_	_	_
600684	_	_	_	_	_
605269	_	_	_	_	_
606592	_	_	_	_	_
604770	_	_	_	_	_
606093	_	_	_	_	_
602160	_	_	_	_	_
603589	_	_	_	_	_
606801	_	_	_	_	_
164022	_	_	_	_	_
604829	_	_	_	_	_
606997	_	_	_	_	_
605920	_	_	_	_	_
207731	_	_	_	_	_
606308	_	_	_	_	_
606198	_	_	_	_	_
117340	_	_	_	_	_
606594	_	_	_	_	_
604660	_	_	_	_	_
164031	_	_	_	_	_
602040	_	_	_	_	_
600055	_	_	_	_	_
606361	_	_	_	_	_
602806	_	_	_	_	_
605045	_	_	_	_	_
606802	_	_	_	_	_
604771	_	_	_	_	_
607065	_	_	_	_	_
606599	_	_	_	_	_
600056	_	_	_	_	_
606863	_	_	_	_	_
603316	_	_	_	_	_
606535	_	_	_	_	_
606803	_	_	_	_	_
602041	_	_	_	_	_
601537	_	_	_	_	_
602161	_	_	_	_	_
117350	_	_	_	_	_
604987	_	_	_	_	_
604661	_	_	_	_	_
603907	_	_	_	_	_
603591	_	_	_	_	_
164700	_	_	_	_	_
600685	_	_	_	_	_
605046	_	_	_	_	_
601540	_	_	_	_	_
607265	_	_	_	_	_
605271	_	_	_	_	_
605456	_	_	_	_	_
601659	_	_	_	_	_
607192	_	_	_	_	_
605688	_	_	_	_	_
604662	_	_	_	_	_
602162	_	_	_	_	_
607266	_	_	_	_	_
600057	_	_	_	_	_
605689	_	_	_	_	_
601541	_	_	_	_	_
606363	_	_	_	_	_
607327	_	_	_	_	_
601660	_	_	_	_	_
207740	_	_	_	_	_
603595	_	_	_	_	_
164710	_	_	_	_	_
606804	_	_	_	_	_
607449	_	_	_	_	_
605922	_	_	_	_	_
607267	_	_	_	_	_
606199	_	_	_	_	_
600058	_	_	_	_	_
605457	_	_	_	_	_
607067	_	_	_	_	_
605690	_	_	_	_	_
603596	_	_	_	_	_
607328	_	_	_	_	_
607595	_	_	_	_	_
603078	_	_	_	_	_
156350	_	_	_	_	_
605923	_	_	_	_	_
606600	_	_	_	_	_
605048	_	_	_	_	_
602807	_	_	_	_	_
601927	_	_	_	_	_
604113	_	_	_	_	_
207765	_	_	_	_	_
606663	_	_	_	_	_
607068	_	_	_	_	_
606601	_	_	_	_	_
606422	_	_	_	_	_
605691	_	_	_	_	_
606203	_	_	_	_	_
603079	_	_	_	_	_
603597	_	_	_	_	_
606602	_	_	_	_	_
601661	_	_	_	_	_
606204	_	_	_	_	_
207770	_	_	_	_	_
607332	_	_	_	_	_
607069	_	_	_	_	_
602808	_	_	_	_	_
602872	_	_	_	_	_
605458	_	_	_	_	_
603598	_	_	_	_	_
207780	_	_	_	_	_
607670	_	_	_	_	_
114130	_	_	_	_	_
607597	_	_	_	_	_
608050	_	_	_	_	_
164720	_	_	_	_	_
605049	_	_	_	_	_
608185	_	_	_	_	_
608250	_	_	_	_	_
207790	_	_	_	_	_
607735	_	_	_	_	_
607785	_	_	_	_	_
114140	_	_	_	_	_
604830	_	_	_	_	_
602873	_	_	_	_	_
607862	_	_	_	_	_
608052	_	_	_	_	_
607073	_	_	_	_	_
606364	_	_	_	_	_
608302	_	_	_	_	_
607138	_	_	_	_	_
602391	_	_	_	_	_
607193	_	_	_	_	_
107800	_	_	_	_	_
600061	_	_	_	_	_
607863	_	_	_	_	_
605693	_	_	_	_	_
114150	_	_	_	_	_
608493	_	_	_	_	_
608054	_	_	_	_	_
113400	_	_	_	_	_
607074	_	_	_	_	_
605272	_	_	_	_	_
604832	_	_	_	_	_
600062	_	_	_	_	_
607599	_	_	_	_	_
608561	_	_	_	_	_
114160	_	_	_	_	_
605088	_	_	_	_	_
606604	_	_	_	_	_
608431	_	_	_	_	_
604053	_	_	_	_	_
605273	_	_	_	_	_
607865	_	_	_	_	_
605694	_	_	_	_	_
607195	_	_	_	_	_
600063	_	_	_	_	_
608624	_	_	_	_	_
164740	_	_	_	_	_
606665	_	_	_	_	_
107830	_	_	_	_	_
604054	_	_	_	_	_
164755	_	_	_	_	_
607866	_	_	_	_	_
607268	_	_	_	_	_
607197	_	_	_	_	_
164756	_	_	_	_	_
602042	_	_	_	_	_
604055	_	_	_	_	_
608432	_	_	_	_	_
607868	_	_	_	_	_
607333	_	_	_	_	_
607269	_	_	_	_	_
608434	_	_	_	_	_
606605	_	_	_	_	_
606365	_	_	_	_	_
607926	_	_	_	_	_
607334	_	_	_	_	_
608929	_	_	_	_	_
606667	_	_	_	_	_
609163	_	_	_	_	_
607927	_	_	_	_	_
603599	_	_	_	_	_
609361	_	_	_	_	_
607272	_	_	_	_	_
608933	_	_	_	_	_
605050	_	_	_	_	_
606366	_	_	_	_	_
600686	_	_	_	_	_
606669	_	_	_	_	_
604056	_	_	_	_	_
609104	_	_	_	_	_
602043	_	_	_	_	_
607930	_	_	_	_	_
607986	_	_	_	_	_
606309	_	_	_	_	_
603908	_	_	_	_	_
609362	_	_	_	_	_
602045	_	_	_	_	_
600687	_	_	_	_	_
602874	_	_	_	_	_
606369	_	_	_	_	_
609421	_	_	_	_	_
609105	_	_	_	_	_
600688	_	_	_	_	_
609363	_	_	_	_	_
164759	_	_	_	_	_
608304	_	_	_	_	_
607673	_	_	_	_	_
603910	_	_	_	_	_
607931	_	_	_	_	_
609164	_	_	_	_	_
606310	_	_	_	_	_
603600	_	_	_	_	_
609537	_	_	_	_	_
607674	_	_	_	_	_
605274	_	_	_	_	_
269200	_	_	_	_	_
602046	_	_	_	_	_
600689	_	_	_	_	_
607933	_	_	_	_	_
605695	_	_	_	_	_
605089	_	_	_	_	_
609538	_	_	_	_	_
606311	_	_	_	_	_
609166	_	_	_	_	_
609666	_	_	_	_	_
607675	_	_	_	_	_
609106	_	_	_	_	_
607201	_	_	_	_	_
605464	_	_	_	_	_
603602	_	_	_	_	_
607987	_	_	_	_	_
609481	_	_	_	_	_
608368	_	_	_	_	_
609540	_	_	_	_	_
609107	_	_	_	_	_
607934	_	_	_	_	_
606312	_	_	_	_	_
164762	_	_	_	_	_
609600	_	_	_	_	_
602047	_	_	_	_	_
609221	_	_	_	_	_
607988	_	_	_	_	_
601929	_	_	_	_	_
608934	_	_	_	_	_
608306	_	_	_	_	_
605926	_	_	_	_	_
609482	_	_	_	_	_
609108	_	_	_	_	_
609293	_	_	_	_	_
606313	_	_	_	_	_
608369	_	_	_	_	_
605090	_	_	_	_	_
608308	_	_	_	_	_
607203	_	_	_	_	_
609422	_	_	_	_	_
609222	_	_	_	_	_
269300	_	_	_	_	_
607679	_	_	_	_	_
602050	_	_	_	_	_
609109	_	_	_	_	_
607935	_	_	_	_	_
605696	_	_	_	_	_
609722	_	_	_	_	_
600064	_	_	_	_	_
606805	_	_	_	_	_
605276	_	_	_	_	_
608311	_	_	_	_	_
609364	_	_	_	_	_
605465	_	_	_	_	_
269630	_	_	_	_	_
604118	_	_	_	_	_
608718	_	_	_	_	_
605277	_	_	_	_	_
607205	_	_	_	_	_
603911	_	_	_	_	_
607937	_	_	_	_	_
605697	_	_	_	_	_
608936	_	_	_	_	_
607274	_	_	_	_	_
269650	_	_	_	_	_
605698	_	_	_	_	_
114170	_	_	_	_	_
269720	_	_	_	_	_
605927	_	_	_	_	_
608370	_	_	_	_	_
605466	_	_	_	_	_
607938	_	_	_	_	_
609483	_	_	_	_	_
606314	_	_	_	_	_
604057	_	_	_	_	_
604166	_	_	_	_	_
608373	_	_	_	_	_
609365	_	_	_	_	_
607940	_	_	_	_	_
604170	_	_	_	_	_
607075	_	_	_	_	_
604058	_	_	_	_	_
607140	_	_	_	_	_
606315	_	_	_	_	_
608376	_	_	_	_	_
604833	_	_	_	_	_
605467	_	_	_	_	_
609167	_	_	_	_	_
608312	_	_	_	_	_
604059	_	_	_	_	_
600066	_	_	_	_	_
604171	_	_	_	_	_
609601	_	_	_	_	_
608377	_	_	_	_	_
609964	_	_	_	_	_
607787	_	_	_	_	_
609169	_	_	_	_	_
607208	_	_	_	_	_
607141	_	_	_	_	_
607275	_	_	_	_	_
609294	_	_	_	_	_
609723	_	_	_	_	_
604835	_	_	_	_	_
606316	_	_	_	_	_
607942	_	_	_	_	_
609295	_	_	_	_	_
607142	_	_	_	_	_
609170	_	_	_	_	_
601662	_	_	_	_	_
609602	_	_	_	_	_
607789	_	_	_	_	_
606317	_	_	_	_	_
606606	_	_	_	_	_
607680	_	_	_	_	_
604119	_	_	_	_	_
605278	_	_	_	_	_
601930	_	_	_	_	_
607943	_	_	_	_	_
610223	_	_	_	_	_
609603	_	_	_	_	_
607146	_	_	_	_	_
606318	_	_	_	_	_
606607	_	_	_	_	_
608314	_	_	_	_	_
609724	_	_	_	_	_
607209	_	_	_	_	_
607790	_	_	_	_	_
610086	_	_	_	_	_
604172	_	_	_	_	_
609966	_	_	_	_	_
607076	_	_	_	_	_
609604	_	_	_	_	_
604120	_	_	_	_	_
164765	_	_	_	_	_
610225	_	_	_	_	_
608719	_	_	_	_	_
609779	_	_	_	_	_
607681	_	_	_	_	_
610023	_	_	_	_	_
608937	_	_	_	_	_
607945	_	_	_	_	_
607280	_	_	_	_	_
609605	_	_	_	_	_
600067	_	_	_	_	_
610088	_	_	_	_	_
608720	_	_	_	_	_
601665	_	_	_	_	_
607077	_	_	_	_	_
164772	_	_	_	_	_
607281	_	_	_	_	_
606610	_	_	_	_	_
610301	_	_	_	_	_
607946	_	_	_	_	_
604176	_	_	_	_	_
610089	_	_	_	_	_
610024	_	_	_	_	_
607792	_	_	_	_	_
609967	_	_	_	_	_
607682	_	_	_	_	_
608315	_	_	_	_	_
608721	_	_	_	_	_
164795	_	_	_	_	_
607079	_	_	_	_	_
607214	_	_	_	_	_
601931	_	_	_	_	_
608938	_	_	_	_	_
605279	_	_	_	_	_
610415	_	_	_	_	_
609606	_	_	_	_	_
609110	_	_	_	_	_
608319	_	_	_	_	_
606611	_	_	_	_	_
604177	_	_	_	_	_
609296	_	_	_	_	_
605699	_	_	_	_	_
608435	_	_	_	_	_
607686	_	_	_	_	_
605468	_	_	_	_	_
610025	_	_	_	_	_
610481	_	_	_	_	_
607216	_	_	_	_	_
606614	_	_	_	_	_
610416	_	_	_	_	_
609297	_	_	_	_	_
604122	_	_	_	_	_
610364	_	_	_	_	_
604178	_	_	_	_	_
601932	_	_	_	_	_
610026	_	_	_	_	_
602392	_	_	_	_	_
601667	_	_	_	_	_
608722	_	_	_	_	_
607217	_	_	_	_	_
600068	_	_	_	_	_
605700	_	_	_	_	_
606615	_	_	_	_	_
607081	_	_	_	_	_
610302	_	_	_	_	_
609111	_	_	_	_	_
601668	_	_	_	_	_
610091	_	_	_	_	_
608939	_	_	_	_	_
610228	_	_	_	_	_
607282	_	_	_	_	_
610365	_	_	_	_	_
604180	_	_	_	_	_
605281	_	_	_	_	_
608321	_	_	_	_	_
610027	_	_	_	_	_
609844	_	_	_	_	_
604126	_	_	_	_	_
607219	_	_	_	_	_
610545	_	_	_	_	_
605701	_	_	_	_	_
610149	_	_	_	_	_
608941	_	_	_	_	_
164800	_	_	_	_	_
608724	_	_	_	_	_
609969	_	_	_	_	_
603955	_	_	_	_	_
608436	_	_	_	_	_
605287	_	_	_	_	_
607220	_	_	_	_	_
609725	_	_	_	_	_
609112	_	_	_	_	_
610229	_	_	_	_	_
606617	_	_	_	_	_
269800	_	_	_	_	_
610482	_	_	_	_	_
609298	_	_	_	_	_
610667	_	_	_	_	_
609846	_	_	_	_	_
608322	_	_	_	_	_
610900	_	_	_	_	_
610028	_	_	_	_	_
610366	_	_	_	_	_
610094	_	_	_	_	_
609366	_	_	_	_	_
610546	_	_	_	_	_
609114	_	_	_	_	_
610231	_	_	_	_	_
605928	_	_	_	_	_
604181	_	_	_	_	_
607222	_	_	_	_	_
610973	_	_	_	_	_
600069	_	_	_	_	_
608438	_	_	_	_	_
609726	_	_	_	_	_
606618	_	_	_	_	_
604836	_	_	_	_	_
610483	_	_	_	_	_
610304	_	_	_	_	_
610368	_	_	_	_	_
611032	_	_	_	_	_
610095	_	_	_	_	_
610727	_	_	_	_	_
610232	_	_	_	_	_
607689	_	_	_	_	_
611164	_	_	_	_	_
610668	_	_	_	_	_
610029	_	_	_	_	_
609542	_	_	_	_	_
609368	_	_	_	_	_
606319	_	_	_	_	_
609171	_	_	_	_	_
609729	_	_	_	_	_
610096	_	_	_	_	_
611033	_	_	_	_	_
610974	_	_	_	_	_
611106	_	_	_	_	_
609780	_	_	_	_	_
610901	_	_	_	_	_
611269	_	_	_	_	_
269860	_	_	_	_	_
610604	_	_	_	_	_
605469	_	_	_	_	_
604182	_	_	_	_	_
610669	_	_	_	_	_
610030	_	_	_	_	_
609970	_	_	_	_	_
609781	_	_	_	_	_
607691	_	_	_	_	_
605929	_	_	_	_	_
606320	_	_	_	_	_
600070	_	_	_	_	_
601669	_	_	_	_	_
604183	_	_	_	_	_
609971	_	_	_	_	_
610033	_	_	_	_	_
611371	_	_	_	_	_
269870	_	_	_	_	_
610369	_	_	_	_	_
609730	_	_	_	_	_
609543	_	_	_	_	_
611270	_	_	_	_	_
601670	_	_	_	_	_
603957	_	_	_	_	_
605470	_	_	_	_	_
611624	_	_	_	_	_
610097	_	_	_	_	_
610484	_	_	_	_	_
611108	_	_	_	_	_
608440	_	_	_	_	_
608725	_	_	_	_	_
609301	_	_	_	_	_
608942	_	_	_	_	_
610975	_	_	_	_	_
610671	_	_	_	_	_
605702	_	_	_	_	_
606619	_	_	_	_	_
610605	_	_	_	_	_
611435	_	_	_	_	_
610305	_	_	_	_	_
609847	_	_	_	_	_
610902	_	_	_	_	_
607147	_	_	_	_	_
603958	_	_	_	_	_
611323	_	_	_	_	_
611905	_	_	_	_	_
611110	_	_	_	_	_
609370	_	_	_	_	_
610485	_	_	_	_	_
610606	_	_	_	_	_
609117	_	_	_	_	_
611165	_	_	_	_	_
612303	_	_	_	_	_
164810	_	_	_	_	_
610101	_	_	_	_	_
605471	_	_	_	_	_
600071	_	_	_	_	_
610037	_	_	_	_	_
608444	_	_	_	_	_
612207	_	_	_	_	_
612038	_	_	_	_	_
605703	_	_	_	_	_
609783	_	_	_	_	_
605930	_	_	_	_	_
612305	_	_	_	_	_
609371	_	_	_	_	_
611166	_	_	_	_	_
612153	_	_	_	_	_
611436	_	_	_	_	_
610151	_	_	_	_	_
602393	_	_	_	_	_
610976	_	_	_	_	_
605707	_	_	_	_	_
612039	_	_	_	_	_
611372	_	_	_	_	_
610728	_	_	_	_	_
610038	_	_	_	_	_
603960	_	_	_	_	_
611906	_	_	_	_	_
612396	_	_	_	_	_
611324	_	_	_	_	_
164830	_	_	_	_	_
612208	_	_	_	_	_
607692	_	_	_	_	_
612307	_	_	_	_	_
609784	_	_	_	_	_
610103	_	_	_	_	_
605472	_	_	_	_	_
608726	_	_	_	_	_
609119	_	_	_	_	_
610729	_	_	_	_	_
612154	_	_	_	_	_
605708	_	_	_	_	_
610607	_	_	_	_	_
609303	_	_	_	_	_
610486	_	_	_	_	_
611909	_	_	_	_	_
611682	_	_	_	_	_
602394	_	_	_	_	_
604184	_	_	_	_	_
603962	_	_	_	_	_
609372	_	_	_	_	_
611437	_	_	_	_	_
610609	_	_	_	_	_
611373	_	_	_	_	_
609785	_	_	_	_	_
611968	_	_	_	_	_
612155	_	_	_	_	_
607695	_	_	_	_	_
612397	_	_	_	_	_
609120	_	_	_	_	_
612694	_	_	_	_	_
610039	_	_	_	_	_
611683	_	_	_	_	_
610487	_	_	_	_	_
612466	_	_	_	_	_
610610	_	_	_	_	_
612209	_	_	_	_	_
611325	_	_	_	_	_
612156	_	_	_	_	_
606620	_	_	_	_	_
607698	_	_	_	_	_
610977	_	_	_	_	_
610903	_	_	_	_	_
604128	_	_	_	_	_
611438	_	_	_	_	_
611111	_	_	_	_	_
611969	_	_	_	_	_
605473	_	_	_	_	_
603963	_	_	_	_	_
612752	_	_	_	_	_
612040	_	_	_	_	_
605931	_	_	_	_	_
612973	_	_	_	_	_
612398	_	_	_	_	_
610904	_	_	_	_	_
609848	_	_	_	_	_
610488	_	_	_	_	_
612888	_	_	_	_	_
609121	_	_	_	_	_
606371	_	_	_	_	_
600074	_	_	_	_	_
604186	_	_	_	_	_
611970	_	_	_	_	_
602395	_	_	_	_	_
610152	_	_	_	_	_
611167	_	_	_	_	_
612467	_	_	_	_	_
605709	_	_	_	_	_
609972	_	_	_	_	_
604130	_	_	_	_	_
610490	_	_	_	_	_
612210	_	_	_	_	_
610979	_	_	_	_	_
611374	_	_	_	_	_
600076	_	_	_	_	_
611972	_	_	_	_	_
611742	_	_	_	_	_
612157	_	_	_	_	_
610157	_	_	_	_	_
612308	_	_	_	_	_
612524	_	_	_	_	_
606372	_	_	_	_	_
605710	_	_	_	_	_
609305	_	_	_	_	_
612043	_	_	_	_	_
611973	_	_	_	_	_
610611	_	_	_	_	_
613344	_	_	_	_	_
610905	_	_	_	_	_
612531	_	_	_	_	_
612468	_	_	_	_	_
609315	_	_	_	_	_
610159	_	_	_	_	_
611216	_	_	_	_	_
611439	_	_	_	_	_
611684	_	_	_	_	_
602396	_	_	_	_	_
609316	_	_	_	_	_
604131	_	_	_	_	_
612314	_	_	_	_	_
613688	_	_	_	_	_
610907	_	_	_	_	_
613813	_	_	_	_	_
164831	_	_	_	_	_
613588	_	_	_	_	_
613427	_	_	_	_	_
611975	_	_	_	_	_
612044	_	_	_	_	_
613346	_	_	_	_	_
609786	_	_	_	_	_
607699	_	_	_	_	_
614100	_	_	_	_	_
611912	_	_	_	_	_
613060	_	_	_	_	_
610614	_	_	_	_	_
614310	_	_	_	_	_
613922	_	_	_	_	_
614216	_	_	_	_	_
613429	_	_	_	_	_
606375	_	_	_	_	_
611743	_	_	_	_	_
604189	_	_	_	_	_
612532	_	_	_	_	_
610160	_	_	_	_	_
613691	_	_	_	_	_
610909	_	_	_	_	_
600077	_	_	_	_	_
612045	_	_	_	_	_
610491	_	_	_	_	_
610104	_	_	_	_	_
613066	_	_	_	_	_
609373	_	_	_	_	_
613923	_	_	_	_	_
609318	_	_	_	_	_
611440	_	_	_	_	_
613430	_	_	_	_	_
609973	_	_	_	_	_
609374	_	_	_	_	_
611217	_	_	_	_	_
605715	_	_	_	_	_
614686	_	_	_	_	_
609322	_	_	_	_	_
610980	_	_	_	_	_
612317	_	_	_	_	_
609788	_	_	_	_	_
612046	_	_	_	_	_
613928	_	_	_	_	_
613590	_	_	_	_	_
611976	_	_	_	_	_
614687	_	_	_	_	_
612533	_	_	_	_	_
611914	_	_	_	_	_
613069	_	_	_	_	_
610105	_	_	_	_	_
613504	_	_	_	_	_
614217	_	_	_	_	_
610615	_	_	_	_	_
604132	_	_	_	_	_
609323	_	_	_	_	_
614767	_	_	_	_	_
613351	_	_	_	_	_
611441	_	_	_	_	_
609974	_	_	_	_	_
611218	_	_	_	_	_
610106	_	_	_	_	_
614981	_	_	_	_	_
610492	_	_	_	_	_
611977	_	_	_	_	_
610616	_	_	_	_	_
612534	_	_	_	_	_
614103	_	_	_	_	_
612211	_	_	_	_	_
612158	_	_	_	_	_
606623	_	_	_	_	_
605716	_	_	_	_	_
614311	_	_	_	_	_
612047	_	_	_	_	_
606376	_	_	_	_	_
604133	_	_	_	_	_
611979	_	_	_	_	_
613431	_	_	_	_	_
609324	_	_	_	_	_
615199	_	_	_	_	_
614768	_	_	_	_	_
615461	_	_	_	_	_
611915	_	_	_	_	_
610617	_	_	_	_	_
610108	_	_	_	_	_
614688	_	_	_	_	_
606624	_	_	_	_	_
604135	_	_	_	_	_
615580	_	_	_	_	_
612320	_	_	_	_	_
609976	_	_	_	_	_
615263	_	_	_	_	_
611685	_	_	_	_	_
606377	_	_	_	_	_
612470	_	_	_	_	_
611219	_	_	_	_	_
614106	_	_	_	_	_
604191	_	_	_	_	_
611916	_	_	_	_	_
605717	_	_	_	_	_
615466	_	_	_	_	_
610981	_	_	_	_	_
614875	_	_	_	_	_
610040	_	_	_	_	_
613356	_	_	_	_	_
614586	_	_	_	_	_
615822	_	_	_	_	_
616020	_	_	_	_	_
615265	_	_	_	_	_
612049	_	_	_	_	_
615581	_	_	_	_	_
614234	_	_	_	_	_
604136	_	_	_	_	_
606625	_	_	_	_	_
612472	_	_	_	_	_
613432	_	_	_	_	_
613505	_	_	_	_	_
610109	_	_	_	_	_
615913	_	_	_	_	_
616122	_	_	_	_	_
613357	_	_	_	_	_
614107	_	_	_	_	_
613184	_	_	_	_	_
616021	_	_	_	_	_
604137	_	_	_	_	_
615275	_	_	_	_	_
611442	_	_	_	_	_
612050	_	_	_	_	_
613081	_	_	_	_	_
610620	_	_	_	_	_
616123	_	_	_	_	_
605718	_	_	_	_	_
606626	_	_	_	_	_
616372	_	_	_	_	_
609325	_	_	_	_	_
614894	_	_	_	_	_
615283	_	_	_	_	_
611221	_	_	_	_	_
613510	_	_	_	_	_
611980	_	_	_	_	_
616023	_	_	_	_	_
615666	_	_	_	_	_
613082	_	_	_	_	_
611917	_	_	_	_	_
613358	_	_	_	_	_
616285	_	_	_	_	_
613185	_	_	_	_	_
615289	_	_	_	_	_
616124	_	_	_	_	_
614313	_	_	_	_	_
615587	_	_	_	_	_
604138	_	_	_	_	_
613433	_	_	_	_	_
614902	_	_	_	_	_
606378	_	_	_	_	_
610623	_	_	_	_	_
616526	_	_	_	_	_
613511	_	_	_	_	_
610983	_	_	_	_	_
613083	_	_	_	_	_
616024	_	_	_	_	_
615467	_	_	_	_	_
609326	_	_	_	_	_
614983	_	_	_	_	_
616288	_	_	_	_	_
616374	_	_	_	_	_
605719	_	_	_	_	_
610985	_	_	_	_	_
616660	_	_	_	_	_
613434	_	_	_	_	_
613512	_	_	_	_	_
611686	_	_	_	_	_
611375	_	_	_	_	_
614903	_	_	_	_	_
612212	_	_	_	_	_
609977	_	_	_	_	_
616375	_	_	_	_	_
606627	_	_	_	_	_
611222	_	_	_	_	_
615469	_	_	_	_	_
606379	_	_	_	_	_
616125	_	_	_	_	_
612052	_	_	_	_	_
610986	_	_	_	_	_
616662	_	_	_	_	_
616593	_	_	_	_	_
614690	_	_	_	_	_
613437	_	_	_	_	_
614235	_	_	_	_	_
616880	_	_	_	_	_
608943	_	_	_	_	_
613186	_	_	_	_	_
609978	_	_	_	_	_
606630	_	_	_	_	_
614693	_	_	_	_	_
615295	_	_	_	_	_
616527	_	_	_	_	_
609327	_	_	_	_	_
611226	_	_	_	_	_
616799	_	_	_	_	_
616594	_	_	_	_	_
612053	_	_	_	_	_
617029	_	_	_	_	_
611981	_	_	_	_	_
614314	_	_	_	_	_
616960	_	_	_	_	_
611227	_	_	_	_	_
609328	_	_	_	_	_
610987	_	_	_	_	_
605721	_	_	_	_	_
614694	_	_	_	_	_
608946	_	_	_	_	_
604140	_	_	_	_	_
616800	_	_	_	_	_
616128	_	_	_	_	_
613090	_	_	_	_	_
615296	_	_	_	_	_
616290	_	_	_	_	_
617215	_	_	_	_	_
614695	_	_	_	_	_
617138	_	_	_	_	_
609329	_	_	_	_	_
614904	_	_	_	_	_
610111	_	_	_	_	_
616961	_	_	_	_	_
609979	_	_	_	_	_
616664	_	_	_	_	_
608947	_	_	_	_	_
615470	_	_	_	_	_
616528	_	_	_	_	_
613359	_	_	_	_	_
604141	_	_	_	_	_
615299	_	_	_	_	_
617216	_	_	_	_	_
609330	_	_	_	_	_
616376	_	_	_	_	_
614697	_	_	_	_	_
611982	_	_	_	_	_
616665	_	_	_	_	_
610112	_	_	_	_	_
617434	_	_	_	_	_
617491	_	_	_	_	_
612054	_	_	_	_	_
617221	_	_	_	_	_
616529	_	_	_	_	_
616802	_	_	_	_	_
609331	_	_	_	_	_
604143	_	_	_	_	_
610115	_	_	_	_	_
606380	_	_	_	_	_
612055	_	_	_	_	_
617367	_	_	_	_	_
617636	_	_	_	_	_
616377	_	_	_	_	_
617307	_	_	_	_	_
605722	_	_	_	_	_
616666	_	_	_	_	_
610041	_	_	_	_	_
614905	_	_	_	_	_
617792	_	_	_	_	_
616962	_	_	_	_	_
616731	_	_	_	_	_
611688	_	_	_	_	_
617139	_	_	_	_	_
614315	_	_	_	_	_
617793	_	_	_	_	_
617716	_	_	_	_	_
613187	_	_	_	_	_
610116	_	_	_	_	_
611983	_	_	_	_	_
617858	_	_	_	_	_
612056	_	_	_	_	_
617492	_	_	_	_	_
617144	_	_	_	_	_
618041	_	_	_	_	_
616804	_	_	_	_	_
615301	_	_	_	_	_
613361	_	_	_	_	_
617309	_	_	_	_	_
616741	_	_	_	_	_
617720	_	_	_	_	_
610161	_	_	_	_	_
617551	_	_	_	_	_
616447	_	_	_	_	_
614236	_	_	_	_	_
606381	_	_	_	_	_
617794	_	_	_	_	_
617147	_	_	_	_	_
615588	_	_	_	_	_
605723	_	_	_	_	_
612057	_	_	_	_	_
618042	_	_	_	_	_
611984	_	_	_	_	_
613362	_	_	_	_	_
617722	_	_	_	_	_
616742	_	_	_	_	_
614703	_	_	_	_	_
617368	_	_	_	_	_
611689	_	_	_	_	_
611229	_	_	_	_	_
610164	_	_	_	_	_
605729	_	_	_	_	_
618043	_	_	_	_	_
616530	_	_	_	_	_
613365	_	_	_	_	_
618297	_	_	_	_	_
612058	_	_	_	_	_
616378	_	_	_	_	_
610042	_	_	_	_	_
612473	_	_	_	_	_
614316	_	_	_	_	_
616964	_	_	_	_	_
610117	_	_	_	_	_
609980	_	_	_	_	_
617369	_	_	_	_	_
617723	_	_	_	_	_
616379	_	_	_	_	_
614769	_	_	_	_	_
617640	_	_	_	_	_
617494	_	_	_	_	_
615472	_	_	_	_	_
612059	_	_	_	_	_
614239	_	_	_	_	_
610118	_	_	_	_	_
616667	_	_	_	_	_
614985	_	_	_	_	_
616965	_	_	_	_	_
611690	_	_	_	_	_
615303	_	_	_	_	_
616805	_	_	_	_	_
614240	_	_	_	_	_
613188	_	_	_	_	_
616448	_	_	_	_	_
614704	_	_	_	_	_
616966	_	_	_	_	_
617645	_	_	_	_	_
617859	_	_	_	_	_
614906	_	_	_	_	_
618408	_	_	_	_	_
610165	_	_	_	_	_
606383	_	_	_	_	_
617310	_	_	_	_	_
615475	_	_	_	_	_
617495	_	_	_	_	_
614771	_	_	_	_	_
617646	_	_	_	_	_
612060	_	_	_	_	_
616743	_	_	_	_	_
615477	_	_	_	_	_
616533	_	_	_	_	_
617148	_	_	_	_	_
614907	_	_	_	_	_
618409	_	_	_	_	_
614705	_	_	_	_	_
617860	_	_	_	_	_
617311	_	_	_	_	_
609982	_	_	_	_	_
617647	_	_	_	_	_
606385	_	_	_	_	_
617795	_	_	_	_	_
611230	_	_	_	_	_
613366	_	_	_	_	_
618137	_	_	_	_	_
617496	_	_	_	_	_
612061	_	_	_	_	_
618411	_	_	_	_	_
617648	_	_	_	_	_
613189	_	_	_	_	_
614708	_	_	_	_	_
609983	_	_	_	_	_
616745	_	_	_	_	_
613367	_	_	_	_	_
614986	_	_	_	_	_
617861	_	_	_	_	_
610166	_	_	_	_	_
617149	_	_	_	_	_
617724	_	_	_	_	_
611231	_	_	_	_	_
612062	_	_	_	_	_
616450	_	_	_	_	_
616536	_	_	_	_	_
617312	_	_	_	_	_
617797	_	_	_	_	_
614709	_	_	_	_	_
612476	_	_	_	_	_
617371	_	_	_	_	_
616746	_	_	_	_	_
615594	_	_	_	_	_
612063	_	_	_	_	_
615478	_	_	_	_	_
617725	_	_	_	_	_
614241	_	_	_	_	_
617801	_	_	_	_	_
610043	_	_	_	_	_
617726	_	_	_	_	_
616129	_	_	_	_	_
616453	_	_	_	_	_
609984	_	_	_	_	_
617649	_	_	_	_	_
615479	_	_	_	_	_
616670	_	_	_	_	_
612477	_	_	_	_	_
617727	_	_	_	_	_
610046	_	_	_	_	_
615600	_	_	_	_	_
617497	_	_	_	_	_
617650	_	_	_	_	_
611232	_	_	_	_	_
608948	_	_	_	_	_
617372	_	_	_	_	_
616130	_	_	_	_	_
#MIM_Number	Location	Phenotype	Phenotype_MIM_number	Inheritance	Phenotype_mapping_key
100650	12q24.12	Alcohol sensitivity, acute	610251	AD	3
100650	12q24.12	{Esophageal cancer, alcohol-related, susceptibility to}	_	_	3
100650	12q24.12	{Hangover, susceptibility to}	610251	AD	3
100650	12q24.12	{Sublingual nitroglycerin, susceptibility to poor response to}	_	_	3
100070	19q13	Aortic aneurysm, familial abdominal 1	100070	AD	2
100100	1q43	?Prune belly syndrome	100100	AR	3
100300	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
100678	6q25.3	?ACAT2 deficiency	614055	IC	1
100690	2q31.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100690	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
100690	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AD,AR	3
100710	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
100710	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
100720	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100720	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AD,AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
100730	2q37.1	Escobar syndrome	265000	AR	3
100730	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100740	7q22.1	[Blood group, Yt system]	112100	_	3
100790	12q23.2	Central hypoventilation syndrome, congenital	209880	AD	3
100790	12q23.2	Haddad syndrome	209880	AD	3
100800	4p16.3	Achondroplasia	100800	AD	3
100850	22q13.2	?Optic atrophy 9	616289	AR	3
100850	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
101000	22q12.2	Neurofibromatosis, type 2	101000	AD	3
101200	10q26.13	Apert syndrome	101200	AD	3
101800	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
101850	2p25-p12	?Keratoderma, palmoplantar, punctate type 3	101850	AD	2
101900	12q24.11	Acrokeratosis verruciformis	101900	AD	3
102300	12q12-q21	{Restless legs syndrome 1}	102300	AD	2
102370	15q21.1	Acromicric dysplasia	102370	AD	3
102480	22q13.33	?Male infertility due to acrosin deficiency	102480	_	2
102500	1p12	Hajdu-Cheney syndrome	102500	AD	3
102510	2q36	Acropectorovertebral dysplasia	102510	AD	2
102530	3q26.31	?Spermatogenic failure 6	102530	AR	3
102540	15q14	Atrial septal defect 5	612794	AD	3
102540	15q14	Cardiomyopathy, dilated, 1R	613424	AD	3
102540	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
102540	15q14	Left ventricular noncompaction 4	613424	AD	3
102545	2p13.1	Visceral myopathy	155310	AD	3
102560	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
102560	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
102565	7q32.1	Cardiomyopathy, familial hypertrophic, 26	_	_	3
102565	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
102565	7q32.1	Myopathy, distal, 4	614065	AD	3
102565	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
102573	1q43	Cardiomyopathy, dilated, 1AA, with or without LVNC	612158	AD	3
102573	1q43	Cardiomyopathy, hypertrophic, 23, with or without LVNC	612158	AD	3
102574	11q13.2	[Alpha-actinin-3 deficiency]	617749	_	3
102574	11q13.2	[Sprinting performance]	617749	_	3
102575	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
102576	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
102578	15q24.1	Leukemia, acute promyelocytic, PML/RARA type	_	_	3
102579	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
102582	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
102582	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
102600	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
102610	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
102610	1q42.13	Myopathy, actin, congenital, with cores	161800	AD,AR	3
102610	1q42.13	Myopathy, actin, congenital, with excess of thin myofilaments	161800	AD,AR	3
102610	1q42.13	Myopathy, congenital, with fiber-type disproportion 1	255310	AD,AR	3
102610	1q42.13	Nemaline myopathy 3, autosomal dominant or recessive	161800	AD,AR	3
102620	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
102620	10q23.31	Moyamoya disease 5	614042	_	3
102620	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
102630	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
102630	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
102680	4p16.3	{Hypertension, essential, salt-sensitive}	145500	Mu	3
102750	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
102770	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
102771	1p13.3	?Spastic paraplegia 63	615686	AR	3
102771	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
102772	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
102900	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
103000	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
103020	1p35.1	Reticular dysgenesis	267500	AR	3
103050	22q13.1	Adenylosuccinase deficiency	103050	AR	3
103072	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
103180	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
103220	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
103270	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
103280	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
103280	11p15.5	Silver-Russell syndrome	180860	AD	3
103280	11p15.5	Wilms tumor 2	194071	AD,SMu	3
103285	3q28	ADULT syndrome	103285	AD	3
103320	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
103500	3p13	Tietz albinism-deafness syndrome	103500	AD	3
103580	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
103600	4q13.3	Analbuminemia	616000	_	3
103600	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
103720	4q23	{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}	103780	Mu	3
103720	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
103850	16p11.2	Glycogen storage disease XII	611881	AR	3
103900	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
103950	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
103950	12p13.31	{Alzheimer disease, susceptibility to}	104300	AD	3
104000	18p11.3-p11.2	Alopecia areata 1	104000	Mu	2
104100	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
104150	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
104150	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
104155	16q22.2-q22.3	Prostate cancer, somatic	176807	_	3
104160	11q12.3	Polycystic kidney disease 3	600666	AD	3
104170	22q13.2	Kanzaki disease	609242	AR	3
104170	22q13.2	Schindler disease, type I	609241	AR	3
104170	22q13.2	Schindler disease, type III	609241	AR	3
104200	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
104225	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
104250	4p16.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
104260	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
104290	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
104310	19q13.32	Alzheimer disease-2	104310	AD	3
104311	14q24.2	?Acne inversa, familial, 3	613737	AD	3
104311	14q24.2	Alzheimer disease, type 3	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	AD	3
104311	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
104311	14q24.2	Dementia, frontotemporal	600274	AD	3
104311	14q24.2	Pick disease	172700	AD	3
104500	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
104510	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
104530	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
104614	2p21	Cystinuria	220100	AD,AR	3
104620	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
104760	21q21.3	Alzheimer disease 1, familial	104300	AD	3
104760	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
104770	1q23.2	{?Amyloidosis, secondary, susceptibility to}	_	_	1
105120	9q33.2	Amyloidosis, Finnish type	105120	AD	3
105150	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
105210	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
105250	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
105500	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
105550	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
105580	11q22-qter	?Anal canal carcinoma	105580	AD	2
105590	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
105600	15q21	Dyserythropoietic anemia, congenital, type III	105600	AD	2
105650	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
105800	7q11.2	Aneurysm, intracranial berry, 1	105800	AD	2
105830	15q11.2	Angelman syndrome	105830	AD	3
105850	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
106100	11q12.1	Angioedema, hereditary, types I and II	106100	AD,AR	3
106150	1q42.2	Renal tubular dysgenesis	267430	AR	3
106150	1q42.2	{Hypertension, essential, susceptibility to}	145500	Mu	3
106150	1q42.2	{Preeclampsia, susceptibility to}	_	_	3
106165	3q24	Renal tubular dysgenesis	267430	AR	3
106165	3q24	{Hypertension, essential}	145500	Mu	3
106180	17q23.3	Renal tubular dysgenesis	267430	AR	3
106180	17q23.3	[Angiotensin I-converting enzyme, benign serum increase]	_	_	3
106180	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
106180	17q23.3	{Myocardial infarction, susceptibility to}	_	_	3
106180	17q23.3	{SARS, progression of}	_	_	3
106180	17q23.3	{Stroke, hemorrhagic}	614519	_	3
106190	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
106260	3q28	Hay-Wells syndrome	106260	AD	3
106300	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
106410	4q25-q26	Cardiac arrhythmia, ankyrin-B-related	600919	AD	3
106410	4q25-q26	Long QT syndrome 4	600919	AD	3
106600	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
106700	4q12	Total anomalous pulmonary venous return	106700	AD	2
107200	18p11.23-q12.2	Anosmia, isolated congenital	107200	AD	2
107250	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
107265	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
107269	11p13	[Blood group, Indian system]	609027	_	3
107271	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
107280	14q32.13	Alpha-1-antichymotrypsin deficiency	_	_	3
107280	14q32.13	Cerebrovascular disease, occlusive	_	_	3
107300	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AD,AR	3
107310	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
107320	6p21.3	?Antiphospholipid syndrome, familial	107320	AD	2
107323	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
107400	14q32.13	Emphysema due to AAT deficiency	613490	AR	3
107400	14q32.13	Emphysema-cirrhosis, due to AAT deficiency	613490	AR	3
107400	14q32.13	Hemorrhagic diathesis due to antithrombin Pittsburgh	613490	AR	3
107400	14q32.13	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	1
107470	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
107470	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
107470	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
107470	6q23.3	{Hepatitis B virus infection, susceptibility to}	610424	_	3
107470	6q23.3	{Tuberculosis infection, protection against}	607948	_	3
107470	6q23.3	{Tuberculosis, susceptibility to}	607948	_	3
107580	6p24.3	Branchiooculofacial syndrome	113620	AD	3
107600	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
107670	1q23.3	Apolipoprotein A-II deficiency	_	_	3
107670	1q23.3	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
107680	11q23.3	Amyloidosis, 3 or more types	105200	AD	3
107680	11q23.3	ApoA-I and apoC-III deficiency, combined	_	_	3
107680	11q23.3	Corneal clouding, autosomal recessive	_	_	3
107680	11q23.3	Hypoalphalipoproteinemia	604091	_	3
107720	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
107730	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
107730	2p24.1	Hypobetalipoproteinemia	615558	AR	3
107741	19q13.32	Alzheimer disease-2	104310	AD	3
107741	19q13.32	Hyperlipoproteinemia, type III	617347	_	3
107741	19q13.32	Lipoprotein glomerulopathy	611771	_	3
107741	19q13.32	Sea-blue histiocyte disease	269600	AR	3
107741	19q13.32	{?Macular degeneration, age-related}	603075	AD	3
107741	19q13.32	{Coronary artery disease, severe, susceptibility to}	617347	_	3
107770	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
107773	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
107776	7p14.3	[Aquaporin-1 deficiency]	110450	_	3
107776	7p14.3	[Blood group, Colton]	110450	_	3
107777	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
107820	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
107910	15q21.2	Aromatase deficiency	613546	_	3
107910	15q21.2	Aromatase excess syndrome	139300	AD	3
107930	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
107970	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
108145	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
108300	12q13.11	Stickler syndrome, type I	108300	AD	3
108370	7q21.3	Asparagine synthetase deficiency	615574	AR	3
108420	Chr.1	Spermatogenic failure 2	108420	AD	2
108500	19p13.13	Episodic ataxia, type 2	108500	AD	3
108600	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
108720	3p14.3	Atelosteogenesis, type I	108720	AD	3
108721	3p14.3	Atelosteogenesis, type III	108721	AD	3
108725	19p13.3-p13.2	{Atherosclerosis, susceptibility to}	108725	AD	2
108730	16p11.2	Brody myopathy	601003	AR	3
108733	3p25.3	{Deafness, autosomal recessive 12, modifier of}	601386	AR	3
108740	12q24.11	Acrokeratosis verruciformis	101900	AD	3
108740	12q24.11	Darier disease	124200	AD	3
108746	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
108770	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
108780	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
108780	1p36.22	Atrial standstill 2	615745	AR	3
108800	5p	Atrial septal defect 1	108800	AD	2
108900	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
108961	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
108961	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
108961	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
108962	5p13.3	?Hypertension, salt-resistant	_	_	1
108985	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
109091	19p13.13	Myelofibrosis, somatic	254450	_	3
109091	19p13.13	Thrombocythemia, somatic	187950	_	3
109150	14q32.12	Machado-Joseph disease	109150	AD	3
109200	3q26	Alopecia, androgenetic, 1	109200	AD	2
109270	17q21.31	Cryohydrocytosis	185020	AD	3
109270	17q21.31	Ovalocytosis, SA type	166900	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
109270	17q21.31	Spherocytosis, type 4	612653	AD	3
109270	17q21.31	[Blood group, Diego]	110500	_	3
109270	17q21.31	[Blood group, Froese]	601551	_	3
109270	17q21.31	[Blood group, Swann]	601550	_	3
109270	17q21.31	[Blood group, Waldner]	112010	_	3
109270	17q21.31	[Blood group, Wright]	112050	_	3
109270	17q21.31	[Malaria, resistance to]	611162	_	3
109350	13q14	Gastroesophageal reflux	109350	AD	2
109480	19p13.3	[Blood group, OK]	111380	_	3
109535	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
109543	13q14	{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	AD	2
109560	19q13.32	Leukemia/lymphoma, B-cell, 3	109560	_	2
109565	3q27.3	Lymphoma, B-cell	109565	_	2
109630	10q25.3	[Resting heart rate]	607276	_	3
109630	10q25.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
109690	5q32	Beta-2-adrenoreceptor agonist, reduced response to	_	_	3
109690	5q32	{Asthma, nocturnal, susceptibility to}	600807	AD	3
109690	5q32	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109691	8p11.23	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109700	15q21.1	?Amyloidosis, familial visceral	105200	AD	3
109700	15q21.1	Immunodeficiency 43	241600	AR	3
109720	3p12-q13.2	Biliary cirrhosis, primary, 1	109720	AD	2
109730	9q34.3	Aortic valve disease 1	109730	AD	3
109750	7p13	Hyperbiliverdinemia	614156	AD,AR	3
109760	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
110300	9q34.2	[Blood group, ABO system]	616093	_	3
110500	17q21.31	[Blood group, Diego]	110500	_	3
110600	12p12.3	[Blood group, Dombrock]	616060	_	3
110700	1q23.2	[Blood group, Duffy system]	110700	AD,AR	3
110750	2q14.3	[Blood group, Gerbich]	616089	_	3
110750	2q14.3	{Malaria, resistance to}	611162	_	3
110900	7q34	[Blood group, Kell]	110900	_	3
111000	18q12.3	[Blood group, Kidd]	111000	_	3
111100	19p13.3	[Blood group, Lewis]	_	_	3
111150	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
111250	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
111300	4q31.21	[Blood group, MNSs system]	111300	_	3
111380	19p13.3	[Blood group, OK]	111380	_	3
111600	2q35	[Blood group, Langereis system]	111600	_	3
111620	1p34.2	[Blood group, Radin]	111620	_	3
111680	1p36.11	[Rh-negative blood type]	_	_	3
111700	1p36.11	Rh-null disease, amorph type	617970	_	3
111700	1p36.11	[Blood group, Rhesus]	_	_	3
111740	4q31.21	[Blood group, Ss]	111740	_	3
111750	1p34.2	[Blood group, Scianna system]	111750	_	3
111800	4q28-q31	[Blood group, Stoltzfus system]	111800	_	2
112010	17q21.31	[Blood group, Waldner]	112010	_	3
112050	17q21.31	[Blood group, Wright]	112050	_	3
112100	7q22.1	[Blood group, Yt system]	112100	_	3
112205	19q13.2	Agammaglobulinemia 3	613501	AR	3
112210	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
112240	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
112250	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
112261	20p12.3	Brachydactyly, type A2	112600	AD	3
112261	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
112261	20p12.3	{HFE hemochromatosis, modifier of}	235200	AR	3
112262	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
112262	14q22.2	Orofacial cleft 11	600625	_	3
112264	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
112310	3p14.3	Boomerang dysplasia	112310	AD	3
112410	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
112500	2q35	Brachydactyly, type A1	112500	AD	3
113000	9q22.31	Brachydactyly, type B1	113000	AD	3
113100	20q11.22	Brachydactyly, type C	113100	AD	3
113200	2q31.1	Brachydactyly, type D	113200	AD	3
113300	2q31.1	Brachydactyly, type E	113300	AD	3
113500	12q24.11	Brachyolmia type 3	113500	AD	3
113520	12p12.1	?Hyperleucinemia-isoleucinemia or hypervalinemia	_	_	1
113530	19q13.33	?Hypervalinemia or hyperleucine-isoleucinemia	_	_	1
113620	6p24.3	Branchiooculofacial syndrome	113620	AD	3
113650	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
113705	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
113705	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	AD,Mu	3
113705	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
113721	17p13.3	Breast cancer	_	_	1
113810	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
113810	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, localisata variant	226650	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
113811	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
113970	8q24.21	Burkitt lymphoma, somatic	113970	_	3
114000	17q21.33	Caffey disease	114000	AD	3
114010	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
114019	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
114021	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
114021	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
114025	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
114078	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
114078	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
114090	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
114105	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
114105	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
114131	7q21.3	{Osteoporosis, postmenopausal, susceptibility}	166710	AD	3
114180	14q32.11	Long QT syndrome 14	616247	AD	3
114180	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
114182	2p21	Long QT syndrome 15	616249	AD	3
114200	3q11.2-q13.12	Camptodactyly 1	114200	AD	2
114205	12p13.33	Brugada syndrome 3	611875	_	3
114205	12p13.33	Long QT syndrome 8	618447	_	3
114205	12p13.33	Timothy syndrome	601005	AD	3
114206	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
114206	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
114208	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
114208	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
114208	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
114220	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
114250	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
114251	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
114300	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
114350	9q34.13	Leukemia, acute myeloid, somatic	601626	_	3
114350	9q34.13	Leukemia, T-cell acute lymphoblastic, somatic	613065	_	3
114350	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
114580	2p22.3-p21	Candidiasis, familial, 1, autosomal dominant	114580	AD	2
114760	17q23.1	Retinitis pigmentosa 17	600852	AD	3
114761	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
114815	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
114835	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
114840	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
115080	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
115150	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
115195	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
115196	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
115197	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
115200	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
115210	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
115300	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
115310	1p36.13	Paragangliomas 4	115310	AD	3
115430	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
115440	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
115470	22q11	Cat eye syndrome	115470	AD	4
115500	11p13	Acatalasemia	614097	_	3
115501	9p23	Albinism, oculocutaneous, type III	203290	AR	3
115501	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
115650	14q22-q23	Cataract 32, multiple types	115650	AD	2
115660	17q24	Cataract 7	115660	AD	2
115665	1pter-p36.13	Cataract 8, multiple types	115665	AD	2
115700	2q33.3	Cataract 4, multiple types	115700	AD	3
115800	2pter-p24	Cataract 29, coralliform	115800	AD	2
115900	2q35	?Cataract 42	115900	AD	3
116100	3q27.3	Cataract 20, multiple types	116100	AD	3
116200	1q21.2	Cataract 1, multiple types	116200	AD	3
116300	10p13	Cataract 30, pulverulent	116300	AD	3
116400	4p16.1	?Cataract 41	116400	AD	3
116600	1p36.13	Cataract 6, multiple types	116600	AD	3
116700	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
116790	22q11.21	{Panic disorder, susceptibility to}	167870	?AD	3
116790	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
116800	16q22.1	Cataract 5, multiple types	116800	AD	3
116805	5q31.2	Macular dystrophy, patterned, 2	608970	AD	3
116806	3p22.1	Colorectal cancer, somatic	114500	_	3
116806	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
116806	3p22.1	Hepatocellular carcinoma, somatic	114550	_	3
116806	3p22.1	Medulloblastoma, somatic	155255	_	3
116806	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
116806	3p22.1	Ovarian cancer, somatic	167000	_	3
116806	3p22.1	Pilomatricoma, somatic	132600	_	3
116810	8p23.1	Keratolytic winter erythema	148370	AD	4
116840	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
116896	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
116897	19q13.11	?Leukemia, acute myeloid	601626	AD,SMu	3
116897	19q13.11	Leukemia, acute myeloid, somatic	601626	_	3
116920	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
116945	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
116952	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
116955	3q21.3	Myotonic dystrophy 2	602668	AD	3
117100	11p13	Centrotemporal epilepsy	117100	IC	2
117143	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
117210	16q21	Spinocerebellar ataxia 31	117210	AD	3
117300	13q14.2	Dementia, familial Danish	117300	AD	3
117360	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
117550	5q35.3	Sotos syndrome 1	117550	AD	3
117650	20p13	Cerebrocostomandibular syndrome	117650	AD	3
117700	3q24-q25	Cerebellar ataxia	604290	AR	3
117700	3q24-q25	Hemosiderosis, systemic, due to aceruloplasminemia	604290	AR	3
117700	3q24-q25	[Hypoceruloplasminemia, hereditary]	604290	AR	3
118100	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
118190	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
118190	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
118200	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
118210	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
118220	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
118300	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
118400	4p16.3	Cherubism	118400	AD	3
118423	2q31.1	Duane retraction syndrome 2	604356	_	3
118425	7q34	Myotonia congenita, dominant	160800	AD	3
118425	7q34	Myotonia congenita, recessive	255700	AR	3
118425	7q34	Myotonia levior, recessive	_	_	3
118450	20p12.2	Alagille syndrome 1	118450	AD	3
118470	16q13	Hyperalphalipoproteinemia	143470	AD	3
118470	16q13	[High density lipoprotein cholesterol level QTL 10]	143470	AD	3
118485	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
118490	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
118494	1q43	?Prune belly syndrome	100100	AR	3
118502	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
118503	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118504	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
118504	20q13.33	{Nicotine addiction, susceptibility to}	188890	_	3
118505	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118505	15q25.1	{Nicotine dependence, susceptibility to}	612052	_	3
118507	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
118600	5p15.2	Chondrocalcinosis 2	118600	AD	3
118661	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
118700	14q13.3	Chorea, hereditary benign	118700	AD	3
118800	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
118955	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
119100	1q42.2-q43	Split-hand/foot malformation with long bone deficiency 1	119100	AD	2
119300	1q32.2	van der Woude syndrome	119300	AD	3
119500	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
119530	6p24.3	Orofacial cleft-1	119530	AD	2
119580	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
119800	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
119900	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
120070	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120070	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
120070	2q36.3	Hematuria, benign familial	141200	AD	3
120080	7q21.12	{Colchicine resistance}	120080	_	3
120090	13q34	Brain small vessel disease 2	614483	AD	3
120090	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120100	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
120110	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
120120	3p21.31	EBD inversa	226600	AR	3
120120	3p21.31	EBD, Bart type	132000	AD	3
120120	3p21.31	EBD, localisata variant	_	_	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AR	226600	AR	3
120120	3p21.31	Epidermolysis bullosa pruriginosa	604129	AD,AR	3
120120	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
120120	3p21.31	Toenail dystrophy, isolated	607523	AD	3
120120	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
120130	13q34	?Retinal arteries, tortuosity of	180000	AD	3
120130	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
120130	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
120130	13q34	Schizencephaly	269160	_	3
120130	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120131	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120131	2q36.3	Hematuria, familial benign	141200	AD	3
120140	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
120140	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
120140	12q13.11	Czech dysplasia	609162	AD	3
120140	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
120140	12q13.11	Kniest dysplasia	156550	AD	3
120140	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
120140	12q13.11	Osteoarthritis with mild chondrodysplasia	604864	AD	3
120140	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
120140	12q13.11	SED congenita	183900	AD	3
120140	12q13.11	SMED Strudwick type	184250	AD	3
120140	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
120140	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
120140	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
120140	12q13.11	Stickler syndrome, type I	108300	AD	3
120140	12q13.11	Vitreoretinopathy with phalangeal epiphyseal dysplasia	_	_	3
120150	17q21.33	Caffey disease	114000	AD	3
120150	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
120150	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
120150	17q21.33	Osteogenesis imperfecta, type II	166210	AD	3
120150	17q21.33	Osteogenesis imperfecta, type III	259420	AD	3
120150	17q21.33	Osteogenesis imperfecta, type IV	166220	AD	3
120150	17q21.33	{Bone mineral density variation QTL, osteoporosis}	166710	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
120160	7q21.3	Osteogenesis imperfecta, type II	166210	AD	3
120160	7q21.3	Osteogenesis imperfecta, type III	259420	AD	3
120160	7q21.3	Osteogenesis imperfecta, type IV	166220	AD	3
120160	7q21.3	{Osteoporosis, postmenopausal}	166710	AD	3
120180	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
120180	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
120190	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
120200	11p13	?Coloboma, ocular	120200	AD	3
120210	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
120210	6q13	Stickler syndrome, type IV	614134	_	3
120215	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
120220	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120220	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120240	21q22.3	?Myosclerosis, congenital	255600	AR	3
120240	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120240	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120250	2q37.3	Bethlem myopathy 1	158810	AD,AR	3
120250	2q37.3	Dystonia 27	616411	AR	3
120250	2q37.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120252	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
120252	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
120260	1p34.2	?Stickler syndrome, type V	614284	AR	3
120260	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
120270	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
120270	20q13.33	{Intervertebral disc disease, susceptibility to}	603932	_	3
120280	1p21.1	Fibrochondrogenesis 1	228520	AR	3
120280	1p21.1	Marshall syndrome	154780	AD	3
120280	1p21.1	Stickler syndrome, type II	604841	AD	3
120280	1p21.1	{Lumbar disc herniation, susceptibility to}	603932	_	3
120290	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
120290	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
120290	6p21.32	Fibrochondrogenesis 2	614524	AD,AR	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
120320	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
120320	6q13-q14	Bethlem myopathy 2	616471	AD	3
120328	21q22.3	Knobloch syndrome, type 1	267750	AR	3
120330	10q24.31	Papillorenal syndrome	120330	AD	3
120350	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
120353	11q22.2	COPD, rate of decline of lung function in	606963	_	3
120353	11q22.2	{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}	226600	AR	3
120360	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
120361	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
120433	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
120435	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
120436	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
120436	3p22.2	Mismatch repair cancer syndrome	276300	AR	3
120436	3p22.2	Muir-Torre syndrome	158320	AD	3
120470	18q21.2	Colorectal cancer, somatic	114500	_	3
120470	18q21.2	Esophageal carcinoma, somatic	133239	_	3
120470	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
120470	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
120502	1q31	Branchiootic syndrome 2	120502	AD	2
120520	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
120520	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AD,AR	3
120550	1p36.12	C1q deficiency	613652	AR	3
120570	1p36.12	C1q deficiency	613652	AR	3
120575	1p36.12	C1q deficiency	613652	AR	3
120580	12p13.31	C1s deficiency	613783	_	3
120580	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
120620	1q32.2	CR1 deficiency	_	_	1
120620	1q32.2	[Blood group, Knops system]	607486	_	3
120620	1q32.2	{?SLE susceptibility}	_	_	1
120620	1q32.2	{Malaria, severe, resistance to}	611162	_	3
120650	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
120650	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
120700	19p13.3	C3 deficiency	613779	AR	3
120700	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
120700	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
120790	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
120810	6p21.33	C4a deficiency	614380	AR	3
120810	6p21.33	[Blood group, Rodgers]	614374	_	3
120820	6p21.33	C4B deficiency	614379	_	3
120900	9q33.2	C5 deficiency	609536	_	3
120900	9q33.2	[Eculizumab, poor response to]	615749	AD	3
120920	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AD,AR	3
120940	5p13.1	C9 deficiency	613825	_	3
120940	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
120950	1p32.2	C8 deficiency, type I	613790	AR	3
120960	1p32.2	C8 deficiency, type II	613789	AR	3
120970	19q13.33	Cone-rod retinal dystrophy-2	120970	AD	3
121011	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
121011	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
121011	13q12.11	Deafness, autosomal recessive 1A	220290	AR	3
121011	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
121011	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
121011	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
121011	13q12.11	Vohwinkel syndrome	124500	AD	3
121013	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
121013	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
121014	6q22.31	Atrioventricular septal defect 3	600309	AD	3
121014	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
121014	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
121014	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
121014	6q22.31	Oculodentodigital dysplasia	164200	AD	3
121014	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
121014	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
121014	6q22.31	Syndactyly, type III	186100	AD	3
121015	13q12.11	Cataract 14, multiple types	601885	AD	3
121050	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
121201	8q24.22	Seizures, benign neonatal, 2	121201	AD	3
121210	8q13-q21	Febrile seizures, familial, 1	121210	AD	2
121360	16q22.1	Myeloid leukemia, acute, M4/M4Eo subtype, somatic	601626	_	1
121400	12q21.33	Cornea plana 1, autosomal dominant	121400	AD	2
121800	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
121820	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
121850	2q34	Corneal fleck dystrophy	121850	AD	3
121900	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
122000	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
122200	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
122400	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
122470	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
122500	14q32.13	Corticosteroid-binding globulin deficiency	611489	AD,AR	3
122600	16p11.2	Spondylocostal dysostosis 5	122600	AD,AR	3
122720	19q13.2	Coumarin resistance	122700	AD	3
122720	19q13.2	{Lung cancer, resistance to}	211980	AD,SMu	3
122720	19q13.2	{Nicotine addiction, protection from}	188890	_	3
122860	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
122880	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
123000	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
123100	7p21.1	Craniosynostosis 1	123100	AD	3
123101	5q35.2	Craniosynostosis 2	604757	AD	3
123101	5q35.2	Parietal foramina 1	168500	AD	3
123101	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
123155	8q12.2-q21.2	?Hydrocephalus, autosomal dominant	123155	AD	2
123270	14q32	[Creatine kinase, brain type, ectopic expression of]	123270	_	2
123320	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
123500	10q26.13	Crouzon syndrome	123500	AD	3
123570	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
123580	21q22.3	Cataract 9, multiple types	604219	AD,AR	3
123590	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
123590	11q23.1	Cataract 16, multiple types	613763	AD,AR	3
123590	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
123590	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
123610	17q11.2	Cataract 10, multiple types	600881	AD	3
123620	22q11.23	Cataract 3, multiple types	601547	AD	3
123630	22q11.23	Cataract 22	609741	AD,AR	3
123631	22q12.1	Cataract 23	610425	_	3
123670	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
123680	2q33.3	Cataract 2, multiple types	604307	AD	3
123690	2q33.3	Cataract 4, multiple types	115700	AD	3
123695	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
123700	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
123730	3q27.3	Cataract 20, multiple types	116100	AD	3
123740	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
123790	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
123805	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
123810	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
123825	4p12	Retinitis pigmentosa 49	613756	_	3
123829	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
123831	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
123833	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
123841	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
123860	1p34.2	Immunodeficiency 24	615897	AR	3
123870	11q13.1	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
123889	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
123889	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
123890	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
123890	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
123890	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
123890	2q33.2	{Hashimoto thyroiditis}	140300	AD	3
123890	2q33.2	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
123930	19q13.2	Efavirenz, poor metabolism of	614546	_	3
123930	19q13.2	{Efavirenz central nervous system toxicity, susceptibility to}	614546	_	3
123940	12q13.13	White sponge nevus 1	193900	AD	3
123970	7p15.3	Thrombocytopenia 4	612004	AD	3
123980	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
124000	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
124015	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
124015	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
124020	10q23.33	Clopidogrel, impaired responsiveness to	609535	AR	3
124020	10q23.33	Mephenytoin poor metabolizer	609535	AR	3
124020	10q23.33	Omeprazole poor metabolizer	609535	AR	3
124020	10q23.33	Proguanil poor metabolizer	609535	AR	3
124030	22q13.2	{Codeine sensitivity}	608902	AR	3
124030	22q13.2	{Debrisoquine sensitivity}	608902	AR	3
124080	8q24.3	Aldosterone to renin ratio raised	_	_	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
124080	8q24.3	{Low renin hypertension, susceptibility to}	_	_	3
124089	19q13.12	Mitochondrial complex IV deficiency	220110	Mi,AR	3
124092	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
124092	1q32.1	{HIV-1, susceptibility to}	609423	_	3
124092	1q32.1	{Rheumatoid arthritis, progression of}	180300	_	3
124200	12q24.11	Darier disease	124200	AD	3
124480	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
124500	13q12.11	Vohwinkel syndrome	124500	AD	3
124900	5q31.3	Deafness, autosomal dominant 1	124900	AD	3
125240	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
125240	1q32.2	[Blood group Cromer]	613793	AR	3
125250	3q29	Optic atrophy plus syndrome	125250	AD	3
125255	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
125264	6p22.3	Leukemia, acute nonlymphocytic	125264	_	2
125270	9q32	Porphyria, acute hepatic	612740	AR	3
125270	9q32	{Lead poisoning, susceptibility to}	612740	AR	3
125310	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
125350	3p21.31	Failure of tooth eruption, primary	125350	AD	3
125370	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
125400	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
125420	4q22.1	Dentin dysplasia, type II	125420	AD	3
125480	18p	{Major affective disorder 1}	125480	AD	2
125485	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
125485	4q22.1	Dentin dysplasia, type II	125420	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125490	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125500	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125505	16p13.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
125520	22q11	Cayler cardiofacial syndrome	125520	AD	2
125595	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
125630	19p13.12	Vibratory urticaria	125630	AD	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11	610476	AD,AR	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	AD,AR	3
125647	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
125647	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
125647	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
125647	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
125647	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
125647	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
125660	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
125660	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
125660	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
125670	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
125670	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
125671	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
125671	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
125700	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
125800	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
125850	20q13.12	MODY, type I	125850	AD	3
125851	7p13	MODY, type II	125851	AD	3
125852	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
125860	16q22.1	{Benzene toxicity, susceptibility to}	_	_	3
125860	16q22.1	{Breast cancer, poor survival after chemotherapy for}	_	_	3
125860	16q22.1	{Leukemia, post-chemotherapy, susceptibility to}	_	_	3
126060	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
126063	14q24.3	Paragangliomas 7	618475	AD	3
126064	16q22.2	Miller syndrome	263750	AR	3
126065	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
126090	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
126141	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
126141	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
126150	5q31.3	{Diphtheria, susceptibility to}	_	_	1
126340	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
126340	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
126340	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
126375	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
126375	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
126380	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
126420	20q12	DNA topoisomerase I, camptothecin-resistant	_	_	3
126430	17q21.2	DNA topoisomerase II, resistance to inhibition of, by amsacrine	_	_	3
126451	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
126451	3q13.31	{Schizophrenia, susceptibility to}	181500	AD	3
126452	11p15.5	Autonomic nervous system dysfunction	_	_	3
126452	11p15.5	[Novelty seeking personality]	601696	?AD	1
126452	11p15.5	{Attention deficit-hyperactivity disorder}	143465	AD	3
126453	4p16.1	{Attention deficit-hyperactivity disorder, susceptibility to}	143465	AD	3
126453	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
126455	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
126455	5p15.33	{Nicotine dependence, protection against}	188890	_	3
126600	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
126650	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
126700	1q31.3	Basal laminar drusen	126700	AD	3
126800	8q13	Duane retraction syndrome 1	126800	AD	2
126900	16q11.1-q22	Dupuytren contracture 1	126900	AD	2
127000	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
127400	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
127500	6q24.2-q25.2	Dyschromatosis universalis hereditaria 1	127500	AD	2
127550	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
127600	4q35	Dyskeratosis, hereditary benign intraepithelial	127600	AD	2
127700	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
128100	9q34.11	Dystonia-1, torsion	128100	AD	3
128101	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
128200	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
128230	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
128235	19q13.2	Dystonia-12	128235	AD	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
128260	1q32.1	Hypotrichosis 11	615059	AD	3
128700	8q11.1-q13.3	?Preauricular fistulae, congenital	128700	AD	2
129010	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
129010	10q21.3	Dejerine-Sottas disease	145900	AD,AR	3
129010	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AD,AR	3
129190	6q14.3	Calcification of joints and arteries	211800	AR	3
129200	4q22.3	Basan syndrome	129200	AD	3
129400	3q28	Rapp-Hodgkin syndrome	129400	AD	3
129490	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
129500	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
129600	15q21.1	Ectopia lentis, familial	129600	AD	3
129900	7q11.2-q21.3	?EEC syndrome-1	129900	AD	2
130000	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
130010	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
130050	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
130060	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
130070	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
130080	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
130130	19p13.3	Neutropenia, cyclic	162800	AD	3
130130	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
130160	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
130160	7q11.23	Supravalvar aortic stenosis	185500	AD	3
130410	19q13.41	Glutaric acidemia IIB	231680	AR	3
130500	1p35.3	Elliptocytosis-1	611804	AD,AR	3
130600	1q23.1	Elliptocytosis-2	130600	AD	3
130610	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
130620	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
130720	19p13.12	Lateral meningocele syndrome	130720	AD	3
130900	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
131100	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
131195	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
131200	10q26	{Endometriosis, susceptibility to, 1}	131200	AR,Mu	2
131222	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
131230	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
131240	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
131240	6p24.1	Question mark ears, isolated	612798	AD	3
131240	6p24.1	{High density lipoprotein cholesterol level QTL 7}	_	_	3
131242	20q13.32	Central hypoventilation syndrome, congenital	209880	AD	3
131242	20q13.32	Waardenburg syndrome, type 4B	613265	AD,AR	3
131242	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
131243	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
131243	4q31.22-q31.23	{Migraine, resistance to}	157300	AD	3
131244	13q22.3	ABCD syndrome	600501	AR	3
131244	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
131244	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
131300	19q13.2	Camurati-Engelmann disease	131300	AD	3
131320	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
131340	20p13	Spinocerebellar ataxia 23	610245	AD	3
131370	17p13.2	?Glycogen storage disease XIII	612932	AR	3
131399	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
131400	5q31-q33	Eosinophilia, familial	131400	AD	2
131440	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
131530	4q25	Hypomagnesemia 4, renal	611718	_	3
131550	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
131550	7p11.2	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	{Nonsmall cell lung cancer, susceptibility to}	211980	AD,SMu	3
131705	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
131750	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
131850	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
131950	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
131960	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
132000	3p21.31	EBD, Bart type	132000	AD	3
132100	6p21.1	Photoparoxysmal response 1	132100	AD	2
132400	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
132450	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
132700	16q12.1	Cylindromatosis, familial	132700	AD	3
132800	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
132810	1q42.12	?Hypercholanemia, familial	607748	AR	3
132811	8p21.2-p21.1	{Hypercholesterolemia, familial, due to LDLR defect, modifier of}	143890	AD	3
132890	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
132900	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
133170	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
133170	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
133170	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
133171	19p13.2	[Erythrocytosis, familial, 1]	133100	AD	3
133180	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
133190	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
133200	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AD,AR	3
133430	6q25.1-q25.2	Breast cancer, somatic	114480	_	3
133430	6q25.1-q25.2	Estrogen resistance	615363	AR	3
133430	6q25.1-q25.2	{Atherosclerosis, susceptibility to}	_	_	3
133430	6q25.1-q25.2	{HDL response to hormone replacement, augmented}	_	_	3
133430	6q25.1-q25.2	{Migraine, susceptibility to}	157300	AD	3
133430	6q25.1-q25.2	{Myocardial infarction, susceptibility to}	608446	_	3
133440	4q23	{Autism, susceptibility to, 19}	615091	_	3
133450	22q12.2	Ewing sarcoma	612219	_	3
133450	22q12.2	Neuroepithelioma	612219	_	3
133510	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
133510	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
133520	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
133520	16p13.12	Xeroderma pigmentosum, group F	278760	AR	3
133520	16p13.12	Xeroderma pigmentosum, type F/Cockayne syndrome	278760	AR	3
133520	16p13.12	XFE progeroid syndrome	610965	AR	3
133530	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G	278780	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G/Cockayne syndrome	278780	AR	3
133540	10q11.23	Cockayne syndrome, type B	133540	AR	3
133550	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
133550	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
133700	8q24.11	Exostoses, multiple, type 1	133700	AD	3
133701	11p11.2	Exostoses, multiple, type 2	133701	AD	3
134350	19p13.3	Complement factor D deficiency	613912	AR	3
134370	1q31.3	Basal laminar drusen	126700	AD	3
134370	1q31.3	Complement factor H deficiency	609814	AD,AR	3
134370	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	AD,AR	3
134370	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
134371	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AD,AR	3
134371	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
134570	6p25.1	Factor XIIIA deficiency	613225	AR	3
134570	6p25.1	{Myocardial infarction, protection against}	608446	_	3
134570	6p25.1	{Venous thrombosis, protection against}	188050	AD	3
134580	1q31.3	Factor XIIIB deficiency	613235	AR	3
134600	15q15.3	Fanconi renotubular syndrome 1	134600	AD	2
134610	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
134629	1q22	Porokeratosis 9, multiple types	616631	AD	3
134637	10q23.31	Autoimmune lymphoproliferative syndrome, type IA	601859	AD	3
134637	10q23.31	Squamous cell carcinoma, burn scar-related, somatic	_	_	3
134637	10q23.31	{Autoimmune lymphoproliferative syndrome}	601859	AD	3
134638	1q24.3	Autoimmune lymphoproliferative syndrome, type IB	601859	AD	3
134638	1q24.3	{Lung cancer, susceptibility to}	211980	AD,SMu	3
134770	11q12.3	?Hemochromatosis, type 5	615517	AD	3
134790	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
134790	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AD,AR	3
134790	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
134797	15q21.1	Acromicric dysplasia	102370	AD	3
134797	15q21.1	Ectopia lentis, familial	129600	AD	3
134797	15q21.1	Geleophysic dysplasia 2	614185	AD	3
134797	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
134797	15q21.1	Marfan syndrome	154700	AD	3
134797	15q21.1	MASS syndrome	604308	_	3
134797	15q21.1	Stiff skin syndrome	184900	AD	3
134797	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
134820	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134820	4q31.3	Amyloidosis, familial visceral	105200	AD	3
134820	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134820	4q31.3	Hypodysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134830	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Hypofibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Afibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Dysfibrinogenemia, congenital	616004	_	3
134850	4q32.1	Hypodysfibrinogenemia	616004	_	3
134850	4q32.1	Hypofibrinogenemia, congenital	202400	AR	3
134934	4p16.3	Achondroplasia	100800	AD	3
134934	4p16.3	Bladder cancer, somatic	109800	_	3
134934	4p16.3	CATSHL syndrome	610474	AD,AR	3
134934	4p16.3	Cervical cancer, somatic	603956	_	3
134934	4p16.3	Colorectal cancer, somatic	114500	_	3
134934	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
134934	4p16.3	Hypochondroplasia	146000	AD	3
134934	4p16.3	LADD syndrome	149730	AD	3
134934	4p16.3	Muenke syndrome	602849	AD	3
134934	4p16.3	Nevus, epidermal, somatic	162900	_	3
134934	4p16.3	SADDAN	616482	AD	3
134934	4p16.3	Spermatocytic seminoma, somatic	273300	_	3
134934	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
134934	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
134935	5q35.2	{Cancer progression/metastasis}	_	_	3
135100	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
135150	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
135290	5q22.2	Desmoid disease, hereditary	135290	AD	3
135300	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
135400	17q24.2-q24.3	Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400	AR	4
135500	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
135600	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
135600	2q35	Plasma fibronectin deficiency	614101	AD	1
135600	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
135750	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
135820	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
135900	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
135940	1q21.3	Ichthyosis vulgaris	146700	AD	3
135940	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
136000	4q22.3	Adermatoglyphia	136000	AD	3
136120	16q22.1	Fish-eye disease	136120	AR	3
136132	1q24.3	Trimethylaminuria	602079	AR	3
136140	16p11.2	Floating-Harbor syndrome	136140	AD	3
136350	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
136350	8p11.23	Hartsfield syndrome	615465	AD	3
136350	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
136350	8p11.23	Jackson-Weiss syndrome	123150	AD	3
136350	8p11.23	Osteoglophonic dysplasia	166250	AD	3
136350	8p11.23	Pfeiffer syndrome	101600	AD	3
136350	8p11.23	Trigonocephaly 1	190440	AD	3
136351	13q12.2	Leukemia, acute lymphoblastic, somatic	613065	_	3
136351	13q12.2	Leukemia, acute myeloid, reduced survival in, somatic	601626	_	3
136351	13q12.2	Leukemia, acute myeloid, somatic	601626	_	3
136352	5q35.3	Hemangioma, capillary infantile, somatic	602089	_	3
136352	5q35.3	Lymphatic malformation 1	153100	AD	3
136430	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
136435	2p16.3	Ovarian dysgenesis 1	233300	AR	3
136435	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
136435	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
136440	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
136520	11p13	Foveal hypoplasia 1	136520	AD	3
136530	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
136533	13q14.11	Rhabdomyosarcoma, alveolar	268220	SMu	3
136550	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
136570	16p12	Chromosome 16p12.1 deletion syndrome, 520kb	136570	_	4
136630	12q13.12	Mental retardation, FRA12A type	136630	AD	3
136680	11p13	Frasier syndrome	136680	AD,SMu	3
136760	1p13.3	Frontonasal dysplasia 1	136760	AR	3
136800	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
136836	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
136850	1q43	Fumarase deficiency	606812	AR	3
136850	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
136900	22q12.3	Sorsby fundus dystrophy	136900	AD	3
137035	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
137060	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
137070	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
137070	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
137100	6p21.3	Immunoglobulin A deficiency	137100	AD,AR,IC	2
137140	4p12	{Alcohol dependence, susceptibility to}	103780	Mu	3
137150	16p13.2	GABA-transaminase deficiency	613163	AR	3
137160	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
137160	5q34	{Epilepsy, childhood absence, susceptibility to, 4}	611136	_	3
137160	5q34	{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136	_	3
137163	1p36.33	{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	AD	3
137163	1p36.33	{Epilepsy, idiopathic generalized, 10}	613060	AD	3
137163	1p36.33	{Epilepsy, juvenile myoclonic, susceptibility to}	613060	AD	3
137164	5q34	Epilepsy, generalized, with febrile seizures plus, type 3	607681	AD	3
137164	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
137164	5q34	Febrile seizures, familial, 8	607681	AD	3
137165	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
137167	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
137167	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
137181	22q11.21	[Gamma-glutamyltransferase, familial high serum]	137181	_	2
137190	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
137192	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
137192	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
137200	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
137241	19q13.32	[Plasma glucose, 2-hour, QTL 2]	137241	_	2
137245	1p22.3	Lymphoma, MALT, somatic	137245	_	3
137290	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
137295	3q21.3	Emberger syndrome	614038	AD	3
137295	3q21.3	Immunodeficiency 21	614172	AD	3
137295	3q21.3	{Leukemia, acute myeloid, susceptibility to}	601626	AD,SMu	3
137295	3q21.3	{Myelodysplastic syndrome, susceptibility to}	614286	_	3
137350	9q33.2	Amyloidosis, Finnish type	105120	AD	3
137580	11q23	Tourette syndrome	137580	AD	2
137600	4q25	Anterior segment dysgenesis 4	137600	AD	3
137750	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
137760	10p13	Glaucoma 1, open angle, E	137760	AD	3
137780	17q21.31	Alexander disease	203450	AD	3
137920	17q12	Renal cysts and diabetes syndrome	137920	AD	3
137940	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
137950	1q32	Glomerulopathy with fibronectin deposits 1	137950	AD	2
137960	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
137960	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
138000	1p22.1	Glomuvenous malformations	138000	AD	3
138030	2q24.2	[?Hyperproglucagonemia]	_	_	1
138033	17q25.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138040	5q31.3	Glucocorticoid resistance	615962	AD	3
138079	7p13	Diabetes mellitus, noninsulin-dependent, late onset	125853	AD	3
138079	7p13	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
138079	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
138079	7p13	MODY, type II	125851	AD	3
138090	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
138130	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
138140	1p34.2	Dystonia 9	601042	AD	3
138140	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AD,AR	3
138140	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
138140	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
138140	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
138160	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
138160	3q26.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138180	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
138210	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
138244	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
138246	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
138250	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
138250	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
138250	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
138250	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
138252	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
138252	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
138253	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
138280	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
138280	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
138280	2q32.2	Global developmental delay, progressive ataxia, and elevated glutamine	618312	_	3
138290	1q25.3	Glutamine deficiency, congenital	610015	AR	3
138292	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
138295	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
138300	8p12	Hemolytic anemia due to glutathione reductase deficiency	_	_	1
138320	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
138322	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
138420	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
138430	2q24.1	{Diabetes, type 2, susceptibility to}	125853	AD	3
138470	6p21.33	?Complement factor B deficiency	615561	_	3
138470	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
138470	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
138491	5q33.1	Hyperekplexia 1	149400	AD,AR	3
138492	4q32.1	Hyperekplexia 2	614619	AR	3
138570	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
138571	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
138680	3q27.3	?Alopecia-mental retardation syndrome 1	203650	AR	3
138720	22q11.21	Bernard-Soulier syndrome, type B	231200	AR	3
138720	22q11.21	Giant platelet disorder, isolated	231200	AR	3
138760	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
138800	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
138850	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
138890	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
138900	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
138945	17q21.31	Aphasia, primary progressive	607485	AD	3
138945	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
138945	17q21.31	Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485	AD	3
138971	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
138981	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
139090	3p21.31	Gray platelet syndrome	139090	AR	3
139130	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
139130	12p13.31	{Hypertension, essential, susceptibility to}	145500	Mu	3
139150	5q14.3	Basal cell carcinoma, somatic	605462	_	3
139150	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
139190	20q11.23	?Isolated growth hormone deficiency due to defect in GHRF	_	_	1
139190	20q11.23	Gigantism due to GHRF hypersecretion	_	_	1
139191	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
139210	18q21.2	Myhre syndrome	139210	AD	3
139250	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
139250	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
139250	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
139250	17q23.3	Kowarski syndrome	262650	AR	3
139300	15q21.2	Aromatase excess syndrome	139300	AD	3
139311	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
139311	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
139312	18p11.21	Dystonia 25	615073	AD	3
139313	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
139313	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
139320	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
139320	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
139320	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
139320	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
139320	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ib	603233	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
139320	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
139330	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
139330	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
139340	1p13.3	Achromatopsia 4	613856	_	3
139350	12q13.13	Epidermolytic hyperkeratosis	113800	AD,AR	3
139350	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
139350	12q13.13	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
139350	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
139350	12q13.13	Palmoplantar keratoderma, epidermolytic	144200	AD	3
139350	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
139360	3p21.31	Pituitary ACTH-secreting adenoma	_	_	3
139360	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
139370	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
139380	1p36.33	Leukemia, acute lymphoblastic, somatic	613065	_	3
139380	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
139393	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
139396	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
139450	1q21.3	Hair, curly	139450	AD	2
139900	2p12-q22	[Handedness]	139900	AD	2
140000	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
140100	16q22.2	[Anhaptoglobinemia]	614081	_	3
140100	16q22.2	[Hypohaptoglobinemia]	614081	_	3
140300	8q23-q24	Hashimoto thyroiditis	140300	AD	2
140350	12q24.31	Hawkinsinuria	140350	AD	3
140400	1q32	Progressive familial heart block, type II	140400	AD	2
140600	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
141250	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
141250	22q12.3	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	3
141750	16pter-p13.3	Alpha-thalassemia/mental retardation syndrome, type 1	141750	AD	4
141800	16p13.3	Erythrocytosis, 7	617981	_	3
141800	16p13.3	Heinz body anemias, alpha-	140700	AD	3
141800	16p13.3	Hemoglobin H disease, nondeletional	613978	_	3
141800	16p13.3	Methemoglobinemia, alpha type	617973	_	3
141800	16p13.3	Thalassemias, alpha-	604131	_	3
141850	16p13.3	Erythrocytosis 7	617981	_	3
141850	16p13.3	Heinz body anemia	140700	AD	3
141850	16p13.3	Hemoglobin H disease, deletional and nondeletional	613978	_	3
141850	16p13.3	Thalassemia, alpha-	604131	_	3
141900	11p15.4	Delta-beta thalassemia	141749	AD	3
141900	11p15.4	Erythrocytosis 6	617980	_	3
141900	11p15.4	Heinz body anemia	140700	AD	3
141900	11p15.4	Hereditary persistence of fetal hemoglobin	141749	AD	3
141900	11p15.4	Methmoglobinemia, beta type	617971	_	3
141900	11p15.4	Sickle cell anemia	603903	AR	3
141900	11p15.4	Thalassemia, beta	613985	_	3
141900	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
141900	11p15.4	{Malaria, resistance to}	611162	_	3
142000	11p15.4	Thalassemia due to Hb Lepore	_	_	3
142000	11p15.4	Thalassemia, delta-	_	_	3
142200	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142220	6p22.2	Rahman syndrome	617537	AD	3
142250	11p15.4	Cyanosis, transient neonatal	613977	AD	3
142250	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142330	12q24.31	Hepatic adenoma, somatic	142330	_	3
142335	2p16.1	[Fetal hemoglobin QTL5]	142335	AD	2
142340	15q26.1	Hernia, congenital diaphragmatic 1	142340	Mu	2
142360	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
142409	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
142410	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
142410	12q24.31	Hepatic adenoma, somatic	142330	_	3
142410	12q24.31	MODY, type III	600496	AD	3
142410	12q24.31	Renal cell carcinoma	144700	_	3
142410	12q24.31	{Diabetes mellitus, insulin-dependent}	222100	AR	3
142410	12q24.31	{Diabetes mellitus, noninsulin-dependent, 2}	125853	AD	3
142445	8p12	{?Schizophrenia, susceptibility to}	603013	_	1
142461	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
142461	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
142470	6q22.3-q23.1	Fetal hemoglobin quantitative trait locus 2	142470	AD	2
142600	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
142600	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
142600	10q22.1	Retinitis pigmentosa 79	617460	AD	3
142622	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
142640	3q27.3	Thrombophilia due to elevated HRG	613116	AD	1
142640	3q27.3	Thrombophilia due to HRG deficiency	613116	AD	3
142669	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
142680	12p13.31	Periodic fever, familial	142680	AD	3
142690	1q23.2	Acne inversa, familial, 1	142690	AD	3
142700	13q22	Developmental dysplasia of the hip 1	142700	Mu	2
142704	15q21.2	{Gilles de la Tourette syndrome, susceptibility to}	137580	AD	3
142800	6p22.1	{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}	608579	_	3
142810	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
142810	5q31.3	Usher syndrome type 3B	614504	AR	3
142830	6p21.33	{Abacavir hypersensitivity, susceptibility to}	_	_	3
142830	6p21.33	{Drug-induced liver injury due to flucloxacillin}	_	_	3
142830	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
142830	6p21.33	{Stevens-Johnson syndrome, susceptibility to}	608579	_	3
142830	6p21.33	{Synovitis, chronic, susceptibility to}	_	_	3
142830	6p21.33	{Toxic epidermal necrolysis, susceptibility to}	608579	_	3
142840	6p21.33	{HIV-1 viremia, susceptibility to}	609423	_	3
142840	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
142857	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
142857	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
142858	6p21.32	{Beryllium disease, chronic, susceptibility to}	_	_	3
142871	6p22.1	{Asthma, susceptibility to}	600807	AD	2
142900	12q24.21	Holt-Oram syndrome	142900	AD	3
142910	5q13.3	[Low density lipoprotein cholesterol level QTL 3]	_	_	3
142910	5q13.3	[Statins, attenuated cholesterol lowering by]	_	_	3
142945	7q36.3	Holoprosencephaly 3	142945	AD	3
142946	18p11.31	Holoprosencephaly 4	142946	AD	3
142955	7p15.2	Athabaskan brainstem dysgenesis syndrome	601536	_	3
142955	7p15.2	Bosley-Salih-Alorainy syndrome	601536	_	3
142958	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
142959	7p15.2	?Guttmacher syndrome	176305	AD	3
142959	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
142968	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
142976	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
142983	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
142983	4p16.2	Orofacial cleft 5	608874	_	3
142983	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
142984	2q31.1	Charcot-Marie-Tooth disease, foot deformity of	192950	AD	3
142984	2q31.1	Vertical talus, congenital	192950	AD	3
142989	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
142989	2q31.1	Brachydactyly, type D	113200	AD	3
142989	2q31.1	Brachydactyly, type E	113300	AD	3
142989	2q31.1	Syndactyly, type V	186300	AD	3
142989	2q31.1	Synpolydactyly 1	186000	AD	3
142992	4p16.1	Oculoauricular syndrome	612109	AR	3
142993	14q24.3	Microphthalmia with coloboma 3	610092	_	3
142993	14q24.3	Microphthalmia, isolated 2	610093	_	3
142994	7q36.3	Currarino syndrome	176450	AD	3
143054	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
143095	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
143100	4p16.3	Huntington disease	143100	AD	3
143200	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
143400	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
143450	2p23.3	Trifunctional protein deficiency	609015	AR	3
143500	2q37.1	[Gilbert syndrome]	143500	AR	3
143850	18q	Orthostatic hypotensive disorder of Streeten	143850	AD	2
143860	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
143870	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
143880	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
144010	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
144110	14q11.2-q13	Hyperhidrosis palmaris et plantaris	144110	AD	2
144120	14q32.33	?Hyperimmunoglobulin G1 syndrome	144120	AD	2
144250	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
144650	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
144755	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
145000	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
145250	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
145260	1q31-q42	Pseudohypoaldosteronism, type IIA	145260	AD	2
145410	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
145420	22q11.23	Hypertelorism, Teebi type	145420	AD	3
145505	16p12.3	{?Hypertension, essential}	_	_	1
145650	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
145680	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
145701	8q22	?Hypertrichosis universalis congenita, Ambras type	145701	AD	2
145750	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
145980	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
145981	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
146000	4p16.3	Hypochondroplasia	146000	AD	3
146110	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
146255	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
146390	18p	Chromosome 18p deletion syndrome	146390	AD	4
146450	7q32.2-q36.1	Hypospadias 3, autosomal	146450	AD,Mu	2
146500	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AD,AR	3
146510	7p14.1	Pallister-Hall syndrome	146510	AD	3
146520	6p21.33	Hypotrichosis 2	146520	AD	3
146550	8p21.3	Hypotrichosis 4	146550	AD	3
146590	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
146660	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
146661	5p13.2	Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type	608971	AR	3
146690	7q32.1	Leber congenital amaurosis 11	613837	AD	3
146690	7q32.1	Retinitis pigmentosa 10	180105	AD	3
146691	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
146700	1q21.3	Ichthyosis vulgaris	146700	AD	3
146738	19p13.11	Cryptorchidism	219050	AD	3
146740	1q23.3	Immunodeficiency 20	615707	AR	3
146760	1q21.2	[IgG receptor I, phagocytic, familial deficiency of]	_	_	3
146770	22q11.23	Agammaglobulinemia 2	613500	AR	3
146790	1q23.3	{Lupus nephritis, susceptibility to}	152700	AD	3
146790	1q23.3	{Malaria, severe, susceptibility to}	611162	_	3
146790	1q23.3	{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	AR	3
146800	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
146880	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
146920	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
146920	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
146929	2q35	{AIDS, slow progression to}	609423	_	3
146933	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
147020	14q32.33	Agammaglobulinemia 1	601495	AR	3
147060	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
147061	5q31.1	{?Allergy and asthma susceptibility}	147061	_	2
147110	14q32.33	IgG2 deficiency, selective	_	_	3
147138	11q12.1	{Atopy, susceptibility to}	147050	AD	3
147141	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
147183	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
147200	2p11.2	Kappa light chain deficiency	614102	AR	3
147245	17q23.3	Agammaglobulinemia 6	612692	AR	3
147250	7q36.3	Single median maxillary central incisor	147250	AD	3
147265	3p26.1	Gillespie syndrome	206700	AD,AR	3
147265	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
147265	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
147267	6p21.31	{Diabetes, type 1, susceptibility to}	222100	AR	2
147280	6q25.3	Hepatocellular carcinoma, somatic	114550	_	3
147370	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
147430	14q11.2	?Marsili syndrome	147430	AD	3
147440	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
147450	21q22.11	Amyotrophic lateral sclerosis 1	105400	AD,AR	3
147460	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
147470	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
147480	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
147520	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
147520	20p13	[Inosine triphosphatase deficiency]	613850	_	3
147545	2q36.3	{Coronary artery disease, susceptibility to}	_	_	3
147545	2q36.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
147556	2q31.1	Epidermolysis bullosa, junctional, with pyloric stenosis	226730	AR	3
147557	17q25.1	Epidermolysis bullosa of hands and feet	131800	AD	3
147557	17q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
147557	17q25.1	Epidermolysis bullosa, junctional, with pyloric atresia	226730	AR	3
147558	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
147569	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
147570	12q15	{AIDS, rapid progression to}	609423	_	3
147570	12q15	{Aplastic anemia}	609135	_	3
147570	12q15	{Hepatitis C virus, response to therapy of}	609532	_	3
147570	12q15	{TSC2 angiomyolipomas, renal, modifier of}	613254	AD	3
147570	12q15	{Tuberculosis, protection against}	607948	_	3
147571	1p36.33	Immunodeficiency 38	616126	AR	3
147575	5q31.1	Gastric cancer, somatic	613659	_	3
147575	5q31.1	Myelodysplastic syndrome, preleukemic	_	_	3
147575	5q31.1	Myelogenous leukemia, acute	_	_	3
147575	5q31.1	Nonsmall cell lung cancer, somatic	211980	_	3
147582	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
147620	7p15.3	{Crohn disease-associated growth failure}	266600	Mu	3
147620	7p15.3	{Diabetes, susceptibility to},	222100	AR	3
147620	7p15.3	{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	AD	3
147620	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
147620	7p15.3	{Rheumatoid arthritis, systemic juvenile}	604302	_	3
147630	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
147650	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
147660	9p21.3	Interferon, alpha, deficiency	_	_	1
147670	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
147670	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
147670	19p13.2	Leprechaunism	246200	AR	3
147670	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
147679	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
147679	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147679	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
147683	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
147683	5q31.1	{Asthma, susceptibility to}	600807	AD	3
147700	2q34	{Glioma, susceptibility to, somatic}	137800	_	3
147720	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147730	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
147730	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
147750	20q13.2	IVIC syndrome	147750	AD	3
147781	16p12.1	{AIDS, slow progression to}	609423	_	3
147781	16p12.1	{Atopy, susceptibility to}	147050	AD	3
147791	11q23	Jacobsen syndrome	147791	IC	4
147796	9p24.1	Erythrocytosis, somatic	133100	_	3
147796	9p24.1	Leukemia, acute myeloid, somatic	601626	_	3
147796	9p24.1	Myelofibrosis, somatic	254450	_	3
147796	9p24.1	Polycythemia vera, somatic	263300	_	3
147796	9p24.1	Thrombocythemia 3	614521	AD,SMu	3
147796	9p24.1	{Budd-Chiari syndrome, somatic}	600880	_	3
147840	19p13.2	{Malaria, cerebral, susceptibility to}	611162	_	3
147880	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
147880	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
147891	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
147910	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
147920	12q13.12	Kabuki syndrome 1	147920	AD	3
147950	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
148000	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
148040	12q13.13	Dowling-Degos disease 1	179850	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148040	12q13.13	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148040	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
148040	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
148041	12q13.13	Pachyonychia congenita 3	615726	_	3
148042	12q13.13	Pachyonychia congenita 4	615728	_	3
148043	12q13.13	Meesmann corneal dystrophy	122100	AD	3
148050	16q24.3	KBG syndrome	148050	AD	3
148060	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148060	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148065	17q21.2	White sponge nevus 2	615785	AD	3
148066	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148066	17q21.2	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148066	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
148067	17q21.2	Pachyonychia congenita 1	167200	AD	3
148067	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
148069	17q21.2	Pachyonychia congenita 2	167210	AD	3
148069	17q21.2	Steatocystoma multiplex	184500	AD	3
148070	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148070	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148080	17q21.2	Epidermolytic hyperkeratosis	113800	AD,AR	3
148080	17q21.2	Ichthyosis with confetti	609165	AD	3
148080	17q21.2	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
148190	11p13	Keratitis	148190	AD	3
148200	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
148210	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
148300	20p11.21	Keratoconus 1	148300	AD	3
148350	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
148370	8p23-p22	Keratolytic winter erythema	148370	AD	2
148500	17q25.1	Tylosis with esophageal cancer	148500	AD	3
148600	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
148700	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
148760	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
148820	2q36.1	Waardenburg syndrome, type 3	148820	AD,AR	3
149000	8q22.3	Klippel-Trenaunay-Weber syndrome	149000	IC	2
149200	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
149400	5q33.1	Hyperekplexia 1	149400	AD,AR	3
149700	1p13.1	?Lacrimal duct defect	149700	AR	3
150000	11p15.1	Glycogen storage disease XI	612933	AR	3
150100	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
150200	17q23.3	[Placental lactogen deficiency]	_	_	1
150230	8q24.11-q24.13	Trichorhinophalangeal syndrome, type II	150230	AD	4
150240	7q31.1	Lissencephaly 5	615191	AR	3
150250	3p14.3	Larsen syndrome	150250	AD	3
150270	6p21.3-p21.2	?Laryngeal adductor paralysis	150270	AD	2
150292	1q25.3	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150292	1q25.3	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150310	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
150310	1q32.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150310	1q32.2	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150320	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
150325	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
150325	3p21.31	Pierson syndrome	609049	AR	3
150330	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
150330	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
150330	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
150330	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
150330	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
150330	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
150330	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
150330	1q22	Malouf syndrome	212112	AD	3
150330	1q22	Mandibuloacral dysplasia	248370	AR	3
150330	1q22	Muscular dystrophy, congenital	613205	AD	3
150330	1q22	Restrictive dermopathy, lethal	275210	AR	3
150340	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
150341	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
150341	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
150370	3p22.1	Asplenia, isolated congenital	271400	AD	3
150400	2q35	Tooth agenesis, selective, 4	150400	AD,AR	3
150571	22q13.1	{Myocardial infarction, susceptibility to}	608446	_	3
150600	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
150699	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
150800	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
151050	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
151100	12q24.13	LEOPARD syndrome 1	151100	AD	3
151200	8q22.1	Leri pleonosteosis chromosome duplication syndrome	151200	AD	4
151210	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
151350	5q32	?Infantile liver failure syndrome 1	615438	AR	3
151385	21q22.12	Leukemia, acute myeloid	601626	AD,SMu	3
151385	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
151410	22q11.23	Leukemia, acute lymphocytic, somatic	613065	_	3
151410	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
151430	18q21.33	Leukemia/lymphoma, B-cell, 2	_	_	3
151440	19p13.13	Leukemia, T-cell acute lymphoblastoid	151440	_	2
151443	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
151460	1q31.3-q32.1	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	AR	3
151460	1q31.3-q32.1	{Hepatitis C virus, susceptibility to}	609532	_	3
151600	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AD,AR	3
151623	17p13.1	Li-Fraumeni syndrome	151623	AD	3
151660	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
151670	15q21.3	Hepatic lipase deficiency	614025	AR	3
151670	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
151670	15q21.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
151750	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
152200	6q25-q26	[LPA deficiency, congenital]	_	_	3
152200	6q25-q26	{Coronary artery disease, susceptibility to}	_	_	1
152390	10q11.21	{Asthma, diminished response to antileukotriene treatment in}	600807	AD	3
152390	10q11.21	{Atherosclerosis, susceptibility to}	_	_	3
152424	11p15.4	Thalassemia, Hispanic gamma-delta-beta	613985	_	3
152427	7q36.1	Long QT syndrome 2	613688	AD	3
152427	7q36.1	Short QT syndrome 1	609620	_	3
152427	7q36.1	{Long QT syndrome 2, acquired, susceptibility to}	613688	AD	3
152430	4q25	[Longevity 1]	152430	_	2
152445	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
152760	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
152780	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
152790	2p16.3	Leydig cell adenoma, somatic, with precocious puberty	176410	_	3
152790	2p16.3	Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	AR	3
152790	2p16.3	Leydig cell hypoplasia with pseudohermaphroditism	238320	AR	3
152790	2p16.3	Luteinizing hormone resistance, female	238320	AR	3
152790	2p16.3	Precocious puberty, male	176410	AD	3
152950	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
153100	5q35.3	Lymphatic malformation 1	153100	AD	3
153245	4q25	Sebaceous tumors, somatic	_	_	3
153390	1p35.2	?Immunodeficiency 22	615758	AR	3
153440	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
153440	6p21.33	{Myocardial infarction, susceptibility to}	608446	_	3
153440	6p21.33	{Psoriatic arthritis, susceptibility to}	607507	_	3
153450	12q15	Amyloidosis, renal	105200	AD	3
153454	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
153455	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
153456	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
153550	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
153600	6p21.3	{Macroglobulinemia, Waldenstrom, susceptibility to, 1}	153600	AD	2
153620	22q11.23	{Rheumatoid arthritis, systemic juvenile, susceptibility to}	604302	_	3
153622	8p22	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
153670	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
153700	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
153800	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
153880	7p21-p15	Macular dystrophy, dominant cystoid	153880	AD	2
154020	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
154045	19q13.41	Cataract 19, multiple types	615277	AR	3
154050	12q13.3	Cataract 15, multiple types	615274	AD	3
154100	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
154230	9p24.3	46XY sex reversal 4	154230	_	4
154235	6p24.2	Retinitis pigmentosa 62	614181	AR	3
154275	17q11.2-q24	{Malignant hyperthermia susceptibility 2}	154275	AD	2
154276	7q21-q22	{Malignant hyperthermia susceptibility 3}	154276	AD	2
154400	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
154500	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
154545	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
154550	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
154700	15q21.1	Marfan syndrome	154700	AD	3
154780	1p21.1	Marshall syndrome	154780	AD	3
154870	12p12.3	Keutel syndrome	245150	AR	3
154950	14q23.3	{Pheochromocytoma, susceptibility to}	171300	AD	3
155100	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
155310	2p13.1	Visceral myopathy	155310	AD	3
155500	3q26.32	Macrodactyly, somatic	155500	_	3
155540	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
155541	18q21.32	Obesity (BMIQ20)	618406	_	3
155541	18q21.32	{Obesity, resistence to (BMIQ20)}	618306	_	3
155555	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	AR	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	AR	3
155555	16q24.3	{Albinism, oculocutaneous, type II, modifier of}	203200	AR	3
155555	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
155555	16q24.3	{UV-induced skin damage}	266300	AR	3
155600	1p36	{Melanoma, cutaneous malignant, 1}	155600	AD	2
155601	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
155755	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
155760	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
155760	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
155760	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
155900	9p11	?Melkersson-Rosenthal syndrome	155900	AD	2
156100	22q12.1	Meningioma	607174	AD	3
156200	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
156225	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
156225	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
156232	2q24-q32	Mesomelic dysplasia, Kantaputra type	156232	AD	2
156250	12q24.13	Metachondromatosis	156250	AD	3
156400	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
156490	17q21.33	Neuroblastoma	256700	AD,SMu	3
156500	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
156510	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
156530	12q24.11	Metatropic dysplasia	156530	AD	3
156540	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
156550	12q13.11	Kniest dysplasia	156550	AD	3
156560	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
156560	12q13.3	Interstitial lung and liver disease	615486	AR	3
156570	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
156570	1q43	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
156600	13q32	Microcoria, congenital	156600	AD	4
156610	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
156845	3p13	COMMAD syndrome	617306	AR	3
156845	3p13	Tietz albinism-deafness syndrome	103500	AD	3
156845	3p13	Waardenburg syndrome, type 2A	193510	AD	3
156845	3p13	Waardenburg syndrome/ocular albinism, digenic	103470	AD	3
156845	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
156850	16p13.3	Microphthalmia with cataract 1	156850	AD	2
157140	17q21.31	Dementia, frontotemporal, with or without parkinsonism	600274	AD	3
157140	17q21.31	Pick disease	172700	AD	3
157140	17q21.31	Supranuclear palsy, progressive	601104	AD	3
157140	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
157140	17q21.31	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
157145	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
157147	4q23	Abetalipoproteinemia	200100	AR	3
157147	4q23	{Metabolic syndrome, protection against}	605552	AD	3
157170	2p21	Holoprosencephaly 2	157170	AD	3
157300	4q24	{Migraine with or without aura, susceptibility to, 1}	157300	AD	2
157600	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
157640	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
157655	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
157660	9p13.3	Anauxetic dysplasia 1	607095	AR	3
157660	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
157660	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
157700	16p12.1-p11.2	Mitral valve prolapse, myxomatous 1	157700	AD	2
157800	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
157900	13q12.2-q13	?Moebius syndrome	157900	AD,IC	2
158105	17q12	{Coronary artery disease, modifier of}	_	_	3
158105	17q12	{HIV-1, resistance to}	609423	_	3
158105	17q12	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
158105	17q12	{Spina bifida, susceptibility to}	182940	AD	3
158170	9p	Chromosome 9p deletion syndrome	158170	AD	4
158300	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
158330	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
158340	1q22	Medullary cystic kidney disease 1	174000	AD	3
158375	4q13.3	{Asthma, protection against}	600807	AD	3
158378	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
158580	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
158590	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
158600	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
158900	4q35	Facioscapulohumeral muscular dystrophy 1	158900	AD	4
158901	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
159350	5q22.2	Colorectal cancer, somatic	114500	_	3
159440	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
159440	1q23.3	Dejerine-Sottas disease	145900	AD,AR	3
159440	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
159440	1q23.3	Roussy-Levy syndrome	180800	AD	3
159460	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
159465	6p22.1	?Narcolepsy 7	614250	AD	3
159530	1p34.2	Myelofibrosis with myeloid metaplasia, somatic	254450	_	3
159530	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
159530	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
159550	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
159555	11q23.3	Leukemia, myeloid/lymphoid or mixed-lineage	159555	AD	2
159555	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
159595	21q11.2	Leukemia, transient, of Down syndrome	159595	_	2
159900	7q21.3	Dystonia-11, myoclonic	159900	AD	3
159950	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
159990	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
160120	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
160500	14q11.2	Laing distal myopathy	160500	AD	3
160565	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
160700	18p11.31	Myopia-2	160700	AD	2
160710	14q11.2	Atrial septal defect 3	614089	_	3
160710	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
160710	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
160710	14q11.2	{Sick sinus syndrome 3}	614090	_	3
160720	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
160720	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
160740	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AD,AR	3
160741	17p13.1	Carney complex variant	608837	_	3
160741	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
160745	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
160760	14q11.2	Cardiomyopathy, dilated, 1S	613426	AD	3
160760	14q11.2	Cardiomyopathy, hypertrophic, 1	192600	AD	3
160760	14q11.2	Laing distal myopathy	160500	AD	3
160760	14q11.2	Left ventricular noncompaction 5	613426	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
160760	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
160770	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
160775	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
160775	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
160777	15q21.2	Griscelli syndrome, type 1	214450	AR	3
160780	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
160781	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
160790	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AD,AR	3
160794	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
160794	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
160800	7q34	Myotonia congenita, dominant	160800	AD	3
160900	19q13.32	Myotonic dystrophy 1	160900	AD	3
160980	17q24.2	Carney complex, type 1	160980	AD	3
160998	6p25.2	{?Breast cancer susceptibility}	114480	AD,SMu	1
161000	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
161015	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
161200	9q33.3	Nail-patella syndrome	161200	AD	3
161400	17q21.2	?Narcolepsy 1	161400	AD	3
161550	6p21.3	{Nasopharyngeal carcinoma, susceptibility to, 2}	161550	_	2
161561	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
161650	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
161900	1q21	Nephropathy-hypertension	161900	AD	2
161950	6q22-q23	{IgA nephropathy, susceptibility to, 1}	161950	?AD	2
162000	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
162030	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
162080	14q11-q12	Retinal degeneration, autosomal recessive, clumped pigment type	_	_	3
162080	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
162100	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
162150	5q15	Obesity with impaired prohormone processing	600955	AR	3
162150	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
162200	17q11.2	Neurofibromatosis, type 1	162200	AD	3
162210	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
162230	22q12.2	?{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
162230	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AD,AR	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
162300	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
162330	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
162332	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
162350	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
162400	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
162500	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
162643	2q22.1	Myelokathexis, isolated	_	_	3
162643	2q22.1	WHIM syndrome	193670	AD	3
162662	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
162800	19p13.3	Neutropenia, cyclic	162800	AD	3
162820	7q22-qter	?Neutrophil chemotactic response, abnormal	162820	AD	2
163000	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
163500	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
163729	7q36.1	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
163729	7q36.1	{Coronary artery spasm 1, susceptibility to}	_	_	3
163729	7q36.1	{Hypertension, pregnancy-induced}	189800	AD	3
163729	7q36.1	{Hypertension, susceptibility to}	145500	Mu	3
163729	7q36.1	{Ischemic stroke, susceptibility to}	601367	Mu	3
163729	7q36.1	{Placental abruption}	_	_	3
163730	17q11.2	{Hypertension, susceptibility to}	145500	Mu	2
163730	17q11.2	{Malaria, resistance to}	611162	_	3
163800	15q24.1	Sick sinus syndrome 2	163800	AD	3
163890	4q22.1	Dementia, Lewy body	127750	AD	3
163890	4q22.1	Parkinson disease 1	168601	AD	3
163890	4q22.1	Parkinson disease 4	605543	AD	3
163950	12q24.13	Noonan syndrome 1	163950	AD	3
163970	16q12.2	?Orthostatic intolerance	604715	_	3
164005	19p13.13	Marshall-Smith syndrome	602535	AD	3
164005	19p13.13	Sotos syndrome 2	614753	AD	3
164008	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
164009	11q13.4	Leukemia, acute promyelocytic, somatic	612376	_	3
164010	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
164011	4q24	Immunodeficiency, common variable, 12	616576	AD	3
164012	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
164014	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
164015	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
164017	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
164017	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
164040	5q35.1	Leukemia, acute myeloid, somatic	601626	_	3
164050	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
164100	6p12	Nystagmus 2, congenital, autosomal dominant	164100	AD	2
164160	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
164200	6q22.31	Oculodentodigital dysplasia	164200	AD	3
164210	14q32	Hemifacial microsomia	164210	AD	2
164280	2p24.3	Feingold syndrome 1	164280	AD	3
164300	14q11.2	Oculopharyngeal muscular dystrophy	164300	AD	3
164360	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
164360	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
164400	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
164500	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
164690	1q25.2	Leukemia, acute myeloid, with eosinophilia	_	_	1
164730	14q32.33	Breast cancer, somatic	114480	_	3
164730	14q32.33	Colorectal cancer, somatic	114500	_	3
164730	14q32.33	Cowden syndrome 6	615109	_	3
164730	14q32.33	Ovarian cancer, somatic	167000	_	3
164730	14q32.33	Proteus syndrome, somatic	176920	_	3
164730	14q32.33	{Schizophrenia, susceptibility to}	181500	AD	2
164731	19q13.2	Diabetes mellitus, type II	125853	AD	3
164731	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
164745	17q21.31	Omodysplasia 2	164745	AD	3
164750	1p31.3	Omphalocele due to duplication of 1p31.3	164750	IC	4
164757	7q34	Adenocarcinoma of lung, somatic	211980	_	3
164757	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
164757	7q34	Colorectal cancer, somatic	_	_	3
164757	7q34	LEOPARD syndrome 3	613707	AD	3
164757	7q34	Melanoma, malignant, somatic	_	_	3
164757	7q34	Nonsmall cell lung cancer, somatic	_	_	3
164757	7q34	Noonan syndrome 7	613706	AD	3
164760	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
164760	3p25.2	LEOPARD syndrome 2	611554	_	3
164760	3p25.2	Noonan syndrome 5	611553	AD	3
164761	10q11.21	Central hypoventilation syndrome, congenital	209880	AD	3
164761	10q11.21	Medullary thyroid carcinoma	155240	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
164761	10q11.21	Pheochromocytoma	171300	AD	3
164761	10q11.21	{Hirschsprung disease, protection against}	142623	AD	3
164761	10q11.21	{Hirschsprung disease, susceptibility to, 1}	142623	AD	3
164770	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
164770	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
164780	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
164785	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
164790	1p13.2	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	614470	_	3
164790	1p13.2	Colorectal cancer, somatic	114500	_	3
164790	1p13.2	Epidermal nevus, somatic	162900	_	3
164790	1p13.2	Melanocytic nevus syndrome, congenital, somatic	137550	_	3
164790	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
164790	1p13.2	Noonan syndrome 6	613224	AD	3
164790	1p13.2	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
164790	1p13.2	Thyroid carcinoma, follicular, somatic	188470	_	3
164820	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
164820	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
164840	2p24.3	Feingold syndrome 1	164280	AD	3
164860	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
164860	7q31.2	Hepatocellular carcinoma, childhood type, somatic	114550	_	3
164860	7q31.2	Renal cell carcinoma, papillary, 1, familial and somatic	605074	_	3
164860	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
164870	17q12	Adenocarcinoma of lung, somatic	211980	_	3
164870	17q12	Gastric cancer, somatic	613659	_	3
164870	17q12	Glioblastoma, somatic	137800	_	3
164870	17q12	Ovarian cancer, somatic	_	_	3
164874	14q12	Rett syndrome, congenital variant	613454	AD	3
164920	4q12	Gastrointestinal stromal tumor, familial	606764	AD,IC	3
164920	4q12	Germ cell tumors, somatic	273300	_	3
164920	4q12	Leukemia, acute myeloid	601626	AD,SMu	3
164920	4q12	Mastocytosis, cutaneous	154800	AD	3
164920	4q12	Mastocytosis, systemic, somatic	154800	_	3
164920	4q12	Piebaldism	172800	AD	3
164950	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
164953	19p13.2-q13.3	Liposarcoma	_	_	1
165190	4q21.21	Trichomegaly	190330	AR	3
165215	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
165220	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
165220	12q13.3	Polydactyly, preaxial I	174400	AR	3
165230	2q14.2	Culler-Jones syndrome	615849	AD	3
165230	2q14.2	Holoprosencephaly 9	610829	AD	3
165240	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
165240	7p14.1	Pallister-Hall syndrome	146510	AD	3
165240	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
165240	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
165240	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
165300	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
165320	2q14-q21	?Hepatocellular carcinoma	_	_	1
165330	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
165360	11q23.3	?Juvenile myelomonocytic leukemia	607785	AD,SMu	3
165360	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
165500	3q29	Optic atrophy 1	165500	AD	3
165550	11p13	Optic nerve hypoplasia	165550	AD	3
165640	2p25.1	{Colonic adenoma recurrence, reduced risk of}	114500	AD,SMu	3
165720	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
165800	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
166200	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
166250	8p11.23	Osteoglophonic dysplasia	166250	AD	3
166260	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
166300	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
166350	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
166600	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
166750	11q13	Otodental dysplasia chromosome deletion syndrome	166750	AD	4
166760	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
166780	8q13.3	?Otofaciocervical syndrome	166780	AD	3
166800	15q26.1-qter	Otosclerosis 1	166800	AD	2
166900	17q21.31	Ovalocytosis, SA type	166900	AD	3
167030	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
167200	17q21.2	Pachyonychia congenita 1	167200	AD	3
167210	17q21.2	Pachyonychia congenita 2	167210	AD	3
167250	5q35.3	Paget disease of bone 3	167250	AD	3
167320	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
167400	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
167409	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
167409	10q24.31	Papillorenal syndrome	120330	AD	3
167410	1p36.13	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
167411	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
167413	7q32.1	Diabetes mellitus, type 2	125853	AD	3
167413	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
167413	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AD,AR	3
167414	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
167415	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
167416	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
167420	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
167790	5q32	Pancreatitis, hereditary	167800	AD	3
167790	5q32	Tropical calcific pancreatitis	608189	AD,AR	3
167790	5q32	{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	AD,AR	3
167870	13q22-q32	Panic disorder syndrome 1	167870	?AD	2
168000	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
168300	17q23.3	Paramyotonia congenita	168300	AD	3
168400	12q24.11	Parastremmatic dwarfism	168400	AD	3
168450	11p15.3	Hypoparathyroidism, autosomal dominant	146200	AD,AR	3
168450	11p15.3	Hypoparathyroidism, autosomal recessive	146200	AD,AR	3
168461	11q13.3	{Colorectal cancer, susceptibility to}	114500	AD,SMu	3
168461	11q13.3	{Multiple myeloma, susceptibility to}	254500	SMu	3
168461	11q13.3	{von Hippel-Lindau syndrome, modifier of}	193300	AD	3
168468	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
168468	3p21.31	Eiken syndrome	600002	AR	3
168468	3p21.31	Failure of tooth eruption, primary	125350	AD	3
168468	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
168470	12p11.22	Brachydactyly, type E2	613382	AD	3
168500	5q35.2	Parietal foramina 1	168500	AD	3
168550	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
168601	4q22.1	Parkinson disease 1	168601	AD	3
168605	2p13.1	Perry syndrome	168605	AD	3
168820	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
168820	7q21.3	{Coronary artery spasm 2, susceptibility to	_	_	3
168820	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
168820	7q21.3	{Organophosphate poisoning, sensitivity to}	_	_	3
168860	17q21-q22	Patella aplasia or hypoplasia	168860	AD	2
169100	6p12.3	Char syndrome	169100	AD	3
169150	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
169400	1q42.12	Pelger-Huet anomaly	169400	AD	3
169500	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
169600	3q22.1	Hailey-Hailey disease	169600	AD	3
170100	19q13.11	Prolidase deficiency	170100	AR	3
170260	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
170261	6p21.32	Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	AR	3
170280	10q22.1	Aplastic anemia	609135	_	3
170280	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
170280	10q22.1	Lymphoma, non-Hodgkin	605027	_	3
170285	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
170290	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
170390	17q24.3	Andersen syndrome	170390	AD	3
170400	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
170500	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
170650	11q14.2	Periodontitis 1, juvenile	170650	AR	3
170710	12q13.12	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
170715	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
170993	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
170993	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
170995	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
170998	22q13.31	{Hyperapobetalipoproteinemia, susceptibility to}	_	_	3
171050	7q21.12	{Colchicine resistance}	120080	_	3
171050	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
171060	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AD,AR	3
171060	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
171060	7q21.12	Gallbladder disease 1	600803	AD,AR	3
171200	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
171400	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
171640	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
171650	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
171720	9q34.13	{Alkaline phosphatase, plasma level of, QTL1}	171720	?AD	2
171760	1p36.12	Hypophosphatasia, adult	146300	AD,AR	3
171760	1p36.12	Hypophosphatasia, childhood	241510	AR	3
171760	1p36.12	Hypophosphatasia, infantile	241500	AR	3
171760	1p36.12	Odontohypophosphatasia	146300	AD,AR	3
171833	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
171833	5q13.1	Immunodeficiency 36	616005	AD	3
171833	5q13.1	SHORT syndrome	269880	AD	3
171834	3q26.32	Breast cancer, somatic	114480	_	3
171834	3q26.32	CLAPO syndrome, somatic	613089	_	3
171834	3q26.32	CLOVE syndrome, somatic	612918	_	3
171834	3q26.32	Colorectal cancer, somatic	114500	_	3
171834	3q26.32	Cowden syndrome 5	615108	_	3
171834	3q26.32	Gastric cancer, somatic	613659	_	3
171834	3q26.32	Hepatocellular carcinoma, somatic	114550	_	3
171834	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
171834	3q26.32	Macrodactyly, somatic	155500	_	3
171834	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
171834	3q26.32	Nevus, epidermal, somatic	162900	_	3
171834	3q26.32	Nonsmall cell lung cancer, somatic	211980	_	3
171834	3q26.32	Ovarian cancer, somatic	167000	_	3
171860	21q22.3	Hemolytic anemia due to phosphofructokinase deficiency	_	_	1
171900	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
172100	6q14.1	Immunodeficiency 23	615816	AR	3
172400	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
172405	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
172405	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
172411	1p36.13	{?Colorectal cancer, susceptibility to}	114500	AD,SMu	3
172425	20q13.12	[High density lipoprotein cholesterol level QTL 9]	_	_	3
172430	1p36.23	Enolase deficiency	_	_	1
172460	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
172460	14q23.3	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
172471	16p11.2	Cirrhosis due to liver phosphorylase kinase deficiency	_	_	3
172471	16p11.2	Glycogen storage disease IXc	613027	AR	3
172480	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
172490	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
172860	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
172870	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
173100	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
173110	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AD,AR	3
173200	17q25.3	Pityriasis rubra pilaris	173200	AD	3
173321	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
173325	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
173325	17q21.2	Naxos disease	601214	AR	3
173335	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
173335	6q23.2	Cole disease	615522	AD	3
173335	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
173335	6q23.2	{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	AD	3
173335	6q23.2	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
173350	6q26	Dysplasminogenemia	217090	AR	3
173350	6q26	Plasminogen deficiency, type I	217090	AR	3
173360	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AD,AR	3
173360	7q22.1	{Transcription of plasminogen activator inhibitor, modulator of}	_	_	3
173370	8p11.21	Hyperfibrinolysis, familial, due to increased release of PLAT	612348	_	1
173370	8p11.21	Thrombophilia, familial, due to decreased release of PLAT	612348	_	1
173410	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
173410	5q32	Kosaki overgrowth syndrome	616592	AD	3
173410	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
173410	5q32	Myofibromatosis, infantile, 1	228550	AD	3
173410	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
173470	17q21.32	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
173470	17q21.32	Glanzmann thrombasthenia	273800	AR	3
173470	17q21.32	Purpura, posttransfusion	_	_	3
173470	17q21.32	Thrombocytopenia, neonatal alloimmune	_	_	3
173470	17q21.32	{Myocardial infarction, susceptibility to}	608446	_	3
173490	4q12	Gastrointestinal stromal tumor, somatic or familial	606764	_	3
173490	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
173510	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
173510	7q21.11	[Macrothrombocytopenia]	_	_	1
173510	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
173510	7q21.11	{Malaria, cerebral, reduced risk of}	611162	_	3
173510	7q21.11	{Malaria, cerebral, susceptibility to}	611162	_	3
173515	3q21.3	Bernard-Soulier syndrome, type C	231200	AR	3
173600	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
173650	20p12.3	Kindler syndrome	173650	AR	3
173900	16p13.3	Polycystic kidney disease 1	173900	AD	3
173910	4q22.1	Polycystic kidney disease 2	613095	AD	3
174000	1q22	Medullary cystic kidney disease 1	174000	AD	3
174050	19p13.2	Polycystic liver disease 1	174050	AD	3
174200	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
174300	1q32.1	Orofaciodigital syndrome V	174300	AR	3
174400	12q13.3	Polydactyly, preaxial I	174400	AR	3
174700	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
174761	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
174761	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
174762	12q24.33	FILS syndrome	615139	AR	3
174762	12q24.33	IMAGE-I syndrome	618336	AR	3
174762	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
174763	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
174800	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
174810	18q21.33	Osteolysis, familial expansile	174810	AD	3
175050	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
175200	19p13.3	Peutz-Jeghers syndrome	175200	AD	3
175700	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
175780	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
175800	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
175850	12q24.1-q24.2	Porokeratosis 2, palmar, plantar, and disseminated	175850	AD	2
175900	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
176258	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
176260	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
176261	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
176261	21q22.12	Long QT syndrome 5	613695	AD	3
176262	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
176264	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
176266	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
176267	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
176300	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
176300	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
176300	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
176305	7p15.2	?Guttmacher syndrome	176305	AD	3
176310	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
176400	19p13.3	?Precocious puberty, central, 1	176400	AD	3
176430	15q15.1	[Premature chromatid separation trait]	176430	AD	3
176450	7q36.3	Currarino syndrome	176450	AD	3
176500	13q14.2	Dementia, familial British	176500	AD	3
176610	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
176640	20p13	Cerebral amyloid angiopathy, PRNP-related	137440	AD	3
176640	20p13	Creutzfeldt-Jakob disease	123400	AD	3
176640	20p13	Gerstmann-Straussler disease	137440	AD	3
176640	20p13	Huntington disease-like 1	603218	AD	3
176640	20p13	Insomnia, fatal familial	600072	AD	3
176640	20p13	Prion disease with protracted course	606688	AD	3
176640	20p13	{Kuru, susceptibility to}	245300	_	3
176670	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
176705	17q21.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
176730	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
176730	11p15.5	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
176730	11p15.5	Hyperproinsulinemia	616214	AD	3
176730	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
176740	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
176761	5p13.2	Hyperprolactinemia	615555	AD,AR	3
176761	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
176763	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type, digenic	277400	AR	3
176780	1q31	{Pelvic organ prolapse, susceptibility to, 1}	176780	AD	2
176790	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
176797	11q23.2	Leukemia, acute promyelocytic, PL2F/RARA type	_	_	3
176797	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
176801	10q22.1	Combined SAP deficiency	611721	AR	3
176801	10q22.1	Gaucher disease, atypical	610539	_	3
176801	10q22.1	Krabbe disease, atypical	611722	AR	3
176801	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
176804	14q22.1	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
176830	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
176830	2p23.3	{Obesity, early-onset, susceptibility to}	601665	AD,AR,Mu	3
176860	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
176872	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
176876	12q24.13	LEOPARD syndrome 1	151100	AD	3
176876	12q24.13	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
176876	12q24.13	Metachondromatosis	156250	AD	3
176876	12q24.13	Noonan syndrome 1	163950	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
176885	20q13.13	{Insulin resistance, susceptibility to}	125853	AD	3
176893	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
176894	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
176895	13q34	[Protein Z deficiency]	614024	_	3
176915	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
176920	14q32.33	Proteus syndrome, somatic	176920	_	3
176930	11p11.2	Dysprothrombinemia	613679	AR	3
176930	11p11.2	Hypoprothrombinemia	613679	AR	3
176930	11p11.2	Thrombophilia due to thrombin defect	188050	AD	3
176930	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
176930	11p11.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
176941	19p13.2	Immunodeficiency 35	611521	AR	3
176943	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
176943	10q26.13	Apert syndrome	101200	AD	3
176943	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
176943	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
176943	10q26.13	Craniofacial-skeletal-dermatologic dysplasia	101600	AD	3
176943	10q26.13	Craniosynostosis, nonspecific	_	_	3
176943	10q26.13	Crouzon syndrome	123500	AD	3
176943	10q26.13	Gastric cancer, somatic	613659	_	3
176943	10q26.13	Jackson-Weiss syndrome	123150	AD	3
176943	10q26.13	LADD syndrome	149730	AD	3
176943	10q26.13	Pfeiffer syndrome	101600	AD	3
176943	10q26.13	Saethre-Chotzen syndrome	101400	AD	3
176943	10q26.13	Scaphocephaly and Axenfeld-Rieger anomaly	_	_	3
176943	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
176946	1p36.13	Cataract 6, multiple types	116600	AD	3
176947	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
176947	2q11.2	Immunodeficiency 48	269840	AR	3
176960	17q24.2	Pituitary tumor, invasive	_	_	3
176977	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
176980	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
177000	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
177045	6p21.32	?Proteasome-associated autoinflammatory syndrome 3, digenic	617591	AR	3
177046	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
177060	19p13.2	Polycystic liver disease 1	174050	AD	3
177070	15q15.2	Spherocytosis, type 5	612690	_	3
177075	16q23.2	Ayme-Gripp syndrome	601088	AD	3
177075	16q23.2	Cataract 21, multiple types	610202	AD	3
177170	19p13.11	Pseudoachondroplasia	177170	AD	3
177200	16p12.2	Liddle syndrome 1	177200	AD	3
177400	3q26.1	Butyrylcholinesterase deficiency	617936	_	3
177400	3q26.1	{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}	617936	_	3
177650	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
177700	12q14	Glaucoma 1, open angle, P	177700	AD	4
177735	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
177820	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
177850	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
177900	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
178110	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
178300	1p34.1-p32	Ptosis, hereditary congenital, 1	178300	AD	2
178620	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
178640	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
178642	10q22.3	Pulmonary fibrosis, idiopathic	178500	AD	3
179010	12q	Pyloric stenosis, infantile hypertrophic 1	179010	AD,Mu	2
179035	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
179035	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
179060	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
179095	5q31.1	?Male infertility	_	_	1
179410	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
179450	6p21.3	?Ragweed sensitivity	179450	AD	2
179502	4q23	Lymphocytic leukemia, acute T-cell	_	_	3
179590	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
179605	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
179605	6p21.1	Leber congenital amaurosis 18	608133	AD,AR	3
179605	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
179605	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
179605	6p21.1	Retinitis pigmentosa 7 and digenic form	608133	AD,AR	3
179605	6p21.1	Retinitis punctata albescens	136880	AD,AR	3
179615	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
179615	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179615	11p12	Omenn syndrome	603554	AR	3
179615	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179616	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179616	11p12	Omenn syndrome	603554	AR	3
179616	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179617	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
179617	15q15.1	Mirror movements 2	614508	AD	3
179617	15q15.1	{Breast cancer, susceptibility to}	114480	AD,SMu	3
179620	11p15.5	[Blood group, Raph]	179620	_	3
179755	1q23.1	Renal cell carcinoma, papillary	605074	_	3
179800	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
179820	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
179820	1q32.1	Renal tubular dysgenesis	267430	AR	3
179820	1q32.1	[Hyperproreninemia]	_	_	3
179850	12q13.13	Dowling-Degos disease 1	179850	AD	3
180000	13q34	?Retinal arteries, tortuosity of	180000	AD	3
180020	6q25-q26	?Retinal cone dystrophy-1	180020	AD	2
180040	1q32.3	Leber congenital amaurosis 12	610612	AR	3
180069	1p31.3	Leber congenital amaurosis 2	204100	AR	3
180069	1p31.3	Retinitis pigmentosa 20	613794	AR	3
180071	5q32	Retinitis pigmentosa 43	613810	_	3
180072	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
180072	4p16.3	Retinitis pigmentosa-40	613801	AR	3
180073	17q25.3	Retinitis pigmentosa 57	613582	AR	3
180090	15q26.1	Bothnia retinal dystrophy	607475	AR	3
180090	15q26.1	Fundus albipunctatus	136880	AD,AR	3
180090	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
180090	15q26.1	Retinitis punctata albescens	136880	AD,AR	3
180100	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AD,AR	3
180104	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
180105	7q32.1	Retinitis pigmentosa 10	180105	AD	3
180220	3p24.2	Microphthalmia, syndromic 12	615524	AD,AR	3
180240	17q21.2	Leukemia, acute promyelocytic	612376	_	1
180250	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
180250	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
180290	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
180295	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
180297	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
180297	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
180300	6q23	{Rheumatoid arthritis, susceptibility to}	180300	_	2
180380	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
180380	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AD,AR	3
180380	3q22.1	Retinitis punctata albescens	136880	AD,AR	3
180381	13q34	Oguchi disease-2	613411	_	3
180385	11p13	Leukemia, acute T-cell	180385	_	2
180430	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
180435	1q25.3	Prostate cancer 1	601518	AD	3
180468	3q29	Diamond-Blackfan anemia 5	612528	AD	3
180472	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
180500	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
180550	4q25	Ring dermoid of cornea	180550	AD	3
180700	3p14.3	Robinow syndrome, autosomal dominant 1	180700	AD	3
180721	11q12.3	Retinitis pigmentosa 7, digenic form	608133	AD,AR	3
180750	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
180849	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
180860	7p11.2	Silver-Russell syndrome	180860	AD	4
180901	19q13.2	Central core disease	117000	AD,AR	3
180901	19q13.2	King-Denborough syndrome	145600	AD	3
180901	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
180901	19q13.2	Neuromuscular disease, congenital, with uniform type 1 fiber	117000	AD,AR	3
180901	19q13.2	{Malignant hyperthermia susceptibility 1}	145600	AD	3
180902	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
180902	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
180920	5p12	Aplasia of lacrimal and salivary glands	180920	AD	3
180960	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
181000	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
181030	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
181031	2q37.1	Oguchi disease-1	258100	AR	3
181031	2q37.1	Retinitis pigmentosa 47	613758	_	3
181270	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
181350	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
181400	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
181405	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
181430	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
181450	12q24.21	Ulnar-mammary syndrome	181450	AD	3
181460	5q31-q33	{Schistosoma mansoni infection, susceptibility/resistance to}	181460	AD	2
181510	5q23-q35	{Schizophrenia}	181500	AD	2
181590	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
181600	4q22.3	Huriez syndrome	181600	AD	3
181800	19p13.3	Scoliosis, idiopathic 1	181800	AD	2
182000	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
182100	19q13.33	[Bombay phenotype, digenic]	616754	AR	3
182100	19q13.33	{Norwalk virus infection, resistance to}	_	_	3
182100	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
182120	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
182125	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
182135	13q14.2	{Alcohol dependence, susceptibility to}	103780	Mu	3
182135	13q14.2	{Anorexia nervosa, susceptibility to}	606788	_	3
182135	13q14.2	{Major depressive disorder, response to citalopram therapy in}	608516	_	3
182135	13q14.2	{Obsessive-compulsive disorder, susceptibility to}	164230	AD	3
182135	13q14.2	{Schizophrenia, susceptibility to}	181500	AD	3
182135	13q14.2	{Seasonal affective disorder, susceptibility to}	608516	_	3
182138	17q11.2	{Anxiety-related personality traits}	607834	_	3
182138	17q11.2	{Obsessive-compulsive disorder}	164230	AD	3
182170	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
182212	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
182250	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
182279	15q11.2	Prader-Willi syndrome	176270	AD	3
182280	3p23-p21	Small-cell cancer of lung	182280	AD	2
182282	20p13	Cerebrocostomandibular syndrome	117650	AD	3
182283	17q12	{HIV infection, resistance to}	609423	_	2
182290	17p11.2	Smith-Magenis syndrome	182290	AD,IC	3
182307	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
182309	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
182309	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
182309	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
182310	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
182310	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
182330	1q24.2	[Blood pressure regulation QTL]	145500	Mu	2
182340	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
182340	1q23.2	Migraine, familial basilar	602481	AD	3
182340	1q23.2	Migraine, familial hemiplegic, 2	602481	AD	3
182350	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
182350	19q13.2	CAPOS syndrome	601338	AD	3
182350	19q13.2	Dystonia-12	128235	AD	3
182380	22q12.3	Glucose/galactose malabsorption	606824	AR	3
182381	16p11.2	Renal glucosuria	233100	AD,AR	3
182389	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 2	604403	AD	3
182389	2q24.3	Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)	607208	AD	3
182389	2q24.3	Febrile seizures, familial, 3A	604403	AD	3
182389	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
182390	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
182390	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
182391	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
182391	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
182410	22q11.1	?Sneddon syndrome	182410	AR	3
182455	16p13.3	Somatostatin analog, resistance to	_	_	3
182465	21q22.11	ZTTK syndrome	617140	AD	3
182500	15q21.1	?Cataract, congenital	182500	_	2
182530	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
182530	2p22.1	Noonan syndrome 4	610733	AD	3
182600	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
182601	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
182810	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
182860	1q23.1	Elliptocytosis-2	130600	AD	3
182860	1q23.1	Pyropoikilocytosis	266140	AR	3
182860	1q23.1	Spherocytosis, type 3	270970	AR	3
182870	14q23.3	Anemia, neonatal hemolytic, fatal or near-fatal	617948	_	3
182870	14q23.3	Elliptocytosis-3	617948	_	3
182870	14q23.3	Spherocytosis, type 2	616649	AD	3
182888	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
182889	7q11.23	Oocyte maturation defect 3	617712	AD	3
182900	8p11.21	Spherocytosis, type 1	182900	AD,AR	3
182920	5q31.2	Myopathy, spheroid body	182920	AD	3
182960	7q34-q36	Neuronopathy, distal hereditary motor, type I	182960	AD	2
182980	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
183086	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
183600	7q21.2-q21.3	Split hand/foot malformation 1	183600	AD	4
183840	9q31-q34	{Spondyloarthropathy, susceptibility to, 2}	183840	AD	2
183900	12q13.11	SED congenita	183900	AD	3
184095	12q24.11	SED, Maroteaux type	184095	AD	3
184100	12q13	Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100	AD	2
184250	12q13.11	SMED Strudwick type	184250	AD	3
184252	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
184255	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
184260	14q32.12	Osteochondrodysplasia	184260	AR	3
184420	8p23.1	Squalene synthase deficiency	618156	_	3
184429	3q26.33	Microphthalmia, syndromic 3	206900	AD	3
184429	3q26.33	Optic nerve hypoplasia and abnormalities of the central nervous system	206900	AD	3
184450	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
184460	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
184500	17q21.2	Steatocystoma multiplex	184500	AD	3
184600	3q21.1	Peeling skin syndrome 4	607936	AR	3
184700	19p13.2	Polycystic ovary syndrome 1	184700	AD	2
184745	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
184745	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
184745	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
184755	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
184757	9q33.3	46, XX sex reversal 4	617480	AD	3
184757	9q33.3	46XY sex reversal 3	612965	AD	3
184757	9q33.3	Adrenocortical insufficiency	612964	AD	3
184757	9q33.3	Premature ovarian failure 7	612964	AD	3
184757	9q33.3	Spermatogenic failure 8	613957	AD	3
184840	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
184900	15q21.1	Stiff skin syndrome	184900	AD	3
185000	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
185020	17q21.31	Cryohydrocytosis	185020	AD	3
185070	11p15.4	Stormorken syndrome	185070	AD	3
185100	7p22.1	{Strabismus, susceptibility to, 1}	185100	_	2
185250	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
185300	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
185470	1p36.13	Gastrointestinal stromal tumor	606764	AD,IC	3
185470	1p36.13	Paraganglioma and gastric stromal sarcoma	606864	_	3
185470	1p36.13	Paragangliomas 4	115310	AD	3
185470	1p36.13	Pheochromocytoma	171300	AD	3
185490	4p15.2	[Superoxide dismutase, elevated extracellular]	_	_	3
185500	7q11.23	Supravalvar aortic stenosis	185500	AD	3
185535	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
185535	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
185605	12q21.2	Baker-Gordon syndrome	618218	AD	3
185620	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
185620	9q34.2	Leigh syndrome, due to COX IV deficiency	256000	Mi,AR	3
185800	17q22	Symphalangism, proximal, 1A	185800	AD	3
185880	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
185880	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
185900	2q34-q36	Syndactyly, type 1, with or without craniosynostosis	185900	AD	4
186000	2q31.1	Synpolydactyly 1	186000	AD	3
186100	6q22.31	Syndactyly, type III	186100	AD	3
186200	7q36.3	Syndactyly, type IV	186200	AD	3
186300	2q31.1	Syndactyly, type V	186300	AD	3
186357	1p35.2	{Obesity, association with}	601665	AD,AR,Mu	3
186500	17q22	Multiple synostoses syndrome 1	186500	AD	3
186550	5q31.1	Liebenberg syndrome	186550	AD	4
186570	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
186580	16q12.1	Blau syndrome	186580	AD	3
186711	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
186740	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
186780	1q24.2	?Immunodeficiency 25	610163	AR	3
186790	11q23.3	Immunodeficiency 19	615617	AR	3
186830	11q23.3	Immunodeficiency 18	615615	AR	3
186830	11q23.3	Immunodeficiency 18, SCID variant	615615	AR	3
186845	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
186855	9q31.2	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
186860	2q34	Leukemia/lymphoma, T-cell	186860	_	2
186880	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
186910	2p11.2	CD8 deficiency, familial	608957	AR	3
186921	11p15.4	Leukemia, T-cell acute lymphoblastic	186921	_	2
186940	12p13.31	OKT4 epitope deficiency	613949	_	3
186960	14q32.13	Leukemia/lymphoma, T-cell	186960	_	2
186973	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
187011	17q12	{HIV-1 disease, delayed progression of}	_	_	3
187011	17q12	{HIV-1 disease, rapid progression of}	_	_	3
187040	1p33	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
187260	5q14	Telangiectasia, hereditary benign	187260	AD	2
187270	5p15.33	{Dyskeratosis congenita, autosomal dominant 2}	613989	AD,AR	3
187270	5p15.33	{Dyskeratosis congenita, autosomal recessive 4}	613989	AD,AR	3
187270	5p15.33	{Leukemia, acute myeloid}	601626	AD,SMu	3
187270	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
187270	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
187300	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
187370	2q31.3-q32.1	Arthrogryposis, distal, type 10	187370	AD	2
187380	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
187395	3p21.31	Forebrain defects	_	_	3
187600	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
187601	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
187680	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
187900	9q34.13	Bleeding disorder, platelet-type, 17	187900	AD,AR	3
188000	10p12.1	Thrombocytopenia 2	188000	AD	3
188025	11q23	?Thrombocytopenia, Paris-Trousseau type	188025	IC	4
188030	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
188040	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
188040	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
188061	6q27	{Lumbar disc herniation, susceptibility to}	603932	_	3
188070	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
188250	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
188250	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
188400	22q11.21	DiGeorge syndrome	188400	AD	3
188450	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
188450	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
188540	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
188545	8q23.1	Thyrotropin-releasing hormone resistance, generalized	_	_	3
188550	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
188570	3p24.2	Thyroid hormone resistance	188570	AD	3
188580	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
188740	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
188826	22q12.3	Sorsby fundus dystrophy	136900	AD	3
188830	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
188830	17q24.2	Adrenocortical tumor, somatic	_	_	3
188830	17q24.2	Carney complex, type 1	160980	AD	3
188830	17q24.2	Myxoma, intracardiac	255960	AD	3
188830	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
188840	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
188840	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
188840	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
188840	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
188840	2q31.2	Salih myopathy	611705	AR	3
188840	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
189500	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
189800	2p13	Preeclampsia/eclampsia 1	189800	AD	2
189907	17q12	Diabetes mellitus, noninsulin-dependent	125853	AD	3
189907	17q12	Renal cysts and diabetes syndrome	137920	AD	3
189907	17q12	{Renal cell carcinoma}	144700	_	3
189909	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
189909	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
189964	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
189967	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
189980	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
189980	9q34.12	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	_	_	3
189990	6q23.3	{T-cell acute lymphoblastic leukemia}	_	_	3
190000	3q22.1	Atransferrinemia	209300	AR	3
190010	3q29	Immunodeficiency 46	616740	AR	3
190020	11p15.5	Bladder cancer, somatic	109800	_	3
190020	11p15.5	Congenital myopathy with excess of muscle spindles	218040	AD	3
190020	11p15.5	Costello syndrome	218040	AD	3
190020	11p15.5	Nevus sebaceous or woolly hair nevus, somatic	162900	_	3
190020	11p15.5	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190020	11p15.5	Spitz nevus or nevus spilus, somatic	137550	_	3
190020	11p15.5	Thyroid carcinoma, follicular, somatic	188470	_	3
190040	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
190040	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
190040	22q13.1	Meningioma, SIS-related	607174	AD	3
190070	12p12.1	Arteriovenous malformation of the brain, somatic	108010	_	3
190070	12p12.1	Bladder cancer, somatic	109800	_	3
190070	12p12.1	Breast cancer, somatic	114480	_	3
190070	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
190070	12p12.1	Gastric cancer, somatic	137215	_	3
190070	12p12.1	Leukemia, acute myeloid	601626	AD,SMu	3
190070	12p12.1	Lung cancer, somatic	211980	_	3
190070	12p12.1	Noonan syndrome 3	609942	AD	3
190070	12p12.1	Pancreatic carcinoma, somatic	260350	_	3
190070	12p12.1	RAS-associated autoimmune leukoproliferative disorder	614470	AD	3
190070	12p12.1	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190080	8q24.21	Burkitt lymphoma, somatic	113970	_	3
190090	20q11.23	?Thrombocytopenia 6	616937	AD	3
190090	20q11.23	Colon cancer, advanced, somatic	114500	_	3
190100	9q13-q21	Geniospasm	190100	AD	2
190120	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
190151	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
190151	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
190160	3p24.2	Thyroid hormone resistance	188570	AD	3
190160	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
190160	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
190180	19q13.2	Camurati-Engelmann disease	131300	AD	3
190180	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
190180	19q13.2	{Cystic fibrosis lung disease, modifier of}	219700	AR	3
190181	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
190181	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
190182	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
190182	3p24.1	Esophageal cancer, somatic	133239	_	3
190182	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
190195	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
190197	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
190198	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
190198	9q34.3	Aortic valve disease 1	109730	AD	3
190220	1q41	Loeys-Dietz syndrome 4	614816	AD	3
190230	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
190230	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
190300	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
190315	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
190315	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
190320	17q21.33	Trichodontoosseous syndrome	190320	AD	3
190330	4q21.21	Trichomegaly	190330	AR	3
190350	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
190351	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
190370	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
190440	8p11.23	Trigonocephaly 1	190440	AD	3
190450	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
190685	21q22.3	Down syndrome	190685	IC	4
190900	7q32.1	Colorblindness, tritan	190900	AD	3
190990	9p13.3	Arthrogryposis, distal, type 1A	108120	AD	3
190990	9p13.3	Arthrogryposis, distal, type 2B4	108120	AD	3
190990	9p13.3	CAP myopathy 2	609285	AD	3
190990	9p13.3	Nemaline myopathy 4, autosomal dominant	609285	AD	3
191010	15q22.2	Cardiomyopathy, dilated, 1Y	611878	AD	3
191010	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
191010	15q22.2	Left ventricular noncompaction 9	611878	AD	3
191030	1q21.3	CAP myopathy 1	609284	AD,AR	3
191030	1q21.3	Myopathy, congenital, with fiber-type disproportion	255310	AD,AR	3
191030	1q21.3	Nemaline myopathy 1, autosomal dominant or recessive	609284	AD,AR	3
191040	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
191040	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
191041	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
191043	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
191044	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
191044	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
191044	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
191044	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
191045	1q32.1	Cardiomyopathy, dilated, 1D	601494	AD	3
191045	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
191045	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
191045	1q32.1	Left ventricular noncompaction 6	601494	AD	3
191050	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
191070	4q32.1	[?Hypertryptophanemia]	600627	AR	3
191092	16p13.3	?Focal cortical dysplasia, type II, somatic	607341	_	3
191092	16p13.3	Lymphangioleiomyomatosis, somatic	606690	_	3
191092	16p13.3	Tuberous sclerosis-2	613254	AD	3
191100	9q34.13	Tuberous sclerosis-1	191100	AD	3
191110	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
191130	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
191130	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
191135	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
191160	6p21.33	{Asthma, susceptibility to}	600807	AD	3
191160	6p21.33	{Dementia, vascular, susceptibility to}	_	_	3
191160	6p21.33	{Malaria, cerebral, susceptibility to}	611162	_	3
191160	6p21.33	{Migraine without aura, susceptibility to}	157300	AD	3
191160	6p21.33	{Septic shock, susceptibility to}	_	_	3
191163	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
191170	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
191170	17p13.1	Breast cancer, somatic	114480	_	3
191170	17p13.1	Hepatocellular carcinoma, somatic	114550	_	3
191170	17p13.1	Li-Fraumeni syndrome	151623	AD	3
191170	17p13.1	Nasopharyngeal carcinoma, somatic	607107	_	3
191170	17p13.1	Pancreatic cancer, somatic	260350	_	3
191170	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
191170	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
191170	17p13.1	{Choroid plexus papilloma}	260500	AD	3
191170	17p13.1	{Colorectal cancer}	114500	AD,SMu	3
191170	17p13.1	{Glioma susceptibility 1}	137800	AD,SMu	3
191170	17p13.1	{Osteosarcoma}	259500	SMu	3
191181	11q13	Cervical carcinoma	191181	_	2
191190	12p13.31	Periodic fever, familial	142680	AD	3
191190	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
191195	10p11.23	Lung cancer, somatic	211980	_	3
191290	11p15.5	Segawa syndrome, recessive	605407	AR	3
191305	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
191306	4q12	Hemangioma, capillary infantile, somatic	602089	_	3
191306	4q12	{Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
191311	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
191311	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
191315	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
191315	1q23.1	Medullary thyroid carcinoma, familial	155240	AD	3
191329	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
191330	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
191342	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
191342	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
191350	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
191350	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
191390	7q22	{Inflammatory bowel disease 11}	191390	Mu	2
191480	1p36.13	Uncombable hair syndrome	191480	AR	3
191523	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
191525	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
191540	1p22	[Urate oxidase deficiency]	_	_	1
191740	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
191740	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
191740	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
191740	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
191740	2q37.1	[Gilbert syndrome]	143500	AR	3
191830	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
191840	10q22.2	Quebec platelet disorder	601709	AD	3
191840	10q22.2	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
191845	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
191845	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
191845	16p12.3	Medullary cystic kidney disease 2	603860	_	3
191900	1q44	Muckle-Wells syndrome	191900	AD	3
192090	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
192090	16q22.1	Endometrial carcinoma, somatic	608089	_	3
192090	16q22.1	Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate	137215	AD	3
192090	16q22.1	Ovarian cancer, somatic	167000	_	3
192090	16q22.1	{Breast cancer, lobular}	114480	AD,SMu	3
192090	16q22.1	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
192132	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
192150	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
192240	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
192315	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
192340	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
192430	22q11.21	Velocardiofacial syndrome	192430	AD	3
192605	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
192974	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
192977	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
193000	1p13	Vesicoureteral reflux	193000	AD	2
193001	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
193003	13q31-q33	Nystagmus 4, congenital, autosomal dominant	193003	AD	2
193007	6q	Vestibulopathy, familial	193007	AD	2
193060	10p13	Cataract 30, pulverulent	116300	AD	3
193065	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
193065	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
193067	11q24.3	Bleeding disorder, platelet-type, 21	617443	AD,AR	3
193100	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
193200	6p21.3	{Vitiligo-associated multiple autoimmune disease susceptibility 6}	193200	AR	2
193230	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
193235	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
193400	12p13.31	von Willebrand disease, type 1	193400	AD	3
193500	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
193510	3p13	Waardenburg syndrome, type 2A	193510	AD	3
193520	17q11.2	Watson syndrome	193520	AD	3
193670	2q22.1	WHIM syndrome	193670	AD	3
193700	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
193900	12q13.13	White sponge nevus 1	193900	AD	3
194050	7q11.23	Williams-Beuren syndrome	194050	AD	4
194071	11p15.5	Wilms tumor 2	194071	AD,SMu	3
194072	11p13	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	AD,SMu	4
194080	11p13	Denys-Drash syndrome	194080	AD,SMu	3
194090	16q	Wilms tumor, type 3	194090	AD	2
194190	4p16.3	Wolf-Hirschhorn syndrome	194190	IC	4
194200	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
194300	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
194355	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
194360	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
194363	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
194380	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
194648	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
195000	11q12.2	Oocyte maturation defect 1	615774	AR	3
200100	4q23	Abetalipoproteinemia	200100	AR	3
200110	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
200150	9q21.2	Choreoacanthocytosis	200150	AR	3
200350	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
200500	7q36.3	Acheiropody	200500	AR	3
200600	14q32.12	Achondrogenesis, type IA	200600	AR	3
200610	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
200700	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
200950	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
201000	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
201100	8q24.3	Acrodermatitis enteropathica	201100	AR	3
201250	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
201300	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
201400	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
201450	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
201470	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
201475	17p13.1	VLCAD deficiency	201475	AR	3
201710	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
201750	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
201810	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
202010	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
202200	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
202300	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
202370	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
202650	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
202700	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
203100	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
203290	9p23	Albinism, oculocutaneous, type III	203290	AR	3
203300	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
203400	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
203450	17q21.31	Alexander disease	203450	AD	3
203500	3q13.33	Alkaptonuria	203500	AR	3
203650	3q26.3-q27.3	Alopecia-mental retardation syndrome 1	203650	AR	2
203655	8p21.3	Alopecia universalis	203655	AR	3
203700	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
203740	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
203750	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
203800	2p13.1	Alstrom syndrome	203800	AR	3
204000	17p13.1	Leber congenital amaurosis 1	204000	AR	3
204100	1p31.3	Leber congenital amaurosis 2	204100	AR	3
204200	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
204300	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
204500	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
204650	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
204690	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
204700	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
204750	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
204870	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
205100	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
205400	9q31.1	Tangier disease	205400	AR	3
205950	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
206100	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
206200	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
206500	5q22.3	?Anencephaly	206500	AR	3
206700	3p26.1	Gillespie syndrome	206700	AD,AR	3
206800	20p13	Anonychia congenita	206800	AR	3
206920	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
207410	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
207750	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
207800	6q23.2	Argininemia	207800	AR	3
207900	7q11.21	Argininosuccinic aciduria	207900	AR	3
208000	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
208050	20q13.12	Arterial tortuosity syndrome	208050	AR	3
208085	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
208100	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
208150	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
208250	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
208400	4q34.3	Aspartylglucosaminuria	208400	AR	3
208500	15q13	Short-rib thoracic dysplasia 1 with or without polydactyly	208500	AR	2
208530	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
208540	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
208900	11q22.3	Ataxia-telangiectasia	208900	AR	3
208920	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
209300	3q22.1	Atransferrinemia	209300	AR	3
209500	8p21.3	Atrichia with papular lesions	209500	AR	3
209850	7q22	{Autism susceptibility 1}	209850	IC,Mu	2
209885	2q37.3	Barber-Say syndrome	209885	AD	3
209901	11q13.2	Bardet-Biedl syndrome 1	209900	DR,AR	3
209950	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
210000	3q29	Behr syndrome	210000	AR	3
210100	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
210200	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
210210	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
210370	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
210600	3q23	Seckel syndrome 1	210600	AR	3
210710	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
210720	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
210900	15q26.1	Bloom syndrome	210900	AR	3
211100	19q13.33	[Bombay phenotype]	616754	AR	3
211180	12p13.31	Bowen-Conradi syndrome	211180	AR	3
211380	16q21	Elsahy-Waters syndrome	211380	AR	3
211500	20p13	?Fazio-Londe disease	211500	AR	3
211530	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
211600	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
211750	3q13.1-q13.2	C syndrome	211750	AD	3
211800	6q14.3	Calcification of joints and arteries	211800	AR	3
211900	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
212050	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
212065	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
212066	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
212070	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
212093	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
212112	1q22	Malouf syndrome	212112	AD	3
212138	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
212140	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
212200	18q21.3	Carnosinemia	212200	AR	2
212350	7q34	Sengers syndrome	212350	AR	3
212500	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
212550	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
212720	1q41	Martsolf syndrome	212720	AR	3
212780	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
212840	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
213200	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
213300	9q34.3	Joubert syndrome 1	213300	AR	3
213600	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
213700	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
213980	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
214100	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
214110	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
214150	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
214300	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
214350	21q22.3	CHAND syndrome	214350	AR	3
214400	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
214450	15q21.2	Griscelli syndrome, type 1	214450	AR	3
214500	1q42.3	Chediak-Higashi syndrome	214500	AR	3
214700	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
214900	15q	Cholestasis-lymphedema syndrome	214900	AR	2
214950	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
215045	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
215100	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
215140	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
215150	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
215300	8q24.11	Chondrosarcoma	215300	AR	3
215400	6q27	{Chordoma, susceptibility to}	215400	AD	4
215470	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
215500	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
215700	9q34.11	Citrullinemia	215700	AR	3
216340	6q21	Yunis-Varon syndrome	216340	AR	3
216400	5q12.1	Cockayne syndrome, type A	216400	AR	3
216550	8q22.2	Cohen syndrome	216550	AR	3
216820	14q11.2	?Coloboma, ocular, autosomal recessive	216820	AR	3
216900	2q11.2	Achromatopsia 2	216900	AR	3
217000	6p21.33	C2 deficiency	217000	AR	3
217030	4q25	Complement factor I deficiency	610984	AR	3
217030	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
217030	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
217050	5p13.1	C6 deficiency	612446	_	3
217050	5p13.1	Combined C6/C7 deficiency	_	_	3
217070	5p13.1	C7 deficiency	610102	_	3
217080	2q11.2	Jalili syndrome	217080	AR	3
217085	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
217300	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
217400	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
217700	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
217800	16q23.1	Macular corneal dystrophy	217800	AR	3
218000	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
218030	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
218330	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
218340	12p13.31	Temtamy syndrome	218340	AR	3
218400	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
218600	8q24.3	Baller-Gerold syndrome	218600	AR	3
218700	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
218800	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
219000	4q21.21	Fraser syndrome 1	219000	AR	3
219050	19p13.11	Cryptorchidism	219050	AD	3
219080	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
219090	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
219100	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
219150	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
219200	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
219500	1p31.1	Cystathioninuria	219500	AR	3
219730	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
219750	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
219900	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
220111	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
220120	3p21.2	D-glyceric aciduria	220120	AR	3
220150	11q13.1	Hypouricemia, renal	220150	AR	3
220200	3q22-q24	Dandy-Walker syndrome	220200	IC	4
220210	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
220400	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
220500	16p13.3	DOORS syndrome	220500	AR	3
220600	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
221200	13q31.1	Deafness and myopia	221200	AR	3
221750	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
221770	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
221820	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
221900	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
222100	6p21.3	{Diabetes mellitus, insulin-dependent-1}	222100	AR	2
222300	4p16.1	Wolfram syndrome 1	222300	AR	3
222400	8p23.1	Hernia, congenital diaphragmatic 2	222400	AR	2
222448	2q31.1	Donnai-Barrow syndrome	222448	AR	3
222470	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
222700	14q11.2	Lysinuric protein intolerance	222700	AR	3
222730	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
222748	8q22.3	Dihydropyrimidinuria	222748	AR	3
222765	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
222800	7q33	Erythrocytosis, familial, 8	222800	AR	3
222900	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
223000	2q21.3	Lactase deficiency, congenital	223000	AR	3
223100	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
223360	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
223800	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
223900	9q31.3	Dysautonomia, familial	223900	AR	3
224050	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
224100	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
224120	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
224230	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
224410	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
224500	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
224690	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
224750	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
224900	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
225100	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
225200	1q21.2	Ectopia lentis et pupillae	225200	AR	3
225250	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
225280	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
225300	12q13.12	Split-hand/foot malformation 6	225300	AR	3
225320	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
225400	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
225410	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
225750	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AD,AR	3
225753	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
225790	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
226200	21q21.1	Enterokinase deficiency	226200	AR	3
226300	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
226400	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
226670	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
226750	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
226900	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
226980	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
226990	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
227050	19q13.2	Transient erythroblastopenia of childhood	227050	AR	2
227260	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
227300	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
227400	1q24.2	Factor V deficiency	227400	AR	3
227500	13q34	Factor VII deficiency	227500	AR	3
227600	13q34	Factor X deficiency	227600	AR	3
227645	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
227646	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
227650	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
227810	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
228000	8p22	Farber lipogranulomatosis	228000	AR	3
228300	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
228520	1p21.1	Fibrochondrogenesis 1	228520	AR	3
228550	5q32	Myofibromatosis, infantile, 1	228550	AD	3
228600	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
228900	20q11.22	Du Pan syndrome	228900	AR	3
228930	3p25.1	Fuhrmann syndrome	228930	AR	3
228980	1p36.13	[Fleck retina, familial benign]	228980	AR	3
229000	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
229050	17q11.2	Folate malabsorption, hereditary	229050	AR	3
229070	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
229100	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
229200	16q24.2	Brittle cornea syndrome 1	229200	AR	3
229600	9q31.1	Fructose intolerance, hereditary	229600	AR	3
229700	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
229800	2p23.3	[Fructosuria]	229800	AR	3
230000	1p36.11	Fucosidosis	230000	AR	3
230200	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
230350	1p36.11	Galactose epimerase deficiency	230350	AR	3
230400	9p13.3	Galactosemia	230400	AR	3
230450	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
230500	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
230600	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
230650	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
230740	2p13.3	GAPO syndrome	230740	AR	3
230800	1q22	Gaucher disease, type I	230800	AR	3
230900	1q22	Gaucher disease, type II	230900	AR	3
231000	1q22	Gaucher disease, type III	231000	AR	3
231005	1q22	Gaucher disease, type IIIC	231005	AR	3
231050	9q34.2	Geleophysic dysplasia 1	231050	AR	3
231070	1q24.2	Geroderma osteodysplasticum	231070	AR	3
231090	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
231095	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
231300	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
231530	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
231550	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
231670	19p13.13	Glutaricaciduria, type I	231670	AR	3
231675	4q32.1	Glutaric acidemia IIC	231680	AR	3
231690	7p14.1	Glutaric aciduria III	231690	AR	3
231900	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
231950	22q11.23	?Glutathioninuria	231950	AR	3
232000	13q32.3	Propionicacidemia	606054	AR	3
232050	3q22.3	Propionicacidemia	606054	AR	3
232200	17q21.31	Glycogen storage disease Ia	232200	AR	3
232220	11q23.3	Glycogen storage disease Ib	232220	AR	3
232240	11q23.3	Glycogen storage disease Ic	232240	AR	3
232300	17q25.3	Glycogen storage disease II	232300	AR	3
232500	3p12.2	Glycogen storage disease IV	232500	AR	3
232600	11q13.1	McArdle disease	232600	AR	3
232700	14q22.1	Glycogen storage disease VI	232700	AR	3
232800	12q13.11	Glycogen storage disease VII	232800	AR	3
233100	16p11.2	Renal glucosuria	233100	AD,AR	3
233300	2p16.3	Ovarian dysgenesis 1	233300	AR	3
233400	5q23.1	Perrault syndrome 1	233400	AR	3
233420	12q13.12	46XY sex reversal 7	233420	AR	3
233600	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
233690	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
233700	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
233710	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
233910	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
234000	5q35.3	Factor XII deficiency	234000	AR	3
234050	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
234200	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
234500	5p15.33	Hartnup disorder	234500	AR	3
234580	7q21.2	Heimler syndrome 1	234580	AR	3
234810	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
235000	11p15	Hemihypertrophy	235000	AD	2
235510	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
235550	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
235555	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
235700	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
235730	2q22.3	Mowat-Wilson syndrome	235730	AD	3
235800	12q23.1	[Histidinemia]	235800	AD,AR	3
236000	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
236100	21q22.3	Holoprosencephaly 1	236100	AD,IC	2
236250	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
236270	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
236500	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
236600	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
236670	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
236680	11q24.2	Hydrolethalus syndrome	236680	AR	3
236700	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
236730	10q24.2	Urofacial syndrome 1	236730	AR	3
236792	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
236800	2q22.2	?Hydroxykynureninuria	236800	AR	3
237300	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
237310	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
237500	10q24.2	Dubin-Johnson syndrome	237500	AR	3
237900	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
238300	9p24.1	Glycine encephalopathy	605899	AR	3
238310	3p21.31	Glycine encephalopathy	605899	AR	3
238330	16q23.2	?Glycine encephalopathy	605899	AR	3
238331	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
238700	7q31.32	Hyperlysinemia	238700	AR	3
238970	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
239000	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
239100	17q21.31	Van Buchem disease	239100	AR	3
239200	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
239300	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
239500	22q11.21	Hyperprolinemia, type I	239500	AR	3
239510	1p36.13	Hyperprolinemia, type II	239510	AR	3
239850	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
240300	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AD,AR	3
240400	8p21.1	Scurvy	_	_	3
240500	17p11.2	Immunodeficiency, common variable, 2	240500	AD,AR	3
240600	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
240800	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
240900	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
241080	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
241200	11q24.3	Bartter syndrome, type 2	241200	AR	3
241410	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
241500	1p36.12	Hypophosphatasia, infantile	241500	AR	3
241510	1p36.12	Hypophosphatasia, childhood	241510	AR	3
241520	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
241530	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
241550	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
241600	15q21.1	Immunodeficiency 43	241600	AR	3
241800	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
241850	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
242100	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
242300	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
242500	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
242840	18q12.3-q21.1	Vici syndrome	242840	AR	3
242860	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
242900	2q35	Schimke immunoosseous dysplasia	242900	AR	3
243060	19q13.43	Spermatogenic failure 5	243060	AR	3
243150	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
243300	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
243305	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
243310	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
243400	8p22	[Acetylation, slow]	243400	AR	3
243500	15q15.1	Isovaleric acidemia	243500	AR	3
243605	1q41	Stromme syndrome	243605	AR	3
243700	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
243800	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
244200	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
244400	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
244450	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
244460	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
245000	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
245010	11q14.2	Haim-Munk syndrome	245010	AR	3
245050	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
245150	12p12.3	Keutel syndrome	245150	AR	3
245200	14q31.3	Krabbe disease	245200	AR	3
245300	20p13	{Kuru, susceptibility to}	245300	_	3
245340	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
245348	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
245349	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
245400	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
245450	16q23.1	D-lactic aciduria	245450	AR	3
245480	14q11.2	Specific granule deficiency	245480	AR	3
245570	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
245590	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
245600	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
245660	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
245800	19p13.2	?Laurence-Moon syndrome	245800	AR	3
245900	16q22.1	Norum disease	245900	AR	3
246200	19p13.2	Leprechaunism	246200	AR	3
246300	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
246450	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
246530	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
246560	10q24	Split-hand/foot malformation 3, gene duplication syndrome	246560	AD	4
246600	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
246650	16p13.3	Lipase deficiency, combined	246650	AR	3
246700	5q31.1	Chylomicron retention disease	246700	AR	3
246900	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
247100	1q21.2	Urbach-Wiethe disease	247100	AR	3
247200	17p13.3	Miller-Dieker lissencephaly syndrome	247200	AD	4
247420	19q13.32	[Blood group, Lutheran null]	247420	AR	3
247640	9p22-p21	Leukemia, acute lymphoblastic	247640	AR	2
248000	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
248190	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
248250	3q28	Hypomagnesemia 3, renal	248250	AR	3
248300	8q24.3	Meleda disease	248300	AR	3
248310	5q31-q33	{Malaria, intensity of infection}	248310	AR	2
248340	8q24.12	3MC syndrome 3	248340	AR	3
248360	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
248370	1q22	Mandibuloacral dysplasia	248370	AR	3
248390	6p21.1	Treacher Collins syndrome 3	248390	AR	3
248450	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
248500	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
248510	4q24	Mannosidosis, beta	248510	AR	3
248610	1p21.2	Maple syrup urine disease, type II	248600	AR	3
248611	6q14.1	Maple syrup urine disease, type Ib	248600	AR	3
248700	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
248800	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
248900	15q22.31	Mast syndrome	248900	AR	3
249000	17q22	Meckel syndrome 1	249000	AR	3
249100	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
249270	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
249400	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
249420	5q35.1	Frank-ter Haar syndrome	249420	AR	3
249500	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
249900	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
250100	22q13.33	Metachromatic leukodystrophy	250100	AR	3
250220	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
250250	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
250400	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
250410	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
250460	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
250620	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
250790	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
250940	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
250950	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
251000	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
251100	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
251110	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
251120	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
251170	12q24.11	Hyper-IgD syndrome	260920	AR	3
251170	12q24.11	Mevalonic aciduria	610377	AR	3
251170	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
251200	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
251230	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
251255	18q11.2	Jawad syndrome	251255	AR	3
251260	8q21.3	Nijmegen breakage syndrome	251260	AR	3
251270	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
251280	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
251290	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
251300	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
251450	17q25.3	Desbuquois dysplasia 1	251450	AR	3
251600	14q32	Microphthalmia, isolated 1	251600	AR	2
251750	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
251850	18q21.1	Microvillus inclusion disease	251850	AR	3
251880	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
251900	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
251950	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
252010	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
252150	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
252160	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
252270	7q	Myelodysplasia and leukemia syndrome with monosomy 7	252270	AR	4
252350	3p26-p24.2	Moyamoya disease	252350	AR	2
252500	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
252600	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
252605	16p13.3	Mucolipidosis III gamma	252605	AR	3
252650	19p13.2	Mucolipidosis IV	252650	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
252800	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
252900	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
252920	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
252930	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
252940	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
253000	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
253010	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
253200	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
253220	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
253250	17q22	Mulibrey nanism	253250	AR	3
253260	3p25.1	Biotinidase deficiency	253260	AR	3
253270	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
253280	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
253300	5q13.2	Spinal muscular atrophy-1	253300	AR	3
253310	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
253550	5q13.2	Spinal muscular atrophy-2	253550	AR	3
253600	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
253601	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
253700	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
253800	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
254110	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
254130	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
254210	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
254300	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
254600	17q22	Myeloperoxidase deficiency	254600	AR	3
254770	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
254800	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
254900	4q21.1	Epilepsy, progressive myoclonic 4, with or without renal failure	254900	AR	3
254940	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
255100	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
255110	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
255120	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
255125	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
255160	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
255200	2q14.3	Centronuclear myopathy 2	255200	AR	3
255320	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
255500	14q22.1-q24.2	Myopia 18	255500	AR	2
255600	21q22.3	?Myosclerosis, congenital	255600	AR	3
255700	7q34	Myotonia congenita, recessive	255700	AR	3
255800	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
255960	17q24.2	Myxoma, intracardiac	255960	AD	3
255995	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
256030	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
256040	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
256100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
256300	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
256370	11p13	Nephrotic syndrome, type 4	256370	AD	3
256450	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
256500	5q32	Netherton syndrome	256500	AR	3
256520	1p12	Neu-Laxova syndrome 1	256520	AR	3
256540	20q13.12	Galactosialidosis	256540	AR	3
256600	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
256730	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
256731	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
256800	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
256810	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
256840	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
256850	16q23.2	Giant axonal neuropathy-1	256850	AR	3
257200	11p15.4	Niemann-Pick disease, type A	257200	AR	3
257270	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
257300	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
257320	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
257550	2q13	Oculomotor apraxia, congenital, Cogan-type	257550	AR	2
257850	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
257920	3q27.3	3MC syndrome 1	257920	AR	3
257980	2q35	Odontoonychodermal dysplasia	257980	AR	3
258100	2q37.1	Oguchi disease-1	258100	AR	3
258315	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
258450	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
258480	11q13.4	Opsismodysplasia	258480	AR	3
258500	8q21-q22	Optic atrophy 6	258500	AR	2
258501	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
258660	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
258860	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
258870	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
258900	3q21.2	Orotic aciduria	258900	AR	3
259050	3q13.31	Primrose syndrome	259050	AD	3
259440	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
259450	17q21.2	Bruck syndrome 1	259450	AR	3
259600	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
259700	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
259710	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
259720	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
259730	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
259770	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
259775	7p22.3	Raine syndrome	259775	AR	3
259900	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
260000	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
260005	8q24.3	5-oxoprolinase deficiency	260005	AD,AR	3
260300	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
260370	13q12.2	Pancreatic agenesis 1	260370	AR	3
260400	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
260500	17p13.1	{Choroid plexus papilloma}	260500	AD	3
260540	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
260565	17q12	PEHO syndrome	260565	AR	3
260600	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
260660	1p12	Cousin syndrome	260660	AR	3
260800	17q25.3	[Pentosuria]	260800	AR	3
260920	12q24.11	Hyper-IgD syndrome	260920	AR	3
261000	11q12.1	Intrinsic factor deficiency	261000	AR	3
261500	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
261515	5q23.1	D-bifunctional protein deficiency	261515	AR	3
261540	13q12.3	Peters-plus syndrome	261540	AR	3
261630	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
261640	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
261650	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
261670	7p13	Glycogen storage disease X	261670	AR	3
261680	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
261740	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
261750	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
261800	17q24.3-q25.1	Pierre Robin syndrome	261800	AR	2
261990	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
262000	2q35	Bjornstad syndrome	262000	AR	3
262190	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
262300	8q21.3	Achromatopsia 3	262300	AR	3
262400	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
262500	5p13-p12	Laron dwarfism	262500	AR	3
262600	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
262650	17q23.3	Kowarski syndrome	262650	AR	3
262700	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
262850	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
262890	12q12	Scott syndrome	262890	AR	3
263200	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
263210	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
263300	9p24.1	Polycythemia vera, somatic	263300	_	3
263400	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
263450	13q13.3-q21	Polydactyly, postaxial, type A5	263450	AR	2
263520	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	DR,AR	3
263570	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
263650	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
263700	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
263750	16q22.2	Miller syndrome	263750	AR	3
263800	16q13	Gitelman syndrome	263800	AR	3
264070	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
264080	11q22.1	?Progesterone resistance	264080	AR	2
264090	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
264300	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
264470	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
264600	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
264700	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
264900	4q35.2	Factor XI deficiency, autosomal dominant	612416	_	3
264900	4q35.2	Factor XI deficiency, autosomal recessive	612416	_	3
265000	2q37.1	Escobar syndrome	265000	AR	3
265050	2p25.3	3MC syndrome 2	265050	AR	3
265100	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
265120	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
265380	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
265450	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
265800	1q21.3	Pycnodysostosis	265800	AR	3
265900	7p14.1	Pyle disease	265900	AR	3
266100	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
266120	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
266130	20q11.22	Glutathione synthetase deficiency	266130	AR	3
266140	1q23.1	Pyropoikilocytosis	266140	AR	3
266150	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
266200	1q22	Pyruvate kinase deficiency	266200	AR	3
266265	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
266280	8q24.3	RAPADILINO syndrome	266280	AR	3
266500	10p13	Refsum disease	266500	AR	3
266510	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
266900	2q13	Senior-Loken syndrome-1	266900	AR	3
266920	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
267000	2q37.1	Perlman syndrome	267000	AR	3
267010	3q22.1	Meckel syndrome 7	267010	AR	3
267300	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
267500	1p35.1	Reticular dysgenesis	267500	AR	3
267700	9q21.3-q22	Hemophagocytic lymphohistiocytosis, familial, 1	267700	AR	2
267750	21q22.3	Knobloch syndrome, type 1	267750	AR	3
268100	15q23	Enhanced S-cone syndrome	268100	AR	3
268130	14q12	Revesz syndrome	268130	AD	3
268150	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
268200	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
268210	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
268300	8p21.1	Roberts syndrome	268300	AR	3
268305	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
268310	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
268400	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
268700	7q31.32	Saccharopinuria	268700	AR	1
268800	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
268900	9q34.2	[Sarcosinemia]	268900	AR	3
269000	8p21.1	SC phocomelia syndrome	269000	AR	3
269150	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
269250	1p31.3	Schneckenbecken dysplasia	269250	AR	3
269400	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
269500	17q21.31	Sclerosteosis 1	269500	AR	3
269600	19q13.32	Sea-blue histiocyte disease	269600	AR	3
269700	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
269840	2q11.2	Immunodeficiency 48	269840	AR	3
269880	5q13.1	SHORT syndrome	269880	AD	3
269920	6q13	Sialic acid storage disorder, infantile	269920	AR	3
269921	9p13.3	Sialuria	269921	AD	3
270100	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
270200	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
270300	6p21.33	Peeling skin syndrome 1	270300	AR	3
270400	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
270420	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
270450	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
270550	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
270685	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
270700	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
270750	1q32.1	Spastic paraplegia 23	270750	AR	3
270800	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
270970	1q23.1	Spherocytosis, type 3	270970	AR	3
271150	5q13.2	Spinal muscular atrophy-4	271150	AR	3
271245	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
271250	6p23-p21	Spinocerebellar ataxia, autosomal recessive 3	271250	AR	2
271400	3p22.1	Asplenia, isolated congenital	271400	AD	3
271640	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
271665	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
271700	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
271900	17p13.2	Canavan disease	271900	AR	3
271930	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
271980	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
272120	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
272200	3p26.1	Multiple sulfatase deficiency	272200	AR	3
272300	12q13.2	Sulfite oxidase deficiency	272300	AR	3
272430	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
272440	2q14.1	Filippi syndrome	272440	AR	3
272460	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
272750	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
273395	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
273750	6p21.1	3-M syndrome 1	273750	AR	3
273900	5p13.1	Thrombocytopenia 3	273900	AR	3
274000	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
274150	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
274180	7q34	?Thromboxane synthase deficiency	614158	AD	1
274180	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
274300	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
274400	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
274500	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
274600	7q22.3	Pendred syndrome	274600	AR	3
274700	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
274800	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
274900	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
275000	14q31	{Graves disease, susceptibility to, 1}	275000	AR	2
275100	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
275120	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
275200	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
275220	8q24.1	?Tibial hemimelia	275220	AR	2
275350	22q12.2	Transcobalamin II deficiency	275350	AR	3
275360	11q23.3	Trehalase deficiency	612119	AR	3
275400	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
275630	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
275900	13q13.3	Troyer syndrome	275900	AR	3
276000	7q34	Pancreatitis, hereditary	167800	AD	3
276000	7q34	Trypsinogen deficiency	614044	AR	1
276400	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
276600	16q22.2	Tyrosinemia, type II	276600	AR	3
276700	15q25.1	Tyrosinemia, type I	276700	AR	3
276710	12q24.31	Tyrosinemia, type III	276710	AR	3
276820	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
276880	3q21.3	?Urocanase deficiency	276880	AR	3
276900	11q13.5	Usher syndrome, type 1B	276900	AR	3
276902	3q25.1	Usher syndrome, type 3A	276902	AR	3
276903	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
276903	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
276903	11q13.5	Usher syndrome, type 1B	276900	AR	3
276904	11p15.1	Usher syndrome, type 1C	276904	AR	3
277170	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
277180	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
277300	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
277380	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
277440	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
277450	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
277460	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
277470	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
277480	12p13.31	von Willibrand disease, type 3	277480	AR	3
277580	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
277590	7q36.1	Weaver syndrome	277590	AD	3
277600	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
277700	8p12	Werner syndrome	277700	AR	3
277900	13q14.3	Wilson disease	277900	AR	3
277950	14q11.2	?Winchester syndrome	277950	_	3
278250	12q24.31	Wrinkly skin syndrome	278250	AR	3
278300	2p23.1	Xanthinuria, type I	278300	AR	3
278700	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
278720	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
278730	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
278740	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
278750	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
278800	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
278850	17q24.3-q25.1	46XX sex reversal 2	278850	AD	4
280000	17p11.2	CHIME syndrome	280000	AR	3
300000	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300004	Xp21.3	Proud syndrome	300004	XL	3
300005	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300005	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300005	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300005	Xq28	Rett syndrome	312750	XLD	3
300005	Xq28	Rett syndrome, atypical	312750	XLD	3
300005	Xq28	Rett syndrome, preserved speech variant	312750	XLD	3
300005	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300008	Xp11.23	Dent disease	300009	XLR	3
300008	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300008	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
300008	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
300009	Xp11.23	Dent disease	300009	XLR	3
300011	Xq21.1	Menkes disease	309400	XLR	3
300011	Xq21.1	Occipital horn syndrome	304150	XLR	3
300011	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300013	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
300013	Xq28	Ogden syndrome	300855	XLR,XLD	3
300014	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
300017	Xq28	?FG syndrome 2	300321	XL	3
300017	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
300017	Xq28	Congenital short bowel syndrome	300048	XLR	3
300017	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
300017	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300017	Xq28	Intestinal pseudoobstruction, neuronal	300048	XLR	3
300017	Xq28	Melnick-Needles syndrome	309350	XLD	3
300017	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
300017	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
300017	Xq28	Terminal osseous dysplasia	300244	XLD	3
300018	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300019	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
300029	Xp11.4	Retinitis pigmentosa 3	300029	_	3
300030	Xp21.2	Deafness, X-linked 3	300030	XL	2
300032	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300032	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
300032	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
300035	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
300036	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300037	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
300037	Xq26.2	Wilms tumor, somatic	194070	_	3
300039	Xq21.1	Deafness, X-linked 2	304400	XLR	3
300040	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300046	Xq23-q24	Mental retardation, X-linked 23	300046	XL	2
300047	Xp11-q21	Mental retardation, X-linked 20	300047	XL	2
300049	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300055	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300056	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
300060	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
300062	Xp11.3-q13.3	Mental retardation, X-linked 14	300062	XL	2
300066	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300068	Xq12	Androgen insensitivity	300068	XLR	3
300071	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300072	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300072	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300075	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
300075	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300076	Xq26-qter	Woods-Black-Norbury syndrome	300076	XLD	2
300078	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
300079	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300080	Xp11.3	TARP syndrome	311900	XLR	3
300082	Xq	[Social cognition]	300082	XL	2
300084	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300085	Xq27	Cone dystrophy, progressive X-linked, 2	300085	XL	2
300087	Xq13.2	X-inactivation, familial skewed	300087	_	3
300088	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300090	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300095	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300096	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300104	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300105	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
300106	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
300108	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300110	Xp11.23	Aland Island eye disease	300600	XL	3
300110	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300110	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300114	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
300115	Xp11.3-p11.21	Mental retardation, X-linked 50	300115	XL	2
300120	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300121	Xq23	Lissencephaly, X-linked	300067	XL	3
300121	Xq23	Subcortical laminal heterotopia, X-linked	300067	XL	3
300123	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
300125	Xq	{Migraine, familial typical, susceptibility to, 2}	300125	XL	2
300126	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
300127	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300128	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300131	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300135	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
300136	Xp11	{Diabetes mellitus, insulin-dependent, X-linked}	300136	_	2
300137	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300138	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300139	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300142	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300143	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300144	Xq24	{Parkinson disease, age of onset, modifier}	168600	AD,Mu	3
300145	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300147	Xq27-q28	{Prostate cancer, hereditary, X-linked 1}	300147	_	2
300148	Xp22.11	MEHMO syndrome	300148	XLR	3
300155	Xq26-q27	Retinitis pigmentosa 24	300155	_	2
300157	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300160	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300161	Xp22.11	MEHMO syndrome	300148	XLR	3
300163	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300163	Xq26.3	Emery-Dreifuss muscular dystrophy 6, X-linked	300696	XLR	3
300163	Xq26.3	Myopathy, X-linked, with postural muscle atrophy	300696	XLR	3
300163	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300163	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300163	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300166	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300168	Xq26.2	Keipert syndrome	301026	XLR	3
300169	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300169	Xq26.1	Cowchock syndrome	310490	XLR	3
300169	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300170	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300170	Xp22.2	Joubert syndrome 10	300804	XLR	3
300170	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
300170	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300172	Xp11.4	FG syndrome 4	300422	_	3
300172	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300172	Xp11.4	Mental retardation, with or without nystagmus	300422	_	3
300179	Xq25-q26	X inactivation, familial skewed, 2	300179	_	2
300180	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
300188	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
300188	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300188	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
300189	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300192	Xp11.22	?Sarcoma, synovial	300813	_	3
300193	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300194	Xq22.3	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis	300194	_	4
300195	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300197	Xq28	Immunodeficiency 47	300972	XLR	3
300199	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300200	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300202	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
300203	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300204	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300205	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
300205	Xp11.23	MEND syndrome	300960	XLR	3
300206	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300209	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300210	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300211	Xp22.3	Episodic muscle weakness, X-linked	300211	_	2
300218	Xp11.3-q22	Mental retardation, X-linked syndromic 7	300218	_	2
300221	Xpter-p22.32	{Hodgkin disease susceptibility, pseudoautosomal}	300221	_	2
300226	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300228	Xq27	Testicular germ cell tumor	300228	_	2
300231	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300238	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300243	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300244	Xq28	Terminal osseous dysplasia	300244	XLD	3
300245	Xq24-q27.1	Ptosis, hereditary congenital 2	300245	XLD	2
300247	Xp11.22	Ovarian dysgenesis 2	300510	XL	3
300247	Xp11.22	Premature ovarian failure 4	300510	XL	3
300248	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300248	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300248	Xq28	Immunodeficiency 33	300636	XLR	3
300248	Xq28	Immunodeficiency, isolated	300584	_	3
300248	Xq28	Incontinentia pigmenti	308300	XLD	3
300248	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300255	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300256	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300257	Xq24	Danon disease	300257	XLD	3
300259	Xq	{Mycobacterium tuberculosis, susceptibility, X-linked}	300259	_	2
300260	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300261	Xq28	Mental retardation syndrome, X-linked, Armfield type	300261	XLR	2
300262	Xq13.2	Mental retardation, X-linked syndromic, Abidi type	300262	_	2
300263	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300264	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300265	Xq26.3	Congenital heart defects, nonsyndromic, 1, X-linked	306955	XLR	3
300265	Xq26.3	Heterotaxy, visceral, 1, X-linked	306955	XLR	3
300265	Xq26.3	VACTERL association, X-linked	314390	XLR	3
300266	Xq11.2	Spastic paraplegia 16, X-linked, complicated	300266	XLR	2
300269	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300271	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300272	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300273	Xp22	Goiter, multinodular, 2	300273	XLD	2
300275	Xq28	CHILD syndrome	308050	XLD	3
300275	Xq28	CK syndrome	300831	XLR	3
300278	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
300280	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300291	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300292	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
300294	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300294	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
300294	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
300294	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
300298	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300299	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300300	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300300	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
300301	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300304	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300306	Xq24	{Obesity, susceptibility to, BMIQ11}	300306	_	2
300307	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
300307	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
300310	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300311	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
300321	Xq28	?FG syndrome 2	300321	XL	3
300322	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
300323	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
300324	Xq22.2-q26	Mental retardation, X-linked 53	300324	XLR	2
300331	Chr.X	Thrombocythemia, X-linked	300331	XLR	2
300336	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300336	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300345	Chr.X	Microphthalmia with coloboma 1	300345	_	2
300350	Xq23	Megalocornea 1, X-linked	309300	XLR	3
300351	Xp11	{Graves disease, susceptibility to, X-linked}	300351	_	2
300352	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300354	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300355	Xp22.2	Mental retardation, X-linked 73	300355	XLR	2
300356	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
300367	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
300368	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
300371	Xq28	Adrenoleukodystrophy	300100	XLR	3
300371	Xq28	Adrenomyeloneuropathy, adult	300100	XLR	3
300372	Xq26	Mental retardation, X-linked 42	300372	_	2
300373	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300374	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300376	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
300377	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
300378	Xq24-q25	Radial ray deficiency	300378	_	2
300379	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300382	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
300382	Xp21.3	Hydranencephaly with abnormal genitalia	300215	XL	3
300382	Xp21.3	Lissencephaly, X-linked 2	300215	XL	3
300382	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300382	Xp21.3	Partington syndrome	309510	XLR	3
300382	Xp21.3	Proud syndrome	300004	XL	3
300383	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
300384	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
300386	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
300387	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300388	Xq27.2-q28	Polymicrogyria, bilateral perisylvian	300388	XLD	2
300390	Xq21.2	Choroideremia	303100	XLD	3
300391	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
300392	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked	313900	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked, intermittent	313900	XLR	3
300392	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
300393	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300394	Xq28	Barth syndrome	302060	XLR	3
300395	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300398	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300400	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
300401	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
300401	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
300403	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
300403	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300406	Xp22.3	FG syndrome 3	300406	_	2
300414	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
300415	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
300419	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300423	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300424	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300425	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300427	Xp22.32-p22.31	Mental retardation, X-linked	300495	IC,Mu,XL	3
300427	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300427	Xp22.32-p22.31	{Autism susceptibility, X-linked 2}	300495	IC,Mu,XL	3
300428	Xp22.3	Mental retardation, X-linked 2	300428	XL	2
300429	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300433	Xp11.2-q12	Mental retardation, X-linked 81	300433	XLR	2
300434	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300436	Xq25-q26	Mental retardation, X-linked 46	300436	XLR	2
300438	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300448	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300451	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
300451	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
300454	Xq12-q21.3	Mental retardation, X-linked 77	300454	XLR	2
300455	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
300457	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
300457	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
300460	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300461	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
300463	Xp11.23	Renpenning syndrome	309500	XLR	3
300464	Xq23-q26	{Coronary heart disease, susceptibility to, 3}	300464	_	2
300470	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300471	Chr.X	Cubitus valgus with mental retardation and unusual facies	300471	XLR	2
300472	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300473	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300473	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300474	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
300475	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300476	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300481	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
300481	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300484	Chr.X	Orofaciodigital syndrome VIII	300484	XLR	2
300485	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300486	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300488	Xp21.3	{Menopause, natural, age at, QTL1}	300488	XLD	2
300489	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300490	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
300491	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
300494	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300496	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300497	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300498	Xp11.3-p11.21	Mental retardation,X-linked 45	300498	XL	2
300499	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
300500	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300502	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
300505	Xp11.3-q22.3	Mental retardation, X-linked 84	300505	XLR	2
300509	Xq27.3	{Dyslexia, susceptibility to, 9}	300509	_	2
300511	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300514	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300515	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300516	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
300518	Xq24-q25	Mental retardation, X-linked 82	300518	XLR	2
300519	Chr.X	Mental retardation, X-linked, syndromic, Martin-Probst type	300519	XLR	2
300521	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300522	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
300523	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300524	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300526	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300534	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
300535	Xq26.1	Dent disease 2	300555	XLR	3
300535	Xq26.1	Lowe syndrome	309000	XLR	3
300536	Xq27	[Bone mineral density QTL 4]	300536	_	2
300538	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
300538	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300539	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300545	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
300546	Xp11.22	Aarskog-Scott syndrome	305400	XLR	3
300546	Xp11.22	Mental retardation, X-linked syndromic 16	305400	XLR	3
300550	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
300552	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300553	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300554	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300555	Xq26.1	Dent disease 2	300555	XLR	3
300556	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300556	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300557	Xq21-q25	{Parkinson disease 12}	300557	_	2
300558	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300559	Xq13.1	Muscle glycogenosis	300559	XLR	3
300560	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300572	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300576	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300577	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300578	Xp11.3	Chromosome Xp11.3 deletion syndrome	300578	XLR	4
300579	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300580	Xq13.1-q22.1	Myopathy, congenital, with fiber-type disproportion, X-linked	300580	XLD	2
300581	Xq22.3	FG syndrome 5	300581	_	2
300584	Xq28	Immunodeficiency, isolated	300584	_	3
300589	Xp11.4	Nystagmus 5, congenital, X-linked	300589	XLD	2
300590	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300591	Xq24-q25	{Stature QTL 6}	300591	_	2
300600	Xp11.23	Aland Island eye disease	300600	XL	3
300603	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300604	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300605	Xq28	Retinitis pigmentosa 34	300605	_	2
300607	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300610	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300611	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300613	Xq23-q27.2	Myopia 13	300613	_	2
300614	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300622	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300623	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
300624	Xq27.3	Fragile X syndrome	300624	XLD	3
300628	Xq26.2	Nystagmus 1, congenital, X-linked	310700	XL	3
300628	Xq26.2	Nystagmus, infantile periodic alternating, X-linked	310700	XL	3
300629	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
300633	Xq12	Hypospadias 1, X-linked	300633	XLR	3
300635	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300636	Xq28	Immunodeficiency 33	300636	XLR	3
300640	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300642	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300643	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300644	Xq22.1	Fabry disease	301500	XL	3
300644	Xq22.1	Fabry disease, cardiac variant	301500	XL	3
300645	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300646	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300647	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300650	Xp22.3	Ocular albinism with sensorineural deafness	300650	XL	2
300651	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
300652	Xp11.3-q12	Angio serpiginosum	300652	XLD	2
300653	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
300658	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
300658	Xp11.3	Norrie disease	310600	XLR	3
300659	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300660	Xq25-q27	Leukoencephalopathy with metaphyseal chondrodysplasia	300660	XLR	2
300672	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300673	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300676	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300679	Xp21	Chromosome Xp21 deletion syndrome	300679	_	4
300695	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300697	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
300699	Xq25	Mental retardation, X-linked 94	300699	XLR	3
300700	Xq24-q26	Albinism-deafness syndrome	300700	XL	2
300703	Xq25-q27.1	Spinocerebellar ataxia, X-linked 5	300703	XLR	2
300704	Xp11.22	{Prostate cancer, hereditary, X-linked 2}	300704	_	2
300705	Xp11.22	Xp11.22 microduplication syndrome	300705	_	4
300707	Xq28	STAR syndrome	300707	XLD	3
300708	Xq28	STAR syndrome	300707	XLD	3
300709	Xq12-q21.31	Mental retardation, X-linked, syndromic 9	300709	_	2
300710	Xq11-q12	Alopecia, androgenetic, 2	300710	_	2
300711	Xq23	Pyloric stenosis, infantile hypertrophic, 4	300711	_	2
300712	Xq26-q27	?Craniofacioskeletal syndrome	300712	XLR,XLD	2
300715	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300716	Chr.X	Mental retardation, X-linked 95	300716	XLD	2
300717	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300718	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300719	Chr.X	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	XLR	2
300724	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
300746	Xq27.1	Hemophilia B	306900	XLR	3
300746	Xq27.1	Thrombophilia, X-linked, due to factor IX defect	300807	_	3
300746	Xq27.1	{Deep venous thrombosis, protection against}	300807	_	3
300746	Xq27.1	{Warfarin sensitivity}	122700	AD	3
300747	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
300749	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300750	Xq24-q25	Spastic paraplegia 34, X-linked	300750	XLR	2
300751	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
300752	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
300755	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300756	Xq21.3	{Alzheimer disease 16}	300756	_	2
300757	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
300758	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300770	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
300774	Xq28	?Waisman syndrome	311510	XLR	3
300774	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300776	Xq23	?Congenital disorder of glycosylation, type Is	300884	XLD	3
300776	Xq23	Epileptic encephalopathy, early infantile, 36	300884	XLD	3
300777	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300778	Xp22.3	Corneal dystrophy, Lisch epithelial	300778	XLD	2
300779	Xq25	Corneal dystrophy, endothelial, X-linked	300779	XLD	2
300798	Xp22.13	Glycogen storage disease, type IXa1	306000	XLR	3
300798	Xp22.13	Glycogen storage disease, type IXa2	306000	XLR	3
300799	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300801	Xp11.23-p11.22	Chromosome Xp11.23-p11.22 duplication syndrome	300801	XLD	4
300802	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
300803	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
300804	Xp22.2	Joubert syndrome 10	300804	XLR	3
300806	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
300808	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300808	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300809	Xq28	{Systemic lupus erythematosus, susceptibility to, 15}	300809	_	2
300814	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300815	Xq28	Chromosome Xq28 duplication syndrome	300815	_	4
300816	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300818	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
300821	Xq28	Blue cone monochromacy	303700	XLR	3
300821	Xq28	Colorblindness, deutan	303800	XL	3
300822	Xq28	Blue cone monochromacy	303700	XLR	3
300822	Xq28	Colorblindness, protan	303900	XL	3
300823	Xq28	Mucopolysaccharidosis II	309900	XLR	3
300826	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
300827	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
300828	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300830	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300831	Xq28	CK syndrome	300831	XLR	3
300833	Xq26.3	46XX sex reversal 3	300833	XLD	4
300834	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
300835	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
300836	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
300838	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300839	Xp22.13	Retinoschisis	312700	XLR	3
300841	Xq28	Hemophilia A	306700	XLR	3
300842	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
300843	Xq28	Bornholm eye disease	300843	XLR	2
300844	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300845	Xq28	Moyamoya disease 4	300845	XLR	4
300847	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
300848	Xp11.3	Mental retardation, X-linked 89	300848	XLD	2
300849	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300850	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300851	Xp11.3	Mental retardation, X-linked 92	300851	XLR	2
300852	Xq24	Mental retardation, X-linked 88	300852	XL	2
300853	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300854	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
300855	Xq28	Ogden syndrome	300855	XLR,XLD	3
300856	Xp11.22	{Hypospadias 4, X-linked, susceptibility to}	300856	_	2
300857	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300858	Xp21.1-p11.23	Mental retardation, X-linked, syndromic 17	300858	XLR	2
300859	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300860	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
300861	Xq21.33-q23	Mental retardation, X-linked, syndromic, Chudley-Schwartz type	300861	XLR	2
300863	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300864	Chr.X	Cerebral-cerebellar-coloboma syndrome, X-linked	300864	XLR	2
300867	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300868	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
300869	Xq27.3-q28	Chromosome Xq27.3-q28 duplication syndrome	300869	XLR	4
300870	Xp22	Aneurysm, intracranial berry, 5	300870	_	2
300872	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300882	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300885	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300886	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300887	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300888	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300894	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300895	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300896	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
300897	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
300905	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300906	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300908	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
300909	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300910	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300911	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300912	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300913	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
300914	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
300915	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300918	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300919	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300923	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300928	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300932	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
300933	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300934	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300942	Xq26.3	Chromosome Xq26.3 duplication syndrome	300942	XLD	4
300943	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300945	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300946	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300951	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300952	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300953	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300957	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300958	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300960	Xp11.23	MEND syndrome	300960	XLR	3
300963	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300964	Xq12	Wilson-Turner syndrome	309585	XLR	3
300966	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
300967	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300968	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300969	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
300971	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300972	Xq28	Immunodeficiency 47	300972	XLR	3
300975	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300978	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300979	Xq25	Xq25 duplication syndrome	300979	XL	4
300980	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300982	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300983	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300984	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300985	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300986	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300988	Xq12	Immunodeficiency 50	300988	XLR	3
300989	Xq28	Meester-Loeys syndrome	300989	XL	3
300990	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300991	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300997	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300998	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
301000	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
301006	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
301008	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
301010	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301012	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301013	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301014	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
301015	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
301018	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
301020	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
301021	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
301022	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
301024	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
301025	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
301026	Xq26.2	Keipert syndrome	301026	XLR	3
301040	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
301050	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
301200	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
301201	Xq22-q28	?Amelogenesis imperfecta, type IE, X-linked 2	301201	XL	2
301220	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
301300	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
301300	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
301310	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
301590	Xq27-q28	?Microphthalmia, syndromic 4	301590	XLR	2
301770	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301830	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
301835	Xq22.3	Arts syndrome	301835	XLR	3
301845	Xq24-q27	Bazex syndrome	301845	XLD	2
301870	Xq28	Meester-Loeys syndrome	300989	XL	3
301870	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
301900	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
302045	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
302060	Xq28	Barth syndrome	302060	XLR	3
302200	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
302350	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
302500	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
302800	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
302801	Xp22.2	Charcot-Marie-Tooth neuropathy, X-linked recessive, 2	302801	XLR	2
302802	Xq26	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	XLR	4
302905	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
302910	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
302950	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
302960	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
303100	Xq21.2	Choroideremia	303100	XLD	3
303110	Xq21	Choroideremia, deafness, and mental retardation	303110	XLR	4
303400	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
303600	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
303630	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
303631	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
303800	Xq28	Colorblindness, deutan	303800	XL	3
303900	Xq28	Colorblindness, protan	303900	XL	3
304020	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
304040	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
304050	Xp22	Aicardi syndrome	304050	XLD	2
304100	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
304110	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
304120	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
304150	Xq21.1	Occipital horn syndrome	304150	XLR	3
304340	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
304400	Xq21.1	Deafness, X-linked 2	304400	XLR	3
304500	Xq22.3	Deafness, X-linked 1	304500	XL	3
304700	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
304730	Xq24-qter	Dermoids of cornea	304730	XL	2
304790	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
304800	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
305000	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
305100	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
305371	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
305371	Xp11.23	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	_	3
305371	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
305371	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
305390	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
305435	Xp22.2	Fetal hemoglobin quantitative trait locus 3	305435	XL	2
305450	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
305600	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
305620	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
305900	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
305900	Xq28	{Resistance to malaria due to G6PD deficiency}	611162	_	3
305915	Xq25	Mental retardation, X-linked 94	300699	XLR	3
306250	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
306400	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
306700	Xq28	Hemophilia A	306700	XLR	3
306900	Xq27.1	Hemophilia B	306900	XLR	3
306995	Xq28	[?Homosexuality, male]	306995	XL	2
307030	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
307150	Xq27.1	Hypertrichosis, congenital generalized	307150	XLD	4
307200	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
307700	Xq27.1	Hypoparathyroidism, X-linked	307700	XL	4
307800	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
308000	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
308000	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
308050	Xq28	CHILD syndrome	308050	XLD	3
308100	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
308205	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
308230	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
308240	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
308300	Xq28	Incontinentia pigmenti	308300	XLD	3
308350	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
308380	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
308380	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
308700	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
308800	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
308840	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
308840	Xq28	CRASH syndrome	303350	XLR	3
308840	Xq28	Hydrocephalus due to aqueductal stenosis	307000	XLR	3
308840	Xq28	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	XLR	3
308840	Xq28	Hydrocephalus with Hirschsprung disease	307000	XLR	3
308840	Xq28	MASA syndrome	303350	XLR	3
308905	Xp11	{Leber optic atrophy, susceptibility to}	308905	XL	2
308990	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
309000	Xq26.1	Lowe syndrome	309000	XLR	3
309060	Xq24	Danon disease	300257	XLD	3
309120	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
309200	Xq28	{?Major affective disorder 2}	309200	XLD	2
309300	Xq23	Megalocornea 1, X-linked	309300	XLR	3
309350	Xq28	Melnick-Needles syndrome	309350	XLD	3
309400	Xq21.1	Menkes disease	309400	XLR	3
309500	Xp11.23	Renpenning syndrome	309500	XLR	3
309510	Xp21.3	Partington syndrome	309510	XLR	3
309520	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
309530	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
309541	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
309545	Xp11	?Mental retardation, X-linked, syndromic 12	309545	XL	2
309548	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
309549	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
309550	Xq27.3	Fragile X syndrome	300624	XLD	3
309550	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
309550	Xq27.3	Premature ovarian failure 1	311360	XL	3
309555	Xq26	Gustavson syndrome	309555	XL	2
309580	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
309583	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
309585	Xq12	Wilson-Turner syndrome	309585	XLR	3
309590	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
309610	Xp11-q21	Prieto syndrome	309610	XLR	2
309620	Xq28	Mental retardation-skeletal dysplasia	309620	XL	2
309630	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
309800	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
309801	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
309845	Xq12	Immunodeficiency 50	300988	XLR	3
309850	Xp11.3	Brunner syndrome	300615	XLR	3
309850	Xp11.3	{Antisocial behavior}	300615	XLR	3
309900	Xq28	Mucopolysaccharidosis II	309900	XLR	3
310200	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
310300	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
310400	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
310440	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
310460	Xq28	Myopia-1	310460	XLR	2
310468	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
310490	Xq26.1	Cowchock syndrome	310490	XLR	3
310500	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
310600	Xp11.3	Norrie disease	310600	XLR	3
311050	Xp11.4-p11.21	Optic atrophy 2, X-linked	311050	XL	2
311070	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311200	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
311250	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
311300	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
311360	Xq27.3	Premature ovarian failure 1	311360	XL	3
311510	Xq28	?Waisman syndrome	311510	XLR	3
311770	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
311770	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
311800	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
311850	Xq22.3	Arts syndrome	301835	XLR	3
311850	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311850	Xq22.3	Deafness, X-linked 1	304500	XL	3
311850	Xq22.3	Gout, PRPS-related	300661	XLR	3
311850	Xq22.3	Phosphoribosylpyrophosphate synthetase superactivity	300661	XLR	3
311870	Xq13.1	Muscle glycogenosis	300559	XLR	3
311900	Xp11.3	TARP syndrome	311900	XLR	3
312000	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
312040	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
312060	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
312080	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
312170	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
312173	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
312173	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
312180	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
312300	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
312600	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
312610	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
312610	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
312610	Xp11.4	Retinitis pigmentosa 3	300029	_	3
312610	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
312612	Xp21.3-p21.2	?Retinitis pigmentosa, X-linked recessive, 6	312612	XL	2
312700	Xp22.13	Retinoschisis	312700	XLR	3
312820	Xp11.23	?Sarcoma, synovial	300813	_	3
312863	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
312865	Xp22.33	Langer mesomelic dysplasia	249700	_	3
312865	Xp22.33	Leri-Weill dyschondrosteosis	127300	_	3
312865	Xp22.33	Short stature, idiopathic familial	300582	_	3
312870	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
312920	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
313000	Xp22.33	Turner syndrome-associated neurocognitive phenotype	313000	?XLR	2
313000	Xp22.33	[Visuospatial/perceptual abilities]	313000	?XLR	2
313200	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313350	Xq26	Split hand/foot malformation 2	313350	XL	2
313400	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
313430	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
313430	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
313440	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
313475	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
313500	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
313650	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
313650	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
313700	Xq12	Androgen insensitivity	300068	XLR	3
313700	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
313700	Xq12	Hypospadias 1, X-linked	300633	XLR	3
313700	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313700	Xq12	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
313850	Xq25-q26.1	Thoracoabdominal syndrome	313850	XL	2
314050	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
314200	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
314250	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
314300	Xq28	Goeminne TKCR syndrome	314300	XL	2
314310	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
314370	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
314375	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
314390	Xq26.3	VACTERL association, X-linked	314390	XLR	3
314400	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
314580	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
314670	Xq13.2	X-inactivation, familial skewed	300087	_	3
314690	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
314700	Xpter-p22.32	[Blood group, XG system]	_	_	3
314850	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
314990	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
400003	Yq11.223	?Sertoli-cell-only syndrome	_	_	1
400004	Chr.Y	Retinitis pigmentosa, Y-linked	400004	YL	2
400005	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
400020	Yp11.2	Langer mesomelic dysplasia	249700	_	3
400020	Yp11.2	Leri-Weill dyschondrosteosis	127300	_	3
400020	Yp11.2	Short stature, idiopathic familial	300582	_	3
400033	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
400042	Yq11	Spermatogenic failure, Y-linked, 1	400042	_	4
400043	Chr.Y	Deafness, Y-linked 1	400043	YL	2
400044	Yp11.2	46XY sex reversal 1	400044	YL	3
400045	Yp11.2	46XX sex reversal 1	400045	XLD	4
400047	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
415000	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
425500	Yq	?Hairy ears, Y-linked	425500	YL	2
480000	Yp11.2	46XX sex reversal 1	400045	XLD	4
480000	Yp11.2	46XY sex reversal 1	400044	YL	3
580000	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
600001	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
600002	3p21.31	Eiken syndrome	600002	AR	3
600003	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
600005	16p13.13	Bare lymphocyte syndrome, type II, complementation group A	209920	AR	3
600005	16p13.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600008	11q23.2	Homocysteine plasma level	600008	_	2
600011	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
600011	7q22.1	Lymphatic malformation 7	617300	AD	3
600013	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
600014	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
600016	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
600019	17q23.3	Orthostatic hypotension 2	618182	AR	3
600020	10q25.2	Neurofibrosarcoma, somatic	_	_	3
600020	10q25.2	Prostate cancer, somatic	176807	_	3
600023	16q21	Elsahy-Waters syndrome	211380	AR	3
600024	1q42.12	?Reynolds syndrome	613471	AD	3
600024	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
600024	1q42.12	Pelger-Huet anomaly	169400	AD	3
600024	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
600028	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
600031	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
600035	10q26.11	Schizencephaly	269160	_	3
600037	14q22.3	Microphthalmia, syndromic 5	610125	AD	3
600037	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
600037	14q22.3	Retinal dystrophy, early-onset, with or without pituitary dysfunction	610125	AD	3
600040	19q13.33	Colorectal cancer, somatic	114500	_	3
600040	19q13.33	T-cell acute lymphoblastic leukemia, somatic	613065	_	3
600044	3q27.1	Thrombocythemia 1	187950	AD	3
600046	9q31.1	HDL deficiency, type 2	604091	_	3
600046	9q31.1	Tangier disease	205400	AR	3
600049	3q26	Myelodysplasia syndrome-1	_	_	3
600053	2q11.2	Achromatopsia 2	216900	AR	3
600059	17p13.3	Retinitis pigmentosa 13	600059	AD	3
600060	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
600065	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
600072	20p13	Insomnia, fatal familial	600072	AD	3
600073	2q31.1	Donnai-Barrow syndrome	222448	AR	3
600075	6q27	Spinocerebellar ataxia 17	607136	AD	3
600075	6q27	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
600079	7q11.23	Colon cancer, somatic	114500	_	3
600081	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
600089	6p21.3	?Diabetes mellitus, insulin-dependent, neonatal	600089	AR	2
600098	11p15.2	Ovarian carcinoma	_	_	3
600101	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
600104	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
600105	1q31.3	Retinitis pigmentosa-12	600105	AR	3
600108	11q22.2	Metaphyseal anadysplasia 1	602111	AD	3
600108	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
600108	11q22.2	Spondyloepimetaphyseal dysplasia, Missouri type	602111	AD	3
600110	6q14.1	Stargardt disease 3	600110	AD	3
600111	5p13.2	Episodic ataxia, type 6	612656	AD	3
600112	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
600112	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
600112	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
600116	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
600118	2q21.3	Warburg micro syndrome 1	600118	AR	3
600119	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
600121	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
600124	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
600129	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
600131	8q24	Epilepsy, childhood absence, 1	600131	AD	2
600132	6p21.31	Retinitis pigmentosa 14	600132	AR	3
600133	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
600138	19q13.42	Retinitis pigmentosa 11	600138	AD	3
600140	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
600140	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
600142	10q26.13	CARASIL syndrome	600142	AR	3
600143	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
600144	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
600145	1p13.1	Caudal regression syndrome	600145	AD	3
600147	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
600150	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
600150	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
600151	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
600154	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
600155	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
600156	9q31	{Hirschsprung disease, susceptibility to, 5}	600156	AD	2
600160	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
600160	9p21.3	Orolaryngeal cancer, multiple	_	_	3
600160	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
600160	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
600163	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
600163	3p22.2	Brugada syndrome 1	601144	AD	3
600163	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
600163	3p22.2	Heart block, nonprogressive	113900	AD	3
600163	3p22.2	Heart block, progressive, type IA	113900	AD	3
600163	3p22.2	Long QT syndrome-3	603830	AD	3
600163	3p22.2	Sick sinus syndrome 1	608567	AR	3
600163	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
600163	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
600165	11p	Nanophthalmos-1	600165	AD	2
600168	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
600170	9p13.3	[Blood group GIL]	607457	_	3
600173	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600175	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
600179	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
600179	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
600179	17p13.1	Leber congenital amaurosis 1	204000	AR	3
600184	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
600185	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
600185	13q13.1	Wilms tumor	194070	AD,SMu	3
600185	13q13.1	{Breast cancer, male, susceptibility to}	114480	AD,SMu	3
600185	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
600185	13q13.1	{Glioblastoma 3}	613029	AR	3
600185	13q13.1	{Medulloblastoma}	155255	AD,AR	3
600185	13q13.1	{Pancreatic cancer 2}	613347	_	3
600185	13q13.1	{Prostate cancer}	176807	AD,SMu	3
600192	18q11.2	Sarcoma, synovial	_	_	1
600193	1p21-p13.3	Waardenburg syndrome, type 2B	600193	AD	2
600194	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
600195	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	_	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, dark/light hair]	611742	_	3
600202	6p22-p21	{Dyslexia, susceptibility to, 2}	600202	AD	2
600204	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
600206	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
600209	19p	Exostoses, multiple, type 3	600209	AD	2
600211	6p21.1	Cleidocranial dysplasia	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	AD	3
600211	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
600220	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
600220	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
600221	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
600221	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600223	16q22.1	Spinocerebellar ataxia 4	600223	AD	2
600224	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
600225	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
600225	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
600228	12p13.31	?Liddle syndrome 3	618126	AD	3
600228	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
600228	12p13.31	Pseudohypoaldosteronism, type I	264350	AR	3
600229	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
600231	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600232	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
600234	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
600235	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
600235	19q13.11	Brugada syndrome 5	612838	_	3
600235	19q13.11	Cardiac conduction defect, nonspecific	612838	_	3
600235	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
600235	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
600236	1q41	Stromme syndrome	243605	AR	3
600238	20p13	?Uncombable hair syndrome 2	617251	AR	3
600244	2q37.3	{Multiple sclerosis, disease progression, modifier of}	126200	Mu	3
600244	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
600251	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
600253	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
600257	8q12.2-q21.2	Bor-Duane hydrocephalus contiguous gene syndrome	600257	AD	4
600259	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
600259	7p22.1	Mismatch repair cancer syndrome	276300	AR	3
600263	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
600266	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
600266	2q35	{Mycobacterium tuberculosis, susceptibility to infection by}	607948	_	3
600271	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
600273	16p13.3	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	AD	4
600275	1p12	Alagille syndrome 2	610205	AD	3
600275	1p12	Hajdu-Cheney syndrome	102500	AD	3
600276	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
600276	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
600276	19p13.12	Lateral meningocele syndrome	130720	AD	3
600279	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
600281	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
600281	20q13.12	MODY, type I	125850	AD	3
600281	20q13.12	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600286	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
600287	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
600287	7p14.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
600291	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
600293	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
600294	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
600300	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
600301	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
600309	6q22.31	Atrioventricular septal defect 3	600309	AD	3
600310	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
600310	19p13.11	Pseudoachondroplasia	177170	AD	3
600315	1p36.33	?Immunodeficiency 16	615593	AR	3
600316	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
600318	15q26	{Diabetes mellitus, insulin-dependent, 3}	600318	_	2
600319	11q13	{Diabetes mellitus, insulin-dependent, 4}	600319	_	2
600320	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
600321	2q31	{Diabetes mellitus, insulin-dependent, 7}	600321	_	2
600322	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
600332	1q41	Rippling muscle disease-1	600332	AD	2
600334	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
600336	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
600342	10q23.1	Retinitis pigmentosa 44	613769	_	3
600346	17q12	Turnpenny-Fry syndrome	618371	AD	3
600348	14q32.2	Band heterotopia	600348	AR	3
600354	5q13.2	Spinal muscular atrophy-1	253300	AR	3
600354	5q13.2	Spinal muscular atrophy-2	253550	AR	3
600354	5q13.2	Spinal muscular atrophy-3	253400	AR	3
600354	5q13.2	Spinal muscular atrophy-4	271150	AR	3
600359	11q24.3	Bartter syndrome, type 2	241200	AR	3
600361	4q34.3-q35.2	Hereditary motor and sensory neuropathy V	600361	AD	2
600363	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
600364	6p21.1	Cone dystrophy-3	602093	AD	3
600364	6p21.1	Cone-rod dystrophy 14	602093	AD	3
600370	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
600373	19p13.3	CODAS syndrome	600373	AR	3
600374	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
600375	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
600376	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
600383	8q13	Mesomelia-synostoses syndrome	600383	AD	4
600397	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
600414	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
600414	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
600414	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
600415	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
600417	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
600423	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
600423	1p36.12	{Hypertension, essential, susceptibility to}	145500	Mu	3
600429	6p24.3-p24.2	Adult i phenotype without cataract	110800	AD	3
600429	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
600429	6p24.3-p24.2	[Blood group, Ii]	110800	AD	3
600430	2q37	Chromosome 2q37 deletion syndrome	600430	AD	4
600438	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
600442	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600450	10p15.1	46XY sex reversal 8	614279	AR	3
600451	10p15.1	{46XY sex reversal 8, modifier of}	614279	AR	3
600456	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
600456	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
600462	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
600463	15q26.3	Microphthalmia, isolated 8	615113	AR	3
600465	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
600467	3q13.1	{Malignant hyperthermia susceptibility 4}	600467	AD	2
600470	3q24	Craniosynostosis 6	616602	AD	3
600473	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
600478	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
600480	15q21.3	Craniosynostosis 3	615314	AD	3
600483	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
600492	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
600495	3q27.1	{Parkinson disease 18}	614251	AD	3
600496	12q24.31	MODY, type III	600496	AD	3
600501	13q22.3	ABCD syndrome	600501	AR	3
600502	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
600502	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
600509	11p15.1	Diabetes mellitus, noninsulin-dependent	125853	AD	3
600509	11p15.1	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
600509	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
600509	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
600509	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
600510	7q35-q36	Pigment dispersion syndrome	600510	AD	2
600511	6p23	{Schizophrenia}	181500	AD	2
600512	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
600513	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
600514	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
600514	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
600515	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
600521	3q27.3	3MC syndrome 1	257920	AR	3
600522	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
600523	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
600525	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
600525	17q21.33	Trichodontoosseous syndrome	190320	AD	3
600528	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
600529	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
600532	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
600533	1q23.2	Neural tube defects	182940	AD	3
600536	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
600542	9q31.1	Chondrosarcoma, extraskeletal myxoid	612237	_	3
600543	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
600548	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
600548	5q31.2	Even-plus syndrome	616854	AR	3
600555	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
600555	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
600555	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
600556	12q13.3	Immunodeficiency 44	616636	AR	3
600558	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
600565	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
600565	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
600570	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
600570	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
600570	3q27.1	{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile absence, susceptibility to, 2}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	AD	3
600571	4q12	Fibromatosis, gingival, 5	617626	AD	3
600571	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
600574	22q11.21	Noonan syndrome 10	616564	AD	3
600574	22q11.21	Noonan syndrome 2	605275	AR	3
600574	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
600576	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
600576	8p23.1	Atrial septal defect 2	607941	AD	3
600576	8p23.1	Atrioventricular septal defect 4	614430	AD	3
600576	8p23.1	Tetralogy of Fallot	187500	AD	3
600576	8p23.1	Ventricular septal defect 1	614429	AD	3
600577	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
600579	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
600582	8q12.3	Traboulsi syndrome	601552	AR	3
600584	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
600584	5q35.1	Conotruncal heart malformations, variable	217095	_	3
600584	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
600584	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
600584	5q35.1	Tetralogy of Fallot	187500	AD	3
600584	5q35.1	Ventricular septal defect 3	614432	AD	3
600590	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
600593	4p16	Craniosynostosis, Adelaide type	600593	?AD	2
600599	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
600599	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
600599	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
600608	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
600617	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
600618	12p13.2	Leukemia, acute myeloid, somatic	601626	_	3
600618	12p13.2	Thrombocytopenia 5	616216	AD	3
600624	18q21.1-q21.3	Cone-rod retinal dystrophy-1	600624	AD	2
600625	14q22.2	Orofacial cleft 11	600625	_	3
600627	4q32.1	[?Hypertryptophanemia]	600627	AR	3
600630	10q11.23	UV-sensitive syndrome 1	600630	AR	3
600631	13q13-q14.3	Enuresis, nocturnal, 1	600631	AD	2
600632	11q25	Ovarian cancer, somatic	167000	_	3
600635	14q13.3	Chorea, hereditary benign	118700	AD	3
600635	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
600635	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
600638	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
600644	11q23.3	Cleft lip/palate-ectodermal dysplasia syndrome	225060	AR	3
600644	11q23.3	Orofacial cleft 7	225060	AR	3
600649	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
600650	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
600650	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AD,AR	3
600652	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
600660	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
600662	5q14.3	Chromosome 5q14.3 deletion syndrome	613443	AD	4
600662	5q14.3	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	613443	AD	3
600664	10q24.31	Cocoon syndrome	613630	_	3
600666	11q12.3	Polycystic kidney disease 3	600666	AD	3
600667	17q21.31	Omodysplasia 2	164745	AD	3
600668	8q	Chondrocalcinosis with early-onset osteoarthritis	600668	AD	2
600669	8q24	{Epilepsy, idiopathic generalized, susceptibility to, 1}	600669	AD	2
600673	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
600675	14q32.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600675	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
600678	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
600678	2p16.3	Mismatch repair cancer syndrome	276300	AR	3
600678	2p16.3	{Endometrial cancer, familial}	608089	_	3
600681	17q24.3	Andersen syndrome	170390	AD	3
600681	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
600681	17q24.3	Short QT syndrome 3	609622	_	3
600682	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
600682	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
600682	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AD,AR	3
600692	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
600698	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
600700	3q27-q28	Leukemia, acute myeloid	601626	AD,SMu	3
600700	3q27-q28	Lipoma	_	_	3
600701	6p21.31	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
600702	12q13.13	?Myoclonus, familial, 2	618364	AD	3
600702	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
600702	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
600702	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
600709	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
600712	9q21.32	Au-Kline syndrome	616580	AD	3
600713	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
600716	1p13.2	{Diabetes, type 1, susceptibility to}	222100	AR	3
600716	1p13.2	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600716	1p13.2	{Systemic lupus erythematosus susceptibility to}	152700	AD	3
600721	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
600722	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
600724	16q21	Retinitis pigmentosa 45	613767	AR	3
600725	7q36.3	Holoprosencephaly 3	142945	AD	3
600725	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
600725	7q36.3	Schizencephaly	269160	_	3
600725	7q36.3	Single median maxillary central incisor	147250	AD	3
600726	2q35	Acrocapitofemoral dysplasia	607778	AR	3
600726	2q35	Brachydactyly, type A1	112500	AD	3
600727	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
600728	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
600733	13q12.2	MODY, type IV	606392	_	3
600733	13q12.2	Pancreatic agenesis 1	260370	AR	3
600733	13q12.2	{Diabetes mellitus, type II, susceptibility to}	125853	AD	3
600734	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
600734	11q24.3	Long QT syndrome 13	613485	AD	3
600740	19q13.32	Hypocalciuric hypercalcemia, type III	600740	AD	3
600747	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
600749	14q11.2	Specific granule deficiency	245480	AR	3
600754	14q11.2	?Winchester syndrome	277950	_	3
600755	3p25.2	{Schizophrenia, susceptibility to}	181500	AD	3
600757	19q13	Orofacial cleft 3	600757	?AD	2
600759	1q42.13	Alzheimer disease-4	606889	AD	3
600759	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
600760	16p12.2	Bronchiectasis with or without elevated sweat chloride 1	211400	AD	3
600760	16p12.2	Liddle syndrome 1	177200	AD	3
600760	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600761	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
600761	16p12.2	Liddle syndrome 2	618114	AD	3
600761	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600770	11p15.5	{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	AD	3
600774	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
600775	19q13.2	Craniosynostosis 4	600775	AD	3
600778	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
600783	5q31.3	?Perrault syndrome 2	614926	AR	3
600790	6q14-q16.2	Chorioretinal atrophy, progressive bifocal	600790	AD	2
600792	14q12	Deafness, autosomal recessive 5	600792	AR	2
600795	3p11.2	Dementia, familial, nonspecific	600795	AD	3
600797	13q34	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, familial primary, 1, with or without HHT	178600	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	AD	3
600799	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
600802	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600803	7q21.12	Gallbladder disease 1	600803	AD,AR	3
600804	11q14.3	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600805	18q11.2	Epidermolysis bullosa, generalized atrophic benign	226650	AR	3
600805	18q11.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
600805	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
600808	12q13-q21	Enuresis, nocturnal, 2	600808	AD	2
600810	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AD,AR	3
600811	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
600814	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
600820	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
600824	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
600824	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
600825	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
600827	10q23.33	Cone dystrophy 4	613093	AR	3
600829	11q13.4	Opsismodysplasia	258480	AR	3
600835	10q11.21	{AIDS, resistance to}	609423	_	3
600836	2q35	?Cataract 42	115900	AD	3
600837	5p13.2	Central hypoventilation syndrome	209880	AD	3
600837	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
600837	5p13.2	{Pheochromocytoma, modifier of}	171300	AD	3
600838	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
600839	15q21.1	Bartter syndrome, type 1	601678	AR	3
600842	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
600844	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
600850	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
600852	17q23.1	Retinitis pigmentosa 17	600852	AD	3
600853	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
600855	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
600856	11p15.4	Beckwith-Wiedemann syndrome	130650	AD	3
600856	11p15.4	IMAGE syndrome	614732	AD	3
600857	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
600857	5p15.33	Leigh syndrome	256000	Mi,AR	3
600857	5p15.33	Mitochondrial respiratory chain complex II deficiency	252011	AR	3
600857	5p15.33	Paragangliomas 5	614165	AD	3
600858	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
600859	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
600864	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
600871	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
600871	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
600877	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
600881	17q11.2	Cataract 10, multiple types	600881	AD	3
600882	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
600883	6q25-q27	{Diabetes mellitus, insulin-dependent, 8}	600883	_	2
600884	9q13	Cardiomyopathy, dilated 1B	600884	AD	2
600886	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
600887	5q14.1	Endometrial carcinoma, somatic	608089	_	3
600887	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
600890	2p23.3	Fatty liver, acute, of pregnancy	609016	AR	3
600890	2p23.3	HELLP syndrome, maternal, of pregnancy	609016	AR	3
600890	2p23.3	LCHAD deficiency	609016	AR	3
600890	2p23.3	Trifunctional protein deficiency	609015	AR	3
600897	1q21.2	Cataract 1, multiple types	116200	AD	3
600898	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
600899	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
600900	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
600901	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
600909	21q22.3	Cataract 44	616509	AR	3
600909	21q22.3	Hypotrichosis 14	618275	AR	3
600917	7q31.1	Insulin resistance, severe, digenic	125853	AD	3
600920	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
600921	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
600922	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
600923	1q23.3	Porphyria variegata	176200	AD	3
600924	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
600925	11p11.2	Colon cancer, somatic	114500	_	3
600928	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
600929	22q12.1	Cataract 17, multiple types	611544	AD,AR	3
600936	5q34	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600937	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
600937	11p15.1	Diabetes, permanent neonatal, with or without neurologic features	606176	AD,AR	3
600937	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
600937	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
600937	11p15.1	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600939	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
600943	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
600943	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
600944	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
600946	5p13-p12	Growth hormone insensitivity, partial	604271	AD	3
600946	5p13-p12	Increased responsiveness to growth hormone	604271	AD	3
600946	5p13-p12	Laron dwarfism	262500	AR	3
600946	5p13-p12	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
600955	5q15	Obesity with impaired prohormone processing	600955	AR	3
600956	12q13.13	Persistent Mullerian duct syndrome, type II	261550	AR	3
600957	19p13.3	Persistent Mullerian duct syndrome, type I	261550	AR	3
600958	11p11.2	Cardiomyopathy, dilated, 1MM	615396	AD	3
600958	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
600958	11p11.2	Left ventricular noncompaction 10	615396	AD	3
600960	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
600962	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
600963	19q13.32	Branchiootorenal syndrome 2	610896	_	3
600965	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
600968	16q13	Gitelman syndrome	263800	AR	3
600969	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
600970	6q14.1	Deafness, autosomal dominant 22	606346	AD	3
600970	6q14.1	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	AD	3
600970	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
600971	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
600972	5q32	Achondrogenesis Ib	600972	AR	3
600974	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
600975	1p36.2-p36.1	Glaucoma 3, primary infantile, B	600975	AR	2
600977	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
600980	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
600982	5q11.2	46XY sex reversal 6	613762	AD	3
600983	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
600983	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
600985	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
600985	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
600987	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
600993	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
600993	18q21.2	Myhre syndrome	139210	AD	3
600993	18q21.2	Pancreatic cancer, somatic	260350	_	3
600993	18q21.2	Polyposis, juvenile intestinal	174900	AD	3
600994	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
600995	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
600996	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
600997	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
600997	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
600998	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
600998	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
601002	20q11.22	Glutathione synthetase deficiency	266130	AR	3
601002	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
601003	16p11.2	Brody myopathy	601003	AR	3
601005	12p13.33	Timothy syndrome	601005	AD	3
601007	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
601011	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
601011	19p13.13	Episodic ataxia, type 2	108500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1	141500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	AD	3
601011	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
601013	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
601015	14q24.3	Niemann-pick disease, type C2	607625	AR	3
601017	20q11.21	Long QT syndrome 12	612955	AD	3
601019	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
601022	6p21.33	{Rheumatoid arthritis, susceptibility to}	180300	_	3
601023	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
601023	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
601023	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
601040	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
601042	1p34.2	Dystonia 9	601042	AD	3
601045	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
601047	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
601047	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
601047	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
601065	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
601065	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
601068	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
601072	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
601088	16q23.2	Ayme-Gripp syndrome	601088	AD	3
601089	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
601090	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601090	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
601093	5q35.1	Enlarged vestibular aqueduct	600791	AR	3
601094	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
601094	1p33	Cataract 34, multiple types	612968	_	3
601094	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
601097	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
601097	17p12	Dejerine-Sottas disease	145900	AD,AR	3
601097	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
601097	17p12	Roussy-Levy syndrome	180800	AD	3
601098	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
601101	5q31.3-q32	Telangiectasia, hereditary hemorrhagic, type 3	601101	_	2
601103	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
601104	17q21.31	Supranuclear palsy, progressive	601104	AD	3
601105	1q21.3	Pycnodysostosis	265800	AR	3
601107	10q24.2	Dubin-Johnson syndrome	237500	AR	3
601110	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
601119	19p13.3	Perrault syndrome 3	614129	AR	3
601129	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
601130	10q23.33	Tolbutamide poor metabolizer	_	_	3
601130	10q23.33	Warfarin sensitivity	122700	AD	3
601134	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
601143	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
601143	2p13.1	Perry syndrome	168605	AD	3
601143	2p13.1	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
601144	3p22.2	Brugada syndrome 1	601144	AD	3
601145	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
601146	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
601146	20q11.22	Brachydactyly, type A1, C	615072	AD,AR	3
601146	20q11.22	Brachydactyly, type A2	112600	AD	3
601146	20q11.22	Brachydactyly, type C	113100	AD	3
601146	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
601146	20q11.22	Du Pan syndrome	228900	AR	3
601146	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
601146	20q11.22	Symphalangism, proximal, 1B	615298	_	3
601146	20q11.22	{Osteoarthritis-5}	612400	_	3
601147	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
601147	8q22.1	Leber congenital amaurosis 17	615360	AR	3
601147	8q22.1	Microphthalmia with coloboma 6, digenic	613703	AD	3
601147	8q22.1	Microphthalmia, isolated 4	613094	_	3
601147	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
601150	12p11.21	Warsaw breakage syndrome	613398	AR	3
601152	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
601154	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
601156	17q12	{Asthma, susceptibility to}	600807	AD	3
601156	17q12	{HIV1, resistance to}	609423	_	3
601162	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
601176	1p22.1	{Myocardial infarction, susceptibility to}	608446	_	3
601181	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
601184	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
601188	10pter-q11	Prostate adenocarcinoma	601188	_	2
601190	12p12.3	Achromatopsia 6	610024	AD,AR	3
601190	12p12.3	Retinal cone dystrophy 3	610024	AD,AR	3
601192	1p36.13	[Fleck retina, familial benign]	228980	AR	3
601194	4p14	{Leprosy, protection against}	613223	_	3
601194	4p14	{Leprosy, susceptibility to, 5}	613223	_	3
601197	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
601199	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant	601198	AD	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	AD	3
601199	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
601199	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
601200	14q32.13	Pleuropulmonary blastoma	601200	AD	3
601202	17p13	Cataract 24, anterior polar	601202	AD	2
601205	14q23.1	Branchiootic syndrome 3	608389	AD	3
601205	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
601208	14q24.3-q31	{Diabetes mellitus, insulin-dependent, 11}	601208	_	2
601214	17q21.2	Naxos disease	601214	AR	3
601215	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
601215	3q23	Seckel syndrome 1	210600	AR	3
601216	11q13.1	Dental anomalies and short stature	601216	AR	3
601224	11p11.2	Potocki-Shaffer syndrome	601224	_	4
601228	15q15.3-q22.1	Polyposis syndrome, mixed hereditary 1	601228	AD	4
601228	15q15.3-q22.1	{Colorectal cancer, susceptibility to, 4}	601228	AD	4
601231	1p36.22	Focal cortical dysplasia, type II, somatic	607341	_	3
601231	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
601238	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
601239	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
601240	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
601243	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
601243	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
601247	14q21.3	Noonan syndrome 9	616559	AD	3
601248	2q14.3	Centronuclear myopathy 2	255200	AR	3
601253	3p25.3	Cardiomyopathy, familial hypertrophic	192600	AD	3
601253	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
601253	3p25.3	Long QT syndrome 9	611818	AD	3
601253	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
601253	3p25.3	Rippling muscle disease 2	606072	AD	3
601255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
601255	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
601255	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
601259	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
601263	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
601265	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
601267	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601269	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
601277	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
601280	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
601282	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
601282	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
601282	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
601283	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
601284	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
601287	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601288	8q22.3	Popov-Chang syndrome	618428	AD	3
601295	13q33.1	Bile acid malabsorption, primary	613291	AR	3
601296	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
601296	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
601299	10q23.2	Juvenile polyposis syndrome, infantile form	174900	AD	3
601299	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
601299	10q23.2	Polyposis, juvenile intestinal	174900	AD	3
601300	12q13.13	Pancreatic cancer, somatic	_	_	3
601309	9q22.32	Basal cell carcinoma, somatic	605462	_	3
601309	9q22.32	Basal cell nevus syndrome	109400	AD	3
601309	9q22.32	Holoprosencephaly 7	610828	AD	3
601313	16p13.3	Polycystic kidney disease 1	173900	AD	3
601314	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
601316	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
601317	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
601318	2q34	{Diabetes mellitus, insulin-dependent, 13}	601318	_	2
601321	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
601327	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
601330	12p12.3	Diarrhea 6	614616	AD	3
601330	12p12.3	Meconium ileus	614665	AR	3
601331	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
601336	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
601338	19q13.2	CAPOS syndrome	601338	AD	3
601349	6q21	Microphthalmia, syndromic 8	601349	?AD	2
601358	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
601362	10p14-p13	DiGeorge syndrome/velocardiofacial syndrome complex-2	601362	_	2
601363	17q12-q21	Wilms tumor, type 4	601363	AD	2
601365	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
601368	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
601369	14q12	Deafness, autosomal dominant 9	601369	AD	3
601373	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
601373	3p21.31	{Hepatitis C virus, resistance to}	609532	_	3
601373	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601373	3p21.31	{West nile virus, susceptibility to}	610379	_	3
601382	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
601385	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
601388	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
601390	11p15.4	Van Maldergem syndrome 1	601390	AR	3
601395	17q11.2	{HIV/AIDS, susceptibility to}	609423	_	3
601397	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
601397	6q27	{Neural tube defects, susceptibility to}	182940	AD	3
601399	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
601402	3q25.32	Leukemia, acute myeloid	601626	AD,SMu	1
601404	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
601405	1p36.21	{Pancreatitis, chronic, susceptibility to}	167800	AD	3
601406	12q24.31	B-cell non-Hodgkin lymphoma, high-grade	_	_	3
601407	12q24.2	Diabetes mellitus, noninsulin-dependent, 2	601407	_	2
601408	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
601410	6q24	{Diabetes mellitus, transient neonatal, 1}	601410	AD	4
601411	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
601411	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601412	1q21-q23	Deafness, autosomal dominant 7	601412	AD	2
601414	1q21.2	Retinitis pigmentosa 18	601414	AD	3
601419	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
601421	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
601421	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
601424	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
601428	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
601428	2q14.2	Roifman syndrome	616651	AR	3
601439	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
601439	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
601439	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
601440	17q22	Nephrotic syndrome, type 7	615008	AR	3
601440	17q22	{Hemolytic uremic syndrome, atypical, susceptibility to, 7}	615008	AR	3
601443	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
601445	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
601454	4q	{Psoriasis susceptibility 3}	601454	_	2
601455	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
601458	12p13.2-q24.1	{Inflammatory bowel disease 2}	601458	_	2
601460	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
601462	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
601465	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
601465	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
601465	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
601470	3p22.2	{Coronary artery disease, resistance to}	607339	_	3
601470	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
601470	3p22.2	{Rapid progression to AIDS from HIV1 infection}	609423	_	3
601471	3q21-q22	Facial paresis, hereditary congenital, 1	601471	AD	2
601472	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
601479	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
601485	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
601486	3p24.3	{Spermatogenic failure, susceptibility to}	_	_	3
601487	3p25.2	Carotid intimal medial thickness 1	609338	_	3
601487	3p25.2	Insulin resistance, severe, digenic	604367	AD	3
601487	3p25.2	Lipodystrophy, familial partial, type 3	604367	AD	3
601487	3p25.2	Obesity, severe	601665	AD,AR,Mu	3
601487	3p25.2	[Obesity, resistance to]	_	_	3
601487	3p25.2	{Diabetes, type 2}	125853	AD	3
601488	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
601489	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
601492	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
601495	14q32.33	Agammaglobulinemia 1	601495	AR	3
601498	6p21.1	Heimler syndrome 2	616617	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4B	614863	AD,AR	3
601499	13q14	Rieger syndrome, type 2	601499	AD	2
601500	7q32.1	Basal cell carcinoma, somatic	605462	_	3
601500	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601501	16q11.2	{Parkinson disease 17}	614203	AD	3
601513	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
601515	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
601517	12q24.12	Spinocerebellar ataxia 2	183090	AD	3
601517	12q24.12	{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	AD	3
601517	12q24.12	{Parkinson disease, late-onset, susceptibility to}	168600	AD,Mu	3
601518	1q25.3	Prostate cancer 1	601518	AD	3
601525	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
601525	1q32.1	{Schizophrenia, susceptibility to}	181500	AD	3
601527	12q21.31	?Frontonasal dysplasia 3	613456	_	3
601528	4q34.3	Lymphatic malformation 4	615907	AD	3
601530	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
601530	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
601530	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
601530	5q35.3	Paget disease of bone 3	167250	AD	3
601538	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
601539	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
601542	4q25	Anterior segment dysgenesis 4	137600	AD	3
601542	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
601542	4q25	Ring dermoid of cornea	180550	AD	3
601543	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
601544	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
601545	17p13.3	Lissencephaly 1	607432	AD	3
601545	17p13.3	Subcortical laminar heterotopia	607432	AD	3
601547	22q11.23	Cataract 3, multiple types	601547	AD	3
601548	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
601550	17q21.31	[Blood group, Swann]	601550	_	3
601551	17q21.31	[Blood group, Froese]	601551	_	3
601552	8q12.3	Traboulsi syndrome	601552	AR	3
601553	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
601556	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
601559	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
601564	7q34	{Pancreatitis, chronic, protection against}	167800	AD	3
601565	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
601565	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
601566	13q34	Squamous cell carcinoma, head and neck, somatic	275355	_	3
601567	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
601568	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
601570	3p25.1	Fuhrmann syndrome	228930	AR	3
601570	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
601573	7q36.1	Weaver syndrome	277590	AD	3
601574	17q12	Chondrosarcoma, extraskeletal myxoid	612237	_	1
601583	7p14.1	{Wilms tumor susceptibility-5}	601583	AD,SMu	3
601592	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
601592	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
601593	2q35	{Breast cancer, susceptibility to}	114480	AD,SMu	3
601596	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
601601	6p12.3	Char syndrome	169100	AD	3
601601	6p12.3	Patent ductus arteriosus 2	617035	AD	3
601604	19p13.11	Immunodeficiency 30	614891	AR	3
601606	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
601607	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
601607	22q11.23	Rhabdoid tumors, somatic	609322	_	3
601607	22q11.23	{Rhabdoid tumor predisposition syndrome 1}	609322	AD	3
601607	22q11.23	{Schwannomatosis-1, susceptibility to}	162091	AD	3
601609	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
601609	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
601614	17p13.1	Mirror movements 4	618264	AD	3
601615	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
601617	12q13.2	Fundus albipunctatus	136880	AD,AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
601620	12q24.21	Holt-Oram syndrome	142900	AD	3
601621	12q24.21	Ulnar-mammary syndrome	181450	AD	3
601622	7p21.1	Craniosynostosis 1	123100	AD	3
601622	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
601622	7p21.1	Saethre-Chotzen syndrome with or without eyelid anomalies	101400	AD	3
601622	7p21.1	Sweeney-Cox syndrome	617746	AD	3
601623	15q11.2	Angelman syndrome	105830	AD	3
601627	5q13.2	{Spinal muscular atrophy, type III, modifier of}	253400	AR	3
601631	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601639	19p13.12	Cushing syndrome, ACTH-independent adrenal, somatic	615830	_	3
601641	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
601646	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
601650	11q12.2	Paragangliomas 2	601650	AD	3
601652	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
601653	8q13.3	?Otofaciocervical syndrome	166780	AD	3
601653	8q13.3	Anterior segment anomalies with or without cataract	602588	AD	3
601653	8q13.3	Branchiootic syndrome 1	602588	AD	3
601653	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
601656	18q11.2	Atrial septal defect 9	614475	AD	3
601656	18q11.2	Atrioventricular septal defect 5	614474	AD	3
601656	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
601656	18q11.2	Persistent truncus arteriosus	217095	_	3
601656	18q11.2	Tetralogy of Fallot	187500	AD	3
601663	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
601664	2q11.2	Retinitis pigmentosa 33	610359	AD	3
601666	6q21	{Diabetes mellitus, insulin-dependent, 15}	601666	_	2
601671	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
601675	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
601676	1p31	Acute insulin response	601676	_	2
601678	15q21.1	Bartter syndrome, type 1	601678	AR	3
601680	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
601682	3q21-q24	Glaucoma 1C, primary open angle	601682	AD	2
601683	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
601687	17q21.2	Meesmann corneal dystrophy	122100	AD	3
601688	4q34.1	Cranioosteoarthropathy	259100	AR	3
601688	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
601688	4q34.1	Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	AR	3
601689	18q11.2	?Spermatogenic failure 13	615841	AR	3
601690	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
601690	6p12.3	{Asthma, susceptibility to}	600807	AD	3
601690	6p12.3	{Atopy, susceptibility to}	147050	AD	3
601691	1p22.1	Cone-rod dystrophy 3	604116	_	3
601691	1p22.1	Fundus flavimaculatus	248200	AR	3
601691	1p22.1	Retinal dystrophy, early-onset severe	248200	AR	3
601691	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601691	1p22.1	Stargardt disease 1	248200	AR	3
601691	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
601692	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
601692	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
601692	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
601692	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
601692	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
601692	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
601692	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
601693	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
601694	2p21	[Leptin serum levels QTL1]	601694	_	2
601696	11p15.5	[Novelty seeking personality]	601696	?AD	1
601697	18q22.1	Peeling skin syndrome 5	617115	AR	3
601699	20q13.13	Hypertension, essential	145500	Mu	3
601705	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
601707	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601709	10q22.2	Quebec platelet disorder	601709	AD	3
601717	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
601718	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601719	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
601724	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
601724	2q31.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
601725	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
601728	10q23.31	Cowden syndrome 1	158350	AD	3
601728	10q23.31	Lhermitte-Duclos syndrome	158350	AD	3
601728	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
601728	10q23.31	Prostate cancer, somatic	176807	_	3
601728	10q23.31	{Glioma susceptibility 2}	613028	_	3
601728	10q23.31	{Meningioma}	607174	AD	3
601730	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
601731	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
601734	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
601736	17q23.3	Specific granule deficiency 2	617475	AR	3
601740	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
601743	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
601746	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
601749	1p22.1	Glomuvenous malformations	138000	AD	3
601752	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
601756	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
601757	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
601757	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
601758	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
601758	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
601762	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
601762	2q33.1	Gastric cancer, somatic	613659	_	3
601762	2q33.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
601763	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
601763	2q33.1	Hepatocellular carcinoma, somatic	114550	_	3
601763	2q33.1	{Breast cancer, protection against}	114480	AD,SMu	3
601763	2q33.1	{Lung cancer, protection against}	211980	AD,SMu	3
601764	19q	Seizures, benign familial infantile, 1	601764	AD	2
601768	19p13.3	Leukemia, acute myeloid	601626	AD,SMu	1
601769	12q13.11	?Osteoporosis, involutional	166710	AD	1
601769	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
601771	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
601771	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
601776	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
601777	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
601780	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
601785	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
601788	2q32.2	Muscle hypertrophy	614160	_	3
601789	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
601789	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
601791	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
601802	3p14.3	Growth hormone deficiency with pituitary anomalies	182230	AD,AR	3
601802	3p14.3	Pituitary hormone deficiency, combined, 5	182230	AD,AR	3
601802	3p14.3	Septooptic dysplasia	182230	AD,AR	3
601803	12p	Pallister-Killian syndrome	601803	SMo	4
601806	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
601807	12q13.2	Cavitary optic disc anomalies	611543	AD	3
601808	18q	Chromosome 18q deletion syndrome	601808	AD	4
601810	10q21.3	?Seckel syndrome 8	615807	AR	3
601810	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
601812	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
601813	11q13.2	Exudative vitreoretinopathy 4	601813	AD,AR	3
601814	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
601815	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
601816	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
601819	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
601820	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
601825	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
601837	13q33.3	LIG4 syndrome	606593	AR	3
601837	13q33.3	{Multiple myeloma, resistance to}	254500	SMu	3
601843	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
601844	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
601846	19p13.3	Muscular dystrophy with rimmed vacuoles	601846	AD	2
601847	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
601855	19q13.2	?Immunodeficiency 62	618459	AR	3
601860	5q23.1	D-bifunctional protein deficiency	261515	AR	3
601860	5q23.1	Perrault syndrome 1	233400	AR	3
601861	13q13.3	Bare lymphocyte syndrome, type II, complementation group D	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group C	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group E	209920	AR	3
601865	3q24	Bruck syndrome 2	609220	AR	3
601868	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
601869	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
601873	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
601881	18q21.32	Microphthalmia, isolated 3	611038	AR	3
601884	11q13.2	[Bone mineral density variability 1]	601884	AD	3
601885	13q12.11	Cataract 14, multiple types	601885	AD	3
601887	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
601888	5p	{Malignant hyperthermia susceptibility 6}	601888	_	2
601893	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
601894	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
601896	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
601897	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
601898	3q26.31	Growth hormone deficiency, isolated partial	615925	AD,AR	3
601900	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
601902	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
601903	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
601906	12q13.12	Split-hand/foot malformation 6	225300	AR	3
601906	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
601911	17q21.33	?Orofacial cleft 15	616788	AD	3
601912	2q33.1	?Orofacial cleft 10	613705	IC	3
601918	5q31.1	?Premature ovarian failure 14	618014	AR	3
601920	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
601920	20p12.2	Alagille syndrome 1	118450	AD	3
601920	20p12.2	Tetralogy of Fallot	187500	AD	3
601924	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
601925	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
601928	12q13.13	Monilethrix	158000	AD	3
601933	12q23.3	{Delayed sleep phase disorder, susceptibility to}	614163	AD	3
601941	18q21	{Diabetes mellitus, insulin-dependent, 6}	601941	_	2
601942	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
601949	2q23.3	Episodic ataxia, type 5	613855	AD	3
601949	2q23.3	{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	AD	3
601949	2q23.3	{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	AD	3
601952	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
601954	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
601962	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
601968	1p13.2	Diarrhea 9	618168	AR	3
601972	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
601975	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
601977	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
601978	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
601978	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
601982	3p25.3	Renal cell carcinoma, clear cell, somatic	144700	_	3
601992	9p23-p11	Friedreich ataxia 2	601992	AR	2
602011	3p25	?Pancreatic endocrine tumors	_	_	1
602014	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
602023	1p36.13	Bartter syndrome, type 3	607364	AR	3
602023	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602024	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602025	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
602026	10p13	Refsum disease	266500	AR	3
602032	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602033	14q32.2	Band heterotopia	600348	AR	3
602037	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
602044	11q13.4	{Obesity, severe, and type II diabetes}	601665	AD,AR,Mu	3
602048	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
602049	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
602053	10p15.2	Gastric cancer, somatic	613659	_	3
602053	10p15.2	Prostate cancer, somatic	176807	_	3
602054	22q11.21	Conotruncal anomaly face syndrome	217095	_	3
602054	22q11.21	DiGeorge syndrome	188400	AD	3
602054	22q11.21	Tetralogy of Fallot	187500	AD	3
602054	22q11.21	Velocardiofacial syndrome	192430	AD	3
602063	11p15.5	Transaldolase deficiency	606003	AR	3
602064	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
602066	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
602072	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
602078	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602079	1q24.3	Trimethylaminuria	602079	AR	3
602080	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
602081	7q31.1	Speech-language disorder-1	602081	AD	3
602082	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
602083	10q21.1	Usher syndrome, type 1F	602083	AR	3
602085	13q21-q32	Postaxial polydactyly, type A2	602085	AD	2
602086	14q12-q22	Arrhythmogenic right ventricular dysplasia 3	602086	AD	2
602087	2q32.1-q32.3	Arrhythmogenic right ventricular dysplasia 4	602087	AD	2
602088	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
602090	11q13.1	Dental anomalies and short stature	601216	AR	3
602090	11q13.1	Geleophysic dysplasia 3	617809	AD	3
602091	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
602091	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
602091	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
602092	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
602096	12p11.23-q13.12	Alzheimer disease-5	602096	AD	2
602097	21q21	Usher syndrome, type 1E	602097	AR	2
602099	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
602104	4p16.3	Cherubism	118400	AD	3
602109	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
602109	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
602109	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
602134	2p25-p22	Essential tremor, hereditary, 2	602134	AD	2
602136	7q21.2	Heimler syndrome 1	234580	AR	3
602136	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
602136	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
602137	5q31.3	?Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3
602138	22q13.2	Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3
602140	10q24.31	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3
602141	11q13.2	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3
602142	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AR,AD	3
602144	1p22.1	?Spermatogenic failure 21	617644	AR	3
602146	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
602149	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
602149	5q31.1	Liebenberg syndrome	186550	AD	4
602150	8q11.21	Piebaldism	172800	AD	3
602150	8q11.21	Waardenburg syndrome, type 2D	608890	AR	3
602152	8q22.1	?RHYNS syndrome	602152	AR	3
602153	12q13.13	Monilethrix	158000	AD	3
602166	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
602167	14q24.3	Deafness, autosomal recessive 35	608565	AR	3
602168	14q32.2	Pontocerebellar hypoplasia type 1A	607596	AR	3
602170	3p22.2	Macroglobulinemia, Waldenstrom, somatic	153600	_	3
602170	3p22.2	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	_	3
602177	1q21.3	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms	617591	AR	3
602183	4p15.33	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3
602286	11q23.3-q24.1	Lathosterolosis	607330	AR	3
602290	9q33.1	?Bardet-Biedl syndrome 11	615988	AR	3
602290	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
602292	10q26.3	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3
602293	15q26.1	Epidermodysplasia verruciformis 3	618267	AR	3
602296	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
602298	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
602302	8p21.3	Alopecia universalis	203655	AR	3
602302	8p21.3	Atrichia with papular lesions	209500	AR	3
602302	8p21.3	Hypotrichosis 4	146550	AD	3
602311	16q22.1	{Leanness, inherited}	_	_	3
602311	16q22.1	{Obesity, late-onset}	601665	AR,Mu,AD	3
602322	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
602322	3q26.2	{Aplastic anemia}	614743	AD	3
602322	3q26.2	{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	AD	3
602332	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
602334	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
602336	1p31.3	?Deafness, autosomal recessive 108	617654	AR	3
602337	9q22.31	Brachydactyly, type B1	113000	AD	3
602337	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
602342	3q26.32	Pierpont syndrome	602342	AD	3
602345	4q27	?Spinocerebellar ataxia 41	616410	AD	3
602346	17q21.2	Hypomyelinating neuropathy, congenital, 3	618186	AR	3
602346	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
602347	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
602354	16p11.2	Immunodeficiency 52	617514	AR	3
602357	2q31.1	?Wiskott-Aldrich syndrome 2	614493	_	3
602358	17q21.2	?Narcolepsy 1	161400	AD	3
602360	15q21.1	Cerebral creatine deficiency syndrome 3	612718	AR	3
602361	11q12.1	Gracile bone dysplasia	602361	AD	3
602365	11q14.2	Haim-Munk syndrome	245010	AR	3
602365	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
602365	11q14.2	Periodontitis 1, juvenile	170650	AR	3
602368	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
602376	21q22.11	?Immunodeficiency 45	616669	AR	3
602376	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
602377	9q34.11	Epileptic encephalopathy, early infantile, 31	616346	AD	3
602378	19p13.2	Centronuclear myopathy 1	160150	AD	3
602378	19p13.2	Charcot-Marie-Tooth disease, axonal type 2M	606482	AD	3
602378	19p13.2	Charcot-Marie-Tooth disease, dominant intermediate B	606482	AD	3
602378	19p13.2	Lethal congenital contracture syndrome 5	615368	AR	3
602382	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
602389	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
602390	1q21.1	Hemochromatosis, type 2A	602390	AR	3
602397	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
602397	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
602397	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
602398	1p32.3	Desmosterolosis	602398	AR	3
602400	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
602401	18q22.1-q22.3	Ectodermal dysplasia 8, hair/tooth/nail type	602401	AR	2
602402	16q24.1	Lymphedema-distichiasis syndrome	153400	AD	3
602402	16q24.1	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400	AD	3
602404	2p13	{Parkinson disease 3}	602404	_	2
602409	10p12.31	Leukemia, acute myeloid	601626	SMu,AD	3
602410	3p25.3	Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3
602412	10q22.3	Diamond-blackfan anemia 3	610629	AD	3
602413	1q23.3	Gastrointestinal stromal tumor	606764	IC,AD	3
602413	1q23.3	Paraganglioma and gastric stromal sarcoma	606864	_	3
602413	1q23.3	Paragangliomas 3	605373	AD	3
602421	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
602421	7q31.2	Cystic fibrosis	219700	AR	3
602421	7q31.2	Sweat chloride elevation without CF	_	_	3
602421	7q31.2	{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	AD	3
602421	7q31.2	{Hypertrypsinemia, neonatal}	_	_	3
602421	7q31.2	{Pancreatitis, hereditary}	167800	AD	3
602427	16p11.2	Spondylocostal dysostosis 5	122600	AR,AD	3
602429	8q23	Glaucoma 1D, primary open angle	602429	_	2
602431	3p12.3	Vesicoureteral reflux 2	610878	_	3
602432	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
602432	10p13	Glaucoma 1, open angle, E	137760	AD	3
602432	10p13	{Glaucoma, normal tension, susceptibility to}	606657	_	3
602433	9q34.13	Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3
602438	16q22.1	Cataract 5, multiple types	116800	AD	3
602441	3p21.2	{Bacteremia, susceptibility to}	614383	_	3
602441	3p21.2	{Malaria, susceptibility to}	611162	_	3
602441	3p21.2	{Tuberculosis, susceptibility to}	607948	_	3
602445	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
602447	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
602450	10p13	Severe combined immunodeficiency, Athabascan type	602450	AR	3
602452	2q13	Colorectal cancer with chromosomal instability, somatic	_	_	3
602457	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
602458	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
602459	5q32	Deafness, autosomal dominant 15	602459	AD	3
602460	5q32	Deafness, autosomal dominant 15	602459	AD	3
602466	13q31.1	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3
602471	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
602473	19q13.31	Ethylmalonic encephalopathy	602473	AR	3
602477	19p13.3	Febrile seizures, familial, 2	602477	AD	2
602482	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
602483	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
602485	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
602486	8q22.2	Anauxetic dysplasia 2	617396	AR	3
602490	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
602491	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
602498	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
602498	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
602499	2p22.2	Macrophthalmia, colobomatous, with microcornea	602499	AD	4
602501	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
602529	12q13.12	Lissencephaly 3	611603	AD	3
602531	1q22	Grange syndrome	602531	AR	3
602533	1p36.23	Parkinson disease 7, autosomal recessive early-onset	606324	AR	3
602535	19p13.13	Marshall-Smith syndrome	602535	AD	3
602536	2q21.3	Warburg micro syndrome 1	600118	AR	3
602537	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
602540	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
602541	22q13.33	Muscular dystrophy, congenital, megaconial type	602541	AR	3
602544	6q26	Adenocarcinoma of lung, somatic	211980	_	3
602544	6q26	Ovarian cancer, somatic	167000	_	3
602544	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
602552	17p13.2	Fetal akinesia deformation sequence 4	618393	AR	3
602557	20p13	Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3
602568	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
602568	5p15.31	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
602569	5q35.2	Dementia, Lewy body	127750	AD	3
602572	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
602574	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
602574	11q23.3	Deafness, autosomal recessive 21	603629	AR	3
602575	9q33.3	Nail-patella syndrome	161200	AD	3
602576	7p22.3	Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3
602579	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
602589	14q23.3	Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3
602590	11q13.5-q14.1	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3
602591	5q12.1	Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3
602593	6p21.33	Hypotrichosis 2	146520	AD	3
602593	6p21.33	Peeling skin syndrome 1	270300	AR	3
602594	16p12.3-p12.1	Retinitis pigmentosa 22	602594	_	2
602600	1p32.3	{Myocardial infarction, susceptibility to}	608446	_	3
602601	12p13.2	{Myocardial infarction, susceptibility to}	608446	_	3
602606	5q13.2	{?Obesity, susceptibility to}	601665	AR,Mu,AD	3
602614	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
602614	6q15	Frontometaphyseal dysplasia 2	617137	AD	3
602616	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
602617	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
602617	9q22.33	{Thyroid cancer, nonmedullary, 4}	616534	AD	3
602618	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
602623	6p21.31	{Major depressive disorder and accelerated response to antidepressant drug treatment}	608516	_	3
602627	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
602629	8p11.21	Dystonia 6, torsion	602629	AD	3
602630	18p11.31	Holoprosencephaly 4	142946	AD	3
602631	11p15.4	Breast cancer, somatic	114480	_	3
602631	11p15.4	Lung cancer, somatic	211980	_	3
602631	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
602635	11p15.5	?Dyskinesia, seizures, and intellectual developmental disorder	617171	AR	3
602635	11p15.5	Mental retardation, autosomal dominant 24	615828	AD	3
602638	8q11.21	Immunodeficiency 54	609981	AR	3
602639	16q12.1	Tooth agenesis, selective, 2	602639	_	2
602642	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
602643	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
602656	16p13.3	Familial adenomatous polyposis 3	616415	AR	3
602660	9q34.3	Leber congenital amaurosis with early-onset deafness	617879	AD	3
602661	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
602661	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
602662	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
602662	19p13.3	Leukodystrophy, hypomyelinating, 6	612438	AD	3
602666	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
602667	8q21.3	Aplastic anemia	609135	_	3
602667	8q21.3	Leukemia, acute lymphoblastic	613065	_	3
602667	8q21.3	Nijmegen breakage syndrome	251260	AR	3
602668	3q21.3	Myotonic dystrophy 2	602668	AD	3
602669	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
602669	10q24.32	Cataract 11, multiple types	610623	AR,AD	3
602669	10q24.32	Cataract 11, syndromic, autosomal recessive	610623	AR,AD	3
602671	11q23.3	Glycogen storage disease Ib	232220	AR	3
602671	11q23.3	Glycogen storage disease Ic	232240	AR	3
602676	2q37.1	?Joubert syndrome 22	615665	AR	3
602678	14q32.32-q32.33	?Visual impairment and progressive phthisis bulbi	618283	AR	3
602685	15q24	Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685	_	2
602686	7p22.3	Lymphoma, somatic	_	_	3
602686	7p22.3	Prostate cancer, somatic	176807	_	3
602690	11q23.1	Mitochondrial complex II deficiency	252011	AR	3
602690	11q23.1	Paraganglioma and gastric stromal sarcoma	606864	_	3
602690	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
602690	11q23.1	Pheochromocytoma	171300	AD	3
602694	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
602696	22q12.3	?Meier-Gorlin syndrome 8	617564	AR	3
602700	22q13.2	Colorectal cancer, somatic	114500	_	3
602700	22q13.2	Menke-Hennekam syndrome 2	618333	_	3
602700	22q13.2	Rubinstein-Taybi syndrome 2	613684	AD	3
602703	16q21	Lissencephaly 6, with microcephaly	616212	AR	3
602713	8p11.22	Cone-rod dystrophy 9	612775	_	3
602716	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
602717	19q13.33	Epileptic encephalopathy, early infantile, 46	617162	AD	3
602722	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
602723	17q25.3	Psoriasis 2	602723	AD	3
602727	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
602727	16p13.3	Osteopetrosis, autosomal recessive 4	611490	AR	3
602730	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
602731	5p13.1	Thrombocytopenia 3	273900	AR	3
602743	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
602743	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
602743	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
602744	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
602748	12q21.33	Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3
602753	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602754	19q13.31	Dehydrated hereditary stomatocytosis 2	616689	AD	3
602759	1q42.2-q43	{Prostate cancer, susceptibility to}	602759	_	2
602765	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
602765	12q13.13	Monilethrix	158000	AD	3
602767	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602768	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
602769	2p23.3	Acute myeloid leukemia, somatic	601626	_	3
602769	2p23.3	Tatton-Brown-Rahman syndrome	615879	AD	3
602770	17q25.3	?46XY sex reversal 5	613080	AR	3
602771	1p36.11	Muscular dystrophy, rigid spine, 1	602771	AR	3
602772	6q12	Retinitis pigmentosa 25	602772	AR	3
602773	3q21.1	Renal cell carcinoma	144700	_	1
602774	17q22	Fanconi anemia, complementation group O	613390	AR	3
602774	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
602775	10q25.2	Noonan-like syndrome with loose anagen hair	607721	AD	3
602780	5p12	Epileptic encephalopathy, early infantile, 24	615871	AD	3
602780	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
602782	10q22.1	Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3
602783	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
602821	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
602821	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
602821	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
602839	1p36.22	Immunodeficiency 14	615513	AD	3
602840	19p13.3	Lymphoproliferative syndrome 3	618261	AR	3
602842	6p22.3	Meier-Gorlin syndrome 6	616835	AD	3
602849	4p16.3	Muenke syndrome	602849	AD	3
602851	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
602851	5q14.3	Usher syndrome, type 2C	605472	AR	3
602851	5q14.3	Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	AR	3
602855	14q13.2	{Myocardial infarction, susceptibility to}	608446	_	3
602858	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
602859	1p36.32	Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3
602859	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
602860	15q15.1	Colorectal cancer, somatic	114500	_	3
602860	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
602860	15q15.1	[Premature chromatid separation trait]	176430	AD	3
602861	12p11.21	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3
602867	4q12	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3
602869	1q44	Epileptic encephalopathy, early infantile, 54	617391	AD	3
602870	6q14.1	Macular dystrophy, vitelliform, 4	616151	AD	3
602875	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
602876	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
602879	20q11.23	?Mental retardation, autosomal dominant 11	614257	AD	3
602880	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
602880	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
602900	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
606025	3q13.31	Primrose syndrome	259050	AD	3
606220	13q22.3	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3
604270	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
604270	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
604270	11p11.2	Sclerosteosis 2	614305	AR,AD	3
603295	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
605635	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
606612	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	AR	3
603685	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
606613	9p	[High density lipoprotein cholesterol level QTL 1]	606613	_	2
606806	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
607001	9q34.3	Kleefstra syndrome 1	610253	AD	3
606807	3p14.3	Hypogonadotropic hypogonadism 18 with or without anosmia	615267	AR,AD	3
603297	11q22.3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR,DR	3
605637	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AR,AD	3
606808	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607002	3p13	Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3
604272	22q13.33	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	AR	3
604272	22q13.33	Myopia 6	608908	AD	3
605833	1q21-q23	[Bone mineral density QTL 2]	605833	_	2
607196	17q25.1	Microcephaly, Amish type	607196	AR	3
603490	1p36.12	?SERKAL syndrome	611812	AR	3
603490	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
606224	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
604273	17p11.2	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3
603491	1p13.1	?Lacrimal duct defect	149700	AR	3
603688	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
607198	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
607004	5p13.3-p13.2	Brachydactyly, type A1, B	607004	AD	2
603301	2p25.1	Maturity-onset diabetes of the young, type VII	610508	_	3
607199	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
607199	1q32.2	van der Woude syndrome	119300	AD	3
607199	1q32.2	{Orofacial cleft 6}	608864	AD	3
607976	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
608170	5q35.3	{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3
606810	22q11.21	Hyperprolinemia, type I	239500	AR	3
606810	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
603689	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
603690	3q25.31	Congenital cataracts, hearing loss, and neurodegeneration	614482	AR	3
603690	3q25.31	Spastic paraplegia 42, autosomal dominant	612539	AD	3
608171	12p13.33	Retinal cone dystrophy 4	610478	AR	3
608172	1p36.11	?Congenital disorder of glycosylation, type 1bb	613861	AR	3
608172	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
608172	1p36.11	Retinitis pigmentosa 59	613861	AR	3
607393	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
607393	1q31.2	Hyperparathyroidism-jaw tumor syndrome	145001	AD	3
607393	1q31.2	Parathyroid adenoma with cystic changes	145001	AD	3
607393	1q31.2	Parathyroid carcinoma	608266	_	3
603511	7q36.3	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3
602911	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
603467	11p14.3	Fanconi anemia, complementation group F	603467	_	3
604261	6q21	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3
605102	1p36.22	MASP2 deficiency	613791	AR	3
605376	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
606771	14p11.2-q13	{Adiponectin, serum level of, QTL3}	606771	_	2
604710	19q13.2	Cutis laxa, autosomal recessive, type IC	613177	AR	3
605572	17p12	Abdominal obesity-metabolic syndrome	605572	AD	2
604144	19q13.11	Cystinuria	220100	AR,AD	3
604507	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
606494	1p34.1	?Epileptic encephalopathy, early infantile, 15	615006	AR	3
606494	1p34.1	Mental retardation, autosomal recessive 12	611090	AR	3
606454	14q24.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606454	14q24.3	Ovarioleukodystrophy	603896	AR	3
603390	5q13.3	Pigmented nodular adrenocortical disease, primary, 3	614190	_	3
603390	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
603550	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
603550	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
604223	7q22.1	Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease	617718	AR	3
607017	6p24.1-p22.3	Deafness, autosomal dominant 21	607017	AD	2
606258	13q32-q33	{Stature QTL 4}	606258	_	2
607095	9p13.3	Anauxetic dysplasia 1	607095	AR	3
605377	19q13.32	Myotonic dystrophy 1	160900	AD	3
604145	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
606972	14q23	{Epilepsy, idiopathic generalized, susceptibility to, 2}	606972	_	2
603513	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
606933	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
606933	11q14.3	Albinism, oculocutaneous, type IB	606952	_	3
606933	11q14.3	Waardenburg syndrome/albinism, digenic	103470	AD	3
606933	11q14.3	[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	AD	3
606933	11q14.3	[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	AD	3
606933	11q14.3	{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	AD	3
605573	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
607096	11q13.1	Hypouricemia, renal	220150	AR	3
607134	13q21	Specific language impairment QTL, 3	607134	_	2
603028	4q31.3	{Colorectal cancer, susceptibility to}	114500	SMu,AD	3
603028	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
603028	4q31.3	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
604827	15q14	Epilepsy, juvenile myoclonic	604827	AR	2
604827	15q14	{Epilepsy, idiopathic generalized, susceptibility to, 7}	604827	AR	2
604624	5q11.2	?Neuronopathy, distal hereditary motor, type IIC	613376	AD	3
604712	8q22.3	Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	AR	3
604712	8q22.3	Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	AR	3
604712	8q22.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3
603830	3p22.2	Long QT syndrome-3	603830	AD	3
603147	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
607373	3q25-q27	{Autism susceptibility 8}	607373	IC,Mu	2
603714	2p21	Holoprosencephaly 2	157170	AD	3
603714	2p21	Schizencephaly	269160	_	3
606934	15q15.1	Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3
604985	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
604985	11q13.2	Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3
603552	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
605610	19q13.33	Ataxia-oculomotor apraxia 4	616267	AR	3
605610	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
605378	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
607295	22q12.1	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3
603629	11q23.3	Deafness, autosomal recessive 21	603629	AR	3
606973	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
607056	3q12.3	Macular dystrophy, vitelliform, 5	616152	AD	3
607056	3q12.3	Retinitis pigmentosa 56	613581	AR	3
606896	3p12-q13	{Dyslexia, susceptibility to, 5}	606896	_	2
605379	16q23.2	Giant axonal neuropathy-1	256850	AR	3
604625	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
605814	7q21.3	Citrullinemia, type II, neonatal-onset	605814	AR	3
606214	19q13.2	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3
604025	17q24.1	Colorectal cancer, somatic	114500	_	3
604025	17q24.1	Oligodontia-colorectal cancer syndrome	608615	AD	3
606496	6p12.2	?Candidiasis, familial, 6, autosomal dominant	613956	_	3
606856	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
607572	6q25	{Leprosy, susceptibility to, 2}	607572	_	2
606936	19q13.33	Progressive familial heart block, type IB	604559	AD	3
604346	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
607100	2q13	Joubert syndrome 4	609583	AR	3
607100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
607100	2q13	Senior-Loken syndrome-1	266900	AR	3
605815	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
604305	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
604305	6p21.32	{Creutzfeldt-Jakob disease, variant, resistance to}	123400	AD	3
604305	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
607728	15q25.1-q26.1	Porokeratosis 4, disseminated superficial actinic	607728	_	2
606215	1p31-p21	{Atrioventricular septal defect, susceptibility to, 1}	606215	_	2
603553	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
603667	2q31.1	Epileptic encephalopathy, early infantile, 39	612949	AR	3
604946	19q13.42	{AIDS, delayed/rapid progression to}	609423	_	3
603395	8q22.2	Ciliary dyskinesia, primary, 28	615505	AR	3
606574	5p13.2	Albinism, oculocutaneous, type IV	606574	_	3
603716	6p24.2	Hyperparathyroidism 4	617343	AD	3
603716	6p24.2	Hypoparathyroidism, familial isolated	146200	AR,AD	3
606857	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
606857	6p12.1	{Myocardial infarction, susceptibility to}	608446	_	3
605577	11q13.1	?Bleeding disorder, platelet-type, 18	615888	AR	3
607057	22q11.21	Pseudo-TORCH syndrome 2	617397	AR	3
606938	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
605537	1q23.3	Achromatopsia 7	616517	AR	3
604027	17q21.32	Epilepsy, progressive myoclonic 6	614018	AR	3
605495	12p12.2	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3
604065	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
604065	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
603263	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
603150	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
607457	9p13.3	[Blood group GIL]	607457	_	3
607731	8q13-q23	Charcot-Marie-Tooth disease, axonal, type 2H	607731	AR	2
606897	1q42.3	Chediak-Higashi syndrome	214500	AR	3
607536	19p13.11	Mucoepidermoid salivary gland carcinoma	_	_	3
605579	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
608160	17q24.3	Acampomelic campomelic dysplasia	114290	AD	3
608160	17q24.3	Campomelic dysplasia	114290	AD	3
608160	17q24.3	Campomelic dysplasia with autosomal sex reversal	114290	AD	3
606060	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
603188	10p	{Obesity, susceptibility to, BMIQ8}	603188	_	2
607613	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
607613	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
607458	7q22-q32	Spinocerebellar ataxia 18	607458	AD	2
603313	12q12	{Long QT syndrome, acquired, reduced susceptibility to}	613688	AD	3
606382	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
606012	3q22	Deafness, autosomal dominant 18	606012	AD	2
604185	10q21.3-q22.1	Facial paresis, hereditary congenital, 2	604185	AD	2
606939	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
606939	8p21.3	Zimmermann-Laband syndrome 2	616455	AD	3
607574	22q13.33	Metachromatic leukodystrophy	250100	AR	3
607614	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
604867	7q31.32	[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}	617956	_	3
608161	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
607459	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
604348	2q37.3	Advanced sleep phase syndrome, familial, 1	604348	AD	3
606821	7q22.3	Congenital disorder of glycosylation, type IIi	613612	_	3
604110	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
604110	16q21	Polymicrogyria, bilateral perisylvian	615752	_	3
604831	4p16.2	?Weyers acrofacial dysostosis	193530	AD	3
604831	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607965	10q22.3	{Systemic lupus erythematosus with nephritis, susceptibility to, 1}	607965	_	2
603632	6p21.31	Diamond-Blackfan anemia 9	613308	AD	3
608320	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
603590	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3
603590	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	AR	3
607537	11q21	Mucoepidermoid salivary gland carcinoma	_	_	3
607339	16pter-p13	{Coronary heart disease, susceptibility to}	607339	_	2
608904	17p11	{Attention deficit-hyperactivity disorder}	143465	AD	2
608787	3q22-q24	Otosclerosis 5	608787	_	2
603671	5q12.1	Acromelic frontonasal dysostosis	603671	AD	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3
606822	1p34.1	Retinitis pigmentosa 76	617123	AR	3
605582	6q12-q16	Cardiomyopathy, dilated, 1K	605582	_	2
605497	3p22.3	Osteogenesis imperfecta, type VII	610682	AR	3
603718	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
608905	6q12	{Attention deficit-hyperactivity disorder}	143465	AD	2
606061	7p14.2	Atrial septal defect 4	611363	_	3
604629	11q22.2	Amelogenesis imperfecta, type IIA2	612529	AR	3
604149	7q21.3	Dystonia-11, myoclonic	159900	AD	3
608358	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
605025	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
608124	16p12.3	Desbuquois dysplasia 2	615777	AR	3
608124	16p12.3	{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3
606179	16q22	Aneurysmal bone cysts	606179	_	2
608593	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
603673	1p34.1	Basal cell carcinoma, somatic	605462	_	3
603673	1p34.1	Basal cell nevus syndrome	109400	AD	3
603673	1p34.1	Medulloblastoma, somatic	155255	_	3
607461	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
607461	18q21.1	Smith-McCort dysplasia	607326	AR	3
606180	4q27	Pontocerebellar hypoplasia, type 1D	618065	AR	3
606384	18q21.31	Periventricular nodular heterotopia 7	617201	AD	3
604630	1p36.11	Obesity, mild, early-onset	601665	AR,Mu,AD	3
603557	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
608982	3p26	{Stature QTL 5}	608982	_	2
606824	22q12.3	Glucose/galactose malabsorption	606824	AR	3
608125	17q21.33	Spondyloocular syndrome	605822	AR	3
608125	17q21.33	{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3
603756	4q22.1	[Junior blood group system]	614490	_	3
603756	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
607462	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
608906	5p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
604067	17q24.1	Bradyopsia	608415	_	3
605818	2q23-q31	Deafness, autosomal recessive 27	605818	AR	2
608047	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
608515	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
606860	11q12.1	Angioedema, hereditary, types I and II	106100	AR,AD	3
606860	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
608709	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
605380	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
605380	12p13.32	Osteomalacia, tumor-induced	_	_	1
605380	12p13.32	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	_	3
603795	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
607258	4q33-qter	Hypercalciuria, absorptive	607258	_	2
608907	19p13.3	{Alzheimer disease 9, susceptibility to}	608907	AD	3
607966	2q34-q35	{Systemic lupus erythematosus with nephritis, susceptibility to, 2}	607966	_	2
608594	9q34.3	Lipodystrophy, congenital generalized, type 1	608594	AR	3
603796	21q22.11	Atrial fibrillation, familial, 4	611493	_	3
603796	21q22.11	Long QT syndrome 6	613693	AD	3
608710	6p21.3	Granulomatosis with polyangiitis	608710	_	2
604834	12q14.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3
604834	12q14.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3
607967	11p15.5	{Systemic lupus erythematosus with nephritis, susceptibility to, 3}	607967	_	2
603758	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
607059	8q24.3	Acrodermatitis enteropathica	201100	AR	3
603560	22q13.33	Charcot-Marie-Tooth disease, type 4B3	615284	AR	3
607027	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
607027	3q13.31	Epileptic encephalopathy, infantile or early childhood, 3	618012	AD	3
609060	3q25.32	Combined oxidative phosphorylation deficiency 1	609060	AR	3
608908	22q13.33	Myopia 6	608908	AD	3
607259	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
607417	3p26.2	Mental retardation, autosomal recessive 2	607417	AR	3
608323	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
607060	12q12	{Parkinson disease 8}	607060	AD	3
607968	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
607464	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
607616	11p15.4	Niemann-Pick disease, type B	607616	AR	3
609334	18q22	Chromosome 18 pericentric inversion	609334	_	4
604349	9q34.12	Cortical malformations, occipital	614115	AR	3
608049	13q14.2-q14.1	{Autism susceptibility 3}	608049	IC,Mu	2
608984	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
607465	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
607847	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
604114	15q15.1	Platelet PLC beta-2 deficiency	_	_	1
606693	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
608051	4p15.32	Macular dystrophy, retinal, 2	608051	AD	3
609023	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
609179	15q11.2-q12	{Migraine with aura, susceptibility to, 7}	609179	_	2
609607	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
607849	14q24.1	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3
609180	17p13.1	Congenital disorder of glycosylation, type If	609180	AR	3
604115	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
608713	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
606742	4q32.3	Atrial septal defect 6	613087	AD	3
609412	5q12.1	Cockayne syndrome, type A	216400	AR	3
609412	5q12.1	UV-sensitive syndrome 2	614621	AR	3
604427	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
607468	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
608869	1p13.2	Urofacial syndrome 2	615112	AR	3
609840	14q32.12	Amelogenesis imperfecta, type IIA5	615887	AR	3
609840	14q32.12	[Skin/hair/eye pigmentation 6, blond/brown hair]	210750	AR	3
609840	14q32.12	[Skin/hair/eye pigmentation 6, blue/green eyes]	210750	AR	3
609025	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
604116	1p22.1	Cone-rod dystrophy 3	604116	_	3
603799	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
609918	1p36.21	Gallbladder disease 2	609918	_	2
609452	10q23.2	Myopathy, myofibrillar, 4	609452	AD	3
607850	9q22.31	{Osteoarthritis susceptibility 3}	607850	AD	3
604473	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
604473	6q24.3	Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3
610113	1q21.2	Ectopia lentis et pupillae	225200	AR	3
610113	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
610192	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
607498	6p21.1-p12.2	{Migraine with or without aura, susceptibility to, 3}	607498	AD	2
604117	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
610193	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
606744	18q11.2	Seckel syndrome 2	606744	AR	3
609062	7p14.1	{Wilms tumor susceptibility-5}	601583	SMu,AD	3
610230	22q13.31	Liver failure, transient infantile	613070	AR	3
610230	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
607499	10p	{Bulimia nervosa, susceptibility to}	607499	Mu	2
603563	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
603355	16q23.3-q24.1	?Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3
610308	13q12.3	Peters-plus syndrome	261540	AR	3
610542	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
603356	6q21	?Deafness, autosomal dominant 66	616969	AD	3
609919	1p34.3	Gallbladder disease 3	609919	_	2
609026	6p12-q12	{Cataract 28, age-related cortical, susceptibility to}	609026	_	2
610114	9q22	{Stature QTL 8}	610114	_	2
610425	22q12.1	Cataract 23	610425	_	3
610543	16p13.3	Chromosome 16p13.3 deletion syndrome	610543	_	4
608053	15q24.2-q24.3	Glutaric acidemia IIA	231680	AR	3
608360	9q34.11	?Agammaglobulinemia 5	613506	AD	3
610504	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
610698	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
606694	5p13.2	?Atrial fibrillation 15	615770	AR	3
607853	9q31	Panic disorder 2	607853	_	2
603592	18q12.2	Xanthinuria, type II	603592	AR	3
604556	19q13.2	Abdominal obesity-metabolic syndrome 3	615812	AD	3
610194	1q42.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	AR	3
610738	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
609255	6q22-q24	Febrile seizures, familial, 5	609255	AD	2
610815	8q22.3	?Exercise intolerance, riboflavin-responsive	616839	AR	3
603593	14q11.2	Lysinuric protein intolerance	222700	AR	3
604557	16q12.1	Joubert syndrome 19	614844	AR,AD	3
604557	16q12.1	Nephronophthisis 14	614844	AR,AD	3
610505	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
609027	11p13	[Blood group, Indian system]	609027	_	3
610621	4q28.1	?Orofaciodigital syndrome XVII	617926	AR	3
610621	4q28.1	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3
608553	1p36.22	Leber congenital amaurosis 9	608553	AR	3
608361	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
610582	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
610933	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
609610	15q15.3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3
611088	12q13.12	Ciliary dyskinesia, primary, 27	615504	AR	3
610350	15q26.3	Mental retardation, autosomal recessive 27	614340	AR	3
609256	11p13	Myopia 7	609256	Mu	2
603594	1q25.1	{Myocardial infarction, susceptibility to}	608446	_	3
609958	2p16	{Asthma-related traits, susceptibility to, 3}	609958	_	2
610934	7q35	Premature ovarian failure 5	611548	AD	3
609257	3q26	Myopia 8	609257	Mu	2
610427	11q13.2	Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3
603357	18q21.33	Palmoplantar keratoderma, Nagashima type	615598	AR	3
610389	1q22	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3
608874	4p16.2	Orofacial cleft 5	608874	_	3
609922	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
610855	10p12.1	Thrombocytopenia 2	188000	AD	3
608875	14q32	{Gene expression, variation in, QTL}	608875	_	2
610353	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
610622	19q13.33	{Neural tube defects, susceptibility to}	182940	AD	3
611051	3q28	?Deafness, autosomal dominant 44	607453	AD	3
604558	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
610197	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
610197	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
608716	1q31.3	Microcephaly 5, primary, autosomal recessive	608716	AR	3
610234	14q11.2-q12	Synpolydactyly 3	610234	_	2
609883	17q22	Bardet-Biedl syndrome 13	615990	AR	3
609883	17q22	Joubert syndrome 28	617121	AR	3
609883	17q22	Meckel syndrome 1	249000	AR	3
603564	9q34.11	Congenital disorder of glycosylation, type Iu	615042	AR	3
608363	22q11.2	Chromosome 22q11.2 microduplication syndrome	608363	IC,AD	4
610198	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
603358	2q35	GRACILE syndrome	603358	_	3
608364	12q13.12	[Low density lipoprotein cholesterol level QTL 8]	618079	_	3
611209	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
607575	22q11.1	?Sneddon syndrome	182410	AR	3
607575	22q11.1	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3
610236	2q31.1	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3
609727	1p31.1-p21.1	Spastic paraplegia 29, autosomal dominant	609727	AD	2
609762	19q13.32	Hermansky-Pudlak syndrome 8	614077	AR	3
607892	18q12.1	Hypotrichosis 6	607903	AR	3
611363	7p14.2	Atrial septal defect 4	611363	_	3
611283	11q25	Isobutyryl-CoA dehydrogenase deficiency	611283	_	3
603805	15q15.2	Peeling skin syndrome 2	609796	AR	3
609923	9p21.1	Retinitis pigmentosa 31	609923	_	3
604559	19q13.33	Progressive familial heart block, type IB	604559	AD	3
609728	2q33.1	?Combined oxidative phosphorylation deficiency 25	616430	AR	3
609728	2q33.1	Spastic ataxia 3, autosomal recessive	611390	AR	3
607893	3p25-p22	{Ovarian cancer, susceptibility to}	607893	_	2
611211	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
611556	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
608367	7p15	Myopia 17	608367	AD	2
607854	11q12.3	Bestrophinopathy, autosomal recessive	611809	_	3
607854	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
607854	11q12.3	Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	193220	AD	3
607854	11q12.3	Retinitis pigmentosa, concentric	613194	_	3
607854	11q12.3	Retinitis pigmentosa-50	613194	_	3
607854	11q12.3	Vitreoretinochoroidopathy	193220	AD	3
611053	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
611364	5q12-q14	Myoclonic epilepsy, juvenile, 4	611364	AD	2
611595	18q23	Burn-McKeown syndrome	608572	AR	3
607855	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
609063	22q12.3	?Combined oxidative phosphorylation deficiency 29	616811	AR	3
611868	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
611634	3p24.2-p23	Febrile seizures, familial, 9	611634	AD	2
609258	4q12	Myopia 9	609258	Mu	2
610819	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
609924	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
611907	19q13	Episodic ataxia, type 7	611907	AD	2
603570	6q23.2	[High density lipoprotein cholesterol level QTL 8]	_	_	3
607776	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
610624	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
611715	4q12	Congenital disorder of glycosylation, type Iq	612379	AR	3
611715	4q12	Kahrizi syndrome	612713	AR	3
607501	14q21.2-q22.3	{Migraine without aura, susceptibility to, 4}	607501	AD	2
610430	4q	{Macroglobulinemia, Waldenstrom, susceptibility to, 2}	610430	_	2
608877	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
608878	20q13	{Gene expression, variation in, QTL}	608878	_	2
607778	2q35	Acrocapitofemoral dysplasia	607778	AR	3
607857	4q31-q34	{Psoriasis susceptibility 9}	607857	_	2
612298	11p13	?Aniridia 3	617142	AD	3
611716	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
611716	12q24.31	Wrinkly skin syndrome	278250	AR	3
603810	11q21	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3
611637	4p16	Primary lateral sclerosis, adult, 1	611637	AD	2
611247	16p12	Major affective disorder 4	611247	_	2
609646	3q13.33	Deafness, autosomal recessive 42	609646	AR	3
609647	18p11.32-p11.31	Deafness, autosomal recessive 46	609647	AR	2
603601	11p15.1	Oculoskeletodental syndrome	618440	AR	3
611638	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
612025	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
609965	14q11.2-q12	Deafness, autosomal dominant 53	609965	AD	2
608879	15q22.2	Parkinson disease 23, autosomal recessive, early onset	616840	AR	3
612453	5q23.2	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	614399	AR	3
612453	5q23.2	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	614399	AR	3
611597	3q22.1	Cataract 12, multiple types	611597	AD	3
603811	11q13.1	Nestor-Guillermo progeria syndrome	614008	AR	3
609648	19q13.42	Familial cold autoinflammatory syndrome 2	611762	AD	3
612570	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
612570	5q23.3	Macular degeneration, early-onset	616118	AD	3
608556	1q41	{Legionnaire disease, susceptibility to}	608556	_	3
609259	8p23	Myopia 10	609259	Mu	2
611718	4q25	Hypomagnesemia 4, renal	611718	_	3
611951	19q13.2	?Meckel syndrome 10	614175	AR	3
611951	19q13.2	Joubert syndrome 34	614175	AR	3
612648	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
611598	4q27	{Autoimmune disease, susceptibility to, 5}	611598	_	2
611598	4q27	{Celiac disease, susceptibility to, 6}	611598	_	2
613077	8q22.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3
612804	19q13.2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3
612300	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
612026	4q25	Alazami syndrome	615071	AR	3
613155	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	AR	3
612882	6q21	{Menarche, age at, QTL2}	612882	_	2
613078	5q31.1	Nijmegen breakage syndrome-like disorder	613078	_	3
612649	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
612301	18q21.33	Osteopetrosis, autosomal recessive 7	612301	AR	3
612961	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
609260	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
603813	1p36.11	Hypercholesterolemia, familial, 4	603813	AR	3
612378	6q23	{Systemic lupus erythematosus, susceptibility to, 13}	612378	_	2
612999	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
604961	2q31.2	Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3
613038	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AR,AD	3
612805	1q21.2	?Combined oxidative phosphorylation deficiency 21	615918	AR	3
607472	10p12.1	?Optic atrophy 11	617302	AR	3
609261	12q24.1	Stuttering, familial persistent, 2	609261	_	2
610355	16p12.2	Fanconi anemia, complementation group N	610832	_	3
610355	16p12.2	{Breast cancer, susceptibility to}	114480	SMu,AD	3
610355	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
610823	19p13.11	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3
613195	15q26.3	Weill-Marchesani 4 syndrome, recessive	613195	AR	3
613000	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
611010	11p15	Fibromatosis, gingival, 4	611010	_	2
612336	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
609262	3p26.2	Mental retardation, autosomal recessive 2	607417	AR	3
612105	10q23.31	Cowden syndrome 4	615107	_	3
607473	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
612337	1q44	Mental retardation, autosomal dominant 22	612337	AD	3
610826	5q22.1	Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3
612379	4q12	Congenital disorder of glycosylation, type Iq	612379	AR	3
613274	18q12.2	Xanthinuria, type II	603592	AR	3
610827	20q13.12	Microcephaly 10, primary, autosomal recessive	615095	AR	3
612650	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
608750	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
608557	13q12	{Myocardial infarction, susceptibility to, 2}	608557	_	2
612651	6p12.1	Endocrine-cerebroosteodysplasia	612651	AR	3
611875	12p13.33	Brugada syndrome 3	611875	_	3
613468	8p22	Farber lipogranulomatosis	228000	AR	3
613468	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
612571	5p15.33	{Lung cancer susceptibility 3}	612571	_	2
609769	12q13.3	Ichthyosis, congenital, autosomal recessive 13	617574	AR	3
613818	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
613896	7q33	Erythrocytosis, familial, 8	222800	AR	3
613545	1p34-p32	Macrostomia	613545	_	2
612380	17q21.2	{Inflammatory bowel disease 22}	612380	_	2
612381	1q32.1	{Inflammatory bowel disease 23}	612381	_	2
613001	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
609968	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
613819	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
614091	2p24.1	Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3
612572	20p13	Retinitis pigmentosa 46	612572	_	3
614052	8q21.11	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3
614208	9p23-p13.3	Mental retardation, autosomal recessive 16	614208	AR	2
613662	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
612107	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
610397	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
613350	20p13	?Fazio-Londe disease	211500	AR	3
613350	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
613002	4q35.1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}	613002	AR,AD	3
612653	17q21.31	Spherocytosis, type 4	612653	AD	3
613897	11p14.3	Fanconi anemia, complementation group F	603467	_	3
612108	2q24-q32	[Fasting plasma glucose level QTL 1]	612108	_	2
614169	3p21.31	Gray platelet syndrome	139090	AR	3
612573	12q24.31	[Mean platelet volume QTL1]	612573	_	2
613118	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AR,AD	3
607982	11q13.1	Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3
612067	2q31.2	Dystonia 16	612067	AR	3
607983	1q24.2	Geroderma osteodysplasticum	231070	AR	3
612574	3p21-p13	[Mean platelet volume QTL2]	612574	_	2
613702	12p13.31	Klippel-Feil syndrome 3, autosomal dominant	613702	_	3
613119	11q13.4	?Brugada syndrome 6	613119	_	3
614170	4q27	Brittle cornea syndrome 2	614170	AR	3
613779	19p13.3	C3 deficiency	613779	AR	3
614559	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
612921	2q35	3-M syndrome 2	612921	AR	3
613780	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
614482	3q25.31	Congenital cataracts, hearing loss, and neurodegeneration	614482	AR	3
608988	6q14-q16	Atrial fibrillation, familial, 2	608988	_	2
613352	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
613820	2q24.3	Nephronophthisis 12	613820	AR,AD	3
613665	1q23.2	[Blood group, Duffy system]	110700	AR,AD	3
613665	1q23.2	[White blood cell count QTL]	611862	AR	3
613665	1q23.2	{Malaria, vivax, protection against}	611162	_	3
612847	10q23.2-q23.3	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3
614209	17p11.2	?Meckel syndrome 9	614209	AR	3
612575	17q11.2	[Mean platelet volume QTL3]	612575	_	2
614053	20q13.32	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	_	3
614676	7p12.1-q21	Cardiomyopathy, hypertrophic, 21	614676	AD	2
614210	3q28	{Lung cancer susceptibility 5}	614210	_	2
613079	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
604965	20q13.12	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	_	3
612848	19q13.12	Mitochondrial complex II deficiency	252011	AR	3
603816	16p13.3	?Caudal duplication anomaly	607864	_	3
603816	16p13.3	Hepatocellular carcinoma, somatic	114550	_	3
614249	6q23.2	Mental retardation, autosomal recessive 18	614249	AR	3
612109	4p16.1	Oculoauricular syndrome	612109	AR	3
614949	16q23.1	Joubert syndrome 20	614970	AR	3
614949	16q23.1	Meckel syndrome 11	615397	AR	3
603604	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
603604	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
603604	22q13.1	Parkinson disease 14, autosomal recessive	612953	AR	3
613080	17q25.3	?46XY sex reversal 5	613080	AR	3
614250	6p22.1	?Narcolepsy 7	614250	AD	3
614055	6q25.3	?ACAT2 deficiency	614055	IC	1
604267	19q13.2	Carpenter syndrome 2	614976	AR	3
614756	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
614325	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
612110	13q14	[Bone mineral density QTL 9]	612110	_	2
603720	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
615145	4q34.3-q35.1	Microphthalmia, isolated, with coloboma 9	615145	AR	3
603576	15q13.3	Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	_	3
614757	11p15.5	Osteogenesis imperfecta, type V	610967	AD	3
614871	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
614677	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
603605	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
607508	19p13	{Migraine with or without aura, susceptibility to, 5}	607508	AD	2
613587	8p23.1	Occult macular dystrophy	613587	AD	3
613506	9q34.11	?Agammaglobulinemia 5	613506	AD	3
614251	3q27.1	{Parkinson disease 18}	614251	AD	3
613823	15q21.1	Seckel syndrome 5	613823	AR	3
615028	11q22.3	Epidermolysis bullosa, nonspecific, autosomal recessive	615028	AR	3
615262	17q25.1	Mental retardation, autosomal recessive 44	615942	AR	3
614252	8p22	Aneurysm, intracranial berry, 11	614252	_	2
613507	3q24	?Glycogen storage disease XV	613507	AR	3
613003	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
613390	17q22	Fanconi anemia, complementation group O	613390	AR	3
614872	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
610828	9q22.32	Holoprosencephaly 7	610828	AD	3
615457	6q14.2	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3
614211	13q34	Deafness, autosomal dominant 33	614211	AD	2
615224	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
615302	19p13.3	Mental retardation, autosomal recessive 36	615286	AR	3
615264	1p36.32	[Blood group, Vel system]	615264	AR	3
613589	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
613824	17q11.2	?Nephronophthisis 9	613824	_	3
613004	4p16.3	Huntington disease	143100	AD	3
613004	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
614095	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
615418	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
615184	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
610829	2q14.2	Holoprosencephaly 9	610829	AD	3
613666	13q14.3	Congenital disorder of glycosylation, type Ip	613661	AR	3
613121	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
613121	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
612727	16q23	[Bone mineral density QTL 13]	612727	_	2
614873	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
615225	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
614561	17p13.1	Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3
607511	15q26.3	Weill-Marchesani 4 syndrome, recessive	613195	AR	3
615574	7q21.3	Asparagine synthetase deficiency	615574	AR	3
615067	19q13.33	Ciliary dyskinesia, primary, 20	615067	AR	3
613898	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
614131	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
613825	5p13.1	C9 deficiency	613825	_	3
615185	3q26.33	Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3
614988	11p15.5	Deafness autosomal recessive 106	617637	AR	3
610356	9p24.2	Retinal cone dystrophy 3B	610356	AR	3
615226	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
615575	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
613391	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
606702	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
612850	6p25.2	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3
613899	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
614096	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
614874	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
615068	18q12.3-q21.1	Vici syndrome	242840	AR	3
615030	4q25	Spastic paraplegia 56, autosomal recessive	615030	AR	3
607512	16q23.1	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3
613122	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
612851	14q11.2	{Narcolepsy 5}	612851	_	2
604269	5q33.1	Spinocerebellar ataxia 45	617769	AD	3
603722	9q31.3	Dysautonomia, familial	223900	AR	3
615340	3p22.1	Nemaline myopathy 8, autosomal recessive	615348	_	3
613704	12p13.31	Microphthalmia, isolated 7	613704	AD	3
615381	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
613667	6q21	Mental retardation, anterior maxillary protrusion, and strabismus	613671	AR	3
614563	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
613625	2p21	Factor V and factor VIII, combined deficiency of	613625	_	3
613783	12p13.31	C1s deficiency	613783	_	3
615031	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
614212	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AR,AD	3
614097	11p13	Acatalasemia	614097	_	3
615770	5p13.2	?Atrial fibrillation 15	615770	AR	3
615458	16q23.1	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3
614832	4q21.1	Amelogenesis imperfecta, type IIA4	614832	AR	3
613392	17p12-q11.2	Deafness, autosomal recessive 85	613392	AR	2
613668	11q21	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3
614564	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
613784	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
615032	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
615731	2q31.1	Nemaline myopathy 9	615731	AR	3
615187	11p15.4	Hyperphosphatasia with mental retardation syndrome 3	614207	AR	3
615228	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
613900	20p13	Spinocerebellar ataxia 35	613908	AD	3
613393	2p13.3	[?Birbeck granule deficiency]	613393	_	3
614640	4p16.3	UV-sensitive syndrome 3	614640	AR	3
610595	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
615382	9q22.33	Nephronophthisis 16	615382	AR	3
615809	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
615887	14q32.12	Amelogenesis imperfecta, type IIA5	615887	AR	3
614833	18q22.2	Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3
615342	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
614602	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
615033	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
613123	15q24.1	Brugada syndrome 8	613123	_	3
616082	12p13.32	Mental retardation, autosomal recessive 66	618221	AR	3
614834	17q24.3	{Thyrotoxic periodic paralysis, susceptibility to, 3}	614834	_	2
613508	12q24.11	[Sodium serum level QTL 1]	613508	_	3
612539	3q25.31	Spastic paraplegia 42, autosomal dominant	612539	AD	3
613785	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
615188	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
615888	11q13.1	?Bleeding disorder, platelet-type, 18	615888	AR	3
615034	11p14.3-p14.2	Dystonia 24	615034	AD	3
616083	10p15.3	Mental retardation, autosomal dominant 30	616083	AD	3
613509	4q21	Chromosome 4q21 deletion syndrome	613509	IC	4
614565	17q12	Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3
615147	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
614876	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
613629	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
615419	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
616005	5q13.1	Immunodeficiency 36	616005	AD	3
615654	2p21-p12	Deafness, autosomal dominant 58	615654	AD	2
614643	7p21.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3
616044	16p13.3	Deafness, autosomal dominant 65	616044	AD	3
613596	2p15	Retinitis pigmentosa 28	606068	_	3
615343	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
616199	3q24	Polyglucosan body myopathy 2	616199	AR	3
612540	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
613741	14q22.1	Glycogen storage disease VI	232700	AR	3
603725	8p21.3	Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3
615496	15q25.3	Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3
607514	10q23.33	{Obesity, susceptibility to}	607514	_	3
615420	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
614759	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
613630	10q24.31	Cocoon syndrome	613630	_	3
616045	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
613597	10q24.2	Hyperoxaluria, primary, type III	613616	_	3
615656	15q11.2	Chromosome 15q11.2 deletion syndrome	615656	AD	4
615735	12q13.13	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3
615812	19q13.2	Abdominal obesity-metabolic syndrome 3	615812	AD	3
614877	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
616200	1q42.2	Ruijs-Aalfs syndrome	616200	AR	3
615926	15q25.1	?Webb-Dattani syndrome	615926	AR	3
603824	9p13.3	Nonaka myopathy	605820	AR	3
603824	9p13.3	Sialuria	269921	AD	3
612113	8q24	[Bone mineral density QTL 10]	612113	_	2
614836	3p22	{Human herpesvirus 8, susceptibility to}	614836	_	2
616394	2p23.3	Retinitis pigmentosa 71	616394	AR	3
616277	10q26.3	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3
615071	4q25	Alazami syndrome	615071	AR	3
613705	2q33.1	?Orofacial cleft 10	613705	IC	3
613598	2p23.3	?Retinitis pigmentosa 58	613617	AR	3
616201	3p24.3	Chronic atrial and intestinal dysrhythmia	616201	AR	3
612114	6q25	[Bone mineral density QTL 11]	612114	_	2
614837	19p13.3	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3
613599	20p11.21	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3
616355	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
614213	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
616395	6q25.3	Trichothiodystrophy 3, photosensitive	616395	_	3
613742	17q21.31	Glycogen storage disease Ia	232200	AR	3
615344	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
616278	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
616589	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
614838	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
616084	3p26.2	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3
614878	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
614839	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
607516	1q31	{Migraine with or without aura, susceptibility to, 6}	607516	AD	2
607516	1q31	{Migraine, familial hemiplegic, 4}	607516	AD	2
612542	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
616433	5q35.1	Immunodeficiency 40	616433	AR	3
615345	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
614603	14q22.1	Spastic paraplegia 28, autosomal recessive	609340	AR	3
614879	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
603826	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
616279	17q12	?Cataract 43	616279	AD	3
614840	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
613128	10q24.33	Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3
616629	2q37.3	Senior-Loken syndrome 9	616629	AR	3
614215	10q22.1	?Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3
614215	10q22.1	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
613669	10p11.23	?Spastic ataxia 4, autosomal recessive	613672	AR	3
613789	1p32.2	C8 deficiency, type II	613789	AR	3
614841	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
615696	3q13.33	Dowling-Degos disease 4	615696	AD	3
616668	15q21.1	Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3
616592	5q32	Kosaki overgrowth syndrome	616592	AD	3
616006	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
613790	1p32.2	C8 deficiency, type I	613790	AR	3
613602	2p24.1	Cranioectodermal dysplasia 2	613610	AR	3
613602	2p24.1	Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3
604277	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
616398	22q12.3	Dystonia 26, myoclonic	616398	AD	3
616007	1q41	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3
616901	17p13.3	Developmental delay with short stature, dysmorphic features, and sparse hair	616901	AR	3
615191	7q31.1	Lissencephaly 5	615191	AR	3
614842	1q32.1	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3
616126	1p36.33	Immunodeficiency 38	616126	AR	3
613706	7q34	Noonan syndrome 7	613706	AD	3
616239	11q14.1	Combined oxidative phosphorylation deficiency 24	616239	AR	3
615889	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
615421	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
616086	1q42.2	Ruijs-Aalfs syndrome	616200	AR	3
616127	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
615658	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
613670	3p13	Mental retardation with language impairment and with or without autistic features	613670	AD	3
614880	2q14.3	{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3
613129	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
606703	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
613671	6q21	Mental retardation, anterior maxillary protrusion, and strabismus	613671	AR	3
616669	21q22.11	?Immunodeficiency 45	616669	AR	3
616399	1p13.2	Brugada syndrome 9	616399	AD	3
616784	16p12.1	Joubert syndrome 26	616784	AR	3
612498	14q32.33	Myopathy, distal, 5	617030	AR	3
613672	10p11.23	?Spastic ataxia 4, autosomal recessive	613672	AR	3
614881	2q35	Spinal muscular atrophy, distal, autosomal recessive, 5	614881	AR	3
617020	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
615422	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
617021	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
614845	11q23.3	Nephronophthisis 15	614845	AR	3
614882	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
616280	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
616087	13q22.2	{Diabetes mellitus, noninsulin-dependent, 5}	616087	_	3
617214	12p12.3	?Spermatogenic failure 17	617214	AR	3
615966	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
617022	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
614883	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
606705	9q21.13	Deafness, autosomal dominant 36	606705	AD	3
616672	13q34	Combined oxidative phosphorylation deficiency 27	616672	AR	3
614846	15q26-qter	Levy-Shanske syndrome	614846	_	4
614678	9p13.2	Pontocerebellar hypoplasia, type 1B	614678	AR	3
615192	6p22.3	[Birth weight QTL4]	615192	_	2
613908	20p13	Spinocerebellar ataxia 35	613908	AD	3
614847	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
614679	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
614884	2q11.2	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3
606706	9q21.13	Deafness, autosomal dominant 36	606705	AD	3
606706	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
603727	3p21.31	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3
617370	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
616089	2q14.3	[Blood group, Gerbich]	616089	_	3
617409	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
616357	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
617061	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
616281	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
613909	7q32-q33	Spinocerebellar ataxia 32	613909	AD	2
617565	17q11.2	Perrault syndrome 6	617565	AR	3
615193	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
615771	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
617682	5q15-q21	Pilarowski-Bjornsson syndrome	617682	AD	3
617175	13q14.2	Retinal dystrophy with or without extraocular anomalies	617175	AR	3
612965	9q33.3	46XY sex reversal 3	612965	AD	3
617023	2p23.3	Retinitis pigmentosa 75	617023	AR	3
617799	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
614680	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
617643	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
617526	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
617099	5p15.2	Autoinflammation, panniculitis, and dermatosis syndrome	617099	AR	3
617024	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
616282	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
616981	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
617062	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
617100	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
616982	5q23.2	Patent ductus arteriosus 3	617039	AD	3
617063	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
617527	9p21.2	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3
617137	6q15	Frontometaphyseal dysplasia 2	617137	AD	3
617644	1p22.1	?Spermatogenic failure 21	617644	AR	3
617760	2q31.1	Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3
615892	1p31	Orofacial cleft 14	615892	AR	2
612576	17p13.3-p13.1	Split-hand/foot malformation with long bone deficiency 3	612576	AD	4
612577	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
616093	9q34.2	[Blood group, ABO system]	616093	_	3
612967	17q23.2-q25.1	[Body mass index QTL 15]	612967	_	2
617449	14q22.3	Structural heart defects and renal anomalies syndrome	617478	AR	3
618074	16p12.1	?Epilepsy, familial adult myoclonic, 6	618074	_	3
617064	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
618152	12q24.31	Spermatogenic failure 33	618152	AR	3
618113	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
617917	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
612578	8q21.13	{Stature QTL 15}	612578	_	2
612968	1p33	Cataract 34, multiple types	612968	_	3
617995	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
617956	7q31.32	[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}	617956	_	3
618114	16p12.2	Liddle syndrome 2	618114	AD	3
617450	17q23.2	Jansen de Vries syndrome	617450	AD	3
613707	7q34	LEOPARD syndrome 3	613707	AD	3
618230	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
616094	8p11.21	?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12	616094	AR	3
612579	15q22.32	{Stature QTL 16}	612579	_	2
613708	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
612502	2p25.3	3MC syndrome 2	265050	AR	3
618347	21q22.3	Galloway-Mowat syndrome 6	618347	AR	3
618115	9q34.3	Spermatogenic failure 32	618115	AD	3
618386	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
618153	2q32.1	Spermatogenic failure 34	618153	AR	3
614017	14q24.3	Ciliary dyskinesia, primary, 16	614017	AR	3
618075	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
618269	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
612503	17q24.3	?Hypertrichosis, congenital generalized, with gingival hyperplasia	135400	AR	3
616095	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AR,AD	3
618154	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
618309	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
616361	3q22	Parkinson disease 21	616361	AD	2
618425	2q35	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3
615197	5q31	{Restless legs syndrome 8}	615197	_	2
618348	12q15	Galloway-Mowat syndrome 7	618348	AR	3
618076	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
618310	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
614018	17q21.32	Epilepsy, progressive myoclonic 6	614018	AR	3
618116	1p32.1	Bone marrow failure syndrome 4	618116	AR	3
617959	7q21.13	Spermatogenic failure 24	617959	AR	3
612580	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
614019	16p13.11	Lissencephaly 4 (with microcephaly)	614019	AR	3
616097	11q12.3	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3
618270	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
612581	11q24.2	Mental retardation, autosomal dominant 4	612581	AD	2
618117	3q23	Ovarian dysgenesis 7	618117	AR	3
618426	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
616098	1p22.3	?Immunodeficiency 37	616098	AR	3
612582	6pter-p24	Chromosome 6pter-p24 deletion syndrome	612582	IC	4
618387	1p32.3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3
618155	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
614020	19p13.12	Mental retardation, autosomal recessive 14	614020	AR	3
617960	8p12	Spermatogenic failure 25	617960	AR	3
618313	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
618388	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
617961	2q11.2	?Spermatogenic failure 26	617961	AR	3
618156	8p23.1	Squalene synthase deficiency	618156	_	3
618389	4p16.3	?Fetal akinesia deformation sequence 3	618389	_	3
618314	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
618272	14q32.13	GLOW syndrome, somatic mosaic	618272	_	3
618428	8q22.3	Popov-Chang syndrome	618428	AD	3
603409	8q22.3	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	AR	3
603066	7q22.1	Lysyl hydroxylase 3 deficiency	612394	AR	3
604210	1q31.3	Leber congenital amaurosis 8	613835	_	3
604210	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
604210	1q31.3	Retinitis pigmentosa-12	600105	AR	3
603324	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
603324	1p34.3	Deafness, autosomal dominant, with peripheral neuropathy	_	_	3
603324	1p34.3	Deafness, autosomal recessive	_	_	3
603324	1p34.3	Deafness, digenic, GJB2/GJB3	220290	AR	3
603324	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AR,AD	3
602997	10p13	Megaloblastic anemia-1, Finnish type	261100	AR	3
603448	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
606843	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
606557	2p16.1	Dias-Logan syndrome	617101	AD	3
603829	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
605239	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
606464	19q13.12	Hemochromatosis, type 2B	613313	AR	3
606082	3q26.1-q26.3	Goiter, multinodular, 3	606082	_	2
607014	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
603933	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
606240	2q21	{Thyroid carcinoma, nonmedullary, 3}	606240	AD	2
604595	13q	[Cholesterol level QTL 1]	604595	_	2
603544	14q32.2	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3
604365	4p15.32	Cone-rod dystrophy 12	612657	_	3
604365	4p15.32	Macular dystrophy, retinal, 2	608051	AD	3
604365	4p15.32	Retinitis pigmentosa 41	612095	AR	3
604365	4p15.32	Stargardt disease 4	603786	_	3
603951	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
605789	18q12.1-q12.2	Symmetric circumferential skin creases, congenital, 2	616734	AD	3
603368	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
605205	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
606755	1p36.13	Uncombable hair syndrome	191480	AR	3
605909	1p36.12	Parkinson disease 6, early onset	605909	AR	3
606721	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
604906	1q42.2	{Schizophrenia 9, susceptibility to}	604906	_	3
603426	2q37.3	Advanced sleep phase syndrome, familial, 1	604348	AD	3
606257	12p11.2-q14	{Stature QTL 3}	606257	_	2
604400	3p25.1	Arrhythmogenic right ventricular dysplasia 5	604400	AD	3
603465	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
603527	17p13.3	Developmental delay with short stature, dysmorphic features, and sparse hair	616901	AR	3
603122	5q35.1	Immunodeficiency 40	616433	AR	3
607086	11q23.3-q24	Aortic aneurysm, familial thoracic 1	607086	_	2
605546	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
606540	18q21.1	Microvillus inclusion disease	251850	AR	3
605389	18p11.22	Hypotrichosis 1	605389	AD	3
605981	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
606521	17q25.1	Microcephaly, Amish type	607196	AR	3
606521	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
607144	22q13.33	Congenital disorder of glycosylation, type Ig	607143	AR	3
604774	1p31.3	Hypobetalipoproteinemia, familial, 2	605019	AR	3
605257	12p13.31	Immunodeficiency with hyper-IgM, type 2	605258	AR	3
606100	19p13.12	Vibratory urticaria	125630	AD	3
604417	5q31.1	CHOPS syndrome	616368	AD	3
603649	6q13	Cone-rod dystrophy 7	603649	_	3
606394	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
605206	15q24.1	Brugada syndrome 8	613123	_	3
605206	15q24.1	Sick sinus syndrome 2	163800	AD	3
603342	11q14-q21	{?Schizophrenia}	181500	AD	2
605427	12q24.11	?Avascular necrosis of femoral head, primary, 2	617383	AD	3
605427	12q24.11	Brachyolmia type 3	113500	AD	3
605427	12q24.11	Digital arthropathy-brachydactyly, familial	606835	AD	3
605427	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
605427	12q24.11	Metatropic dysplasia	156530	AD	3
605427	12q24.11	Parastremmatic dwarfism	168400	AD	3
605427	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
605427	12q24.11	SED, Maroteaux type	184095	AD	3
605427	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
605427	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
605427	12q24.11	[Sodium serum level QTL 1]	613508	_	3
604125	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
604459	12q14.3	{Asthma susceptibility 5}	611064	_	3
605367	17p12	Combined oxidative phosphorylation deficiency 17	615440	AR	3
605367	17p12	{Prostate cancer, hereditary, 2, susceptibility to}	614731	_	3
605998	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
605080	8q21.3	Achromatopsia 3	262300	AR	3
605080	8q21.3	Macular degeneration, juvenile	248200	AR	3
607202	15q11-q13	{Celiac disease, susceptibility to, 5}	607202	_	2
606558	14q32.2	Immunodeficiency 49	617237	AD	3
606558	14q32.2	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3
604383	9q34.13	Bleeding disorder, platelet-type, 17	187900	AR,AD	3
604093	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
606777	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AR,AD	3
607087	5q13-q14	Aortic aneurysm, familial thoracic 2	607087	_	2
604322	6q13	Salla disease	604369	AR	3
604322	6q13	Sialic acid storage disorder, infantile	269920	AR	3
604194	9q34.11	Ichthyosis prematurity syndrome	608649	_	3
603427	1p36.23	?Advanced sleep phase syndrome, familial, 3	616882	AD	3
606151	16q13	Bardet-Biedl syndrome 2	615981	AR	3
606151	16q13	Retinitis pigmentosa 74	616562	AR	3
606019	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
602981	7p13	Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3
606195	16q12.2	Hamamy syndrome	611174	AR	3
606885	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
603123	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
606869	15q23	GM2-gangliosidosis, several forms	272800	AR	3
606869	15q23	Tay-Sachs disease	272800	AR	3
606869	15q23	[Hex A pseudodeficiency]	272800	AR	3
604401	10p14-p12	Arrhythmogenic right ventricular dysplasia 6	604401	_	2
603164	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
603164	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
605483	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
605207	2p13.2	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	_	3
607237	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
604613	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
604873	11q23.3	Deafness, autosomal recessive 111	618145	AR	3
606522	12p13.31	Klippel-Feil syndrome 3, autosomal dominant	613702	_	3
606522	12p13.31	Microphthalmia with coloboma 6	613703	AD	3
606522	12p13.31	Microphthalmia, isolated 7	613704	AD	3
604638	19q13.2	Glomerulosclerosis, focal segmental, 1	603278	AD	3
607330	11q23.3-q24.1	Lathosterolosis	607330	AR	3
603220	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
603650	2q31.1	Bardet-Biedl syndrome 5	615983	AR	3
603072	20q13.2	{Colon cancer, susceptibility to}	114500	SMu,AD	3
607015	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
603294	21q22.3	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3
606350	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
606263	5q31	Paget disease of bone 4	606263	AD	2
607313	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
607254	22q12.3	{Schizophrenia}	181500	AD	1
604775	8q21.11	?Episodic pain syndrome, familial, 1	615040	AD	3
607293	6p21.1	?Deafness, autosomal recessive 103	616042	AR	3
607145	6p22.3	Hermansky-Pudlak syndrome 7	614076	AR	3
605258	12p13.31	Immunodeficiency with hyper-IgM, type 2	605258	AR	3
604307	2q33.3	Cataract 2, multiple types	604307	AD	3
607111	13q13.3	Troyer syndrome	275900	AR	3
604384	3q22.1	Hailey-Hailey disease	169600	AD	3
603033	3p25.1	Myasthenic syndrome, congenital, 5	603034	AR	3
603202	2q21.3	Lactase deficiency, congenital	223000	AR	3
606940	8q21.13	?Ptosis, congenital	178300	AD	2
605910	19p13.2	Plasma triglyceride level QTL, low	615881	AD	3
606523	12q14.2	{Thyroid cancer, nonmedullary, 2}	188470	SMu,AD	3
603546	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
603165	3q21	{Dermatitis, atopic, susceptibility to, 1}	603165	AD	2
606580	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
606580	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
605874	8q24.3	Birk-Barel mental retardation dysmorphism syndrome	612292	_	3
607088	11q13	Spinal muscular atrophy, chronic distal, autosomal recessive	607088	AR	2
605407	11p15.5	Segawa syndrome, recessive	605407	AR	3
606152	2q36.3	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	AR	3
607016	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
603107	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
603305	1q32.2	Temple-Baraitser syndrome	611816	AD	3
603305	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
604802	4p15.3	Huntington disease-like 3	604802	AR	2
603221	12q21-q23	Myopia-3	603221	AD	2
604212	16p13.12	Dyskeratosis congenita, autosomal recessive 6	616353	AR	3
604212	16p13.12	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371	AD	3
603345	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
604173	16q21	Poikiloderma with neutropenia	604173	AR	3
602931	15q22.31	Aortic valve disease 2	614823	AD	3
602931	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
605911	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
603073	13q32.3	Holoprosencephaly 5	609637	AD	3
605309	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
604614	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
605947	17p11.2	CHIME syndrome	280000	AR	3
603729	10q22.1	Nephrotic syndrome, type 14	617575	AR	3
606887	12q13.2	Sulfite oxidase deficiency	272300	AR	3
606264	12p13.2	Candidiasis, familial, 4, autosomal recessive	613108	AR	3
606264	12p13.2	{Aspergillosis, susceptibility to}	614079	_	3
605507	2q14.1	Psoriasis 14, pustular	614204	AR	3
607070	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
604418	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
604418	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
604418	13q12.11	Deafness, digenic GJB2/GJB6	220290	AR	3
604418	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
606871	11q25	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3
605983	19q13.41	Mental retardation, autosomal dominant 36	616362	AD	3
607314	11q13.2	Deafness, autosomal recessive 93	614899	AR	3
603034	3p25.1	Myasthenic syndrome, congenital, 5	603034	AR	3
604094	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
607397	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
605549	1q12-q24	Cone-rod dystrophy 8	605549	AR	2
604308	15q21.1	MASS syndrome	604308	_	3
607647	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
603633	14q21.3	Diamond-Blackfan anemia 13	615909	AD	3
604213	1p13.3	Chudley-McCullough syndrome	604213	AR	3
605792	17q22	?Spermatogenic failure 23	617707	AR	3
605653	13q22.3	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3
607486	1q32.2	[Blood group, Knops system]	607486	_	3
603902	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
604366	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
604402	2p11.2	Salt and pepper developmental regression syndrome	609056	AR	3
605428	4q31.21	?Deafness, autosomal recessive 26	605428	AR	3
607071	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
604804	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
604385	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
604385	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
606448	22q11.21	?Glucocorticoid deficiency 5	617825	AR	3
606102	19p13.3	Lethal congenital contractural syndrome 3	611369	AR	3
604174	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
607031	4p14	Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3
605984	11q14.2	Cohen-Gibson syndrome	617561	AD	3
604875	15q23	Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3
603204	15q24	Epilepsy, nocturnal frontal lobe, type 2	603204	AD	2
607667	10q21.3	Arrhythmogenic right ventricular dysplasia, familial, 13	615616	AD	3
607526	17q21.31	?Diamond-Blackfan anemia 16	617408	AD	3
604653	2q32.2	Hemochromatosis, type 4	606069	AD	3
604325	5q32	Spinocerebellar ataxia 12	604326	AD	3
604214	7q21.2	Cavernous malformations of CNS and retina	116860	AD	3
604214	7q21.2	Cerebral cavernous malformations-1	116860	AD	3
604214	7q21.2	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860	AD	3
605654	6q16.1-q16.2	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3
605192	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
606210	1p36.11	Muscular dystrophy, rigid spine, 1	602771	AR	3
606210	1p36.11	Myopathy, congenital, with fiber-type disproportion	255310	AR,AD	3
603612	8p21.3	Squamous cell carcinoma, head and neck	275355	AR	3
606351	1p36.31	Deafness, autosomal recessive 36	609006	AR	3
606351	1p36.31	Deafness, neurosensory, without vestibular involvement, autosomal dominant	_	_	3
607398	21q22.11	Glucocorticoid deficiency 2	607398	AR	3
603834	12p13.32	Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3
605429	1q24	{Deafness, nonsyndromic, modifier 1}	605429	AD	2
602932	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
606241	14q32.13	GLOW syndrome, somatic mosaic	618272	_	3
606241	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
606241	14q32.13	Pleuropulmonary blastoma	601200	AD	3
606241	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
604095	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
604095	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
604095	2q13	[Hair morphology 1, hair thickness]	612630	_	3
607829	11p15.4	Mitral valve prolapse 2	607829	AD	3
606844	2p13.1	Alstrom syndrome	203800	AR	3
607701	2q31.1	Nemaline myopathy 9	615731	AR	3
607684	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
605010	5q32	Netherton syndrome	256500	AR	3
604515	10q24.1	?Agammaglobulinemia 4	613502	AR	3
603835	2q37.3	Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3
607261	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607261	4p16.2	Weyers acrofacial dysostosis	193530	AD	3
604127	1p12	Cousin syndrome	260660	AR	3
607875	17p13.3	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3
607354	17p11.2	Scoliosis, idiopathic 2	607354	_	2
607907	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
604326	5q32	Spinocerebellar ataxia 12	604326	AD	3
603307	20p12.1	Cataract 33, multiple types	611391	AR,AD	3
603183	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
607239	10p11.23-q21.1	Deafness, autosomal recessive 33	607239	AR	2
604805	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
604368	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
603206	18p	{Schizophrenia}	181500	AD	2
604386	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
604386	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
605031	4q28.1	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3
606242	1p36.32-p35.3	Kondoh syndrome	606242	AR	2
606544	5q13.3	Combined oxidative phosphorylation deficiency 39	618397	AR	3
603634	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
607685	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
607908	2q14.3	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3
604237	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
604197	15q25.1	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3
607876	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
606581	1p33	{Drug addiction, susceptibility to}	606581	_	3
607998	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
607998	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
607830	4q21.21	Fraser syndrome 1	219000	AR	3
605552	3q27	Abdominal obesity-metabolic syndrome 1	605552	AD	2
605446	14q11.2	Cone-rod dystrophy 13	608194	_	3
605446	14q11.2	Leber congenital amaurosis 6	613826	_	3
607649	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
606597	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
606597	2q36.1	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
606597	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
606597	2q36.1	Waardenburg syndrome, type 3	148820	AR,AD	3
604369	6q13	Salla disease	604369	AR	3
603330	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
605313	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
604175	1p36.11	Diamond-Blackfan anemia 7	612562	AD	3
607487	17q12	Cardiomyopathy, hypertrophic, 25	607487	AD	3
605011	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
603371	9q34.11	Congenital arthrogryposis with anterior horn cell disease	611890	AR	3
603371	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
604129	3p21.31	Epidermolysis bullosa pruriginosa	604129	AR,AD	3
604577	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
604198	19p13.2	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3
607999	1q22	Mental retardation, autosomal dominant 52	617796	AD	3
605896	2q37.1	Arthrogryposis, distal, type 5D	615065	AR	3
604404	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
607812	14q21.1	Craniolenticulosutural dysplasia	607812	AR	3
605352	8p23.1	Malignant fibrous histiocytoma	605352	_	2
606545	17p13.1	Ichthyosis, congenital, autosomal recessive 3	606545	AR	3
604096	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
604808	20p12.1	Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3
603489	15q22.31	{Lumbar disc disease, susceptibility to}	603932	_	3
605370	5q31.3	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
607687	16q24.1	{High density lipoprotein cholesterol, low serum, 3}	607687	_	2
603372	14q31.1	Hyperthyroidism, familial gestational	603373	_	3
603372	14q31.1	Hyperthyroidism, nonautoimmune	609152	AD	3
603372	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
603372	14q31.1	Thyroid adenoma, hyperfunctioning, somatic	_	_	3
603372	14q31.1	Thyroid carcinoma with thyrotoxicosis	_	_	3
606598	8q21.11	Charcot-Marie-Tooth disease, axonal, type 2K	607831	AR,AD	3
606598	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
606598	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
606598	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
606470	5q35.3	Dyskeratosis congenita, autosomal recessive 2	613987	AR	3
607488	18p11	Dystonia-15, myoclonic	607488	AD	2
607221	4p15	Epilepsy, partial, with pericentral spikes	607221	_	2
607566	6q24.3	Epilepsy, progressive myoclonic 2A (Lafora)	254780	AR	3
608181	15q22.31	Mast syndrome	248900	AR	3
605013	16p13.11	?Microhydranencephaly	605013	AR	3
603903	11p15.4	Sickle cell anemia	603903	AR	3
605293	18q12.2-q12.3	Optic atrophy 4	605293	_	2
605353	3p25.3	{Obesity, susceptibility to}	601665	AR,Mu,AD	3
608097	20q13.13	Periventricular heterotopia with microcephaly	608097	AR	3
606889	1q42.13	Alzheimer disease-4	606889	AD	3
603386	19p13.2	Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386	_	2
605511	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
604387	3q22.1	Nephronophthisis 3	604387	AR	3
605259	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
605194	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
606045	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
606243	17q25.3	Alveolar soft-part sarcoma	606243	_	3
603867	1q21.1	?Peroxisome biogenesis disorder 14B	614920	AR	3
603968	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
608115	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
604943	7q22.1	?Deafness, autosomal recessive 61	613865	AR	3
603918	17q	{Hypertension, essential, susceptibility to, 1}	145500	Mu	2
607434	6p21.1	Jaberi-Elahi syndrome	617988	AR	3
608000	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
605913	1q23	Bleeding disorder, east Texas type	605913	_	2
603652	11q22.1	Glomerulosclerosis, focal segmental, 2	603965	AD	3
608232	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
607832	6p12.3	Glomerulosclerosis, focal segmental, 3	607832	_	3
606410	2p13.3	GAPO syndrome	230740	AR	3
606410	2p13.3	{?Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
608266	1q31.2	Parathyroid carcinoma	608266	_	3
605809	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AR,AD	3
604641	11p11.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
603373	14q31.1	Hyperthyroidism, familial gestational	603373	_	3
606636	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
606636	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
606636	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
603208	2q37.1	Leber congenital amaurosis 16	614186	AR	3
603208	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
604254	2p16-p15	{Dyslexia, susceptibility to, 3}	604254	_	2
605014	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
606847	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
607091	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
608033	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
607331	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
605210	1q42.2	{Schizophrenia 9, susceptibility to}	604906	_	3
607688	2q37.1	{Parkinson disease 11}	607688	_	3
603332	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
603332	3p21.1	Spermatogenic failure 18	617576	AR	3
606352	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
606352	2q33.1	Primary lateral sclerosis, juvenile	606353	AR	3
606352	2q33.1	Spastic paralysis, infantile onset ascending	607225	AR	3
607928	9q32	Deafness, autosomal recessive 31	607084	AR	3
607928	9q32	Usher syndrome, type 2D	611383	AR	3
606153	20q13.32	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	_	3
605554	1q23.3	{Rheumatoid arthritis, susceptibility to}	180300	_	3
607317	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
605294	16q23.1	Macular corneal dystrophy	217800	AR	3
604310	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
607047	14q32.12	Machado-Joseph disease	109150	AD	3
608328	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
607669	16p12.3	?Spastic paraplegia 61, autosomal recessive	615685	AR	3
607371	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
604777	19p13.12	Ichthyosis, congenital, autosomal recessive 5	604777	AR	3
603904	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
603904	13q14.2	Dementia, familial British	176500	AD	3
603904	13q14.2	Dementia, familial Danish	117300	AD	3
608345	7p11.2	Nystagmus 3, congenital, autosomal dominant	608345	AD	2
605242	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
605242	11p15.1	Usher syndrome, type 1C	276904	AR	3
607035	10q24.32	Basal cell nevus syndrome	109400	AD	3
607035	10q24.32	Joubert syndrome 32	617757	AR	3
607035	10q24.32	Medulloblastoma, desmoplastic	155255	AR,AD	3
607035	10q24.32	{Meningioma, familial, susceptibility to}	607174	AD	3
607814	19q13.11	Bradyopsia	608415	_	3
604327	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
603387	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
607450	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
603868	15q21.3	Griscelli syndrome, type 2	607624	AR	3
605512	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
605512	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
605512	6q14.1	Stargardt disease 3	600110	AD	3
604819	8q24.3	Verheij syndrome	615583	AD	3
606526	2q37.3	Griscelli syndrome, type 3	609227	AR	3
607490	16q23.1	D-lactic aciduria	245450	AR	3
603506	11q13.2	Exudative vitreoretinopathy 4	601813	AR,AD	3
603506	11q13.2	Hyperostosis, endosteal	144750	AD	3
603506	11q13.2	Osteopetrosis, autosomal dominant 1	607634	AD	3
603506	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
603506	11q13.2	Osteosclerosis	144750	AD	3
603506	11q13.2	Polycystic liver disease 4 with or without kidney cysts	617875	AD	3
603506	11q13.2	van Buchem disease, type 2	607636	AD	3
603506	11q13.2	[Bone mineral density variability 1]	601884	AD	3
603506	11q13.2	{Osteoporosis}	166710	AD	3
605629	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
603051	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
603349	2p21	Erythrocytosis, familial, 4	611783	_	3
605880	10q22.2	Genitopatellar syndrome	606170	AD	3
605880	10q22.2	SBBYSS syndrome	603736	AD	3
604370	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	Mu,AD	3
608233	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
607654	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
603005	10q23.2-q23.3	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3
607529	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
605810	3q23	Combined oxidative phosphorylation deficiency 5	611719	AR	3
605810	3q23	Ovarian dysgenesis 7	618117	AR	3
607590	4q27	Bardet-Biedl syndrome 7	615984	AR	3
607759	17q21.31	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
607759	17q21.31	Glanzmann thrombasthenia	273800	AR	3
607759	17q21.31	Thrombocytopenia, neonatal alloimmune, BAK antigen related	_	_	3
603309	7p14.1	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3
608303	19q13.12	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	617468	AR	3
605371	20q13.13	Periventricular heterotopia with microcephaly	608097	AR	3
606353	2q33.1	Primary lateral sclerosis, juvenile	606353	AR	3
603636	13q12.2	Hypotrichosis 12	615885	AD	3
607568	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
606656	2q37	Basal ganglia calcification, idiopathic, 2	606656	_	2
605795	8p12	Spermatogenic failure 25	617960	AR	3
608389	14q23.1	Branchiootic syndrome 3	608389	AD	3
605195	15q26.1	Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3
603191	21q22.3	Retinal dystrophy with macular staphyloma	617547	AR	3
603191	21q22.3	Spondylometaphyseal dysplasia, axial	602271	AR	3
608372	1q21-q23	Deafness, autosomal dominant 49	608372	AD	2
607435	17q11.2	Perrault syndrome 6	617565	AR	3
603935	1q21	{Psoriasis susceptibility 4}	603935	_	2
605047	11p15.5	?Immunodeficiency 39	616345	AR	3
607721	10q25.2	Noonan-like syndrome with loose anagen hair	607721	AD	3
607929	7p13	Cerebral cavernous malformations-2	603284	AD	3
604579	11q14.2	Exudative vitreoretinopathy 1	133780	AD	3
604579	11q14.2	Retinopathy of prematurity	133780	AD	3
608183	15q26.3	Temtamy preaxial brachydactyly syndrome	605282	AR	3
606411	20q13.12	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3
605593	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
607860	1q22	Grange syndrome	602531	AR	3
606919	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
608441	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
608441	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
605881	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
608567	3p22.2	Sick sinus syndrome 1	608567	AR	3
607944	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
606282	4q35-qter	Deafness, autosomal dominant 24	606282	AD	2
607491	20q11.21	Dowling-Degos disease 2	615327	AD	3
608002	3q22.1	Meckel syndrome 7	267010	AR	3
608002	3q22.1	Nephronophthisis 3	604387	AR	3
608002	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
603507	12p13.2	Tooth agenesis, selective, 7	616724	AD	3
603507	12p13.2	{Coronary artery disease, autosomal dominant, 2}	610947	AD	3
605431	16p13.3	Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3
608034	17p13.2	Canavan disease	271900	AR	3
602966	2p13	Orofacial cleft 2	602966	_	2
608545	6p25	Larsen-like syndrome	608545	IC	2
606483	10q24.1-q25.1	Charcot-Marie-Tooth disease, dominant intermediate A	606483	AD	2
603388	20q13.11	{Graves disease, susceptibility to, 2}	603388	_	2
605967	7q36	Acropectoral syndrome	605967	AD	2
607690	5q31.1	Chylomicron retention disease	246700	AR	3
607861	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
604580	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
604580	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
604580	14q32.12	Macular degeneration, age-related, 3	608895	AD	3
604580	14q32.12	Neuropathy, hereditary, with or without age-related macular degeneration	608895	AD	3
606397	3q25.1	Retinitis pigmentosa 61	614180	_	3
606397	3q25.1	Usher syndrome, type 3A	276902	AR	3
603531	7q22.1	MEDNIK syndrome	609313	AR	3
604616	2q24.2	Intellectual developmental disorder with autism and speech delay	606053	AD	3
608442	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
604519	6p21.3	{Inflammatory bowel disease 3}	604519	AD	2
608568	19q13.33	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3
608568	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
608638	3q25-q27	{Asperger syndrome susceptibility 1}	608638	IC,Mu	2
607704	9p24.3	Cerebral palsy, spastic quadriplegic, 2	612900	_	3
605262	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
608201	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
605317	7q31.1	Speech-language disorder-1	602081	AD	3
606048	19q13.42	Mental retardation, autosomal recessive 57	617188	AR	3
603335	5p15.2	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	_	3
604060	11q25-qter	Deafness, autosomal recessive 20	604060	AR	2
608755	17q25.1	?Pontocerebellar hypoplasia type 5	610204	AR	3
608755	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
608755	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
605244	2p16	Carney complex, type II	605244	_	2
604536	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
605197	2q22.2	?Hydroxykynureninuria	236800	AR	3
605197	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
607671	1p36.32-p36.13	Dystonia 13, torsion	607671	AD	2
608305	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
606471	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
608145	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
608546	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
608735	11p11.2	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3
607655	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
608845	3q11.2	?Retinitis pigmentosa 55	613575	_	3
608845	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
608845	3q11.2	{Bardet-Biedl syndrome 1, modifier of}	209900	AR,DR	3
608166	7q21.11	?CHARGE syndrome	214800	AD	3
607592	19q	{Prostate cancer aggressiveness QTL}	607592	_	2
606528	11p15-p14	Chromosome 11p15-p14 deletion syndrome	606528	AR	4
604927	18q23	Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3
606585	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
606585	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
606689	2cen-q13	Glaucoma 1B, primary open angle, adult onset	606689	_	2
604241	6p12.3	Glomerulosclerosis, focal segmental, 3	607832	_	3
604061	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
604061	17q25.3	Leukemia, acute myeloid, therapy-related	_	_	1
604061	17q25.3	Ovarian carcinoma	_	_	1
605373	1q23.3	Paragangliomas 3	605373	AD	3
606658	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
606068	2p15	Retinitis pigmentosa 28	606068	_	3
608846	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
605632	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
605837	15q13.1	Mental retardation, autosomal recessive 38	615516	AR	3
605837	15q13.1	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3
605837	15q13.1	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3
603360	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
603360	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
607182	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
607672	11q13.2	Cold-induced sweating syndrome 2	610313	AR	3
603839	2q33.1	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3
604537	6q14.1	Leber congenital amaurosis 5	604537	_	3
605120	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
608605	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
608347	17q25.3	[Pentosuria]	260800	AR	3
608656	20q13	{Prostate cancer, susceptibility to, 3}	608656	_	2
608118	1p36.11	Zinc deficiency, transient neonatal	608118	AD	3
604312	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
604312	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
605820	9p13.3	Nonaka myopathy	605820	AR	3
608756	1q25.3	Pontocerebellar hypoplasia, type 2F	617026	AR	3
608921	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
608083	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
604581	18p11.21	Spastic ataxia 5, autosomal recessive	614487	AR	3
604581	18p11.21	Spinocerebellar ataxia 28	610246	AD	3
606049	Chr.11	Acromegaloid features, overgrowth, cleft palate, and hernia	606049	_	2
604134	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
607223	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
607878	5p12	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3
604878	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
604928	4q24	Wolfram syndrome 2	604928	AR	3
608829	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
606412	1p32.3	Bartter syndrome, type 4a	602522	AR	3
606412	1p32.3	Sensorineural deafness with mild renal dysfunction	602522	AR	3
604619	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
604521	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
607532	13q21.3-q22.1	Joubert syndrome 33	617767	AR	3
608996	3q22.3	Premature ovarian failure 3	608996	AD	3
603377	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
606247	2p13.1	Microcephaly-capillary malformation syndrome	614261	AR	3
609054	17q23.2	Fanconi anemia, complementation group J	609054	_	3
606069	2q32.2	Hemochromatosis, type 4	606069	AD	3
608547	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
608547	16p11.2	Warfarin resistance	122700	AD	3
608236	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
603956	4p16.3	Cervical cancer, somatic	603956	_	3
608898	17q25.1	Hemophagocytic lymphohistiocytosis, familial, 3	608898	_	3
604313	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
603937	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AR,AD	3
605616	3p21.31	Hyperglycinuria	138500	AD	3
605616	3p21.31	Iminoglycinuria, digenic	242600	AR,DR	3
607864	16p13.3	?Caudal duplication anomaly	607864	_	3
603921	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
607817	8q22.2	Cohen syndrome	216550	AR	3
608757	11q12.1	Pontocerebellar hypoplasia, type 10	615803	AR	3
604217	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
608348	19q13.2	Maple syrup urine disease, type Ia	248600	AR	3
605432	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
607706	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
608374	1q21.1	Hemochromatosis, type 2A	602390	AR	3
608706	15q21.3	Ciliary dyskinesia, primary, 25	615482	AR	3
608706	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
604539	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
608167	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
608167	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
607745	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
608461	9q32	Steel syndrome	615155	AR	3
606797	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
606070	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
606530	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
607818	10q21.2	{Nephrolithiasis, uric acid, susceptibility to}	605990	_	3
608940	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
608512	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
609162	12q13.11	Czech dysplasia	609162	AD	3
607093	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
607093	1p36.22	{Neural tube defects, susceptibility to}	601634	AR	3
607093	1p36.22	{Schizophrenia, susceptibility to}	181500	AD	3
607093	1p36.22	{Thromboembolism, susceptibility to}	188050	AD	3
607093	1p36.22	{Vascular disease, susceptibility to}	_	_	3
607707	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
607693	9q22.2	Thyroid hormone metabolism, abnormal	609698	_	3
609320	9q	[Hematocrit/hemoglobin quantitative trait locus 2]	609320	_	2
605018	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
605018	16q12.1	Cylindromatosis, familial	132700	AD	3
605018	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
608758	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
604391	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
603212	3q22.1	Cataract 12, multiple types	611597	AD	3
604218	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
604242	13q12.13	Esophageal carcinoma, somatic	133239	_	3
608736	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
608736	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
603175	6q13-q26	{Schizophrenia}	181500	AD	2
606692	16p13.3	Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3
607834	17q11.2	{Anxiety-related personality traits}	607834	_	3
609408	14q13	Holoprosencephaly 8	609408	_	2
608830	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
608462	16q23	{Hirschsprung disease, susceptibility to, 8}	608462	_	2
606227	11q23.3	Microphthalmia, isolated 5	611040	AR	3
606227	11q23.3	Nanophthalmos 2	609549	_	3
608375	1p31.3	Parkinson disease 19a, juvenile-onset	615528	AR	3
608375	1p31.3	Parkinson disease 19b, early-onset	615528	AR	3
606798	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
609056	2p11.2	Salt and pepper developmental regression syndrome	609056	AR	3
609533	10q21.1	Deafness, autosomal recessive 23	609533	AR	3
608707	11q24.2	Holoprosencephaly 11	614226	AD	3
607300	17p13.3	Retinitis pigmentosa 13	600059	AD	3
609186	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
603213	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
608658	7p11-q21	{Prostate cancer, susceptibility to, 4}	608658	_	2
607225	2q33.1	Spastic paralysis, infantile onset ascending	607225	AR	3
609304	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
609204	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
605704	20q13.32	Amyotrophic lateral sclerosis 8	608627	AD	3
605704	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
608289	3q27.2	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
609321	1p21.2	?Microcephaly 14, primary, autosomal recessive	616402	AR	3
603639	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
609057	11p15.5	Nephropathy with pretibial epidermolysis bullosa and deafness	609057	_	3
608569	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
603176	13q32	{Schizophrenia}	181500	AD	2
606708	2q31	Split-hand/foot malformation 5	606708	_	2
605634	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
604931	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
609187	7p14.1	Glutaric aciduria III	231690	AR	3
604329	15q	{Hypertension, essential, susceptibility to, 2}	145500	Mu	2
608132	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
608132	14q31.3	Bardet-Biedl syndrome 8	615985	AR	3
605266	8q21.11	?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K	607831	AR,AD	3
607301	1q21.2	Retinitis pigmentosa 18	601414	AD	3
608776	11q23.1	Congenital disorder of glycosylation, type Il	608776	AR	3
609698	9q22.2	Thyroid hormone metabolism, abnormal	609698	_	3
608957	2p11.2	CD8 deficiency, familial	608957	AR	3
606268	2q35	Odontoonychodermal dysplasia	257980	AR	3
606268	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
606268	2q35	Tooth agenesis, selective, 4	150400	AR,AD	3
606873	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
605822	17q21.33	Spondyloocular syndrome	605822	AR	3
609145	1q32.1	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3
608219	6q26-q27	Deafness, autosomal recessive 38	608219	AR	2
606170	10q22.2	Genitopatellar syndrome	606170	AD	3
608850	5p15.33-p13.1	Macular dystrophy, retinal, 3	608850	AD	2
606071	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
608831	14q13-q21	{Restless legs syndrome 2}	608831	_	2
609058	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
604373	22q12.1	Li-Fraumeni syndrome	609265	_	3
604373	22q12.1	Osteosarcoma, somatic	259500	_	3
604373	22q12.1	{Breast and colorectal cancer, susceptibility to}	_	_	3
604373	22q12.1	{Breast cancer, susceptibility to}	114480	SMu,AD	3
604373	22q12.1	{Prostate cancer, familial, susceptibility to}	176807	SMu,AD	3
609427	6p21.31	Deafness, autosomal recessive 67	610265	AR	3
606416	1q44	CINCA syndrome	607115	AD	3
606416	1q44	Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3
606416	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
606416	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
606416	1q44	Muckle-Wells syndrome	191900	AD	3
607694	10q22.3	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3
604219	21q22.3	Cataract 9, multiple types	604219	AR,AD	3
607151	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
609014	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
608148	2q33.1	Glass syndrome	612313	AD	3
606709	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
603924	10q25.3	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3
603924	10q25.3	{Venous thromboembolism, susceptibility to}	188050	AD	3
605019	1p31.3	Hypobetalipoproteinemia, familial, 2	605019	AR	3
609739	3q13.33	Deafness, autosomal recessive 42	609646	AR	3
609283	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
606874	3p21	{Hirschsprung disease, susceptibility to, 6}	606874	_	2
607594	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
606531	5q32	{Asthma, susceptibility to}	600807	AD	3
609428	21q22	Tukel syndrome	609428	AR	2
609915	7q22.3-q31.1	Cardiomyopathy, dilated, 1Q	609915	_	2
609188	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
605705	21q22.3	Epileptic encephalopathy, early infantile, 30	616341	AD	3
607101	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607657	1p31.1	Cystathioninuria	219500	AR	3
607657	1p31.1	Homocysteine, total plasma, elevated	_	_	3
608548	1q25.3-q31.1	{Macular degeneration, age-related, 1}	603075	AD	3
606603	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
606603	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
609536	9q33.2	C5 deficiency	609536	_	3
608517	10q21.3	Cardiomyopathy, dilated, 1KK	615248	AD	3
608517	10q21.3	Cardiomyopathy, familial restrictive, 4	615248	AD	3
608517	10q21.3	Cardiomyopathy, hypertrophic, 22	615248	AD	3
608517	10q21.3	Nemaline myopathy 11, autosomal recessive	617336	AR	3
608149	14q32	Kagami-Ogata syndrome	608149	AD	4
604063	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
607152	9q	Spastic paraplegia 19, autosomal dominant	607152	AD	2
608220	6q23-q24.1	Spastic paraplegia 25, autosomal recessive	608220	AR	2
605514	10q21.1	Deafness, autosomal recessive 23	609533	AR	3
605514	10q21.1	Usher syndrome, type 1D/F digenic	601067	AR,DR	3
605514	10q21.1	Usher syndrome, type 1F	602083	AR	3
609876	21q22.13-qter	[Bone mineral density QTL 6]	609876	_	2
603178	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
608761	2q12.3	Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3
608761	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
607379	22q12.2	Meningioma, NF2-related, somatic	607174	_	3
607379	22q12.2	Neurofibromatosis, type 2	101000	AD	3
607379	22q12.2	Schwannomatosis, somatic	162091	_	3
608173	6p11	{Autoimmune thyroid disease, susceptibility to, 1}	608173	_	2
609757	7q11.23	Chromosome 7q11.23 duplication syndrome	609757	AD	4
609113	14q23.2	[Telomere length, mean leukocyte]	609113	_	2
609588	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
609588	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
605642	1q21	Thyroid carcinoma, papillary, with papillary renal neoplasia	605642	_	2
609446	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
606451	15q25-q26	Deafness, autosomal dominant 30	606451	AD	2
606417	10q26.12	Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3
608549	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
606711	16q	Specific language impairment QTL, 1	606711	Mu	2
608762	9q32-q33	{Epilepsy, idiopathic generalized, susceptibility to, 3}	608762	AR	2
604316	3q21	{Psoriasis susceptibility 5}	604316	_	2
608832	1q43	Tooth agenesis, selective, 9	617275	AD	3
604392	17p13.2	Cone-rod dystrophy	604393	AR	3
604392	17p13.2	Leber congenital amaurosis 4	604393	AR	3
604392	17p13.2	Retinitis pigmentosa, juvenile	604393	AR	3
607102	11p13	Denys-Drash syndrome	194080	SMu,AD	3
607102	11p13	Frasier syndrome	136680	SMu,AD	3
607102	11p13	Meacham syndrome	608978	_	3
607102	11p13	Mesothelioma, somatic	156240	_	3
607102	11p13	Nephrotic syndrome, type 4	256370	AD	3
607102	11p13	Wilms tumor, type 1	194070	SMu,AD	3
604330	17p11.2	Deafness, autosomal recessive 114	618456	AR	3
610004	4q25	Fibrosis of extraocular muscles, congenital, 5	616219	AR	3
610055	19p13.12	Mental retardation, autosomal recessive 3	608443	AR	3
606072	3p25.3	Rippling muscle disease 2	606072	AD	3
603381	3p14.3	Atelosteogenesis, type I	108720	AD	3
603381	3p14.3	Atelosteogenesis, type III	108721	AD	3
603381	3p14.3	Boomerang dysplasia	112310	AD	3
603381	3p14.3	Larsen syndrome	150250	AD	3
603381	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
610021	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
609681	13q31.1	Deafness and myopia	221200	AR	3
609825	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
609825	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AR,AD	3
605706	21q22.3	CHAND syndrome	214350	AR	3
605706	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
602985	1q23.3	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3
606362	19q13.33	Amelogenesis imperfecta, type IJ	617297	AR	3
603382	6p21.33	?Premature ovarian failure 13	617442	AR	3
607380	2q37.3	Senior-Loken syndrome 9	616629	AR	3
607440	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
606875	19q12	{Hirschsprung disease, susceptibility to, 7}	606875	_	2
609826	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
607709	9q21.11	Cholestasis, progressive familial intrahepatic 4	615878	AR	3
607709	9q21.11	Hypercholanemia, familial	607748	AR	3
610181	13q14.3	Aicardi-Goutieres syndrome 2	610181	AR	3
608833	20q13.33	Dyskeratosis congenita, autosomal dominant 4	615190	AR,AD	3
608833	20q13.33	Dyskeratosis congenita, autosomal recessive 5	615190	AR,AD	3
608833	20q13.33	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373	AD	3
609842	15q24.1	?Mental retardation, autosomal recessive 50	616460	AR	3
608135	9q22.31	{Lumbar disc degeneration}	603932	_	3
608135	9q22.31	{Osteoarthritis susceptibility 3}	607850	AD	3
610248	20q13.2-q13.3	Deafness, autosomal recessive 65	610248	AR	2
606799	5q12	{Stroke, susceptibility to, 1}	606799	_	2
605841	4p13-q21	Narcolepsy 2	605841	_	2
609306	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
606230	22q13.33	Phelan-McDermid syndrome	606232	AD	3
606230	22q13.33	{Schizophrenia 15}	613950	AD	3
608174	5q31-q33	{Autoimmune thyroid disease, susceptibility to, 2}	608174	_	2
605799	14q32.32	Megaloblastic anemia-1, Norwegian type	261100	AR	3
608088	3p24-p22	Neuropathy, hereditary sensory, type IB	608088	AD	2
607949	2q35	{Tuberculosis, susceptibility to}	607949	_	2
604229	11p13	Anterior segment dysgenesis 5, multiple subtypes	604229	_	3
609225	7p22.1	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3
607696	17q25.1	Usher syndrome, type 1G	606943	AR	3
608552	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
604317	19q13.12	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3
603383	7q36.1	Glaucoma 1, open angle, F	603383	_	3
609741	22q11.23	Cataract 22	609741	AR,AD	3
610005	3q26.2-q26.3	Mental retardation, autosomal recessive 54	617028	AR	3
606712	19q	Specific language impairment QTL, 2	606712	Mu	2
606453	4q31.3	Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3
605515	3p13	Mental retardation with language impairment and with or without autistic features	613670	AD	3
608136	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
607270	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
609059	11p15.5	Neutral lipid storage disease with myopathy	610717	AR	3
610438	9p24-p22	{Restless legs syndrome 3}	610438	_	2
610299	1p13.3	Mental retardation, autosomal recessive 48	616269	AR	3
609226	17q25.3	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3
610282	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
610090	17q21.32	Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3
609307	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
609570	5q21	{Migraine, susceptibility to, 8}	609570	_	2
610057	19p13.12	Mental retardation, autosomal recessive 14	614020	AR	3
604201	6q22-q23	{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}	604201	_	2
604377	22q13.33	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	AR	3
605218	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
610439	2q33	{Restless legs syndrome 4}	610439	_	2
606713	1p36.11	Van der Woude syndrome 2	606713	AD	3
609397	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
604319	14q12	Dyskeratosis congenita, autosomal dominant 3	613990	AD	3
604319	14q12	Revesz syndrome	268130	AD	3
609227	2q37.3	Griscelli syndrome, type 3	609227	AR	3
607154	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
609017	1p34.2	[Blood group, Radin]	111620	_	3
609017	1p34.2	[Blood group, Scianna system]	111750	_	3
607596	14q32.2	Pontocerebellar hypoplasia type 1A	607596	AR	3
608222	22q13.1	Adenylosuccinase deficiency	103050	AR	3
607697	11p15.4	Charcot-Marie-Tooth disease, type 4B2	604563	AR	3
603941	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
608558	16p13	[Body mass index QTL5]	608558	_	2
610381	19p13.3	Cone-rod dystrophy 11	610381	AD	3
610320	1p36	Myopia 14	610320	_	2
606418	1p32.3	Desmosterolosis	602398	AR	3
609644	14q21.2	?Premature ovarian failure 15	618096	AR	3
609644	14q21.2	Spermatogenic failure 28	618086	AR	3
610250	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
610206	20p13	Corneal dystrophy, Fuchs endothelial, 4	613268	_	3
610206	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
610206	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
605882	17q23.2	Fanconi anemia, complementation group J	609054	_	3
605882	17q23.2	{Breast cancer, early-onset, susceptibility to}	114480	SMu,AD	3
610283	1q22	Cone-rod dystrophy 10	610283	AR	3
605828	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
603317	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
603317	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
608765	8q12	{Scoliosis, isolated, susceptibility to, 3}	608765	_	2
607304	2p12	Cataract 27, nuclear progressive	607304	_	2
602987	7p14.3	?Deafness, autosomal dominant 74	618140	AD	3
607764	16p11.2	Bile acid synthesis defect, congenital, 1	607765	AR	3
603942	3q24	?Glycogen storage disease XV	613507	AR	3
603942	3q24	Polyglucosan body myopathy 2	616199	AR	3
609308	9q34.13	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3
610092	14q24.3	Microphthalmia with coloboma 3	610092	_	3
609649	3p24-p21.2	Trichilemmal cyst 1	609649	AD	2
606419	19q13.42	Retinitis pigmentosa 11	600138	AD	3
605516	10q22.1	Deafness, autosomal recessive 12	601386	AR	3
605516	10q22.1	Usher syndrome, type 1D	601067	AR,DR	3
605516	10q22.1	Usher syndrome, type 1D/F digenic	601067	AR,DR	3
605516	10q22.1	{Pituitary adenoma 5, multiple types}	617540	AD	3
609115	4q21.22	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3
609520	8p11.21	Dystonia 6, torsion	602629	AD	3
610284	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
607271	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
606232	22q13.33	Phelan-McDermid syndrome	606232	AD	3
609898	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
608852	6q21-q22	{Pulmonary function}	608852	_	2
608778	17q21.2	Spermatogenic failure 11	615081	AD	3
608137	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
605219	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
609018	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
606800	17q25.3	Glycogen storage disease II	232300	AR	3
607765	16p11.2	Bile acid synthesis defect, congenital, 1	607765	AR	3
610651	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
608559	20pter-p11.2	[Body mass index QTL6]	608559	_	2
607155	19q13.32	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3
609591	1q22	Noonan syndrome 8	615355	AD	3
605020	20p11.21	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	_	3
605020	20p11.21	Keratoconus 1	148300	AD	3
604202	22q11.21	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3
607951	11q21	Mosaic variegated aneuploidy syndrome 2	614114	AR	3
604320	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
610339	1p34.2	Osteogenesis imperfecta, type VIII	610915	AR	3
602974	9p13.3	[Glycerol quantitative trait locus]	614411	AR	3
608465	9q34.13	Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3
608465	9q34.13	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3
607381	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
609884	8q22.1	?RHYNS syndrome	602152	AR	3
609884	8q22.1	COACH syndrome	216360	AR	3
609884	8q22.1	Joubert syndrome 6	610688	AR	3
609884	8q22.1	Meckel syndrome 3	607361	AR	3
609884	8q22.1	Nephronophthisis 11	613550	AR	3
609884	8q22.1	{Bardet-Biedl syndrome 14, modifier of}	615991	AR	3
604649	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
610774	6p21.1	Epileptic encephalopathy, early infantile, 60	617929	AR	3
610265	6p21.31	Deafness, autosomal recessive 67	610265	AR	3
610130	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
609286	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
610938	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
610285	4p16.3	?Fetal akinesia deformation sequence 3	618389	_	3
610285	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
610652	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
610652	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
604544	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
604544	3p21.31	Perrault syndrome 4	615300	AR	3
609927	8p22	Spastic paraplegia 53, autosomal recessive	614898	AR	3
605844	13q12-q14	{Dermatitis, atopic, susceptibility to, 5}	605844	_	2
609701	17q21.2	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3
609701	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
610455	7q21.2	Tumoral calcinosis, familial, normophosphatemic	610455	AR	3
610612	1q32.3	Leber congenital amaurosis 12	610612	AR	3
604139	2q35	Spinal muscular atrophy, distal, autosomal recessive, 5	614881	AR	3
609469	11q24	Nephropathy, progressive, with deafness	609469	_	2
610321	15q12	{Prostate cancer, hereditary, 7}	610321	_	2
609572	13q31.3	Photoparoxysmal response 2	609572	_	2
610253	9q34.3	Kleefstra syndrome 1	610253	AD	3
609845	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
608176	10q	{Autoimmune thyroid disease, susceptibility to, 4}	608176	_	2
609309	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
609309	2p21-p16	Mismatch repair cancer syndrome	276300	AR	3
609309	2p21-p16	Muir-Torre syndrome	158320	AD	3
609573	7q32	Photoparoxysmal response 3	609573	_	2
610538	1q32.1	Fanconi anemia, complementation group T	616435	AR	3
606252	11q24.2	{Bacteremia, protection against}	614382	_	3
606252	11q24.2	{Malaria, protection against}	611162	_	3
606252	11q24.2	{Pneumococcal disease, invasive, protection against}	610799	_	3
606252	11q24.2	{Tuberculosis, protection against}	607948	_	3
607554	11p15.5-p15.4	Atrial fibrillation, familial, 3	607554	AD	3
610613	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
610613	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
609192	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
608958	20q13.12	Adenosine deaminase deficiency, partial	102700	AR,SMo	3
608958	20q13.12	Severe combined immunodeficiency due to ADA deficiency	102700	AR,SMo	3
608836	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
609310	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
610185	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
610006	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
609539	12q12	Coffin-Siris syndrome 6	617808	AD	3
605622	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
610303	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
610107	14q11.2	Galloway-Mowat syndrome 3	617729	AR	3
610687	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
607598	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
604321	15q15.1	Microcephaly 4, primary, autosomal recessive	604321	AR	3
608779	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
609400	4q13-q21	{Autoimmune disease, susceptibility to, 4}	609400	_	2
610991	2q35	3-M syndrome 2	612921	AR	3
608837	17p13.1	Carney complex variant	608837	_	3
611154	1q25	{Alzheimer disease-14}	611154	_	2
610883	17p11.2	Potocki-Lupski syndrome	610883	IC	4
610598	17q25.1	Retinitis pigmentosa 36	610599	_	3
610758	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
609116	10q26	[Respiratory rhythmicity in sleep]	609116	_	2
605802	2q22.3	Mowat-Wilson syndrome	235730	AD	3
604933	1p34.1	Adenomas, multiple colorectal	608456	AR	3
604933	1p34.1	Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas	132600	SMu	3
604933	1p34.1	Gastric cancer, somatic	613659	_	3
610956	1q25.1	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3
609311	12p11.21	Charcot-Marie-Tooth disease, type 4H	609311	AR	3
610688	8q22.1	Joubert syndrome 6	610688	AR	3
605021	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
605803	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
610759	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
609541	11q13.2	Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3
611155	3q22-q24	{Alzheimer disease-15}	611155	_	2
610957	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
604233	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
608224	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
607273	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
607273	17p11.2	Colorectal cancer, somatic	114500	_	3
607273	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
607273	17p11.2	Renal carcinoma, chromophobe, somatic	144700	_	3
610635	8q22.3	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
610760	2p24-p22	[Cholesterol level QTL 2]	610760	_	2
609720	9q33.3	Focal segmental glomerulosclerosis 9	616220	AR	3
609720	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
609761	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
604882	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
610599	17q25.1	Retinitis pigmentosa 36	610599	_	3
611274	15q22-q24	Glaucoma 1, open angle, N	611274	_	2
603384	6p21.32	Mental retardation, autosomal dominant 5	612621	AD	3
604416	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
603930	14q23.3-q24.1	Molybdenum cofactor deficiency C	615501	AR	3
607306	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
610131	17q23.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3
606718	5q32	Achondrogenesis Ib	600972	AR	3
606718	5q32	Atelosteogenesis, type II	256050	AR	3
606718	5q32	De la Chapelle dysplasia	256050	AR	3
606718	5q32	Diastrophic dysplasia	222600	AR	3
606718	5q32	Diastrophic dysplasia, broad bone-platyspondylic variant	222600	AR	3
606718	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
608780	6q25.3	Trichothiodystrophy 3, photosensitive	616395	_	3
608977	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
611543	12q13.2	Cavitary optic disc anomalies	611543	AD	3
604395	14q24.3	Colorectal cancer, hereditary nonpolyposis, type 7	614385	_	3
604395	14q24.3	Colorectal cancer, somatic	114500	_	3
604395	14q24.3	{Endometrial cancer, susceptibility to}	608089	_	3
606438	16q24.2	Huntington disease-like 2	606438	AD	3
610942	9q21.12	?Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3
610906	1p31	{Asthma-related traits, susceptibility to, 4}	610906	_	2
606719	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
602978	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
610456	7q21.2	MIRAGE syndrome	617053	AD	3
610456	7q21.2	Tumoral calcinosis, familial, normophosphatemic	610455	AR	3
611276	2p16-p15	Glaucoma 1, open angle, H	611276	_	2
609118	3q26.1	Cerebral cavernous malformations 3	603285	_	3
611644	4q31.3-q32.3	{Hirschsprung disease, susceptibility to, 9}	611644	_	2
610110	11p14.3-p14.2	Dystonia 24	615034	AD	3
611458	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
611458	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
611458	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
611458	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
610852	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
611087	17q23.3	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3
610761	3q24-q26	[High density lipoprotein cholesterol level QTL 5]	610761	_	2
610187	8q23.1	Diaphragmatic hernia 3	610187	_	3
610313	11q13.2	Cold-induced sweating syndrome 2	610313	AR	3
608978	11p13	Meacham syndrome	608978	_	3
611258	9q22.33	Cataract 36	613887	AR	3
610044	1q31.3	?Epileptic encephalopathy, early infantile, 57	617771	AD	3
609019	3p25.1	Biotinidase deficiency	253260	AR	3
611604	10q24.31	Spastic paraplegia 62	615681	AR	3
608781	1q21-q22	{Asperger syndrome susceptibility 3}	608781	_	2
611390	2q33.1	Spastic ataxia 3, autosomal recessive	611390	AR	3
611562	16p13.3	Spermatogenic failure 10	614822	AD	3
610978	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
610188	12q21.32	Joubert syndrome 5	610188	AR	3
606157	20p13	HARP syndrome	607236	AR	3
606157	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
611773	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
611605	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
611492	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
610045	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
608562	7q22	Polydactyly, postaxial, type A4	608562	_	2
611407	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
610992	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
608226	10q26.11	Spermatogenic failure 12	615413	AD	3
610908	12q14.2	{Autism susceptibility 13}	610908	_	2
609903	13q32	{Systemic lupus erythematosus, susceptibility to, 5}	609903	_	2
611960	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
611493	21q22.11	Atrial fibrillation, familial, 4	611493	_	3
611408	6q14.1	Leber congenital amaurosis 5	604537	_	3
606255	6q24-q25	{Stature QTL 1}	606255	_	2
611936	3q29	Chromosome 3q29 microduplication syndrome	611936	AD	4
611528	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
607601	19p13.3	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AR,AD	3
611494	4q25	{Atrial fibrillation, familial, 5}	611494	_	2
610189	12q21.32	Senior-Loken syndrome 6	610189	AR	3
611738	20p12.3	{Osteoporosis}	166710	AD	2
611409	15q12-q13	Albinism, brown oculocutaneous	203200	AR	3
611409	15q12-q13	Albinism, oculocutaneous, type II	203200	AR	3
611409	15q12-q13	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3
611409	15q12-q13	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3
611812	1p36.12	?SERKAL syndrome	611812	AR	3
611495	19p13.12	Ichthyosis, congenital, autosomal recessive 5	604777	AR	3
609706	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
611410	6p22.3	?Deafness, autosomal recessive 104	616515	AR	3
612228	20q11.22	{Stature QTL 14}	612228	_	2
608782	8q22.1	Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3
610539	10q22.1	Gaucher disease, atypical	610539	_	3
611496	20q13.33	Congenital heart defects, multiple types, 5	617912	AR,AD	3
611775	19q13.2	{Kawasaki disease, susceptibility to}	611775	_	3
611884	7p15.3	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3
612245	7q32.1	{Inflammatory bowel disease 14}	612245	_	3
612012	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
606439	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
606439	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
610048	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
612280	1p36.11	Fucosidosis	230000	AR	3
611497	17q21.31	?Osteopetrosis, autosomal recessive 6	611497	AR	3
611938	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
602991	17q22	Brachydactyly, type B2	611377	AD	3
602991	17q22	Multiple synostoses syndrome 1	186500	AD	3
602991	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
602991	17q22	Symphalangism, proximal, 1A	185800	AD	3
602991	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
611332	7q36.3	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3
606158	11q12.3	Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3
606158	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
606158	11q12.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
606158	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
611606	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
610540	20q13.32	Pseudohypoparathyroidism, type IB	603233	AD	3
609029	22q11.2	Emanuel syndrome	609029	ICB	4
612013	4p15.32	COACH syndrome	216360	AR	3
612013	4p15.32	Joubert syndrome 9	612285	AR	3
612013	4p15.32	Meckel syndrome 6	612284	AR	3
612319	16q23.1	Spastic paraplegia 35, autosomal recessive	612319	AR	3
611391	20p12.1	Cataract 33, multiple types	611391	AR,AD	3
609617	1p36.11	Zinc deficiency, transient neonatal	608118	AD	3
611045	17q21.31	Dursun syndrome	612541	AR	3
611045	17q21.31	Neutropenia, severe congenital 4, autosomal recessive	612541	AR	3
611776	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
606440	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
611279	1q32.1	?Meckel syndrome 12	616258	AR	3
611279	1q32.1	Microcephaly 20, primary, autosomal recessive	617914	AR	3
612399	19p13.3	Preimplantation embryonic lethality	616814	AR	3
611565	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
612074	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
606256	7q31.3	{Stature QTL 2}	606256	_	2
612229	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
612123	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
612433	1q43-q44	Deafness, autosomal recessive 45	612433	AR	2
611046	8q12-q13	{Mycobacterium tuberculosis, susceptibility to, 2}	611046	_	2
610190	19q13.11	?Peeling skin syndrome 3	616265	AR	3
612014	2q24.3	Nephronophthisis 12	613820	AR,AD	3
612014	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
612263	20q11.2	{Melanoma, cutaneous malignant, 7}	612263	_	2
612230	10p14	{Colorectal cancer, susceptibility to, 5}	612230	_	2
612400	20q11.22	{Osteoarthritis-5}	612400	_	3
611777	3p22.3	Brugada syndrome 2	611777	_	3
612599	5q31.1-q33.1	{Psoriasis susceptibility 11}	612599	_	2
612124	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
610982	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
610982	14q32.33	Glomerulosclerosis, focal segmental, 5	613237	_	3
612015	3p21.1	Congenital disorder of glycosylation, type In	612015	AR	3
609148	6p21.33	{Malaria, mild, susceptibility to}	609148	_	3
612656	5p13.2	Episodic ataxia, type 6	612656	AD	3
609853	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
612691	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
607664	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
609708	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
609708	8p21.3	Lipoprotein lipase deficiency	238600	AR	3
609708	8p21.3	[High density lipoprotein cholesterol level QTL 11]	238600	AR	3
612517	14q21.3	Ciliary dyskinesia, primary, 10	612518	_	3
606441	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
606441	2p13.1	{Parkinson disease 13}	610297	_	3
612372	12p13.3	{Major affective disorder-9, susceptibility to}	612372	_	2
612761	4q22.3	Adermatoglyphia	136000	AD	3
612761	4q22.3	Basan syndrome	129200	AD	3
612761	4q22.3	Huriez syndrome	181600	AD	3
612469	11p13-p12	WAGRO syndrome	612469	_	4
612728	1p33-p32	[Bone mineral density QTL 14]	612728	_	2
610316	2p16.1	Combined oxidative phosphorylation deficiency 13	614932	AR	3
610316	2p16.1	Deafness, autosomal recessive 70	614934	AR	3
610984	4q25	Complement factor I deficiency	610984	AR	3
612692	17q23.3	Agammaglobulinemia 6	612692	AR	3
612657	4p15.32	Cone-rod dystrophy 12	612657	_	3
612674	20p11.21	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3
612401	3p24.3	{Osteoarthritis susceptibility 6}	612401	_	2
612373	10q22.1	Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3
612632	15q22-q23	Usher syndrome, type 1H	612632	_	2
612781	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
612798	6p24.1	Question mark ears, isolated	612798	AD	3
611282	10q24.2	Cataract 48	618415	AR	3
607556	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
607556	2q37.3	Barber-Say syndrome	209885	AD	3
607556	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
612931	7p13	Glycogen storage disease X	261670	AR	3
610419	19p13.2	Deafness, autosomal recessive 68	610419	AR	3
612878	11q22.3	Epidermolysis bullosa, nonspecific, autosomal recessive	615028	AR	3
611263	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
612247	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
612862	6p21.3	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}	612862	_	2
612231	8q23	{Colorectal cancer, susceptibility to, 6}	612231	_	2
611778	3p22.3	Brugada syndrome 2	611777	_	3
609402	2p25	Preeclampsia/eclampsia 2	609402	_	2
607557	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
612932	17p13.2	?Glycogen storage disease XIII	612932	AR	3
612729	8q23	[Lean body mass QTL 1]	612729	_	2
612633	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
612016	1q42.13	Coenzyme Q10 deficiency, primary, 4	612016	AR	3
613031	20q13.33	{Glioma susceptibility 6}	613031	_	2
607786	1p32.3	Hypercholesterolemia, familial, 3	603776	AD	3
607786	1p32.3	{Low density lipoprotein cholesterol level QTL 1}	603776	AD	3
612374	5q31.2	STING-associated vasculopathy, infantile-onset	615934	AD	3
611816	1q32.2	Temple-Baraitser syndrome	611816	AD	3
612991	2p23.3	Shashi-Pena syndrome	617190	AD	3
605479	2q31.1	Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3
612975	12p12.1	[Short sleeper]	612975	AD	3
612863	6q24-q25	Chromosome 6q25-q25 deletion syndrome	612863	_	4
613014	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
612017	11q14-q22	Pyloric stenosis, infantile hypertrophic, 3	612017	_	2
612095	4p15.32	Retinitis pigmentosa 41	612095	AR	3
612799	16p12.2	Combined oxidative phosphorylation deficiency 12	614924	AR	3
613093	10q23.33	Cone dystrophy 4	613093	AR	3
613071	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
612837	16q21	Coenzyme Q10 deficiency, primary, 5	614654	AR	3
612232	11q23	{Colorectal cancer, susceptibility to, 7}	612232	_	2
612634	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
612126	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
610420	14q11.2-q12	Preauricular tag, isolated, autosomal dominant, 1	610420	AD	2
609403	9p13	Preeclampsia/eclampsia 3	609403	_	2
607604	9p24.2	Retinal cone dystrophy 3B	610356	AR	3
605480	4p16-p15.2	{Systemic lupus erythematosus, susceptibility to, 3}	605480	_	2
613032	8q24.21	{Glioma susceptibility 7}	613032	_	2
613015	6p22	{Neuroblastoma, susceptibility to, 4}	613015	_	2
613055	16q22	Atrial fibrillation, familial, 8	613055	_	2
612018	10q23.31	Cataract 47, juvenile, with microcornea	612018	AD	3
609033	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
612635	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
613094	8q22.1	Microphthalmia, isolated 4	613094	_	3
612881	5q14.3-q15	Periventricular nodular heterotopia 5	612881	_	4
605804	20p	{Dermatitis, atopic, susceptibility to, 3}	605804	_	2
610947	12p13.2	{Coronary artery disease, autosomal dominant, 2}	610947	AD	3
612233	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
612034	19p13.3	?Sotos syndrome 3	617169	AR	3
608786	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
612782	12q24.31	Immunodeficiency 9	612782	AR	3
610199	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
613111	20q13.12	Galactosialidosis	256540	AR	3
612712	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
609712	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
609712	1q22	Pyruvate kinase deficiency	266200	AR	3
612471	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
610093	14q24.3	Microphthalmia, isolated 2	610093	_	3
612096	9p13.1-q21.11	Otosclerosis 8	612096	AD	2
610053	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
611611	15q24.3	Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3
613180	22q11.21	Cortical dysplasia, complex, with other brain malformations 8	613180	AR	3
610948	3p14.1-q12.3	{Hypertension, essential, susceptibility to, 7}	610948	_	2
613145	1q21-q23	{Systemic lupus erythematosus, susceptibility to, 14}	613145	_	2
605481	1q31.3	Microcephaly 5, primary, autosomal recessive	608716	AR	3
613270	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
612783	11p15.4	Immunodeficiency 10	612783	AR	3
605805	17q25.3	{Dermatitis, atopic, susceptibility to, 4}	605805	_	2
613112	20q13.32	Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	AD	3
613219	7p15-p13	[Birth weight QTL 1]	613219	_	2
613219	7p15-p13	[Fasting plasma glucose level QTL 2]	613219	_	2
613236	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
612452	17q21.31	Koolen-De Vries syndrome	610443	AD	3
607788	2p21	Factor V and factor VIII, combined deficiency of	613625	_	3
611888	19q13.2	Chitayat syndrome	617180	AD	3
611888	19q13.2	Craniosynostosis 4	600775	AD	3
612800	13q34	Combined oxidative phosphorylation deficiency 27	616672	AR	3
607955	6q24.3-q25.1	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3
607955	6q24.3-q25.1	Dyschromatosis universalis hereditaria 1	127500	AD	3
613095	4q22.1	Polycystic kidney disease 2	613095	AD	3
611705	2q31.2	Salih myopathy	611705	AR	3
611908	3p21.1	Congenital disorder of glycosylation, type In	612015	AR	3
610422	3q26.2-q26.31	Alopecia-mental retardation syndrome 2	610422	AR	2
609312	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
612035	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
612035	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
613016	2q35	{Neuroblastoma, susceptibility to, 5}	613016	_	2
612713	4q12	Kahrizi syndrome	612713	AR	3
613290	6p22.3	{?Hearing loss, cisplatin-induced, susceptibility to}	613290	_	2
609855	17q21.2	Neurodegeneration with brain iron accumulation 6	615643	AR	3
609855	17q21.2	Pontocerebellar hypoplasia, type 12	618266	AR	3
613163	16p13.2	GABA-transaminase deficiency	613163	AR	3
610949	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
612020	19p13.2	Spastic paraplegia 39, autosomal recessive	612020	AR	3
611966	8q24.3	Mental retardation, autosomal recessive 13	613192	AR	3
613271	9p24.1-p22.1	Corneal dystrophy, Fuchs endothelial, 7	613271	_	2
607606	17q21.2	Palmoplantar keratoderma, epidermolytic	144200	AD	3
611706	10q22-q23	{Migraine, with or without aura, susceptibility to, 12}	611706	AD	2
613096	12q23-q24	Spastic paraplegia 36, autosomal dominant	613096	AD	2
613146	15q25.1	EDICT syndrome	614303	AD	3
609313	7q22.1	MEDNIK syndrome	609313	AR	3
613435	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
612994	4p15.33	Cone-rod dystrophy 18	615374	AR	3
610423	14q32.33	Epileptic encephalopathy, early infantile, 66	618067	AD	3
609620	7q36.1	Short QT syndrome 1	609620	_	3
613033	5p15.33	{Glioma susceptibility 8}	613033	_	2
613401	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
612714	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
613072	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
613291	13q33.1	Bile acid malabsorption, primary	613291	AR	3
613418	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
613237	14q32.33	Glomerulosclerosis, focal segmental, 5	613237	_	3
613058	1q42	{Basal cell carcinoma, susceptibility to, 2}	613058	_	2
611124	4q28.2	Ceroid lipofuscinosis, neuronal, 7	610951	AR	3
611124	4q28.2	Macular dystrophy with central cone involvement	616170	AR	3
613471	1q42.12	?Reynolds syndrome	613471	AD	3
613529	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613529	15q21.1	Seckel syndrome 5	613823	AR	3
610132	1p13.1	Caudal regression syndrome	600145	AD	3
610132	1p13.1	{Neural tube defects, susceptibility to}	182940	AD	3
612036	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
613581	3q12.3	Retinitis pigmentosa 56	613581	AR	3
606187	10p13	Alzheimer disease-7	606187	_	2
613547	16q24	{Stature QTL 22}	613547	_	2
612021	8q21.3	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3
613017	1q21.1	{Neuroblastoma, susceptibility to, 6}	613017	_	2
612251	7q32.1	{Systemic lupus erythematosus, susceptibility to, 10}	612251	_	3
613436	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
612866	1p21.3	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3
611531	12p13.31	Bowen-Conradi syndrome	211180	AR	3
612386	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
613690	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
613402	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
610951	4q28.2	Ceroid lipofuscinosis, neuronal, 7	610951	AR	3
613238	2q36.1-q36.3	{Spondyloarthropathy, susceptibility to, 3}	613238	_	2
609621	11p15.5-p15.4	Short QT syndrome 2	609621	AD	3
607560	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
606460	6q21	[Longevity 2]	606460	_	2
613113	17q11.2	Leukemia, juvenile myelomonocytic	607785	SMu,AD	3
613113	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
613113	17q11.2	Neurofibromatosis, type 1	162200	AD	3
613113	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
613113	17q11.2	Watson syndrome	193520	AD	3
613752	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
608742	12p12.2-p12.1	{Hypertension, essential, susceptibility to, 4}	145500	Mu	2
613453	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
613564	2p12-p11.2	Chromosome 2p12-p11.2 deletion syndrome	613564	_	4
613255	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
613582	17q25.3	Retinitis pigmentosa 57	613582	AR	3
610489	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
611818	3p25.3	Long QT syndrome 9	611818	AD	3
611398	17q12	?Ciliary dyskinesia, primary, 41	618449	AR	3
611192	16q24.3	KBG syndrome	148050	AD	3
611060	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
611060	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
613059	5p15.33	{Basal cell carcinoma, susceptibility to, 3}	613059	_	2
613715	13q12.2	Treacher Collins syndrome 2	613717	AR,AD	3
613857	1p33	Orofacial cleft 13	613857	AD	2
612356	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
613548	1p32	{Stature QTL 23}	613548	_	2
613325	19p13.2	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3
611910	10q23.31	Cataract 47, juvenile, with microcornea	612018	AD	3
613798	3q26.33	Ciliary dyskinesia, primary, 14	613807	_	3
613815	6p21.33	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	AR	3
613815	6p21.33	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	AR	3
612387	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
613239	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
609622	17q24.3	Short QT syndrome 3	609622	_	3
613420	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
613769	10q23.1	Retinitis pigmentosa 44	613769	_	3
610997	17q21-q22	{Prostate cancer, hereditary, 9}	610997	_	2
613673	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
613293	5q35.1	Frank-ter Haar syndrome	249420	AR	3
613148	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
611290	2q35	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	_	3
613891	3q21.2	Orotic aciduria	258900	AR	3
613381	21q22.3	Homocystinuria, B6-responsive and nonresponsive types	236200	AR	3
613381	21q22.3	Thrombosis, hyperhomocysteinemic	236200	AR	3
611890	9q34.11	Congenital arthrogryposis with anterior horn cell disease	611890	AR	3
612098	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
613858	2q37.1	Microphthalmia, isolated 6	613517	AR	3
612357	10q21	{Major affective disorder-8, susceptibility to}	612357	_	2
613454	14q12	Rett syndrome, congenital variant	613454	AD	3
612474	1q21.1	Chromosome 1q21.1 deletion syndrome	612474	IC,AD	4
612933	11p15.1	Glycogen storage disease XI	612933	AR	3
613276	16q21	Poikiloderma with neutropenia	604173	AR	3
607791	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
612238	9q31.2-q34.2	{Scoliosis, idiopathic, susceptibility to, 4}	612238	_	2
613874	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
613530	3p25.1-p23	Muscular dystrophy, limb-girdle, type 1H	613530	AD	2
611073	8p12-q22	{Alzheimer disease 12}	611073	_	2
613403	2q11.2	{Pheochromocytoma, susceptibility to}	171300	AD	3
613549	2p16	{Stature QTL 24}	613549	_	2
614009	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
611978	1q25.1	?Combined oxidative phosphorylation deficiency 38	618378	AR	3
614034	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
613674	8q11.23	Vesicoureteral reflux 3	613674	AD	3
611911	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
613183	2p13.1	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3
613382	12p11.22	Brachydactyly, type E2	613382	AD	3
610502	6q21	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	616732	AR	3
612099	9p21	Trichoepithelioma, multiple familial, 2	612099	_	2
614098	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
613404	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
611126	3q21.3	Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3
612636	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
611820	7q21.2	?Long QT syndrome-11	611820	AD	3
612388	10q22.3	{Sarcoidosis, susceptibility to, 3}	612388	_	2
612475	1q21.1	Chromosome 1q21.1 duplication syndrome	612475	IC,AD	4
614074	11p15.1	Hermansky-Pudlak syndrome 5	614074	AR	3
613036	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
614231	18q21.1	Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3
613061	12q13	{Basal cell carcinoma, susceptibility to, 4}	613061	_	2
614187	14q31	Hypertelorism, preauricular sinus, punctal pits, and deafness	614187	AD	2
612239	17q25.3	{Scoliosis, idiopathic, susceptibility to, 5}	612239	_	2
612997	11q13.1	Spermatogenic failure 7	612997	AR	3
612253	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
613326	8q22.3	Dihydropyrimidinuria	222748	AR	3
610954	18q21.2	Pitt-Hopkins syndrome	610954	AD	3
614254	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
611801	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
613204	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
609122	1p36.13-p34.3	Aneurysm, intracranial berry, 3	609122	AD	2
614035	21q22.13	Deafness, autosomal recessive 29	614035	AR	3
613860	1p36.11	Immunodeficiency due to ficolin 3 deficiency	613860	AR	3
612801	1q41	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3
610762	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
614151	16q23.1	?Fanconi anemia, complementation group W	617784	AR	3
610432	18q12.1	Tenorio syndrome	616260	AD	3
611783	2p21	Erythrocytosis, familial, 4	611783	_	3
612417	22q13	{Narcolepsy 4}	612417	_	2
612732	3q11.2	Coproporphyria	121300	AD	3
612732	3q11.2	Harderoporphyria	121300	AD	3
613257	1q32.1	Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3
612389	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
606190	1p11	Meningioma, radiation-induced	606190	_	2
611376	8q23-q24	Mungan syndrome	611376	AR	2
612358	3q27.3	[High molecular weight kininogen deficiency]	228960	AR	3
612358	3q27.3	[Kininogen deficiency]	228960	AR	3
610988	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
613717	13q12.2	Treacher Collins syndrome 2	613717	AR,AD	3
614168	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
612254	8p23.1	{Systemic lupus erythematosus, susceptibility to, 12}	612254	_	2
613327	17q21.2	Lipodystrophy, congenital generalized, type 4	613327	AR	3
612868	12q21.33	Corneal dystrophy, posterior amorphous	612868	AD	4
614134	6q13	Stickler syndrome, type IV	614134	_	3
614058	2p23.3	[Fructosuria]	229800	AR	3
613976	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
613940	4q28.1	Epilepsy, hearing loss, and mental retardation syndrome	616577	AR	3
613583	19q13.12	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3
612637	3q26.2-q26.33	Febrile seizures, familial, 10	612637	_	2
613826	14q11.2	Leber congenital amaurosis 6	613826	_	3
614171	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
610098	6q22.31	Ovarian dysgenesis 4	616185	AR	3
614326	13q31.3	Feingold syndrome 2	614326	AD	3
612390	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
612998	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
613277	11q12.2	Joubert syndrome 2	608091	AR	3
613277	11q12.2	Meckel syndrome 2	603194	AR	3
614152	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
611089	3p25.3	{Centronuclear myopathy, autosomal, modifier of}	160150	AD	3
612584	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
614075	10q24.32	Hermansky-Pudlak syndrome 6	614075	AR	3
613862	2q13	Retinitis pigmentosa 38	613862	AR	3
614232	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
613756	4p12	Retinitis pigmentosa 49	613756	_	3
614327	3p21.1	Tumor predisposition syndrome	614327	AD	3
612554	5p15.33-p15.2	Myopia 16	612554	_	2
614188	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
613603	4q32.1-q32.2	Chromosome 4q32.1-q32.2 triplication syndrome	613603	AD	4
612100	7q35-q36	{Autism susceptibility 15}	612100	_	3
613278	16p13.3	Fanconi anemia, complementation group P	613951	AR	3
613328	15q11-q21.1	?Roifman-Chitayat syndrome	613328	AR	2
613977	11p15.4	Cyanosis, transient neonatal	613977	AD	3
613037	9q34.3	Joubert syndrome 1	213300	AR	3
613037	9q34.3	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	AR	3
612360	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
612418	8q21.11	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3
611804	1p35.3	Elliptocytosis-1	611804	AR,AD	3
614343	18p11.3	Mental retardation, autosomal recessive 19	614343	AR	2
613827	6p21.1	Retinitis pigmentosa 48	613827	_	3
614172	3q21.3	Immunodeficiency 21	614172	AD	3
612638	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
613757	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
613924	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
614255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
614328	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
613842	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
610099	8p22-q11	Myopathy, distal 3	610099	AD	2
611403	17q21	{Asthma-related traits, susceptibility to, 6}	611403	_	2
614291	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
612639	12q15	{Inflammatory bowel disease 26}	612639	_	2
612586	2q33.1	{Aneurysm, intracranial berry, 9}	612586	_	2
612392	8q22.1	Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3
612361	2q32.1	{Schizophrenia, susceptibility to, 14}	612361	_	2
614395	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
613279	14q31.3	Mental retardation, autosomal recessive 56	617125	AR	3
611805	6p12.1	Spinocerebellar ataxia 38	615957	AD	3
610100	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
614452	10q23.31	Hyperekplexia 4	618011	AR	3
612555	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
611535	2q22-q24	{Major affective disorder 5}	611535	_	2
614329	4q12-q13.1	Mental retardation, autosomal recessive 31	614329	AR	2
613006	10q23.31	{Diabetes mellitus, insulin-dependent, 24}	613006	_	2
611341	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
613675	17q11.2	Chromosome 17q11.2 deletion syndrome, 1.4Mb	613675	AD	4
612362	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
612458	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
611719	3q23	Combined oxidative phosphorylation deficiency 5	611719	AR	3
613405	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
612621	6p21.32	Mental retardation, autosomal dominant 5	612621	AD	3
613843	6p21.31	Leber congenital amaurosis 15	613843	AR	3
613205	1q22	Muscular dystrophy, congenital	613205	AD	3
611090	1p34.1	Mental retardation, autosomal recessive 12	611090	AR	3
614429	8p23.1	Ventricular septal defect 1	614429	AD	3
613329	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AR,AD	3
613150	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
612622	4q27	{Diabetes mellitus, insulin-dependent, 23}	612622	_	2
613758	2q37.1	Retinitis pigmentosa 47	613758	_	3
614292	3q28	Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3
614233	19pter-p13.1	Hyperpigmentation, familial progressive, 1	614233	_	2
613406	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
612641	8p11.21	Spherocytosis, type 1	182900	AR,AD	3
612001	15q13.3	Chromosome 15q13.3 microdeletion syndrome	612001	_	4
611788	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
611170	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
614521	9p24.1	Thrombocythemia 3	614521	SMu,AD	3
612459	2q14.1	[Body mass index QTL13]	612459	_	2
613942	20q11.21	Spermatogenic failure 16	617187	AR	3
614411	9p13.3	[Glycerol quantitative trait locus]	614411	AR	3
613385	20q11.22	Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3
613828	6q16.3-q22.31	Epilepsy, generalized, with febrile seizures plus, type 8	613828	_	2
612587	8q12.1	{Aneurysm, intracranial berry, 10}	612587	_	2
613477	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
614344	11p13-q14.1	Mental retardation, autosomal recessive 23	614344	AR	2
613676	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
613114	5p15.1	Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3
612623	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
613007	6p21.3	{Biliary cirrhosis, primary, 2}	613007	_	2
613533	17q21.31	Chromosome 17q21.31 duplication syndrome	613533	_	4
612556	3q27.3	Adiponectin deficiency	612556	_	3
613151	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
612240	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
614504	5q31.3	Usher syndrome type 3B	614504	AR	3
608792	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
614293	6q13	Hydatidiform mole, recurrent, 2	614293	AR	3
613845	19q13.2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3
612642	11p14.2-q12.3	Deafness, autosomal dominant 59	612642	AD	2
613008	1p31.2	{Biliary cirrhosis, primary, 3}	613008	_	2
611536	6q23-q24	{Major affective disorder 6}	611536	_	2
613759	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
614487	18p11.21	Spastic ataxia 5, autosomal recessive	614487	AR	3
613604	16p12.2-p11.2	Chromosome 16p12.2-p11.2 deletion syndrome	613604	IC	4
612255	10q21	{Inflammatory bowel disease 15}	612255	_	2
614468	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
614345	6p12.2-q12	Mental retardation, autosomal recessive 24	614345	AR	2
613280	1q41	Hypermanganesemia with dystonia 1	613280	AR	3
614831	6q24.3	Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3
612241	3p21.3	{Inflammatory bowel disease 12}	612241	_	2
614505	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
614700	4q31.3	Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3
614331	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
612557	9q34.1	{Leukemia, chronic lymphocytic, susceptibility to, 3}	612557	_	2
612643	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
613943	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
613407	13q14.11	{Leprosy, susceptibility to, 6}	613407	_	2
611913	16p11.2	Chromosome 16p11.2 deletion syndrome, 593kb	611913	_	4
611913	16p11.2	{Autism susceptibility 14A}	611913	_	2
614864	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
611482	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
611482	4q35.1	?Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3
612119	11q23.3	Trehalase deficiency	612119	AR	3
613605	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
613206	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
614848	11q23.3	Nephronophthisis 15	614845	AR	3
614190	5q13.3	Pigmented nodular adrenocortical disease, primary, 3	614190	_	3
614619	4q32.1	Hyperekplexia 2	614619	AR	3
612802	6p21.33	Combined oxidative phosphorylation deficiency 20	615917	AR	3
611003	10q22	{Smoking as a quantitative trait locus 1}	611003	_	2
614010	8q12.1	Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3
612589	14q22.2	{Colorectal cancer, susceptibility to, 8}	612589	_	2
612676	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
613115	5p15.1	Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3
609625	10q26	Chromosome 10q26 deletion syndrome	609625	AD	4
614946	6p25.1	Combined oxidative phosphorylation deficiency 14	614946	AR	3
612624	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
612256	19p13.13	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3
614173	12q24.11	Joubert syndrome 13	614173	AR	3
612120	3p25.3	?Lipodystrophy, familial partial, type 5	615238	AR	3
612242	10q23	Chromosome 10q22.3-q23.2 deletion syndrome	612242	_	4
612644	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
614455	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
613761	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
613207	9q33	{Asthma-related traits, susceptibility to, 8}	613207	_	2
613944	2q36	{IgA nephropathy, susceptibility to, 2}	613944	?AD	2
614947	15q22.31	Combined oxidative phosphorylation deficiency 15	614947	AR	3
613606	1p33-p31.1	Forsythe-Wakeling syndrome	613606	AR	2
611570	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
614541	16q22	Chromosome 16q22 deletion syndrome	614541	IC	4
614849	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
614456	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
614814	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
613534	15q13.3	Interstitial nephritis, karyomegalic	614817	AR	3
615135	4q22.1	?Maple syrup urine disease, mild variant	615135	_	3
614414	1p36.31-p36.13	Deafness, autosomal recessive 96	614414	AR	2
611004	22q12	{Smoking as a quantitative trait locus 2}	611004	_	2
613550	8q22.1	Nephronophthisis 11	613550	AR	3
613386	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
613386	13q12.3	Proteasome-associated autoinflammatory syndrome 2	618048	AD	3
615003	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
613190	16q24.1	Ciliary dyskinesia, primary, 13	613193	AR	3
613208	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
613566	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
612243	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
614929	12q13.13	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3
615119	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
614736	5p12	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3
615083	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
615271	20p12.1	Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3
613387	11q23	{Fatty liver disease, nonalcoholic, susceptibility to, 2}	613387	Mu	2
613282	22q13	{Fatty liver disease, nonalcoholic, susceptibility to, 1}	613282	Mu	2
613846	12q24.31	?Meckel syndrome 8	613885	AR	3
613846	12q24.31	Joubert syndrome 24	616654	AR	3
613009	4p15.2	Pontocerebellar hypoplasia type 2D	613811	AR	3
612625	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
614278	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
612160	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
614620	16p13.3	Retinitis pigmentosa 80	617781	AR	3
614620	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
614815	10q24.1	Joubert syndrome 18	614815	AR	3
615084	20p11.23	Mitochondrial DNA depletion syndrome 11	615084	AR	3
614644	6p21.3-p21.2	Mean platelet volume QTL4	614644	_	2
614582	3q22.1	Combined oxidative phosphorylation deficiency 9	614582	AR	3
614490	4q22.1	[Junior blood group system]	614490	_	3
611091	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
613283	4p13	Deafness, autosomal recessive 25	613285	AR	3
612161	11q24-q25	Aneurysm, intracranial berry, 7	612161	_	2
614621	5q12.1	UV-sensitive syndrome 2	614621	AR	3
611571	16q22.1-q23.1	{Otosclerosis 4}	611571	AD	2
611092	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
615085	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
615515	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
613847	10q24.1	Joubert syndrome 18	614815	AR	3
613847	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
613608	5p15.31-p15.1	Epilepsy, myoclonic, familial adult, 3	613608	AD	2
614063	4p16.3	?N-acetylaspartate deficiency	614063	AR	3
615463	1p34.2	Epileptic encephalopathy, early infantile, 18	615476	AR	3
615427	2p11.2	?Deafness, autosomal recessive 88	615429	AR	3
614622	5q14.1-q21.3	Keratoconus 5	614622	AD	2
613284	22q12-q13	[Hematocrit/hemoglobin quantitative trait locus 3]	613284	_	2
615481	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
615272	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
615311	11p14.1	{Bone mineral density, low, susceptibility to}	615311	_	3
615549	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
611572	6q13-q16.1	Otosclerosis 7	611572	AD	2
614583	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
615273	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
615787	5p13.2	?2,4-dienoyl-CoA reductase deficiency	616034	AR	3
615567	19q13.2	Nephrotic syndrome, type 9	615573	AR	3
615288	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614645	6q23.3	Mean platelet volume QTL5	614645	_	2
615767	4q27	?Immunodeficiency, common variable, 11	615767	AR	3
614021	7p22-p14	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	2
612244	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
615120	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
615500	21q22.11	Ciliary dyskinesia, primary, 26	615500	AR	3
612558	6p25	{Leukemia, chronic lymphocytic susceptibility to, 4}	612558	_	2
615464	1q32.1	Orofaciodigital syndrome V	174300	AR	3
611539	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
614915	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
614738	6q27	Mitochondrial pyruvate carrier deficiency	614741	AR	3
614491	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
612590	16q22.1	{Colorectal cancer, susceptibility to, 9}	612590	_	2
615586	3q29	Morbid obesity and spermatogenic failure	615703	AR	3
615274	12q13.3	Cataract 15, multiple types	615274	AD	3
615159	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
614022	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
615721	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
615550	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
611093	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
613848	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
615004	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
615429	2p11.2	?Deafness, autosomal recessive 88	615429	AR	3
615843	1q42.11	Leukodystrophy, hypomyelinating, 18	618404	AR	3
614492	12p13.33	Pseudohypoaldosteronism, type IIC	614492	AD	3
613285	4p13	Deafness, autosomal recessive 25	613285	AR	3
615902	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
615902	14q13.2	Spermatogenic failure 36	618420	AD	3
615501	14q23.3-q24.1	Molybdenum cofactor deficiency C	615501	AR	3
615482	15q21.3	Ciliary dyskinesia, primary, 25	615482	AR	3
613876	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
615368	19p13.2	Lethal congenital contracture syndrome 5	615368	AR	3
613345	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
615312	4q24	Albinism, oculocutaneous, type V	615312	AR	2
615551	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
614623	9q34	Keratoconus 6	614623	AD	2
614506	7p22.3	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3
614506	7p22.3	Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3
615390	12p11-q13	Vesicoureteral reflux 7	615390	_	2
613849	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
612559	11q24.1	{Leukemia, chronic lymphocytic susceptibility to, 5}	612559	_	2
612259	9q32	{Inflammatory bowel disease 16}	612259	_	2
615683	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
615465	8p11.23	Hartsfield syndrome	615465	AD	3
615327	20q11.21	Dowling-Degos disease 2	615327	AD	3
615179	10q22.2-q22.3	Albinism, oculocutaneous, type VII	615179	AR	3
613609	6p22.2	Hemochromatosis	235200	AR	3
613609	6p22.2	[Transferrin serum level QTL2]	614193	_	3
613609	6p22.2	{Alzheimer disease, susceptibility to}	104300	AD	3
613609	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
613609	6p22.2	{Porphyria cutanea tarda, susceptibility to}	176100	AR,AD	3
613609	6p22.2	{Porphyria variegata, susceptibility to}	176200	AD	3
611663	20p13	Warburg micro syndrome 4	615663	AR	3
611377	17q22	Brachydactyly, type B2	611377	AD	3
615160	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
612803	11q14.1	?Deafness, autosomal recessive 94	618434	AR	3
612803	11q14.1	Combined oxidative phosphorylation deficiency 24	616239	AR	3
616033	4q23	Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3
616053	14q32.11-q32.12	?Spinocerebellar ataxia 40	616053	AD	3
613850	20p13	[Inosine triphosphatase deficiency]	613850	_	3
616182	12q13	{Chronic mountain sickness, susceptibility to}	616182	_	2
614916	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
616202	14q32.33	Cerebellofaciodental syndrome	616202	AR	3
615502	16q22.1	Mental retardation, autosomal dominant 21	615502	AD	3
614739	6q25.3	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3
614507	1p36.12	?Congenital disorder of glycosylation, type Ir	614507	AR	3
615684	1p22.2	Premature ovarian failure 9	615724	AR	3
613551	11q24.2	{Autoimmune disease, susceptibility to, 6}	613551	_	3
613286	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
611664	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
615903	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
615903	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
615903	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
612260	3p22.2	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	_	3
611971	9q34.3	Combined oxidative phosphorylation deficiency 36	617950	AR	3
615992	2p15	?Bardet-Biedl syndrome 15	615992	AR	3
616219	4q25	Fibrosis of extraocular muscles, congenital, 5	616219	AR	3
616295	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
614895	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
613877	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
616034	5p13.2	?2,4-dienoyl-CoA reductase deficiency	616034	AR	3
611006	9q21.33	Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3
614917	6q25.1	Combined oxidative phosphorylation deficiency 11	614922	AR	3
616255	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
614076	6p22.3	Hermansky-Pudlak syndrome 7	614076	AR	3
613610	2p24.1	Cranioectodermal dysplasia 2	613610	AR	3
615503	7q36.3	Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3
616329	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
613011	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
616054	18q12.2	Mental retardation, autosomal recessive 58	617270	AR	3
615993	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
612261	1p31.3	{Inflammatory bowel disease 17, protection against}	612261	_	3
615162	17q21.31-q22	Mental retardation, autosomal recessive 35	615162	AR	2
613211	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
615956	19p13.2	Ciliary dyskinesia, primary, 30	616037	AR	3
614524	6p21.32	Fibrochondrogenesis 2	614524	AR,AD	3
615181	1q42.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	AR	3
613611	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
615860	14q24.3	Cone-rod dystrophy 19	615860	AR	3
614740	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
616462	2p11.2	Acrofacial dysostosis, Cincinnati type	616462	AD	3
615504	12q13.12	Ciliary dyskinesia, primary, 27	615504	AR	3
615846	2q24.2	Aicardi-Goutieres syndrome 7	615846	AD	3
614023	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
614896	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
615314	15q21.3	Craniosynostosis 3	615314	AD	3
615122	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
616346	9q34.11	Epileptic encephalopathy, early infantile, 31	616346	AD	3
614800	2p24.3	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3
616531	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
615005	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
613852	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
616330	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
612262	5p13.1	{Inflammatory bowel disease 18}	612262	_	2
616410	4q27	?Spinocerebellar ataxia 41	616410	AD	3
613612	7q22.3	Congenital disorder of glycosylation, type IIi	613612	_	3
615861	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
615483	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
616481	6q25.3	Ciliary dyskinesia, primary, 32	616481	AR	3
614508	15q15.1	Mirror movements 2	614508	AD	3
616055	1p36.13-p34.3	Episodic ataxia, type 8	616055	AD	2
614493	2q31.1	?Wiskott-Aldrich syndrome 2	614493	_	3
614897	7q21.11	{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3
615431	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
613878	13q34	Factor VII deficiency	227500	AR	3
613878	13q34	{Myocardial infarction, decreased susceptibility to}	608446	_	3
616719	11q13.1	Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3
612482	17q22	Sessile serrated polyposis cancer syndrome	617108	AD	3
612421	20p11.22	Alopecia, androgenetic, 3	612421	_	2
613347	13q13.1	{Pancreatic cancer 2}	613347	_	3
616411	2q37.3	Dystonia 27	616411	AR	3
613865	7q22.1	?Deafness, autosomal recessive 61	613865	AR	3
615862	12q22	Nephronophthisis 18	615862	AR	3
615505	8q22.2	Ciliary dyskinesia, primary, 28	615505	AR	3
616532	19q13.33	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3
616428	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
615065	2q37.1	Arthrogryposis, distal, type 5D	615065	AR	3
613301	7q31.32	Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3
616736	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
615847	12q22	Nephronophthisis 18	615862	AR	3
616720	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
616204	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
615942	17q25.1	Mental retardation, autosomal recessive 44	615942	AR	3
615276	15q26.3	Ichthyosis, congenital, autosomal recessive 9	615023	AR	3
614024	13q34	[Protein Z deficiency]	614024	_	3
616685	20q13.12	{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3
615905	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
615532	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
616331	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
612591	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
616645	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
614646	7q22.3	Mean platelet volume QTL6	614646	_	2
614920	1q21.1	?Peroxisome biogenesis disorder 14B	614920	AR	3
614741	6q27	Mitochondrial pyruvate carrier deficiency	614741	AR	3
616165	3p14.1	Nemaline myopathy 10	616165	AR	3
615066	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
615432	2q36.3	{Specific language impairment 5}	615432	AD	3
616625	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
616549	22q12.1	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3
612592	20p12.3	{Colorectal cancer, susceptibility to, 11}	612592	_	2
614332	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
615506	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
616445	3p25.3	Candidiasis, familial, 9	616445	AR	3
615957	6p12.1	Spinocerebellar ataxia 38	615957	AD	3
616646	17q21.2	Woolly hair, autosomal recessive 3	616760	AR	3
614898	8p22	Spastic paraplegia 53, autosomal recessive	614898	AR	3
616166	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
614526	17q12	Chromosome 17q12 duplication syndrome	614526	AD	4
614921	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
611666	9p24.1	Phospholipid phosphatase 6	611666	_	3
616183	17p13.1	?Joubert syndrome 29	617562	AR	3
616183	17p13.1	Meckel syndrome 13	617562	AR	3
616183	17p13.1	Orofaciodigital syndrome XVI	617563	AR	3
616312	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
616430	2q33.1	?Combined oxidative phosphorylation deficiency 25	616430	AR	3
616840	15q22.2	Parkinson disease 23, autosomal recessive, early onset	616840	AR	3
612422	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
614025	15q21.3	Hepatic lipase deficiency	614025	AR	3
616647	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
612736	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
616515	6p22.3	?Deafness, autosomal recessive 104	616515	AR	3
615768	16p13.3	Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3
613012	3q21.3	?Urocanase deficiency	276880	AR	3
614922	6q25.1	Combined oxidative phosphorylation deficiency 11	614922	AR	3
615072	20q11.22	Brachydactyly, type A1, C	615072	AR,AD	3
615907	4q34.3	Lymphatic malformation 4	615907	AD	3
615978	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
612423	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
616056	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
616313	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
614333	4q27-q28.2	Mental retardation, autosomal recessive 29	614333	AR	2
614415	20q11.23	?Chilblain lupus 2	614415	AD	3
613213	22q13.2	Methemoglobinemia, type I	250800	AR	3
613213	22q13.2	Methemoglobinemia, type II	250800	AR	3
612737	7p15	{Stature QTL 17}	612737	_	2
617083	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
616516	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
616534	9q22.33	{Thyroid cancer, nonmedullary, 4}	616534	AD	3
616648	16q21-q22	Optic atrophy 8	616648	AD	2
616737	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
613348	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
617066	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
617025	14q24.3	Nevus comedonicus, somatic	617025	_	3
615828	11p15.5	Mental retardation, autosomal dominant 24	615828	AD	3
614742	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
615552	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
616413	1q25.3	Basal ganglia calcification, idiopathic, 6	616413	AD	3
614457	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
616276	9q34.11	Coenzyme Q10 deficiency, primary, 7	616276	AR	3
615444	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
611974	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
614527	17q12	Chromosome 17q12 deletion syndrome	614527	AD	4
612424	6q12	Retinitis pigmentosa 25	602772	AR	3
615468	18q21.32	Immunodeficiency 12	615468	AR	3
616314	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
613214	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
611542	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
615073	18p11.21	Dystonia 25	615073	AD	3
617174	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
616535	10q25.3	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3
614494	6q23	Retinitis pigmentosa 63	614494	AD	2
614923	16p11.2	Branched-chain ketoacid dehydrogenase kinase deficiency	614923	_	3
616788	17q21.33	?Orofacial cleft 15	616788	AD	3
615277	19q13.41	Cataract 19, multiple types	615277	AR	3
616649	14q23.3	Spherocytosis, type 2	616649	AD	3
615789	2p21	Short stature with microcephaly and distinctive facies	615789	AR	3
615829	1p36.1-p35.3	Xia-Gibbs syndrome	615829	AD	3
615091	4q23	{Autism, susceptibility to, 19}	615091	_	3
616258	1q32.1	?Meckel syndrome 12	616258	AR	3
616517	1q23.3	Achromatopsia 7	616517	AR	3
617140	21q22.11	ZTTK syndrome	617140	AD	3
617044	3p21.1	Short stature, developmental delay, and congenital heart defects	617044	AR	3
615163	10q26	Cone-rod dystrophy 17	615163	AD	2
613215	17p13.3	Chromosome 17p13.3 duplication syndrome	613215	_	4
615994	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
616892	16q13	Nephrotic syndrome, type 12	616892	AR	3
616414	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
615533	11q14.1	Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3
615485	18q12.1	Bainbridge-Ropers syndrome	615485	AD	3
617157	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
616738	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
616185	6q22.31	Ovarian dysgenesis 4	616185	AR	3
616283	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
614899	11q13.2	Deafness, autosomal recessive 93	614899	AR	3
614416	2p13.2	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	_	3
616756	6q16.3	Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3
615909	14q21.3	Diamond-Blackfan anemia 13	615909	AD	3
616650	16p12.1	Joubert syndrome 26	616784	AR	3
614458	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
612162	14q23	Aneurysm, intracranial berry, 8	612162	_	2
613349	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
617180	19q13.2	Chitayat syndrome	617180	AD	3
617121	17q22	Joubert syndrome 28	617121	AR	3
614924	16p12.2	Combined oxidative phosphorylation deficiency 12	614924	AR	3
617068	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
615092	18q11.2	Left ventricular noncompaction 7	615092	AD	3
614335	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
613135	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
615959	2q35	Centronuclear myopathy 5	615959	AR	3
615790	1p36.1-p35.3	Xia-Gibbs syndrome	615829	AD	3
615127	3q26.32-q28	Epilepsy, myoclonic, familial adult, 4	615127	AD	2
616208	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
613776	17p13.1	Chromosome 17p13.1 deletion syndrome	613776	AD	4
617248	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
617158	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
616415	16p13.3	Familial adenomatous polyposis 3	616415	AR	3
616893	7q33	?Nephrotic syndrome, type 13	616893	_	3
617004	6q21	Polycystic liver disease 2	617004	AD	3
615573	19q13.2	Nephrotic syndrome, type 9	615573	AR	3
617282	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
615589	1q41-q44	Otosclerosis 10	615589	AD	2
616559	14q21.3	Noonan syndrome 9	616559	AD	3
615534	3q13.33	Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3
615830	19p13	Pigmented nodular adrenocortical disease, primary, 4	615830	AD	4
612163	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
616186	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
616284	1q21.3	Peeling skin syndrome 6	618084	AR	3
613216	15q13.3	Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	_	3
614744	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
617069	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
614925	12q21.31	Deafness, autosomal recessive 84B	614944	AR	3
616661	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3
615486	12q13.3	Interstitial lung and liver disease	615486	AR	3
616037	19p13.2	Ciliary dyskinesia, primary, 30	616037	AR	3
615944	11q13.4	Orofaciodigital syndrome XIV	615948	AR	3
616209	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
613330	4p15.33	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3
614459	11q12.2	Joubert syndrome 16	614465	AR	3
613388	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
617213	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
615960	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
617141	11p13	?Aniridia 2	617141	AD	3
616789	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
616260	18q12.1	Tenorio syndrome	616260	AD	3
615577	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
615553	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
616432	19p13.2	Retinitis pigmentosa 78	617433	AR	3
616187	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
615278	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
615979	16q24.2	?Mental retardation, autosomal recessive 45	615979	AR	3
617046	6p25.1	Spastic paraplegia 77, autosomal recessive	617046	AR	3
611669	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
615910	13q34	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3
614417	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
617070	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
614530	12q22	?Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3
616758	1p36.11	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3
613353	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
614336	16p13.3	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3
616910	2q31.1	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3
616858	20p11.23	?Cowden syndrome 7	616858	AD	3
615590	15q21.3	{Alzheimer disease 18, susceptibility to}	615590	_	3
617352	20q11-q13	Mulchandani-Bhoj-Conlin syndrome	617352	_	3
616261	7q22.3	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3
616651	2q14.2	Roifman syndrome	616651	AR	3
612164	9q34.11	Epileptic encephalopathy, early infantile, 4	612164	AD	3
612593	6p21.33	{Lung cancer susceptibility 4}	612593	_	2
617300	7q22.1	Lymphatic malformation 7	617300	AD	3
616739	2q22.1	Mental retardation, autosomal recessive 51	616739	AR	3
615919	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
615554	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
615792	13q14.2	{Thiopurines, poor metabolism of, 2}	616903	AD	3
616631	1q22	Porokeratosis 9, multiple types	616631	AD	3
615980	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
615279	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
616482	4p16.3	SADDAN	616482	AD	3
615911	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
616705	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
614512	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
613073	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
614077	19q13.32	Hermansky-Pudlak syndrome 8	614077	AR	3
614745	15q24.1	[Blood group, John-Milton-Hagen system]	614745	_	3
613217	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
615945	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
614900	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
615961	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
616687	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
616286	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
616188	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
616038	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
616963	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
617142	11p13	?Aniridia 3	617142	AD	3
615591	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
613440	2q37.1	{Stature QTL 21}	613440	_	2
616663	17p13.1	Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3
617123	1p34.1	Retinitis pigmentosa 76	617123	AR	3
616652	17p12-p11.2	Yuan-Harel-Lupski syndrome	616652	AD	4
615863	8q24.3	?Diarrhea 7, protein-losing enteropathy type	615863	AR	3
617353	3q29	Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3
616894	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
610436	18q22.2	Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3
616859	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
617159	12p13.31	Sifrim-Hitz-Weiss syndrome	617159	AD	3
614337	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
617387	3p21.31	Ververi-Brady syndrome	617982	AD	3
617404	17p13.3	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3
617284	19q13.12	Dystonia 28, childhood-onset	617284	AD	3
616632	5q31.3	Seizures, cortical blindness, microcephaly syndrome	616632	AR	3
615981	16q13	Bardet-Biedl syndrome 2	615981	AR	3
615280	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
616483	2p24.3	Infantile liver failure syndrome 2	616483	AR	3
617047	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
612165	4q32-q34	Retinitis pigmentosa 29	612165	AR	2
617478	14q22.3	Structural heart defects and renal anomalies syndrome	617478	AR	3
616777	3p21.31	Seckel syndrome 9	616777	AR	3
615095	20q13.12	Microcephaly 10, primary, autosomal recessive	615095	AR	3
617301	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
616875	1p36.13	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3
615831	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
614752	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
614078	8q12.1	Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3
616335	15q15.3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3
614647	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
614028	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
613778	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
614926	5q31.3	?Perrault syndrome 2	614926	AR	3
615555	5p13.2	Hyperprolactinemia	615555	AR,AD	3
615774	11q12.2	Oocyte maturation defect 1	615774	AR	3
614901	16p11.2	Branched-chain ketoacid dehydrogenase kinase deficiency	614923	_	3
617424	1q42.11-q42.12	Skraban-Deardorff syndrome	617616	AD	3
616287	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
617086	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
614746	19q13	[Uric acid concentration, serum, QTL5]	614746	_	2
613074	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
615592	8p11.21	Immunodeficiency 15B	615592	AR	3
615946	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
617143	2q12.3	Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3
614418	8q13.2	Febrile seizures, familial, 11	614418	AR	3
616521	2p25.3	Mental retardation, autosomal dominant 39	616521	AD	3
613441	22q12.2	Transcobalamin II deficiency	275350	AR	3
617441	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
612594	10p15.1	{Multiple sclerosis, susceptibility to, 2}	612594	_	2
614461	6p21.31	Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3
613138	7q31.31	Exudative vitreoretinopathy 5	613310	AD	3
616860	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
617336	10q21.3	Nemaline myopathy 11, autosomal recessive	617336	AR	3
616740	3q29	Immunodeficiency 46	616740	AR	3
615281	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
613218	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
617531	19p13.11	Brain small vessel disease 3	618360	AR	3
617072	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
616562	16q13	Retinitis pigmentosa 74	616562	AR	3
616538	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
616211	16q23.1-q23.2	Epileptic encephalopathy, early infantile, 28	616211	AR	3
614338	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
617217	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
615074	1q21.3	Mental retardation, autosomal dominant 18	615074	AD	3
617388	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
616500	2q11.2	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3	616500	AR	3
614927	10q24.32-q25.1	Ectodermal dysplasia 5, hair/nail type	614927	AR	2
617405	3q29	Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3
616688	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3
616827	2q14.3	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3
614747	1q21.1	[Uric acid concentration, serum, QTL6]	614747	_	2
613791	1p36.22	MASP2 deficiency	613791	AR	3
617302	10p12.1	?Optic atrophy 11	617302	AR	3
612595	5p13.2	{Multiple sclerosis, susceptibility to, 3}	612595	_	2
614419	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
617425	8p21.1	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3
611672	17q11.2	Folate malabsorption, hereditary	229050	AR	3
617087	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
615182	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
616418	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
617125	14q31.3	Mental retardation, autosomal recessive 56	617125	AR	3
617442	6p21.33	?Premature ovarian failure 13	617442	AR	3
617532	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
617619	1q22	Myopathy, mitochondrial, and ataxia	617675	AR,AD	3
615593	1p36.33	?Immunodeficiency 16	615593	AR	3
616435	1q32.1	Fanconi anemia, complementation group T	616435	AR	3
614462	4p14	Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3
615282	2q23.1-q23.2	Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3
616170	4q28.2	Macular dystrophy with central cone involvement	616170	AR	3
617480	9q33.3	46, XX sex reversal 4	617480	AD	3
617389	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
614080	18q21.33	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3
616501	1q42.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	616501	AR	3
614928	17p12-q21.2	Ectodermal dysplasia 6, hair/nail type	614928	AR	2
617218	12q21.32	Lissencephaly 8	617255	AR	3
615490	4q31.3	Charcot-Marie-Tooth disease, type 2R	615490	AR	3
617406	8q22.1	Bardet-Biedl syndrome 21	617406	AR	3
615075	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
616896	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
616212	16q21	Lissencephaly 6, with microcephaly	616212	AR	3
615833	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
614748	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
617232	3q13.33	?Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3
614514	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
613354	9q34.3	Deafness, autosomal recessive 79	613307	AR	3
614420	3p14.3	Systemic lupus erythematosus 16	614420	AR	3
613615	1q43-q44	Senior-Loken syndrome 7	613615	_	3
615471	6q16.1-q16.2	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3
612596	1p36	{Multiple sclerosis, susceptibility to, 4}	612596	_	2
613792	3pter-p25	3p- syndrome	613792	AD	4
617319	19p13.11	Anterior segment dysgenesis 8	617319	AR	3
617088	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
616539	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
617514	16p11.2	Immunodeficiency 52	617514	AR	3
613075	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
617637	11p15.5	Deafness autosomal recessive 106	617637	AR	3
616436	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
617443	11q24.3	Bleeding disorder, platelet-type, 21	617443	AR,AD	3
617145	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
615328	13q14.11	Shaheen syndrome	615328	AR	3
615962	5q31.3	Glucocorticoid resistance	615962	AD	3
617219	19q13.11	Chromosome 19q13.11 deletion syndrome, proximal	617219	AD	4
617585	19q13.32	?Immunodeficiency 53	617585	AR	3
617765	1q42.3	?Immunodeficiency, common variable, 14	617765	AD	3
615491	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
617730	20q13.12	Galloway-Mowat syndrome 4	617730	AR	3
613616	10q24.2	Hyperoxaluria, primary, type III	613616	_	3
613355	17q23.1-q23.2	Chromosome 17q23.1-q23.2 deletion syndrome	613355	IC	4
615777	16p12.3	Desbuquois dysplasia 2	615777	AR	3
614340	15q26.3	Mental retardation, autosomal recessive 27	614340	AR	3
615947	8q24.3	Hyperlipoproteinemia, type 1D	615947	AR	3
615866	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
615834	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
617800	3q23	?Microcephaly 19, primary, autosomal recessive	617800	AR	3
617481	1q21.3	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3
617713	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
616502	1p13.3	Cone-rod dystrophy 21	616502	AR	3
615535	19q13.12	Deafness, autosomal recessive 76	615540	AR	3
613444	16p11.2	Chromosome 16p11.2 deletion syndrome, 220kb	613444	_	4
613444	16p11.2	[Body mass index QTL16]	613444	_	4
616863	16p13.2	Chromosome 16p13.2 deletion syndrome	616863	AD	4
616878	22q11.21	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3
617659	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
616244	7p11.2	Parkinson disease 22, autosomal dominant	616710	AD	3
616828	2q21.1	Congenital disorder of glycosylation, type IIo	616828	AR	3
617320	19p13.12	Ichthyosis, congenital, autosomal recessive 12	617320	AR	3
615963	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
616689	19q13.31	Dehydrated hereditary stomatocytosis 2	616689	AD	3
616437	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
616486	1p34.2	Microcephaly 15, primary, autosomal recessive	616486	AR	3
617220	12p12.1	Myopathy, myofibrillar, 8	617258	AR	3
617675	1q22	Myopathy, mitochondrial, and ataxia	617675	AR,AD	3
614515	17q12	Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3
617731	2p13.1	Galloway-Mowat syndrome 5	617731	AR	3
615595	6p25.1	?Combined oxidative phosphorylation deficiency 19	615595	AR	3
617146	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
613076	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
614422	12q24.2-q24.3	Cataract 37, autosomal dominant	614422	AD	2
617182	15q21.2	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182	AR	3
617782	18q11.1-q11.2	Renal hypodysplasia/aplasia 3	617805	AD	3
617922	4q31.21	[Blood group, MNSs system]	111300	_	3
617922	4q31.21	{Malaria, resistance to}	611162	_	3
616214	11p15.5	Hyperproinsulinemia	616214	AD	3
614341	17p13.2-p13.1	Mental retardation, autosomal recessive 33	614341	AR	2
613793	1q32.2	[Blood group Cromer]	613793	AR	3
617408	17q21.31	?Diamond-Blackfan anemia 16	617408	AD	3
617698	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
615473	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
615948	11q13.4	Orofaciodigital syndrome XIV	615948	AR	3
617006	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
617321	16q12.1	{Yao syndrome}	617321	Mu	3
614649	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
616829	17q11.2	Congenital disorder of glycosylation, type IIp	616829	AR	3
617090	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
616690	1p36.32	Joubert syndrome 25	616781	AR	3
617660	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
616487	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
616503	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
615330	1q42.13	Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3
616540	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
617783	19p13.2	Nephrotic syndrome, type 16	617783	AR	3
616636	12q13.3	Immunodeficiency 44	616636	AR	3
617767	13q21.3-q22.1	Joubert syndrome 33	617767	AR	3
617183	1p36.33	Harel-Yoon syndrome	617183	AR,AD	3
615557	1q41	{Melioidosis, susceptibility to}	615557	_	3
614342	6q12-q15	Mental retardation, autosomal recessive 30	614342	AR	2
617871	14q24.3	?Retinitis pigmentosa 81	617871	AR	3
615493	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
617980	11p15.4	Erythrocytosis 6	617980	_	3
617466	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
618049	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
617412	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
616215	11p11.2	Osteogenesis imperfecta, type XVI	616229	AR	3
615407	16q13	Retinitis pigmentosa with or without situs inversus	615434	AR	3
616289	22q13.2	?Optic atrophy 9	616289	AR	3
616830	22q11.21	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3
615949	17q11.2	Nanophthalmos 4	615972	AD	3
617768	7q36.1	Kleefstra syndrome 2	617768	AD	3
616488	9q34.12	Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3
618126	12p13.31	?Liddle syndrome 3	618126	AD	3
618143	17q11.2	Glycosylphosphatidylinositol biosynthesis defect 18	618143	AR	3
615537	15q21.3	Reticulate acropigmentation of Kitamura	615537	AD	3
617638	7p22.2	Immunodeficiency 11B with atopic dermatitis	617638	AD	3
614423	2q33.1	Joubert syndrome 14	614424	AR	3
617802	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
617904	9q22.33	Epileptic encephalopathy, early infantile, 59	617904	AD	3
616339	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
617836	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
617872	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
617570	3q22.3	Polycystic kidney disease 5	617610	AR	3
616911	10q23.33	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3
616439	12q14.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3
618067	14q32.33	Epileptic encephalopathy, early infantile, 66	618067	AD	3
615950	2q35	Centronuclear myopathy 5	615959	AR	3
618050	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
616638	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
617516	17q24.2	Stankiewicz-Isidor syndrome	617516	AD	3
617602	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
614749	9p13.3	Hyperphosphatasia with mental retardation syndrome 2	614749	AR	3
615494	21q22.11	Ciliary dyskinesia, primary, 26	615500	AR	3
617941	15q25.2	Shwachman-Diamond syndrome 2	617941	AR	3
615332	1q42.3	?Immunodeficiency, common variable, 14	617765	AD	3
618015	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
616059	22q13.1	?Mirror movements 3	616059	AR	3
613446	5q23.2	Joubert syndrome 31	617761	AR	3
613446	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
616247	14q32.11	Long QT syndrome 14	616247	AD	3
618182	17q23.3	Orthostatic hypotension 2	618182	AR	3
617784	16q23.1	?Fanconi anemia, complementation group W	617784	AR	3
617639	17q25.1	Deafness, autosomal recessive 107	617639	AR	3
616489	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
618051	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
616389	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
618307	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
616639	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
617184	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
615796	2q32.1	Spermatogenic failure 34	618153	AR	3
618273	19p13.13	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3
616897	4p15.32	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3
614033	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
616216	12p13.2	Thrombocytopenia 5	616216	AD	3
618165	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
618331	16q24.3	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3
615408	10p12.1	Ciliary dyskinesia, primary, 23	615451	AR	3
617008	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
616881	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
616541	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
618016	1p21.1	?Growth hormone deficiency, isolated, type V	618160	AR	3
615969	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
617303	12q24.31	Mucopolysaccharidosis-plus syndrome	617303	AR	3
618183	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
616490	14q23.1	Joubert syndrome 23	616490	AR	3
616340	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
617468	19q13.12	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	617468	AR	3
616248	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
616640	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
617873	1p34.2	Combined oxidative phosphorylation deficiency 35	617873	AR	3
618367	15q25.1	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3
618384	20q13.12	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3
616806	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
615495	2q35	Alacrima, achalasia, and mental retardation syndrome	615510	AR	3
618128	1p12	Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3
618332	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
618481	17q12	?Deafness, autosomal recessive 99	618481	_	3
616217	6p22.3	Nephronophthisis 19	616217	AR	3
617661	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
615970	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
618406	18q21.32	Obesity (BMIQ20)	618406	_	3
616291	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
617874	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
614750	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
615951	5q12.1	Acromelic frontonasal dysostosis	603671	AD	3
615951	5q12.1	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3
618275	21q22.3	Hypotrichosis 14	618275	AR	3
617304	19p13.3	Retinitis pigmentosa 77	617304	AR	3
616913	17q12	Bleeding disorder, platelet-type, 20	616913	AD	3
617537	6p22.2	Rahman syndrome	617537	AD	3
616491	17q21.2	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3
618422	5q21.1	Deafness, autosomal recessive 100	618422	AR	3
616341	21q22.3	Epileptic encephalopathy, early infantile, 30	616341	AD	3
617323	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
616866	15q22.31	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3
618333	22q13.2	Menke-Hennekam syndrome 2	618333	_	3
617186	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
617641	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
616564	22q11.21	Noonan syndrome 10	616564	AD	3
616390	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
617538	15q25.2	Shwachman-Diamond syndrome 2	617941	AR	3
616249	2p21	Long QT syndrome 15	616249	AD	3
617839	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
616060	12p12.3	[Blood group, Dombrock]	616060	_	3
616914	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
618129	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
617662	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
617982	3p21.31	Ververi-Brady syndrome	617982	AD	3
616441	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
617604	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
617519	19q13.2	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3
614518	7q21.2	?Cardiomyopathy, dilated, 2B	614672	AR	3
618252	10q24.31	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3
616882	1p36.23	?Advanced sleep phase syndrome, familial, 3	616882	AD	3
618103	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
618350	7q22.1	?Microcephaly 25, primary, autosomal recessive	618351	AR	3
617642	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
617875	11q13.2	Polycystic liver disease 4 with or without kidney cysts	617875	AD	3
617222	4q24	Sudden cardiac failure, infantile	617222	AR	3
615952	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
616842	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
617907	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
617605	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
616898	15q14	Chromosome 15q14 deletion syndrome	616898	AD	4
617663	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
617520	4q21.23	?Microcephaly 18, primary, autosomal dominant	617520	AD	3
617983	12p13.31	?Microcephaly 21, primary, autosomal recessive	617983	AR	3
618351	7q22.1	?Microcephaly 25, primary, autosomal recessive	618351	AR	3
616342	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
618276	9q21.33	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3
616566	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
618424	6q21	Spermatogenic failure 38	618433	AR	3
616809	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
616843	16q24.3	Lymphatic malformation 6	616843	AR	3
615076	20p11.23	Mitochondrial DNA depletion syndrome 11	615084	AR	3
617984	11q25	Microcephaly 22, primary, autosomal recessive	617984	AR	3
618291	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3
617223	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
618429	3p22.2	Spermatogenic failure 37	618429	AR	3
615410	6q14.2	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3
618369	1p12	Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3
618201	3p22.1	Epileptic encephalopathy, early infantile, 68	618201	AR	3
618036	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
617985	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
617820	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
615596	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
617162	19q13.33	Epileptic encephalopathy, early infantile, 46	617162	AD	3
617452	8q21.3	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3
617571	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
616899	4q24	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3
615953	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
618462	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
618353	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
618430	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
618410	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
617787	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
617963	14q32.33	?Spermatogenic failure 30	618110	AR	3
617717	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
616568	7q31.33	{Glioma susceptibility 9}	616568	AD	3
617606	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
618253	22q13.2	Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3
617360	7p14.1	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3
615954	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
618292	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
618018	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
616867	10q22.1	?Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3
618431	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
617821	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
616062	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
618354	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
616900	4q24	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3
618464	17p13.2	Paragangliomas 6	618464	AD	3
615972	17q11.2	Nanophthalmos 4	615972	AD	3
618106	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
617718	7q22.1	Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease	617718	AR	3
616321	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
617964	7p21.3	Leukodystrophy, hypomyelinating, 16	617964	AD	3
618019	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
617607	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
617804	3p21.31	Neurodevelopmental disorder with severe motor impairment and absent language	617804	AD	3
616887	2q11.2	?Mental retardation, autosomal recessive, 52	616887	AR	3
617788	11q13.2	Mental retardation, autosomal dominant 51	617788	AD	3
615597	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
616868	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
617840	1p34.2	Combined oxidative phosphorylation deficiency 35	617873	AR	3
616322	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
618107	17q21.31	Osteopetrosis, autosomal dominant 3	618107	AD	3
618086	14q21.2	Spermatogenic failure 28	618086	AR	3
616063	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
618204	8p11.21	Immunodeficiency 15A	618204	AD	3
618482	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
616811	22q12.3	?Combined oxidative phosphorylation deficiency 29	616811	AR	3
617923	4q31.21	[Blood group, Ss]	111740	_	3
617923	4q31.21	{Malaria, resistance to}	611162	_	3
616345	11p15.5	?Immunodeficiency 39	616345	AR	3
613360	1p13.3	Cone-rod dystrophy 21	616502	AR	3
617719	17q25.3	Epiphyseal dysplasia, multiple, 7	617719	AR	3
618218	12q21.2	Baker-Gordon syndrome	618218	AD	3
618184	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
618087	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
615598	18q21.33	Palmoplantar keratoderma, Nagashima type	615598	AR	3
616812	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
617924	6p12.1	{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3
615870	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
618108	6p25.2	Immunodeficiency 57	618108	AR	3
617681	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
617225	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
618088	14q24.3	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3
618185	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
618219	8q22.1	?Polydactyly, postaxial, type A9	618219	AR	3
616294	4q26	Cole-Carpenter syndrome 2	616294	AR	3
616393	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
618205	17p13.1	Snijders Blok-Campeau syndrome	618205	AD	3
614204	2q14.1	Psoriasis 14, pustular	614204	AR	3
617706	16p13.3	?Spermatogenic failure 22	617706	AR	3
616890	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
618315	9q33.3	?Diamond-Blackfan anemia 19	618312	_	3
618073	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
617608	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
615080	6p21.2	Alzheimer disease 17	615080	_	2
618432	11q13.2	Hydatidiform mole, recurrent, 4	618432	_	3
618220	16q22.2	Retinitis pigmentosa 84	618220	AR	3
617911	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
618186	17q21.2	Hypomyelinating neuropathy, congenital, 3	618186	AR	3
618109	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
617721	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
616400	17p13.2	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3
618021	8q23.1	Tetraamelia syndrome 2	618021	AR	3
617925	4q28.1	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3
614205	19q13.32	3-M syndrome 3	614205	AR	3
618433	6q21	Spermatogenic failure 38	618433	AR	3
617592	10q25.1	Spermatogenic failure 19	617592	AR	3
615081	17q21.2	Spermatogenic failure 11	615081	AD	3
617912	20q13.33	Congenital heart defects, multiple types, 5	617912	AR,AD	3
617364	14q12	Congenital heart defects and ectodermal dysplasia	617364	AD	3
618077	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
617822	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
616871	5q35.3	{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3
616323	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
618434	11q14.1	?Deafness, autosomal recessive 94	618434	AR	3
618316	17q25.1	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3
617707	17q22	?Spermatogenic failure 23	617707	AR	3
615082	6p22.1	[C3HEX, ability to smell]	615082	AD	3
617609	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
617686	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
616697	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
618110	14q32.33	?Spermatogenic failure 30	618110	AR	3
618221	12p13.32	Mental retardation, autosomal recessive 66	618221	AR	3
617926	4q28.1	?Orofaciodigital syndrome XVII	617926	AR	3
616402	1p21.2	?Microcephaly 14, primary, autosomal recessive	616402	AR	3
618187	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
617610	3q22.3	Polycystic kidney disease 5	617610	AR	3
618089	2p16.3	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3
616814	19p13.3	Preimplantation embryonic lethality	616814	AR	3
618435	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
618443	16p13.3	Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3
617687	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
618022	8q23.1	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3
617593	3q13.2	?Spermatogenic failure 20	617593	AR	3
617927	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
615922	9q32	Retinitis pigmentosa 70	615922	AD	3
618317	9p13.3	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3
618436	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
618090	2q31.1	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3
616815	17q11.2	Congenital disorder of glycosylation, type IIp	616829	AR	3
618188	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
618222	11q13.2	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3
617709	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
618091	4q12	?Spermatogenic failure 29	618091	AR	3
617825	22q11.21	?Glucocorticoid deficiency 5	617825	AR	3
617710	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
616846	1p36.13	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3
618223	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
614424	2q33.1	Joubert syndrome 14	614424	AR	3
617164	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
617928	2q21.1	Keratoconus 9	617928	AD	3
615923	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
618189	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
617690	9q34.3	Ovarian dysgenesis 5	617690	AR	3
617929	6p21.1	Epileptic encephalopathy, early infantile, 60	617929	AR	3
617965	14q32.2	?Spermatogenic failure 27	617965	AR	3
618092	14q32.2	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3
617691	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
617711	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
615924	11q12.3	Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3
618447	12p13.33	Long QT syndrome 8	618447	_	3
618437	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
617930	1p35	Chromosome 1p35 deletion syndrome	617930	AD	4
618093	16p13.3	?Spinocerebellar ataxia 48	618093	AD	3
617460	10q22.1	Retinitis pigmentosa 79	617460	AD	3
614207	11p15.4	Hyperphosphatasia with mental retardation syndrome 3	614207	AR	3
617712	7q11.23	Oocyte maturation defect 3	617712	AD	3
618438	15q15.1	?Spastic ataxia 9, autosomal recessive	618438	AR	3
617931	1p35.2	Spinocerebellar ataxia 47	617931	AD	3
618094	14q12	?Deafness, autosomal recessive 110	618094	AR	3
614426	8p12	Mental retardation, autosomal recessive 39	615541	AR	3
618112	16q22.2	Spermatogenic failure 31	618112	AR	3
617166	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
618321	13q34	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3
614464	7q32.2	Joubert syndrome 15	614464	AR	3
614427	18q22.3	Aural atresia, congenital	607842	AD	3
618193	6p21.1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	_	3
616654	12q24.31	Joubert syndrome 24	616654	AR	3
618027	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
616254	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
618440	11p15.1	Oculoskeletodental syndrome	618440	AR	3
614218	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
614218	17p13.3	Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3
618323	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
618095	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
617694	16q24.3	Al Kaissi syndrome	617694	AR	3
617933	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
618120	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
617695	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
617306	3p13	COMMAD syndrome	617306	AR	3
618469	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
617913	17p13.3	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3
614219	19p13.2	Adams-Oliver syndrome 2	614219	AR	3
618096	14q21.2	?Premature ovarian failure 15	618096	AR	3
614465	11q12.2	Joubert syndrome 16	614465	AR	3
618470	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
617308	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
614220	7q32	Biliary cirrhosis, primary, 4	614220	_	2
614466	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
614221	17q12	Biliary cirrhosis, primary, 5	614221	_	2
617330	10q26.3	Hypotonia, ataxia, and delayed development syndrome	617330	AD	3
618123	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
618224	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
616039	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
614222	10p12.1	Warburg micro syndrome 3	614222	AR	3
618124	21q22.3	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3
613339	10q21.3-q22.3	Epilepsy, hot water, 1	613339	AD	2
614223	19p13.2	Narcolepsy 6	614223	_	2
618225	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
618195	15q24.3	Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3
616324	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
616067	8q23.1	46XY sex reversal 9	616067	AD	3
614224	4q12	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3
616325	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
618196	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
617967	17p13.3	Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3
616040	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
618449	17q12	?Ciliary dyskinesia, primary, 41	618449	AR	3
617011	15q22.31	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3
618197	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
616326	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
614225	1q41	Warburg micro syndrome 2	614225	AR	3
617333	3p25.3	Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3
616917	4p16.3	Mental retardation, autosomal recessive 53	616917	AR	3
614226	11q24.2	Holoprosencephaly 11	614226	AD	3
616327	13q34	Mental retardation, autosomal dominant 40	616579	AD	3
618198	15q23	Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3
616918	4p16.3	Mental retardation, autosomal recessive 53	616917	AR	3
617970	1p36.11	Rh-null disease, amorph type	617970	_	3
614227	2p22.1-p21	Hyperuricemic nephropathy, familial juvenile, 3	614227	AD	2
617013	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
616042	6p21.1	?Deafness, autosomal recessive 103	616042	AR	3
618226	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
616069	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
618031	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
614228	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
618227	11p15.5	Ciliary dyskinesia, primary, 39	618254	AR	3
614229	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
614230	8q21.11	Chromosome 8q21.11 deletion syndrome	614230	IC,AD	4
618451	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
618228	1q23.3	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3
618229	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
618231	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
618453	7p22.1	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3
618454	7q22.1	Developmental delay with or without dysmorphic facies and autism	618454	AD	3
618455	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
617612	2q37.1	Joubert syndrome 30	617622	AR	3
618232	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
617613	9q21.33	Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3
614082	9p13.3	Fanconi anemia, complementation group G	614082	_	3
618233	5q12.1	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3
614083	2p16.1	Fanconi anemia, complementation group L	614083	AR	3
618234	15q15.1	Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3
617475	17q23.3	Specific granule deficiency 2	617475	AR	3
616404	2p11.2	Acrofacial dysostosis, Cincinnati type	616462	AD	3
616050	2p22.3	Autoinflammation with infantile enterocolitis	616050	AD	3
616051	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
616052	7p21.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3
614084	7q34	Oocyte maturation defect 5	617996	AR	3
618475	14q24.3	Paragangliomas 7	618475	AD	3
618476	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
618477	15q25.3	[Uridine-cytidineuria]	618477	AR	3
618479	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
618480	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
603859	7q21.3	Citrullinemia, adult-onset type II	603471	AR	3
603859	7q21.3	Citrullinemia, type II, neonatal-onset	605814	AR	3
606202	5p13.2	Albinism, oculocutaneous, type IV	606574	_	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	AR	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	AR	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	AR	3
605225	1p36	{Inflammatory bowel disease 7}	605225	_	2
604584	8p22	Colorectal cancer, somatic	114500	_	3
604584	8p22	Hepatocellular cancer, somatic	114550	_	3
607036	15q15.1	Isovaleric acidemia	243500	AR	3
604004	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603848	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
604983	17q23.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3
607072	3p21.31	Epilepsy, familial focal, with variable foci 2	617116	AD	3
603694	20q12-q13.1	{Diabetes mellitus, noninsulin-dependent}	125853	AD	2
604499	11p	Hyperlipidemia, combined, 2	604499	_	2
607250	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
604566	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
605236	4p12	Preeclampsia/eclampsia 5	614595	_	3
606236	17q25.3	Alveolar soft-part sarcoma	606243	_	3
603113	11q23.1	Lung cancer, somatic	211980	_	3
606608	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
607292	1q22	Cone-rod dystrophy 10	610283	AR	3
607292	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
606960	22q12.1-q12.2	Insulinoma	_	_	1
603707	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
607131	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
603495	19q13.43	Spermatogenic failure 5	243060	AR	3
605725	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
605725	19q13.2	Dejerine-Sottas disease	145900	AR,AD	3
605425	1p34.3	Erythrokeratodermia variabilis et progressiva 2	617524	AD	3
606053	2q24.2	Intellectual developmental disorder with autism and speech delay	606053	AD	3
604286	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
604484	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
605383	16p12.1	Immunodeficiency 56	615207	AR	3
605383	16p12.1	[IgE, elevated level of]	147050	AD	3
606635	21q21.1	Enterokinase deficiency	226200	AR	3
607479	18p11.22	Hypotrichosis 1	605389	AD	3
604433	11q13.4	?Brugada syndrome 6	613119	_	3
606763	19q13.42	Ciliary dyskinesia, primary, 2	606763	AR	3
605275	22q11.21	Noonan syndrome 2	605275	AR	3
606686	12q24.31	Leukoencephalopathy with vanishing white matter	603896	AR	3
606425	1q42.2	Erythrocytosis, familial, 3	609820	AD	3
606425	1q42.2	[Hemoglobin, high altitude adaptation]	609070	AD	3
602926	9q34.11	Epileptic encephalopathy, early infantile, 4	612164	AD	3
605073	17q22	Mulibrey nanism	253250	AR	3
604973	1p36.11	Immunodeficiency due to ficolin 3 deficiency	613860	AR	3
607408	13q33.2	{Schizophrenia}	181500	AD	2
606985	11p13	?Aniridia 2	617141	AD	3
607037	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
606566	20q11.21	Cardiomyopathy, hypertrophic, 1, digenic	192600	AD	3
605286	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
605872	19p13.2	SARS infection, protection against	605872	_	2
604258	8p22	Colorectal cancer, somatic	114500	_	3
605226	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
605115	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
606077	1p13.3	Megakaryoblastic leukemia, acute	606077	_	2
607447	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
607623	18q11.2	Niemann-Pick disease, type C1	257220	AR	3
607623	18q11.2	Niemann-Pick disease, type D	257220	AR	3
607170	3p25.3	Atrioventricular septal defect, partial, with heterotaxy syndrome	606217	AD	3
607170	3p25.3	{Atrioventricular septal defect, susceptibility to, 2}	606217	AD	3
605543	4q22.1	Parkinson disease 4	605543	AD	3
604455	9q34.2	[Sarcosinemia]	268900	AR	3
607361	8q22.1	Meckel syndrome 3	607361	AR	3
605336	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AR,AD	3
605336	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
606609	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AR,AD	3
606609	3p21.31	Chilblain lupus	610448	AD	3
606609	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
606609	3p21.31	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
605755	6p22.3	?Deafness, autosomal recessive 66	610212	AR	3
605755	6p22.3	Nephronophthisis 19	616217	AR	3
605755	6p22.3	Sclerosing cholangitis, neonatal	617394	AR	3
605692	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
607143	22q13.33	Congenital disorder of glycosylation, type Ig	607143	AR	3
604485	15q23	Enhanced S-cone syndrome	268100	AR	3
604485	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
606974	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
605978	9q21.2	Choreoacanthocytosis	200150	AR	3
606367	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
607839	3p12.2	Glycogen storage disease IV	232500	AR	3
607839	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
604190	5q31.1	{Rheumatoid arthritis, susceptibility to}	180300	_	3
607084	9q32	Deafness, autosomal recessive 31	607084	AR	3
607236	20p13	HARP syndrome	607236	AR	3
603860	16p12.3	Medullary cystic kidney disease 2	603860	_	3
605564	15q25.1	Deafness, autosomal recessive 48	609439	AR	3
605564	15q25.1	Usher syndrome, type IJ	614869	AR	3
608031	20p13	Amyotrophic lateral sclerosis 7	608031	_	2
605254	1q23.2	Acne inversa, familial, 1	142690	AD	3
605726	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
606323	5q33.3	Epileptic encephalopathy, early infantile, 65	618008	AD	3
605158	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
604720	7q22.1	Hemochromatosis, type 3	604250	AR	3
607329	2p25-p24	{Hypertension, essential, susceptibility to, 3}	145500	Mu	2
607186	4q26	Cole-Carpenter syndrome 2	616294	AR	3
605526	10q24	Alzheimer disease 6	605526	_	2
604610	15q26.1	Bloom syndrome	210900	AR	3
603422	5q31.1	{Osteoporosis, susceptibility to}	166710	AD	3
603023	7p12.2	Immunodeficiency, common variable, 13	616873	AD	3
605325	7q22.1	{Hypertension, salt-sensitive essential, susceptibility to}	145500	Mu	3
606078	22q13.1-q13.2	Megakaryoblastic leukemia, acute	_	_	3
604500	17q12	PEHO syndrome	260565	AR	3
607252	22q12.3	{Schizophrenia}	181500	AD	1
603048	8q24.3	Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3
604032	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
608111	2p16.1	Fanconi anemia, complementation group L	614083	AR	3
607204	1p35.2	Spinocerebellar ataxia 47	617931	AD	3
606962	17q25.1	Deafness, autosomal recessive 107	617639	AR	3
605517	11q13.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3
605452	2q35	Dyschromatosis universalis hereditaria 3	615402	AD	3
605452	2q35	Microphthalmia, isolated, with coloboma 7	614497	AD	3
605452	2q35	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	3
605452	2q35	[Blood group, Langereis system]	111600	_	3
604360	15q21.1	Spastic paraplegia 11, autosomal recessive	604360	AR	3
608264	22q11.21-q12.1	Deafness, autosomal recessive 40	608264	AR	2
607215	1p36.31	Nephronophthisis 4	606966	AR	3
607215	1p36.31	Senior-Loken syndrome 4	606996	AR	3
608309	1p36.12	Parkinson disease 6, early onset	605909	AR	3
603131	7q22.1	Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3
607038	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
604288	2q14-q22	Cardiomyopathy, dilated, 1H	604288	_	2
606368	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
606368	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
608035	1p22	{Melanoma, cutaneous malignant, 4}	608035	_	2
605185	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
607900	20p12.3	Kindler syndrome	173650	AR	3
605411	1p13.2	Brugada syndrome 9	616399	AD	3
605411	1p13.2	Spinocerebellar ataxia 19	607346	AD	3
604975	12p12.1	Lamb-Shaffer syndrome	616803	AD	3
608156	8q22.1	Nablus mask-like facial syndrome	608156	AD	4
603967	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
603967	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
603967	17q23.3	Myasthenic syndrome, congenital, 16	614198	AR	3
603967	17q23.3	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3
603967	17q23.3	Paramyotonia congenita	168300	AD	3
607521	11p15.1	Hermansky-Pudlak syndrome 5	614074	AR	3
608205	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
607624	15q21.3	Griscelli syndrome, type 2	607624	AR	3
605100	17q23.2	Breast cancer, somatic	114480	_	3
605100	17q23.2	Jansen de Vries syndrome	617450	AD	3
607135	3p	Creatinine clearance QTL	607135	_	2
606324	1p36.23	Parkinson disease 7, autosomal recessive early-onset	606324	AR	3
604772	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
603861	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
604103	5q31.2	Myopathy, myofibrillar, 3	609200	AD	3
604103	5q31.2	Myopathy, spheroid body	182920	AD	3
605848	19p13.12	Ichthyosis, congenital, autosomal recessive 12	617320	AR	3
605124	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
603457	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
603474	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
605039	20q11.21	Bohring-Opitz syndrome	605039	AD	3
604900	8q24.3	?Diarrhea 7, protein-losing enteropathy type	615863	AR	3
606142	4p16.1	Hypouricemia, renal, 2	612076	AR,AD	3
606142	4p16.1	{Uric acid concentration, serum, QTL 2}	612076	AR,AD	3
607481	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
606882	13q14.3	Wilson disease	277900	AR	3
603767	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
604501	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
604501	15q22.31	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3
608078	10q22.3	{Schizophrenia}	181500	AD	2
605938	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
603615	1p34.1	Adenocarcinoma, colonic, somatic	_	_	3
603615	1p34.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
603615	1p34.1	{Breast cancer, invasive ductal}	114480	SMu,AD	3
603516	22q13.31	Spinocerebellar ataxia 10	603516	AD	3
605000	16p11.2	Immunodeficiency 8	615401	AR	3
608429	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
604705	2q13	Retinitis pigmentosa 38	613862	AR	3
606056	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
606963	2q	Pulmonary disease, chronic obstructive, severe early-onset	606963	_	2
606829	9q21.11	Friedreich ataxia	229300	AR	3
606829	9q21.11	Friedreich ataxia with retained reflexes	229300	AR	3
604990	17q25.1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3
603010	7q31	Deafness, autosomal recessive 17	603010	AR	2
606407	2p21	Hypotonia-cystinuria syndrome	606407	AR	4
604297	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
604297	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
608414	10q23.33	Nephrotic syndrome, type 3	610725	AR	3
605727	7q34-q36	Otosclerosis 2	605727	_	2
606568	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
608310	7q11.21	Argininosuccinic aciduria	207900	AR	3
603290	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
604457	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
604457	2q37.1	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
607901	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
606034	19p13.13	Aicardi-Goutieres syndrome 4	610333	AR	3
605544	5q13-q22	Fibromatosis, gingival, 2	605544	_	2
604841	1p21.1	Stickler syndrome, type II	604841	AD	3
606687	2p23.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606687	2p23.3	Ovarioleukodystrophy	603896	AR	3
606854	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
606639	3q25.32	Combined oxidative phosphorylation deficiency 1	609060	AR	3
608265	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
607039	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
608036	5q34-q35.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	2
604588	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	AR,DR	3
604588	4q33	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3
607625	14q24.3	Niemann-pick disease, type C2	607625	AR	3
604611	8p12	Werner syndrome	277700	AR	3
608371	4q21-q31	Orofacial cleft 4	608371	_	2
608533	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
605289	3q28	Split-hand/foot malformation 4	605289	AD	3
608112	3p22.1	Epileptic encephalopathy, early infantile, 68	618201	AR	3
604773	11q25	Isobutyryl-CoA dehydrogenase deficiency	611283	_	3
608241	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
606999	9p13.3	Galactosemia	230400	AR	3
608331	5q33.1	Hyperglycinuria	138500	AD	3
608331	5q33.1	Iminoglycinuria, digenic	242600	AR,DR	3
608283	12q12	Fibrosis of extraocular muscles, congenital, 1	135700	AD	3
608283	12q12	Fibrosis of extraocular muscles, congenital, 3B	135700	AD	3
605101	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
606988	15q15.1	?Spastic ataxia 9, autosomal recessive	618438	AR	3
608100	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
604901	16q22	North American Indian childhood cirrhosis	604901	_	2
606475	19p13.2	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	_	3
604289	8q22.1	Colon cancer, somatic	114500	_	3
604289	8q22.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
603056	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
608443	19p13.12	Mental retardation, autosomal recessive 3	608443	AR	3
607053	8q23	[High density lipoprotein cholesterol level QTL 2]	607053	_	2
604526	20p13	Retinitis pigmentosa 46	612572	_	3
605714	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
603517	1p22.3	?Immunodeficiency 37	616098	AR	3
603517	1p22.3	Lymphoma, MALT, somatic	137245	_	3
603517	1p22.3	{Lymphoma, follicular, somatic}	605027	_	3
603517	1p22.3	{Male germ cell tumor, somatic}	273300	_	3
603517	1p22.3	{Mesothelioma, somatic}	156240	_	3
603517	1p22.3	{Sezary syndrome, somatic}	_	_	3
606370	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
607482	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
607411	12q24	{Patent ductus arteriosus, susceptibility to}	607411	AR	2
606062	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
606640	18q21	Amyotrophic lateral sclerosis 3	606640	AD	2
606830	9q21.33	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3
606035	6q22-q24	[Fasting insulin level quantitative trait locus 1]	606035	_	2
605728	15q21-q22	Cataract 25	605728	_	2
603024	1p36.11	Coffin-Siris syndrome 2	614607	AD	3
608645	6p21.3	Deafness, autosomal dominant 31	608645	AD	2
607364	1p36.13	Bartter syndrome, type 3	607364	AR	3
607961	15q24.1	[Blood group, John-Milton-Hagen system]	614745	_	3
602959	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
602959	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
606144	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
608695	9q22	Glaucoma, primary open angle, juvenile-onset, 2	608695	_	2
606408	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
607040	16q12.1	[Axillary odor, variation in]	117800	AD	3
607040	16q12.1	[Colostrum secretion, variation in]	117800	AD	3
607040	16q12.1	[Earwax, wet/dry]	117800	AD	3
604159	11p15.1	Hyperekplexia 3	614618	AR,AD	3
606129	8p23.3-p22	Diamond-Blackfan anemia 2	606129	_	2
603850	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
603850	12p11.21	Optic atrophy 5	610708	AD	3
602935	1p33	{Drug addiction, susceptibility to}	606581	_	3
605849	5q14.1	Dimethylglycine dehydrogenase deficiency	605850	AR	3
606325	6q21	?Heterotaxy, visceral, 3, autosomal	606325	_	2
605290	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
605290	3q29	Behr syndrome	210000	AR	3
605290	3q29	Optic atrophy 1	165500	AD	3
605290	3q29	Optic atrophy plus syndrome	125250	AD	3
605290	3q29	{Glaucoma, normal tension, susceptibility to}	606657	_	3
608480	6p21.31	Spermatogenic failure 3	606766	AD	3
608271	1p34.3	Lissencephaly 9 with complex brainstem malformation	618325	AD	3
606883	12q12	Invasive pneumococcal disease, recurrent isolated, 1	610799	_	3
606883	12q12	IRAK4 deficiency	607676	_	3
604723	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
606476	19q13.2	{Kawasaki disease, susceptibility to}	611775	_	3
608010	7p13	[Ezetimibe, nonresponse to]	617966	_	3
608010	7p13	[Low density lipoprotein cholesterol level QTL 7]	617966	_	3
606551	8p21.3	Esophageal squamous cell carcinoma, somatic	133239	_	3
608633	11q22.3	{Sepsis, susceptibility to}	_	_	3
604902	14q32.33	Cerebellofaciodental syndrome	616202	AR	3
605267	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
607823	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
605361	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
608603	15q21.2	Lethal congenital contracture syndrome 11	617194	AR	3
603883	10q26.11	Cardiomyopathy, dilated, 1HH	613881	AD	3
603883	10q26.11	Myopathy, myofibrillar, 6	612954	AD	3
608723	6p24.1	Epileptic encephalopathy, early infantile, 70	618298	AD	3
607903	18q12.1	Hypotrichosis 6	607903	AR	3
606036	15q25.1	?Webb-Dattani syndrome	615926	AR	3
608390	17q23.3	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3
607136	6q27	Spinocerebellar ataxia 17	607136	AD	3
603057	11p15.4	Mitral valve prolapse 2	607829	AD	3
603057	11p15.4	Van Maldergem syndrome 1	601390	AR	3
603025	11q14.2	Leukemia, acute myeloid, somatic	601626	_	3
606831	2p22.3	?Familial cold autoinflammatory syndrome 4	616115	AD	3
606831	2p22.3	Autoinflammation with infantile enterocolitis	616050	AD	3
606641	7q32.3	[Body mass index QTL1]	606641	_	2
608177	8q24.11	Chondrosarcoma	215300	AR	3
608177	8q24.11	Exostoses, multiple, type 1	133700	AD	3
608646	15q13.1-q15.1	Ciliary dyskinesia, primary, 4	608646	_	2
607311	11q22.1	?Progesterone resistance	264080	AR	2
603254	19p13.2	Coffin-Siris syndrome 4	614609	AD	3
603254	19p13.2	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3
605850	5q14.1	Dimethylglycine dehydrogenase deficiency	605850	AR	3
607453	3q28	?Deafness, autosomal dominant 44	607453	AD	3
606269	22q13.2	Immunodeficiency, common variable, 4	613494	AR	3
606409	20q11.22	Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3
603769	14q32.13	Leukemia/lymphoma, T-cell	603769	_	2
607365	3q27.2	Hypotrichosis 7	604379	AR	3
607365	3q27.2	Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379	AR	3
603851	4p13	Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	AD	3
603851	4p13	Neuroblastoma with Hirschsprung disease	613013	_	3
603851	4p13	{Neuroblastoma, susceptibility to, 2}	613013	_	3
607626	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
608634	7q11.23	Neuropathy, distal hereditary motor, type IIB	608634	AD	3
603678	7q31	Deafness, autosomal recessive 14	603678	AR	2
608416	10q26.2	Heterotaxy, visceral, 7, autosomal	616749	AR	3
605670	11q23.3	Retinal degeneration, late-onset, autosomal dominant	605670	AD	3
605744	8p21.1	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3
605268	16q24.2	Huntington disease-like 2	606438	AD	3
606966	1p36.31	Nephronophthisis 4	606966	AR	3
606989	17q22	Myeloperoxidase deficiency	254600	AR	3
606989	17q22	{Alzheimer disease, susceptibility to}	104300	AD	3
606989	17q22	{Lung cancer, protection against, in smokers}	_	_	3
608256	11q23.3	Atrial fibrillation, familial, 17	611819	AD	3
608256	11q23.3	Long QT syndrome-10	611819	AD	3
607276	10q25.3	[Resting heart rate]	607276	_	3
606145	20q13.12	Arterial tortuosity syndrome	208050	AR	3
605362	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
607243	14q12	Spastic paraplegia 52, autosomal recessive	614067	AR	3
608243	15q13.1	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3
608391	Chr.7	{Autoimmune disease, susceptibility to, 2}	608391	_	2
607137	4q21.22	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3
603026	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
606326	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
606037	3q13.1-q13.2	C syndrome	211750	AD	3
606754	20q11.23	?Chilblain lupus 2	614415	AD	3
606754	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
608313	6q23.2	Argininemia	207800	AR	3
608696	20p12	Glaucoma 1K, primary open angle, juvenile-onset	608696	_	2
605555	11q13.2	Pituitary adenoma 1, multiple types	102200	SMu,AD	3
605555	11q13.2	Pituitary adenoma predisposition	102200	SMu,AD	3
607454	1p36.33	Spinocerebellar ataxia 21	607454	AD	3
604088	7p14.3	{Hypercholesterolemia, susceptibility to}	143890	AD	3
607042	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
608272	6p21.33	Sialidosis, type I	256550	AR	3
608272	6p21.33	Sialidosis, type II	256550	AR	3
608647	16q22.2	Ciliary dyskinesia, primary, 5	608647	AR	3
603258	8p11.21	Immunodeficiency 15A	618204	AD	3
603258	8p11.21	Immunodeficiency 15B	615592	AR	3
606570	7p14.1	Pyle disease	265900	AR	3
606781	3p21.1	Short stature, developmental delay, and congenital heart defects	617044	AR	3
607984	5q31.3	Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3
608565	14q24.3	Deafness, autosomal recessive 35	608565	AR	3
608980	9p22.3	Bifid nose with or without anorectal and renal anomalies	608980	_	3
608662	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
608662	11p14.3	Miyoshi muscular dystrophy 3	613319	AR	3
608662	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
606478	7q31.33	{Glioma susceptibility 9}	616568	AD	3
606478	7q31.33	{Melanoma, cutaneous malignant, susceptibility to, 10}	615848	AD	3
608380	2q31.3	Retinitis pigmentosa 26	608380	_	3
607008	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
603518	2p13.3	Welander distal myopathy	604454	AR,AD	3
609040	12p11.21	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3
604714	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
608536	19p13.11	Combined oxidative phosphorylation deficiency 23	616198	AR	3
608803	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608803	1q42.13	Lymphatic malformation 3	613480	AD	3
608803	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
606990	3q23	?Microcephaly 19, primary, autosomal recessive	617800	AR	3
605363	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
608392	Chr.8	{Autoimmune disease, susceptibility to, 3}	608392	_	2
606967	16q22.1	Fish-eye disease	136120	AR	3
606967	16q22.1	Norum disease	245900	AR	3
607244	15q21.2	Spastic paraplegia 51, autosomal recessive	613744	AR	3
607244	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
608744	1p13.3	Fontaine progeroid syndrome	612289	AD	3
606833	7q36.1	Kleefstra syndrome 2	617768	AD	3
608697	2p13.3	Premature ovarian failure 6	612310	AD	3
608611	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
605229	3q27-q28	Spastic paraplegia 14, autosomal recessive	605229	AR	2
603136	2q36.2	Pseudohypoaldosteronism, type IIE	614496	AD	3
608684	14q22.1	?Seckel syndrome 7	614851	AR	3
605988	10p13	Omenn syndrome	603554	AR	3
605988	10p13	Severe combined immunodeficiency, Athabascan type	602450	AR	3
603644	17p13.1	Mitochondrial complex IV deficiency	220110	Mi,AR	3
608918	17p11.2	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3
607277	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
607043	6q21	?Candidiasis, familial, 8	615527	AR	3
607043	6q21	{Psoriasis susceptibility 13}	614070	_	3
606373	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
606421	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
606271	1q42.2	Schizophrenia	181500	AD	2
607474	3q13.33	Alkaptonuria	203500	AR	3
606520	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
609247	3q25.1	Epileptic encephalopathy, early infantile, 73	618379	AD	3
606837	8q11.23	Breast cancer, somatic	114480	_	3
607009	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
604824	13q13.1	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	_	3
608663	12q12	Scott syndrome	262890	AR	3
603339	7p15.3	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3
606643	13q14	[Body mass index QTL2]	606643	_	2
608648	6q21	Polycystic liver disease 2	617004	AD	3
609141	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
606890	14q31.3	Krabbe disease	245200	AR	3
604715	16q12.2	?Orthostatic intolerance	604715	_	3
606834	19q13.12	Dystonia 28, childhood-onset	617284	AD	3
608445	3p12-q13	{Speech-sound disorder}	608445	_	2
607245	1p13.2	Spastic paraplegia 47, autosomal recessive	614066	AR	3
605588	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
605041	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
607840	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
607840	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
604757	5q35.2	Craniosynostosis 2	604757	AD	3
605032	4p16.3	Epileptic encephalopathy, early infantile, 63	617976	AR	3
609382	18q21.1	Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3
608526	1q25	Periodontitis, aggressive, 2	608526	_	2
608393	13q12.12-q12.13	Microcephaly 6, primary, autosomal recessive	608393	AR	3
607278	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
609302	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
609195	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
604487	11p15.1	Deafness, autosomal recessive 18B	614945	AR	3
608013	1q22	Gaucher disease, perinatal lethal	608013	AR	3
607475	15q26.1	Bothnia retinal dystrophy	607475	AR	3
608636	15q11	{Autism susceptibility 4}	608636	AD	2
608354	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
607323	20q13.2	Duane-radial ray syndrome	607323	AD	3
608194	14q11.2	Cone-rod dystrophy 13	608194	_	3
606628	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
609053	15q26.1	Fanconi anemia, complementation group I	609053	AR	3
605270	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
609628	18p11.31	Majeed syndrome	609628	_	3
608419	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
606480	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
606480	1p34.2	Restrictive dermopathy, lethal	275210	AR	3
604161	19p13.3	?Precocious puberty, central, 1	176400	AD	3
604161	19p13.3	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3
604758	19q13.32	?Immunodeficiency 53	617585	AR	3
608699	7p14.3	Diaphanospondylodysostosis	608022	AR	3
607279	11q14	{Systemic lupus erythematosus with hemolytic anemia}	607279	_	2
605589	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
603646	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
603646	10q24.2	Leigh syndrome due to cytochrome c oxidase deficiency	256000	Mi,AR	3
603424	2q31.2	Dystonia 16	612067	AR	3
607246	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
608897	17q25.1	Hemophagocytic lymphohistiocytosis, familial, 3	608898	_	3
605042	6q23.2	Mental retardation, autosomal recessive 18	614249	AR	3
609196	21q22.11	Glucocorticoid deficiency 2	607398	AR	3
609657	5q	{Bone size QTL}	609657	_	2
604488	17q12	Cardiomyopathy, hypertrophic, 25	607487	AD	3
604488	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
603060	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
609510	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
607476	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
609314	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
609449	16p13.11	?Microhydranencephaly	605013	AR	3
609449	16p13.11	Lissencephaly 4 (with microcephaly)	614019	AR	3
608572	18q23	Burn-McKeown syndrome	608572	AR	3
609750	10q25-q26	{Epilepsy, idiopathic generalized, susceptibility to 4}	609750	_	2
608804	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608990	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
608890	8q11.21	Waardenburg syndrome, type 2D	608890	AR	3
609332	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
608433	1q44	Mental retardation, autosomal dominant 22	612337	AD	3
605364	19p13	{Psoriasis susceptibility 6}	605364	_	2
609279	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
609279	13q12.12-q12.13	Microcephaly 6, primary, autosomal recessive	608393	AR	3
608151	4p14	?Cranioectodermal dysplasia 4	614378	AR	3
608151	4p14	?Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3
608151	4p14	Nephronophthisis 13	614377	AR	3
608151	4p14	Senior-Loken syndrome 8	616307	AR	3
606374	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
607324	19p13.2-p13.1	Polydactyly, postaxial, type A3	607324	_	2
609575	17p13.1	VLCAD deficiency	201475	AR	3
608665	17q21.2	Ovarian dysgenesis 3	614324	AR	3
609383	5q33.3	Ichthyosis, congenital, autosomal recessive 6	612281	AR	3
604759	12q23.2	Pregnancy loss, recurrent, 4	270960	AD	3
604759	12q23.2	Spermatogenic failure 4	270960	AD	3
609669	5q22.1	Glaucoma 1, open angle, G	609887	_	3
609237	3q13.33	Senior-Loken syndrome 5	609254	AR	3
608394	2p12	Deafness, autosomal dominant 43	608394	AD	2
607631	6p12.2	{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3
608649	9q34.11	Ichthyosis prematurity syndrome	608649	_	3
609435	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
609435	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
604717	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
606765	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
605602	4q26	Cardiomyopathy, hypertrophic, 16	613838	AD	3
603708	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
609528	22q11.21	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3
608022	7p14.3	Diaphanospondylodysostosis	608022	AR	3
608179	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
609695	12q24.31	Hawkinsinuria	140350	AD	3
609695	12q24.31	Tyrosinemia, type III	276710	AR	3
603647	2q35	Bjornstad syndrome	262000	AR	3
603647	2q35	GRACILE syndrome	603358	_	3
603647	2q35	Leigh syndrome	256000	Mi,AR	3
603647	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
609454	1q31.1	Supranuclear palsy, progressive, 2	609454	AD	2
609736	2p16.1	?PEHO syndrome-like	617507	AR	3
608700	1p36.22	Leber congenital amaurosis 9	608553	AR	3
605231	20p12.2	Bardet-Biedl syndrome 6	605231	AR	3
608014	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
608014	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
609197	8q11.2-q13.2	Glucocorticoid deficiency 3	609197	AR	2
606893	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
608805	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
609640	14q22.1-q22.3	Frias syndrome	609640	AD	4
608901	3q21.1-q21.2	{Coronary heart disease, susceptibility to, 5}	608901	_	3
608747	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
609670	11q24	{Migraine with aura, susceptibility to, 9}	609670	_	2
609280	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
608666	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
608666	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
604083	2q35	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3
603709	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
609988	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
609988	4q24	Sudden cardiac failure, infantile	617222	AR	3
608728	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
609529	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
608612	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
609751	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
610066	20q13	{Systemic lupus erythematosus, susceptibility to, 8}	610066	_	2
603266	10q25	{Diabetes mellitus, insulin-dependent, 17}	603266	_	2
606766	6p21.31	Spermatogenic failure 3	606766	AD	3
607248	15q23-q26.3	{Glioma susceptibility 4}	607248	_	2
607179	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
605232	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
605232	12p13.33	Pseudohypoaldosteronism, type IIC	614492	AD	3
608404	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
609346	19p13.3	Retinitis pigmentosa 77	617304	AR	3
608687	11q12	Spinocerebellar ataxia 20	608687	AD	4
604733	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
609512	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
609512	3p11.2	Dementia, familial, nonspecific	600795	AD	3
609289	15q26	Syncope, familial vasovagal	609289	AD	2
609630	11p11	{Leukemia, chronic lymphocytic, susceptibility to, 1}	609630	_	2
607326	18q21.1	Smith-McCort dysplasia	607326	AR	3
609502	10q23.1	Cone-rod dystrophy 15	613660	AR	3
609502	10q23.1	Retinitis pigmentosa 65	613660	AR	3
609671	2q14.2	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3
608667	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
608751	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AR,AD	3
609875	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
608922	3q11.1-q11.2	Joubert syndrome 8	612291	AR	3
610202	16q23.2	Cataract 21, multiple types	610202	AD	3
608892	8q12.2	CHARGE syndrome	214800	AD	3
608892	8q12.2	Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3
610034	12q24.31	Mucopolysaccharidosis-plus syndrome	617303	AR	3
610219	2q31.2	Deafness, autosomal recessive 59	610220	AR	3
609530	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
608447	12q24	Carotid intimal medial thickness	608447	_	2
609822	1p21	{Stature QTL 7}	609822	_	2
608180	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
610015	1q25.3	Glutamine deficiency, congenital	610015	AR	3
604364	22q12.2-q12.3	Epilepsy, familial focal, with variable foci 1	604364	AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal dominant	615625	AR,AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal recessive	615625	AR,AD	3
610239	4q32.3	[High density lipoprotein cholesterol level QTL 4]	610239	_	2
609317	5q22.3	?Anencephaly	206500	AR	3
610513	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
610513	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
610256	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
609787	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
603400	6q21	Arthropathy, progressive pseudorheumatoid, of childhood	208230	AR	3
603400	6q21	Spondyloepiphyseal dysplasia tarda with progressive arthropathy	208230	AR	3
610535	5q22.1-q32	Glaucoma 1, open angle, M	610535	AD	2
608668	10p15.3	Mental retardation, autosomal dominant 30	616083	AD	3
610475	2q31.2	Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3
608893	5p15.33	Hartnup disorder	234500	AR	3
608893	5p15.33	Hyperglycinuria	138500	AD	3
608893	5p15.33	Iminoglycinuria, digenic	242600	AR,DR	3
604982	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
608752	11q23.3	Retinal degeneration, late-onset, autosomal dominant	605670	AD	3
609886	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
610162	1p35.2	{Bardet-Biedl syndrome 1, modifier of}	209900	AR,DR	3
608614	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
610035	1q21.2	Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3
610220	2q31.2	Deafness, autosomal recessive 59	610220	AR	3
608688	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
604677	5q13.3	Mental retardation, autosomal dominant 34	616351	AD	3
610647	4p16.3	?N-acetylaspartate deficiency	614063	AR	3
609631	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
607632	19q13.12	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3
610271	17q11.2	Glycosylphosphatidylinositol biosynthesis defect 18	618143	AR	3
609823	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
610140	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
609470	11p15	Left ventricular noncompaction 2	609470	_	2
603401	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
603711	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
603711	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
608396	3q24	{?Autism susceptibility 16}	613410	_	3
605746	16q13-q21	Anisomastia	605746	_	2
610069	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
605235	16q22.1	?Myoclonus, familial, 1	614937	AD	3
610685	6q14.1	Split-hand/foot malformation with long bone deficiency 2	610685	_	2
610840	13q31.3-q32.1	Mitral valve prolapse, myxomatous 3	610840	AD	2
609006	1p36.31	Deafness, autosomal recessive 36	609006	AR	3
608730	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
610859	16q22.1	Immunodeficiency 58	618131	AR	3
610536	17q21.31	Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3
607841	12q13-q14	Deafness, autosomal dominant 48	607841	AD	2
610648	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
610662	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
610359	2q11.2	Retinitis pigmentosa 33	610359	AD	3
609439	15q25.1	Deafness, autosomal recessive 48	609439	AR	3
609577	6p21.1	3-M syndrome 1	273750	AR	3
608187	20p12.3	?Premature ovarian failure 10	612885	AR	3
610804	1p31.3	Schneckenbecken dysplasia	269250	AR	3
610017	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
610222	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
608652	9p22-p21	Deafness, autosomal dominant 47	608652	AD	2
610141	1q23.3	[QT interval, variation in]	610141	_	2
610272	20q13.12	?Paroxysmal nocturnal hemoglobinuria 2	615399	SMu,AD	3
610272	20q13.12	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3
609887	5q22.1	Glaucoma 1, open angle, G	609887	_	3
608691	15q25.3-q26.2	Major depressive disorder 2	608516	_	2
609952	4q12-q13.2	Deafness, autosomal recessive 55	609952	AR	2
608840	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	AR	3
609753	19p13.11	{Celiac disease, susceptibility to, 4}	609753	_	3
611023	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
607633	2p23.1	Xanthinuria, type I	278300	AR	3
609745	15q11-q13	Glaucoma 1, open angle, I	609745	_	2
609007	12q12	{Parkinson disease 8}	607060	AD	3
610649	8q24	[Bone size quantitative trait locus 3]	610649	_	2
609578	10q23.3	Cardiomyopathy, familial restrictive, 2	609578	_	2
611064	12q14.3	{Asthma susceptibility 5}	611064	_	3
611034	6p22.2	[Uric acid concentration, serum, QTL4]	612671	AD	3
611034	6p22.2	{Gout susceptibility 4}	612671	AD	3
603846	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
609888	10p13	{Leprosy, paucibacillary type, susceptibility to}	609888	_	2
608615	17q24.1	Oligodontia-colorectal cancer syndrome	608615	AD	3
610549	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
606075	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
606075	10q24.31	Perrault syndrome 5	616138	AR	3
606075	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
609471	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
610676	17q21	{Autism susceptibility 7}	610676	_	2
609754	5q31-q33	{Celiac disease, susceptibility to, 2}	609754	_	2
607634	11q13.2	Osteopetrosis, autosomal dominant 1	607634	AD	3
610290	9q22.33	{Colorectal cancer, susceptibility to, 1}	608812	_	3
610326	13q14.3	Aicardi-Goutieres syndrome 2	610181	AR	3
608841	19p13.11	Anterior segment dysgenesis 8	617319	AR	3
610071	2p14-p13.3	Hyperparathyroidism 3	610071	_	2
611065	4q22.1	?Maple syrup urine disease, mild variant	615135	_	3
609856	3q26.31	?Spermatogenic failure 6	102530	AR	3
608732	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
606164	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
611177	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
609981	8q11.21	Immunodeficiency 54	609981	AR	3
609755	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
611107	1p21.1-p13.3	Mental retardation, autosomal recessive, 4	611107	AR	2
610478	12p13.33	Retinal cone dystrophy 4	610478	AR	3
610550	10q22.3	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850	AR,AD	3
610550	10q22.3	Methionine adenosyltransferase deficiency, autosomal recessive	250850	AR,AD	3
608653	1p21.2	Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3
607012	5q13.2	?Deafness, autosomal recessive 112	618257	AR	3
610260	16p13-p12	Pyloric stenosis, infantile hypertrophic, 2	610260	_	2
610453	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
610453	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
609653	5q12.1	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3
609797	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
609797	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3
611225	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
610965	16p13.12	XFE progeroid syndrome	610965	AR	3
611302	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
609954	3p24-p21	{Asperger syndrome susceptibility 4}	609954	_	2
610860	1p21.2	Glycogen storage disease IIIa	232400	AR	3
610860	1p21.2	Glycogen storage disease IIIb	232400	AR	3
610931	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
608400	1q41	Retinitis pigmentosa 39	613809	_	3
608400	1q41	Usher syndrome, type 2A	276901	AR	3
610516	3p21.2	D-glyceric aciduria	220120	AR	3
609579	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
610551	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
609955	2p23.3-p22.3	Fibromatosis, gingival, 3	609955	_	2
611378	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
611423	4q12	Microcephaly 8, primary, autosomal recessive	614673	AR	3
610655	7p14	Telangiectasia, hereditary hemorrhagic, type 4	610655	AD	2
605763	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
610753	16q11-q22	Alopecia areata 2	610753	AR,AD	2
611109	4q32.3	[Cinnamon odor, pleasantness of]	611109	_	2
604741	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
611037	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
604165	17p13.2	Paragangliomas 6	618464	AD	3
610966	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
610966	16q12.2	{Obesity, susceptibility to, BMIQ14}	612460	AR	3
605130	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
610706	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
610665	1q23.3	Neutropenia, alloimmune neonatal	_	_	3
609790	9p22.1	Alzheimer disease-11	609790	_	2
610019	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
611642	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3
611642	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	AD	3
611291	2q35	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	_	3
611654	8q13.1-q13.2	Joubert syndrome 21	615636	AR	3
611724	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
610967	11p15.5	Osteogenesis imperfecta, type V	610967	AD	3
609798	14q24.3	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3
609798	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
609798	14q24.3	Nevus comedonicus, somatic	617025	_	3
603009	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
603009	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
603009	2p13.2	Myopathy, distal, with anterior tibial onset	606768	AR	3
610460	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
611038	18q21.32	Microphthalmia, isolated 3	611038	AR	3
603734	19q13.33	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3
606652	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
606768	2p13.2	Myopathy, distal, with anterior tibial onset	606768	AR	3
610036	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
609782	4q31	Aortic aneurysm, familial abdominal 2	609782	_	2
605131	16q23.1-q23.2	Epileptic encephalopathy, early infantile, 28	616211	AR	3
605131	16q23.1-q23.2	Esophageal squamous cell carcinoma, somatic	133239	_	3
605131	16q23.1-q23.2	Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3
609791	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
609352	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
610968	17q21.2	Osteogenesis imperfecta, type XI	610968	AR	3
611725	7q11.21	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3
610863	3q26.33	Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3
604432	15q15.2	Spinocerebellar ataxia 11	604432	AD	3
609868	14q31.3	Leber congenital amaurosis 3	604232	_	3
609868	14q31.3	Retinitis pigmentosa, juvenile, autosomal recessive	604232	_	3
611953	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
609656	17q23	{Bone size QTL}	609656	_	2
610657	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
610657	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
611892	9p21	{Aneurysm, intracranial berry, 6}	611892	_	2
611655	2q33.1	Mental retardation, autosomal recessive 42	615802	AR	3
610755	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
609985	4q31-q34	Panic disorder 3	609985	_	2
612083	14q24.3	Muscle strength quantitative trait locus 1	612083	_	2
604685	7p15.2	?Microtia, hearing impairment, and cleft palate (AR)	612290	AR,AD	3
604685	7p15.2	Microtia with or without hearing impairment (AD)	612290	AR,AD	3
611867	22q11.2	Chromosome 22q11.2 deletion syndrome, distal	611867	_	4
611379	12q13.12	Mental retardation, FRA12A type	136630	AD	3
611242	20p13	{Restless legs syndrome 5}	611242	_	2
609353	8p21.1	Roberts syndrome	268300	AR	3
609353	8p21.1	SC phocomelia syndrome	269000	AR	3
609799	17q11.2	?Nephronophthisis 9	613824	_	3
609799	17q11.2	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3
609253	18p11.2	Febrile seizures, familial, 6	609253	AD	2
604167	16q22.1	Mental retardation, autosomal dominant 21	615502	AD	3
609721	7p12.3	Heterotaxy, visceral, 8, autosomal	617205	AR	3
607522	10q24.32	Hermansky-Pudlak syndrome 6	614075	AR	3
611893	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
611040	11q23.3	Microphthalmia, isolated 5	611040	AR	3
611295	3q27.1	Epidermolysis bullosa simplex, generalized, with scarring and hair loss	617294	AD	3
611026	16q23.1	Spastic paraplegia 35, autosomal recessive	612319	AR	3
611549	13q32.3-q33.1	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3
611549	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
610552	3q22.1	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3
610552	3q22.1	Epileptic encephalopathy, early infantile, 44	617132	AR	3
610842	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
609010	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
612223	7q21	{Stature QTL 11}	612223	_	2
612048	3p25.1	Arrhythmogenic right ventricular dysplasia 5	604400	AD	3
612048	3p25.1	Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3
611726	7q11.21	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3
606770	5p15.2-p14	{Adiponectin, serum level of, QTL2}	606770	_	2
610341	3q28	Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3
611876	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
609254	3q13.33	Senior-Loken syndrome 5	609254	AR	3
609354	11q23	[Bone mineral density QTL 5]	609354	_	2
611934	10p11.22	{Epilepsy, idiopathic generalized, susceptibility to, 5}	611934	_	2
607523	3p21.31	Toenail dystrophy, isolated	607523	AD	3
609800	2p24	Epilepsy, generalized, with febrile seizures plus, type 4	609800	AD	2
611955	17q12	{Prostate cancer, hereditary, 11}	611955	_	2
611550	6p21.33	{Malaria, mild, susceptibility to}	609148	_	3
609239	13q14.2	Hypotrichosis 8	278150	AR	3
609239	13q14.2	Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	AR	3
605764	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
609069	10p12.2	Pancreatic and cerebellar agenesis	609069	AR	3
610553	13q13.3	Leukodystrophy, hypomyelinating, 14	617899	AR	3
610773	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
612310	2p13.3	Premature ovarian failure 6	612310	AD	3
611381	1p22	{Kala-azar, susceptibility to, 2}	611381	_	2
612283	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
612283	2q14.3	Thrombophilia due to protein C deficiency, autosomal recessive	612304	AR	3
612460	16q12.2	{Obesity, susceptibility to, BMIQ14}	612460	AR	3
612349	12q23.2	Phenylketonuria	261600	AR	3
612349	12q23.2	[Hyperphenylalaninemia, non-PKU mild]	261600	AR	3
611895	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
609070	1q42.2	[Hemoglobin, high altitude adaptation]	609070	AD	3
609802	15q21.1	Albinism, oculocutaneous, type VI	113750	AR	3
609802	15q21.1	[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	AR	3
610329	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
611014	18q21.2	{Hypertension, essential, susceptibility to, 8}	611014	_	2
612369	10q21	{Alkaline phosphatase, plasma level of, QTL4}	612369	_	2
610661	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
610898	11p12-p11	Supranuclear palsy, progressive, 3	610898	_	2
610844	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
610844	15q21.1	Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3
610844	15q21.1	Spastic paraplegia 11, autosomal recessive	604360	AR	3
611382	6q27	{Kala-azar, susceptibility to, 3}	611382	_	2
609264	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
611428	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
611428	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
612311	2q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 5}	612311	_	2
612659	6q22.1	Mitchell-Riley syndrome	615710	AR	3
612753	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
612271	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
610670	4q25	Spastic paraplegia 56, autosomal recessive	615030	AR	3
608532	7q36.3	Kahn-Kahn-Katsanis syndrome	618460	AR	3
612718	15q21.1	Cerebral creatine deficiency syndrome 3	612718	AR	3
611015	7q31	{Autism, susceptibility to, 9}	611015	_	2
603084	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
612626	15q26-qter	Chromosome 15q26-qter deletion syndrome	612626	IC	4
609102	16q24.2	?Mental retardation, autosomal recessive 45	615979	AR	3
611067	1p36.31	Spinal muscular atrophy, distal, autosomal recessive, 4	611067	AR	3
610330	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
610554	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
612796	13q13.3	{Inflammatory bowel disease 27}	612796	_	2
609039	21q11.2	Narcolepsy 3	609039	AD	2
612853	2p14-p13	{Restless legs syndrome 7}	612853	_	2
612370	8q12.2	Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3
608654	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
612335	4p16-p15	Spastic paraplegia 38, autosomal dominant	612335	AD	2
610798	1q22	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3
612520	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
612312	13q12.11	{Attention deficit-hyperactivity disorder, susceptibility to, 6}	612312	_	2
611521	19p13.2	Immunodeficiency 35	611521	AR	3
609265	22q12.1	Li-Fraumeni syndrome	609265	_	3
612567	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
611897	2q11-q14	Nanophthalmos 3	611897	_	2
610936	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
610936	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
612911	3p21.31	Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3
612900	9p24.3	Cerebral palsy, spastic quadriplegic, 2	612900	_	3
611879	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
612719	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
605060	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
612003	2q37.1	{Parkinson disease 11}	607688	_	3
609413	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
609413	10q11.23	Cockayne syndrome, type B	133540	AR	3
609413	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
609413	10q11.23	Premature ovarian failure 11	616946	AD	3
609413	10q11.23	UV-sensitive syndrome 1	600630	AR	3
609413	10q11.23	{Lung cancer, susceptibility to}	211980	SMu,AD	3
609413	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
609975	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
612371	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
609831	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type	277400	AR	3
612702	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
611016	7q36	{Autism, susceptibility to, 10}	611016	_	2
612521	6q25	{Diabetes mellitus, insulin-dependent, 21}	612521	_	2
606759	15q21.1	Thyroid dyshormonogenesis 6	607200	AR	3
613088	9q21	{Pelvic organ prolapse, susceptibility to, 2}	613088	_	2
611430	3p22.2	Spermatogenic failure 37	618429	AR	3
613065	10q21	{Leukemia, acute lymphocytic, susceptibility to, 1}	613065	_	2
610370	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
612797	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
612313	2q33.1	Glass syndrome	612313	AD	3
611630	4q13.2-q21.3	Epilepsy, familial temporal lobe, 3	611630	AD	2
604687	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
612004	7p15.3	Thrombocytopenia 4	612004	AD	3
612661	17p13.1	Dyskeratosis congenita, autosomal recessive 3	613988	AR	3
612952	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
610672	19p13.13	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3
609414	2q34	Corneal fleck dystrophy	121850	AD	3
611095	14q11.2-q12	Mental retardation, autosomal recessive, 9/26	611095	AR	2
609796	15q15.2	Peeling skin syndrome 2	609796	AR	3
611729	11q13.2	Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3
610060	6p21.1	Leukodystrophy, hypomyelinating, 11	616494	AR	3
610060	6p21.1	Treacher Collins syndrome 3	248390	AR	3
613229	13q31.1	?Trichotillomania	613229	Mu,AD	3
613309	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
611880	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
612522	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
611584	22q13.1	Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	AD	3
608410	4p15-p14	{Obesity, susceptibility to, BMIQ7}	608410	_	2
612394	7q22.1	Lysyl hydroxylase 3 deficiency	612394	AR	3
613464	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
612005	1q31	{Celiac disease, susceptibility to, 7}	612005	_	2
612901	20q13.32	Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	AD	3
613320	16p13.3	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3
612627	1p36.12-p35.1	Seizures, benign familial infantile, 4	612627	_	2
611631	9q21-q22	Epilepsy, familial temporal lobe, 4	611631	AD	2
613171	10q25.2	Cardiomyopathy, dilated, 1DD	613172	AD	3
611523	6q15	Pontocerebellar hypoplasia, type 6	611523	AR	3
613495	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
612874	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
612703	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
609734	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
613105	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
613024	6p21.33	{Follicular lymphoma, susceptibility to, 1}	613024	_	2
611881	16p11.2	Glycogen storage disease XII	611881	AR	3
613571	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
613370	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
613618	17q23.1-q23.2	Chromosome 17q23.1-q23.2 duplication syndrome	613618	AD	4
609415	13q31.3	Feingold syndrome 2	614326	AD	3
612431	4q12-q13.1	Deafness, autosomal dominant 27	612431	AD	2
612976	3p26.1-p25.1	{Age-related hearing impairment 2}	612976	_	2
611139	9p21	{Coronary heart disease, susceptibility to, 8}	611139	_	2
609523	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
613640	14q24.3	Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3
612089	13q13.1	Hypophosphatemic rickets and hyperparathyroidism	612089	AD	2
613677	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
612943	7p15.3	Retinitis pigmentosa 42	612943	AD	3
612274	15q24-q25	Ciliary dyskinesia, primary, 8	612274	_	2
612343	4q22	[Musical aptitude QTL 1]	612343	_	2
612929	20q13.31-q13.33	{Mycobacterium tuberculosis, susceptibility to, 3}	612929	_	2
613310	7q31.31	Exudative vitreoretinopathy 5	613310	AD	3
611632	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
612395	22q13.33	Muscular dystrophy, congenital, megaconial type	602541	AR	3
612006	2q11-q12	{Celiac disease, susceptibility to, 8}	612006	_	2
613172	10q25.2	Cardiomyopathy, dilated, 1DD	613172	AD	3
610463	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
610463	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
613722	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
613106	22q12	Vertigo, benign recurrent, 2	613106	_	2
613371	4q34.3-q35.1	?Spinocerebellar ataxia 30	613371	AD	2
612315	12q13.13	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3
612628	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
613496	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
613158	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
613641	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
610756	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
611140	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
612789	8p22-p21.3	Deafness, autosomal recessive 71	612789	AR	2
609524	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
613410	3q24	{?Autism susceptibility 16}	613410	_	3
613619	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
612944	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
613830	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
612007	3p21	{Celiac disease, susceptibility to, 9}	612007	_	2
610474	4p16.3	CATSHL syndrome	610474	AR,AD	3
612629	11q23-q24	{Adiponectin, serum level of, QTL4}	612629	_	2
610333	19p13.13	Aicardi-Goutieres syndrome 4	610333	AR	3
612525	16q24.3	Pyloric stenosis, infantile hypertrophic, 5	612525	_	2
611524	6q15	Pontocerebellar hypoplasia, type 6	611523	AR	3
610970	16q24.3	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3
613890	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
613689	22q12.3-q13.1	Mammary-digital-nail syndrome	613689	AD	2
613723	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
613879	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
613497	10q23.31	Cholesteryl ester storage disease	278000	AR	3
613497	10q23.31	Wolman disease	278000	AR	3
613642	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
612121	6p21.31	Ichthyosis, congenital, autosomal recessive 10	615024	AR	3
612858	8q24.3	Orofacial cleft 12	612858	_	2
613107	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
612316	1p36.33	Harel-Yoon syndrome	617183	AR,AD	3
611031	16q13-q22.1	Episodic kinesigenic dyskinesia 2	611031	AD	2
612008	3q25-q26	{Celiac disease, susceptibility to, 10}	612008	_	2
613485	11q24.3	Long QT syndrome 13	613485	AD	3
613558	9q21.11	Deafness, autosomal dominant 51	613558	AD	4
613174	5p13	Chromosome 5p13 duplication syndrome	613174	IC	4
612892	6p22.1	{Stature QTL 18}	612892	_	2
613972	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
612304	2q14.3	Thrombophilia due to protein C deficiency, autosomal recessive	612304	AR	3
613805	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
613680	16p13.3	Beaulieu-Boycott-Innes syndrome	613680	AR	3
613724	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
614073	22q12.1	Hermansky-Pudlak syndrome 4	614073	AR	3
612877	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
612345	2q31.2	Chromosome 2q31.2 deletion syndrome	612345	_	4
606761	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
610608	20p11.21	Immunodeficiency 55	617827	AR	3
614114	11q21	Mosaic variegated aneuploidy syndrome 2	614114	AR	3
613621	14q12	Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3
612630	2q13	[Hair morphology 1, hair thickness]	612630	_	3
612893	6p21.31	{Stature QTL 19}	612893	_	2
611544	22q12.1	Cataract 17, multiple types	611544	AR,AD	3
613990	14q12	Dyskeratosis congenita, autosomal dominant 3	613990	AD	3
612953	22q13.1	Parkinson disease 14, autosomal recessive	612953	AR	3
614049	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
614139	2p25.3	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3
613559	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
613108	12p13.2	Candidiasis, familial, 4, autosomal recessive	613108	AR	3
613881	10q26.11	Cardiomyopathy, dilated, 1HH	613881	AD	3
614038	3q21.3	Emberger syndrome	614038	AD	3
611081	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
612318	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
606762	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
613681	2q31.1	Chromosome 2q31.1 duplication syndrome	613681	AD	4
614200	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
613643	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
612631	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
612954	10q26.11	Myopathy, myofibrillar, 6	612954	AD	3
614185	15q21.1	Geleophysic dysplasia 2	614185	AD	3
614050	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
614261	2p13.1	Microcephaly-capillary malformation syndrome	614261	AR	3
612792	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
612306	5q13	[Thyroid-stimulating hormone level QTL 1]	612306	_	2
614297	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614297	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
613950	22q13.33	{Schizophrenia 15}	613950	AD	3
612666	1q32.1	Congenital anomalies of kidney and urinary tract 1	610805	AD	3
612666	1q32.1	Spastic paraplegia 23	270750	AR	3
612894	13q14.3	{Stature QTL 20}	612894	_	2
613067	7p12.2	{Leukemia, acute lymphoblastic, susceptibility to, 2}	613067	_	2
614140	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
614140	22q11.23	Hypertelorism, Teebi type	145420	AD	3
614140	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
614115	9q34.12	Cortical malformations, occipital	614115	AR	3
613159	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613109	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
614322	16q23.1-q23.2	Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3
614243	8q24.3	5-oxoprolinase deficiency	260005	AR,AD	3
611022	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
614262	14q24.3	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3
614377	4p14	Nephronophthisis 13	614377	AR	3
612955	20q11.21	Long QT syndrome 12	612955	AD	3
614298	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
614388	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
611920	10q23-q24	[C-reactive protein QTL]	611920	_	2
612645	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
614366	12q23.3	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3
613311	6p25.1	?Combined oxidative phosphorylation deficiency 19	615595	AR	3
613428	2p23.2	Retinitis pigmentosa 54	613428	_	3
614609	19p13.2	Coffin-Siris syndrome 4	614609	AD	3
613622	11q24.2	Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3
614312	17p13.2	?Spermatogenic failure 14	615842	AR	3
613152	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
613951	16p13.3	Fanconi anemia, complementation group P	613951	AR	3
614141	4q31.3	Charcot-Marie-Tooth disease, type 2R	615490	AR	3
614153	20p13	Spinocerebellar ataxia 36	614153	AD	3
614116	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
614064	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
612956	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
611547	12q14.3	{Stature QTL 9}	611547	_	2
614651	10p12.1	Coenzyme Q10 deficiency, primary, 2	614651	AR	3
614702	6q13	Combined oxidative phosphorylation deficiency 10	614702	AR	3
612794	15q14	Atrial septal defect 5	612794	AD	3
613930	18q11.2-q12.2	Alopecia-mental retardation syndrome 3	613930	AR	2
614450	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
612957	1p36.12	{Vitamin B6 plasma level QTL 1}	612957	_	2
612030	8p22	{Coronary heart disease, susceptibility to, 9}	612030	_	2
611515	21q22	Febrile seizures, familial, 7	611515	_	2
614610	19p13.2	Nephrotic syndrome, type 16	617783	AR	3
614610	19p13.2	Palmoplantar keratoderma and woolly hair	616099	AR	3
611548	7q35	Premature ovarian failure 5	611548	AD	3
609595	1p34.3	Palmoplantar hyperkeratosis and true hermaphroditism	610644	AR	3
609595	1p34.3	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644	AR	3
614154	20p13	Spinocerebellar ataxia 36	614153	AD	3
614574	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
613953	22q11.1	Immunodeficiency 51	613953	AR	3
612870	6q14.1	Developmental delay, intellectual disability, obesity, and dysmorphic features	617991	AD	3
614556	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
611731	5q22.2	Adenoma, periampullary, somatic	_	_	3
611731	5q22.2	Adenomatous polyposis coli	175100	AD	3
611731	5q22.2	Brain tumor-polyposis syndrome 2	175100	AD	3
611731	5q22.2	Colorectal cancer, somatic	114500	_	3
611731	5q22.2	Desmoid disease, hereditary	135290	AD	3
611731	5q22.2	Gardner syndrome	175100	AD	3
611731	5q22.2	Gastric cancer, somatic	613659	_	3
611731	5q22.2	Hepatoblastoma, somatic	114550	_	3
614324	17q21.2	Ovarian dysgenesis 3	614324	AR	3
614662	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
613931	1p34.1	Pontocerebellar hypoplasia, type 7	614969	AR	3
614065	7q32.1	Myopathy, distal, 4	614065	AD	3
613451	11p11.2	Frontonasal dysplasia 2	613451	AR	3
614156	7p13	Hyperbiliverdinemia	614156	AR,AD	3
612169	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
614817	15q13.3	Interstitial nephritis, karyomegalic	614817	AR	3
615011	5q35.3	[?Phosphohydroxylysinuria]	615011	_	3
613456	12q21.31	?Frontonasal dysplasia 3	613456	_	3
612277	9q34.2	Geleophysic dysplasia 1	231050	AR	3
614779	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
614972	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AR,AD	3
614870	1p36.32	Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3
614590	6p21.3	{Podoconiosis, susceptibility to}	614590	_	2
614789	3p14.1	Adams-Oliver syndrome 4	615297	AR	3
614858	10q26.12	Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3
614299	2p13.1	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3
614575	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
612278	5q33.1	{Inflammatory bowel disease (Crohn disease) 19}	612278	_	3
614780	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
611383	9q32	Usher syndrome, type 2D	611383	AR	3
614144	17p11.2	?Meckel syndrome 9	614209	AR	3
614144	17p11.2	Joubert syndrome 27	617120	AR	3
614859	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
614885	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
614931	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
614591	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
614591	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
611935	2q23.2	Homocystinuria, cblD type, variant 1	277410	AR	3
611935	2q23.2	Methylmalonic aciduria and homocystinuria, cblD type	277410	AR	3
611935	2q23.2	Methylmalonic aciduria, cblD type, variant 2	277410	AR	3
611384	10p15	{Plasmodium falciparum fever episodes QTL1}	611384	_	2
614819	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
614557	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
615023	15q26.3	Ichthyosis, congenital, autosomal recessive 9	615023	AR	3
612309	1q24.2	Factor V deficiency	227400	AR	3
612309	1q24.2	Thrombophilia due to activated protein C resistance	188055	AD	3
612309	1q24.2	{Budd-Chiari syndrome}	600880	AR	3
612309	1q24.2	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3
612309	1q24.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
612309	1q24.2	{Thrombophilia, susceptibility to, due to factor V Leiden}	188055	AD	3
614628	14q24.3	Keratoconus 8	614628	AD	2
611061	7p22.3	Raine syndrome	259775	AR	3
614984	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
614984	10p14	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3
615219	9p23	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3
614886	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
615249	8p11.21	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	615249	AR	3
614629	13q32	Keratoconus 7	614629	AD	2
615294	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614145	19q13.32	3-M syndrome 3	614205	AR	3
615024	6p21.31	Ichthyosis, congenital, autosomal recessive 10	615024	AR	3
615220	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
614592	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
611062	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
615238	3p25.3	?Lipodystrophy, familial partial, type 5	615238	AR	3
614714	16q24.2	Porokeratosis 7, multiple types	614714	AD	3
615041	12q14.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3
612279	8p23-p21	Epilepsy, generalized, with febrile seizures plus, type 6	612279	_	2
614558	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
614820	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
613954	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
614706	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
615270	8p21.3	Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3
615221	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
615363	6q25.1-q25.2	Estrogen resistance	615363	AR	3
612281	5q33.3	Ichthyosis, congenital, autosomal recessive 6	612281	AR	3
614860	9q34	Dystonia 23	614860	AD	2
614974	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
615042	9q34.11	Congenital disorder of glycosylation, type Iu	615042	AR	3
615352	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
615025	10p14	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3
614566	19q13.42	Ciliary dyskinesia, primary, 2	606763	AR	3
615364	14q32.2	?Spermatogenic failure 27	617965	AR	3
612041	4p16.3	Recombination rate QTL 1	612042	_	3
615376	1p36.31	Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3
614300	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
615434	16q13	Retinitis pigmentosa with or without situs inversus	615434	AR	3
615222	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
614861	21q22.3	?Deafness, autosomal recessive 98	614861	AR	3
612042	4p16.3	Recombination rate QTL 1	612042	_	3
615316	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
615316	1q42.13	Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3
615026	17p13.2	Riboflavin deficiency	615026	AD	3
615043	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614245	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
615134	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
615474	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
612530	1q41-q42	Chromosome 1q41-q42 deletion syndrome	612530	IC	4
615541	8p12	Mental retardation, autosomal recessive 39	615541	AR	3
614998	1q21.3	Mental retardation, autosomal dominant 18	615074	AD	3
614477	8q22.1	Bardet-Biedl syndrome 21	617406	AR	3
614477	8q22.1	Cone-rod dystrophy 16	614500	AR	3
614477	8q22.1	Retinitis pigmentosa 64	614500	AR	3
615048	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
615561	6p21.33	?Complement factor B deficiency	615561	_	3
614567	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
615623	1p32.3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3
614862	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
615512	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
613955	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
615395	2q36.1	?Combined oxidative phosphorylation deficiency 16	615395	AR	3
614594	17p13.2	Olmsted syndrome	614594	AD	3
615451	10p12.1	Ciliary dyskinesia, primary, 23	615451	AR	3
615317	14q24.3	Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3
611943	3q29	RIDDLE syndrome	611943	AR	3
612883	9q31.2	{Menarche, age at, QTL3}	612883	_	2
614822	16p13.3	Spermatogenic failure 10	614822	AD	3
615542	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
615049	10p12.1	Desanto-Shinawi syndrome	616708	AD	3
612526	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
613646	19p13.2	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	_	3
615436	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
615584	11q12.1	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	615704	AD	3
612884	19q13.4	{Menopause, natural, age at, QTL2}	612884	_	2
614595	4p12	Preeclampsia/eclampsia 5	614595	_	3
614665	12p12.3	Meconium ileus	614665	AR	3
613956	6p12.2	?Candidiasis, familial, 6, autosomal dominant	613956	_	3
613893	12q14.2	Spermatogenic failure 9	613958	AR	3
614823	15q22.31	Aortic valve disease 2	614823	AD	3
613733	11q13.1	Adrenal adenoma, somatic	_	_	3
613733	11q13.1	Angiofibroma, somatic	_	_	3
613733	11q13.1	Carcinoid tumor of lung	_	_	3
613733	11q13.1	Lipoma, somatic	_	_	3
613733	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
613733	11q13.1	Parathyroid adenoma, somatic	_	_	3
614707	8q24.3	Brown-Vialetto-Van Laere syndrome 2	614707	AR	3
615706	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
614576	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
615016	6p22.1	[C3HEX, ability to smell]	615082	AD	3
611944	6q16.2-q22.1	Lymphatic malformation 2	611944	AD	2
614256	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
615544	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
615665	2q37.1	?Joubert syndrome 22	615665	AR	3
613957	9q33.3	Spermatogenic failure 8	613957	AD	3
615585	16q23.3	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3
615707	1q23.3	Immunodeficiency 20	615707	AR	3
613734	2q21.1	Congenital disorder of glycosylation, type IIo	616828	AR	3
615476	1p34.2	Epileptic encephalopathy, early infantile, 18	615476	AR	3
615453	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
615355	1q22	Noonan syndrome 8	615355	AD	3
615636	8q13.1-q13.2	Joubert syndrome 21	615636	AR	3
615564	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
613735	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
612527	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
615438	5q32	?Infantile liver failure syndrome 1	615438	AR	3
615730	1p31.3	Epileptic encephalopathy, early infantile, 23	615859	AR	3
615000	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
615752	16q21	Polymicrogyria, bilateral perisylvian	615752	_	3
613700	22q11.2	Supernumerary der(22)t(8-22) syndrome	613700	_	4
614157	8q22.3	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	AR	3
615397	16q23.1	Meckel syndrome 11	615397	AR	3
614825	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
615709	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
615743	3p25.3	Mental retardation, autosomal dominant 23	615761	AD	3
615565	1q32.3	?Retinitis pigmentosa 67	615565	AR	3
612528	3q29	Diamond-Blackfan anemia 5	612528	AD	3
615356	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
615637	19q13.32	Mental retardation, autosomal recessive 41	615637	AR	3
615377	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
612936	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
615817	12q23.3	?Mental retardation, autosomal recessive 43	615817	AR	3
615876	6q25.3	Ciliary dyskinesia, primary, 32	616481	AR	3
615720	3q26.2	Retinitis pigmentosa 68	615725	AR	3
614158	7q34	?Thromboxane synthase deficiency	614158	AD	1
615744	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
613736	19q13.12	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3
615763	6p25.2	Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3
615035	12q24.31	Spastic paraplegia 55, autosomal recessive	615035	AR	3
615710	6q22.1	Mitchell-Riley syndrome	615710	AR	3
615398	20q13.12	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3
614666	16p13.3	?Centronuclear myopathy 4	614807	AD	3
615006	1p34.1	?Epileptic encephalopathy, early infantile, 15	615006	AR	3
613737	14q24.2	?Acne inversa, familial, 3	613737	AD	3
612813	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
615638	12p13.31	?Microcephaly 21, primary, autosomal recessive	617983	AR	3
615895	20p13	Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3
614571	5p13.2	Joubert syndrome 17	614615	AR	3
614571	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
613710	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
614159	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
615599	8q24.12	Mental retardation, autosomal recessive 40	615599	AR	3
615232	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
615974	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
615838	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
615995	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
614932	2p16.1	Combined oxidative phosphorylation deficiency 13	614932	AR	3
615399	20q13.12	?Paroxysmal nocturnal hemoglobinuria 2	615399	SMu,AD	3
615745	1p36.22	Atrial standstill 2	615745	AR	3
614473	16p13.11	Arterial calcification, generalized, of infancy, 2	614473	AR	3
615722	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
615877	4q31.3	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AR,AD	3
614667	6q13	Combined oxidative phosphorylation deficiency 10	614702	AR	3
615982	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
615896	12q13.13	?Hypotrichosis 13	615896	AD	3
615233	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
613711	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
615007	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
616026	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
614160	2q32.2	Muscle hypertrophy	614160	_	3
615723	7q22.1	Premature ovarian failure 8	615723	AR	3
615996	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
615897	1p34.2	Immunodeficiency 24	615897	AR	3
613712	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
615983	2q31.1	Bardet-Biedl syndrome 5	615983	AR	3
616116	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
615400	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
616105	6q14.3	Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3
615724	1p22.2	Premature ovarian failure 9	615724	AR	3
614161	4q27	Brittle cornea syndrome 2	614170	AR	3
615878	9q21.11	Cholestasis, progressive familial intrahepatic 4	615878	AR	3
614607	1p36.11	Coffin-Siris syndrome 2	614607	AD	3
615649	5q31	Deafness, autosomal dominant 54	615649	AD	2
615038	19q13.33	Ciliary dyskinesia, primary, 20	615067	AR	3
614782	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
615234	2q14.2	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3
615667	9q22.32	Bone marrow failure syndrome 2	615715	AR	3
614608	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
612795	11q12-q13.1	[Polyunsaturated fatty acids plasma level QTL1]	612795	_	2
615879	2p23.3	Tatton-Brown-Rahman syndrome	615879	AD	3
616117	1p31.1	Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3
614934	2p16.1	Deafness, autosomal recessive 70	614934	AR	3
614783	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
615984	4q27	Bardet-Biedl syndrome 7	615984	AR	3
615401	16p11.2	Immunodeficiency 8	615401	AR	3
615235	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
616230	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
615378	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
616267	19q13.33	Ataxia-oculomotor apraxia 4	616267	AR	3
615668	5q12	Chromosome 5q12 deletion syndrome	615668	AD	4
615139	12q24.33	FILS syndrome	615139	AR	3
615651	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
615681	10q24.31	Spastic paraplegia 62	615681	AR	3
616118	5q23.3	Macular degeneration, early-onset	616118	AD	3
614935	8q24.22	Ciliary dyskinesia, primary, 19	614935	AR	3
615985	14q31.3	Bardet-Biedl syndrome 8	615985	AR	3
616151	6q14.1	Macular dystrophy, vitelliform, 4	616151	AD	3
616198	19p13.11	Combined oxidative phosphorylation deficiency 23	616198	AR	3
613375	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
616268	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
615986	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
616231	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
613376	5q11.2	?Neuronopathy, distal hereditary motor, type IIC	613376	AD	3
616269	1p13.3	Mental retardation, autosomal recessive 48	616269	AR	3
615140	12p13.31	Temtamy syndrome	218340	AR	3
616304	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
615237	11q24.1	Congenital short bowel syndrome	615237	AR	3
615360	8q22.1	Leber congenital amaurosis 17	615360	AR	3
614990	10p11.21-q21.1	Usher syndrome, type IK	614990	AR	2
616409	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
616220	9q33.3	Focal segmental glomerulosclerosis 9	616220	AR	3
615841	18q11.2	?Spermatogenic failure 13	615841	AR	3
616152	3q12.3	Macular dystrophy, vitelliform, 5	616152	AD	3
616305	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
616370	14q24.3	Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3
614723	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
615725	3q26.2	Retinitis pigmentosa 68	615725	AR	3
616451	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
615361	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
615685	16p12.3	?Spastic paraplegia 61, autosomal recessive	615685	AR	3
615881	19p13.2	Plasma triglyceride level QTL, low	615881	AD	3
616371	16p13.12	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371	AD	3
615508	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
616479	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
616511	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
616171	4q28.1	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3
613398	12p11.21	Warsaw breakage syndrome	613398	AR	3
615686	1p13.3	?Spastic paraplegia 63	615686	AR	3
615362	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
616583	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
616682	11p11.2	?Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3
615338	16p13.3	Epileptic encephalopathy, early infantile, 16	615338	AR	3
616902	11p13	Chromosome 11p13 deletion syndrome, distal	616902	AD	4
616351	5q13.3	Mental retardation, autosomal dominant 34	616351	AD	3
616728	1p36.12	Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3
615697	3q25-q26	Epilepsy, familial temporal lobe, 6	615697	AD	2
616683	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
616716	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
612937	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
616468	11p11.2	?Exudative vitreoretinopathy 6	616468	AD	3
615900	2p23.3	Retinitis pigmentosa 75	617023	AR	3
616831	3p21.31	Luscan-Lumish syndrome	616831	AD	3
614585	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
616307	4p14	Senior-Loken syndrome 8	616307	AR	3
615698	19q13.2	?Spinocerebellar ataxia 46	617770	AD	3
616154	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
615510	2q35	Alacrima, achalasia, and mental retardation syndrome	615510	AR	3
612560	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
616903	13q14.2	{Thiopurines, poor metabolism of, 2}	616903	AD	3
617018	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
617053	7q21.2	MIRAGE syndrome	617053	AD	3
616373	20q13.33	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373	AD	3
612938	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
616585	16q13	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3
615688	22q11.1	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3
616469	11p11.2	Retinitis pigmentosa 72	616469	AR	3
616849	4q22.3	Brachydactyly, type A1, D	616849	AD	3
614936	8q24.13-q24.21	Keratoderma, palmoplantar, punctate type IB	614936	AD	2
616586	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
617026	1q25.3	Pontocerebellar hypoplasia, type 2F	617026	AR	3
617101	2p16.1	Dias-Logan syndrome	617101	AD	3
616602	3q24	Craniosynostosis 6	616602	AD	3
613399	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
616544	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
612009	3q28	{Celiac disease, susceptibility to, 11}	612009	_	2
617054	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
617027	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
616851	19q13.1-q13.2	?Cataract 45	616851	AR	3
617272	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
616924	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
612561	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
617247	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
617273	8q22.1	?Polydactyly, postaxial, type A9	618219	AR	3
617028	3q26.2-q26.3	Mental retardation, autosomal recessive 54	617028	AR	3
615987	12q21.2	Bardet-Biedl syndrome 10	615987	AR	3
616959	3p26.2	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3
617102	20q13.12	Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3
614937	16q22.1	?Myoclonus, familial, 1	614937	AD	3
617236	9q21.2	Cone-rod dystrophy and hearing loss	617236	AR	3
617403	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
617251	20p13	?Uncombable hair syndrome 2	617251	AR	3
617055	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
615988	9q33.1	?Bardet-Biedl syndrome 11	615988	AR	3
616833	1q21.3	Paget disease of bone 6	616833	AD	3
612010	6q25.3	{Celiac disease, susceptibility to, 12}	612010	_	2
614104	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
617525	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
617080	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
615989	4q27	Bardet-Biedl syndrome 12	615989	AR	3
616622	1q21.3	Immunodeficiency 42	616622	AR	3
617341	10q24.33	Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3
617413	1q21.3	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3
616730	12q15	Nephrotic syndrome, type 11	616730	AR	3
615916	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
616311	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
617056	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
612562	1p36.11	Diamond-Blackfan anemia 7	612562	AD	3
615990	17q22	Bardet-Biedl syndrome 13	615990	AR	3
612011	12q24	{Celiac disease, susceptibility to, 13}	612011	_	2
617616	1q42.11-q42.12	Skraban-Deardorff syndrome	617616	AD	3
617629	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
617237	14q32.2	Immunodeficiency 49	617237	AD	3
614105	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
617547	21q22.3	Retinal dystrophy with macular staphyloma	617547	AR	3
616732	6q21	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	616732	AR	3
613653	7p22.1	Spastic paraplegia 48, autosomal recessive	613647	AR	3
617252	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
617105	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
617392	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
613457	14q11-q22	Chromosome 14q11-q22 deletion syndrome	613457	IC	4
614784	12q21.33	Cone-rod dystrophy 20	615973	AR	3
614317	5q14.2	Vesicoureteral reflux 4	614317	_	2
616733	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
617393	19p13.13	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3
617809	11q13.1	Geleophysic dysplasia 3	617809	AD	3
617830	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
616155	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
616734	18q12.1-q12.2	Symmetric circumferential skin creases, congenital, 2	616734	AD	3
617506	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
611145	8q24.11	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
617810	8q24.3	Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3
617877	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
617082	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
617631	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
617253	8q24.13	Seckel syndrome 10	617253	AR	3
613458	16p13.3	Chromosome 16p13.3 duplication syndrome	613458	IC,AD	4
613655	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
612563	2p25.3	Diamond-Blackfan anemia 8	612563	AD	3
614785	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
616735	3p25.1	Hypotonia, infantile, with psychomotor retardation	616816	AR	3
617878	2q21.1	Keratoconus 9	617928	AD	3
615917	6p21.33	Combined oxidative phosphorylation deficiency 20	615917	AR	3
617091	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
613656	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
617622	2q37.1	Joubert syndrome 30	617622	AR	3
613459	3q25.3	[Birth weight QTL 2]	613459	_	2
611146	1q41	Hypermanganesemia with dystonia 1	613280	AR	3
617493	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
617394	6p22.3	Sclerosing cholangitis, neonatal	617394	AR	3
617633	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
615386	11q13.2	Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3
617507	2p16.1	?PEHO syndrome-like	617507	AR	3
611147	2q31	Paroxysmal nonkinesigenic dyskinesia 2	611147	AD	2
617751	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
617664	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
617395	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
618131	16q22.1	Immunodeficiency 58	618131	AR	3
617255	12q21.32	Lissencephaly 8	617255	AR	3
615918	1q21.2	?Combined oxidative phosphorylation deficiency 21	615918	AR	3
617954	7q22.1	Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3
617752	2q36.3	Mental retardation, autosomal dominant 49	617752	AD	3
617092	17q21.2	Ciliary dyskinesia, primary, 35	617092	AR	3
615387	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
616744	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
617987	1q24.3	?{Deafness, autosomal recessive 26, modifier of}	605429	AD	3
613657	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
617557	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
615925	3q26.31	Growth hormone deficiency, isolated partial	615925	AR,AD	3
615058	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
618279	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
617988	6p21.1	Jaberi-Elahi syndrome	617988	AR	3
618336	12q24.33	IMAGE-I syndrome	618336	AR	3
617432	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
618260	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
613460	3q21	[Birth weight QTL 3]	613460	_	2
613460	3q21	[Fasting plasma glucose level QTL 6]	613460	_	2
613460	3q21	[Plasma glucose, 2-hour, QTL 1]	613460	_	2
617057	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
618379	3q25.1	Epileptic encephalopathy, early infantile, 73	618379	AD	3
617780	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
617093	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
617014	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
613658	2q36.2	Rajab syndrome	613658	AR	2
617903	9q22.33	Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3
617433	19p13.2	Retinitis pigmentosa 78	617433	AR	3
615059	1q32.1	Hypotrichosis 11	615059	AD	3
618416	19p13.11	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3
617396	8q22.2	Anauxetic dysplasia 2	617396	AR	3
615155	9q32	Steel syndrome	615155	AR	3
616420	1q42.12	Leukodystrophy, hypomyelinating, 10	616420	AR	3
612566	20q13	{Inflammatory bowel disease 24}	612566	_	2
617755	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
613932	1p31.1	Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3
617781	16p13.3	Retinitis pigmentosa 80	617781	AR	3
617584	6q21	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3
617558	10q25.1	Spermatogenic failure 19	617592	AR	3
615156	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
617065	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
617914	1q32.1	Microcephaly 20, primary, autosomal recessive	617914	AR	3
617756	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
613933	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
618261	19p13.3	Lymphoproliferative syndrome 3	618261	AR	3
618324	16q22.1	Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3
618398	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
615157	17p12	Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3
617559	3q13.2	?Spermatogenic failure 20	617593	AR	3
618280	11q12.2	Cardiac-urogenital syndrome	618280	AD	3
617796	1q22	Mental retardation, autosomal dominant 52	617796	AD	3
617094	20q13.12	Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3
616421	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
617595	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
617816	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
617397	22q11.21	Pseudo-TORCH syndrome 2	617397	AR	3
613462	7p21.2	[Fasting plasma glucose level QTL 4]	613462	_	2
617560	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
617095	17q21.2	Ciliary dyskinesia, primary, 35	617092	AR	3
617827	20p11.21	Immunodeficiency 55	617827	AR	3
616158	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
617915	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
615748	12q23.3	?Mental retardation, autosomal recessive 43	615817	AR	3
613463	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
617757	10q24.32	Joubert syndrome 32	617757	AR	3
617862	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
617073	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
618325	1p34.3	Lissencephaly 9 with complex brainstem malformation	618325	AD	3
617561	11q14.2	Cohen-Gibson syndrome	617561	AD	3
618011	10q23.31	Hyperekplexia 4	618011	AR	3
618339	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
615749	9q33.2	[Eculizumab, poor response to]	615749	AD	3
617106	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
617879	9q34.3	Leber congenital amaurosis with early-onset deafness	617879	AD	3
617828	14q11.2	?Marsili syndrome	147430	AD	3
617864	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
617540	10q22.1	{Pituitary adenoma 5, multiple types}	617540	AD	3
614111	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
617865	5q12.1	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3
618295	11p15.4	Mental retardation, autosomal recessive 67	618295	AR	3
617829	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
617761	5q23.2	Joubert syndrome 31	617761	AR	3
617866	14q24.3	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3
617107	11q13.1	Thauvin-Robinet-Faivre syndrome	617107	AR	3
617665	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
618060	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
618048	13q12.3	Proteasome-associated autoinflammatory syndrome 2	618048	AD	3
617075	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
617108	17q22	Sessile serrated polyposis cancer syndrome	617108	AD	3
617762	11q13.5	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3
618052	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
613938	20q12-q13.12	Parasomnia, sleepwalking type	613938	Mu,AD	2
614113	9p24	Mental retardation, autosomal dominant 2	614113	AD	4
617402	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
618061	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
614588	2q14.3-q21.3	Dystonia 21	614588	AD	2
617831	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
617916	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
615820	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
618400	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
614589	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
617110	9q21.2	Cone-rod dystrophy and hearing loss	617236	AR	3
618173	10q24.32	Retinitis pigmentosa 83	618173	AD	3
615821	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
618160	1p21.1	?Growth hormone deficiency, isolated, type V	618160	AR	3
613949	12p13.31	OKT4 epitope deficiency	613949	_	3
617882	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
617111	3p21.2	?Macular dystrophy, patterned, 3	617111	AD	3
613661	13q14.3	Congenital disorder of glycosylation, type Ip	613661	AR	3
617883	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
618298	6p24.1	Epileptic encephalopathy, early infantile, 70	618298	AD	3
618402	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
617112	17p13.1	?Orofaciodigital syndrome XV	617127	AR	3
618056	7p22.3	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3
618328	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
618057	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
618058	11q22.1	Ciliary dyskinesia, primary, 38	618063	AR	3
618329	19p13.3	Combined oxidative phosphorylation deficiency 37	618329	AR	3
618404	1q42.11	Leukodystrophy, hypomyelinating, 18	618404	AR	3
615824	6p21.31	Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3
618161	10q24.32	Joubert syndrome 35	618161	AR	3
618162	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
618330	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
618163	17q25.1	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3
617666	13q13.3	Fraser syndrome 2	617666	AR	3
618164	16p13.3	Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3
618414	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
615837	5q32	?Deafness, autosomal recessive 101	615837	AR	3
618415	10q24.2	Cataract 48	618415	AR	3
617854	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
616423	3p21.31	Neurodevelopmental disorder with severe motor impairment and absent language	617804	AD	3
617017	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AR,AD	3
615511	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
617542	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
616425	17q24	46XY sex reversal 10	616425	AD	4
617030	14q32.33	Myopathy, distal, 5	617030	AR	3
617258	12p12.1	Myopathy, myofibrillar, 8	617258	AR	3
617729	14q11.2	Galloway-Mowat syndrome 3	617729	AR	3
617383	12q24.11	?Avascular necrosis of femoral head, primary, 2	617383	AD	3
616449	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
617563	17p13.1	Orofaciodigital syndrome XVI	617563	AR	3
618174	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
616470	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
618175	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
617384	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
618282	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
618176	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
616471	6q13-q14	Bethlem myopathy 2	616471	AD	3
618177	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
618178	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
604633	11q13.1	Cutis laxa, autosomal recessive, type IB	614437	AR	3
604296	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
606953	1p36.11	Galactose epimerase deficiency	230350	AR	3
606666	11p14.1	{Bone mineral density, low, susceptibility to}	615311	_	3
605742	22q11.21	Cortical dysplasia, complex, with other brain malformations 8	613180	AR	3
603786	4p15.32	Stargardt disease 4	603786	_	3
604592	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
605779	17p13	Nail disorder, nonsyndromic congenital, 7	605779	AD	2
606789	8q	Fetal hemoglobin quantitative trait locus 4	606789	_	2
606969	17p13.3	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3
606660	3q24-q26	{Melanoma, uveal, susceptibility to, 1}	606660	_	2
603700	13q12.3	{Stroke, susceptibility to}	601367	Mu	3
603873	9p21.2	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3
605111	19p13.2	Deafness, autosomal recessive 68	610419	AR	3
603666	20q13.32	Pseudohypoparathyroidism, type IB	603233	AD	3
605956	16q12.1	Blau syndrome	186580	AD	3
605956	16q12.1	{Inflammatory bowel disease 1, Crohn disease}	266600	Mu	3
605956	16q12.1	{Psoriatic arthritis, susceptibility to}	607507	_	2
605956	16q12.1	{Yao syndrome}	617321	Mu	3
605950	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
605676	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
604672	19p13.2	{Dengue fever, protection against}	614371	_	3
604672	19p13.2	{HIV type 1, susceptibility to}	609423	_	3
604672	19p13.2	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
606672	17p13.2	Bernard-Soulier syndrome, type A1 (recessive)	231200	AR	3
606672	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
606672	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
606672	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
606207	15q25.3	[Uridine-cytidineuria]	618477	AR	3
605347	1p36.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
604436	8p11.23	Epilepsy, early-onset, vitamin B6-dependent	617290	AR	3
605093	12q24.12	Erythrocytosis, somatic	133100	_	3
605093	12q24.12	Myelofibrosis, somatic	254450	_	3
605093	12q24.12	Thrombocythemia, somatic	187950	_	3
606979	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
607357	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
604124	18q11.2	Jawad syndrome	251255	AR	3
604124	18q11.2	Pancreatic carcinoma, somatic	_	_	3
604124	18q11.2	Seckel syndrome 2	606744	AR	3
607584	13q14	Spastic paraplegia 24, autosomal recessive	607584	AR	2
607115	1q44	CINCA syndrome	607115	AD	3
605394	6q15	Immunodeficiency 60	618394	AD	3
605724	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
606000	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
603741	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
603103	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
603157	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
605387	20q11.22	Cataract 31, multiple types	605387	AD	3
605280	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
603013	8p21	{Schizophrenia}	181500	AD	2
605204	9q34.11	Dystonia-1, torsion	128100	AD	3
605204	9q34.11	{Dystonia-1, modifier of}	_	_	3
606579	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
603198	17q21.2	Lipodystrophy, congenital generalized, type 4	613327	AR	3
607212	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
606673	22q11.23	Beta-ureidopropionase deficiency	613161	AR	3
607206	17p13.1	Ichthyosis, congenital, autosomal recessive 3	606545	AR	3
604574	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
603116	22q12-q13	CDAGS syndrome	603116	AR	2
604011	17q11.2	?Cone-rod dystrophy	_	_	3
604011	17q11.2	?Immunodeficiency 13	615518	AD	3
607078	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
603701	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
605388	9p12-q12	Cerebral palsy, ataxic, autosomal recessive	605388	AR	2
606995	3q22	Senior-Loken syndrome 3	606995	AR	2
605711	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
607116	20p	Alzheimer disease 8	607116	_	2
605753	4q12	?Spermatogenic failure 29	618091	AR	3
603499	18q21.33	Osteolysis, familial expansile	174810	AD	3
603499	18q21.33	Osteopetrosis, autosomal recessive 7	612301	AR	3
603499	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
605375	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
606980	1q42.13	Coenzyme Q10 deficiency, primary, 4	612016	AR	3
605747	1p36.11	Hypercholesterolemia, familial, 4	603813	AR	3
603158	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
606685	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
606996	1p36.31	Senior-Loken syndrome 4	606996	AR	3
607207	16p13.3	?Spinocerebellar ataxia 48	618093	AD	3
607207	16p13.3	Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3
606389	11q13.1	Spermatogenic failure 7	612997	AR	3
606668	16p	{Inflammatory bowel disease 8}	606668	_	2
605083	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
603674	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
607836	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
606785	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
605748	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
606347	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
607880	2p13.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3
605906	10q23.2	Cardiomyopathy, dilated, 1C, with or without LVNC	601493	AD	3
605906	10q23.2	Cardiomyopathy, hypertrophic, 24	601493	AD	3
605906	10q23.2	Left ventricular noncompaction 3	601493	AD	3
605906	10q23.2	Myopathy, myofibrillar, 4	609452	AD	3
603914	11p15.4	Mental retardation, autosomal recessive 67	618295	AR	3
603283	6q22.31	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	AR	3
607805	2q11.2	Jalili syndrome	217080	AR	3
607683	5q31.1-q32	Deafness, autosomal dominant 52	607683	AD	2
605712	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
607117	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
603218	20p13	Huntington disease-like 1	603218	AD	3
605414	19p13.3	{Alzheimer disease 9, susceptibility to}	608907	AD	3
607541	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
603702	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
606688	20p13	Prion disease with protracted course	606688	AD	3
604846	2q14.3	{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3
605749	9q13-q22	Cataract 26, multiple types	605749	_	2
604352	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
606348	5q31	{Inflammatory bowel disease 5}	606348	_	2
605907	16p13.3	Congenital disorder of glycosylation, type Ik	608540	AR	3
604299	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
605084	10q22.1	Myopathy with extrapyramidal signs	615673	AR	3
607066	17p13.2	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3
607066	17p13.2	Olmsted syndrome	614594	AD	3
605178	16q24.3	Ciliary dyskinesia, primary, 33	616726	AR	3
606272	17p13.2	Cystinosis, atypical nephropathic	219800	AR	3
606272	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
606272	17p13.2	Cystinosis, nephropathic	219800	AR	3
606272	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
603284	7p13	Cerebral cavernous malformations-2	603284	AD	3
604450	17q24.2	Stankiewicz-Isidor syndrome	617516	AD	3
604505	14q32.12	Achondrogenesis, type IA	200600	AR	3
604505	14q32.12	Osteochondrodysplasia	184260	AR	3
603622	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
607932	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
603015	7q22.1	Developmental delay with or without dysmorphic facies and autism	618454	AD	3
608040	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
604912	8q24.12	Mental retardation, autosomal recessive 40	615599	AR	3
605518	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
603543	3q28	Limb-mammary syndrome	603543	AD	3
605775	5q31.2	Pseudohypoaldosteronism, type IID	614495	AR,AD	3
607446	6q23-q25	[Body mass index QTL3]	607446	_	2
607795	9q32	Retinitis pigmentosa 70	615922	AD	3
605237	1q25.3	Basal ganglia calcification, idiopathic, 6	616413	AD	3
605355	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
605738	15q12-q15	Microphthalmia with coloboma 2	605738	_	2
606014	1p13.3	Frontonasal dysplasia 1	136760	AR	3
607194	10p12.2	Pancreatic agenesis 2	615935	AR	3
607194	10p12.2	Pancreatic and cerebellar agenesis	609069	AR	3
603200	19p13.11	MHC class II deficiency, complementation group B	209920	AR	3
605419	15q15	{Schizophrenia 10}	605419	AD	2
603285	3q26.1	Cerebral cavernous malformations 3	603285	_	3
604142	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
605423	12q13.12	46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	_	3
605423	12q13.12	46XY sex reversal 7	233420	AR	3
607939	3p26.1	Multiple sulfatase deficiency	272200	AR	3
604918	7q21.11	?Pontocerebellar hypoplasia, type 3	608027	AR	3
603623	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
605750	11p13-p12	Exudative vitreoretinopathy 3	605750	AD	2
605384	4q27	?Immunodeficiency, common variable, 11	615767	AR	3
608029	20q11-q13	Spinocerebellar ataxia, autosomal recessive 6	608029	AR	2
608212	5q33.1	{Inflammatory bowel disease (Crohn disease) 19}	612278	_	3
608212	5q33.1	{Mycobacterium tuberculosis, protection against}	607948	_	3
607118	3q22.1	Combined oxidative phosphorylation deficiency 9	614582	AR	3
604934	1q42.3	Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3
604934	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
604934	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
607800	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
607800	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
605720	11q13.1	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3
606852	1p32	{Parkinson disease 10}	606852	_	2
606928	1p36	[Bone mineral density QTL 3]	606928	_	2
607585	11q22.3	Ataxia-telangiectasia	208900	AR	3
607585	11q22.3	Lymphoma, B-cell non-Hodgkin, somatic	_	_	3
607585	11q22.3	Lymphoma, mantle cell, somatic	_	_	3
607585	11q22.3	T-cell prolymphocytic leukemia, somatic	_	_	3
607585	11q22.3	{Breast cancer, susceptibility to}	114480	SMu,AD	3
607542	11p15.5-p15.4	Atrial fibrillation, familial, 3	607554	AD	3
607542	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
607542	11p15.5-p15.4	Long QT syndrome 1	192500	AD	3
607542	11p15.5-p15.4	Short QT syndrome 2	609621	AD	3
607542	11p15.5-p15.4	{Long QT syndrome 1, acquired, susceptibility to}	192500	AD	3
606725	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
606725	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
605565	19p13.2	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
605565	19p13.2	{Hypertension, insulin resistance-related, susceptibility to}	125853	AD	3
608300	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
602937	6q24.1	Atrial septal defect 8	614433	AD	3
602937	6q24.1	Ventricular septal defect 2	614431	AD	3
605113	7q31.32	Hyperlysinemia	238700	AR	3
605113	7q31.32	Saccharopinuria	268700	AR	1
603046	8q24.13	Renal cell carcinoma	144700	_	3
608206	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
608206	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
608318	14q32	{Coronary heart disease, susceptibility to, 4}	608318	_	2
605739	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
605908	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603658	2p25.3	Diamond-Blackfan anemia 8	612563	AD	3
603273	3q28	ADULT syndrome	103285	AD	3
603273	3q28	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3
603273	3q28	Hay-Wells syndrome	106260	AD	3
603273	3q28	Limb-mammary syndrome	603543	AD	3
603273	3q28	Orofacial cleft 8	618149	_	3
603273	3q28	Rapp-Hodgkin syndrome	129400	AD	3
603273	3q28	Split-hand/foot malformation 4	605289	AD	3
606159	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
605519	18p11.31	Majeed syndrome	609628	_	3
603945	3q27.1	Leukoencephalopathy with vanishing white matter	603896	AR	3
603945	3q27.1	Ovarioleukodystrophy	603896	AR	3
605238	2q22.1	Mental retardation, autosomal recessive 51	616739	AR	3
605238	2q22.1	{Asthma, susceptibility to}	600807	AD	3
607906	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
604590	1q23.3	{Malaria, resistance to}	611162	_	3
604590	1q23.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
605356	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
603537	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
607562	1p31.3	{Inflammatory bowel disease 17, protection against}	612261	_	3
607562	1p31.3	{Psoriasis, protection against}	605606	_	3
606726	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
606726	20q13.12	{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3
607200	15q21.1	Thyroid dyshormonogenesis 6	607200	AR	3
608520	12q22-q23.2	Major depressive disorder 1	608516	_	2
605751	16p11.2	Seizures, benign familial infantile, 2	605751	AD	3
602938	9q31.1	Hypercholanemia, familial	607748	AR	3
607080	12q13.12	46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	_	3
608455	11q13.1	McArdle disease	232600	AR	3
604439	4q31.21	?Deafness, autosomal recessive 26	605428	AR	3
603236	16q24.2	Porokeratosis 7, multiple types	614714	AD	3
604607	17q21.32	{Prostate cancer, hereditary, 9}	610997	_	3
604799	15q25.2	?Deafness, autosomal dominant 68	616707	AD	3
605109	15q22.31	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3
608207	22q12	{Kala-azar, susceptibility to, 1}	608207	_	2
608630	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
606879	1p12	Neu-Laxova syndrome 1	256520	AR	3
606879	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
608329	11q12.2	Cardiac-urogenital syndrome	618280	AD	3
608329	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
608030	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
603946	10q23.33	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3
608109	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
607941	8p23.1	Atrial septal defect 2	607941	AD	3
608703	2p21-p13	Spinocerebellar ataxia 25	608703	AD	2
608500	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
608631	17p13	{Asperger syndrome susceptibility 2}	608631	IC,Mu	2
605201	11q23.3	High density lipoprotein cholesterol level QTL14	605201	_	2
605566	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
603415	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 7	613863	AD	3
603415	2q24.3	Erythermalgia, primary	133020	AD	3
603415	2q24.3	Febrile seizures, familial, 3B	613863	AD	3
603415	2q24.3	HSAN2D, autosomal recessive	243000	AR	3
603415	2q24.3	Insensitivity to pain, congenital	243000	AR	3
603415	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
603415	2q24.3	Small fiber neuropathy	133020	AD	3
603415	2q24.3	{Dravet syndrome, modifier of}	607208	AD	3
607210	7p22.2	B-cell expansion with NFKB and T-cell anergy	616452	AD	3
607210	7p22.2	Immunodeficiency 11A	615206	AR	3
607210	7p22.2	Immunodeficiency 11B with atopic dermatitis	617638	AD	3
608456	1p34.1	Adenomas, multiple colorectal	608456	AR	3
605713	14q24.3	Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3
608815	6p12.2	{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3
608815	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
606674	19p13	{Inflammatory bowel disease 6}	606674	_	2
606593	13q33.3	LIG4 syndrome	606593	AR	3
608677	18q11.2	Left ventricular noncompaction 7	615092	AD	3
608798	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
603089	3p21.1	Tumor predisposition syndrome	614327	AD	3
608340	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
608885	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
608474	17q21-q22	Myopia 5	608474	AD	2
607478	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
607478	12q21.1	{Unipolar depression, susceptibility to}	608516	_	3
603286	1q32.1	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3
608810	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
605870	13q12.13	?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	AR	3
608248	12q13.13	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3
608248	12q13.13	?Hypotrichosis 3	613981	AD	3
608248	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
605420	11p11.2	Frontonasal dysplasia 2	613451	AR	3
605420	11p11.2	Parietal foramina 2	609597	AD	3
605420	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
608307	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
608307	2q34	{Pulmonary hypertension, neonatal, susceptibility to}	615371	_	3
604332	4q12	{Leukemia, acute myeloid}	601626	SMu,AD	3
607211	17q25.3	Pityriasis rubra pilaris	173200	AD	3
607211	17q25.3	Psoriasis 2	602723	AD	3
608995	1p36-p34	{Dyslexia, susceptibility to, 8}	608995	Mu,AD	2
603276	1q23.3	[Blood pressure regulation QTL]	145500	Mu	2
608251	Chr.14	Phobia, specific	608251	_	2
608799	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
608641	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608930	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AR,AD	3
608542	19q13	Aneurysm, intracranial berry, 2	608542	_	2
608894	6q23.3	Joubert syndrome 3	608629	AR	3
608470	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
607640	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
608673	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
606595	7q11.23	Charcot-Marie-Tooth disease, axonal, type 2F	606595	AD	3
603287	17q21.32	Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3
608214	11q24.1	Atrial fibrillation, familial, 16	613120	AD	3
608214	11q24.1	Brugada syndrome 7	613120	AD	3
608625	17q23.1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3
606621	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
605202	9q22.33	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442	AR	3
609200	5q31.2	Myopathy, myofibrillar, 3	609200	AD	3
608471	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
603234	16p13.11	Arterial calcification, generalized, of infancy, 2	614473	AR	3
603234	16p13.11	Pseudoxanthoma elasticum	264800	AR	3
603234	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
607544	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
605435	14q12	Congenital heart defects and ectodermal dysplasia	617364	AD	3
608543	1p36.2	{Schizophrenia 12}	181500	AD	2
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
608507	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
604593	2q23.1-q23.2	Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3
607734	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AR,AD	3
603277	12p13.31	Sifrim-Hitz-Weiss syndrome	617159	AD	3
609220	3q24	Bruck syndrome 2	609220	AR	3
609369	11q13.1	Neuropathy, hereditary sensory, type IF	615632	AD	3
608626	17q23.3	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3
609044	10q23.33	{Obesity, susceptibility to}	607514	_	3
604860	18q21.32	Immunodeficiency 12	615468	AR	3
607641	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
609338	3p25.2	Carotid intimal medial thickness 1	609338	_	3
609242	22q13.2	Kanzaki disease	609242	AR	3
608862	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
607617	12q15	?Ovarian dysgenesis 6	618078	AR	3
607617	12q15	Galloway-Mowat syndrome 7	618348	AR	3
607617	12q15	Nephrotic syndrome, type 11	616730	AR	3
608627	20q13.32	Amyotrophic lateral sclerosis 8	608627	AD	3
608896	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
608210	11p11.2	?Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3
608210	11p11.2	Exostoses, multiple, type 2	133701	AD	3
608812	9q22.33	{Colorectal cancer, susceptibility to, 1}	608812	_	3
608643	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
609136	22q13.1	PCWH syndrome	609136	AD	3
608381	2q31.3	Retinitis pigmentosa 26	608380	_	3
608965	11q13.2	Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3
606976	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
606976	16q22.1	Saul-Wilson syndrome	618150	AD	3
607608	11p15.4	Niemann-Pick disease, type A	257200	AR	3
607608	11p15.4	Niemann-Pick disease, type B	607616	AR	3
606002	9q34.13	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3
609506	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
609291	15q14	Legius syndrome	611431	AD	3
606622	2q35	Schimke immunoosseous dysplasia	242900	AR	3
608644	5p15.2	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	_	3
609458	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
608903	16p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
610032	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
610261	20q11-q13	{Hypertension, essential, susceptibility to, 5}	145500	Mu	2
610213	5p15.2-p14.3	Aneurysm, intracranial berry, 4	610213	_	2
609132	1p36.12	Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3
610224	9q34.3	Ovarian dysgenesis 5	617690	AR	3
610224	9q34.3	Spermatogenic failure 32	618115	AD	3
609213	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
609139	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
609139	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
610362	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
610362	19p13.3	Cone-rod dystrophy 11	610381	AD	3
607642	17p11.2	Smith-Magenis syndrome	182290	IC,AD	3
610377	12q24.11	Mevalonic aciduria	610377	AR	3
609821	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
606977	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
606977	13q14.11	Shaheen syndrome	615328	AR	3
610168	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
610498	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
609342	11q12.1	Intrinsic factor deficiency	261000	AR	3
609041	10q22.1-q24.1	Spastic paraplegia 27, autosomal recessive	609041	AR	2
608864	1q32.2	{Orofacial cleft 6}	608864	AD	3
608675	16q22.1	Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3
610512	20p11.23	?Cowden syndrome 7	616858	AD	3
610512	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
603743	22q12.3	{End-stage renal disease, nondiabetic, susceptibility to}	612551	_	3
603743	22q12.3	{Glomerulosclerosis, focal segmental, 4, susceptibility to}	612551	_	3
609815	3p21.31	Zygodactyly 1	609815	_	2
610274	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
609549	11q23.3	Nanophthalmos 2	609549	_	3
610243	10q24.2	Spastic paraplegia 33, autosomal dominant	610244	AD	3
610767	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
607643	17q25.3	Retinitis pigmentosa 30	607921	_	3
603278	19q13.2	Glomerulosclerosis, focal segmental, 1	603278	AD	3
610838	21p13-q11	{Autism susceptibility 12}	610838	_	2
610832	16p12.2	Fanconi anemia, complementation group N	610832	_	3
610127	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
608800	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
611182	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
609891	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
609140	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
610163	1q24.2	?Immunodeficiency 25	610163	AR	3
610079	11q24.2	{Autoimmune disease, susceptibility to, 6}	613551	_	3
610262	5p13-q12	{Hypertension, essential, susceptibility to, 6}	145500	Mu	2
610915	1p34.2	Osteogenesis imperfecta, type VIII	610915	AR	3
606273	1p34.1	Leukoencephalopathy with vanishing white matter	603896	AR	3
611150	22q13.31	Spinocerebellar ataxia 10	603516	AD	3
609319	6q23	[Hematocrit/hemoglobin quantitative trait locus 1]	609319	_	2
610363	1p36.13	Preimplantation embryonic lethality 2	617234	AR	3
610244	10q24.2	Spastic paraplegia 33, autosomal dominant	610244	AD	3
610523	7q32.2	Joubert syndrome 15	614464	AR	3
604801	1q42	Muscular dystrophy, congenital, 1B	604801	AR	2
611220	17q12	?Cataract 43	616279	AD	3
610928	8q11.23	Vesicoureteral reflux 3	613674	AD	3
610713	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
605557	1p36.32	Cardiomyopathy, dilated, 1LL	615373	AD	3
605557	1p36.32	Left ventricular noncompaction 8	615373	AD	3
610768	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
611102	15q15.3	Deafness and male infertility	611102	AR	4
609507	9p21.1	Retinitis pigmentosa 31	609923	_	3
610565	22q13.1	?Mirror movements 3	616059	AR	3
607545	4q32.3	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3
609340	14q22.1	Spastic paraplegia 28, autosomal recessive	609340	AR	3
609129	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
606489	9p13.2	Pontocerebellar hypoplasia, type 1B	614678	AR	3
603680	13q21.33	Spinocerebellar ataxia 8	608768	AD	3
603680	13q21.33	{Parkinson disease, susceptibility to}	168600	Mu,AD	3
610733	2p22.1	Noonan syndrome 4	610733	AD	3
610128	12q23.3	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3
610839	2q33.3	{Osteoarthritis susceptibility 4}	610839	_	2
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	AD	3
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	AD	3
605597	3q22.3	Premature ovarian failure 3	608996	AD	3
610873	22q13	{Menarche, age at, QTL}	610873	_	2
610263	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
608801	19p13.13	Glutaricaciduria, type I	231670	AR	3
610707	16q	{Psoriasis susceptibility 8}	610707	_	2
610745	15q24.1	Microphthalmia, isolated, with coloboma 8	601186	AR	3
610745	15q24.1	Microphthalmia, syndromic 9	601186	AR	3
610444	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
610245	20p13	Spinocerebellar ataxia 23	610245	AD	3
611174	16q12.2	Hamamy syndrome	611174	AR	3
610916	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
611228	6q21	Charcot-Marie-Tooth disease, type 4J	611228	AR	3
609913	1p21.3-p13.3	Retinitis pigmentosa 32	609913	_	2
610805	1q32.1	Congenital anomalies of kidney and urinary tract 1	610805	AD	3
609552	2q11.2	?Mental retardation, autosomal recessive, 52	616887	AR	3
608423	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
609508	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
611448	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
610531	7p15.3	Leukodystrophy, hypomyelinating, 5	610532	AR	3
610876	6q16.3	Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3
605598	5q31.1-q33.1	{Diabetes mellitus, insulin-dependent, 18}	605598	_	2
609893	15q25.3-q26.1	Hypothyroidism, congenital, nongoitrous, 3	609893	_	2
611588	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
610865	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
610142	12q21.32	?Bardet-Biedl syndrome 14	615991	AR	3
610142	12q21.32	Joubert syndrome 5	610188	AR	3
610142	12q21.32	Leber congenital amaurosis 10	611755	_	3
610142	12q21.32	Meckel syndrome 4	611134	AR	3
610142	12q21.32	Senior-Loken syndrome 6	610189	AR	3
610708	12p11.21	Optic atrophy 5	610708	AD	3
610226	17q25.3	Seborrhea-like dermatitis with psoriasiform elements	610227	_	3
610600	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
607882	8q24.3	Brown-Vialetto-Van Laere syndrome 2	614707	AR	3
608428	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
610246	18p11.21	Spinocerebellar ataxia 28	610246	AD	3
611082	22q12.1	{Myocardial infarction, susceptibility to}	608446	_	3
609633	21q22.13	{Major affective disorder 3, early onset}	609633	_	2
610911	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
610739	16p12.1	?Epilepsy, familial adult myoclonic, 6	618074	_	3
609144	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
609376	19q13	Cataract 35, congenital nuclear	609376	AR	2
610746	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
611103	3q21.3	Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3
611152	1q21	{Alzheimer disease-13}	611152	_	2
608807	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
610293	1q23.2	Glycosylphosphatidylinositol deficiency	610293	AR	3
611369	19p13.3	Lethal congenital contractural syndrome 3	611369	AR	3
610528	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
609299	3p26	{Prostate cancer, hereditary, 5}	609299	_	2
608437	12q24	{Systemic lupus erythematosus, susceptibility to, 4}	608437	_	2
611131	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
610297	2p13.1	{Parkinson disease 13}	610297	_	3
609218	16q23.3	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3
609048	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
609245	1p13.3	Chudley-McCullough syndrome	604213	AR	3
611762	19q13.42	Familial cold autoinflammatory syndrome 2	611762	AD	3
609862	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
609300	10q24.32	17,20-lyase deficiency, isolated	202110	AR	3
609300	10q24.32	17-alpha-hydroxylase/17,20-lyase deficiency	202110	AR	3
610345	7q34	Cataract 38, autosomal recessive	614691	AR	3
610345	7q34	Sengers syndrome	212350	AR	3
610912	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
605740	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
605740	17q21.31	Sclerosteosis 1	269500	AR	3
605740	17q21.31	Van Buchem disease	239100	AR	3
611104	12p11.21	Charcot-Marie-Tooth disease, type 4H	609311	AR	3
609489	4q24	Mannosidosis, beta	248510	AR	3
609161	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
609460	10q22.1	Goldberg-Shprintzen megacolon syndrome	609460	AR	3
610532	7p15.3	Leukodystrophy, hypomyelinating, 5	610532	AR	3
605845	5q31-q33	{Dermatitis, atopic, susceptibility to, 6}	605845	_	2
608576	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
608576	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608576	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
607483	2q36.3	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	AR	3
608488	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
610445	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
606003	11p15.5	Transaldolase deficiency	606003	AR	3
609049	3p21.31	Pierson syndrome	609049	AR	3
611204	14q32.11-q32.12	?Spinocerebellar ataxia 40	616053	AD	3
611204	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
611456	6p23	Essential tremor, hereditary, 3	611456	_	2
609863	12q24.11	Joubert syndrome 13	614173	AR	3
611184	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
611184	16q24.3	Lymphatic malformation 6	616843	AR	3
611647	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
611153	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
610743	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
608586	3p14-q13	Keratoconus 3	608586	_	2
612078	16q24.2	Brittle cornea syndrome 1	229200	AR	3
605437	14q23.1	{Cerebral infarction, susceptibility to}	601367	Mu	3
610812	16q22.2	Ciliary dyskinesia, primary, 5	608647	AR	3
610913	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
611739	11p12	{Osteoporosis}	166710	AD	2
607622	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
604862	2p13.3	[?Birbeck granule deficiency]	613393	_	3
608489	7q22.1	Premature ovarian failure 8	615723	AR	3
609689	20q11.22	Cone-rod dystrophy and hearing loss 2	618358	AR	3
608808	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
606978	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
612291	3q11.1-q11.2	Joubert syndrome 8	612291	AR	3
609889	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
611770	8p21.2	Conotruncal heart malformations	217095	_	3
611770	8p21.2	Persistent truncus arteriosus	217095	_	3
612285	4p15.32	Joubert syndrome 9	612285	AR	3
610083	4q34.3-q35.1	Microphthalmia, isolated, with coloboma 9	615145	AR	3
604809	6p21.3	Panbronchiolitis, diffuse	604809	Mu	2
609273	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
612222	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
611185	6p21	{Restless legs syndrome 6}	611185	_	2
610725	10q23.33	Nephrotic syndrome, type 3	610725	AR	3
612411	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
612411	4q28.1	Van Maldergem syndrome 2	615546	AR	3
610568	1q21.3	Paget disease of bone 6	616833	AD	3
611722	10q22.1	Krabbe disease, atypical	611722	AR	3
611105	1q25.1	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3
612138	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
612465	13q22.2	{Diabetes mellitus, noninsulin-dependent, 5}	616087	_	3
610170	5p13	Kyphoscoliosis 1	610170	_	2
610446	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
608968	20q12	Duane retraction syndrome 3	617041	AD	3
608968	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
612448	8q24.13-q24.22	{Age-related hearing impairment 1}	612448	_	2
609173	15q15.1	Microcephaly 4, primary, autosomal recessive	604321	AR	3
611590	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
603539	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
612079	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
612348	8p12	?Thrombophilia due to decreased release of tissue plasminogen	_	_	1
608075	12p12.3	?Spermatogenic failure 17	617214	AR	3
611648	5q21.1	Deafness, autosomal recessive 100	618422	AR	3
611687	6q13	Hydatidiform mole, recurrent, 2	614293	AR	3
610217	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
610294	6p25.3-p22.3	{Intelligence QTL3}	610294	_	2
612267	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
609690	2q36.1	Rajab interstitial lung disease with brain calcifications	613658	AR	3
604594	2p21	Short stature with microcephaly and distinctive facies	615789	AR	3
611766	15q22.31	Combined oxidative phosphorylation deficiency 15	614947	AR	3
611766	15q22.31	Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3
612923	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
607736	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
608025	2p24.3	Infantile liver failure syndrome 2	616483	AR	3
608025	2p24.3	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3
612775	8p11.22	Cone-rod dystrophy 9	612775	_	3
611223	1q43-q44	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3
607492	11q13.1-q13.2	Schuurs-Hoeijmakers syndrome	615009	AD	3
610618	5q35.3	Angioedema, hereditary, type III	610618	AD	3
613085	14q24.3	Glaucoma 3, primary congenital, C	613085	_	2
610143	12p13.2-p11.23	Deafness, autosomal recessive 62	610143	AR	2
612958	17q23.3	Mitochondrial complex IV deficiency	220110	Mi,AR	3
612716	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
612176	1p32.1	Bone marrow failure syndrome 4	618116	AR	3
613092	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
608448	3p26	{Inflammatory bowel disease 9}	608448	_	2
611994	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
611771	19q13.32	Lipoprotein glomerulopathy	611771	_	3
611603	12q13.12	Lissencephaly 3	611603	AD	3
604863	4q32.1	Leber congenital amaurosis 14	613341	AR	3
604863	4q32.1	Retinal dystrophy, early-onset severe	613341	AR	3
604863	4q32.1	Retinitis pigmentosa, juvenile	613341	AR	3
613168	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
612286	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
613161	22q11.23	Beta-ureidopropionase deficiency	613161	AR	3
611459	4q31.22	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3
612192	6p22.1	Diabetes mellitus, transient neonatal, 1	601410	AD	3
612224	4q31	{Stature QTL 12}	612224	_	2
609165	17q21.2	Ichthyosis with confetti	609165	AD	3
613251	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
611945	8p21.1-q13.3	Spastic paraplegia 37, autosomal dominant	611945	AD	2
612132	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
613027	16p11.2	Glycogen storage disease IXc	613027	AR	3
610295	2q24.1-q31.1	{Intelligence QTL3}	610295	_	2
613265	20q13.32	Waardenburg syndrome, type 4B	613265	AR,AD	3
613235	1q31.3	Factor XIIIB deficiency	613235	AR	3
612518	14q21.3	Ciliary dyskinesia, primary, 10	612518	_	3
613228	4q34.3	Aspartylglucosaminuria	208400	AR	3
611307	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
612690	15q15.2	Spherocytosis, type 5	612690	_	3
610508	2p25.1	Maturity-onset diabetes of the young, type VII	610508	_	3
609820	1q42.2	Erythrocytosis, familial, 3	609820	AD	3
610836	1q41-q42	{Autism susceptibility 11}	610836	_	2
612350	11p11.2	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3
608026	9q31-q32	Hypertensive nephropathy	608026	_	2
612924	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
612268	14q24.3	Cone-rod dystrophy 19	615860	AR	3
613179	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
613413	7p21.3	Leukodystrophy, hypomyelinating, 16	617964	AD	3
608316	2q21.1-q22	{Coronary heart disease, susceptibility to, 2}	608316	_	2
612080	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
611203	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
609946	2p25.1-p24.3	Deafness, neurosensory, autosomal recessive 47	609946	AR	2
610921	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
611224	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
609562	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
609562	8q13.2	Febrile seizures, familial, 11	614418	AR	3
613086	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
613019	11q12.2	Paragangliomas 2	601650	AD	3
604597	12q14.3	Fraser syndrome 3	617667	AR	3
612647	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
612406	20p11.2-q13.12	Dystonia-17, primary torsion	612406	AR	2
608931	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
609456	4p16.3	Muscular dystrophy, congenital, merosin-positive	609456	AR	2
608537	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
608537	3p25.3	Hemangioblastoma, cerebellar, somatic	_	_	3
608537	3p25.3	Pheochromocytoma	171300	AD	3
608537	3p25.3	Renal cell carcinoma, somatic	144700	_	3
608537	3p25.3	von Hippel-Lindau syndrome	193300	AD	3
611469	8q24	{Colorectal cancer, susceptibility to, 2}	611469	_	2
612292	8q24.3	Birk-Barel mental retardation dysmorphism syndrome	612292	_	3
613480	1q42.13	Lymphatic malformation 3	613480	AD	3
608622	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
613169	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
609275	1q41	Martsolf syndrome	212720	AR	3
609275	1q41	Warburg micro syndrome 2	614225	AR	3
613098	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
610619	5q35.3	Angioedema, hereditary, type III	610618	AD	3
610619	5q35.3	Factor XII deficiency	234000	AR	3
612959	8q22.1	?Deafness, autosomal recessive 109	618013	AR	3
610178	14q23.1	Joubert syndrome 23	616490	AR	3
610178	14q23.1	Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3
610357	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
613541	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
613541	12q24.31	Spastic paraplegia 55, autosomal recessive	615035	AR	3
611357	6q14.1	Osteogenesis imperfecta, type XVIII	617952	AR	3
613695	21q22.12	Long QT syndrome 5	613695	AD	3
611252	14q12-q21	Spastic paraplegia 32, autosomal recessive	611252	AR	2
612287	17q25.1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3
609270	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
613719	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
613028	10q23.31	{Glioma susceptibility 2}	613028	_	3
613728	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
612437	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
612925	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
613768	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
611421	16p11.2	Floating-Harbor syndrome	136140	AD	3
612444	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
612529	11q22.2	Amelogenesis imperfecta, type IIA2	612529	AR	3
613744	15q21.2	Spastic paraplegia 51, autosomal recessive	613744	AR	3
606675	14q11-q12	{Inflammatory bowel disease 4}	606675	_	2
608595	7p14.3	{Asthma, susceptibility to, 2}	608584	_	3
612186	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
612186	15q21.2	?Polyendocrine-polyneuropathy syndrome	616113	AR	3
610448	3p21.31	Chilblain lupus	610448	AD	3
613153	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3
613762	5q11.2	46XY sex reversal 6	613762	AD	3
613835	1q31.3	Leber congenital amaurosis 8	613835	_	3
612225	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
608027	7q21.11	?Pontocerebellar hypoplasia, type 3	608027	AR	3
613162	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
613869	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
612757	8q24.3	Hyperlipoproteinemia, type 1D	615947	AR	3
613883	7q34	[Blood group, Kell]	110900	_	3
608932	16q22.3-q23.1	Keratoconus 2	608932	_	2
614037	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
613087	4q32.3	Atrial septal defect 6	613087	AD	3
612988	11q14.1	Optic atrophy 7	612989	AR	3
613521	1p34.1	Porphyria cutanea tarda	176100	AR,AD	3
613521	1p34.1	Porphyria, hepatoerythropoietic	176100	AR,AD	3
609367	10q22.1	Goldberg-Shprintzen megacolon syndrome	609460	AR	3
614044	7q34	Trypsinogen deficiency	614044	AR	1
613500	22q11.23	Agammaglobulinemia 2	613500	AR	3
613099	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
612293	1p31.3-p31.1	Porokeratosis 5, disseminated superficial actinic	612293	_	2
611849	2q36.1	?Combined oxidative phosphorylation deficiency 16	615395	AR	3
610361	13q33.1-q34	Orofacial cleft 9	610361	_	2
612199	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
611958	11q13	{Prostate cancer, hereditary, 14}	611958	_	2
611891	9p21	{Aneurysm, familial abdominal 3}	611891	_	2
613553	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613230	19q13.11	Prolidase deficiency	170100	AR	3
612288	10q23-q24	{Inflammatory bowel disease 20}	612288	_	2
613920	2q11.2	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3	616500	AR	3
612051	16q21	Spinocerebellar ataxia 31	117210	AD	3
611553	3p25.2	Noonan syndrome 5	611553	AD	3
609271	2p24	Keratoconus 4	609271	_	2
604632	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
613252	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
613636	11p14	[Tuberculin skin test reactivity, absence of]	613636	_	2
608769	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
607883	17p13.2	Riboflavin deficiency	615026	AD	3
609276	11q25	Microcephaly 22, primary, autosomal recessive	617984	AR	3
613720	20q13.33	Epileptic encephalopathy, early infantile, 7	613720	AD	3
614237	10q11.23-q22.3	Hypotrichosis 9	614237	AR	2
611134	12q21.32	Meckel syndrome 4	611134	AR	3
614303	15q25.1	EDICT syndrome	614303	AD	3
614067	14q12	Spastic paraplegia 52, autosomal recessive	614067	AR	3
611623	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
614258	10q22.3	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3
614258	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
608439	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
614402	10q25.3	?Microphthalmia, syndromic 11	614402	AR	3
614374	6p21.33	[Blood group, Rodgers]	614374	_	3
609479	2q31.1	Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3
609479	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
613763	11q23.1	Cataract 16, multiple types	613763	AR,AD	3
614280	2q33-q36	{Epilepsy, juvenile myoclonic, susceptibility to, 9}	614280	AD	2
613884	13q14	Chromosome 13q14 deletion syndrome	613884	IC,AD	4
614478	12q13.12	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
613224	1p13.2	Noonan syndrome 6	613224	AD	3
614319	18q12.3	Vesicoureteral reflux 6	614319	_	2
614039	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
612462	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
612926	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
614381	12q23.3	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3
613021	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
613164	1q32	{Parkinson disease 16}	613164	_	2
613029	13q13.1	{Glioblastoma 3}	613029	AR	3
613969	5p15.1-p13.3	Myopia 19	613969	AD	2
612226	4p15.3	{Stature QTL 13}	612226	_	2
614433	6q24.1	Atrial septal defect 8	614433	AD	3
613289	13q21	Spinocerebellar ataxia 8	608768	AD	3
614135	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
609948	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
613836	16q23.3	{Adiponectin, serum level of, QTL5]	613836	_	2
611862	1q23.2	[White blood cell count QTL]	611862	AR	3
613814	17p12	Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3
614120	15q26.1	?Hydrolethalus syndrome 2	614120	AR	3
612082	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
614165	5p15.33	Paragangliomas 5	614165	AD	3
614199	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
613154	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3
613192	8q24.3	Mental retardation, autosomal recessive 13	613192	AR	3
613176	19q13.31	Heart and brain malformation syndrome	616920	AR	3
612989	11q14.1	Optic atrophy 7	612989	AR	3
613870	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
614616	12p12.3	Diarrhea 6	614616	AD	3
613958	12q14.2	Spermatogenic failure 9	613958	AR	3
610374	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
613915	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
611096	16p12.2-q12.1	Mental retardation, autosomal recessive 10/20	611096	AR	2
613064	11q13.5	{Dermatitis, atopic, susceptibility to, 7}	613064	_	2
611554	3p25.2	LEOPARD syndrome 2	611554	_	3
612758	4p15.32	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3
611236	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
614672	7q21.2	?Cardiomyopathy, dilated, 2B	614672	AR	3
613721	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
613794	1p31.3	Retinitis pigmentosa 20	613794	AR	3
614238	7p22.3-p21.3	Hypotrichosis 10	614238	AR	2
614382	11q24.2	{Bacteremia, protection against}	614382	_	3
614727	4q12	Congenital disorder of glycosylation, type IIk	614727	AR	3
609806	11q23.3	Porphyria, acute intermittent	176000	AD	3
609806	11q23.3	Porphyria, acute intermittent, nonerythroid variant	176000	AD	3
614691	7q34	Cataract 38, autosomal recessive	614691	AR	3
614290	18p	Tetrasomy 18p	614290	_	4
613340	4q24-q28	Epilepsy, hot water, 2	613340	_	2
608770	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
607904	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
607904	16p13.3	{Epilepsy, childhood absence, susceptibility to, 6}	611942	_	3
607904	16p13.3	{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942	_	3
613854	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
613970	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
612463	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
613165	17q25.3	Desbuquois dysplasia 1	251450	AR	3
613165	17q25.3	Epiphyseal dysplasia, multiple, 7	617719	AR	3
613522	7q32.1	Colorblindness, tritan	190900	AD	3
614375	12q13.3	Aortic aneurysm, familial abdominal, 4	614375	_	2
612227	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AR,AD	3
603909	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
609168	3p24.3	Chronic atrial and intestinal dysrhythmia	616201	AR	3
609678	13q31.1	?Trichotillomania	613229	Mu,AD	3
609678	13q31.1	Tourette syndrome	137580	AD	3
614852	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613573	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
614166	13q12.12	Myopia 20, autosomal dominant	614166	_	2
613885	12q24.31	?Meckel syndrome 8	613885	AR	3
614193	6p22.2	[Transferrin serum level QTL2]	614193	_	3
613837	7q32.1	Leber congenital amaurosis 11	613837	AD	3
614501	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
614976	19q13.2	Carpenter syndrome 2	614976	AR	3
614397	1p34.2	Microcephaly 15, primary, autosomal recessive	616486	AR	3
612289	1p13.3	Fontaine progeroid syndrome	612289	AD	3
614893	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
612759	2q24.1	Synesthesia	612759	_	2
613916	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
614389	1q24.2	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3
611863	4p16-p15	Microtia with nasolacrimal duct imperforation and eye coloboma	611863	_	4
613022	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
614863	6p21.1	Peroxisome biogenesis disorder 4B	614863	AR,AD	3
614383	3p21.2	{Bacteremia, susceptibility to}	614383	_	3
613156	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
613959	7q36.3	Schizophrenia 16	613959	_	4
613089	3q26.32	CLAPO syndrome, somatic	613089	_	3
615103	18p11.21	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction	617732	AD	3
613765	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
612990	20q11.21	Bohring-Opitz syndrome	605039	AD	3
612990	20q11.21	Myelodysplastic syndrome, somatic	614286	_	3
614434	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
613307	9q34.3	Deafness, autosomal recessive 79	613307	AR	3
613829	19q13.33	Leber congenital amaurosis 7	613829	_	3
613068	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
613177	19q13.2	Cutis laxa, autosomal recessive, type IC	613177	AR	3
615214	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
613030	9p21.3	{Glioma susceptibility 5}	613030	_	2
612221	3q23	{Stature QTL 10}	612221	_	2
610204	17q25.1	?Pontocerebellar hypoplasia type 5	610204	AR	3
614654	16q21	Coenzyme Q10 deficiency, primary, 5	614654	AR	3
614728	3q22.2	?Seckel syndrome 6	614728	AR	3
608771	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
608771	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
614068	14q24.3	?Cranioectodermal dysplasia 3	614099	AR	3
614068	14q24.3	?Retinitis pigmentosa 81	617871	AR	3
614068	14q24.3	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3
614661	15q21.1	Oocyte maturation defect 4	617743	AR	3
614194	19p13.2	Adams-Oliver syndrome 2	614219	AR	3
612182	8p22	[Acetylation, slow]	243400	AR	3
614698	1q44	Mitochondrial complex IV deficiency	220110	Mi,AR	3
614480	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
613855	2q23.3	Episodic ataxia, type 5	613855	AD	3
612410	18p11.23	{Psoriasis susceptibility 10}	612410	_	2
614369	19q13.33	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3
613501	19q13.2	Agammaglobulinemia 3	613501	AR	3
614305	11p11.2	Sclerosteosis 2	614305	AR,AD	3
614320	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
613523	8p11	Chromosome 8p11 myeloproliferative syndrome	613523	_	4
613308	6p21.31	Diamond-Blackfan anemia 9	613308	AD	3
613157	1p34.1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3
614294	15q25	Chromosome 15q25 deletion syndrome	614294	AD	4
613726	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
614692	6p21.3	{?Membranous nephropathy, susceptibility to}	614692	_	2
614376	4p14	?Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3
614404	17q25.1	Tylosis with esophageal cancer	148500	AD	3
611360	15q26.1	Fanconi anemia, complementation group I	609053	AR	3
610205	1p12	Alagille syndrome 2	610205	AD	3
614201	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
612438	19p13.3	Leukodystrophy, hypomyelinating, 6	612438	AD	3
615284	22q13.33	Charcot-Marie-Tooth disease, type 4B3	615284	AR	3
611254	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
611254	15q26.1	?Hydrolethalus syndrome 2	614120	AR	3
611254	15q26.1	Acrocallosal syndrome	200990	AR	3
611254	15q26.1	Joubert syndrome 12	200990	AR	3
613025	15q13	{Schizophrenia, susceptibility to, 13}	613025	_	2
613062	9p21	{Basal cell carcinoma, susceptibility to, 5}	613062	_	2
611097	19q13.2-q13.3	Mental retardation, autosomal recessive, 11	611097	AR	2
613979	20q13.33	Retinitis pigmentosa 60	613983	AD	3
615300	3p21.31	Perrault syndrome 4	615300	AR	3
613838	4q26	Cardiomyopathy, hypertrophic, 16	613838	AD	3
615440	17p12	Combined oxidative phosphorylation deficiency 17	615440	AR	3
614982	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
614982	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
615548	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
614283	7p21.3	{Glucocorticoid therapy, response to}	614400	_	3
613488	12q13.1	Myxoid liposarcoma	613488	_	4
607905	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
607905	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
614195	20p11.21	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	_	3
613871	15q25.1	Tyrosinemia, type I	276700	AR	3
614306	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
614668	16q12.1-q23.1	Stuttering, familial persistent, 4	614668	_	2
613750	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
614321	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
615374	4p15.33	Cone-rod dystrophy 18	615374	AR	3
614295	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
613070	22q13.31	Liver failure, transient infantile	613070	AR	3
614699	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
614655	3q13.2-q13.33	Stuttering, familial persistent, 3	614655	_	2
614866	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
615611	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
614390	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
615538	22q13	Chromosome 22q13 duplication syndrome	615538	IC	4
614378	4p14	?Cranioectodermal dysplasia 4	614378	AR	3
615670	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
613489	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
614483	13q34	Brain small vessel disease 2	614483	AD	3
615521	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
613502	10q24.1	?Agammaglobulinemia 4	613502	AR	3
614908	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
614122	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
613233	11q21-q22	[Fasting plasma glucose level QTL 3]	613233	_	2
613018	16q22.2	Tyrosinemia, type II	276600	AR	3
614202	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
615726	12q13.13	Pachyonychia congenita 3	615726	_	3
614370	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
615158	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
615242	1p36.32	[Blood group, Vel system]	615264	AR	3
613839	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
613960	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
615285	1q21.2	Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3
615441	6q22.31	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	AR	3
615612	3p22.2	Developmental dysplasia of the hip 2	615612	AD	2
616120	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
616079	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
614669	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AR,AD	3
616032	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
613026	19q13.11	Chromosome 19q13.11 deletion syndrome, distal	613026	AD	4
614284	1p34.2	?Stickler syndrome, type V	614284	AR	3
615629	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
614307	5p13.2	Alpha-methylacyl-CoA racemase deficiency	614307	AR	3
613872	13q34	Factor X deficiency	227600	AR	3
613411	13q34	Oguchi disease-2	613411	_	3
615872	5q11.2	Ciliary dyskinesia, primary, 29	615872	AR	3
610212	6p22.3	?Deafness, autosomal recessive 66	610212	AR	3
615369	15q26.1	Epileptic encephalopathy, childhood-onset	615369	AD	3
615558	2p24.1	Hypobetalipoproteinemia	615558	AR	3
614346	12q13.11-q15	Mental retardation, autosomal recessive 25	614346	AR	2
614196	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
615423	3q12.3	Combined oxidative phosphorylation deficiency 30	616974	AR	3
615760	3p21.31	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3
615412	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
615849	2q14.2	Culler-Jones syndrome	615849	AD	3
616178	17q12	?Deafness, autosomal recessive 99	618481	_	3
609457	12q23.1	[Histidinemia]	235800	AR,AD	3
615522	6q23.2	Cole disease	615522	AD	3
614123	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
613516	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
614810	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
613637	5p15	[Tuberculin skin test reactivity QTL]	613637	_	2
615348	3p22.1	Nemaline myopathy 8, autosomal recessive	615348	_	3
614435	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
612322	2q33.3	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
615785	17q21.2	White sponge nevus 2	615785	AD	3
613727	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
613524	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
613524	1q43-q44	Senior-Loken syndrome 7	613615	_	3
616080	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
616025	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
615413	10q26.11	Spermatogenic failure 12	615413	AD	3
613751	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
615850	17p13.3	Pontocerebellar hypoplasia, type 2E	615851	AR	3
615630	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
616362	19q13.41	Mental retardation, autosomal dominant 36	616362	AD	3
615618	3q13.33	?Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3
615618	3q13.33	Dowling-Degos disease 4	615696	AD	3
615370	9q22.33	Nephronophthisis 16	615382	AR	3
614203	16q11.2	{Parkinson disease 17}	614203	AD	3
616265	19q13.11	?Peeling skin syndrome 3	616265	AR	3
615021	3q26.1	[Blood group, globoside system]	615021	_	3
615559	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
612414	11q13.4	Deafness, autosomal recessive 63	611451	AR	3
615112	1p13.2	Urofacial syndrome 2	615112	AR	3
615424	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
613517	2q37.1	Microphthalmia, isolated 6	613517	AR	3
615873	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
614318	13q33.2	Vesicoureteral reflux 5	614318	_	2
615885	13q12.2	Hypotrichosis 12	615885	AD	3
615643	17q21.2	Neurodegeneration with brain iron accumulation 6	615643	AR	3
615761	3p25.3	Mental retardation, autosomal dominant 23	615761	AD	3
615107	10q23.31	Cowden syndrome 4	615107	_	3
613312	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
615349	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
616222	14q32	Temple syndrome	616222	AD	4
612346	22q11.23	?Glutathioninuria	231950	AR	3
613767	16q21	Retinitis pigmentosa 45	613767	AR	3
615539	6q22.1	Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3
616012	3p25.3	Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3
616172	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
615523	15q25.3	Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3
614347	6q26-q27	Mental retardation, autosomal recessive 28	614347	AR	2
615113	15q26.3	Microphthalmia, isolated 8	615113	AR	3
614954	9q31.1	Congenital heart defects, multiple types, 3	614954	AD	2
615802	2q33.1	Mental retardation, autosomal recessive 42	615802	AR	3
613980	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
616406	1q42.12	Leukodystrophy, hypomyelinating, 10	616420	AR	3
616580	9q21.32	Au-Kline syndrome	616580	AD	3
615631	15q14	Dyserythropoietic anemia, congenital, type Ib	615631	AR	3
616111	11q12.3	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3
612778	3p21.31	Luscan-Lumish syndrome	616831	AD	3
614856	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
616455	8p21.3	Zimmermann-Laband syndrome 2	616455	AD	3
616494	6p21.1	Leukodystrophy, hypomyelinating, 11	616494	AR	3
611100	8q24	{Prostate cancer, hereditary, 10}	611100	_	2
614041	13q14.2	Bladder cancer, somatic	109800	_	3
614041	13q14.2	Osteosarcoma, somatic	259500	_	3
614041	13q14.2	Retinoblastoma	180200	SMu,AD	3
614041	13q14.2	Retinoblastoma, trilateral	180200	SMu,AD	3
614041	13q14.2	Small cell cancer of the lung, somatic	182280	_	3
614696	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
613412	5q22	{Esophagitis, eosinophilic, 2}	613412	Mu	2
614770	19p13.2	Mitochondrial complex IV deficiency	220110	Mi,AR	3
613873	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
616368	5q31.1	CHOPS syndrome	616368	AD	3
615350	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
613313	19q13.12	Hemochromatosis, type 2B	613313	AR	3
615582	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
616144	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
615244	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
615425	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
611317	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
616726	16q24.3	Ciliary dyskinesia, primary, 33	616726	AR	3
614671	16p11.2	Chromosome 16p11.2 duplication syndrome	614671	_	4
614671	16p11.2	{Autism, susceptibility to, 14B}	614671	_	2
608796	8q23	Moyamoya disease 3	608796	_	2
615779	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
614730	9p13.3	Hyperphosphatasia with mental retardation syndrome 2	614749	AR	3
614828	3p22.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AR	3
614828	3p22.1	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3
616461	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
615022	12p11.2-q13.1	Ichthyosis, congenital, autosomal recessive 7	615022	AR	2
613684	22q13.2	Rubinstein-Taybi syndrome 2	613684	AD	3
604569	7q35-q36	Cortical dysplasia-focal epilepsy syndrome	610042	AR	3
604569	7q35-q36	Pitt-Hopkins like syndrome 1	610042	AR	3
604569	7q35-q36	{Autism susceptibility 15}	612100	_	3
615101	6p25.2	Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3
614486	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
616228	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
612347	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
613193	16q24.1	Ciliary dyskinesia, primary, 13	613193	AR	3
613554	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
612898	9q34.11	Coenzyme Q10 deficiency, primary, 7	616276	AR	3
613886	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
613795	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
615560	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
613575	3q11.2	?Retinitis pigmentosa 55	613575	_	3
616835	6p22.3	Meier-Gorlin syndrome 6	616835	AD	3
614673	4q12	Microcephaly 8, primary, autosomal recessive	614673	AR	3
613518	4q22.1	{Dermatitis, atopic, susceptibility to, 8}	613518	_	2
613882	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
614701	8q24.11	Cornelia de Lange syndrome 4	614701	AD	3
615414	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
615712	5p15.2	Autoinflammation, panniculitis, and dermatosis syndrome	617099	AR	3
615266	5q31.3	Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3
615632	11q13.1	Neuropathy, hereditary sensory, type IF	615632	AD	3
614198	17q23.3	Myasthenic syndrome, congenital, 16	614198	AR	3
615402	2q35	Dyschromatosis universalis hereditaria 3	615402	AD	3
616763	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
616721	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
616975	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
615426	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
616969	6q21	?Deafness, autosomal dominant 66	616969	AD	3
614857	14q24.3	Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3
614008	11q13.1	Nestor-Guillermo progeria syndrome	614008	AR	3
616266	13q32.3-q33.1	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3
614296	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
610564	6q21	Coenzyme Q10 deficiency, primary, 3	614652	AR	3
616364	1q21.3	White-Sutton syndrome	616364	AD	3
616947	10q26.3	?Premature ovarian failure 12	616947	AR	3
616145	13q32.1	Catel-Manzke syndrome	616145	AR	3
614042	10q23.31	Moyamoya disease 5	614042	_	3
616027	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
615540	19q13.12	Deafness, autosomal recessive 76	615540	AR	3
616786	15q15.1	Nephronophthisis 20	617271	AR	3
615583	8q24.3	Verheij syndrome	615583	AD	3
614184	2q37.1	Perlman syndrome	267000	AR	3
617156	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
616922	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
615351	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
614485	9p22.3	Trigonocephaly 2	614485	AD	3
616224	2p21	Myasthenic syndrome, congenital, 22	616224	AR	3
617132	3q22.1	Epileptic encephalopathy, early infantile, 44	617132	AR	3
617052	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
611451	11q13.4	Deafness, autosomal recessive 63	611451	AR	3
614731	17p12	{Prostate cancer, hereditary, 2, susceptibility to}	614731	_	3
616941	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
614930	8q24.22	Ciliary dyskinesia, primary, 19	614935	AR	3
613084	2p25.3	Mental retardation, autosomal dominant 39	616521	AD	3
614385	14q24.3	Colorectal cancer, hereditary nonpolyposis, type 7	614385	_	3
613887	9q22.33	Cataract 36	613887	AR	3
615108	3q26.32	Cowden syndrome 5	615108	_	3
616013	4q23	Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3
615673	10q22.1	Myopathy with extrapyramidal signs	615673	AR	3
614149	17q25.1-q25.3	Nail disorder, nonsyndromic congenital, 9	614149	AR	2
611431	15q14	Legius syndrome	611431	AD	3
614036	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
616779	10q26.13	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	616779	AD	3
617173	15q21.2	Intellectual developmental disorder with cardiac arrhythmia	617173	AR	3
614302	3p25.1	Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3
616138	10q24.31	Perrault syndrome 5	616138	AR	3
613796	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
616270	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
616299	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
613856	1p13.3	Achromatopsia 4	613856	_	3
614409	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
614495	5q31.2	Pseudohypoaldosteronism, type IID	614495	AR,AD	3
616509	21q22.3	Cataract 44	616509	AR	3
616457	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
617234	1p36.13	Preimplantation embryonic lethality 2	617234	AR	3
616028	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
616948	2q11.2	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3
617168	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
616229	11p11.2	Osteogenesis imperfecta, type XVI	616229	AR	3
614813	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
617260	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
615803	11q12.1	Pontocerebellar hypoplasia, type 10	615803	AR	3
615620	19q13.32	Mental retardation, autosomal recessive 41	615637	AR	3
614732	11p15.4	IMAGE syndrome	614732	AD	3
615633	9q34.11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3
614772	1q42.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	616501	AR	3
611101	1p36.31	Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3
611101	1p36.31	Spinal muscular atrophy, distal, autosomal recessive, 4	611067	AR	3
615545	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
617574	12q13.3	Ichthyosis, congenital, autosomal recessive 13	617574	AR	3
617041	20q12	Duane retraction syndrome 3	617041	AD	3
615973	12q21.33	Cone-rod dystrophy 20	615973	AR	3
615415	17q11.2	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3
614162	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
617187	20q11.21	Spermatogenic failure 16	617187	AR	3
617391	1q44	Epileptic encephalopathy, early infantile, 54	617391	AD	3
615040	8q21.11	?Episodic pain syndrome, familial, 1	615040	AD	3
614386	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
614386	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
614386	16p11.2	Seizures, benign familial infantile, 2	605751	AD	3
616271	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
616780	10p15.3	Oocyte maturation defect 2	616780	AR,AD	3
617113	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
617600	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
615433	3q13.31	Chromosome 3q13.31 deletion syndrome	615433	AD	4
617744	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
616146	13q32.1	Catel-Manzke syndrome	616145	AR	3
614496	2q36.2	Pseudohypoaldosteronism, type IIE	614496	AD	3
612899	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
616029	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
616680	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
617898	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
616655	19q13.1-q13.2	?Cataract 45	616851	AR	3
616139	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
614436	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
617575	10q22.1	Nephrotic syndrome, type 14	617575	AR	3
612940	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
613576	7p21.2-p14.3	Ectodermal dysplasia-syndactyly syndrome 2	613576	AR	2
616977	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
617242	4q13.1	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	3
613799	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
617169	19p13.3	?Sotos syndrome 3	617169	AR	3
617807	19p13.2	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3
617133	3q22.1	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3
614980	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
617188	19q13.42	Mental retardation, autosomal recessive 57	617188	AR	3
614867	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
617952	6q14.1	Osteogenesis imperfecta, type XVIII	617952	AR	3
617235	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
617294	3q27.1	Epidermolysis bullosa simplex, generalized, with scarring and hair loss	617294	AD	3
614940	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
616681	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
617337	1p36.11	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3
608072	6p22.3	Epilepsy, progressive myoclonic 2B (Lafora)	254780	AR	3
615206	7p22.2	Immunodeficiency 11A	615206	AR	3
614807	16p13.3	?Centronuclear myopathy 4	614807	AD	3
617048	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
616458	9q34.12	Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3
615762	5q32	?Deafness, autosomal recessive 101	615837	AR	3
617991	6q14.1	Developmental delay, intellectual disability, obesity, and dysmorphic features	617991	AD	3
617114	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
614497	2q35	Microphthalmia, isolated, with coloboma 7	614497	AD	3
615416	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
615416	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
615439	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
616781	1p36.32	Joubert syndrome 25	616781	AR	3
613519	3p24	{Dermatitis, atopic, susceptibility to, 9}	613519	_	2
617770	19q13.2	?Spinocerebellar ataxia 46	617770	AD	3
615115	18q12.1	Bainbridge-Ropers syndrome	615485	AD	3
618005	14q23.3	Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3
617576	3p21.1	Spermatogenic failure 18	617576	AR	3
612779	1p21.3	5-fluorouracil toxicity	274270	AR	3
612779	1p21.3	Dihydropyrimidine dehydrogenase deficiency	274270	AR	3
615462	7q36.3	Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3
615816	6q14.1	Immunodeficiency 23	615816	AR	3
617808	12q12	Coffin-Siris syndrome 6	617808	AD	3
617935	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
616452	7p22.2	B-cell expansion with NFKB and T-cell anergy	616452	AD	3
617946	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
617035	6p12.3	Patent ductus arteriosus 2	617035	AD	3
618013	8q22.1	?Deafness, autosomal recessive 109	618013	AR	3
615578	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
616140	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
614808	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
615602	5q34	[Memory, enhanced, QTL]	615602	_	3
615999	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
614868	20q13.12	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	_	3
617435	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
614829	4q21.1	Amelogenesis imperfecta, type IIA4	614832	AR	3
614498	7p22.3	Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3
615109	14q32.33	Cowden syndrome 6	615109	_	3
615605	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
617243	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
617992	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
615616	10q21.3	Arrhythmogenic right ventricular dysplasia, familial, 13	615616	AD	3
618236	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
616722	9q21.12	?Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3
618084	1q21.3	Peeling skin syndrome 6	618084	AR	3
615757	20p11.23	Retinitis pigmentosa 69	615780	AR	3
615807	10q21.3	?Seckel syndrome 8	615807	AR	3
618014	5q31.1	?Premature ovarian failure 14	618014	AR	3
614809	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
617205	7p12.3	Heterotaxy, visceral, 8, autosomal	617205	AR	3
614441	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
618284	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
617190	2p23.3	Shashi-Pena syndrome	617190	AD	3
616749	10q26.2	Heterotaxy, visceral, 7, autosomal	616749	AR	3
614430	8p23.1	Atrioventricular septal defect 4	614430	AD	3
618138	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
615291	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
615291	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
616227	1p21.3	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3
617892	4q33	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3
617049	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
616973	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
617238	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
616943	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
615617	11q23.3	Immunodeficiency 19	615617	AR	3
616386	22q12.3	Dystonia 26, myoclonic	616398	AD	3
615758	1p35.2	?Immunodeficiency 22	615758	AR	3
618085	16q22.2	Spermatogenic failure 31	618112	AR	3
618257	5q13.2	?Deafness, autosomal recessive 112	618257	AR	3
616459	11q24.2	Al-Raqad syndrome	616459	AR	3
618266	17q21.2	Pontocerebellar hypoplasia, type 12	618266	AR	3
616000	4q13.3	Analbuminemia	616000	_	3
614830	3p22.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AR	3
618006	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
614163	17q25	{Delayed sleep phase syndrome, susceptibility to}	614163	AD	2
617153	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
615207	16p12.1	Immunodeficiency 56	615207	AR	3
615054	7q36.1	Glaucoma 1, open angle, F	603383	_	3
618341	17q25.1	Spermatogenic failure 35	618341	AR	3
617239	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
616657	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
616723	16q13	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3
618346	21q22.3	Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3
613868	18q12.3	[Blood group, Kidd]	111000	_	3
614499	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
616949	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
618213	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
617993	12p13.32	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	_	3
617577	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
617746	7p21.1	Sweeney-Cox syndrome	617746	AD	3
615859	1p31.3	Epileptic encephalopathy, early infantile, 23	615859	AR	3
617244	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
618097	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
617971	11p15.4	Methmoglobinemia, beta type	617971	_	3
615883	12q24.31	Myopathy, tubular aggregate, 2	615883	AD	3
616001	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
615604	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AR,AD	3
614260	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
615292	11q12.1	Gracile bone dysplasia	602361	AD	3
615292	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
613493	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
614869	15q25.1	Usher syndrome, type IJ	614869	AR	3
615842	17p13.2	?Spermatogenic failure 14	615842	AR	3
618242	14q12	Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3
618145	11q23.3	Deafness, autosomal recessive 111	618145	AR	3
618267	15q26.1	Epidermodysplasia verruciformis 3	618267	AR	3
616078	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
618300	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
618360	19p13.11	Brain small vessel disease 3	618360	AR	3
616724	12p13.2	Tooth agenesis, selective, 7	616724	AD	3
612780	1q23.2	SESAME syndrome	612780	AR	3
616546	14q23.1	Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3
617564	22q12.3	?Meier-Gorlin syndrome 8	617564	AR	3
618078	12q15	?Ovarian dysgenesis 6	618078	AR	3
617885	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
618248	15q22.31	Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3
618396	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
614850	19p13.3	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AR,AD	3
608797	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
616603	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
617667	12q14.3	Fraser syndrome 3	617667	AR	3
615546	4q28.1	Van Maldergem syndrome 2	615546	AR	3
614431	6q24.1	Ventricular septal defect 2	614431	AD	3
615371	2q34	{Pulmonary hypertension, neonatal, susceptibility to}	615371	_	3
614164	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
615759	2p25.1	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3
616658	19p13.3	Combined oxidative phosphorylation deficiency 37	618329	AR	3
618285	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
618140	7p14.3	?Deafness, autosomal dominant 74	618140	AD	3
617596	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
617268	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
614941	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
618146	12q24.31	Spermatogenic failure 33	618152	AR	3
617339	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
616366	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
617115	18q22.1	Peeling skin syndrome 5	617115	AR	3
618063	11q22.1	Ciliary dyskinesia, primary, 38	618063	AR	3
616974	3q12.3	Combined oxidative phosphorylation deficiency 30	616974	AR	3
616263	17q23.1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3
617672	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
615524	3p24.2	Microphthalmia, syndromic 12	615524	AR,AD	3
616298	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
615009	11q13.1-q13.2	Schuurs-Hoeijmakers syndrome	615009	AD	3
616950	10q26.3	?Spermatogenic failure 15	616950	AR	3
617994	13q13.1	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	_	3
618268	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
616954	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
618098	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
618397	5q13.3	Combined oxidative phosphorylation deficiency 39	618397	AR	3
618349	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
617241	15q13.1	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3
618286	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
617798	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
618147	14q32.2	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3
618000	7p13	Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3
615626	15q14	Dyserythropoietic anemia, congenital, type Ib	615631	AR	3
618141	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
617207	1q42.3	Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3
616367	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
617523	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
615547	15q11.2	Schaaf-Yang syndrome	615547	AD	3
616570	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
618243	2q37.3	Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3
618237	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
614088	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
618342	7q22.3	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3
617973	16p13.3	Methemoglobinemia, alpha type	617973	_	3
617343	6p24.2	Hyperparathyroidism 4	617343	AD	3
614851	14q22.1	?Seckel syndrome 7	614851	AR	3
615848	7q31.33	{Melanoma, cutaneous malignant, susceptibility to, 10}	615848	AD	3
610924	20p13	Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3
616944	3q26.32	Mental retardation, autosomal dominant 41	616944	AD	3
617116	3p21.31	Epilepsy, familial focal, with variable foci 2	617116	AD	3
617290	8p11.23	Epilepsy, early-onset, vitamin B6-dependent	617290	AR	3
615674	17p13.3	Dowling-Degos disease 3	615674	AD	2
616839	8q22.3	?Exercise intolerance, riboflavin-responsive	616839	AR	3
614474	18q11.2	Atrioventricular septal defect 5	614474	AD	3
618079	12q13.12	[Low density lipoprotein cholesterol level QTL 8]	618079	_	3
618287	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
616460	15q24.1	?Mental retardation, autosomal recessive 50	616460	AR	3
614089	14q11.2	Atrial septal defect 3	614089	_	3
614432	5q35.1	Ventricular septal defect 3	614432	AD	3
617732	18p11.21	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction	617732	AD	3
617974	4q35.1	?Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3
618148	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
617805	18q11.1-q11.2	Renal hypodysplasia/aplasia 3	617805	AD	3
616852	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
616617	6p21.1	Heimler syndrome 2	616617	AR	3
618371	17q12	Turnpenny-Fry syndrome	618371	AD	3
617895	12q24.11	Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3
617439	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
618356	1q32.1	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3
614475	18q11.2	Atrial septal defect 9	614475	AD	3
616300	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
618343	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
618456	17p11.2	Deafness, autosomal recessive 114	618456	AR	3
616792	11p15	{Neuroblastoma, susceptibility to, 7}	616792	_	2
617245	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
610925	3p25.3	Candidiasis, familial, 9	616445	AR	3
617771	1q31.3	?Epileptic encephalopathy, early infantile, 57	617771	AD	3
614944	12q21.31	Deafness, autosomal recessive 84B	614944	AR	3
618302	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
618235	5q31.3	?Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3
614437	11q13.1	Cutis laxa, autosomal recessive, type IB	614437	AR	3
618418	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
616112	3p14.1	Nemaline myopathy 10	616165	AR	3
613494	22q13.2	Immunodeficiency, common variable, 4	613494	AR	3
616604	14q32	{Myeloproliferative neoplasms, familial, susceptibility to}	616604	AD	4
617524	1p34.3	Erythrokeratodermia variabilis et progressiva 2	617524	AD	3
618264	17p13.1	Mirror movements 4	618264	AD	3
614090	14q11.2	{Sick sinus syndrome 3}	614090	_	3
618142	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
617572	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
617270	18q12.2	Mental retardation, autosomal recessive 58	617270	AR	3
618244	12q22	?Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3
616907	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
614257	20q11.23	?Mental retardation, autosomal dominant 11	614257	AD	3
617772	1q44	Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3
615010	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
618249	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
618149	3q28	Orofacial cleft 8	618149	_	3
618277	10q25.3	FINCA syndrome	618278	AR	3
618135	3p22.1	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3
618357	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
617228	13q12.12	Combined oxidative phosphorylation deficiency 31	617228	AR	3
617278	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
617036	11q13.5	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3
618419	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
617349	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
610926	10q11.2-q21	Tooth agenesis, selective, 5	610926	_	2
614265	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
613498	17p13	[Sex hormone-binding globulin circulating level QTL 1]	613498	_	2
617668	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
616113	15q21.2	?Polyendocrine-polyneuropathy syndrome	616113	AR	3
617598	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
618250	11q14.1	Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3
618150	16q22.1	Saul-Wilson syndrome	618150	AD	3
614751	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
610927	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
615607	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
614689	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
618372	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
617773	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
617599	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
614438	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
618278	10q25.3	FINCA syndrome	618278	AR	3
618457	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
618420	14q13.2	Spermatogenic failure 36	618420	AD	3
617669	2p25.3	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3
617579	13q32.1	HELIX syndrome	617671	AR	3
616946	10q11.23	Premature ovarian failure 11	616946	AD	3
614753	19p13.13	Sotos syndrome 2	614753	AD	3
617246	8q24.13	Seckel syndrome 10	617253	AR	3
618251	3q13.33	Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3
617350	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
617170	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
614816	1q41	Loeys-Dietz syndrome 4	614816	AD	3
616353	16p13.12	Dyskeratosis congenita, autosomal recessive 6	616353	AR	3
618304	17q25.1	Spermatogenic failure 35	618341	AR	3
616920	19q13.31	Heart and brain malformation syndrome	616920	AR	3
617670	16p13.3	?Spermatogenic failure 22	617706	AR	3
616030	7q31.32	Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3
618373	6q24.3-q25.1	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3
615780	20p11.23	Retinitis pigmentosa 69	615780	AR	3
618459	19q13.2	?Immunodeficiency 62	618459	AR	3
618345	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
616794	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
618245	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
616968	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
616354	6q14.3	Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3
618283	14q32.32-q32.33	?Visual impairment and progressive phthisis bulbi	618283	AR	3
617171	11p15.5	?Dyskinesia, seizures, and intellectual developmental disorder	617171	AR	3
617280	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
618254	11p15.5	Ciliary dyskinesia, primary, 39	618254	AR	3
617271	15q15.1	Nephronophthisis 20	617271	AR	3
616115	2p22.3	?Familial cold autoinflammatory syndrome 4	616115	AD	3
618460	7q36.3	Kahn-Kahn-Katsanis syndrome	618460	AR	3
618374	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
618144	17q24.2	Usher syndrome, type IV	618144	AR	3
618255	9p13.3	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3
617281	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
615781	2q36.1	{Psoriasis 15, pustular, susceptibility to}	616106	AD	3
618246	2q33.1	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3
617671	13q32.1	HELIX syndrome	617671	AR	3
616854	5q31.2	Even-plus syndrome	616854	AR	3
615715	9q22.32	Bone marrow failure syndrome 2	615715	AR	3
617743	15q21.1	Oocyte maturation defect 4	617743	AR	3
618377	1p33	?Pain sensitivity QTL1	618377	AD	4
617039	5q23.2	Patent ductus arteriosus 3	617039	AD	3
618383	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
618247	12p13.32	Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3
617275	1q43	Tooth agenesis, selective, 9	617275	AD	3
618378	1q25.1	?Combined oxidative phosphorylation deficiency 38	618378	AR	3
616795	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
616505	5q22.1	Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3
618362	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
616606	Chr.14	Ring chromosome 14 syndrome	616606	IC	4
618392	16q23.3-q24.1	?Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3
614826	1q31.3-q32.1	Nystagmus 7, congenital, autosomal dominant	614826	AD	2
618363	4q31.22	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3
616873	7p12.2	Immunodeficiency, common variable, 13	616873	AD	3
618381	11q13.1	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3
618364	12q13.13	?Myoclonus, familial, 2	618364	AD	3
618393	17p13.2	Fetal akinesia deformation sequence 4	618393	AR	3
617601	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
618394	6q15	Immunodeficiency 60	618394	AD	3
617276	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
618395	2p13.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3
616507	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
616937	20q11.23	?Thrombocytopenia 6	616937	AD	3
616938	17q21.2	Coffin-Siris syndrome 5	616938	AD	3
616939	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
604604	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
603736	10q22.2	SBBYSS syndrome	603736	AD	3
603201	2q31.1	Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3
603201	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
604169	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
604490	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
605606	1p	{Psoriasis susceptibility 7}	605606	_	2
606392	13q12.2	MODY, type IV	606392	_	3
603453	6p25.2	Immunodeficiency 57	618108	AR	3
605285	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
605461	22q11.1	Immunodeficiency 51	613953	AR	3
603961	7q21.11	{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3
605583	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
605648	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
603464	16q24.3	Al Kaissi syndrome	617694	AR	3
605829	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
604292	3q28	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3
605951	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
606812	1q43	Fumarase deficiency	606812	AR	3
606661	3p25.2-p25.1	{Melanoma, uveal, susceptibility to, 2}	606661	_	2
605525	16q24.3	Meier-Gorlin syndrome 4	613804	AR	3
603785	9p23	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3
603964	2q23-q24.3	Deafness, autosomal dominant 16	603964	AD	2
606941	11q23.1	Congenital disorder of glycosylation, type Il	608776	AR	3
606941	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
605282	15q26.3	Temtamy preaxial brachydactyly syndrome	605282	AR	3
606629	6q13	Cone-rod dystrophy 7	603649	_	3
605393	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
603094	3q26.1	[Blood group, globoside system]	615021	_	3
603094	3q26.1	[Blood group, P1PK system, P(k) phenotype]	111400	_	3
604356	2q31.1	Duane retraction syndrome 2	604356	_	3
603214	14q24.3	Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3
604278	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
607120	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
603693	8q23.1	46XY sex reversal 9	616067	AD	3
603693	8q23.1	Diaphragmatic hernia 3	610187	_	3
603693	8q23.1	Tetralogy of Fallot	187500	AD	3
606119	8q24.3	Meleda disease	248300	AR	3
607123	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
603683	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
605584	16q22.2	Retinitis pigmentosa 84	618220	AR	3
603783	4p16-q34	{Intelligence QTL1}	603783	_	2
606662	8p23	Waardenburg syndrome, type 2C	606662	_	2
606782	12p13.2	{Aspergillosis, susceptibility to}	614079	_	3
603617	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
603663	4p	{Mental health wellness-1}	603663	_	2
606664	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
605924	21q22.3	Galloway-Mowat syndrome 6	618347	AR	3
605924	21q22.3	Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3
604605	3q21.1-q21.2	{Coronary heart disease, susceptibility to, 5}	608901	_	3
603040	11q23	{Nonsmall cell lung cancer}	603040	_	2
605934	2q37.1-q37.3	Holoprosencephaly 6	605934	_	2
603029	4q35.1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}	613002	AR,AD	3
603029	4q35.1	{HIV1 infection, resistance to}	609423	_	3
603965	11q22.1	Glomerulosclerosis, focal segmental, 2	603965	AD	3
603892	17q21.31	Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3
606787	1p31	Peripheral arterial occlusive disease 1	606787	_	2
606107	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
605489	12q24.11	Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3
606682	22q12.1	Hermansky-Pudlak syndrome 4	614073	AR	3
604843	12p12.1	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3
606616	18p11.2	{Dyslexia, susceptibility to, 6}	606616	_	2
603454	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
604040	5q31.1	Nijmegen breakage syndrome-like disorder	613078	_	3
603780	8q24.3	Baller-Gerold syndrome	218600	AR	3
603780	8q24.3	RAPADILINO syndrome	266280	AR	3
603780	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
604250	7q22.1	Hemochromatosis, type 3	604250	AR	3
604121	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
607444	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
607444	7q11.21	{Aplastic anemia, susceptibility to}	609135	_	3
605391	10q23.2	{Thyroid carcinoma, follicular}	188470	SMu,AD	3
605958	3p21.31	Seckel syndrome 9	616777	AR	3
603959	3q28	Hypomagnesemia 3, renal	248250	AR	3
604765	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
605441	3q27.3	Adiponectin deficiency	612556	_	3
607429	10p12.1	Coenzyme Q10 deficiency, primary, 2	614651	AR	3
605608	21q22.13	Deafness, autosomal recessive 29	614035	AR	3
607107	4p15.1-q12	{Nasopharyngeal carcinoma 1}	607107	_	2
606680	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
605590	2q33.1	Myelodysplastic syndrome, somatic	614286	_	3
603098	7q34-q36	Deafness, autosomal recessive 13	603098	AR	2
606811	1p36.13	Hyperprolinemia, type II	239510	AR	3
606462	8q24.11	?Mungan syndrome	611376	AR	3
606462	8q24.11	Cornelia de Lange syndrome 4	614701	AD	3
603248	4q22.3	Acromesomelic dysplasia, Demirhan type	609441	AR	3
603248	4q22.3	Brachydactyly, type A1, D	616849	AD	3
603248	4q22.3	Brachydactyly, type A2	112600	AD	3
607752	5q11.2	Ciliary dyskinesia, primary, 29	615872	AR	3
605993	8q22.1	Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3
607636	11q13.2	van Buchem disease, type 2	607636	AD	3
603664	4q	{Mental health wellness-2}	603664	_	2
604498	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
603155	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
604357	4q31.3	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AR,AD	3
604489	5p13.2	Alpha-methylacyl-CoA racemase deficiency	614307	AR	3
604489	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
606200	12p12.1	[Short sleeper]	612975	AD	3
604001	7q21.2	?Long QT syndrome-11	611820	AD	3
606943	17q25.1	Usher syndrome, type 1G	606943	AR	3
606951	2q24.2	Aicardi-Goutieres syndrome 7	615846	AD	3
606951	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
605522	7q36.3	Acheiropody	200500	AR	3
605522	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
605522	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
605522	7q36.3	Polydactyly, preaxial type II	174500	AD	3
605522	7q36.3	Syndactyly, type IV	186200	AD	3
605522	7q36.3	Triphalangeal thumb, type I	174500	AD	3
605522	7q36.3	Triphalangeal thumb-polysyndactyly syndrome	174500	AD	3
605862	12q14.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3
607421	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
603194	11q12.2	Meckel syndrome 2	603194	AR	3
604260	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
604260	17q21.2	Leukemia, acute promyelocytic, somatic	102578	_	3
606835	12q24.11	Digital arthropathy-brachydactyly, familial	606835	AD	3
604187	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
603196	14q12	?Deafness, autosomal recessive 110	618094	AR	3
603196	14q12	Deafness, autosomal dominant 9	601369	AD	3
604294	10q25.3	?Microphthalmia, syndromic 11	614402	AR	3
607677	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
607218	7q32.1	{Inflammatory bowel disease 14}	612245	_	3
607218	7q32.1	{Systemic lupus erythematosus, susceptibility to, 10}	612251	_	3
607402	19q13.2	{Hepatitis C virus infection, response to therapy of}	609532	_	3
604895	17q21.32	Asthma and nasal polyps	208550	AR	3
604895	17q21.32	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
605921	11p15.4	Immunodeficiency 10	612783	AR	3
605921	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
605921	11p15.4	Stormorken syndrome	185070	AD	3
604443	5q31.1	Myelodysplastic syndrome	_	_	3
604443	5q31.1	Myelogenous leukemia, acute	_	_	3
605490	19p13.3	CODAS syndrome	600373	AR	3
603288	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
606681	5q35.3	Leukemia, acute myeloid	601626	SMu,AD	1
606681	5q35.3	Sotos syndrome 1	117550	AD	3
603855	19q13.2-q13.4	{Meconium ileus in cystic fibrosis, susceptibility to}	603855	_	2
607844	12q14.3	Buschke-Ollendorff syndrome	166700	AD	3
607844	12q14.3	Osteopoikilosis with or without melorheostosis	166700	AD	3
607407	10q26.3	Hypotonia, ataxia, and delayed development syndrome	617330	AD	3
604506	2q36.3	Mental retardation, autosomal dominant 49	617752	AD	3
607108	11p13	?Coloboma of optic nerve	120430	AD	3
607108	11p13	?Coloboma, ocular	120200	AD	3
607108	11p13	?Morning glory disc anomaly	120430	AD	3
607108	11p13	Aniridia	106210	AD	3
607108	11p13	Anterior segment dysgenesis 5, multiple subtypes	604229	_	3
607108	11p13	Cataract with late-onset corneal dystrophy	106210	AD	3
607108	11p13	Foveal hypoplasia 1	136520	AD	3
607108	11p13	Keratitis	148190	AD	3
607108	11p13	Optic nerve hypoplasia	165550	AD	3
606952	11q14.3	Albinism, oculocutaneous, type IB	606952	_	3
607871	2p16.3	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3
604766	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
604694	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
607340	9q22.33	Epileptic encephalopathy, early infantile, 59	617904	AD	3
607340	9q22.33	Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3
607340	9q22.33	{Nicotine dependence, protection against}	188890	_	3
607340	9q22.33	{Nicotine dependence, susceptibility to}	188890	_	3
608104	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608296	11q13.1	Thauvin-Robinet-Faivre syndrome	617107	AR	3
607678	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
608092	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	AR	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3
608041	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
608107	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
608107	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
608945	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
608945	13q13.3	Fraser syndrome 2	617666	AR	3
607213	16q11.2	Meier-Gorlin syndrome 3	613803	AR	3
604188	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
606945	19p13.2	Hypercholesterolemia, familial, 1	143890	AD	3
606945	19p13.2	LDL cholesterol level QTL2	143890	AD	3
608508	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
604041	17p13.1	Congenital disorder of glycosylation, type If	609180	AR	3
605558	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
608244	6p22.3-p21.3	Otosclerosis 3	608244	AD	2
607838	16p13.3	Mucolipidosis III gamma	252605	AR	3
604896	20p12.2	Bardet-Biedl syndrome 6	605231	AR	3
604896	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
603041	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
607751	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
604780	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
607352	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
605594	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
607539	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
607166	2q11.2	?Spermatogenic failure 26	617961	AR	3
603856	15q11.2	Precocious puberty, central, 2	615346	AD	3
608317	1p36.11	Van der Woude syndrome 2	606713	AD	3
609153	2q35-q36	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	2
605248	19p13.2	Mucolipidosis IV	252650	AR	3
608451	19q13.31	Ethylmalonic encephalopathy	602473	AR	3
608203	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
603197	19p13.2	?Laurence-Moon syndrome	245800	AR	3
603197	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
603197	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
603197	19p13.2	Spastic paraplegia 39, autosomal recessive	612020	AR	3
606554	1q42	Episodic ataxia, type 3	606554	AD	2
608105	16p12-p11.2	Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp	608105	AR	2
609814	1q31.3	Complement factor H deficiency	609814	AR,AD	3
610148	12q21.2	Bardet-Biedl syndrome 10	615987	AR	3
609634	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
603704	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
604283	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
607343	20q13.2	Duane-radial ray syndrome	607323	AD	3
607343	20q13.2	IVIC syndrome	147750	AD	3
610629	10q22.3	Diamond-blackfan anemia 3	610629	AD	3
610277	12q24.31	Immunodeficiency 9	612782	AR	3
610277	12q24.31	Myopathy, tubular aggregate, 2	615883	AD	3
607386	2p23.3	Retinitis pigmentosa 71	616394	AR	3
607386	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
605145	5p15.2	Chondrocalcinosis 2	118600	AD	3
605145	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
610572	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
609390	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
609390	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
609390	6q21	Charcot-Marie-Tooth disease, type 4J	611228	AR	3
609390	6q21	Yunis-Varon syndrome	216340	AR	3
610062	14q24.3	Ciliary dyskinesia, primary, 16	614017	AR	3
608059	17p13.1	Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3
610273	1q23.2	Glycosylphosphatidylinositol deficiency	610293	AR	3
605995	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
605995	1p36.22	Pheochromocytoma	171300	AD	3
605995	1p36.22	{Neuroblastoma, susceptibility to, 1}	256700	SMu,AD	3
607676	12q12	IRAK4 deficiency	607676	_	3
607921	17q25.3	Retinitis pigmentosa 30	607921	_	3
609583	2q13	Joubert syndrome 4	609583	AR	3
610156	9q34.3	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	AR	3
609378	17q11	{Autism susceptibility 6}	609378	_	2
609384	13q12.11	Fibrosis of extraocular muscles, congenital, 3C	609384	AD	2
610000	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
607842	18q22.3	Aural atresia, congenital	607842	AD	3
603100	9q34.3	Lipodystrophy, congenital generalized, type 1	608594	AR	3
603681	2p23.3	Auditory neuropathy, autosomal recessive, 1	601071	AR	3
603681	2p23.3	Deafness, autosomal recessive 9	601071	AR	3
610150	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
608204	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
609432	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
610683	4q27	Bardet-Biedl syndrome 12	615989	AR	3
607803	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
607803	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
610575	8q23.1	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3
610575	8q23.1	Tetraamelia syndrome 2	618021	AR	3
609584	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
607872	1p36	Chromosome 1p36 deletion syndrome	607872	IC	4
610153	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
609425	3q29	Chromosome 3q29 microdeletion syndrome	609425	IC	4
607936	3q21.1	Peeling skin syndrome 4	607936	AR	3
607922	22q13.2	NOR polyagglutination syndrome	111400	_	3
607922	22q13.2	[Blood group, P1Pk system, p phenotype]	111400	_	3
607922	22q13.2	[Blood group, P1Pk system, P(2) phenotype]	111400	_	3
607063	17q21.2	Bruck syndrome 1	259450	AR	3
607063	17q21.2	Osteogenesis imperfecta, type XI	610968	AR	3
608093	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
611507	4q24	Wolfram syndrome 2	604928	AR	3
610717	11p15.5	Neutral lipid storage disease with myopathy	610717	AR	3
603031	1q41	{Legionnaire disease, susceptibility to}	608556	_	3
603031	1q41	{Melioidosis, susceptibility to}	615557	_	3
603031	1q41	{Systemic lupus erythematosus, resistance to}	601744	_	3
603031	1q41	{Systemic lupus erythematosus, susceptibility to, 1}	601744	_	3
609566	4q21-q23	Parietal foramina 3	609566	AD	2
606201	4p16.1	?Cataract 41	116400	AD	3
606201	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
606201	4p16.1	Wolfram syndrome 1	222300	AR	3
606201	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
606201	4p16.1	{Diabetes mellitus, noninsulin-dependent, association with}	125853	AD	3
610678	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
609404	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
611501	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
609994	4q22-q27	Myopia 11	609994	_	2
608106	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
610275	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
611486	10q26.3	?Premature ovarian failure 12	616947	AR	3
611486	10q26.3	?Spermatogenic failure 15	616950	AR	3
611755	12q21.32	Leber congenital amaurosis 10	611755	_	3
605990	10q21.2	{Nephrolithiasis, uric acid, susceptibility to}	605990	_	3
610627	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
610690	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
610064	Chr.17	{Opioid dependence, susceptibility to, 1}	610064	_	2
610573	20p13	Anonychia congenita	206800	AR	3
610158	13pter-q12.13	Corneal dystrophy, Fuchs endothelial, 2	610158	AD	2
610227	17q25.3	Seborrhea-like dermatitis with psoriasiform elements	610227	_	3
608091	11q12.2	Joubert syndrome 2	608091	AR	3
609909	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
612717	10q21.1	Myopia 15	612717	AD	2
611119	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
611119	7p15.3	Retinitis pigmentosa 42	612943	AD	3
607809	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
611489	14q32.13	Corticosteroid-binding globulin deficiency	611489	AR,AD	3
612447	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
612367	1p36	{Alkaline phosphatase, plasma level of, QTL 2}	612367	_	2
611466	17q21.31	?Osteopetrosis, autosomal recessive 6	611497	AR	3
611466	17q21.31	Osteopetrosis, autosomal dominant 3	618107	AD	3
611761	16p13.3	Lipase deficiency, combined	246650	AR	3
610442	9q22.33	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442	AR	3
612772	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
605086	6p21.1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	_	3
611615	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
604285	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
602943	1q21.3	Immunodeficiency 42	616622	AR	3
610003	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
609812	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
611313	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
610896	19q13.32	Branchiootorenal syndrome 2	610896	_	3
608245	12q13.13	?Hypotrichosis 13	615896	AD	3
610065	20p12	{Systemic lupus erythematosus, susceptibility to, 7}	610065	_	2
612950	20q13	{Psoriasis susceptibility 12}	612950	_	2
613268	20p13	Corneal dystrophy, Fuchs endothelial, 4	613268	_	3
604695	10q24.32	Joubert syndrome 35	618161	AR	3
604695	10q24.32	Retinitis pigmentosa 83	618173	AD	3
609637	13q32.3	Holoprosencephaly 5	609637	AD	3
602954	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
611498	16p13.3	Nephronophthisis 7	611498	_	3
612368	6p22	{Alkaline phosphatase, plasma level of, QTL3}	612368	_	2
613063	7q32	{Basal cell carcinoma, susceptibility to, 6}	613063	_	2
611432	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
612907	3p26.2	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3
612907	3p26.2	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3
612773	19q13.32	[Blood group, Auberger system]	111200	_	3
612773	19q13.32	[Blood group, Lutheran null]	247420	AR	3
612773	19q13.32	[Blood group, Lutheran system]	111200	_	3
609558	22q12.3	{Prostate cancer, susceptibility to}	609558	_	2
609813	7p22.3	Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3
613100	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
608944	9p22.3	Bifid nose with or without anorectal and renal anomalies	608980	_	3
608944	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
608944	9p22.3	Trigonocephaly 2	614485	AD	3
612920	21q22.3	?Deafness, autosomal recessive 98	614861	AR	3
612920	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
613425	2p23.2	Retinitis pigmentosa 54	613428	_	3
612841	1p21.1-q21.3	Hypotrichosis 5	612841	AD	2
613617	2p23.3	?Retinitis pigmentosa 58	613617	AR	3
613697	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
610693	11q24.2	Hydrolethalus syndrome	236680	AR	3
608753	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
610628	3p13	Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3
613269	5q33.1-q35.2	Corneal dystrophy, Fuchs endothelial, 5	613269	_	2
613988	17p13.1	Dyskeratosis congenita, autosomal recessive 3	613988	AR	3
611386	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
611959	19q13.4	{Prostate cancer, hereditary, 15}	611959	_	2
613693	21q22.11	Long QT syndrome 6	613693	AD	3
610878	3p12.3	Vesicoureteral reflux 2	610878	_	3
612353	18p11.3	Porokeratosis 6, multiple types	612353	AD	2
612951	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
613927	6p21.33	C2 deficiency	217000	AR	3
613927	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
610897	20q11.22	Cataract 31, multiple types	605387	AD	3
608935	6q23-q25	{Lung cancer susceptibility}	608935	_	2
610084	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
604358	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
613698	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
613266	22q13.1	Waardenburg syndrome, type 4C	613266	AD	3
613544	6q11-q14	Chromosome 6q11-q14 deletion syndrome	613544	IC	4
613800	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
613982	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
614372	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
613363	9q34.11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3
613803	16q11.2	Meier-Gorlin syndrome 3	613803	AR	3
614380	6p21.33	C4a deficiency	614380	AR	3
613810	5q32	Retinitis pigmentosa 43	613810	_	3
602955	7q22.1	Alazami-Yuan syndrome	617126	AR	3
606463	1q22	Gaucher disease, perinatal lethal	608013	AR	3
606463	1q22	Gaucher disease, type I	230800	AR	3
606463	1q22	Gaucher disease, type II	230900	AR	3
606463	1q22	Gaucher disease, type III	231000	AR	3
606463	1q22	Gaucher disease, type IIIC	231005	AR	3
606463	1q22	{Lewy body dementia, susceptibility to}	127750	AD	3
606463	1q22	{Parkinson disease, late-onset, susceptibility to}	168600	Mu,AD	3
611472	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
613834	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
611927	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
614072	3q24	Hermansky-Pudlak syndrome 3	614072	AR	3
613686	17p13.1	Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3
614373	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
612284	4p15.32	Meckel syndrome 6	612284	AR	3
613563	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
612885	20p12.3	?Premature ovarian failure 10	612885	AR	3
612918	3q26.32	CLOVE syndrome, somatic	612918	_	3
614724	3q22.2	?Seckel syndrome 6	614728	AR	3
611488	9q32-q33	Macular degeneration, age-related, 10	611488	_	2
614615	5p13.2	Joubert syndrome 17	614615	AR	3
609636	7q36	Alzheimer disease-10	609636	AD	2
614631	7p21.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3
614631	7p21.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3
612688	3q29	RIDDLE syndrome	611943	AR	3
614167	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
614391	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
611499	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
614776	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
614138	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
613925	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3
614963	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
613694	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
611720	14q24.3	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3
613801	4p16.3	Retinitis pigmentosa-40	613801	AR	3
614101	2q35	Plasma fibronectin deficiency	614101	AD	1
614891	19p13.11	Immunodeficiency 30	614891	AR	3
612839	4q24	Myelodysplastic syndrome, somatic	614286	_	3
614888	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
613287	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
611928	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
614069	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
608754	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
615403	16p13.3	Beaulieu-Boycott-Innes syndrome	613680	AR	3
614379	6p21.33	C4B deficiency	614379	_	3
613364	11p14.1-p11.2	?Spastic paraplegia 41, autosomal dominant	613364	AD	2
614652	6q21	Coenzyme Q10 deficiency, primary, 3	614652	AR	3
613267	18q21.2	Corneal dystrophy, Fuchs endothelial, 3	613267	AD	3
613807	3q26.33	Ciliary dyskinesia, primary, 14	613807	_	3
614632	4p16.3	UV-sensitive syndrome 3	614640	AR	3
614617	16p13.3	Deafness , autosomal recessive 86	614617	AR	3
615286	19p13.3	Mental retardation, autosomal recessive 36	615286	AR	3
612886	5q35.2	{Menopause, natural, age at, QTL4}	612886	_	2
613160	12p13.31	von Willebrand disease, type 1	193400	AD	3
613160	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
613160	12p13.31	von Willibrand disease, type 3	277480	AR	3
615217	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
612073	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
615268	13q12.13	?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	AR	3
613546	15q21.2	Aromatase deficiency	613546	_	3
615513	1p36.22	Immunodeficiency 14	615513	AD	3
613926	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	AD	3
615663	20p13	Warburg micro syndrome 4	615663	AR	3
611721	10q22.1	Combined SAP deficiency	611721	AR	3
612354	18p11	{Inflammatory bowel disease 21}	612354	AD	2
616108	14q24.1	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3
613091	11q22.3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR,DR	3
612908	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
616022	3p25.3	Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3
602956	9p13.3	Fanconi anemia, complementation group G	614082	_	3
615290	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
612852	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
614128	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
616101	1p36.33	Spinocerebellar ataxia 21	607454	AD	3
613647	7p22.1	Spastic paraplegia 48, autosomal recessive	613647	AR	3
615298	20q11.22	Symphalangism, proximal, 1B	615298	_	3
614889	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
614066	1p13.2	Spastic paraplegia 47, autosomal recessive	614066	AR	3
613912	19p13.3	Complement factor D deficiency	613912	AR	3
614725	6q25.3	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3
616109	11q13.2	Hydatidiform mole, recurrent, 4	618432	_	3
608005	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
613577	16p13.3	Deafness , autosomal recessive 86	614617	AR	3
613577	16p13.3	Deafness, autosomal dominant 65	616044	AD	3
613577	16p13.3	DOORS syndrome	220500	AR	3
613577	16p13.3	Epileptic encephalopathy, early infantile, 16	615338	AR	3
613577	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
615287	11q13.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3
603109	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
609560	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
614618	11p15.1	Hyperekplexia 3	614618	AR,AD	3
604447	15q21.2	Intellectual developmental disorder with cardiac arrhythmia	617173	AR	3
604447	15q21.2	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182	AR	3
616817	1q32.1	Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3
616579	13q34	Mental retardation, autosomal dominant 40	616579	AD	3
615851	17p13.3	Pontocerebellar hypoplasia, type 2E	615851	AR	3
616221	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
614892	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
614099	14q24.3	?Cranioectodermal dysplasia 3	614099	AR	3
614129	19p13.3	Perrault syndrome 3	614129	AR	3
610247	7q11.2	{Esophagitis, eosinophilic, 1}	610247	Mu	2
615934	5q31.2	STING-associated vasculopathy, infantile-onset	615934	AD	3
615293	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
615404	2q36.3	{Specific language impairment 5}	615432	AD	3
614887	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
613318	8q22.3	Miyoshi muscular dystrophy 2	613318	_	2
604454	2p13.3	Welander distal myopathy	604454	AR,AD	3
604123	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
617769	5q33.1	Spinocerebellar ataxia 45	617769	AD	3
616192	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
613981	12q13.13	?Hypotrichosis 3	613981	AD	3
614890	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
618179	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
614726	4q12	Congenital disorder of glycosylation, type IIk	614727	AR	3
617654	1p31.3	?Deafness, autosomal recessive 108	617654	AR	3
614102	2p11.2	Kappa light chain deficiency	614102	AR	3
617051	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
607426	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
618012	3q13.31	Epileptic encephalopathy, infantile or early childhood, 3	618012	AD	3
616710	7p11.2	Parkinson disease 22, autosomal dominant	616710	AD	3
616834	4q32.3	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3
616684	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
610511	14q21.1	Craniolenticulosutural dysplasia	607812	AR	3
607821	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
615297	3p14.1	Adams-Oliver syndrome 4	615297	AR	3
618004	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
615269	12q21.33	Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3
618180	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
614371	19p13.2	{Dengue fever, protection against}	614371	_	3
613101	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
615703	3q29	Morbid obesity and spermatogenic failure	615703	AR	3
614787	1q21.3	White-Sutton syndrome	616364	AD	3
616768	10p15.3	Oocyte maturation defect 2	616780	AR,AD	3
612446	5p13.1	C6 deficiency	612446	_	3
618239	8q22.1	Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3
618157	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
617193	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
617976	4p16.3	Epileptic encephalopathy, early infantile, 63	617976	AR	3
616081	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
617118	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
617950	9q34.3	Combined oxidative phosphorylation deficiency 36	617950	AR	3
616576	4q24	Immunodeficiency, common variable, 12	616576	AD	3
618168	1p13.2	Diarrhea 9	618168	AR	3
616193	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
613319	11p14.3	Miyoshi muscular dystrophy 3	613319	AR	3
617120	17p11.2	Joubert syndrome 27	617120	AR	3
615517	11q12.3	?Hemochromatosis, type 5	615517	AD	3
617297	19q13.33	Amelogenesis imperfecta, type IJ	617297	AR	3
616174	2q14.1	Filippi syndrome	272440	AR	3
613986	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
616803	12p12.1	Lamb-Shaffer syndrome	616803	AD	3
615871	5p12	Epileptic encephalopathy, early infantile, 24	615871	AD	3
617626	4q12	Fibromatosis, gingival, 5	617626	AD	3
614400	7p21.3	{Glucocorticoid therapy, response to}	614400	_	3
616577	4q28.1	Epilepsy, hearing loss, and mental retardation syndrome	616577	AR	3
617119	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
618008	5q33.3	Epileptic encephalopathy, early infantile, 65	618008	AD	3
617201	18q21.31	Periventricular nodular heterotopia 7	617201	AD	3
616099	19p13.2	Palmoplantar keratoderma and woolly hair	616099	AR	3
615346	15q11.2	Precocious puberty, central, 2	615346	AD	3
616760	17q21.2	Woolly hair, autosomal recessive 3	616760	AR	3
613102	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
618158	11q13.5-q14.1	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3
616707	15q25.2	?Deafness, autosomal dominant 68	616707	AD	3
616818	13q31.1	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3
617763	9q34.12	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	617763	AR	3
606097	18q21.33	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3
616816	3p25.1	Hypotonia, infantile, with psychomotor retardation	616816	AR	3
616801	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
618167	12q23.3	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3
611490	16p13.3	Osteopetrosis, autosomal recessive 4	611490	AR	3
617296	2p25.1	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3
616819	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
603111	17q21.2	Coffin-Siris syndrome 5	616938	AD	3
603111	17q21.2	{Meningioma, familial, susceptibility to}	607174	AD	3
617996	7q34	Oocyte maturation defect 5	617996	AR	3
604168	18q23	Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3
616100	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
618003	10q24.31	Deafness, autosomal recessive 57	618003	AR	3
610443	17q21.31	Koolen-De Vries syndrome	610443	AD	3
616921	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
614958	17q12	Bleeding disorder, platelet-type, 20	616913	AD	3
614070	6q21	{Psoriasis susceptibility 13}	614070	_	3
616708	10p12.1	Desanto-Shinawi syndrome	616708	AD	3
617315	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
616106	2q36.1	{Psoriasis 15, pustular, susceptibility to}	616106	AD	3
613804	16q24.3	Meier-Gorlin syndrome 4	613804	AR	3
614959	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
617899	13q13.3	Leukodystrophy, hypomyelinating, 14	617899	AR	3
614945	11p15.1	Deafness, autosomal recessive 18B	614945	AR	3
617949	7q21.13	Spermatogenic failure 24	617959	AR	3
614674	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
615935	10p12.2	Pancreatic agenesis 2	615935	AR	3
618010	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
608584	7p14.3	{Asthma, susceptibility to, 2}	608584	_	3
618065	4q27	Pontocerebellar hypoplasia, type 1D	618065	AR	3
608099	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
608581	8p23.1	Occult macular dystrophy	613587	AD	3
613718	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
613806	3p21	Cholangitis, primary sclerosing	613806	_	2
615527	6q21	?Candidiasis, familial, 8	615527	AR	3
616107	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
617938	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
613561	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
609441	4q22.3	Acromesomelic dysplasia, Demirhan type	609441	AR	3
615728	12q13.13	Pachyonychia congenita 4	615728	_	3
617900	12q14.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3
613729	7q11.23	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	_	4
614653	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
618181	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
608102	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
617951	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
608970	5q21.3-q33.2	Macular dystrophy, butterfly-shaped pigmentary, 2	608970	AD	2
609937	2q31.1	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3
613730	11q25	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3
610533	5q34	[Memory, enhanced, QTL]	615602	_	3
608103	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608103	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
608628	3q26.32	Mental retardation, autosomal dominant 41	616944	AD	3
608628	3q26.32	Pierpont syndrome	602342	AD	3
610534	11q24.2	Al-Raqad syndrome	616459	AR	3
614961	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
617485	4q21.23	?Microcephaly 18, primary, autosomal dominant	617520	AD	3
615750	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
616176	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
608629	6q23.3	Joubert syndrome 3	608629	AR	3
609941	11p13-p12	Deafness, autosomal recessive 51	609941	AR	2
618240	3p21.31	Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3
616454	11p11.2	?Exudative vitreoretinopathy 6	616468	AD	3
616454	11p11.2	Retinitis pigmentosa 72	616469	AR	3
615937	1q43-q44	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3
605925	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
610681	12q13.11	Glycogen storage disease VII	232800	AR	3
616177	20p13	Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3
611693	11q24.1	Congenital short bowel syndrome	615237	AR	3
610682	3p22.3	Osteogenesis imperfecta, type VII	610682	AR	3
608583	10q22-q24	Atrial fibrillation, familial, 1	608583	AD	2
618241	11q24.2	Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3
609995	2q37.1	Myopia 12	609995	_	2
611695	15q15.2	Spinocerebellar ataxia 11	604432	AD	3
615938	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
609939	16p12.3-q12.2	{Systemic lupus erythematosus, susceptibility to, 6}	609939	_	2
608679	20q13.12	Galloway-Mowat syndrome 4	617730	AR	3
614962	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
617050	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
613731	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AR,AD	3
614650	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
613469	10q24.2	Urofacial syndrome 1	236730	AR	3
612715	12q21-q23	Dyschromatosis universalis hereditaria 2	612715	_	2
613983	20q13.33	Retinitis pigmentosa 60	613983	AD	3
608680	2p13.1	Galloway-Mowat syndrome 5	617731	AR	3
613743	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
615751	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
613984	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
613808	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
613809	1q41	Retinitis pigmentosa 39	613809	_	3
613638	19p13.13	Chromosome 19p13.13 deletion syndrome	613638	_	4
613638	19p13.13	Chromosome 19p13.13 duplication syndrome	613638	_	4
615411	5q12.1	Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3
610008	17q24.2	Usher syndrome, type IV	618144	AR	3
610154	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
605463	14q11.2	Radiation sensitivity/chromosome instability syndrome, autosomal dominant	_	_	1
610937	16q12.2	COACH syndrome	216360	AR	3
610937	16q12.2	Joubert syndrome 7	611560	AR	3
610937	16q12.2	Meckel syndrome 5	611561	AR	3
604043	1q32.3	?Retinitis pigmentosa 67	615565	AR	3
609942	12p12.1	Noonan syndrome 3	609942	AD	3
603504	1p21.2	Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3
606118	3q24	Hermansky-Pudlak syndrome 3	614072	AR	3
610379	3p21.31	{West nile virus, susceptibility to}	610379	_	3
607085	6p21.3	Myasthenia gravis with thymus hyperplasia	607085	_	2
612325	6p12.1	Endocrine-cerebroosteodysplasia	612651	AR	3
612325	6p12.1	{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3
607346	1p13.2	Spinocerebellar ataxia 19	607346	AD	3
605460	2p21	Sitosterolemia	210250	AR	3
605460	2p21	{Gallbladder disease 4}	611465	_	3
603585	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
605392	6q27	Myeloproliferative disorder	605392	_	2
607358	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AR,AD	3
605459	2p21	Sitosterolemia	210250	AR	3
607867	13q14.2	Retinal dystrophy with or without extraocular anomalies	617175	AR	3
608539	16p13.3	Nephronophthisis 7	611498	_	3
605283	15q11.2	Schaaf-Yang syndrome	615547	AD	3
609557	2p21	Myasthenic syndrome, congenital, 22	616224	AR	3
612201	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
610102	5p13.1	C7 deficiency	610102	_	3
610087	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
605955	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
612922	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AR,AD	3
606633	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
607644	11p13-q12	Candidiasis, familial, 3	607644	AD	2
611465	2p21	{Gallbladder disease 4}	611465	_	3
611561	16q12.2	Meckel syndrome 5	611561	AR	3
612269	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
607139	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
604563	11p15.4	Charcot-Marie-Tooth disease, type 4B2	604563	AR	3
614186	2q37.1	Leber congenital amaurosis 16	614186	AR	3
614352	7q33	?Nephrotic syndrome, type 13	616893	_	3
609638	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
614180	3q25.1	Retinitis pigmentosa 61	614180	_	3
604179	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
610881	11q13.2	Mental retardation, autosomal dominant 51	617788	AD	3
603503	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
609152	14q31.1	Hyperthyroidism, nonautoimmune	609152	AD	3
614401	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
613580	2p15	?Bardet-Biedl syndrome 15	615992	AR	3
613580	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
613470	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
612515	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
609377	16q22.1	?Dyskeratosis congenita, autosomal dominant 6	616553	AR,AD	3
609377	16q22.1	?Dyskeratosis congenita, autosomal recessive 7	616553	AR,AD	3
613812	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
605078	1p36.22	Amyotrophic lateral sclerosis 10, with or without FTD	612069	AD	3
605078	1p36.22	Frontotemporal lobar degeneration, TARDBP-related	612069	AD	3
615716	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
607620	8q24.12	3MC syndrome 3	248340	AR	3
605462	1p36	{Basal cell carcinoma, susceptibility to, 1}	605462	_	2
618170	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
613225	6p25.1	Factor XIIIA deficiency	613225	AR	3
617921	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
614351	16q13	Nephrotic syndrome, type 12	616892	AR	3
613227	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
617127	17p13.1	?Orofaciodigital syndrome XV	617127	AR	3
614191	22q12.2-q12.3	Epilepsy, familial focal, with variable foci 1	604364	AD	3
612840	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
608096	12q22-q23.3	Epilepsy, familial temporal lobe, 2	608096	AD	2
605284	9q34.13	Focal cortical dysplasia, type II, somatic	607341	_	3
605284	9q34.13	Lymphangioleiomyomatosis	606690	_	3
605284	9q34.13	Tuberous sclerosis-1	191100	AD	3
614614	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
611592	6p25.1	Combined oxidative phosphorylation deficiency 14	614946	AR	3
611592	6p25.1	Spastic paraplegia 77, autosomal recessive	617046	AR	3
617126	7q22.1	Alazami-Yuan syndrome	617126	AR	3
608098	5p15.1	Periventricular nodular heterotopia 3	608098	_	2
613244	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
605942	6q22.1	Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3
617635	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
613811	4p15.2	Pontocerebellar hypoplasia type 2D	613811	AR	3
605253	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AR,AD	3
614970	16q23.1	Joubert syndrome 20	614970	AR	3
615518	17q11.2	?Immunodeficiency 13	615518	AD	3
618358	20q11.22	Cone-rod dystrophy and hearing loss 2	618358	AR	3
617920	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
609597	11p11.2	Parietal foramina 2	609597	AD	3
608681	15q26.1	Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3
613685	9p23-p21.2	Deafness, autosomal recessive 83	613685	AR	2
610155	2q24.3	{Diabetes mellitus, insulin-dependent, 19}	610155	_	2
614675	4q12	Bone marrow failure syndrome 1	614675	AD	3
615530	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
614350	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
614181	6p24.2	Retinitis pigmentosa 62	614181	AR	3
615705	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
613243	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
612655	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
604907	17p11.2	Immunodeficiency, common variable, 2	240500	AR,AD	3
604907	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
618238	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
610031	6p25.2	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3
617194	15q21.2	Lethal congenital contracture syndrome 11	617194	AR	3
616002	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
617977	17q25.3	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3
614537	10q22.2-q22.3	Albinism, oculocutaneous, type VII	615179	AR	3
603470	9q34.11	Citrullinemia	215700	AR	3
614613	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
612513	2p16.1-p15	Chromosome 2p16.1-p15 deletion syndrome	612513	IC	4
608816	6p21	Epilepsy, juvenile myoclonic 3	608816	_	2
614683	5q35.3	[?Phosphohydroxylysinuria]	615011	_	3
614969	1p34.1	Pontocerebellar hypoplasia, type 7	614969	AR	3
612724	9q31.1	Fructose intolerance, hereditary	229600	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
606731	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
612971	10q24.31	Deafness, autosomal recessive 57	618003	AR	3
612971	10q24.31	Usher syndrome, type IIC, GPR98/PDZD7 digenic	605472	AR	3
612971	10q24.31	{Retinal disease in Usher syndrome type IIA, modifier of}	276901	AR	3
615529	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
603471	7q21.3	Citrullinemia, adult-onset type II	603471	AR	3
608540	16p13.3	Congenital disorder of glycosylation, type Ik	608540	AR	3
618265	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
609661	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
602241	13q12.12	Combined oxidative phosphorylation deficiency 31	617228	AR	3
602201	1q21.2	Urbach-Wiethe disease	247100	AR	3
602117	15q11.2	Prader-Willi syndrome	176270	AD	3
602118	5q15-q21	Pilarowski-Bjornsson syndrome	617682	AD	3
602119	15q26.1	Epileptic encephalopathy, childhood-onset	615369	AD	3
602202	1p36.12	?Congenital disorder of glycosylation, type Ir	614507	AR	3
602120	17p13.1	Snijders Blok-Campeau syndrome	618205	AD	3
602121	5q31.3	Deafness, autosomal dominant 1	124900	AD	3
602121	5q31.3	Seizures, cortical blindness, microcephaly syndrome	616632	AR	3
602207	10p12.1	Warburg micro syndrome 3	614222	AR	3
602122	4q12	Bone marrow failure syndrome 1	614675	AD	3
602124	18p	Dystonia-7, torsion	602124	AD	2
602125	17p12	Leigh syndrome due to mitochondrial COX4 deficiency	256000	Mi,AR	3
602125	17p12	Mitochondrial complex IV deficiency	220110	Mi,AR	3
602129	19p13.11	{Celiac disease, susceptibility to, 4}	609753	_	3
602130	3p21.2	?Macular dystrophy, patterned, 3	617111	AD	3
#MIM_Number	Location	Phenotype	Phenotype_MIM_number	Inheritance	Phenotype_mapping_key
100650	12q24.12	Alcohol sensitivity, acute	610251	AD	3
100650	12q24.12	{Esophageal cancer, alcohol-related, susceptibility to}	_	_	3
100650	12q24.12	{Hangover, susceptibility to}	610251	AD	3
100650	12q24.12	{Sublingual nitroglycerin, susceptibility to poor response to}	_	_	3
100070	19q13	Aortic aneurysm, familial abdominal 1	100070	AD	2
100100	1q43	?Prune belly syndrome	100100	AR	3
100300	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
100678	6q25.3	?ACAT2 deficiency	614055	IC	1
100690	2q31.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100690	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
100690	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AD,AR	3
100710	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
100710	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
100720	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100720	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AD,AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
100730	2q37.1	Escobar syndrome	265000	AR	3
100730	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100740	7q22.1	[Blood group, Yt system]	112100	_	3
100790	12q23.2	Central hypoventilation syndrome, congenital	209880	AD	3
100790	12q23.2	Haddad syndrome	209880	AD	3
100800	4p16.3	Achondroplasia	100800	AD	3
100850	22q13.2	?Optic atrophy 9	616289	AR	3
100850	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
101000	22q12.2	Neurofibromatosis, type 2	101000	AD	3
101200	10q26.13	Apert syndrome	101200	AD	3
101800	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
101850	2p25-p12	?Keratoderma, palmoplantar, punctate type 3	101850	AD	2
101900	12q24.11	Acrokeratosis verruciformis	101900	AD	3
102300	12q12-q21	{Restless legs syndrome 1}	102300	AD	2
102370	15q21.1	Acromicric dysplasia	102370	AD	3
102480	22q13.33	?Male infertility due to acrosin deficiency	102480	_	2
102500	1p12	Hajdu-Cheney syndrome	102500	AD	3
102510	2q36	Acropectorovertebral dysplasia	102510	AD	2
102530	3q26.31	?Spermatogenic failure 6	102530	AR	3
102540	15q14	Atrial septal defect 5	612794	AD	3
102540	15q14	Cardiomyopathy, dilated, 1R	613424	AD	3
102540	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
102540	15q14	Left ventricular noncompaction 4	613424	AD	3
102545	2p13.1	Visceral myopathy	155310	AD	3
102560	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
102560	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
102565	7q32.1	Cardiomyopathy, familial hypertrophic, 26	_	_	3
102565	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
102565	7q32.1	Myopathy, distal, 4	614065	AD	3
102565	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
102573	1q43	Cardiomyopathy, dilated, 1AA, with or without LVNC	612158	AD	3
102573	1q43	Cardiomyopathy, hypertrophic, 23, with or without LVNC	612158	AD	3
102574	11q13.2	[Alpha-actinin-3 deficiency]	617749	_	3
102574	11q13.2	[Sprinting performance]	617749	_	3
102575	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
102576	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
102578	15q24.1	Leukemia, acute promyelocytic, PML/RARA type	_	_	3
102579	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
102582	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
102582	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
102600	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
102610	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
102610	1q42.13	Myopathy, actin, congenital, with cores	161800	AD,AR	3
102610	1q42.13	Myopathy, actin, congenital, with excess of thin myofilaments	161800	AD,AR	3
102610	1q42.13	Myopathy, congenital, with fiber-type disproportion 1	255310	AD,AR	3
102610	1q42.13	Nemaline myopathy 3, autosomal dominant or recessive	161800	AD,AR	3
102620	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
102620	10q23.31	Moyamoya disease 5	614042	_	3
102620	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
102630	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
102630	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
102680	4p16.3	{Hypertension, essential, salt-sensitive}	145500	Mu	3
102750	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
102770	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
102771	1p13.3	?Spastic paraplegia 63	615686	AR	3
102771	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
102772	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
102900	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
103000	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
103020	1p35.1	Reticular dysgenesis	267500	AR	3
103050	22q13.1	Adenylosuccinase deficiency	103050	AR	3
103072	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
103180	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
103220	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
103270	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
103280	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
103280	11p15.5	Silver-Russell syndrome	180860	AD	3
103280	11p15.5	Wilms tumor 2	194071	AD,SMu	3
103285	3q28	ADULT syndrome	103285	AD	3
103320	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
103500	3p13	Tietz albinism-deafness syndrome	103500	AD	3
103580	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
103600	4q13.3	Analbuminemia	616000	_	3
103600	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
103720	4q23	{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}	103780	Mu	3
103720	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
103850	16p11.2	Glycogen storage disease XII	611881	AR	3
103900	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
103950	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
103950	12p13.31	{Alzheimer disease, susceptibility to}	104300	AD	3
104000	18p11.3-p11.2	Alopecia areata 1	104000	Mu	2
104100	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
104150	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
104150	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
104155	16q22.2-q22.3	Prostate cancer, somatic	176807	_	3
104160	11q12.3	Polycystic kidney disease 3	600666	AD	3
104170	22q13.2	Kanzaki disease	609242	AR	3
104170	22q13.2	Schindler disease, type I	609241	AR	3
104170	22q13.2	Schindler disease, type III	609241	AR	3
104200	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
104225	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
104250	4p16.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
104260	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
104290	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
104310	19q13.32	Alzheimer disease-2	104310	AD	3
104311	14q24.2	?Acne inversa, familial, 3	613737	AD	3
104311	14q24.2	Alzheimer disease, type 3	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	AD	3
104311	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
104311	14q24.2	Dementia, frontotemporal	600274	AD	3
104311	14q24.2	Pick disease	172700	AD	3
104500	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
104510	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
104530	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
104614	2p21	Cystinuria	220100	AD,AR	3
104620	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
104760	21q21.3	Alzheimer disease 1, familial	104300	AD	3
104760	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
104770	1q23.2	{?Amyloidosis, secondary, susceptibility to}	_	_	1
105120	9q33.2	Amyloidosis, Finnish type	105120	AD	3
105150	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
105210	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
105250	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
105500	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
105550	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
105580	11q22-qter	?Anal canal carcinoma	105580	AD	2
105590	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
105600	15q21	Dyserythropoietic anemia, congenital, type III	105600	AD	2
105650	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
105800	7q11.2	Aneurysm, intracranial berry, 1	105800	AD	2
105830	15q11.2	Angelman syndrome	105830	AD	3
105850	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
106100	11q12.1	Angioedema, hereditary, types I and II	106100	AD,AR	3
106150	1q42.2	Renal tubular dysgenesis	267430	AR	3
106150	1q42.2	{Hypertension, essential, susceptibility to}	145500	Mu	3
106150	1q42.2	{Preeclampsia, susceptibility to}	_	_	3
106165	3q24	Renal tubular dysgenesis	267430	AR	3
106165	3q24	{Hypertension, essential}	145500	Mu	3
106180	17q23.3	Renal tubular dysgenesis	267430	AR	3
106180	17q23.3	[Angiotensin I-converting enzyme, benign serum increase]	_	_	3
106180	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
106180	17q23.3	{Myocardial infarction, susceptibility to}	_	_	3
106180	17q23.3	{SARS, progression of}	_	_	3
106180	17q23.3	{Stroke, hemorrhagic}	614519	_	3
106190	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
106260	3q28	Hay-Wells syndrome	106260	AD	3
106300	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
106410	4q25-q26	Cardiac arrhythmia, ankyrin-B-related	600919	AD	3
106410	4q25-q26	Long QT syndrome 4	600919	AD	3
106600	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
106700	4q12	Total anomalous pulmonary venous return	106700	AD	2
107200	18p11.23-q12.2	Anosmia, isolated congenital	107200	AD	2
107250	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
107265	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
107269	11p13	[Blood group, Indian system]	609027	_	3
107271	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
107280	14q32.13	Alpha-1-antichymotrypsin deficiency	_	_	3
107280	14q32.13	Cerebrovascular disease, occlusive	_	_	3
107300	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AD,AR	3
107310	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
107320	6p21.3	?Antiphospholipid syndrome, familial	107320	AD	2
107323	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
107400	14q32.13	Emphysema due to AAT deficiency	613490	AR	3
107400	14q32.13	Emphysema-cirrhosis, due to AAT deficiency	613490	AR	3
107400	14q32.13	Hemorrhagic diathesis due to antithrombin Pittsburgh	613490	AR	3
107400	14q32.13	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	1
107470	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
107470	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
107470	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
107470	6q23.3	{Hepatitis B virus infection, susceptibility to}	610424	_	3
107470	6q23.3	{Tuberculosis infection, protection against}	607948	_	3
107470	6q23.3	{Tuberculosis, susceptibility to}	607948	_	3
107580	6p24.3	Branchiooculofacial syndrome	113620	AD	3
107600	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
107670	1q23.3	Apolipoprotein A-II deficiency	_	_	3
107670	1q23.3	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
107680	11q23.3	Amyloidosis, 3 or more types	105200	AD	3
107680	11q23.3	ApoA-I and apoC-III deficiency, combined	_	_	3
107680	11q23.3	Corneal clouding, autosomal recessive	_	_	3
107680	11q23.3	Hypoalphalipoproteinemia	604091	_	3
107720	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
107730	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
107730	2p24.1	Hypobetalipoproteinemia	615558	AR	3
107741	19q13.32	Alzheimer disease-2	104310	AD	3
107741	19q13.32	Hyperlipoproteinemia, type III	617347	_	3
107741	19q13.32	Lipoprotein glomerulopathy	611771	_	3
107741	19q13.32	Sea-blue histiocyte disease	269600	AR	3
107741	19q13.32	{?Macular degeneration, age-related}	603075	AD	3
107741	19q13.32	{Coronary artery disease, severe, susceptibility to}	617347	_	3
107770	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
107773	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
107776	7p14.3	[Aquaporin-1 deficiency]	110450	_	3
107776	7p14.3	[Blood group, Colton]	110450	_	3
107777	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
107820	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
107910	15q21.2	Aromatase deficiency	613546	_	3
107910	15q21.2	Aromatase excess syndrome	139300	AD	3
107930	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
107970	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
108145	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
108300	12q13.11	Stickler syndrome, type I	108300	AD	3
108370	7q21.3	Asparagine synthetase deficiency	615574	AR	3
108420	Chr.1	Spermatogenic failure 2	108420	AD	2
108500	19p13.13	Episodic ataxia, type 2	108500	AD	3
108600	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
108720	3p14.3	Atelosteogenesis, type I	108720	AD	3
108721	3p14.3	Atelosteogenesis, type III	108721	AD	3
108725	19p13.3-p13.2	{Atherosclerosis, susceptibility to}	108725	AD	2
108730	16p11.2	Brody myopathy	601003	AR	3
108733	3p25.3	{Deafness, autosomal recessive 12, modifier of}	601386	AR	3
108740	12q24.11	Acrokeratosis verruciformis	101900	AD	3
108740	12q24.11	Darier disease	124200	AD	3
108746	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
108770	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
108780	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
108780	1p36.22	Atrial standstill 2	615745	AR	3
108800	5p	Atrial septal defect 1	108800	AD	2
108900	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
108961	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
108961	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
108961	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
108962	5p13.3	?Hypertension, salt-resistant	_	_	1
108985	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
109091	19p13.13	Myelofibrosis, somatic	254450	_	3
109091	19p13.13	Thrombocythemia, somatic	187950	_	3
109150	14q32.12	Machado-Joseph disease	109150	AD	3
109200	3q26	Alopecia, androgenetic, 1	109200	AD	2
109270	17q21.31	Cryohydrocytosis	185020	AD	3
109270	17q21.31	Ovalocytosis, SA type	166900	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
109270	17q21.31	Spherocytosis, type 4	612653	AD	3
109270	17q21.31	[Blood group, Diego]	110500	_	3
109270	17q21.31	[Blood group, Froese]	601551	_	3
109270	17q21.31	[Blood group, Swann]	601550	_	3
109270	17q21.31	[Blood group, Waldner]	112010	_	3
109270	17q21.31	[Blood group, Wright]	112050	_	3
109270	17q21.31	[Malaria, resistance to]	611162	_	3
109350	13q14	Gastroesophageal reflux	109350	AD	2
109480	19p13.3	[Blood group, OK]	111380	_	3
109535	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
109543	13q14	{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	AD	2
109560	19q13.32	Leukemia/lymphoma, B-cell, 3	109560	_	2
109565	3q27.3	Lymphoma, B-cell	109565	_	2
109630	10q25.3	[Resting heart rate]	607276	_	3
109630	10q25.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
109690	5q32	Beta-2-adrenoreceptor agonist, reduced response to	_	_	3
109690	5q32	{Asthma, nocturnal, susceptibility to}	600807	AD	3
109690	5q32	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109691	8p11.23	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109700	15q21.1	?Amyloidosis, familial visceral	105200	AD	3
109700	15q21.1	Immunodeficiency 43	241600	AR	3
109720	3p12-q13.2	Biliary cirrhosis, primary, 1	109720	AD	2
109730	9q34.3	Aortic valve disease 1	109730	AD	3
109750	7p13	Hyperbiliverdinemia	614156	AD,AR	3
109760	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
110300	9q34.2	[Blood group, ABO system]	616093	_	3
110500	17q21.31	[Blood group, Diego]	110500	_	3
110600	12p12.3	[Blood group, Dombrock]	616060	_	3
110700	1q23.2	[Blood group, Duffy system]	110700	AD,AR	3
110750	2q14.3	[Blood group, Gerbich]	616089	_	3
110750	2q14.3	{Malaria, resistance to}	611162	_	3
110900	7q34	[Blood group, Kell]	110900	_	3
111000	18q12.3	[Blood group, Kidd]	111000	_	3
111100	19p13.3	[Blood group, Lewis]	_	_	3
111150	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
111250	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
111300	4q31.21	[Blood group, MNSs system]	111300	_	3
111380	19p13.3	[Blood group, OK]	111380	_	3
111600	2q35	[Blood group, Langereis system]	111600	_	3
111620	1p34.2	[Blood group, Radin]	111620	_	3
111680	1p36.11	[Rh-negative blood type]	_	_	3
111700	1p36.11	Rh-null disease, amorph type	617970	_	3
111700	1p36.11	[Blood group, Rhesus]	_	_	3
111740	4q31.21	[Blood group, Ss]	111740	_	3
111750	1p34.2	[Blood group, Scianna system]	111750	_	3
111800	4q28-q31	[Blood group, Stoltzfus system]	111800	_	2
112010	17q21.31	[Blood group, Waldner]	112010	_	3
112050	17q21.31	[Blood group, Wright]	112050	_	3
112100	7q22.1	[Blood group, Yt system]	112100	_	3
112205	19q13.2	Agammaglobulinemia 3	613501	AR	3
112210	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
112240	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
112250	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
112261	20p12.3	Brachydactyly, type A2	112600	AD	3
112261	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
112261	20p12.3	{HFE hemochromatosis, modifier of}	235200	AR	3
112262	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
112262	14q22.2	Orofacial cleft 11	600625	_	3
112264	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
112310	3p14.3	Boomerang dysplasia	112310	AD	3
112410	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
112500	2q35	Brachydactyly, type A1	112500	AD	3
113000	9q22.31	Brachydactyly, type B1	113000	AD	3
113100	20q11.22	Brachydactyly, type C	113100	AD	3
113200	2q31.1	Brachydactyly, type D	113200	AD	3
113300	2q31.1	Brachydactyly, type E	113300	AD	3
113500	12q24.11	Brachyolmia type 3	113500	AD	3
113520	12p12.1	?Hyperleucinemia-isoleucinemia or hypervalinemia	_	_	1
113530	19q13.33	?Hypervalinemia or hyperleucine-isoleucinemia	_	_	1
113620	6p24.3	Branchiooculofacial syndrome	113620	AD	3
113650	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
113705	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
113705	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	AD,Mu	3
113705	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
113721	17p13.3	Breast cancer	_	_	1
113810	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
113810	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, localisata variant	226650	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
113811	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
113970	8q24.21	Burkitt lymphoma, somatic	113970	_	3
114000	17q21.33	Caffey disease	114000	AD	3
114010	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
114019	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
114021	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
114021	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
114025	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
114078	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
114078	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
114090	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
114105	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
114105	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
114131	7q21.3	{Osteoporosis, postmenopausal, susceptibility}	166710	AD	3
114180	14q32.11	Long QT syndrome 14	616247	AD	3
114180	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
114182	2p21	Long QT syndrome 15	616249	AD	3
114200	3q11.2-q13.12	Camptodactyly 1	114200	AD	2
114205	12p13.33	Brugada syndrome 3	611875	_	3
114205	12p13.33	Long QT syndrome 8	618447	_	3
114205	12p13.33	Timothy syndrome	601005	AD	3
114206	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
114206	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
114208	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
114208	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
114208	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
114220	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
114250	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
114251	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
114300	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
114350	9q34.13	Leukemia, acute myeloid, somatic	601626	_	3
114350	9q34.13	Leukemia, T-cell acute lymphoblastic, somatic	613065	_	3
114350	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
114580	2p22.3-p21	Candidiasis, familial, 1, autosomal dominant	114580	AD	2
114760	17q23.1	Retinitis pigmentosa 17	600852	AD	3
114761	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
114815	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
114835	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
114840	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
115080	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
115150	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
115195	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
115196	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
115197	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
115200	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
115210	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
115300	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
115310	1p36.13	Paragangliomas 4	115310	AD	3
115430	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
115440	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
115470	22q11	Cat eye syndrome	115470	AD	4
115500	11p13	Acatalasemia	614097	_	3
115501	9p23	Albinism, oculocutaneous, type III	203290	AR	3
115501	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
115650	14q22-q23	Cataract 32, multiple types	115650	AD	2
115660	17q24	Cataract 7	115660	AD	2
115665	1pter-p36.13	Cataract 8, multiple types	115665	AD	2
115700	2q33.3	Cataract 4, multiple types	115700	AD	3
115800	2pter-p24	Cataract 29, coralliform	115800	AD	2
115900	2q35	?Cataract 42	115900	AD	3
116100	3q27.3	Cataract 20, multiple types	116100	AD	3
116200	1q21.2	Cataract 1, multiple types	116200	AD	3
116300	10p13	Cataract 30, pulverulent	116300	AD	3
116400	4p16.1	?Cataract 41	116400	AD	3
116600	1p36.13	Cataract 6, multiple types	116600	AD	3
116700	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
116790	22q11.21	{Panic disorder, susceptibility to}	167870	?AD	3
116790	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
116800	16q22.1	Cataract 5, multiple types	116800	AD	3
116805	5q31.2	Macular dystrophy, patterned, 2	608970	AD	3
116806	3p22.1	Colorectal cancer, somatic	114500	_	3
116806	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
116806	3p22.1	Hepatocellular carcinoma, somatic	114550	_	3
116806	3p22.1	Medulloblastoma, somatic	155255	_	3
116806	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
116806	3p22.1	Ovarian cancer, somatic	167000	_	3
116806	3p22.1	Pilomatricoma, somatic	132600	_	3
116810	8p23.1	Keratolytic winter erythema	148370	AD	4
116840	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
116896	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
116897	19q13.11	?Leukemia, acute myeloid	601626	AD,SMu	3
116897	19q13.11	Leukemia, acute myeloid, somatic	601626	_	3
116920	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
116945	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
116952	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
116955	3q21.3	Myotonic dystrophy 2	602668	AD	3
117100	11p13	Centrotemporal epilepsy	117100	IC	2
117143	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
117210	16q21	Spinocerebellar ataxia 31	117210	AD	3
117300	13q14.2	Dementia, familial Danish	117300	AD	3
117360	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
117550	5q35.3	Sotos syndrome 1	117550	AD	3
117650	20p13	Cerebrocostomandibular syndrome	117650	AD	3
117700	3q24-q25	Cerebellar ataxia	604290	AR	3
117700	3q24-q25	Hemosiderosis, systemic, due to aceruloplasminemia	604290	AR	3
117700	3q24-q25	[Hypoceruloplasminemia, hereditary]	604290	AR	3
118100	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
118190	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
118190	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
118200	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
118210	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
118220	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
118300	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
118400	4p16.3	Cherubism	118400	AD	3
118423	2q31.1	Duane retraction syndrome 2	604356	_	3
118425	7q34	Myotonia congenita, dominant	160800	AD	3
118425	7q34	Myotonia congenita, recessive	255700	AR	3
118425	7q34	Myotonia levior, recessive	_	_	3
118450	20p12.2	Alagille syndrome 1	118450	AD	3
118470	16q13	Hyperalphalipoproteinemia	143470	AD	3
118470	16q13	[High density lipoprotein cholesterol level QTL 10]	143470	AD	3
118485	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
118490	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
118494	1q43	?Prune belly syndrome	100100	AR	3
118502	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
118503	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118504	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
118504	20q13.33	{Nicotine addiction, susceptibility to}	188890	_	3
118505	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118505	15q25.1	{Nicotine dependence, susceptibility to}	612052	_	3
118507	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
118600	5p15.2	Chondrocalcinosis 2	118600	AD	3
118661	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
118700	14q13.3	Chorea, hereditary benign	118700	AD	3
118800	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
118955	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
119100	1q42.2-q43	Split-hand/foot malformation with long bone deficiency 1	119100	AD	2
119300	1q32.2	van der Woude syndrome	119300	AD	3
119500	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
119530	6p24.3	Orofacial cleft-1	119530	AD	2
119580	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
119800	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
119900	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
120070	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120070	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
120070	2q36.3	Hematuria, benign familial	141200	AD	3
120080	7q21.12	{Colchicine resistance}	120080	_	3
120090	13q34	Brain small vessel disease 2	614483	AD	3
120090	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120100	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
120110	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
120120	3p21.31	EBD inversa	226600	AR	3
120120	3p21.31	EBD, Bart type	132000	AD	3
120120	3p21.31	EBD, localisata variant	_	_	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AR	226600	AR	3
120120	3p21.31	Epidermolysis bullosa pruriginosa	604129	AD,AR	3
120120	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
120120	3p21.31	Toenail dystrophy, isolated	607523	AD	3
120120	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
120130	13q34	?Retinal arteries, tortuosity of	180000	AD	3
120130	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
120130	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
120130	13q34	Schizencephaly	269160	_	3
120130	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120131	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120131	2q36.3	Hematuria, familial benign	141200	AD	3
120140	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
120140	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
120140	12q13.11	Czech dysplasia	609162	AD	3
120140	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
120140	12q13.11	Kniest dysplasia	156550	AD	3
120140	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
120140	12q13.11	Osteoarthritis with mild chondrodysplasia	604864	AD	3
120140	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
120140	12q13.11	SED congenita	183900	AD	3
120140	12q13.11	SMED Strudwick type	184250	AD	3
120140	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
120140	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
120140	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
120140	12q13.11	Stickler syndrome, type I	108300	AD	3
120140	12q13.11	Vitreoretinopathy with phalangeal epiphyseal dysplasia	_	_	3
120150	17q21.33	Caffey disease	114000	AD	3
120150	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
120150	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
120150	17q21.33	Osteogenesis imperfecta, type II	166210	AD	3
120150	17q21.33	Osteogenesis imperfecta, type III	259420	AD	3
120150	17q21.33	Osteogenesis imperfecta, type IV	166220	AD	3
120150	17q21.33	{Bone mineral density variation QTL, osteoporosis}	166710	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
120160	7q21.3	Osteogenesis imperfecta, type II	166210	AD	3
120160	7q21.3	Osteogenesis imperfecta, type III	259420	AD	3
120160	7q21.3	Osteogenesis imperfecta, type IV	166220	AD	3
120160	7q21.3	{Osteoporosis, postmenopausal}	166710	AD	3
120180	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
120180	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
120190	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
120200	11p13	?Coloboma, ocular	120200	AD	3
120210	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
120210	6q13	Stickler syndrome, type IV	614134	_	3
120215	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
120220	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120220	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120240	21q22.3	?Myosclerosis, congenital	255600	AR	3
120240	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120240	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120250	2q37.3	Bethlem myopathy 1	158810	AD,AR	3
120250	2q37.3	Dystonia 27	616411	AR	3
120250	2q37.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120252	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
120252	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
120260	1p34.2	?Stickler syndrome, type V	614284	AR	3
120260	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
120270	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
120270	20q13.33	{Intervertebral disc disease, susceptibility to}	603932	_	3
120280	1p21.1	Fibrochondrogenesis 1	228520	AR	3
120280	1p21.1	Marshall syndrome	154780	AD	3
120280	1p21.1	Stickler syndrome, type II	604841	AD	3
120280	1p21.1	{Lumbar disc herniation, susceptibility to}	603932	_	3
120290	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
120290	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
120290	6p21.32	Fibrochondrogenesis 2	614524	AD,AR	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
120320	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
120320	6q13-q14	Bethlem myopathy 2	616471	AD	3
120328	21q22.3	Knobloch syndrome, type 1	267750	AR	3
120330	10q24.31	Papillorenal syndrome	120330	AD	3
120350	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
120353	11q22.2	COPD, rate of decline of lung function in	606963	_	3
120353	11q22.2	{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}	226600	AR	3
120360	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
120361	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
120433	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
120435	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
120436	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
120436	3p22.2	Mismatch repair cancer syndrome	276300	AR	3
120436	3p22.2	Muir-Torre syndrome	158320	AD	3
120470	18q21.2	Colorectal cancer, somatic	114500	_	3
120470	18q21.2	Esophageal carcinoma, somatic	133239	_	3
120470	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
120470	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
120502	1q31	Branchiootic syndrome 2	120502	AD	2
120520	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
120520	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AD,AR	3
120550	1p36.12	C1q deficiency	613652	AR	3
120570	1p36.12	C1q deficiency	613652	AR	3
120575	1p36.12	C1q deficiency	613652	AR	3
120580	12p13.31	C1s deficiency	613783	_	3
120580	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
120620	1q32.2	CR1 deficiency	_	_	1
120620	1q32.2	[Blood group, Knops system]	607486	_	3
120620	1q32.2	{?SLE susceptibility}	_	_	1
120620	1q32.2	{Malaria, severe, resistance to}	611162	_	3
120650	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
120650	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
120700	19p13.3	C3 deficiency	613779	AR	3
120700	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
120700	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
120790	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
120810	6p21.33	C4a deficiency	614380	AR	3
120810	6p21.33	[Blood group, Rodgers]	614374	_	3
120820	6p21.33	C4B deficiency	614379	_	3
120900	9q33.2	C5 deficiency	609536	_	3
120900	9q33.2	[Eculizumab, poor response to]	615749	AD	3
120920	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AD,AR	3
120940	5p13.1	C9 deficiency	613825	_	3
120940	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
120950	1p32.2	C8 deficiency, type I	613790	AR	3
120960	1p32.2	C8 deficiency, type II	613789	AR	3
120970	19q13.33	Cone-rod retinal dystrophy-2	120970	AD	3
121011	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
121011	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
121011	13q12.11	Deafness, autosomal recessive 1A	220290	AR	3
121011	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
121011	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
121011	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
121011	13q12.11	Vohwinkel syndrome	124500	AD	3
121013	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
121013	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
121014	6q22.31	Atrioventricular septal defect 3	600309	AD	3
121014	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
121014	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
121014	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
121014	6q22.31	Oculodentodigital dysplasia	164200	AD	3
121014	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
121014	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
121014	6q22.31	Syndactyly, type III	186100	AD	3
121015	13q12.11	Cataract 14, multiple types	601885	AD	3
121050	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
121201	8q24.22	Seizures, benign neonatal, 2	121201	AD	3
121210	8q13-q21	Febrile seizures, familial, 1	121210	AD	2
121360	16q22.1	Myeloid leukemia, acute, M4/M4Eo subtype, somatic	601626	_	1
121400	12q21.33	Cornea plana 1, autosomal dominant	121400	AD	2
121800	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
121820	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
121850	2q34	Corneal fleck dystrophy	121850	AD	3
121900	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
122000	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
122200	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
122400	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
122470	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
122500	14q32.13	Corticosteroid-binding globulin deficiency	611489	AD,AR	3
122600	16p11.2	Spondylocostal dysostosis 5	122600	AD,AR	3
122720	19q13.2	Coumarin resistance	122700	AD	3
122720	19q13.2	{Lung cancer, resistance to}	211980	AD,SMu	3
122720	19q13.2	{Nicotine addiction, protection from}	188890	_	3
122860	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
122880	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
123000	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
123100	7p21.1	Craniosynostosis 1	123100	AD	3
123101	5q35.2	Craniosynostosis 2	604757	AD	3
123101	5q35.2	Parietal foramina 1	168500	AD	3
123101	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
123155	8q12.2-q21.2	?Hydrocephalus, autosomal dominant	123155	AD	2
123270	14q32	[Creatine kinase, brain type, ectopic expression of]	123270	_	2
123320	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
123500	10q26.13	Crouzon syndrome	123500	AD	3
123570	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
123580	21q22.3	Cataract 9, multiple types	604219	AD,AR	3
123590	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
123590	11q23.1	Cataract 16, multiple types	613763	AD,AR	3
123590	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
123590	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
123610	17q11.2	Cataract 10, multiple types	600881	AD	3
123620	22q11.23	Cataract 3, multiple types	601547	AD	3
123630	22q11.23	Cataract 22	609741	AD,AR	3
123631	22q12.1	Cataract 23	610425	_	3
123670	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
123680	2q33.3	Cataract 2, multiple types	604307	AD	3
123690	2q33.3	Cataract 4, multiple types	115700	AD	3
123695	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
123700	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
123730	3q27.3	Cataract 20, multiple types	116100	AD	3
123740	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
123790	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
123805	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
123810	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
123825	4p12	Retinitis pigmentosa 49	613756	_	3
123829	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
123831	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
123833	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
123841	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
123860	1p34.2	Immunodeficiency 24	615897	AR	3
123870	11q13.1	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
123889	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
123889	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
123890	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
123890	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
123890	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
123890	2q33.2	{Hashimoto thyroiditis}	140300	AD	3
123890	2q33.2	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
123930	19q13.2	Efavirenz, poor metabolism of	614546	_	3
123930	19q13.2	{Efavirenz central nervous system toxicity, susceptibility to}	614546	_	3
123940	12q13.13	White sponge nevus 1	193900	AD	3
123970	7p15.3	Thrombocytopenia 4	612004	AD	3
123980	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
124000	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
124015	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
124015	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
124020	10q23.33	Clopidogrel, impaired responsiveness to	609535	AR	3
124020	10q23.33	Mephenytoin poor metabolizer	609535	AR	3
124020	10q23.33	Omeprazole poor metabolizer	609535	AR	3
124020	10q23.33	Proguanil poor metabolizer	609535	AR	3
124030	22q13.2	{Codeine sensitivity}	608902	AR	3
124030	22q13.2	{Debrisoquine sensitivity}	608902	AR	3
124080	8q24.3	Aldosterone to renin ratio raised	_	_	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
124080	8q24.3	{Low renin hypertension, susceptibility to}	_	_	3
124089	19q13.12	Mitochondrial complex IV deficiency	220110	Mi,AR	3
124092	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
124092	1q32.1	{HIV-1, susceptibility to}	609423	_	3
124092	1q32.1	{Rheumatoid arthritis, progression of}	180300	_	3
124200	12q24.11	Darier disease	124200	AD	3
124480	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
124500	13q12.11	Vohwinkel syndrome	124500	AD	3
124900	5q31.3	Deafness, autosomal dominant 1	124900	AD	3
125240	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
125240	1q32.2	[Blood group Cromer]	613793	AR	3
125250	3q29	Optic atrophy plus syndrome	125250	AD	3
125255	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
125264	6p22.3	Leukemia, acute nonlymphocytic	125264	_	2
125270	9q32	Porphyria, acute hepatic	612740	AR	3
125270	9q32	{Lead poisoning, susceptibility to}	612740	AR	3
125310	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
125350	3p21.31	Failure of tooth eruption, primary	125350	AD	3
125370	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
125400	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
125420	4q22.1	Dentin dysplasia, type II	125420	AD	3
125480	18p	{Major affective disorder 1}	125480	AD	2
125485	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
125485	4q22.1	Dentin dysplasia, type II	125420	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125490	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125500	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125505	16p13.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
125520	22q11	Cayler cardiofacial syndrome	125520	AD	2
125595	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
125630	19p13.12	Vibratory urticaria	125630	AD	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11	610476	AD,AR	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	AD,AR	3
125647	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
125647	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
125647	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
125647	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
125647	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
125647	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
125660	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
125660	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
125660	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
125670	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
125670	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
125671	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
125671	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
125700	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
125800	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
125850	20q13.12	MODY, type I	125850	AD	3
125851	7p13	MODY, type II	125851	AD	3
125852	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
125860	16q22.1	{Benzene toxicity, susceptibility to}	_	_	3
125860	16q22.1	{Breast cancer, poor survival after chemotherapy for}	_	_	3
125860	16q22.1	{Leukemia, post-chemotherapy, susceptibility to}	_	_	3
126060	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
126063	14q24.3	Paragangliomas 7	618475	AD	3
126064	16q22.2	Miller syndrome	263750	AR	3
126065	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
126090	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
126141	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
126141	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
126150	5q31.3	{Diphtheria, susceptibility to}	_	_	1
126340	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
126340	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
126340	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
126375	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
126375	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
126380	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
126420	20q12	DNA topoisomerase I, camptothecin-resistant	_	_	3
126430	17q21.2	DNA topoisomerase II, resistance to inhibition of, by amsacrine	_	_	3
126451	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
126451	3q13.31	{Schizophrenia, susceptibility to}	181500	AD	3
126452	11p15.5	Autonomic nervous system dysfunction	_	_	3
126452	11p15.5	[Novelty seeking personality]	601696	?AD	1
126452	11p15.5	{Attention deficit-hyperactivity disorder}	143465	AD	3
126453	4p16.1	{Attention deficit-hyperactivity disorder, susceptibility to}	143465	AD	3
126453	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
126455	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
126455	5p15.33	{Nicotine dependence, protection against}	188890	_	3
126600	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
126650	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
126700	1q31.3	Basal laminar drusen	126700	AD	3
126800	8q13	Duane retraction syndrome 1	126800	AD	2
126900	16q11.1-q22	Dupuytren contracture 1	126900	AD	2
127000	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
127400	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
127500	6q24.2-q25.2	Dyschromatosis universalis hereditaria 1	127500	AD	2
127550	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
127600	4q35	Dyskeratosis, hereditary benign intraepithelial	127600	AD	2
127700	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
128100	9q34.11	Dystonia-1, torsion	128100	AD	3
128101	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
128200	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
128230	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
128235	19q13.2	Dystonia-12	128235	AD	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
128260	1q32.1	Hypotrichosis 11	615059	AD	3
128700	8q11.1-q13.3	?Preauricular fistulae, congenital	128700	AD	2
129010	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
129010	10q21.3	Dejerine-Sottas disease	145900	AD,AR	3
129010	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AD,AR	3
129190	6q14.3	Calcification of joints and arteries	211800	AR	3
129200	4q22.3	Basan syndrome	129200	AD	3
129400	3q28	Rapp-Hodgkin syndrome	129400	AD	3
129490	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
129500	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
129600	15q21.1	Ectopia lentis, familial	129600	AD	3
129900	7q11.2-q21.3	?EEC syndrome-1	129900	AD	2
130000	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
130010	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
130050	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
130060	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
130070	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
130080	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
130130	19p13.3	Neutropenia, cyclic	162800	AD	3
130130	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
130160	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
130160	7q11.23	Supravalvar aortic stenosis	185500	AD	3
130410	19q13.41	Glutaric acidemia IIB	231680	AR	3
130500	1p35.3	Elliptocytosis-1	611804	AD,AR	3
130600	1q23.1	Elliptocytosis-2	130600	AD	3
130610	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
130620	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
130720	19p13.12	Lateral meningocele syndrome	130720	AD	3
130900	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
131100	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
131195	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
131200	10q26	{Endometriosis, susceptibility to, 1}	131200	AR,Mu	2
131222	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
131230	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
131240	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
131240	6p24.1	Question mark ears, isolated	612798	AD	3
131240	6p24.1	{High density lipoprotein cholesterol level QTL 7}	_	_	3
131242	20q13.32	Central hypoventilation syndrome, congenital	209880	AD	3
131242	20q13.32	Waardenburg syndrome, type 4B	613265	AD,AR	3
131242	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
131243	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
131243	4q31.22-q31.23	{Migraine, resistance to}	157300	AD	3
131244	13q22.3	ABCD syndrome	600501	AR	3
131244	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
131244	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
131300	19q13.2	Camurati-Engelmann disease	131300	AD	3
131320	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
131340	20p13	Spinocerebellar ataxia 23	610245	AD	3
131370	17p13.2	?Glycogen storage disease XIII	612932	AR	3
131399	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
131400	5q31-q33	Eosinophilia, familial	131400	AD	2
131440	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
131530	4q25	Hypomagnesemia 4, renal	611718	_	3
131550	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
131550	7p11.2	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	{Nonsmall cell lung cancer, susceptibility to}	211980	AD,SMu	3
131705	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
131750	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
131850	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
131950	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
131960	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
132000	3p21.31	EBD, Bart type	132000	AD	3
132100	6p21.1	Photoparoxysmal response 1	132100	AD	2
132400	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
132450	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
132700	16q12.1	Cylindromatosis, familial	132700	AD	3
132800	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
132810	1q42.12	?Hypercholanemia, familial	607748	AR	3
132811	8p21.2-p21.1	{Hypercholesterolemia, familial, due to LDLR defect, modifier of}	143890	AD	3
132890	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
132900	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
133170	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
133170	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
133170	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
133171	19p13.2	[Erythrocytosis, familial, 1]	133100	AD	3
133180	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
133190	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
133200	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AD,AR	3
133430	6q25.1-q25.2	Breast cancer, somatic	114480	_	3
133430	6q25.1-q25.2	Estrogen resistance	615363	AR	3
133430	6q25.1-q25.2	{Atherosclerosis, susceptibility to}	_	_	3
133430	6q25.1-q25.2	{HDL response to hormone replacement, augmented}	_	_	3
133430	6q25.1-q25.2	{Migraine, susceptibility to}	157300	AD	3
133430	6q25.1-q25.2	{Myocardial infarction, susceptibility to}	608446	_	3
133440	4q23	{Autism, susceptibility to, 19}	615091	_	3
133450	22q12.2	Ewing sarcoma	612219	_	3
133450	22q12.2	Neuroepithelioma	612219	_	3
133510	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
133510	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
133520	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
133520	16p13.12	Xeroderma pigmentosum, group F	278760	AR	3
133520	16p13.12	Xeroderma pigmentosum, type F/Cockayne syndrome	278760	AR	3
133520	16p13.12	XFE progeroid syndrome	610965	AR	3
133530	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G	278780	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G/Cockayne syndrome	278780	AR	3
133540	10q11.23	Cockayne syndrome, type B	133540	AR	3
133550	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
133550	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
133700	8q24.11	Exostoses, multiple, type 1	133700	AD	3
133701	11p11.2	Exostoses, multiple, type 2	133701	AD	3
134350	19p13.3	Complement factor D deficiency	613912	AR	3
134370	1q31.3	Basal laminar drusen	126700	AD	3
134370	1q31.3	Complement factor H deficiency	609814	AD,AR	3
134370	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	AD,AR	3
134370	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
134371	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AD,AR	3
134371	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
134570	6p25.1	Factor XIIIA deficiency	613225	AR	3
134570	6p25.1	{Myocardial infarction, protection against}	608446	_	3
134570	6p25.1	{Venous thrombosis, protection against}	188050	AD	3
134580	1q31.3	Factor XIIIB deficiency	613235	AR	3
134600	15q15.3	Fanconi renotubular syndrome 1	134600	AD	2
134610	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
134629	1q22	Porokeratosis 9, multiple types	616631	AD	3
134637	10q23.31	Autoimmune lymphoproliferative syndrome, type IA	601859	AD	3
134637	10q23.31	Squamous cell carcinoma, burn scar-related, somatic	_	_	3
134637	10q23.31	{Autoimmune lymphoproliferative syndrome}	601859	AD	3
134638	1q24.3	Autoimmune lymphoproliferative syndrome, type IB	601859	AD	3
134638	1q24.3	{Lung cancer, susceptibility to}	211980	AD,SMu	3
134770	11q12.3	?Hemochromatosis, type 5	615517	AD	3
134790	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
134790	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AD,AR	3
134790	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
134797	15q21.1	Acromicric dysplasia	102370	AD	3
134797	15q21.1	Ectopia lentis, familial	129600	AD	3
134797	15q21.1	Geleophysic dysplasia 2	614185	AD	3
134797	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
134797	15q21.1	Marfan syndrome	154700	AD	3
134797	15q21.1	MASS syndrome	604308	_	3
134797	15q21.1	Stiff skin syndrome	184900	AD	3
134797	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
134820	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134820	4q31.3	Amyloidosis, familial visceral	105200	AD	3
134820	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134820	4q31.3	Hypodysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134830	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Hypofibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Afibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Dysfibrinogenemia, congenital	616004	_	3
134850	4q32.1	Hypodysfibrinogenemia	616004	_	3
134850	4q32.1	Hypofibrinogenemia, congenital	202400	AR	3
134934	4p16.3	Achondroplasia	100800	AD	3
134934	4p16.3	Bladder cancer, somatic	109800	_	3
134934	4p16.3	CATSHL syndrome	610474	AD,AR	3
134934	4p16.3	Cervical cancer, somatic	603956	_	3
134934	4p16.3	Colorectal cancer, somatic	114500	_	3
134934	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
134934	4p16.3	Hypochondroplasia	146000	AD	3
134934	4p16.3	LADD syndrome	149730	AD	3
134934	4p16.3	Muenke syndrome	602849	AD	3
134934	4p16.3	Nevus, epidermal, somatic	162900	_	3
134934	4p16.3	SADDAN	616482	AD	3
134934	4p16.3	Spermatocytic seminoma, somatic	273300	_	3
134934	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
134934	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
134935	5q35.2	{Cancer progression/metastasis}	_	_	3
135100	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
135150	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
135290	5q22.2	Desmoid disease, hereditary	135290	AD	3
135300	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
135400	17q24.2-q24.3	Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400	AR	4
135500	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
135600	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
135600	2q35	Plasma fibronectin deficiency	614101	AD	1
135600	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
135750	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
135820	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
135900	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
135940	1q21.3	Ichthyosis vulgaris	146700	AD	3
135940	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
136000	4q22.3	Adermatoglyphia	136000	AD	3
136120	16q22.1	Fish-eye disease	136120	AR	3
136132	1q24.3	Trimethylaminuria	602079	AR	3
136140	16p11.2	Floating-Harbor syndrome	136140	AD	3
136350	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
136350	8p11.23	Hartsfield syndrome	615465	AD	3
136350	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
136350	8p11.23	Jackson-Weiss syndrome	123150	AD	3
136350	8p11.23	Osteoglophonic dysplasia	166250	AD	3
136350	8p11.23	Pfeiffer syndrome	101600	AD	3
136350	8p11.23	Trigonocephaly 1	190440	AD	3
136351	13q12.2	Leukemia, acute lymphoblastic, somatic	613065	_	3
136351	13q12.2	Leukemia, acute myeloid, reduced survival in, somatic	601626	_	3
136351	13q12.2	Leukemia, acute myeloid, somatic	601626	_	3
136352	5q35.3	Hemangioma, capillary infantile, somatic	602089	_	3
136352	5q35.3	Lymphatic malformation 1	153100	AD	3
136430	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
136435	2p16.3	Ovarian dysgenesis 1	233300	AR	3
136435	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
136435	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
136440	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
136520	11p13	Foveal hypoplasia 1	136520	AD	3
136530	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
136533	13q14.11	Rhabdomyosarcoma, alveolar	268220	SMu	3
136550	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
136570	16p12	Chromosome 16p12.1 deletion syndrome, 520kb	136570	_	4
136630	12q13.12	Mental retardation, FRA12A type	136630	AD	3
136680	11p13	Frasier syndrome	136680	AD,SMu	3
136760	1p13.3	Frontonasal dysplasia 1	136760	AR	3
136800	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
136836	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
136850	1q43	Fumarase deficiency	606812	AR	3
136850	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
136900	22q12.3	Sorsby fundus dystrophy	136900	AD	3
137035	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
137060	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
137070	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
137070	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
137100	6p21.3	Immunoglobulin A deficiency	137100	AD,AR,IC	2
137140	4p12	{Alcohol dependence, susceptibility to}	103780	Mu	3
137150	16p13.2	GABA-transaminase deficiency	613163	AR	3
137160	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
137160	5q34	{Epilepsy, childhood absence, susceptibility to, 4}	611136	_	3
137160	5q34	{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136	_	3
137163	1p36.33	{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	AD	3
137163	1p36.33	{Epilepsy, idiopathic generalized, 10}	613060	AD	3
137163	1p36.33	{Epilepsy, juvenile myoclonic, susceptibility to}	613060	AD	3
137164	5q34	Epilepsy, generalized, with febrile seizures plus, type 3	607681	AD	3
137164	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
137164	5q34	Febrile seizures, familial, 8	607681	AD	3
137165	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
137167	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
137167	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
137181	22q11.21	[Gamma-glutamyltransferase, familial high serum]	137181	_	2
137190	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
137192	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
137192	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
137200	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
137241	19q13.32	[Plasma glucose, 2-hour, QTL 2]	137241	_	2
137245	1p22.3	Lymphoma, MALT, somatic	137245	_	3
137290	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
137295	3q21.3	Emberger syndrome	614038	AD	3
137295	3q21.3	Immunodeficiency 21	614172	AD	3
137295	3q21.3	{Leukemia, acute myeloid, susceptibility to}	601626	AD,SMu	3
137295	3q21.3	{Myelodysplastic syndrome, susceptibility to}	614286	_	3
137350	9q33.2	Amyloidosis, Finnish type	105120	AD	3
137580	11q23	Tourette syndrome	137580	AD	2
137600	4q25	Anterior segment dysgenesis 4	137600	AD	3
137750	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
137760	10p13	Glaucoma 1, open angle, E	137760	AD	3
137780	17q21.31	Alexander disease	203450	AD	3
137920	17q12	Renal cysts and diabetes syndrome	137920	AD	3
137940	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
137950	1q32	Glomerulopathy with fibronectin deposits 1	137950	AD	2
137960	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
137960	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
138000	1p22.1	Glomuvenous malformations	138000	AD	3
138030	2q24.2	[?Hyperproglucagonemia]	_	_	1
138033	17q25.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138040	5q31.3	Glucocorticoid resistance	615962	AD	3
138079	7p13	Diabetes mellitus, noninsulin-dependent, late onset	125853	AD	3
138079	7p13	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
138079	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
138079	7p13	MODY, type II	125851	AD	3
138090	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
138130	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
138140	1p34.2	Dystonia 9	601042	AD	3
138140	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AD,AR	3
138140	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
138140	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
138140	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
138160	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
138160	3q26.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138180	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
138210	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
138244	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
138246	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
138250	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
138250	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
138250	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
138250	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
138252	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
138252	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
138253	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
138280	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
138280	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
138280	2q32.2	Global developmental delay, progressive ataxia, and elevated glutamine	618312	_	3
138290	1q25.3	Glutamine deficiency, congenital	610015	AR	3
138292	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
138295	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
138300	8p12	Hemolytic anemia due to glutathione reductase deficiency	_	_	1
138320	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
138322	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
138420	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
138430	2q24.1	{Diabetes, type 2, susceptibility to}	125853	AD	3
138470	6p21.33	?Complement factor B deficiency	615561	_	3
138470	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
138470	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
138491	5q33.1	Hyperekplexia 1	149400	AD,AR	3
138492	4q32.1	Hyperekplexia 2	614619	AR	3
138570	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
138571	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
138680	3q27.3	?Alopecia-mental retardation syndrome 1	203650	AR	3
138720	22q11.21	Bernard-Soulier syndrome, type B	231200	AR	3
138720	22q11.21	Giant platelet disorder, isolated	231200	AR	3
138760	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
138800	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
138850	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
138890	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
138900	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
138945	17q21.31	Aphasia, primary progressive	607485	AD	3
138945	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
138945	17q21.31	Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485	AD	3
138971	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
138981	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
139090	3p21.31	Gray platelet syndrome	139090	AR	3
139130	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
139130	12p13.31	{Hypertension, essential, susceptibility to}	145500	Mu	3
139150	5q14.3	Basal cell carcinoma, somatic	605462	_	3
139150	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
139190	20q11.23	?Isolated growth hormone deficiency due to defect in GHRF	_	_	1
139190	20q11.23	Gigantism due to GHRF hypersecretion	_	_	1
139191	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
139210	18q21.2	Myhre syndrome	139210	AD	3
139250	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
139250	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
139250	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
139250	17q23.3	Kowarski syndrome	262650	AR	3
139300	15q21.2	Aromatase excess syndrome	139300	AD	3
139311	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
139311	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
139312	18p11.21	Dystonia 25	615073	AD	3
139313	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
139313	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
139320	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
139320	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
139320	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
139320	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
139320	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ib	603233	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
139320	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
139330	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
139330	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
139340	1p13.3	Achromatopsia 4	613856	_	3
139350	12q13.13	Epidermolytic hyperkeratosis	113800	AD,AR	3
139350	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
139350	12q13.13	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
139350	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
139350	12q13.13	Palmoplantar keratoderma, epidermolytic	144200	AD	3
139350	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
139360	3p21.31	Pituitary ACTH-secreting adenoma	_	_	3
139360	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
139370	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
139380	1p36.33	Leukemia, acute lymphoblastic, somatic	613065	_	3
139380	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
139393	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
139396	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
139450	1q21.3	Hair, curly	139450	AD	2
139900	2p12-q22	[Handedness]	139900	AD	2
140000	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
140100	16q22.2	[Anhaptoglobinemia]	614081	_	3
140100	16q22.2	[Hypohaptoglobinemia]	614081	_	3
140300	8q23-q24	Hashimoto thyroiditis	140300	AD	2
140350	12q24.31	Hawkinsinuria	140350	AD	3
140400	1q32	Progressive familial heart block, type II	140400	AD	2
140600	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
141250	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
141250	22q12.3	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	3
141750	16pter-p13.3	Alpha-thalassemia/mental retardation syndrome, type 1	141750	AD	4
141800	16p13.3	Erythrocytosis, 7	617981	_	3
141800	16p13.3	Heinz body anemias, alpha-	140700	AD	3
141800	16p13.3	Hemoglobin H disease, nondeletional	613978	_	3
141800	16p13.3	Methemoglobinemia, alpha type	617973	_	3
141800	16p13.3	Thalassemias, alpha-	604131	_	3
141850	16p13.3	Erythrocytosis 7	617981	_	3
141850	16p13.3	Heinz body anemia	140700	AD	3
141850	16p13.3	Hemoglobin H disease, deletional and nondeletional	613978	_	3
141850	16p13.3	Thalassemia, alpha-	604131	_	3
141900	11p15.4	Delta-beta thalassemia	141749	AD	3
141900	11p15.4	Erythrocytosis 6	617980	_	3
141900	11p15.4	Heinz body anemia	140700	AD	3
141900	11p15.4	Hereditary persistence of fetal hemoglobin	141749	AD	3
141900	11p15.4	Methmoglobinemia, beta type	617971	_	3
141900	11p15.4	Sickle cell anemia	603903	AR	3
141900	11p15.4	Thalassemia, beta	613985	_	3
141900	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
141900	11p15.4	{Malaria, resistance to}	611162	_	3
142000	11p15.4	Thalassemia due to Hb Lepore	_	_	3
142000	11p15.4	Thalassemia, delta-	_	_	3
142200	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142220	6p22.2	Rahman syndrome	617537	AD	3
142250	11p15.4	Cyanosis, transient neonatal	613977	AD	3
142250	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142330	12q24.31	Hepatic adenoma, somatic	142330	_	3
142335	2p16.1	[Fetal hemoglobin QTL5]	142335	AD	2
142340	15q26.1	Hernia, congenital diaphragmatic 1	142340	Mu	2
142360	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
142409	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
142410	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
142410	12q24.31	Hepatic adenoma, somatic	142330	_	3
142410	12q24.31	MODY, type III	600496	AD	3
142410	12q24.31	Renal cell carcinoma	144700	_	3
142410	12q24.31	{Diabetes mellitus, insulin-dependent}	222100	AR	3
142410	12q24.31	{Diabetes mellitus, noninsulin-dependent, 2}	125853	AD	3
142445	8p12	{?Schizophrenia, susceptibility to}	603013	_	1
142461	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
142461	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
142470	6q22.3-q23.1	Fetal hemoglobin quantitative trait locus 2	142470	AD	2
142600	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
142600	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
142600	10q22.1	Retinitis pigmentosa 79	617460	AD	3
142622	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
142640	3q27.3	Thrombophilia due to elevated HRG	613116	AD	1
142640	3q27.3	Thrombophilia due to HRG deficiency	613116	AD	3
142669	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
142680	12p13.31	Periodic fever, familial	142680	AD	3
142690	1q23.2	Acne inversa, familial, 1	142690	AD	3
142700	13q22	Developmental dysplasia of the hip 1	142700	Mu	2
142704	15q21.2	{Gilles de la Tourette syndrome, susceptibility to}	137580	AD	3
142800	6p22.1	{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}	608579	_	3
142810	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
142810	5q31.3	Usher syndrome type 3B	614504	AR	3
142830	6p21.33	{Abacavir hypersensitivity, susceptibility to}	_	_	3
142830	6p21.33	{Drug-induced liver injury due to flucloxacillin}	_	_	3
142830	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
142830	6p21.33	{Stevens-Johnson syndrome, susceptibility to}	608579	_	3
142830	6p21.33	{Synovitis, chronic, susceptibility to}	_	_	3
142830	6p21.33	{Toxic epidermal necrolysis, susceptibility to}	608579	_	3
142840	6p21.33	{HIV-1 viremia, susceptibility to}	609423	_	3
142840	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
142857	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
142857	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
142858	6p21.32	{Beryllium disease, chronic, susceptibility to}	_	_	3
142871	6p22.1	{Asthma, susceptibility to}	600807	AD	2
142900	12q24.21	Holt-Oram syndrome	142900	AD	3
142910	5q13.3	[Low density lipoprotein cholesterol level QTL 3]	_	_	3
142910	5q13.3	[Statins, attenuated cholesterol lowering by]	_	_	3
142945	7q36.3	Holoprosencephaly 3	142945	AD	3
142946	18p11.31	Holoprosencephaly 4	142946	AD	3
142955	7p15.2	Athabaskan brainstem dysgenesis syndrome	601536	_	3
142955	7p15.2	Bosley-Salih-Alorainy syndrome	601536	_	3
142958	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
142959	7p15.2	?Guttmacher syndrome	176305	AD	3
142959	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
142968	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
142976	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
142983	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
142983	4p16.2	Orofacial cleft 5	608874	_	3
142983	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
142984	2q31.1	Charcot-Marie-Tooth disease, foot deformity of	192950	AD	3
142984	2q31.1	Vertical talus, congenital	192950	AD	3
142989	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
142989	2q31.1	Brachydactyly, type D	113200	AD	3
142989	2q31.1	Brachydactyly, type E	113300	AD	3
142989	2q31.1	Syndactyly, type V	186300	AD	3
142989	2q31.1	Synpolydactyly 1	186000	AD	3
142992	4p16.1	Oculoauricular syndrome	612109	AR	3
142993	14q24.3	Microphthalmia with coloboma 3	610092	_	3
142993	14q24.3	Microphthalmia, isolated 2	610093	_	3
142994	7q36.3	Currarino syndrome	176450	AD	3
143054	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
143095	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
143100	4p16.3	Huntington disease	143100	AD	3
143200	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
143400	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
143450	2p23.3	Trifunctional protein deficiency	609015	AR	3
143500	2q37.1	[Gilbert syndrome]	143500	AR	3
143850	18q	Orthostatic hypotensive disorder of Streeten	143850	AD	2
143860	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
143870	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
143880	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
144010	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
144110	14q11.2-q13	Hyperhidrosis palmaris et plantaris	144110	AD	2
144120	14q32.33	?Hyperimmunoglobulin G1 syndrome	144120	AD	2
144250	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
144650	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
144755	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
145000	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
145250	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
145260	1q31-q42	Pseudohypoaldosteronism, type IIA	145260	AD	2
145410	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
145420	22q11.23	Hypertelorism, Teebi type	145420	AD	3
145505	16p12.3	{?Hypertension, essential}	_	_	1
145650	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
145680	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
145701	8q22	?Hypertrichosis universalis congenita, Ambras type	145701	AD	2
145750	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
145980	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
145981	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
146000	4p16.3	Hypochondroplasia	146000	AD	3
146110	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
146255	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
146390	18p	Chromosome 18p deletion syndrome	146390	AD	4
146450	7q32.2-q36.1	Hypospadias 3, autosomal	146450	AD,Mu	2
146500	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AD,AR	3
146510	7p14.1	Pallister-Hall syndrome	146510	AD	3
146520	6p21.33	Hypotrichosis 2	146520	AD	3
146550	8p21.3	Hypotrichosis 4	146550	AD	3
146590	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
146660	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
146661	5p13.2	Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type	608971	AR	3
146690	7q32.1	Leber congenital amaurosis 11	613837	AD	3
146690	7q32.1	Retinitis pigmentosa 10	180105	AD	3
146691	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
146700	1q21.3	Ichthyosis vulgaris	146700	AD	3
146738	19p13.11	Cryptorchidism	219050	AD	3
146740	1q23.3	Immunodeficiency 20	615707	AR	3
146760	1q21.2	[IgG receptor I, phagocytic, familial deficiency of]	_	_	3
146770	22q11.23	Agammaglobulinemia 2	613500	AR	3
146790	1q23.3	{Lupus nephritis, susceptibility to}	152700	AD	3
146790	1q23.3	{Malaria, severe, susceptibility to}	611162	_	3
146790	1q23.3	{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	AR	3
146800	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
146880	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
146920	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
146920	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
146929	2q35	{AIDS, slow progression to}	609423	_	3
146933	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
147020	14q32.33	Agammaglobulinemia 1	601495	AR	3
147060	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
147061	5q31.1	{?Allergy and asthma susceptibility}	147061	_	2
147110	14q32.33	IgG2 deficiency, selective	_	_	3
147138	11q12.1	{Atopy, susceptibility to}	147050	AD	3
147141	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
147183	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
147200	2p11.2	Kappa light chain deficiency	614102	AR	3
147245	17q23.3	Agammaglobulinemia 6	612692	AR	3
147250	7q36.3	Single median maxillary central incisor	147250	AD	3
147265	3p26.1	Gillespie syndrome	206700	AD,AR	3
147265	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
147265	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
147267	6p21.31	{Diabetes, type 1, susceptibility to}	222100	AR	2
147280	6q25.3	Hepatocellular carcinoma, somatic	114550	_	3
147370	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
147430	14q11.2	?Marsili syndrome	147430	AD	3
147440	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
147450	21q22.11	Amyotrophic lateral sclerosis 1	105400	AD,AR	3
147460	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
147470	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
147480	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
147520	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
147520	20p13	[Inosine triphosphatase deficiency]	613850	_	3
147545	2q36.3	{Coronary artery disease, susceptibility to}	_	_	3
147545	2q36.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
147556	2q31.1	Epidermolysis bullosa, junctional, with pyloric stenosis	226730	AR	3
147557	17q25.1	Epidermolysis bullosa of hands and feet	131800	AD	3
147557	17q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
147557	17q25.1	Epidermolysis bullosa, junctional, with pyloric atresia	226730	AR	3
147558	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
147569	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
147570	12q15	{AIDS, rapid progression to}	609423	_	3
147570	12q15	{Aplastic anemia}	609135	_	3
147570	12q15	{Hepatitis C virus, response to therapy of}	609532	_	3
147570	12q15	{TSC2 angiomyolipomas, renal, modifier of}	613254	AD	3
147570	12q15	{Tuberculosis, protection against}	607948	_	3
147571	1p36.33	Immunodeficiency 38	616126	AR	3
147575	5q31.1	Gastric cancer, somatic	613659	_	3
147575	5q31.1	Myelodysplastic syndrome, preleukemic	_	_	3
147575	5q31.1	Myelogenous leukemia, acute	_	_	3
147575	5q31.1	Nonsmall cell lung cancer, somatic	211980	_	3
147582	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
147620	7p15.3	{Crohn disease-associated growth failure}	266600	Mu	3
147620	7p15.3	{Diabetes, susceptibility to},	222100	AR	3
147620	7p15.3	{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	AD	3
147620	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
147620	7p15.3	{Rheumatoid arthritis, systemic juvenile}	604302	_	3
147630	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
147650	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
147660	9p21.3	Interferon, alpha, deficiency	_	_	1
147670	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
147670	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
147670	19p13.2	Leprechaunism	246200	AR	3
147670	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
147679	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
147679	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147679	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
147683	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
147683	5q31.1	{Asthma, susceptibility to}	600807	AD	3
147700	2q34	{Glioma, susceptibility to, somatic}	137800	_	3
147720	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147730	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
147730	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
147750	20q13.2	IVIC syndrome	147750	AD	3
147781	16p12.1	{AIDS, slow progression to}	609423	_	3
147781	16p12.1	{Atopy, susceptibility to}	147050	AD	3
147791	11q23	Jacobsen syndrome	147791	IC	4
147796	9p24.1	Erythrocytosis, somatic	133100	_	3
147796	9p24.1	Leukemia, acute myeloid, somatic	601626	_	3
147796	9p24.1	Myelofibrosis, somatic	254450	_	3
147796	9p24.1	Polycythemia vera, somatic	263300	_	3
147796	9p24.1	Thrombocythemia 3	614521	AD,SMu	3
147796	9p24.1	{Budd-Chiari syndrome, somatic}	600880	_	3
147840	19p13.2	{Malaria, cerebral, susceptibility to}	611162	_	3
147880	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
147880	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
147891	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
147910	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
147920	12q13.12	Kabuki syndrome 1	147920	AD	3
147950	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
148000	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
148040	12q13.13	Dowling-Degos disease 1	179850	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148040	12q13.13	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148040	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
148040	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
148041	12q13.13	Pachyonychia congenita 3	615726	_	3
148042	12q13.13	Pachyonychia congenita 4	615728	_	3
148043	12q13.13	Meesmann corneal dystrophy	122100	AD	3
148050	16q24.3	KBG syndrome	148050	AD	3
148060	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148060	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148065	17q21.2	White sponge nevus 2	615785	AD	3
148066	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148066	17q21.2	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148066	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
148067	17q21.2	Pachyonychia congenita 1	167200	AD	3
148067	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
148069	17q21.2	Pachyonychia congenita 2	167210	AD	3
148069	17q21.2	Steatocystoma multiplex	184500	AD	3
148070	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148070	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148080	17q21.2	Epidermolytic hyperkeratosis	113800	AD,AR	3
148080	17q21.2	Ichthyosis with confetti	609165	AD	3
148080	17q21.2	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
148190	11p13	Keratitis	148190	AD	3
148200	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
148210	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
148300	20p11.21	Keratoconus 1	148300	AD	3
148350	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
148370	8p23-p22	Keratolytic winter erythema	148370	AD	2
148500	17q25.1	Tylosis with esophageal cancer	148500	AD	3
148600	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
148700	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
148760	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
148820	2q36.1	Waardenburg syndrome, type 3	148820	AD,AR	3
149000	8q22.3	Klippel-Trenaunay-Weber syndrome	149000	IC	2
149200	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
149400	5q33.1	Hyperekplexia 1	149400	AD,AR	3
149700	1p13.1	?Lacrimal duct defect	149700	AR	3
150000	11p15.1	Glycogen storage disease XI	612933	AR	3
150100	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
150200	17q23.3	[Placental lactogen deficiency]	_	_	1
150230	8q24.11-q24.13	Trichorhinophalangeal syndrome, type II	150230	AD	4
150240	7q31.1	Lissencephaly 5	615191	AR	3
150250	3p14.3	Larsen syndrome	150250	AD	3
150270	6p21.3-p21.2	?Laryngeal adductor paralysis	150270	AD	2
150292	1q25.3	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150292	1q25.3	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150310	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
150310	1q32.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150310	1q32.2	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150320	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
150325	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
150325	3p21.31	Pierson syndrome	609049	AR	3
150330	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
150330	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
150330	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
150330	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
150330	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
150330	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
150330	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
150330	1q22	Malouf syndrome	212112	AD	3
150330	1q22	Mandibuloacral dysplasia	248370	AR	3
150330	1q22	Muscular dystrophy, congenital	613205	AD	3
150330	1q22	Restrictive dermopathy, lethal	275210	AR	3
150340	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
150341	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
150341	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
150370	3p22.1	Asplenia, isolated congenital	271400	AD	3
150400	2q35	Tooth agenesis, selective, 4	150400	AD,AR	3
150571	22q13.1	{Myocardial infarction, susceptibility to}	608446	_	3
150600	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
150699	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
150800	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
151050	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
151100	12q24.13	LEOPARD syndrome 1	151100	AD	3
151200	8q22.1	Leri pleonosteosis chromosome duplication syndrome	151200	AD	4
151210	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
151350	5q32	?Infantile liver failure syndrome 1	615438	AR	3
151385	21q22.12	Leukemia, acute myeloid	601626	AD,SMu	3
151385	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
151410	22q11.23	Leukemia, acute lymphocytic, somatic	613065	_	3
151410	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
151430	18q21.33	Leukemia/lymphoma, B-cell, 2	_	_	3
151440	19p13.13	Leukemia, T-cell acute lymphoblastoid	151440	_	2
151443	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
151460	1q31.3-q32.1	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	AR	3
151460	1q31.3-q32.1	{Hepatitis C virus, susceptibility to}	609532	_	3
151600	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AD,AR	3
151623	17p13.1	Li-Fraumeni syndrome	151623	AD	3
151660	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
151670	15q21.3	Hepatic lipase deficiency	614025	AR	3
151670	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
151670	15q21.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
151750	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
152200	6q25-q26	[LPA deficiency, congenital]	_	_	3
152200	6q25-q26	{Coronary artery disease, susceptibility to}	_	_	1
152390	10q11.21	{Asthma, diminished response to antileukotriene treatment in}	600807	AD	3
152390	10q11.21	{Atherosclerosis, susceptibility to}	_	_	3
152424	11p15.4	Thalassemia, Hispanic gamma-delta-beta	613985	_	3
152427	7q36.1	Long QT syndrome 2	613688	AD	3
152427	7q36.1	Short QT syndrome 1	609620	_	3
152427	7q36.1	{Long QT syndrome 2, acquired, susceptibility to}	613688	AD	3
152430	4q25	[Longevity 1]	152430	_	2
152445	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
152760	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
152780	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
152790	2p16.3	Leydig cell adenoma, somatic, with precocious puberty	176410	_	3
152790	2p16.3	Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	AR	3
152790	2p16.3	Leydig cell hypoplasia with pseudohermaphroditism	238320	AR	3
152790	2p16.3	Luteinizing hormone resistance, female	238320	AR	3
152790	2p16.3	Precocious puberty, male	176410	AD	3
152950	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
153100	5q35.3	Lymphatic malformation 1	153100	AD	3
153245	4q25	Sebaceous tumors, somatic	_	_	3
153390	1p35.2	?Immunodeficiency 22	615758	AR	3
153440	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
153440	6p21.33	{Myocardial infarction, susceptibility to}	608446	_	3
153440	6p21.33	{Psoriatic arthritis, susceptibility to}	607507	_	3
153450	12q15	Amyloidosis, renal	105200	AD	3
153454	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
153455	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
153456	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
153550	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
153600	6p21.3	{Macroglobulinemia, Waldenstrom, susceptibility to, 1}	153600	AD	2
153620	22q11.23	{Rheumatoid arthritis, systemic juvenile, susceptibility to}	604302	_	3
153622	8p22	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
153670	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
153700	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
153800	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
153880	7p21-p15	Macular dystrophy, dominant cystoid	153880	AD	2
154020	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
154045	19q13.41	Cataract 19, multiple types	615277	AR	3
154050	12q13.3	Cataract 15, multiple types	615274	AD	3
154100	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
154230	9p24.3	46XY sex reversal 4	154230	_	4
154235	6p24.2	Retinitis pigmentosa 62	614181	AR	3
154275	17q11.2-q24	{Malignant hyperthermia susceptibility 2}	154275	AD	2
154276	7q21-q22	{Malignant hyperthermia susceptibility 3}	154276	AD	2
154400	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
154500	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
154545	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
154550	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
154700	15q21.1	Marfan syndrome	154700	AD	3
154780	1p21.1	Marshall syndrome	154780	AD	3
154870	12p12.3	Keutel syndrome	245150	AR	3
154950	14q23.3	{Pheochromocytoma, susceptibility to}	171300	AD	3
155100	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
155310	2p13.1	Visceral myopathy	155310	AD	3
155500	3q26.32	Macrodactyly, somatic	155500	_	3
155540	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
155541	18q21.32	Obesity (BMIQ20)	618406	_	3
155541	18q21.32	{Obesity, resistence to (BMIQ20)}	618306	_	3
155555	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	AR	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	AR	3
155555	16q24.3	{Albinism, oculocutaneous, type II, modifier of}	203200	AR	3
155555	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
155555	16q24.3	{UV-induced skin damage}	266300	AR	3
155600	1p36	{Melanoma, cutaneous malignant, 1}	155600	AD	2
155601	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
155755	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
155760	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
155760	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
155760	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
155900	9p11	?Melkersson-Rosenthal syndrome	155900	AD	2
156100	22q12.1	Meningioma	607174	AD	3
156200	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
156225	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
156225	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
156232	2q24-q32	Mesomelic dysplasia, Kantaputra type	156232	AD	2
156250	12q24.13	Metachondromatosis	156250	AD	3
156400	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
156490	17q21.33	Neuroblastoma	256700	AD,SMu	3
156500	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
156510	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
156530	12q24.11	Metatropic dysplasia	156530	AD	3
156540	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
156550	12q13.11	Kniest dysplasia	156550	AD	3
156560	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
156560	12q13.3	Interstitial lung and liver disease	615486	AR	3
156570	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
156570	1q43	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
156600	13q32	Microcoria, congenital	156600	AD	4
156610	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
156845	3p13	COMMAD syndrome	617306	AR	3
156845	3p13	Tietz albinism-deafness syndrome	103500	AD	3
156845	3p13	Waardenburg syndrome, type 2A	193510	AD	3
156845	3p13	Waardenburg syndrome/ocular albinism, digenic	103470	AD	3
156845	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
156850	16p13.3	Microphthalmia with cataract 1	156850	AD	2
157140	17q21.31	Dementia, frontotemporal, with or without parkinsonism	600274	AD	3
157140	17q21.31	Pick disease	172700	AD	3
157140	17q21.31	Supranuclear palsy, progressive	601104	AD	3
157140	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
157140	17q21.31	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
157145	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
157147	4q23	Abetalipoproteinemia	200100	AR	3
157147	4q23	{Metabolic syndrome, protection against}	605552	AD	3
157170	2p21	Holoprosencephaly 2	157170	AD	3
157300	4q24	{Migraine with or without aura, susceptibility to, 1}	157300	AD	2
157600	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
157640	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
157655	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
157660	9p13.3	Anauxetic dysplasia 1	607095	AR	3
157660	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
157660	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
157700	16p12.1-p11.2	Mitral valve prolapse, myxomatous 1	157700	AD	2
157800	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
157900	13q12.2-q13	?Moebius syndrome	157900	AD,IC	2
158105	17q12	{Coronary artery disease, modifier of}	_	_	3
158105	17q12	{HIV-1, resistance to}	609423	_	3
158105	17q12	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
158105	17q12	{Spina bifida, susceptibility to}	182940	AD	3
158170	9p	Chromosome 9p deletion syndrome	158170	AD	4
158300	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
158330	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
158340	1q22	Medullary cystic kidney disease 1	174000	AD	3
158375	4q13.3	{Asthma, protection against}	600807	AD	3
158378	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
158580	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
158590	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
158600	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
158900	4q35	Facioscapulohumeral muscular dystrophy 1	158900	AD	4
158901	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
159350	5q22.2	Colorectal cancer, somatic	114500	_	3
159440	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
159440	1q23.3	Dejerine-Sottas disease	145900	AD,AR	3
159440	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
159440	1q23.3	Roussy-Levy syndrome	180800	AD	3
159460	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
159465	6p22.1	?Narcolepsy 7	614250	AD	3
159530	1p34.2	Myelofibrosis with myeloid metaplasia, somatic	254450	_	3
159530	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
159530	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
159550	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
159555	11q23.3	Leukemia, myeloid/lymphoid or mixed-lineage	159555	AD	2
159555	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
159595	21q11.2	Leukemia, transient, of Down syndrome	159595	_	2
159900	7q21.3	Dystonia-11, myoclonic	159900	AD	3
159950	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
159990	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
160120	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
160500	14q11.2	Laing distal myopathy	160500	AD	3
160565	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
160700	18p11.31	Myopia-2	160700	AD	2
160710	14q11.2	Atrial septal defect 3	614089	_	3
160710	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
160710	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
160710	14q11.2	{Sick sinus syndrome 3}	614090	_	3
160720	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
160720	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
160740	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AD,AR	3
160741	17p13.1	Carney complex variant	608837	_	3
160741	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
160745	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
160760	14q11.2	Cardiomyopathy, dilated, 1S	613426	AD	3
160760	14q11.2	Cardiomyopathy, hypertrophic, 1	192600	AD	3
160760	14q11.2	Laing distal myopathy	160500	AD	3
160760	14q11.2	Left ventricular noncompaction 5	613426	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
160760	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
160770	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
160775	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
160775	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
160777	15q21.2	Griscelli syndrome, type 1	214450	AR	3
160780	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
160781	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
160790	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AD,AR	3
160794	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
160794	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
160800	7q34	Myotonia congenita, dominant	160800	AD	3
160900	19q13.32	Myotonic dystrophy 1	160900	AD	3
160980	17q24.2	Carney complex, type 1	160980	AD	3
160998	6p25.2	{?Breast cancer susceptibility}	114480	AD,SMu	1
161000	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
161015	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
161200	9q33.3	Nail-patella syndrome	161200	AD	3
161400	17q21.2	?Narcolepsy 1	161400	AD	3
161550	6p21.3	{Nasopharyngeal carcinoma, susceptibility to, 2}	161550	_	2
161561	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
161650	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
161900	1q21	Nephropathy-hypertension	161900	AD	2
161950	6q22-q23	{IgA nephropathy, susceptibility to, 1}	161950	?AD	2
162000	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
162030	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
162080	14q11-q12	Retinal degeneration, autosomal recessive, clumped pigment type	_	_	3
162080	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
162100	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
162150	5q15	Obesity with impaired prohormone processing	600955	AR	3
162150	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
162200	17q11.2	Neurofibromatosis, type 1	162200	AD	3
162210	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
162230	22q12.2	?{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
162230	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AD,AR	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
162300	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
162330	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
162332	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
162350	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
162400	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
162500	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
162643	2q22.1	Myelokathexis, isolated	_	_	3
162643	2q22.1	WHIM syndrome	193670	AD	3
162662	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
162800	19p13.3	Neutropenia, cyclic	162800	AD	3
162820	7q22-qter	?Neutrophil chemotactic response, abnormal	162820	AD	2
163000	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
163500	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
163729	7q36.1	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
163729	7q36.1	{Coronary artery spasm 1, susceptibility to}	_	_	3
163729	7q36.1	{Hypertension, pregnancy-induced}	189800	AD	3
163729	7q36.1	{Hypertension, susceptibility to}	145500	Mu	3
163729	7q36.1	{Ischemic stroke, susceptibility to}	601367	Mu	3
163729	7q36.1	{Placental abruption}	_	_	3
163730	17q11.2	{Hypertension, susceptibility to}	145500	Mu	2
163730	17q11.2	{Malaria, resistance to}	611162	_	3
163800	15q24.1	Sick sinus syndrome 2	163800	AD	3
163890	4q22.1	Dementia, Lewy body	127750	AD	3
163890	4q22.1	Parkinson disease 1	168601	AD	3
163890	4q22.1	Parkinson disease 4	605543	AD	3
163950	12q24.13	Noonan syndrome 1	163950	AD	3
163970	16q12.2	?Orthostatic intolerance	604715	_	3
164005	19p13.13	Marshall-Smith syndrome	602535	AD	3
164005	19p13.13	Sotos syndrome 2	614753	AD	3
164008	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
164009	11q13.4	Leukemia, acute promyelocytic, somatic	612376	_	3
164010	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
164011	4q24	Immunodeficiency, common variable, 12	616576	AD	3
164012	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
164014	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
164015	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
164017	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
164017	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
164040	5q35.1	Leukemia, acute myeloid, somatic	601626	_	3
164050	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
164100	6p12	Nystagmus 2, congenital, autosomal dominant	164100	AD	2
164160	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
164200	6q22.31	Oculodentodigital dysplasia	164200	AD	3
164210	14q32	Hemifacial microsomia	164210	AD	2
164280	2p24.3	Feingold syndrome 1	164280	AD	3
164300	14q11.2	Oculopharyngeal muscular dystrophy	164300	AD	3
164360	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
164360	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
164400	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
164500	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
164690	1q25.2	Leukemia, acute myeloid, with eosinophilia	_	_	1
164730	14q32.33	Breast cancer, somatic	114480	_	3
164730	14q32.33	Colorectal cancer, somatic	114500	_	3
164730	14q32.33	Cowden syndrome 6	615109	_	3
164730	14q32.33	Ovarian cancer, somatic	167000	_	3
164730	14q32.33	Proteus syndrome, somatic	176920	_	3
164730	14q32.33	{Schizophrenia, susceptibility to}	181500	AD	2
164731	19q13.2	Diabetes mellitus, type II	125853	AD	3
164731	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
164745	17q21.31	Omodysplasia 2	164745	AD	3
164750	1p31.3	Omphalocele due to duplication of 1p31.3	164750	IC	4
164757	7q34	Adenocarcinoma of lung, somatic	211980	_	3
164757	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
164757	7q34	Colorectal cancer, somatic	_	_	3
164757	7q34	LEOPARD syndrome 3	613707	AD	3
164757	7q34	Melanoma, malignant, somatic	_	_	3
164757	7q34	Nonsmall cell lung cancer, somatic	_	_	3
164757	7q34	Noonan syndrome 7	613706	AD	3
164760	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
164760	3p25.2	LEOPARD syndrome 2	611554	_	3
164760	3p25.2	Noonan syndrome 5	611553	AD	3
164761	10q11.21	Central hypoventilation syndrome, congenital	209880	AD	3
164761	10q11.21	Medullary thyroid carcinoma	155240	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
164761	10q11.21	Pheochromocytoma	171300	AD	3
164761	10q11.21	{Hirschsprung disease, protection against}	142623	AD	3
164761	10q11.21	{Hirschsprung disease, susceptibility to, 1}	142623	AD	3
164770	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
164770	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
164780	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
164785	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
164790	1p13.2	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	614470	_	3
164790	1p13.2	Colorectal cancer, somatic	114500	_	3
164790	1p13.2	Epidermal nevus, somatic	162900	_	3
164790	1p13.2	Melanocytic nevus syndrome, congenital, somatic	137550	_	3
164790	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
164790	1p13.2	Noonan syndrome 6	613224	AD	3
164790	1p13.2	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
164790	1p13.2	Thyroid carcinoma, follicular, somatic	188470	_	3
164820	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
164820	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
164840	2p24.3	Feingold syndrome 1	164280	AD	3
164860	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
164860	7q31.2	Hepatocellular carcinoma, childhood type, somatic	114550	_	3
164860	7q31.2	Renal cell carcinoma, papillary, 1, familial and somatic	605074	_	3
164860	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
164870	17q12	Adenocarcinoma of lung, somatic	211980	_	3
164870	17q12	Gastric cancer, somatic	613659	_	3
164870	17q12	Glioblastoma, somatic	137800	_	3
164870	17q12	Ovarian cancer, somatic	_	_	3
164874	14q12	Rett syndrome, congenital variant	613454	AD	3
164920	4q12	Gastrointestinal stromal tumor, familial	606764	AD,IC	3
164920	4q12	Germ cell tumors, somatic	273300	_	3
164920	4q12	Leukemia, acute myeloid	601626	AD,SMu	3
164920	4q12	Mastocytosis, cutaneous	154800	AD	3
164920	4q12	Mastocytosis, systemic, somatic	154800	_	3
164920	4q12	Piebaldism	172800	AD	3
164950	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
164953	19p13.2-q13.3	Liposarcoma	_	_	1
165190	4q21.21	Trichomegaly	190330	AR	3
165215	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
165220	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
165220	12q13.3	Polydactyly, preaxial I	174400	AR	3
165230	2q14.2	Culler-Jones syndrome	615849	AD	3
165230	2q14.2	Holoprosencephaly 9	610829	AD	3
165240	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
165240	7p14.1	Pallister-Hall syndrome	146510	AD	3
165240	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
165240	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
165240	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
165300	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
165320	2q14-q21	?Hepatocellular carcinoma	_	_	1
165330	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
165360	11q23.3	?Juvenile myelomonocytic leukemia	607785	AD,SMu	3
165360	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
165500	3q29	Optic atrophy 1	165500	AD	3
165550	11p13	Optic nerve hypoplasia	165550	AD	3
165640	2p25.1	{Colonic adenoma recurrence, reduced risk of}	114500	AD,SMu	3
165720	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
165800	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
166200	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
166250	8p11.23	Osteoglophonic dysplasia	166250	AD	3
166260	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
166300	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
166350	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
166600	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
166750	11q13	Otodental dysplasia chromosome deletion syndrome	166750	AD	4
166760	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
166780	8q13.3	?Otofaciocervical syndrome	166780	AD	3
166800	15q26.1-qter	Otosclerosis 1	166800	AD	2
166900	17q21.31	Ovalocytosis, SA type	166900	AD	3
167030	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
167200	17q21.2	Pachyonychia congenita 1	167200	AD	3
167210	17q21.2	Pachyonychia congenita 2	167210	AD	3
167250	5q35.3	Paget disease of bone 3	167250	AD	3
167320	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
167400	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
167409	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
167409	10q24.31	Papillorenal syndrome	120330	AD	3
167410	1p36.13	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
167411	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
167413	7q32.1	Diabetes mellitus, type 2	125853	AD	3
167413	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
167413	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AD,AR	3
167414	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
167415	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
167416	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
167420	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
167790	5q32	Pancreatitis, hereditary	167800	AD	3
167790	5q32	Tropical calcific pancreatitis	608189	AD,AR	3
167790	5q32	{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	AD,AR	3
167870	13q22-q32	Panic disorder syndrome 1	167870	?AD	2
168000	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
168300	17q23.3	Paramyotonia congenita	168300	AD	3
168400	12q24.11	Parastremmatic dwarfism	168400	AD	3
168450	11p15.3	Hypoparathyroidism, autosomal dominant	146200	AD,AR	3
168450	11p15.3	Hypoparathyroidism, autosomal recessive	146200	AD,AR	3
168461	11q13.3	{Colorectal cancer, susceptibility to}	114500	AD,SMu	3
168461	11q13.3	{Multiple myeloma, susceptibility to}	254500	SMu	3
168461	11q13.3	{von Hippel-Lindau syndrome, modifier of}	193300	AD	3
168468	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
168468	3p21.31	Eiken syndrome	600002	AR	3
168468	3p21.31	Failure of tooth eruption, primary	125350	AD	3
168468	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
168470	12p11.22	Brachydactyly, type E2	613382	AD	3
168500	5q35.2	Parietal foramina 1	168500	AD	3
168550	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
168601	4q22.1	Parkinson disease 1	168601	AD	3
168605	2p13.1	Perry syndrome	168605	AD	3
168820	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
168820	7q21.3	{Coronary artery spasm 2, susceptibility to	_	_	3
168820	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
168820	7q21.3	{Organophosphate poisoning, sensitivity to}	_	_	3
168860	17q21-q22	Patella aplasia or hypoplasia	168860	AD	2
169100	6p12.3	Char syndrome	169100	AD	3
169150	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
169400	1q42.12	Pelger-Huet anomaly	169400	AD	3
169500	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
169600	3q22.1	Hailey-Hailey disease	169600	AD	3
170100	19q13.11	Prolidase deficiency	170100	AR	3
170260	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
170261	6p21.32	Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	AR	3
170280	10q22.1	Aplastic anemia	609135	_	3
170280	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
170280	10q22.1	Lymphoma, non-Hodgkin	605027	_	3
170285	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
170290	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
170390	17q24.3	Andersen syndrome	170390	AD	3
170400	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
170500	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
170650	11q14.2	Periodontitis 1, juvenile	170650	AR	3
170710	12q13.12	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
170715	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
170993	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
170993	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
170995	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
170998	22q13.31	{Hyperapobetalipoproteinemia, susceptibility to}	_	_	3
171050	7q21.12	{Colchicine resistance}	120080	_	3
171050	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
171060	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AD,AR	3
171060	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
171060	7q21.12	Gallbladder disease 1	600803	AD,AR	3
171200	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
171400	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
171640	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
171650	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
171720	9q34.13	{Alkaline phosphatase, plasma level of, QTL1}	171720	?AD	2
171760	1p36.12	Hypophosphatasia, adult	146300	AD,AR	3
171760	1p36.12	Hypophosphatasia, childhood	241510	AR	3
171760	1p36.12	Hypophosphatasia, infantile	241500	AR	3
171760	1p36.12	Odontohypophosphatasia	146300	AD,AR	3
171833	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
171833	5q13.1	Immunodeficiency 36	616005	AD	3
171833	5q13.1	SHORT syndrome	269880	AD	3
171834	3q26.32	Breast cancer, somatic	114480	_	3
171834	3q26.32	CLAPO syndrome, somatic	613089	_	3
171834	3q26.32	CLOVE syndrome, somatic	612918	_	3
171834	3q26.32	Colorectal cancer, somatic	114500	_	3
171834	3q26.32	Cowden syndrome 5	615108	_	3
171834	3q26.32	Gastric cancer, somatic	613659	_	3
171834	3q26.32	Hepatocellular carcinoma, somatic	114550	_	3
171834	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
171834	3q26.32	Macrodactyly, somatic	155500	_	3
171834	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
171834	3q26.32	Nevus, epidermal, somatic	162900	_	3
171834	3q26.32	Nonsmall cell lung cancer, somatic	211980	_	3
171834	3q26.32	Ovarian cancer, somatic	167000	_	3
171860	21q22.3	Hemolytic anemia due to phosphofructokinase deficiency	_	_	1
171900	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
172100	6q14.1	Immunodeficiency 23	615816	AR	3
172400	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
172405	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
172405	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
172411	1p36.13	{?Colorectal cancer, susceptibility to}	114500	AD,SMu	3
172425	20q13.12	[High density lipoprotein cholesterol level QTL 9]	_	_	3
172430	1p36.23	Enolase deficiency	_	_	1
172460	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
172460	14q23.3	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
172471	16p11.2	Cirrhosis due to liver phosphorylase kinase deficiency	_	_	3
172471	16p11.2	Glycogen storage disease IXc	613027	AR	3
172480	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
172490	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
172860	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
172870	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
173100	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
173110	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AD,AR	3
173200	17q25.3	Pityriasis rubra pilaris	173200	AD	3
173321	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
173325	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
173325	17q21.2	Naxos disease	601214	AR	3
173335	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
173335	6q23.2	Cole disease	615522	AD	3
173335	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
173335	6q23.2	{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	AD	3
173335	6q23.2	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
173350	6q26	Dysplasminogenemia	217090	AR	3
173350	6q26	Plasminogen deficiency, type I	217090	AR	3
173360	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AD,AR	3
173360	7q22.1	{Transcription of plasminogen activator inhibitor, modulator of}	_	_	3
173370	8p11.21	Hyperfibrinolysis, familial, due to increased release of PLAT	612348	_	1
173370	8p11.21	Thrombophilia, familial, due to decreased release of PLAT	612348	_	1
173410	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
173410	5q32	Kosaki overgrowth syndrome	616592	AD	3
173410	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
173410	5q32	Myofibromatosis, infantile, 1	228550	AD	3
173410	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
173470	17q21.32	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
173470	17q21.32	Glanzmann thrombasthenia	273800	AR	3
173470	17q21.32	Purpura, posttransfusion	_	_	3
173470	17q21.32	Thrombocytopenia, neonatal alloimmune	_	_	3
173470	17q21.32	{Myocardial infarction, susceptibility to}	608446	_	3
173490	4q12	Gastrointestinal stromal tumor, somatic or familial	606764	_	3
173490	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
173510	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
173510	7q21.11	[Macrothrombocytopenia]	_	_	1
173510	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
173510	7q21.11	{Malaria, cerebral, reduced risk of}	611162	_	3
173510	7q21.11	{Malaria, cerebral, susceptibility to}	611162	_	3
173515	3q21.3	Bernard-Soulier syndrome, type C	231200	AR	3
173600	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
173650	20p12.3	Kindler syndrome	173650	AR	3
173900	16p13.3	Polycystic kidney disease 1	173900	AD	3
173910	4q22.1	Polycystic kidney disease 2	613095	AD	3
174000	1q22	Medullary cystic kidney disease 1	174000	AD	3
174050	19p13.2	Polycystic liver disease 1	174050	AD	3
174200	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
174300	1q32.1	Orofaciodigital syndrome V	174300	AR	3
174400	12q13.3	Polydactyly, preaxial I	174400	AR	3
174700	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
174761	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
174761	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
174762	12q24.33	FILS syndrome	615139	AR	3
174762	12q24.33	IMAGE-I syndrome	618336	AR	3
174762	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
174763	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
174800	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
174810	18q21.33	Osteolysis, familial expansile	174810	AD	3
175050	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
175200	19p13.3	Peutz-Jeghers syndrome	175200	AD	3
175700	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
175780	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
175800	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
175850	12q24.1-q24.2	Porokeratosis 2, palmar, plantar, and disseminated	175850	AD	2
175900	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
176258	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
176260	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
176261	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
176261	21q22.12	Long QT syndrome 5	613695	AD	3
176262	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
176264	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
176266	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
176267	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
176300	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
176300	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
176300	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
176305	7p15.2	?Guttmacher syndrome	176305	AD	3
176310	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
176400	19p13.3	?Precocious puberty, central, 1	176400	AD	3
176430	15q15.1	[Premature chromatid separation trait]	176430	AD	3
176450	7q36.3	Currarino syndrome	176450	AD	3
176500	13q14.2	Dementia, familial British	176500	AD	3
176610	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
176640	20p13	Cerebral amyloid angiopathy, PRNP-related	137440	AD	3
176640	20p13	Creutzfeldt-Jakob disease	123400	AD	3
176640	20p13	Gerstmann-Straussler disease	137440	AD	3
176640	20p13	Huntington disease-like 1	603218	AD	3
176640	20p13	Insomnia, fatal familial	600072	AD	3
176640	20p13	Prion disease with protracted course	606688	AD	3
176640	20p13	{Kuru, susceptibility to}	245300	_	3
176670	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
176705	17q21.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
176730	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
176730	11p15.5	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
176730	11p15.5	Hyperproinsulinemia	616214	AD	3
176730	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
176740	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
176761	5p13.2	Hyperprolactinemia	615555	AD,AR	3
176761	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
176763	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type, digenic	277400	AR	3
176780	1q31	{Pelvic organ prolapse, susceptibility to, 1}	176780	AD	2
176790	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
176797	11q23.2	Leukemia, acute promyelocytic, PL2F/RARA type	_	_	3
176797	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
176801	10q22.1	Combined SAP deficiency	611721	AR	3
176801	10q22.1	Gaucher disease, atypical	610539	_	3
176801	10q22.1	Krabbe disease, atypical	611722	AR	3
176801	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
176804	14q22.1	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
176830	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
176830	2p23.3	{Obesity, early-onset, susceptibility to}	601665	AD,AR,Mu	3
176860	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
176872	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
176876	12q24.13	LEOPARD syndrome 1	151100	AD	3
176876	12q24.13	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
176876	12q24.13	Metachondromatosis	156250	AD	3
176876	12q24.13	Noonan syndrome 1	163950	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
176885	20q13.13	{Insulin resistance, susceptibility to}	125853	AD	3
176893	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
176894	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
176895	13q34	[Protein Z deficiency]	614024	_	3
176915	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
176920	14q32.33	Proteus syndrome, somatic	176920	_	3
176930	11p11.2	Dysprothrombinemia	613679	AR	3
176930	11p11.2	Hypoprothrombinemia	613679	AR	3
176930	11p11.2	Thrombophilia due to thrombin defect	188050	AD	3
176930	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
176930	11p11.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
176941	19p13.2	Immunodeficiency 35	611521	AR	3
176943	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
176943	10q26.13	Apert syndrome	101200	AD	3
176943	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
176943	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
176943	10q26.13	Craniofacial-skeletal-dermatologic dysplasia	101600	AD	3
176943	10q26.13	Craniosynostosis, nonspecific	_	_	3
176943	10q26.13	Crouzon syndrome	123500	AD	3
176943	10q26.13	Gastric cancer, somatic	613659	_	3
176943	10q26.13	Jackson-Weiss syndrome	123150	AD	3
176943	10q26.13	LADD syndrome	149730	AD	3
176943	10q26.13	Pfeiffer syndrome	101600	AD	3
176943	10q26.13	Saethre-Chotzen syndrome	101400	AD	3
176943	10q26.13	Scaphocephaly and Axenfeld-Rieger anomaly	_	_	3
176943	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
176946	1p36.13	Cataract 6, multiple types	116600	AD	3
176947	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
176947	2q11.2	Immunodeficiency 48	269840	AR	3
176960	17q24.2	Pituitary tumor, invasive	_	_	3
176977	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
176980	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
177000	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
177045	6p21.32	?Proteasome-associated autoinflammatory syndrome 3, digenic	617591	AR	3
177046	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
177060	19p13.2	Polycystic liver disease 1	174050	AD	3
177070	15q15.2	Spherocytosis, type 5	612690	_	3
177075	16q23.2	Ayme-Gripp syndrome	601088	AD	3
177075	16q23.2	Cataract 21, multiple types	610202	AD	3
177170	19p13.11	Pseudoachondroplasia	177170	AD	3
177200	16p12.2	Liddle syndrome 1	177200	AD	3
177400	3q26.1	Butyrylcholinesterase deficiency	617936	_	3
177400	3q26.1	{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}	617936	_	3
177650	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
177700	12q14	Glaucoma 1, open angle, P	177700	AD	4
177735	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
177820	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
177850	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
177900	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
178110	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
178300	1p34.1-p32	Ptosis, hereditary congenital, 1	178300	AD	2
178620	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
178640	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
178642	10q22.3	Pulmonary fibrosis, idiopathic	178500	AD	3
179010	12q	Pyloric stenosis, infantile hypertrophic 1	179010	AD,Mu	2
179035	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
179035	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
179060	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
179095	5q31.1	?Male infertility	_	_	1
179410	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
179450	6p21.3	?Ragweed sensitivity	179450	AD	2
179502	4q23	Lymphocytic leukemia, acute T-cell	_	_	3
179590	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
179605	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
179605	6p21.1	Leber congenital amaurosis 18	608133	AD,AR	3
179605	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
179605	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
179605	6p21.1	Retinitis pigmentosa 7 and digenic form	608133	AD,AR	3
179605	6p21.1	Retinitis punctata albescens	136880	AD,AR	3
179615	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
179615	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179615	11p12	Omenn syndrome	603554	AR	3
179615	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179616	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179616	11p12	Omenn syndrome	603554	AR	3
179616	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179617	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
179617	15q15.1	Mirror movements 2	614508	AD	3
179617	15q15.1	{Breast cancer, susceptibility to}	114480	AD,SMu	3
179620	11p15.5	[Blood group, Raph]	179620	_	3
179755	1q23.1	Renal cell carcinoma, papillary	605074	_	3
179800	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
179820	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
179820	1q32.1	Renal tubular dysgenesis	267430	AR	3
179820	1q32.1	[Hyperproreninemia]	_	_	3
179850	12q13.13	Dowling-Degos disease 1	179850	AD	3
180000	13q34	?Retinal arteries, tortuosity of	180000	AD	3
180020	6q25-q26	?Retinal cone dystrophy-1	180020	AD	2
180040	1q32.3	Leber congenital amaurosis 12	610612	AR	3
180069	1p31.3	Leber congenital amaurosis 2	204100	AR	3
180069	1p31.3	Retinitis pigmentosa 20	613794	AR	3
180071	5q32	Retinitis pigmentosa 43	613810	_	3
180072	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
180072	4p16.3	Retinitis pigmentosa-40	613801	AR	3
180073	17q25.3	Retinitis pigmentosa 57	613582	AR	3
180090	15q26.1	Bothnia retinal dystrophy	607475	AR	3
180090	15q26.1	Fundus albipunctatus	136880	AD,AR	3
180090	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
180090	15q26.1	Retinitis punctata albescens	136880	AD,AR	3
180100	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AD,AR	3
180104	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
180105	7q32.1	Retinitis pigmentosa 10	180105	AD	3
180220	3p24.2	Microphthalmia, syndromic 12	615524	AD,AR	3
180240	17q21.2	Leukemia, acute promyelocytic	612376	_	1
180250	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
180250	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
180290	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
180295	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
180297	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
180297	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
180300	6q23	{Rheumatoid arthritis, susceptibility to}	180300	_	2
180380	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
180380	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AD,AR	3
180380	3q22.1	Retinitis punctata albescens	136880	AD,AR	3
180381	13q34	Oguchi disease-2	613411	_	3
180385	11p13	Leukemia, acute T-cell	180385	_	2
180430	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
180435	1q25.3	Prostate cancer 1	601518	AD	3
180468	3q29	Diamond-Blackfan anemia 5	612528	AD	3
180472	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
180500	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
180550	4q25	Ring dermoid of cornea	180550	AD	3
180700	3p14.3	Robinow syndrome, autosomal dominant 1	180700	AD	3
180721	11q12.3	Retinitis pigmentosa 7, digenic form	608133	AD,AR	3
180750	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
180849	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
180860	7p11.2	Silver-Russell syndrome	180860	AD	4
180901	19q13.2	Central core disease	117000	AD,AR	3
180901	19q13.2	King-Denborough syndrome	145600	AD	3
180901	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
180901	19q13.2	Neuromuscular disease, congenital, with uniform type 1 fiber	117000	AD,AR	3
180901	19q13.2	{Malignant hyperthermia susceptibility 1}	145600	AD	3
180902	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
180902	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
180920	5p12	Aplasia of lacrimal and salivary glands	180920	AD	3
180960	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
181000	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
181030	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
181031	2q37.1	Oguchi disease-1	258100	AR	3
181031	2q37.1	Retinitis pigmentosa 47	613758	_	3
181270	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
181350	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
181400	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
181405	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
181430	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
181450	12q24.21	Ulnar-mammary syndrome	181450	AD	3
181460	5q31-q33	{Schistosoma mansoni infection, susceptibility/resistance to}	181460	AD	2
181510	5q23-q35	{Schizophrenia}	181500	AD	2
181590	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
181600	4q22.3	Huriez syndrome	181600	AD	3
181800	19p13.3	Scoliosis, idiopathic 1	181800	AD	2
182000	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
182100	19q13.33	[Bombay phenotype, digenic]	616754	AR	3
182100	19q13.33	{Norwalk virus infection, resistance to}	_	_	3
182100	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
182120	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
182125	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
182135	13q14.2	{Alcohol dependence, susceptibility to}	103780	Mu	3
182135	13q14.2	{Anorexia nervosa, susceptibility to}	606788	_	3
182135	13q14.2	{Major depressive disorder, response to citalopram therapy in}	608516	_	3
182135	13q14.2	{Obsessive-compulsive disorder, susceptibility to}	164230	AD	3
182135	13q14.2	{Schizophrenia, susceptibility to}	181500	AD	3
182135	13q14.2	{Seasonal affective disorder, susceptibility to}	608516	_	3
182138	17q11.2	{Anxiety-related personality traits}	607834	_	3
182138	17q11.2	{Obsessive-compulsive disorder}	164230	AD	3
182170	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
182212	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
182250	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
182279	15q11.2	Prader-Willi syndrome	176270	AD	3
182280	3p23-p21	Small-cell cancer of lung	182280	AD	2
182282	20p13	Cerebrocostomandibular syndrome	117650	AD	3
182283	17q12	{HIV infection, resistance to}	609423	_	2
182290	17p11.2	Smith-Magenis syndrome	182290	AD,IC	3
182307	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
182309	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
182309	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
182309	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
182310	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
182310	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
182330	1q24.2	[Blood pressure regulation QTL]	145500	Mu	2
182340	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
182340	1q23.2	Migraine, familial basilar	602481	AD	3
182340	1q23.2	Migraine, familial hemiplegic, 2	602481	AD	3
182350	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
182350	19q13.2	CAPOS syndrome	601338	AD	3
182350	19q13.2	Dystonia-12	128235	AD	3
182380	22q12.3	Glucose/galactose malabsorption	606824	AR	3
182381	16p11.2	Renal glucosuria	233100	AD,AR	3
182389	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 2	604403	AD	3
182389	2q24.3	Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)	607208	AD	3
182389	2q24.3	Febrile seizures, familial, 3A	604403	AD	3
182389	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
182390	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
182390	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
182391	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
182391	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
182410	22q11.1	?Sneddon syndrome	182410	AR	3
182455	16p13.3	Somatostatin analog, resistance to	_	_	3
182465	21q22.11	ZTTK syndrome	617140	AD	3
182500	15q21.1	?Cataract, congenital	182500	_	2
182530	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
182530	2p22.1	Noonan syndrome 4	610733	AD	3
182600	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
182601	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
182810	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
182860	1q23.1	Elliptocytosis-2	130600	AD	3
182860	1q23.1	Pyropoikilocytosis	266140	AR	3
182860	1q23.1	Spherocytosis, type 3	270970	AR	3
182870	14q23.3	Anemia, neonatal hemolytic, fatal or near-fatal	617948	_	3
182870	14q23.3	Elliptocytosis-3	617948	_	3
182870	14q23.3	Spherocytosis, type 2	616649	AD	3
182888	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
182889	7q11.23	Oocyte maturation defect 3	617712	AD	3
182900	8p11.21	Spherocytosis, type 1	182900	AD,AR	3
182920	5q31.2	Myopathy, spheroid body	182920	AD	3
182960	7q34-q36	Neuronopathy, distal hereditary motor, type I	182960	AD	2
182980	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
183086	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
183600	7q21.2-q21.3	Split hand/foot malformation 1	183600	AD	4
183840	9q31-q34	{Spondyloarthropathy, susceptibility to, 2}	183840	AD	2
183900	12q13.11	SED congenita	183900	AD	3
184095	12q24.11	SED, Maroteaux type	184095	AD	3
184100	12q13	Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100	AD	2
184250	12q13.11	SMED Strudwick type	184250	AD	3
184252	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
184255	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
184260	14q32.12	Osteochondrodysplasia	184260	AR	3
184420	8p23.1	Squalene synthase deficiency	618156	_	3
184429	3q26.33	Microphthalmia, syndromic 3	206900	AD	3
184429	3q26.33	Optic nerve hypoplasia and abnormalities of the central nervous system	206900	AD	3
184450	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
184460	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
184500	17q21.2	Steatocystoma multiplex	184500	AD	3
184600	3q21.1	Peeling skin syndrome 4	607936	AR	3
184700	19p13.2	Polycystic ovary syndrome 1	184700	AD	2
184745	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
184745	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
184745	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
184755	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
184757	9q33.3	46, XX sex reversal 4	617480	AD	3
184757	9q33.3	46XY sex reversal 3	612965	AD	3
184757	9q33.3	Adrenocortical insufficiency	612964	AD	3
184757	9q33.3	Premature ovarian failure 7	612964	AD	3
184757	9q33.3	Spermatogenic failure 8	613957	AD	3
184840	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
184900	15q21.1	Stiff skin syndrome	184900	AD	3
185000	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
185020	17q21.31	Cryohydrocytosis	185020	AD	3
185070	11p15.4	Stormorken syndrome	185070	AD	3
185100	7p22.1	{Strabismus, susceptibility to, 1}	185100	_	2
185250	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
185300	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
185470	1p36.13	Gastrointestinal stromal tumor	606764	AD,IC	3
185470	1p36.13	Paraganglioma and gastric stromal sarcoma	606864	_	3
185470	1p36.13	Paragangliomas 4	115310	AD	3
185470	1p36.13	Pheochromocytoma	171300	AD	3
185490	4p15.2	[Superoxide dismutase, elevated extracellular]	_	_	3
185500	7q11.23	Supravalvar aortic stenosis	185500	AD	3
185535	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
185535	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
185605	12q21.2	Baker-Gordon syndrome	618218	AD	3
185620	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
185620	9q34.2	Leigh syndrome, due to COX IV deficiency	256000	Mi,AR	3
185800	17q22	Symphalangism, proximal, 1A	185800	AD	3
185880	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
185880	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
185900	2q34-q36	Syndactyly, type 1, with or without craniosynostosis	185900	AD	4
186000	2q31.1	Synpolydactyly 1	186000	AD	3
186100	6q22.31	Syndactyly, type III	186100	AD	3
186200	7q36.3	Syndactyly, type IV	186200	AD	3
186300	2q31.1	Syndactyly, type V	186300	AD	3
186357	1p35.2	{Obesity, association with}	601665	AD,AR,Mu	3
186500	17q22	Multiple synostoses syndrome 1	186500	AD	3
186550	5q31.1	Liebenberg syndrome	186550	AD	4
186570	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
186580	16q12.1	Blau syndrome	186580	AD	3
186711	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
186740	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
186780	1q24.2	?Immunodeficiency 25	610163	AR	3
186790	11q23.3	Immunodeficiency 19	615617	AR	3
186830	11q23.3	Immunodeficiency 18	615615	AR	3
186830	11q23.3	Immunodeficiency 18, SCID variant	615615	AR	3
186845	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
186855	9q31.2	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
186860	2q34	Leukemia/lymphoma, T-cell	186860	_	2
186880	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
186910	2p11.2	CD8 deficiency, familial	608957	AR	3
186921	11p15.4	Leukemia, T-cell acute lymphoblastic	186921	_	2
186940	12p13.31	OKT4 epitope deficiency	613949	_	3
186960	14q32.13	Leukemia/lymphoma, T-cell	186960	_	2
186973	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
187011	17q12	{HIV-1 disease, delayed progression of}	_	_	3
187011	17q12	{HIV-1 disease, rapid progression of}	_	_	3
187040	1p33	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
187260	5q14	Telangiectasia, hereditary benign	187260	AD	2
187270	5p15.33	{Dyskeratosis congenita, autosomal dominant 2}	613989	AD,AR	3
187270	5p15.33	{Dyskeratosis congenita, autosomal recessive 4}	613989	AD,AR	3
187270	5p15.33	{Leukemia, acute myeloid}	601626	AD,SMu	3
187270	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
187270	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
187300	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
187370	2q31.3-q32.1	Arthrogryposis, distal, type 10	187370	AD	2
187380	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
187395	3p21.31	Forebrain defects	_	_	3
187600	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
187601	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
187680	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
187900	9q34.13	Bleeding disorder, platelet-type, 17	187900	AD,AR	3
188000	10p12.1	Thrombocytopenia 2	188000	AD	3
188025	11q23	?Thrombocytopenia, Paris-Trousseau type	188025	IC	4
188030	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
188040	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
188040	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
188061	6q27	{Lumbar disc herniation, susceptibility to}	603932	_	3
188070	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
188250	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
188250	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
188400	22q11.21	DiGeorge syndrome	188400	AD	3
188450	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
188450	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
188540	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
188545	8q23.1	Thyrotropin-releasing hormone resistance, generalized	_	_	3
188550	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
188570	3p24.2	Thyroid hormone resistance	188570	AD	3
188580	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
188740	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
188826	22q12.3	Sorsby fundus dystrophy	136900	AD	3
188830	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
188830	17q24.2	Adrenocortical tumor, somatic	_	_	3
188830	17q24.2	Carney complex, type 1	160980	AD	3
188830	17q24.2	Myxoma, intracardiac	255960	AD	3
188830	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
188840	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
188840	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
188840	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
188840	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
188840	2q31.2	Salih myopathy	611705	AR	3
188840	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
189500	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
189800	2p13	Preeclampsia/eclampsia 1	189800	AD	2
189907	17q12	Diabetes mellitus, noninsulin-dependent	125853	AD	3
189907	17q12	Renal cysts and diabetes syndrome	137920	AD	3
189907	17q12	{Renal cell carcinoma}	144700	_	3
189909	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
189909	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
189964	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
189967	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
189980	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
189980	9q34.12	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	_	_	3
189990	6q23.3	{T-cell acute lymphoblastic leukemia}	_	_	3
190000	3q22.1	Atransferrinemia	209300	AR	3
190010	3q29	Immunodeficiency 46	616740	AR	3
190020	11p15.5	Bladder cancer, somatic	109800	_	3
190020	11p15.5	Congenital myopathy with excess of muscle spindles	218040	AD	3
190020	11p15.5	Costello syndrome	218040	AD	3
190020	11p15.5	Nevus sebaceous or woolly hair nevus, somatic	162900	_	3
190020	11p15.5	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190020	11p15.5	Spitz nevus or nevus spilus, somatic	137550	_	3
190020	11p15.5	Thyroid carcinoma, follicular, somatic	188470	_	3
190040	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
190040	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
190040	22q13.1	Meningioma, SIS-related	607174	AD	3
190070	12p12.1	Arteriovenous malformation of the brain, somatic	108010	_	3
190070	12p12.1	Bladder cancer, somatic	109800	_	3
190070	12p12.1	Breast cancer, somatic	114480	_	3
190070	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
190070	12p12.1	Gastric cancer, somatic	137215	_	3
190070	12p12.1	Leukemia, acute myeloid	601626	AD,SMu	3
190070	12p12.1	Lung cancer, somatic	211980	_	3
190070	12p12.1	Noonan syndrome 3	609942	AD	3
190070	12p12.1	Pancreatic carcinoma, somatic	260350	_	3
190070	12p12.1	RAS-associated autoimmune leukoproliferative disorder	614470	AD	3
190070	12p12.1	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190080	8q24.21	Burkitt lymphoma, somatic	113970	_	3
190090	20q11.23	?Thrombocytopenia 6	616937	AD	3
190090	20q11.23	Colon cancer, advanced, somatic	114500	_	3
190100	9q13-q21	Geniospasm	190100	AD	2
190120	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
190151	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
190151	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
190160	3p24.2	Thyroid hormone resistance	188570	AD	3
190160	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
190160	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
190180	19q13.2	Camurati-Engelmann disease	131300	AD	3
190180	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
190180	19q13.2	{Cystic fibrosis lung disease, modifier of}	219700	AR	3
190181	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
190181	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
190182	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
190182	3p24.1	Esophageal cancer, somatic	133239	_	3
190182	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
190195	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
190197	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
190198	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
190198	9q34.3	Aortic valve disease 1	109730	AD	3
190220	1q41	Loeys-Dietz syndrome 4	614816	AD	3
190230	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
190230	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
190300	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
190315	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
190315	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
190320	17q21.33	Trichodontoosseous syndrome	190320	AD	3
190330	4q21.21	Trichomegaly	190330	AR	3
190350	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
190351	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
190370	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
190440	8p11.23	Trigonocephaly 1	190440	AD	3
190450	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
190685	21q22.3	Down syndrome	190685	IC	4
190900	7q32.1	Colorblindness, tritan	190900	AD	3
190990	9p13.3	Arthrogryposis, distal, type 1A	108120	AD	3
190990	9p13.3	Arthrogryposis, distal, type 2B4	108120	AD	3
190990	9p13.3	CAP myopathy 2	609285	AD	3
190990	9p13.3	Nemaline myopathy 4, autosomal dominant	609285	AD	3
191010	15q22.2	Cardiomyopathy, dilated, 1Y	611878	AD	3
191010	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
191010	15q22.2	Left ventricular noncompaction 9	611878	AD	3
191030	1q21.3	CAP myopathy 1	609284	AD,AR	3
191030	1q21.3	Myopathy, congenital, with fiber-type disproportion	255310	AD,AR	3
191030	1q21.3	Nemaline myopathy 1, autosomal dominant or recessive	609284	AD,AR	3
191040	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
191040	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
191041	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
191043	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
191044	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
191044	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
191044	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
191044	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
191045	1q32.1	Cardiomyopathy, dilated, 1D	601494	AD	3
191045	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
191045	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
191045	1q32.1	Left ventricular noncompaction 6	601494	AD	3
191050	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
191070	4q32.1	[?Hypertryptophanemia]	600627	AR	3
191092	16p13.3	?Focal cortical dysplasia, type II, somatic	607341	_	3
191092	16p13.3	Lymphangioleiomyomatosis, somatic	606690	_	3
191092	16p13.3	Tuberous sclerosis-2	613254	AD	3
191100	9q34.13	Tuberous sclerosis-1	191100	AD	3
191110	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
191130	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
191130	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
191135	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
191160	6p21.33	{Asthma, susceptibility to}	600807	AD	3
191160	6p21.33	{Dementia, vascular, susceptibility to}	_	_	3
191160	6p21.33	{Malaria, cerebral, susceptibility to}	611162	_	3
191160	6p21.33	{Migraine without aura, susceptibility to}	157300	AD	3
191160	6p21.33	{Septic shock, susceptibility to}	_	_	3
191163	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
191170	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
191170	17p13.1	Breast cancer, somatic	114480	_	3
191170	17p13.1	Hepatocellular carcinoma, somatic	114550	_	3
191170	17p13.1	Li-Fraumeni syndrome	151623	AD	3
191170	17p13.1	Nasopharyngeal carcinoma, somatic	607107	_	3
191170	17p13.1	Pancreatic cancer, somatic	260350	_	3
191170	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
191170	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
191170	17p13.1	{Choroid plexus papilloma}	260500	AD	3
191170	17p13.1	{Colorectal cancer}	114500	AD,SMu	3
191170	17p13.1	{Glioma susceptibility 1}	137800	AD,SMu	3
191170	17p13.1	{Osteosarcoma}	259500	SMu	3
191181	11q13	Cervical carcinoma	191181	_	2
191190	12p13.31	Periodic fever, familial	142680	AD	3
191190	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
191195	10p11.23	Lung cancer, somatic	211980	_	3
191290	11p15.5	Segawa syndrome, recessive	605407	AR	3
191305	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
191306	4q12	Hemangioma, capillary infantile, somatic	602089	_	3
191306	4q12	{Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
191311	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
191311	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
191315	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
191315	1q23.1	Medullary thyroid carcinoma, familial	155240	AD	3
191329	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
191330	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
191342	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
191342	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
191350	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
191350	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
191390	7q22	{Inflammatory bowel disease 11}	191390	Mu	2
191480	1p36.13	Uncombable hair syndrome	191480	AR	3
191523	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
191525	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
191540	1p22	[Urate oxidase deficiency]	_	_	1
191740	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
191740	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
191740	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
191740	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
191740	2q37.1	[Gilbert syndrome]	143500	AR	3
191830	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
191840	10q22.2	Quebec platelet disorder	601709	AD	3
191840	10q22.2	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
191845	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
191845	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
191845	16p12.3	Medullary cystic kidney disease 2	603860	_	3
191900	1q44	Muckle-Wells syndrome	191900	AD	3
192090	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
192090	16q22.1	Endometrial carcinoma, somatic	608089	_	3
192090	16q22.1	Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate	137215	AD	3
192090	16q22.1	Ovarian cancer, somatic	167000	_	3
192090	16q22.1	{Breast cancer, lobular}	114480	AD,SMu	3
192090	16q22.1	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
192132	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
192150	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
192240	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
192315	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
192340	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
192430	22q11.21	Velocardiofacial syndrome	192430	AD	3
192605	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
192974	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
192977	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
193000	1p13	Vesicoureteral reflux	193000	AD	2
193001	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
193003	13q31-q33	Nystagmus 4, congenital, autosomal dominant	193003	AD	2
193007	6q	Vestibulopathy, familial	193007	AD	2
193060	10p13	Cataract 30, pulverulent	116300	AD	3
193065	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
193065	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
193067	11q24.3	Bleeding disorder, platelet-type, 21	617443	AD,AR	3
193100	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
193200	6p21.3	{Vitiligo-associated multiple autoimmune disease susceptibility 6}	193200	AR	2
193230	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
193235	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
193400	12p13.31	von Willebrand disease, type 1	193400	AD	3
193500	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
193510	3p13	Waardenburg syndrome, type 2A	193510	AD	3
193520	17q11.2	Watson syndrome	193520	AD	3
193670	2q22.1	WHIM syndrome	193670	AD	3
193700	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
193900	12q13.13	White sponge nevus 1	193900	AD	3
194050	7q11.23	Williams-Beuren syndrome	194050	AD	4
194071	11p15.5	Wilms tumor 2	194071	AD,SMu	3
194072	11p13	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	AD,SMu	4
194080	11p13	Denys-Drash syndrome	194080	AD,SMu	3
194090	16q	Wilms tumor, type 3	194090	AD	2
194190	4p16.3	Wolf-Hirschhorn syndrome	194190	IC	4
194200	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
194300	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
194355	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
194360	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
194363	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
194380	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
194648	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
195000	11q12.2	Oocyte maturation defect 1	615774	AR	3
200100	4q23	Abetalipoproteinemia	200100	AR	3
200110	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
200150	9q21.2	Choreoacanthocytosis	200150	AR	3
200350	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
200500	7q36.3	Acheiropody	200500	AR	3
200600	14q32.12	Achondrogenesis, type IA	200600	AR	3
200610	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
200700	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
200950	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
201000	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
201100	8q24.3	Acrodermatitis enteropathica	201100	AR	3
201250	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
201300	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
201400	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
201450	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
201470	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
201475	17p13.1	VLCAD deficiency	201475	AR	3
201710	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
201750	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
201810	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
202010	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
202200	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
202300	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
202370	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
202650	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
202700	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
203100	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
203290	9p23	Albinism, oculocutaneous, type III	203290	AR	3
203300	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
203400	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
203450	17q21.31	Alexander disease	203450	AD	3
203500	3q13.33	Alkaptonuria	203500	AR	3
203650	3q26.3-q27.3	Alopecia-mental retardation syndrome 1	203650	AR	2
203655	8p21.3	Alopecia universalis	203655	AR	3
203700	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
203740	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
203750	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
203800	2p13.1	Alstrom syndrome	203800	AR	3
204000	17p13.1	Leber congenital amaurosis 1	204000	AR	3
204100	1p31.3	Leber congenital amaurosis 2	204100	AR	3
204200	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
204300	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
204500	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
204650	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
204690	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
204700	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
204750	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
204870	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
205100	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
205400	9q31.1	Tangier disease	205400	AR	3
205950	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
206100	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
206200	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
206500	5q22.3	?Anencephaly	206500	AR	3
206700	3p26.1	Gillespie syndrome	206700	AD,AR	3
206800	20p13	Anonychia congenita	206800	AR	3
206920	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
207410	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
207750	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
207800	6q23.2	Argininemia	207800	AR	3
207900	7q11.21	Argininosuccinic aciduria	207900	AR	3
208000	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
208050	20q13.12	Arterial tortuosity syndrome	208050	AR	3
208085	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
208100	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
208150	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
208250	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
208400	4q34.3	Aspartylglucosaminuria	208400	AR	3
208500	15q13	Short-rib thoracic dysplasia 1 with or without polydactyly	208500	AR	2
208530	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
208540	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
208900	11q22.3	Ataxia-telangiectasia	208900	AR	3
208920	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
209300	3q22.1	Atransferrinemia	209300	AR	3
209500	8p21.3	Atrichia with papular lesions	209500	AR	3
209850	7q22	{Autism susceptibility 1}	209850	IC,Mu	2
209885	2q37.3	Barber-Say syndrome	209885	AD	3
209901	11q13.2	Bardet-Biedl syndrome 1	209900	DR,AR	3
209950	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
210000	3q29	Behr syndrome	210000	AR	3
210100	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
210200	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
210210	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
210370	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
210600	3q23	Seckel syndrome 1	210600	AR	3
210710	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
210720	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
210900	15q26.1	Bloom syndrome	210900	AR	3
211100	19q13.33	[Bombay phenotype]	616754	AR	3
211180	12p13.31	Bowen-Conradi syndrome	211180	AR	3
211380	16q21	Elsahy-Waters syndrome	211380	AR	3
211500	20p13	?Fazio-Londe disease	211500	AR	3
211530	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
211600	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
211750	3q13.1-q13.2	C syndrome	211750	AD	3
211800	6q14.3	Calcification of joints and arteries	211800	AR	3
211900	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
212050	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
212065	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
212066	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
212070	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
212093	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
212112	1q22	Malouf syndrome	212112	AD	3
212138	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
212140	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
212200	18q21.3	Carnosinemia	212200	AR	2
212350	7q34	Sengers syndrome	212350	AR	3
212500	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
212550	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
212720	1q41	Martsolf syndrome	212720	AR	3
212780	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
212840	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
213200	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
213300	9q34.3	Joubert syndrome 1	213300	AR	3
213600	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
213700	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
213980	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
214100	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
214110	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
214150	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
214300	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
214350	21q22.3	CHAND syndrome	214350	AR	3
214400	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
214450	15q21.2	Griscelli syndrome, type 1	214450	AR	3
214500	1q42.3	Chediak-Higashi syndrome	214500	AR	3
214700	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
214900	15q	Cholestasis-lymphedema syndrome	214900	AR	2
214950	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
215045	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
215100	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
215140	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
215150	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
215300	8q24.11	Chondrosarcoma	215300	AR	3
215400	6q27	{Chordoma, susceptibility to}	215400	AD	4
215470	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
215500	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
215700	9q34.11	Citrullinemia	215700	AR	3
216340	6q21	Yunis-Varon syndrome	216340	AR	3
216400	5q12.1	Cockayne syndrome, type A	216400	AR	3
216550	8q22.2	Cohen syndrome	216550	AR	3
216820	14q11.2	?Coloboma, ocular, autosomal recessive	216820	AR	3
216900	2q11.2	Achromatopsia 2	216900	AR	3
217000	6p21.33	C2 deficiency	217000	AR	3
217030	4q25	Complement factor I deficiency	610984	AR	3
217030	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
217030	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
217050	5p13.1	C6 deficiency	612446	_	3
217050	5p13.1	Combined C6/C7 deficiency	_	_	3
217070	5p13.1	C7 deficiency	610102	_	3
217080	2q11.2	Jalili syndrome	217080	AR	3
217085	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
217300	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
217400	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
217700	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
217800	16q23.1	Macular corneal dystrophy	217800	AR	3
218000	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
218030	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
218330	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
218340	12p13.31	Temtamy syndrome	218340	AR	3
218400	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
218600	8q24.3	Baller-Gerold syndrome	218600	AR	3
218700	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
218800	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
219000	4q21.21	Fraser syndrome 1	219000	AR	3
219050	19p13.11	Cryptorchidism	219050	AD	3
219080	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
219090	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
219100	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
219150	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
219200	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
219500	1p31.1	Cystathioninuria	219500	AR	3
219730	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
219750	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
219900	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
220111	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
220120	3p21.2	D-glyceric aciduria	220120	AR	3
220150	11q13.1	Hypouricemia, renal	220150	AR	3
220200	3q22-q24	Dandy-Walker syndrome	220200	IC	4
220210	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
220400	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
220500	16p13.3	DOORS syndrome	220500	AR	3
220600	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
221200	13q31.1	Deafness and myopia	221200	AR	3
221750	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
221770	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
221820	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
221900	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
222100	6p21.3	{Diabetes mellitus, insulin-dependent-1}	222100	AR	2
222300	4p16.1	Wolfram syndrome 1	222300	AR	3
222400	8p23.1	Hernia, congenital diaphragmatic 2	222400	AR	2
222448	2q31.1	Donnai-Barrow syndrome	222448	AR	3
222470	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
222700	14q11.2	Lysinuric protein intolerance	222700	AR	3
222730	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
222748	8q22.3	Dihydropyrimidinuria	222748	AR	3
222765	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
222800	7q33	Erythrocytosis, familial, 8	222800	AR	3
222900	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
223000	2q21.3	Lactase deficiency, congenital	223000	AR	3
223100	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
223360	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
223800	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
223900	9q31.3	Dysautonomia, familial	223900	AR	3
224050	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
224100	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
224120	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
224230	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
224410	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
224500	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
224690	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
224750	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
224900	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
225100	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
225200	1q21.2	Ectopia lentis et pupillae	225200	AR	3
225250	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
225280	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
225300	12q13.12	Split-hand/foot malformation 6	225300	AR	3
225320	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
225400	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
225410	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
225750	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AD,AR	3
225753	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
225790	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
226200	21q21.1	Enterokinase deficiency	226200	AR	3
226300	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
226400	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
226670	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
226750	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
226900	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
226980	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
226990	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
227050	19q13.2	Transient erythroblastopenia of childhood	227050	AR	2
227260	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
227300	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
227400	1q24.2	Factor V deficiency	227400	AR	3
227500	13q34	Factor VII deficiency	227500	AR	3
227600	13q34	Factor X deficiency	227600	AR	3
227645	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
227646	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
227650	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
227810	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
228000	8p22	Farber lipogranulomatosis	228000	AR	3
228300	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
228520	1p21.1	Fibrochondrogenesis 1	228520	AR	3
228550	5q32	Myofibromatosis, infantile, 1	228550	AD	3
228600	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
228900	20q11.22	Du Pan syndrome	228900	AR	3
228930	3p25.1	Fuhrmann syndrome	228930	AR	3
228980	1p36.13	[Fleck retina, familial benign]	228980	AR	3
229000	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
229050	17q11.2	Folate malabsorption, hereditary	229050	AR	3
229070	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
229100	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
229200	16q24.2	Brittle cornea syndrome 1	229200	AR	3
229600	9q31.1	Fructose intolerance, hereditary	229600	AR	3
229700	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
229800	2p23.3	[Fructosuria]	229800	AR	3
230000	1p36.11	Fucosidosis	230000	AR	3
230200	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
230350	1p36.11	Galactose epimerase deficiency	230350	AR	3
230400	9p13.3	Galactosemia	230400	AR	3
230450	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
230500	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
230600	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
230650	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
230740	2p13.3	GAPO syndrome	230740	AR	3
230800	1q22	Gaucher disease, type I	230800	AR	3
230900	1q22	Gaucher disease, type II	230900	AR	3
231000	1q22	Gaucher disease, type III	231000	AR	3
231005	1q22	Gaucher disease, type IIIC	231005	AR	3
231050	9q34.2	Geleophysic dysplasia 1	231050	AR	3
231070	1q24.2	Geroderma osteodysplasticum	231070	AR	3
231090	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
231095	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
231300	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
231530	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
231550	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
231670	19p13.13	Glutaricaciduria, type I	231670	AR	3
231675	4q32.1	Glutaric acidemia IIC	231680	AR	3
231690	7p14.1	Glutaric aciduria III	231690	AR	3
231900	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
231950	22q11.23	?Glutathioninuria	231950	AR	3
232000	13q32.3	Propionicacidemia	606054	AR	3
232050	3q22.3	Propionicacidemia	606054	AR	3
232200	17q21.31	Glycogen storage disease Ia	232200	AR	3
232220	11q23.3	Glycogen storage disease Ib	232220	AR	3
232240	11q23.3	Glycogen storage disease Ic	232240	AR	3
232300	17q25.3	Glycogen storage disease II	232300	AR	3
232500	3p12.2	Glycogen storage disease IV	232500	AR	3
232600	11q13.1	McArdle disease	232600	AR	3
232700	14q22.1	Glycogen storage disease VI	232700	AR	3
232800	12q13.11	Glycogen storage disease VII	232800	AR	3
233100	16p11.2	Renal glucosuria	233100	AD,AR	3
233300	2p16.3	Ovarian dysgenesis 1	233300	AR	3
233400	5q23.1	Perrault syndrome 1	233400	AR	3
233420	12q13.12	46XY sex reversal 7	233420	AR	3
233600	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
233690	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
233700	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
233710	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
233910	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
234000	5q35.3	Factor XII deficiency	234000	AR	3
234050	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
234200	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
234500	5p15.33	Hartnup disorder	234500	AR	3
234580	7q21.2	Heimler syndrome 1	234580	AR	3
234810	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
235000	11p15	Hemihypertrophy	235000	AD	2
235510	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
235550	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
235555	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
235700	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
235730	2q22.3	Mowat-Wilson syndrome	235730	AD	3
235800	12q23.1	[Histidinemia]	235800	AD,AR	3
236000	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
236100	21q22.3	Holoprosencephaly 1	236100	AD,IC	2
236250	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
236270	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
236500	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
236600	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
236670	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
236680	11q24.2	Hydrolethalus syndrome	236680	AR	3
236700	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
236730	10q24.2	Urofacial syndrome 1	236730	AR	3
236792	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
236800	2q22.2	?Hydroxykynureninuria	236800	AR	3
237300	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
237310	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
237500	10q24.2	Dubin-Johnson syndrome	237500	AR	3
237900	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
238300	9p24.1	Glycine encephalopathy	605899	AR	3
238310	3p21.31	Glycine encephalopathy	605899	AR	3
238330	16q23.2	?Glycine encephalopathy	605899	AR	3
238331	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
238700	7q31.32	Hyperlysinemia	238700	AR	3
238970	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
239000	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
239100	17q21.31	Van Buchem disease	239100	AR	3
239200	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
239300	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
239500	22q11.21	Hyperprolinemia, type I	239500	AR	3
239510	1p36.13	Hyperprolinemia, type II	239510	AR	3
239850	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
240300	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AD,AR	3
240400	8p21.1	Scurvy	_	_	3
240500	17p11.2	Immunodeficiency, common variable, 2	240500	AD,AR	3
240600	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
240800	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
240900	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
241080	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
241200	11q24.3	Bartter syndrome, type 2	241200	AR	3
241410	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
241500	1p36.12	Hypophosphatasia, infantile	241500	AR	3
241510	1p36.12	Hypophosphatasia, childhood	241510	AR	3
241520	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
241530	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
241550	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
241600	15q21.1	Immunodeficiency 43	241600	AR	3
241800	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
241850	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
242100	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
242300	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
242500	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
242840	18q12.3-q21.1	Vici syndrome	242840	AR	3
242860	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
242900	2q35	Schimke immunoosseous dysplasia	242900	AR	3
243060	19q13.43	Spermatogenic failure 5	243060	AR	3
243150	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
243300	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
243305	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
243310	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
243400	8p22	[Acetylation, slow]	243400	AR	3
243500	15q15.1	Isovaleric acidemia	243500	AR	3
243605	1q41	Stromme syndrome	243605	AR	3
243700	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
243800	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
244200	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
244400	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
244450	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
244460	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
245000	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
245010	11q14.2	Haim-Munk syndrome	245010	AR	3
245050	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
245150	12p12.3	Keutel syndrome	245150	AR	3
245200	14q31.3	Krabbe disease	245200	AR	3
245300	20p13	{Kuru, susceptibility to}	245300	_	3
245340	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
245348	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
245349	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
245400	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
245450	16q23.1	D-lactic aciduria	245450	AR	3
245480	14q11.2	Specific granule deficiency	245480	AR	3
245570	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
245590	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
245600	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
245660	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
245800	19p13.2	?Laurence-Moon syndrome	245800	AR	3
245900	16q22.1	Norum disease	245900	AR	3
246200	19p13.2	Leprechaunism	246200	AR	3
246300	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
246450	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
246530	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
246560	10q24	Split-hand/foot malformation 3, gene duplication syndrome	246560	AD	4
246600	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
246650	16p13.3	Lipase deficiency, combined	246650	AR	3
246700	5q31.1	Chylomicron retention disease	246700	AR	3
246900	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
247100	1q21.2	Urbach-Wiethe disease	247100	AR	3
247200	17p13.3	Miller-Dieker lissencephaly syndrome	247200	AD	4
247420	19q13.32	[Blood group, Lutheran null]	247420	AR	3
247640	9p22-p21	Leukemia, acute lymphoblastic	247640	AR	2
248000	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
248190	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
248250	3q28	Hypomagnesemia 3, renal	248250	AR	3
248300	8q24.3	Meleda disease	248300	AR	3
248310	5q31-q33	{Malaria, intensity of infection}	248310	AR	2
248340	8q24.12	3MC syndrome 3	248340	AR	3
248360	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
248370	1q22	Mandibuloacral dysplasia	248370	AR	3
248390	6p21.1	Treacher Collins syndrome 3	248390	AR	3
248450	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
248500	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
248510	4q24	Mannosidosis, beta	248510	AR	3
248610	1p21.2	Maple syrup urine disease, type II	248600	AR	3
248611	6q14.1	Maple syrup urine disease, type Ib	248600	AR	3
248700	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
248800	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
248900	15q22.31	Mast syndrome	248900	AR	3
249000	17q22	Meckel syndrome 1	249000	AR	3
249100	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
249270	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
249400	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
249420	5q35.1	Frank-ter Haar syndrome	249420	AR	3
249500	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
249900	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
250100	22q13.33	Metachromatic leukodystrophy	250100	AR	3
250220	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
250250	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
250400	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
250410	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
250460	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
250620	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
250790	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
250940	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
250950	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
251000	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
251100	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
251110	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
251120	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
251170	12q24.11	Hyper-IgD syndrome	260920	AR	3
251170	12q24.11	Mevalonic aciduria	610377	AR	3
251170	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
251200	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
251230	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
251255	18q11.2	Jawad syndrome	251255	AR	3
251260	8q21.3	Nijmegen breakage syndrome	251260	AR	3
251270	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
251280	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
251290	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
251300	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
251450	17q25.3	Desbuquois dysplasia 1	251450	AR	3
251600	14q32	Microphthalmia, isolated 1	251600	AR	2
251750	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
251850	18q21.1	Microvillus inclusion disease	251850	AR	3
251880	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
251900	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
251950	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
252010	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
252150	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
252160	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
252270	7q	Myelodysplasia and leukemia syndrome with monosomy 7	252270	AR	4
252350	3p26-p24.2	Moyamoya disease	252350	AR	2
252500	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
252600	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
252605	16p13.3	Mucolipidosis III gamma	252605	AR	3
252650	19p13.2	Mucolipidosis IV	252650	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
252800	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
252900	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
252920	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
252930	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
252940	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
253000	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
253010	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
253200	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
253220	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
253250	17q22	Mulibrey nanism	253250	AR	3
253260	3p25.1	Biotinidase deficiency	253260	AR	3
253270	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
253280	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
253300	5q13.2	Spinal muscular atrophy-1	253300	AR	3
253310	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
253550	5q13.2	Spinal muscular atrophy-2	253550	AR	3
253600	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
253601	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
253700	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
253800	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
254110	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
254130	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
254210	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
254300	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
254600	17q22	Myeloperoxidase deficiency	254600	AR	3
254770	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
254800	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
254900	4q21.1	Epilepsy, progressive myoclonic 4, with or without renal failure	254900	AR	3
254940	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
255100	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
255110	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
255120	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
255125	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
255160	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
255200	2q14.3	Centronuclear myopathy 2	255200	AR	3
255320	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
255500	14q22.1-q24.2	Myopia 18	255500	AR	2
255600	21q22.3	?Myosclerosis, congenital	255600	AR	3
255700	7q34	Myotonia congenita, recessive	255700	AR	3
255800	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
255960	17q24.2	Myxoma, intracardiac	255960	AD	3
255995	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
256030	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
256040	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
256100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
256300	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
256370	11p13	Nephrotic syndrome, type 4	256370	AD	3
256450	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
256500	5q32	Netherton syndrome	256500	AR	3
256520	1p12	Neu-Laxova syndrome 1	256520	AR	3
256540	20q13.12	Galactosialidosis	256540	AR	3
256600	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
256730	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
256731	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
256800	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
256810	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
256840	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
256850	16q23.2	Giant axonal neuropathy-1	256850	AR	3
257200	11p15.4	Niemann-Pick disease, type A	257200	AR	3
257270	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
257300	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
257320	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
257550	2q13	Oculomotor apraxia, congenital, Cogan-type	257550	AR	2
257850	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
257920	3q27.3	3MC syndrome 1	257920	AR	3
257980	2q35	Odontoonychodermal dysplasia	257980	AR	3
258100	2q37.1	Oguchi disease-1	258100	AR	3
258315	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
258450	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
258480	11q13.4	Opsismodysplasia	258480	AR	3
258500	8q21-q22	Optic atrophy 6	258500	AR	2
258501	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
258660	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
258860	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
258870	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
258900	3q21.2	Orotic aciduria	258900	AR	3
259050	3q13.31	Primrose syndrome	259050	AD	3
259440	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
259450	17q21.2	Bruck syndrome 1	259450	AR	3
259600	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
259700	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
259710	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
259720	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
259730	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
259770	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
259775	7p22.3	Raine syndrome	259775	AR	3
259900	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
260000	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
260005	8q24.3	5-oxoprolinase deficiency	260005	AD,AR	3
260300	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
260370	13q12.2	Pancreatic agenesis 1	260370	AR	3
260400	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
260500	17p13.1	{Choroid plexus papilloma}	260500	AD	3
260540	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
260565	17q12	PEHO syndrome	260565	AR	3
260600	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
260660	1p12	Cousin syndrome	260660	AR	3
260800	17q25.3	[Pentosuria]	260800	AR	3
260920	12q24.11	Hyper-IgD syndrome	260920	AR	3
261000	11q12.1	Intrinsic factor deficiency	261000	AR	3
261500	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
261515	5q23.1	D-bifunctional protein deficiency	261515	AR	3
261540	13q12.3	Peters-plus syndrome	261540	AR	3
261630	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
261640	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
261650	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
261670	7p13	Glycogen storage disease X	261670	AR	3
261680	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
261740	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
261750	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
261800	17q24.3-q25.1	Pierre Robin syndrome	261800	AR	2
261990	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
262000	2q35	Bjornstad syndrome	262000	AR	3
262190	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
262300	8q21.3	Achromatopsia 3	262300	AR	3
262400	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
262500	5p13-p12	Laron dwarfism	262500	AR	3
262600	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
262650	17q23.3	Kowarski syndrome	262650	AR	3
262700	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
262850	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
262890	12q12	Scott syndrome	262890	AR	3
263200	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
263210	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
263300	9p24.1	Polycythemia vera, somatic	263300	_	3
263400	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
263450	13q13.3-q21	Polydactyly, postaxial, type A5	263450	AR	2
263520	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	DR,AR	3
263570	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
263650	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
263700	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
263750	16q22.2	Miller syndrome	263750	AR	3
263800	16q13	Gitelman syndrome	263800	AR	3
264070	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
264080	11q22.1	?Progesterone resistance	264080	AR	2
264090	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
264300	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
264470	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
264600	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
264700	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
264900	4q35.2	Factor XI deficiency, autosomal dominant	612416	_	3
264900	4q35.2	Factor XI deficiency, autosomal recessive	612416	_	3
265000	2q37.1	Escobar syndrome	265000	AR	3
265050	2p25.3	3MC syndrome 2	265050	AR	3
265100	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
265120	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
265380	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
265450	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
265800	1q21.3	Pycnodysostosis	265800	AR	3
265900	7p14.1	Pyle disease	265900	AR	3
266100	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
266120	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
266130	20q11.22	Glutathione synthetase deficiency	266130	AR	3
266140	1q23.1	Pyropoikilocytosis	266140	AR	3
266150	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
266200	1q22	Pyruvate kinase deficiency	266200	AR	3
266265	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
266280	8q24.3	RAPADILINO syndrome	266280	AR	3
266500	10p13	Refsum disease	266500	AR	3
266510	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
266900	2q13	Senior-Loken syndrome-1	266900	AR	3
266920	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
267000	2q37.1	Perlman syndrome	267000	AR	3
267010	3q22.1	Meckel syndrome 7	267010	AR	3
267300	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
267500	1p35.1	Reticular dysgenesis	267500	AR	3
267700	9q21.3-q22	Hemophagocytic lymphohistiocytosis, familial, 1	267700	AR	2
267750	21q22.3	Knobloch syndrome, type 1	267750	AR	3
268100	15q23	Enhanced S-cone syndrome	268100	AR	3
268130	14q12	Revesz syndrome	268130	AD	3
268150	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
268200	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
268210	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
268300	8p21.1	Roberts syndrome	268300	AR	3
268305	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
268310	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
268400	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
268700	7q31.32	Saccharopinuria	268700	AR	1
268800	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
268900	9q34.2	[Sarcosinemia]	268900	AR	3
269000	8p21.1	SC phocomelia syndrome	269000	AR	3
269150	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
269250	1p31.3	Schneckenbecken dysplasia	269250	AR	3
269400	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
269500	17q21.31	Sclerosteosis 1	269500	AR	3
269600	19q13.32	Sea-blue histiocyte disease	269600	AR	3
269700	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
269840	2q11.2	Immunodeficiency 48	269840	AR	3
269880	5q13.1	SHORT syndrome	269880	AD	3
269920	6q13	Sialic acid storage disorder, infantile	269920	AR	3
269921	9p13.3	Sialuria	269921	AD	3
270100	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
270200	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
270300	6p21.33	Peeling skin syndrome 1	270300	AR	3
270400	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
270420	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
270450	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
270550	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
270685	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
270700	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
270750	1q32.1	Spastic paraplegia 23	270750	AR	3
270800	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
270970	1q23.1	Spherocytosis, type 3	270970	AR	3
271150	5q13.2	Spinal muscular atrophy-4	271150	AR	3
271245	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
271250	6p23-p21	Spinocerebellar ataxia, autosomal recessive 3	271250	AR	2
271400	3p22.1	Asplenia, isolated congenital	271400	AD	3
271640	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
271665	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
271700	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
271900	17p13.2	Canavan disease	271900	AR	3
271930	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
271980	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
272120	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
272200	3p26.1	Multiple sulfatase deficiency	272200	AR	3
272300	12q13.2	Sulfite oxidase deficiency	272300	AR	3
272430	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
272440	2q14.1	Filippi syndrome	272440	AR	3
272460	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
272750	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
273395	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
273750	6p21.1	3-M syndrome 1	273750	AR	3
273900	5p13.1	Thrombocytopenia 3	273900	AR	3
274000	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
274150	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
274180	7q34	?Thromboxane synthase deficiency	614158	AD	1
274180	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
274300	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
274400	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
274500	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
274600	7q22.3	Pendred syndrome	274600	AR	3
274700	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
274800	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
274900	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
275000	14q31	{Graves disease, susceptibility to, 1}	275000	AR	2
275100	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
275120	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
275200	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
275220	8q24.1	?Tibial hemimelia	275220	AR	2
275350	22q12.2	Transcobalamin II deficiency	275350	AR	3
275360	11q23.3	Trehalase deficiency	612119	AR	3
275400	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
275630	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
275900	13q13.3	Troyer syndrome	275900	AR	3
276000	7q34	Pancreatitis, hereditary	167800	AD	3
276000	7q34	Trypsinogen deficiency	614044	AR	1
276400	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
276600	16q22.2	Tyrosinemia, type II	276600	AR	3
276700	15q25.1	Tyrosinemia, type I	276700	AR	3
276710	12q24.31	Tyrosinemia, type III	276710	AR	3
276820	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
276880	3q21.3	?Urocanase deficiency	276880	AR	3
276900	11q13.5	Usher syndrome, type 1B	276900	AR	3
276902	3q25.1	Usher syndrome, type 3A	276902	AR	3
276903	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
276903	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
276903	11q13.5	Usher syndrome, type 1B	276900	AR	3
276904	11p15.1	Usher syndrome, type 1C	276904	AR	3
277170	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
277180	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
277300	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
277380	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
277440	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
277450	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
277460	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
277470	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
277480	12p13.31	von Willibrand disease, type 3	277480	AR	3
277580	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
277590	7q36.1	Weaver syndrome	277590	AD	3
277600	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
277700	8p12	Werner syndrome	277700	AR	3
277900	13q14.3	Wilson disease	277900	AR	3
277950	14q11.2	?Winchester syndrome	277950	_	3
278250	12q24.31	Wrinkly skin syndrome	278250	AR	3
278300	2p23.1	Xanthinuria, type I	278300	AR	3
278700	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
278720	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
278730	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
278740	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
278750	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
278800	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
278850	17q24.3-q25.1	46XX sex reversal 2	278850	AD	4
280000	17p11.2	CHIME syndrome	280000	AR	3
300000	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300004	Xp21.3	Proud syndrome	300004	XL	3
300005	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300005	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300005	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300005	Xq28	Rett syndrome	312750	XLD	3
300005	Xq28	Rett syndrome, atypical	312750	XLD	3
300005	Xq28	Rett syndrome, preserved speech variant	312750	XLD	3
300005	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300008	Xp11.23	Dent disease	300009	XLR	3
300008	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300008	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
300008	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
300009	Xp11.23	Dent disease	300009	XLR	3
300011	Xq21.1	Menkes disease	309400	XLR	3
300011	Xq21.1	Occipital horn syndrome	304150	XLR	3
300011	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300013	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
300013	Xq28	Ogden syndrome	300855	XLR,XLD	3
300014	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
300017	Xq28	?FG syndrome 2	300321	XL	3
300017	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
300017	Xq28	Congenital short bowel syndrome	300048	XLR	3
300017	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
300017	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300017	Xq28	Intestinal pseudoobstruction, neuronal	300048	XLR	3
300017	Xq28	Melnick-Needles syndrome	309350	XLD	3
300017	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
300017	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
300017	Xq28	Terminal osseous dysplasia	300244	XLD	3
300018	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300019	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
300029	Xp11.4	Retinitis pigmentosa 3	300029	_	3
300030	Xp21.2	Deafness, X-linked 3	300030	XL	2
300032	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300032	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
300032	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
300035	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
300036	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300037	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
300037	Xq26.2	Wilms tumor, somatic	194070	_	3
300039	Xq21.1	Deafness, X-linked 2	304400	XLR	3
300040	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300046	Xq23-q24	Mental retardation, X-linked 23	300046	XL	2
300047	Xp11-q21	Mental retardation, X-linked 20	300047	XL	2
300049	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300055	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300056	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
300060	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
300062	Xp11.3-q13.3	Mental retardation, X-linked 14	300062	XL	2
300066	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300068	Xq12	Androgen insensitivity	300068	XLR	3
300071	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300072	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300072	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300075	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
300075	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300076	Xq26-qter	Woods-Black-Norbury syndrome	300076	XLD	2
300078	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
300079	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300080	Xp11.3	TARP syndrome	311900	XLR	3
300082	Xq	[Social cognition]	300082	XL	2
300084	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300085	Xq27	Cone dystrophy, progressive X-linked, 2	300085	XL	2
300087	Xq13.2	X-inactivation, familial skewed	300087	_	3
300088	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300090	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300095	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300096	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300104	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300105	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
300106	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
300108	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300110	Xp11.23	Aland Island eye disease	300600	XL	3
300110	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300110	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300114	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
300115	Xp11.3-p11.21	Mental retardation, X-linked 50	300115	XL	2
300120	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300121	Xq23	Lissencephaly, X-linked	300067	XL	3
300121	Xq23	Subcortical laminal heterotopia, X-linked	300067	XL	3
300123	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
300125	Xq	{Migraine, familial typical, susceptibility to, 2}	300125	XL	2
300126	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
300127	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300128	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300131	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300135	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
300136	Xp11	{Diabetes mellitus, insulin-dependent, X-linked}	300136	_	2
300137	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300138	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300139	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300142	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300143	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300144	Xq24	{Parkinson disease, age of onset, modifier}	168600	AD,Mu	3
300145	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300147	Xq27-q28	{Prostate cancer, hereditary, X-linked 1}	300147	_	2
300148	Xp22.11	MEHMO syndrome	300148	XLR	3
300155	Xq26-q27	Retinitis pigmentosa 24	300155	_	2
300157	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300160	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300161	Xp22.11	MEHMO syndrome	300148	XLR	3
300163	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300163	Xq26.3	Emery-Dreifuss muscular dystrophy 6, X-linked	300696	XLR	3
300163	Xq26.3	Myopathy, X-linked, with postural muscle atrophy	300696	XLR	3
300163	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300163	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300163	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300166	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300168	Xq26.2	Keipert syndrome	301026	XLR	3
300169	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300169	Xq26.1	Cowchock syndrome	310490	XLR	3
300169	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300170	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300170	Xp22.2	Joubert syndrome 10	300804	XLR	3
300170	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
300170	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300172	Xp11.4	FG syndrome 4	300422	_	3
300172	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300172	Xp11.4	Mental retardation, with or without nystagmus	300422	_	3
300179	Xq25-q26	X inactivation, familial skewed, 2	300179	_	2
300180	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
300188	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
300188	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300188	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
300189	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300192	Xp11.22	?Sarcoma, synovial	300813	_	3
300193	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300194	Xq22.3	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis	300194	_	4
300195	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300197	Xq28	Immunodeficiency 47	300972	XLR	3
300199	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300200	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300202	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
300203	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300204	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300205	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
300205	Xp11.23	MEND syndrome	300960	XLR	3
300206	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300209	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300210	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300211	Xp22.3	Episodic muscle weakness, X-linked	300211	_	2
300218	Xp11.3-q22	Mental retardation, X-linked syndromic 7	300218	_	2
300221	Xpter-p22.32	{Hodgkin disease susceptibility, pseudoautosomal}	300221	_	2
300226	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300228	Xq27	Testicular germ cell tumor	300228	_	2
300231	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300238	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300243	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300244	Xq28	Terminal osseous dysplasia	300244	XLD	3
300245	Xq24-q27.1	Ptosis, hereditary congenital 2	300245	XLD	2
300247	Xp11.22	Ovarian dysgenesis 2	300510	XL	3
300247	Xp11.22	Premature ovarian failure 4	300510	XL	3
300248	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300248	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300248	Xq28	Immunodeficiency 33	300636	XLR	3
300248	Xq28	Immunodeficiency, isolated	300584	_	3
300248	Xq28	Incontinentia pigmenti	308300	XLD	3
300248	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300255	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300256	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300257	Xq24	Danon disease	300257	XLD	3
300259	Xq	{Mycobacterium tuberculosis, susceptibility, X-linked}	300259	_	2
300260	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300261	Xq28	Mental retardation syndrome, X-linked, Armfield type	300261	XLR	2
300262	Xq13.2	Mental retardation, X-linked syndromic, Abidi type	300262	_	2
300263	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300264	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300265	Xq26.3	Congenital heart defects, nonsyndromic, 1, X-linked	306955	XLR	3
300265	Xq26.3	Heterotaxy, visceral, 1, X-linked	306955	XLR	3
300265	Xq26.3	VACTERL association, X-linked	314390	XLR	3
300266	Xq11.2	Spastic paraplegia 16, X-linked, complicated	300266	XLR	2
300269	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300271	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300272	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300273	Xp22	Goiter, multinodular, 2	300273	XLD	2
300275	Xq28	CHILD syndrome	308050	XLD	3
300275	Xq28	CK syndrome	300831	XLR	3
300278	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
300280	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300291	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300292	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
300294	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300294	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
300294	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
300294	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
300298	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300299	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300300	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300300	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
300301	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300304	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300306	Xq24	{Obesity, susceptibility to, BMIQ11}	300306	_	2
300307	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
300307	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
300310	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300311	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
300321	Xq28	?FG syndrome 2	300321	XL	3
300322	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
300323	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
300324	Xq22.2-q26	Mental retardation, X-linked 53	300324	XLR	2
300331	Chr.X	Thrombocythemia, X-linked	300331	XLR	2
300336	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300336	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300345	Chr.X	Microphthalmia with coloboma 1	300345	_	2
300350	Xq23	Megalocornea 1, X-linked	309300	XLR	3
300351	Xp11	{Graves disease, susceptibility to, X-linked}	300351	_	2
300352	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300354	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300355	Xp22.2	Mental retardation, X-linked 73	300355	XLR	2
300356	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
300367	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
300368	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
300371	Xq28	Adrenoleukodystrophy	300100	XLR	3
300371	Xq28	Adrenomyeloneuropathy, adult	300100	XLR	3
300372	Xq26	Mental retardation, X-linked 42	300372	_	2
300373	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300374	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300376	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
300377	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
300378	Xq24-q25	Radial ray deficiency	300378	_	2
300379	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300382	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
300382	Xp21.3	Hydranencephaly with abnormal genitalia	300215	XL	3
300382	Xp21.3	Lissencephaly, X-linked 2	300215	XL	3
300382	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300382	Xp21.3	Partington syndrome	309510	XLR	3
300382	Xp21.3	Proud syndrome	300004	XL	3
300383	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
300384	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
300386	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
300387	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300388	Xq27.2-q28	Polymicrogyria, bilateral perisylvian	300388	XLD	2
300390	Xq21.2	Choroideremia	303100	XLD	3
300391	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
300392	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked	313900	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked, intermittent	313900	XLR	3
300392	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
300393	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300394	Xq28	Barth syndrome	302060	XLR	3
300395	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300398	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300400	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
300401	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
300401	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
300403	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
300403	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300406	Xp22.3	FG syndrome 3	300406	_	2
300414	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
300415	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
300419	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300423	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300424	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300425	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300427	Xp22.32-p22.31	Mental retardation, X-linked	300495	IC,Mu,XL	3
300427	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300427	Xp22.32-p22.31	{Autism susceptibility, X-linked 2}	300495	IC,Mu,XL	3
300428	Xp22.3	Mental retardation, X-linked 2	300428	XL	2
300429	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300433	Xp11.2-q12	Mental retardation, X-linked 81	300433	XLR	2
300434	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300436	Xq25-q26	Mental retardation, X-linked 46	300436	XLR	2
300438	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300448	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300451	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
300451	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
300454	Xq12-q21.3	Mental retardation, X-linked 77	300454	XLR	2
300455	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
300457	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
300457	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
300460	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300461	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
300463	Xp11.23	Renpenning syndrome	309500	XLR	3
300464	Xq23-q26	{Coronary heart disease, susceptibility to, 3}	300464	_	2
300470	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300471	Chr.X	Cubitus valgus with mental retardation and unusual facies	300471	XLR	2
300472	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300473	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300473	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300474	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
300475	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300476	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300481	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
300481	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300484	Chr.X	Orofaciodigital syndrome VIII	300484	XLR	2
300485	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300486	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300488	Xp21.3	{Menopause, natural, age at, QTL1}	300488	XLD	2
300489	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300490	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
300491	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
300494	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300496	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300497	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300498	Xp11.3-p11.21	Mental retardation,X-linked 45	300498	XL	2
300499	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
300500	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300502	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
300505	Xp11.3-q22.3	Mental retardation, X-linked 84	300505	XLR	2
300509	Xq27.3	{Dyslexia, susceptibility to, 9}	300509	_	2
300511	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300514	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300515	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300516	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
300518	Xq24-q25	Mental retardation, X-linked 82	300518	XLR	2
300519	Chr.X	Mental retardation, X-linked, syndromic, Martin-Probst type	300519	XLR	2
300521	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300522	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
300523	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300524	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300526	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300534	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
300535	Xq26.1	Dent disease 2	300555	XLR	3
300535	Xq26.1	Lowe syndrome	309000	XLR	3
300536	Xq27	[Bone mineral density QTL 4]	300536	_	2
300538	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
300538	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300539	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300545	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
300546	Xp11.22	Aarskog-Scott syndrome	305400	XLR	3
300546	Xp11.22	Mental retardation, X-linked syndromic 16	305400	XLR	3
300550	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
300552	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300553	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300554	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300555	Xq26.1	Dent disease 2	300555	XLR	3
300556	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300556	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300557	Xq21-q25	{Parkinson disease 12}	300557	_	2
300558	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300559	Xq13.1	Muscle glycogenosis	300559	XLR	3
300560	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300572	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300576	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300577	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300578	Xp11.3	Chromosome Xp11.3 deletion syndrome	300578	XLR	4
300579	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300580	Xq13.1-q22.1	Myopathy, congenital, with fiber-type disproportion, X-linked	300580	XLD	2
300581	Xq22.3	FG syndrome 5	300581	_	2
300584	Xq28	Immunodeficiency, isolated	300584	_	3
300589	Xp11.4	Nystagmus 5, congenital, X-linked	300589	XLD	2
300590	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300591	Xq24-q25	{Stature QTL 6}	300591	_	2
300600	Xp11.23	Aland Island eye disease	300600	XL	3
300603	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300604	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300605	Xq28	Retinitis pigmentosa 34	300605	_	2
300607	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300610	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300611	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300613	Xq23-q27.2	Myopia 13	300613	_	2
300614	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300622	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300623	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
300624	Xq27.3	Fragile X syndrome	300624	XLD	3
300628	Xq26.2	Nystagmus 1, congenital, X-linked	310700	XL	3
300628	Xq26.2	Nystagmus, infantile periodic alternating, X-linked	310700	XL	3
300629	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
300633	Xq12	Hypospadias 1, X-linked	300633	XLR	3
300635	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300636	Xq28	Immunodeficiency 33	300636	XLR	3
300640	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300642	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300643	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300644	Xq22.1	Fabry disease	301500	XL	3
300644	Xq22.1	Fabry disease, cardiac variant	301500	XL	3
300645	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300646	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300647	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300650	Xp22.3	Ocular albinism with sensorineural deafness	300650	XL	2
300651	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
300652	Xp11.3-q12	Angio serpiginosum	300652	XLD	2
300653	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
300658	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
300658	Xp11.3	Norrie disease	310600	XLR	3
300659	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300660	Xq25-q27	Leukoencephalopathy with metaphyseal chondrodysplasia	300660	XLR	2
300672	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300673	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300676	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300679	Xp21	Chromosome Xp21 deletion syndrome	300679	_	4
300695	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300697	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
300699	Xq25	Mental retardation, X-linked 94	300699	XLR	3
300700	Xq24-q26	Albinism-deafness syndrome	300700	XL	2
300703	Xq25-q27.1	Spinocerebellar ataxia, X-linked 5	300703	XLR	2
300704	Xp11.22	{Prostate cancer, hereditary, X-linked 2}	300704	_	2
300705	Xp11.22	Xp11.22 microduplication syndrome	300705	_	4
300707	Xq28	STAR syndrome	300707	XLD	3
300708	Xq28	STAR syndrome	300707	XLD	3
300709	Xq12-q21.31	Mental retardation, X-linked, syndromic 9	300709	_	2
300710	Xq11-q12	Alopecia, androgenetic, 2	300710	_	2
300711	Xq23	Pyloric stenosis, infantile hypertrophic, 4	300711	_	2
300712	Xq26-q27	?Craniofacioskeletal syndrome	300712	XLR,XLD	2
300715	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300716	Chr.X	Mental retardation, X-linked 95	300716	XLD	2
300717	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300718	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300719	Chr.X	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	XLR	2
300724	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
300746	Xq27.1	Hemophilia B	306900	XLR	3
300746	Xq27.1	Thrombophilia, X-linked, due to factor IX defect	300807	_	3
300746	Xq27.1	{Deep venous thrombosis, protection against}	300807	_	3
300746	Xq27.1	{Warfarin sensitivity}	122700	AD	3
300747	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
300749	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300750	Xq24-q25	Spastic paraplegia 34, X-linked	300750	XLR	2
300751	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
300752	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
300755	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300756	Xq21.3	{Alzheimer disease 16}	300756	_	2
300757	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
300758	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300770	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
300774	Xq28	?Waisman syndrome	311510	XLR	3
300774	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300776	Xq23	?Congenital disorder of glycosylation, type Is	300884	XLD	3
300776	Xq23	Epileptic encephalopathy, early infantile, 36	300884	XLD	3
300777	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300778	Xp22.3	Corneal dystrophy, Lisch epithelial	300778	XLD	2
300779	Xq25	Corneal dystrophy, endothelial, X-linked	300779	XLD	2
300798	Xp22.13	Glycogen storage disease, type IXa1	306000	XLR	3
300798	Xp22.13	Glycogen storage disease, type IXa2	306000	XLR	3
300799	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300801	Xp11.23-p11.22	Chromosome Xp11.23-p11.22 duplication syndrome	300801	XLD	4
300802	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
300803	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
300804	Xp22.2	Joubert syndrome 10	300804	XLR	3
300806	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
300808	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300808	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300809	Xq28	{Systemic lupus erythematosus, susceptibility to, 15}	300809	_	2
300814	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300815	Xq28	Chromosome Xq28 duplication syndrome	300815	_	4
300816	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300818	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
300821	Xq28	Blue cone monochromacy	303700	XLR	3
300821	Xq28	Colorblindness, deutan	303800	XL	3
300822	Xq28	Blue cone monochromacy	303700	XLR	3
300822	Xq28	Colorblindness, protan	303900	XL	3
300823	Xq28	Mucopolysaccharidosis II	309900	XLR	3
300826	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
300827	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
300828	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300830	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300831	Xq28	CK syndrome	300831	XLR	3
300833	Xq26.3	46XX sex reversal 3	300833	XLD	4
300834	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
300835	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
300836	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
300838	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300839	Xp22.13	Retinoschisis	312700	XLR	3
300841	Xq28	Hemophilia A	306700	XLR	3
300842	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
300843	Xq28	Bornholm eye disease	300843	XLR	2
300844	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300845	Xq28	Moyamoya disease 4	300845	XLR	4
300847	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
300848	Xp11.3	Mental retardation, X-linked 89	300848	XLD	2
300849	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300850	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300851	Xp11.3	Mental retardation, X-linked 92	300851	XLR	2
300852	Xq24	Mental retardation, X-linked 88	300852	XL	2
300853	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300854	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
300855	Xq28	Ogden syndrome	300855	XLR,XLD	3
300856	Xp11.22	{Hypospadias 4, X-linked, susceptibility to}	300856	_	2
300857	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300858	Xp21.1-p11.23	Mental retardation, X-linked, syndromic 17	300858	XLR	2
300859	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300860	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
300861	Xq21.33-q23	Mental retardation, X-linked, syndromic, Chudley-Schwartz type	300861	XLR	2
300863	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300864	Chr.X	Cerebral-cerebellar-coloboma syndrome, X-linked	300864	XLR	2
300867	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300868	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
300869	Xq27.3-q28	Chromosome Xq27.3-q28 duplication syndrome	300869	XLR	4
300870	Xp22	Aneurysm, intracranial berry, 5	300870	_	2
300872	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300882	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300885	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300886	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300887	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300888	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300894	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300895	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300896	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
300897	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
300905	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300906	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300908	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
300909	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300910	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300911	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300912	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300913	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
300914	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
300915	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300918	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300919	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300923	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300928	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300932	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
300933	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300934	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300942	Xq26.3	Chromosome Xq26.3 duplication syndrome	300942	XLD	4
300943	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300945	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300946	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300951	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300952	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300953	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300957	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300958	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300960	Xp11.23	MEND syndrome	300960	XLR	3
300963	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300964	Xq12	Wilson-Turner syndrome	309585	XLR	3
300966	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
300967	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300968	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300969	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
300971	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300972	Xq28	Immunodeficiency 47	300972	XLR	3
300975	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300978	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300979	Xq25	Xq25 duplication syndrome	300979	XL	4
300980	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300982	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300983	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300984	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300985	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300986	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300988	Xq12	Immunodeficiency 50	300988	XLR	3
300989	Xq28	Meester-Loeys syndrome	300989	XL	3
300990	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300991	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300997	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300998	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
301000	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
301006	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
301008	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
301010	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301012	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301013	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301014	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
301015	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
301018	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
301020	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
301021	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
301022	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
301024	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
301025	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
301026	Xq26.2	Keipert syndrome	301026	XLR	3
301040	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
301050	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
301200	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
301201	Xq22-q28	?Amelogenesis imperfecta, type IE, X-linked 2	301201	XL	2
301220	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
301300	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
301300	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
301310	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
301590	Xq27-q28	?Microphthalmia, syndromic 4	301590	XLR	2
301770	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301830	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
301835	Xq22.3	Arts syndrome	301835	XLR	3
301845	Xq24-q27	Bazex syndrome	301845	XLD	2
301870	Xq28	Meester-Loeys syndrome	300989	XL	3
301870	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
301900	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
302045	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
302060	Xq28	Barth syndrome	302060	XLR	3
302200	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
302350	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
302500	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
302800	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
302801	Xp22.2	Charcot-Marie-Tooth neuropathy, X-linked recessive, 2	302801	XLR	2
302802	Xq26	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	XLR	4
302905	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
302910	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
302950	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
302960	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
303100	Xq21.2	Choroideremia	303100	XLD	3
303110	Xq21	Choroideremia, deafness, and mental retardation	303110	XLR	4
303400	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
303600	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
303630	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
303631	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
303800	Xq28	Colorblindness, deutan	303800	XL	3
303900	Xq28	Colorblindness, protan	303900	XL	3
304020	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
304040	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
304050	Xp22	Aicardi syndrome	304050	XLD	2
304100	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
304110	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
304120	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
304150	Xq21.1	Occipital horn syndrome	304150	XLR	3
304340	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
304400	Xq21.1	Deafness, X-linked 2	304400	XLR	3
304500	Xq22.3	Deafness, X-linked 1	304500	XL	3
304700	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
304730	Xq24-qter	Dermoids of cornea	304730	XL	2
304790	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
304800	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
305000	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
305100	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
305371	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
305371	Xp11.23	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	_	3
305371	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
305371	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
305390	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
305435	Xp22.2	Fetal hemoglobin quantitative trait locus 3	305435	XL	2
305450	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
305600	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
305620	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
305900	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
305900	Xq28	{Resistance to malaria due to G6PD deficiency}	611162	_	3
305915	Xq25	Mental retardation, X-linked 94	300699	XLR	3
306250	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
306400	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
306700	Xq28	Hemophilia A	306700	XLR	3
306900	Xq27.1	Hemophilia B	306900	XLR	3
306995	Xq28	[?Homosexuality, male]	306995	XL	2
307030	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
307150	Xq27.1	Hypertrichosis, congenital generalized	307150	XLD	4
307200	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
307700	Xq27.1	Hypoparathyroidism, X-linked	307700	XL	4
307800	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
308000	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
308000	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
308050	Xq28	CHILD syndrome	308050	XLD	3
308100	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
308205	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
308230	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
308240	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
308300	Xq28	Incontinentia pigmenti	308300	XLD	3
308350	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
308380	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
308380	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
308700	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
308800	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
308840	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
308840	Xq28	CRASH syndrome	303350	XLR	3
308840	Xq28	Hydrocephalus due to aqueductal stenosis	307000	XLR	3
308840	Xq28	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	XLR	3
308840	Xq28	Hydrocephalus with Hirschsprung disease	307000	XLR	3
308840	Xq28	MASA syndrome	303350	XLR	3
308905	Xp11	{Leber optic atrophy, susceptibility to}	308905	XL	2
308990	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
309000	Xq26.1	Lowe syndrome	309000	XLR	3
309060	Xq24	Danon disease	300257	XLD	3
309120	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
309200	Xq28	{?Major affective disorder 2}	309200	XLD	2
309300	Xq23	Megalocornea 1, X-linked	309300	XLR	3
309350	Xq28	Melnick-Needles syndrome	309350	XLD	3
309400	Xq21.1	Menkes disease	309400	XLR	3
309500	Xp11.23	Renpenning syndrome	309500	XLR	3
309510	Xp21.3	Partington syndrome	309510	XLR	3
309520	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
309530	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
309541	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
309545	Xp11	?Mental retardation, X-linked, syndromic 12	309545	XL	2
309548	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
309549	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
309550	Xq27.3	Fragile X syndrome	300624	XLD	3
309550	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
309550	Xq27.3	Premature ovarian failure 1	311360	XL	3
309555	Xq26	Gustavson syndrome	309555	XL	2
309580	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
309583	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
309585	Xq12	Wilson-Turner syndrome	309585	XLR	3
309590	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
309610	Xp11-q21	Prieto syndrome	309610	XLR	2
309620	Xq28	Mental retardation-skeletal dysplasia	309620	XL	2
309630	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
309800	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
309801	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
309845	Xq12	Immunodeficiency 50	300988	XLR	3
309850	Xp11.3	Brunner syndrome	300615	XLR	3
309850	Xp11.3	{Antisocial behavior}	300615	XLR	3
309900	Xq28	Mucopolysaccharidosis II	309900	XLR	3
310200	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
310300	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
310400	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
310440	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
310460	Xq28	Myopia-1	310460	XLR	2
310468	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
310490	Xq26.1	Cowchock syndrome	310490	XLR	3
310500	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
310600	Xp11.3	Norrie disease	310600	XLR	3
311050	Xp11.4-p11.21	Optic atrophy 2, X-linked	311050	XL	2
311070	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311200	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
311250	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
311300	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
311360	Xq27.3	Premature ovarian failure 1	311360	XL	3
311510	Xq28	?Waisman syndrome	311510	XLR	3
311770	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
311770	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
311800	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
311850	Xq22.3	Arts syndrome	301835	XLR	3
311850	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311850	Xq22.3	Deafness, X-linked 1	304500	XL	3
311850	Xq22.3	Gout, PRPS-related	300661	XLR	3
311850	Xq22.3	Phosphoribosylpyrophosphate synthetase superactivity	300661	XLR	3
311870	Xq13.1	Muscle glycogenosis	300559	XLR	3
311900	Xp11.3	TARP syndrome	311900	XLR	3
312000	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
312040	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
312060	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
312080	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
312170	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
312173	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
312173	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
312180	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
312300	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
312600	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
312610	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
312610	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
312610	Xp11.4	Retinitis pigmentosa 3	300029	_	3
312610	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
312612	Xp21.3-p21.2	?Retinitis pigmentosa, X-linked recessive, 6	312612	XL	2
312700	Xp22.13	Retinoschisis	312700	XLR	3
312820	Xp11.23	?Sarcoma, synovial	300813	_	3
312863	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
312865	Xp22.33	Langer mesomelic dysplasia	249700	_	3
312865	Xp22.33	Leri-Weill dyschondrosteosis	127300	_	3
312865	Xp22.33	Short stature, idiopathic familial	300582	_	3
312870	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
312920	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
313000	Xp22.33	Turner syndrome-associated neurocognitive phenotype	313000	?XLR	2
313000	Xp22.33	[Visuospatial/perceptual abilities]	313000	?XLR	2
313200	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313350	Xq26	Split hand/foot malformation 2	313350	XL	2
313400	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
313430	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
313430	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
313440	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
313475	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
313500	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
313650	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
313650	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
313700	Xq12	Androgen insensitivity	300068	XLR	3
313700	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
313700	Xq12	Hypospadias 1, X-linked	300633	XLR	3
313700	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313700	Xq12	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
313850	Xq25-q26.1	Thoracoabdominal syndrome	313850	XL	2
314050	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
314200	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
314250	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
314300	Xq28	Goeminne TKCR syndrome	314300	XL	2
314310	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
314370	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
314375	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
314390	Xq26.3	VACTERL association, X-linked	314390	XLR	3
314400	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
314580	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
314670	Xq13.2	X-inactivation, familial skewed	300087	_	3
314690	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
314700	Xpter-p22.32	[Blood group, XG system]	_	_	3
314850	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
314990	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
400003	Yq11.223	?Sertoli-cell-only syndrome	_	_	1
400004	Chr.Y	Retinitis pigmentosa, Y-linked	400004	YL	2
400005	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
400020	Yp11.2	Langer mesomelic dysplasia	249700	_	3
400020	Yp11.2	Leri-Weill dyschondrosteosis	127300	_	3
400020	Yp11.2	Short stature, idiopathic familial	300582	_	3
400033	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
400042	Yq11	Spermatogenic failure, Y-linked, 1	400042	_	4
400043	Chr.Y	Deafness, Y-linked 1	400043	YL	2
400044	Yp11.2	46XY sex reversal 1	400044	YL	3
400045	Yp11.2	46XX sex reversal 1	400045	XLD	4
400047	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
415000	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
425500	Yq	?Hairy ears, Y-linked	425500	YL	2
480000	Yp11.2	46XX sex reversal 1	400045	XLD	4
480000	Yp11.2	46XY sex reversal 1	400044	YL	3
580000	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
600001	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
600002	3p21.31	Eiken syndrome	600002	AR	3
600003	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
600005	16p13.13	Bare lymphocyte syndrome, type II, complementation group A	209920	AR	3
600005	16p13.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600008	11q23.2	Homocysteine plasma level	600008	_	2
600011	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
600011	7q22.1	Lymphatic malformation 7	617300	AD	3
600013	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
600014	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
600016	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
600019	17q23.3	Orthostatic hypotension 2	618182	AR	3
600020	10q25.2	Neurofibrosarcoma, somatic	_	_	3
600020	10q25.2	Prostate cancer, somatic	176807	_	3
600023	16q21	Elsahy-Waters syndrome	211380	AR	3
600024	1q42.12	?Reynolds syndrome	613471	AD	3
600024	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
600024	1q42.12	Pelger-Huet anomaly	169400	AD	3
600024	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
600028	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
600031	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
600035	10q26.11	Schizencephaly	269160	_	3
600037	14q22.3	Microphthalmia, syndromic 5	610125	AD	3
600037	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
600037	14q22.3	Retinal dystrophy, early-onset, with or without pituitary dysfunction	610125	AD	3
600040	19q13.33	Colorectal cancer, somatic	114500	_	3
600040	19q13.33	T-cell acute lymphoblastic leukemia, somatic	613065	_	3
600044	3q27.1	Thrombocythemia 1	187950	AD	3
600046	9q31.1	HDL deficiency, type 2	604091	_	3
600046	9q31.1	Tangier disease	205400	AR	3
600049	3q26	Myelodysplasia syndrome-1	_	_	3
600053	2q11.2	Achromatopsia 2	216900	AR	3
600059	17p13.3	Retinitis pigmentosa 13	600059	AD	3
600060	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
600065	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
600072	20p13	Insomnia, fatal familial	600072	AD	3
600073	2q31.1	Donnai-Barrow syndrome	222448	AR	3
600075	6q27	Spinocerebellar ataxia 17	607136	AD	3
600075	6q27	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
600079	7q11.23	Colon cancer, somatic	114500	_	3
600081	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
600089	6p21.3	?Diabetes mellitus, insulin-dependent, neonatal	600089	AR	2
600098	11p15.2	Ovarian carcinoma	_	_	3
600101	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
600104	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
600105	1q31.3	Retinitis pigmentosa-12	600105	AR	3
600108	11q22.2	Metaphyseal anadysplasia 1	602111	AD	3
600108	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
600108	11q22.2	Spondyloepimetaphyseal dysplasia, Missouri type	602111	AD	3
600110	6q14.1	Stargardt disease 3	600110	AD	3
600111	5p13.2	Episodic ataxia, type 6	612656	AD	3
600112	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
600112	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
600112	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
600116	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
600118	2q21.3	Warburg micro syndrome 1	600118	AR	3
600119	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
600121	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
600124	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
600129	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
600131	8q24	Epilepsy, childhood absence, 1	600131	AD	2
600132	6p21.31	Retinitis pigmentosa 14	600132	AR	3
600133	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
600138	19q13.42	Retinitis pigmentosa 11	600138	AD	3
600140	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
600140	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
600142	10q26.13	CARASIL syndrome	600142	AR	3
600143	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
600144	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
600145	1p13.1	Caudal regression syndrome	600145	AD	3
600147	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
600150	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
600150	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
600151	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
600154	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
600155	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
600156	9q31	{Hirschsprung disease, susceptibility to, 5}	600156	AD	2
600160	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
600160	9p21.3	Orolaryngeal cancer, multiple	_	_	3
600160	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
600160	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
600163	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
600163	3p22.2	Brugada syndrome 1	601144	AD	3
600163	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
600163	3p22.2	Heart block, nonprogressive	113900	AD	3
600163	3p22.2	Heart block, progressive, type IA	113900	AD	3
600163	3p22.2	Long QT syndrome-3	603830	AD	3
600163	3p22.2	Sick sinus syndrome 1	608567	AR	3
600163	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
600163	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
600165	11p	Nanophthalmos-1	600165	AD	2
600168	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
600170	9p13.3	[Blood group GIL]	607457	_	3
600173	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600175	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
600179	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
600179	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
600179	17p13.1	Leber congenital amaurosis 1	204000	AR	3
600184	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
600185	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
600185	13q13.1	Wilms tumor	194070	AD,SMu	3
600185	13q13.1	{Breast cancer, male, susceptibility to}	114480	AD,SMu	3
600185	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
600185	13q13.1	{Glioblastoma 3}	613029	AR	3
600185	13q13.1	{Medulloblastoma}	155255	AD,AR	3
600185	13q13.1	{Pancreatic cancer 2}	613347	_	3
600185	13q13.1	{Prostate cancer}	176807	AD,SMu	3
600192	18q11.2	Sarcoma, synovial	_	_	1
600193	1p21-p13.3	Waardenburg syndrome, type 2B	600193	AD	2
600194	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
600195	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	_	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, dark/light hair]	611742	_	3
600202	6p22-p21	{Dyslexia, susceptibility to, 2}	600202	AD	2
600204	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
600206	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
600209	19p	Exostoses, multiple, type 3	600209	AD	2
600211	6p21.1	Cleidocranial dysplasia	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	AD	3
600211	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
600220	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
600220	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
600221	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
600221	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600223	16q22.1	Spinocerebellar ataxia 4	600223	AD	2
600224	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
600225	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
600225	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
600228	12p13.31	?Liddle syndrome 3	618126	AD	3
600228	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
600228	12p13.31	Pseudohypoaldosteronism, type I	264350	AR	3
600229	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
600231	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600232	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
600234	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
600235	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
600235	19q13.11	Brugada syndrome 5	612838	_	3
600235	19q13.11	Cardiac conduction defect, nonspecific	612838	_	3
600235	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
600235	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
600236	1q41	Stromme syndrome	243605	AR	3
600238	20p13	?Uncombable hair syndrome 2	617251	AR	3
600244	2q37.3	{Multiple sclerosis, disease progression, modifier of}	126200	Mu	3
600244	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
600251	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
600253	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
600257	8q12.2-q21.2	Bor-Duane hydrocephalus contiguous gene syndrome	600257	AD	4
600259	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
600259	7p22.1	Mismatch repair cancer syndrome	276300	AR	3
600263	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
600266	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
600266	2q35	{Mycobacterium tuberculosis, susceptibility to infection by}	607948	_	3
600271	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
600273	16p13.3	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	AD	4
600275	1p12	Alagille syndrome 2	610205	AD	3
600275	1p12	Hajdu-Cheney syndrome	102500	AD	3
600276	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
600276	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
600276	19p13.12	Lateral meningocele syndrome	130720	AD	3
600279	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
600281	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
600281	20q13.12	MODY, type I	125850	AD	3
600281	20q13.12	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600286	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
600287	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
600287	7p14.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
600291	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
600293	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
600294	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
600300	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
600301	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
600309	6q22.31	Atrioventricular septal defect 3	600309	AD	3
600310	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
600310	19p13.11	Pseudoachondroplasia	177170	AD	3
600315	1p36.33	?Immunodeficiency 16	615593	AR	3
600316	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
600318	15q26	{Diabetes mellitus, insulin-dependent, 3}	600318	_	2
600319	11q13	{Diabetes mellitus, insulin-dependent, 4}	600319	_	2
600320	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
600321	2q31	{Diabetes mellitus, insulin-dependent, 7}	600321	_	2
600322	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
600332	1q41	Rippling muscle disease-1	600332	AD	2
600334	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
600336	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
600342	10q23.1	Retinitis pigmentosa 44	613769	_	3
600346	17q12	Turnpenny-Fry syndrome	618371	AD	3
600348	14q32.2	Band heterotopia	600348	AR	3
600354	5q13.2	Spinal muscular atrophy-1	253300	AR	3
600354	5q13.2	Spinal muscular atrophy-2	253550	AR	3
600354	5q13.2	Spinal muscular atrophy-3	253400	AR	3
600354	5q13.2	Spinal muscular atrophy-4	271150	AR	3
600359	11q24.3	Bartter syndrome, type 2	241200	AR	3
600361	4q34.3-q35.2	Hereditary motor and sensory neuropathy V	600361	AD	2
600363	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
600364	6p21.1	Cone dystrophy-3	602093	AD	3
600364	6p21.1	Cone-rod dystrophy 14	602093	AD	3
600370	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
600373	19p13.3	CODAS syndrome	600373	AR	3
600374	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
600375	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
600376	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
600383	8q13	Mesomelia-synostoses syndrome	600383	AD	4
600397	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
600414	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
600414	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
600414	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
600415	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
600417	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
600423	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
600423	1p36.12	{Hypertension, essential, susceptibility to}	145500	Mu	3
600429	6p24.3-p24.2	Adult i phenotype without cataract	110800	AD	3
600429	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
600429	6p24.3-p24.2	[Blood group, Ii]	110800	AD	3
600430	2q37	Chromosome 2q37 deletion syndrome	600430	AD	4
600438	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
600442	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600450	10p15.1	46XY sex reversal 8	614279	AR	3
600451	10p15.1	{46XY sex reversal 8, modifier of}	614279	AR	3
600456	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
600456	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
600462	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
600463	15q26.3	Microphthalmia, isolated 8	615113	AR	3
600465	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
600467	3q13.1	{Malignant hyperthermia susceptibility 4}	600467	AD	2
600470	3q24	Craniosynostosis 6	616602	AD	3
600473	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
600478	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
600480	15q21.3	Craniosynostosis 3	615314	AD	3
600483	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
600492	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
600495	3q27.1	{Parkinson disease 18}	614251	AD	3
600496	12q24.31	MODY, type III	600496	AD	3
600501	13q22.3	ABCD syndrome	600501	AR	3
600502	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
600502	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
600509	11p15.1	Diabetes mellitus, noninsulin-dependent	125853	AD	3
600509	11p15.1	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
600509	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
600509	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
600509	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
600510	7q35-q36	Pigment dispersion syndrome	600510	AD	2
600511	6p23	{Schizophrenia}	181500	AD	2
600512	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
600513	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
600514	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
600514	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
600515	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
600521	3q27.3	3MC syndrome 1	257920	AR	3
600522	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
600523	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
600525	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
600525	17q21.33	Trichodontoosseous syndrome	190320	AD	3
600528	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
600529	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
600532	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
600533	1q23.2	Neural tube defects	182940	AD	3
600536	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
600542	9q31.1	Chondrosarcoma, extraskeletal myxoid	612237	_	3
600543	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
600548	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
600548	5q31.2	Even-plus syndrome	616854	AR	3
600555	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
600555	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
600555	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
600556	12q13.3	Immunodeficiency 44	616636	AR	3
600558	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
600565	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
600565	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
600570	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
600570	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
600570	3q27.1	{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile absence, susceptibility to, 2}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	AD	3
600571	4q12	Fibromatosis, gingival, 5	617626	AD	3
600571	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
600574	22q11.21	Noonan syndrome 10	616564	AD	3
600574	22q11.21	Noonan syndrome 2	605275	AR	3
600574	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
600576	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
600576	8p23.1	Atrial septal defect 2	607941	AD	3
600576	8p23.1	Atrioventricular septal defect 4	614430	AD	3
600576	8p23.1	Tetralogy of Fallot	187500	AD	3
600576	8p23.1	Ventricular septal defect 1	614429	AD	3
600577	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
600579	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
600582	8q12.3	Traboulsi syndrome	601552	AR	3
600584	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
600584	5q35.1	Conotruncal heart malformations, variable	217095	_	3
600584	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
600584	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
600584	5q35.1	Tetralogy of Fallot	187500	AD	3
600584	5q35.1	Ventricular septal defect 3	614432	AD	3
600590	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
600593	4p16	Craniosynostosis, Adelaide type	600593	?AD	2
600599	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
600599	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
600599	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
600608	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
600617	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
600618	12p13.2	Leukemia, acute myeloid, somatic	601626	_	3
600618	12p13.2	Thrombocytopenia 5	616216	AD	3
600624	18q21.1-q21.3	Cone-rod retinal dystrophy-1	600624	AD	2
600625	14q22.2	Orofacial cleft 11	600625	_	3
600627	4q32.1	[?Hypertryptophanemia]	600627	AR	3
600630	10q11.23	UV-sensitive syndrome 1	600630	AR	3
600631	13q13-q14.3	Enuresis, nocturnal, 1	600631	AD	2
600632	11q25	Ovarian cancer, somatic	167000	_	3
600635	14q13.3	Chorea, hereditary benign	118700	AD	3
600635	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
600635	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
600638	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
600644	11q23.3	Cleft lip/palate-ectodermal dysplasia syndrome	225060	AR	3
600644	11q23.3	Orofacial cleft 7	225060	AR	3
600649	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
600650	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
600650	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AD,AR	3
600652	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
600660	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
600662	5q14.3	Chromosome 5q14.3 deletion syndrome	613443	AD	4
600662	5q14.3	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	613443	AD	3
600664	10q24.31	Cocoon syndrome	613630	_	3
600666	11q12.3	Polycystic kidney disease 3	600666	AD	3
600667	17q21.31	Omodysplasia 2	164745	AD	3
600668	8q	Chondrocalcinosis with early-onset osteoarthritis	600668	AD	2
600669	8q24	{Epilepsy, idiopathic generalized, susceptibility to, 1}	600669	AD	2
600673	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
600675	14q32.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600675	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
600678	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
600678	2p16.3	Mismatch repair cancer syndrome	276300	AR	3
600678	2p16.3	{Endometrial cancer, familial}	608089	_	3
600681	17q24.3	Andersen syndrome	170390	AD	3
600681	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
600681	17q24.3	Short QT syndrome 3	609622	_	3
600682	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
600682	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
600682	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AD,AR	3
600692	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
600698	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
600700	3q27-q28	Leukemia, acute myeloid	601626	AD,SMu	3
600700	3q27-q28	Lipoma	_	_	3
600701	6p21.31	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
600702	12q13.13	?Myoclonus, familial, 2	618364	AD	3
600702	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
600702	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
600702	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
600709	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
600712	9q21.32	Au-Kline syndrome	616580	AD	3
600713	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
600716	1p13.2	{Diabetes, type 1, susceptibility to}	222100	AR	3
600716	1p13.2	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600716	1p13.2	{Systemic lupus erythematosus susceptibility to}	152700	AD	3
600721	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
600722	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
600724	16q21	Retinitis pigmentosa 45	613767	AR	3
600725	7q36.3	Holoprosencephaly 3	142945	AD	3
600725	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
600725	7q36.3	Schizencephaly	269160	_	3
600725	7q36.3	Single median maxillary central incisor	147250	AD	3
600726	2q35	Acrocapitofemoral dysplasia	607778	AR	3
600726	2q35	Brachydactyly, type A1	112500	AD	3
600727	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
600728	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
600733	13q12.2	MODY, type IV	606392	_	3
600733	13q12.2	Pancreatic agenesis 1	260370	AR	3
600733	13q12.2	{Diabetes mellitus, type II, susceptibility to}	125853	AD	3
600734	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
600734	11q24.3	Long QT syndrome 13	613485	AD	3
600740	19q13.32	Hypocalciuric hypercalcemia, type III	600740	AD	3
600747	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
600749	14q11.2	Specific granule deficiency	245480	AR	3
600754	14q11.2	?Winchester syndrome	277950	_	3
600755	3p25.2	{Schizophrenia, susceptibility to}	181500	AD	3
600757	19q13	Orofacial cleft 3	600757	?AD	2
600759	1q42.13	Alzheimer disease-4	606889	AD	3
600759	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
600760	16p12.2	Bronchiectasis with or without elevated sweat chloride 1	211400	AD	3
600760	16p12.2	Liddle syndrome 1	177200	AD	3
600760	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600761	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
600761	16p12.2	Liddle syndrome 2	618114	AD	3
600761	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600770	11p15.5	{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	AD	3
600774	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
600775	19q13.2	Craniosynostosis 4	600775	AD	3
600778	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
600783	5q31.3	?Perrault syndrome 2	614926	AR	3
600790	6q14-q16.2	Chorioretinal atrophy, progressive bifocal	600790	AD	2
600792	14q12	Deafness, autosomal recessive 5	600792	AR	2
600795	3p11.2	Dementia, familial, nonspecific	600795	AD	3
600797	13q34	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, familial primary, 1, with or without HHT	178600	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	AD	3
600799	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
600802	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600803	7q21.12	Gallbladder disease 1	600803	AD,AR	3
600804	11q14.3	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600805	18q11.2	Epidermolysis bullosa, generalized atrophic benign	226650	AR	3
600805	18q11.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
600805	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
600808	12q13-q21	Enuresis, nocturnal, 2	600808	AD	2
600810	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AD,AR	3
600811	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
600814	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
600820	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
600824	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
600824	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
600825	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
600827	10q23.33	Cone dystrophy 4	613093	AR	3
600829	11q13.4	Opsismodysplasia	258480	AR	3
600835	10q11.21	{AIDS, resistance to}	609423	_	3
600836	2q35	?Cataract 42	115900	AD	3
600837	5p13.2	Central hypoventilation syndrome	209880	AD	3
600837	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
600837	5p13.2	{Pheochromocytoma, modifier of}	171300	AD	3
600838	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
600839	15q21.1	Bartter syndrome, type 1	601678	AR	3
600842	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
600844	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
600850	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
600852	17q23.1	Retinitis pigmentosa 17	600852	AD	3
600853	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
600855	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
600856	11p15.4	Beckwith-Wiedemann syndrome	130650	AD	3
600856	11p15.4	IMAGE syndrome	614732	AD	3
600857	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
600857	5p15.33	Leigh syndrome	256000	Mi,AR	3
600857	5p15.33	Mitochondrial respiratory chain complex II deficiency	252011	AR	3
600857	5p15.33	Paragangliomas 5	614165	AD	3
600858	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
600859	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
600864	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
600871	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
600871	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
600877	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
600881	17q11.2	Cataract 10, multiple types	600881	AD	3
600882	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
600883	6q25-q27	{Diabetes mellitus, insulin-dependent, 8}	600883	_	2
600884	9q13	Cardiomyopathy, dilated 1B	600884	AD	2
600886	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
600887	5q14.1	Endometrial carcinoma, somatic	608089	_	3
600887	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
600890	2p23.3	Fatty liver, acute, of pregnancy	609016	AR	3
600890	2p23.3	HELLP syndrome, maternal, of pregnancy	609016	AR	3
600890	2p23.3	LCHAD deficiency	609016	AR	3
600890	2p23.3	Trifunctional protein deficiency	609015	AR	3
600897	1q21.2	Cataract 1, multiple types	116200	AD	3
600898	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
600899	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
600900	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
600901	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
600909	21q22.3	Cataract 44	616509	AR	3
600909	21q22.3	Hypotrichosis 14	618275	AR	3
600917	7q31.1	Insulin resistance, severe, digenic	125853	AD	3
600920	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
600921	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
600922	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
600923	1q23.3	Porphyria variegata	176200	AD	3
600924	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
600925	11p11.2	Colon cancer, somatic	114500	_	3
600928	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
600929	22q12.1	Cataract 17, multiple types	611544	AD,AR	3
600936	5q34	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600937	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
600937	11p15.1	Diabetes, permanent neonatal, with or without neurologic features	606176	AD,AR	3
600937	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
600937	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
600937	11p15.1	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600939	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
600943	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
600943	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
600944	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
600946	5p13-p12	Growth hormone insensitivity, partial	604271	AD	3
600946	5p13-p12	Increased responsiveness to growth hormone	604271	AD	3
600946	5p13-p12	Laron dwarfism	262500	AR	3
600946	5p13-p12	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
600955	5q15	Obesity with impaired prohormone processing	600955	AR	3
600956	12q13.13	Persistent Mullerian duct syndrome, type II	261550	AR	3
600957	19p13.3	Persistent Mullerian duct syndrome, type I	261550	AR	3
600958	11p11.2	Cardiomyopathy, dilated, 1MM	615396	AD	3
600958	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
600958	11p11.2	Left ventricular noncompaction 10	615396	AD	3
600960	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
600962	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
600963	19q13.32	Branchiootorenal syndrome 2	610896	_	3
600965	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
600968	16q13	Gitelman syndrome	263800	AR	3
600969	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
600970	6q14.1	Deafness, autosomal dominant 22	606346	AD	3
600970	6q14.1	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	AD	3
600970	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
600971	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
600972	5q32	Achondrogenesis Ib	600972	AR	3
600974	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
600975	1p36.2-p36.1	Glaucoma 3, primary infantile, B	600975	AR	2
600977	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
600980	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
600982	5q11.2	46XY sex reversal 6	613762	AD	3
600983	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
600983	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
600985	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
600985	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
600987	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
600993	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
600993	18q21.2	Myhre syndrome	139210	AD	3
600993	18q21.2	Pancreatic cancer, somatic	260350	_	3
600993	18q21.2	Polyposis, juvenile intestinal	174900	AD	3
600994	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
600995	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
600996	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
600997	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
600997	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
600998	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
600998	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
601002	20q11.22	Glutathione synthetase deficiency	266130	AR	3
601002	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
601003	16p11.2	Brody myopathy	601003	AR	3
601005	12p13.33	Timothy syndrome	601005	AD	3
601007	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
601011	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
601011	19p13.13	Episodic ataxia, type 2	108500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1	141500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	AD	3
601011	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
601013	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
601015	14q24.3	Niemann-pick disease, type C2	607625	AR	3
601017	20q11.21	Long QT syndrome 12	612955	AD	3
601019	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
601022	6p21.33	{Rheumatoid arthritis, susceptibility to}	180300	_	3
601023	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
601023	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
601023	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
601040	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
601042	1p34.2	Dystonia 9	601042	AD	3
601045	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
601047	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
601047	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
601047	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
601065	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
601065	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
601068	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
601072	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
601088	16q23.2	Ayme-Gripp syndrome	601088	AD	3
601089	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
601090	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601090	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
601093	5q35.1	Enlarged vestibular aqueduct	600791	AR	3
601094	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
601094	1p33	Cataract 34, multiple types	612968	_	3
601094	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
601097	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
601097	17p12	Dejerine-Sottas disease	145900	AD,AR	3
601097	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
601097	17p12	Roussy-Levy syndrome	180800	AD	3
601098	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
601101	5q31.3-q32	Telangiectasia, hereditary hemorrhagic, type 3	601101	_	2
601103	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
601104	17q21.31	Supranuclear palsy, progressive	601104	AD	3
601105	1q21.3	Pycnodysostosis	265800	AR	3
601107	10q24.2	Dubin-Johnson syndrome	237500	AR	3
601110	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
601119	19p13.3	Perrault syndrome 3	614129	AR	3
601129	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
601130	10q23.33	Tolbutamide poor metabolizer	_	_	3
601130	10q23.33	Warfarin sensitivity	122700	AD	3
601134	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
601143	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
601143	2p13.1	Perry syndrome	168605	AD	3
601143	2p13.1	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
601144	3p22.2	Brugada syndrome 1	601144	AD	3
601145	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
601146	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
601146	20q11.22	Brachydactyly, type A1, C	615072	AD,AR	3
601146	20q11.22	Brachydactyly, type A2	112600	AD	3
601146	20q11.22	Brachydactyly, type C	113100	AD	3
601146	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
601146	20q11.22	Du Pan syndrome	228900	AR	3
601146	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
601146	20q11.22	Symphalangism, proximal, 1B	615298	_	3
601146	20q11.22	{Osteoarthritis-5}	612400	_	3
601147	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
601147	8q22.1	Leber congenital amaurosis 17	615360	AR	3
601147	8q22.1	Microphthalmia with coloboma 6, digenic	613703	AD	3
601147	8q22.1	Microphthalmia, isolated 4	613094	_	3
601147	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
601150	12p11.21	Warsaw breakage syndrome	613398	AR	3
601152	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
601154	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
601156	17q12	{Asthma, susceptibility to}	600807	AD	3
601156	17q12	{HIV1, resistance to}	609423	_	3
601162	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
601176	1p22.1	{Myocardial infarction, susceptibility to}	608446	_	3
601181	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
601184	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
601188	10pter-q11	Prostate adenocarcinoma	601188	_	2
601190	12p12.3	Achromatopsia 6	610024	AD,AR	3
601190	12p12.3	Retinal cone dystrophy 3	610024	AD,AR	3
601192	1p36.13	[Fleck retina, familial benign]	228980	AR	3
601194	4p14	{Leprosy, protection against}	613223	_	3
601194	4p14	{Leprosy, susceptibility to, 5}	613223	_	3
601197	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
601199	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant	601198	AD	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	AD	3
601199	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
601199	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
601200	14q32.13	Pleuropulmonary blastoma	601200	AD	3
601202	17p13	Cataract 24, anterior polar	601202	AD	2
601205	14q23.1	Branchiootic syndrome 3	608389	AD	3
601205	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
601208	14q24.3-q31	{Diabetes mellitus, insulin-dependent, 11}	601208	_	2
601214	17q21.2	Naxos disease	601214	AR	3
601215	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
601215	3q23	Seckel syndrome 1	210600	AR	3
601216	11q13.1	Dental anomalies and short stature	601216	AR	3
601224	11p11.2	Potocki-Shaffer syndrome	601224	_	4
601228	15q15.3-q22.1	Polyposis syndrome, mixed hereditary 1	601228	AD	4
601228	15q15.3-q22.1	{Colorectal cancer, susceptibility to, 4}	601228	AD	4
601231	1p36.22	Focal cortical dysplasia, type II, somatic	607341	_	3
601231	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
601238	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
601239	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
601240	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
601243	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
601243	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
601247	14q21.3	Noonan syndrome 9	616559	AD	3
601248	2q14.3	Centronuclear myopathy 2	255200	AR	3
601253	3p25.3	Cardiomyopathy, familial hypertrophic	192600	AD	3
601253	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
601253	3p25.3	Long QT syndrome 9	611818	AD	3
601253	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
601253	3p25.3	Rippling muscle disease 2	606072	AD	3
601255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
601255	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
601255	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
601259	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
601263	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
601265	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
601267	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601269	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
601277	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
601280	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
601282	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
601282	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
601282	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
601283	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
601284	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
601287	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601288	8q22.3	Popov-Chang syndrome	618428	AD	3
601295	13q33.1	Bile acid malabsorption, primary	613291	AR	3
601296	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
601296	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
601299	10q23.2	Juvenile polyposis syndrome, infantile form	174900	AD	3
601299	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
601299	10q23.2	Polyposis, juvenile intestinal	174900	AD	3
601300	12q13.13	Pancreatic cancer, somatic	_	_	3
601309	9q22.32	Basal cell carcinoma, somatic	605462	_	3
601309	9q22.32	Basal cell nevus syndrome	109400	AD	3
601309	9q22.32	Holoprosencephaly 7	610828	AD	3
601313	16p13.3	Polycystic kidney disease 1	173900	AD	3
601314	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
601316	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
601317	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
601318	2q34	{Diabetes mellitus, insulin-dependent, 13}	601318	_	2
601321	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
601327	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
601330	12p12.3	Diarrhea 6	614616	AD	3
601330	12p12.3	Meconium ileus	614665	AR	3
601331	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
601336	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
601338	19q13.2	CAPOS syndrome	601338	AD	3
601349	6q21	Microphthalmia, syndromic 8	601349	?AD	2
601358	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
601362	10p14-p13	DiGeorge syndrome/velocardiofacial syndrome complex-2	601362	_	2
601363	17q12-q21	Wilms tumor, type 4	601363	AD	2
601365	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
601368	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
601369	14q12	Deafness, autosomal dominant 9	601369	AD	3
601373	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
601373	3p21.31	{Hepatitis C virus, resistance to}	609532	_	3
601373	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601373	3p21.31	{West nile virus, susceptibility to}	610379	_	3
601382	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
601385	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
601388	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
601390	11p15.4	Van Maldergem syndrome 1	601390	AR	3
601395	17q11.2	{HIV/AIDS, susceptibility to}	609423	_	3
601397	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
601397	6q27	{Neural tube defects, susceptibility to}	182940	AD	3
601399	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
601402	3q25.32	Leukemia, acute myeloid	601626	AD,SMu	1
601404	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
601405	1p36.21	{Pancreatitis, chronic, susceptibility to}	167800	AD	3
601406	12q24.31	B-cell non-Hodgkin lymphoma, high-grade	_	_	3
601407	12q24.2	Diabetes mellitus, noninsulin-dependent, 2	601407	_	2
601408	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
601410	6q24	{Diabetes mellitus, transient neonatal, 1}	601410	AD	4
601411	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
601411	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601412	1q21-q23	Deafness, autosomal dominant 7	601412	AD	2
601414	1q21.2	Retinitis pigmentosa 18	601414	AD	3
601419	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
601421	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
601421	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
601424	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
601428	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
601428	2q14.2	Roifman syndrome	616651	AR	3
601439	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
601439	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
601439	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
601440	17q22	Nephrotic syndrome, type 7	615008	AR	3
601440	17q22	{Hemolytic uremic syndrome, atypical, susceptibility to, 7}	615008	AR	3
601443	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
601445	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
601454	4q	{Psoriasis susceptibility 3}	601454	_	2
601455	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
601458	12p13.2-q24.1	{Inflammatory bowel disease 2}	601458	_	2
601460	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
601462	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
601465	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
601465	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
601465	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
601470	3p22.2	{Coronary artery disease, resistance to}	607339	_	3
601470	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
601470	3p22.2	{Rapid progression to AIDS from HIV1 infection}	609423	_	3
601471	3q21-q22	Facial paresis, hereditary congenital, 1	601471	AD	2
601472	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
601479	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
601485	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
601486	3p24.3	{Spermatogenic failure, susceptibility to}	_	_	3
601487	3p25.2	Carotid intimal medial thickness 1	609338	_	3
601487	3p25.2	Insulin resistance, severe, digenic	604367	AD	3
601487	3p25.2	Lipodystrophy, familial partial, type 3	604367	AD	3
601487	3p25.2	Obesity, severe	601665	AD,AR,Mu	3
601487	3p25.2	[Obesity, resistance to]	_	_	3
601487	3p25.2	{Diabetes, type 2}	125853	AD	3
601488	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
601489	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
601492	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
601495	14q32.33	Agammaglobulinemia 1	601495	AR	3
601498	6p21.1	Heimler syndrome 2	616617	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4B	614863	AD,AR	3
601499	13q14	Rieger syndrome, type 2	601499	AD	2
601500	7q32.1	Basal cell carcinoma, somatic	605462	_	3
601500	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601501	16q11.2	{Parkinson disease 17}	614203	AD	3
601513	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
601515	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
601517	12q24.12	Spinocerebellar ataxia 2	183090	AD	3
601517	12q24.12	{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	AD	3
601517	12q24.12	{Parkinson disease, late-onset, susceptibility to}	168600	AD,Mu	3
601518	1q25.3	Prostate cancer 1	601518	AD	3
601525	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
601525	1q32.1	{Schizophrenia, susceptibility to}	181500	AD	3
601527	12q21.31	?Frontonasal dysplasia 3	613456	_	3
601528	4q34.3	Lymphatic malformation 4	615907	AD	3
601530	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
601530	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
601530	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
601530	5q35.3	Paget disease of bone 3	167250	AD	3
601538	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
601539	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
601542	4q25	Anterior segment dysgenesis 4	137600	AD	3
601542	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
601542	4q25	Ring dermoid of cornea	180550	AD	3
601543	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
601544	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
601545	17p13.3	Lissencephaly 1	607432	AD	3
601545	17p13.3	Subcortical laminar heterotopia	607432	AD	3
601547	22q11.23	Cataract 3, multiple types	601547	AD	3
601548	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
601550	17q21.31	[Blood group, Swann]	601550	_	3
601551	17q21.31	[Blood group, Froese]	601551	_	3
601552	8q12.3	Traboulsi syndrome	601552	AR	3
601553	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
601556	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
601559	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
601564	7q34	{Pancreatitis, chronic, protection against}	167800	AD	3
601565	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
601565	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
601566	13q34	Squamous cell carcinoma, head and neck, somatic	275355	_	3
601567	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
601568	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
601570	3p25.1	Fuhrmann syndrome	228930	AR	3
601570	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
601573	7q36.1	Weaver syndrome	277590	AD	3
601574	17q12	Chondrosarcoma, extraskeletal myxoid	612237	_	1
601583	7p14.1	{Wilms tumor susceptibility-5}	601583	AD,SMu	3
601592	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
601592	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
601593	2q35	{Breast cancer, susceptibility to}	114480	AD,SMu	3
601596	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
601601	6p12.3	Char syndrome	169100	AD	3
601601	6p12.3	Patent ductus arteriosus 2	617035	AD	3
601604	19p13.11	Immunodeficiency 30	614891	AR	3
601606	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
601607	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
601607	22q11.23	Rhabdoid tumors, somatic	609322	_	3
601607	22q11.23	{Rhabdoid tumor predisposition syndrome 1}	609322	AD	3
601607	22q11.23	{Schwannomatosis-1, susceptibility to}	162091	AD	3
601609	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
601609	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
601614	17p13.1	Mirror movements 4	618264	AD	3
601615	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
601617	12q13.2	Fundus albipunctatus	136880	AD,AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
601620	12q24.21	Holt-Oram syndrome	142900	AD	3
601621	12q24.21	Ulnar-mammary syndrome	181450	AD	3
601622	7p21.1	Craniosynostosis 1	123100	AD	3
601622	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
601622	7p21.1	Saethre-Chotzen syndrome with or without eyelid anomalies	101400	AD	3
601622	7p21.1	Sweeney-Cox syndrome	617746	AD	3
601623	15q11.2	Angelman syndrome	105830	AD	3
601627	5q13.2	{Spinal muscular atrophy, type III, modifier of}	253400	AR	3
601631	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601639	19p13.12	Cushing syndrome, ACTH-independent adrenal, somatic	615830	_	3
601641	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
601646	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
601650	11q12.2	Paragangliomas 2	601650	AD	3
601652	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
601653	8q13.3	?Otofaciocervical syndrome	166780	AD	3
601653	8q13.3	Anterior segment anomalies with or without cataract	602588	AD	3
601653	8q13.3	Branchiootic syndrome 1	602588	AD	3
601653	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
601656	18q11.2	Atrial septal defect 9	614475	AD	3
601656	18q11.2	Atrioventricular septal defect 5	614474	AD	3
601656	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
601656	18q11.2	Persistent truncus arteriosus	217095	_	3
601656	18q11.2	Tetralogy of Fallot	187500	AD	3
601663	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
601664	2q11.2	Retinitis pigmentosa 33	610359	AD	3
601666	6q21	{Diabetes mellitus, insulin-dependent, 15}	601666	_	2
601671	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
601675	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
601676	1p31	Acute insulin response	601676	_	2
601678	15q21.1	Bartter syndrome, type 1	601678	AR	3
601680	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
601682	3q21-q24	Glaucoma 1C, primary open angle	601682	AD	2
601683	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
601687	17q21.2	Meesmann corneal dystrophy	122100	AD	3
601688	4q34.1	Cranioosteoarthropathy	259100	AR	3
601688	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
601688	4q34.1	Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	AR	3
601689	18q11.2	?Spermatogenic failure 13	615841	AR	3
601690	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
601690	6p12.3	{Asthma, susceptibility to}	600807	AD	3
601690	6p12.3	{Atopy, susceptibility to}	147050	AD	3
601691	1p22.1	Cone-rod dystrophy 3	604116	_	3
601691	1p22.1	Fundus flavimaculatus	248200	AR	3
601691	1p22.1	Retinal dystrophy, early-onset severe	248200	AR	3
601691	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601691	1p22.1	Stargardt disease 1	248200	AR	3
601691	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
601692	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
601692	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
601692	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
601692	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
601692	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
601692	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
601692	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
601693	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
601694	2p21	[Leptin serum levels QTL1]	601694	_	2
601696	11p15.5	[Novelty seeking personality]	601696	?AD	1
601697	18q22.1	Peeling skin syndrome 5	617115	AR	3
601699	20q13.13	Hypertension, essential	145500	Mu	3
601705	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
601707	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601709	10q22.2	Quebec platelet disorder	601709	AD	3
601717	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
601718	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601719	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
601724	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
601724	2q31.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
601725	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
601728	10q23.31	Cowden syndrome 1	158350	AD	3
601728	10q23.31	Lhermitte-Duclos syndrome	158350	AD	3
601728	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
601728	10q23.31	Prostate cancer, somatic	176807	_	3
601728	10q23.31	{Glioma susceptibility 2}	613028	_	3
601728	10q23.31	{Meningioma}	607174	AD	3
601730	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
601731	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
601734	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
601736	17q23.3	Specific granule deficiency 2	617475	AR	3
601740	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
601743	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
601746	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
601749	1p22.1	Glomuvenous malformations	138000	AD	3
601752	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
601756	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
601757	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
601757	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
601758	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
601758	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
601762	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
601762	2q33.1	Gastric cancer, somatic	613659	_	3
601762	2q33.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
601763	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
601763	2q33.1	Hepatocellular carcinoma, somatic	114550	_	3
601763	2q33.1	{Breast cancer, protection against}	114480	AD,SMu	3
601763	2q33.1	{Lung cancer, protection against}	211980	AD,SMu	3
601764	19q	Seizures, benign familial infantile, 1	601764	AD	2
601768	19p13.3	Leukemia, acute myeloid	601626	AD,SMu	1
601769	12q13.11	?Osteoporosis, involutional	166710	AD	1
601769	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
601771	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
601771	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
601776	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
601777	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
601780	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
601785	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
601788	2q32.2	Muscle hypertrophy	614160	_	3
601789	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
601789	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
601791	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
601802	3p14.3	Growth hormone deficiency with pituitary anomalies	182230	AD,AR	3
601802	3p14.3	Pituitary hormone deficiency, combined, 5	182230	AD,AR	3
601802	3p14.3	Septooptic dysplasia	182230	AD,AR	3
601803	12p	Pallister-Killian syndrome	601803	SMo	4
601806	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
601807	12q13.2	Cavitary optic disc anomalies	611543	AD	3
601808	18q	Chromosome 18q deletion syndrome	601808	AD	4
601810	10q21.3	?Seckel syndrome 8	615807	AR	3
601810	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
601812	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
601813	11q13.2	Exudative vitreoretinopathy 4	601813	AD,AR	3
601814	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
601815	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
601816	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
601819	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
601820	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
601825	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
601837	13q33.3	LIG4 syndrome	606593	AR	3
601837	13q33.3	{Multiple myeloma, resistance to}	254500	SMu	3
601843	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
601844	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
601846	19p13.3	Muscular dystrophy with rimmed vacuoles	601846	AD	2
601847	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
601855	19q13.2	?Immunodeficiency 62	618459	AR	3
601860	5q23.1	D-bifunctional protein deficiency	261515	AR	3
601860	5q23.1	Perrault syndrome 1	233400	AR	3
601861	13q13.3	Bare lymphocyte syndrome, type II, complementation group D	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group C	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group E	209920	AR	3
601865	3q24	Bruck syndrome 2	609220	AR	3
601868	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
601869	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
601873	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
601881	18q21.32	Microphthalmia, isolated 3	611038	AR	3
601884	11q13.2	[Bone mineral density variability 1]	601884	AD	3
601885	13q12.11	Cataract 14, multiple types	601885	AD	3
601887	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
601888	5p	{Malignant hyperthermia susceptibility 6}	601888	_	2
601893	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
601894	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
601896	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
601897	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
601898	3q26.31	Growth hormone deficiency, isolated partial	615925	AD,AR	3
601900	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
601902	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
601903	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
601906	12q13.12	Split-hand/foot malformation 6	225300	AR	3
601906	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
601911	17q21.33	?Orofacial cleft 15	616788	AD	3
601912	2q33.1	?Orofacial cleft 10	613705	IC	3
601918	5q31.1	?Premature ovarian failure 14	618014	AR	3
601920	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
601920	20p12.2	Alagille syndrome 1	118450	AD	3
601920	20p12.2	Tetralogy of Fallot	187500	AD	3
601924	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
601925	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
601928	12q13.13	Monilethrix	158000	AD	3
601933	12q23.3	{Delayed sleep phase disorder, susceptibility to}	614163	AD	3
601941	18q21	{Diabetes mellitus, insulin-dependent, 6}	601941	_	2
601942	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
601949	2q23.3	Episodic ataxia, type 5	613855	AD	3
601949	2q23.3	{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	AD	3
601949	2q23.3	{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	AD	3
601952	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
601954	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
601962	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
601968	1p13.2	Diarrhea 9	618168	AR	3
601972	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
601975	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
601977	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
601978	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
601978	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
601982	3p25.3	Renal cell carcinoma, clear cell, somatic	144700	_	3
601992	9p23-p11	Friedreich ataxia 2	601992	AR	2
602011	3p25	?Pancreatic endocrine tumors	_	_	1
602014	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
602023	1p36.13	Bartter syndrome, type 3	607364	AR	3
602023	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602024	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602025	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
602026	10p13	Refsum disease	266500	AR	3
602032	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602033	14q32.2	Band heterotopia	600348	AR	3
602037	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
602044	11q13.4	{Obesity, severe, and type II diabetes}	601665	AD,AR,Mu	3
602048	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
602049	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
602053	10p15.2	Gastric cancer, somatic	613659	_	3
602053	10p15.2	Prostate cancer, somatic	176807	_	3
602054	22q11.21	Conotruncal anomaly face syndrome	217095	_	3
602054	22q11.21	DiGeorge syndrome	188400	AD	3
602054	22q11.21	Tetralogy of Fallot	187500	AD	3
602054	22q11.21	Velocardiofacial syndrome	192430	AD	3
602063	11p15.5	Transaldolase deficiency	606003	AR	3
602064	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
602066	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
602072	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
602078	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602079	1q24.3	Trimethylaminuria	602079	AR	3
602080	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
602081	7q31.1	Speech-language disorder-1	602081	AD	3
602082	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
602083	10q21.1	Usher syndrome, type 1F	602083	AR	3
602085	13q21-q32	Postaxial polydactyly, type A2	602085	AD	2
602086	14q12-q22	Arrhythmogenic right ventricular dysplasia 3	602086	AD	2
602087	2q32.1-q32.3	Arrhythmogenic right ventricular dysplasia 4	602087	AD	2
602088	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
602090	11q13.1	Dental anomalies and short stature	601216	AR	3
602090	11q13.1	Geleophysic dysplasia 3	617809	AD	3
602091	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
602091	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
602091	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
602092	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
602096	12p11.23-q13.12	Alzheimer disease-5	602096	AD	2
602097	21q21	Usher syndrome, type 1E	602097	AR	2
602099	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
602104	4p16.3	Cherubism	118400	AD	3
602109	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
602109	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
602109	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
602134	2p25-p22	Essential tremor, hereditary, 2	602134	AD	2
602136	7q21.2	Heimler syndrome 1	234580	AR	3
602136	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
602136	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
602137	5q31.3	?Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3
602138	22q13.2	Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3
602140	10q24.31	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3
602141	11q13.2	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3
602142	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AR,AD	3
602144	1p22.1	?Spermatogenic failure 21	617644	AR	3
602146	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
602149	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
602149	5q31.1	Liebenberg syndrome	186550	AD	4
602150	8q11.21	Piebaldism	172800	AD	3
602150	8q11.21	Waardenburg syndrome, type 2D	608890	AR	3
602152	8q22.1	?RHYNS syndrome	602152	AR	3
602153	12q13.13	Monilethrix	158000	AD	3
602166	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
602167	14q24.3	Deafness, autosomal recessive 35	608565	AR	3
602168	14q32.2	Pontocerebellar hypoplasia type 1A	607596	AR	3
602170	3p22.2	Macroglobulinemia, Waldenstrom, somatic	153600	_	3
602170	3p22.2	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	_	3
602177	1q21.3	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms	617591	AR	3
602183	4p15.33	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3
602286	11q23.3-q24.1	Lathosterolosis	607330	AR	3
602290	9q33.1	?Bardet-Biedl syndrome 11	615988	AR	3
602290	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
602292	10q26.3	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3
602293	15q26.1	Epidermodysplasia verruciformis 3	618267	AR	3
602296	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
602298	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
602302	8p21.3	Alopecia universalis	203655	AR	3
602302	8p21.3	Atrichia with papular lesions	209500	AR	3
602302	8p21.3	Hypotrichosis 4	146550	AD	3
602311	16q22.1	{Leanness, inherited}	_	_	3
602311	16q22.1	{Obesity, late-onset}	601665	AR,Mu,AD	3
602322	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
602322	3q26.2	{Aplastic anemia}	614743	AD	3
602322	3q26.2	{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	AD	3
602332	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
602334	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
602336	1p31.3	?Deafness, autosomal recessive 108	617654	AR	3
602337	9q22.31	Brachydactyly, type B1	113000	AD	3
602337	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
602342	3q26.32	Pierpont syndrome	602342	AD	3
602345	4q27	?Spinocerebellar ataxia 41	616410	AD	3
602346	17q21.2	Hypomyelinating neuropathy, congenital, 3	618186	AR	3
602346	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
602347	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
602354	16p11.2	Immunodeficiency 52	617514	AR	3
602357	2q31.1	?Wiskott-Aldrich syndrome 2	614493	_	3
602358	17q21.2	?Narcolepsy 1	161400	AD	3
602360	15q21.1	Cerebral creatine deficiency syndrome 3	612718	AR	3
602361	11q12.1	Gracile bone dysplasia	602361	AD	3
602365	11q14.2	Haim-Munk syndrome	245010	AR	3
602365	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
602365	11q14.2	Periodontitis 1, juvenile	170650	AR	3
602368	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
602376	21q22.11	?Immunodeficiency 45	616669	AR	3
602376	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
602377	9q34.11	Epileptic encephalopathy, early infantile, 31	616346	AD	3
602378	19p13.2	Centronuclear myopathy 1	160150	AD	3
602378	19p13.2	Charcot-Marie-Tooth disease, axonal type 2M	606482	AD	3
602378	19p13.2	Charcot-Marie-Tooth disease, dominant intermediate B	606482	AD	3
602378	19p13.2	Lethal congenital contracture syndrome 5	615368	AR	3
602382	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
602389	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
602390	1q21.1	Hemochromatosis, type 2A	602390	AR	3
602397	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
602397	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
602397	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
602398	1p32.3	Desmosterolosis	602398	AR	3
602400	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
602401	18q22.1-q22.3	Ectodermal dysplasia 8, hair/tooth/nail type	602401	AR	2
602402	16q24.1	Lymphedema-distichiasis syndrome	153400	AD	3
602402	16q24.1	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400	AD	3
602404	2p13	{Parkinson disease 3}	602404	_	2
602409	10p12.31	Leukemia, acute myeloid	601626	SMu,AD	3
602410	3p25.3	Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3
602412	10q22.3	Diamond-blackfan anemia 3	610629	AD	3
602413	1q23.3	Gastrointestinal stromal tumor	606764	IC,AD	3
602413	1q23.3	Paraganglioma and gastric stromal sarcoma	606864	_	3
602413	1q23.3	Paragangliomas 3	605373	AD	3
602421	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
602421	7q31.2	Cystic fibrosis	219700	AR	3
602421	7q31.2	Sweat chloride elevation without CF	_	_	3
602421	7q31.2	{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	AD	3
602421	7q31.2	{Hypertrypsinemia, neonatal}	_	_	3
602421	7q31.2	{Pancreatitis, hereditary}	167800	AD	3
602427	16p11.2	Spondylocostal dysostosis 5	122600	AR,AD	3
602429	8q23	Glaucoma 1D, primary open angle	602429	_	2
602431	3p12.3	Vesicoureteral reflux 2	610878	_	3
602432	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
602432	10p13	Glaucoma 1, open angle, E	137760	AD	3
602432	10p13	{Glaucoma, normal tension, susceptibility to}	606657	_	3
602433	9q34.13	Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3
602438	16q22.1	Cataract 5, multiple types	116800	AD	3
602441	3p21.2	{Bacteremia, susceptibility to}	614383	_	3
602441	3p21.2	{Malaria, susceptibility to}	611162	_	3
602441	3p21.2	{Tuberculosis, susceptibility to}	607948	_	3
602445	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
602447	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
602450	10p13	Severe combined immunodeficiency, Athabascan type	602450	AR	3
602452	2q13	Colorectal cancer with chromosomal instability, somatic	_	_	3
602457	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
602458	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
602459	5q32	Deafness, autosomal dominant 15	602459	AD	3
602460	5q32	Deafness, autosomal dominant 15	602459	AD	3
602466	13q31.1	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3
602471	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
602473	19q13.31	Ethylmalonic encephalopathy	602473	AR	3
602477	19p13.3	Febrile seizures, familial, 2	602477	AD	2
602482	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
602483	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
602485	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
602486	8q22.2	Anauxetic dysplasia 2	617396	AR	3
602490	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
602491	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
602498	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
602498	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
602499	2p22.2	Macrophthalmia, colobomatous, with microcornea	602499	AD	4
602501	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
602529	12q13.12	Lissencephaly 3	611603	AD	3
602531	1q22	Grange syndrome	602531	AR	3
602533	1p36.23	Parkinson disease 7, autosomal recessive early-onset	606324	AR	3
602535	19p13.13	Marshall-Smith syndrome	602535	AD	3
602536	2q21.3	Warburg micro syndrome 1	600118	AR	3
602537	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
602540	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
602541	22q13.33	Muscular dystrophy, congenital, megaconial type	602541	AR	3
602544	6q26	Adenocarcinoma of lung, somatic	211980	_	3
602544	6q26	Ovarian cancer, somatic	167000	_	3
602544	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
602552	17p13.2	Fetal akinesia deformation sequence 4	618393	AR	3
602557	20p13	Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3
602568	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
602568	5p15.31	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
602569	5q35.2	Dementia, Lewy body	127750	AD	3
602572	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
602574	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
602574	11q23.3	Deafness, autosomal recessive 21	603629	AR	3
602575	9q33.3	Nail-patella syndrome	161200	AD	3
602576	7p22.3	Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3
602579	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
602589	14q23.3	Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3
602590	11q13.5-q14.1	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3
602591	5q12.1	Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3
602593	6p21.33	Hypotrichosis 2	146520	AD	3
602593	6p21.33	Peeling skin syndrome 1	270300	AR	3
602594	16p12.3-p12.1	Retinitis pigmentosa 22	602594	_	2
602600	1p32.3	{Myocardial infarction, susceptibility to}	608446	_	3
602601	12p13.2	{Myocardial infarction, susceptibility to}	608446	_	3
602606	5q13.2	{?Obesity, susceptibility to}	601665	AR,Mu,AD	3
602614	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
602614	6q15	Frontometaphyseal dysplasia 2	617137	AD	3
602616	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
602617	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
602617	9q22.33	{Thyroid cancer, nonmedullary, 4}	616534	AD	3
602618	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
602623	6p21.31	{Major depressive disorder and accelerated response to antidepressant drug treatment}	608516	_	3
602627	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
602629	8p11.21	Dystonia 6, torsion	602629	AD	3
602630	18p11.31	Holoprosencephaly 4	142946	AD	3
602631	11p15.4	Breast cancer, somatic	114480	_	3
602631	11p15.4	Lung cancer, somatic	211980	_	3
602631	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
602635	11p15.5	?Dyskinesia, seizures, and intellectual developmental disorder	617171	AR	3
602635	11p15.5	Mental retardation, autosomal dominant 24	615828	AD	3
602638	8q11.21	Immunodeficiency 54	609981	AR	3
602639	16q12.1	Tooth agenesis, selective, 2	602639	_	2
602642	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
602643	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
602656	16p13.3	Familial adenomatous polyposis 3	616415	AR	3
602660	9q34.3	Leber congenital amaurosis with early-onset deafness	617879	AD	3
602661	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
602661	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
602662	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
602662	19p13.3	Leukodystrophy, hypomyelinating, 6	612438	AD	3
602666	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
602667	8q21.3	Aplastic anemia	609135	_	3
602667	8q21.3	Leukemia, acute lymphoblastic	613065	_	3
602667	8q21.3	Nijmegen breakage syndrome	251260	AR	3
602668	3q21.3	Myotonic dystrophy 2	602668	AD	3
602669	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
602669	10q24.32	Cataract 11, multiple types	610623	AR,AD	3
602669	10q24.32	Cataract 11, syndromic, autosomal recessive	610623	AR,AD	3
602671	11q23.3	Glycogen storage disease Ib	232220	AR	3
602671	11q23.3	Glycogen storage disease Ic	232240	AR	3
602676	2q37.1	?Joubert syndrome 22	615665	AR	3
602678	14q32.32-q32.33	?Visual impairment and progressive phthisis bulbi	618283	AR	3
602685	15q24	Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685	_	2
602686	7p22.3	Lymphoma, somatic	_	_	3
602686	7p22.3	Prostate cancer, somatic	176807	_	3
602690	11q23.1	Mitochondrial complex II deficiency	252011	AR	3
602690	11q23.1	Paraganglioma and gastric stromal sarcoma	606864	_	3
602690	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
602690	11q23.1	Pheochromocytoma	171300	AD	3
602694	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
602696	22q12.3	?Meier-Gorlin syndrome 8	617564	AR	3
602700	22q13.2	Colorectal cancer, somatic	114500	_	3
602700	22q13.2	Menke-Hennekam syndrome 2	618333	_	3
602700	22q13.2	Rubinstein-Taybi syndrome 2	613684	AD	3
602703	16q21	Lissencephaly 6, with microcephaly	616212	AR	3
602713	8p11.22	Cone-rod dystrophy 9	612775	_	3
602716	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
602717	19q13.33	Epileptic encephalopathy, early infantile, 46	617162	AD	3
602722	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
602723	17q25.3	Psoriasis 2	602723	AD	3
602727	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
602727	16p13.3	Osteopetrosis, autosomal recessive 4	611490	AR	3
602730	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
602731	5p13.1	Thrombocytopenia 3	273900	AR	3
602743	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
602743	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
602743	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
602744	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
602748	12q21.33	Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3
602753	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602754	19q13.31	Dehydrated hereditary stomatocytosis 2	616689	AD	3
602759	1q42.2-q43	{Prostate cancer, susceptibility to}	602759	_	2
602765	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
602765	12q13.13	Monilethrix	158000	AD	3
602767	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602768	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
602769	2p23.3	Acute myeloid leukemia, somatic	601626	_	3
602769	2p23.3	Tatton-Brown-Rahman syndrome	615879	AD	3
602770	17q25.3	?46XY sex reversal 5	613080	AR	3
602771	1p36.11	Muscular dystrophy, rigid spine, 1	602771	AR	3
602772	6q12	Retinitis pigmentosa 25	602772	AR	3
602773	3q21.1	Renal cell carcinoma	144700	_	1
602774	17q22	Fanconi anemia, complementation group O	613390	AR	3
602774	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
602775	10q25.2	Noonan-like syndrome with loose anagen hair	607721	AD	3
602780	5p12	Epileptic encephalopathy, early infantile, 24	615871	AD	3
602780	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
602782	10q22.1	Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3
602783	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
602821	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
602821	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
602821	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
602839	1p36.22	Immunodeficiency 14	615513	AD	3
602840	19p13.3	Lymphoproliferative syndrome 3	618261	AR	3
602842	6p22.3	Meier-Gorlin syndrome 6	616835	AD	3
602849	4p16.3	Muenke syndrome	602849	AD	3
602851	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
602851	5q14.3	Usher syndrome, type 2C	605472	AR	3
602851	5q14.3	Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	AR	3
602855	14q13.2	{Myocardial infarction, susceptibility to}	608446	_	3
602858	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
602859	1p36.32	Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3
602859	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
602860	15q15.1	Colorectal cancer, somatic	114500	_	3
602860	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
602860	15q15.1	[Premature chromatid separation trait]	176430	AD	3
602861	12p11.21	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3
602867	4q12	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3
602869	1q44	Epileptic encephalopathy, early infantile, 54	617391	AD	3
602870	6q14.1	Macular dystrophy, vitelliform, 4	616151	AD	3
602875	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
602876	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
602879	20q11.23	?Mental retardation, autosomal dominant 11	614257	AD	3
602880	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
602880	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
602900	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
606025	3q13.31	Primrose syndrome	259050	AD	3
606220	13q22.3	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3
604270	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
604270	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
604270	11p11.2	Sclerosteosis 2	614305	AR,AD	3
603295	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
605635	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
606612	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	AR	3
603685	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
606613	9p	[High density lipoprotein cholesterol level QTL 1]	606613	_	2
606806	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
607001	9q34.3	Kleefstra syndrome 1	610253	AD	3
606807	3p14.3	Hypogonadotropic hypogonadism 18 with or without anosmia	615267	AR,AD	3
603297	11q22.3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR,DR	3
605637	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AR,AD	3
606808	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607002	3p13	Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3
604272	22q13.33	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	AR	3
604272	22q13.33	Myopia 6	608908	AD	3
605833	1q21-q23	[Bone mineral density QTL 2]	605833	_	2
607196	17q25.1	Microcephaly, Amish type	607196	AR	3
603490	1p36.12	?SERKAL syndrome	611812	AR	3
603490	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
606224	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
604273	17p11.2	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3
603491	1p13.1	?Lacrimal duct defect	149700	AR	3
603688	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
607198	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
607004	5p13.3-p13.2	Brachydactyly, type A1, B	607004	AD	2
603301	2p25.1	Maturity-onset diabetes of the young, type VII	610508	_	3
607199	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
607199	1q32.2	van der Woude syndrome	119300	AD	3
607199	1q32.2	{Orofacial cleft 6}	608864	AD	3
607976	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
608170	5q35.3	{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3
606810	22q11.21	Hyperprolinemia, type I	239500	AR	3
606810	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
603689	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
603690	3q25.31	Congenital cataracts, hearing loss, and neurodegeneration	614482	AR	3
603690	3q25.31	Spastic paraplegia 42, autosomal dominant	612539	AD	3
608171	12p13.33	Retinal cone dystrophy 4	610478	AR	3
608172	1p36.11	?Congenital disorder of glycosylation, type 1bb	613861	AR	3
608172	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
608172	1p36.11	Retinitis pigmentosa 59	613861	AR	3
607393	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
607393	1q31.2	Hyperparathyroidism-jaw tumor syndrome	145001	AD	3
607393	1q31.2	Parathyroid adenoma with cystic changes	145001	AD	3
607393	1q31.2	Parathyroid carcinoma	608266	_	3
603511	7q36.3	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3
602911	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
603467	11p14.3	Fanconi anemia, complementation group F	603467	_	3
604261	6q21	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3
605102	1p36.22	MASP2 deficiency	613791	AR	3
605376	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
606771	14p11.2-q13	{Adiponectin, serum level of, QTL3}	606771	_	2
604710	19q13.2	Cutis laxa, autosomal recessive, type IC	613177	AR	3
605572	17p12	Abdominal obesity-metabolic syndrome	605572	AD	2
604144	19q13.11	Cystinuria	220100	AR,AD	3
604507	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
606494	1p34.1	?Epileptic encephalopathy, early infantile, 15	615006	AR	3
606494	1p34.1	Mental retardation, autosomal recessive 12	611090	AR	3
606454	14q24.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606454	14q24.3	Ovarioleukodystrophy	603896	AR	3
603390	5q13.3	Pigmented nodular adrenocortical disease, primary, 3	614190	_	3
603390	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
603550	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
603550	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
604223	7q22.1	Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease	617718	AR	3
607017	6p24.1-p22.3	Deafness, autosomal dominant 21	607017	AD	2
606258	13q32-q33	{Stature QTL 4}	606258	_	2
607095	9p13.3	Anauxetic dysplasia 1	607095	AR	3
605377	19q13.32	Myotonic dystrophy 1	160900	AD	3
604145	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
606972	14q23	{Epilepsy, idiopathic generalized, susceptibility to, 2}	606972	_	2
603513	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
606933	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
606933	11q14.3	Albinism, oculocutaneous, type IB	606952	_	3
606933	11q14.3	Waardenburg syndrome/albinism, digenic	103470	AD	3
606933	11q14.3	[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	AD	3
606933	11q14.3	[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	AD	3
606933	11q14.3	{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	AD	3
605573	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
607096	11q13.1	Hypouricemia, renal	220150	AR	3
607134	13q21	Specific language impairment QTL, 3	607134	_	2
603028	4q31.3	{Colorectal cancer, susceptibility to}	114500	SMu,AD	3
603028	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
603028	4q31.3	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
604827	15q14	Epilepsy, juvenile myoclonic	604827	AR	2
604827	15q14	{Epilepsy, idiopathic generalized, susceptibility to, 7}	604827	AR	2
604624	5q11.2	?Neuronopathy, distal hereditary motor, type IIC	613376	AD	3
604712	8q22.3	Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	AR	3
604712	8q22.3	Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	AR	3
604712	8q22.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3
603830	3p22.2	Long QT syndrome-3	603830	AD	3
603147	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
607373	3q25-q27	{Autism susceptibility 8}	607373	IC,Mu	2
603714	2p21	Holoprosencephaly 2	157170	AD	3
603714	2p21	Schizencephaly	269160	_	3
606934	15q15.1	Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3
604985	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
604985	11q13.2	Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3
603552	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
605610	19q13.33	Ataxia-oculomotor apraxia 4	616267	AR	3
605610	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
605378	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
607295	22q12.1	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3
603629	11q23.3	Deafness, autosomal recessive 21	603629	AR	3
606973	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
607056	3q12.3	Macular dystrophy, vitelliform, 5	616152	AD	3
607056	3q12.3	Retinitis pigmentosa 56	613581	AR	3
606896	3p12-q13	{Dyslexia, susceptibility to, 5}	606896	_	2
605379	16q23.2	Giant axonal neuropathy-1	256850	AR	3
604625	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
605814	7q21.3	Citrullinemia, type II, neonatal-onset	605814	AR	3
606214	19q13.2	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3
604025	17q24.1	Colorectal cancer, somatic	114500	_	3
604025	17q24.1	Oligodontia-colorectal cancer syndrome	608615	AD	3
606496	6p12.2	?Candidiasis, familial, 6, autosomal dominant	613956	_	3
606856	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
607572	6q25	{Leprosy, susceptibility to, 2}	607572	_	2
606936	19q13.33	Progressive familial heart block, type IB	604559	AD	3
604346	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
607100	2q13	Joubert syndrome 4	609583	AR	3
607100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
607100	2q13	Senior-Loken syndrome-1	266900	AR	3
605815	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
604305	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
604305	6p21.32	{Creutzfeldt-Jakob disease, variant, resistance to}	123400	AD	3
604305	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
607728	15q25.1-q26.1	Porokeratosis 4, disseminated superficial actinic	607728	_	2
606215	1p31-p21	{Atrioventricular septal defect, susceptibility to, 1}	606215	_	2
603553	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
603667	2q31.1	Epileptic encephalopathy, early infantile, 39	612949	AR	3
604946	19q13.42	{AIDS, delayed/rapid progression to}	609423	_	3
603395	8q22.2	Ciliary dyskinesia, primary, 28	615505	AR	3
606574	5p13.2	Albinism, oculocutaneous, type IV	606574	_	3
603716	6p24.2	Hyperparathyroidism 4	617343	AD	3
603716	6p24.2	Hypoparathyroidism, familial isolated	146200	AR,AD	3
606857	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
606857	6p12.1	{Myocardial infarction, susceptibility to}	608446	_	3
605577	11q13.1	?Bleeding disorder, platelet-type, 18	615888	AR	3
607057	22q11.21	Pseudo-TORCH syndrome 2	617397	AR	3
606938	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
605537	1q23.3	Achromatopsia 7	616517	AR	3
604027	17q21.32	Epilepsy, progressive myoclonic 6	614018	AR	3
605495	12p12.2	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3
604065	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
604065	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
603263	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
603150	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
607457	9p13.3	[Blood group GIL]	607457	_	3
607731	8q13-q23	Charcot-Marie-Tooth disease, axonal, type 2H	607731	AR	2
606897	1q42.3	Chediak-Higashi syndrome	214500	AR	3
607536	19p13.11	Mucoepidermoid salivary gland carcinoma	_	_	3
605579	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
608160	17q24.3	Acampomelic campomelic dysplasia	114290	AD	3
608160	17q24.3	Campomelic dysplasia	114290	AD	3
608160	17q24.3	Campomelic dysplasia with autosomal sex reversal	114290	AD	3
606060	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
603188	10p	{Obesity, susceptibility to, BMIQ8}	603188	_	2
607613	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
607613	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
607458	7q22-q32	Spinocerebellar ataxia 18	607458	AD	2
603313	12q12	{Long QT syndrome, acquired, reduced susceptibility to}	613688	AD	3
606382	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
606012	3q22	Deafness, autosomal dominant 18	606012	AD	2
604185	10q21.3-q22.1	Facial paresis, hereditary congenital, 2	604185	AD	2
606939	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
606939	8p21.3	Zimmermann-Laband syndrome 2	616455	AD	3
607574	22q13.33	Metachromatic leukodystrophy	250100	AR	3
607614	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
604867	7q31.32	[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}	617956	_	3
608161	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
607459	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
604348	2q37.3	Advanced sleep phase syndrome, familial, 1	604348	AD	3
606821	7q22.3	Congenital disorder of glycosylation, type IIi	613612	_	3
604110	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
604110	16q21	Polymicrogyria, bilateral perisylvian	615752	_	3
604831	4p16.2	?Weyers acrofacial dysostosis	193530	AD	3
604831	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607965	10q22.3	{Systemic lupus erythematosus with nephritis, susceptibility to, 1}	607965	_	2
603632	6p21.31	Diamond-Blackfan anemia 9	613308	AD	3
608320	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
603590	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3
603590	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	AR	3
607537	11q21	Mucoepidermoid salivary gland carcinoma	_	_	3
607339	16pter-p13	{Coronary heart disease, susceptibility to}	607339	_	2
608904	17p11	{Attention deficit-hyperactivity disorder}	143465	AD	2
608787	3q22-q24	Otosclerosis 5	608787	_	2
603671	5q12.1	Acromelic frontonasal dysostosis	603671	AD	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
606822	1p34.1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3
606822	1p34.1	Retinitis pigmentosa 76	617123	AR	3
605582	6q12-q16	Cardiomyopathy, dilated, 1K	605582	_	2
605497	3p22.3	Osteogenesis imperfecta, type VII	610682	AR	3
603718	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
608905	6q12	{Attention deficit-hyperactivity disorder}	143465	AD	2
606061	7p14.2	Atrial septal defect 4	611363	_	3
604629	11q22.2	Amelogenesis imperfecta, type IIA2	612529	AR	3
604149	7q21.3	Dystonia-11, myoclonic	159900	AD	3
608358	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
605025	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
608124	16p12.3	Desbuquois dysplasia 2	615777	AR	3
608124	16p12.3	{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3
606179	16q22	Aneurysmal bone cysts	606179	_	2
608593	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
603673	1p34.1	Basal cell carcinoma, somatic	605462	_	3
603673	1p34.1	Basal cell nevus syndrome	109400	AD	3
603673	1p34.1	Medulloblastoma, somatic	155255	_	3
607461	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
607461	18q21.1	Smith-McCort dysplasia	607326	AR	3
606180	4q27	Pontocerebellar hypoplasia, type 1D	618065	AR	3
606384	18q21.31	Periventricular nodular heterotopia 7	617201	AD	3
604630	1p36.11	Obesity, mild, early-onset	601665	AR,Mu,AD	3
603557	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
608982	3p26	{Stature QTL 5}	608982	_	2
606824	22q12.3	Glucose/galactose malabsorption	606824	AR	3
608125	17q21.33	Spondyloocular syndrome	605822	AR	3
608125	17q21.33	{Pseudoxanthoma elasticum, modifier of severity of}	264800	AR	3
603756	4q22.1	[Junior blood group system]	614490	_	3
603756	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
607462	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
608906	5p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
604067	17q24.1	Bradyopsia	608415	_	3
605818	2q23-q31	Deafness, autosomal recessive 27	605818	AR	2
608047	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
608515	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
606860	11q12.1	Angioedema, hereditary, types I and II	106100	AR,AD	3
606860	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
608709	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
605380	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
605380	12p13.32	Osteomalacia, tumor-induced	_	_	1
605380	12p13.32	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	_	3
603795	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
607258	4q33-qter	Hypercalciuria, absorptive	607258	_	2
608907	19p13.3	{Alzheimer disease 9, susceptibility to}	608907	AD	3
607966	2q34-q35	{Systemic lupus erythematosus with nephritis, susceptibility to, 2}	607966	_	2
608594	9q34.3	Lipodystrophy, congenital generalized, type 1	608594	AR	3
603796	21q22.11	Atrial fibrillation, familial, 4	611493	_	3
603796	21q22.11	Long QT syndrome 6	613693	AD	3
608710	6p21.3	Granulomatosis with polyangiitis	608710	_	2
604834	12q14.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3
604834	12q14.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3
607967	11p15.5	{Systemic lupus erythematosus with nephritis, susceptibility to, 3}	607967	_	2
603758	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
607059	8q24.3	Acrodermatitis enteropathica	201100	AR	3
603560	22q13.33	Charcot-Marie-Tooth disease, type 4B3	615284	AR	3
607027	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
607027	3q13.31	Epileptic encephalopathy, infantile or early childhood, 3	618012	AD	3
609060	3q25.32	Combined oxidative phosphorylation deficiency 1	609060	AR	3
608908	22q13.33	Myopia 6	608908	AD	3
607259	16q24.3	Spastic paraplegia 7, autosomal recessive	607259	AR,AD	3
607417	3p26.2	Mental retardation, autosomal recessive 2	607417	AR	3
608323	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
607060	12q12	{Parkinson disease 8}	607060	AD	3
607968	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
607464	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
607616	11p15.4	Niemann-Pick disease, type B	607616	AR	3
609334	18q22	Chromosome 18 pericentric inversion	609334	_	4
604349	9q34.12	Cortical malformations, occipital	614115	AR	3
608049	13q14.2-q14.1	{Autism susceptibility 3}	608049	IC,Mu	2
608984	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
607465	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
607847	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
604114	15q15.1	Platelet PLC beta-2 deficiency	_	_	1
606693	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
608051	4p15.32	Macular dystrophy, retinal, 2	608051	AD	3
609023	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
609179	15q11.2-q12	{Migraine with aura, susceptibility to, 7}	609179	_	2
609607	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
607849	14q24.1	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3
609180	17p13.1	Congenital disorder of glycosylation, type If	609180	AR	3
604115	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
608713	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
606742	4q32.3	Atrial septal defect 6	613087	AD	3
609412	5q12.1	Cockayne syndrome, type A	216400	AR	3
609412	5q12.1	UV-sensitive syndrome 2	614621	AR	3
604427	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
607468	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
608869	1p13.2	Urofacial syndrome 2	615112	AR	3
609840	14q32.12	Amelogenesis imperfecta, type IIA5	615887	AR	3
609840	14q32.12	[Skin/hair/eye pigmentation 6, blond/brown hair]	210750	AR	3
609840	14q32.12	[Skin/hair/eye pigmentation 6, blue/green eyes]	210750	AR	3
609025	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
604116	1p22.1	Cone-rod dystrophy 3	604116	_	3
603799	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
609918	1p36.21	Gallbladder disease 2	609918	_	2
609452	10q23.2	Myopathy, myofibrillar, 4	609452	AD	3
607850	9q22.31	{Osteoarthritis susceptibility 3}	607850	AD	3
604473	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
604473	6q24.3	Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3
610113	1q21.2	Ectopia lentis et pupillae	225200	AR	3
610113	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
610192	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
607498	6p21.1-p12.2	{Migraine with or without aura, susceptibility to, 3}	607498	AD	2
604117	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
610193	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
606744	18q11.2	Seckel syndrome 2	606744	AR	3
609062	7p14.1	{Wilms tumor susceptibility-5}	601583	SMu,AD	3
610230	22q13.31	Liver failure, transient infantile	613070	AR	3
610230	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
607499	10p	{Bulimia nervosa, susceptibility to}	607499	Mu	2
603563	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
603355	16q23.3-q24.1	?Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3
610308	13q12.3	Peters-plus syndrome	261540	AR	3
610542	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
603356	6q21	?Deafness, autosomal dominant 66	616969	AD	3
609919	1p34.3	Gallbladder disease 3	609919	_	2
609026	6p12-q12	{Cataract 28, age-related cortical, susceptibility to}	609026	_	2
610114	9q22	{Stature QTL 8}	610114	_	2
610425	22q12.1	Cataract 23	610425	_	3
610543	16p13.3	Chromosome 16p13.3 deletion syndrome	610543	_	4
608053	15q24.2-q24.3	Glutaric acidemia IIA	231680	AR	3
608360	9q34.11	?Agammaglobulinemia 5	613506	AD	3
610504	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
610698	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
606694	5p13.2	?Atrial fibrillation 15	615770	AR	3
607853	9q31	Panic disorder 2	607853	_	2
603592	18q12.2	Xanthinuria, type II	603592	AR	3
604556	19q13.2	Abdominal obesity-metabolic syndrome 3	615812	AD	3
610194	1q42.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	AR	3
610738	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
609255	6q22-q24	Febrile seizures, familial, 5	609255	AD	2
610815	8q22.3	?Exercise intolerance, riboflavin-responsive	616839	AR	3
603593	14q11.2	Lysinuric protein intolerance	222700	AR	3
604557	16q12.1	Joubert syndrome 19	614844	AR,AD	3
604557	16q12.1	Nephronophthisis 14	614844	AR,AD	3
610505	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
609027	11p13	[Blood group, Indian system]	609027	_	3
610621	4q28.1	?Orofaciodigital syndrome XVII	617926	AR	3
610621	4q28.1	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3
608553	1p36.22	Leber congenital amaurosis 9	608553	AR	3
608361	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
610582	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
610933	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
609610	15q15.3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3
611088	12q13.12	Ciliary dyskinesia, primary, 27	615504	AR	3
610350	15q26.3	Mental retardation, autosomal recessive 27	614340	AR	3
609256	11p13	Myopia 7	609256	Mu	2
603594	1q25.1	{Myocardial infarction, susceptibility to}	608446	_	3
609958	2p16	{Asthma-related traits, susceptibility to, 3}	609958	_	2
610934	7q35	Premature ovarian failure 5	611548	AD	3
609257	3q26	Myopia 8	609257	Mu	2
610427	11q13.2	Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3
603357	18q21.33	Palmoplantar keratoderma, Nagashima type	615598	AR	3
610389	1q22	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3
608874	4p16.2	Orofacial cleft 5	608874	_	3
609922	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
610855	10p12.1	Thrombocytopenia 2	188000	AD	3
608875	14q32	{Gene expression, variation in, QTL}	608875	_	2
610353	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
610622	19q13.33	{Neural tube defects, susceptibility to}	182940	AD	3
611051	3q28	?Deafness, autosomal dominant 44	607453	AD	3
604558	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
610197	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
610197	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
608716	1q31.3	Microcephaly 5, primary, autosomal recessive	608716	AR	3
610234	14q11.2-q12	Synpolydactyly 3	610234	_	2
609883	17q22	Bardet-Biedl syndrome 13	615990	AR	3
609883	17q22	Joubert syndrome 28	617121	AR	3
609883	17q22	Meckel syndrome 1	249000	AR	3
603564	9q34.11	Congenital disorder of glycosylation, type Iu	615042	AR	3
608363	22q11.2	Chromosome 22q11.2 microduplication syndrome	608363	IC,AD	4
610198	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
603358	2q35	GRACILE syndrome	603358	_	3
608364	12q13.12	[Low density lipoprotein cholesterol level QTL 8]	618079	_	3
611209	17q25.1	Congenital disorder of glycosylation, type IIg	611209	AR	3
607575	22q11.1	?Sneddon syndrome	182410	AR	3
607575	22q11.1	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3
610236	2q31.1	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3
609727	1p31.1-p21.1	Spastic paraplegia 29, autosomal dominant	609727	AD	2
609762	19q13.32	Hermansky-Pudlak syndrome 8	614077	AR	3
607892	18q12.1	Hypotrichosis 6	607903	AR	3
611363	7p14.2	Atrial septal defect 4	611363	_	3
611283	11q25	Isobutyryl-CoA dehydrogenase deficiency	611283	_	3
603805	15q15.2	Peeling skin syndrome 2	609796	AR	3
609923	9p21.1	Retinitis pigmentosa 31	609923	_	3
604559	19q13.33	Progressive familial heart block, type IB	604559	AD	3
609728	2q33.1	?Combined oxidative phosphorylation deficiency 25	616430	AR	3
609728	2q33.1	Spastic ataxia 3, autosomal recessive	611390	AR	3
607893	3p25-p22	{Ovarian cancer, susceptibility to}	607893	_	2
611211	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
611556	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
608367	7p15	Myopia 17	608367	AD	2
607854	11q12.3	Bestrophinopathy, autosomal recessive	611809	_	3
607854	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
607854	11q12.3	Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	193220	AD	3
607854	11q12.3	Retinitis pigmentosa, concentric	613194	_	3
607854	11q12.3	Retinitis pigmentosa-50	613194	_	3
607854	11q12.3	Vitreoretinochoroidopathy	193220	AD	3
611053	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
611364	5q12-q14	Myoclonic epilepsy, juvenile, 4	611364	AD	2
611595	18q23	Burn-McKeown syndrome	608572	AR	3
607855	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
609063	22q12.3	?Combined oxidative phosphorylation deficiency 29	616811	AR	3
611868	2p15	{Prostate cancer, hereditary, 12}	611868	_	3
611634	3p24.2-p23	Febrile seizures, familial, 9	611634	AD	2
609258	4q12	Myopia 9	609258	Mu	2
610819	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
609924	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
611907	19q13	Episodic ataxia, type 7	611907	AD	2
603570	6q23.2	[High density lipoprotein cholesterol level QTL 8]	_	_	3
607776	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
610624	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
611715	4q12	Congenital disorder of glycosylation, type Iq	612379	AR	3
611715	4q12	Kahrizi syndrome	612713	AR	3
607501	14q21.2-q22.3	{Migraine without aura, susceptibility to, 4}	607501	AD	2
610430	4q	{Macroglobulinemia, Waldenstrom, susceptibility to, 2}	610430	_	2
608877	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
608878	20q13	{Gene expression, variation in, QTL}	608878	_	2
607778	2q35	Acrocapitofemoral dysplasia	607778	AR	3
607857	4q31-q34	{Psoriasis susceptibility 9}	607857	_	2
612298	11p13	?Aniridia 3	617142	AD	3
611716	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
611716	12q24.31	Wrinkly skin syndrome	278250	AR	3
603810	11q21	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3
611637	4p16	Primary lateral sclerosis, adult, 1	611637	AD	2
611247	16p12	Major affective disorder 4	611247	_	2
609646	3q13.33	Deafness, autosomal recessive 42	609646	AR	3
609647	18p11.32-p11.31	Deafness, autosomal recessive 46	609647	AR	2
603601	11p15.1	Oculoskeletodental syndrome	618440	AR	3
611638	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
612025	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
609965	14q11.2-q12	Deafness, autosomal dominant 53	609965	AD	2
608879	15q22.2	Parkinson disease 23, autosomal recessive, early onset	616840	AR	3
612453	5q23.2	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	614399	AR	3
612453	5q23.2	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	614399	AR	3
611597	3q22.1	Cataract 12, multiple types	611597	AD	3
603811	11q13.1	Nestor-Guillermo progeria syndrome	614008	AR	3
609648	19q13.42	Familial cold autoinflammatory syndrome 2	611762	AD	3
612570	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
612570	5q23.3	Macular degeneration, early-onset	616118	AD	3
608556	1q41	{Legionnaire disease, susceptibility to}	608556	_	3
609259	8p23	Myopia 10	609259	Mu	2
611718	4q25	Hypomagnesemia 4, renal	611718	_	3
611951	19q13.2	?Meckel syndrome 10	614175	AR	3
611951	19q13.2	Joubert syndrome 34	614175	AR	3
612648	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
611598	4q27	{Autoimmune disease, susceptibility to, 5}	611598	_	2
611598	4q27	{Celiac disease, susceptibility to, 6}	611598	_	2
613077	8q22.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077	AD	3
612804	19q13.2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3
612300	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
612026	4q25	Alazami syndrome	615071	AR	3
613155	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	AR	3
612882	6q21	{Menarche, age at, QTL2}	612882	_	2
613078	5q31.1	Nijmegen breakage syndrome-like disorder	613078	_	3
612649	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
612301	18q21.33	Osteopetrosis, autosomal recessive 7	612301	AR	3
612961	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
609260	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
603813	1p36.11	Hypercholesterolemia, familial, 4	603813	AR	3
612378	6q23	{Systemic lupus erythematosus, susceptibility to, 13}	612378	_	2
612999	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
604961	2q31.2	Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3
613038	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AR,AD	3
612805	1q21.2	?Combined oxidative phosphorylation deficiency 21	615918	AR	3
607472	10p12.1	?Optic atrophy 11	617302	AR	3
609261	12q24.1	Stuttering, familial persistent, 2	609261	_	2
610355	16p12.2	Fanconi anemia, complementation group N	610832	_	3
610355	16p12.2	{Breast cancer, susceptibility to}	114480	SMu,AD	3
610355	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
610823	19p13.11	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3
613195	15q26.3	Weill-Marchesani 4 syndrome, recessive	613195	AR	3
613000	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
611010	11p15	Fibromatosis, gingival, 4	611010	_	2
612336	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
609262	3p26.2	Mental retardation, autosomal recessive 2	607417	AR	3
612105	10q23.31	Cowden syndrome 4	615107	_	3
607473	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
612337	1q44	Mental retardation, autosomal dominant 22	612337	AD	3
610826	5q22.1	Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3
612379	4q12	Congenital disorder of glycosylation, type Iq	612379	AR	3
613274	18q12.2	Xanthinuria, type II	603592	AR	3
610827	20q13.12	Microcephaly 10, primary, autosomal recessive	615095	AR	3
612650	6p21.1	Ciliary dyskinesia, primary, 12	612650	_	3
608750	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
608557	13q12	{Myocardial infarction, susceptibility to, 2}	608557	_	2
612651	6p12.1	Endocrine-cerebroosteodysplasia	612651	AR	3
611875	12p13.33	Brugada syndrome 3	611875	_	3
613468	8p22	Farber lipogranulomatosis	228000	AR	3
613468	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
612571	5p15.33	{Lung cancer susceptibility 3}	612571	_	2
609769	12q13.3	Ichthyosis, congenital, autosomal recessive 13	617574	AR	3
613818	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
613896	7q33	Erythrocytosis, familial, 8	222800	AR	3
613545	1p34-p32	Macrostomia	613545	_	2
612380	17q21.2	{Inflammatory bowel disease 22}	612380	_	2
612381	1q32.1	{Inflammatory bowel disease 23}	612381	_	2
613001	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
609968	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
613819	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
614091	2p24.1	Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3
612572	20p13	Retinitis pigmentosa 46	612572	_	3
614052	8q21.11	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3
614208	9p23-p13.3	Mental retardation, autosomal recessive 16	614208	AR	2
613662	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
612107	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
610397	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
613350	20p13	?Fazio-Londe disease	211500	AR	3
613350	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
613002	4q35.1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}	613002	AR,AD	3
612653	17q21.31	Spherocytosis, type 4	612653	AD	3
613897	11p14.3	Fanconi anemia, complementation group F	603467	_	3
612108	2q24-q32	[Fasting plasma glucose level QTL 1]	612108	_	2
614169	3p21.31	Gray platelet syndrome	139090	AR	3
612573	12q24.31	[Mean platelet volume QTL1]	612573	_	2
613118	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AR,AD	3
607982	11q13.1	Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3
612067	2q31.2	Dystonia 16	612067	AR	3
607983	1q24.2	Geroderma osteodysplasticum	231070	AR	3
612574	3p21-p13	[Mean platelet volume QTL2]	612574	_	2
613702	12p13.31	Klippel-Feil syndrome 3, autosomal dominant	613702	_	3
613119	11q13.4	?Brugada syndrome 6	613119	_	3
614170	4q27	Brittle cornea syndrome 2	614170	AR	3
613779	19p13.3	C3 deficiency	613779	AR	3
614559	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
612921	2q35	3-M syndrome 2	612921	AR	3
613780	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
614482	3q25.31	Congenital cataracts, hearing loss, and neurodegeneration	614482	AR	3
608988	6q14-q16	Atrial fibrillation, familial, 2	608988	_	2
613352	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
613820	2q24.3	Nephronophthisis 12	613820	AR,AD	3
613665	1q23.2	[Blood group, Duffy system]	110700	AR,AD	3
613665	1q23.2	[White blood cell count QTL]	611862	AR	3
613665	1q23.2	{Malaria, vivax, protection against}	611162	_	3
612847	10q23.2-q23.3	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3
614209	17p11.2	?Meckel syndrome 9	614209	AR	3
612575	17q11.2	[Mean platelet volume QTL3]	612575	_	2
614053	20q13.32	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	_	3
614676	7p12.1-q21	Cardiomyopathy, hypertrophic, 21	614676	AD	2
614210	3q28	{Lung cancer susceptibility 5}	614210	_	2
613079	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
604965	20q13.12	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	_	3
612848	19q13.12	Mitochondrial complex II deficiency	252011	AR	3
603816	16p13.3	?Caudal duplication anomaly	607864	_	3
603816	16p13.3	Hepatocellular carcinoma, somatic	114550	_	3
614249	6q23.2	Mental retardation, autosomal recessive 18	614249	AR	3
612109	4p16.1	Oculoauricular syndrome	612109	AR	3
614949	16q23.1	Joubert syndrome 20	614970	AR	3
614949	16q23.1	Meckel syndrome 11	615397	AR	3
603604	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
603604	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
603604	22q13.1	Parkinson disease 14, autosomal recessive	612953	AR	3
613080	17q25.3	?46XY sex reversal 5	613080	AR	3
614250	6p22.1	?Narcolepsy 7	614250	AD	3
614055	6q25.3	?ACAT2 deficiency	614055	IC	1
604267	19q13.2	Carpenter syndrome 2	614976	AR	3
614756	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
614325	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
612110	13q14	[Bone mineral density QTL 9]	612110	_	2
603720	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
615145	4q34.3-q35.1	Microphthalmia, isolated, with coloboma 9	615145	AR	3
603576	15q13.3	Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	_	3
614757	11p15.5	Osteogenesis imperfecta, type V	610967	AD	3
614871	1p36.32	Peroxisome biogenesis disorder 6B	614871	AR	3
614677	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
603605	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
607508	19p13	{Migraine with or without aura, susceptibility to, 5}	607508	AD	2
613587	8p23.1	Occult macular dystrophy	613587	AD	3
613506	9q34.11	?Agammaglobulinemia 5	613506	AD	3
614251	3q27.1	{Parkinson disease 18}	614251	AD	3
613823	15q21.1	Seckel syndrome 5	613823	AR	3
615028	11q22.3	Epidermolysis bullosa, nonspecific, autosomal recessive	615028	AR	3
615262	17q25.1	Mental retardation, autosomal recessive 44	615942	AR	3
614252	8p22	Aneurysm, intracranial berry, 11	614252	_	2
613507	3q24	?Glycogen storage disease XV	613507	AR	3
613003	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
613390	17q22	Fanconi anemia, complementation group O	613390	AR	3
614872	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
610828	9q22.32	Holoprosencephaly 7	610828	AD	3
615457	6q14.2	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3
614211	13q34	Deafness, autosomal dominant 33	614211	AD	2
615224	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
615302	19p13.3	Mental retardation, autosomal recessive 36	615286	AR	3
615264	1p36.32	[Blood group, Vel system]	615264	AR	3
613589	1p13.3	[Low density lipoprotein cholesterol level QTL6]	613589	AD	3
613824	17q11.2	?Nephronophthisis 9	613824	_	3
613004	4p16.3	Huntington disease	143100	AD	3
613004	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
614095	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
615418	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
615184	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
610829	2q14.2	Holoprosencephaly 9	610829	AD	3
613666	13q14.3	Congenital disorder of glycosylation, type Ip	613661	AR	3
613121	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
613121	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
612727	16q23	[Bone mineral density QTL 13]	612727	_	2
614873	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
615225	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
614561	17p13.1	Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3
607511	15q26.3	Weill-Marchesani 4 syndrome, recessive	613195	AR	3
615574	7q21.3	Asparagine synthetase deficiency	615574	AR	3
615067	19q13.33	Ciliary dyskinesia, primary, 20	615067	AR	3
613898	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
614131	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
613825	5p13.1	C9 deficiency	613825	_	3
615185	3q26.33	Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3
614988	11p15.5	Deafness autosomal recessive 106	617637	AR	3
610356	9p24.2	Retinal cone dystrophy 3B	610356	AR	3
615226	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
615575	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
613391	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
606702	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
612850	6p25.2	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3
613899	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
614096	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
614874	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
615068	18q12.3-q21.1	Vici syndrome	242840	AR	3
615030	4q25	Spastic paraplegia 56, autosomal recessive	615030	AR	3
607512	16q23.1	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3
613122	1p31.1	Cardiomyopathy, dilated, 1CC	613122	AD	3
612851	14q11.2	{Narcolepsy 5}	612851	_	2
604269	5q33.1	Spinocerebellar ataxia 45	617769	AD	3
603722	9q31.3	Dysautonomia, familial	223900	AR	3
615340	3p22.1	Nemaline myopathy 8, autosomal recessive	615348	_	3
613704	12p13.31	Microphthalmia, isolated 7	613704	AD	3
615381	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
613667	6q21	Mental retardation, anterior maxillary protrusion, and strabismus	613671	AR	3
614563	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
613625	2p21	Factor V and factor VIII, combined deficiency of	613625	_	3
613783	12p13.31	C1s deficiency	613783	_	3
615031	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
614212	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AR,AD	3
614097	11p13	Acatalasemia	614097	_	3
615770	5p13.2	?Atrial fibrillation 15	615770	AR	3
615458	16q23.1	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	AR	3
614832	4q21.1	Amelogenesis imperfecta, type IIA4	614832	AR	3
613392	17p12-q11.2	Deafness, autosomal recessive 85	613392	AR	2
613668	11q21	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	AR	3
614564	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
613784	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
615032	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
615731	2q31.1	Nemaline myopathy 9	615731	AR	3
615187	11p15.4	Hyperphosphatasia with mental retardation syndrome 3	614207	AR	3
615228	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
613900	20p13	Spinocerebellar ataxia 35	613908	AD	3
613393	2p13.3	[?Birbeck granule deficiency]	613393	_	3
614640	4p16.3	UV-sensitive syndrome 3	614640	AR	3
610595	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
615382	9q22.33	Nephronophthisis 16	615382	AR	3
615809	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
615887	14q32.12	Amelogenesis imperfecta, type IIA5	615887	AR	3
614833	18q22.2	Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3
615342	13q13.3	Pulmonary hypertension, primary, 2	615342	AD	3
614602	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
615033	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
613123	15q24.1	Brugada syndrome 8	613123	_	3
616082	12p13.32	Mental retardation, autosomal recessive 66	618221	AR	3
614834	17q24.3	{Thyrotoxic periodic paralysis, susceptibility to, 3}	614834	_	2
613508	12q24.11	[Sodium serum level QTL 1]	613508	_	3
612539	3q25.31	Spastic paraplegia 42, autosomal dominant	612539	AD	3
613785	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
615188	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
615888	11q13.1	?Bleeding disorder, platelet-type, 18	615888	AR	3
615034	11p14.3-p14.2	Dystonia 24	615034	AD	3
616083	10p15.3	Mental retardation, autosomal dominant 30	616083	AD	3
613509	4q21	Chromosome 4q21 deletion syndrome	613509	IC	4
614565	17q12	Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3
615147	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
614876	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
613629	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
613629	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
615419	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
616005	5q13.1	Immunodeficiency 36	616005	AD	3
615654	2p21-p12	Deafness, autosomal dominant 58	615654	AD	2
614643	7p21.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3
616044	16p13.3	Deafness, autosomal dominant 65	616044	AD	3
613596	2p15	Retinitis pigmentosa 28	606068	_	3
615343	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
616199	3q24	Polyglucosan body myopathy 2	616199	AR	3
612540	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
613741	14q22.1	Glycogen storage disease VI	232700	AR	3
603725	8p21.3	Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3
615496	15q25.3	Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3
607514	10q23.33	{Obesity, susceptibility to}	607514	_	3
615420	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
614759	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
613630	10q24.31	Cocoon syndrome	613630	_	3
616045	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
613597	10q24.2	Hyperoxaluria, primary, type III	613616	_	3
615656	15q11.2	Chromosome 15q11.2 deletion syndrome	615656	AD	4
615735	12q13.13	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3
615812	19q13.2	Abdominal obesity-metabolic syndrome 3	615812	AD	3
614877	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
616200	1q42.2	Ruijs-Aalfs syndrome	616200	AR	3
615926	15q25.1	?Webb-Dattani syndrome	615926	AR	3
603824	9p13.3	Nonaka myopathy	605820	AR	3
603824	9p13.3	Sialuria	269921	AD	3
612113	8q24	[Bone mineral density QTL 10]	612113	_	2
614836	3p22	{Human herpesvirus 8, susceptibility to}	614836	_	2
616394	2p23.3	Retinitis pigmentosa 71	616394	AR	3
616277	10q26.3	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277	AR	3
615071	4q25	Alazami syndrome	615071	AR	3
613705	2q33.1	?Orofacial cleft 10	613705	IC	3
613598	2p23.3	?Retinitis pigmentosa 58	613617	AR	3
616201	3p24.3	Chronic atrial and intestinal dysrhythmia	616201	AR	3
612114	6q25	[Bone mineral density QTL 11]	612114	_	2
614837	19p13.3	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3
613599	20p11.21	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3
616355	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
614213	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
616395	6q25.3	Trichothiodystrophy 3, photosensitive	616395	_	3
613742	17q21.31	Glycogen storage disease Ia	232200	AR	3
615344	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
616278	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
616589	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
614838	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
616084	3p26.2	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3
614878	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
614839	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
607516	1q31	{Migraine with or without aura, susceptibility to, 6}	607516	AD	2
607516	1q31	{Migraine, familial hemiplegic, 4}	607516	AD	2
612542	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
616433	5q35.1	Immunodeficiency 40	616433	AR	3
615345	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
614603	14q22.1	Spastic paraplegia 28, autosomal recessive	609340	AR	3
614879	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
603826	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
616279	17q12	?Cataract 43	616279	AD	3
614840	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
613128	10q24.33	Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3
616629	2q37.3	Senior-Loken syndrome 9	616629	AR	3
614215	10q22.1	?Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3
614215	10q22.1	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
613669	10p11.23	?Spastic ataxia 4, autosomal recessive	613672	AR	3
613789	1p32.2	C8 deficiency, type II	613789	AR	3
614841	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
615696	3q13.33	Dowling-Degos disease 4	615696	AD	3
616668	15q21.1	Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3
616592	5q32	Kosaki overgrowth syndrome	616592	AD	3
616006	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
613790	1p32.2	C8 deficiency, type I	613790	AR	3
613602	2p24.1	Cranioectodermal dysplasia 2	613610	AR	3
613602	2p24.1	Short-rib thoracic dysplasia 7 with or without polydactyly	614091	AR	3
604277	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
616398	22q12.3	Dystonia 26, myoclonic	616398	AD	3
616007	1q41	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3
616901	17p13.3	Developmental delay with short stature, dysmorphic features, and sparse hair	616901	AR	3
615191	7q31.1	Lissencephaly 5	615191	AR	3
614842	1q32.1	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3
616126	1p36.33	Immunodeficiency 38	616126	AR	3
613706	7q34	Noonan syndrome 7	613706	AD	3
616239	11q14.1	Combined oxidative phosphorylation deficiency 24	616239	AR	3
615889	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
615421	4q35.1	Myopia 22, autosomal dominant	615420	AD	3
616086	1q42.2	Ruijs-Aalfs syndrome	616200	AR	3
616127	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
615658	3q12.2	?Spastic paraplegia 57, autosomal recessive	615658	AR	3
613670	3p13	Mental retardation with language impairment and with or without autistic features	613670	AD	3
614880	2q14.3	{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3
613129	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
606703	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
613671	6q21	Mental retardation, anterior maxillary protrusion, and strabismus	613671	AR	3
616669	21q22.11	?Immunodeficiency 45	616669	AR	3
616399	1p13.2	Brugada syndrome 9	616399	AD	3
616784	16p12.1	Joubert syndrome 26	616784	AR	3
612498	14q32.33	Myopathy, distal, 5	617030	AR	3
613672	10p11.23	?Spastic ataxia 4, autosomal recessive	613672	AR	3
614881	2q35	Spinal muscular atrophy, distal, autosomal recessive, 5	614881	AR	3
617020	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
615422	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
617021	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
614845	11q23.3	Nephronophthisis 15	614845	AR	3
614882	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
616280	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
616087	13q22.2	{Diabetes mellitus, noninsulin-dependent, 5}	616087	_	3
617214	12p12.3	?Spermatogenic failure 17	617214	AR	3
615966	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
617022	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
614883	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
606705	9q21.13	Deafness, autosomal dominant 36	606705	AD	3
616672	13q34	Combined oxidative phosphorylation deficiency 27	616672	AR	3
614846	15q26-qter	Levy-Shanske syndrome	614846	_	4
614678	9p13.2	Pontocerebellar hypoplasia, type 1B	614678	AR	3
615192	6p22.3	[Birth weight QTL4]	615192	_	2
613908	20p13	Spinocerebellar ataxia 35	613908	AD	3
614847	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
614679	17q21.31	Ciliary dyskinesia, primary, 17	614679	AR	3
614884	2q11.2	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3
606706	9q21.13	Deafness, autosomal dominant 36	606705	AD	3
606706	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
603727	3p21.31	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3
617370	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
616089	2q14.3	[Blood group, Gerbich]	616089	_	3
617409	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
616357	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
617061	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
616281	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
613909	7q32-q33	Spinocerebellar ataxia 32	613909	AD	2
617565	17q11.2	Perrault syndrome 6	617565	AR	3
615193	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
615771	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
617682	5q15-q21	Pilarowski-Bjornsson syndrome	617682	AD	3
617175	13q14.2	Retinal dystrophy with or without extraocular anomalies	617175	AR	3
612965	9q33.3	46XY sex reversal 3	612965	AD	3
617023	2p23.3	Retinitis pigmentosa 75	617023	AR	3
617799	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
614680	11p15.5	{Influenza, severe, susceptibility to}	614680	_	3
617643	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
617526	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
617099	5p15.2	Autoinflammation, panniculitis, and dermatosis syndrome	617099	AR	3
617024	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
616282	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
616981	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
617062	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
617100	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
616982	5q23.2	Patent ductus arteriosus 3	617039	AD	3
617063	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
617527	9p21.2	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3
617137	6q15	Frontometaphyseal dysplasia 2	617137	AD	3
617644	1p22.1	?Spermatogenic failure 21	617644	AR	3
617760	2q31.1	Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3
615892	1p31	Orofacial cleft 14	615892	AR	2
612576	17p13.3-p13.1	Split-hand/foot malformation with long bone deficiency 3	612576	AD	4
612577	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
616093	9q34.2	[Blood group, ABO system]	616093	_	3
612967	17q23.2-q25.1	[Body mass index QTL 15]	612967	_	2
617449	14q22.3	Structural heart defects and renal anomalies syndrome	617478	AR	3
618074	16p12.1	?Epilepsy, familial adult myoclonic, 6	618074	_	3
617064	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
618152	12q24.31	Spermatogenic failure 33	618152	AR	3
618113	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
617917	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
612578	8q21.13	{Stature QTL 15}	612578	_	2
612968	1p33	Cataract 34, multiple types	612968	_	3
617995	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
617956	7q31.32	[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}	617956	_	3
618114	16p12.2	Liddle syndrome 2	618114	AD	3
617450	17q23.2	Jansen de Vries syndrome	617450	AD	3
613707	7q34	LEOPARD syndrome 3	613707	AD	3
618230	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
616094	8p11.21	?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12	616094	AR	3
612579	15q22.32	{Stature QTL 16}	612579	_	2
613708	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
612502	2p25.3	3MC syndrome 2	265050	AR	3
618347	21q22.3	Galloway-Mowat syndrome 6	618347	AR	3
618115	9q34.3	Spermatogenic failure 32	618115	AD	3
618386	11q13.4	Amelogenesis imperfecta, type IIIC	618386	AR	3
618153	2q32.1	Spermatogenic failure 34	618153	AR	3
614017	14q24.3	Ciliary dyskinesia, primary, 16	614017	AR	3
618075	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
618269	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
612503	17q24.3	?Hypertrichosis, congenital generalized, with gingival hyperplasia	135400	AR	3
616095	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AR,AD	3
618154	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
618309	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
616361	3q22	Parkinson disease 21	616361	AD	2
618425	2q35	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3
615197	5q31	{Restless legs syndrome 8}	615197	_	2
618348	12q15	Galloway-Mowat syndrome 7	618348	AR	3
618076	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
618310	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
614018	17q21.32	Epilepsy, progressive myoclonic 6	614018	AR	3
618116	1p32.1	Bone marrow failure syndrome 4	618116	AR	3
617959	7q21.13	Spermatogenic failure 24	617959	AR	3
612580	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
614019	16p13.11	Lissencephaly 4 (with microcephaly)	614019	AR	3
616097	11q12.3	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3
618270	21q11.2-q21.1	?Congenital anomalies of kidney and urinary tract 3	618270	AD	3
612581	11q24.2	Mental retardation, autosomal dominant 4	612581	AD	2
618117	3q23	Ovarian dysgenesis 7	618117	AR	3
618426	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
616098	1p22.3	?Immunodeficiency 37	616098	AR	3
612582	6pter-p24	Chromosome 6pter-p24 deletion syndrome	612582	IC	4
618387	1p32.3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3
618155	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
614020	19p13.12	Mental retardation, autosomal recessive 14	614020	AR	3
617960	8p12	Spermatogenic failure 25	617960	AR	3
618313	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
618388	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
617961	2q11.2	?Spermatogenic failure 26	617961	AR	3
618156	8p23.1	Squalene synthase deficiency	618156	_	3
618389	4p16.3	?Fetal akinesia deformation sequence 3	618389	_	3
618314	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
618272	14q32.13	GLOW syndrome, somatic mosaic	618272	_	3
618428	8q22.3	Popov-Chang syndrome	618428	AD	3
603409	8q22.3	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	AR	3
603066	7q22.1	Lysyl hydroxylase 3 deficiency	612394	AR	3
604210	1q31.3	Leber congenital amaurosis 8	613835	_	3
604210	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
604210	1q31.3	Retinitis pigmentosa-12	600105	AR	3
603324	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
603324	1p34.3	Deafness, autosomal dominant, with peripheral neuropathy	_	_	3
603324	1p34.3	Deafness, autosomal recessive	_	_	3
603324	1p34.3	Deafness, digenic, GJB2/GJB3	220290	AR	3
603324	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AR,AD	3
602997	10p13	Megaloblastic anemia-1, Finnish type	261100	AR	3
603448	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
606843	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
606557	2p16.1	Dias-Logan syndrome	617101	AD	3
603829	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
605239	7q34	Renal tubular acidosis, distal, autosomal recessive	602722	_	3
606464	19q13.12	Hemochromatosis, type 2B	613313	AR	3
606082	3q26.1-q26.3	Goiter, multinodular, 3	606082	_	2
607014	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
603933	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
606240	2q21	{Thyroid carcinoma, nonmedullary, 3}	606240	AD	2
604595	13q	[Cholesterol level QTL 1]	604595	_	2
603544	14q32.2	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3
604365	4p15.32	Cone-rod dystrophy 12	612657	_	3
604365	4p15.32	Macular dystrophy, retinal, 2	608051	AD	3
604365	4p15.32	Retinitis pigmentosa 41	612095	AR	3
604365	4p15.32	Stargardt disease 4	603786	_	3
603951	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
605789	18q12.1-q12.2	Symmetric circumferential skin creases, congenital, 2	616734	AD	3
603368	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
605205	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
606755	1p36.13	Uncombable hair syndrome	191480	AR	3
605909	1p36.12	Parkinson disease 6, early onset	605909	AR	3
606721	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
604906	1q42.2	{Schizophrenia 9, susceptibility to}	604906	_	3
603426	2q37.3	Advanced sleep phase syndrome, familial, 1	604348	AD	3
606257	12p11.2-q14	{Stature QTL 3}	606257	_	2
604400	3p25.1	Arrhythmogenic right ventricular dysplasia 5	604400	AD	3
603465	22q11.21	Meier-Gorlin syndrome 7	617063	AR	3
603527	17p13.3	Developmental delay with short stature, dysmorphic features, and sparse hair	616901	AR	3
603122	5q35.1	Immunodeficiency 40	616433	AR	3
607086	11q23.3-q24	Aortic aneurysm, familial thoracic 1	607086	_	2
605546	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
606540	18q21.1	Microvillus inclusion disease	251850	AR	3
605389	18p11.22	Hypotrichosis 1	605389	AD	3
605981	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
606521	17q25.1	Microcephaly, Amish type	607196	AR	3
606521	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
607144	22q13.33	Congenital disorder of glycosylation, type Ig	607143	AR	3
604774	1p31.3	Hypobetalipoproteinemia, familial, 2	605019	AR	3
605257	12p13.31	Immunodeficiency with hyper-IgM, type 2	605258	AR	3
606100	19p13.12	Vibratory urticaria	125630	AD	3
604417	5q31.1	CHOPS syndrome	616368	AD	3
603649	6q13	Cone-rod dystrophy 7	603649	_	3
606394	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
605206	15q24.1	Brugada syndrome 8	613123	_	3
605206	15q24.1	Sick sinus syndrome 2	163800	AD	3
603342	11q14-q21	{?Schizophrenia}	181500	AD	2
605427	12q24.11	?Avascular necrosis of femoral head, primary, 2	617383	AD	3
605427	12q24.11	Brachyolmia type 3	113500	AD	3
605427	12q24.11	Digital arthropathy-brachydactyly, familial	606835	AD	3
605427	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
605427	12q24.11	Metatropic dysplasia	156530	AD	3
605427	12q24.11	Parastremmatic dwarfism	168400	AD	3
605427	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
605427	12q24.11	SED, Maroteaux type	184095	AD	3
605427	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
605427	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
605427	12q24.11	[Sodium serum level QTL 1]	613508	_	3
604125	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
604459	12q14.3	{Asthma susceptibility 5}	611064	_	3
605367	17p12	Combined oxidative phosphorylation deficiency 17	615440	AR	3
605367	17p12	{Prostate cancer, hereditary, 2, susceptibility to}	614731	_	3
605998	1q21.3	Neutropenia, severe congenital 3, autosomal recessive	610738	AR	3
605080	8q21.3	Achromatopsia 3	262300	AR	3
605080	8q21.3	Macular degeneration, juvenile	248200	AR	3
607202	15q11-q13	{Celiac disease, susceptibility to, 5}	607202	_	2
606558	14q32.2	Immunodeficiency 49	617237	AD	3
606558	14q32.2	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3
604383	9q34.13	Bleeding disorder, platelet-type, 17	187900	AR,AD	3
604093	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
606777	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AR,AD	3
607087	5q13-q14	Aortic aneurysm, familial thoracic 2	607087	_	2
604322	6q13	Salla disease	604369	AR	3
604322	6q13	Sialic acid storage disorder, infantile	269920	AR	3
604194	9q34.11	Ichthyosis prematurity syndrome	608649	_	3
603427	1p36.23	?Advanced sleep phase syndrome, familial, 3	616882	AD	3
606151	16q13	Bardet-Biedl syndrome 2	615981	AR	3
606151	16q13	Retinitis pigmentosa 74	616562	AR	3
606019	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
602981	7p13	Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3
606195	16q12.2	Hamamy syndrome	611174	AR	3
606885	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
603123	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
606869	15q23	GM2-gangliosidosis, several forms	272800	AR	3
606869	15q23	Tay-Sachs disease	272800	AR	3
606869	15q23	[Hex A pseudodeficiency]	272800	AR	3
604401	10p14-p12	Arrhythmogenic right ventricular dysplasia 6	604401	_	2
603164	6q24.2	?Peroxisome biogenesis disorder 10B	617370	AR	3
603164	6q24.2	Peroxisome biogenesis disorder 10A (Zellweger)	614882	AR	3
605483	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
605207	2p13.2	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	_	3
607237	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
604613	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
604873	11q23.3	Deafness, autosomal recessive 111	618145	AR	3
606522	12p13.31	Klippel-Feil syndrome 3, autosomal dominant	613702	_	3
606522	12p13.31	Microphthalmia with coloboma 6	613703	AD	3
606522	12p13.31	Microphthalmia, isolated 7	613704	AD	3
604638	19q13.2	Glomerulosclerosis, focal segmental, 1	603278	AD	3
607330	11q23.3-q24.1	Lathosterolosis	607330	AR	3
603220	2p23.3	Pulmonary hypertension, primary, 4	615344	AD	3
603650	2q31.1	Bardet-Biedl syndrome 5	615983	AR	3
603072	20q13.2	{Colon cancer, susceptibility to}	114500	SMu,AD	3
607015	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
603294	21q22.3	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3
606350	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
606263	5q31	Paget disease of bone 4	606263	AD	2
607313	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
607254	22q12.3	{Schizophrenia}	181500	AD	1
604775	8q21.11	?Episodic pain syndrome, familial, 1	615040	AD	3
607293	6p21.1	?Deafness, autosomal recessive 103	616042	AR	3
607145	6p22.3	Hermansky-Pudlak syndrome 7	614076	AR	3
605258	12p13.31	Immunodeficiency with hyper-IgM, type 2	605258	AR	3
604307	2q33.3	Cataract 2, multiple types	604307	AD	3
607111	13q13.3	Troyer syndrome	275900	AR	3
604384	3q22.1	Hailey-Hailey disease	169600	AD	3
603033	3p25.1	Myasthenic syndrome, congenital, 5	603034	AR	3
603202	2q21.3	Lactase deficiency, congenital	223000	AR	3
606940	8q21.13	?Ptosis, congenital	178300	AD	2
605910	19p13.2	Plasma triglyceride level QTL, low	615881	AD	3
606523	12q14.2	{Thyroid cancer, nonmedullary, 2}	188470	SMu,AD	3
603546	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
603165	3q21	{Dermatitis, atopic, susceptibility to, 1}	603165	AD	2
606580	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
606580	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
605874	8q24.3	Birk-Barel mental retardation dysmorphism syndrome	612292	_	3
607088	11q13	Spinal muscular atrophy, chronic distal, autosomal recessive	607088	AR	2
605407	11p15.5	Segawa syndrome, recessive	605407	AR	3
606152	2q36.3	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	AR	3
607016	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
603107	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
603305	1q32.2	Temple-Baraitser syndrome	611816	AD	3
603305	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
604802	4p15.3	Huntington disease-like 3	604802	AR	2
603221	12q21-q23	Myopia-3	603221	AD	2
604212	16p13.12	Dyskeratosis congenita, autosomal recessive 6	616353	AR	3
604212	16p13.12	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371	AD	3
603345	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
604173	16q21	Poikiloderma with neutropenia	604173	AR	3
602931	15q22.31	Aortic valve disease 2	614823	AD	3
602931	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
605911	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
603073	13q32.3	Holoprosencephaly 5	609637	AD	3
605309	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
604614	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
605947	17p11.2	CHIME syndrome	280000	AR	3
603729	10q22.1	Nephrotic syndrome, type 14	617575	AR	3
606887	12q13.2	Sulfite oxidase deficiency	272300	AR	3
606264	12p13.2	Candidiasis, familial, 4, autosomal recessive	613108	AR	3
606264	12p13.2	{Aspergillosis, susceptibility to}	614079	_	3
605507	2q14.1	Psoriasis 14, pustular	614204	AR	3
607070	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
604418	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
604418	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
604418	13q12.11	Deafness, digenic GJB2/GJB6	220290	AR	3
604418	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
606871	11q25	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3
605983	19q13.41	Mental retardation, autosomal dominant 36	616362	AD	3
607314	11q13.2	Deafness, autosomal recessive 93	614899	AR	3
603034	3p25.1	Myasthenic syndrome, congenital, 5	603034	AR	3
604094	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
607397	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
605549	1q12-q24	Cone-rod dystrophy 8	605549	AR	2
604308	15q21.1	MASS syndrome	604308	_	3
607647	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
603633	14q21.3	Diamond-Blackfan anemia 13	615909	AD	3
604213	1p13.3	Chudley-McCullough syndrome	604213	AR	3
605792	17q22	?Spermatogenic failure 23	617707	AR	3
605653	13q22.3	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220	AR	3
607486	1q32.2	[Blood group, Knops system]	607486	_	3
603902	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
604366	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
604402	2p11.2	Salt and pepper developmental regression syndrome	609056	AR	3
605428	4q31.21	?Deafness, autosomal recessive 26	605428	AR	3
607071	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
604804	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
604385	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
604385	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
606448	22q11.21	?Glucocorticoid deficiency 5	617825	AR	3
606102	19p13.3	Lethal congenital contractural syndrome 3	611369	AR	3
604174	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
607031	4p14	Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3
605984	11q14.2	Cohen-Gibson syndrome	617561	AD	3
604875	15q23	Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3
603204	15q24	Epilepsy, nocturnal frontal lobe, type 2	603204	AD	2
607667	10q21.3	Arrhythmogenic right ventricular dysplasia, familial, 13	615616	AD	3
607526	17q21.31	?Diamond-Blackfan anemia 16	617408	AD	3
604653	2q32.2	Hemochromatosis, type 4	606069	AD	3
604325	5q32	Spinocerebellar ataxia 12	604326	AD	3
604214	7q21.2	Cavernous malformations of CNS and retina	116860	AD	3
604214	7q21.2	Cerebral cavernous malformations-1	116860	AD	3
604214	7q21.2	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860	AD	3
605654	6q16.1-q16.2	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3
605192	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
606210	1p36.11	Muscular dystrophy, rigid spine, 1	602771	AR	3
606210	1p36.11	Myopathy, congenital, with fiber-type disproportion	255310	AR,AD	3
603612	8p21.3	Squamous cell carcinoma, head and neck	275355	AR	3
606351	1p36.31	Deafness, autosomal recessive 36	609006	AR	3
606351	1p36.31	Deafness, neurosensory, without vestibular involvement, autosomal dominant	_	_	3
607398	21q22.11	Glucocorticoid deficiency 2	607398	AR	3
603834	12p13.32	Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3
605429	1q24	{Deafness, nonsyndromic, modifier 1}	605429	AD	2
602932	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
606241	14q32.13	GLOW syndrome, somatic mosaic	618272	_	3
606241	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
606241	14q32.13	Pleuropulmonary blastoma	601200	AD	3
606241	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
604095	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
604095	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
604095	2q13	[Hair morphology 1, hair thickness]	612630	_	3
607829	11p15.4	Mitral valve prolapse 2	607829	AD	3
606844	2p13.1	Alstrom syndrome	203800	AR	3
607701	2q31.1	Nemaline myopathy 9	615731	AR	3
607684	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
605010	5q32	Netherton syndrome	256500	AR	3
604515	10q24.1	?Agammaglobulinemia 4	613502	AR	3
603835	2q37.3	Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3
607261	4p16.2	Ellis-van Creveld syndrome	225500	AR	3
607261	4p16.2	Weyers acrofacial dysostosis	193530	AD	3
604127	1p12	Cousin syndrome	260660	AR	3
607875	17p13.3	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3
607354	17p11.2	Scoliosis, idiopathic 2	607354	_	2
607907	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
604326	5q32	Spinocerebellar ataxia 12	604326	AD	3
603307	20p12.1	Cataract 33, multiple types	611391	AR,AD	3
603183	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
607239	10p11.23-q21.1	Deafness, autosomal recessive 33	607239	AR	2
604805	19q13.32	Spastic paraplegia 12, autosomal dominant	604805	AD	3
604368	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
603206	18p	{Schizophrenia}	181500	AD	2
604386	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
604386	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
605031	4q28.1	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3
606242	1p36.32-p35.3	Kondoh syndrome	606242	AR	2
606544	5q13.3	Combined oxidative phosphorylation deficiency 39	618397	AR	3
603634	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
607685	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
607908	2q14.3	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3
604237	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
604197	15q25.1	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3
607876	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
606581	1p33	{Drug addiction, susceptibility to}	606581	_	3
607998	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
607998	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
607830	4q21.21	Fraser syndrome 1	219000	AR	3
605552	3q27	Abdominal obesity-metabolic syndrome 1	605552	AD	2
605446	14q11.2	Cone-rod dystrophy 13	608194	_	3
605446	14q11.2	Leber congenital amaurosis 6	613826	_	3
607649	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
606597	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
606597	2q36.1	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
606597	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
606597	2q36.1	Waardenburg syndrome, type 3	148820	AR,AD	3
604369	6q13	Salla disease	604369	AR	3
603330	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
605313	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
604175	1p36.11	Diamond-Blackfan anemia 7	612562	AD	3
607487	17q12	Cardiomyopathy, hypertrophic, 25	607487	AD	3
605011	4q13.3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154	AR	3
603371	9q34.11	Congenital arthrogryposis with anterior horn cell disease	611890	AR	3
603371	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
604129	3p21.31	Epidermolysis bullosa pruriginosa	604129	AR,AD	3
604577	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
604198	19p13.2	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3
607999	1q22	Mental retardation, autosomal dominant 52	617796	AD	3
605896	2q37.1	Arthrogryposis, distal, type 5D	615065	AR	3
604404	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
607812	14q21.1	Craniolenticulosutural dysplasia	607812	AR	3
605352	8p23.1	Malignant fibrous histiocytoma	605352	_	2
606545	17p13.1	Ichthyosis, congenital, autosomal recessive 3	606545	AR	3
604096	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
604808	20p12.1	Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3
603489	15q22.31	{Lumbar disc disease, susceptibility to}	603932	_	3
605370	5q31.3	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
607687	16q24.1	{High density lipoprotein cholesterol, low serum, 3}	607687	_	2
603372	14q31.1	Hyperthyroidism, familial gestational	603373	_	3
603372	14q31.1	Hyperthyroidism, nonautoimmune	609152	AD	3
603372	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
603372	14q31.1	Thyroid adenoma, hyperfunctioning, somatic	_	_	3
603372	14q31.1	Thyroid carcinoma with thyrotoxicosis	_	_	3
606598	8q21.11	Charcot-Marie-Tooth disease, axonal, type 2K	607831	AR,AD	3
606598	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
606598	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
606598	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
606470	5q35.3	Dyskeratosis congenita, autosomal recessive 2	613987	AR	3
607488	18p11	Dystonia-15, myoclonic	607488	AD	2
607221	4p15	Epilepsy, partial, with pericentral spikes	607221	_	2
607566	6q24.3	Epilepsy, progressive myoclonic 2A (Lafora)	254780	AR	3
608181	15q22.31	Mast syndrome	248900	AR	3
605013	16p13.11	?Microhydranencephaly	605013	AR	3
603903	11p15.4	Sickle cell anemia	603903	AR	3
605293	18q12.2-q12.3	Optic atrophy 4	605293	_	2
605353	3p25.3	{Obesity, susceptibility to}	601665	AR,Mu,AD	3
608097	20q13.13	Periventricular heterotopia with microcephaly	608097	AR	3
606889	1q42.13	Alzheimer disease-4	606889	AD	3
603386	19p13.2	Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386	_	2
605511	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
604387	3q22.1	Nephronophthisis 3	604387	AR	3
605259	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
605194	2q21.1	Heterotaxy, visceral, 2, autosomal	605376	AD	3
606045	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
606243	17q25.3	Alveolar soft-part sarcoma	606243	_	3
603867	1q21.1	?Peroxisome biogenesis disorder 14B	614920	AR	3
603968	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
608115	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
604943	7q22.1	?Deafness, autosomal recessive 61	613865	AR	3
603918	17q	{Hypertension, essential, susceptibility to, 1}	145500	Mu	2
607434	6p21.1	Jaberi-Elahi syndrome	617988	AR	3
608000	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
605913	1q23	Bleeding disorder, east Texas type	605913	_	2
603652	11q22.1	Glomerulosclerosis, focal segmental, 2	603965	AD	3
608232	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
607832	6p12.3	Glomerulosclerosis, focal segmental, 3	607832	_	3
606410	2p13.3	GAPO syndrome	230740	AR	3
606410	2p13.3	{?Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
608266	1q31.2	Parathyroid carcinoma	608266	_	3
605809	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AR,AD	3
604641	11p11.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
603373	14q31.1	Hyperthyroidism, familial gestational	603373	_	3
606636	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
606636	17p13.2	Palmoplantar carcinoma, multiple self-healing	615225	AD	3
606636	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
603208	2q37.1	Leber congenital amaurosis 16	614186	AR	3
603208	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
604254	2p16-p15	{Dyslexia, susceptibility to, 3}	604254	_	2
605014	6q24.2	Hemophagocytic lymphohistiocytosis, familial, 4	603552	AR	3
606847	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
607091	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
608033	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
607331	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
605210	1q42.2	{Schizophrenia 9, susceptibility to}	604906	_	3
607688	2q37.1	{Parkinson disease 11}	607688	_	3
603332	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
603332	3p21.1	Spermatogenic failure 18	617576	AR	3
606352	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
606352	2q33.1	Primary lateral sclerosis, juvenile	606353	AR	3
606352	2q33.1	Spastic paralysis, infantile onset ascending	607225	AR	3
607928	9q32	Deafness, autosomal recessive 31	607084	AR	3
607928	9q32	Usher syndrome, type 2D	611383	AR	3
606153	20q13.32	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	_	3
605554	1q23.3	{Rheumatoid arthritis, susceptibility to}	180300	_	3
607317	1p36.22-p36.21	Spinocerebellar ataxia, autosomal recessive 4	607317	AR	3
605294	16q23.1	Macular corneal dystrophy	217800	AR	3
604310	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
607047	14q32.12	Machado-Joseph disease	109150	AD	3
608328	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
607669	16p12.3	?Spastic paraplegia 61, autosomal recessive	615685	AR	3
607371	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
604777	19p13.12	Ichthyosis, congenital, autosomal recessive 5	604777	AR	3
603904	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
603904	13q14.2	Dementia, familial British	176500	AD	3
603904	13q14.2	Dementia, familial Danish	117300	AD	3
608345	7p11.2	Nystagmus 3, congenital, autosomal dominant	608345	AD	2
605242	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
605242	11p15.1	Usher syndrome, type 1C	276904	AR	3
607035	10q24.32	Basal cell nevus syndrome	109400	AD	3
607035	10q24.32	Joubert syndrome 32	617757	AR	3
607035	10q24.32	Medulloblastoma, desmoplastic	155255	AR,AD	3
607035	10q24.32	{Meningioma, familial, susceptibility to}	607174	AD	3
607814	19q13.11	Bradyopsia	608415	_	3
604327	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
603387	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
607450	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
603868	15q21.3	Griscelli syndrome, type 2	607624	AR	3
605512	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
605512	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
605512	6q14.1	Stargardt disease 3	600110	AD	3
604819	8q24.3	Verheij syndrome	615583	AD	3
606526	2q37.3	Griscelli syndrome, type 3	609227	AR	3
607490	16q23.1	D-lactic aciduria	245450	AR	3
603506	11q13.2	Exudative vitreoretinopathy 4	601813	AR,AD	3
603506	11q13.2	Hyperostosis, endosteal	144750	AD	3
603506	11q13.2	Osteopetrosis, autosomal dominant 1	607634	AD	3
603506	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
603506	11q13.2	Osteosclerosis	144750	AD	3
603506	11q13.2	Polycystic liver disease 4 with or without kidney cysts	617875	AD	3
603506	11q13.2	van Buchem disease, type 2	607636	AD	3
603506	11q13.2	[Bone mineral density variability 1]	601884	AD	3
603506	11q13.2	{Osteoporosis}	166710	AD	3
605629	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
603051	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
603349	2p21	Erythrocytosis, familial, 4	611783	_	3
605880	10q22.2	Genitopatellar syndrome	606170	AD	3
605880	10q22.2	SBBYSS syndrome	603736	AD	3
604370	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	Mu,AD	3
608233	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
607654	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
603005	10q23.2-q23.3	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	AR	3
607529	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
605810	3q23	Combined oxidative phosphorylation deficiency 5	611719	AR	3
605810	3q23	Ovarian dysgenesis 7	618117	AR	3
607590	4q27	Bardet-Biedl syndrome 7	615984	AR	3
607759	17q21.31	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
607759	17q21.31	Glanzmann thrombasthenia	273800	AR	3
607759	17q21.31	Thrombocytopenia, neonatal alloimmune, BAK antigen related	_	_	3
603309	7p14.1	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3
608303	19q13.12	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	617468	AR	3
605371	20q13.13	Periventricular heterotopia with microcephaly	608097	AR	3
606353	2q33.1	Primary lateral sclerosis, juvenile	606353	AR	3
603636	13q12.2	Hypotrichosis 12	615885	AD	3
607568	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
606656	2q37	Basal ganglia calcification, idiopathic, 2	606656	_	2
605795	8p12	Spermatogenic failure 25	617960	AR	3
608389	14q23.1	Branchiootic syndrome 3	608389	AD	3
605195	15q26.1	Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3
603191	21q22.3	Retinal dystrophy with macular staphyloma	617547	AR	3
603191	21q22.3	Spondylometaphyseal dysplasia, axial	602271	AR	3
608372	1q21-q23	Deafness, autosomal dominant 49	608372	AD	2
607435	17q11.2	Perrault syndrome 6	617565	AR	3
603935	1q21	{Psoriasis susceptibility 4}	603935	_	2
605047	11p15.5	?Immunodeficiency 39	616345	AR	3
607721	10q25.2	Noonan-like syndrome with loose anagen hair	607721	AD	3
607929	7p13	Cerebral cavernous malformations-2	603284	AD	3
604579	11q14.2	Exudative vitreoretinopathy 1	133780	AD	3
604579	11q14.2	Retinopathy of prematurity	133780	AD	3
608183	15q26.3	Temtamy preaxial brachydactyly syndrome	605282	AR	3
606411	20q13.12	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3
605593	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
607860	1q22	Grange syndrome	602531	AR	3
606919	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
608441	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
608441	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
605881	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
608567	3p22.2	Sick sinus syndrome 1	608567	AR	3
607944	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
606282	4q35-qter	Deafness, autosomal dominant 24	606282	AD	2
607491	20q11.21	Dowling-Degos disease 2	615327	AD	3
608002	3q22.1	Meckel syndrome 7	267010	AR	3
608002	3q22.1	Nephronophthisis 3	604387	AR	3
608002	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
603507	12p13.2	Tooth agenesis, selective, 7	616724	AD	3
603507	12p13.2	{Coronary artery disease, autosomal dominant, 2}	610947	AD	3
605431	16p13.3	Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3
608034	17p13.2	Canavan disease	271900	AR	3
602966	2p13	Orofacial cleft 2	602966	_	2
608545	6p25	Larsen-like syndrome	608545	IC	2
606483	10q24.1-q25.1	Charcot-Marie-Tooth disease, dominant intermediate A	606483	AD	2
603388	20q13.11	{Graves disease, susceptibility to, 2}	603388	_	2
605967	7q36	Acropectoral syndrome	605967	AD	2
607690	5q31.1	Chylomicron retention disease	246700	AR	3
607861	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
604580	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
604580	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
604580	14q32.12	Macular degeneration, age-related, 3	608895	AD	3
604580	14q32.12	Neuropathy, hereditary, with or without age-related macular degeneration	608895	AD	3
606397	3q25.1	Retinitis pigmentosa 61	614180	_	3
606397	3q25.1	Usher syndrome, type 3A	276902	AR	3
603531	7q22.1	MEDNIK syndrome	609313	AR	3
604616	2q24.2	Intellectual developmental disorder with autism and speech delay	606053	AD	3
608442	14q23.2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	AD	3
604519	6p21.3	{Inflammatory bowel disease 3}	604519	AD	2
608568	19q13.33	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3
608568	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
608638	3q25-q27	{Asperger syndrome susceptibility 1}	608638	IC,Mu	2
607704	9p24.3	Cerebral palsy, spastic quadriplegic, 2	612900	_	3
605262	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
608201	9q33.2	Microcephaly 3, primary, autosomal recessive	604804	AR	3
605317	7q31.1	Speech-language disorder-1	602081	AD	3
606048	19q13.42	Mental retardation, autosomal recessive 57	617188	AR	3
603335	5p15.2	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	_	3
604060	11q25-qter	Deafness, autosomal recessive 20	604060	AR	2
608755	17q25.1	?Pontocerebellar hypoplasia type 5	610204	AR	3
608755	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
608755	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
605244	2p16	Carney complex, type II	605244	_	2
604536	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
605197	2q22.2	?Hydroxykynureninuria	236800	AR	3
605197	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
607671	1p36.32-p36.13	Dystonia 13, torsion	607671	AD	2
608305	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
606471	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
608145	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
608546	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
608735	11p11.2	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3
607655	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
608845	3q11.2	?Retinitis pigmentosa 55	613575	_	3
608845	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
608845	3q11.2	{Bardet-Biedl syndrome 1, modifier of}	209900	AR,DR	3
608166	7q21.11	?CHARGE syndrome	214800	AD	3
607592	19q	{Prostate cancer aggressiveness QTL}	607592	_	2
606528	11p15-p14	Chromosome 11p15-p14 deletion syndrome	606528	AR	4
604927	18q23	Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3
606585	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
606585	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
606689	2cen-q13	Glaucoma 1B, primary open angle, adult onset	606689	_	2
604241	6p12.3	Glomerulosclerosis, focal segmental, 3	607832	_	3
604061	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
604061	17q25.3	Leukemia, acute myeloid, therapy-related	_	_	1
604061	17q25.3	Ovarian carcinoma	_	_	1
605373	1q23.3	Paragangliomas 3	605373	AD	3
606658	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
606068	2p15	Retinitis pigmentosa 28	606068	_	3
608846	19q13.33	?Spastic paraplegia 73, autosomal dominant	616282	AD	3
605632	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
605837	15q13.1	Mental retardation, autosomal recessive 38	615516	AR	3
605837	15q13.1	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3
605837	15q13.1	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3
603360	11p11.2	Peroxisome biogenesis disorder 8A (Zellweger)	614876	AR	3
603360	11p11.2	Peroxisome biogenesis disorder 8B	614877	AR	3
607182	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
607672	11q13.2	Cold-induced sweating syndrome 2	610313	AR	3
603839	2q33.1	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3
604537	6q14.1	Leber congenital amaurosis 5	604537	_	3
605120	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
608605	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
608347	17q25.3	[Pentosuria]	260800	AR	3
608656	20q13	{Prostate cancer, susceptibility to, 3}	608656	_	2
608118	1p36.11	Zinc deficiency, transient neonatal	608118	AD	3
604312	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
604312	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
605820	9p13.3	Nonaka myopathy	605820	AR	3
608756	1q25.3	Pontocerebellar hypoplasia, type 2F	617026	AR	3
608921	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
608083	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
604581	18p11.21	Spastic ataxia 5, autosomal recessive	614487	AR	3
604581	18p11.21	Spinocerebellar ataxia 28	610246	AD	3
606049	Chr.11	Acromegaloid features, overgrowth, cleft palate, and hernia	606049	_	2
604134	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
607223	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
607878	5p12	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3
604878	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
604928	4q24	Wolfram syndrome 2	604928	AR	3
608829	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
606412	1p32.3	Bartter syndrome, type 4a	602522	AR	3
606412	1p32.3	Sensorineural deafness with mild renal dysfunction	602522	AR	3
604619	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
604521	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
607532	13q21.3-q22.1	Joubert syndrome 33	617767	AR	3
608996	3q22.3	Premature ovarian failure 3	608996	AD	3
603377	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
606247	2p13.1	Microcephaly-capillary malformation syndrome	614261	AR	3
609054	17q23.2	Fanconi anemia, complementation group J	609054	_	3
606069	2q32.2	Hemochromatosis, type 4	606069	AD	3
608547	16p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	_	3
608547	16p11.2	Warfarin resistance	122700	AD	3
608236	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
603956	4p16.3	Cervical cancer, somatic	603956	_	3
608898	17q25.1	Hemophagocytic lymphohistiocytosis, familial, 3	608898	_	3
604313	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
603937	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AR,AD	3
605616	3p21.31	Hyperglycinuria	138500	AD	3
605616	3p21.31	Iminoglycinuria, digenic	242600	AR,DR	3
607864	16p13.3	?Caudal duplication anomaly	607864	_	3
603921	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
607817	8q22.2	Cohen syndrome	216550	AR	3
608757	11q12.1	Pontocerebellar hypoplasia, type 10	615803	AR	3
604217	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
608348	19q13.2	Maple syrup urine disease, type Ia	248600	AR	3
605432	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
607706	8q21.11	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	AR	3
608374	1q21.1	Hemochromatosis, type 2A	602390	AR	3
608706	15q21.3	Ciliary dyskinesia, primary, 25	615482	AR	3
608706	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
604539	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
608167	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
608167	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
607745	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
608461	9q32	Steel syndrome	615155	AR	3
606797	11q24.3	Ichthyosis, congenital, autosomal recessive 11	602400	AR	3
606070	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
606530	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
607818	10q21.2	{Nephrolithiasis, uric acid, susceptibility to}	605990	_	3
608940	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
608512	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
609162	12q13.11	Czech dysplasia	609162	AD	3
607093	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
607093	1p36.22	{Neural tube defects, susceptibility to}	601634	AR	3
607093	1p36.22	{Schizophrenia, susceptibility to}	181500	AD	3
607093	1p36.22	{Thromboembolism, susceptibility to}	188050	AD	3
607093	1p36.22	{Vascular disease, susceptibility to}	_	_	3
607707	7p13	Mental retardation, autosomal dominant 54	617799	AD	3
607693	9q22.2	Thyroid hormone metabolism, abnormal	609698	_	3
609320	9q	[Hematocrit/hemoglobin quantitative trait locus 2]	609320	_	2
605018	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
605018	16q12.1	Cylindromatosis, familial	132700	AD	3
605018	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
608758	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
604391	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
603212	3q22.1	Cataract 12, multiple types	611597	AD	3
604218	3q26.1	Encephalopathy, familial, with neuroserpin inclusion bodies	604218	AD	3
604242	13q12.13	Esophageal carcinoma, somatic	133239	_	3
608736	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
608736	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
603175	6q13-q26	{Schizophrenia}	181500	AD	2
606692	16p13.3	Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3
607834	17q11.2	{Anxiety-related personality traits}	607834	_	3
609408	14q13	Holoprosencephaly 8	609408	_	2
608830	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
608462	16q23	{Hirschsprung disease, susceptibility to, 8}	608462	_	2
606227	11q23.3	Microphthalmia, isolated 5	611040	AR	3
606227	11q23.3	Nanophthalmos 2	609549	_	3
608375	1p31.3	Parkinson disease 19a, juvenile-onset	615528	AR	3
608375	1p31.3	Parkinson disease 19b, early-onset	615528	AR	3
606798	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
609056	2p11.2	Salt and pepper developmental regression syndrome	609056	AR	3
609533	10q21.1	Deafness, autosomal recessive 23	609533	AR	3
608707	11q24.2	Holoprosencephaly 11	614226	AD	3
607300	17p13.3	Retinitis pigmentosa 13	600059	AD	3
609186	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
603213	16p11.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	AD	3
608658	7p11-q21	{Prostate cancer, susceptibility to, 4}	608658	_	2
607225	2q33.1	Spastic paralysis, infantile onset ascending	607225	AR	3
609304	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
609204	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
605704	20q13.32	Amyotrophic lateral sclerosis 8	608627	AD	3
605704	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
607439	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
608289	3q27.2	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
609321	1p21.2	?Microcephaly 14, primary, autosomal recessive	616402	AR	3
603639	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
609057	11p15.5	Nephropathy with pretibial epidermolysis bullosa and deafness	609057	_	3
608569	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
603176	13q32	{Schizophrenia}	181500	AD	2
606708	2q31	Split-hand/foot malformation 5	606708	_	2
605634	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
604931	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
609187	7p14.1	Glutaric aciduria III	231690	AR	3
604329	15q	{Hypertension, essential, susceptibility to, 2}	145500	Mu	2
608132	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
608132	14q31.3	Bardet-Biedl syndrome 8	615985	AR	3
605266	8q21.11	?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K	607831	AR,AD	3
607301	1q21.2	Retinitis pigmentosa 18	601414	AD	3
608776	11q23.1	Congenital disorder of glycosylation, type Il	608776	AR	3
609698	9q22.2	Thyroid hormone metabolism, abnormal	609698	_	3
608957	2p11.2	CD8 deficiency, familial	608957	AR	3
606268	2q35	Odontoonychodermal dysplasia	257980	AR	3
606268	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
606268	2q35	Tooth agenesis, selective, 4	150400	AR,AD	3
606873	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
605822	17q21.33	Spondyloocular syndrome	605822	AR	3
609145	1q32.1	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3
608219	6q26-q27	Deafness, autosomal recessive 38	608219	AR	2
606170	10q22.2	Genitopatellar syndrome	606170	AD	3
608850	5p15.33-p13.1	Macular dystrophy, retinal, 3	608850	AD	2
606071	12q24.11	Hereditary motor and sensory neuropathy, type IIc	606071	AD	3
608831	14q13-q21	{Restless legs syndrome 2}	608831	_	2
609058	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
604373	22q12.1	Li-Fraumeni syndrome	609265	_	3
604373	22q12.1	Osteosarcoma, somatic	259500	_	3
604373	22q12.1	{Breast and colorectal cancer, susceptibility to}	_	_	3
604373	22q12.1	{Breast cancer, susceptibility to}	114480	SMu,AD	3
604373	22q12.1	{Prostate cancer, familial, susceptibility to}	176807	SMu,AD	3
609427	6p21.31	Deafness, autosomal recessive 67	610265	AR	3
606416	1q44	CINCA syndrome	607115	AD	3
606416	1q44	Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3
606416	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
606416	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
606416	1q44	Muckle-Wells syndrome	191900	AD	3
607694	10q22.3	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3
604219	21q22.3	Cataract 9, multiple types	604219	AR,AD	3
607151	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
609014	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
608148	2q33.1	Glass syndrome	612313	AD	3
606709	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
603924	10q25.3	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3
603924	10q25.3	{Venous thromboembolism, susceptibility to}	188050	AD	3
605019	1p31.3	Hypobetalipoproteinemia, familial, 2	605019	AR	3
609739	3q13.33	Deafness, autosomal recessive 42	609646	AR	3
609283	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
606874	3p21	{Hirschsprung disease, susceptibility to, 6}	606874	_	2
607594	2q33.2	Immunodeficiency, common variable, 1	607594	AR	3
606531	5q32	{Asthma, susceptibility to}	600807	AD	3
609428	21q22	Tukel syndrome	609428	AR	2
609915	7q22.3-q31.1	Cardiomyopathy, dilated, 1Q	609915	_	2
609188	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
605705	21q22.3	Epileptic encephalopathy, early infantile, 30	616341	AD	3
607101	10p12.1	Deafness, autosomal recessive 30	607101	AR	3
607657	1p31.1	Cystathioninuria	219500	AR	3
607657	1p31.1	Homocysteine, total plasma, elevated	_	_	3
608548	1q25.3-q31.1	{Macular degeneration, age-related, 1}	603075	AD	3
606603	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
606603	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
609536	9q33.2	C5 deficiency	609536	_	3
608517	10q21.3	Cardiomyopathy, dilated, 1KK	615248	AD	3
608517	10q21.3	Cardiomyopathy, familial restrictive, 4	615248	AD	3
608517	10q21.3	Cardiomyopathy, hypertrophic, 22	615248	AD	3
608517	10q21.3	Nemaline myopathy 11, autosomal recessive	617336	AR	3
608149	14q32	Kagami-Ogata syndrome	608149	AD	4
604063	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
607152	9q	Spastic paraplegia 19, autosomal dominant	607152	AD	2
608220	6q23-q24.1	Spastic paraplegia 25, autosomal recessive	608220	AR	2
605514	10q21.1	Deafness, autosomal recessive 23	609533	AR	3
605514	10q21.1	Usher syndrome, type 1D/F digenic	601067	AR,DR	3
605514	10q21.1	Usher syndrome, type 1F	602083	AR	3
609876	21q22.13-qter	[Bone mineral density QTL 6]	609876	_	2
603178	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
608761	2q12.3	Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3
608761	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
607379	22q12.2	Meningioma, NF2-related, somatic	607174	_	3
607379	22q12.2	Neurofibromatosis, type 2	101000	AD	3
607379	22q12.2	Schwannomatosis, somatic	162091	_	3
608173	6p11	{Autoimmune thyroid disease, susceptibility to, 1}	608173	_	2
609757	7q11.23	Chromosome 7q11.23 duplication syndrome	609757	AD	4
609113	14q23.2	[Telomere length, mean leukocyte]	609113	_	2
609588	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
609588	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
605642	1q21	Thyroid carcinoma, papillary, with papillary renal neoplasia	605642	_	2
609446	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
606451	15q25-q26	Deafness, autosomal dominant 30	606451	AD	2
606417	10q26.12	Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3
608549	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
606711	16q	Specific language impairment QTL, 1	606711	Mu	2
608762	9q32-q33	{Epilepsy, idiopathic generalized, susceptibility to, 3}	608762	AR	2
604316	3q21	{Psoriasis susceptibility 5}	604316	_	2
608832	1q43	Tooth agenesis, selective, 9	617275	AD	3
604392	17p13.2	Cone-rod dystrophy	604393	AR	3
604392	17p13.2	Leber congenital amaurosis 4	604393	AR	3
604392	17p13.2	Retinitis pigmentosa, juvenile	604393	AR	3
607102	11p13	Denys-Drash syndrome	194080	SMu,AD	3
607102	11p13	Frasier syndrome	136680	SMu,AD	3
607102	11p13	Meacham syndrome	608978	_	3
607102	11p13	Mesothelioma, somatic	156240	_	3
607102	11p13	Nephrotic syndrome, type 4	256370	AD	3
607102	11p13	Wilms tumor, type 1	194070	SMu,AD	3
604330	17p11.2	Deafness, autosomal recessive 114	618456	AR	3
610004	4q25	Fibrosis of extraocular muscles, congenital, 5	616219	AR	3
610055	19p13.12	Mental retardation, autosomal recessive 3	608443	AR	3
606072	3p25.3	Rippling muscle disease 2	606072	AD	3
603381	3p14.3	Atelosteogenesis, type I	108720	AD	3
603381	3p14.3	Atelosteogenesis, type III	108721	AD	3
603381	3p14.3	Boomerang dysplasia	112310	AD	3
603381	3p14.3	Larsen syndrome	150250	AD	3
603381	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
610021	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
609681	13q31.1	Deafness and myopia	221200	AR	3
609825	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
609825	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AR,AD	3
605706	21q22.3	CHAND syndrome	214350	AR	3
605706	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
602985	1q23.3	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3
606362	19q13.33	Amelogenesis imperfecta, type IJ	617297	AR	3
603382	6p21.33	?Premature ovarian failure 13	617442	AR	3
607380	2q37.3	Senior-Loken syndrome 9	616629	AR	3
607440	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
607440	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
606875	19q12	{Hirschsprung disease, susceptibility to, 7}	606875	_	2
609826	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
607709	9q21.11	Cholestasis, progressive familial intrahepatic 4	615878	AR	3
607709	9q21.11	Hypercholanemia, familial	607748	AR	3
610181	13q14.3	Aicardi-Goutieres syndrome 2	610181	AR	3
608833	20q13.33	Dyskeratosis congenita, autosomal dominant 4	615190	AR,AD	3
608833	20q13.33	Dyskeratosis congenita, autosomal recessive 5	615190	AR,AD	3
608833	20q13.33	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373	AD	3
609842	15q24.1	?Mental retardation, autosomal recessive 50	616460	AR	3
608135	9q22.31	{Lumbar disc degeneration}	603932	_	3
608135	9q22.31	{Osteoarthritis susceptibility 3}	607850	AD	3
610248	20q13.2-q13.3	Deafness, autosomal recessive 65	610248	AR	2
606799	5q12	{Stroke, susceptibility to, 1}	606799	_	2
605841	4p13-q21	Narcolepsy 2	605841	_	2
609306	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
606230	22q13.33	Phelan-McDermid syndrome	606232	AD	3
606230	22q13.33	{Schizophrenia 15}	613950	AD	3
608174	5q31-q33	{Autoimmune thyroid disease, susceptibility to, 2}	608174	_	2
605799	14q32.32	Megaloblastic anemia-1, Norwegian type	261100	AR	3
608088	3p24-p22	Neuropathy, hereditary sensory, type IB	608088	AD	2
607949	2q35	{Tuberculosis, susceptibility to}	607949	_	2
604229	11p13	Anterior segment dysgenesis 5, multiple subtypes	604229	_	3
609225	7p22.1	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3
607696	17q25.1	Usher syndrome, type 1G	606943	AR	3
608552	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
604317	19q13.12	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3
603383	7q36.1	Glaucoma 1, open angle, F	603383	_	3
609741	22q11.23	Cataract 22	609741	AR,AD	3
610005	3q26.2-q26.3	Mental retardation, autosomal recessive 54	617028	AR	3
606712	19q	Specific language impairment QTL, 2	606712	Mu	2
606453	4q31.3	Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3
605515	3p13	Mental retardation with language impairment and with or without autistic features	613670	AD	3
608136	8p23.3	?Slowed nerve conduction velocity, AD	608236	AD	3
607270	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
609059	11p15.5	Neutral lipid storage disease with myopathy	610717	AR	3
610438	9p24-p22	{Restless legs syndrome 3}	610438	_	2
610299	1p13.3	Mental retardation, autosomal recessive 48	616269	AR	3
609226	17q25.3	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3
610282	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
610090	17q21.32	Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3
609307	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
609570	5q21	{Migraine, susceptibility to, 8}	609570	_	2
610057	19p13.12	Mental retardation, autosomal recessive 14	614020	AR	3
604201	6q22-q23	{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}	604201	_	2
604377	22q13.33	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	AR	3
605218	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
610439	2q33	{Restless legs syndrome 4}	610439	_	2
606713	1p36.11	Van der Woude syndrome 2	606713	AD	3
609397	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
604319	14q12	Dyskeratosis congenita, autosomal dominant 3	613990	AD	3
604319	14q12	Revesz syndrome	268130	AD	3
609227	2q37.3	Griscelli syndrome, type 3	609227	AR	3
607154	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
609017	1p34.2	[Blood group, Radin]	111620	_	3
609017	1p34.2	[Blood group, Scianna system]	111750	_	3
607596	14q32.2	Pontocerebellar hypoplasia type 1A	607596	AR	3
608222	22q13.1	Adenylosuccinase deficiency	103050	AR	3
607697	11p15.4	Charcot-Marie-Tooth disease, type 4B2	604563	AR	3
603941	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
608558	16p13	[Body mass index QTL5]	608558	_	2
610381	19p13.3	Cone-rod dystrophy 11	610381	AD	3
610320	1p36	Myopia 14	610320	_	2
606418	1p32.3	Desmosterolosis	602398	AR	3
609644	14q21.2	?Premature ovarian failure 15	618096	AR	3
609644	14q21.2	Spermatogenic failure 28	618086	AR	3
610250	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
610206	20p13	Corneal dystrophy, Fuchs endothelial, 4	613268	_	3
610206	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
610206	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
605882	17q23.2	Fanconi anemia, complementation group J	609054	_	3
605882	17q23.2	{Breast cancer, early-onset, susceptibility to}	114480	SMu,AD	3
610283	1q22	Cone-rod dystrophy 10	610283	AR	3
605828	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
603317	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
603317	12q21.31	Deafness, autosomal recessive 84A	613391	AR	3
608765	8q12	{Scoliosis, isolated, susceptibility to, 3}	608765	_	2
607304	2p12	Cataract 27, nuclear progressive	607304	_	2
602987	7p14.3	?Deafness, autosomal dominant 74	618140	AD	3
607764	16p11.2	Bile acid synthesis defect, congenital, 1	607765	AR	3
603942	3q24	?Glycogen storage disease XV	613507	AR	3
603942	3q24	Polyglucosan body myopathy 2	616199	AR	3
609308	9q34.13	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3
610092	14q24.3	Microphthalmia with coloboma 3	610092	_	3
609649	3p24-p21.2	Trichilemmal cyst 1	609649	AD	2
606419	19q13.42	Retinitis pigmentosa 11	600138	AD	3
605516	10q22.1	Deafness, autosomal recessive 12	601386	AR	3
605516	10q22.1	Usher syndrome, type 1D	601067	AR,DR	3
605516	10q22.1	Usher syndrome, type 1D/F digenic	601067	AR,DR	3
605516	10q22.1	{Pituitary adenoma 5, multiple types}	617540	AD	3
609115	4q21.22	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3
609520	8p11.21	Dystonia 6, torsion	602629	AD	3
610284	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
607271	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
606232	22q13.33	Phelan-McDermid syndrome	606232	AD	3
609898	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
608852	6q21-q22	{Pulmonary function}	608852	_	2
608778	17q21.2	Spermatogenic failure 11	615081	AD	3
608137	9q34.3	Hypogonadotropic hypogonadism 9 with or without anosmia	614838	AD	3
605219	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
609018	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
606800	17q25.3	Glycogen storage disease II	232300	AR	3
607765	16p11.2	Bile acid synthesis defect, congenital, 1	607765	AR	3
610651	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
608559	20pter-p11.2	[Body mass index QTL6]	608559	_	2
607155	19q13.32	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3
609591	1q22	Noonan syndrome 8	615355	AD	3
605020	20p11.21	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	_	3
605020	20p11.21	Keratoconus 1	148300	AD	3
604202	22q11.21	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3
607951	11q21	Mosaic variegated aneuploidy syndrome 2	614114	AR	3
604320	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
610339	1p34.2	Osteogenesis imperfecta, type VIII	610915	AR	3
602974	9p13.3	[Glycerol quantitative trait locus]	614411	AR	3
608465	9q34.13	Amyotrophic lateral sclerosis 4, juvenile	602433	AD	3
608465	9q34.13	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3
607381	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
609884	8q22.1	?RHYNS syndrome	602152	AR	3
609884	8q22.1	COACH syndrome	216360	AR	3
609884	8q22.1	Joubert syndrome 6	610688	AR	3
609884	8q22.1	Meckel syndrome 3	607361	AR	3
609884	8q22.1	Nephronophthisis 11	613550	AR	3
609884	8q22.1	{Bardet-Biedl syndrome 14, modifier of}	615991	AR	3
604649	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
610774	6p21.1	Epileptic encephalopathy, early infantile, 60	617929	AR	3
610265	6p21.31	Deafness, autosomal recessive 67	610265	AR	3
610130	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
609286	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
610938	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
610285	4p16.3	?Fetal akinesia deformation sequence 3	618389	_	3
610285	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
610652	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
610652	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
604544	3p21.31	?Hydrops, lactic acidosis, and sideroblastic anemia	617021	AR	3
604544	3p21.31	Perrault syndrome 4	615300	AR	3
609927	8p22	Spastic paraplegia 53, autosomal recessive	614898	AR	3
605844	13q12-q14	{Dermatitis, atopic, susceptibility to, 5}	605844	_	2
609701	17q21.2	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3
609701	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
610455	7q21.2	Tumoral calcinosis, familial, normophosphatemic	610455	AR	3
610612	1q32.3	Leber congenital amaurosis 12	610612	AR	3
604139	2q35	Spinal muscular atrophy, distal, autosomal recessive, 5	614881	AR	3
609469	11q24	Nephropathy, progressive, with deafness	609469	_	2
610321	15q12	{Prostate cancer, hereditary, 7}	610321	_	2
609572	13q31.3	Photoparoxysmal response 2	609572	_	2
610253	9q34.3	Kleefstra syndrome 1	610253	AD	3
609845	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
608176	10q	{Autoimmune thyroid disease, susceptibility to, 4}	608176	_	2
609309	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
609309	2p21-p16	Mismatch repair cancer syndrome	276300	AR	3
609309	2p21-p16	Muir-Torre syndrome	158320	AD	3
609573	7q32	Photoparoxysmal response 3	609573	_	2
610538	1q32.1	Fanconi anemia, complementation group T	616435	AR	3
606252	11q24.2	{Bacteremia, protection against}	614382	_	3
606252	11q24.2	{Malaria, protection against}	611162	_	3
606252	11q24.2	{Pneumococcal disease, invasive, protection against}	610799	_	3
606252	11q24.2	{Tuberculosis, protection against}	607948	_	3
607554	11p15.5-p15.4	Atrial fibrillation, familial, 3	607554	AD	3
610613	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
610613	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
609192	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
608958	20q13.12	Adenosine deaminase deficiency, partial	102700	AR,SMo	3
608958	20q13.12	Severe combined immunodeficiency due to ADA deficiency	102700	AR,SMo	3
608836	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
609310	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
610185	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
610006	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
609539	12q12	Coffin-Siris syndrome 6	617808	AD	3
605622	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
610303	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
610107	14q11.2	Galloway-Mowat syndrome 3	617729	AR	3
610687	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
607598	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
604321	15q15.1	Microcephaly 4, primary, autosomal recessive	604321	AR	3
608779	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
609400	4q13-q21	{Autoimmune disease, susceptibility to, 4}	609400	_	2
610991	2q35	3-M syndrome 2	612921	AR	3
608837	17p13.1	Carney complex variant	608837	_	3
611154	1q25	{Alzheimer disease-14}	611154	_	2
610883	17p11.2	Potocki-Lupski syndrome	610883	IC	4
610598	17q25.1	Retinitis pigmentosa 36	610599	_	3
610758	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
609116	10q26	[Respiratory rhythmicity in sleep]	609116	_	2
605802	2q22.3	Mowat-Wilson syndrome	235730	AD	3
604933	1p34.1	Adenomas, multiple colorectal	608456	AR	3
604933	1p34.1	Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas	132600	SMu	3
604933	1p34.1	Gastric cancer, somatic	613659	_	3
610956	1q25.1	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3
609311	12p11.21	Charcot-Marie-Tooth disease, type 4H	609311	AR	3
610688	8q22.1	Joubert syndrome 6	610688	AR	3
605021	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
605803	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
610759	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
609541	11q13.2	Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3
611155	3q22-q24	{Alzheimer disease-15}	611155	_	2
610957	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
604233	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
608224	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
607273	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
607273	17p11.2	Colorectal cancer, somatic	114500	_	3
607273	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
607273	17p11.2	Renal carcinoma, chromophobe, somatic	144700	_	3
610635	8q22.3	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
610760	2p24-p22	[Cholesterol level QTL 2]	610760	_	2
609720	9q33.3	Focal segmental glomerulosclerosis 9	616220	AR	3
609720	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
609761	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
604882	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
610599	17q25.1	Retinitis pigmentosa 36	610599	_	3
611274	15q22-q24	Glaucoma 1, open angle, N	611274	_	2
603384	6p21.32	Mental retardation, autosomal dominant 5	612621	AD	3
604416	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
603930	14q23.3-q24.1	Molybdenum cofactor deficiency C	615501	AR	3
607306	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
610131	17q23.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3
606718	5q32	Achondrogenesis Ib	600972	AR	3
606718	5q32	Atelosteogenesis, type II	256050	AR	3
606718	5q32	De la Chapelle dysplasia	256050	AR	3
606718	5q32	Diastrophic dysplasia	222600	AR	3
606718	5q32	Diastrophic dysplasia, broad bone-platyspondylic variant	222600	AR	3
606718	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
608780	6q25.3	Trichothiodystrophy 3, photosensitive	616395	_	3
608977	3q26.33	3-methylglutaconic aciduria, type V	610198	AR	3
611543	12q13.2	Cavitary optic disc anomalies	611543	AD	3
604395	14q24.3	Colorectal cancer, hereditary nonpolyposis, type 7	614385	_	3
604395	14q24.3	Colorectal cancer, somatic	114500	_	3
604395	14q24.3	{Endometrial cancer, susceptibility to}	608089	_	3
606438	16q24.2	Huntington disease-like 2	606438	AD	3
610942	9q21.12	?Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3
610906	1p31	{Asthma-related traits, susceptibility to, 4}	610906	_	2
606719	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
602978	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
610456	7q21.2	MIRAGE syndrome	617053	AD	3
610456	7q21.2	Tumoral calcinosis, familial, normophosphatemic	610455	AR	3
611276	2p16-p15	Glaucoma 1, open angle, H	611276	_	2
609118	3q26.1	Cerebral cavernous malformations 3	603285	_	3
611644	4q31.3-q32.3	{Hirschsprung disease, susceptibility to, 9}	611644	_	2
610110	11p14.3-p14.2	Dystonia 24	615034	AD	3
611458	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
611458	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
611458	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
611458	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
610852	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
611087	17q23.3	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3
610761	3q24-q26	[High density lipoprotein cholesterol level QTL 5]	610761	_	2
610187	8q23.1	Diaphragmatic hernia 3	610187	_	3
610313	11q13.2	Cold-induced sweating syndrome 2	610313	AR	3
608978	11p13	Meacham syndrome	608978	_	3
611258	9q22.33	Cataract 36	613887	AR	3
610044	1q31.3	?Epileptic encephalopathy, early infantile, 57	617771	AD	3
609019	3p25.1	Biotinidase deficiency	253260	AR	3
611604	10q24.31	Spastic paraplegia 62	615681	AR	3
608781	1q21-q22	{Asperger syndrome susceptibility 3}	608781	_	2
611390	2q33.1	Spastic ataxia 3, autosomal recessive	611390	AR	3
611562	16p13.3	Spermatogenic failure 10	614822	AD	3
610978	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
610188	12q21.32	Joubert syndrome 5	610188	AR	3
606157	20p13	HARP syndrome	607236	AR	3
606157	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
611773	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
611605	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
611492	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
610045	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
608562	7q22	Polydactyly, postaxial, type A4	608562	_	2
611407	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
610992	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
608226	10q26.11	Spermatogenic failure 12	615413	AD	3
610908	12q14.2	{Autism susceptibility 13}	610908	_	2
609903	13q32	{Systemic lupus erythematosus, susceptibility to, 5}	609903	_	2
611960	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
611493	21q22.11	Atrial fibrillation, familial, 4	611493	_	3
611408	6q14.1	Leber congenital amaurosis 5	604537	_	3
606255	6q24-q25	{Stature QTL 1}	606255	_	2
611936	3q29	Chromosome 3q29 microduplication syndrome	611936	AD	4
611528	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
607601	19p13.3	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AR,AD	3
611494	4q25	{Atrial fibrillation, familial, 5}	611494	_	2
610189	12q21.32	Senior-Loken syndrome 6	610189	AR	3
611738	20p12.3	{Osteoporosis}	166710	AD	2
611409	15q12-q13	Albinism, brown oculocutaneous	203200	AR	3
611409	15q12-q13	Albinism, oculocutaneous, type II	203200	AR	3
611409	15q12-q13	[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	AR	3
611409	15q12-q13	[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	AR	3
611812	1p36.12	?SERKAL syndrome	611812	AR	3
611495	19p13.12	Ichthyosis, congenital, autosomal recessive 5	604777	AR	3
609706	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
611410	6p22.3	?Deafness, autosomal recessive 104	616515	AR	3
612228	20q11.22	{Stature QTL 14}	612228	_	2
608782	8q22.1	Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3
610539	10q22.1	Gaucher disease, atypical	610539	_	3
611496	20q13.33	Congenital heart defects, multiple types, 5	617912	AR,AD	3
611775	19q13.2	{Kawasaki disease, susceptibility to}	611775	_	3
611884	7p15.3	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3
612245	7q32.1	{Inflammatory bowel disease 14}	612245	_	3
612012	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
606439	14q22.1	Neuropathy, hereditary sensory, type ID	613708	AD	3
606439	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
610048	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
612280	1p36.11	Fucosidosis	230000	AR	3
611497	17q21.31	?Osteopetrosis, autosomal recessive 6	611497	AR	3
611938	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
602991	17q22	Brachydactyly, type B2	611377	AD	3
602991	17q22	Multiple synostoses syndrome 1	186500	AD	3
602991	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
602991	17q22	Symphalangism, proximal, 1A	185800	AD	3
602991	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
611332	7q36.3	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511	AD	3
606158	11q12.3	Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3
606158	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
606158	11q12.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
606158	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
611606	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
610540	20q13.32	Pseudohypoparathyroidism, type IB	603233	AD	3
609029	22q11.2	Emanuel syndrome	609029	ICB	4
612013	4p15.32	COACH syndrome	216360	AR	3
612013	4p15.32	Joubert syndrome 9	612285	AR	3
612013	4p15.32	Meckel syndrome 6	612284	AR	3
612319	16q23.1	Spastic paraplegia 35, autosomal recessive	612319	AR	3
611391	20p12.1	Cataract 33, multiple types	611391	AR,AD	3
609617	1p36.11	Zinc deficiency, transient neonatal	608118	AD	3
611045	17q21.31	Dursun syndrome	612541	AR	3
611045	17q21.31	Neutropenia, severe congenital 4, autosomal recessive	612541	AR	3
611776	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
606440	15q15.3	Deafness, autosomal recessive 16	603720	AR	3
611279	1q32.1	?Meckel syndrome 12	616258	AR	3
611279	1q32.1	Microcephaly 20, primary, autosomal recessive	617914	AR	3
612399	19p13.3	Preimplantation embryonic lethality	616814	AR	3
611565	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
612074	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
606256	7q31.3	{Stature QTL 2}	606256	_	2
612229	18q21.1	{Colorectal cancer, susceptibility to, 3}	612229	_	3
612123	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
612433	1q43-q44	Deafness, autosomal recessive 45	612433	AR	2
611046	8q12-q13	{Mycobacterium tuberculosis, susceptibility to, 2}	611046	_	2
610190	19q13.11	?Peeling skin syndrome 3	616265	AR	3
612014	2q24.3	Nephronophthisis 12	613820	AR,AD	3
612014	2q24.3	Short-rib thoracic dysplasia 4 with or without polydactyly	613819	AR	3
612263	20q11.2	{Melanoma, cutaneous malignant, 7}	612263	_	2
612230	10p14	{Colorectal cancer, susceptibility to, 5}	612230	_	2
612400	20q11.22	{Osteoarthritis-5}	612400	_	3
611777	3p22.3	Brugada syndrome 2	611777	_	3
612599	5q31.1-q33.1	{Psoriasis susceptibility 11}	612599	_	2
612124	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
610982	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
610982	14q32.33	Glomerulosclerosis, focal segmental, 5	613237	_	3
612015	3p21.1	Congenital disorder of glycosylation, type In	612015	AR	3
609148	6p21.33	{Malaria, mild, susceptibility to}	609148	_	3
612656	5p13.2	Episodic ataxia, type 6	612656	AD	3
609853	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
612691	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
607664	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
609708	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
609708	8p21.3	Lipoprotein lipase deficiency	238600	AR	3
609708	8p21.3	[High density lipoprotein cholesterol level QTL 11]	238600	AR	3
612517	14q21.3	Ciliary dyskinesia, primary, 10	612518	_	3
606441	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
606441	2p13.1	{Parkinson disease 13}	610297	_	3
612372	12p13.3	{Major affective disorder-9, susceptibility to}	612372	_	2
612761	4q22.3	Adermatoglyphia	136000	AD	3
612761	4q22.3	Basan syndrome	129200	AD	3
612761	4q22.3	Huriez syndrome	181600	AD	3
612469	11p13-p12	WAGRO syndrome	612469	_	4
612728	1p33-p32	[Bone mineral density QTL 14]	612728	_	2
610316	2p16.1	Combined oxidative phosphorylation deficiency 13	614932	AR	3
610316	2p16.1	Deafness, autosomal recessive 70	614934	AR	3
610984	4q25	Complement factor I deficiency	610984	AR	3
612692	17q23.3	Agammaglobulinemia 6	612692	AR	3
612657	4p15.32	Cone-rod dystrophy 12	612657	_	3
612674	20p11.21	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	AR	3
612401	3p24.3	{Osteoarthritis susceptibility 6}	612401	_	2
612373	10q22.1	Histiocytosis-lymphadenopathy plus syndrome	602782	AR	3
612632	15q22-q23	Usher syndrome, type 1H	612632	_	2
612781	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
612798	6p24.1	Question mark ears, isolated	612798	AD	3
611282	10q24.2	Cataract 48	618415	AR	3
607556	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
607556	2q37.3	Barber-Say syndrome	209885	AD	3
607556	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
612931	7p13	Glycogen storage disease X	261670	AR	3
610419	19p13.2	Deafness, autosomal recessive 68	610419	AR	3
612878	11q22.3	Epidermolysis bullosa, nonspecific, autosomal recessive	615028	AR	3
611263	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
612247	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
612862	6p21.3	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}	612862	_	2
612231	8q23	{Colorectal cancer, susceptibility to, 6}	612231	_	2
611778	3p22.3	Brugada syndrome 2	611777	_	3
609402	2p25	Preeclampsia/eclampsia 2	609402	_	2
607557	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
612932	17p13.2	?Glycogen storage disease XIII	612932	AR	3
612729	8q23	[Lean body mass QTL 1]	612729	_	2
612633	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
612016	1q42.13	Coenzyme Q10 deficiency, primary, 4	612016	AR	3
613031	20q13.33	{Glioma susceptibility 6}	613031	_	2
607786	1p32.3	Hypercholesterolemia, familial, 3	603776	AD	3
607786	1p32.3	{Low density lipoprotein cholesterol level QTL 1}	603776	AD	3
612374	5q31.2	STING-associated vasculopathy, infantile-onset	615934	AD	3
611816	1q32.2	Temple-Baraitser syndrome	611816	AD	3
612991	2p23.3	Shashi-Pena syndrome	617190	AD	3
605479	2q31.1	Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3
612975	12p12.1	[Short sleeper]	612975	AD	3
612863	6q24-q25	Chromosome 6q25-q25 deletion syndrome	612863	_	4
613014	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
612017	11q14-q22	Pyloric stenosis, infantile hypertrophic, 3	612017	_	2
612095	4p15.32	Retinitis pigmentosa 41	612095	AR	3
612799	16p12.2	Combined oxidative phosphorylation deficiency 12	614924	AR	3
613093	10q23.33	Cone dystrophy 4	613093	AR	3
613071	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
612837	16q21	Coenzyme Q10 deficiency, primary, 5	614654	AR	3
612232	11q23	{Colorectal cancer, susceptibility to, 7}	612232	_	2
612634	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
612126	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
610420	14q11.2-q12	Preauricular tag, isolated, autosomal dominant, 1	610420	AD	2
609403	9p13	Preeclampsia/eclampsia 3	609403	_	2
607604	9p24.2	Retinal cone dystrophy 3B	610356	AR	3
605480	4p16-p15.2	{Systemic lupus erythematosus, susceptibility to, 3}	605480	_	2
613032	8q24.21	{Glioma susceptibility 7}	613032	_	2
613015	6p22	{Neuroblastoma, susceptibility to, 4}	613015	_	2
613055	16q22	Atrial fibrillation, familial, 8	613055	_	2
612018	10q23.31	Cataract 47, juvenile, with microcornea	612018	AD	3
609033	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
612635	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
613094	8q22.1	Microphthalmia, isolated 4	613094	_	3
612881	5q14.3-q15	Periventricular nodular heterotopia 5	612881	_	4
605804	20p	{Dermatitis, atopic, susceptibility to, 3}	605804	_	2
610947	12p13.2	{Coronary artery disease, autosomal dominant, 2}	610947	AD	3
612233	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
612034	19p13.3	?Sotos syndrome 3	617169	AR	3
608786	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
612782	12q24.31	Immunodeficiency 9	612782	AR	3
610199	9p24.2	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	AR	3
613111	20q13.12	Galactosialidosis	256540	AR	3
612712	14q24.1	Leber congenital amaurosis 13	612712	AR,AD	3
609712	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
609712	1q22	Pyruvate kinase deficiency	266200	AR	3
612471	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
610093	14q24.3	Microphthalmia, isolated 2	610093	_	3
612096	9p13.1-q21.11	Otosclerosis 8	612096	AD	2
610053	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
611611	15q24.3	Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3
613180	22q11.21	Cortical dysplasia, complex, with other brain malformations 8	613180	AR	3
610948	3p14.1-q12.3	{Hypertension, essential, susceptibility to, 7}	610948	_	2
613145	1q21-q23	{Systemic lupus erythematosus, susceptibility to, 14}	613145	_	2
605481	1q31.3	Microcephaly 5, primary, autosomal recessive	608716	AR	3
613270	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
612783	11p15.4	Immunodeficiency 10	612783	AR	3
605805	17q25.3	{Dermatitis, atopic, susceptibility to, 4}	605805	_	2
613112	20q13.32	Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	AD	3
613219	7p15-p13	[Birth weight QTL 1]	613219	_	2
613219	7p15-p13	[Fasting plasma glucose level QTL 2]	613219	_	2
613236	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
612452	17q21.31	Koolen-De Vries syndrome	610443	AD	3
607788	2p21	Factor V and factor VIII, combined deficiency of	613625	_	3
611888	19q13.2	Chitayat syndrome	617180	AD	3
611888	19q13.2	Craniosynostosis 4	600775	AD	3
612800	13q34	Combined oxidative phosphorylation deficiency 27	616672	AR	3
607955	6q24.3-q25.1	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3
607955	6q24.3-q25.1	Dyschromatosis universalis hereditaria 1	127500	AD	3
613095	4q22.1	Polycystic kidney disease 2	613095	AD	3
611705	2q31.2	Salih myopathy	611705	AR	3
611908	3p21.1	Congenital disorder of glycosylation, type In	612015	AR	3
610422	3q26.2-q26.31	Alopecia-mental retardation syndrome 2	610422	AR	2
609312	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
612035	6p21.1	Combined oxidative phosphorylation deficiency 8	614096	AR	3
612035	6p21.1	Leukoencephalopathy, progressive, with ovarian failure	615889	AR	3
613016	2q35	{Neuroblastoma, susceptibility to, 5}	613016	_	2
612713	4q12	Kahrizi syndrome	612713	AR	3
613290	6p22.3	{?Hearing loss, cisplatin-induced, susceptibility to}	613290	_	2
609855	17q21.2	Neurodegeneration with brain iron accumulation 6	615643	AR	3
609855	17q21.2	Pontocerebellar hypoplasia, type 12	618266	AR	3
613163	16p13.2	GABA-transaminase deficiency	613163	AR	3
610949	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
612020	19p13.2	Spastic paraplegia 39, autosomal recessive	612020	AR	3
611966	8q24.3	Mental retardation, autosomal recessive 13	613192	AR	3
613271	9p24.1-p22.1	Corneal dystrophy, Fuchs endothelial, 7	613271	_	2
607606	17q21.2	Palmoplantar keratoderma, epidermolytic	144200	AD	3
611706	10q22-q23	{Migraine, with or without aura, susceptibility to, 12}	611706	AD	2
613096	12q23-q24	Spastic paraplegia 36, autosomal dominant	613096	AD	2
613146	15q25.1	EDICT syndrome	614303	AD	3
609313	7q22.1	MEDNIK syndrome	609313	AR	3
613435	10p13	Amyotrophic lateral sclerosis 12	613435	_	3
612994	4p15.33	Cone-rod dystrophy 18	615374	AR	3
610423	14q32.33	Epileptic encephalopathy, early infantile, 66	618067	AD	3
609620	7q36.1	Short QT syndrome 1	609620	_	3
613033	5p15.33	{Glioma susceptibility 8}	613033	_	2
613401	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
612714	20q11.21	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	AR	3
613072	18q21.1	Deafness, autosomal recessive 77	613079	AR	3
613291	13q33.1	Bile acid malabsorption, primary	613291	AR	3
613418	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
613237	14q32.33	Glomerulosclerosis, focal segmental, 5	613237	_	3
613058	1q42	{Basal cell carcinoma, susceptibility to, 2}	613058	_	2
611124	4q28.2	Ceroid lipofuscinosis, neuronal, 7	610951	AR	3
611124	4q28.2	Macular dystrophy with central cone involvement	616170	AR	3
613471	1q42.12	?Reynolds syndrome	613471	AD	3
613529	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613529	15q21.1	Seckel syndrome 5	613823	AR	3
610132	1p13.1	Caudal regression syndrome	600145	AD	3
610132	1p13.1	{Neural tube defects, susceptibility to}	182940	AD	3
612036	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
613581	3q12.3	Retinitis pigmentosa 56	613581	AR	3
606187	10p13	Alzheimer disease-7	606187	_	2
613547	16q24	{Stature QTL 22}	613547	_	2
612021	8q21.3	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3
613017	1q21.1	{Neuroblastoma, susceptibility to, 6}	613017	_	2
612251	7q32.1	{Systemic lupus erythematosus, susceptibility to, 10}	612251	_	3
613436	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
612866	1p21.3	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3
611531	12p13.31	Bowen-Conradi syndrome	211180	AR	3
612386	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
613690	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
613402	19q13.33	Microcephaly, seizures, and developmental delay	613402	AR	3
610951	4q28.2	Ceroid lipofuscinosis, neuronal, 7	610951	AR	3
613238	2q36.1-q36.3	{Spondyloarthropathy, susceptibility to, 3}	613238	_	2
609621	11p15.5-p15.4	Short QT syndrome 2	609621	AD	3
607560	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
606460	6q21	[Longevity 2]	606460	_	2
613113	17q11.2	Leukemia, juvenile myelomonocytic	607785	SMu,AD	3
613113	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
613113	17q11.2	Neurofibromatosis, type 1	162200	AD	3
613113	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
613113	17q11.2	Watson syndrome	193520	AD	3
613752	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
608742	12p12.2-p12.1	{Hypertension, essential, susceptibility to, 4}	145500	Mu	2
613453	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
613564	2p12-p11.2	Chromosome 2p12-p11.2 deletion syndrome	613564	_	4
613255	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
613582	17q25.3	Retinitis pigmentosa 57	613582	AR	3
610489	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
611818	3p25.3	Long QT syndrome 9	611818	AD	3
611398	17q12	?Ciliary dyskinesia, primary, 41	618449	AR	3
611192	16q24.3	KBG syndrome	148050	AD	3
611060	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
611060	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
613059	5p15.33	{Basal cell carcinoma, susceptibility to, 3}	613059	_	2
613715	13q12.2	Treacher Collins syndrome 2	613717	AR,AD	3
613857	1p33	Orofacial cleft 13	613857	AD	2
612356	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
613548	1p32	{Stature QTL 23}	613548	_	2
613325	19p13.2	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3
611910	10q23.31	Cataract 47, juvenile, with microcornea	612018	AD	3
613798	3q26.33	Ciliary dyskinesia, primary, 14	613807	_	3
613815	6p21.33	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	AR	3
613815	6p21.33	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	AR	3
612387	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
613239	17p11.2	{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	AD	3
609622	17q24.3	Short QT syndrome 3	609622	_	3
613420	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
613769	10q23.1	Retinitis pigmentosa 44	613769	_	3
610997	17q21-q22	{Prostate cancer, hereditary, 9}	610997	_	2
613673	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
613293	5q35.1	Frank-ter Haar syndrome	249420	AR	3
613148	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
611290	2q35	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	_	3
613891	3q21.2	Orotic aciduria	258900	AR	3
613381	21q22.3	Homocystinuria, B6-responsive and nonresponsive types	236200	AR	3
613381	21q22.3	Thrombosis, hyperhomocysteinemic	236200	AR	3
611890	9q34.11	Congenital arthrogryposis with anterior horn cell disease	611890	AR	3
612098	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
613858	2q37.1	Microphthalmia, isolated 6	613517	AR	3
612357	10q21	{Major affective disorder-8, susceptibility to}	612357	_	2
613454	14q12	Rett syndrome, congenital variant	613454	AD	3
612474	1q21.1	Chromosome 1q21.1 deletion syndrome	612474	IC,AD	4
612933	11p15.1	Glycogen storage disease XI	612933	AR	3
613276	16q21	Poikiloderma with neutropenia	604173	AR	3
607791	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
612238	9q31.2-q34.2	{Scoliosis, idiopathic, susceptibility to, 4}	612238	_	2
613874	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
613530	3p25.1-p23	Muscular dystrophy, limb-girdle, type 1H	613530	AD	2
611073	8p12-q22	{Alzheimer disease 12}	611073	_	2
613403	2q11.2	{Pheochromocytoma, susceptibility to}	171300	AD	3
613549	2p16	{Stature QTL 24}	613549	_	2
614009	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
611978	1q25.1	?Combined oxidative phosphorylation deficiency 38	618378	AR	3
614034	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
613674	8q11.23	Vesicoureteral reflux 3	613674	AD	3
611911	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
613183	2p13.1	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3
613382	12p11.22	Brachydactyly, type E2	613382	AD	3
610502	6q21	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	616732	AR	3
612099	9p21	Trichoepithelioma, multiple familial, 2	612099	_	2
614098	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
613404	14q24.3	Arthrogryposis, renal dysfunction, and cholestasis 2	613404	AR	3
611126	3q21.3	Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3
612636	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
611820	7q21.2	?Long QT syndrome-11	611820	AD	3
612388	10q22.3	{Sarcoidosis, susceptibility to, 3}	612388	_	2
612475	1q21.1	Chromosome 1q21.1 duplication syndrome	612475	IC,AD	4
614074	11p15.1	Hermansky-Pudlak syndrome 5	614074	AR	3
613036	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
614231	18q21.1	Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3
613061	12q13	{Basal cell carcinoma, susceptibility to, 4}	613061	_	2
614187	14q31	Hypertelorism, preauricular sinus, punctal pits, and deafness	614187	AD	2
612239	17q25.3	{Scoliosis, idiopathic, susceptibility to, 5}	612239	_	2
612997	11q13.1	Spermatogenic failure 7	612997	AR	3
612253	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
613326	8q22.3	Dihydropyrimidinuria	222748	AR	3
610954	18q21.2	Pitt-Hopkins syndrome	610954	AD	3
614254	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
611801	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
613204	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
609122	1p36.13-p34.3	Aneurysm, intracranial berry, 3	609122	AD	2
614035	21q22.13	Deafness, autosomal recessive 29	614035	AR	3
613860	1p36.11	Immunodeficiency due to ficolin 3 deficiency	613860	AR	3
612801	1q41	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007	AR	3
610762	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
614151	16q23.1	?Fanconi anemia, complementation group W	617784	AR	3
610432	18q12.1	Tenorio syndrome	616260	AD	3
611783	2p21	Erythrocytosis, familial, 4	611783	_	3
612417	22q13	{Narcolepsy 4}	612417	_	2
612732	3q11.2	Coproporphyria	121300	AD	3
612732	3q11.2	Harderoporphyria	121300	AD	3
613257	1q32.1	Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3
612389	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
606190	1p11	Meningioma, radiation-induced	606190	_	2
611376	8q23-q24	Mungan syndrome	611376	AR	2
612358	3q27.3	[High molecular weight kininogen deficiency]	228960	AR	3
612358	3q27.3	[Kininogen deficiency]	228960	AR	3
610988	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
613717	13q12.2	Treacher Collins syndrome 2	613717	AR,AD	3
614168	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
612254	8p23.1	{Systemic lupus erythematosus, susceptibility to, 12}	612254	_	2
613327	17q21.2	Lipodystrophy, congenital generalized, type 4	613327	AR	3
612868	12q21.33	Corneal dystrophy, posterior amorphous	612868	AD	4
614134	6q13	Stickler syndrome, type IV	614134	_	3
614058	2p23.3	[Fructosuria]	229800	AR	3
613976	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
613940	4q28.1	Epilepsy, hearing loss, and mental retardation syndrome	616577	AR	3
613583	19q13.12	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	AR	3
612637	3q26.2-q26.33	Febrile seizures, familial, 10	612637	_	2
613826	14q11.2	Leber congenital amaurosis 6	613826	_	3
614171	15q21.1	?Hermansky-pudlak syndrome 9	614171	AR	3
610098	6q22.31	Ovarian dysgenesis 4	616185	AR	3
614326	13q31.3	Feingold syndrome 2	614326	AD	3
612390	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
612998	6q25.2	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	AD	3
613277	11q12.2	Joubert syndrome 2	608091	AR	3
613277	11q12.2	Meckel syndrome 2	603194	AR	3
614152	12q24.31	Deafness, autosomal dominant 64	614152	AD	3
611089	3p25.3	{Centronuclear myopathy, autosomal, modifier of}	160150	AD	3
612584	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
614075	10q24.32	Hermansky-Pudlak syndrome 6	614075	AR	3
613862	2q13	Retinitis pigmentosa 38	613862	AR	3
614232	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
613756	4p12	Retinitis pigmentosa 49	613756	_	3
614327	3p21.1	Tumor predisposition syndrome	614327	AD	3
612554	5p15.33-p15.2	Myopia 16	612554	_	2
614188	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
613603	4q32.1-q32.2	Chromosome 4q32.1-q32.2 triplication syndrome	613603	AD	4
612100	7q35-q36	{Autism susceptibility 15}	612100	_	3
613278	16p13.3	Fanconi anemia, complementation group P	613951	AR	3
613328	15q11-q21.1	?Roifman-Chitayat syndrome	613328	AR	2
613977	11p15.4	Cyanosis, transient neonatal	613977	AD	3
613037	9q34.3	Joubert syndrome 1	213300	AR	3
613037	9q34.3	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	AR	3
612360	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
612418	8q21.11	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	AR	3
611804	1p35.3	Elliptocytosis-1	611804	AR,AD	3
614343	18p11.3	Mental retardation, autosomal recessive 19	614343	AR	2
613827	6p21.1	Retinitis pigmentosa 48	613827	_	3
614172	3q21.3	Immunodeficiency 21	614172	AD	3
612638	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
613757	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
613924	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
614255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
614328	2p25.1	?Inflammatory skin and bowel disease, neonatal, 1	614328	AR	3
613842	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
610099	8p22-q11	Myopathy, distal 3	610099	AD	2
611403	17q21	{Asthma-related traits, susceptibility to, 6}	611403	_	2
614291	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
612639	12q15	{Inflammatory bowel disease 26}	612639	_	2
612586	2q33.1	{Aneurysm, intracranial berry, 9}	612586	_	2
612392	8q22.1	Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3
612361	2q32.1	{Schizophrenia, susceptibility to, 14}	612361	_	2
614395	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
613279	14q31.3	Mental retardation, autosomal recessive 56	617125	AR	3
611805	6p12.1	Spinocerebellar ataxia 38	615957	AD	3
610100	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
614452	10q23.31	Hyperekplexia 4	618011	AR	3
612555	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
611535	2q22-q24	{Major affective disorder 5}	611535	_	2
614329	4q12-q13.1	Mental retardation, autosomal recessive 31	614329	AR	2
613006	10q23.31	{Diabetes mellitus, insulin-dependent, 24}	613006	_	2
611341	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
613675	17q11.2	Chromosome 17q11.2 deletion syndrome, 1.4Mb	613675	AD	4
612362	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
612458	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
611719	3q23	Combined oxidative phosphorylation deficiency 5	611719	AR	3
613405	9q34.11	[Bone mineral density QTL 15]	613418	AR,AD	3
612621	6p21.32	Mental retardation, autosomal dominant 5	612621	AD	3
613843	6p21.31	Leber congenital amaurosis 15	613843	AR	3
613205	1q22	Muscular dystrophy, congenital	613205	AD	3
611090	1p34.1	Mental retardation, autosomal recessive 12	611090	AR	3
614429	8p23.1	Ventricular septal defect 1	614429	AD	3
613329	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AR,AD	3
613150	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	AR	3
612622	4q27	{Diabetes mellitus, insulin-dependent, 23}	612622	_	2
613758	2q37.1	Retinitis pigmentosa 47	613758	_	3
614292	3q28	Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3
614233	19pter-p13.1	Hyperpigmentation, familial progressive, 1	614233	_	2
613406	15q24.2	Witteveen-Kolk syndrome	613406	AD	3
612641	8p11.21	Spherocytosis, type 1	182900	AR,AD	3
612001	15q13.3	Chromosome 15q13.3 microdeletion syndrome	612001	_	4
611788	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
611170	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
614521	9p24.1	Thrombocythemia 3	614521	SMu,AD	3
612459	2q14.1	[Body mass index QTL13]	612459	_	2
613942	20q11.21	Spermatogenic failure 16	617187	AR	3
614411	9p13.3	[Glycerol quantitative trait locus]	614411	AR	3
613385	20q11.22	Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3
613828	6q16.3-q22.31	Epilepsy, generalized, with febrile seizures plus, type 8	613828	_	2
612587	8q12.1	{Aneurysm, intracranial berry, 10}	612587	_	2
613477	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
614344	11p13-q14.1	Mental retardation, autosomal recessive 23	614344	AR	2
613676	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
613114	5p15.1	Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3
612623	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
613007	6p21.3	{Biliary cirrhosis, primary, 2}	613007	_	2
613533	17q21.31	Chromosome 17q21.31 duplication syndrome	613533	_	4
612556	3q27.3	Adiponectin deficiency	612556	_	3
613151	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	AR	3
612240	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
614504	5q31.3	Usher syndrome type 3B	614504	AR	3
608792	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
614293	6q13	Hydatidiform mole, recurrent, 2	614293	AR	3
613845	19q13.2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	AR	3
612642	11p14.2-q12.3	Deafness, autosomal dominant 59	612642	AD	2
613008	1p31.2	{Biliary cirrhosis, primary, 3}	613008	_	2
611536	6q23-q24	{Major affective disorder 6}	611536	_	2
613759	11q13.3	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	613759	AR	3
614487	18p11.21	Spastic ataxia 5, autosomal recessive	614487	AR	3
613604	16p12.2-p11.2	Chromosome 16p12.2-p11.2 deletion syndrome	613604	IC	4
612255	10q21	{Inflammatory bowel disease 15}	612255	_	2
614468	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
614345	6p12.2-q12	Mental retardation, autosomal recessive 24	614345	AR	2
613280	1q41	Hypermanganesemia with dystonia 1	613280	AR	3
614831	6q24.3	Spinocerebellar ataxia, autosomal recessive 13	614831	AR	3
612241	3p21.3	{Inflammatory bowel disease 12}	612241	_	2
614505	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
614700	4q31.3	Immunodeficiency, common variable, 8, with autoimmunity	614700	AR	3
614331	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
612557	9q34.1	{Leukemia, chronic lymphocytic, susceptibility to, 3}	612557	_	2
612643	13q12.11	Deafness, autosomal dominant 3B	612643	AD	3
613943	10q23.31	Ichthyosis, congenital, autosomal recessive 8	613943	AR	3
613407	13q14.11	{Leprosy, susceptibility to, 6}	613407	_	2
611913	16p11.2	Chromosome 16p11.2 deletion syndrome, 593kb	611913	_	4
611913	16p11.2	{Autism susceptibility 14A}	611913	_	2
614864	7p22.3	Ciliary dyskinesia, primary, 18	614874	AR	3
611482	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
611482	4q35.1	?Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3
612119	11q23.3	Trehalase deficiency	612119	AR	3
613605	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
613206	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
614848	11q23.3	Nephronophthisis 15	614845	AR	3
614190	5q13.3	Pigmented nodular adrenocortical disease, primary, 3	614190	_	3
614619	4q32.1	Hyperekplexia 2	614619	AR	3
612802	6p21.33	Combined oxidative phosphorylation deficiency 20	615917	AR	3
611003	10q22	{Smoking as a quantitative trait locus 1}	611003	_	2
614010	8q12.1	Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3
612589	14q22.2	{Colorectal cancer, susceptibility to, 8}	612589	_	2
612676	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
613115	5p15.1	Neuropathy, hereditary sensory and autonomic, type IIB	613115	AR	3
609625	10q26	Chromosome 10q26 deletion syndrome	609625	AD	4
614946	6p25.1	Combined oxidative phosphorylation deficiency 14	614946	AR	3
612624	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
612256	19p13.13	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3
614173	12q24.11	Joubert syndrome 13	614173	AR	3
612120	3p25.3	?Lipodystrophy, familial partial, type 5	615238	AR	3
612242	10q23	Chromosome 10q22.3-q23.2 deletion syndrome	612242	_	4
612644	1p34.3	Deafness, autosomal dominant 2B	612644	AD	3
614455	14q32.33	Charcot-Marie-Tooth disease, dominant intermediate E	614455	AD	3
613761	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
613207	9q33	{Asthma-related traits, susceptibility to, 8}	613207	_	2
613944	2q36	{IgA nephropathy, susceptibility to, 2}	613944	?AD	2
614947	15q22.31	Combined oxidative phosphorylation deficiency 15	614947	AR	3
613606	1p33-p31.1	Forsythe-Wakeling syndrome	613606	AR	2
611570	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
614541	16q22	Chromosome 16q22 deletion syndrome	614541	IC	4
614849	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
614456	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
614814	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
613534	15q13.3	Interstitial nephritis, karyomegalic	614817	AR	3
615135	4q22.1	?Maple syrup urine disease, mild variant	615135	_	3
614414	1p36.31-p36.13	Deafness, autosomal recessive 96	614414	AR	2
611004	22q12	{Smoking as a quantitative trait locus 2}	611004	_	2
613550	8q22.1	Nephronophthisis 11	613550	AR	3
613386	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
613386	13q12.3	Proteasome-associated autoinflammatory syndrome 2	618048	AD	3
615003	8p11.23	Spastic paraplegia 54, autosomal recessive	615033	AR	3
613190	16q24.1	Ciliary dyskinesia, primary, 13	613193	AR	3
613208	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
613566	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
612243	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
614929	12q13.13	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3
615119	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
614736	5p12	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736	AR	3
615083	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
615271	20p12.1	Hypogonadotropic hypogonadism 21 with anosmia	615271	AD	3
613387	11q23	{Fatty liver disease, nonalcoholic, susceptibility to, 2}	613387	Mu	2
613282	22q13	{Fatty liver disease, nonalcoholic, susceptibility to, 1}	613282	Mu	2
613846	12q24.31	?Meckel syndrome 8	613885	AR	3
613846	12q24.31	Joubert syndrome 24	616654	AR	3
613009	4p15.2	Pontocerebellar hypoplasia type 2D	613811	AR	3
612625	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
614278	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
612160	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
614620	16p13.3	Retinitis pigmentosa 80	617781	AR	3
614620	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
614815	10q24.1	Joubert syndrome 18	614815	AR	3
615084	20p11.23	Mitochondrial DNA depletion syndrome 11	615084	AR	3
614644	6p21.3-p21.2	Mean platelet volume QTL4	614644	_	2
614582	3q22.1	Combined oxidative phosphorylation deficiency 9	614582	AR	3
614490	4q22.1	[Junior blood group system]	614490	_	3
611091	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
613283	4p13	Deafness, autosomal recessive 25	613285	AR	3
612161	11q24-q25	Aneurysm, intracranial berry, 7	612161	_	2
614621	5q12.1	UV-sensitive syndrome 2	614621	AR	3
611571	16q22.1-q23.1	{Otosclerosis 4}	611571	AD	2
611092	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
615085	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
615515	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
613847	10q24.1	Joubert syndrome 18	614815	AR	3
613847	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
613608	5p15.31-p15.1	Epilepsy, myoclonic, familial adult, 3	613608	AD	2
614063	4p16.3	?N-acetylaspartate deficiency	614063	AR	3
615463	1p34.2	Epileptic encephalopathy, early infantile, 18	615476	AR	3
615427	2p11.2	?Deafness, autosomal recessive 88	615429	AR	3
614622	5q14.1-q21.3	Keratoconus 5	614622	AD	2
613284	22q12-q13	[Hematocrit/hemoglobin quantitative trait locus 3]	613284	_	2
615481	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
615272	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
615311	11p14.1	{Bone mineral density, low, susceptibility to}	615311	_	3
615549	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
611572	6q13-q16.1	Otosclerosis 7	611572	AD	2
614583	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
615273	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
615787	5p13.2	?2,4-dienoyl-CoA reductase deficiency	616034	AR	3
615567	19q13.2	Nephrotic syndrome, type 9	615573	AR	3
615288	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614645	6q23.3	Mean platelet volume QTL5	614645	_	2
615767	4q27	?Immunodeficiency, common variable, 11	615767	AR	3
614021	7p22-p14	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	2
612244	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
615120	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
615500	21q22.11	Ciliary dyskinesia, primary, 26	615500	AR	3
612558	6p25	{Leukemia, chronic lymphocytic susceptibility to, 4}	612558	_	2
615464	1q32.1	Orofaciodigital syndrome V	174300	AR	3
611539	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
614915	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
614738	6q27	Mitochondrial pyruvate carrier deficiency	614741	AR	3
614491	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
612590	16q22.1	{Colorectal cancer, susceptibility to, 9}	612590	_	2
615586	3q29	Morbid obesity and spermatogenic failure	615703	AR	3
615274	12q13.3	Cataract 15, multiple types	615274	AD	3
615159	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
614022	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
615721	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
615550	3p24.2	?Diamond-Blackfan anemia 12	615550	AD	3
611093	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
613848	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
615004	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
615429	2p11.2	?Deafness, autosomal recessive 88	615429	AR	3
615843	1q42.11	Leukodystrophy, hypomyelinating, 18	618404	AR	3
614492	12p13.33	Pseudohypoaldosteronism, type IIC	614492	AD	3
613285	4p13	Deafness, autosomal recessive 25	613285	AR	3
615902	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
615902	14q13.2	Spermatogenic failure 36	618420	AD	3
615501	14q23.3-q24.1	Molybdenum cofactor deficiency C	615501	AR	3
615482	15q21.3	Ciliary dyskinesia, primary, 25	615482	AR	3
613876	1p31.1	Cardiomyopathy, hypertrophic, 20	613876	AD	3
615368	19p13.2	Lethal congenital contracture syndrome 5	615368	AR	3
613345	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
615312	4q24	Albinism, oculocutaneous, type V	615312	AR	2
615551	3p22.2	Episodic pain syndrome, familial, 2	615551	AD	3
614623	9q34	Keratoconus 6	614623	AD	2
614506	7p22.3	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3
614506	7p22.3	Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3
615390	12p11-q13	Vesicoureteral reflux 7	615390	_	2
613849	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
612559	11q24.1	{Leukemia, chronic lymphocytic susceptibility to, 5}	612559	_	2
612259	9q32	{Inflammatory bowel disease 16}	612259	_	2
615683	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
615465	8p11.23	Hartsfield syndrome	615465	AD	3
615327	20q11.21	Dowling-Degos disease 2	615327	AD	3
615179	10q22.2-q22.3	Albinism, oculocutaneous, type VII	615179	AR	3
613609	6p22.2	Hemochromatosis	235200	AR	3
613609	6p22.2	[Transferrin serum level QTL2]	614193	_	3
613609	6p22.2	{Alzheimer disease, susceptibility to}	104300	AD	3
613609	6p22.2	{Microvascular complications of diabetes 7}	612635	_	3
613609	6p22.2	{Porphyria cutanea tarda, susceptibility to}	176100	AR,AD	3
613609	6p22.2	{Porphyria variegata, susceptibility to}	176200	AD	3
611663	20p13	Warburg micro syndrome 4	615663	AR	3
611377	17q22	Brachydactyly, type B2	611377	AD	3
615160	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
612803	11q14.1	?Deafness, autosomal recessive 94	618434	AR	3
612803	11q14.1	Combined oxidative phosphorylation deficiency 24	616239	AR	3
616033	4q23	Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3
616053	14q32.11-q32.12	?Spinocerebellar ataxia 40	616053	AD	3
613850	20p13	[Inosine triphosphatase deficiency]	613850	_	3
616182	12q13	{Chronic mountain sickness, susceptibility to}	616182	_	2
614916	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
616202	14q32.33	Cerebellofaciodental syndrome	616202	AR	3
615502	16q22.1	Mental retardation, autosomal dominant 21	615502	AD	3
614739	6q25.3	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3
614507	1p36.12	?Congenital disorder of glycosylation, type Ir	614507	AR	3
615684	1p22.2	Premature ovarian failure 9	615724	AR	3
613551	11q24.2	{Autoimmune disease, susceptibility to, 6}	613551	_	3
613286	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
611664	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
615903	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
615903	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
615903	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
612260	3p22.2	Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	_	3
611971	9q34.3	Combined oxidative phosphorylation deficiency 36	617950	AR	3
615992	2p15	?Bardet-Biedl syndrome 15	615992	AR	3
616219	4q25	Fibrosis of extraocular muscles, congenital, 5	616219	AR	3
616295	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
614895	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
613877	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
616034	5p13.2	?2,4-dienoyl-CoA reductase deficiency	616034	AR	3
611006	9q21.33	Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3
614917	6q25.1	Combined oxidative phosphorylation deficiency 11	614922	AR	3
616255	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
614076	6p22.3	Hermansky-Pudlak syndrome 7	614076	AR	3
613610	2p24.1	Cranioectodermal dysplasia 2	613610	AR	3
615503	7q36.3	Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3
616329	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
613011	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
616054	18q12.2	Mental retardation, autosomal recessive 58	617270	AR	3
615993	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
612261	1p31.3	{Inflammatory bowel disease 17, protection against}	612261	_	3
615162	17q21.31-q22	Mental retardation, autosomal recessive 35	615162	AR	2
613211	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
615956	19p13.2	Ciliary dyskinesia, primary, 30	616037	AR	3
614524	6p21.32	Fibrochondrogenesis 2	614524	AR,AD	3
615181	1q42.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	AR	3
613611	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
615860	14q24.3	Cone-rod dystrophy 19	615860	AR	3
614740	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
616462	2p11.2	Acrofacial dysostosis, Cincinnati type	616462	AD	3
615504	12q13.12	Ciliary dyskinesia, primary, 27	615504	AR	3
615846	2q24.2	Aicardi-Goutieres syndrome 7	615846	AD	3
614023	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
614896	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
615314	15q21.3	Craniosynostosis 3	615314	AD	3
615122	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
616346	9q34.11	Epileptic encephalopathy, early infantile, 31	616346	AD	3
614800	2p24.3	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3
616531	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
615005	9q34.3	Epilepsy, nocturnal frontal lobe, 5	615005	AD	3
613852	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
616330	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
612262	5p13.1	{Inflammatory bowel disease 18}	612262	_	2
616410	4q27	?Spinocerebellar ataxia 41	616410	AD	3
613612	7q22.3	Congenital disorder of glycosylation, type IIi	613612	_	3
615861	16p13.13	Nephrotic syndrome, type 10	615861	AR	3
615483	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
616481	6q25.3	Ciliary dyskinesia, primary, 32	616481	AR	3
614508	15q15.1	Mirror movements 2	614508	AD	3
616055	1p36.13-p34.3	Episodic ataxia, type 8	616055	AD	2
614493	2q31.1	?Wiskott-Aldrich syndrome 2	614493	_	3
614897	7q21.11	{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3
615431	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
613878	13q34	Factor VII deficiency	227500	AR	3
613878	13q34	{Myocardial infarction, decreased susceptibility to}	608446	_	3
616719	11q13.1	Spinocerebellar ataxia, autosomal recessive 21	616719	AR	3
612482	17q22	Sessile serrated polyposis cancer syndrome	617108	AD	3
612421	20p11.22	Alopecia, androgenetic, 3	612421	_	2
613347	13q13.1	{Pancreatic cancer 2}	613347	_	3
616411	2q37.3	Dystonia 27	616411	AR	3
613865	7q22.1	?Deafness, autosomal recessive 61	613865	AR	3
615862	12q22	Nephronophthisis 18	615862	AR	3
615505	8q22.2	Ciliary dyskinesia, primary, 28	615505	AR	3
616532	19q13.33	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3
616428	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
615065	2q37.1	Arthrogryposis, distal, type 5D	615065	AR	3
613301	7q31.32	Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3
616736	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
615847	12q22	Nephronophthisis 18	615862	AR	3
616720	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
616204	4q22.1-q22.2	Spinocerebellar ataxia, autosomal recessive 18	616204	AR	3
615942	17q25.1	Mental retardation, autosomal recessive 44	615942	AR	3
615276	15q26.3	Ichthyosis, congenital, autosomal recessive 9	615023	AR	3
614024	13q34	[Protein Z deficiency]	614024	_	3
616685	20q13.12	{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3
615905	17p13.1	Epileptic encephalopathy, early infantile, 25	615905	AR	3
615532	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
616331	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
612591	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
616645	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
614646	7q22.3	Mean platelet volume QTL6	614646	_	2
614920	1q21.1	?Peroxisome biogenesis disorder 14B	614920	AR	3
614741	6q27	Mitochondrial pyruvate carrier deficiency	614741	AR	3
616165	3p14.1	Nemaline myopathy 10	616165	AR	3
615066	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
615432	2q36.3	{Specific language impairment 5}	615432	AD	3
616625	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
616549	22q12.1	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549	AR	3
612592	20p12.3	{Colorectal cancer, susceptibility to, 11}	612592	_	2
614332	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
615506	10q11.22	Telangiectasia, hereditary hemorrhagic, type 5	615506	AD	3
616445	3p25.3	Candidiasis, familial, 9	616445	AR	3
615957	6p12.1	Spinocerebellar ataxia 38	615957	AD	3
616646	17q21.2	Woolly hair, autosomal recessive 3	616760	AR	3
614898	8p22	Spastic paraplegia 53, autosomal recessive	614898	AR	3
616166	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
614526	17q12	Chromosome 17q12 duplication syndrome	614526	AD	4
614921	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
611666	9p24.1	Phospholipid phosphatase 6	611666	_	3
616183	17p13.1	?Joubert syndrome 29	617562	AR	3
616183	17p13.1	Meckel syndrome 13	617562	AR	3
616183	17p13.1	Orofaciodigital syndrome XVI	617563	AR	3
616312	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
616430	2q33.1	?Combined oxidative phosphorylation deficiency 25	616430	AR	3
616840	15q22.2	Parkinson disease 23, autosomal recessive, early onset	616840	AR	3
612422	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
614025	15q21.3	Hepatic lipase deficiency	614025	AR	3
616647	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
612736	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
616515	6p22.3	?Deafness, autosomal recessive 104	616515	AR	3
615768	16p13.3	Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3
613012	3q21.3	?Urocanase deficiency	276880	AR	3
614922	6q25.1	Combined oxidative phosphorylation deficiency 11	614922	AR	3
615072	20q11.22	Brachydactyly, type A1, C	615072	AR,AD	3
615907	4q34.3	Lymphatic malformation 4	615907	AD	3
615978	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
612423	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
616056	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
616313	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
614333	4q27-q28.2	Mental retardation, autosomal recessive 29	614333	AR	2
614415	20q11.23	?Chilblain lupus 2	614415	AD	3
613213	22q13.2	Methemoglobinemia, type I	250800	AR	3
613213	22q13.2	Methemoglobinemia, type II	250800	AR	3
612737	7p15	{Stature QTL 17}	612737	_	2
617083	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
616516	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
616534	9q22.33	{Thyroid cancer, nonmedullary, 4}	616534	AD	3
616648	16q21-q22	Optic atrophy 8	616648	AD	2
616737	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
613348	16p12.2	{Pancreatic cancer, susceptibility to, 3}	613348	_	3
617066	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
617025	14q24.3	Nevus comedonicus, somatic	617025	_	3
615828	11p15.5	Mental retardation, autosomal dominant 24	615828	AD	3
614742	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
615552	3p22.2	Episodic pain syndrome, familial, 3	615552	AD	3
616413	1q25.3	Basal ganglia calcification, idiopathic, 6	616413	AD	3
614457	6q14.1	Ichthyosis, spastic quadriplegia, and mental retardation	614457	AR	3
616276	9q34.11	Coenzyme Q10 deficiency, primary, 7	616276	AR	3
615444	3p21.31	Ciliary dyskinesia, primary, 22	615444	AR	3
611974	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
614527	17q12	Chromosome 17q12 deletion syndrome	614527	AD	4
612424	6q12	Retinitis pigmentosa 25	602772	AR	3
615468	18q21.32	Immunodeficiency 12	615468	AR	3
616314	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
613214	15q21.3	Amelogenesis imperfecta, type IIA3	613211	AR	3
611542	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
615073	18p11.21	Dystonia 25	615073	AD	3
617174	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
616535	10q25.3	{?Thyroid cancer, nonmedullary, 5}	616535	AD	3
614494	6q23	Retinitis pigmentosa 63	614494	AD	2
614923	16p11.2	Branched-chain ketoacid dehydrogenase kinase deficiency	614923	_	3
616788	17q21.33	?Orofacial cleft 15	616788	AD	3
615277	19q13.41	Cataract 19, multiple types	615277	AR	3
616649	14q23.3	Spherocytosis, type 2	616649	AD	3
615789	2p21	Short stature with microcephaly and distinctive facies	615789	AR	3
615829	1p36.1-p35.3	Xia-Gibbs syndrome	615829	AD	3
615091	4q23	{Autism, susceptibility to, 19}	615091	_	3
616258	1q32.1	?Meckel syndrome 12	616258	AR	3
616517	1q23.3	Achromatopsia 7	616517	AR	3
617140	21q22.11	ZTTK syndrome	617140	AD	3
617044	3p21.1	Short stature, developmental delay, and congenital heart defects	617044	AR	3
615163	10q26	Cone-rod dystrophy 17	615163	AD	2
613215	17p13.3	Chromosome 17p13.3 duplication syndrome	613215	_	4
615994	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
616892	16q13	Nephrotic syndrome, type 12	616892	AR	3
616414	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
615533	11q14.1	Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3
615485	18q12.1	Bainbridge-Ropers syndrome	615485	AD	3
617157	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
616738	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
616185	6q22.31	Ovarian dysgenesis 4	616185	AR	3
616283	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
614899	11q13.2	Deafness, autosomal recessive 93	614899	AR	3
614416	2p13.2	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	_	3
616756	6q16.3	Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3
615909	14q21.3	Diamond-Blackfan anemia 13	615909	AD	3
616650	16p12.1	Joubert syndrome 26	616784	AR	3
614458	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
612162	14q23	Aneurysm, intracranial berry, 8	612162	_	2
613349	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
617180	19q13.2	Chitayat syndrome	617180	AD	3
617121	17q22	Joubert syndrome 28	617121	AR	3
614924	16p12.2	Combined oxidative phosphorylation deficiency 12	614924	AR	3
617068	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
615092	18q11.2	Left ventricular noncompaction 7	615092	AD	3
614335	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
613135	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
615959	2q35	Centronuclear myopathy 5	615959	AR	3
615790	1p36.1-p35.3	Xia-Gibbs syndrome	615829	AD	3
615127	3q26.32-q28	Epilepsy, myoclonic, familial adult, 4	615127	AD	2
616208	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
613776	17p13.1	Chromosome 17p13.1 deletion syndrome	613776	AD	4
617248	2p13.1	3-methylglutaconic aciduria, type VIII	617248	AR	3
617158	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
616415	16p13.3	Familial adenomatous polyposis 3	616415	AR	3
616893	7q33	?Nephrotic syndrome, type 13	616893	_	3
617004	6q21	Polycystic liver disease 2	617004	AD	3
615573	19q13.2	Nephrotic syndrome, type 9	615573	AR	3
617282	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
615589	1q41-q44	Otosclerosis 10	615589	AD	2
616559	14q21.3	Noonan syndrome 9	616559	AD	3
615534	3q13.33	Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3
615830	19p13	Pigmented nodular adrenocortical disease, primary, 4	615830	AD	4
612163	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
616186	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
616284	1q21.3	Peeling skin syndrome 6	618084	AR	3
613216	15q13.3	Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	_	3
614744	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
617069	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
614925	12q21.31	Deafness, autosomal recessive 84B	614944	AR	3
616661	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3
615486	12q13.3	Interstitial lung and liver disease	615486	AR	3
616037	19p13.2	Ciliary dyskinesia, primary, 30	616037	AR	3
615944	11q13.4	Orofaciodigital syndrome XIV	615948	AR	3
616209	22q11.23	?Myopathy, isolated mitochondrial, autosomal dominant	616209	AD	3
613330	4p15.33	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	AR	3
614459	11q12.2	Joubert syndrome 16	614465	AR	3
613388	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
617213	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
615960	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
617141	11p13	?Aniridia 2	617141	AD	3
616789	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
616260	18q12.1	Tenorio syndrome	616260	AD	3
615577	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
615553	1p21.2	?Arthrogryposis, mental retardation, and seizures	615553	AR	3
616432	19p13.2	Retinitis pigmentosa 78	617433	AR	3
616187	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
615278	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
615979	16q24.2	?Mental retardation, autosomal recessive 45	615979	AR	3
617046	6p25.1	Spastic paraplegia 77, autosomal recessive	617046	AR	3
611669	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
615910	13q34	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3
614417	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
617070	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
614530	12q22	?Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3
616758	1p36.11	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3
613353	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
614336	16p13.3	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3
616910	2q31.1	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3
616858	20p11.23	?Cowden syndrome 7	616858	AD	3
615590	15q21.3	{Alzheimer disease 18, susceptibility to}	615590	_	3
617352	20q11-q13	Mulchandani-Bhoj-Conlin syndrome	617352	_	3
616261	7q22.3	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3
616651	2q14.2	Roifman syndrome	616651	AR	3
612164	9q34.11	Epileptic encephalopathy, early infantile, 4	612164	AD	3
612593	6p21.33	{Lung cancer susceptibility 4}	612593	_	2
617300	7q22.1	Lymphatic malformation 7	617300	AD	3
616739	2q22.1	Mental retardation, autosomal recessive 51	616739	AR	3
615919	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
615554	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
615792	13q14.2	{Thiopurines, poor metabolism of, 2}	616903	AD	3
616631	1q22	Porokeratosis 9, multiple types	616631	AD	3
615980	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
615279	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
616482	4p16.3	SADDAN	616482	AD	3
615911	22q11.23	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	AD	3
616705	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
614512	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
613073	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
614077	19q13.32	Hermansky-Pudlak syndrome 8	614077	AR	3
614745	15q24.1	[Blood group, John-Milton-Hagen system]	614745	_	3
613217	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
615945	1p32.2	Spinocerebellar ataxia 37	615945	AD	3
614900	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
615961	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
616687	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
616286	17q21.2	Lethal congenital contracture syndrome 7	616286	AR	3
616188	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
616038	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
616963	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
617142	11p13	?Aniridia 3	617142	AD	3
615591	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
613440	2q37.1	{Stature QTL 21}	613440	_	2
616663	17p13.1	Leukoencephalopathy, brain calcifications, and cysts	614561	AR	3
617123	1p34.1	Retinitis pigmentosa 76	617123	AR	3
616652	17p12-p11.2	Yuan-Harel-Lupski syndrome	616652	AD	4
615863	8q24.3	?Diarrhea 7, protein-losing enteropathy type	615863	AR	3
617353	3q29	Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3
616894	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
610436	18q22.2	Microcephaly, short stature, and polymicrogyria with seizures	614833	AR	3
616859	14q32.13	Spasticity, childhood-onset, with hyperglycinemia	616859	AR	3
617159	12p13.31	Sifrim-Hitz-Weiss syndrome	617159	AD	3
614337	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
617387	3p21.31	Ververi-Brady syndrome	617982	AD	3
617404	17p13.3	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404	AR	3
617284	19q13.12	Dystonia 28, childhood-onset	617284	AD	3
616632	5q31.3	Seizures, cortical blindness, microcephaly syndrome	616632	AR	3
615981	16q13	Bardet-Biedl syndrome 2	615981	AR	3
615280	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
616483	2p24.3	Infantile liver failure syndrome 2	616483	AR	3
617047	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
612165	4q32-q34	Retinitis pigmentosa 29	612165	AR	2
617478	14q22.3	Structural heart defects and renal anomalies syndrome	617478	AR	3
616777	3p21.31	Seckel syndrome 9	616777	AR	3
615095	20q13.12	Microcephaly 10, primary, autosomal recessive	615095	AR	3
617301	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
616875	1p36.13	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3
615831	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
614752	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
614078	8q12.1	Chondrodysplasia with joint dislocations, GPAPP type	614078	AR	3
616335	15q15.3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335	AR	3
614647	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
614028	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
613778	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
614926	5q31.3	?Perrault syndrome 2	614926	AR	3
615555	5p13.2	Hyperprolactinemia	615555	AR,AD	3
615774	11q12.2	Oocyte maturation defect 1	615774	AR	3
614901	16p11.2	Branched-chain ketoacid dehydrogenase kinase deficiency	614923	_	3
617424	1q42.11-q42.12	Skraban-Deardorff syndrome	617616	AD	3
616287	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
617086	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
614746	19q13	[Uric acid concentration, serum, QTL5]	614746	_	2
613074	7q32.2	Deafness, autosomal dominant 50	613074	AD	3
615592	8p11.21	Immunodeficiency 15B	615592	AR	3
615946	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
617143	2q12.3	Myasthenic syndrome, congenital, 20, presynaptic	617143	AR	3
614418	8q13.2	Febrile seizures, familial, 11	614418	AR	3
616521	2p25.3	Mental retardation, autosomal dominant 39	616521	AD	3
613441	22q12.2	Transcobalamin II deficiency	275350	AR	3
617441	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
612594	10p15.1	{Multiple sclerosis, susceptibility to, 2}	612594	_	2
614461	6p21.31	Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3
613138	7q31.31	Exudative vitreoretinopathy 5	613310	AD	3
616860	14q32.13	Anemia, sideroblastic, 3, pyridoxine-refractory	616860	AR	3
617336	10q21.3	Nemaline myopathy 11, autosomal recessive	617336	AR	3
616740	3q29	Immunodeficiency 46	616740	AR	3
615281	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
613218	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
617531	19p13.11	Brain small vessel disease 3	618360	AR	3
617072	1q25.2	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	617072	AR	3
616562	16q13	Retinitis pigmentosa 74	616562	AR	3
616538	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
616211	16q23.1-q23.2	Epileptic encephalopathy, early infantile, 28	616211	AR	3
614338	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
617217	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
615074	1q21.3	Mental retardation, autosomal dominant 18	615074	AD	3
617388	17p13.2	Autoinflammation with arthritis and dyskeratosis	617388	AR,AD	3
616500	2q11.2	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3	616500	AR	3
614927	10q24.32-q25.1	Ectodermal dysplasia 5, hair/nail type	614927	AR	2
617405	3q29	Short-rib thoracic dysplasia 17 with or without polydactyly	617405	AR	3
616688	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2Z	616688	AD	3
616827	2q14.3	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	616827	AR	3
614747	1q21.1	[Uric acid concentration, serum, QTL6]	614747	_	2
613791	1p36.22	MASP2 deficiency	613791	AR	3
617302	10p12.1	?Optic atrophy 11	617302	AR	3
612595	5p13.2	{Multiple sclerosis, susceptibility to, 3}	612595	_	2
614419	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
617425	8p21.1	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3
611672	17q11.2	Folate malabsorption, hereditary	229050	AR	3
617087	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
615182	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
616418	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
617125	14q31.3	Mental retardation, autosomal recessive 56	617125	AR	3
617442	6p21.33	?Premature ovarian failure 13	617442	AR	3
617532	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
617619	1q22	Myopathy, mitochondrial, and ataxia	617675	AR,AD	3
615593	1p36.33	?Immunodeficiency 16	615593	AR	3
616435	1q32.1	Fanconi anemia, complementation group T	616435	AR	3
614462	4p14	Hyperglycinemia, lactic acidosis, and seizures	614462	AR	3
615282	2q23.1-q23.2	Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3
616170	4q28.2	Macular dystrophy with central cone involvement	616170	AR	3
617480	9q33.3	46, XX sex reversal 4	617480	AD	3
617389	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
614080	18q21.33	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3
616501	1q42.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	616501	AR	3
614928	17p12-q21.2	Ectodermal dysplasia 6, hair/nail type	614928	AR	2
617218	12q21.32	Lissencephaly 8	617255	AR	3
615490	4q31.3	Charcot-Marie-Tooth disease, type 2R	615490	AR	3
617406	8q22.1	Bardet-Biedl syndrome 21	617406	AR	3
615075	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
616896	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
616212	16q21	Lissencephaly 6, with microcephaly	616212	AR	3
615833	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
614748	17q21.33	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	AR	3
617232	3q13.33	?Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3
614514	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
613354	9q34.3	Deafness, autosomal recessive 79	613307	AR	3
614420	3p14.3	Systemic lupus erythematosus 16	614420	AR	3
613615	1q43-q44	Senior-Loken syndrome 7	613615	_	3
615471	6q16.1-q16.2	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	AR	3
612596	1p36	{Multiple sclerosis, susceptibility to, 4}	612596	_	2
613792	3pter-p25	3p- syndrome	613792	AD	4
617319	19p13.11	Anterior segment dysgenesis 8	617319	AR	3
617088	2p21	Short-rib thoracic dysplasia 15 with polydactyly	617088	AR	3
616539	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
617514	16p11.2	Immunodeficiency 52	617514	AR	3
613075	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
617637	11p15.5	Deafness autosomal recessive 106	617637	AR	3
616436	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
617443	11q24.3	Bleeding disorder, platelet-type, 21	617443	AR,AD	3
617145	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
615328	13q14.11	Shaheen syndrome	615328	AR	3
615962	5q31.3	Glucocorticoid resistance	615962	AD	3
617219	19q13.11	Chromosome 19q13.11 deletion syndrome, proximal	617219	AD	4
617585	19q13.32	?Immunodeficiency 53	617585	AR	3
617765	1q42.3	?Immunodeficiency, common variable, 14	617765	AD	3
615491	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
617730	20q13.12	Galloway-Mowat syndrome 4	617730	AR	3
613616	10q24.2	Hyperoxaluria, primary, type III	613616	_	3
613355	17q23.1-q23.2	Chromosome 17q23.1-q23.2 deletion syndrome	613355	IC	4
615777	16p12.3	Desbuquois dysplasia 2	615777	AR	3
614340	15q26.3	Mental retardation, autosomal recessive 27	614340	AR	3
615947	8q24.3	Hyperlipoproteinemia, type 1D	615947	AR	3
615866	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
615834	7q11.22	Mental retardation, autosomal dominant 26	615834	AD	3
617800	3q23	?Microcephaly 19, primary, autosomal recessive	617800	AR	3
617481	1q21.3	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3
617713	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
616502	1p13.3	Cone-rod dystrophy 21	616502	AR	3
615535	19q13.12	Deafness, autosomal recessive 76	615540	AR	3
613444	16p11.2	Chromosome 16p11.2 deletion syndrome, 220kb	613444	_	4
613444	16p11.2	[Body mass index QTL16]	613444	_	4
616863	16p13.2	Chromosome 16p13.2 deletion syndrome	616863	AD	4
616878	22q11.21	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3
617659	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
616244	7p11.2	Parkinson disease 22, autosomal dominant	616710	AD	3
616828	2q21.1	Congenital disorder of glycosylation, type IIo	616828	AR	3
617320	19p13.12	Ichthyosis, congenital, autosomal recessive 12	617320	AR	3
615963	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
616689	19q13.31	Dehydrated hereditary stomatocytosis 2	616689	AD	3
616437	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
616486	1p34.2	Microcephaly 15, primary, autosomal recessive	616486	AR	3
617220	12p12.1	Myopathy, myofibrillar, 8	617258	AR	3
617675	1q22	Myopathy, mitochondrial, and ataxia	617675	AR,AD	3
614515	17q12	Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	AR	3
617731	2p13.1	Galloway-Mowat syndrome 5	617731	AR	3
615595	6p25.1	?Combined oxidative phosphorylation deficiency 19	615595	AR	3
617146	18p11.22-p11.21	Arthrogryposis, distal, with impaired proprioception and touch	617146	AR	3
613076	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
614422	12q24.2-q24.3	Cataract 37, autosomal dominant	614422	AD	2
617182	15q21.2	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182	AR	3
617782	18q11.1-q11.2	Renal hypodysplasia/aplasia 3	617805	AD	3
617922	4q31.21	[Blood group, MNSs system]	111300	_	3
617922	4q31.21	{Malaria, resistance to}	611162	_	3
616214	11p15.5	Hyperproinsulinemia	616214	AD	3
614341	17p13.2-p13.1	Mental retardation, autosomal recessive 33	614341	AR	2
613793	1q32.2	[Blood group Cromer]	613793	AR	3
617408	17q21.31	?Diamond-Blackfan anemia 16	617408	AD	3
617698	19q13.2	3-methylglutaconic aciduria, type IX	617698	AR	3
615473	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
615948	11q13.4	Orofaciodigital syndrome XIV	615948	AR	3
617006	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
617321	16q12.1	{Yao syndrome}	617321	Mu	3
614649	8p11.21	Ataxia, sensory, 1, autosomal dominant	608984	AD	3
616829	17q11.2	Congenital disorder of glycosylation, type IIp	616829	AR	3
617090	12q24.23	Microcephaly 17, primary, autosomal recessive	617090	AR	3
616690	1p36.32	Joubert syndrome 25	616781	AR	3
617660	2p21	Vertebral, cardiac, renal, and limb defects syndrome 1	617660	AR	3
616487	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
616503	6q24.2	Lethal congenital contracture syndrome 9	616503	AR	3
615330	1q42.13	Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3
616540	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
617783	19p13.2	Nephrotic syndrome, type 16	617783	AR	3
616636	12q13.3	Immunodeficiency 44	616636	AR	3
617767	13q21.3-q22.1	Joubert syndrome 33	617767	AR	3
617183	1p36.33	Harel-Yoon syndrome	617183	AR,AD	3
615557	1q41	{Melioidosis, susceptibility to}	615557	_	3
614342	6q12-q15	Mental retardation, autosomal recessive 30	614342	AR	2
617871	14q24.3	?Retinitis pigmentosa 81	617871	AR	3
615493	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
617980	11p15.4	Erythrocytosis 6	617980	_	3
617466	14q23.1	?Townes-Brocks syndrome 2	617466	AD	3
618049	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
617412	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
616215	11p11.2	Osteogenesis imperfecta, type XVI	616229	AR	3
615407	16q13	Retinitis pigmentosa with or without situs inversus	615434	AR	3
616289	22q13.2	?Optic atrophy 9	616289	AR	3
616830	22q11.21	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878	AR	3
615949	17q11.2	Nanophthalmos 4	615972	AD	3
617768	7q36.1	Kleefstra syndrome 2	617768	AD	3
616488	9q34.12	Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3
618126	12p13.31	?Liddle syndrome 3	618126	AD	3
618143	17q11.2	Glycosylphosphatidylinositol biosynthesis defect 18	618143	AR	3
615537	15q21.3	Reticulate acropigmentation of Kitamura	615537	AD	3
617638	7p22.2	Immunodeficiency 11B with atopic dermatitis	617638	AD	3
614423	2q33.1	Joubert syndrome 14	614424	AR	3
617802	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
617904	9q22.33	Epileptic encephalopathy, early infantile, 59	617904	AD	3
616339	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
617836	1p36.11	Developmental delay and seizures with or without movement abnormalities	617836	AD	3
617872	17q25.1	?Combined oxidative phosphorylation deficiency 34	617872	AR	3
617570	3q22.3	Polycystic kidney disease 5	617610	AR	3
616911	10q23.33	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3
616439	12q14.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439	AD	3
618067	14q32.33	Epileptic encephalopathy, early infantile, 66	618067	AD	3
615950	2q35	Centronuclear myopathy 5	615959	AR	3
618050	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
616638	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
617516	17q24.2	Stankiewicz-Isidor syndrome	617516	AD	3
617602	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
614749	9p13.3	Hyperphosphatasia with mental retardation syndrome 2	614749	AR	3
615494	21q22.11	Ciliary dyskinesia, primary, 26	615500	AR	3
617941	15q25.2	Shwachman-Diamond syndrome 2	617941	AR	3
615332	1q42.3	?Immunodeficiency, common variable, 14	617765	AD	3
618015	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
616059	22q13.1	?Mirror movements 3	616059	AR	3
613446	5q23.2	Joubert syndrome 31	617761	AR	3
613446	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
616247	14q32.11	Long QT syndrome 14	616247	AD	3
618182	17q23.3	Orthostatic hypotension 2	618182	AR	3
617784	16q23.1	?Fanconi anemia, complementation group W	617784	AR	3
617639	17q25.1	Deafness, autosomal recessive 107	617639	AR	3
616489	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
618051	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
616389	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
618307	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
616639	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
617184	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
615796	2q32.1	Spermatogenic failure 34	618153	AR	3
618273	19p13.13	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273	AD	3
616897	4p15.32	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3
614033	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
616216	12p13.2	Thrombocytopenia 5	616216	AD	3
618165	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
618331	16q24.3	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3
615408	10p12.1	Ciliary dyskinesia, primary, 23	615451	AR	3
617008	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
616881	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
616541	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
618016	1p21.1	?Growth hormone deficiency, isolated, type V	618160	AR	3
615969	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
617303	12q24.31	Mucopolysaccharidosis-plus syndrome	617303	AR	3
618183	19p13.11	Diarrhea 10, protein-losing enteropathy type	618183	AR	3
616490	14q23.1	Joubert syndrome 23	616490	AR	3
616340	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
617468	19q13.12	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	617468	AR	3
616248	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
616640	4q21.21	?Epilepsy, progressive myoclonic, 10	616640	AR	3
617873	1p34.2	Combined oxidative phosphorylation deficiency 35	617873	AR	3
618367	15q25.1	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367	AR	3
618384	20q13.12	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384	AR	3
616806	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
615495	2q35	Alacrima, achalasia, and mental retardation syndrome	615510	AR	3
618128	1p12	Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3
618332	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
618481	17q12	?Deafness, autosomal recessive 99	618481	_	3
616217	6p22.3	Nephronophthisis 19	616217	AR	3
617661	2q22.2	Vertebral, cardiac, renal, and limb defects syndrome 2	617661	AR	3
615970	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
618406	18q21.32	Obesity (BMIQ20)	618406	_	3
616291	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
617874	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
614750	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
615951	5q12.1	Acromelic frontonasal dysostosis	603671	AD	3
615951	5q12.1	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3
618275	21q22.3	Hypotrichosis 14	618275	AR	3
617304	19p13.3	Retinitis pigmentosa 77	617304	AR	3
616913	17q12	Bleeding disorder, platelet-type, 20	616913	AD	3
617537	6p22.2	Rahman syndrome	617537	AD	3
616491	17q21.2	?Charcot-Marie-Tooth disease, axonal, type 2V	616491	AD	3
618422	5q21.1	Deafness, autosomal recessive 100	618422	AR	3
616341	21q22.3	Epileptic encephalopathy, early infantile, 30	616341	AD	3
617323	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
616866	15q22.31	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3
618333	22q13.2	Menke-Hennekam syndrome 2	618333	_	3
617186	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
617641	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
616564	22q11.21	Noonan syndrome 10	616564	AD	3
616390	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
617538	15q25.2	Shwachman-Diamond syndrome 2	617941	AR	3
616249	2p21	Long QT syndrome 15	616249	AD	3
617839	10q22.3	Amytrophic lateral sclerosis 23	617839	AD	3
616060	12p12.3	[Blood group, Dombrock]	616060	_	3
616914	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
618129	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
617662	20p11.21	Joint laxity, short stature, and myopia	617662	AR	3
617982	3p21.31	Ververi-Brady syndrome	617982	AD	3
616441	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
617604	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
617519	19q13.2	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519	AR	3
614518	7q21.2	?Cardiomyopathy, dilated, 2B	614672	AR	3
618252	10q24.31	Mitochondrial complex I deficiency, nuclear type 32	618252	AR	3
616882	1p36.23	?Advanced sleep phase syndrome, familial, 3	616882	AD	3
618103	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
618350	7q22.1	?Microcephaly 25, primary, autosomal recessive	618351	AR	3
617642	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
617875	11q13.2	Polycystic liver disease 4 with or without kidney cysts	617875	AD	3
617222	4q24	Sudden cardiac failure, infantile	617222	AR	3
615952	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
616842	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
617907	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
617605	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
616898	15q14	Chromosome 15q14 deletion syndrome	616898	AD	4
617663	12q21.31	Deafness, autosomal dominant 73	617663	AD	3
617520	4q21.23	?Microcephaly 18, primary, autosomal dominant	617520	AD	3
617983	12p13.31	?Microcephaly 21, primary, autosomal recessive	617983	AR	3
618351	7q22.1	?Microcephaly 25, primary, autosomal recessive	618351	AR	3
616342	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
618276	9q21.33	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3
616566	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
618424	6q21	Spermatogenic failure 38	618433	AR	3
616809	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
616843	16q24.3	Lymphatic malformation 6	616843	AR	3
615076	20p11.23	Mitochondrial DNA depletion syndrome 11	615084	AR	3
617984	11q25	Microcephaly 22, primary, autosomal recessive	617984	AR	3
618291	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3
617223	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
618429	3p22.2	Spermatogenic failure 37	618429	AR	3
615410	6q14.2	{?Obesity, susceptibility to, BMIQ18}	615457	AD	3
618369	1p12	Spinocerebellar ataxia, autosomal recessive 27	618369	AR	3
618201	3p22.1	Epileptic encephalopathy, early infantile, 68	618201	AR	3
618036	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
617985	2q11.2	?Microcephaly 23, primary, autosomal recessive	617985	AR	3
617820	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
615596	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
617162	19q13.33	Epileptic encephalopathy, early infantile, 46	617162	AD	3
617452	8q21.3	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452	AR	3
617571	19q13.33	Ichthyosis, congenital, autosomal recessive 14	617571	AR	3
616899	4q24	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3
615953	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
618462	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
618353	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
618430	22q13.2	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430	AD	3
618410	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
617787	4q31.1	Mental retardation, autosomal dominant 50	617787	AD	3
617963	14q32.33	?Spermatogenic failure 30	618110	AR	3
617717	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
616568	7q31.33	{Glioma susceptibility 9}	616568	AD	3
617606	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
618253	22q13.2	Mitochondrial complex I deficiency, nuclear type 33	618253	AR	3
617360	7p14.1	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360	AD	3
615954	16p11.2	ACTH-independent macronodular adrenal hyperplasia 2	615954	SMu,AD	3
618292	3p21.2	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292	AR	3
618018	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
616867	10q22.1	?Spinal muscular atrophy with congenital bone fractures 2	616867	AR	3
618431	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
617821	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
616062	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
618354	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
616900	4q24	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900	AR	3
618464	17p13.2	Paragangliomas 6	618464	AD	3
615972	17q11.2	Nanophthalmos 4	615972	AD	3
618106	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
617718	7q22.1	Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease	617718	AR	3
616321	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
617964	7p21.3	Leukodystrophy, hypomyelinating, 16	617964	AD	3
618019	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
617607	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
617804	3p21.31	Neurodevelopmental disorder with severe motor impairment and absent language	617804	AD	3
616887	2q11.2	?Mental retardation, autosomal recessive, 52	616887	AR	3
617788	11q13.2	Mental retardation, autosomal dominant 51	617788	AD	3
615597	3p23	?Congenital disorder of glycosylation, type Ix	615597	AR	3
616868	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
617840	1p34.2	Combined oxidative phosphorylation deficiency 35	617873	AR	3
616322	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
618107	17q21.31	Osteopetrosis, autosomal dominant 3	618107	AD	3
618086	14q21.2	Spermatogenic failure 28	618086	AR	3
616063	20q13.33	Porokeratosis 8, disseminated superficial actinic type	616063	AD	3
618204	8p11.21	Immunodeficiency 15A	618204	AD	3
618482	5p12	Generalized epilepsy with febrile seizures plus, type 10	618482	_	3
616811	22q12.3	?Combined oxidative phosphorylation deficiency 29	616811	AR	3
617923	4q31.21	[Blood group, Ss]	111740	_	3
617923	4q31.21	{Malaria, resistance to}	611162	_	3
616345	11p15.5	?Immunodeficiency 39	616345	AR	3
613360	1p13.3	Cone-rod dystrophy 21	616502	AR	3
617719	17q25.3	Epiphyseal dysplasia, multiple, 7	617719	AR	3
618218	12q21.2	Baker-Gordon syndrome	618218	AD	3
618184	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
618087	17q21.33	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087	AD	3
615598	18q21.33	Palmoplantar keratoderma, Nagashima type	615598	AR	3
616812	6q21	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812	AR	3
617924	6p12.1	{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3
615870	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
618108	6p25.2	Immunodeficiency 57	618108	AR	3
617681	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
617225	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
618088	14q24.3	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3
618185	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
618219	8q22.1	?Polydactyly, postaxial, type A9	618219	AR	3
616294	4q26	Cole-Carpenter syndrome 2	616294	AR	3
616393	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
618205	17p13.1	Snijders Blok-Campeau syndrome	618205	AD	3
614204	2q14.1	Psoriasis 14, pustular	614204	AR	3
617706	16p13.3	?Spermatogenic failure 22	617706	AR	3
616890	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
618315	9q33.3	?Diamond-Blackfan anemia 19	618312	_	3
618073	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
617608	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
615080	6p21.2	Alzheimer disease 17	615080	_	2
618432	11q13.2	Hydatidiform mole, recurrent, 4	618432	_	3
618220	16q22.2	Retinitis pigmentosa 84	618220	AR	3
617911	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
618186	17q21.2	Hypomyelinating neuropathy, congenital, 3	618186	AR	3
618109	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
617721	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
616400	17p13.2	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3
618021	8q23.1	Tetraamelia syndrome 2	618021	AR	3
617925	4q28.1	?Short-rib thoracic dysplasia 20 with polydactyly	617925	AR	3
614205	19q13.32	3-M syndrome 3	614205	AR	3
618433	6q21	Spermatogenic failure 38	618433	AR	3
617592	10q25.1	Spermatogenic failure 19	617592	AR	3
615081	17q21.2	Spermatogenic failure 11	615081	AD	3
617912	20q13.33	Congenital heart defects, multiple types, 5	617912	AR,AD	3
617364	14q12	Congenital heart defects and ectodermal dysplasia	617364	AD	3
618077	1q32.1	{Inflammatory bowel disease 29}	618077	_	3
617822	4q27	Alkuraya-Kucinskas syndrome	617822	AR	3
616871	5q35.3	{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	AD	3
616323	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
618434	11q14.1	?Deafness, autosomal recessive 94	618434	AR	3
618316	17q25.1	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3
617707	17q22	?Spermatogenic failure 23	617707	AR	3
615082	6p22.1	[C3HEX, ability to smell]	615082	AD	3
617609	7q21.11	Nephrotic syndrome, type 15	617609	AR	3
617686	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
616697	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
618110	14q32.33	?Spermatogenic failure 30	618110	AR	3
618221	12p13.32	Mental retardation, autosomal recessive 66	618221	AR	3
617926	4q28.1	?Orofaciodigital syndrome XVII	617926	AR	3
616402	1p21.2	?Microcephaly 14, primary, autosomal recessive	616402	AR	3
618187	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
617610	3q22.3	Polycystic kidney disease 5	617610	AR	3
618089	2p16.3	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3
616814	19p13.3	Preimplantation embryonic lethality	616814	AR	3
618435	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
618443	16p13.3	Neurodevelopmental disorder with or without variable brain abnormalities	618443	AD	3
617687	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
618022	8q23.1	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3
617593	3q13.2	?Spermatogenic failure 20	617593	AR	3
617927	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
615922	9q32	Retinitis pigmentosa 70	615922	AD	3
618317	9p13.3	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3
618436	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
618090	2q31.1	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090	AR	3
616815	17q11.2	Congenital disorder of glycosylation, type IIp	616829	AR	3
618188	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
618222	11q13.2	Mitochondrial complex I deficiency, nuclear type 2	618222	AR	3
617709	1p13.3	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709	AR	3
618091	4q12	?Spermatogenic failure 29	618091	AR	3
617825	22q11.21	?Glucocorticoid deficiency 5	617825	AR	3
617710	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
616846	1p36.13	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875	AR	3
618223	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
614424	2q33.1	Joubert syndrome 14	614424	AR	3
617164	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
617928	2q21.1	Keratoconus 9	617928	AD	3
615923	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
618189	1p34.2	Cardiomyopathy, dilated, 2C	618189	AR	3
617690	9q34.3	Ovarian dysgenesis 5	617690	AR	3
617929	6p21.1	Epileptic encephalopathy, early infantile, 60	617929	AR	3
617965	14q32.2	?Spermatogenic failure 27	617965	AR	3
618092	14q32.2	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092	AD	3
617691	6q24.3	Spinocerebellar ataxia 44	617691	AD	3
617711	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
615924	11q12.3	Encephalopathy, progressive, with or without lipodystrophy	615924	AR	3
618447	12p13.33	Long QT syndrome 8	618447	_	3
618437	1p32.3	Epileptic encephalopathy, early infantile, 75	618437	AR	3
617930	1p35	Chromosome 1p35 deletion syndrome	617930	AD	4
618093	16p13.3	?Spinocerebellar ataxia 48	618093	AD	3
617460	10q22.1	Retinitis pigmentosa 79	617460	AD	3
614207	11p15.4	Hyperphosphatasia with mental retardation syndrome 3	614207	AR	3
617712	7q11.23	Oocyte maturation defect 3	617712	AD	3
618438	15q15.1	?Spastic ataxia 9, autosomal recessive	618438	AR	3
617931	1p35.2	Spinocerebellar ataxia 47	617931	AD	3
618094	14q12	?Deafness, autosomal recessive 110	618094	AR	3
614426	8p12	Mental retardation, autosomal recessive 39	615541	AR	3
618112	16q22.2	Spermatogenic failure 31	618112	AR	3
617166	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
618321	13q34	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321	AR	3
614464	7q32.2	Joubert syndrome 15	614464	AR	3
614427	18q22.3	Aural atresia, congenital	607842	AD	3
618193	6p21.1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	_	3
616654	12q24.31	Joubert syndrome 24	616654	AR	3
618027	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
616254	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
618440	11p15.1	Oculoskeletodental syndrome	618440	AR	3
614218	17p13.3	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	AR	3
614218	17p13.3	Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3
618323	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
618095	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
617694	16q24.3	Al Kaissi syndrome	617694	AR	3
617933	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
618120	19p13.3	Mitochondrial complex V (ATP synthase) deficiency	618120	AR	3
617695	3q12.1-q12.2	Pontocerebellar hypoplasia, type 11	617695	AR	3
617306	3p13	COMMAD syndrome	617306	AR	3
618469	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
617913	17p13.3	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3
614219	19p13.2	Adams-Oliver syndrome 2	614219	AR	3
618096	14q21.2	?Premature ovarian failure 15	618096	AR	3
614465	11q12.2	Joubert syndrome 16	614465	AR	3
618470	7q22.1	Intellectual developmental disorder with severe speech and ambulation defects	618470	AD	3
617308	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
614220	7q32	Biliary cirrhosis, primary, 4	614220	_	2
614466	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
614221	17q12	Biliary cirrhosis, primary, 5	614221	_	2
617330	10q26.3	Hypotonia, ataxia, and delayed development syndrome	617330	AD	3
618123	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
618224	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
616039	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
614222	10p12.1	Warburg micro syndrome 3	614222	AR	3
618124	21q22.3	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124	AR	3
613339	10q21.3-q22.3	Epilepsy, hot water, 1	613339	AD	2
614223	19p13.2	Narcolepsy 6	614223	_	2
618225	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
618195	15q24.3	Intellectual developmental disorder and retinitis pigmentosa	618195	AR	3
616324	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
616067	8q23.1	46XY sex reversal 9	616067	AD	3
614224	4q12	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	AR	3
616325	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
618196	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
617967	17p13.3	Hydrocephalus, congenital, 3, with brain anomalies	617967	AR	3
616040	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
618449	17q12	?Ciliary dyskinesia, primary, 41	618449	AR	3
617011	15q22.31	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3
618197	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
616326	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
614225	1q41	Warburg micro syndrome 2	614225	AR	3
617333	3p25.3	Intellectual developmental disorder with dysmorphic facies and ptosis	617333	AD	3
616917	4p16.3	Mental retardation, autosomal recessive 53	616917	AR	3
614226	11q24.2	Holoprosencephaly 11	614226	AD	3
616327	13q34	Mental retardation, autosomal dominant 40	616579	AD	3
618198	15q23	Myasthenic syndrome, congenital, 24, presynaptic	618198	AR	3
616918	4p16.3	Mental retardation, autosomal recessive 53	616917	AR	3
617970	1p36.11	Rh-null disease, amorph type	617970	_	3
614227	2p22.1-p21	Hyperuricemic nephropathy, familial juvenile, 3	614227	AD	2
617013	8p21.3	Hypermanganesemia with dystonia 2	617013	AR	3
616042	6p21.1	?Deafness, autosomal recessive 103	616042	AR	3
618226	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
616069	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
618031	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
614228	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
618227	11p15.5	Ciliary dyskinesia, primary, 39	618254	AR	3
614229	1q32.2	?Spinocerebellar ataxia, autosomal recessive 11	614229	AR	3
614230	8q21.11	Chromosome 8q21.11 deletion syndrome	614230	IC,AD	4
618451	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
618228	1q23.3	Mitochondrial complex I deficiency, nuclear type 6	618228	AR	3
618229	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
618231	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
618453	7p22.1	?Intellectual developmental disorder with short stature and variable skeletal anomalies	618453	AR	3
618454	7q22.1	Developmental delay with or without dysmorphic facies and autism	618454	AD	3
618455	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
617612	2q37.1	Joubert syndrome 30	617622	AR	3
618232	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
617613	9q21.33	Multiple mitochondrial dysfunctions syndrome 5	617613	AR	3
614082	9p13.3	Fanconi anemia, complementation group G	614082	_	3
618233	5q12.1	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3
614083	2p16.1	Fanconi anemia, complementation group L	614083	AR	3
618234	15q15.1	Mitochondrial complex I deficiency, nuclear type 11	618234	AR	3
617475	17q23.3	Specific granule deficiency 2	617475	AR	3
616404	2p11.2	Acrofacial dysostosis, Cincinnati type	616462	AD	3
616050	2p22.3	Autoinflammation with infantile enterocolitis	616050	AD	3
616051	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
616052	7p21.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3
614084	7q34	Oocyte maturation defect 5	617996	AR	3
618475	14q24.3	Paragangliomas 7	618475	AD	3
618476	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
618477	15q25.3	[Uridine-cytidineuria]	618477	AR	3
618479	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
618480	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
603859	7q21.3	Citrullinemia, adult-onset type II	603471	AR	3
603859	7q21.3	Citrullinemia, type II, neonatal-onset	605814	AR	3
606202	5p13.2	Albinism, oculocutaneous, type IV	606574	_	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	AR	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	AR	3
606202	5p13.2	[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	AR	3
605225	1p36	{Inflammatory bowel disease 7}	605225	_	2
604584	8p22	Colorectal cancer, somatic	114500	_	3
604584	8p22	Hepatocellular cancer, somatic	114550	_	3
607036	15q15.1	Isovaleric acidemia	243500	AR	3
604004	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603848	5p15.33	Mitochondrial complex I deficiency, nuclear type 9	618232	AR	3
604983	17q23.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	AD	3
607072	3p21.31	Epilepsy, familial focal, with variable foci 2	617116	AD	3
603694	20q12-q13.1	{Diabetes mellitus, noninsulin-dependent}	125853	AD	2
604499	11p	Hyperlipidemia, combined, 2	604499	_	2
607250	14q32.11	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	607250	AR	3
604566	1p31.3	Congenital disorder of glycosylation, type Ic	603147	AR	3
605236	4p12	Preeclampsia/eclampsia 5	614595	_	3
606236	17q25.3	Alveolar soft-part sarcoma	606243	_	3
603113	11q23.1	Lung cancer, somatic	211980	_	3
606608	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
607292	1q22	Cone-rod dystrophy 10	610283	AR	3
607292	1q22	Retinitis pigmentosa 35	610282	AR,AD	3
606960	22q12.1-q12.2	Insulinoma	_	_	1
603707	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
607131	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
603495	19q13.43	Spermatogenic failure 5	243060	AR	3
605725	19q13.2	Charcot-Marie-Tooth disease, type 4F	614895	AR	3
605725	19q13.2	Dejerine-Sottas disease	145900	AR,AD	3
605425	1p34.3	Erythrokeratodermia variabilis et progressiva 2	617524	AD	3
606053	2q24.2	Intellectual developmental disorder with autism and speech delay	606053	AD	3
604286	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
604484	3q12.2	Hereditary motor and sensory neuropathy, Okinawa type	604484	AD	3
605383	16p12.1	Immunodeficiency 56	615207	AR	3
605383	16p12.1	[IgE, elevated level of]	147050	AD	3
606635	21q21.1	Enterokinase deficiency	226200	AR	3
607479	18p11.22	Hypotrichosis 1	605389	AD	3
604433	11q13.4	?Brugada syndrome 6	613119	_	3
606763	19q13.42	Ciliary dyskinesia, primary, 2	606763	AR	3
605275	22q11.21	Noonan syndrome 2	605275	AR	3
606686	12q24.31	Leukoencephalopathy with vanishing white matter	603896	AR	3
606425	1q42.2	Erythrocytosis, familial, 3	609820	AD	3
606425	1q42.2	[Hemoglobin, high altitude adaptation]	609070	AD	3
602926	9q34.11	Epileptic encephalopathy, early infantile, 4	612164	AD	3
605073	17q22	Mulibrey nanism	253250	AR	3
604973	1p36.11	Immunodeficiency due to ficolin 3 deficiency	613860	AR	3
607408	13q33.2	{Schizophrenia}	181500	AD	2
606985	11p13	?Aniridia 2	617141	AD	3
607037	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
606566	20q11.21	Cardiomyopathy, hypertrophic, 1, digenic	192600	AD	3
605286	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
605872	19p13.2	SARS infection, protection against	605872	_	2
604258	8p22	Colorectal cancer, somatic	114500	_	3
605226	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
605115	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
606077	1p13.3	Megakaryoblastic leukemia, acute	606077	_	2
607447	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
607623	18q11.2	Niemann-Pick disease, type C1	257220	AR	3
607623	18q11.2	Niemann-Pick disease, type D	257220	AR	3
607170	3p25.3	Atrioventricular septal defect, partial, with heterotaxy syndrome	606217	AD	3
607170	3p25.3	{Atrioventricular septal defect, susceptibility to, 2}	606217	AD	3
605543	4q22.1	Parkinson disease 4	605543	AD	3
604455	9q34.2	[Sarcosinemia]	268900	AR	3
607361	8q22.1	Meckel syndrome 3	607361	AR	3
605336	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AR,AD	3
605336	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
606609	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AR,AD	3
606609	3p21.31	Chilblain lupus	610448	AD	3
606609	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
606609	3p21.31	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
605755	6p22.3	?Deafness, autosomal recessive 66	610212	AR	3
605755	6p22.3	Nephronophthisis 19	616217	AR	3
605755	6p22.3	Sclerosing cholangitis, neonatal	617394	AR	3
605692	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
607143	22q13.33	Congenital disorder of glycosylation, type Ig	607143	AR	3
604485	15q23	Enhanced S-cone syndrome	268100	AR	3
604485	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
606974	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
605978	9q21.2	Choreoacanthocytosis	200150	AR	3
606367	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
607839	3p12.2	Glycogen storage disease IV	232500	AR	3
607839	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
604190	5q31.1	{Rheumatoid arthritis, susceptibility to}	180300	_	3
607084	9q32	Deafness, autosomal recessive 31	607084	AR	3
607236	20p13	HARP syndrome	607236	AR	3
603860	16p12.3	Medullary cystic kidney disease 2	603860	_	3
605564	15q25.1	Deafness, autosomal recessive 48	609439	AR	3
605564	15q25.1	Usher syndrome, type IJ	614869	AR	3
608031	20p13	Amyotrophic lateral sclerosis 7	608031	_	2
605254	1q23.2	Acne inversa, familial, 1	142690	AD	3
605726	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
606323	5q33.3	Epileptic encephalopathy, early infantile, 65	618008	AD	3
605158	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
604720	7q22.1	Hemochromatosis, type 3	604250	AR	3
607329	2p25-p24	{Hypertension, essential, susceptibility to, 3}	145500	Mu	2
607186	4q26	Cole-Carpenter syndrome 2	616294	AR	3
605526	10q24	Alzheimer disease 6	605526	_	2
604610	15q26.1	Bloom syndrome	210900	AR	3
603422	5q31.1	{Osteoporosis, susceptibility to}	166710	AD	3
603023	7p12.2	Immunodeficiency, common variable, 13	616873	AD	3
605325	7q22.1	{Hypertension, salt-sensitive essential, susceptibility to}	145500	Mu	3
606078	22q13.1-q13.2	Megakaryoblastic leukemia, acute	_	_	3
604500	17q12	PEHO syndrome	260565	AR	3
607252	22q12.3	{Schizophrenia}	181500	AD	1
603048	8q24.3	Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3
604032	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
608111	2p16.1	Fanconi anemia, complementation group L	614083	AR	3
607204	1p35.2	Spinocerebellar ataxia 47	617931	AD	3
606962	17q25.1	Deafness, autosomal recessive 107	617639	AR	3
605517	11q13.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3
605452	2q35	Dyschromatosis universalis hereditaria 3	615402	AD	3
605452	2q35	Microphthalmia, isolated, with coloboma 7	614497	AD	3
605452	2q35	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	3
605452	2q35	[Blood group, Langereis system]	111600	_	3
604360	15q21.1	Spastic paraplegia 11, autosomal recessive	604360	AR	3
608264	22q11.21-q12.1	Deafness, autosomal recessive 40	608264	AR	2
607215	1p36.31	Nephronophthisis 4	606966	AR	3
607215	1p36.31	Senior-Loken syndrome 4	606996	AR	3
608309	1p36.12	Parkinson disease 6, early onset	605909	AR	3
603131	7q22.1	Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3
607038	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
604288	2q14-q22	Cardiomyopathy, dilated, 1H	604288	_	2
606368	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
606368	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
608035	1p22	{Melanoma, cutaneous malignant, 4}	608035	_	2
605185	15q15.1	Adams-Oliver syndrome 6	616589	AD	3
607900	20p12.3	Kindler syndrome	173650	AR	3
605411	1p13.2	Brugada syndrome 9	616399	AD	3
605411	1p13.2	Spinocerebellar ataxia 19	607346	AD	3
604975	12p12.1	Lamb-Shaffer syndrome	616803	AD	3
608156	8q22.1	Nablus mask-like facial syndrome	608156	AD	4
603967	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
603967	17q23.3	Hypokalemic periodic paralysis, type 2	613345	AD	3
603967	17q23.3	Myasthenic syndrome, congenital, 16	614198	AR	3
603967	17q23.3	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3
603967	17q23.3	Paramyotonia congenita	168300	AD	3
607521	11p15.1	Hermansky-Pudlak syndrome 5	614074	AR	3
608205	1p35.3	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282	AR	3
607624	15q21.3	Griscelli syndrome, type 2	607624	AR	3
605100	17q23.2	Breast cancer, somatic	114480	_	3
605100	17q23.2	Jansen de Vries syndrome	617450	AD	3
607135	3p	Creatinine clearance QTL	607135	_	2
606324	1p36.23	Parkinson disease 7, autosomal recessive early-onset	606324	AR	3
604772	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
603861	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
604103	5q31.2	Myopathy, myofibrillar, 3	609200	AD	3
604103	5q31.2	Myopathy, spheroid body	182920	AD	3
605848	19p13.12	Ichthyosis, congenital, autosomal recessive 12	617320	AR	3
605124	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
603457	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
603474	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
605039	20q11.21	Bohring-Opitz syndrome	605039	AD	3
604900	8q24.3	?Diarrhea 7, protein-losing enteropathy type	615863	AR	3
606142	4p16.1	Hypouricemia, renal, 2	612076	AR,AD	3
606142	4p16.1	{Uric acid concentration, serum, QTL 2}	612076	AR,AD	3
607481	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
606882	13q14.3	Wilson disease	277900	AR	3
603767	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
604501	15q22.31	?Muscular dystrophy, congenital, Davignon-Chauveau type	617066	AR	3
604501	15q22.31	Spinal muscular atrophy with congenital bone fractures 1	616866	AR	3
608078	10q22.3	{Schizophrenia}	181500	AD	2
605938	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
603615	1p34.1	Adenocarcinoma, colonic, somatic	_	_	3
603615	1p34.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
603615	1p34.1	{Breast cancer, invasive ductal}	114480	SMu,AD	3
603516	22q13.31	Spinocerebellar ataxia 10	603516	AD	3
605000	16p11.2	Immunodeficiency 8	615401	AR	3
608429	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
604705	2q13	Retinitis pigmentosa 38	613862	AR	3
606056	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
606963	2q	Pulmonary disease, chronic obstructive, severe early-onset	606963	_	2
606829	9q21.11	Friedreich ataxia	229300	AR	3
606829	9q21.11	Friedreich ataxia with retained reflexes	229300	AR	3
604990	17q25.1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3
603010	7q31	Deafness, autosomal recessive 17	603010	AR	2
606407	2p21	Hypotonia-cystinuria syndrome	606407	AR	4
604297	21q22.11	Epileptic encephalopathy, early infantile, 53	617389	AR	3
604297	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
608414	10q23.33	Nephrotic syndrome, type 3	610725	AR	3
605727	7q34-q36	Otosclerosis 2	605727	_	2
606568	3p21.31	Bardet-Biedl syndrome 17	615994	AR	3
608310	7q11.21	Argininosuccinic aciduria	207900	AR	3
603290	11q13.3-q13.4	{Autism susceptibility 17}	613436	_	3
604457	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
604457	2q37.1	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
607901	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
606034	19p13.13	Aicardi-Goutieres syndrome 4	610333	AR	3
605544	5q13-q22	Fibromatosis, gingival, 2	605544	_	2
604841	1p21.1	Stickler syndrome, type II	604841	AD	3
606687	2p23.3	Leukoencephalopathy with vanishing white matter	603896	AR	3
606687	2p23.3	Ovarioleukodystrophy	603896	AR	3
606854	16q21	Polymicrogyria, bilateral frontoparietal	606854	AR	3
606639	3q25.32	Combined oxidative phosphorylation deficiency 1	609060	AR	3
608265	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
607039	16p12.2	Deafness, autosomal recessive 22	607039	AR	3
608036	5q34-q35.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	2
604588	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	AR,DR	3
604588	4q33	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3
607625	14q24.3	Niemann-pick disease, type C2	607625	AR	3
604611	8p12	Werner syndrome	277700	AR	3
608371	4q21-q31	Orofacial cleft 4	608371	_	2
608533	5q32	Neuronopathy, distal hereditary motor, type IID	615575	AD	3
605289	3q28	Split-hand/foot malformation 4	605289	AD	3
608112	3p22.1	Epileptic encephalopathy, early infantile, 68	618201	AR	3
604773	11q25	Isobutyryl-CoA dehydrogenase deficiency	611283	_	3
608241	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
606999	9p13.3	Galactosemia	230400	AR	3
608331	5q33.1	Hyperglycinuria	138500	AD	3
608331	5q33.1	Iminoglycinuria, digenic	242600	AR,DR	3
608283	12q12	Fibrosis of extraocular muscles, congenital, 1	135700	AD	3
608283	12q12	Fibrosis of extraocular muscles, congenital, 3B	135700	AD	3
605101	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
606988	15q15.1	?Spastic ataxia 9, autosomal recessive	618438	AR	3
608100	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
604901	16q22	North American Indian childhood cirrhosis	604901	_	2
606475	19p13.2	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	_	3
604289	8q22.1	Colon cancer, somatic	114500	_	3
604289	8q22.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
603056	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
608443	19p13.12	Mental retardation, autosomal recessive 3	608443	AR	3
607053	8q23	[High density lipoprotein cholesterol level QTL 2]	607053	_	2
604526	20p13	Retinitis pigmentosa 46	612572	_	3
605714	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
603517	1p22.3	?Immunodeficiency 37	616098	AR	3
603517	1p22.3	Lymphoma, MALT, somatic	137245	_	3
603517	1p22.3	{Lymphoma, follicular, somatic}	605027	_	3
603517	1p22.3	{Male germ cell tumor, somatic}	273300	_	3
603517	1p22.3	{Mesothelioma, somatic}	156240	_	3
603517	1p22.3	{Sezary syndrome, somatic}	_	_	3
606370	7q35	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	AR	3
607482	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
607411	12q24	{Patent ductus arteriosus, susceptibility to}	607411	AR	2
606062	10q25.2	Cornelia de Lange syndrome 3	610759	AD	3
606640	18q21	Amyotrophic lateral sclerosis 3	606640	AD	2
606830	9q21.33	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276	AR	3
606035	6q22-q24	[Fasting insulin level quantitative trait locus 1]	606035	_	2
605728	15q21-q22	Cataract 25	605728	_	2
603024	1p36.11	Coffin-Siris syndrome 2	614607	AD	3
608645	6p21.3	Deafness, autosomal dominant 31	608645	AD	2
607364	1p36.13	Bartter syndrome, type 3	607364	AR	3
607961	15q24.1	[Blood group, John-Milton-Hagen system]	614745	_	3
602959	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
602959	20q13.33	Mental retardation, autosomal dominant 38	616393	AD	3
606144	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
608695	9q22	Glaucoma, primary open angle, juvenile-onset, 2	608695	_	2
606408	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
607040	16q12.1	[Axillary odor, variation in]	117800	AD	3
607040	16q12.1	[Colostrum secretion, variation in]	117800	AD	3
607040	16q12.1	[Earwax, wet/dry]	117800	AD	3
604159	11p15.1	Hyperekplexia 3	614618	AR,AD	3
606129	8p23.3-p22	Diamond-Blackfan anemia 2	606129	_	2
603850	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
603850	12p11.21	Optic atrophy 5	610708	AD	3
602935	1p33	{Drug addiction, susceptibility to}	606581	_	3
605849	5q14.1	Dimethylglycine dehydrogenase deficiency	605850	AR	3
606325	6q21	?Heterotaxy, visceral, 3, autosomal	606325	_	2
605290	3q29	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	616896	_	3
605290	3q29	Behr syndrome	210000	AR	3
605290	3q29	Optic atrophy 1	165500	AD	3
605290	3q29	Optic atrophy plus syndrome	125250	AD	3
605290	3q29	{Glaucoma, normal tension, susceptibility to}	606657	_	3
608480	6p21.31	Spermatogenic failure 3	606766	AD	3
608271	1p34.3	Lissencephaly 9 with complex brainstem malformation	618325	AD	3
606883	12q12	Invasive pneumococcal disease, recurrent isolated, 1	610799	_	3
606883	12q12	IRAK4 deficiency	607676	_	3
604723	12q14.1	Combined oxidative phosphorylation deficiency 3	610505	AR	3
606476	19q13.2	{Kawasaki disease, susceptibility to}	611775	_	3
608010	7p13	[Ezetimibe, nonresponse to]	617966	_	3
608010	7p13	[Low density lipoprotein cholesterol level QTL 7]	617966	_	3
606551	8p21.3	Esophageal squamous cell carcinoma, somatic	133239	_	3
608633	11q22.3	{Sepsis, susceptibility to}	_	_	3
604902	14q32.33	Cerebellofaciodental syndrome	616202	AR	3
605267	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
607823	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
605361	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
608603	15q21.2	Lethal congenital contracture syndrome 11	617194	AR	3
603883	10q26.11	Cardiomyopathy, dilated, 1HH	613881	AD	3
603883	10q26.11	Myopathy, myofibrillar, 6	612954	AD	3
608723	6p24.1	Epileptic encephalopathy, early infantile, 70	618298	AD	3
607903	18q12.1	Hypotrichosis 6	607903	AR	3
606036	15q25.1	?Webb-Dattani syndrome	615926	AR	3
608390	17q23.3	Myotonia congenita, atypical, acetazolamide-responsive	608390	AD	3
607136	6q27	Spinocerebellar ataxia 17	607136	AD	3
603057	11p15.4	Mitral valve prolapse 2	607829	AD	3
603057	11p15.4	Van Maldergem syndrome 1	601390	AR	3
603025	11q14.2	Leukemia, acute myeloid, somatic	601626	_	3
606831	2p22.3	?Familial cold autoinflammatory syndrome 4	616115	AD	3
606831	2p22.3	Autoinflammation with infantile enterocolitis	616050	AD	3
606641	7q32.3	[Body mass index QTL1]	606641	_	2
608177	8q24.11	Chondrosarcoma	215300	AR	3
608177	8q24.11	Exostoses, multiple, type 1	133700	AD	3
608646	15q13.1-q15.1	Ciliary dyskinesia, primary, 4	608646	_	2
607311	11q22.1	?Progesterone resistance	264080	AR	2
603254	19p13.2	Coffin-Siris syndrome 4	614609	AD	3
603254	19p13.2	{Rhabdoid tumor predisposition syndrome 2}	613325	AD	3
605850	5q14.1	Dimethylglycine dehydrogenase deficiency	605850	AR	3
607453	3q28	?Deafness, autosomal dominant 44	607453	AD	3
606269	22q13.2	Immunodeficiency, common variable, 4	613494	AR	3
606409	20q11.22	Autoimmune disease, multisystem, with facial dysmorphism	613385	AR	3
603769	14q32.13	Leukemia/lymphoma, T-cell	603769	_	2
607365	3q27.2	Hypotrichosis 7	604379	AR	3
607365	3q27.2	Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379	AR	3
603851	4p13	Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	AD	3
603851	4p13	Neuroblastoma with Hirschsprung disease	613013	_	3
603851	4p13	{Neuroblastoma, susceptibility to, 2}	613013	_	3
607626	3q28	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	AR	3
608634	7q11.23	Neuropathy, distal hereditary motor, type IIB	608634	AD	3
603678	7q31	Deafness, autosomal recessive 14	603678	AR	2
608416	10q26.2	Heterotaxy, visceral, 7, autosomal	616749	AR	3
605670	11q23.3	Retinal degeneration, late-onset, autosomal dominant	605670	AD	3
605744	8p21.1	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425	AR	3
605268	16q24.2	Huntington disease-like 2	606438	AD	3
606966	1p36.31	Nephronophthisis 4	606966	AR	3
606989	17q22	Myeloperoxidase deficiency	254600	AR	3
606989	17q22	{Alzheimer disease, susceptibility to}	104300	AD	3
606989	17q22	{Lung cancer, protection against, in smokers}	_	_	3
608256	11q23.3	Atrial fibrillation, familial, 17	611819	AD	3
608256	11q23.3	Long QT syndrome-10	611819	AD	3
607276	10q25.3	[Resting heart rate]	607276	_	3
606145	20q13.12	Arterial tortuosity syndrome	208050	AR	3
605362	6q23.2	?Cardiomyopathy, dilated, 1J	605362	AD	3
607243	14q12	Spastic paraplegia 52, autosomal recessive	614067	AR	3
608243	15q13.1	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3
608391	Chr.7	{Autoimmune disease, susceptibility to, 2}	608391	_	2
607137	4q21.22	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115	AD	3
603026	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
606326	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
606037	3q13.1-q13.2	C syndrome	211750	AD	3
606754	20q11.23	?Chilblain lupus 2	614415	AD	3
606754	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
608313	6q23.2	Argininemia	207800	AR	3
608696	20p12	Glaucoma 1K, primary open angle, juvenile-onset	608696	_	2
605555	11q13.2	Pituitary adenoma 1, multiple types	102200	SMu,AD	3
605555	11q13.2	Pituitary adenoma predisposition	102200	SMu,AD	3
607454	1p36.33	Spinocerebellar ataxia 21	607454	AD	3
604088	7p14.3	{Hypercholesterolemia, susceptibility to}	143890	AD	3
607042	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
608272	6p21.33	Sialidosis, type I	256550	AR	3
608272	6p21.33	Sialidosis, type II	256550	AR	3
608647	16q22.2	Ciliary dyskinesia, primary, 5	608647	AR	3
603258	8p11.21	Immunodeficiency 15A	618204	AD	3
603258	8p11.21	Immunodeficiency 15B	615592	AR	3
606570	7p14.1	Pyle disease	265900	AR	3
606781	3p21.1	Short stature, developmental delay, and congenital heart defects	617044	AR	3
607984	5q31.3	Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3
608565	14q24.3	Deafness, autosomal recessive 35	608565	AR	3
608980	9p22.3	Bifid nose with or without anorectal and renal anomalies	608980	_	3
608662	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
608662	11p14.3	Miyoshi muscular dystrophy 3	613319	AR	3
608662	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
606478	7q31.33	{Glioma susceptibility 9}	616568	AD	3
606478	7q31.33	{Melanoma, cutaneous malignant, susceptibility to, 10}	615848	AD	3
608380	2q31.3	Retinitis pigmentosa 26	608380	_	3
607008	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
603518	2p13.3	Welander distal myopathy	604454	AR,AD	3
609040	12p11.21	Arrhythmogenic right ventricular dysplasia 9	609040	AD	3
604714	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
608536	19p13.11	Combined oxidative phosphorylation deficiency 23	616198	AR	3
608803	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608803	1q42.13	Lymphatic malformation 3	613480	AD	3
608803	1q42.13	Spastic paraplegia 44, autosomal recessive	613206	AR	3
606990	3q23	?Microcephaly 19, primary, autosomal recessive	617800	AR	3
605363	2q31.1	?Cerebral palsy, spastic quadriplegic, 1	603513	AR	3
608392	Chr.8	{Autoimmune disease, susceptibility to, 3}	608392	_	2
606967	16q22.1	Fish-eye disease	136120	AR	3
606967	16q22.1	Norum disease	245900	AR	3
607244	15q21.2	Spastic paraplegia 51, autosomal recessive	613744	AR	3
607244	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
608744	1p13.3	Fontaine progeroid syndrome	612289	AD	3
606833	7q36.1	Kleefstra syndrome 2	617768	AD	3
608697	2p13.3	Premature ovarian failure 6	612310	AD	3
608611	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
605229	3q27-q28	Spastic paraplegia 14, autosomal recessive	605229	AR	2
603136	2q36.2	Pseudohypoaldosteronism, type IIE	614496	AD	3
608684	14q22.1	?Seckel syndrome 7	614851	AR	3
605988	10p13	Omenn syndrome	603554	AR	3
605988	10p13	Severe combined immunodeficiency, Athabascan type	602450	AR	3
603644	17p13.1	Mitochondrial complex IV deficiency	220110	Mi,AR	3
608918	17p11.2	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	AR	3
607277	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
607043	6q21	?Candidiasis, familial, 8	615527	AR	3
607043	6q21	{Psoriasis susceptibility 13}	614070	_	3
606373	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
606421	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
606271	1q42.2	Schizophrenia	181500	AD	2
607474	3q13.33	Alkaptonuria	203500	AR	3
606520	6p21.33	?Thrombocytopenia, anemia, and myelofibrosis	617441	AR	3
609247	3q25.1	Epileptic encephalopathy, early infantile, 73	618379	AD	3
606837	8q11.23	Breast cancer, somatic	114480	_	3
607009	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
604824	13q13.1	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	_	3
608663	12q12	Scott syndrome	262890	AR	3
603339	7p15.3	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	AR	3
606643	13q14	[Body mass index QTL2]	606643	_	2
608648	6q21	Polycystic liver disease 2	617004	AD	3
609141	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
606890	14q31.3	Krabbe disease	245200	AR	3
604715	16q12.2	?Orthostatic intolerance	604715	_	3
606834	19q13.12	Dystonia 28, childhood-onset	617284	AD	3
608445	3p12-q13	{Speech-sound disorder}	608445	_	2
607245	1p13.2	Spastic paraplegia 47, autosomal recessive	614066	AR	3
605588	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
605041	16q12.1	Brooke-Spiegler syndrome	605041	AD	3
607840	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
607840	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
604757	5q35.2	Craniosynostosis 2	604757	AD	3
605032	4p16.3	Epileptic encephalopathy, early infantile, 63	617976	AR	3
609382	18q21.1	Microcephaly, epilepsy, and diabetes syndrome	614231	AR	3
608526	1q25	Periodontitis, aggressive, 2	608526	_	2
608393	13q12.12-q12.13	Microcephaly 6, primary, autosomal recessive	608393	AR	3
607278	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
609302	11p15.5	Epileptic encephalopathy, early infantile, 3	609304	AR	3
609195	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
604487	11p15.1	Deafness, autosomal recessive 18B	614945	AR	3
608013	1q22	Gaucher disease, perinatal lethal	608013	AR	3
607475	15q26.1	Bothnia retinal dystrophy	607475	AR	3
608636	15q11	{Autism susceptibility 4}	608636	AD	2
608354	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
607323	20q13.2	Duane-radial ray syndrome	607323	AD	3
608194	14q11.2	Cone-rod dystrophy 13	608194	_	3
606628	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
609053	15q26.1	Fanconi anemia, complementation group I	609053	AR	3
605270	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
609628	18p11.31	Majeed syndrome	609628	_	3
608419	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
606480	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
606480	1p34.2	Restrictive dermopathy, lethal	275210	AR	3
604161	19p13.3	?Precocious puberty, central, 1	176400	AD	3
604161	19p13.3	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	AR	3
604758	19q13.32	?Immunodeficiency 53	617585	AR	3
608699	7p14.3	Diaphanospondylodysostosis	608022	AR	3
607279	11q14	{Systemic lupus erythematosus with hemolytic anemia}	607279	_	2
605589	19q13.33	?Charcot-Marie-Tooth disease, type 2B2	605589	AR	3
603646	10q24.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	AR	3
603646	10q24.2	Leigh syndrome due to cytochrome c oxidase deficiency	256000	Mi,AR	3
603424	2q31.2	Dystonia 16	612067	AR	3
607246	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
608897	17q25.1	Hemophagocytic lymphohistiocytosis, familial, 3	608898	_	3
605042	6q23.2	Mental retardation, autosomal recessive 18	614249	AR	3
609196	21q22.11	Glucocorticoid deficiency 2	607398	AR	3
609657	5q	{Bone size QTL}	609657	_	2
604488	17q12	Cardiomyopathy, hypertrophic, 25	607487	AD	3
604488	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
603060	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
609510	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
607476	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
609314	21q22.3	Ciliary dyskinesia, primary, 24	615481	AR	3
609449	16p13.11	?Microhydranencephaly	605013	AR	3
609449	16p13.11	Lissencephaly 4 (with microcephaly)	614019	AR	3
608572	18q23	Burn-McKeown syndrome	608572	AR	3
609750	10q25-q26	{Epilepsy, idiopathic generalized, susceptibility to 4}	609750	_	2
608804	1q42.13	Leukodystrophy, hypomyelinating, 2	608804	AR	3
608990	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
608890	8q11.21	Waardenburg syndrome, type 2D	608890	AR	3
609332	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
608433	1q44	Mental retardation, autosomal dominant 22	612337	AD	3
605364	19p13	{Psoriasis susceptibility 6}	605364	_	2
609279	13q12.12-q12.13	?Seckel syndrome 4	613676	AR	3
609279	13q12.12-q12.13	Microcephaly 6, primary, autosomal recessive	608393	AR	3
608151	4p14	?Cranioectodermal dysplasia 4	614378	AR	3
608151	4p14	?Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3
608151	4p14	Nephronophthisis 13	614377	AR	3
608151	4p14	Senior-Loken syndrome 8	616307	AR	3
606374	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
607324	19p13.2-p13.1	Polydactyly, postaxial, type A3	607324	_	2
609575	17p13.1	VLCAD deficiency	201475	AR	3
608665	17q21.2	Ovarian dysgenesis 3	614324	AR	3
609383	5q33.3	Ichthyosis, congenital, autosomal recessive 6	612281	AR	3
604759	12q23.2	Pregnancy loss, recurrent, 4	270960	AD	3
604759	12q23.2	Spermatogenic failure 4	270960	AD	3
609669	5q22.1	Glaucoma 1, open angle, G	609887	_	3
609237	3q13.33	Senior-Loken syndrome 5	609254	AR	3
608394	2p12	Deafness, autosomal dominant 43	608394	AD	2
607631	6p12.2	{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3
608649	9q34.11	Ichthyosis prematurity syndrome	608649	_	3
609435	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
609435	19p13.11	{Thyroid carcinoma, Hurthle cell}	607464	_	3
604717	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
606765	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
605602	4q26	Cardiomyopathy, hypertrophic, 16	613838	AD	3
603708	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
609528	22q11.21	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	AR	3
608022	7p14.3	Diaphanospondylodysostosis	608022	AR	3
608179	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
609695	12q24.31	Hawkinsinuria	140350	AD	3
609695	12q24.31	Tyrosinemia, type III	276710	AR	3
603647	2q35	Bjornstad syndrome	262000	AR	3
603647	2q35	GRACILE syndrome	603358	_	3
603647	2q35	Leigh syndrome	256000	Mi,AR	3
603647	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
609454	1q31.1	Supranuclear palsy, progressive, 2	609454	AD	2
609736	2p16.1	?PEHO syndrome-like	617507	AR	3
608700	1p36.22	Leber congenital amaurosis 9	608553	AR	3
605231	20p12.2	Bardet-Biedl syndrome 6	605231	AR	3
608014	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
608014	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
609197	8q11.2-q13.2	Glucocorticoid deficiency 3	609197	AR	2
606893	20q13.12	Vascular malformation, primary intraosseous	606893	AR	3
608805	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
609640	14q22.1-q22.3	Frias syndrome	609640	AD	4
608901	3q21.1-q21.2	{Coronary heart disease, susceptibility to, 5}	608901	_	3
608747	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
609670	11q24	{Migraine with aura, susceptibility to, 9}	609670	_	2
609280	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
608666	22q11.21	Peroxisome biogenesis disorder 7A (Zellweger)	614872	AR	3
608666	22q11.21	Peroxisome biogenesis disorder 7B	614873	AR	3
604083	2q35	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425	AR	3
603709	7q21.12	?Epileptic encephalopathy, early infantile, 61	617933	AR	3
609988	4q24	?Sudden cardiac failure, alcohol-induced	617223	AR	3
609988	4q24	Sudden cardiac failure, infantile	617222	AR	3
608728	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
609529	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
608612	1p34.2	Mandibuloacral dysplasia with type B lipodystrophy	608612	AR	3
609751	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
610066	20q13	{Systemic lupus erythematosus, susceptibility to, 8}	610066	_	2
603266	10q25	{Diabetes mellitus, insulin-dependent, 17}	603266	_	2
606766	6p21.31	Spermatogenic failure 3	606766	AD	3
607248	15q23-q26.3	{Glioma susceptibility 4}	607248	_	2
607179	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
605232	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
605232	12p13.33	Pseudohypoaldosteronism, type IIC	614492	AD	3
608404	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
609346	19p13.3	Retinitis pigmentosa 77	617304	AR	3
608687	11q12	Spinocerebellar ataxia 20	608687	AD	4
604733	1p12	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710	AR	3
609512	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
609512	3p11.2	Dementia, familial, nonspecific	600795	AD	3
609289	15q26	Syncope, familial vasovagal	609289	AD	2
609630	11p11	{Leukemia, chronic lymphocytic, susceptibility to, 1}	609630	_	2
607326	18q21.1	Smith-McCort dysplasia	607326	AR	3
609502	10q23.1	Cone-rod dystrophy 15	613660	AR	3
609502	10q23.1	Retinitis pigmentosa 65	613660	AR	3
609671	2q14.2	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3
608667	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
608751	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AR,AD	3
609875	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
608922	3q11.1-q11.2	Joubert syndrome 8	612291	AR	3
610202	16q23.2	Cataract 21, multiple types	610202	AD	3
608892	8q12.2	CHARGE syndrome	214800	AD	3
608892	8q12.2	Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3
610034	12q24.31	Mucopolysaccharidosis-plus syndrome	617303	AR	3
610219	2q31.2	Deafness, autosomal recessive 59	610220	AR	3
609530	4q32.1	?Epilepsy, familial adult myoclonic, 7	618075	_	3
608447	12q24	Carotid intimal medial thickness	608447	_	2
609822	1p21	{Stature QTL 7}	609822	_	2
608180	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
610015	1q25.3	Glutamine deficiency, congenital	610015	AR	3
604364	22q12.2-q12.3	Epilepsy, familial focal, with variable foci 1	604364	AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal dominant	615625	AR,AD	3
609347	5q31.2	?Spastic paraplegia 72, autosomal recessive	615625	AR,AD	3
610239	4q32.3	[High density lipoprotein cholesterol level QTL 4]	610239	_	2
609317	5q22.3	?Anencephaly	206500	AR	3
610513	1p36.13	Kufor-Rakeb syndrome	606693	AR	3
610513	1p36.13	Spastic paraplegia 78, autosomal recessive	617225	AR	3
610256	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
609787	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
603400	6q21	Arthropathy, progressive pseudorheumatoid, of childhood	208230	AR	3
603400	6q21	Spondyloepiphyseal dysplasia tarda with progressive arthropathy	208230	AR	3
610535	5q22.1-q32	Glaucoma 1, open angle, M	610535	AD	2
608668	10p15.3	Mental retardation, autosomal dominant 30	616083	AD	3
610475	2q31.2	Pigmented nodular adrenocortical disease, primary, 2	610475	AD	3
608893	5p15.33	Hartnup disorder	234500	AR	3
608893	5p15.33	Hyperglycinuria	138500	AD	3
608893	5p15.33	Iminoglycinuria, digenic	242600	AR,DR	3
604982	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
608752	11q23.3	Retinal degeneration, late-onset, autosomal dominant	605670	AD	3
609886	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
610162	1p35.2	{Bardet-Biedl syndrome 1, modifier of}	209900	AR,DR	3
608614	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
610035	1q21.2	Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3
610220	2q31.2	Deafness, autosomal recessive 59	610220	AR	3
608688	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
604677	5q13.3	Mental retardation, autosomal dominant 34	616351	AD	3
610647	4p16.3	?N-acetylaspartate deficiency	614063	AR	3
609631	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
607632	19q13.12	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3
610271	17q11.2	Glycosylphosphatidylinositol biosynthesis defect 18	618143	AR	3
609823	22q13.1	Deafness, autosomal recessive 28	609823	AR	3
610140	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
609470	11p15	Left ventricular noncompaction 2	609470	_	2
603401	5q14.1	Hermansky-Pudlak syndrome 2	608233	AR	3
603711	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
603711	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
608396	3q24	{?Autism susceptibility 16}	613410	_	3
605746	16q13-q21	Anisomastia	605746	_	2
610069	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
605235	16q22.1	?Myoclonus, familial, 1	614937	AD	3
610685	6q14.1	Split-hand/foot malformation with long bone deficiency 2	610685	_	2
610840	13q31.3-q32.1	Mitral valve prolapse, myxomatous 3	610840	AD	2
609006	1p36.31	Deafness, autosomal recessive 36	609006	AR	3
608730	12q13.3	Myopia 24, autosomal dominant	615946	AD	3
610859	16q22.1	Immunodeficiency 58	618131	AR	3
610536	17q21.31	Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3
607841	12q13-q14	Deafness, autosomal dominant 48	607841	AD	2
610648	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
610662	4q22.1	Hyperphosphatasia with mental retardation syndrome 6	616809	AR	3
610359	2q11.2	Retinitis pigmentosa 33	610359	AD	3
609439	15q25.1	Deafness, autosomal recessive 48	609439	AR	3
609577	6p21.1	3-M syndrome 1	273750	AR	3
608187	20p12.3	?Premature ovarian failure 10	612885	AR	3
610804	1p31.3	Schneckenbecken dysplasia	269250	AR	3
610017	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
610222	20p11.23	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	AR	3
608652	9p22-p21	Deafness, autosomal dominant 47	608652	AD	2
610141	1q23.3	[QT interval, variation in]	610141	_	2
610272	20q13.12	?Paroxysmal nocturnal hemoglobinuria 2	615399	SMu,AD	3
610272	20q13.12	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3
609887	5q22.1	Glaucoma 1, open angle, G	609887	_	3
608691	15q25.3-q26.2	Major depressive disorder 2	608516	_	2
609952	4q12-q13.2	Deafness, autosomal recessive 55	609952	AR	2
608840	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	AR	3
609753	19p13.11	{Celiac disease, susceptibility to, 4}	609753	_	3
611023	14q23.1	Combined oxidative phosphorylation deficiency 26	616539	AR	3
607633	2p23.1	Xanthinuria, type I	278300	AR	3
609745	15q11-q13	Glaucoma 1, open angle, I	609745	_	2
609007	12q12	{Parkinson disease 8}	607060	AD	3
610649	8q24	[Bone size quantitative trait locus 3]	610649	_	2
609578	10q23.3	Cardiomyopathy, familial restrictive, 2	609578	_	2
611064	12q14.3	{Asthma susceptibility 5}	611064	_	3
611034	6p22.2	[Uric acid concentration, serum, QTL4]	612671	AD	3
611034	6p22.2	{Gout susceptibility 4}	612671	AD	3
603846	11p11.2	Mitochondrial complex I deficiency, nuclear type 8	618230	AR	3
609888	10p13	{Leprosy, paucibacillary type, susceptibility to}	609888	_	2
608615	17q24.1	Oligodontia-colorectal cancer syndrome	608615	AD	3
610549	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
606075	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
606075	10q24.31	Perrault syndrome 5	616138	AR	3
606075	10q24.31	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	AD	3
609471	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
610676	17q21	{Autism susceptibility 7}	610676	_	2
609754	5q31-q33	{Celiac disease, susceptibility to, 2}	609754	_	2
607634	11q13.2	Osteopetrosis, autosomal dominant 1	607634	AD	3
610290	9q22.33	{Colorectal cancer, susceptibility to, 1}	608812	_	3
610326	13q14.3	Aicardi-Goutieres syndrome 2	610181	AR	3
608841	19p13.11	Anterior segment dysgenesis 8	617319	AR	3
610071	2p14-p13.3	Hyperparathyroidism 3	610071	_	2
611065	4q22.1	?Maple syrup urine disease, mild variant	615135	_	3
609856	3q26.31	?Spermatogenic failure 6	102530	AR	3
608732	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
606164	19p13.2	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164	AD	3
611177	3q25.33	Short-rib thoracic dysplasia 2 with or without polydactyly	611263	AR	3
609981	8q11.21	Immunodeficiency 54	609981	AR	3
609755	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
611107	1p21.1-p13.3	Mental retardation, autosomal recessive, 4	611107	AR	2
610478	12p13.33	Retinal cone dystrophy 4	610478	AR	3
610550	10q22.3	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850	AR,AD	3
610550	10q22.3	Methionine adenosyltransferase deficiency, autosomal recessive	250850	AR,AD	3
608653	1p21.2	Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3
607012	5q13.2	?Deafness, autosomal recessive 112	618257	AR	3
610260	16p13-p12	Pyloric stenosis, infantile hypertrophic, 2	610260	_	2
610453	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
610453	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
609653	5q12.1	Mitochondrial complex I deficiency, nuclear type 10	618233	AR	3
609797	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
609797	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291	AD	3
611225	8p11.23	Spastic paraplegia 18, autosomal recessive	611225	AR	3
610965	16p13.12	XFE progeroid syndrome	610965	AR	3
611302	17p13.2	Spastic ataxia 2, autosomal recessive	611302	AR	3
609954	3p24-p21	{Asperger syndrome susceptibility 4}	609954	_	2
610860	1p21.2	Glycogen storage disease IIIa	232400	AR	3
610860	1p21.2	Glycogen storage disease IIIb	232400	AR	3
610931	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
608400	1q41	Retinitis pigmentosa 39	613809	_	3
608400	1q41	Usher syndrome, type 2A	276901	AR	3
610516	3p21.2	D-glyceric aciduria	220120	AR	3
609579	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
610551	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
609955	2p23.3-p22.3	Fibromatosis, gingival, 3	609955	_	2
611378	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
611423	4q12	Microcephaly 8, primary, autosomal recessive	614673	AR	3
610655	7p14	Telangiectasia, hereditary hemorrhagic, type 4	610655	AD	2
605763	1p36.23	Intellectual developmental disorder with neuropsychiatric features	617532	AR	3
610753	16q11-q22	Alopecia areata 2	610753	AR,AD	2
611109	4q32.3	[Cinnamon odor, pleasantness of]	611109	_	2
604741	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
611037	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
604165	17p13.2	Paragangliomas 6	618464	AD	3
610966	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
610966	16q12.2	{Obesity, susceptibility to, BMIQ14}	612460	AR	3
605130	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
610706	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
610665	1q23.3	Neutropenia, alloimmune neonatal	_	_	3
609790	9p22.1	Alzheimer disease-11	609790	_	2
610019	3p21.31	Cataract 18, autosomal recessive	610019	AR	3
611642	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3
611642	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	AD	3
611291	2q35	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	_	3
611654	8q13.1-q13.2	Joubert syndrome 21	615636	AR	3
611724	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
610967	11p15.5	Osteogenesis imperfecta, type V	610967	AD	3
609798	14q24.3	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3
609798	14q24.3	Lethal congenital contracture syndrome 10	617022	AR	3
609798	14q24.3	Nevus comedonicus, somatic	617025	_	3
603009	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
603009	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
603009	2p13.2	Myopathy, distal, with anterior tibial onset	606768	AR	3
610460	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
611038	18q21.32	Microphthalmia, isolated 3	611038	AR	3
603734	19q13.33	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}	616532	AD	3
606652	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
606768	2p13.2	Myopathy, distal, with anterior tibial onset	606768	AR	3
610036	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
609782	4q31	Aortic aneurysm, familial abdominal 2	609782	_	2
605131	16q23.1-q23.2	Epileptic encephalopathy, early infantile, 28	616211	AR	3
605131	16q23.1-q23.2	Esophageal squamous cell carcinoma, somatic	133239	_	3
605131	16q23.1-q23.2	Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3
609791	15q24.3	Mental retardation, autosomal recessive 64	618103	AR	3
609352	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
610968	17q21.2	Osteogenesis imperfecta, type XI	610968	AR	3
611725	7q11.21	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3
610863	3q26.33	Charcot-Marie-Tooth disease, dominant intermediate F	615185	AD	3
604432	15q15.2	Spinocerebellar ataxia 11	604432	AD	3
609868	14q31.3	Leber congenital amaurosis 3	604232	_	3
609868	14q31.3	Retinitis pigmentosa, juvenile, autosomal recessive	604232	_	3
611953	20p11.21	{Macular degeneration, age-related, 11}	611953	_	3
609656	17q23	{Bone size QTL}	609656	_	2
610657	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
610657	8q24.13	Spastic paraplegia 8, autosomal dominant	603563	AD	3
611892	9p21	{Aneurysm, intracranial berry, 6}	611892	_	2
611655	2q33.1	Mental retardation, autosomal recessive 42	615802	AR	3
610755	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
609985	4q31-q34	Panic disorder 3	609985	_	2
612083	14q24.3	Muscle strength quantitative trait locus 1	612083	_	2
604685	7p15.2	?Microtia, hearing impairment, and cleft palate (AR)	612290	AR,AD	3
604685	7p15.2	Microtia with or without hearing impairment (AD)	612290	AR,AD	3
611867	22q11.2	Chromosome 22q11.2 deletion syndrome, distal	611867	_	4
611379	12q13.12	Mental retardation, FRA12A type	136630	AD	3
611242	20p13	{Restless legs syndrome 5}	611242	_	2
609353	8p21.1	Roberts syndrome	268300	AR	3
609353	8p21.1	SC phocomelia syndrome	269000	AR	3
609799	17q11.2	?Nephronophthisis 9	613824	_	3
609799	17q11.2	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3
609253	18p11.2	Febrile seizures, familial, 6	609253	AD	2
604167	16q22.1	Mental retardation, autosomal dominant 21	615502	AD	3
609721	7p12.3	Heterotaxy, visceral, 8, autosomal	617205	AR	3
607522	10q24.32	Hermansky-Pudlak syndrome 6	614075	AR	3
611893	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
611040	11q23.3	Microphthalmia, isolated 5	611040	AR	3
611295	3q27.1	Epidermolysis bullosa simplex, generalized, with scarring and hair loss	617294	AD	3
611026	16q23.1	Spastic paraplegia 35, autosomal recessive	612319	AR	3
611549	13q32.3-q33.1	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3
611549	13q32.3-q33.1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419	AR	3
610552	3q22.1	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3
610552	3q22.1	Epileptic encephalopathy, early infantile, 44	617132	AR	3
610842	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
609010	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
612223	7q21	{Stature QTL 11}	612223	_	2
612048	3p25.1	Arrhythmogenic right ventricular dysplasia 5	604400	AD	3
612048	3p25.1	Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3
611726	7q11.21	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	AR	3
606770	5p15.2-p14	{Adiponectin, serum level of, QTL2}	606770	_	2
610341	3q28	Myopia, high, with cataract and vitreoretinal degeneration	614292	AR	3
611876	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
609254	3q13.33	Senior-Loken syndrome 5	609254	AR	3
609354	11q23	[Bone mineral density QTL 5]	609354	_	2
611934	10p11.22	{Epilepsy, idiopathic generalized, susceptibility to, 5}	611934	_	2
607523	3p21.31	Toenail dystrophy, isolated	607523	AD	3
609800	2p24	Epilepsy, generalized, with febrile seizures plus, type 4	609800	AD	2
611955	17q12	{Prostate cancer, hereditary, 11}	611955	_	2
611550	6p21.33	{Malaria, mild, susceptibility to}	609148	_	3
609239	13q14.2	Hypotrichosis 8	278150	AR	3
609239	13q14.2	Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	AR	3
605764	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
609069	10p12.2	Pancreatic and cerebellar agenesis	609069	AR	3
610553	13q13.3	Leukodystrophy, hypomyelinating, 14	617899	AR	3
610773	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
612310	2p13.3	Premature ovarian failure 6	612310	AD	3
611381	1p22	{Kala-azar, susceptibility to, 2}	611381	_	2
612283	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
612283	2q14.3	Thrombophilia due to protein C deficiency, autosomal recessive	612304	AR	3
612460	16q12.2	{Obesity, susceptibility to, BMIQ14}	612460	AR	3
612349	12q23.2	Phenylketonuria	261600	AR	3
612349	12q23.2	[Hyperphenylalaninemia, non-PKU mild]	261600	AR	3
611895	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
609070	1q42.2	[Hemoglobin, high altitude adaptation]	609070	AD	3
609802	15q21.1	Albinism, oculocutaneous, type VI	113750	AR	3
609802	15q21.1	[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	AR	3
610329	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
611014	18q21.2	{Hypertension, essential, susceptibility to, 8}	611014	_	2
612369	10q21	{Alkaline phosphatase, plasma level of, QTL4}	612369	_	2
610661	3p24.2	Congenital disorder of deglycosylation	615273	AR	3
610898	11p12-p11	Supranuclear palsy, progressive, 3	610898	_	2
610844	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
610844	15q21.1	Charcot-Marie-Tooth disease, axonal, type 2X	616668	AR	3
610844	15q21.1	Spastic paraplegia 11, autosomal recessive	604360	AR	3
611382	6q27	{Kala-azar, susceptibility to, 3}	611382	_	2
609264	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
611428	21q22.11	Microcephaly, short stature, and limb abnormalities	617604	AR	3
611428	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
612311	2q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 5}	612311	_	2
612659	6q22.1	Mitchell-Riley syndrome	615710	AR	3
612753	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
612271	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
610670	4q25	Spastic paraplegia 56, autosomal recessive	615030	AR	3
608532	7q36.3	Kahn-Kahn-Katsanis syndrome	618460	AR	3
612718	15q21.1	Cerebral creatine deficiency syndrome 3	612718	AR	3
611015	7q31	{Autism, susceptibility to, 9}	611015	_	2
603084	2q21.3	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	AR	3
612626	15q26-qter	Chromosome 15q26-qter deletion syndrome	612626	IC	4
609102	16q24.2	?Mental retardation, autosomal recessive 45	615979	AR	3
611067	1p36.31	Spinal muscular atrophy, distal, autosomal recessive, 4	611067	AR	3
610330	11q13.1	Aicardi-Goutieres syndrome 3	610329	AR	3
610554	1q23.3	Neurodevelopmental disorder with spasticity and poor growth	618076	AR	3
612796	13q13.3	{Inflammatory bowel disease 27}	612796	_	2
609039	21q11.2	Narcolepsy 3	609039	AD	2
612853	2p14-p13	{Restless legs syndrome 7}	612853	_	2
612370	8q12.2	Hypogonadotropic hypogonadism 5 with or without anosmia	612370	AD	3
608654	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
612335	4p16-p15	Spastic paraplegia 38, autosomal dominant	612335	AD	2
610798	1q22	Immunodeficiency due to defect in MAPBP-interacting protein	610798	AR	3
612520	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
612312	13q12.11	{Attention deficit-hyperactivity disorder, susceptibility to, 6}	612312	_	2
611521	19p13.2	Immunodeficiency 35	611521	AR	3
609265	22q12.1	Li-Fraumeni syndrome	609265	_	3
612567	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
611897	2q11-q14	Nanophthalmos 3	611897	_	2
610936	9q21.2	?Phosphoserine aminotransferase deficiency	610992	AR	3
610936	9q21.2	Neu-Laxova syndrome 2	616038	AR	3
612911	3p21.31	Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3
612900	9p24.3	Cerebral palsy, spastic quadriplegic, 2	612900	_	3
611879	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
612719	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
605060	17p13.2	[Sedoheptulokinase deficiency]	617213	AR	3
612003	2q37.1	{Parkinson disease 11}	607688	_	3
609413	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
609413	10q11.23	Cockayne syndrome, type B	133540	AR	3
609413	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
609413	10q11.23	Premature ovarian failure 11	616946	AD	3
609413	10q11.23	UV-sensitive syndrome 1	600630	AR	3
609413	10q11.23	{Lung cancer, susceptibility to}	211980	SMu,AD	3
609413	10q11.23	{Macular degeneration, age-related, susceptibility to, 5}	613761	_	3
609975	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
612371	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
609831	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type	277400	AR	3
612702	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
611016	7q36	{Autism, susceptibility to, 10}	611016	_	2
612521	6q25	{Diabetes mellitus, insulin-dependent, 21}	612521	_	2
606759	15q21.1	Thyroid dyshormonogenesis 6	607200	AR	3
613088	9q21	{Pelvic organ prolapse, susceptibility to, 2}	613088	_	2
611430	3p22.2	Spermatogenic failure 37	618429	AR	3
613065	10q21	{Leukemia, acute lymphocytic, susceptibility to, 1}	613065	_	2
610370	10q22.1	Diarrhea 4, malabsorptive, congenital	610370	AR	3
612797	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
612313	2q33.1	Glass syndrome	612313	AD	3
611630	4q13.2-q21.3	Epilepsy, familial temporal lobe, 3	611630	AD	2
604687	14q22.1	{Asthma, susceptibility to, 1}	607277	_	3
612004	7p15.3	Thrombocytopenia 4	612004	AD	3
612661	17p13.1	Dyskeratosis congenita, autosomal recessive 3	613988	AR	3
612952	20q11.23	Aicardi-Goutieres syndrome 5	612952	AR	3
610672	19p13.13	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3
609414	2q34	Corneal fleck dystrophy	121850	AD	3
611095	14q11.2-q12	Mental retardation, autosomal recessive, 9/26	611095	AR	2
609796	15q15.2	Peeling skin syndrome 2	609796	AR	3
611729	11q13.2	Spastic paraplegia, optic atrophy, and neuropathy	609541	AR	3
610060	6p21.1	Leukodystrophy, hypomyelinating, 11	616494	AR	3
610060	6p21.1	Treacher Collins syndrome 3	248390	AR	3
613229	13q31.1	?Trichotillomania	613229	Mu,AD	3
613309	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
611880	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
612522	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
611584	22q13.1	Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	AD	3
608410	4p15-p14	{Obesity, susceptibility to, BMIQ7}	608410	_	2
612394	7q22.1	Lysyl hydroxylase 3 deficiency	612394	AR	3
613464	14q31.3	?Retinitis pigmentosa 51	613464	AR	3
612005	1q31	{Celiac disease, susceptibility to, 7}	612005	_	2
612901	20q13.32	Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	AD	3
613320	16p13.3	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320	AR	3
612627	1p36.12-p35.1	Seizures, benign familial infantile, 4	612627	_	2
611631	9q21-q22	Epilepsy, familial temporal lobe, 4	611631	AD	2
613171	10q25.2	Cardiomyopathy, dilated, 1DD	613172	AD	3
611523	6q15	Pontocerebellar hypoplasia, type 6	611523	AR	3
613495	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
612874	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
612703	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
609734	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
613105	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
613024	6p21.33	{Follicular lymphoma, susceptibility to, 1}	613024	_	2
611881	16p11.2	Glycogen storage disease XII	611881	AR	3
613571	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
613370	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
613618	17q23.1-q23.2	Chromosome 17q23.1-q23.2 duplication syndrome	613618	AD	4
609415	13q31.3	Feingold syndrome 2	614326	AD	3
612431	4q12-q13.1	Deafness, autosomal dominant 27	612431	AD	2
612976	3p26.1-p25.1	{Age-related hearing impairment 2}	612976	_	2
611139	9p21	{Coronary heart disease, susceptibility to, 8}	611139	_	2
609523	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
613640	14q24.3	Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3
612089	13q13.1	Hypophosphatemic rickets and hyperparathyroidism	612089	AD	2
613677	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
612943	7p15.3	Retinitis pigmentosa 42	612943	AD	3
612274	15q24-q25	Ciliary dyskinesia, primary, 8	612274	_	2
612343	4q22	[Musical aptitude QTL 1]	612343	_	2
612929	20q13.31-q13.33	{Mycobacterium tuberculosis, susceptibility to, 3}	612929	_	2
613310	7q31.31	Exudative vitreoretinopathy 5	613310	AD	3
611632	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
612395	22q13.33	Muscular dystrophy, congenital, megaconial type	602541	AR	3
612006	2q11-q12	{Celiac disease, susceptibility to, 8}	612006	_	2
613172	10q25.2	Cardiomyopathy, dilated, 1DD	613172	AD	3
610463	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
610463	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
613722	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
613106	22q12	Vertigo, benign recurrent, 2	613106	_	2
613371	4q34.3-q35.1	?Spinocerebellar ataxia 30	613371	AD	2
612315	12q13.13	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735	AD	3
612628	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
613496	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
613158	14q24.3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	AR	3
613641	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
610756	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
611140	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
612789	8p22-p21.3	Deafness, autosomal recessive 71	612789	AR	2
609524	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
613410	3q24	{?Autism susceptibility 16}	613410	_	3
613619	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
612944	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
613830	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
612007	3p21	{Celiac disease, susceptibility to, 9}	612007	_	2
610474	4p16.3	CATSHL syndrome	610474	AR,AD	3
612629	11q23-q24	{Adiponectin, serum level of, QTL4}	612629	_	2
610333	19p13.13	Aicardi-Goutieres syndrome 4	610333	AR	3
612525	16q24.3	Pyloric stenosis, infantile hypertrophic, 5	612525	_	2
611524	6q15	Pontocerebellar hypoplasia, type 6	611523	AR	3
610970	16q24.3	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331	AR	3
613890	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
613689	22q12.3-q13.1	Mammary-digital-nail syndrome	613689	AD	2
613723	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
613879	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
613497	10q23.31	Cholesteryl ester storage disease	278000	AR	3
613497	10q23.31	Wolman disease	278000	AR	3
613642	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
612121	6p21.31	Ichthyosis, congenital, autosomal recessive 10	615024	AR	3
612858	8q24.3	Orofacial cleft 12	612858	_	2
613107	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
612316	1p36.33	Harel-Yoon syndrome	617183	AR,AD	3
611031	16q13-q22.1	Episodic kinesigenic dyskinesia 2	611031	AD	2
612008	3q25-q26	{Celiac disease, susceptibility to, 10}	612008	_	2
613485	11q24.3	Long QT syndrome 13	613485	AD	3
613558	9q21.11	Deafness, autosomal dominant 51	613558	AD	4
613174	5p13	Chromosome 5p13 duplication syndrome	613174	IC	4
612892	6p22.1	{Stature QTL 18}	612892	_	2
613972	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
612304	2q14.3	Thrombophilia due to protein C deficiency, autosomal recessive	612304	AR	3
613805	17q21.2	?Meier-Gorlin syndrome 5	613805	AR	3
613680	16p13.3	Beaulieu-Boycott-Innes syndrome	613680	AR	3
613724	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
614073	22q12.1	Hermansky-Pudlak syndrome 4	614073	AR	3
612877	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
612345	2q31.2	Chromosome 2q31.2 deletion syndrome	612345	_	4
606761	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
610608	20p11.21	Immunodeficiency 55	617827	AR	3
614114	11q21	Mosaic variegated aneuploidy syndrome 2	614114	AR	3
613621	14q12	Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3
612630	2q13	[Hair morphology 1, hair thickness]	612630	_	3
612893	6p21.31	{Stature QTL 19}	612893	_	2
611544	22q12.1	Cataract 17, multiple types	611544	AR,AD	3
613990	14q12	Dyskeratosis congenita, autosomal dominant 3	613990	AD	3
612953	22q13.1	Parkinson disease 14, autosomal recessive	612953	AR	3
614049	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
614139	2p25.3	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3
613559	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
613108	12p13.2	Candidiasis, familial, 4, autosomal recessive	613108	AR	3
613881	10q26.11	Cardiomyopathy, dilated, 1HH	613881	AD	3
614038	3q21.3	Emberger syndrome	614038	AD	3
611081	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
612318	12q13.13	{Pseudofolliculitis barbae, susceptibility to}	612318	_	3
606762	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
613681	2q31.1	Chromosome 2q31.1 duplication syndrome	613681	AD	4
614200	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
613643	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
612631	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
612954	10q26.11	Myopathy, myofibrillar, 6	612954	AD	3
614185	15q21.1	Geleophysic dysplasia 2	614185	AD	3
614050	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
614261	2p13.1	Microcephaly-capillary malformation syndrome	614261	AR	3
612792	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
612306	5q13	[Thyroid-stimulating hormone level QTL 1]	612306	_	2
614297	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614297	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
613950	22q13.33	{Schizophrenia 15}	613950	AD	3
612666	1q32.1	Congenital anomalies of kidney and urinary tract 1	610805	AD	3
612666	1q32.1	Spastic paraplegia 23	270750	AR	3
612894	13q14.3	{Stature QTL 20}	612894	_	2
613067	7p12.2	{Leukemia, acute lymphoblastic, susceptibility to, 2}	613067	_	2
614140	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
614140	22q11.23	Hypertelorism, Teebi type	145420	AD	3
614140	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
614115	9q34.12	Cortical malformations, occipital	614115	AR	3
613159	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613109	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
614322	16q23.1-q23.2	Spinocerebellar ataxia, autosomal recessive 12	614322	AR	3
614243	8q24.3	5-oxoprolinase deficiency	260005	AR,AD	3
611022	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
614262	14q24.3	?Arthrogryposis, Perthes disease, and upward gaze palsy	614262	AR	3
614377	4p14	Nephronophthisis 13	614377	AR	3
612955	20q11.21	Long QT syndrome 12	612955	AD	3
614298	19q12	Neurodegeneration with brain iron accumulation 4	614298	AR	3
614388	12p11.21	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388	AR,AD	3
611920	10q23-q24	[C-reactive protein QTL]	611920	_	2
612645	13q12.11	Deafness, autosomal recessive 1B	612645	AR	3
614366	12q23.3	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3
613311	6p25.1	?Combined oxidative phosphorylation deficiency 19	615595	AR	3
613428	2p23.2	Retinitis pigmentosa 54	613428	_	3
614609	19p13.2	Coffin-Siris syndrome 4	614609	AD	3
613622	11q24.2	Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3
614312	17p13.2	?Spermatogenic failure 14	615842	AR	3
613152	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	AR	3
613951	16p13.3	Fanconi anemia, complementation group P	613951	AR	3
614141	4q31.3	Charcot-Marie-Tooth disease, type 2R	615490	AR	3
614153	20p13	Spinocerebellar ataxia 36	614153	AD	3
614116	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
614064	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
612956	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
611547	12q14.3	{Stature QTL 9}	611547	_	2
614651	10p12.1	Coenzyme Q10 deficiency, primary, 2	614651	AR	3
614702	6q13	Combined oxidative phosphorylation deficiency 10	614702	AR	3
612794	15q14	Atrial septal defect 5	612794	AD	3
613930	18q11.2-q12.2	Alopecia-mental retardation syndrome 3	613930	AR	2
614450	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
612957	1p36.12	{Vitamin B6 plasma level QTL 1}	612957	_	2
612030	8p22	{Coronary heart disease, susceptibility to, 9}	612030	_	2
611515	21q22	Febrile seizures, familial, 7	611515	_	2
614610	19p13.2	Nephrotic syndrome, type 16	617783	AR	3
614610	19p13.2	Palmoplantar keratoderma and woolly hair	616099	AR	3
611548	7q35	Premature ovarian failure 5	611548	AD	3
609595	1p34.3	Palmoplantar hyperkeratosis and true hermaphroditism	610644	AR	3
609595	1p34.3	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644	AR	3
614154	20p13	Spinocerebellar ataxia 36	614153	AD	3
614574	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
613953	22q11.1	Immunodeficiency 51	613953	AR	3
612870	6q14.1	Developmental delay, intellectual disability, obesity, and dysmorphic features	617991	AD	3
614556	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
611731	5q22.2	Adenoma, periampullary, somatic	_	_	3
611731	5q22.2	Adenomatous polyposis coli	175100	AD	3
611731	5q22.2	Brain tumor-polyposis syndrome 2	175100	AD	3
611731	5q22.2	Colorectal cancer, somatic	114500	_	3
611731	5q22.2	Desmoid disease, hereditary	135290	AD	3
611731	5q22.2	Gardner syndrome	175100	AD	3
611731	5q22.2	Gastric cancer, somatic	613659	_	3
611731	5q22.2	Hepatoblastoma, somatic	114550	_	3
614324	17q21.2	Ovarian dysgenesis 3	614324	AR	3
614662	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
613931	1p34.1	Pontocerebellar hypoplasia, type 7	614969	AR	3
614065	7q32.1	Myopathy, distal, 4	614065	AD	3
613451	11p11.2	Frontonasal dysplasia 2	613451	AR	3
614156	7p13	Hyperbiliverdinemia	614156	AR,AD	3
612169	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
614817	15q13.3	Interstitial nephritis, karyomegalic	614817	AR	3
615011	5q35.3	[?Phosphohydroxylysinuria]	615011	_	3
613456	12q21.31	?Frontonasal dysplasia 3	613456	_	3
612277	9q34.2	Geleophysic dysplasia 1	231050	AR	3
614779	18q21.1	Heterotaxy, visceral, 6, autosomal recessive	614779	AR	3
614972	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AR,AD	3
614870	1p36.32	Peroxisome biogenesis disorder 6A (Zellweger)	614870	AR	3
614590	6p21.3	{Podoconiosis, susceptibility to}	614590	_	2
614789	3p14.1	Adams-Oliver syndrome 4	615297	AR	3
614858	10q26.12	Hypogonadotropic hypogonadism 14 with or without anosmia	614858	AD	3
614299	2p13.1	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299	AR	3
614575	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
612278	5q33.1	{Inflammatory bowel disease (Crohn disease) 19}	612278	_	3
614780	7p15.2	Osteopetrosis, autosomal recessive 8	615085	AR	3
611383	9q32	Usher syndrome, type 2D	611383	AR	3
614144	17p11.2	?Meckel syndrome 9	614209	AR	3
614144	17p11.2	Joubert syndrome 27	617120	AR	3
614859	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
614885	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
614931	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
614591	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
614591	19q13.31-q13.32	Deafness, autosomal recessive 113	618410	AR	3
611935	2q23.2	Homocystinuria, cblD type, variant 1	277410	AR	3
611935	2q23.2	Methylmalonic aciduria and homocystinuria, cblD type	277410	AR	3
611935	2q23.2	Methylmalonic aciduria, cblD type, variant 2	277410	AR	3
611384	10p15	{Plasmodium falciparum fever episodes QTL1}	611384	_	2
614819	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
614557	7p14.3	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557	AR	3
615023	15q26.3	Ichthyosis, congenital, autosomal recessive 9	615023	AR	3
612309	1q24.2	Factor V deficiency	227400	AR	3
612309	1q24.2	Thrombophilia due to activated protein C resistance	188055	AD	3
612309	1q24.2	{Budd-Chiari syndrome}	600880	AR	3
612309	1q24.2	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3
612309	1q24.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
612309	1q24.2	{Thrombophilia, susceptibility to, due to factor V Leiden}	188055	AD	3
614628	14q24.3	Keratoconus 8	614628	AD	2
611061	7p22.3	Raine syndrome	259775	AR	3
614984	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
614984	10p14	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3
615219	9p23	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3
614886	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
615249	8p11.21	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	615249	AR	3
614629	13q32	Keratoconus 7	614629	AD	2
615294	2p23.3	Ciliary dyskinesia, primary, 21	615294	AR	3
614145	19q13.32	3-M syndrome 3	614205	AR	3
615024	6p21.31	Ichthyosis, congenital, autosomal recessive 10	615024	AR	3
615220	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
614592	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
611062	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
615238	3p25.3	?Lipodystrophy, familial partial, type 5	615238	AR	3
614714	16q24.2	Porokeratosis 7, multiple types	614714	AD	3
615041	12q14.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3
612279	8p23-p21	Epilepsy, generalized, with febrile seizures plus, type 6	612279	_	2
614558	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
614820	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
613954	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
614706	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
615270	8p21.3	Hypogonadotropic hypogonadism 20 with or without anosmia	615270	AD	3
615221	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
615363	6q25.1-q25.2	Estrogen resistance	615363	AR	3
612281	5q33.3	Ichthyosis, congenital, autosomal recessive 6	612281	AR	3
614860	9q34	Dystonia 23	614860	AD	2
614974	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
615042	9q34.11	Congenital disorder of glycosylation, type Iu	615042	AR	3
615352	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
615025	10p14	?Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AD	3
614566	19q13.42	Ciliary dyskinesia, primary, 2	606763	AR	3
615364	14q32.2	?Spermatogenic failure 27	617965	AR	3
612041	4p16.3	Recombination rate QTL 1	612042	_	3
615376	1p36.31	Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3
614300	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
615434	16q13	Retinitis pigmentosa with or without situs inversus	615434	AR	3
615222	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
614861	21q22.3	?Deafness, autosomal recessive 98	614861	AR	3
612042	4p16.3	Recombination rate QTL 1	612042	_	3
615316	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
615316	1q42.13	Multiple mitochondrial dysfunctions syndrome 3	615330	AR	3
615026	17p13.2	Riboflavin deficiency	615026	AD	3
615043	19q12	?Spastic paraplegia 43, autosomal recessive	615043	AR	3
614245	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
615134	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
615474	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
612530	1q41-q42	Chromosome 1q41-q42 deletion syndrome	612530	IC	4
615541	8p12	Mental retardation, autosomal recessive 39	615541	AR	3
614998	1q21.3	Mental retardation, autosomal dominant 18	615074	AD	3
614477	8q22.1	Bardet-Biedl syndrome 21	617406	AR	3
614477	8q22.1	Cone-rod dystrophy 16	614500	AR	3
614477	8q22.1	Retinitis pigmentosa 64	614500	AR	3
615048	22q11.23	Spinal muscular atrophy, Jokela type	615048	AD	3
615561	6p21.33	?Complement factor B deficiency	615561	_	3
614567	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
615623	1p32.3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387	AR	3
614862	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
615512	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
613955	5q11.2	?Amyloidosis, primary localized cutaneous, 2	613955	AD	3
615395	2q36.1	?Combined oxidative phosphorylation deficiency 16	615395	AR	3
614594	17p13.2	Olmsted syndrome	614594	AD	3
615451	10p12.1	Ciliary dyskinesia, primary, 23	615451	AR	3
615317	14q24.3	Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3
611943	3q29	RIDDLE syndrome	611943	AR	3
612883	9q31.2	{Menarche, age at, QTL3}	612883	_	2
614822	16p13.3	Spermatogenic failure 10	614822	AD	3
615542	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
615049	10p12.1	Desanto-Shinawi syndrome	616708	AD	3
612526	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
613646	19p13.2	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646	_	3
615436	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
615584	11q12.1	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	615704	AD	3
612884	19q13.4	{Menopause, natural, age at, QTL2}	612884	_	2
614595	4p12	Preeclampsia/eclampsia 5	614595	_	3
614665	12p12.3	Meconium ileus	614665	AR	3
613956	6p12.2	?Candidiasis, familial, 6, autosomal dominant	613956	_	3
613893	12q14.2	Spermatogenic failure 9	613958	AR	3
614823	15q22.31	Aortic valve disease 2	614823	AD	3
613733	11q13.1	Adrenal adenoma, somatic	_	_	3
613733	11q13.1	Angiofibroma, somatic	_	_	3
613733	11q13.1	Carcinoid tumor of lung	_	_	3
613733	11q13.1	Lipoma, somatic	_	_	3
613733	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
613733	11q13.1	Parathyroid adenoma, somatic	_	_	3
614707	8q24.3	Brown-Vialetto-Van Laere syndrome 2	614707	AR	3
615706	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
614576	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
615016	6p22.1	[C3HEX, ability to smell]	615082	AD	3
611944	6q16.2-q22.1	Lymphatic malformation 2	611944	AD	2
614256	22q12.3	?Mental retardation, autosomal dominant 10	614256	AD	3
615544	6q27	?Periventricular nodular heterotopia 6	615544	AD	3
615665	2q37.1	?Joubert syndrome 22	615665	AR	3
613957	9q33.3	Spermatogenic failure 8	613957	AD	3
615585	16q23.3	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3
615707	1q23.3	Immunodeficiency 20	615707	AR	3
613734	2q21.1	Congenital disorder of glycosylation, type IIo	616828	AR	3
615476	1p34.2	Epileptic encephalopathy, early infantile, 18	615476	AR	3
615453	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
615355	1q22	Noonan syndrome 8	615355	AD	3
615636	8q13.1-q13.2	Joubert syndrome 21	615636	AR	3
615564	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
613735	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
612527	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
615438	5q32	?Infantile liver failure syndrome 1	615438	AR	3
615730	1p31.3	Epileptic encephalopathy, early infantile, 23	615859	AR	3
615000	14q32.31	Spastic paraplegia 49, autosomal recessive	615031	AR	3
615752	16q21	Polymicrogyria, bilateral perisylvian	615752	_	3
613700	22q11.2	Supernumerary der(22)t(8-22) syndrome	613700	_	4
614157	8q22.3	Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	AR	3
615397	16q23.1	Meckel syndrome 11	615397	AR	3
614825	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
615709	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
615743	3p25.3	Mental retardation, autosomal dominant 23	615761	AD	3
615565	1q32.3	?Retinitis pigmentosa 67	615565	AR	3
612528	3q29	Diamond-Blackfan anemia 5	612528	AD	3
615356	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
615637	19q13.32	Mental retardation, autosomal recessive 41	615637	AR	3
615377	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
612936	7q22.1	Spastic paraplegia 50, autosomal recessive	612936	AR	3
615817	12q23.3	?Mental retardation, autosomal recessive 43	615817	AR	3
615876	6q25.3	Ciliary dyskinesia, primary, 32	616481	AR	3
615720	3q26.2	Retinitis pigmentosa 68	615725	AR	3
614158	7q34	?Thromboxane synthase deficiency	614158	AD	1
615744	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
613736	19q13.12	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736	AD	3
615763	6p25.2	Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3
615035	12q24.31	Spastic paraplegia 55, autosomal recessive	615035	AR	3
615710	6q22.1	Mitchell-Riley syndrome	615710	AR	3
615398	20q13.12	Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	AR	3
614666	16p13.3	?Centronuclear myopathy 4	614807	AD	3
615006	1p34.1	?Epileptic encephalopathy, early infantile, 15	615006	AR	3
613737	14q24.2	?Acne inversa, familial, 3	613737	AD	3
612813	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
615638	12p13.31	?Microcephaly 21, primary, autosomal recessive	617983	AR	3
615895	20p13	Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3
614571	5p13.2	Joubert syndrome 17	614615	AR	3
614571	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
613710	17q25.1	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	AR	3
614159	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
615599	8q24.12	Mental retardation, autosomal recessive 40	615599	AR	3
615232	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
615974	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
615838	5q23.3-q31.1	Mitochondrial complex III deficiency, nuclear type 8	615838	AR	3
615995	10q25.2	?Bardet-Biedl syndrome 18	615995	AR	3
614932	2p16.1	Combined oxidative phosphorylation deficiency 13	614932	AR	3
615399	20q13.12	?Paroxysmal nocturnal hemoglobinuria 2	615399	SMu,AD	3
615745	1p36.22	Atrial standstill 2	615745	AR	3
614473	16p13.11	Arterial calcification, generalized, of infancy, 2	614473	AR	3
615722	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
615877	4q31.3	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AR,AD	3
614667	6q13	Combined oxidative phosphorylation deficiency 10	614702	AR	3
615982	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
615896	12q13.13	?Hypotrichosis 13	615896	AD	3
615233	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
613711	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
615007	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
616026	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
614160	2q32.2	Muscle hypertrophy	614160	_	3
615723	7q22.1	Premature ovarian failure 8	615723	AR	3
615996	22q12.3	?Bardet-Biedl syndrome 19	615996	AR	3
615897	1p34.2	Immunodeficiency 24	615897	AR	3
613712	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
615983	2q31.1	Bardet-Biedl syndrome 5	615983	AR	3
616116	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
615400	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
616105	6q14.3	Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3
615724	1p22.2	Premature ovarian failure 9	615724	AR	3
614161	4q27	Brittle cornea syndrome 2	614170	AR	3
615878	9q21.11	Cholestasis, progressive familial intrahepatic 4	615878	AR	3
614607	1p36.11	Coffin-Siris syndrome 2	614607	AD	3
615649	5q31	Deafness, autosomal dominant 54	615649	AD	2
615038	19q13.33	Ciliary dyskinesia, primary, 20	615067	AR	3
614782	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
615234	2q14.2	?Anemia, hypochromic microcytic, with iron overload 2	615234	AD	3
615667	9q22.32	Bone marrow failure syndrome 2	615715	AR	3
614608	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
612795	11q12-q13.1	[Polyunsaturated fatty acids plasma level QTL1]	612795	_	2
615879	2p23.3	Tatton-Brown-Rahman syndrome	615879	AD	3
616117	1p31.1	Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3
614934	2p16.1	Deafness, autosomal recessive 70	614934	AR	3
614783	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
615984	4q27	Bardet-Biedl syndrome 7	615984	AR	3
615401	16p11.2	Immunodeficiency 8	615401	AR	3
615235	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
616230	19p13.11	?Epilepsy, progressive myoclonic, 8	616230	AR	3
615378	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
616267	19q13.33	Ataxia-oculomotor apraxia 4	616267	AR	3
615668	5q12	Chromosome 5q12 deletion syndrome	615668	AD	4
615139	12q24.33	FILS syndrome	615139	AR	3
615651	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
615320	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	AR	3
615681	10q24.31	Spastic paraplegia 62	615681	AR	3
616118	5q23.3	Macular degeneration, early-onset	616118	AD	3
614935	8q24.22	Ciliary dyskinesia, primary, 19	614935	AR	3
615985	14q31.3	Bardet-Biedl syndrome 8	615985	AR	3
616151	6q14.1	Macular dystrophy, vitelliform, 4	616151	AD	3
616198	19p13.11	Combined oxidative phosphorylation deficiency 23	616198	AR	3
613375	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
616268	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
615986	7p14.3	Bardet-Biedl syndrome 9	615986	AR	3
616231	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
613376	5q11.2	?Neuronopathy, distal hereditary motor, type IIC	613376	AD	3
616269	1p13.3	Mental retardation, autosomal recessive 48	616269	AR	3
615140	12p13.31	Temtamy syndrome	218340	AR	3
616304	11p11.2	?Myasthenic syndrome, congenital, 17	616304	AR	3
615237	11q24.1	Congenital short bowel syndrome	615237	AR	3
615360	8q22.1	Leber congenital amaurosis 17	615360	AR	3
614990	10p11.21-q21.1	Usher syndrome, type IK	614990	AR	2
616409	20q13.33	Epileptic encephalopathy, early infantile, 33	616409	AD	3
616220	9q33.3	Focal segmental glomerulosclerosis 9	616220	AR	3
615841	18q11.2	?Spermatogenic failure 13	615841	AR	3
616152	3q12.3	Macular dystrophy, vitelliform, 5	616152	AD	3
616305	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
616370	14q24.3	Multiple mitochondrial dysfunctions syndrome 4	616370	AR	3
614723	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
615725	3q26.2	Retinitis pigmentosa 68	615725	AR	3
616451	1q42.13	?Spastic paraplegia 74, autosomal recessive	616451	AR	3
615361	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
615685	16p12.3	?Spastic paraplegia 61, autosomal recessive	615685	AR	3
615881	19p13.2	Plasma triglyceride level QTL, low	615881	AD	3
616371	16p13.12	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371	AD	3
615508	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
616479	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
616511	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
616171	4q28.1	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171	AR	3
613398	12p11.21	Warsaw breakage syndrome	613398	AR	3
615686	1p13.3	?Spastic paraplegia 63	615686	AR	3
615362	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
616583	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
616682	11p11.2	?Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3
615338	16p13.3	Epileptic encephalopathy, early infantile, 16	615338	AR	3
616902	11p13	Chromosome 11p13 deletion syndrome, distal	616902	AD	4
616351	5q13.3	Mental retardation, autosomal dominant 34	616351	AD	3
616728	1p36.12	Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3
615697	3q25-q26	Epilepsy, familial temporal lobe, 6	615697	AD	2
616683	11q23.3	Leukodystrophy, hypomyelinating, 12	616683	AR	3
616716	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
612937	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
616468	11p11.2	?Exudative vitreoretinopathy 6	616468	AD	3
615900	2p23.3	Retinitis pigmentosa 75	617023	AR	3
616831	3p21.31	Luscan-Lumish syndrome	616831	AD	3
614585	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
616307	4p14	Senior-Loken syndrome 8	616307	AR	3
615698	19q13.2	?Spinocerebellar ataxia 46	617770	AD	3
616154	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
615510	2q35	Alacrima, achalasia, and mental retardation syndrome	615510	AR	3
612560	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
616903	13q14.2	{Thiopurines, poor metabolism of, 2}	616903	AD	3
617018	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
617053	7q21.2	MIRAGE syndrome	617053	AD	3
616373	20q13.33	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373	AD	3
612938	16q12.2	Growth retardation, developmental delay, facial dysmorphism	612938	AR	3
616585	16q13	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3
615688	22q11.1	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688	AR	3
616469	11p11.2	Retinitis pigmentosa 72	616469	AR	3
616849	4q22.3	Brachydactyly, type A1, D	616849	AD	3
614936	8q24.13-q24.21	Keratoderma, palmoplantar, punctate type IB	614936	AD	2
616586	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
617026	1q25.3	Pontocerebellar hypoplasia, type 2F	617026	AR	3
617101	2p16.1	Dias-Logan syndrome	617101	AD	3
616602	3q24	Craniosynostosis 6	616602	AD	3
613399	17q22	{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	_	3
616544	8p11.2-p11.1	Retinitis pigmentosa 73	616544	AR	3
612009	3q28	{Celiac disease, susceptibility to, 11}	612009	_	2
617054	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
617027	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
616851	19q13.1-q13.2	?Cataract 45	616851	AR	3
617272	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
616924	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
612561	1p22.1	Diamond-Blackfan anemia 6	612561	AD	3
617247	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
617273	8q22.1	?Polydactyly, postaxial, type A9	618219	AR	3
617028	3q26.2-q26.3	Mental retardation, autosomal recessive 54	617028	AR	3
615987	12q21.2	Bardet-Biedl syndrome 10	615987	AR	3
616959	3p26.2	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3
617102	20q13.12	Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3
614937	16q22.1	?Myoclonus, familial, 1	614937	AD	3
617236	9q21.2	Cone-rod dystrophy and hearing loss	617236	AR	3
617403	3q13.31	Cutis laxa, autosomal recessive, type IID	617403	AR	3
617251	20p13	?Uncombable hair syndrome 2	617251	AR	3
617055	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
615988	9q33.1	?Bardet-Biedl syndrome 11	615988	AR	3
616833	1q21.3	Paget disease of bone 6	616833	AD	3
612010	6q25.3	{Celiac disease, susceptibility to, 12}	612010	_	2
614104	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
617525	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
617080	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
615989	4q27	Bardet-Biedl syndrome 12	615989	AR	3
616622	1q21.3	Immunodeficiency 42	616622	AR	3
617341	10q24.33	Cerebroretinal microangiopathy with calcifications and cysts 2	617341	AR	3
617413	1q21.3	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481	AR	3
616730	12q15	Nephrotic syndrome, type 11	616730	AR	3
615916	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
616311	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
617056	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
612562	1p36.11	Diamond-Blackfan anemia 7	612562	AD	3
615990	17q22	Bardet-Biedl syndrome 13	615990	AR	3
612011	12q24	{Celiac disease, susceptibility to, 13}	612011	_	2
617616	1q42.11-q42.12	Skraban-Deardorff syndrome	617616	AD	3
617629	20q11.22	{Schizophrenia 19, susceptibility to}	617629	AD	3
617237	14q32.2	Immunodeficiency 49	617237	AD	3
614105	14q24.3	Methylmalonate semialdehyde dehydrogenase deficiency	614105	AR	3
617547	21q22.3	Retinal dystrophy with macular staphyloma	617547	AR	3
616732	6q21	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	616732	AR	3
613653	7p22.1	Spastic paraplegia 48, autosomal recessive	613647	AR	3
617252	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
617105	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
617392	22q12.1	Ectodermal dysplasia 13, hair/tooth type	617392	AR	3
613457	14q11-q22	Chromosome 14q11-q22 deletion syndrome	613457	IC	4
614784	12q21.33	Cone-rod dystrophy 20	615973	AR	3
614317	5q14.2	Vesicoureteral reflux 4	614317	_	2
616733	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
617393	19p13.13	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393	AD	3
617809	11q13.1	Geleophysic dysplasia 3	617809	AD	3
617830	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
616155	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
616734	18q12.1-q12.2	Symmetric circumferential skin creases, congenital, 2	616734	AD	3
617506	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
611145	8q24.11	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
617810	8q24.3	Glycosylphosphatidylinositol biosynthesis defect 15	617810	AR	3
617877	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
617082	6q22.1	?Congenital disorder of glycosylation, type 1aa	617082	AR	3
617631	7p22.3	?Polydactyly, postaxial, type A7	617642	AR	3
617253	8q24.13	Seckel syndrome 10	617253	AR	3
613458	16p13.3	Chromosome 16p13.3 duplication syndrome	613458	IC,AD	4
613655	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
612563	2p25.3	Diamond-Blackfan anemia 8	612563	AD	3
614785	2q36.3	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086	AR	3
616735	3p25.1	Hypotonia, infantile, with psychomotor retardation	616816	AR	3
617878	2q21.1	Keratoconus 9	617928	AD	3
615917	6p21.33	Combined oxidative phosphorylation deficiency 20	615917	AR	3
617091	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
613656	10q25.3	{Migraine, with or without aura, susceptibility to, 13}	613656	_	3
617622	2q37.1	Joubert syndrome 30	617622	AR	3
613459	3q25.3	[Birth weight QTL 2]	613459	_	2
611146	1q41	Hypermanganesemia with dystonia 1	613280	AR	3
617493	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
617394	6p22.3	Sclerosing cholangitis, neonatal	617394	AR	3
617633	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
615386	11q13.2	Spinocerebellar ataxia, autosomal recessive 14	615386	AR	3
617507	2p16.1	?PEHO syndrome-like	617507	AR	3
611147	2q31	Paroxysmal nonkinesigenic dyskinesia 2	611147	AD	2
617751	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
617664	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
617395	1q42.2	?Congenital disorder of glycosylation, type IIq	617395	AR	3
618131	16q22.1	Immunodeficiency 58	618131	AR	3
617255	12q21.32	Lissencephaly 8	617255	AR	3
615918	1q21.2	?Combined oxidative phosphorylation deficiency 21	615918	AR	3
617954	7q22.1	Multiple mitochondrial dysfunctions syndrome 6	617954	AR	3
617752	2q36.3	Mental retardation, autosomal dominant 49	617752	AD	3
617092	17q21.2	Ciliary dyskinesia, primary, 35	617092	AR	3
615387	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
616744	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
617987	1q24.3	?{Deafness, autosomal recessive 26, modifier of}	605429	AD	3
613657	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
617557	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
615925	3q26.31	Growth hormone deficiency, isolated partial	615925	AR,AD	3
615058	4q25	Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	AR	3
618279	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
617988	6p21.1	Jaberi-Elahi syndrome	617988	AR	3
618336	12q24.33	IMAGE-I syndrome	618336	AR	3
617432	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
618260	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
613460	3q21	[Birth weight QTL 3]	613460	_	2
613460	3q21	[Fasting plasma glucose level QTL 6]	613460	_	2
613460	3q21	[Plasma glucose, 2-hour, QTL 1]	613460	_	2
617057	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
618379	3q25.1	Epileptic encephalopathy, early infantile, 73	618379	AD	3
617780	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
617093	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
617014	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
613658	2q36.2	Rajab syndrome	613658	AR	2
617903	9q22.33	Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3
617433	19p13.2	Retinitis pigmentosa 78	617433	AR	3
615059	1q32.1	Hypotrichosis 11	615059	AD	3
618416	19p13.11	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416	AR	3
617396	8q22.2	Anauxetic dysplasia 2	617396	AR	3
615155	9q32	Steel syndrome	615155	AR	3
616420	1q42.12	Leukodystrophy, hypomyelinating, 10	616420	AR	3
612566	20q13	{Inflammatory bowel disease 24}	612566	_	2
617755	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
613932	1p31.1	Cardiac conduction disease with or without dilated cardiomyopathy	616117	AD	3
617781	16p13.3	Retinitis pigmentosa 80	617781	AR	3
617584	6q21	?Spinocerebellar ataxia, autosomal recessive 25	617584	AR	3
617558	10q25.1	Spermatogenic failure 19	617592	AR	3
615156	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
617065	4p12	?Epileptic encephalopathy, early infantile, 40	617065	AR	3
617914	1q32.1	Microcephaly 20, primary, autosomal recessive	617914	AR	3
617756	12q13.13	Erythrokeratodermia variabilis et progressiva 5	617756	AR	3
613933	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
618261	19p13.3	Lymphoproliferative syndrome 3	618261	AR	3
618324	16q22.1	Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3
618398	5q33.3	T-cell lymphoma, subcutaneous panniculitis-like	618398	AR	3
615157	17p12	Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3
617559	3q13.2	?Spermatogenic failure 20	617593	AR	3
618280	11q12.2	Cardiac-urogenital syndrome	618280	AD	3
617796	1q22	Mental retardation, autosomal dominant 52	617796	AD	3
617094	20q13.12	Short-rib thoracic dysplasia 16 with or without polydactyly	617102	AR	3
616421	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
617595	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
617816	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
617397	22q11.21	Pseudo-TORCH syndrome 2	617397	AR	3
613462	7p21.2	[Fasting plasma glucose level QTL 4]	613462	_	2
617560	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
617095	17q21.2	Ciliary dyskinesia, primary, 35	617092	AR	3
617827	20p11.21	Immunodeficiency 55	617827	AR	3
616158	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
617915	4p16.3	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915	AD	3
615748	12q23.3	?Mental retardation, autosomal recessive 43	615817	AR	3
613463	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
617757	10q24.32	Joubert syndrome 32	617757	AR	3
617862	14q21.1	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862	AR	3
617073	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
618325	1p34.3	Lissencephaly 9 with complex brainstem malformation	618325	AD	3
617561	11q14.2	Cohen-Gibson syndrome	617561	AD	3
618011	10q23.31	Hyperekplexia 4	618011	AR	3
618339	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
615749	9q33.2	[Eculizumab, poor response to]	615749	AD	3
617106	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
617879	9q34.3	Leber congenital amaurosis with early-onset deafness	617879	AD	3
617828	14q11.2	?Marsili syndrome	147430	AD	3
617864	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
617540	10q22.1	{Pituitary adenoma 5, multiple types}	617540	AD	3
614111	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
617865	5q12.1	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865	AD	3
618295	11p15.4	Mental retardation, autosomal recessive 67	618295	AR	3
617829	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
617761	5q23.2	Joubert syndrome 31	617761	AR	3
617866	14q24.3	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3
617107	11q13.1	Thauvin-Robinet-Faivre syndrome	617107	AR	3
617665	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
618060	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
618048	13q12.3	Proteasome-associated autoinflammatory syndrome 2	618048	AD	3
617075	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
617108	17q22	Sessile serrated polyposis cancer syndrome	617108	AD	3
617762	11q13.5	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3
618052	15q25.3	Cardiomyopathy, familial hypertrophic 27	618052	AR	3
613938	20q12-q13.12	Parasomnia, sleepwalking type	613938	Mu,AD	2
614113	9p24	Mental retardation, autosomal dominant 2	614113	AD	4
617402	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
618061	3q27.3	Polycystic kidney disease 6 with or without polycystic liver disease	618061	AD	3
614588	2q14.3-q21.3	Dystonia 21	614588	AD	2
617831	6q22.1	Mental retardation, autosomal dominant 55, with seizures	617831	AD	3
617916	6q24.1	?Neurodegeneration with brain iron accumulation 7	617916	AR	3
615820	1q23.2	?Giant axonal neuropathy 2, autosomal dominant	610100	AD	3
618400	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
614589	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
617110	9q21.2	Cone-rod dystrophy and hearing loss	617236	AR	3
618173	10q24.32	Retinitis pigmentosa 83	618173	AD	3
615821	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
618160	1p21.1	?Growth hormone deficiency, isolated, type V	618160	AR	3
613949	12p13.31	OKT4 epitope deficiency	613949	_	3
617882	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
617111	3p21.2	?Macular dystrophy, patterned, 3	617111	AD	3
613661	13q14.3	Congenital disorder of glycosylation, type Ip	613661	AR	3
617883	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
618298	6p24.1	Epileptic encephalopathy, early infantile, 70	618298	AD	3
618402	3q25.32	Intellectual developmental disorder, autosomal recessive 70	618402	AR	3
617112	17p13.1	?Orofaciodigital syndrome XV	617127	AR	3
618056	7p22.3	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056	AR	3
618328	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
618057	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
618058	11q22.1	Ciliary dyskinesia, primary, 38	618063	AR	3
618329	19p13.3	Combined oxidative phosphorylation deficiency 37	618329	AR	3
618404	1q42.11	Leukodystrophy, hypomyelinating, 18	618404	AR	3
615824	6p21.31	Mitochondrial complex III deficiency, nuclear type 7	615824	AR	3
618161	10q24.32	Joubert syndrome 35	618161	AR	3
618162	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
618330	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
618163	17q25.1	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316	AR	3
617666	13q13.3	Fraser syndrome 2	617666	AR	3
618164	16p13.3	Cardiac, facial, and digital anomalies with developmental delay	618164	AD	3
618414	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
615837	5q32	?Deafness, autosomal recessive 101	615837	AR	3
618415	10q24.2	Cataract 48	618415	AR	3
617854	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
616423	3p21.31	Neurodevelopmental disorder with severe motor impairment and absent language	617804	AD	3
617017	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AR,AD	3
615511	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
617542	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
616425	17q24	46XY sex reversal 10	616425	AD	4
617030	14q32.33	Myopathy, distal, 5	617030	AR	3
617258	12p12.1	Myopathy, myofibrillar, 8	617258	AR	3
617729	14q11.2	Galloway-Mowat syndrome 3	617729	AR	3
617383	12q24.11	?Avascular necrosis of femoral head, primary, 2	617383	AD	3
616449	19q13.33	Basel-Vanagait-Smirin-Yosef syndrome	616449	AR	3
617563	17p13.1	Orofaciodigital syndrome XVI	617563	AR	3
618174	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
616470	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
618175	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
617384	10q21.3	Hyperphenylalaninemia, mild, non-BH4-deficient	617384	AR	3
618282	20q11.22	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282	AR	3
618176	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
616471	6q13-q14	Bethlem myopathy 2	616471	AD	3
618177	1q42.13	Nephrotic syndrome, type 18	618177	AR	3
618178	11p11.2	?Nephrotic syndrome, type 19	618178	AR	3
604633	11q13.1	Cutis laxa, autosomal recessive, type IB	614437	AR	3
604296	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
606953	1p36.11	Galactose epimerase deficiency	230350	AR	3
606666	11p14.1	{Bone mineral density, low, susceptibility to}	615311	_	3
605742	22q11.21	Cortical dysplasia, complex, with other brain malformations 8	613180	AR	3
603786	4p15.32	Stargardt disease 4	603786	_	3
604592	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
605779	17p13	Nail disorder, nonsyndromic congenital, 7	605779	AD	2
606789	8q	Fetal hemoglobin quantitative trait locus 4	606789	_	2
606969	17p13.3	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913	AR	3
606660	3q24-q26	{Melanoma, uveal, susceptibility to, 1}	606660	_	2
603700	13q12.3	{Stroke, susceptibility to}	601367	Mu	3
603873	9p21.2	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527	AR	3
605111	19p13.2	Deafness, autosomal recessive 68	610419	AR	3
603666	20q13.32	Pseudohypoparathyroidism, type IB	603233	AD	3
605956	16q12.1	Blau syndrome	186580	AD	3
605956	16q12.1	{Inflammatory bowel disease 1, Crohn disease}	266600	Mu	3
605956	16q12.1	{Psoriatic arthritis, susceptibility to}	607507	_	2
605956	16q12.1	{Yao syndrome}	617321	Mu	3
605950	4q31.1	Smith-McCort dysplasia 2	615222	AR	3
605676	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
604672	19p13.2	{Dengue fever, protection against}	614371	_	3
604672	19p13.2	{HIV type 1, susceptibility to}	609423	_	3
604672	19p13.2	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
606672	17p13.2	Bernard-Soulier syndrome, type A1 (recessive)	231200	AR	3
606672	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
606672	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
606672	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
606207	15q25.3	[Uridine-cytidineuria]	618477	AR	3
605347	1p36.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
604436	8p11.23	Epilepsy, early-onset, vitamin B6-dependent	617290	AR	3
605093	12q24.12	Erythrocytosis, somatic	133100	_	3
605093	12q24.12	Myelofibrosis, somatic	254450	_	3
605093	12q24.12	Thrombocythemia, somatic	187950	_	3
606979	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
607357	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
604124	18q11.2	Jawad syndrome	251255	AR	3
604124	18q11.2	Pancreatic carcinoma, somatic	_	_	3
604124	18q11.2	Seckel syndrome 2	606744	AR	3
607584	13q14	Spastic paraplegia 24, autosomal recessive	607584	AR	2
607115	1q44	CINCA syndrome	607115	AD	3
605394	6q15	Immunodeficiency 60	618394	AD	3
605724	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
606000	6p21.32	{Sarcoidosis, susceptibility to, 2}	612387	AD	3
603741	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
603103	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
603157	19p13.11	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387	AD	3
605387	20q11.22	Cataract 31, multiple types	605387	AD	3
605280	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
603013	8p21	{Schizophrenia}	181500	AD	2
605204	9q34.11	Dystonia-1, torsion	128100	AD	3
605204	9q34.11	{Dystonia-1, modifier of}	_	_	3
606579	17p13.2	{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	_	3
603198	17q21.2	Lipodystrophy, congenital generalized, type 4	613327	AR	3
607212	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
606673	22q11.23	Beta-ureidopropionase deficiency	613161	AR	3
607206	17p13.1	Ichthyosis, congenital, autosomal recessive 3	606545	AR	3
604574	9q31.3	Epileptic encephalopathy, early infantile, 37	616981	AR	3
603116	22q12-q13	CDAGS syndrome	603116	AR	2
604011	17q11.2	?Cone-rod dystrophy	_	_	3
604011	17q11.2	?Immunodeficiency 13	615518	AD	3
607078	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
603701	12q13.2	Diamond-Blackfan anemia 10	613309	AD	3
605388	9p12-q12	Cerebral palsy, ataxic, autosomal recessive	605388	AR	2
606995	3q22	Senior-Loken syndrome 3	606995	AR	2
605711	2p13.3	Multiple mitochondrial dysfunctions syndrome 1	605711	AR	3
607116	20p	Alzheimer disease 8	607116	_	2
605753	4q12	?Spermatogenic failure 29	618091	AR	3
603499	18q21.33	Osteolysis, familial expansile	174810	AD	3
603499	18q21.33	Osteopetrosis, autosomal recessive 7	612301	AR	3
603499	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
605375	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
606980	1q42.13	Coenzyme Q10 deficiency, primary, 4	612016	AR	3
605747	1p36.11	Hypercholesterolemia, familial, 4	603813	AR	3
603158	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
606685	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
606996	1p36.31	Senior-Loken syndrome 4	606996	AR	3
607207	16p13.3	?Spinocerebellar ataxia 48	618093	AD	3
607207	16p13.3	Spinocerebellar ataxia, autosomal recessive 16	615768	AR	3
606389	11q13.1	Spermatogenic failure 7	612997	AR	3
606668	16p	{Inflammatory bowel disease 8}	606668	_	2
605083	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
603674	16p12.3	?Diamond-Blackfan anemia 20	618313	AD	3
607836	1p31.3	{Autoimmune disease, susceptibility to, 1}	607836	AD	3
606785	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
605748	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
606347	15q24.3	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	AD	3
607880	2p13.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3
605906	10q23.2	Cardiomyopathy, dilated, 1C, with or without LVNC	601493	AD	3
605906	10q23.2	Cardiomyopathy, hypertrophic, 24	601493	AD	3
605906	10q23.2	Left ventricular noncompaction 3	601493	AD	3
605906	10q23.2	Myopathy, myofibrillar, 4	609452	AD	3
603914	11p15.4	Mental retardation, autosomal recessive 67	618295	AR	3
603283	6q22.31	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	AR	3
607805	2q11.2	Jalili syndrome	217080	AR	3
607683	5q31.1-q32	Deafness, autosomal dominant 52	607683	AD	2
605712	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
607117	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
603218	20p13	Huntington disease-like 1	603218	AD	3
605414	19p13.3	{Alzheimer disease 9, susceptibility to}	608907	AD	3
607541	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
603702	1q21.3	?Diamond-Blackfan anemia 17	617409	AD	3
606688	20p13	Prion disease with protracted course	606688	AD	3
604846	2q14.3	{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	AD	3
605749	9q13-q22	Cataract 26, multiple types	605749	_	2
604352	5q14.3	?Febrile seizures, familial, 4	604352	AD	3
606348	5q31	{Inflammatory bowel disease 5}	606348	_	2
605907	16p13.3	Congenital disorder of glycosylation, type Ik	608540	AR	3
604299	3p14.3	{Maturity-onset diabetes of the young, type 14}	616511	AD	3
605084	10q22.1	Myopathy with extrapyramidal signs	615673	AR	3
607066	17p13.2	?Palmoplantar keratoderma, nonepidermolytic, focal 2	616400	AD	3
607066	17p13.2	Olmsted syndrome	614594	AD	3
605178	16q24.3	Ciliary dyskinesia, primary, 33	616726	AR	3
606272	17p13.2	Cystinosis, atypical nephropathic	219800	AR	3
606272	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
606272	17p13.2	Cystinosis, nephropathic	219800	AR	3
606272	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
603284	7p13	Cerebral cavernous malformations-2	603284	AD	3
604450	17q24.2	Stankiewicz-Isidor syndrome	617516	AD	3
604505	14q32.12	Achondrogenesis, type IA	200600	AR	3
604505	14q32.12	Osteochondrodysplasia	184260	AR	3
603622	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
607932	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
603015	7q22.1	Developmental delay with or without dysmorphic facies and autism	618454	AD	3
608040	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
604912	8q24.12	Mental retardation, autosomal recessive 40	615599	AR	3
605518	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
603543	3q28	Limb-mammary syndrome	603543	AD	3
605775	5q31.2	Pseudohypoaldosteronism, type IID	614495	AR,AD	3
607446	6q23-q25	[Body mass index QTL3]	607446	_	2
607795	9q32	Retinitis pigmentosa 70	615922	AD	3
605237	1q25.3	Basal ganglia calcification, idiopathic, 6	616413	AD	3
605355	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
605738	15q12-q15	Microphthalmia with coloboma 2	605738	_	2
606014	1p13.3	Frontonasal dysplasia 1	136760	AR	3
607194	10p12.2	Pancreatic agenesis 2	615935	AR	3
607194	10p12.2	Pancreatic and cerebellar agenesis	609069	AR	3
603200	19p13.11	MHC class II deficiency, complementation group B	209920	AR	3
605419	15q15	{Schizophrenia 10}	605419	AD	2
603285	3q26.1	Cerebral cavernous malformations 3	603285	_	3
604142	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
605423	12q13.12	46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	_	3
605423	12q13.12	46XY sex reversal 7	233420	AR	3
607939	3p26.1	Multiple sulfatase deficiency	272200	AR	3
604918	7q21.11	?Pontocerebellar hypoplasia, type 3	608027	AR	3
603623	1p35.1	Charcot-Marie-Tooth disease, dominant intermediate C	608323	AD	3
605750	11p13-p12	Exudative vitreoretinopathy 3	605750	AD	2
605384	4q27	?Immunodeficiency, common variable, 11	615767	AR	3
608029	20q11-q13	Spinocerebellar ataxia, autosomal recessive 6	608029	AR	2
608212	5q33.1	{Inflammatory bowel disease (Crohn disease) 19}	612278	_	3
608212	5q33.1	{Mycobacterium tuberculosis, protection against}	607948	_	3
607118	3q22.1	Combined oxidative phosphorylation deficiency 9	614582	AR	3
604934	1q42.3	Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3
604934	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
604934	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
607800	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
607800	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
605720	11q13.1	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3
606852	1p32	{Parkinson disease 10}	606852	_	2
606928	1p36	[Bone mineral density QTL 3]	606928	_	2
607585	11q22.3	Ataxia-telangiectasia	208900	AR	3
607585	11q22.3	Lymphoma, B-cell non-Hodgkin, somatic	_	_	3
607585	11q22.3	Lymphoma, mantle cell, somatic	_	_	3
607585	11q22.3	T-cell prolymphocytic leukemia, somatic	_	_	3
607585	11q22.3	{Breast cancer, susceptibility to}	114480	SMu,AD	3
607542	11p15.5-p15.4	Atrial fibrillation, familial, 3	607554	AD	3
607542	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
607542	11p15.5-p15.4	Long QT syndrome 1	192500	AD	3
607542	11p15.5-p15.4	Short QT syndrome 2	609621	AD	3
607542	11p15.5-p15.4	{Long QT syndrome 1, acquired, susceptibility to}	192500	AD	3
606725	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
606725	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
605565	19p13.2	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
605565	19p13.2	{Hypertension, insulin resistance-related, susceptibility to}	125853	AD	3
608300	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
602937	6q24.1	Atrial septal defect 8	614433	AD	3
602937	6q24.1	Ventricular septal defect 2	614431	AD	3
605113	7q31.32	Hyperlysinemia	238700	AR	3
605113	7q31.32	Saccharopinuria	268700	AR	1
603046	8q24.13	Renal cell carcinoma	144700	_	3
608206	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
608206	5q32	Mononeuropathy of the median nerve, mild	613353	AD	3
608318	14q32	{Coronary heart disease, susceptibility to, 4}	608318	_	2
605739	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
605908	22q13.33	Megalencephalic leukoencephalopathy with subcortical cysts	604004	AR	3
603658	2p25.3	Diamond-Blackfan anemia 8	612563	AD	3
603273	3q28	ADULT syndrome	103285	AD	3
603273	3q28	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3
603273	3q28	Hay-Wells syndrome	106260	AD	3
603273	3q28	Limb-mammary syndrome	603543	AD	3
603273	3q28	Orofacial cleft 8	618149	_	3
603273	3q28	Rapp-Hodgkin syndrome	129400	AD	3
603273	3q28	Split-hand/foot malformation 4	605289	AD	3
606159	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
605519	18p11.31	Majeed syndrome	609628	_	3
603945	3q27.1	Leukoencephalopathy with vanishing white matter	603896	AR	3
603945	3q27.1	Ovarioleukodystrophy	603896	AR	3
605238	2q22.1	Mental retardation, autosomal recessive 51	616739	AR	3
605238	2q22.1	{Asthma, susceptibility to}	600807	AD	3
607906	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
604590	1q23.3	{Malaria, resistance to}	611162	_	3
604590	1q23.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
605356	7q11.23	Epileptic encephalopathy, early infantile, 56	617665	AD	3
603537	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
607562	1p31.3	{Inflammatory bowel disease 17, protection against}	612261	_	3
607562	1p31.3	{Psoriasis, protection against}	605606	_	3
606726	20q13.12	Epileptic encephalopathy, early infantile, 34	616645	AR	3
606726	20q13.12	{Epilepsy, idiopathic generalized, susceptibility to, 14}	616685	AD	3
607200	15q21.1	Thyroid dyshormonogenesis 6	607200	AR	3
608520	12q22-q23.2	Major depressive disorder 1	608516	_	2
605751	16p11.2	Seizures, benign familial infantile, 2	605751	AD	3
602938	9q31.1	Hypercholanemia, familial	607748	AR	3
607080	12q13.12	46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	_	3
608455	11q13.1	McArdle disease	232600	AR	3
604439	4q31.21	?Deafness, autosomal recessive 26	605428	AR	3
603236	16q24.2	Porokeratosis 7, multiple types	614714	AD	3
604607	17q21.32	{Prostate cancer, hereditary, 9}	610997	_	3
604799	15q25.2	?Deafness, autosomal dominant 68	616707	AD	3
605109	15q22.31	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011	AR	3
608207	22q12	{Kala-azar, susceptibility to, 1}	608207	_	2
608630	11q24.2	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	AR	3
606879	1p12	Neu-Laxova syndrome 1	256520	AR	3
606879	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
608329	11q12.2	Cardiac-urogenital syndrome	618280	AD	3
608329	11q12.2	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113	AD	3
608030	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
603946	10q23.33	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911	AR	3
608109	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
607941	8p23.1	Atrial septal defect 2	607941	AD	3
608703	2p21-p13	Spinocerebellar ataxia 25	608703	AD	2
608500	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
608631	17p13	{Asperger syndrome susceptibility 2}	608631	IC,Mu	2
605201	11q23.3	High density lipoprotein cholesterol level QTL14	605201	_	2
605566	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
603415	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 7	613863	AD	3
603415	2q24.3	Erythermalgia, primary	133020	AD	3
603415	2q24.3	Febrile seizures, familial, 3B	613863	AD	3
603415	2q24.3	HSAN2D, autosomal recessive	243000	AR	3
603415	2q24.3	Insensitivity to pain, congenital	243000	AR	3
603415	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
603415	2q24.3	Small fiber neuropathy	133020	AD	3
603415	2q24.3	{Dravet syndrome, modifier of}	607208	AD	3
607210	7p22.2	B-cell expansion with NFKB and T-cell anergy	616452	AD	3
607210	7p22.2	Immunodeficiency 11A	615206	AR	3
607210	7p22.2	Immunodeficiency 11B with atopic dermatitis	617638	AD	3
608456	1p34.1	Adenomas, multiple colorectal	608456	AR	3
605713	14q24.3	Neuropathy, hereditary sensory and autonomic, type IC	613640	AD	3
608815	6p12.2	{Epilepsy, juvenile absence, susceptibility to, 1}	607631	AD	3
608815	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
606674	19p13	{Inflammatory bowel disease 6}	606674	_	2
606593	13q33.3	LIG4 syndrome	606593	AR	3
608677	18q11.2	Left ventricular noncompaction 7	615092	AD	3
608798	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
603089	3p21.1	Tumor predisposition syndrome	614327	AD	3
608340	8q21.11	Charcot-Marie-Tooth disease, recessive intermediate, A	608340	AR	3
608885	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
608474	17q21-q22	Myopia 5	608474	AD	2
607478	12q21.1	{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	_	3
607478	12q21.1	{Unipolar depression, susceptibility to}	608516	_	3
603286	1q32.1	?Hypogonadotropic hypogonadism 13 with or without anosmia	614842	AR	3
608810	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
605870	13q12.13	?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	AR	3
608248	12q13.13	?Ectodermal dysplasia 7, hair/nail type	614929	AR	3
608248	12q13.13	?Hypotrichosis 3	613981	AD	3
608248	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
605420	11p11.2	Frontonasal dysplasia 2	613451	AR	3
605420	11p11.2	Parietal foramina 2	609597	AD	3
605420	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
608307	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
608307	2q34	{Pulmonary hypertension, neonatal, susceptibility to}	615371	_	3
604332	4q12	{Leukemia, acute myeloid}	601626	SMu,AD	3
607211	17q25.3	Pityriasis rubra pilaris	173200	AD	3
607211	17q25.3	Psoriasis 2	602723	AD	3
608995	1p36-p34	{Dyslexia, susceptibility to, 8}	608995	Mu,AD	2
603276	1q23.3	[Blood pressure regulation QTL]	145500	Mu	2
608251	Chr.14	Phobia, specific	608251	_	2
608799	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
608641	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608930	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AR,AD	3
608542	19q13	Aneurysm, intracranial berry, 2	608542	_	2
608894	6q23.3	Joubert syndrome 3	608629	AR	3
608470	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
607640	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
608673	12q24.23	Charcot-Marie-Tooth disease, axonal, type 2L	608673	AD	3
606595	7q11.23	Charcot-Marie-Tooth disease, axonal, type 2F	606595	AD	3
603287	17q21.32	Pyridoxamine 5'-phosphate oxidase deficiency	610090	AR	3
608214	11q24.1	Atrial fibrillation, familial, 16	613120	AD	3
608214	11q24.1	Brugada syndrome 7	613120	AD	3
608625	17q23.1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3
606621	3q13.12-q13.13	?Orofaciodigital syndrome XVIII	617927	AR	3
605202	9q22.33	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442	AR	3
609200	5q31.2	Myopathy, myofibrillar, 3	609200	AD	3
608471	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
603234	16p13.11	Arterial calcification, generalized, of infancy, 2	614473	AR	3
603234	16p13.11	Pseudoxanthoma elasticum	264800	AR	3
603234	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
607544	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
605435	14q12	Congenital heart defects and ectodermal dysplasia	617364	AD	3
608543	1p36.2	{Schizophrenia 12}	181500	AD	2
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260	AD	3
608507	1p36.22	Charcot-Marie-Tooth disease, axonal, type 2A2B	617087	AR	3
608507	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
604593	2q23.1-q23.2	Cortical dysplasia, complex, with other brain malformations 2	615282	AD	3
607734	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AR,AD	3
603277	12p13.31	Sifrim-Hitz-Weiss syndrome	617159	AD	3
609220	3q24	Bruck syndrome 2	609220	AR	3
609369	11q13.1	Neuropathy, hereditary sensory, type IF	615632	AD	3
608626	17q23.3	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	AR	3
606596	19q13.32	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	AR	3
609044	10q23.33	{Obesity, susceptibility to}	607514	_	3
604860	18q21.32	Immunodeficiency 12	615468	AR	3
607641	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
609338	3p25.2	Carotid intimal medial thickness 1	609338	_	3
609242	22q13.2	Kanzaki disease	609242	AR	3
608862	1q22	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186	AR	3
607617	12q15	?Ovarian dysgenesis 6	618078	AR	3
607617	12q15	Galloway-Mowat syndrome 7	618348	AR	3
607617	12q15	Nephrotic syndrome, type 11	616730	AR	3
608627	20q13.32	Amyotrophic lateral sclerosis 8	608627	AD	3
608896	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
608210	11p11.2	?Seizures, scoliosis, and macrocephaly syndrome	616682	AR	3
608210	11p11.2	Exostoses, multiple, type 2	133701	AD	3
608812	9q22.33	{Colorectal cancer, susceptibility to, 1}	608812	_	3
608643	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
609136	22q13.1	PCWH syndrome	609136	AD	3
608381	2q31.3	Retinitis pigmentosa 26	608380	_	3
608965	11q13.2	Cone-rod synaptic disorder, congenital nonprogressive	610427	AR	3
606976	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
606976	16q22.1	Saul-Wilson syndrome	618150	AD	3
607608	11p15.4	Niemann-Pick disease, type A	257200	AR	3
607608	11p15.4	Niemann-Pick disease, type B	607616	AR	3
606002	9q34.13	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002	AR	3
609506	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
609291	15q14	Legius syndrome	611431	AD	3
606622	2q35	Schimke immunoosseous dysplasia	242900	AR	3
608644	5p15.2	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	_	3
609458	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
608903	16p13	{Attention deficit-hyperactivity disorder}	143465	AD	2
610032	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
610261	20q11-q13	{Hypertension, essential, susceptibility to, 5}	145500	Mu	2
610213	5p15.2-p14.3	Aneurysm, intracranial berry, 4	610213	_	2
609132	1p36.12	Cleft palate, psychomotor retardation, and distinctive facial features	616728	AD	3
610224	9q34.3	Ovarian dysgenesis 5	617690	AR	3
610224	9q34.3	Spermatogenic failure 32	618115	AD	3
609213	3q21.3	Hyperuricemic nephropathy, familial juvenile, 4	617056	AD	3
609139	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
609139	2p11.2	Spastic paraplegia 31, autosomal dominant	610250	AD	3
610362	19p13.3	?Macular degeneration, age-related, 6	613757	_	3
610362	19p13.3	Cone-rod dystrophy 11	610381	AD	3
607642	17p11.2	Smith-Magenis syndrome	182290	IC,AD	3
610377	12q24.11	Mevalonic aciduria	610377	AR	3
609821	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
606977	13q14.11	Congenital disorder of glycosylation, type IIl	614576	AR	3
606977	13q14.11	Shaheen syndrome	615328	AR	3
610168	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
610498	10q22.2	Combined oxidative phosphorylation deficiency 2	610498	AR	3
609342	11q12.1	Intrinsic factor deficiency	261000	AR	3
609041	10q22.1-q24.1	Spastic paraplegia 27, autosomal recessive	609041	AR	2
608864	1q32.2	{Orofacial cleft 6}	608864	AD	3
608675	16q22.1	Congenital disorder of glycosylation with defective fucosylation 2	618324	AR	3
610512	20p11.23	?Cowden syndrome 7	616858	AD	3
610512	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
603743	22q12.3	{End-stage renal disease, nondiabetic, susceptibility to}	612551	_	3
603743	22q12.3	{Glomerulosclerosis, focal segmental, 4, susceptibility to}	612551	_	3
609815	3p21.31	Zygodactyly 1	609815	_	2
610274	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
609549	11q23.3	Nanophthalmos 2	609549	_	3
610243	10q24.2	Spastic paraplegia 33, autosomal dominant	610244	AD	3
610767	2q37.1	{Inflammatory bowel disease (Crohn disease) 10}	611081	_	3
607643	17q25.3	Retinitis pigmentosa 30	607921	_	3
603278	19q13.2	Glomerulosclerosis, focal segmental, 1	603278	AD	3
610838	21p13-q11	{Autism susceptibility 12}	610838	_	2
610832	16p12.2	Fanconi anemia, complementation group N	610832	_	3
610127	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
608800	6q22.1	Sudden infant death with dysgenesis of the testes syndrome	608800	AR	3
611182	16q22.1	Congenital disorder of glycosylation, type IIh	611182	_	3
609891	6q14.2	?Spondylocostal dysostosis 6	616566	AR	3
609140	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
610163	1q24.2	?Immunodeficiency 25	610163	AR	3
610079	11q24.2	{Autoimmune disease, susceptibility to, 6}	613551	_	3
610262	5p13-q12	{Hypertension, essential, susceptibility to, 6}	145500	Mu	2
610915	1p34.2	Osteogenesis imperfecta, type VIII	610915	AR	3
606273	1p34.1	Leukoencephalopathy with vanishing white matter	603896	AR	3
611150	22q13.31	Spinocerebellar ataxia 10	603516	AD	3
609319	6q23	[Hematocrit/hemoglobin quantitative trait locus 1]	609319	_	2
610363	1p36.13	Preimplantation embryonic lethality 2	617234	AR	3
610244	10q24.2	Spastic paraplegia 33, autosomal dominant	610244	AD	3
610523	7q32.2	Joubert syndrome 15	614464	AR	3
604801	1q42	Muscular dystrophy, congenital, 1B	604801	AR	2
611220	17q12	?Cataract 43	616279	AD	3
610928	8q11.23	Vesicoureteral reflux 3	613674	AD	3
610713	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
605557	1p36.32	Cardiomyopathy, dilated, 1LL	615373	AD	3
605557	1p36.32	Left ventricular noncompaction 8	615373	AD	3
610768	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
611102	15q15.3	Deafness and male infertility	611102	AR	4
609507	9p21.1	Retinitis pigmentosa 31	609923	_	3
610565	22q13.1	?Mirror movements 3	616059	AR	3
607545	4q32.3	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3
609340	14q22.1	Spastic paraplegia 28, autosomal recessive	609340	AR	3
609129	13q21.2	Auditory neuropathy, autosomal dominant, 1	609129	AD	3
606489	9p13.2	Pontocerebellar hypoplasia, type 1B	614678	AR	3
603680	13q21.33	Spinocerebellar ataxia 8	608768	AD	3
603680	13q21.33	{Parkinson disease, susceptibility to}	168600	Mu,AD	3
610733	2p22.1	Noonan syndrome 4	610733	AD	3
610128	12q23.3	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3
610839	2q33.3	{Osteoarthritis susceptibility 4}	610839	_	2
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	AD	3
605597	3q22.3	Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	AD	3
605597	3q22.3	Premature ovarian failure 3	608996	AD	3
610873	22q13	{Menarche, age at, QTL}	610873	_	2
610263	11q13.4	Ciliary dyskinesia, primary, 34	617091	AR	3
608801	19p13.13	Glutaricaciduria, type I	231670	AR	3
610707	16q	{Psoriasis susceptibility 8}	610707	_	2
610745	15q24.1	Microphthalmia, isolated, with coloboma 8	601186	AR	3
610745	15q24.1	Microphthalmia, syndromic 9	601186	AR	3
610444	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
610245	20p13	Spinocerebellar ataxia 23	610245	AD	3
611174	16q12.2	Hamamy syndrome	611174	AR	3
610916	5p15.31	Mental retardation, autosomal recessive 5	611091	AR	3
611228	6q21	Charcot-Marie-Tooth disease, type 4J	611228	AR	3
609913	1p21.3-p13.3	Retinitis pigmentosa 32	609913	_	2
610805	1q32.1	Congenital anomalies of kidney and urinary tract 1	610805	AD	3
609552	2q11.2	?Mental retardation, autosomal recessive, 52	616887	AR	3
608423	7q32.1	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423	AD	3
609508	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
611448	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
610531	7p15.3	Leukodystrophy, hypomyelinating, 5	610532	AR	3
610876	6q16.3	Spastic paraplegia and psychomotor retardation with or without seizures	616756	AR	3
605598	5q31.1-q33.1	{Diabetes mellitus, insulin-dependent, 18}	605598	_	2
609893	15q25.3-q26.1	Hypothyroidism, congenital, nongoitrous, 3	609893	_	2
611588	9q31.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	AR	3
610865	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
610142	12q21.32	?Bardet-Biedl syndrome 14	615991	AR	3
610142	12q21.32	Joubert syndrome 5	610188	AR	3
610142	12q21.32	Leber congenital amaurosis 10	611755	_	3
610142	12q21.32	Meckel syndrome 4	611134	AR	3
610142	12q21.32	Senior-Loken syndrome 6	610189	AR	3
610708	12p11.21	Optic atrophy 5	610708	AD	3
610226	17q25.3	Seborrhea-like dermatitis with psoriasiform elements	610227	_	3
610600	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
607882	8q24.3	Brown-Vialetto-Van Laere syndrome 2	614707	AR	3
608428	10q23.33	Focal facial dermal dysplasia 4	614974	AR	3
610246	18p11.21	Spinocerebellar ataxia 28	610246	AD	3
611082	22q12.1	{Myocardial infarction, susceptibility to}	608446	_	3
609633	21q22.13	{Major affective disorder 3, early onset}	609633	_	2
610911	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
610739	16p12.1	?Epilepsy, familial adult myoclonic, 6	618074	_	3
609144	1q32.3	Ataxia, posterior column, with retinitis pigmentosa	609033	AR	3
609376	19q13	Cataract 35, congenital nuclear	609376	AR	2
610746	9q34.11	Congenital disorder of glycosylation, type Im	610768	AR	3
611103	3q21.3	Mitochondrial complex I deficiency, nuclear type 20	611126	AR	3
611152	1q21	{Alzheimer disease-13}	611152	_	2
608807	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
610293	1q23.2	Glycosylphosphatidylinositol deficiency	610293	AR	3
611369	19p13.3	Lethal congenital contractural syndrome 3	611369	AR	3
610528	14q11.2	{Autism, susceptibility to, 18}	615032	AD	3
609299	3p26	{Prostate cancer, hereditary, 5}	609299	_	2
608437	12q24	{Systemic lupus erythematosus, susceptibility to, 4}	608437	_	2
611131	15q23	Retinitis pigmentosa 37	611131	AR,AD	3
610297	2p13.1	{Parkinson disease 13}	610297	_	3
609218	16q23.3	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218	AR	3
609048	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
609245	1p13.3	Chudley-McCullough syndrome	604213	AR	3
611762	19q13.42	Familial cold autoinflammatory syndrome 2	611762	AD	3
609862	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
609300	10q24.32	17,20-lyase deficiency, isolated	202110	AR	3
609300	10q24.32	17-alpha-hydroxylase/17,20-lyase deficiency	202110	AR	3
610345	7q34	Cataract 38, autosomal recessive	614691	AR	3
610345	7q34	Sengers syndrome	212350	AR	3
610912	4q13.3	?Amelogenesis imperfecta, type IIIB	617607	AD	3
605740	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
605740	17q21.31	Sclerosteosis 1	269500	AR	3
605740	17q21.31	Van Buchem disease	239100	AR	3
611104	12p11.21	Charcot-Marie-Tooth disease, type 4H	609311	AR	3
609489	4q24	Mannosidosis, beta	248510	AR	3
609161	5q13.3	Striatal degeneration, autosomal dominant	609161	AD	3
609460	10q22.1	Goldberg-Shprintzen megacolon syndrome	609460	AR	3
610532	7p15.3	Leukodystrophy, hypomyelinating, 5	610532	AR	3
605845	5q31-q33	{Dermatitis, atopic, susceptibility to, 6}	605845	_	2
608576	8q22.3	Corneal dystrophy, posterior polymorphous, 4	618031	AD	3
608576	8q22.3	Deafness, autosomal dominant 28	608641	AD	3
608576	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
607483	2q36.3	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	AR	3
608488	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
610445	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
606003	11p15.5	Transaldolase deficiency	606003	AR	3
609049	3p21.31	Pierson syndrome	609049	AR	3
611204	14q32.11-q32.12	?Spinocerebellar ataxia 40	616053	AD	3
611204	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
611456	6p23	Essential tremor, hereditary, 3	611456	_	2
609863	12q24.11	Joubert syndrome 13	614173	AR	3
611184	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
611184	16q24.3	Lymphatic malformation 6	616843	AR	3
611647	1q42.2	Epileptic encephalopathy, early infantile, 38	617020	AR	3
611153	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
610743	6q25.2	Spinocerebellar ataxia, autosomal recessive 8	610743	AR	3
608586	3p14-q13	Keratoconus 3	608586	_	2
612078	16q24.2	Brittle cornea syndrome 1	229200	AR	3
605437	14q23.1	{Cerebral infarction, susceptibility to}	601367	Mu	3
610812	16q22.2	Ciliary dyskinesia, primary, 5	608647	AR	3
610913	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
611739	11p12	{Osteoporosis}	166710	AD	2
607622	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
604862	2p13.3	[?Birbeck granule deficiency]	613393	_	3
608489	7q22.1	Premature ovarian failure 8	615723	AR	3
609689	20q11.22	Cone-rod dystrophy and hearing loss 2	618358	AR	3
608808	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
606978	16p12.2	Congenital disorder of glycosylation, type IIe	608779	AR	3
612291	3q11.1-q11.2	Joubert syndrome 8	612291	AR	3
609889	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
611770	8p21.2	Conotruncal heart malformations	217095	_	3
611770	8p21.2	Persistent truncus arteriosus	217095	_	3
612285	4p15.32	Joubert syndrome 9	612285	AR	3
610083	4q34.3-q35.1	Microphthalmia, isolated, with coloboma 9	615145	AR	3
604809	6p21.3	Panbronchiolitis, diffuse	604809	Mu	2
609273	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
612222	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
611185	6p21	{Restless legs syndrome 6}	611185	_	2
610725	10q23.33	Nephrotic syndrome, type 3	610725	AR	3
612411	4q28.1	Hennekam lymphangiectasia-lymphedema syndrome 2	616006	AR	3
612411	4q28.1	Van Maldergem syndrome 2	615546	AR	3
610568	1q21.3	Paget disease of bone 6	616833	AD	3
611722	10q22.1	Krabbe disease, atypical	611722	AR	3
611105	1q25.1	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	AR	3
612138	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
612465	13q22.2	{Diabetes mellitus, noninsulin-dependent, 5}	616087	_	3
610170	5p13	Kyphoscoliosis 1	610170	_	2
610446	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
608968	20q12	Duane retraction syndrome 3	617041	AD	3
608968	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
612448	8q24.13-q24.22	{Age-related hearing impairment 1}	612448	_	2
609173	15q15.1	Microcephaly 4, primary, autosomal recessive	604321	AR	3
611590	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
603539	11q13.2	Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	AR	3
612079	7q32.1	?Alopecia, neurologic defects, and endocrinopathy syndrome	612079	AR	3
612348	8p12	?Thrombophilia due to decreased release of tissue plasminogen	_	_	1
608075	12p12.3	?Spermatogenic failure 17	617214	AR	3
611648	5q21.1	Deafness, autosomal recessive 100	618422	AR	3
611687	6q13	Hydatidiform mole, recurrent, 2	614293	AR	3
610217	22q13.1	Neurodegeneration with brain iron accumulation 2B	610217	AR	3
610294	6p25.3-p22.3	{Intelligence QTL3}	610294	_	2
612267	11q13.3	[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	_	3
609690	2q36.1	Rajab interstitial lung disease with brain calcifications	613658	AR	3
604594	2p21	Short stature with microcephaly and distinctive facies	615789	AR	3
611766	15q22.31	Combined oxidative phosphorylation deficiency 15	614947	AR	3
611766	15q22.31	Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3
612923	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
607736	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
608025	2p24.3	Infantile liver failure syndrome 2	616483	AR	3
608025	2p24.3	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	AR	3
612775	8p11.22	Cone-rod dystrophy 9	612775	_	3
611223	1q43-q44	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3
607492	11q13.1-q13.2	Schuurs-Hoeijmakers syndrome	615009	AD	3
610618	5q35.3	Angioedema, hereditary, type III	610618	AD	3
613085	14q24.3	Glaucoma 3, primary congenital, C	613085	_	2
610143	12p13.2-p11.23	Deafness, autosomal recessive 62	610143	AR	2
612958	17q23.3	Mitochondrial complex IV deficiency	220110	Mi,AR	3
612716	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
612176	1p32.1	Bone marrow failure syndrome 4	618116	AR	3
613092	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
608448	3p26	{Inflammatory bowel disease 9}	608448	_	2
611994	16p13.3	Combined oxidative phosphorylation deficiency 32	617664	AR	3
611771	19q13.32	Lipoprotein glomerulopathy	611771	_	3
611603	12q13.12	Lissencephaly 3	611603	AD	3
604863	4q32.1	Leber congenital amaurosis 14	613341	AR	3
604863	4q32.1	Retinal dystrophy, early-onset severe	613341	AR	3
604863	4q32.1	Retinitis pigmentosa, juvenile	613341	AR	3
613168	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
612286	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
613161	22q11.23	Beta-ureidopropionase deficiency	613161	AR	3
611459	4q31.22	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3
612192	6p22.1	Diabetes mellitus, transient neonatal, 1	601410	AD	3
612224	4q31	{Stature QTL 12}	612224	_	2
609165	17q21.2	Ichthyosis with confetti	609165	AD	3
613251	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
611945	8p21.1-q13.3	Spastic paraplegia 37, autosomal dominant	611945	AD	2
612132	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
613027	16p11.2	Glycogen storage disease IXc	613027	AR	3
610295	2q24.1-q31.1	{Intelligence QTL3}	610295	_	2
613265	20q13.32	Waardenburg syndrome, type 4B	613265	AR,AD	3
613235	1q31.3	Factor XIIIB deficiency	613235	AR	3
612518	14q21.3	Ciliary dyskinesia, primary, 10	612518	_	3
613228	4q34.3	Aspartylglucosaminuria	208400	AR	3
611307	11p14.3	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307	AR	3
612690	15q15.2	Spherocytosis, type 5	612690	_	3
610508	2p25.1	Maturity-onset diabetes of the young, type VII	610508	_	3
609820	1q42.2	Erythrocytosis, familial, 3	609820	AD	3
610836	1q41-q42	{Autism susceptibility 11}	610836	_	2
612350	11p11.2	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350	AR	3
608026	9q31-q32	Hypertensive nephropathy	608026	_	2
612924	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
612268	14q24.3	Cone-rod dystrophy 19	615860	AR	3
613179	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
613413	7p21.3	Leukodystrophy, hypomyelinating, 16	617964	AD	3
608316	2q21.1-q22	{Coronary heart disease, susceptibility to, 2}	608316	_	2
612080	5q31.1	Mitochondrial complex III deficiency, nuclear type 4	615159	AR	3
611203	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
609946	2p25.1-p24.3	Deafness, neurosensory, autosomal recessive 47	609946	AR	2
610921	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
611224	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
609562	8q13.2	Epilepsy, familial temporal lobe, 5	614417	AR,AD	3
609562	8q13.2	Febrile seizures, familial, 11	614418	AR	3
613086	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
613019	11q12.2	Paragangliomas 2	601650	AD	3
604597	12q14.3	Fraser syndrome 3	617667	AR	3
612647	6q22.1	Ciliary dyskinesia, primary, 11	612649	_	3
612406	20p11.2-q13.12	Dystonia-17, primary torsion	612406	AR	2
608931	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
609456	4p16.3	Muscular dystrophy, congenital, merosin-positive	609456	AR	2
608537	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
608537	3p25.3	Hemangioblastoma, cerebellar, somatic	_	_	3
608537	3p25.3	Pheochromocytoma	171300	AD	3
608537	3p25.3	Renal cell carcinoma, somatic	144700	_	3
608537	3p25.3	von Hippel-Lindau syndrome	193300	AD	3
611469	8q24	{Colorectal cancer, susceptibility to, 2}	611469	_	2
612292	8q24.3	Birk-Barel mental retardation dysmorphism syndrome	612292	_	3
613480	1q42.13	Lymphatic malformation 3	613480	AD	3
608622	5q35.1	{Hypertension, diastolic, resistance to}	608622	AD	3
613169	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
609275	1q41	Martsolf syndrome	212720	AR	3
609275	1q41	Warburg micro syndrome 2	614225	AR	3
613098	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
610619	5q35.3	Angioedema, hereditary, type III	610618	AD	3
610619	5q35.3	Factor XII deficiency	234000	AR	3
612959	8q22.1	?Deafness, autosomal recessive 109	618013	AR	3
610178	14q23.1	Joubert syndrome 23	616490	AR	3
610178	14q23.1	Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3
610357	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
613541	12q24.31	Combined oxidative phosphorylation deficiency 7	613559	AR	3
613541	12q24.31	Spastic paraplegia 55, autosomal recessive	615035	AR	3
611357	6q14.1	Osteogenesis imperfecta, type XVIII	617952	AR	3
613695	21q22.12	Long QT syndrome 5	613695	AD	3
611252	14q12-q21	Spastic paraplegia 32, autosomal recessive	611252	AR	2
612287	17q25.1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	AD	3
609270	11p15.4	Spinocerebellar ataxia, autosomal recessive 7	609270	AR	3
613719	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
613028	10q23.31	{Glioma susceptibility 2}	613028	_	3
613728	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
612437	12q12	Epilepsy, progressive myoclonic 1B	612437	AR	3
612925	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
613768	17q25.3	{Moyamoya disease 2, susceptibility to}	607151	_	3
611421	16p11.2	Floating-Harbor syndrome	136140	AD	3
612444	17q25.1	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	_	3
612529	11q22.2	Amelogenesis imperfecta, type IIA2	612529	AR	3
613744	15q21.2	Spastic paraplegia 51, autosomal recessive	613744	AR	3
606675	14q11-q12	{Inflammatory bowel disease 4}	606675	_	2
608595	7p14.3	{Asthma, susceptibility to, 2}	608584	_	3
612186	15q21.2	?Deafness, autosomal dominant 71	617605	AD	3
612186	15q21.2	?Polyendocrine-polyneuropathy syndrome	616113	AR	3
610448	3p21.31	Chilblain lupus	610448	AD	3
613153	19q13.32	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	AR	3
613762	5q11.2	46XY sex reversal 6	613762	AD	3
613835	1q31.3	Leber congenital amaurosis 8	613835	_	3
612225	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
608027	7q21.11	?Pontocerebellar hypoplasia, type 3	608027	AR	3
613162	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
613869	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
612757	8q24.3	Hyperlipoproteinemia, type 1D	615947	AR	3
613883	7q34	[Blood group, Kell]	110900	_	3
608932	16q22.3-q23.1	Keratoconus 2	608932	_	2
614037	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
613087	4q32.3	Atrial septal defect 6	613087	AD	3
612988	11q14.1	Optic atrophy 7	612989	AR	3
613521	1p34.1	Porphyria cutanea tarda	176100	AR,AD	3
613521	1p34.1	Porphyria, hepatoerythropoietic	176100	AR,AD	3
609367	10q22.1	Goldberg-Shprintzen megacolon syndrome	609460	AR	3
614044	7q34	Trypsinogen deficiency	614044	AR	1
613500	22q11.23	Agammaglobulinemia 2	613500	AR	3
613099	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
612293	1p31.3-p31.1	Porokeratosis 5, disseminated superficial actinic	612293	_	2
611849	2q36.1	?Combined oxidative phosphorylation deficiency 16	615395	AR	3
610361	13q33.1-q34	Orofacial cleft 9	610361	_	2
612199	17p13.1	Cerebroretinal microangiopathy with calcifications and cysts	612199	AR	3
611958	11q13	{Prostate cancer, hereditary, 14}	611958	_	2
611891	9p21	{Aneurysm, familial abdominal 3}	611891	_	2
613553	22q13.2	Nephronophthisis-like nephropathy 1	613159	AR	3
613230	19q13.11	Prolidase deficiency	170100	AR	3
612288	10q23-q24	{Inflammatory bowel disease 20}	612288	_	2
613920	2q11.2	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3	616500	AR	3
612051	16q21	Spinocerebellar ataxia 31	117210	AD	3
611553	3p25.2	Noonan syndrome 5	611553	AD	3
609271	2p24	Keratoconus 4	609271	_	2
604632	16q22.1-q22.2	Striatonigral degeneration, childhood-onset	617054	AR	3
613252	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
613636	11p14	[Tuberculin skin test reactivity, absence of]	613636	_	2
608769	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
607883	17p13.2	Riboflavin deficiency	615026	AD	3
609276	11q25	Microcephaly 22, primary, autosomal recessive	617984	AR	3
613720	20q13.33	Epileptic encephalopathy, early infantile, 7	613720	AD	3
614237	10q11.23-q22.3	Hypotrichosis 9	614237	AR	2
611134	12q21.32	Meckel syndrome 4	611134	AR	3
614303	15q25.1	EDICT syndrome	614303	AD	3
614067	14q12	Spastic paraplegia 52, autosomal recessive	614067	AR	3
611623	12p13.31	?Epileptic encephalopathy, early infantile, 21	615833	AR	3
614258	10q22.3	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	AR	3
614258	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
608439	17q23.2	Mental retardation, autosomal dominant 57	618050	AD	3
614402	10q25.3	?Microphthalmia, syndromic 11	614402	AR	3
614374	6p21.33	[Blood group, Rodgers]	614374	_	3
609479	2q31.1	Centronuclear myopathy 6 with fiber-type disproportion	617760	AR	3
609479	2q31.1	Split-foot malformation with mesoaxial polydactyly	616890	AR	3
613763	11q23.1	Cataract 16, multiple types	613763	AR,AD	3
614280	2q33-q36	{Epilepsy, juvenile myoclonic, susceptibility to, 9}	614280	AD	2
613884	13q14	Chromosome 13q14 deletion syndrome	613884	IC,AD	4
614478	12q13.12	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
613224	1p13.2	Noonan syndrome 6	613224	AD	3
614319	18q12.3	Vesicoureteral reflux 6	614319	_	2
614039	16q24.3	Cortical dysplasia, complex, with other brain malformations 1	614039	AD	3
612462	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
612926	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
614381	12q23.3	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	AR	3
613021	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
613164	1q32	{Parkinson disease 16}	613164	_	2
613029	13q13.1	{Glioblastoma 3}	613029	AR	3
613969	5p15.1-p13.3	Myopia 19	613969	AD	2
612226	4p15.3	{Stature QTL 13}	612226	_	2
614433	6q24.1	Atrial septal defect 8	614433	AD	3
613289	13q21	Spinocerebellar ataxia 8	608768	AD	3
614135	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
609948	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
613836	16q23.3	{Adiponectin, serum level of, QTL5]	613836	_	2
611862	1q23.2	[White blood cell count QTL]	611862	AR	3
613814	17p12	Mitochondrial complex III deficiency, nuclear type 2	615157	AR	3
614120	15q26.1	?Hydrolethalus syndrome 2	614120	AR	3
612082	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
614165	5p15.33	Paragangliomas 5	614165	AD	3
614199	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
613154	22q12.3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	AR	3
613192	8q24.3	Mental retardation, autosomal recessive 13	613192	AR	3
613176	19q13.31	Heart and brain malformation syndrome	616920	AR	3
612989	11q14.1	Optic atrophy 7	612989	AR	3
613870	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
614616	12p12.3	Diarrhea 6	614616	AD	3
613958	12q14.2	Spermatogenic failure 9	613958	AR	3
610374	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
613915	14q32.33	?Lethal congenital contracture syndrome 6	616248	AR	3
611096	16p12.2-q12.1	Mental retardation, autosomal recessive 10/20	611096	AR	2
613064	11q13.5	{Dermatitis, atopic, susceptibility to, 7}	613064	_	2
611554	3p25.2	LEOPARD syndrome 2	611554	_	3
612758	4p15.32	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897	AR	3
611236	9q31.2	Osteogenesis imperfecta, type XIV	615066	_	3
614672	7q21.2	?Cardiomyopathy, dilated, 2B	614672	AR	3
613721	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
613794	1p31.3	Retinitis pigmentosa 20	613794	AR	3
614238	7p22.3-p21.3	Hypotrichosis 10	614238	AR	2
614382	11q24.2	{Bacteremia, protection against}	614382	_	3
614727	4q12	Congenital disorder of glycosylation, type IIk	614727	AR	3
609806	11q23.3	Porphyria, acute intermittent	176000	AD	3
609806	11q23.3	Porphyria, acute intermittent, nonerythroid variant	176000	AD	3
614691	7q34	Cataract 38, autosomal recessive	614691	AR	3
614290	18p	Tetrasomy 18p	614290	_	4
613340	4q24-q28	Epilepsy, hot water, 2	613340	_	2
608770	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
607904	16p13.3	Hyperaldosteronism, familial, type IV	617027	AD	3
607904	16p13.3	{Epilepsy, childhood absence, susceptibility to, 6}	611942	_	3
607904	16p13.3	{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942	_	3
613854	19p13.11	Congenital heart defects, multiple types, 6	613854	AD	3
613970	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
612463	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
613165	17q25.3	Desbuquois dysplasia 1	251450	AR	3
613165	17q25.3	Epiphyseal dysplasia, multiple, 7	617719	AR	3
613522	7q32.1	Colorblindness, tritan	190900	AD	3
614375	12q13.3	Aortic aneurysm, familial abdominal, 4	614375	_	2
612227	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AR,AD	3
603909	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
609168	3p24.3	Chronic atrial and intestinal dysrhythmia	616201	AR	3
609678	13q31.1	?Trichotillomania	613229	Mu,AD	3
609678	13q31.1	Tourette syndrome	137580	AD	3
614852	15q21.1	Microcephaly 9, primary, autosomal recessive	614852	AR	3
613573	1q23.3	Ectodermal dysplasia-syndactyly syndrome 1	613573	AR	3
614166	13q12.12	Myopia 20, autosomal dominant	614166	_	2
613885	12q24.31	?Meckel syndrome 8	613885	AR	3
614193	6p22.2	[Transferrin serum level QTL2]	614193	_	3
613837	7q32.1	Leber congenital amaurosis 11	613837	AD	3
614501	1p34.3	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	AR	3
614976	19q13.2	Carpenter syndrome 2	614976	AR	3
614397	1p34.2	Microcephaly 15, primary, autosomal recessive	616486	AR	3
612289	1p13.3	Fontaine progeroid syndrome	612289	AD	3
614893	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
612759	2q24.1	Synesthesia	612759	_	2
613916	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
614389	1q24.2	{Pregnancy loss, recurrent, susceptibility to, 1}	614389	AD	3
611863	4p16-p15	Microtia with nasolacrimal duct imperforation and eye coloboma	611863	_	4
613022	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
614863	6p21.1	Peroxisome biogenesis disorder 4B	614863	AR,AD	3
614383	3p21.2	{Bacteremia, susceptibility to}	614383	_	3
613156	14q24.3	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	AR	3
613959	7q36.3	Schizophrenia 16	613959	_	4
613089	3q26.32	CLAPO syndrome, somatic	613089	_	3
615103	18p11.21	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction	617732	AD	3
613765	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
612990	20q11.21	Bohring-Opitz syndrome	605039	AD	3
612990	20q11.21	Myelodysplastic syndrome, somatic	614286	_	3
614434	14q32.12	Cutis laxa, autosomal dominant 2	614434	_	3
613307	9q34.3	Deafness, autosomal recessive 79	613307	AR	3
613829	19q13.33	Leber congenital amaurosis 7	613829	_	3
613068	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
613177	19q13.2	Cutis laxa, autosomal recessive, type IC	613177	AR	3
615214	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
613030	9p21.3	{Glioma susceptibility 5}	613030	_	2
612221	3q23	{Stature QTL 10}	612221	_	2
610204	17q25.1	?Pontocerebellar hypoplasia type 5	610204	AR	3
614654	16q21	Coenzyme Q10 deficiency, primary, 5	614654	AR	3
614728	3q22.2	?Seckel syndrome 6	614728	AR	3
608771	12q24.21	Mental retardation and distinctive facial features with or without cardiac defects	616789	AD	3
608771	12q24.21	Transposition of the great arteries, dextro-looped 1	608808	AD	3
614068	14q24.3	?Cranioectodermal dysplasia 3	614099	AR	3
614068	14q24.3	?Retinitis pigmentosa 81	617871	AR	3
614068	14q24.3	Short-rib thoracic dysplasia 18 with polydactyly	617866	AR	3
614661	15q21.1	Oocyte maturation defect 4	617743	AR	3
614194	19p13.2	Adams-Oliver syndrome 2	614219	AR	3
612182	8p22	[Acetylation, slow]	243400	AR	3
614698	1q44	Mitochondrial complex IV deficiency	220110	Mi,AR	3
614480	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
613855	2q23.3	Episodic ataxia, type 5	613855	AD	3
612410	18p11.23	{Psoriasis susceptibility 10}	612410	_	2
614369	19q13.33	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	AD	3
613501	19q13.2	Agammaglobulinemia 3	613501	AR	3
614305	11p11.2	Sclerosteosis 2	614305	AR,AD	3
614320	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
613523	8p11	Chromosome 8p11 myeloproliferative syndrome	613523	_	4
613308	6p21.31	Diamond-Blackfan anemia 9	613308	AD	3
613157	1p34.1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	AR	3
614294	15q25	Chromosome 15q25 deletion syndrome	614294	AD	4
613726	3p22.1-p21.3	Spinocerebellar ataxia, autosomal recessive 10	613728	AR	3
614692	6p21.3	{?Membranous nephropathy, susceptibility to}	614692	_	2
614376	4p14	?Short-rib thoracic dysplasia 5 with or without polydactyly	614376	AR	3
614404	17q25.1	Tylosis with esophageal cancer	148500	AD	3
611360	15q26.1	Fanconi anemia, complementation group I	609053	AR	3
610205	1p12	Alagille syndrome 2	610205	AD	3
614201	19q13.42	Bleeding disorder, platelet-type, 11	614201	AR	3
612438	19p13.3	Leukodystrophy, hypomyelinating, 6	612438	AD	3
615284	22q13.33	Charcot-Marie-Tooth disease, type 4B3	615284	AR	3
611254	15q26.1	?Al-Gazali-Bakalinova syndrome	607131	AR	3
611254	15q26.1	?Hydrolethalus syndrome 2	614120	AR	3
611254	15q26.1	Acrocallosal syndrome	200990	AR	3
611254	15q26.1	Joubert syndrome 12	200990	AR	3
613025	15q13	{Schizophrenia, susceptibility to, 13}	613025	_	2
613062	9p21	{Basal cell carcinoma, susceptibility to, 5}	613062	_	2
611097	19q13.2-q13.3	Mental retardation, autosomal recessive, 11	611097	AR	2
613979	20q13.33	Retinitis pigmentosa 60	613983	AD	3
615300	3p21.31	Perrault syndrome 4	615300	AR	3
613838	4q26	Cardiomyopathy, hypertrophic, 16	613838	AD	3
615440	17p12	Combined oxidative phosphorylation deficiency 17	615440	AR	3
614982	18p11.32	Bosma arhinia microphthalmia syndrome	603457	AD	3
614982	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
615548	3p22.2	Neuropathy, hereditary sensory and autonomic, type VII	615548	AD	3
614283	7p21.3	{Glucocorticoid therapy, response to}	614400	_	3
613488	12q13.1	Myxoid liposarcoma	613488	_	4
607905	9q22.33	?Congenital disorder of glycosylation, type Ii	607906	AR	3
607905	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
614195	20p11.21	?Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	_	3
613871	15q25.1	Tyrosinemia, type I	276700	AR	3
614306	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
614668	16q12.1-q23.1	Stuttering, familial persistent, 4	614668	_	2
613750	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
614321	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
615374	4p15.33	Cone-rod dystrophy 18	615374	AR	3
614295	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
613070	22q13.31	Liver failure, transient infantile	613070	AR	3
614699	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
614655	3q13.2-q13.33	Stuttering, familial persistent, 3	614655	_	2
614866	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
615611	15q22.31	?Protoporphyria, erythropoietic, 2	618015	AD	3
614390	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
615538	22q13	Chromosome 22q13 duplication syndrome	615538	IC	4
614378	4p14	?Cranioectodermal dysplasia 4	614378	AR	3
615670	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
613489	16q22.1	Congenital disorder of glycosylation, type IIj	613489	AR	3
614483	13q34	Brain small vessel disease 2	614483	AD	3
615521	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
613502	10q24.1	?Agammaglobulinemia 4	613502	AR	3
614908	11q14.2	Leukodystrophy, hypomyelinating, 13	616881	AR	3
614122	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
613233	11q21-q22	[Fasting plasma glucose level QTL 3]	613233	_	2
613018	16q22.2	Tyrosinemia, type II	276600	AR	3
614202	9q34.3	Mental retardation, autosomal recessive 15	614202	AR	3
615726	12q13.13	Pachyonychia congenita 3	615726	_	3
614370	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
615158	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
615242	1p36.32	[Blood group, Vel system]	615264	AR	3
613839	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
613960	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
615285	1q21.2	Neutropenia, severe congenital, 5, autosomal recessive	615285	AR	3
615441	6q22.31	Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	AR	3
615612	3p22.2	Developmental dysplasia of the hip 2	615612	AD	2
616120	10q24.31	Spinocerebellar ataxia, autosomal recessive 17	616127	AR	3
616079	13q14.2	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	AD	3
614669	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AR,AD	3
616032	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
613026	19q13.11	Chromosome 19q13.11 deletion syndrome, distal	613026	AD	4
614284	1p34.2	?Stickler syndrome, type V	614284	AR	3
615629	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
614307	5p13.2	Alpha-methylacyl-CoA racemase deficiency	614307	AR	3
613872	13q34	Factor X deficiency	227600	AR	3
613411	13q34	Oguchi disease-2	613411	_	3
615872	5q11.2	Ciliary dyskinesia, primary, 29	615872	AR	3
610212	6p22.3	?Deafness, autosomal recessive 66	610212	AR	3
615369	15q26.1	Epileptic encephalopathy, childhood-onset	615369	AD	3
615558	2p24.1	Hypobetalipoproteinemia	615558	AR	3
614346	12q13.11-q15	Mental retardation, autosomal recessive 25	614346	AR	2
614196	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
615423	3q12.3	Combined oxidative phosphorylation deficiency 30	616974	AR	3
615760	3p21.31	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760	AR	3
615412	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
615849	2q14.2	Culler-Jones syndrome	615849	AD	3
616178	17q12	?Deafness, autosomal recessive 99	618481	_	3
609457	12q23.1	[Histidinemia]	235800	AR,AD	3
615522	6q23.2	Cole disease	615522	AD	3
614123	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
613516	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
614810	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
613637	5p15	[Tuberculin skin test reactivity QTL]	613637	_	2
615348	3p22.1	Nemaline myopathy 8, autosomal recessive	615348	_	3
614435	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
612322	2q33.3	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
615785	17q21.2	White sponge nevus 2	615785	AD	3
613727	15q22.31	Nemaline myopathy 6, autosomal dominant	609273	AD	3
613524	1q43-q44	Bardet-Biedl syndrome 16	615993	AR	3
613524	1q43-q44	Senior-Loken syndrome 7	613615	_	3
616080	7q21.2	?Microcephaly 12, primary, autosomal recessive	616080	AR	3
616025	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
615413	10q26.11	Spermatogenic failure 12	615413	AD	3
613751	3p22.2	Heterotaxy, visceral, 4, autosomal	613751	_	3
615850	17p13.3	Pontocerebellar hypoplasia, type 2E	615851	AR	3
615630	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
616362	19q13.41	Mental retardation, autosomal dominant 36	616362	AD	3
615618	3q13.33	?Muscular dystrophy, limb-girdle, autosomal recessive 21	617232	AR	3
615618	3q13.33	Dowling-Degos disease 4	615696	AD	3
615370	9q22.33	Nephronophthisis 16	615382	AR	3
614203	16q11.2	{Parkinson disease 17}	614203	AD	3
616265	19q13.11	?Peeling skin syndrome 3	616265	AR	3
615021	3q26.1	[Blood group, globoside system]	615021	_	3
615559	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
612414	11q13.4	Deafness, autosomal recessive 63	611451	AR	3
615112	1p13.2	Urofacial syndrome 2	615112	AR	3
615424	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
613517	2q37.1	Microphthalmia, isolated 6	613517	AR	3
615873	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
614318	13q33.2	Vesicoureteral reflux 5	614318	_	2
615885	13q12.2	Hypotrichosis 12	615885	AD	3
615643	17q21.2	Neurodegeneration with brain iron accumulation 6	615643	AR	3
615761	3p25.3	Mental retardation, autosomal dominant 23	615761	AD	3
615107	10q23.31	Cowden syndrome 4	615107	_	3
613312	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
615349	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
616222	14q32	Temple syndrome	616222	AD	4
612346	22q11.23	?Glutathioninuria	231950	AR	3
613767	16q21	Retinitis pigmentosa 45	613767	AR	3
615539	6q22.1	Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3
616012	3p25.3	Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3
616172	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
615523	15q25.3	Corneal dystrophy, Fuchs endothelial, 8	615523	AD	3
614347	6q26-q27	Mental retardation, autosomal recessive 28	614347	AR	2
615113	15q26.3	Microphthalmia, isolated 8	615113	AR	3
614954	9q31.1	Congenital heart defects, multiple types, 3	614954	AD	2
615802	2q33.1	Mental retardation, autosomal recessive 42	615802	AR	3
613980	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
616406	1q42.12	Leukodystrophy, hypomyelinating, 10	616420	AR	3
616580	9q21.32	Au-Kline syndrome	616580	AD	3
615631	15q14	Dyserythropoietic anemia, congenital, type Ib	615631	AR	3
616111	11q12.3	?Mitochondrial complex III deficiency, nuclear type 9	616111	AR	3
612778	3p21.31	Luscan-Lumish syndrome	616831	AD	3
614856	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
616455	8p21.3	Zimmermann-Laband syndrome 2	616455	AD	3
616494	6p21.1	Leukodystrophy, hypomyelinating, 11	616494	AR	3
611100	8q24	{Prostate cancer, hereditary, 10}	611100	_	2
614041	13q14.2	Bladder cancer, somatic	109800	_	3
614041	13q14.2	Osteosarcoma, somatic	259500	_	3
614041	13q14.2	Retinoblastoma	180200	SMu,AD	3
614041	13q14.2	Retinoblastoma, trilateral	180200	SMu,AD	3
614041	13q14.2	Small cell cancer of the lung, somatic	182280	_	3
614696	3p11.2	Amyotrophic lateral sclerosis 17	614696	AD	3
613412	5q22	{Esophagitis, eosinophilic, 2}	613412	Mu	2
614770	19p13.2	Mitochondrial complex IV deficiency	220110	Mi,AR	3
613873	20q13.12	Cardiomyopathy, hypertrophic, 17	613873	AD	3
616368	5q31.1	CHOPS syndrome	616368	AD	3
615350	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	AR	3
613313	19q13.12	Hemochromatosis, type 2B	613313	AR	3
615582	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
616144	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
615244	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
615425	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
611317	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
616726	16q24.3	Ciliary dyskinesia, primary, 33	616726	AR	3
614671	16p11.2	Chromosome 16p11.2 duplication syndrome	614671	_	4
614671	16p11.2	{Autism, susceptibility to, 14B}	614671	_	2
608796	8q23	Moyamoya disease 3	608796	_	2
615779	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
614730	9p13.3	Hyperphosphatasia with mental retardation syndrome 2	614749	AR	3
614828	3p22.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AR	3
614828	3p22.1	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3
616461	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
615022	12p11.2-q13.1	Ichthyosis, congenital, autosomal recessive 7	615022	AR	2
613684	22q13.2	Rubinstein-Taybi syndrome 2	613684	AD	3
604569	7q35-q36	Cortical dysplasia-focal epilepsy syndrome	610042	AR	3
604569	7q35-q36	Pitt-Hopkins like syndrome 1	610042	AR	3
604569	7q35-q36	{Autism susceptibility 15}	612100	_	3
615101	6p25.2	Cortical dysplasia, complex, with other brain malformations 5	615763	AD	3
614486	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
616228	9q22.33	Myasthenic syndrome, congenital, 14, with tubular aggregates	616228	AR	3
612347	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
613193	16q24.1	Ciliary dyskinesia, primary, 13	613193	AR	3
613554	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
612898	9q34.11	Coenzyme Q10 deficiency, primary, 7	616276	AR	3
613886	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
613795	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
615560	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
613575	3q11.2	?Retinitis pigmentosa 55	613575	_	3
616835	6p22.3	Meier-Gorlin syndrome 6	616835	AD	3
614673	4q12	Microcephaly 8, primary, autosomal recessive	614673	AR	3
613518	4q22.1	{Dermatitis, atopic, susceptibility to, 8}	613518	_	2
613882	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
614701	8q24.11	Cornelia de Lange syndrome 4	614701	AD	3
615414	12p13.31	?Microcephaly 11, primary, autosomal recessive	615414	AR	3
615712	5p15.2	Autoinflammation, panniculitis, and dermatosis syndrome	617099	AR	3
615266	5q31.3	Hypogonadotropic hypogonadism 17 with or without anosmia	615266	AD	3
615632	11q13.1	Neuropathy, hereditary sensory, type IF	615632	AD	3
614198	17q23.3	Myasthenic syndrome, congenital, 16	614198	AR	3
615402	2q35	Dyschromatosis universalis hereditaria 3	615402	AD	3
616763	19q13.2	Leukodystrophy and acquired microcephaly with or without dystonia	616763	AR	3
616721	4q24	Congenital disorder of glycosylation, type IIn	616721	AR	3
616975	1p36.23	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975	AD	3
615426	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
616969	6q21	?Deafness, autosomal dominant 66	616969	AD	3
614857	14q24.3	Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3
614008	11q13.1	Nestor-Guillermo progeria syndrome	614008	AR	3
616266	13q32.3-q33.1	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266	AD	3
614296	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
610564	6q21	Coenzyme Q10 deficiency, primary, 3	614652	AR	3
616364	1q21.3	White-Sutton syndrome	616364	AD	3
616947	10q26.3	?Premature ovarian failure 12	616947	AR	3
616145	13q32.1	Catel-Manzke syndrome	616145	AR	3
614042	10q23.31	Moyamoya disease 5	614042	_	3
616027	7p14.2	Focal segmental glomerulosclerosis 8	616032	AD	3
615540	19q13.12	Deafness, autosomal recessive 76	615540	AR	3
616786	15q15.1	Nephronophthisis 20	617271	AR	3
615583	8q24.3	Verheij syndrome	615583	AD	3
614184	2q37.1	Perlman syndrome	267000	AR	3
617156	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
616922	6q27	Striatal degeneration, autosomal dominant	616922	AD	3
615351	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	AR	3
614485	9p22.3	Trigonocephaly 2	614485	AD	3
616224	2p21	Myasthenic syndrome, congenital, 22	616224	AR	3
617132	3q22.1	Epileptic encephalopathy, early infantile, 44	617132	AR	3
617052	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
611451	11q13.4	Deafness, autosomal recessive 63	611451	AR	3
614731	17p12	{Prostate cancer, hereditary, 2, susceptibility to}	614731	_	3
616941	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
614930	8q24.22	Ciliary dyskinesia, primary, 19	614935	AR	3
613084	2p25.3	Mental retardation, autosomal dominant 39	616521	AD	3
614385	14q24.3	Colorectal cancer, hereditary nonpolyposis, type 7	614385	_	3
613887	9q22.33	Cataract 36	613887	AR	3
615108	3q26.32	Cowden syndrome 5	615108	_	3
616013	4q23	Microcephaly, short stature, and impaired glucose metabolism 1	616033	AR	3
615673	10q22.1	Myopathy with extrapyramidal signs	615673	AR	3
614149	17q25.1-q25.3	Nail disorder, nonsyndromic congenital, 9	614149	AR	2
611431	15q14	Legius syndrome	611431	AD	3
614036	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
616779	10q26.13	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	616779	AD	3
617173	15q21.2	Intellectual developmental disorder with cardiac arrhythmia	617173	AR	3
614302	3p25.1	Emery-Dreifuss muscular dystrophy 7, AD	614302	AD	3
616138	10q24.31	Perrault syndrome 5	616138	AR	3
613796	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
616270	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
616299	2q11.2	Lipoyltransferase 1 deficiency	616299	AR	3
613856	1p13.3	Achromatopsia 4	613856	_	3
614409	9p13.3	Spastic paraplegia 46, autosomal recessive	614409	AR	3
614495	5q31.2	Pseudohypoaldosteronism, type IID	614495	AR,AD	3
616509	21q22.3	Cataract 44	616509	AR	3
616457	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
617234	1p36.13	Preimplantation embryonic lethality 2	617234	AR	3
616028	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
616948	2q11.2	?Spinocerebellar ataxia, autosomal recessive 22	616948	AR	3
617168	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
616229	11p11.2	Osteogenesis imperfecta, type XVI	616229	AR	3
614813	3p21.2	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	AR	3
617260	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
615803	11q12.1	Pontocerebellar hypoplasia, type 10	615803	AR	3
615620	19q13.32	Mental retardation, autosomal recessive 41	615637	AR	3
614732	11p15.4	IMAGE syndrome	614732	AD	3
615633	9q34.11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3
614772	1q42.2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	616501	AR	3
611101	1p36.31	Charcot-Marie-Tooth disease, recessive intermediate C	615376	AR	3
611101	1p36.31	Spinal muscular atrophy, distal, autosomal recessive, 4	611067	AR	3
615545	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
617574	12q13.3	Ichthyosis, congenital, autosomal recessive 13	617574	AR	3
617041	20q12	Duane retraction syndrome 3	617041	AD	3
615973	12q21.33	Cone-rod dystrophy 20	615973	AR	3
615415	17q11.2	Renal-hepatic-pancreatic dysplasia 2	615415	AR	3
614162	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
617187	20q11.21	Spermatogenic failure 16	617187	AR	3
617391	1q44	Epileptic encephalopathy, early infantile, 54	617391	AD	3
615040	8q21.11	?Episodic pain syndrome, familial, 1	615040	AD	3
614386	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
614386	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
614386	16p11.2	Seizures, benign familial infantile, 2	605751	AD	3
616271	11q13.4	3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia	616271	AR	3
616780	10p15.3	Oocyte maturation defect 2	616780	AR,AD	3
617113	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
617600	19q13.2	Mental retardation, autosomal dominant 45	617600	AD	3
615433	3q13.31	Chromosome 3q13.31 deletion syndrome	615433	AD	4
617744	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
616146	13q32.1	Catel-Manzke syndrome	616145	AR	3
614496	2q36.2	Pseudohypoaldosteronism, type IIE	614496	AD	3
612899	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
616029	8q22.3	Ectodermal dysplasia/short stature syndrome	616029	AR	3
616680	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
617898	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
616655	19q13.1-q13.2	?Cataract 45	616851	AR	3
616139	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
614436	9q33.3-q34.1	Charcot-Marie-Tooth disease, axonal, type 2P	614436	AR,AD	3
617575	10q22.1	Nephrotic syndrome, type 14	617575	AR	3
612940	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
613576	7p21.2-p14.3	Ectodermal dysplasia-syndactyly syndrome 2	613576	AR	2
616977	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
617242	4q13.1	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	AR	3
613799	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
617169	19p13.3	?Sotos syndrome 3	617169	AR	3
617807	19p13.2	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807	AD	3
617133	3q22.1	?Spinocerebellar ataxia, autosomal recessive 24	617133	AR	3
614980	6q25.1	Congenital heart defects, nonsyndromic, 2	614980	AD	3
617188	19q13.42	Mental retardation, autosomal recessive 57	617188	AR	3
614867	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
617952	6q14.1	Osteogenesis imperfecta, type XVIII	617952	AR	3
617235	12q13.3	Myoclonus, intractable, neonatal	617235	AD	3
617294	3q27.1	Epidermolysis bullosa simplex, generalized, with scarring and hair loss	617294	AD	3
614940	1q42-q43	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940	AD	3
616681	12q24.33	Microcephaly 16, primary, autosomal recessive	616681	AR	3
617337	1p36.11	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type	617337	AD	3
608072	6p22.3	Epilepsy, progressive myoclonic 2B (Lafora)	254780	AR	3
615206	7p22.2	Immunodeficiency 11A	615206	AR	3
614807	16p13.3	?Centronuclear myopathy 4	614807	AD	3
617048	5p13.2	Bone marrow failure syndrome 3	617052	AR	3
616458	9q34.12	Neuropathy, hereditary sensory and autonomic, type VIII	616488	AR	3
615762	5q32	?Deafness, autosomal recessive 101	615837	AR	3
617991	6q14.1	Developmental delay, intellectual disability, obesity, and dysmorphic features	617991	AD	3
617114	3q22.2	Myopathy, myofibrillar, 7	617114	AR	3
614497	2q35	Microphthalmia, isolated, with coloboma 7	614497	AD	3
615416	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
615416	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
615439	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
616781	1p36.32	Joubert syndrome 25	616781	AR	3
613519	3p24	{Dermatitis, atopic, susceptibility to, 9}	613519	_	2
617770	19q13.2	?Spinocerebellar ataxia 46	617770	AD	3
615115	18q12.1	Bainbridge-Ropers syndrome	615485	AD	3
618005	14q23.3	Congenital disorder of glycosylation with defective fucosylation 1	618005	AR	3
617576	3p21.1	Spermatogenic failure 18	617576	AR	3
612779	1p21.3	5-fluorouracil toxicity	274270	AR	3
612779	1p21.3	Dihydropyrimidine dehydrogenase deficiency	274270	AR	3
615462	7q36.3	Short-rib thoracic dysplasia 8 with or without polydactyly	615503	AR	3
615816	6q14.1	Immunodeficiency 23	615816	AR	3
617808	12q12	Coffin-Siris syndrome 6	617808	AD	3
617935	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
616452	7p22.2	B-cell expansion with NFKB and T-cell anergy	616452	AD	3
617946	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
617035	6p12.3	Patent ductus arteriosus 2	617035	AD	3
618013	8q22.1	?Deafness, autosomal recessive 109	618013	AR	3
615578	10q26.11	Combined oxidative phosphorylation deficiency 18	615578	AR	3
616140	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
614808	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
615602	5q34	[Memory, enhanced, QTL]	615602	_	3
615999	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
614868	20q13.12	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	_	3
617435	4p16.3	Lopes-Maciel-Rodan syndrome	617435	AR	3
614829	4q21.1	Amelogenesis imperfecta, type IIA4	614832	AR	3
614498	7p22.3	Rigidity and multifocal seizure syndrome, lethal neonatal	614498	AR	3
615109	14q32.33	Cowden syndrome 6	615109	_	3
615605	3q27.2	?Fanconi renotubular syndrome 3	615605	AD	3
617243	1p36.22	?Fanconi anemia, complementation group V	617243	AR	3
617992	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
615616	10q21.3	Arrhythmogenic right ventricular dysplasia, familial, 13	615616	AD	3
618236	19p13.3	Mitochondrial complex I deficiency, nuclear type 14	618236	AR	3
616722	9q21.12	?Retinal dystrophy and iris coloboma with or without cataract	616722	AD	3
618084	1q21.3	Peeling skin syndrome 6	618084	AR	3
615757	20p11.23	Retinitis pigmentosa 69	615780	AR	3
615807	10q21.3	?Seckel syndrome 8	615807	AR	3
618014	5q31.1	?Premature ovarian failure 14	618014	AR	3
614809	1q31.3	Nephropathy due to CFHR5 deficiency	614809	AD	3
617205	7p12.3	Heterotaxy, visceral, 8, autosomal	617205	AR	3
614441	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
618284	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
617190	2p23.3	Shashi-Pena syndrome	617190	AD	3
616749	10q26.2	Heterotaxy, visceral, 7, autosomal	616749	AR	3
614430	8p23.1	Atrioventricular septal defect 4	614430	AD	3
618138	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
615291	1p36.33	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349	AR	3
615291	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
616227	1p21.3	?Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	AR	3
617892	4q33	{Amyotrophic lateral sclerosis, susceptibility to, 24}	617892	AD	3
617049	12q23.1	Cholestasis, progressive familial intrahepatic, 5	617049	AR	3
616973	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
617238	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
616943	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
615617	11q23.3	Immunodeficiency 19	615617	AR	3
616386	22q12.3	Dystonia 26, myoclonic	616398	AD	3
615758	1p35.2	?Immunodeficiency 22	615758	AR	3
618085	16q22.2	Spermatogenic failure 31	618112	AR	3
618257	5q13.2	?Deafness, autosomal recessive 112	618257	AR	3
616459	11q24.2	Al-Raqad syndrome	616459	AR	3
618266	17q21.2	Pontocerebellar hypoplasia, type 12	618266	AR	3
616000	4q13.3	Analbuminemia	616000	_	3
614830	3p22.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AR	3
618006	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
614163	17q25	{Delayed sleep phase syndrome, susceptibility to}	614163	AD	2
617153	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
615207	16p12.1	Immunodeficiency 56	615207	AR	3
615054	7q36.1	Glaucoma 1, open angle, F	603383	_	3
618341	17q25.1	Spermatogenic failure 35	618341	AR	3
617239	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
616657	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
616723	16q13	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723	AR	3
618346	21q22.3	Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3
613868	18q12.3	[Blood group, Kidd]	111000	_	3
614499	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
616949	6p22.3	Spinocerebellar ataxia, autosomal recessive 23	616949	AR	3
618213	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
617993	12p13.32	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	_	3
617577	3p21.1	?Ciliary dyskinesia, primary, 37	617577	AR	3
617746	7p21.1	Sweeney-Cox syndrome	617746	AD	3
615859	1p31.3	Epileptic encephalopathy, early infantile, 23	615859	AR	3
617244	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
618097	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
617971	11p15.4	Methmoglobinemia, beta type	617971	_	3
615883	12q24.31	Myopathy, tubular aggregate, 2	615883	AD	3
616001	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
615604	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AR,AD	3
614260	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
615292	11q12.1	Gracile bone dysplasia	602361	AD	3
615292	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
613493	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
614869	15q25.1	Usher syndrome, type IJ	614869	AR	3
615842	17p13.2	?Spermatogenic failure 14	615842	AR	3
618242	14q12	Mitochondrial complex I deficiency, nuclear type 21	618242	AR	3
618145	11q23.3	Deafness, autosomal recessive 111	618145	AR	3
618267	15q26.1	Epidermodysplasia verruciformis 3	618267	AR	3
616078	18q12.3	Mental retardation, autosomal dominant 29	616078	AD	3
618300	17p12	Ciliary dyskinesia, primary, 40	618300	AR	3
618360	19p13.11	Brain small vessel disease 3	618360	AR	3
616724	12p13.2	Tooth agenesis, selective, 7	616724	AD	3
612780	1q23.2	SESAME syndrome	612780	AR	3
616546	14q23.1	Short-rib thoracic dysplasia 14 with polydactyly	616546	AR	3
617564	22q12.3	?Meier-Gorlin syndrome 8	617564	AR	3
618078	12q15	?Ovarian dysgenesis 6	618078	AR	3
617885	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
618248	15q22.31	Mitochondrial complex I deficiency, nuclear type 27	618248	AR	3
618396	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
614850	19p13.3	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}	614850	AR,AD	3
608797	22q13.2	Hydatidiform mole, recurrent, 3	618431	_	3
616603	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
617667	12q14.3	Fraser syndrome 3	617667	AR	3
615546	4q28.1	Van Maldergem syndrome 2	615546	AR	3
614431	6q24.1	Ventricular septal defect 2	614431	AD	3
615371	2q34	{Pulmonary hypertension, neonatal, susceptibility to}	615371	_	3
614164	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
615759	2p25.1	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3
616658	19p13.3	Combined oxidative phosphorylation deficiency 37	618329	AR	3
618285	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
618140	7p14.3	?Deafness, autosomal dominant 74	618140	AD	3
617596	14q24.3	[Maleylacetoacetate isomerase deficiency]	617596	AR	3
617268	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
614941	1q42-q43	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	AR	3
618146	12q24.31	Spermatogenic failure 33	618152	AR	3
617339	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
616366	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
617115	18q22.1	Peeling skin syndrome 5	617115	AR	3
618063	11q22.1	Ciliary dyskinesia, primary, 38	618063	AR	3
616974	3q12.3	Combined oxidative phosphorylation deficiency 30	616974	AR	3
616263	17q23.1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263	AR	3
617672	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
615524	3p24.2	Microphthalmia, syndromic 12	615524	AR,AD	3
616298	9p21.1	Singleton-Merten syndrome 2	616298	AD	3
615009	11q13.1-q13.2	Schuurs-Hoeijmakers syndrome	615009	AD	3
616950	10q26.3	?Spermatogenic failure 15	616950	AR	3
617994	13q13.1	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	_	3
618268	17q23.3	Trichohepatoneurodevelopmental syndrome	618268	AR	3
616954	16p13.3	You-Hoover-Fong syndrome	616954	AR	3
618098	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
618397	5q13.3	Combined oxidative phosphorylation deficiency 39	618397	AR	3
618349	1q42.13	?Galloway-Mowat syndrome 8	618349	AR	3
617241	15q13.1	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241	AR	3
618286	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
617798	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
618147	14q32.2	?Intellectual developmental disorder with hypertelorism and distinctive facies	618147	AD	3
618000	7p13	Ehlers-Danlos syndrome, classic-like, 2	618000	AR	3
615626	15q14	Dyserythropoietic anemia, congenital, type Ib	615631	AR	3
618141	12q24.11-q24.12	Epileptic encephalopathy, early infantile, 67	618141	AD	3
617207	1q42.3	Encephalopathy, progressive, with amyotrophy and optic atrophy	617207	AR	3
616367	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
617523	1q22	?Neurodevelopmental disorder with midbrain and hindbrain malformations	617523	AR	3
615547	15q11.2	Schaaf-Yang syndrome	615547	AD	3
616570	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
618243	2q37.3	Mitochondrial complex I deficiency, nuclear type 22	618243	AR	3
618237	6q16.1	Mitochondrial complex I deficiency, nuclear type 15	618237	AR	3
614088	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
618342	7q22.3	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342	AR	3
617973	16p13.3	Methemoglobinemia, alpha type	617973	_	3
617343	6p24.2	Hyperparathyroidism 4	617343	AD	3
614851	14q22.1	?Seckel syndrome 7	614851	AR	3
615848	7q31.33	{Melanoma, cutaneous malignant, susceptibility to, 10}	615848	AD	3
610924	20p13	Polyglucosan body myopathy 1 with or without immunodeficiency	615895	AR	3
616944	3q26.32	Mental retardation, autosomal dominant 41	616944	AD	3
617116	3p21.31	Epilepsy, familial focal, with variable foci 2	617116	AD	3
617290	8p11.23	Epilepsy, early-onset, vitamin B6-dependent	617290	AR	3
615674	17p13.3	Dowling-Degos disease 3	615674	AD	2
616839	8q22.3	?Exercise intolerance, riboflavin-responsive	616839	AR	3
614474	18q11.2	Atrioventricular septal defect 5	614474	AD	3
618079	12q13.12	[Low density lipoprotein cholesterol level QTL 8]	618079	_	3
618287	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
616460	15q24.1	?Mental retardation, autosomal recessive 50	616460	AR	3
614089	14q11.2	Atrial septal defect 3	614089	_	3
614432	5q35.1	Ventricular septal defect 3	614432	AD	3
617732	18p11.21	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction	617732	AD	3
617974	4q35.1	?Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	AD	3
618148	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
617805	18q11.1-q11.2	Renal hypodysplasia/aplasia 3	617805	AD	3
616852	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
616617	6p21.1	Heimler syndrome 2	616617	AR	3
618371	17q12	Turnpenny-Fry syndrome	618371	AD	3
617895	12q24.11	Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3
617439	15q22.31	{Craniosynostosis 7, susceptibility to}	617439	AD	3
618356	1q32.1	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356	AR	3
614475	18q11.2	Atrial septal defect 9	614475	AD	3
616300	5q23.2	Short-rib thoracic dysplasia 13 with or without polydactyly	616300	AR	3
618343	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
618456	17p11.2	Deafness, autosomal recessive 114	618456	AR	3
616792	11p15	{Neuroblastoma, susceptibility to, 7}	616792	_	2
617245	2q32.3	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268	AD	3
610925	3p25.3	Candidiasis, familial, 9	616445	AR	3
617771	1q31.3	?Epileptic encephalopathy, early infantile, 57	617771	AD	3
614944	12q21.31	Deafness, autosomal recessive 84B	614944	AR	3
618302	19p13.13	Mental retardation, autosomal recessive 68	618302	AR	3
618235	5q31.3	?Mitochondrial complex I deficiency, nuclear type 13	618235	AR	3
614437	11q13.1	Cutis laxa, autosomal recessive, type IB	614437	AR	3
618418	9p13.3	Spastic paraplegia 80, autosomal dominant	618418	AD	3
616112	3p14.1	Nemaline myopathy 10	616165	AR	3
613494	22q13.2	Immunodeficiency, common variable, 4	613494	AR	3
616604	14q32	{Myeloproliferative neoplasms, familial, susceptibility to}	616604	AD	4
617524	1p34.3	Erythrokeratodermia variabilis et progressiva 2	617524	AD	3
618264	17p13.1	Mirror movements 4	618264	AD	3
614090	14q11.2	{Sick sinus syndrome 3}	614090	_	3
618142	16q24.3	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142	AR	3
617572	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
617270	18q12.2	Mental retardation, autosomal recessive 58	617270	AR	3
618244	12q22	?Mitochondrial complex I deficiency, nuclear type 23	618244	AR	3
616907	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
614257	20q11.23	?Mental retardation, autosomal dominant 11	614257	AD	3
617772	1q44	Deafness, autosomal dominant 34, with or without inflammation	617772	AD	3
615010	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
618249	19p13.11	?Mitochondrial complex I deficiency, nuclear type 28	618249	AR	3
618149	3q28	Orofacial cleft 8	618149	_	3
618277	10q25.3	FINCA syndrome	618278	AR	3
618135	3p22.1	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	618135	AR	3
618357	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
617228	13q12.12	Combined oxidative phosphorylation deficiency 31	617228	AR	3
617278	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
617036	11q13.5	?Leukodystrophy, progressive, early childhood-onset	617762	AR	3
618419	14q13.2	Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy	618419	AR	3
617349	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
610926	10q11.2-q21	Tooth agenesis, selective, 5	610926	_	2
614265	16q24.3	Combined malonic and methylmalonic aciduria	614265	_	3
613498	17p13	[Sex hormone-binding globulin circulating level QTL 1]	613498	_	2
617668	11q13.4	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668	AR	3
616113	15q21.2	?Polyendocrine-polyneuropathy syndrome	616113	AR	3
617598	5p15.33	Mosaic variegated aneuploidy syndrome 3	617598	AR	3
618250	11q14.1	Mitochondrial complex I deficiency, nuclear type 29	618250	AR	3
618150	16q22.1	Saul-Wilson syndrome	618150	AD	3
614751	2p11.2	?Neuronopathy, distal hereditary motor, type VB	614751	AD	3
610927	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
615607	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
614689	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
618372	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
617773	9p13.3	Mental retardation, autosomal recessive 61	617773	AR	3
617599	21q22.13	?Epileptic encephalopathy, early infantile, 55	617599	AR	3
614438	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
618278	10q25.3	FINCA syndrome	618278	AR	3
618457	17p13.2	?Deafness, autosomal recessive 115	618457	AR	3
618420	14q13.2	Spermatogenic failure 36	618420	AD	3
617669	2p25.3	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669	AR	3
617579	13q32.1	HELIX syndrome	617671	AR	3
616946	10q11.23	Premature ovarian failure 11	616946	AD	3
614753	19p13.13	Sotos syndrome 2	614753	AD	3
617246	8q24.13	Seckel syndrome 10	617253	AR	3
618251	3q13.33	Mitochondrial complex I deficiency, nuclear type 31	618251	AR	3
617350	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
617170	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
614816	1q41	Loeys-Dietz syndrome 4	614816	AD	3
616353	16p13.12	Dyskeratosis congenita, autosomal recessive 6	616353	AR	3
618304	17q25.1	Spermatogenic failure 35	618341	AR	3
616920	19q13.31	Heart and brain malformation syndrome	616920	AR	3
617670	16p13.3	?Spermatogenic failure 22	617706	AR	3
616030	7q31.32	Hypogonadotropic hypogonadism 22, with or without anosmia	616030	AR	3
618373	6q24.3-q25.1	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	AR	3
615780	20p11.23	Retinitis pigmentosa 69	615780	AR	3
618459	19q13.2	?Immunodeficiency 62	618459	AR	3
618345	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
616794	3p14.1	Combined oxidative phosphorylation deficiency 28	616794	AR	3
618245	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
616968	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
616354	6q14.3	Spinocerebellar ataxia, autosomal recessive 20	616354	AR	3
618283	14q32.32-q32.33	?Visual impairment and progressive phthisis bulbi	618283	AR	3
617171	11p15.5	?Dyskinesia, seizures, and intellectual developmental disorder	617171	AR	3
617280	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
618254	11p15.5	Ciliary dyskinesia, primary, 39	618254	AR	3
617271	15q15.1	Nephronophthisis 20	617271	AR	3
616115	2p22.3	?Familial cold autoinflammatory syndrome 4	616115	AD	3
618460	7q36.3	Kahn-Kahn-Katsanis syndrome	618460	AR	3
618374	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
618144	17q24.2	Usher syndrome, type IV	618144	AR	3
618255	9p13.3	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317	AR	3
617281	11p15.4	Epileptic encephalopathy, early infantile, 49	617281	AR	3
615781	2q36.1	{Psoriasis 15, pustular, susceptibility to}	616106	AD	3
618246	2q33.1	Mitochondrial complex I deficiency, nuclear type 25	618246	AR	3
617671	13q32.1	HELIX syndrome	617671	AR	3
616854	5q31.2	Even-plus syndrome	616854	AR	3
615715	9q22.32	Bone marrow failure syndrome 2	615715	AR	3
617743	15q21.1	Oocyte maturation defect 4	617743	AR	3
618377	1p33	?Pain sensitivity QTL1	618377	AD	4
617039	5q23.2	Patent ductus arteriosus 3	617039	AD	3
618383	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
618247	12p13.32	Mitochondrial complex I deficiency, nuclear type 26	618247	AR	3
617275	1q43	Tooth agenesis, selective, 9	617275	AD	3
618378	1q25.1	?Combined oxidative phosphorylation deficiency 38	618378	AR	3
616795	17q21.33	Spinocerebellar ataxia 42	616795	AD	3
616505	5q22.1	Neuropathy, hereditary motor and sensory, type VIB	616505	AR	3
618362	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
616606	Chr.14	Ring chromosome 14 syndrome	616606	IC	4
618392	16q23.3-q24.1	?Spondyloepiphyseal dysplasia, Kondo-Fu type	618392	AR	3
614826	1q31.3-q32.1	Nystagmus 7, congenital, autosomal dominant	614826	AD	2
618363	4q31.22	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363	AR	3
616873	7p12.2	Immunodeficiency, common variable, 13	616873	AD	3
618381	11q13.1	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381	AD	3
618364	12q13.13	?Myoclonus, familial, 2	618364	AD	3
618393	17p13.2	Fetal akinesia deformation sequence 4	618393	AR	3
617601	6q13	Mental retardation, autosomal dominant 46	617601	AD	3
618394	6q15	Immunodeficiency 60	618394	AD	3
617276	15q25.2	Epileptic encephalopathy, early infantile, 48	617276	AR	3
618395	2p13.2	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395	AR	3
616507	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
616937	20q11.23	?Thrombocytopenia 6	616937	AD	3
616938	17q21.2	Coffin-Siris syndrome 5	616938	AD	3
616939	1p21.2	?Chorea, childhood-onset, with psychomotor retardation	616939	AR	3
604604	4p13	?Birk-Landau-Perez syndrome	617595	AR	3
603736	10q22.2	SBBYSS syndrome	603736	AD	3
603201	2q31.1	Cholestasis, benign recurrent intrahepatic, 2	605479	AR	3
603201	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
604169	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
604490	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
605606	1p	{Psoriasis susceptibility 7}	605606	_	2
606392	13q12.2	MODY, type IV	606392	_	3
603453	6p25.2	Immunodeficiency 57	618108	AR	3
605285	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
605461	22q11.1	Immunodeficiency 51	613953	AR	3
603961	7q21.11	{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	AD	3
605583	12q23.1	Deafness, autosomal dominant 25	605583	AD	3
605648	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
603464	16q24.3	Al Kaissi syndrome	617694	AR	3
605829	17q25.3	Epidermodysplasia verruciformis 2	618231	_	3
604292	3q28	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	AD	3
605951	1q22	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	612937	AR	3
606812	1q43	Fumarase deficiency	606812	AR	3
606661	3p25.2-p25.1	{Melanoma, uveal, susceptibility to, 2}	606661	_	2
605525	16q24.3	Meier-Gorlin syndrome 4	613804	AR	3
603785	9p23	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219	AR	3
603964	2q23-q24.3	Deafness, autosomal dominant 16	603964	AD	2
606941	11q23.1	Congenital disorder of glycosylation, type Il	608776	AR	3
606941	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
605282	15q26.3	Temtamy preaxial brachydactyly syndrome	605282	AR	3
606629	6q13	Cone-rod dystrophy 7	603649	_	3
605393	1q32.1	Mental retardation, autosomal recessive 65	618109	AR	3
603094	3q26.1	[Blood group, globoside system]	615021	_	3
603094	3q26.1	[Blood group, P1PK system, P(k) phenotype]	111400	_	3
604356	2q31.1	Duane retraction syndrome 2	604356	_	3
603214	14q24.3	Methylmalonic aciduria and homocystinuria, cblJ type	614857	AR	3
604278	4q13.3	Renal tubular acidosis, proximal, with ocular abnormalities	604278	AR	3
607120	20p12.3	Epileptic encephalopathy, early infantile, 12	613722	AR	3
603693	8q23.1	46XY sex reversal 9	616067	AD	3
603693	8q23.1	Diaphragmatic hernia 3	610187	_	3
603693	8q23.1	Tetralogy of Fallot	187500	AD	3
606119	8q24.3	Meleda disease	248300	AR	3
607123	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
603683	5q14.2	Brachycephaly, trichomegaly, and developmental delay	617412	AD	3
605584	16q22.2	Retinitis pigmentosa 84	618220	AR	3
603783	4p16-q34	{Intelligence QTL1}	603783	_	2
606662	8p23	Waardenburg syndrome, type 2C	606662	_	2
606782	12p13.2	{Aspergillosis, susceptibility to}	614079	_	3
603617	15q22.31	Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	AR	3
603663	4p	{Mental health wellness-1}	603663	_	2
606664	6p21.1	Glycine N-methyltransferase deficiency	606664	AR	3
605924	21q22.3	Galloway-Mowat syndrome 6	618347	AR	3
605924	21q22.3	Microcephaly, growth deficiency, seizures, and brain malformations	618346	AR	3
604605	3q21.1-q21.2	{Coronary heart disease, susceptibility to, 5}	608901	_	3
603040	11q23	{Nonsmall cell lung cancer}	603040	_	2
605934	2q37.1-q37.3	Holoprosencephaly 6	605934	_	2
603029	4q35.1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}	613002	AR,AD	3
603029	4q35.1	{HIV1 infection, resistance to}	609423	_	3
603965	11q22.1	Glomerulosclerosis, focal segmental, 2	603965	AD	3
603892	17q21.31	Mandibulofacial dysostosis, Guion-Almeida type	610536	AD	3
606787	1p31	Peripheral arterial occlusive disease 1	606787	_	2
606107	6p21.33	?Deafness, autosomal dominant 72	617606	AD	3
605489	12q24.11	Short-rib thoracic dysplasia 19 with or without polydactyly	617895	AR	3
606682	22q12.1	Hermansky-Pudlak syndrome 4	614073	AR	3
604843	12p12.1	Hyperbilirubinemia, Rotor type, digenic	237450	DR	3
606616	18p11.2	{Dyslexia, susceptibility to, 6}	606616	_	2
603454	12q22	Mental retardation, autosomal recessive 34, with variant lissencephaly	614499	AR	3
604040	5q31.1	Nijmegen breakage syndrome-like disorder	613078	_	3
603780	8q24.3	Baller-Gerold syndrome	218600	AR	3
603780	8q24.3	RAPADILINO syndrome	266280	AR	3
603780	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
604250	7q22.1	Hemochromatosis, type 3	604250	AR	3
604121	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
607444	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
607444	7q11.21	{Aplastic anemia, susceptibility to}	609135	_	3
605391	10q23.2	{Thyroid carcinoma, follicular}	188470	SMu,AD	3
605958	3p21.31	Seckel syndrome 9	616777	AR	3
603959	3q28	Hypomagnesemia 3, renal	248250	AR	3
604765	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
605441	3q27.3	Adiponectin deficiency	612556	_	3
607429	10p12.1	Coenzyme Q10 deficiency, primary, 2	614651	AR	3
605608	21q22.13	Deafness, autosomal recessive 29	614035	AR	3
607107	4p15.1-q12	{Nasopharyngeal carcinoma 1}	607107	_	2
606680	7q34	Hyperparathyroidism, transient neonatal	618188	AR	3
605590	2q33.1	Myelodysplastic syndrome, somatic	614286	_	3
603098	7q34-q36	Deafness, autosomal recessive 13	603098	AR	2
606811	1p36.13	Hyperprolinemia, type II	239510	AR	3
606462	8q24.11	?Mungan syndrome	611376	AR	3
606462	8q24.11	Cornelia de Lange syndrome 4	614701	AD	3
603248	4q22.3	Acromesomelic dysplasia, Demirhan type	609441	AR	3
603248	4q22.3	Brachydactyly, type A1, D	616849	AD	3
603248	4q22.3	Brachydactyly, type A2	112600	AD	3
607752	5q11.2	Ciliary dyskinesia, primary, 29	615872	AR	3
605993	8q22.1	Pyruvate dehydrogenase phosphatase deficiency	608782	AR	3
607636	11q13.2	van Buchem disease, type 2	607636	AD	3
603664	4q	{Mental health wellness-2}	603664	_	2
604498	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
603155	1q32-q41	Choanal atresia and lymphedema	613611	AR	3
604357	4q31.3	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877	AR,AD	3
604489	5p13.2	Alpha-methylacyl-CoA racemase deficiency	614307	AR	3
604489	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
606200	12p12.1	[Short sleeper]	612975	AD	3
604001	7q21.2	?Long QT syndrome-11	611820	AD	3
606943	17q25.1	Usher syndrome, type 1G	606943	AR	3
606951	2q24.2	Aicardi-Goutieres syndrome 7	615846	AD	3
606951	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
605522	7q36.3	Acheiropody	200500	AR	3
605522	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
605522	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
605522	7q36.3	Polydactyly, preaxial type II	174500	AD	3
605522	7q36.3	Syndactyly, type IV	186200	AD	3
605522	7q36.3	Triphalangeal thumb, type I	174500	AD	3
605522	7q36.3	Triphalangeal thumb-polysyndactyly syndrome	174500	AD	3
605862	12q14.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	AR	3
607421	7p14.1	Ciliary dyskinesia, primary, 6	610852	AR	3
603194	11q12.2	Meckel syndrome 2	603194	AR	3
604260	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
604260	17q21.2	Leukemia, acute promyelocytic, somatic	102578	_	3
606835	12q24.11	Digital arthropathy-brachydactyly, familial	606835	AD	3
604187	12q13.3	Spastic paraplegia 10, autosomal dominant	604187	AD	3
603196	14q12	?Deafness, autosomal recessive 110	618094	AR	3
603196	14q12	Deafness, autosomal dominant 9	601369	AD	3
604294	10q25.3	?Microphthalmia, syndromic 11	614402	AR	3
607677	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
607218	7q32.1	{Inflammatory bowel disease 14}	612245	_	3
607218	7q32.1	{Systemic lupus erythematosus, susceptibility to, 10}	612251	_	3
607402	19q13.2	{Hepatitis C virus infection, response to therapy of}	609532	_	3
604895	17q21.32	Asthma and nasal polyps	208550	AR	3
604895	17q21.32	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
605921	11p15.4	Immunodeficiency 10	612783	AR	3
605921	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
605921	11p15.4	Stormorken syndrome	185070	AD	3
604443	5q31.1	Myelodysplastic syndrome	_	_	3
604443	5q31.1	Myelogenous leukemia, acute	_	_	3
605490	19p13.3	CODAS syndrome	600373	AR	3
603288	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
606681	5q35.3	Leukemia, acute myeloid	601626	SMu,AD	1
606681	5q35.3	Sotos syndrome 1	117550	AD	3
603855	19q13.2-q13.4	{Meconium ileus in cystic fibrosis, susceptibility to}	603855	_	2
607844	12q14.3	Buschke-Ollendorff syndrome	166700	AD	3
607844	12q14.3	Osteopoikilosis with or without melorheostosis	166700	AD	3
607407	10q26.3	Hypotonia, ataxia, and delayed development syndrome	617330	AD	3
604506	2q36.3	Mental retardation, autosomal dominant 49	617752	AD	3
607108	11p13	?Coloboma of optic nerve	120430	AD	3
607108	11p13	?Coloboma, ocular	120200	AD	3
607108	11p13	?Morning glory disc anomaly	120430	AD	3
607108	11p13	Aniridia	106210	AD	3
607108	11p13	Anterior segment dysgenesis 5, multiple subtypes	604229	_	3
607108	11p13	Cataract with late-onset corneal dystrophy	106210	AD	3
607108	11p13	Foveal hypoplasia 1	136520	AD	3
607108	11p13	Keratitis	148190	AD	3
607108	11p13	Optic nerve hypoplasia	165550	AD	3
606952	11q14.3	Albinism, oculocutaneous, type IB	606952	_	3
607871	2p16.3	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	AD	3
604766	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
604694	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
607340	9q22.33	Epileptic encephalopathy, early infantile, 59	617904	AD	3
607340	9q22.33	Neurodevelopmental disorder with poor language and loss of hand skills	617903	AD	3
607340	9q22.33	{Nicotine dependence, protection against}	188890	_	3
607340	9q22.33	{Nicotine dependence, susceptibility to}	188890	_	3
608104	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608296	11q13.1	Thauvin-Robinet-Faivre syndrome	617107	AR	3
607678	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
608092	4q32.3	{Pancreatic cancer, susceptibility to, 1}	606856	_	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	AR	3
607423	9q34.13	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	AR	3
608041	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
608107	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
608107	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
608945	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
608945	13q13.3	Fraser syndrome 2	617666	AR	3
607213	16q11.2	Meier-Gorlin syndrome 3	613803	AR	3
604188	1q21.3	Extraoral halitosis due to MTO deficiency	618148	AR	3
606945	19p13.2	Hypercholesterolemia, familial, 1	143890	AD	3
606945	19p13.2	LDL cholesterol level QTL2	143890	AD	3
608508	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
604041	17p13.1	Congenital disorder of glycosylation, type If	609180	AR	3
605558	8p22	?Renal hypodysplasia/aplasia 2	615721	AR	3
608244	6p22.3-p21.3	Otosclerosis 3	608244	AD	2
607838	16p13.3	Mucolipidosis III gamma	252605	AR	3
604896	20p12.2	Bardet-Biedl syndrome 6	605231	AR	3
604896	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
603041	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
607751	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
604780	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
607352	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
605594	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
607539	17p13.3	?Camptosynpolydactyly, complex	607539	AR	3
607166	2q11.2	?Spermatogenic failure 26	617961	AR	3
603856	15q11.2	Precocious puberty, central, 2	615346	AD	3
608317	1p36.11	Van der Woude syndrome 2	606713	AD	3
609153	2q35-q36	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	AD	2
605248	19p13.2	Mucolipidosis IV	252650	AR	3
608451	19q13.31	Ethylmalonic encephalopathy	602473	AR	3
608203	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
603197	19p13.2	?Laurence-Moon syndrome	245800	AR	3
603197	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
603197	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
603197	19p13.2	Spastic paraplegia 39, autosomal recessive	612020	AR	3
606554	1q42	Episodic ataxia, type 3	606554	AD	2
608105	16p12-p11.2	Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp	608105	AR	2
609814	1q31.3	Complement factor H deficiency	609814	AR,AD	3
610148	12q21.2	Bardet-Biedl syndrome 10	615987	AR	3
609634	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
603704	17p13.1	?Diamond-Blackfan anemia 11	614900	AD	3
604283	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
607343	20q13.2	Duane-radial ray syndrome	607323	AD	3
607343	20q13.2	IVIC syndrome	147750	AD	3
610629	10q22.3	Diamond-blackfan anemia 3	610629	AD	3
610277	12q24.31	Immunodeficiency 9	612782	AR	3
610277	12q24.31	Myopathy, tubular aggregate, 2	615883	AD	3
607386	2p23.3	Retinitis pigmentosa 71	616394	AR	3
607386	2p23.3	Short-rib thoracic dysplasia 10 with or without polydactyly	615630	AR	3
605145	5p15.2	Chondrocalcinosis 2	118600	AD	3
605145	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
610572	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
609390	6q21	?Polymicrogyria, bilateral temporooccipital	612691	AR	3
609390	6q21	Amyotrophic lateral sclerosis 11	612577	AD	3
609390	6q21	Charcot-Marie-Tooth disease, type 4J	611228	AR	3
609390	6q21	Yunis-Varon syndrome	216340	AR	3
610062	14q24.3	Ciliary dyskinesia, primary, 16	614017	AR	3
608059	17p13.1	Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3
610273	1q23.2	Glycosylphosphatidylinositol deficiency	610293	AR	3
605995	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
605995	1p36.22	Pheochromocytoma	171300	AD	3
605995	1p36.22	{Neuroblastoma, susceptibility to, 1}	256700	SMu,AD	3
607676	12q12	IRAK4 deficiency	607676	_	3
607921	17q25.3	Retinitis pigmentosa 30	607921	_	3
609583	2q13	Joubert syndrome 4	609583	AR	3
610156	9q34.3	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	AR	3
609378	17q11	{Autism susceptibility 6}	609378	_	2
609384	13q12.11	Fibrosis of extraocular muscles, congenital, 3C	609384	AD	2
610000	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
607842	18q22.3	Aural atresia, congenital	607842	AD	3
603100	9q34.3	Lipodystrophy, congenital generalized, type 1	608594	AR	3
603681	2p23.3	Auditory neuropathy, autosomal recessive, 1	601071	AR	3
603681	2p23.3	Deafness, autosomal recessive 9	601071	AR	3
610150	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
608204	11q13.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}	610551	_	3
609432	17p13.3	Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	AR	3
610683	4q27	Bardet-Biedl syndrome 12	615989	AR	3
607803	10q24.32	Hypomagnesemia 6, renal	613882	AD	3
607803	10q24.32	Hypomagnesemia, seizures, and mental retardation	616418	AR,AD	3
610575	8q23.1	?Humerofemoral hypoplasia with radiotibial ray deficiency	618022	AR	3
610575	8q23.1	Tetraamelia syndrome 2	618021	AR	3
609584	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
607872	1p36	Chromosome 1p36 deletion syndrome	607872	IC	4
610153	5q13.2	Deafness, autosomal recessive 49	610153	AR	3
609425	3q29	Chromosome 3q29 microdeletion syndrome	609425	IC	4
607936	3q21.1	Peeling skin syndrome 4	607936	AR	3
607922	22q13.2	NOR polyagglutination syndrome	111400	_	3
607922	22q13.2	[Blood group, P1Pk system, p phenotype]	111400	_	3
607922	22q13.2	[Blood group, P1Pk system, P(2) phenotype]	111400	_	3
607063	17q21.2	Bruck syndrome 1	259450	AR	3
607063	17q21.2	Osteogenesis imperfecta, type XI	610968	AR	3
608093	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
611507	4q24	Wolfram syndrome 2	604928	AR	3
610717	11p15.5	Neutral lipid storage disease with myopathy	610717	AR	3
603031	1q41	{Legionnaire disease, susceptibility to}	608556	_	3
603031	1q41	{Melioidosis, susceptibility to}	615557	_	3
603031	1q41	{Systemic lupus erythematosus, resistance to}	601744	_	3
603031	1q41	{Systemic lupus erythematosus, susceptibility to, 1}	601744	_	3
609566	4q21-q23	Parietal foramina 3	609566	AD	2
606201	4p16.1	?Cataract 41	116400	AD	3
606201	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
606201	4p16.1	Wolfram syndrome 1	222300	AR	3
606201	4p16.1	Wolfram-like syndrome, autosomal dominant	614296	AD	3
606201	4p16.1	{Diabetes mellitus, noninsulin-dependent, association with}	125853	AD	3
610678	16p11.2	Combined oxidative phosphorylation deficiency 4	610678	AR	3
609404	10q22.1	Preeclampsia/eclampsia 4	609404	_	3
611501	1p36.31-p36.23	Cerebellar ataxia, nonprogressive, with mental retardation	614756	AD	3
609994	4q22-q27	Myopia 11	609994	_	2
608106	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
610275	17q12	Glycosylphosphatidylinositol biosynthesis defect 11	616025	AR	3
611486	10q26.3	?Premature ovarian failure 12	616947	AR	3
611486	10q26.3	?Spermatogenic failure 15	616950	AR	3
611755	12q21.32	Leber congenital amaurosis 10	611755	_	3
605990	10q21.2	{Nephrolithiasis, uric acid, susceptibility to}	605990	_	3
610627	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
610690	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
610064	Chr.17	{Opioid dependence, susceptibility to, 1}	610064	_	2
610573	20p13	Anonychia congenita	206800	AR	3
610158	13pter-q12.13	Corneal dystrophy, Fuchs endothelial, 2	610158	AD	2
610227	17q25.3	Seborrhea-like dermatitis with psoriasiform elements	610227	_	3
608091	11q12.2	Joubert syndrome 2	608091	AR	3
609909	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
612717	10q21.1	Myopia 15	612717	AD	2
611119	7p15.3	Cold-induced sweating syndrome 3	617055	AR	3
611119	7p15.3	Retinitis pigmentosa 42	612943	AD	3
607809	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
611489	14q32.13	Corticosteroid-binding globulin deficiency	611489	AR,AD	3
612447	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
612367	1p36	{Alkaline phosphatase, plasma level of, QTL 2}	612367	_	2
611466	17q21.31	?Osteopetrosis, autosomal recessive 6	611497	AR	3
611466	17q21.31	Osteopetrosis, autosomal dominant 3	618107	AD	3
611761	16p13.3	Lipase deficiency, combined	246650	AR	3
610442	9q22.33	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442	AR	3
612772	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
605086	6p21.1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193	_	3
611615	9q31.2	Cardiomyopathy, dilated, 1X	611615	AR	3
604285	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
602943	1q21.3	Immunodeficiency 42	616622	AR	3
610003	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
609812	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
611313	10q26.13	{Macular degeneration, age-related, 8}	613778	_	3
610896	19q13.32	Branchiootorenal syndrome 2	610896	_	3
608245	12q13.13	?Hypotrichosis 13	615896	AD	3
610065	20p12	{Systemic lupus erythematosus, susceptibility to, 7}	610065	_	2
612950	20q13	{Psoriasis susceptibility 12}	612950	_	2
613268	20p13	Corneal dystrophy, Fuchs endothelial, 4	613268	_	3
604695	10q24.32	Joubert syndrome 35	618161	AR	3
604695	10q24.32	Retinitis pigmentosa 83	618173	AD	3
609637	13q32.3	Holoprosencephaly 5	609637	AD	3
602954	17q12	{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	_	3
611498	16p13.3	Nephronophthisis 7	611498	_	3
612368	6p22	{Alkaline phosphatase, plasma level of, QTL3}	612368	_	2
613063	7q32	{Basal cell carcinoma, susceptibility to, 6}	613063	_	2
611432	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
612907	3p26.2	Retinitis pigmentosa and erythrocytic microcytosis	616959	AR	3
612907	3p26.2	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	AR	3
612773	19q13.32	[Blood group, Auberger system]	111200	_	3
612773	19q13.32	[Blood group, Lutheran null]	247420	AR	3
612773	19q13.32	[Blood group, Lutheran system]	111200	_	3
609558	22q12.3	{Prostate cancer, susceptibility to}	609558	_	2
609813	7p22.3	Spondylocostal dysostosis 3, autosomal recessive	609813	AR	3
613100	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
608944	9p22.3	Bifid nose with or without anorectal and renal anomalies	608980	_	3
608944	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
608944	9p22.3	Trigonocephaly 2	614485	AD	3
612920	21q22.3	?Deafness, autosomal recessive 98	614861	AR	3
612920	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
613425	2p23.2	Retinitis pigmentosa 54	613428	_	3
612841	1p21.1-q21.3	Hypotrichosis 5	612841	AD	2
613617	2p23.3	?Retinitis pigmentosa 58	613617	AR	3
613697	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
610693	11q24.2	Hydrolethalus syndrome	236680	AR	3
608753	3p25.2	Pontocerebellar hypoplasia type 2B	612389	AR	3
610628	3p13	Hypogonadotropic hypogonadism 4 with or without anosmia	610628	AD	3
613269	5q33.1-q35.2	Corneal dystrophy, Fuchs endothelial, 5	613269	_	2
613988	17p13.1	Dyskeratosis congenita, autosomal recessive 3	613988	AR	3
611386	20q13.13	Helsmoortel-van der Aa syndrome	615873	AD	3
611959	19q13.4	{Prostate cancer, hereditary, 15}	611959	_	2
613693	21q22.11	Long QT syndrome 6	613693	AD	3
610878	3p12.3	Vesicoureteral reflux 2	610878	_	3
612353	18p11.3	Porokeratosis 6, multiple types	612353	AD	2
612951	6q27	Leukoencephalopathy, cystic, without megalencephaly	612951	AR	3
613927	6p21.33	C2 deficiency	217000	AR	3
613927	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
610897	20q11.22	Cataract 31, multiple types	605387	AD	3
608935	6q23-q25	{Lung cancer susceptibility}	608935	_	2
610084	11q14.1	Essential tremor, hereditary, 5	616736	AD	3
604358	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
613698	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
613266	22q13.1	Waardenburg syndrome, type 4C	613266	AD	3
613544	6q11-q14	Chromosome 6q11-q14 deletion syndrome	613544	IC	4
613800	2q23.1	Meier-Gorlin syndrome 2	613800	AR	3
613982	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
614372	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
613363	9q34.11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633	AR	3
613803	16q11.2	Meier-Gorlin syndrome 3	613803	AR	3
614380	6p21.33	C4a deficiency	614380	AR	3
613810	5q32	Retinitis pigmentosa 43	613810	_	3
602955	7q22.1	Alazami-Yuan syndrome	617126	AR	3
606463	1q22	Gaucher disease, perinatal lethal	608013	AR	3
606463	1q22	Gaucher disease, type I	230800	AR	3
606463	1q22	Gaucher disease, type II	230900	AR	3
606463	1q22	Gaucher disease, type III	231000	AR	3
606463	1q22	Gaucher disease, type IIIC	231005	AR	3
606463	1q22	{Lewy body dementia, susceptibility to}	127750	AD	3
606463	1q22	{Parkinson disease, late-onset, susceptibility to}	168600	Mu,AD	3
611472	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
613834	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
611927	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
614072	3q24	Hermansky-Pudlak syndrome 3	614072	AR	3
613686	17p13.1	Spondylocostal dysostosis 4, autosomal recessive	613686	AR	3
614373	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
612284	4p15.32	Meckel syndrome 6	612284	AR	3
613563	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
612885	20p12.3	?Premature ovarian failure 10	612885	AR	3
612918	3q26.32	CLOVE syndrome, somatic	612918	_	3
614724	3q22.2	?Seckel syndrome 6	614728	AR	3
611488	9q32-q33	Macular degeneration, age-related, 10	611488	_	2
614615	5p13.2	Joubert syndrome 17	614615	AR	3
609636	7q36	Alzheimer disease-10	609636	AD	2
614631	7p21.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	AR	3
614631	7p21.2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	616052	AR	3
612688	3q29	RIDDLE syndrome	611943	AR	3
614167	1p22.2	Myopia 21, autosomal dominant	614167	AD	3
614391	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
611499	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
614776	11q23.3	?Spondyloepimetaphyseal dysplasia, Krakow type	618162	AR	3
614138	4q35.1	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356	AR	3
613925	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	AR	3
614963	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
613694	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
611720	14q24.3	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088	AD	3
613801	4p16.3	Retinitis pigmentosa-40	613801	AR	3
614101	2q35	Plasma fibronectin deficiency	614101	AD	1
614891	19p13.11	Immunodeficiency 30	614891	AR	3
612839	4q24	Myelodysplastic syndrome, somatic	614286	_	3
614888	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
613287	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
611928	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
614069	6q21	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069	AR	3
608754	19q13.42	?Pontocerebellar hypoplasia type 2C	612390	_	3
615403	16p13.3	Beaulieu-Boycott-Innes syndrome	613680	AR	3
614379	6p21.33	C4B deficiency	614379	_	3
613364	11p14.1-p11.2	?Spastic paraplegia 41, autosomal dominant	613364	AD	2
614652	6q21	Coenzyme Q10 deficiency, primary, 3	614652	AR	3
613267	18q21.2	Corneal dystrophy, Fuchs endothelial, 3	613267	AD	3
613807	3q26.33	Ciliary dyskinesia, primary, 14	613807	_	3
614632	4p16.3	UV-sensitive syndrome 3	614640	AR	3
614617	16p13.3	Deafness , autosomal recessive 86	614617	AR	3
615286	19p13.3	Mental retardation, autosomal recessive 36	615286	AR	3
612886	5q35.2	{Menopause, natural, age at, QTL4}	612886	_	2
613160	12p13.31	von Willebrand disease, type 1	193400	AD	3
613160	12p13.31	von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	AR,AD	3
613160	12p13.31	von Willibrand disease, type 3	277480	AR	3
615217	17p13.1	Ataxia-oculomotor apraxia 3	615217	AR	3
612073	13q14.2	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	AR	3
615268	13q12.13	?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	AR	3
613546	15q21.2	Aromatase deficiency	613546	_	3
615513	1p36.22	Immunodeficiency 14	615513	AD	3
613926	11q24.2	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	AD	3
615663	20p13	Warburg micro syndrome 4	615663	AR	3
611721	10q22.1	Combined SAP deficiency	611721	AR	3
612354	18p11	{Inflammatory bowel disease 21}	612354	AD	2
616108	14q24.1	?Retinal dystrophy, juvenile cataracts, and short stature syndrome	616108	AR	3
613091	11q22.3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	AR,DR	3
612908	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
616022	3p25.3	Neutropenia, severe congenital, 6, autosomal recessive	616022	AR	3
602956	9p13.3	Fanconi anemia, complementation group G	614082	_	3
615290	9q22.31	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290	AD	3
612852	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
614128	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
616101	1p36.33	Spinocerebellar ataxia 21	607454	AD	3
613647	7p22.1	Spastic paraplegia 48, autosomal recessive	613647	AR	3
615298	20q11.22	Symphalangism, proximal, 1B	615298	_	3
614889	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
614066	1p13.2	Spastic paraplegia 47, autosomal recessive	614066	AR	3
613912	19p13.3	Complement factor D deficiency	613912	AR	3
614725	6q25.3	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	AR	3
616109	11q13.2	Hydatidiform mole, recurrent, 4	618432	_	3
608005	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
613577	16p13.3	Deafness , autosomal recessive 86	614617	AR	3
613577	16p13.3	Deafness, autosomal dominant 65	616044	AD	3
613577	16p13.3	DOORS syndrome	220500	AR	3
613577	16p13.3	Epileptic encephalopathy, early infantile, 16	615338	AR	3
613577	16p13.3	Myoclonic epilepsy, infantile, familial	605021	AR	3
615287	11q13.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	AR	3
603109	15q22.33	Loeys-Dietz syndrome 3	613795	AD	3
609560	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
614618	11p15.1	Hyperekplexia 3	614618	AR,AD	3
604447	15q21.2	Intellectual developmental disorder with cardiac arrhythmia	617173	AR	3
604447	15q21.2	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182	AR	3
616817	1q32.1	Microcephaly, short stature, and impaired glucose metabolism 2	616817	AR	3
616579	13q34	Mental retardation, autosomal dominant 40	616579	AD	3
615851	17p13.3	Pontocerebellar hypoplasia, type 2E	615851	AR	3
616221	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
614892	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
614099	14q24.3	?Cranioectodermal dysplasia 3	614099	AR	3
614129	19p13.3	Perrault syndrome 3	614129	AR	3
610247	7q11.2	{Esophagitis, eosinophilic, 1}	610247	Mu	2
615934	5q31.2	STING-associated vasculopathy, infantile-onset	615934	AD	3
615293	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
615404	2q36.3	{Specific language impairment 5}	615432	AD	3
614887	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
613318	8q22.3	Miyoshi muscular dystrophy 2	613318	_	2
604454	2p13.3	Welander distal myopathy	604454	AR,AD	3
604123	2p25.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	AR	3
617769	5q33.1	Spinocerebellar ataxia 45	617769	AD	3
616192	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
613981	12q13.13	?Hypotrichosis 3	613981	AD	3
614890	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
618179	12q23.2	?Microcephaly 24, primary, autosomal recessive	618179	AR	3
614726	4q12	Congenital disorder of glycosylation, type IIk	614727	AR	3
617654	1p31.3	?Deafness, autosomal recessive 108	617654	AR	3
614102	2p11.2	Kappa light chain deficiency	614102	AR	3
617051	11q24.2	Mental retardation, autosomal recessive 55	617051	AR	3
607426	4q21.23	Coenzyme Q10 deficiency, primary, 1	607426	AR	3
618012	3q13.31	Epileptic encephalopathy, infantile or early childhood, 3	618012	AD	3
616710	7p11.2	Parkinson disease 22, autosomal dominant	616710	AD	3
616834	4q32.3	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834	AR	3
616684	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
610511	14q21.1	Craniolenticulosutural dysplasia	607812	AR	3
607821	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
615297	3p14.1	Adams-Oliver syndrome 4	615297	AR	3
618004	8p21.3	Epileptic encephalopathy, early infantile, 64	618004	AD	3
615269	12q21.33	Hypogonadotropic hypogonadism 19 with or without anosmia	615269	AD	3
618180	21q22.3	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	AR	3
614371	19p13.2	{Dengue fever, protection against}	614371	_	3
613101	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
615703	3q29	Morbid obesity and spermatogenic failure	615703	AR	3
614787	1q21.3	White-Sutton syndrome	616364	AD	3
616768	10p15.3	Oocyte maturation defect 2	616780	AR,AD	3
612446	5p13.1	C6 deficiency	612446	_	3
618239	8q22.1	Mitochondrial complex I deficiency, nuclear type 17	618239	AR	3
618157	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
617193	17q25.3	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193	AR	3
617976	4p16.3	Epileptic encephalopathy, early infantile, 63	617976	AR	3
616081	13q13.3	Pontocerebellar hypoplasia, type 1C	616081	AR	3
617118	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
617950	9q34.3	Combined oxidative phosphorylation deficiency 36	617950	AR	3
616576	4q24	Immunodeficiency, common variable, 12	616576	AD	3
618168	1p13.2	Diarrhea 9	618168	AR	3
616193	1q43	Mental retardation, autosomal recessive 47	616193	AR	3
613319	11p14.3	Miyoshi muscular dystrophy 3	613319	AR	3
617120	17p11.2	Joubert syndrome 27	617120	AR	3
615517	11q12.3	?Hemochromatosis, type 5	615517	AD	3
617297	19q13.33	Amelogenesis imperfecta, type IJ	617297	AR	3
616174	2q14.1	Filippi syndrome	272440	AR	3
613986	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
616803	12p12.1	Lamb-Shaffer syndrome	616803	AD	3
615871	5p12	Epileptic encephalopathy, early infantile, 24	615871	AD	3
617626	4q12	Fibromatosis, gingival, 5	617626	AD	3
614400	7p21.3	{Glucocorticoid therapy, response to}	614400	_	3
616577	4q28.1	Epilepsy, hearing loss, and mental retardation syndrome	616577	AR	3
617119	9p21.2	?Bardet-Biedl syndrome 20	617119	AR	3
618008	5q33.3	Epileptic encephalopathy, early infantile, 65	618008	AD	3
617201	18q21.31	Periventricular nodular heterotopia 7	617201	AD	3
616099	19p13.2	Palmoplantar keratoderma and woolly hair	616099	AR	3
615346	15q11.2	Precocious puberty, central, 2	615346	AD	3
616760	17q21.2	Woolly hair, autosomal recessive 3	616760	AR	3
613102	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
618158	11q13.5-q14.1	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158	AD	3
616707	15q25.2	?Deafness, autosomal dominant 68	616707	AD	3
616818	13q31.1	{?IgA nephropathy, susceptibility to, 3}	616818	AD	3
617763	9q34.12	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	617763	AR	3
606097	18q21.33	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	AR	3
616816	3p25.1	Hypotonia, infantile, with psychomotor retardation	616816	AR	3
616801	2q34	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801	AR	3
618167	12q23.3	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits	618167	AR	3
611490	16p13.3	Osteopetrosis, autosomal recessive 4	611490	AR	3
617296	2p25.1	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296	AD	3
616819	10p13	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	616819	AR	3
603111	17q21.2	Coffin-Siris syndrome 5	616938	AD	3
603111	17q21.2	{Meningioma, familial, susceptibility to}	607174	AD	3
617996	7q34	Oocyte maturation defect 5	617996	AR	3
604168	18q23	Congenital cataracts, facial dysmorphism, and neuropathy	604168	AR	3
616100	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
618003	10q24.31	Deafness, autosomal recessive 57	618003	AR	3
610443	17q21.31	Koolen-De Vries syndrome	610443	AD	3
616921	6q27	Dyskinesia, limb and orofacial, infantile-onset	616921	AR	3
614958	17q12	Bleeding disorder, platelet-type, 20	616913	AD	3
614070	6q21	{Psoriasis susceptibility 13}	614070	_	3
616708	10p12.1	Desanto-Shinawi syndrome	616708	AD	3
617315	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
616106	2q36.1	{Psoriasis 15, pustular, susceptibility to}	616106	AD	3
613804	16q24.3	Meier-Gorlin syndrome 4	613804	AR	3
614959	9q34.3	Epileptic encephalopathy, early infantile, 14	614959	AD	3
617899	13q13.3	Leukodystrophy, hypomyelinating, 14	617899	AR	3
614945	11p15.1	Deafness, autosomal recessive 18B	614945	AR	3
617949	7q21.13	Spermatogenic failure 24	617959	AR	3
614674	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
615935	10p12.2	Pancreatic agenesis 2	615935	AR	3
618010	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
608584	7p14.3	{Asthma, susceptibility to, 2}	608584	_	3
618065	4q27	Pontocerebellar hypoplasia, type 1D	618065	AR	3
608099	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
608581	8p23.1	Occult macular dystrophy	613587	AD	3
613718	12q14.3	Deafness, autosomal recessive 74	613718	AR	3
613806	3p21	Cholangitis, primary sclerosing	613806	_	2
615527	6q21	?Candidiasis, familial, 8	615527	AR	3
616107	11p15.3	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154	AR	3
617938	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
613561	12p11.21	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	AR	3
609441	4q22.3	Acromesomelic dysplasia, Demirhan type	609441	AR	3
615728	12q13.13	Pachyonychia congenita 4	615728	_	3
617900	12q14.2	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}	617900	AD	3
613729	7q11.23	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	_	4
614653	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
618181	3q12.3	Intellectual developmental disorder, autosomal recessive 69	618383	AR	3
608102	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
617951	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
608970	5q21.3-q33.2	Macular dystrophy, butterfly-shaped pigmentary, 2	608970	AD	2
609937	2q31.1	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910	AR	3
613730	11q25	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	AR	3
610533	5q34	[Memory, enhanced, QTL]	615602	_	3
608103	11q14.1	Congenital disorder of glycosylation, type Ih	608104	AR	3
608103	11q14.1	Polycystic liver disease 3 with or without kidney cysts	617874	AD	3
608628	3q26.32	Mental retardation, autosomal dominant 41	616944	AD	3
608628	3q26.32	Pierpont syndrome	602342	AD	3
610534	11q24.2	Al-Raqad syndrome	616459	AR	3
614961	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
617485	4q21.23	?Microcephaly 18, primary, autosomal dominant	617520	AD	3
615750	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
616176	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
608629	6q23.3	Joubert syndrome 3	608629	AR	3
609941	11p13-p12	Deafness, autosomal recessive 51	609941	AR	2
618240	3p21.31	Mitochondrial complex I deficiency, nuclear type 18	618240	AR	3
616454	11p11.2	?Exudative vitreoretinopathy 6	616468	AD	3
616454	11p11.2	Retinitis pigmentosa 72	616469	AR	3
615937	1q43-q44	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937	AD	3
605925	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
610681	12q13.11	Glycogen storage disease VII	232800	AR	3
616177	20p13	Spondyloepimetaphyseal dysplasia, Shohat type	602557	AR	3
611693	11q24.1	Congenital short bowel syndrome	615237	AR	3
610682	3p22.3	Osteogenesis imperfecta, type VII	610682	AR	3
608583	10q22-q24	Atrial fibrillation, familial, 1	608583	AD	2
618241	11q24.2	Mitochondrial complex I deficiency, nuclear type 19	618241	AR	3
609995	2q37.1	Myopia 12	609995	_	2
611695	15q15.2	Spinocerebellar ataxia 11	604432	AD	3
615938	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
609939	16p12.3-q12.2	{Systemic lupus erythematosus, susceptibility to, 6}	609939	_	2
608679	20q13.12	Galloway-Mowat syndrome 4	617730	AR	3
614962	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
617050	19p13.3	?Hermansky-Pudlak syndrome 10	617050	AR	3
613731	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AR,AD	3
614650	14q24.3	Coenzyme Q10 deficiency, primary, 6	614650	AR	3
613469	10q24.2	Urofacial syndrome 1	236730	AR	3
612715	12q21-q23	Dyschromatosis universalis hereditaria 2	612715	_	2
613983	20q13.33	Retinitis pigmentosa 60	613983	AD	3
608680	2p13.1	Galloway-Mowat syndrome 5	617731	AR	3
613743	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
615751	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
613984	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
613808	17q25.3	Ciliary dyskinesia, primary, 15	613808	_	3
613809	1q41	Retinitis pigmentosa 39	613809	_	3
613638	19p13.13	Chromosome 19p13.13 deletion syndrome	613638	_	4
613638	19p13.13	Chromosome 19p13.13 duplication syndrome	613638	_	4
615411	5q12.1	Cortical dysplasia, complex, with other brain malformations 3	615411	AD	3
610008	17q24.2	Usher syndrome, type IV	618144	AR	3
610154	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
605463	14q11.2	Radiation sensitivity/chromosome instability syndrome, autosomal dominant	_	_	1
610937	16q12.2	COACH syndrome	216360	AR	3
610937	16q12.2	Joubert syndrome 7	611560	AR	3
610937	16q12.2	Meckel syndrome 5	611561	AR	3
604043	1q32.3	?Retinitis pigmentosa 67	615565	AR	3
609942	12p12.1	Noonan syndrome 3	609942	AD	3
603504	1p21.2	Deafness, autosomal recessive 32, with or without immotile sperm	608653	AR	3
606118	3q24	Hermansky-Pudlak syndrome 3	614072	AR	3
610379	3p21.31	{West nile virus, susceptibility to}	610379	_	3
607085	6p21.3	Myasthenia gravis with thymus hyperplasia	607085	_	2
612325	6p12.1	Endocrine-cerebroosteodysplasia	612651	AR	3
612325	6p12.1	{Epilepsy, juvenile myoclonic, susceptibility to, 10}	617924	AD	3
607346	1p13.2	Spinocerebellar ataxia 19	607346	AD	3
605460	2p21	Sitosterolemia	210250	AR	3
605460	2p21	{Gallbladder disease 4}	611465	_	3
603585	6q15	Congenital disorder of glycosylation, type IIf	603585	AR	3
605392	6q27	Myeloproliferative disorder	605392	_	2
607358	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AR,AD	3
605459	2p21	Sitosterolemia	210250	AR	3
607867	13q14.2	Retinal dystrophy with or without extraocular anomalies	617175	AR	3
608539	16p13.3	Nephronophthisis 7	611498	_	3
605283	15q11.2	Schaaf-Yang syndrome	615547	AD	3
609557	2p21	Myasthenic syndrome, congenital, 22	616224	AR	3
612201	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
610102	5p13.1	C7 deficiency	610102	_	3
610087	16q22.1	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157	AR	3
605955	10q26.3	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560	AR	3
612922	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AR,AD	3
606633	12q13.13	Osteogenesis imperfecta, type XII	613849	AR	3
607644	11p13-q12	Candidiasis, familial, 3	607644	AD	2
611465	2p21	{Gallbladder disease 4}	611465	_	3
611561	16q12.2	Meckel syndrome 5	611561	AR	3
612269	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
607139	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
604563	11p15.4	Charcot-Marie-Tooth disease, type 4B2	604563	AR	3
614186	2q37.1	Leber congenital amaurosis 16	614186	AR	3
614352	7q33	?Nephrotic syndrome, type 13	616893	_	3
609638	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
614180	3q25.1	Retinitis pigmentosa 61	614180	_	3
604179	19q13.33	?Diamond-Blackfan anemia 18	618310	AD	3
610881	11q13.2	Mental retardation, autosomal dominant 51	617788	AD	3
603503	20q13.13	Congenital disorder of glycosylation, type Ie	608799	AR	3
609152	14q31.1	Hyperthyroidism, nonautoimmune	609152	AD	3
614401	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
613580	2p15	?Bardet-Biedl syndrome 15	615992	AR	3
613580	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
613470	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
612515	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
609377	16q22.1	?Dyskeratosis congenita, autosomal dominant 6	616553	AR,AD	3
609377	16q22.1	?Dyskeratosis congenita, autosomal recessive 7	616553	AR,AD	3
613812	8q12.3	Bile acid synthesis defect, congenital, 3	613812	AR	3
605078	1p36.22	Amyotrophic lateral sclerosis 10, with or without FTD	612069	AD	3
605078	1p36.22	Frontotemporal lobar degeneration, TARDBP-related	612069	AD	3
615716	17q12	Hyperphosphatasia with mental retardation syndrome 4	615716	AR	3
607620	8q24.12	3MC syndrome 3	248340	AR	3
605462	1p36	{Basal cell carcinoma, susceptibility to, 1}	605462	_	2
618170	1p34.3	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170	AR	3
613225	6p25.1	Factor XIIIA deficiency	613225	AR	3
617921	12q13.3	{Amyotrophic lateral sclerosis, susceptibility to, 25}	617921	AD	3
614351	16q13	Nephrotic syndrome, type 12	616892	AR	3
613227	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
617127	17p13.1	?Orofaciodigital syndrome XV	617127	AR	3
614191	22q12.2-q12.3	Epilepsy, familial focal, with variable foci 1	604364	AD	3
612840	11q13.1	Leukocyte adhesion deficiency, type III	612840	AR	3
608096	12q22-q23.3	Epilepsy, familial temporal lobe, 2	608096	AD	2
605284	9q34.13	Focal cortical dysplasia, type II, somatic	607341	_	3
605284	9q34.13	Lymphangioleiomyomatosis	606690	_	3
605284	9q34.13	Tuberous sclerosis-1	191100	AD	3
614614	19q13.31-q13.32	Deafness, autosomal dominant 4B	614614	AD	3
611592	6p25.1	Combined oxidative phosphorylation deficiency 14	614946	AR	3
611592	6p25.1	Spastic paraplegia 77, autosomal recessive	617046	AR	3
617126	7q22.1	Alazami-Yuan syndrome	617126	AR	3
608098	5p15.1	Periventricular nodular heterotopia 3	608098	_	2
613244	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
605942	6q22.1	Ehlers-Danlos syndrome, musculocontractural type 2	615539	AR	3
617635	3q22.3	Mental retardation, autosomal dominant 47	617635	AD	3
613811	4p15.2	Pontocerebellar hypoplasia type 2D	613811	AR	3
605253	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AR,AD	3
614970	16q23.1	Joubert syndrome 20	614970	AR	3
615518	17q11.2	?Immunodeficiency 13	615518	AD	3
618358	20q11.22	Cone-rod dystrophy and hearing loss 2	618358	AR	3
617920	7p15.3	Amyloidosis, primary localized cutaneous, 3	617920	AR	3
609597	11p11.2	Parietal foramina 2	609597	AD	3
608681	15q26.1	Spondylocostal dysostosis 2, autosomal recessive	608681	AR	3
613685	9p23-p21.2	Deafness, autosomal recessive 83	613685	AR	2
610155	2q24.3	{Diabetes mellitus, insulin-dependent, 19}	610155	_	2
614675	4q12	Bone marrow failure syndrome 1	614675	AD	3
615530	21q22.11	Parkinson disease 20, early-onset	615530	AR	3
614350	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
614181	6p24.2	Retinitis pigmentosa 62	614181	AR	3
615705	3q29	?Spinocerebellar ataxia, autosomal recessive 15	615705	AR	3
613243	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
612655	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
604907	17p11.2	Immunodeficiency, common variable, 2	240500	AR,AD	3
604907	17p11.2	Immunoglobulin A deficiency 2	609529	_	3
618238	20p12.1	Mitochondrial complex I deficiency, nuclear type 16	618238	AR	3
610031	6p25.2	Cortical dysplasia, complex, with other brain malformations 7	610031	AD	3
617194	15q21.2	Lethal congenital contracture syndrome 11	617194	AR	3
616002	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
617977	17q25.3	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977	AR	3
614537	10q22.2-q22.3	Albinism, oculocutaneous, type VII	615179	AR	3
603470	9q34.11	Citrullinemia	215700	AR	3
614613	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
612513	2p16.1-p15	Chromosome 2p16.1-p15 deletion syndrome	612513	IC	4
608816	6p21	Epilepsy, juvenile myoclonic 3	608816	_	2
614683	5q35.3	[?Phosphohydroxylysinuria]	615011	_	3
614969	1p34.1	Pontocerebellar hypoplasia, type 7	614969	AR	3
612724	9q31.1	Fructose intolerance, hereditary	229600	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
607837	8p23.3	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	AR	3
606731	20q13.33	Deafness, autosomal dominant 67	616340	AD	3
612971	10q24.31	Deafness, autosomal recessive 57	618003	AR	3
612971	10q24.31	Usher syndrome, type IIC, GPR98/PDZD7 digenic	605472	AR	3
612971	10q24.31	{Retinal disease in Usher syndrome type IIA, modifier of}	276901	AR	3
615529	11p11.2	{Craniosynostosis 5, susceptibility to}	615529	AD	3
603471	7q21.3	Citrullinemia, adult-onset type II	603471	AR	3
608540	16p13.3	Congenital disorder of glycosylation, type Ik	608540	AR	3
618265	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
609661	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
